data_2lyv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lyv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 CA--C 1.515 -0.37 0 CA-C-O 121.694 0.759 . . . . 74.319999999999993 109.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -92.98 131.36 33.46 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 114.9 -1.045 . . . . 65.319999999999993 110.655 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.26 167.37 7.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.093 2.529 . . . . 61.25 112.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.96 -39.06 71.22 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.427 -0.351 . . . . 72.040000000000006 111.505 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -68.59 -22.79 64.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.836 0.351 . . . . 73.340000000000003 111.639 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -91.81 -6.98 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.519 -0.31 . . . . 74.299999999999997 111.477 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -128.31 1.44 5.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.405 -0.518 . . . . 71.430000000000007 112.124 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.41 145.19 26.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 111.737 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.0 mt -115.09 145.79 41.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.581 -1.191 . . . . 74.219999999999999 110.73 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -98.69 122.69 42.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.534 -0.913 . . . . 75.340000000000003 108.534 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -102.28 111.85 33.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 110.011 -0.366 . . . . 72.239999999999995 110.011 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.8 152.14 17.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.755 -0.736 . . . . 70.120000000000005 111.839 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.69 45.66 57.71 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 65.209999999999994 113.178 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.6 mt -78.33 174.97 10.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.684 -0.487 . . . . 70.109999999999999 109.684 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.76 164.13 19.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.024 -0.732 . . . . 75.439999999999998 109.024 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -73.95 -8.26 55.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.32 0.581 . . . . 64.239999999999995 110.33 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.89 13.81 9.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.588 -0.733 . . . . 61.409999999999997 111.513 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.0 m -74.08 125.39 28.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.456 . . . . 73.019999999999996 110.626 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -99.35 161.87 13.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.816 -0.629 . . . . 73.400000000000006 110.506 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -71.54 -31.51 67.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.437 -0.347 . . . . 72.430000000000007 110.818 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.47 -39.25 93.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.848 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.0 t -72.54 -39.93 67.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.685 . . . . 74.209999999999994 110.362 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.89 -44.87 94.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.825 -0.625 . . . . 63.310000000000002 110.782 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -59.26 -57.12 14.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.734 0.302 . . . . 75.430000000000007 110.383 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -50.16 -36.49 30.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.956 -1.02 . . . . 72.430000000000007 113.215 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.436 ' ND1' HG23 ' A' ' 79' ' ' VAL . 11.7 t-80 -72.67 -56.15 5.74 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.96 -0.296 . . . . 72.049999999999997 111.206 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.205 0.446 . . . . 74.049999999999997 112.205 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.41 -13.15 49.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 111.452 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -63.7 -28.86 70.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.832 -0.167 . . . . 73.340000000000003 111.32 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -99.06 -19.47 17.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.069 0.396 . . . . 72.530000000000001 112.069 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.88 168.97 40.71 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.812 -1.185 . . . . 53.100000000000001 113.0 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.3 m -66.86 118.42 10.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.249 0.547 . . . . 70.109999999999999 111.792 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -88.81 130.57 35.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.361 -0.836 . . . . 74.329999999999998 110.827 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 p -95.92 -24.6 16.33 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.158 -0.928 . . . . 74.540000000000006 110.021 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -152.21 152.3 32.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.586 -0.734 . . . . 61.549999999999997 110.127 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.8 t -161.82 130.95 4.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.655 -0.498 . . . . 63.409999999999997 109.655 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.6 129.34 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.318 0.58 . . . . 74.329999999999998 111.011 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.9 132.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.45 -0.944 . . . . 71.030000000000001 108.45 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.1 mmt -74.08 100.0 3.49 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.417 0.627 . . . . 53.439999999999998 109.857 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -102.14 160.72 14.27 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.703 -1.135 . . . . 74.409999999999997 110.833 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 11.4 t0 -75.46 126.16 87.9 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 114.748 -1.115 . . . . 71.219999999999999 110.566 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.4 -11.56 28.59 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.987 1.791 . . . . 71.299999999999997 113.158 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -85.49 -56.51 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 74.450000000000003 111.779 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -108.72 -9.59 15.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 111.4 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 65.67 49.28 1.78 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.647 -0.706 . . . . 72.140000000000001 110.954 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -120.3 159.46 24.96 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 74.409999999999997 109.342 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -73.46 134.37 43.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 45.539999999999999 111.176 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -85.19 3.49 38.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.179 0.514 . . . . 74.109999999999999 110.804 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.33 63.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.749 -0.66 . . . . 52.43 114.074 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.84 155.88 30.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.58 0.69 . . . . 62.240000000000002 109.96 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.44 -163.89 16.2 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.657 -0.577 . . . . 73.540000000000006 111.657 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.87 150.82 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.14 0.47 . . . . 73.540000000000006 110.399 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 m -131.86 131.05 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.636 -0.711 . . . . 75.239999999999995 109.489 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 m -107.3 122.98 47.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.231 -0.285 . . . . 75.349999999999994 110.231 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -89.37 165.54 14.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.922 0.391 . . . . 75.049999999999997 110.919 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.31 -49.14 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 73.200000000000003 110.587 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.37 155.8 41.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 75.430000000000007 110.903 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 8.1 p -62.21 -37.12 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 111.47 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.83 -44.11 69.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.679 0.622 . . . . 63.549999999999997 112.679 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.93 -29.87 70.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.957 0.408 . . . . 74.319999999999993 110.819 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.94 -49.76 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.682 -0.69 . . . . 73.409999999999997 110.745 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.21 -42.0 85.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 64.530000000000001 111.809 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.59 -31.85 68.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.84 0.682 . . . . 74.510000000000005 112.84 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.76 -34.06 40.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 65.209999999999994 110.351 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mmt -62.79 -49.33 75.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.712 -0.676 . . . . 75.349999999999994 110.476 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -26.73 63.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 73.329999999999998 111.194 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.75 -5.61 35.33 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.956 0.724 . . . . 75.109999999999999 112.956 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -57.8 148.43 58.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.503 0.186 . . . . 75.409999999999997 111.503 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.09 165.61 84.43 Favored 'Cis proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.789 -1.338 . . . . 60.219999999999999 113.454 2.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -123.68 158.01 32.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.613 . . . . 74.540000000000006 111.079 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.1 ttmt -139.41 105.1 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.094 -0.503 . . . . 73.239999999999995 111.531 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 HG23 ' ND1' ' A' ' 33' ' ' HIS . 16.2 t -108.2 128.71 63.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 74.140000000000001 109.541 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.52 31.09 10.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.58 0.55 . . . . 61.420000000000002 111.631 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.08 21.16 80.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.938 -0.649 . . . . 51.549999999999997 111.873 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.0 tpt180 -124.12 136.01 53.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.204 -0.295 . . . . 71.099999999999994 110.204 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.53 108.08 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.203 -0.666 . . . . 75.310000000000002 109.203 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.81 148.4 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.168 0.509 . . . . 74.349999999999994 110.932 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -111.47 95.01 24.76 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.277 -0.874 . . . . 62.219999999999999 110.886 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.52 130.58 12.88 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.897 1.732 . . . . 72.099999999999994 111.183 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -137.78 177.4 7.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.464 -0.789 . . . . 74.310000000000002 109.178 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.407 ' NH1' HG13 ' A' ' 68' ' ' VAL . 17.7 tpp180 -77.41 139.54 39.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 110.066 -0.346 . . . . 75.519999999999996 110.066 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.01 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.998 0.428 . . . . 61.450000000000003 110.194 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 136.21 22.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.909 -1.042 . . . . 74.430000000000007 111.568 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.8 147.06 43.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.725 -0.67 . . . . 53.25 109.732 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -63.52 -20.94 66.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.262 0.838 . . . . 73.019999999999996 113.262 -171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.58 -47.87 68.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.755 0.312 . . . . 65.230000000000004 110.68 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.25 -29.56 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.969 0.414 . . . . 72.439999999999998 110.171 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 t -72.0 -3.01 20.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.921 -0.581 . . . . 74.129999999999995 111.007 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -93.23 -3.15 54.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.327 0.584 . . . . 74.530000000000001 109.916 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -95.44 151.98 38.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.833 -0.622 . . . . 74.219999999999999 110.499 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.1 120.33 7.54 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.748 2.299 . . . . 75.120000000000005 112.346 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.07 40.89 8.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.822 -0.704 . . . . 71.450000000000003 112.389 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -86.01 -46.05 10.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 65.400000000000006 111.525 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.72 10.94 26.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.322 0.582 . . . . 71.319999999999993 110.608 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.01 161.82 19.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.895 -0.78 . . . . 75.519999999999996 108.895 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.3 m -77.05 92.91 3.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.46 0.648 . . . . 74.109999999999999 110.942 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.02 115.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.067 -0.97 . . . . 75.030000000000001 110.032 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.463 ' C ' HG23 ' A' ' 159' ' ' VAL . 76.7 mttt -108.88 18.54 20.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 110.833 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -118.23 139.59 51.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.386 -0.37 . . . . 73.439999999999998 110.854 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.28 153.38 36.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.213 0.53 . . . . 72.019999999999996 111.501 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -103.58 138.25 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.78 -1.1 . . . . 75.239999999999995 109.545 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 10.6 t -126.48 109.56 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.124 -0.695 . . . . 75.019999999999996 109.124 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.91 161.03 19.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.029 -1.081 . . . . 74.430000000000007 113.366 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.0 46.42 36.55 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.065 -0.588 . . . . 63.039999999999999 111.655 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.414 HG21 ' SG ' ' A' ' 175' ' ' CYS . 15.5 pt -90.55 -165.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.478 -0.361 . . . . 73.120000000000005 110.582 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -82.36 -167.48 1.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.652 0.263 . . . . 74.430000000000007 111.315 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.8 -22.31 66.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 111.168 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.9 144.05 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.541 -0.754 . . . . 71.549999999999997 109.142 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -140.05 138.7 35.59 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.882 -0.784 . . . . 64.510000000000005 108.882 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.65 158.59 15.36 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.105 -0.498 . . . . 74.219999999999999 110.778 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -47.05 76.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.188 -0.914 . . . . 62.210000000000001 108.933 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -53.63 -34.39 58.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.017 -0.992 . . . . 72.129999999999995 111.894 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -66.32 -59.45 3.7 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.928 0.394 . . . . 74.140000000000001 111.135 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.78 -26.62 31.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.158 -0.617 . . . . 74.439999999999998 111.353 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 6.1 tmm_? -65.42 -48.63 72.14 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.96 -0.385 . . . . 61.149999999999999 109.96 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.56 -26.67 68.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.209 0.528 . . . . 74.420000000000002 110.579 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -78.92 -55.54 5.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.849 -0.614 . . . . 75.040000000000006 111.781 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 151' ' ' VAL . 35.8 m-85 -69.45 -22.93 63.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.428 0.529 . . . . 65.109999999999999 112.428 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -68.61 -22.93 64.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.807 0.337 . . . . 72.219999999999999 111.477 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.74 -28.35 65.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 74.439999999999998 110.816 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -88.99 -23.99 22.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 72.239999999999995 111.105 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.79 -178.12 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.407 -0.901 . . . . 73.430000000000007 113.696 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -73.4 131.28 41.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.92 0.488 . . . . 74.010000000000005 110.963 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 152' ' ' THR . 65.5 mt -103.12 138.35 27.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.465 . . . . 72.420000000000002 109.986 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.88 -48.0 9.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.694 0.283 . . . . 74.25 110.673 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.06 156.95 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.177 -0.465 . . . . 73.140000000000001 109.824 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.33 126.22 71.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.16 0.505 . . . . 61.509999999999998 109.927 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -99.77 105.23 17.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 74.329999999999998 110.544 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.32 122.6 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.247 -0.649 . . . . 75.439999999999998 109.247 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 64.7 mmm -96.12 128.02 42.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.525 -0.546 . . . . 74.109999999999999 109.525 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.804 0 CA-C-O 121.41 0.624 . . . . 73.120000000000005 111.44 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 119.853 -0.415 . . . . 45.299999999999997 112.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -174.96 154.92 1.93 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.872 -0.418 . . . . 75.209999999999994 109.872 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.4 171.98 13.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.915 -0.584 . . . . 75.129999999999995 109.79 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.48 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 42.3 m-85 -137.53 145.71 43.27 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.833 -0.621 . . . . 72.219999999999999 109.995 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 125' ' ' PHE . 60.4 t -129.86 130.14 66.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.752 0.31 . . . . 75.200000000000003 110.738 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.513 ' O ' HG21 ' A' ' 131' ' ' ILE . 90.4 m -104.76 119.64 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 75.430000000000007 110.601 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -102.87 159.06 15.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.952 0.405 . . . . 72.120000000000005 111.417 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -77.85 -29.21 50.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.562 -0.744 . . . . 70.400000000000006 110.581 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -130.43 155.36 46.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.476 -0.784 . . . . 65.219999999999999 110.259 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.87 -26.44 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.089 -0.505 . . . . 72.430000000000007 110.513 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -59.83 -41.93 92.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.474 -0.785 . . . . 73.019999999999996 111.493 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.96 -34.92 79.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.586 -0.279 . . . . 74.510000000000005 110.915 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -69.61 -40.75 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 73.239999999999995 109.722 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.424 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.82 -31.6 68.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.186 -0.916 . . . . 62.200000000000003 111.441 -178.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 39.3 mttm -56.23 -37.81 70.23 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.779 0.8 . . . . 74.319999999999993 109.871 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.0 mt -79.48 -42.65 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.489 -1.232 . . . . 72.329999999999998 112.522 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 160' ' ' ASP . 21.4 m -74.98 -13.56 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.906 0.384 . . . . 74.109999999999999 111.171 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.9 mt -56.44 -34.83 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.438 -0.801 . . . . 74.120000000000005 109.979 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.95 102.48 10.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.64 -0.874 . . . . 65.319999999999993 108.64 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.415 ' HB2' ' HZ1' ' A' ' 166' ' ' LYS . 3.8 ttmp? -57.26 -31.77 65.9 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.899 0.703 . . . . 73.310000000000002 112.899 -175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.61 135.46 54.99 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.248 -0.581 . . . . 72.439999999999998 110.44 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -126.56 154.84 43.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.521 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.3 m -94.22 107.32 19.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.338 -0.392 . . . . 60.210000000000001 110.257 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.79 131.4 70.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.183 -0.673 . . . . 74.549999999999997 109.183 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 45.4 47.16 10.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.287 0.635 . . . . 55.420000000000002 112.491 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.88 73.96 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 113.575 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -142.29 133.22 25.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.01 -0.367 . . . . 75.310000000000002 110.01 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -82.21 109.58 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.872 0.367 . . . . 72.329999999999998 110.251 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.414 ' SG ' HG21 ' A' ' 112' ' ' ILE . 10.3 m -108.72 155.02 21.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.01 -0.541 . . . . 72.409999999999997 109.938 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.8 tt0 -90.33 137.78 32.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 72.030000000000001 110.472 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -129.59 160.38 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 73.329999999999998 110.343 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -174.09 175.92 2.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.214 -0.903 . . . . 75.239999999999995 111.507 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -62.29 130.81 47.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.735 -0.666 . . . . 74.549999999999997 110.696 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -117.57 114.55 23.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.628 -0.878 . . . . 74.109999999999999 108.628 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 C--N 1.309 -1.167 0 C-N-CA 120.607 -0.437 . . . . 74.219999999999999 109.845 -177.6 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -66.95 130.86 93.88 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.816 -1.084 . . . . 61.439999999999998 110.812 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.23 169.29 12.51 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.216 2.611 . . . . 72.129999999999995 111.751 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.7 pt-20 -52.14 -38.86 58.9 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 112.185 0.439 . . . . 64.409999999999997 112.185 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 6.5 pt20 -65.64 -26.31 67.75 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.108 0.41 . . . . 75.510000000000005 112.108 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.97 -9.88 49.78 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.185 -0.322 . . . . 74.530000000000001 111.165 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HA ' HG23 ' A' ' 68' ' ' VAL . 12.8 ptt180 -118.72 -5.17 10.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 75.129999999999995 111.301 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.7 ttpt -93.69 148.73 21.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.402 0.62 . . . . 74.120000000000005 111.213 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.57 146.39 46.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.973 . . . . 75.439999999999998 110.413 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 16.5 t80 -98.13 131.33 44.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.085 -1.08 . . . . 74.049999999999997 108.085 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.6 mm -106.45 111.55 35.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.892 -0.41 . . . . 74.319999999999993 109.892 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.6 148.65 17.51 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.855 -0.688 . . . . 72.319999999999993 111.9 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.77 46.41 30.42 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.785 -0.722 . . . . 72.230000000000004 113.503 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.1 mt -81.34 174.39 11.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.883 0.373 . . . . 63.340000000000003 110.237 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.0 p -87.64 173.88 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.437 -0.579 . . . . 64.340000000000003 109.437 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.9 -11.51 59.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.119 0.485 . . . . 75.540000000000006 109.78 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -103.67 -0.43 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.366 -0.834 . . . . 74.099999999999994 111.941 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -67.91 123.77 21.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.0 0.429 . . . . 74.010000000000005 111.615 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.9 159.51 15.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.552 -0.749 . . . . 64.219999999999999 110.066 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -68.73 -30.92 69.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.344 . . . . 72.0 111.876 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -25.08 45.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.883 -0.327 . . . . 74.230000000000004 111.145 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.8 m -74.94 -43.5 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.415 . . . . 71.340000000000003 110.406 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.25 -46.2 89.92 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.498 -0.774 . . . . 65.349999999999994 110.065 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -55.63 -59.87 4.24 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.445 -0.798 . . . . 73.430000000000007 111.794 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -50.18 -33.73 20.16 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.787 0.68 . . . . 63.549999999999997 112.654 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.433 ' CG ' HG23 ' A' ' 79' ' ' VAL . 62.3 t60 -69.03 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 74.150000000000006 110.684 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.16 -22.63 62.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.198 0.444 . . . . 75.340000000000003 112.198 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 31.8 tt0 -65.15 -21.53 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 74.310000000000002 111.06 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.49 -23.13 66.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 74.329999999999998 111.941 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -102.42 -21.12 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.514 0.197 . . . . 72.420000000000002 111.528 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.91 161.64 32.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.398 -0.906 . . . . 74.239999999999995 112.603 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -67.88 116.05 8.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.144 0.497 . . . . 70.109999999999999 111.443 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -84.41 136.8 33.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 110.205 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -106.45 -16.5 14.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.428 -0.805 . . . . 74.239999999999995 109.749 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.52 149.42 29.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 75.319999999999993 109.886 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.9 t -160.42 131.09 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.215 -0.291 . . . . 75.150000000000006 110.215 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.12 131.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.996 0.427 . . . . 73.340000000000003 110.254 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -92.96 130.51 41.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.222 -1.029 . . . . 50.439999999999998 108.222 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.401 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 4.0 mmt -75.67 97.59 3.85 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.653 0.74 . . . . 72.120000000000005 110.605 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 29.4 mtt180 -101.94 163.94 11.98 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.598 -1.183 . . . . 74.230000000000004 110.391 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 22.6 t70 -79.27 126.79 80.8 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.145 -0.934 . . . . 64.120000000000005 109.512 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.45 -18.95 49.53 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 121.901 1.734 . . . . 72.439999999999998 113.362 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.405 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 35.9 m-80 -86.02 -56.52 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 71.430000000000007 111.482 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 -10.11 24.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 111.873 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm 66.17 29.93 9.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.998 0.919 . . . . 75.340000000000003 111.481 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -106.15 150.68 25.6 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.792 -0.447 . . . . 73.120000000000005 109.792 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 30.5 t -73.83 133.96 43.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.107 0.479 . . . . 70.430000000000007 110.73 -174.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -83.71 2.61 36.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.386 -0.824 . . . . 71.230000000000004 111.022 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.88 16.91 60.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.883 -0.675 . . . . 73.340000000000003 113.957 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.6 158.4 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.947 0.874 . . . . 75.140000000000001 111.097 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.76 -165.31 17.31 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.459 -0.656 . . . . 52.219999999999999 111.459 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.28 146.35 33.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 117.213 0.507 . . . . 73.409999999999997 110.302 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 126.59 67.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.704 -0.68 . . . . 72.109999999999999 109.333 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 m -103.62 120.72 41.47 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.125 -0.359 . . . . 75.209999999999994 110.426 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -85.98 161.47 18.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.017 -0.538 . . . . 75.109999999999999 110.146 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.58 66.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.591 -0.731 . . . . 64.530000000000001 110.704 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.668 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 89.5 m -141.97 151.8 42.87 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.829 -0.623 . . . . 71.340000000000003 110.785 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -58.06 -36.76 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.609 -0.723 . . . . 73.049999999999997 112.161 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -49.37 -47.73 47.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.017 0.747 . . . . 74.120000000000005 113.017 175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.668 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.9 mp0 -64.7 -31.39 72.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.711 0.291 . . . . 74.239999999999995 111.273 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 52.1 t -63.31 -47.92 89.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 74.450000000000003 110.593 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.29 -43.28 99.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.391 -0.822 . . . . 74.340000000000003 111.062 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.614 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -55.7 -35.65 66.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.746 0.647 . . . . 74.319999999999993 112.746 172.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -31.18 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 74.430000000000007 109.903 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.7 mmt -72.25 -37.69 69.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 72.150000000000006 111.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -76.22 -14.08 60.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.151 0.5 . . . . 64.450000000000003 110.573 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.67 -9.17 50.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.596 -0.729 . . . . 61.109999999999999 111.903 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -56.65 146.88 54.15 Favored Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.22 0.325 . . . . 74.010000000000005 111.642 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.85 167.9 77.46 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.889 -1.296 . . . . 62.530000000000001 113.224 2.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -122.59 154.47 37.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 73.150000000000006 111.315 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.8 ttmt -139.05 109.15 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 74.239999999999995 110.976 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.433 HG23 ' CG ' ' A' ' 33' ' ' HIS . 18.8 t -109.94 129.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.585 -0.524 . . . . 72.150000000000006 109.585 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.9 t70 68.36 22.06 8.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.8 0.81 . . . . 75.549999999999997 110.563 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.08 67.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 64.340000000000003 111.777 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.5 tpt180 -124.0 138.14 54.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.74 -0.467 . . . . 74.040000000000006 109.74 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.7 109.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.48 -0.563 . . . . 72.510000000000005 109.48 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -107.66 148.64 11.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.985 0.422 . . . . 74.129999999999995 110.482 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.51 103.46 52.68 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 111.476 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.52 132.8 19.54 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.008 1.805 . . . . 53.140000000000001 111.363 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 11.4 mmtt -131.6 161.12 33.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.66 -1.237 . . . . 63.32 107.66 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.6 tpp180 -68.34 139.82 55.89 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.465 -0.568 . . . . 74.109999999999999 109.465 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 91.93 1.7 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.471 0.653 . . . . 63.350000000000001 109.786 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.407 ' CG2' HG22 ' A' ' 163' ' ' VAL . 9.8 p -65.18 156.23 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.672 -1.149 . . . . 72.239999999999995 111.598 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 t -60.46 155.71 17.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.649 -0.705 . . . . 71.530000000000001 110.44 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -60.46 -25.31 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.75 -0.659 . . . . 74.430000000000007 112.009 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.28 -54.41 25.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 111.059 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.11 -30.6 63.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.041 -0.264 . . . . 73.340000000000003 111.422 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -68.46 -8.81 44.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.924 0.392 . . . . 72.019999999999996 111.525 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.02 -21.87 59.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.234 -0.439 . . . . 75.340000000000003 110.327 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -79.65 153.98 75.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.409999999999997 110.597 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.26 129.77 16.51 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.693 2.262 . . . . 73.010000000000005 111.4 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.03 57.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 74.329999999999998 112.586 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.32 60.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 110.676 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.469 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 19.8 m170 -100.5 20.93 14.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.51 0.671 . . . . 72.129999999999995 110.548 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.22 179.12 5.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 71.129999999999995 109.423 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 97.08 7.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.172 0.511 . . . . 61.340000000000003 110.597 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.41 113.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.252 -0.885 . . . . 71.540000000000006 109.529 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.446 ' C ' HG22 ' A' ' 159' ' ' VAL . 84.8 mttt -110.72 21.86 16.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.474 -0.49 . . . . 72.519999999999996 111.174 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -126.04 145.78 50.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.855 0.36 . . . . 75.099999999999994 111.859 176.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.77 153.66 39.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.169 0.509 . . . . 75.340000000000003 111.696 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.4 t80 -100.81 139.63 36.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.03 -0.986 . . . . 71.319999999999993 109.364 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t -131.12 111.55 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.622 -0.51 . . . . 74.040000000000006 109.622 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.3 167.88 25.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.546 -1.311 . . . . 75.040000000000006 113.428 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.48 38.34 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.682 -0.77 . . . . 64.099999999999994 112.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.7 143.7 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.701 -0.481 . . . . 70.319999999999993 109.701 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -89.18 -42.05 11.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 74.019999999999996 111.398 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -104.89 -97.28 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.317 -0.401 . . . . 72.209999999999994 110.59 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 147.02 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.67 -0.863 . . . . 73.519999999999996 108.67 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 129.45 36.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.386 0.612 . . . . 74.439999999999998 110.82 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.47 166.14 11.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.905 -1.043 . . . . 75.099999999999994 110.194 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.12 -45.65 90.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 74.340000000000003 109.713 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -57.73 -32.85 67.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 62.219999999999999 111.929 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -67.25 -57.61 6.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.907 0.384 . . . . 75.400000000000006 111.241 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 122' ' ' ARG . 2.4 pp -83.94 -25.0 30.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.298 -0.561 . . . . 73.109999999999999 111.303 -171.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' N ' HD13 ' A' ' 121' ' ' LEU . 6.0 tmm_? -65.28 -51.38 61.09 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.922 -0.399 . . . . 74.120000000000005 109.922 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.66 -27.26 69.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 64.129999999999995 110.635 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.418 ' CD2' HG23 ' A' ' 170' ' ' VAL . 82.0 t80 -80.64 -54.03 6.01 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.012 -0.54 . . . . 74.319999999999993 111.923 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 151' ' ' VAL . 43.4 m-85 -70.88 -23.01 62.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.16 0.43 . . . . 64.200000000000003 112.16 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -67.15 -20.41 65.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.935 0.398 . . . . 72.310000000000002 111.194 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.01 -20.98 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.833 -0.621 . . . . 72.209999999999994 111.373 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.59 -27.87 17.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.548 -0.296 . . . . 70.340000000000003 111.678 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -171.49 44.39 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.528 -0.844 . . . . 51.219999999999999 113.232 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -76.36 130.7 38.46 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.04 0.447 . . . . 74.200000000000003 111.602 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 152' ' ' THR . 55.0 mt -101.38 140.54 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 75.230000000000004 109.804 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.31 -50.41 6.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 110.269 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 p -158.28 158.66 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.581 -0.736 . . . . 71.230000000000004 109.338 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.78 128.92 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 73.340000000000003 109.851 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -104.29 104.71 14.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 45.229999999999997 110.454 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mm -96.6 116.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.44 -0.948 . . . . 74.049999999999997 108.44 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.2 mmm -87.54 135.59 33.29 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.794 -0.363 . . . . 75.010000000000005 110.481 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.383 0.611 . . . . 71.519999999999996 111.127 -178.683 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 112.603 -0.199 . . . . 61.439999999999998 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.56 161.63 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 74.310000000000002 110.153 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.52 173.09 11.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.572 -0.74 . . . . 72.549999999999997 110.159 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.449 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -137.27 145.47 43.56 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.223 -0.899 . . . . 74.209999999999994 109.351 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.427 HG22 ' CD2' ' A' ' 125' ' ' PHE . 61.4 t -128.42 125.63 64.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 120.99 0.424 . . . . 75.310000000000002 110.879 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 131' ' ' ILE . 87.9 m -101.5 119.93 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 73.030000000000001 111.033 -176.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.08 155.23 18.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.986 0.422 . . . . 74.349999999999994 111.743 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.05 -18.46 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.562 -0.745 . . . . 74.519999999999996 110.579 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.04 151.73 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 63.200000000000003 111.152 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.507 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p80 -82.78 -28.15 30.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.599 -0.273 . . . . 75.129999999999995 111.288 -175.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.608 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 23.9 t70 -68.01 -35.26 78.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.995 -0.548 . . . . 52.240000000000002 110.589 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.0 m -67.72 -34.13 76.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 72.219999999999999 110.825 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 105' ' ' LYS . 2.2 t -72.13 -38.36 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.019 -0.537 . . . . 70.510000000000005 109.558 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 4.2 t70 -66.11 -35.79 81.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 72.340000000000003 111.007 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 83.5 mttt -57.46 -37.98 73.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.504 0.669 . . . . 71.239999999999995 110.7 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.69 -42.07 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.807 -1.088 . . . . 74.319999999999993 111.567 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 160' ' ' ASP . 25.8 m -77.81 -8.19 11.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.465 0.65 . . . . 74.340000000000003 110.902 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 mt -60.79 -32.77 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.997 -1.001 . . . . 72.340000000000003 110.382 170.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.528 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 43.2 mt-30 -113.17 114.73 27.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.046 -0.724 . . . . 74.120000000000005 109.046 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.23 -38.07 67.98 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.049 0.759 . . . . 74.310000000000002 113.049 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -123.09 138.43 54.67 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.089 -0.382 . . . . 73.540000000000006 110.574 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.528 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 36.7 m-70 -123.35 140.01 53.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 110.966 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -87.26 104.38 16.34 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.786 -0.643 . . . . 73.239999999999995 111.11 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 124' ' ' TYR . 28.2 t -111.22 127.26 68.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.488 -0.778 . . . . 75.140000000000001 109.143 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 45.18 40.13 4.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.274 0.63 . . . . 60.119999999999997 112.319 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 -6.15 77.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.034 -0.603 . . . . 64.140000000000001 114.152 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -107.68 128.74 54.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.581 0.691 . . . . 74.420000000000002 110.46 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.36 113.1 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.34 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.4 p -112.18 156.57 22.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.337 -0.847 . . . . 75.299999999999997 109.511 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -86.04 137.38 32.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.206 0.527 . . . . 71.239999999999995 110.898 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -129.53 164.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.205 -0.907 . . . . 73.450000000000003 110.721 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -175.66 173.98 2.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.104 -0.953 . . . . 64.540000000000006 111.245 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -61.01 134.82 57.48 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 123.618 0.574 . . . . 75.349999999999994 110.247 173.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -127.73 122.61 33.31 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.311 -0.626 . . . . 74.329999999999998 109.311 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 C--N 1.312 -1.049 0 C-N-CA 119.982 -0.687 . . . . 74.400000000000006 109.546 177.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 108.657 -0.868 . . . . 73.519999999999996 108.657 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -99.44 136.61 20.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.516 -1.22 . . . . 74.219999999999999 110.842 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.51 167.65 14.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.932 2.421 . . . . 75.230000000000004 111.199 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.3 pt-20 -56.49 -35.73 68.31 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.596 0.221 . . . . 73.519999999999996 111.596 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 8.3 pt20 -69.09 -25.49 64.46 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.591 0.234 . . . . 71.430000000000007 111.404 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.63 -11.97 43.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.513 0.196 . . . . 75.310000000000002 111.384 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.45 ' HA ' HG22 ' A' ' 68' ' ' VAL . 31.2 ptt180 -124.12 6.53 8.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.195 0.522 . . . . 73.230000000000004 110.835 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.6 ttpt -97.87 146.87 25.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.353 0.597 . . . . 71.209999999999994 110.908 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.36 145.21 43.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.919 -1.037 . . . . 73.230000000000004 110.354 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 13.5 t80 -101.1 125.67 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.446 -0.946 . . . . 74.519999999999996 108.446 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.1 mm -106.25 111.11 33.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.985 -0.376 . . . . 73.540000000000006 109.985 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.48 157.54 18.23 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.548 -0.834 . . . . 74.409999999999997 111.222 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.29 67.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 74.340000000000003 112.932 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -80.3 170.66 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 74.319999999999993 110.86 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -92.09 165.65 13.06 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.608 -0.724 . . . . 74.430000000000007 109.726 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -67.3 -22.51 65.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.898 -0.592 . . . . 74.099999999999994 110.092 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -97.22 2.7 51.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.639 -0.71 . . . . 73.0 111.408 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.7 m -77.33 117.67 19.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 75.109999999999999 111.546 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 p -105.35 164.47 11.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.059 -0.973 . . . . 74.510000000000005 109.516 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -40.57 90.9 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.416 0.448 . . . . 74.340000000000003 111.132 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.83 -37.38 87.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.942 -0.572 . . . . 73.040000000000006 111.402 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.1 m -78.48 -41.64 31.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.555 -0.293 . . . . 73.540000000000006 110.96 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.7 tp -62.87 -49.01 76.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.167 -0.47 . . . . 72.239999999999995 110.623 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -57.4 -56.04 27.01 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.443 -0.799 . . . . 75.409999999999997 110.886 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 m -48.24 -39.18 20.46 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -70.22 -53.03 18.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 73.25 110.916 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -73.12 -21.96 60.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.925 0.343 . . . . 74.209999999999994 111.925 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -17.8 54.42 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.667 0.387 . . . . 60.219999999999999 111.921 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.73 -27.11 68.98 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.568 -0.287 . . . . 71.349999999999994 111.7 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -99.25 -17.42 18.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.099999999999994 111.688 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 168.34 38.6 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.042 -1.075 . . . . 74.430000000000007 112.862 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -68.61 121.49 16.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.507 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.5 128.94 36.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.709 -0.678 . . . . 74.099999999999994 111.267 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 p -91.25 -29.27 17.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.95 -1.023 . . . . 70.040000000000006 110.164 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -150.39 152.37 34.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 65.439999999999998 109.455 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.67 136.45 6.18 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.475 -0.565 . . . . 44.420000000000002 109.475 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -152.14 121.75 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.375 0.607 . . . . 72.109999999999999 110.471 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.44 131.01 34.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.431 -0.952 . . . . 72.109999999999999 108.431 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.8 mmt -76.22 99.61 4.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.602 0.715 . . . . 65.120000000000005 110.697 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 57.8 mtp85 -109.47 163.6 13.28 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.524 -1.216 . . . . 75.540000000000006 109.251 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.23 126.92 82.64 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.776 -0.453 . . . . 65.409999999999997 109.776 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.25 -18.92 44.81 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.969 1.779 . . . . 72.120000000000005 112.67 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.11 -56.79 3.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 54.149999999999999 111.607 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.411 ' HB ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -100.85 -8.56 22.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 71.400000000000006 111.74 -172.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm 62.27 39.0 12.92 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.65 0.78 . . . . 72.140000000000001 112.57 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HG3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -115.68 153.49 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.256 -0.277 . . . . 74.420000000000002 110.636 177.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.453 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 36.3 t -69.52 134.33 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.749 0.309 . . . . 73.319999999999993 110.48 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -85.35 -4.11 59.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 74.349999999999994 110.279 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.79 18.96 53.42 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.923 -0.656 . . . . 74.319999999999993 113.777 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -159.07 158.35 32.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.564 0.682 . . . . 75.310000000000002 110.425 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.16 -166.62 18.51 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.636 -0.586 . . . . 50.119999999999997 111.636 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -141.12 148.49 40.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.467 0.634 . . . . 74.340000000000003 110.778 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.08 121.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 74.540000000000006 109.931 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 m -101.94 123.58 46.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.51 -0.313 . . . . 71.030000000000001 110.442 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -88.23 171.24 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.16 0.505 . . . . 72.150000000000006 111.368 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.4 -48.39 11.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.416 -0.811 . . . . 74.120000000000005 110.146 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -115.43 149.06 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 73.510000000000005 110.158 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.95 -25.28 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.004 0.43 . . . . 63.32 111.122 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.92 -34.76 73.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 72.219999999999999 110.995 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.56 -28.45 66.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 73.219999999999999 110.38 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 14' ' ' ARG . 21.8 t -68.22 -46.34 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.359 -0.837 . . . . 74.319999999999993 110.198 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.98 -46.12 88.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.417 -0.81 . . . . 72.010000000000005 110.938 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.612 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -61.12 -31.4 71.1 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.679 0.622 . . . . 73.439999999999998 112.679 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 -36.25 65.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.039 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.6 mmt -69.62 -35.22 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.87 -0.604 . . . . 73.109999999999999 110.995 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.612 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 6.6 p30 -79.64 -22.72 43.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.455 -0.339 . . . . 73.099999999999994 111.13 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.84 -5.65 46.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 61.140000000000001 112.449 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mtp-105 -58.96 146.7 76.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.449 -0.341 . . . . 72.019999999999996 111.468 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 168.18 77.85 Favored 'Cis proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.686 -1.381 . . . . 73.400000000000006 113.743 1.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -123.4 155.63 37.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 63.039999999999999 110.654 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.3 ttmt -139.78 104.95 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.042 0.448 . . . . 74.409999999999997 111.176 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 t -105.82 128.23 60.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.787 -0.642 . . . . 74.540000000000006 109.558 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 64.78 29.9 12.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.371 0.668 . . . . 74.310000000000002 111.76 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.89 77.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.784 -0.722 . . . . 71.140000000000001 112.04 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.5 tpt180 -124.93 134.6 52.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.133 -0.321 . . . . 75.299999999999997 110.133 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 113.39 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.834 -0.802 . . . . 71.120000000000005 108.834 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 m -102.5 152.49 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 74.420000000000002 111.272 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' NZ ' ' A' ' 87' ' ' LYS . 5.7 tp10 -113.73 91.8 22.56 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.741 -1.118 . . . . 73.140000000000001 110.542 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -78.37 143.74 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.808 2.338 . . . . 64.049999999999997 111.136 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' NZ ' ' HG3' ' A' ' 85' ' ' GLU . 12.7 mmtm -139.77 159.78 41.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.641 -1.244 . . . . 74.019999999999996 107.641 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.433 ' NH2' ' HA ' ' A' ' 90' ' ' VAL . 2.5 tmm_? -69.49 130.98 43.99 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.845 -1.539 . . . . 72.420000000000002 106.845 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.54 94.7 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.971 0.415 . . . . 64.340000000000003 111.157 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.433 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 25.5 t -58.52 140.82 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.725 -1.125 . . . . 75.219999999999999 111.826 -172.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -56.66 143.32 36.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.386 -0.824 . . . . 71.099999999999994 109.866 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -62.44 -31.31 71.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.593 0.59 . . . . 75.450000000000003 112.593 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.81 -29.1 58.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.463 0.173 . . . . 72.25 111.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.05 -30.46 39.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.391 -0.596 . . . . 73.400000000000006 109.391 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.3 m -74.94 -3.24 31.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.442 -0.799 . . . . 64.439999999999998 111.211 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.38 -13.72 60.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.375 0.607 . . . . 74.209999999999994 109.968 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -106.24 146.96 34.0 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.396 -0.594 . . . . 73.150000000000006 109.396 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.88 140.62 35.47 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.598 2.199 . . . . 72.120000000000005 112.217 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 9.63 60.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.934 -0.651 . . . . 37.57 112.474 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.21 54.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.626 0.251 . . . . 43.020000000000003 111.6 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -96.2 22.7 7.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 72.430000000000007 111.205 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.1 mt -100.46 174.84 5.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 109.957 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 m -78.99 85.49 4.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 72.209999999999994 109.845 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.94 112.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.182 -0.917 . . . . 64.439999999999998 109.946 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.425 ' C ' HG22 ' A' ' 159' ' ' VAL . 69.8 mttt -106.94 13.76 27.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 74.209999999999994 110.653 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -114.67 138.79 50.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.571 -0.286 . . . . 63.240000000000002 111.27 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.13 152.44 37.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.237 0.542 . . . . 72.129999999999995 111.796 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.0 t80 -97.49 137.43 36.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.915 -1.039 . . . . 74.25 109.854 175.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 t -124.72 110.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.128 -0.693 . . . . 72.120000000000005 109.128 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -134.18 155.94 22.12 Favored Glycine 0 CA--C 1.507 -0.45 0 C-N-CA 119.742 -1.218 . . . . 50.329999999999998 113.232 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.48 10.57 31.0 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.564 -0.827 . . . . 74.400000000000006 112.258 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 147' ' ' GLY . 14.1 pt -78.34 110.09 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 70.340000000000003 109.956 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.63 -18.88 24.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 64.109999999999999 111.203 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -112.18 175.22 5.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.841 -0.618 . . . . 71.140000000000001 109.874 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.96 123.98 22.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 71.109999999999999 110.067 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -118.51 144.32 46.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.096 -0.502 . . . . 74.329999999999998 110.125 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.38 162.51 13.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.803 -0.635 . . . . 73.239999999999995 111.217 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -47.69 77.29 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.732 -1.122 . . . . 72.299999999999997 109.755 175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -54.25 -40.65 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.637 0.586 . . . . 74.340000000000003 111.669 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -57.8 -58.51 8.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.855 0.359 . . . . 74.239999999999995 111.127 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.75 -26.41 29.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.802 -0.759 . . . . 73.120000000000005 111.446 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -65.95 -51.46 58.31 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 110.076 -0.342 . . . . 74.430000000000007 110.076 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.21 -25.29 67.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 110.241 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -79.05 -56.75 4.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.857 -0.61 . . . . 74.209999999999994 112.323 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' A' ' 151' ' ' VAL . 45.7 m-85 -69.3 -22.81 63.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.206 0.447 . . . . 74.129999999999995 112.206 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.062 0.458 . . . . 61.030000000000001 110.464 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -58.3 -34.68 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.547 -0.751 . . . . 71.400000000000006 112.001 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -81.51 -31.72 32.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 73.409999999999997 111.316 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.61 48.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.957 -0.639 . . . . 73.239999999999995 112.696 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -72.9 128.04 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 72.019999999999996 111.532 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 152' ' ' THR . 56.6 mt -98.15 136.88 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.661 -0.699 . . . . 75.540000000000006 110.025 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -90.45 -44.02 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.28 . . . . 73.450000000000003 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.7 p -158.18 154.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.45 . . . . 74.439999999999998 109.879 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.19 129.32 70.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.345 0.593 . . . . 75.319999999999993 110.094 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.3 mt-10 -100.83 127.64 47.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.902 -1.045 . . . . 72.109999999999999 110.19 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.1 mm -119.21 122.41 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.594 -0.891 . . . . 64.329999999999998 108.594 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.1 mmm -98.29 123.78 42.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.807 -0.812 . . . . 72.319999999999993 108.807 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.313 -1.002 0 CA-C-O 121.089 0.471 . . . . 64.420000000000002 111.163 -176.043 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 112' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 119.669 -0.517 . . . . 75.140000000000001 113.27 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -175.61 162.6 2.79 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 117.466 0.633 . . . . 74.510000000000005 110.276 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.15 8.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.749 -0.659 . . . . 73.430000000000007 109.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -142.32 145.7 34.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.745 -0.661 . . . . 65.349999999999994 110.016 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.447 HG23 ' CD2' ' A' ' 125' ' ' PHE . 84.0 t -132.75 126.06 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.997 -0.439 . . . . 73.319999999999993 111.049 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 131' ' ' ILE . 30.0 m -102.48 125.17 49.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.835 -0.62 . . . . 75.209999999999994 110.494 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.78 163.62 12.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.992 0.425 . . . . 75.040000000000006 111.671 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.44 -28.2 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.264 -0.88 . . . . 71.120000000000005 110.534 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.46 153.41 51.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.022 -0.535 . . . . 74.239999999999995 110.422 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.446 ' CD2' HG23 ' A' ' 103' ' ' THR . 34.3 p80 -74.73 -28.21 60.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.646 . . . . 71.230000000000004 110.108 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.481 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -58.53 -43.56 89.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.017 -0.992 . . . . 74.340000000000003 111.779 -176.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 m -68.72 -30.75 69.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.718 0.294 . . . . 74.549999999999997 110.937 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.425 HG22 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.17 -39.53 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.636 -0.505 . . . . 73.120000000000005 109.636 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -72.15 -24.64 61.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.448 -0.796 . . . . 64.310000000000002 111.499 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 52.9 mttm -62.81 -40.51 97.58 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.647 0.737 . . . . 71.140000000000001 110.009 170.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.16 -43.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.667 -1.151 . . . . 64.010000000000005 112.574 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 160' ' ' ASP . 32.6 m -73.73 -2.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.115 0.483 . . . . 75.209999999999994 111.63 -173.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 160' ' ' ASP . 76.2 mt -61.27 -38.11 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.508 -0.769 . . . . 74.400000000000006 109.951 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.3 mt-30 -108.47 105.62 15.36 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.45 -0.945 . . . . 74.349999999999994 108.45 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -53.85 -34.27 58.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.856 -0.611 . . . . 72.209999999999994 112.151 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.76 137.83 54.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 110.614 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.5 m-70 -126.0 146.26 49.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.832 -0.622 . . . . 75.420000000000002 110.539 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 m -106.08 118.84 37.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.016 -0.538 . . . . 73.099999999999994 110.726 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.62 142.9 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.548 -0.908 . . . . 74.129999999999995 108.548 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.2 t30 52.11 31.28 8.68 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.537 0.684 . . . . 52.240000000000002 111.767 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.38 10.17 74.35 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.75 -0.659 . . . . 73.25 113.543 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -115.66 139.01 50.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.01 0.405 . . . . 73.120000000000005 110.264 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -101.12 111.2 23.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.643 0.735 . . . . 72.150000000000006 111.016 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.98 156.61 23.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 74.5 110.51 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -86.57 136.64 32.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 110.184 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.2 t -131.97 132.64 61.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.616 -0.72 . . . . 73.030000000000001 109.862 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -153.46 174.63 14.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.797 -0.638 . . . . 74.239999999999995 111.195 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -65.28 136.9 57.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.596 -0.274 . . . . 74.25 110.898 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -125.99 124.94 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.812 -0.44 . . . . 73.209999999999994 109.812 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 120.408 -0.517 . . . . 75.310000000000002 110.525 -179.671 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 108.43 -0.952 . . . . 74.439999999999998 108.43 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 37.5 mp0 -102.5 142.78 25.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.241 -1.345 . . . . 74.530000000000001 110.836 -172.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 12.1 Cg_endo -61.92 166.42 12.29 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.871 2.38 . . . . 72.530000000000001 112.006 172.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.46 -37.18 67.42 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 112.272 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HG3' HD22 ' A' ' 13' ' ' LEU . 10.0 pt20 -61.83 -29.33 70.09 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 74.420000000000002 112.158 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 25.3 mt -89.81 -22.17 22.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.334 . . . . 63.329999999999998 111.162 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HA ' HG22 ' A' ' 68' ' ' VAL . 22.7 ptt180 -106.66 0.05 24.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.332 0.587 . . . . 75.019999999999996 110.071 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -105.47 136.28 45.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.638 0.732 . . . . 74.409999999999997 111.123 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 87' ' ' LYS . 71.3 mt -101.56 146.87 27.09 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.729 -1.123 . . . . 72.409999999999997 110.92 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -97.67 120.79 38.68 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.245 -1.021 . . . . 74.329999999999998 108.245 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.47 110.96 27.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.771 -0.455 . . . . 74.340000000000003 109.771 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.72 147.94 16.32 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.868 -0.893 . . . . 75.239999999999995 110.868 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.9 42.26 13.07 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.978 -1.106 . . . . 53.549999999999997 112.886 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -79.28 174.63 11.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.319 -0.622 . . . . 74.150000000000006 109.319 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -85.98 179.35 7.01 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 60.140000000000001 109.094 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.95 -6.88 59.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.513 0.673 . . . . 71.319999999999993 109.389 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -118.36 20.35 13.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.006 -0.997 . . . . 72.109999999999999 111.845 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -85.75 129.45 34.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.983 0.421 . . . . 75.219999999999999 111.477 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -108.09 165.73 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.695 . . . . 71.120000000000005 109.673 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -25.17 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.005 -0.278 . . . . 73.049999999999997 110.792 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.6 -40.36 69.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.127 -0.229 . . . . 71.439999999999998 110.851 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -76.7 -32.71 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 74.310000000000002 110.618 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.2 tp -66.42 -49.88 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 71.519999999999996 110.314 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -56.77 -54.78 42.31 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.556 -0.747 . . . . 74.209999999999994 111.011 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -44.86 -37.98 4.26 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.539 1.149 . . . . 63.409999999999997 113.415 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -69.83 -52.0 28.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.345 -0.389 . . . . 75.349999999999994 110.953 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.32 -19.91 41.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.195 0.443 . . . . 73.530000000000001 112.195 -170.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -56.73 -24.29 48.67 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.396 0.517 . . . . 53.420000000000002 112.396 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.96 -25.57 68.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.196 0.443 . . . . 73.439999999999998 112.196 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -101.21 -23.25 14.47 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.088 -0.245 . . . . 73.409999999999997 111.267 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.3 157.72 29.19 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.311 -0.947 . . . . 73.340000000000003 112.389 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.6 m -63.24 119.81 10.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.981 0.419 . . . . 72.540000000000006 111.591 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.4 mt -88.43 141.85 28.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.815 -0.63 . . . . 73.200000000000003 110.479 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -107.09 -23.25 12.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 53.450000000000003 110.198 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -153.6 153.72 32.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.642 -0.708 . . . . 65.549999999999997 109.598 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 t -163.27 132.81 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.659 -0.497 . . . . 44.310000000000002 109.659 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.13 127.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 73.109999999999999 111.095 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.42 133.78 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.937 -0.764 . . . . 73.439999999999998 108.937 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.473 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.6 mmt -78.19 99.85 6.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.339 0.59 . . . . 71.409999999999997 110.471 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -101.77 160.92 14.06 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.033 -0.985 . . . . 63.130000000000003 109.864 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.28 130.47 62.33 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.1 -0.333 . . . . 63.420000000000002 110.1 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.12 -19.37 51.16 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.182 1.922 . . . . 74.319999999999993 113.295 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.63 -54.37 4.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.34 0.591 . . . . 72.549999999999997 110.707 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -96.86 -16.14 20.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.182 -0.917 . . . . 70.329999999999998 112.348 -172.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm 65.94 31.09 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.865 0.728 . . . . 72.340000000000003 111.183 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -114.15 158.7 20.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.351 -0.611 . . . . 75.120000000000005 109.351 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 t -70.73 140.78 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.967 0.413 . . . . 63.409999999999997 110.993 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -93.34 3.75 55.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 75.219999999999999 110.596 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.06 68.02 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 114.378 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.3 p90 -156.34 154.8 31.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.768 0.784 . . . . 71.030000000000001 110.496 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.78 -166.24 17.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.371 -0.692 . . . . 74.439999999999998 111.371 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.68 148.59 37.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.295 0.547 . . . . 75.439999999999998 110.598 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.9 m -129.13 127.86 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.595 . . . . 74.420000000000002 109.781 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.6 m -103.36 121.61 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.335 -0.228 . . . . 74.420000000000002 110.532 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -87.95 164.05 16.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.042 0.449 . . . . 74.209999999999994 110.997 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.83 -49.49 37.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.492 -0.776 . . . . 73.219999999999999 110.598 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.5 m -119.37 152.18 37.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 74.400000000000006 110.816 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -65.64 -28.85 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.099 -0.5 . . . . 75.5 111.455 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.53 -29.35 63.52 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.967 -0.458 . . . . 74.310000000000002 111.509 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 6.1 mm-40 -64.92 -29.75 70.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.49 0.662 . . . . 73.109999999999999 109.282 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 24.8 t -66.88 -48.3 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.825 -1.08 . . . . 75.219999999999999 110.298 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -59.14 -49.96 75.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.797 -0.638 . . . . 73.349999999999994 110.704 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.8 -36.72 38.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.957 0.725 . . . . 74.25 112.957 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -29.6 62.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 71.129999999999995 110.745 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -49.66 64.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 65.049999999999997 109.974 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -64.07 -26.84 68.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.18 0.514 . . . . 72.239999999999995 110.882 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.9 -10.73 60.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.237 -0.892 . . . . 65.340000000000003 113.366 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -56.63 149.78 39.22 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 111.883 0.327 . . . . 55.509999999999998 111.883 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.72 165.67 79.12 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.057 -1.226 . . . . 74.319999999999993 112.837 0.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -123.65 152.67 41.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 74.230000000000004 110.483 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.5 ttmt -134.23 107.55 7.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.114 -0.494 . . . . 70.310000000000002 111.251 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 126.59 66.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.678 -0.692 . . . . 75.120000000000005 109.85 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.7 t70 66.29 28.19 9.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.632 0.73 . . . . 74.019999999999996 110.791 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.12 25.87 70.06 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.765 -0.731 . . . . 73.150000000000006 112.498 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.3 tpt180 -129.64 142.09 50.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.101 -0.703 . . . . 74.129999999999995 109.101 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.47 114.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 74.109999999999999 109.838 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.72 153.37 7.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.872 -0.604 . . . . 73.540000000000006 111.119 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -117.09 100.43 53.25 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.272 -0.876 . . . . 75.219999999999999 110.572 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.59 132.54 17.54 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.867 1.711 . . . . 73.409999999999997 110.909 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' O ' HD22 ' A' ' 16' ' ' LEU . 20.3 mttt -136.2 178.97 6.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.053 -1.091 . . . . 75.239999999999995 108.053 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.2 tmm_? -81.88 128.68 34.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.768 -0.827 . . . . 75.239999999999995 108.768 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.28 98.54 0.33 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.242 0.544 . . . . 64.099999999999994 111.097 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 11.1 t -69.22 142.96 15.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.053 -0.976 . . . . 74.319999999999993 110.835 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.42 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 18.1 t -83.21 172.27 12.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.236 -0.438 . . . . 52.210000000000001 109.991 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -61.65 -42.5 98.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.74 0.644 . . . . 75.150000000000006 112.74 -170.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -71.18 -41.46 70.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 65.120000000000005 110.866 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.0 OUTLIER -78.55 -8.12 58.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 111.478 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.6 m -93.62 -4.14 51.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.592 -0.276 . . . . 70.549999999999997 111.195 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.17 -41.59 99.25 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.602 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.93 146.57 75.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.944 -0.571 . . . . 75.510000000000005 110.262 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.57 147.66 90.27 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.025 2.484 . . . . 74.019999999999996 112.259 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.96 28.71 64.13 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.819 -0.705 . . . . 62.109999999999999 112.664 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.29 -52.16 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 64.439999999999998 110.349 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -93.71 2.47 56.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.637 -0.71 . . . . 74.120000000000005 111.061 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -87.94 161.93 17.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.473 . . . . 74.25 109.724 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 156' ' ' HIS . 3.2 m -83.58 97.61 9.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.218 0.533 . . . . 70.129999999999995 112.122 -172.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.523 ' CG1' ' HE3' ' A' ' 179' ' ' LYS . 0.8 OUTLIER -124.52 124.02 67.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.061 174.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 159' ' ' VAL . 72.7 mttt -106.65 22.01 16.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.323 0.583 . . . . 73.310000000000002 110.446 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -117.71 139.66 50.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.786 -0.643 . . . . 73.540000000000006 111.085 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.27 148.52 28.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.307 0.575 . . . . 74.239999999999995 111.45 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -98.63 133.79 42.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.869 -1.059 . . . . 75.310000000000002 109.426 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.37 109.12 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.059 -0.719 . . . . 73.230000000000004 109.059 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -135.86 167.88 24.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.682 -1.246 . . . . 73.430000000000007 113.717 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.11 42.11 5.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.925 -0.655 . . . . 75.450000000000003 111.735 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.19 111.23 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.513 0.673 . . . . 74.439999999999998 110.755 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -78.68 -21.78 47.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.717 0.77 . . . . 71.040000000000006 109.261 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -101.3 151.61 21.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.832 -1.076 . . . . 75.319999999999993 109.181 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.17 123.42 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.534 0.683 . . . . 61.530000000000001 110.677 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 m -107.27 141.61 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.849 -0.614 . . . . 70.129999999999995 110.056 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -113.57 173.64 6.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.248 -0.887 . . . . 74.219999999999999 111.449 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -50.73 72.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 71.310000000000002 110.955 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -63.36 -26.34 68.71 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.29 0.369 . . . . 74.340000000000003 111.491 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -64.23 -61.25 2.36 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.427 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 pp -84.1 -23.91 30.55 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.984 -0.686 . . . . 64.120000000000005 111.883 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -67.51 -51.44 51.06 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 110.357 -0.238 . . . . 73.200000000000003 110.357 178.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.2 -28.71 69.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 71.439999999999998 110.3 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -78.79 -56.28 4.52 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.517 -0.765 . . . . 73.439999999999998 112.14 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -67.91 -23.07 65.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.472 0.545 . . . . 74.450000000000003 112.472 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.7 mt-10 -68.05 -23.05 64.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.645 0.26 . . . . 74.030000000000001 111.415 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.78 -33.84 64.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.515 . . . . 75.439999999999998 111.55 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.24 -31.65 33.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.366 . . . . 75.519999999999996 111.443 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.68 -177.33 48.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.704 -0.76 . . . . 62.229999999999997 113.332 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -75.61 129.98 38.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 75.010000000000005 111.418 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 152' ' ' THR . 59.0 mt -102.25 140.18 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 72.530000000000001 110.071 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -91.35 -46.55 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 61.539999999999999 110.957 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.36 156.27 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.882 0.373 . . . . 72.010000000000005 110.427 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.49 127.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 109.933 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -102.45 105.46 16.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 62.520000000000003 111.206 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.1 117.12 38.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.873 -0.788 . . . . 72.439999999999998 108.873 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.5 mmm -84.45 101.21 11.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 72.329999999999998 110.385 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.855 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.382 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 113.894 0.317 . . . . 72.019999999999996 113.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.66 161.66 32.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 117.188 0.494 . . . . 71.310000000000002 110.43 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.47 173.97 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.487 -0.779 . . . . 64.310000000000002 109.673 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 45.5 m-85 -138.0 148.93 45.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 74.219999999999999 110.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.35 126.25 52.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 71.200000000000003 110.815 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.7 m -98.82 121.28 40.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 75.430000000000007 110.565 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -101.83 160.97 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.68 -0.236 . . . . 74.310000000000002 110.588 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.32 -29.94 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.386 0.613 . . . . 73.25 110.154 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -137.31 162.39 33.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 110.777 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.4 p80 -82.37 -20.56 36.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.978 -0.555 . . . . 73.299999999999997 110.118 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.596 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.2 p30 -60.3 -41.21 92.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 123.564 0.54 . . . . 63.009999999999998 110.943 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 m -73.67 -29.48 62.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.469 -0.332 . . . . 75.310000000000002 110.355 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.8 t -68.63 -42.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.759 -0.655 . . . . 71.450000000000003 109.745 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.85 -26.05 60.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 110.887 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.6 mttt -62.78 -37.99 88.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.521 0.677 . . . . 71.430000000000007 110.218 172.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.6 -42.61 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 72.019999999999996 112.956 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 159' ' ' VAL . 16.8 m -69.74 -9.01 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.095 0.474 . . . . 74.340000000000003 111.625 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.476 HD11 HD23 ' A' ' 13' ' ' LEU . 58.5 mt -56.46 -36.68 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.306 -0.861 . . . . 62.409999999999997 110.368 171.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -109.5 108.95 19.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.224 -0.658 . . . . 71.439999999999998 109.224 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -53.71 -36.13 61.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.429 -0.805 . . . . 75.120000000000005 112.342 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -122.5 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.884 0.373 . . . . 75.299999999999997 110.49 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -121.09 141.63 50.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.064 -0.516 . . . . 72.230000000000004 110.487 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 m -90.26 102.96 15.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.075 -0.511 . . . . 74.109999999999999 110.587 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.2 126.96 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.008 -0.738 . . . . 73.25 109.008 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 t30 53.42 31.53 12.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.584 0.707 . . . . 75.430000000000007 111.528 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.71 2.04 84.79 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.193 -0.527 . . . . 64.439999999999998 113.231 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -106.55 132.36 52.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.557 -0.534 . . . . 73.200000000000003 109.557 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.318 0.58 . . . . 64.519999999999996 110.676 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -106.82 153.89 21.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 65.400000000000006 109.707 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.47 131.23 34.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.198 -0.297 . . . . 72.219999999999999 110.198 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.9 t -130.44 137.25 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 73.239999999999995 111.06 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -158.2 176.67 12.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.001 -0.545 . . . . 74.140000000000001 112.06 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.523 ' HE3' ' CG1' ' A' ' 104' ' ' VAL . 14.1 mmmt -66.32 123.58 20.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.002 -0.545 . . . . 72.549999999999997 109.94 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -106.19 113.99 27.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 75.040000000000006 111.001 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.908 -0.587 . . . . 73.239999999999995 110.125 178.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.007 0.432 . . . . 60.520000000000003 110.692 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 159.88 37.5 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.028 -0.533 . . . . 65.420000000000002 110.191 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.69 166.94 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.294 1.996 . . . . 74.409999999999997 111.304 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -32.79 70.63 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 111.715 0.265 . . . . 73.219999999999999 111.715 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.46 -30.9 71.93 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.063 0.394 . . . . 73.349999999999994 112.063 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -82.97 -12.98 56.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.185 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.41 0.56 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.984 0.421 . . . . 63.119999999999997 111.245 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -96.38 147.18 24.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.379 0.609 . . . . 73.239999999999995 112.108 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -116.31 147.21 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.008 -0.996 . . . . 72.200000000000003 109.727 172.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 29.8 t80 -101.99 118.38 36.78 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.172 -1.048 . . . . 63.100000000000001 108.172 171.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.3 mm -94.78 112.77 27.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 122.108 -0.37 . . . . 75.329999999999998 110.228 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 150.81 18.18 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.958 -0.639 . . . . 61.520000000000003 111.964 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.91 45.14 64.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.168 -0.539 . . . . 64.25 113.586 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD23 ' CG1' ' A' ' 84' ' ' VAL . 50.2 mt -76.47 173.07 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 72.329999999999998 110.409 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -84.4 175.55 9.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 73.340000000000003 109.485 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 92.1 m-85 -84.03 -6.59 59.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 110.632 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -119.51 12.11 12.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.878 -0.601 . . . . 62.340000000000003 111.678 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.9 m -77.41 132.37 38.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.078 0.466 . . . . 70.219999999999999 111.425 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -107.63 167.59 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.633 -0.712 . . . . 75.340000000000003 110.054 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -73.77 -24.42 59.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 72.340000000000003 111.089 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.67 -35.14 58.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.167 -0.213 . . . . 71.420000000000002 110.659 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.8 m -73.23 -38.11 66.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.436 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.95 -45.04 94.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 74.540000000000006 110.178 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -60.0 -52.85 63.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.948 -0.569 . . . . 71.209999999999994 110.559 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m -44.14 -42.3 6.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.327 1.017 . . . . 73.340000000000003 113.603 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 79' ' ' VAL . 66.6 t60 -70.24 -56.45 6.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 64.120000000000005 111.13 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 40' ' ' LEU . 81.8 m-85 -76.05 -17.57 59.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.806 0.299 . . . . 74.439999999999998 111.806 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.6 -28.37 54.7 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.027 0.531 . . . . 72.230000000000004 111.547 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -65.61 -23.96 66.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.465 -0.788 . . . . 71.450000000000003 112.304 -177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -101.41 -21.98 14.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.057 0.391 . . . . 72.010000000000005 112.057 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 177.09 48.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.788 -1.196 . . . . 37.590000000000003 113.24 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -68.01 119.61 12.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.966 0.507 . . . . 74.230000000000004 112.268 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 34' ' ' PHE . 52.8 mt -95.66 125.63 40.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.636 0.731 . . . . 74.420000000000002 110.56 170.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 t -100.92 -17.69 16.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.989 -1.005 . . . . 71.400000000000006 110.12 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.95 151.4 29.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 64.420000000000002 109.981 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.8 t -163.04 133.18 4.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.98 -0.378 . . . . 73.219999999999999 109.98 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 126.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.215 0.531 . . . . 72.120000000000005 110.613 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.56 131.87 33.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.605 -0.887 . . . . 74.209999999999994 108.605 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.9 mmt -79.4 97.44 6.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.773 0.796 . . . . 72.430000000000007 110.94 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -104.51 159.11 16.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.314 -1.312 . . . . 74.400000000000006 109.008 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.37 125.84 91.06 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.885 -0.598 . . . . 74.439999999999998 109.773 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.51 -28.62 87.01 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.214 1.943 . . . . 60.43 113.744 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.92 -55.01 4.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.925 0.393 . . . . 70.150000000000006 111.906 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.43 -15.92 21.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.199 0.444 . . . . 73.400000000000006 112.199 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 65.43 31.34 10.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.71 0.804 . . . . 74.019999999999996 111.747 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -97.92 151.35 20.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.098 -0.704 . . . . 74.120000000000005 109.098 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.1 t -72.7 137.63 46.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.727 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -89.25 -1.65 58.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.778 -0.646 . . . . 63.219999999999999 109.634 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.18 23.52 51.42 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.66 -0.7 . . . . 52.100000000000001 113.825 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -161.51 160.72 29.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.887 0.844 . . . . 73.450000000000003 111.036 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -162.18 12.19 Favored Glycine 0 C--O 1.226 -0.345 0 N-CA-C 111.588 -0.605 . . . . 73.549999999999997 111.588 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -142.32 149.37 39.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.185 0.493 . . . . 75.329999999999998 110.105 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 m -130.69 126.4 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.057 -0.719 . . . . 75.430000000000007 109.057 172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 m -105.85 120.01 40.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.728 0.299 . . . . 75.420000000000002 110.408 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -85.37 171.08 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.854 -0.612 . . . . 73.150000000000006 109.979 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.7 -25.03 24.99 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.139 0.495 . . . . 71.420000000000002 110.488 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 m -143.06 145.4 32.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 64.150000000000006 110.916 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.1 p -56.54 -40.02 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.688 -0.687 . . . . 62.210000000000001 111.867 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -53.05 -42.03 65.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.974 0.731 . . . . 71.200000000000003 112.974 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -65.71 -30.67 71.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.302 0.572 . . . . 74.140000000000001 110.569 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 17.9 t -67.12 -45.57 86.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.381 -0.827 . . . . 73.109999999999999 110.813 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -58.95 -42.94 91.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 73.319999999999993 110.622 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.633 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.71 -37.37 73.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.483 0.549 . . . . 73.120000000000005 112.483 171.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.33 74.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.271 0.558 . . . . 72.510000000000005 110.226 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.25 -36.25 71.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.783 -0.644 . . . . 72.099999999999994 110.786 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 4.5 p30 -79.94 -11.27 59.81 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.968 0.413 . . . . 75.219999999999999 110.952 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.79 -12.06 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 75.209999999999994 111.002 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -55.31 149.14 28.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.68 . . . . 74.420000000000002 111.827 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 168.7 76.62 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 124.274 -1.136 . . . . 75.120000000000005 113.381 2.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -125.77 155.97 40.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.681 -0.691 . . . . 75.200000000000003 110.358 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.3 ttmt -136.75 105.34 5.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.086 0.47 . . . . 73.439999999999998 111.242 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG23 ' CG ' ' A' ' 33' ' ' HIS . 16.4 t -105.62 125.6 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.6 . . . . 74.420000000000002 109.718 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 64.53 33.59 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.776 0.672 . . . . 70.340000000000003 111.281 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.88 26.56 73.77 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.018 -0.611 . . . . 52.25 112.239 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.5 tpt180 -127.5 135.62 50.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.162 -0.31 . . . . 73.510000000000005 110.162 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.95 113.47 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.839 -0.8 . . . . 74.230000000000004 108.839 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' CG1' HD23 ' A' ' 21' ' ' LEU . 5.0 m -106.49 151.99 8.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.356 0.598 . . . . 75.230000000000004 111.208 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -113.82 96.55 41.56 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.956 -1.02 . . . . 74.019999999999996 110.697 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.27 129.97 15.71 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.741 1.627 . . . . 63.210000000000001 110.286 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 50.9 mmtt -121.26 142.01 50.35 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.844 -0.798 . . . . 74.430000000000007 108.844 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.61 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 7.9 tpp180 -64.05 119.51 10.27 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.644 -0.872 . . . . 75.439999999999998 108.644 172.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 93.29 0.09 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 110.671 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.24 156.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.728 -1.124 . . . . 64.409999999999997 110.638 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 p -55.39 153.82 6.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.961 -0.563 . . . . 71.030000000000001 111.428 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 1.4 tmt_? -57.51 -30.62 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.671 -0.695 . . . . 63.210000000000001 111.234 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -52.2 52.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 111.609 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.8 -25.95 59.4 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.789 0.328 . . . . 71.340000000000003 110.318 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -64.4 -17.49 63.82 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.217 -0.447 . . . . 73.030000000000001 111.192 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.29 -11.24 59.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.738 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -79.96 145.55 61.67 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.953 -0.388 . . . . 73.450000000000003 109.953 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.3 115.54 4.08 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.43 2.086 . . . . 75.200000000000003 112.05 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.65 27.59 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.791 -0.719 . . . . 72.340000000000003 112.297 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.01 -36.81 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 111.671 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 18.2 m170 -104.03 21.2 16.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.485 0.66 . . . . 62.219999999999999 110.516 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.2 mt -101.65 -178.55 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 74.129999999999995 109.553 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.408 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.15 100.64 13.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.649 . . . . 72.430000000000007 111.834 -175.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.17 121.97 44.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 74.530000000000001 108.181 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -106.59 19.68 20.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 63.229999999999997 110.505 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -116.43 139.1 50.81 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.378 -0.373 . . . . 73.209999999999994 110.662 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.5 pt -131.7 149.62 33.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.266 0.555 . . . . 74.0 111.293 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -93.45 137.91 32.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 74.150000000000006 109.582 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.82 108.93 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.345 -0.613 . . . . 74.030000000000001 109.345 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.84 147.6 18.08 Favored Glycine 0 CA--C 1.505 -0.587 0 C-N-CA 119.673 -1.251 . . . . 75.049999999999997 112.973 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.87 6.35 22.96 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.32 -0.943 . . . . 73.129999999999995 111.981 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.45 99.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 122.072 0.939 . . . . 71.430000000000007 109.055 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.427 ' HB2' ' HZ1' ' A' ' 113' ' ' LYS . 2.2 ttmp? -91.47 -6.13 53.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.161 -0.927 . . . . 72.140000000000001 112.126 -166.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -126.47 -162.52 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.024 -0.362 . . . . 63.200000000000003 110.024 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.22 67.98 8.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 54.119999999999997 111.003 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -75.56 136.42 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.321 0.581 . . . . 71.239999999999995 109.799 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.3 166.12 10.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.272 -0.876 . . . . 72.319999999999993 111.436 -171.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.01 -53.17 61.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.336 -0.847 . . . . 74.5 110.516 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.23 -12.76 58.16 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.388 0.514 . . . . 73.5 112.388 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -73.01 -57.74 3.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.084 0.468 . . . . 75.209999999999994 109.764 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -81.47 -28.62 34.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.143 -0.623 . . . . 71.140000000000001 110.544 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -64.3 -53.22 52.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.657 -0.247 . . . . 74.140000000000001 110.592 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.6 -26.4 68.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.979 0.419 . . . . 55.140000000000001 110.486 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.1 -54.59 8.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.815 -0.629 . . . . 74.209999999999994 111.194 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -68.32 -23.53 64.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.5 -0.318 . . . . 73.439999999999998 111.609 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.92 -26.18 67.48 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.886 0.374 . . . . 65.230000000000004 111.236 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -56.9 -30.1 63.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.935 -0.575 . . . . 73.530000000000001 111.31 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -86.26 -26.8 24.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 74.299999999999997 111.936 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.69 46.41 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.372 -0.918 . . . . 63.329999999999998 113.353 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.45 131.77 41.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.078 0.466 . . . . 73.430000000000007 111.316 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 152' ' ' THR . 52.4 mt -105.09 141.18 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 75.409999999999997 110.082 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -90.64 -54.44 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 54.229999999999997 110.796 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.76 155.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 74.319999999999993 110.289 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.54 129.48 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.057 0.456 . . . . 74.519999999999996 109.828 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 21.6 mt-10 -101.78 103.41 14.14 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.291 -0.868 . . . . 70.040000000000006 110.566 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -92.47 118.98 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.067 -0.716 . . . . 75.109999999999999 109.067 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 73.1 mmm -90.46 109.36 20.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.283 0.564 . . . . 72.400000000000006 110.554 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 74.109999999999999 109.846 -177.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.22 0 N-CA-C 113.624 0.209 . . . . 53.030000000000001 113.624 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.28 158.96 33.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.104 0.478 . . . . 75.230000000000004 109.764 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.91 176.91 8.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.255 -0.884 . . . . 74.209999999999994 109.633 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 51.6 m-85 -139.84 151.73 45.92 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.28 -0.873 . . . . 75.319999999999993 109.128 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.09 134.04 15.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.281 0.562 . . . . 75.430000000000007 110.95 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 131' ' ' ILE . 54.8 m -105.7 127.66 53.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.071 -0.968 . . . . 75.099999999999994 110.983 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -101.72 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 110.874 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.26 -23.3 30.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.825 -0.625 . . . . 72.209999999999994 110.29 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.56 158.05 44.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 73.230000000000004 110.8 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.559 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 31.2 p80 -83.98 -27.67 28.28 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.646 -0.252 . . . . 74.040000000000006 111.377 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -59.45 -42.22 91.48 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.382 0.427 . . . . 75.129999999999995 110.886 -176.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -65.43 -32.86 74.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.027 -0.533 . . . . 72.010000000000005 110.976 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.0 t -70.81 -44.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.386 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.507 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 26.4 m-20 -68.17 -25.41 65.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.719 . . . . 74.530000000000001 111.269 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.61 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 96.9 mttt -61.68 -45.2 95.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.842 0.829 . . . . 62.439999999999998 110.276 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.6 mt -75.55 -43.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.492 -1.231 . . . . 74.540000000000006 112.387 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 159' ' ' VAL . 15.9 m -75.01 -5.59 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 74.5 111.096 -174.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 160' ' ' ASP . 31.1 mt -57.97 -31.45 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.42 -0.809 . . . . 75.319999999999993 109.748 168.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -114.49 109.35 18.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.557 -0.747 . . . . 75.329999999999998 109.095 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -55.66 -31.9 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 65.450000000000003 112.259 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.62 137.3 54.76 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.649 -0.421 . . . . 74.450000000000003 111.622 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -129.0 149.24 50.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.578 -0.737 . . . . 74.0 109.622 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.5 m -110.92 124.64 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.885 0.374 . . . . 72.200000000000003 110.935 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.58 131.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.985 -0.552 . . . . 74.129999999999995 109.983 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 72.44 23.24 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.42 1.105 . . . . 72.549999999999997 109.63 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.7 85.96 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.155 -0.93 . . . . 71.340000000000003 112.097 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -118.91 122.14 41.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.318 . . . . 73.25 110.816 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.81 108.07 18.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.751 -0.833 . . . . 71.299999999999997 108.751 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.0 p -110.1 154.3 23.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.426 -0.807 . . . . 73.340000000000003 111.101 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -86.62 127.77 34.95 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.626 -0.715 . . . . 75.140000000000001 109.681 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.8 t -124.87 128.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.352 -0.84 . . . . 71.329999999999998 109.987 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -154.35 171.47 19.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.414 -0.812 . . . . 72.230000000000004 111.26 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -58.02 123.61 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.465 0.478 . . . . 74.230000000000004 111.287 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.81 118.82 31.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.995 -0.548 . . . . 71.219999999999999 109.723 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--N 1.311 -1.108 0 N-CA-C 109.486 -0.561 . . . . 72.409999999999997 109.486 179.449 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 120.924 0.392 . . . . 75.200000000000003 110.706 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.49 133.78 86.89 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.683 . . . . 74.200000000000003 110.461 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.66 162.73 35.86 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.824 2.349 . . . . 74.25 110.59 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.1 pt-20 -60.34 -30.54 69.59 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 111.819 0.303 . . . . 63.310000000000002 111.819 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.78 -34.63 75.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.871 0.323 . . . . 75.329999999999998 111.871 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.75 -15.1 58.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.964 0.412 . . . . 74.400000000000006 110.839 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HA ' HG22 ' A' ' 68' ' ' VAL . 24.3 ptt180 -121.58 6.61 10.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.754 -0.657 . . . . 73.299999999999997 110.824 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.4 ttmm -95.19 148.77 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.709 0.766 . . . . 73.230000000000004 111.563 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.8 139.48 50.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.643 -1.162 . . . . 74.219999999999999 110.078 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -96.68 113.26 24.8 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.407 -0.96 . . . . 74.120000000000005 108.407 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.6 mm -92.67 111.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.208 -0.451 . . . . 75.510000000000005 110.252 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.77 147.63 16.72 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.086 -0.578 . . . . 73.25 112.063 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.77 48.57 33.93 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 72.439999999999998 113.399 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 HD23 ' CG1' ' A' ' 84' ' ' VAL . 73.2 mt -79.86 176.94 9.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.118 -0.327 . . . . 75.340000000000003 110.118 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.7 p -89.84 169.57 11.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.003 -0.74 . . . . 71.129999999999995 109.003 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -77.24 -3.61 40.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.973 0.416 . . . . 74.209999999999994 111.377 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.32 13.4 13.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.017 -0.538 . . . . 74.120000000000005 111.29 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -73.13 126.31 29.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 65.209999999999994 110.403 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -105.91 165.53 11.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 109.816 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.81 -24.69 65.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.613 0.244 . . . . 74.340000000000003 110.958 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.96 -35.41 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 65.439999999999998 111.859 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -77.52 -36.1 52.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.93 0.395 . . . . 74.219999999999999 110.362 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.07 -48.51 78.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.62 -0.718 . . . . 65.109999999999999 109.681 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -54.47 -60.05 3.87 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.432 -0.804 . . . . 74.099999999999994 111.878 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -47.82 -38.91 16.97 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.9 0.75 . . . . 75.400000000000006 112.691 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.99 -56.08 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.476 -0.329 . . . . 71.109999999999999 111.084 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.01 -18.59 59.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.676 0.274 . . . . 61.32 111.665 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.11 -22.5 51.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.217 0.607 . . . . 74.450000000000003 111.783 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.79 -27.65 66.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.711 -0.677 . . . . 64.209999999999994 112.208 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.16 -20.64 15.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.608 0.225 . . . . 73.310000000000002 111.608 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.51 165.49 35.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.259 -0.972 . . . . 74.25 112.375 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.4 m -71.69 119.71 16.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.018 0.437 . . . . 74.409999999999997 111.458 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.36 138.29 32.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.567 -0.742 . . . . 73.510000000000005 110.967 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -97.79 -25.36 15.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.808 . . . . 74.430000000000007 110.161 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -150.68 150.26 30.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 72.420000000000002 110.164 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.9 t -158.71 126.37 5.03 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.129 -0.323 . . . . 71.010000000000005 110.129 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.62 126.35 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.339 0.59 . . . . 72.430000000000007 110.513 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.73 133.08 33.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.766 -0.828 . . . . 72.140000000000001 108.766 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.493 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mmt -78.21 99.66 6.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.074 0.464 . . . . 71.420000000000002 110.692 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -100.66 161.04 13.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.43 -0.805 . . . . 74.519999999999996 110.498 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.89 123.81 75.44 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.031 -0.986 . . . . 72.510000000000005 110.055 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.87 -24.56 74.31 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.224 1.949 . . . . 73.340000000000003 113.463 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -84.24 -54.92 4.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 74.25 111.505 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -14.45 28.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 75.5 112.12 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm 62.61 31.16 16.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.883 0.873 . . . . 73.430000000000007 111.662 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -114.71 155.6 26.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.648 -0.871 . . . . 72.340000000000003 108.648 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.3 t -70.34 133.89 47.38 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.05 -0.352 . . . . 65.530000000000001 110.05 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -81.68 4.98 19.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.856 -0.611 . . . . 73.030000000000001 111.106 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.65 15.8 65.13 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 73.239999999999995 113.882 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 33.0 p90 -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.764 0.782 . . . . 73.409999999999997 110.625 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.04 -168.11 21.55 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.448 -0.661 . . . . 72.310000000000002 111.448 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.69 146.36 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.164 0.482 . . . . 70.430000000000007 110.634 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -131.77 121.3 47.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 75.109999999999999 109.911 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.0 m -97.58 123.0 41.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.638 -0.504 . . . . 73.120000000000005 109.638 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -86.03 175.21 8.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.033 0.444 . . . . 74.040000000000006 110.918 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.73 -45.54 16.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.005 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -120.08 149.48 42.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.162 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.8 p -65.4 -30.9 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 123.131 0.269 . . . . 75.530000000000001 111.266 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.94 -39.74 87.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.183 0.438 . . . . 72.450000000000003 112.183 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -26.5 68.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 110.784 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 40.4 t -63.79 -50.83 76.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.744 -0.662 . . . . 75.510000000000005 110.59 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -37.96 87.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 60.149999999999999 111.594 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.01 62.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.029 0.381 . . . . 74.530000000000001 112.029 170.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.47 -33.86 58.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 74.329999999999998 110.445 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -63.97 -41.75 97.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.438 -0.346 . . . . 75.049999999999997 110.642 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -30.3 63.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.965 -0.561 . . . . 70.349999999999994 110.902 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.72 -13.2 61.9 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.791 0.663 . . . . 55.229999999999997 112.791 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -55.06 148.98 26.48 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.212 0.449 . . . . 75.420000000000002 112.212 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.65 157.26 92.77 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.57 -1.429 . . . . 64.140000000000001 114.088 3.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -112.76 156.5 22.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.555 -0.748 . . . . 75.219999999999999 110.867 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 20.3 ttmt -139.45 110.35 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.345 -0.389 . . . . 74.450000000000003 111.539 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.04 130.65 64.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 71.340000000000003 109.81 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.22 26.56 12.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.867 0.842 . . . . 74.400000000000006 110.538 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.68 24.13 70.84 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.949 -0.643 . . . . 60.420000000000002 112.461 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 tpt180 -127.07 139.75 52.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.76 -0.459 . . . . 74.310000000000002 109.76 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -76.07 112.68 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 74.340000000000003 109.46 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -109.27 150.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 110.996 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -114.82 96.38 44.26 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.242 -0.89 . . . . 71.010000000000005 111.486 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.453 ' O ' ' HE1' ' A' ' 72' ' ' MET . 19.3 Cg_endo -70.59 131.68 20.53 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.236 1.291 . . . . 61.119999999999997 110.556 170.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 156' ' ' HIS . 24.3 mttt -129.74 171.83 12.27 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.887 -0.783 . . . . 73.230000000000004 108.887 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.491 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -83.54 126.19 32.55 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.209 -0.996 . . . . 75.140000000000001 109.623 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HA ' ' HE2' ' A' ' 101' ' ' HIS . . . -64.22 103.46 0.63 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.879 -0.601 . . . . 64.209999999999994 111.887 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.53 150.06 9.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.968 -1.015 . . . . 73.409999999999997 108.309 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -53.7 129.69 34.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.63 -0.507 . . . . 73.420000000000002 109.63 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -59.03 -24.29 62.7 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.516 0.51 . . . . 73.540000000000006 111.931 -172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.98 -54.81 41.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 73.099999999999994 110.549 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.38 -14.75 58.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.679 . . . . 62.009999999999998 111.201 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 t -64.85 -17.42 64.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.633 -0.712 . . . . 75.420000000000002 111.218 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -68.67 -21.71 64.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.286 -0.416 . . . . 75.109999999999999 111.013 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -78.73 143.94 63.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.072 -0.344 . . . . 62.439999999999998 110.072 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.37 117.86 5.33 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.724 2.283 . . . . 73.109999999999999 112.441 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.51 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.772 . . . . 70.200000000000003 112.658 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.88 86.6 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.351 0.26 . . . . 72.25 111.625 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 89' ' ' ALA . 3.9 m80 -107.24 12.87 27.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.153 0.427 . . . . 70.099999999999994 112.153 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 49.3 mt -77.24 155.75 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.894 -0.409 . . . . 73.219999999999999 109.894 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -76.96 88.96 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.178 0.513 . . . . 73.200000000000003 110.799 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.84 135.69 63.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.84 -1.17 . . . . 73.310000000000002 107.84 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -112.13 20.71 16.59 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.379 0.609 . . . . 64.519999999999996 110.202 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 142.1 47.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.505 -0.771 . . . . 73.129999999999995 110.288 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.4 pt -126.85 149.63 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.165 0.507 . . . . 64.219999999999999 111.066 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.6 t80 -101.45 136.39 41.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.072 -0.967 . . . . 74.109999999999999 109.016 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 7.1 t -125.88 109.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.544 -0.539 . . . . 75.230000000000004 109.544 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.07 146.98 17.08 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.27 -0.967 . . . . 65.140000000000001 112.309 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.8 50.3 4.72 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.541 -1.024 . . . . 63.210000000000001 110.541 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.59 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 15.2 pt -91.55 -177.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.04 -0.58 . . . . 74.109999999999999 111.481 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.564 ' HD3' ' ND2' ' A' ' 171' ' ' ASN . 87.5 tttt -84.79 154.67 22.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.817 -0.629 . . . . 72.519999999999996 109.757 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -59.25 -37.2 77.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.814 0.34 . . . . 71.510000000000005 110.952 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -108.3 85.48 2.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 110.016 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 m -123.61 122.78 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.695 0.759 . . . . 72.349999999999994 110.426 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.448 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.7 pt-20 -113.22 172.47 6.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.471 -1.241 . . . . 74.340000000000003 110.723 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -48.22 73.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.85 -1.068 . . . . 72.120000000000005 110.128 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -57.19 -34.78 68.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.847 -0.615 . . . . 71.230000000000004 111.817 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.448 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 31.0 m170 -61.27 -60.16 4.18 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.676 0.274 . . . . 65.400000000000006 111.479 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -82.63 -22.39 34.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.519 -0.872 . . . . 73.040000000000006 111.461 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -68.32 -50.74 51.27 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.485 -0.191 . . . . 74.040000000000006 110.485 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.43 -30.76 68.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.086 0.47 . . . . 60.229999999999997 110.436 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.71 -57.08 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.7 -0.682 . . . . 74.430000000000007 112.269 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -69.17 -22.74 63.9 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.918 0.71 . . . . 73.239999999999995 112.918 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.76 -23.23 64.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 111.021 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -59.1 -26.53 64.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.058 -0.519 . . . . 75.200000000000003 111.232 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.11 -33.87 20.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 71.109999999999999 111.521 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.421 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 179.54 -174.96 46.62 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.309 -0.948 . . . . 52.43 113.726 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -76.45 129.11 36.06 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.045 0.45 . . . . 75.310000000000002 111.613 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.82 137.95 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 75.510000000000005 109.975 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.49 -52.03 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 63.5 110.518 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.12 157.32 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 74.140000000000001 109.779 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.22 129.58 72.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.897 0.38 . . . . 75.109999999999999 110.228 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -103.4 104.16 14.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.562 -0.744 . . . . 74.030000000000001 110.767 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.1 mm -92.99 112.63 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.831 -0.803 . . . . 72.400000000000006 108.831 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 78.8 mmm -86.07 117.57 24.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.468 -0.493 . . . . 75.329999999999998 109.873 -173.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 74.129999999999995 110.741 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 111.417 -0.673 . . . . 72.209999999999994 111.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -160.43 168.17 25.74 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.902 -0.407 . . . . 75.530000000000001 109.902 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.12 169.55 17.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.543 -0.753 . . . . 71.200000000000003 109.184 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -132.21 144.66 50.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.153 0.501 . . . . 73.319999999999993 110.164 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 25.5 t -128.77 130.42 68.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.303 -0.408 . . . . 72.219999999999999 110.284 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.507 ' O ' HG22 ' A' ' 131' ' ' ILE . 94.0 m -105.94 120.62 42.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 71.200000000000003 110.941 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.3 160.44 14.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.936 0.398 . . . . 75.439999999999998 111.013 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.59 -31.38 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.599 -0.728 . . . . 71.510000000000005 110.61 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.85 155.85 44.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 74.420000000000002 110.81 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.455 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 20.6 p80 -77.18 -28.54 54.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.339 -0.391 . . . . 75.310000000000002 110.063 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.08 -48.45 33.48 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.037 0.836 . . . . 62.350000000000001 112.089 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.421 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -74.59 -27.87 60.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.702 -0.681 . . . . 72.239999999999995 111.016 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.7 t -73.76 -41.33 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.230000000000004 109.979 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.461 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 6.9 m-20 -69.7 -23.45 63.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 63.399999999999999 110.988 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -65.36 -43.09 91.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.624 0.726 . . . . 72.109999999999999 110.392 170.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mt -73.19 -39.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.638 -1.164 . . . . 65.329999999999998 111.789 -172.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 160' ' ' ASP . 19.1 m -76.54 -8.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.382 . . . . 73.129999999999995 111.04 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 16.3 mt -64.21 -34.12 66.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.532 0.682 . . . . 71.349999999999994 109.859 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 58.5 mt-30 -109.13 96.99 6.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.796 -1.187 . . . . 73.409999999999997 107.796 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -56.55 -30.61 63.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 72.0 112.522 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.909 -0.317 . . . . 74.510000000000005 110.514 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.4 m-70 -125.71 152.53 45.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.979 -0.555 . . . . 74.349999999999994 109.56 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 32.1 m -101.76 105.91 16.85 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.173 0.511 . . . . 73.310000000000002 110.053 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.03 138.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.544 -0.753 . . . . 75.0 109.401 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.564 ' ND2' ' HD3' ' A' ' 113' ' ' LYS . 59.7 t30 49.69 36.21 10.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.579 0.704 . . . . 63.420000000000002 112.591 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.96 5.46 90.12 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.968 -0.56 . . . . 62.43 114.122 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -129.3 134.5 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.424 0.612 . . . . 72.439999999999998 111.324 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 20.3 t-20 -81.04 112.37 18.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.545 . . . . 73.409999999999997 110.853 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.59 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 11.6 m -110.32 156.25 21.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.658 -0.701 . . . . 70.430000000000007 110.339 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.0 tt0 -89.41 140.93 29.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 73.409999999999997 110.369 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -130.39 162.99 37.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.973 0.416 . . . . 73.219999999999999 111.014 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -174.68 175.0 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.023 -0.989 . . . . 71.299999999999997 111.767 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -67.9 122.6 18.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 109.508 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -112.4 148.64 33.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.126 0.488 . . . . 63.130000000000003 110.413 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.314 -0.965 0 N-CA-C 108.925 -0.768 . . . . 73.409999999999997 108.925 178.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.782 -0.451 . . . . 70.340000000000003 109.782 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -82.14 125.24 77.55 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 74.439999999999998 109.983 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD2' HD22 ' A' ' 13' ' ' LEU . 18.8 Cg_endo -61.07 168.35 7.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.508 2.805 . . . . 64.299999999999997 112.822 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.57 -39.67 35.88 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.597 -0.729 . . . . 73.420000000000002 112.752 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 4.3 pt20 -62.65 -35.85 80.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.523 0.329 . . . . 71.519999999999996 111.869 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 10' ' ' PRO . 8.5 mp -79.16 -45.41 20.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.918 -0.313 . . . . 72.129999999999995 110.38 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 18.0 ptt85 -76.7 2.02 15.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.03 0.381 . . . . 65.209999999999994 112.03 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.6 ttpt -95.54 147.9 23.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.671 0.748 . . . . 71.109999999999999 110.976 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -117.25 145.15 44.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.835 -1.075 . . . . 72.349999999999994 110.625 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -98.7 119.48 37.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 74.329999999999998 108.405 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mm -99.54 111.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.703 -0.48 . . . . 75.519999999999996 109.703 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.92 154.36 16.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.673 -0.775 . . . . 60.25 111.553 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.94 39.89 53.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.583 -0.818 . . . . 64.129999999999995 113.489 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 HD23 ' CG1' ' A' ' 84' ' ' VAL . 72.5 mt -80.0 174.5 11.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.009 -0.367 . . . . 74.430000000000007 110.009 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -88.38 168.5 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.659 -0.867 . . . . 53.130000000000003 108.659 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.4 -4.29 53.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.243 0.544 . . . . 74.129999999999995 110.188 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -106.53 5.84 29.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.378 -0.828 . . . . 73.150000000000006 111.411 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.7 m -75.02 132.91 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.999 0.428 . . . . 65.120000000000005 111.168 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.614 ' HB ' ' OE2' ' A' ' 28' ' ' GLU . 19.0 p -112.41 168.38 9.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.217 -0.66 . . . . 72.010000000000005 109.217 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -73.71 -25.9 60.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.768 -0.373 . . . . 62.030000000000001 110.883 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.614 ' OE2' ' HB ' ' A' ' 26' ' ' THR . 2.0 pm0 -79.89 -32.5 40.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.848 -0.16 . . . . 74.030000000000001 111.012 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.7 p -75.92 -35.23 59.85 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 109.828 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.59 -48.12 70.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.533 -0.758 . . . . 73.310000000000002 110.036 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -53.93 -58.75 6.14 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.071 -0.513 . . . . 72.230000000000004 111.475 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 8.7 t -51.41 -30.88 20.68 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.698 0.624 . . . . 70.420000000000002 112.214 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.433 ' CD2' HG21 ' A' ' 79' ' ' VAL . 64.1 t60 -72.47 -61.63 1.73 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.739 -0.21 . . . . 64.019999999999996 110.88 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -71.11 -22.78 62.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.086 0.402 . . . . 75.219999999999999 112.086 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 29.2 tt0 -67.0 -17.97 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.259 0.552 . . . . 74.25 110.869 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 32' ' ' SER . 22.7 mt-30 -64.35 -24.14 67.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.64 . . . . 72.019999999999996 111.503 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -102.52 -17.67 15.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.373 -0.376 . . . . 73.219999999999999 111.63 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -177.82 163.54 31.93 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.311 -0.947 . . . . 73.319999999999993 112.582 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -68.12 118.09 10.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.076 0.465 . . . . 72.030000000000001 111.579 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.2 mt -88.04 129.02 35.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.68 0.752 . . . . 71.409999999999997 111.474 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -93.23 -24.64 18.12 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.882 -1.054 . . . . 71.430000000000007 109.838 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.46 152.3 32.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.08 -0.964 . . . . 75.049999999999997 109.584 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.407 ' SG ' HG11 ' A' ' 60' ' ' VAL . 16.8 t -164.08 126.59 2.44 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.297 -0.631 . . . . 74.349999999999994 109.297 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 p -145.69 113.83 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.726 0.774 . . . . 72.040000000000006 110.11 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 139.54 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.557 -0.905 . . . . 72.400000000000006 108.557 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.462 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 7.4 mmt -77.33 139.37 39.75 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.979 -0.748 . . . . 72.439999999999998 108.979 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -139.78 157.13 46.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.816 -0.629 . . . . 71.209999999999994 111.749 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 29.2 t70 -70.71 134.67 86.07 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.672 -1.149 . . . . 45.240000000000002 109.939 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD3' HH21 ' A' ' 55' ' ' ARG . 57.2 Cg_endo -75.26 -17.25 19.15 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.171 1.914 . . . . 71.530000000000001 113.297 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.9 OUTLIER -85.79 -56.15 3.63 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.997 0.369 . . . . 54.049999999999997 111.997 -176.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -105.75 -9.15 17.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 72.040000000000006 111.218 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 28.3 mmtp 66.67 39.81 3.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.658 -0.701 . . . . 70.239999999999995 111.168 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -105.87 159.88 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.315 -0.624 . . . . 72.530000000000001 109.315 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.6 t -65.56 140.44 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 110.875 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.418 HH21 ' HD3' ' A' ' 49' ' ' PRO . 56.0 mtt-85 -85.87 -3.64 58.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 110.554 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.45 60.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.514 -0.85 . . . . 70.319999999999993 113.754 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.462 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 28.8 p90 -157.98 155.03 28.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.627 0.713 . . . . 74.540000000000006 110.268 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.27 -167.32 20.66 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 111.875 -0.49 . . . . 60.549999999999997 111.875 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.38 148.42 37.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.15 0.475 . . . . 73.150000000000006 110.327 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG11 ' SG ' ' A' ' 43' ' ' CYS . 13.1 m -132.18 131.14 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.545 . . . . 74.239999999999995 109.981 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.457 ' OG1' ' HD3' ' A' ' 15' ' ' LYS . 5.2 m -106.19 120.16 41.1 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.24 -0.287 . . . . 61.409999999999997 110.248 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.545 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 27.8 m-85 -85.7 162.93 18.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.698 0.285 . . . . 74.209999999999994 110.636 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.3 -44.4 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 75.450000000000003 110.66 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.27 154.21 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 75.0 111.058 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.07 -41.3 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 111.055 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -48.39 -40.97 27.51 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.57 0.581 . . . . 63.210000000000001 112.57 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.8 -25.06 59.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 74.219999999999999 111.093 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.79 -44.37 82.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 61.0 109.986 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.39 -50.08 72.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 111.034 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.01 22.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.758 -0.656 . . . . 45.420000000000002 112.701 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.61 57.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.514 . . . . 71.0 110.825 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.78 -40.31 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.894 -0.594 . . . . 75.310000000000002 111.434 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -19.53 61.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.278 0.561 . . . . 71.340000000000003 110.154 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -9.01 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.709 -0.678 . . . . 75.120000000000005 111.541 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -60.08 146.1 83.57 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.402 0.144 . . . . 74.549999999999997 111.326 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.41 164.63 86.17 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.091 -1.212 . . . . 63.109999999999999 113.24 0.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -118.16 155.12 31.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 72.209999999999994 111.084 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.7 ttmt -141.92 107.04 4.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.102 -0.499 . . . . 71.450000000000003 111.176 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 33' ' ' HIS . 11.9 t -106.38 129.42 59.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.755 -0.657 . . . . 73.239999999999995 109.53 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 67.91 21.39 8.99 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.745 0.783 . . . . 72.310000000000002 110.811 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.57 24.16 65.86 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.869 -0.682 . . . . 62.439999999999998 111.771 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.1 tpt180 -124.05 136.93 54.6 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.267 -0.642 . . . . 74.420000000000002 109.267 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.64 112.02 18.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.394 0.616 . . . . 62.130000000000003 109.626 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -107.38 150.84 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.011 -0.541 . . . . 70.299999999999997 110.974 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -112.86 95.46 33.73 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.221 -0.899 . . . . 74.239999999999995 110.828 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.51 127.8 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.95 1.767 . . . . 72.310000000000002 111.095 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -132.45 171.12 14.18 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 74.230000000000004 109.163 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -70.72 133.22 46.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.765 -0.457 . . . . 74.25 109.765 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -67.61 96.62 0.55 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.418 0.628 . . . . 65.239999999999995 109.666 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 t -56.55 135.48 20.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.347 -1.297 . . . . 64.349999999999994 111.643 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t -54.61 143.84 23.5 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.245 -0.889 . . . . 72.140000000000001 109.846 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -61.04 -18.45 57.86 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.43 0.456 . . . . 75.329999999999998 112.137 -173.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.97 -45.24 61.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.458 -0.337 . . . . 74.420000000000002 110.741 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.31 -31.56 24.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.688 -0.233 . . . . 74.040000000000006 111.066 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 21.7 p -76.48 4.05 9.97 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.062 0.458 . . . . 70.439999999999998 111.257 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -86.11 -10.09 55.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 109.138 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -94.94 150.64 38.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.44 -0.8 . . . . 75.140000000000001 109.872 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.54 124.87 7.91 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.585 2.19 . . . . 75.120000000000005 112.511 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.46 30.27 11.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.162 -0.542 . . . . 72.409999999999997 112.23 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.98 -30.28 24.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.976 0.362 . . . . 72.109999999999999 111.976 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.18 8.49 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.654 0.264 . . . . 75.420000000000002 111.55 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.14 159.68 31.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.717 -0.475 . . . . 65.030000000000001 109.717 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 80.28 7.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.595 0.712 . . . . 74.049999999999997 110.481 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -108.78 118.46 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.075 -0.966 . . . . 72.230000000000004 109.46 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -105.53 21.34 17.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.612 . . . . 72.230000000000004 110.081 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -119.2 139.7 51.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 71.420000000000002 110.997 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.7 pt -130.95 149.87 34.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.305 0.574 . . . . 71.239999999999995 111.386 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.8 t80 -94.78 133.33 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.716 -1.129 . . . . 72.129999999999995 109.906 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.58 109.55 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.063 -0.717 . . . . 73.140000000000001 109.063 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.84 159.72 21.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.569 -1.3 . . . . 72.140000000000001 113.755 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.07 6.45 53.84 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.697 -0.764 . . . . 74.310000000000002 112.406 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.0 pt -66.38 124.48 21.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.26 0.553 . . . . 75.140000000000001 109.877 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -21.57 20.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.807 -0.633 . . . . 73.099999999999994 112.284 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -142.16 -168.41 2.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.467 -0.197 . . . . 65.340000000000003 110.467 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.42 101.48 0.05 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 124.073 0.858 . . . . 73.540000000000006 111.364 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -109.63 124.23 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.63 -0.878 . . . . 72.430000000000007 108.63 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -113.01 -179.39 3.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.585 -0.734 . . . . 64.150000000000006 111.635 -169.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.18 -53.66 55.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.929 -1.032 . . . . 70.340000000000003 111.493 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.58 -28.24 69.5 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.079 0.237 . . . . 73.420000000000002 111.182 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -53.84 -62.65 1.52 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.184 0.516 . . . . 72.209999999999994 110.596 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.27 -26.68 28.42 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.113 -0.635 . . . . 75.439999999999998 111.532 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 2.0 tmm_? -67.29 -48.28 68.13 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 110.07 -0.345 . . . . 70.510000000000005 110.07 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.87 -29.76 70.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.99 0.424 . . . . 73.019999999999996 110.5 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -77.39 -56.82 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.081 -0.509 . . . . 71.530000000000001 112.078 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -67.49 -21.99 65.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.414 0.524 . . . . 74.239999999999995 112.414 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.8 mt-10 -69.02 -19.96 64.13 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.527 0.195 . . . . 73.439999999999998 111.527 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.09 -30.05 64.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.985 0.421 . . . . 73.310000000000002 110.98 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.6 -30.89 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 74.329999999999998 111.637 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.23 -172.28 44.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.661 -0.781 . . . . 73.310000000000002 112.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -76.22 136.19 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.176 0.512 . . . . 73.129999999999995 111.681 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 152' ' ' THR . 90.8 mt -106.54 138.45 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 72.230000000000004 110.006 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.61 -46.98 8.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 74.239999999999995 111.038 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.56 154.93 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 75.109999999999999 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -114.62 128.54 71.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.124 0.487 . . . . 73.510000000000005 110.046 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -102.71 104.58 14.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.364 -0.834 . . . . 70.319999999999993 111.047 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.86 122.94 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.261 -0.644 . . . . 70.310000000000002 109.261 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.4 mmm -105.74 141.62 36.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.907 0.384 . . . . 74.030000000000001 110.192 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 74.049999999999997 110.87 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.684 0 CA-C-O 119.408 -0.662 . . . . 74.510000000000005 113.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -173.04 159.74 4.03 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.054 0.927 . . . . 75.450000000000003 110.509 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.55 175.69 9.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.436 -0.802 . . . . 74.510000000000005 109.182 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.402 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 53.6 m-85 -141.16 154.45 45.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.945 0.402 . . . . 70.420000000000002 110.321 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.67 132.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.318 0.58 . . . . 71.430000000000007 111.271 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 131' ' ' ILE . 26.0 m -101.49 126.6 48.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.344 -0.843 . . . . 75.209999999999994 110.883 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.53 158.03 16.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 71.420000000000002 111.45 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.3 -29.3 53.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.637 -0.71 . . . . 75.450000000000003 110.567 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -130.11 155.55 46.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 74.400000000000006 110.877 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -82.89 -26.5 31.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.540000000000006 110.351 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 31.9 t70 -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 110.673 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 m -68.7 -32.78 72.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 61.240000000000002 110.799 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.16 -39.86 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 74.450000000000003 109.783 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HA ' HG21 ' A' ' 163' ' ' VAL . 2.1 t70 -69.5 -33.49 72.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.224 -0.898 . . . . 74.400000000000006 111.152 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 55.9 mttm -53.54 -38.88 64.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.917 0.865 . . . . 75.140000000000001 110.29 172.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.402 ' CG2' HG13 ' A' ' 177' ' ' VAL . 33.8 mt -77.78 -45.32 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.405 -1.27 . . . . 75.349999999999994 113.011 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 160' ' ' ASP . 24.4 m -75.39 -4.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.198 0.523 . . . . 74.439999999999998 111.69 -172.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 161' ' ' LYS . 14.0 mt -58.35 -32.12 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 109.692 169.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.59 148.75 32.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.385 -0.825 . . . . 73.439999999999998 108.788 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.41 -37.04 13.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.0 0.429 . . . . 75.219999999999999 111.08 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.87 131.92 53.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.169 -0.468 . . . . 75.239999999999995 110.145 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -122.11 140.56 52.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.065 -0.516 . . . . 63.119999999999997 110.337 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 m -89.98 106.72 18.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.147 0.499 . . . . 75.409999999999997 111.402 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.22 130.15 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.83 . . . . 72.140000000000001 109.083 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t30 50.22 41.63 24.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.728 0.775 . . . . 74.329999999999998 111.641 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.55 69.54 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.616 -0.72 . . . . 41.130000000000003 113.347 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -126.52 131.55 51.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.79 0.295 . . . . 51.520000000000003 110.453 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.19 108.19 13.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.477 . . . . 75.5 109.711 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.71 146.81 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 109.755 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -86.4 131.9 34.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.841 0.353 . . . . 72.219999999999999 110.228 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 37.4 t -129.19 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.925 -0.58 . . . . 73.209999999999994 111.06 -173.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -157.78 171.6 20.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.593 -0.73 . . . . 75.409999999999997 111.232 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -61.22 122.76 15.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.854 -0.425 . . . . 75.530000000000001 109.854 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -104.82 111.67 24.5 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.339 0.59 . . . . 61.43 109.884 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 115.384 -0.825 . . . . 64.530000000000001 109.395 -178.099 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.127 0.489 . . . . 72.329999999999998 110.838 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.39 137.36 74.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.655 -0.702 . . . . 74.25 110.202 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 10.5 Cg_endo -61.58 161.33 24.8 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.386 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.02 64.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.164 -0.471 . . . . 62.009999999999998 111.664 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.95 -33.33 75.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.322 0.49 . . . . 64.319999999999993 112.322 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 28.8 mt -85.19 -14.58 46.44 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 122.095 -0.378 . . . . 75.099999999999994 110.838 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -117.75 0.8 12.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 111.363 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -96.71 148.08 23.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.667 0.746 . . . . 75.219999999999999 111.53 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -118.74 144.3 46.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.712 -1.131 . . . . 75.510000000000005 110.424 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -96.47 117.02 30.03 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.326 -0.99 . . . . 74.420000000000002 108.326 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 mm -96.88 110.82 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.779 -0.452 . . . . 75.040000000000006 109.779 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.43 155.0 16.73 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.507 -0.854 . . . . 72.049999999999997 111.578 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.57 45.25 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.774 -0.727 . . . . 55.439999999999998 113.244 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD23 ' CG1' ' A' ' 84' ' ' VAL . 94.3 mt -79.56 175.4 10.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.954 0.407 . . . . 71.219999999999999 110.279 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -88.5 166.73 13.99 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.487 -0.561 . . . . 63.439999999999998 109.487 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -75.93 -4.54 41.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.751 0.31 . . . . 73.329999999999998 110.846 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -122.68 14.74 10.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 74.340000000000003 111.096 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.7 m -79.85 124.33 28.55 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 61.039999999999999 110.821 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.1 p -99.78 165.68 11.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 75.319999999999993 110.346 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.67 -21.09 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.73 -0.388 . . . . 63.149999999999999 110.74 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.05 -27.7 30.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.208 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -80.36 -36.57 33.83 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.81 -0.441 . . . . 72.209999999999994 109.81 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.87 -46.58 88.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.583 -0.735 . . . . 75.400000000000006 110.135 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 ttm-85 -56.21 -56.58 19.23 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 115.792 -0.64 . . . . 74.239999999999995 111.314 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.1 t -50.96 -36.2 37.67 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.853 0.721 . . . . 72.409999999999997 112.437 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -70.28 -54.6 11.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.671 -0.24 . . . . 72.310000000000002 111.302 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -78.5 -17.18 56.62 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.895 0.332 . . . . 75.209999999999994 111.895 -170.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.34 -25.65 49.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.454 0.539 . . . . 74.219999999999999 112.454 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.87 -26.36 68.29 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.255 0.465 . . . . 53.219999999999999 112.255 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -99.64 -19.72 16.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.727 0.269 . . . . 74.129999999999995 111.727 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.36 168.74 40.62 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.289 -0.958 . . . . 70.040000000000006 112.343 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -66.96 119.76 12.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 112.008 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.61 133.54 35.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.76 -0.654 . . . . 70.510000000000005 110.524 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -107.43 -19.02 13.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.237 -0.892 . . . . 75.140000000000001 110.215 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.08 153.55 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.255 -0.646 . . . . 60.340000000000003 109.255 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.445 ' SG ' HG11 ' A' ' 60' ' ' VAL . 11.1 t -165.33 131.43 2.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.993 -0.373 . . . . 74.420000000000002 109.993 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.51 128.47 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.509 0.671 . . . . 74.349999999999994 111.348 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.14 133.85 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 73.239999999999995 108.63 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.465 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mmt -74.86 97.66 3.36 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.651 0.738 . . . . 73.530000000000001 110.1 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -99.45 152.32 20.12 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.702 -1.135 . . . . 74.409999999999997 109.49 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 37.2 t70 -70.04 127.89 92.03 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.422 -0.808 . . . . 75.239999999999995 110.619 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.56 -19.3 64.86 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.189 1.926 . . . . 71.420000000000002 113.111 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.506 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 27.6 m-80 -84.76 -56.4 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.785 0.291 . . . . 71.450000000000003 111.785 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -105.48 -8.75 17.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.986 0.422 . . . . 65.329999999999998 111.849 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp 64.16 40.63 6.75 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.577 0.751 . . . . 73.439999999999998 111.626 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -113.83 156.7 23.44 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.952 -0.758 . . . . 74.010000000000005 108.952 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m -75.69 131.68 40.04 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.917 -0.313 . . . . 73.329999999999998 110.358 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -85.66 5.78 30.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 63.5 111.349 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.08 60.07 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.617 -0.801 . . . . 65.530000000000001 114.204 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.4 p90 -158.99 155.31 27.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.82 0.81 . . . . 74.329999999999998 110.343 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.51 -163.13 14.57 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.701 -0.56 . . . . 63.329999999999998 111.701 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.85 148.81 37.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.062 0.431 . . . . 75.030000000000001 110.224 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG11 ' SG ' ' A' ' 43' ' ' CYS . 8.5 m -128.23 128.53 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.826 -0.624 . . . . 72.310000000000002 109.345 171.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.68 118.36 36.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.812 0.339 . . . . 74.349999999999994 110.272 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -85.74 161.67 19.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.902 -0.59 . . . . 65.209999999999994 109.962 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.05 -44.02 64.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.9 -0.591 . . . . 74.099999999999994 110.401 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -120.81 149.22 42.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.916 -0.584 . . . . 64.510000000000005 110.845 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.9 p -62.88 -37.38 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.565 -0.288 . . . . 71.519999999999996 111.044 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.45 -41.74 85.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.588 0.588 . . . . 72.219999999999999 112.588 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.89 -29.24 70.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.019 0.438 . . . . 73.109999999999999 110.78 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 38.9 t -63.14 -49.41 83.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.592 -0.731 . . . . 74.5 111.087 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.22 -40.69 94.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.200000000000003 111.302 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.96 -38.66 57.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 112.295 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.36 58.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.806 0.336 . . . . 74.109999999999999 110.612 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.459 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -66.62 -42.12 87.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 71.439999999999998 111.068 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -29.16 66.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.041 -0.527 . . . . 73.129999999999995 111.015 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.71 -9.29 58.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.075 0.768 . . . . 63.420000000000002 113.075 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -54.39 146.61 31.98 Favored Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.169 0.433 . . . . 72.200000000000003 112.169 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.4 168.98 72.66 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.312 -1.12 . . . . 75.140000000000001 113.385 1.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -123.54 161.19 25.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.532 -0.758 . . . . 71.129999999999995 110.39 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.5 ttmt -137.21 112.64 9.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.826 0.346 . . . . 73.299999999999997 111.35 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.14 126.98 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.973 -0.558 . . . . 71.129999999999995 109.936 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.53 26.9 9.82 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.692 0.62 . . . . 72.230000000000004 111.915 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.88 23.36 66.91 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.951 -0.643 . . . . 37.270000000000003 112.191 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 tpt180 -126.29 135.43 51.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.107 -0.331 . . . . 73.140000000000001 110.107 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.66 111.71 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.123 -0.695 . . . . 75.310000000000002 109.123 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.438 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.3 m -107.7 152.49 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 74.140000000000001 111.853 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.26 94.42 30.93 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.762 -1.108 . . . . 74.340000000000003 111.402 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.459 ' O ' ' HE1' ' A' ' 72' ' ' MET . 22.3 Cg_endo -72.19 127.96 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.678 1.585 . . . . 62.420000000000002 110.463 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -131.69 168.88 16.99 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 75.140000000000001 109.324 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 10.0 tpp180 -73.25 130.51 40.37 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.977 -0.289 . . . . 74.140000000000001 110.562 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.68 93.58 0.73 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.073 0.463 . . . . 74.329999999999998 110.3 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.24 156.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.369 -0.832 . . . . 73.040000000000006 110.546 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -55.3 154.16 6.31 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.098 0.559 . . . . 74.340000000000003 111.808 -177.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -58.16 -40.13 80.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.038 -0.528 . . . . 74.129999999999995 111.883 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.92 -50.59 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 50.530000000000001 110.651 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -70.74 -29.29 65.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.632 -0.713 . . . . 65.540000000000006 111.409 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -67.18 -17.55 64.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.403 -0.362 . . . . 75.239999999999995 111.295 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -82.22 -12.47 58.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.953 0.406 . . . . 64.129999999999995 110.837 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.24 151.23 78.12 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.483 -0.326 . . . . 73.150000000000006 110.379 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.83 117.16 4.06 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.101 2.534 . . . . 74.0 112.717 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.63 43.16 69.26 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.958 -0.564 . . . . 44.530000000000001 112.812 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.05 -34.6 73.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.879 0.371 . . . . 64.400000000000006 111.418 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -99.4 19.71 15.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 111.677 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.0 154.38 35.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 75.519999999999996 109.609 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 m -74.38 86.85 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.706 0.765 . . . . 71.319999999999993 110.445 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.0 t -114.89 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 74.319999999999993 109.343 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -104.19 16.5 26.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.11 0.414 . . . . 72.319999999999993 111.101 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -117.16 139.96 50.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.594 -0.276 . . . . 64.540000000000006 111.022 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.3 pt -123.55 147.48 27.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.263 0.554 . . . . 53.130000000000003 111.111 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.2 t80 -97.68 131.43 44.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.779 -1.1 . . . . 72.219999999999999 109.628 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.04 110.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.868 -0.789 . . . . 74.040000000000006 108.868 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.88 148.02 19.27 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.998 -1.096 . . . . 70.319999999999993 112.31 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.61 6.15 29.07 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.207 -0.997 . . . . 61.539999999999999 112.217 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.6 pt -76.54 103.99 4.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.556 0.693 . . . . 74.099999999999994 110.468 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.19 -24.48 34.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 75.450000000000003 110.996 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.45 171.37 7.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.863 0.364 . . . . 72.099999999999994 110.558 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.99 125.45 26.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 73.150000000000006 110.057 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 m -124.12 139.27 54.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.15 0.5 . . . . 75.120000000000005 110.323 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -112.88 174.69 5.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.591 -0.731 . . . . 75.209999999999994 111.796 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.03 -57.24 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.847 -1.07 . . . . 71.549999999999997 112.132 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -64.68 -23.79 67.37 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 123.07 0.231 . . . . 75.219999999999999 111.066 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -57.08 -58.99 5.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.97 0.415 . . . . 74.530000000000001 110.558 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -83.67 -25.3 30.82 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.674 -0.81 . . . . 75.310000000000002 111.549 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.8 -51.5 58.55 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.737 -0.468 . . . . 75.439999999999998 109.737 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.78 -32.99 73.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 74.439999999999998 110.413 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CD2' HG23 ' A' ' 170' ' ' VAL . 92.6 t80 -73.06 -57.81 3.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.982 -0.554 . . . . 72.209999999999994 112.187 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -68.33 -22.3 64.7 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.563 0.579 . . . . 74.329999999999998 112.563 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.97 -24.93 67.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.827 0.346 . . . . 74.040000000000006 111.468 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -55.78 -26.04 44.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.748 -0.66 . . . . 71.409999999999997 111.83 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -91.82 -20.83 21.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.162 0.43 . . . . 75.430000000000007 112.162 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.01 -172.48 42.12 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.416 -0.897 . . . . 63.340000000000003 113.396 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -76.35 131.99 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 74.310000000000002 111.248 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 152' ' ' THR . 71.8 mt -103.79 139.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.735 -0.666 . . . . 73.540000000000006 109.936 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.76 -48.65 6.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.825 0.345 . . . . 75.340000000000003 110.944 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -157.38 157.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.261 -0.427 . . . . 72.230000000000004 109.961 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.52 130.29 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.551 -0.537 . . . . 73.239999999999995 109.551 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -103.69 103.31 13.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.213 -0.449 . . . . 62.530000000000001 110.946 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.2 mm -91.38 125.43 44.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.461 -0.57 . . . . 72.329999999999998 109.461 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.9 mmm -105.91 133.25 50.93 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.083 -0.71 . . . . 71.230000000000004 109.083 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 74.329999999999998 112.025 -174.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 119.736 -0.48 . . . . 75.109999999999999 113.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -172.85 157.46 3.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.633 0.717 . . . . 75.409999999999997 109.526 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.0 172.3 13.24 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.63 . . . . 75.319999999999993 109.694 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -138.46 155.67 48.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.732 -0.667 . . . . 75.219999999999999 109.745 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.41 136.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.301 0.572 . . . . 71.400000000000006 110.809 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 131' ' ' ILE . 98.9 m -100.52 125.05 46.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.02 -0.991 . . . . 74.310000000000002 110.944 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -100.61 157.67 16.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.875 0.369 . . . . 63.240000000000002 110.59 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.28 -30.29 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.766 -0.652 . . . . 53.240000000000002 110.312 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -130.97 155.34 46.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 74.400000000000006 110.823 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -80.12 -26.34 39.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.310000000000002 110.514 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 17.0 t70 -63.01 -39.16 93.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 111.169 -173.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 -31.42 72.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.375 -0.375 . . . . 73.200000000000003 110.781 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 163' ' ' VAL . 3.2 t -69.81 -45.33 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.289 -0.414 . . . . 61.420000000000002 110.195 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.415 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 20.1 m-20 -71.04 -23.96 62.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.845 -0.616 . . . . 73.209999999999994 111.586 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 88.1 mttt -63.78 -40.95 97.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 74.439999999999998 110.095 170.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.37 -42.54 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.695 -1.139 . . . . 71.109999999999999 112.122 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 159' ' ' VAL . 13.4 m -73.81 -12.25 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 74.510000000000005 110.789 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.431 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 6.8 mt -58.55 -29.37 38.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 72.239999999999995 109.829 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.3 mt-30 -112.44 98.7 7.45 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.613 -0.884 . . . . 74.420000000000002 108.613 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' A' ' 166' ' ' LYS . 1.2 ttmp? -53.37 -37.21 62.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.424 0.898 . . . . 75.019999999999996 113.424 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -121.3 131.67 54.34 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.6 -0.44 . . . . 70.25 110.576 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.7 m-70 -124.85 158.09 34.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 74.019999999999996 109.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.2 m -102.82 103.38 13.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.081 0.467 . . . . 74.040000000000006 110.379 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 124' ' ' TYR . 3.7 t -118.53 140.5 41.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.71 -0.677 . . . . 74.219999999999999 109.177 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.5 t30 56.77 31.02 18.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.966 0.889 . . . . 75.420000000000002 111.009 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.85 16.96 74.88 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.341 -0.845 . . . . 51.210000000000001 113.303 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -130.7 138.67 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.767 0.283 . . . . 72.510000000000005 110.356 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.68 110.9 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 73.450000000000003 110.535 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.81 158.07 29.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.066 -0.97 . . . . 75.430000000000007 111.102 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.56 133.1 34.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.123 -0.49 . . . . 54.030000000000001 110.187 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.8 t -128.83 132.12 67.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.345 -0.843 . . . . 75.409999999999997 110.057 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -155.4 175.98 13.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 75.150000000000006 111.15 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -62.14 122.9 16.73 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.82 -0.437 . . . . 75.540000000000006 109.82 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.441 ' HB1' ' N ' ' A' ' 108' ' ' PHE . . . -107.21 115.13 29.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.084 0.469 . . . . 60.409999999999997 110.719 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 108.392 -0.966 . . . . 74.5 108.392 173.558 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 N-CA-C 112.287 0.477 . . . . 73.120000000000005 112.287 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.91 150.27 38.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 C-N-CA 120.658 -0.417 . . . . 73.420000000000002 110.175 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' HD23 ' A' ' 13' ' ' LEU . 36.1 Cg_endo -70.65 167.32 25.94 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.254 1.969 . . . . 64.340000000000003 112.076 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -37.06 68.75 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.006 -0.543 . . . . 74.329999999999998 112.283 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.43 -16.41 63.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.044 0.387 . . . . 72.439999999999998 112.044 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 10' ' ' PRO . 5.6 mp -96.01 -14.63 22.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.742 0.306 . . . . 73.329999999999998 111.112 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 68' ' ' VAL . 16.5 ptt180 -118.84 2.22 11.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.044 0.45 . . . . 75.450000000000003 110.767 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -98.98 149.63 22.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.751 0.786 . . . . 74.409999999999997 111.603 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 87' ' ' LYS . 61.0 mt -117.13 146.45 43.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.552 -1.203 . . . . 72.129999999999995 110.46 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -99.21 121.62 41.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.65 -0.87 . . . . 74.409999999999997 108.65 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.92 112.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 110.052 -0.351 . . . . 64.430000000000007 110.052 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.77 150.32 18.31 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.929 -0.653 . . . . 71.239999999999995 111.703 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 45.95 42.5 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.767 -0.73 . . . . 65.010000000000005 113.541 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.08 163.43 23.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.704 -0.48 . . . . 73.019999999999996 109.704 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 p -80.97 169.21 17.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.327 -0.62 . . . . 71.430000000000007 109.327 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -72.33 -11.52 60.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 73.530000000000001 110.316 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.89 15.26 17.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 71.329999999999998 111.314 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.1 m -82.41 126.9 32.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.152 0.501 . . . . 73.120000000000005 110.942 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 164.09 12.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 63.439999999999998 110.325 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.06 -25.79 60.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.184 -0.206 . . . . 54.43 110.879 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.67 -37.47 82.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 73.329999999999998 110.493 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 m -80.23 -37.25 33.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 72.239999999999995 110.943 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.0 -43.56 98.44 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.458 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 31' ' ' ARG . 14.6 ttm180 -60.86 -55.49 32.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.886 -0.413 . . . . 75.409999999999997 109.886 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.7 m -47.23 -39.52 14.36 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 124.313 1.008 . . . . 75.030000000000001 113.067 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -70.68 -61.27 1.83 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 71.430000000000007 111.583 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -69.91 -21.82 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 72.530000000000001 112.201 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 28.9 tt0 -63.74 -16.88 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.813 0.445 . . . . 73.209999999999994 111.857 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.27 -26.62 68.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.563 0.221 . . . . 73.439999999999998 111.081 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -99.56 -19.98 16.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.205 0.446 . . . . 75.019999999999996 112.205 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -175.53 168.7 41.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.218 -0.992 . . . . 74.129999999999995 112.707 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.5 m -65.98 119.14 10.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 72.5 111.99 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.72 122.24 34.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.706 0.765 . . . . 71.109999999999999 111.215 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -89.72 -25.77 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.154 -1.385 . . . . 73.099999999999994 110.116 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -152.3 153.34 33.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.394 -0.821 . . . . 62.32 109.642 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -161.06 130.24 4.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.748 -0.464 . . . . 63.32 109.748 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.03 123.8 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.481 0.658 . . . . 71.030000000000001 110.516 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.39 135.06 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.224 -1.028 . . . . 75.329999999999998 108.224 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -74.17 95.35 2.58 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.782 0.801 . . . . 71.150000000000006 109.641 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -104.91 164.57 11.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.102 -1.408 . . . . 75.219999999999999 110.257 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.46 128.46 87.23 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.936 -0.765 . . . . 62.149999999999999 108.936 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.78 -18.73 65.23 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.181 1.921 . . . . 70.030000000000001 113.377 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -86.39 -55.69 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 74.099999999999994 110.89 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -99.63 -14.89 18.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.008 -0.996 . . . . 75.409999999999997 112.331 -170.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm 65.76 26.8 11.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.924 0.89 . . . . 71.409999999999997 111.367 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -102.54 153.32 20.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.552 -0.536 . . . . 75.150000000000006 109.552 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.0 137.72 51.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 73.519999999999996 112.145 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -88.83 4.89 46.14 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.463 -0.79 . . . . 73.129999999999995 110.441 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.08 17.7 58.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.057 -0.592 . . . . 73.129999999999995 114.385 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.4 p90 -159.1 155.68 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.607 0.703 . . . . 73.219999999999999 110.155 174.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.45 20.22 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.825 -0.51 . . . . 50.240000000000002 111.825 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.19 149.76 40.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.032 0.416 . . . . 73.400000000000006 110.852 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.9 127.0 65.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.614 -0.721 . . . . 70.109999999999999 109.496 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 121.37 43.22 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.292 -0.255 . . . . 70.299999999999997 110.654 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.9 178.28 7.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.176 -0.466 . . . . 73.049999999999997 111.084 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.06 -28.81 18.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.683 -0.69 . . . . 41.119999999999997 110.796 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -144.05 147.69 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 74.219999999999999 110.698 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -57.54 -35.38 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 122.863 0.465 . . . . 71.030000000000001 111.913 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.09 -39.56 63.45 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.15 0.796 . . . . 72.230000000000004 113.15 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -70.78 -27.12 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 71.329999999999998 110.303 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 19.7 t -66.61 -47.3 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.334 -0.848 . . . . 72.409999999999997 110.08 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.97 -46.07 85.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 75.409999999999997 110.702 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.53 -41.25 53.55 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.466 0.543 . . . . 65.519999999999996 112.466 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.48 -32.23 58.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 72.120000000000005 110.96 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.3 mmt -70.74 -36.21 73.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 63.130000000000003 110.107 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -12.6 59.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.481 -0.781 . . . . 74.329999999999998 110.512 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.28 -11.35 38.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.731 -0.668 . . . . 71.400000000000006 110.269 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp85 -57.87 142.1 79.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.241 -0.891 . . . . 74.239999999999995 110.402 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 Cg_endo -79.95 169.0 71.5 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.694 -0.961 . . . . 75.099999999999994 114.363 4.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 86' ' ' PRO . 69.0 m-70 -129.0 158.54 38.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.879 . . . . 71.409999999999997 110.447 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -137.43 106.9 6.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.071 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.95 130.9 59.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.242 -0.435 . . . . 72.040000000000006 109.901 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 65.05 29.31 12.19 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.667 0.604 . . . . 73.049999999999997 111.674 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.44 26.08 72.73 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.936 -0.575 . . . . 73.140000000000001 112.117 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.8 tpt180 -129.0 139.11 52.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 65.140000000000001 109.841 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.25 107.67 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.584 -0.525 . . . . 70.230000000000004 109.584 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.48 151.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.259 0.552 . . . . 63.439999999999998 110.824 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -112.03 94.43 25.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 72.420000000000002 111.087 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.434 ' HG3' ' CD2' ' A' ' 77' ' ' HIS . 38.2 Cg_endo -74.31 132.28 16.2 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.069 1.846 . . . . 74.530000000000001 111.385 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' O ' HD21 ' A' ' 16' ' ' LEU . 8.9 mttt -137.12 174.24 10.83 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.291 -1.003 . . . . 73.439999999999998 108.291 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.0 tmm_? -76.77 131.04 38.49 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.653 -0.869 . . . . 73.049999999999997 108.653 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.09 96.36 0.14 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.043 0.449 . . . . 75.420000000000002 111.755 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 100' ' ' ALA . 40.3 t -69.07 137.23 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.113 -0.948 . . . . 73.239999999999995 110.497 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 t -86.88 -176.56 5.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.732 -0.667 . . . . 73.420000000000002 109.789 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -68.63 -41.6 79.23 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.553 0.946 . . . . 72.400000000000006 113.553 -167.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.71 -35.4 52.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.729 -0.389 . . . . 73.510000000000005 111.198 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -14.3 59.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.771 0.319 . . . . 63.219999999999999 110.363 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t -80.57 -20.09 44.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 63.409999999999997 109.824 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -71.33 -20.37 62.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.811 -0.632 . . . . 75.420000000000002 109.797 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.22 147.67 88.07 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.661 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.14 128.61 17.86 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.817 2.345 . . . . 75.439999999999998 112.098 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.4 39.31 22.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.019 -0.61 . . . . 74.040000000000006 111.993 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -66.03 -54.3 27.72 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.876 0.324 . . . . 75.140000000000001 111.876 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -107.66 11.14 28.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.044 0.449 . . . . 75.519999999999996 110.621 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 151.58 25.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.583 -0.525 . . . . 74.450000000000003 109.583 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.427 HG23 ' CD2' ' A' ' 156' ' ' HIS . 5.8 m -72.52 105.84 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.735 . . . . 73.120000000000005 110.359 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.435 ' HB ' ' CE ' ' A' ' 179' ' ' LYS . 61.4 t -132.21 116.27 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.867 -1.061 . . . . 72.430000000000007 109.43 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -102.6 13.6 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.417 -0.513 . . . . 71.349999999999994 110.67 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.38 139.66 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.315 -0.402 . . . . 71.219999999999999 110.792 177.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -120.97 149.16 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.261 0.553 . . . . 65.219999999999999 111.388 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.3 t80 -98.76 132.21 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.774 -1.103 . . . . 74.150000000000006 109.441 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 111.08 28.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.217 -0.66 . . . . 75.0 109.217 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -132.88 148.41 19.27 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 119.907 -1.139 . . . . 72.109999999999999 112.601 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 6.72 36.7 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.347 -0.93 . . . . 60.32 112.948 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.76 105.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.522 0.677 . . . . 75.219999999999999 110.526 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -74.97 -53.44 8.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.496 -0.775 . . . . 70.219999999999999 110.62 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -73.09 155.45 39.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.416 -0.811 . . . . 72.140000000000001 109.805 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.53 134.73 55.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 109.739 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -116.24 145.26 43.27 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 109.899 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.86 158.63 17.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.053 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.12 -44.48 79.18 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 123.93 0.769 . . . . 75.140000000000001 110.289 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -56.52 -35.68 68.32 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.409 0.284 . . . . 74.109999999999999 111.603 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -62.66 -59.92 4.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.331 -0.395 . . . . 73.510000000000005 110.841 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.29 -21.65 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.253 -0.579 . . . . 74.319999999999993 111.138 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 7.2 tmm_? -66.36 -55.67 14.78 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 110.138 -0.319 . . . . 75.420000000000002 110.138 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -61.39 -26.41 67.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.361 0.6 . . . . 72.420000000000002 110.481 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -75.8 -58.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.39 -0.823 . . . . 75.510000000000005 112.252 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CD2' HG22 ' A' ' 151' ' ' VAL . 47.3 m-85 -69.08 -21.84 64.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 111.735 0.272 . . . . 75.109999999999999 111.735 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mm-40 -64.55 -24.73 67.7 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.917 0.389 . . . . 61.009999999999998 111.076 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -58.69 -27.59 64.97 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.921 -0.582 . . . . 64.239999999999995 111.636 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -87.24 -32.19 19.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 74.230000000000004 112.009 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.41 -174.71 47.17 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.828 -0.701 . . . . 75.200000000000003 113.001 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -74.03 126.62 30.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.302 0.572 . . . . 70.219999999999999 112.184 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 152' ' ' THR . 63.3 mt -97.36 139.42 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.118 -0.946 . . . . 74.400000000000006 109.72 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -90.34 -48.62 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 70.099999999999994 110.731 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.52 154.48 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 109.777 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.63 125.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.376 -0.601 . . . . 75.219999999999999 109.376 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.43 103.91 15.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.666 -0.697 . . . . 55.310000000000002 110.7 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.3 mm -95.63 129.47 45.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.775 -0.454 . . . . 73.219999999999999 109.775 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.6 mtp -110.95 146.16 37.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.746 -0.835 . . . . 62.530000000000001 108.746 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 74.530000000000001 112.222 -175.657 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.895 0 CA-C-O 119.918 -0.379 . . . . 75.030000000000001 112.751 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -169.48 148.33 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.688 -0.486 . . . . 75.239999999999995 109.688 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.98 172.76 12.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.844 -0.616 . . . . 74.329999999999998 109.516 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.474 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 55.1 m-85 -140.89 151.72 44.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.012 -0.54 . . . . 71.519999999999996 110.454 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 125' ' ' PHE . 94.9 t -134.13 129.52 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.587 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 131' ' ' ILE . 64.0 m -99.85 123.23 43.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 70.409999999999997 110.206 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -104.06 159.69 15.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.732 0.301 . . . . 73.109999999999999 110.381 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.94 -24.09 48.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.33 0.586 . . . . 64.349999999999994 110.761 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 4.4 t70 -138.41 156.67 47.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.726 . . . . 72.439999999999998 110.148 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.427 ' CD2' HG23 ' A' ' 103' ' ' THR . 23.6 p80 -79.79 -21.41 44.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.415 -0.357 . . . . 74.239999999999995 110.038 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.551 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.4 p-10 -58.91 -39.61 82.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.443 -0.799 . . . . 72.530000000000001 111.026 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -76.32 -29.35 57.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.073 -0.512 . . . . 75.519999999999996 110.532 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.7 t -69.58 -40.22 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.59 -0.522 . . . . 73.299999999999997 109.59 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -24.3 61.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.348 -0.842 . . . . 74.150000000000006 111.453 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 72.8 mttt -68.21 -34.12 75.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 74.549999999999997 110.234 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.86 -40.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.181 -0.918 . . . . 75.239999999999995 112.281 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 159' ' ' VAL . 12.2 m -73.0 -6.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.15 0.5 . . . . 74.129999999999995 111.362 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -54.74 -38.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.079 -0.964 . . . . 75.230000000000004 110.171 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -107.55 114.2 28.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.386 -0.825 . . . . 75.450000000000003 109.473 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -53.85 -41.5 67.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.402 -0.817 . . . . 74.030000000000001 112.187 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.89 138.61 54.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.243 -0.435 . . . . 75.319999999999993 110.859 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -124.25 152.89 42.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.631 -0.713 . . . . 74.150000000000006 109.218 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -122.84 113.28 18.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.324 0.583 . . . . 75.219999999999999 110.035 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.59 113.96 41.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.507 -0.769 . . . . 74.450000000000003 109.92 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 70.44 24.1 4.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.128 0.489 . . . . 53.450000000000003 110.789 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.2 78.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.861 -0.685 . . . . 72.329999999999998 112.448 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.27 111.08 21.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.856 -0.424 . . . . 75.120000000000005 109.856 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.4 131.68 34.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.313 -0.625 . . . . 71.140000000000001 109.313 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 p -143.99 149.27 36.47 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.263 -0.426 . . . . 64.049999999999997 111.436 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.52 130.57 35.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.632 -0.877 . . . . 74.109999999999999 108.632 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.7 t -127.74 137.21 58.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.857 -0.611 . . . . 74.510000000000005 110.501 -175.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -161.99 177.97 9.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.264 -0.88 . . . . 73.450000000000003 110.972 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.435 ' CE ' ' HB ' ' A' ' 104' ' ' VAL . 7.0 mmmm -67.74 122.03 17.23 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.671 -0.492 . . . . 73.439999999999998 109.671 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -93.73 114.9 27.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.895 0.378 . . . . 74.430000000000007 110.445 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 110.831 179.029 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.047 -1.094 . . . . 61.539999999999999 108.047 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 1.6 mp0 -61.55 131.44 92.64 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 113.649 -1.614 . . . . 62.229999999999997 111.704 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 16.4 Cg_endo -59.95 168.43 5.85 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.703 2.935 . . . . 72.230000000000004 112.99 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.45 59.85 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.617 -0.719 . . . . 65.519999999999996 111.92 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.14 0.422 . . . . 72.420000000000002 112.14 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 13.3 mt -85.29 -20.91 29.32 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 122.094 -0.379 . . . . 74.230000000000004 110.671 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 ptt-85 -108.7 -2.9 18.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.863 0.363 . . . . 75.409999999999997 111.027 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.8 ttpt -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.599 0.714 . . . . 74.430000000000007 111.944 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.7 mt -118.97 145.28 45.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.801 -1.09 . . . . 65.409999999999997 110.034 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -97.09 123.57 40.88 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.398 -0.964 . . . . 74.209999999999994 108.398 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -103.02 110.22 29.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.83 -0.433 . . . . 62.409999999999997 109.83 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.69 150.48 17.95 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.046 -0.597 . . . . 64.310000000000002 111.794 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.75 52.92 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.846 -0.692 . . . . 53.43 113.168 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.8 mt -78.74 176.8 9.19 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.283 -0.636 . . . . 73.340000000000003 109.283 171.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p -83.5 167.64 17.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.152 -1.055 . . . . 75.450000000000003 108.152 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -79.51 0.42 29.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.933 0.396 . . . . 74.200000000000003 110.639 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -125.38 15.59 8.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.837 -0.62 . . . . 74.209999999999994 111.568 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -74.11 130.62 40.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.662 0.267 . . . . 74.209999999999994 111.072 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.3 p -104.77 163.67 12.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 74.519999999999996 110.293 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -28.31 64.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.405 -0.361 . . . . 70.549999999999997 111.193 -176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.93 -35.77 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.513 0.197 . . . . 75.450000000000003 111.244 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -75.94 -36.61 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.665 -0.243 . . . . 72.209999999999994 110.687 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.9 -48.25 77.39 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.704 -0.48 . . . . 74.450000000000003 109.704 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -54.96 -60.86 2.78 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 115.379 -0.828 . . . . 73.510000000000005 111.951 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -50.23 -31.66 14.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.738 0.648 . . . . 72.299999999999997 112.386 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -73.14 -60.72 2.1 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.201 -0.2 . . . . 74.310000000000002 110.817 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.36 -22.13 64.68 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.109 0.411 . . . . 74.329999999999998 112.109 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.47 -25.51 51.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.312 0.645 . . . . 61.219999999999999 112.078 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.5 -27.03 65.79 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.236 0.458 . . . . 72.450000000000003 112.236 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -99.05 -19.68 17.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.582 0.215 . . . . 72.530000000000001 111.582 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.0 28.09 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.851 -0.69 . . . . 63.439999999999998 111.771 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -63.82 119.49 10.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.441 . . . . 62.140000000000001 111.329 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.7 136.24 33.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.589 -0.732 . . . . 70.319999999999993 110.487 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 p -103.97 -21.79 13.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.42 -0.809 . . . . 74.230000000000004 110.194 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -150.84 150.11 30.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 75.340000000000003 109.674 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -159.9 130.27 5.57 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.713 -0.477 . . . . 75.430000000000007 109.713 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.76 129.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.383 0.611 . . . . 72.200000000000003 111.083 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -87.77 128.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.79 -0.819 . . . . 71.439999999999998 108.79 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -72.9 98.45 2.47 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.669 0.747 . . . . 64.329999999999998 110.278 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -103.37 161.24 14.0 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.385 -1.279 . . . . 74.120000000000005 110.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.52 125.2 91.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.749 -1.114 . . . . 73.299999999999997 109.793 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -65.45 -20.71 60.99 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.202 1.935 . . . . 74.519999999999996 112.575 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -83.83 -55.43 4.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 74.239999999999995 111.63 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 -8.67 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 64.420000000000002 111.85 -173.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 62.19 38.23 13.72 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 111.447 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -110.09 157.48 19.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.547 -0.909 . . . . 73.129999999999995 108.547 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -73.13 137.89 45.44 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.796 -0.362 . . . . 74.010000000000005 110.262 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -83.4 1.27 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.420000000000002 110.204 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.31 18.3 59.23 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.99 -0.624 . . . . 74.409999999999997 113.871 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -159.57 158.4 31.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.059 0.929 . . . . 74.430000000000007 110.614 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.16 -163.07 14.97 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.34 -0.704 . . . . 71.120000000000005 111.34 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.31 149.83 38.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.235 0.518 . . . . 71.510000000000005 110.702 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 m -129.67 122.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.879 -0.6 . . . . 75.310000000000002 109.844 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.1 m -98.9 121.93 41.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.624 -0.262 . . . . 74.409999999999997 110.386 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -87.18 163.4 16.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 72.420000000000002 110.704 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.15 70.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.637 -0.71 . . . . 62.109999999999999 110.144 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -124.38 144.3 50.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.427 -0.806 . . . . 74.409999999999997 110.384 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.596 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -63.17 -37.09 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.258 -0.428 . . . . 73.510000000000005 110.824 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.02 -36.93 68.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.552 0.575 . . . . 73.129999999999995 112.552 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.41 -26.81 65.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.104 0.478 . . . . 74.209999999999994 110.704 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 37.7 t -64.62 -45.46 95.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.538 -0.756 . . . . 74.099999999999994 110.468 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -52.96 -48.23 67.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.699 -0.682 . . . . 65.400000000000006 111.989 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.632 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -58.12 -37.38 74.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.607 0.595 . . . . 73.400000000000006 112.607 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.84 -34.83 78.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.396 0.617 . . . . 73.25 110.166 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.433 ' HE3' ' O ' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -69.39 -38.23 77.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 74.430000000000007 110.877 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.632 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.0 p30 -76.99 -10.46 59.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.894 0.378 . . . . 75.209999999999994 111.335 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.06 -11.59 43.66 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.906 -0.588 . . . . 75.319999999999993 112.438 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.42 148.78 8.51 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 113.284 0.846 . . . . 73.200000000000003 113.284 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.94 160.87 79.1 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.692 -1.378 . . . . 75.530000000000001 112.438 -2.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -110.4 151.53 27.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 65.400000000000006 110.152 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.1 ttmt -136.76 104.36 5.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.044 0.45 . . . . 74.540000000000006 111.131 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.8 140.31 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.695 -0.684 . . . . 73.439999999999998 109.685 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 66.25 21.68 11.02 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.573 0.749 . . . . 74.420000000000002 110.3 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 25.4 69.1 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.748 -0.66 . . . . 75.530000000000001 112.222 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 tpt180 -129.4 136.64 50.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.374 -0.232 . . . . 72.519999999999996 110.374 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -83.79 111.05 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.655 0.74 . . . . 72.200000000000003 109.992 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 m -102.84 155.34 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 112.183 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.409 ' CG ' ' HZ3' ' A' ' 87' ' ' LYS . 22.9 tp10 -111.53 96.62 32.92 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.469 -1.241 . . . . 75.329999999999998 111.006 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' HE3' ' A' ' 72' ' ' MET . 2.7 Cg_endo -80.58 130.1 7.68 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.35 2.033 . . . . 75.319999999999993 111.073 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HZ3' ' CG ' ' A' ' 85' ' ' GLU . 30.0 mttm -133.8 170.26 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.849 -0.797 . . . . 73.430000000000007 108.849 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.53 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tpp180 -70.38 137.76 50.77 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.507 -0.553 . . . . 72.299999999999997 109.507 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 97.15 0.45 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.292 0.568 . . . . 73.209999999999994 110.348 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 101' ' ' HIS . 6.6 t -55.26 136.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.433 -1.258 . . . . 64.120000000000005 111.786 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.4 ' HB2' HG12 ' A' ' 164' ' ' ILE . 2.4 t -57.84 147.26 29.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.435 -0.802 . . . . 74.129999999999995 109.904 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -52.52 -40.48 62.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.402 0.681 . . . . 73.409999999999997 112.591 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.03 -39.29 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.142 0.423 . . . . 73.140000000000001 112.142 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.28 -32.31 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.03 -0.359 . . . . 74.040000000000006 110.03 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -69.57 -12.32 61.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.941 -0.572 . . . . 72.209999999999994 110.609 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.17 -7.84 59.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 74.439999999999998 110.056 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -94.62 151.11 38.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 74.420000000000002 110.299 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 122.46 8.19 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.557 2.171 . . . . 74.219999999999999 111.974 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.56 19.5 27.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.586 -0.816 . . . . 73.510000000000005 112.578 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.49 54.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.673 0.249 . . . . 74.209999999999994 111.673 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.41 ' CD2' HG22 ' A' ' 90' ' ' VAL . 7.9 m170 -98.96 13.84 31.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.802 0.334 . . . . 71.239999999999995 111.405 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.38 171.1 13.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.851 -0.425 . . . . 74.319999999999993 109.851 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 m -89.01 78.18 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.423 0.63 . . . . 63.509999999999998 110.778 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.01 121.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.933 -1.03 . . . . 74.329999999999998 109.341 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' C ' HG22 ' A' ' 159' ' ' VAL . 88.2 mttt -107.35 21.73 17.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.164 0.507 . . . . 73.0 110.374 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 142.98 49.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.46 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 pt -132.71 150.66 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.31 0.576 . . . . 73.319999999999993 111.561 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.9 t80 -96.29 138.48 33.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.834 -1.075 . . . . 73.420000000000002 110.086 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.98 110.78 25.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.419 -0.585 . . . . 73.239999999999995 109.419 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.17 141.84 12.81 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 119.927 -1.13 . . . . 71.450000000000003 112.387 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.0 6.36 14.04 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.315 -0.945 . . . . 71.409999999999997 112.224 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -73.87 101.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.515 0.674 . . . . 74.219999999999999 109.793 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 22.73 1.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 72.019999999999996 112.628 -170.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.01 175.57 11.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.996 -0.372 . . . . 73.120000000000005 109.996 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.66 120.96 12.2 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.697 0.623 . . . . 65.409999999999997 110.561 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -122.7 146.6 47.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.175 0.512 . . . . 75.099999999999994 110.136 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.5 165.27 11.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.44 -0.8 . . . . 64.439999999999998 111.289 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.52 -47.17 87.35 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.184 -1.371 . . . . 72.109999999999999 109.61 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.47 -0.786 . . . . 74.25 111.712 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.47 -58.03 7.58 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.165 0.291 . . . . 71.349999999999994 111.185 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.16 -27.5 38.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.615 -0.834 . . . . 74.109999999999999 110.918 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.4 tmm_? -66.65 -45.0 80.37 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.977 -0.379 . . . . 73.530000000000001 109.977 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.23 -32.18 71.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.195 0.521 . . . . 75.200000000000003 110.454 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -79.48 -55.82 4.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.503 -0.771 . . . . 71.239999999999995 112.37 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 42.9 m-85 -67.7 -24.03 65.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.095 0.405 . . . . 74.510000000000005 112.095 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.4 mm-40 -66.58 -25.81 66.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.976 0.417 . . . . 74.0 110.899 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -61.03 -32.23 71.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.94 -0.573 . . . . 71.329999999999998 111.589 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -81.69 -27.91 33.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.540000000000006 111.101 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.404 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 171.36 -177.65 44.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.768 -0.651 . . . . 74.109999999999999 112.651 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.6 134.3 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.217 0.532 . . . . 74.150000000000006 111.618 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 152' ' ' THR . 79.4 mt -102.88 144.56 13.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.338 -0.846 . . . . 75.519999999999996 109.872 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -93.49 -49.1 6.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 73.120000000000005 110.825 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.35 155.32 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 109.912 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.74 129.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.344 . . . . 64.530000000000001 110.07 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.79 103.39 14.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 61.420000000000002 111.178 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.38 115.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.561 -0.533 . . . . 55.32 109.561 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ptp -111.48 152.97 26.84 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.349 -0.612 . . . . 54.539999999999999 109.349 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.68 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.834 0 CA-C-O 119.527 -0.596 . . . . 75.340000000000003 113.414 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -170.54 153.68 4.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.903 0.852 . . . . 65.109999999999999 109.973 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.38 174.75 11.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 71.349999999999994 109.474 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.85 155.21 47.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.057 -0.52 . . . . 74.439999999999998 109.985 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.07 132.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.54 0.686 . . . . 73.200000000000003 111.097 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 131' ' ' ILE . 65.0 m -97.58 124.08 41.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.085 -0.961 . . . . 75.239999999999995 110.465 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 3.7 m-85 -99.24 157.83 16.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 73.239999999999995 111.289 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.59 -29.12 45.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.14 -0.936 . . . . 52.219999999999999 110.511 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -128.68 152.22 48.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.526 . . . . 72.010000000000005 110.847 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -77.74 -28.21 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 71.349999999999994 109.887 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.9 t70 -58.12 -48.26 80.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.641 -1.163 . . . . 75.400000000000006 111.955 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.404 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 19.5 m -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 65.310000000000002 111.137 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.435 HG22 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -67.76 -41.11 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 71.019999999999996 109.775 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.41 ' OD1' HG23 ' A' ' 90' ' ' VAL . 12.8 t70 -68.08 -38.16 82.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.077 -0.965 . . . . 64.120000000000005 111.377 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 86.4 mttt -52.87 -37.28 60.23 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.517 0.675 . . . . 73.510000000000005 110.696 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mt -78.18 -44.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 74.409999999999997 112.533 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 160' ' ' ASP . 16.5 m -74.21 -15.17 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 75.319999999999993 110.725 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 91' ' ' SER . 19.0 mt -57.69 -32.11 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.935 -1.03 . . . . 75.219999999999999 110.16 172.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.523 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -111.51 101.45 9.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 75.329999999999998 108.197 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -56.98 -33.79 67.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.233 0.827 . . . . 72.519999999999996 113.233 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -122.15 135.24 54.76 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.569 -0.452 . . . . 65.319999999999993 110.989 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 92.6 m-70 -127.39 156.92 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.754 -0.657 . . . . 74.209999999999994 110.176 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 10.2 m -123.5 115.44 21.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.08 0.467 . . . . 74.439999999999998 110.834 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.58 115.57 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.782 . . . . 73.239999999999995 109.99 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 71.48 23.84 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.922 0.868 . . . . 75.150000000000006 109.749 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 95.3 -13.21 67.16 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.559 -0.746 . . . . 65.230000000000004 112.266 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 169' ' ' THR . 2.6 m80 -81.9 109.99 16.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.154 -0.313 . . . . 74.109999999999999 110.154 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -91.86 107.77 19.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.88 0.848 . . . . 63.020000000000003 109.133 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 5.7 p -124.12 156.8 36.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.093 -0.958 . . . . 72.310000000000002 111.463 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -85.97 130.51 34.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.591 -0.731 . . . . 63.119999999999997 109.154 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 11.3 t -126.63 131.24 71.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.333 -0.849 . . . . 70.209999999999994 109.696 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.38 172.93 17.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 72.25 110.933 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -62.67 124.79 21.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.256 0.348 . . . . 64.5 110.708 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -109.71 112.89 25.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.866 0.365 . . . . 63.329999999999998 110.216 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--N 1.314 -0.968 0 N-CA-C 109.395 -0.595 . . . . 74.450000000000003 109.395 177.684 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -79.1 133.61 60.78 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.833 -1.076 . . . . 75.140000000000001 109.535 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 14' ' ' ARG . 18.3 Cg_endo -62.83 163.3 22.34 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.553 2.169 . . . . 73.109999999999999 111.009 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 7.5 pt-20 -62.56 -27.1 68.94 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 111.981 0.363 . . . . 74.129999999999995 111.981 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -72.79 -32.51 65.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 110.849 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -81.36 -11.69 59.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 74.239999999999995 111.197 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 10' ' ' PRO . 32.0 ptt85 -127.06 15.77 7.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.126 0.488 . . . . 75.540000000000006 110.952 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 18.3 ttmm -97.32 151.29 20.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 75.420000000000002 111.029 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -116.76 142.6 46.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.939 -1.028 . . . . 73.200000000000003 110.129 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -98.11 120.89 39.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.169 -1.049 . . . . 75.099999999999994 108.169 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.45 110.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.873 -0.417 . . . . 74.310000000000002 109.873 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.29 152.29 17.97 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.877 -0.678 . . . . 64.230000000000004 111.565 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.83 46.8 43.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.487 -0.863 . . . . 74.409999999999997 112.981 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD23 ' CG1' ' A' ' 84' ' ' VAL . 80.5 mt -81.98 176.84 9.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.634 -0.506 . . . . 75.140000000000001 109.634 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 p -85.81 164.6 17.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.107 -1.072 . . . . 73.140000000000001 108.107 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -80.63 2.88 23.92 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.039 0.447 . . . . 73.099999999999994 110.455 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -119.81 10.7 11.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.585 -0.734 . . . . 75.209999999999994 110.995 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -71.3 121.52 18.61 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 74.530000000000001 110.807 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -94.62 154.85 17.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.003 -0.544 . . . . 75.219999999999999 109.99 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -27.45 63.83 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 121.109 -0.236 . . . . 61.229999999999997 110.867 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -77.2 -23.02 51.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 62.399999999999999 110.741 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -81.29 -41.42 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.672 -0.492 . . . . 73.430000000000007 109.672 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.13 -47.14 87.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 73.209999999999994 109.655 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.21 -62.68 1.5 Allowed 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 111.71 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.9 t -48.15 -35.05 10.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.337 0.655 . . . . 74.239999999999995 112.551 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' CG ' HG23 ' A' ' 79' ' ' VAL . 55.9 t60 -68.4 -64.91 0.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 74.150000000000006 110.687 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -71.06 -21.75 62.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.47 0.544 . . . . 74.340000000000003 112.47 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -62.54 -21.0 65.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.722 0.409 . . . . 73.239999999999995 111.703 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.76 -30.03 68.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.544 -0.298 . . . . 74.040000000000006 111.751 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -98.51 -17.29 18.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.963 0.356 . . . . 73.310000000000002 111.963 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.72 164.11 33.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.353 -0.927 . . . . 65.420000000000002 112.36 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -65.38 116.49 6.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 70.209999999999994 111.413 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -85.45 134.57 34.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.745 -0.661 . . . . 74.319999999999993 111.1 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -97.26 -28.61 13.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.202 -0.908 . . . . 63.549999999999997 110.052 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.55 150.42 32.23 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.455 -0.793 . . . . 74.239999999999995 110.373 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -158.41 129.49 6.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.467 -0.568 . . . . 73.310000000000002 109.467 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.22 129.07 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.063 0.458 . . . . 74.519999999999996 110.067 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.06 130.29 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.642 -0.873 . . . . 74.030000000000001 108.642 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 6.8 mmt -69.24 135.85 51.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.955 0.407 . . . . 75.430000000000007 109.966 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -137.43 155.62 49.13 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.53 -0.759 . . . . 73.099999999999994 109.887 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 28.5 t70 -71.57 132.48 85.45 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.829 -1.078 . . . . 55.520000000000003 110.168 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.85 -19.97 35.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.969 1.78 . . . . 73.409999999999997 112.998 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -84.82 -55.52 4.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 74.409999999999997 111.505 -176.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 m -102.77 -9.11 20.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.955 0.407 . . . . 73.519999999999996 111.739 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.5 mmtm 66.85 24.86 9.67 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.575 0.75 . . . . 74.200000000000003 112.455 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.69 163.82 12.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.944 -0.391 . . . . 65.319999999999993 109.944 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 t -69.61 143.09 53.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.305 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -88.47 1.66 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 54.420000000000002 110.526 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.39 17.76 61.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.653 -0.784 . . . . 62.210000000000001 113.813 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 41.9 p90 -158.37 159.05 35.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.334 0.567 . . . . 75.310000000000002 110.292 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.93 19.54 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.474 -0.65 . . . . 53.409999999999997 111.474 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 149.61 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.373 0.586 . . . . 75.340000000000003 110.659 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.7 130.65 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.77 -0.65 . . . . 53.310000000000002 109.694 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 m -106.49 123.28 47.84 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 122.135 -0.353 . . . . 75.230000000000004 110.487 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.7 m-85 -90.36 157.75 17.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.769 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.52 80.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 74.209999999999994 111.188 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -123.63 153.94 40.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.005 -0.543 . . . . 61.329999999999998 109.88 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.64 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 p -64.5 -30.9 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.396 -0.365 . . . . 74.340000000000003 111.352 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.17 -37.46 87.33 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.867 0.691 . . . . 74.540000000000006 112.867 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -63.61 -28.77 70.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.73 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.8 t -63.55 -49.91 80.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 65.319999999999993 109.856 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.67 -51.35 60.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.327 -0.851 . . . . 72.140000000000001 111.29 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -46.67 -41.03 14.23 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.87 0.692 . . . . 71.25 112.87 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.23 -29.84 61.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 72.430000000000007 110.871 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 74.129999999999995 110.851 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -70.48 -36.51 73.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.25 0.548 . . . . 73.120000000000005 110.214 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.0 -11.82 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.29 -0.868 . . . . 60.43 113.175 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -57.05 144.77 67.95 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 111.647 0.24 . . . . 71.549999999999997 111.647 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.65 163.0 84.54 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.518 -1.451 . . . . 61.109999999999999 113.248 2.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -116.83 156.35 27.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 73.549999999999997 110.456 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.5 ttmt -136.84 110.64 8.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.45 -0.341 . . . . 73.030000000000001 110.878 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG23 ' CG ' ' A' ' 33' ' ' HIS . 16.9 t -110.2 127.37 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 61.020000000000003 109.654 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.07 28.92 14.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.446 0.641 . . . . 70.239999999999995 111.136 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.17 27.91 63.19 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.742 -0.742 . . . . 53.43 112.446 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 10.1 tpt180 -131.54 140.39 49.47 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 72.049999999999997 109.564 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.88 112.38 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.417 -0.586 . . . . 75.030000000000001 109.417 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.8 m -105.5 148.25 10.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.484 0.659 . . . . 73.329999999999998 111.209 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -113.03 97.58 42.76 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.776 -1.102 . . . . 75.420000000000002 110.755 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -77.43 128.8 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.685 2.257 . . . . 70.030000000000001 111.27 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -132.99 172.08 13.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.326 -0.852 . . . . 75.319999999999993 108.918 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -77.99 137.5 38.33 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.651 -0.42 . . . . 75.120000000000005 110.338 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.51 2.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.158 0.504 . . . . 62.310000000000002 110.664 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.1 151.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.887 -1.051 . . . . 74.540000000000006 111.064 177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -55.05 148.24 14.18 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.611 -0.722 . . . . 75.040000000000006 110.469 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -51.02 -43.71 60.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.357 1.243 . . . . 73.310000000000002 114.357 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.84 -33.82 68.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.976 0.417 . . . . 74.209999999999994 111.014 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -84.33 -26.63 28.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.618 -0.719 . . . . 60.409999999999997 111.969 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 p -74.29 -15.05 60.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.928 0.394 . . . . 74.530000000000001 111.178 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -85.61 -10.08 56.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.91 -0.586 . . . . 72.329999999999998 110.521 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.52 148.24 43.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 73.109999999999999 110.353 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.1 123.81 11.4 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.491 2.127 . . . . 72.420000000000002 111.842 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.91 12.44 34.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.005 -0.616 . . . . 72.209999999999994 112.299 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.5 7.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 111.395 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -97.39 13.76 28.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.003 0.43 . . . . 72.239999999999995 111.347 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -76.81 155.6 32.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.937 -0.764 . . . . 73.420000000000002 108.937 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.442 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.1 m -77.03 90.44 3.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.398 0.618 . . . . 64.439999999999998 110.043 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.41 112.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.427 -0.806 . . . . 74.010000000000005 110.625 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -104.91 17.27 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 74.239999999999995 110.729 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 138.99 52.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.419 -0.355 . . . . 75.120000000000005 110.981 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.21 151.82 35.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.343 0.592 . . . . 75.430000000000007 111.734 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.9 t80 -100.36 133.12 45.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.623 -1.172 . . . . 75.129999999999995 109.667 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.15 110.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.899 -0.778 . . . . 74.150000000000006 108.899 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.38 154.22 19.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.826 -1.178 . . . . 43.140000000000001 112.819 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.96 8.4 58.02 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.633 -0.794 . . . . 72.549999999999997 112.164 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 147' ' ' GLY . 8.6 pt -72.28 93.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.305 0.574 . . . . 71.140000000000001 110.504 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -80.5 -25.31 38.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.818 -0.628 . . . . 75.25 110.799 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -88.85 161.1 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.67 -0.695 . . . . 65.340000000000003 110.534 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.67 104.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.48 0.487 . . . . 72.200000000000003 109.99 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.5 m -109.34 130.43 55.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.853 -0.612 . . . . 72.219999999999999 110.804 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -112.71 175.24 5.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.002 -0.999 . . . . 71.129999999999995 111.13 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.47 -48.92 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.816 -1.083 . . . . 72.420000000000002 110.834 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -56.24 -37.27 69.52 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.275 0.359 . . . . 74.319999999999993 111.638 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.4 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 64.7 m170 -56.7 -60.74 3.12 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.412 0.445 . . . . 72.310000000000002 111.075 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.79 -26.99 29.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.904 -0.718 . . . . 75.140000000000001 111.59 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -66.07 -50.65 63.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.611 -0.144 . . . . 74.519999999999996 110.611 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.79 -24.43 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.039 0.447 . . . . 72.430000000000007 110.399 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -77.34 -57.32 3.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.898 -0.592 . . . . 72.239999999999995 111.878 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -68.58 -23.15 64.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.713 0.634 . . . . 75.540000000000006 112.713 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -69.54 -20.24 63.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 111.503 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -57.25 -28.92 63.38 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.879 -0.601 . . . . 64.519999999999996 111.078 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.66 -30.37 19.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.068 0.396 . . . . 72.439999999999998 112.068 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.2 -176.1 47.82 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.587 -0.816 . . . . 73.439999999999998 113.347 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -75.97 133.26 40.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.159 0.504 . . . . 73.230000000000004 111.178 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 152' ' ' THR . 75.8 mt -102.92 139.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.472 -0.785 . . . . 75.409999999999997 109.507 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -86.39 -50.83 6.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.462 . . . . 74.200000000000003 110.394 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.437 HG11 ' OE2' ' A' ' 135' ' ' GLU . 9.0 p -160.78 159.34 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.661 -0.7 . . . . 71.230000000000004 109.549 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.85 131.93 71.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.342 0.591 . . . . 74.040000000000006 110.693 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 4.1 mp0 -101.88 103.53 14.21 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.054 -0.975 . . . . 75.0 110.378 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.51 116.7 35.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.078 -0.712 . . . . 64.200000000000003 109.078 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 148' ' ' PHE . 73.8 mmm -93.72 124.75 37.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.012 -0.736 . . . . 71.530000000000001 109.012 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.637 -0.711 . . . . 65.510000000000005 110.143 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.425 ' H ' HG13 ' A' ' 112' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.995 -0.442 . . . . 64.230000000000004 111.995 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 137' ' ' MET . 20.2 p90 -170.86 153.93 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.682 -0.858 . . . . 74.420000000000002 108.682 173.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.56 169.81 17.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.944 0.402 . . . . 74.25 109.969 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 72.4 m-85 -138.74 154.68 48.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 73.510000000000005 109.435 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.6 131.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.392 0.615 . . . . 74.299999999999997 111.546 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 131' ' ' ILE . 34.6 m -92.97 124.5 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.963 -1.017 . . . . 72.230000000000004 110.941 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.17 156.9 17.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.393 -0.367 . . . . 74.030000000000001 110.819 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.42 -25.78 46.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 110.582 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -131.1 148.08 52.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.727 -0.67 . . . . 72.400000000000006 110.822 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.442 ' CD2' HG23 ' A' ' 103' ' ' THR . 19.1 p80 -78.29 -27.24 47.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.625 -0.262 . . . . 74.140000000000001 110.76 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 20.8 t70 -64.72 -36.74 85.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.073 -0.512 . . . . 62.399999999999999 110.802 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 -32.74 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 64.409999999999997 110.56 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.4 t -70.77 -39.43 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.925 -0.58 . . . . 72.420000000000002 109.988 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.409 ' HA ' HG21 ' A' ' 163' ' ' VAL . 2.2 t70 -69.96 -33.5 72.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.643 -0.708 . . . . 73.0 111.332 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.9 mttt -54.0 -38.86 65.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.849 0.833 . . . . 75.510000000000005 109.954 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.3 mt -77.07 -43.58 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.126 -1.397 . . . . 73.120000000000005 112.398 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 159' ' ' VAL . 11.2 m -75.71 -11.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.891 -0.506 . . . . 73.299999999999997 110.769 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.51 -31.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.354 -0.839 . . . . 73.319999999999993 109.932 170.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.468 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -112.63 100.96 9.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.39 -0.967 . . . . 72.040000000000006 108.39 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.546 ' HB2' ' HZ2' ' A' ' 166' ' ' LYS . 3.1 ttmp? -58.35 -33.29 69.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.612 0.597 . . . . 73.439999999999998 112.612 -174.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.61 131.3 54.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.824 0.345 . . . . 73.049999999999997 110.92 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.468 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 84.4 m-70 -123.79 151.3 43.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 73.129999999999995 110.672 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 m -94.39 105.24 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.915 0.388 . . . . 73.409999999999997 110.072 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.3 t -117.52 130.57 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.066 -0.716 . . . . 70.340000000000003 109.066 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 53.02 34.56 17.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.863 0.84 . . . . 73.099999999999994 111.448 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 75.41 0.9 63.5 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.663 -0.699 . . . . 73.439999999999998 113.498 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -111.59 128.75 56.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.169 -0.308 . . . . 72.129999999999995 110.169 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.79 109.32 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.325 0.583 . . . . 74.25 110.707 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.84 156.31 20.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.197 -0.91 . . . . 72.5 109.816 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -89.47 131.14 35.66 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.91 0.385 . . . . 74.109999999999999 110.042 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.9 t -128.56 132.92 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.365 -0.834 . . . . 73.099999999999994 110.195 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -157.7 176.14 12.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.688 -0.687 . . . . 73.409999999999997 110.297 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -61.77 128.94 38.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.802 0.334 . . . . 74.340000000000003 110.841 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -107.92 113.54 26.83 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.212 0.53 . . . . 70.439999999999998 109.69 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.389 -0.823 . . . . 75.120000000000005 109.509 179.315 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.944 -0.762 . . . . 75.099999999999994 108.944 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.42 133.28 31.65 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 114.66 -1.154 . . . . 74.310000000000002 110.231 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' HD22 ' A' ' 13' ' ' LEU . 27.5 Cg_endo -65.0 167.15 16.6 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.114 2.543 . . . . 72.209999999999994 111.323 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.19 -34.89 70.85 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 112.19 0.441 . . . . 71.299999999999997 112.19 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -68.49 -20.1 64.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.014 0.376 . . . . 72.400000000000006 112.014 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.0 mp -89.73 -14.3 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.316 . . . . 64.349999999999994 110.816 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 ptt85 -125.36 -2.96 7.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 64.299999999999997 111.676 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.7 ttpt -98.73 144.73 27.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.752 0.787 . . . . 74.549999999999997 111.22 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 87' ' ' LYS . 50.6 mt -120.2 146.92 45.56 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.326 -1.306 . . . . 75.340000000000003 110.969 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.71 115.67 29.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.33 -0.989 . . . . 64.430000000000007 108.33 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.2 mm -95.0 112.6 27.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.964 -0.384 . . . . 64.219999999999999 109.964 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.55 152.45 17.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.986 -0.626 . . . . 73.409999999999997 111.56 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.16 42.5 50.6 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.553 -0.832 . . . . 60.43 113.314 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD21 ' CG1' ' A' ' 84' ' ' VAL . 76.9 mt -77.94 174.02 11.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.929 0.364 . . . . 74.140000000000001 110.171 174.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -84.76 175.92 8.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 75.010000000000005 109.104 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.97 -9.5 59.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.297 0.57 . . . . 74.129999999999995 109.825 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.3 5.15 15.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.47 -0.786 . . . . 73.120000000000005 112.231 -172.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.407 ' HA ' ' OD2' ' A' ' 80' ' ' ASP . 84.9 m -73.0 126.03 29.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.387 0.613 . . . . 73.430000000000007 112.206 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 p -100.73 164.35 11.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.342 -0.844 . . . . 73.549999999999997 110.337 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -24.27 57.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.156 -0.313 . . . . 74.120000000000005 110.156 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -72.43 -37.69 68.53 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.175 0.297 . . . . 70.530000000000001 110.951 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -77.63 -38.26 48.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 71.120000000000005 110.285 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.43 -52.26 65.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.404 -0.816 . . . . 75.019999999999996 109.803 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.86 -60.54 3.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.06 -0.973 . . . . 74.120000000000005 112.009 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -48.31 -36.59 14.54 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.817 0.698 . . . . 74.409999999999997 112.663 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -67.66 -50.8 56.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.785 0.326 . . . . 72.25 110.714 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.44 -20.41 43.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.644 0.239 . . . . 64.349999999999994 111.644 -173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -60.65 -22.76 64.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.036 0.446 . . . . 63.409999999999997 111.476 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -67.48 -28.1 67.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.761 . . . . 71.200000000000003 112.148 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -96.69 -27.64 14.68 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.1 -0.24 . . . . 75.109999999999999 111.381 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.84 160.05 33.41 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.593 -0.813 . . . . 70.140000000000001 112.009 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -64.6 120.12 11.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.676 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.8 mt -89.96 139.6 30.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.486 0.66 . . . . 74.420000000000002 111.174 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 p -105.8 -24.57 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.997 -1.001 . . . . 62.310000000000002 110.006 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -153.45 156.9 39.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.636 -0.711 . . . . 61.329999999999998 109.912 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 t -164.13 131.73 3.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.516 -0.55 . . . . 71.239999999999995 109.516 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.09 117.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.564 0.697 . . . . 71.340000000000003 110.416 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.45 136.04 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.058 -0.719 . . . . 62.32 109.058 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.9 mmt -83.18 97.45 8.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.638 0.732 . . . . 72.0 110.396 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 50.2 mtp85 -102.25 163.68 12.1 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.525 -1.216 . . . . 74.340000000000003 111.032 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.78 125.02 83.12 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 114.726 -1.125 . . . . 75.430000000000007 110.216 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.33 -12.73 34.38 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.93 1.753 . . . . 75.010000000000005 112.929 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -85.44 -56.96 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 73.219999999999999 111.77 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -103.26 -10.53 18.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 74.510000000000005 111.358 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 65.81 39.38 4.72 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.364 -0.835 . . . . 75.109999999999999 110.471 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -121.82 154.85 36.48 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.631 -0.507 . . . . 70.209999999999994 109.631 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.429 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.7 t -66.21 139.11 58.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.93 0.395 . . . . 62.030000000000001 111.68 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -84.33 -1.85 56.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 74.340000000000003 110.465 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.87 57.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.883 -0.675 . . . . 74.310000000000002 113.962 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -157.27 157.43 34.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.189 0.995 . . . . 75.230000000000004 111.078 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.21 -166.07 18.32 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.387 -0.685 . . . . 71.409999999999997 111.387 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.7 m-85 -141.31 149.97 41.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.588 0.694 . . . . 73.439999999999998 110.833 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.53 123.82 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.566 -0.743 . . . . 75.349999999999994 109.869 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.5 m -99.03 118.75 36.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.642 -0.254 . . . . 74.140000000000001 110.498 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.7 169.6 14.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.62 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.34 -51.56 14.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.843 -0.617 . . . . 75.400000000000006 109.892 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -123.8 155.28 38.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 64.230000000000004 110.606 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -62.22 -34.82 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.663 0.268 . . . . 72.420000000000002 111.308 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -57.97 -37.82 74.9 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.221 0.452 . . . . 72.439999999999998 112.221 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.38 -35.12 78.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.245 0.545 . . . . 62.329999999999998 110.006 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 5.2 t -64.86 -47.6 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.117 -0.947 . . . . 71.329999999999998 110.663 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.93 -52.74 62.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 63.210000000000001 110.626 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.64 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.693 0.627 . . . . 54.340000000000003 112.693 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.18 68.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.938 0.399 . . . . 71.049999999999997 110.703 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.4 mmt -67.79 -43.18 80.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.58 . . . . 74.319999999999993 110.764 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.64 -40.35 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.126 0.488 . . . . 62.43 110.568 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.45 -16.59 64.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.177 -0.92 . . . . 74.430000000000007 112.909 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 75' ' ' ARG . 27.7 mtp-105 -54.09 147.23 26.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.233 0.457 . . . . 71.230000000000004 112.233 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.4 168.41 71.86 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.475 -1.469 . . . . 65.200000000000003 113.732 3.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -121.23 162.22 20.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.239 -0.891 . . . . 73.340000000000003 110.346 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.9 ttmt -136.74 111.85 9.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 73.530000000000001 111.604 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.4 130.51 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 64.140000000000001 109.742 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 4.3 m-20 65.07 29.85 11.91 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.804 0.69 . . . . 75.510000000000005 111.96 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.82 24.73 68.89 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.793 -0.718 . . . . 72.049999999999997 112.445 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.9 tpt180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.448 -0.575 . . . . 73.150000000000006 109.448 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.89 113.18 23.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.791 0.805 . . . . 75.329999999999998 109.368 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' HD21 ' A' ' 21' ' ' LEU . 3.2 m -102.83 151.07 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 74.510000000000005 111.236 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 3.5 tp10 -113.11 97.25 41.88 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.79 -1.095 . . . . 60.539999999999999 111.117 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -73.48 129.49 13.84 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.311 2.007 . . . . 74.420000000000002 111.221 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' O ' HD21 ' A' ' 16' ' ' LEU . 19.7 mttt -134.71 -179.02 5.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.349 -1.723 . . . . 73.120000000000005 106.349 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -86.7 141.16 29.11 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 119.581 1.082 . . . . 73.340000000000003 110.855 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 95.47 0.6 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.071 -0.513 . . . . 72.329999999999998 110.663 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.58 133.57 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.666 -0.697 . . . . 74.049999999999997 109.593 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 t -78.61 174.0 11.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 63.509999999999998 110.859 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -49.2 -54.58 15.88 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.964 0.906 . . . . 73.409999999999997 113.302 -171.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.79 -36.61 65.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.904 0.335 . . . . 74.219999999999999 111.904 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -11.52 58.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.951 0.352 . . . . 74.340000000000003 111.951 -176.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.6 p -97.81 2.48 49.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.565 0.222 . . . . 73.349999999999994 111.266 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.96 -37.68 88.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.29 -0.414 . . . . 74.209999999999994 111.074 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -92.57 145.6 30.77 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.328 -0.396 . . . . 75.420000000000002 110.261 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.44 151.12 70.84 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.913 2.409 . . . . 74.219999999999999 111.847 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.71 8.87 57.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.608 -0.806 . . . . 71.310000000000002 111.925 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.87 -49.04 15.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 64.329999999999998 110.562 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -92.77 3.76 55.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 71.0 111.381 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.79 158.56 22.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 72.439999999999998 109.782 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -76.31 93.49 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.803 0.811 . . . . 74.409999999999997 110.511 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.9 t -120.26 108.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.749 -1.114 . . . . 74.349999999999994 109.913 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 156' ' ' HIS . 53.7 mttt -100.09 10.49 41.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 72.439999999999998 110.776 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.52 140.68 49.11 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.11 -0.496 . . . . 72.030000000000001 111.106 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.9 pt -122.84 149.88 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.258 0.552 . . . . 75.040000000000006 111.969 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.6 t80 -98.43 133.8 42.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.883 -1.053 . . . . 72.439999999999998 109.054 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.56 109.23 22.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.491 -0.559 . . . . 71.420000000000002 109.491 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.26 149.96 17.0 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.209 -0.996 . . . . 65.439999999999998 113.05 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.56 25.62 38.41 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.335 -0.936 . . . . 64.209999999999994 112.595 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.492 ' HB ' ' OG1' ' A' ' 116' ' ' THR . 5.2 pt -68.91 131.48 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 74.519999999999996 109.946 174.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 65.2 tttp -82.93 107.17 15.34 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.343 0.868 . . . . 74.319999999999993 113.343 -164.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.27 -53.2 0.7 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.405 1.066 . . . . 63.0 113.456 167.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -165.46 112.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.833 -0.432 . . . . 61.340000000000003 109.833 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 112' ' ' ILE . 14.9 m -123.66 136.77 54.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.283 0.563 . . . . 74.439999999999998 109.629 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -110.88 171.89 7.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.694 -0.684 . . . . 74.129999999999995 111.139 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.44 -49.59 75.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 114.79 -1.095 . . . . 74.409999999999997 110.562 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -54.91 -35.0 63.68 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.399 0.437 . . . . 73.140000000000001 111.783 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.18 -61.18 2.42 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.281 0.363 . . . . 71.329999999999998 111.056 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.77 -23.66 31.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.197 -0.601 . . . . 72.109999999999999 111.46 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -65.33 -55.36 18.69 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.937 -0.394 . . . . 74.209999999999994 109.937 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.323 0.582 . . . . 72.450000000000003 110.495 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -76.32 -56.64 4.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.359 -0.837 . . . . 70.299999999999997 112.22 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.434 ' CD2' HG22 ' A' ' 151' ' ' VAL . 43.1 m-85 -68.95 -23.02 64.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.685 0.254 . . . . 75.439999999999998 111.685 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mm-40 -64.4 -24.54 67.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.027 0.442 . . . . 73.200000000000003 110.905 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.0 -27.42 68.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.822 -0.626 . . . . 72.0 111.777 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.53 -25.79 22.34 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.77 0.285 . . . . 73.510000000000005 111.77 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.25 -175.82 46.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.536 -0.84 . . . . 74.519999999999996 113.312 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -75.47 125.61 29.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 74.200000000000003 112.067 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 152' ' ' THR . 52.8 mt -98.17 136.1 30.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 74.439999999999998 110.301 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.29 -50.49 8.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.309 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.56 157.96 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 75.340000000000003 110.091 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.4 128.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.321 0.582 . . . . 72.329999999999998 110.519 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.29 104.89 16.38 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.255 -0.884 . . . . 70.219999999999999 110.859 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.65 122.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.229 -0.656 . . . . 73.420000000000002 109.229 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.6 mmm -101.95 135.97 42.6 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.636 -0.876 . . . . 74.239999999999995 108.636 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 73.450000000000003 111.913 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.424 ' H ' HG13 ' A' ' 112' ' ' ILE . . . . . . . . 0 N--CA 1.439 -1.15 0 N-CA-C 110.56 -1.016 . . . . 75.420000000000002 110.56 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -171.54 145.87 2.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.374 -0.602 . . . . 74.010000000000005 109.374 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.51 170.49 14.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.628 -0.714 . . . . 70.129999999999995 109.112 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.508 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -136.24 143.4 44.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.844 -0.616 . . . . 74.019999999999996 109.404 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.434 HG22 ' CD2' ' A' ' 125' ' ' PHE . 58.0 t -129.2 121.73 54.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 O-C-N 122.164 -0.335 . . . . 72.430000000000007 110.483 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 131' ' ' ILE . 85.9 m -96.16 118.92 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.678 -0.692 . . . . 74.040000000000006 110.821 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -102.75 156.64 17.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.601 0.238 . . . . 71.540000000000006 110.889 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.22 -29.71 65.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 71.109999999999999 110.288 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.478 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 1.9 t0 -139.06 159.96 40.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.587 -0.733 . . . . 65.25 110.887 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 15.9 p80 -79.18 -19.87 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 75.409999999999997 110.115 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.591 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 1.3 p-10 -60.84 -38.23 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.029 -0.987 . . . . 70.510000000000005 110.979 -174.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -73.85 -31.08 63.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.132 -0.486 . . . . 65.340000000000003 110.227 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.82 -39.01 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.677 -0.692 . . . . 74.010000000000005 109.835 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -26.77 63.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 62.140000000000001 111.242 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 71.7 mttt -69.07 -33.67 73.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.315 0.579 . . . . 70.340000000000003 110.265 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.3 mt -78.02 -42.68 28.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.564 -0.744 . . . . 75.129999999999995 112.672 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.3 m -70.64 -6.14 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.001 0.429 . . . . 75.219999999999999 111.434 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.91 -38.79 46.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.191 -0.913 . . . . 72.299999999999997 109.861 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -109.49 105.28 14.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.578 -0.897 . . . . 73.150000000000006 108.578 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -55.04 -32.34 61.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.864 -0.607 . . . . 65.439999999999998 111.706 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -124.91 133.9 52.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.455 -0.339 . . . . 75.230000000000004 110.687 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -120.98 144.64 48.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.853 -0.612 . . . . 62.329999999999998 109.887 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.8 m -114.03 106.23 14.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.355 -0.384 . . . . 72.310000000000002 110.569 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.91 114.73 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.309 -0.405 . . . . 75.140000000000001 111.203 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.41 31.74 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.759 0.79 . . . . 61.240000000000002 109.656 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.94 5.46 86.14 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.497 -0.774 . . . . 74.450000000000003 112.385 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.551 ' CD2' ' HB3' ' A' ' 113' ' ' LYS . 61.5 m170 -106.04 110.21 22.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.199 -0.297 . . . . 74.150000000000006 110.199 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.75 107.81 19.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.151 0.5 . . . . 75.140000000000001 109.737 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 p -117.05 156.22 27.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 73.019999999999996 111.451 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.31 134.92 33.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.756 -0.657 . . . . 74.409999999999997 109.853 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 26.9 t -130.9 134.0 62.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.166 0.508 . . . . 72.150000000000006 110.667 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -152.92 173.5 15.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.559 -0.746 . . . . 71.040000000000006 111.372 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -65.68 130.31 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.263 -0.426 . . . . 74.400000000000006 110.298 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -120.75 122.34 40.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.478 . . . . 74.420000000000002 109.711 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 120.743 -0.383 . . . . 73.540000000000006 110.375 -175.766 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.749 0.309 . . . . 74.409999999999997 110.675 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -76.09 130.93 76.73 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.246 -0.65 . . . . 74.420000000000002 109.246 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.67 166.36 15.93 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.26 1.973 . . . . 71.450000000000003 111.97 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -41.24 64.41 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.566 -0.743 . . . . 72.439999999999998 112.397 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -71.39 -27.37 63.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.818 0.342 . . . . 73.430000000000007 111.842 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -84.51 -6.16 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.493 -0.322 . . . . 75.099999999999994 111.024 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -127.81 6.17 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.981 0.419 . . . . 74.340000000000003 110.685 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -98.31 146.72 25.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.401 0.62 . . . . 74.019999999999996 111.16 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 87' ' ' LYS . 58.0 mt -115.48 143.47 45.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.664 -1.153 . . . . 72.099999999999994 110.704 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -97.86 120.81 38.92 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.622 -0.881 . . . . 71.439999999999998 108.622 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.49 111.63 29.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 110.093 -0.336 . . . . 74.200000000000003 110.093 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.78 151.26 17.29 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 121.089 -0.577 . . . . 70.219999999999999 111.713 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.9 44.54 55.53 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.683 -0.77 . . . . 71.120000000000005 113.142 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.422 HD23 ' CG1' ' A' ' 84' ' ' VAL . 84.2 mt -78.08 173.73 11.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.736 -0.468 . . . . 72.140000000000001 109.736 171.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -86.11 -178.16 6.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.026 0.441 . . . . 70.010000000000005 110.012 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -81.02 -9.0 59.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.045 -0.525 . . . . 73.310000000000002 110.09 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 19.8 mt-10 -121.81 18.99 11.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.629 0.603 . . . . 72.439999999999998 112.629 -173.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -78.36 115.33 18.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.875 0.369 . . . . 63.409999999999997 110.964 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -97.47 158.76 15.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 110.447 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.664 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 9.6 t0 -59.33 -43.22 92.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.054 0.542 . . . . 55.439999999999998 111.152 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.62 -34.81 77.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.755 . . . . 71.239999999999995 111.543 -175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 m -79.19 -36.37 40.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.452 -0.34 . . . . 70.540000000000006 110.802 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -65.52 -51.72 57.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 74.239999999999995 110.013 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.23 -60.55 3.19 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.304 -0.862 . . . . 65.329999999999998 112.117 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 t -48.67 -33.51 10.14 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.809 0.693 . . . . 75.450000000000003 112.843 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.433 ' ND1' HG21 ' A' ' 79' ' ' VAL . 11.2 t-80 -73.23 -56.12 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.222 -0.191 . . . . 74.409999999999997 110.892 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.45 -23.96 63.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.938 0.347 . . . . 74.409999999999997 111.938 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -57.79 -20.95 39.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.504 0.722 . . . . 72.019999999999996 112.114 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.42 -29.27 69.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.88 0.326 . . . . 73.439999999999998 111.88 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -96.27 -20.82 18.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.689 0.28 . . . . 63.439999999999998 111.203 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.79 164.39 32.77 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.34 -0.933 . . . . 73.439999999999998 112.309 173.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.7 m -62.92 119.79 10.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 73.219999999999999 111.699 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.96 117.04 26.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.739 -0.664 . . . . 75.510000000000005 110.777 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -84.36 -25.71 28.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.037 -0.983 . . . . 74.549999999999997 110.269 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -149.58 150.29 32.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.447 -0.797 . . . . 72.439999999999998 109.486 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.3 t -160.54 138.7 9.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.949 -0.76 . . . . 72.409999999999997 108.949 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.664 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 5.7 p -152.23 122.54 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 121.434 0.635 . . . . 74.010000000000005 111.005 171.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.49 136.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.402 -0.962 . . . . 73.299999999999997 108.402 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.531 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -81.7 100.41 9.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.595 0.712 . . . . 72.019999999999996 110.524 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -101.83 158.11 16.36 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.66 -1.155 . . . . 74.109999999999999 109.205 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.36 132.96 64.62 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.039 -0.356 . . . . 75.120000000000005 110.039 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -22.4 73.18 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.389 2.06 . . . . 43.009999999999998 113.681 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -86.32 -55.71 3.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.288 0.566 . . . . 75.209999999999994 110.792 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -95.84 -14.78 22.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.123 -0.944 . . . . 74.349999999999994 112.346 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm 64.62 26.13 13.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.552 0.741 . . . . 72.439999999999998 111.307 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 23.5 mmm180 -109.18 156.76 19.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.766 -0.457 . . . . 72.409999999999997 109.766 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 m -68.37 132.02 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.178 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -85.84 3.18 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.69 -0.686 . . . . 75.310000000000002 111.225 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 11.44 65.47 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.585 -0.817 . . . . 61.229999999999997 114.069 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.5 p90 -153.82 155.75 36.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.784 0.792 . . . . 75.049999999999997 110.712 175.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.16 -169.51 23.55 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.382 -0.687 . . . . 53.539999999999999 111.382 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.23 142.4 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.178 0.489 . . . . 74.109999999999999 110.389 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 m -126.85 128.19 70.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 64.530000000000001 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 m -104.6 122.06 44.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.525 -0.307 . . . . 70.310000000000002 110.239 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.409 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 31.9 m-85 -88.73 161.37 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.483 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.78 83.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.509 -0.769 . . . . 73.109999999999999 110.744 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.599 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 16.5 m -131.12 154.34 48.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.107 -0.497 . . . . 72.5 110.463 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -65.63 -34.0 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 111.658 0.244 . . . . 64.299999999999997 111.658 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.03 -43.7 78.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.967 0.358 . . . . 72.040000000000006 111.967 175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.599 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 2.7 mp0 -62.01 -33.23 73.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 72.540000000000006 110.644 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 42.3 t -64.21 -50.23 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.281 -0.872 . . . . 74.420000000000002 110.97 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.02 -41.1 91.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.248 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.86 67.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.327 -0.397 . . . . 73.439999999999998 112.026 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.23 66.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 71.430000000000007 110.665 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -37.21 86.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.227 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -28.19 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 64.310000000000002 111.001 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.29 -9.64 54.17 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.741 0.645 . . . . 65.319999999999993 112.741 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 75' ' ' ARG . 24.8 mtp-105 -58.04 146.23 69.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.456 -0.338 . . . . 72.329999999999998 111.501 175.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.01 153.2 99.02 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.967 -1.264 . . . . 64.239999999999995 114.049 3.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -108.65 153.31 23.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.054 -0.976 . . . . 65.150000000000006 110.731 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 13.6 ttmt -136.42 103.16 5.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.037 0.446 . . . . 73.530000000000001 111.198 175.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.433 HG21 ' ND1' ' A' ' 33' ' ' HIS . 21.9 t -107.97 131.52 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.613 -0.721 . . . . 73.400000000000006 109.676 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.0 t70 64.91 29.77 12.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.791 0.805 . . . . 55.109999999999999 110.564 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.35 76.34 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.549 -0.75 . . . . 37.130000000000003 112.16 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 24.8 tpt180 -125.59 136.94 53.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.884 -0.413 . . . . 74.310000000000002 109.884 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.04 109.52 13.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.776 0.798 . . . . 72.439999999999998 109.623 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.422 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.5 m -105.67 152.86 7.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.505 -0.771 . . . . 75.430000000000007 110.787 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -112.07 97.24 37.84 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.423 -0.808 . . . . 73.109999999999999 110.879 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.81 129.63 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.149 1.899 . . . . 75.319999999999993 110.429 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' HD21 ' A' ' 16' ' ' LEU . 25.9 mttt -135.18 179.42 6.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 74.120000000000005 107.781 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 7.8 tpp180 -79.26 162.7 25.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.324 -0.551 . . . . 73.129999999999995 109.667 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.66 93.26 5.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.466 -0.568 . . . . 73.030000000000001 109.466 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.1 154.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.001 -0.999 . . . . 72.439999999999998 111.396 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -59.92 146.98 40.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.59 -0.732 . . . . 60.130000000000003 110.091 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -65.63 -19.17 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.341 -0.39 . . . . 74.239999999999995 111.359 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.39 -39.32 88.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 73.230000000000004 111.65 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.28 -22.02 48.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.226 0.536 . . . . 74.439999999999998 110.12 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 20.1 t -70.41 -0.53 8.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.518 -0.765 . . . . 74.200000000000003 111.233 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -71.08 -24.96 62.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 74.430000000000007 110.222 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -77.78 146.2 72.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 110.216 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.43 114.94 3.82 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.657 2.238 . . . . 74.120000000000005 112.191 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.74 10.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.77 -0.729 . . . . 64.409999999999997 112.185 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -72.79 -27.17 61.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.759 0.314 . . . . 53.539999999999999 111.294 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -99.83 11.85 38.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.359 . . . . 72.030000000000001 111.008 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.16 167.23 19.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.958 -0.756 . . . . 74.230000000000004 108.958 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.453 HG22 ' CD2' ' A' ' 156' ' ' HIS . 7.8 m -75.55 90.17 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 111.054 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.49 115.63 50.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.284 -0.871 . . . . 72.430000000000007 109.831 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.468 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.1 mttt -109.11 22.26 16.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 110.958 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -123.84 140.44 52.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.459 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.79 154.03 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.164 0.507 . . . . 72.150000000000006 111.812 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.2 t80 -100.27 137.19 39.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.835 -1.075 . . . . 72.239999999999995 109.384 175.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.03 113.1 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 75.140000000000001 109.533 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.15 152.89 19.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.014 -1.089 . . . . 64.319999999999993 113.072 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.03 6.35 24.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 75.219999999999999 112.61 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.8 pt -79.95 100.36 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.739 0.78 . . . . 63.240000000000002 110.813 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -93.03 3.37 55.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.872 -0.604 . . . . 75.120000000000005 111.193 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.12 165.58 16.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.093 -0.706 . . . . 74.420000000000002 109.093 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.71 99.94 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.371 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -91.22 139.74 30.45 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.853 -0.612 . . . . 73.239999999999995 109.683 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.46 165.73 10.86 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.502 -0.772 . . . . 70.409999999999997 110.866 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -47.84 84.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.091 -1.413 . . . . 73.400000000000006 108.768 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -55.26 -30.82 60.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.413 -0.812 . . . . 72.299999999999997 111.959 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -66.84 -62.37 1.48 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.213 0.53 . . . . 74.319999999999993 110.844 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.42 -24.03 34.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.038 -0.665 . . . . 73.540000000000006 111.458 -172.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.5 tmm_? -66.14 -49.29 67.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.212 -0.292 . . . . 72.109999999999999 110.212 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.33 -30.11 70.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.276 0.56 . . . . 73.420000000000002 110.78 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -80.59 -54.93 5.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 64.450000000000003 112.209 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' CD2' HG21 ' A' ' 151' ' ' VAL . 21.0 m-85 -68.38 -22.79 64.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.679 0.622 . . . . 74.340000000000003 112.679 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mt-10 -68.66 -23.32 64.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.682 0.277 . . . . 72.010000000000005 111.276 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -60.88 -24.99 66.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 75.430000000000007 111.586 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -85.4 -27.42 25.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.405 . . . . 73.319999999999993 111.365 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.63 -177.8 43.56 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.707 -0.758 . . . . 74.109999999999999 113.223 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -74.11 133.62 42.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.956 0.408 . . . . 74.140000000000001 111.194 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.83 139.37 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.724 -0.671 . . . . 73.420000000000002 109.789 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.93 -50.74 6.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.317 0.58 . . . . 63.119999999999997 110.095 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -156.13 157.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.32 -0.855 . . . . 73.219999999999999 109.638 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -114.5 128.18 71.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.26 0.552 . . . . 74.219999999999999 109.794 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.46 126.01 45.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.174 -0.921 . . . . 60.340000000000003 110.232 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.5 mm -119.65 114.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.249 -1.019 . . . . 73.019999999999996 108.249 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mmm -91.14 120.42 32.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.399 -0.593 . . . . 73.340000000000003 109.399 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 121.145 0.497 . . . . 74.329999999999998 112.172 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 CA-C-O 119.682 -0.51 . . . . 63.439999999999998 112.949 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -173.49 158.62 3.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.317 0.558 . . . . 74.200000000000003 109.769 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.04 173.72 11.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.292 -0.632 . . . . 61.039999999999999 109.292 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.48 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 36.7 m-85 -138.06 143.94 40.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.298 -0.41 . . . . 74.030000000000001 110.133 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 125' ' ' PHE . 50.7 t -126.96 127.77 70.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 O-C-N 122.002 -0.436 . . . . 75.219999999999999 110.828 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 131' ' ' ILE . 63.5 m -106.89 120.22 41.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.613 -0.721 . . . . 73.340000000000003 111.222 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -103.37 160.81 14.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.295 0.569 . . . . 74.219999999999999 111.7 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.09 -27.26 39.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.029 -0.987 . . . . 74.200000000000003 110.71 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -129.58 155.15 46.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 71.340000000000003 110.685 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.453 ' CD2' HG22 ' A' ' 103' ' ' THR . 21.9 p80 -77.51 -29.05 52.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 73.25 110.631 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 13.5 t0 -56.5 -43.58 79.85 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.799 -1.092 . . . . 65.040000000000006 111.602 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.1 t -63.23 -36.57 84.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.821 -0.627 . . . . 73.239999999999995 111.312 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.468 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.9 t -70.44 -39.99 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.146 0.498 . . . . 63.310000000000002 109.986 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 4.8 t70 -68.76 -33.42 73.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.975 -1.011 . . . . 75.120000000000005 111.032 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.5 mttt -59.04 -40.74 85.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.564 0.697 . . . . 72.430000000000007 110.716 173.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.81 -40.61 46.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.634 -1.167 . . . . 71.010000000000005 111.893 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 160' ' ' ASP . 30.7 m -78.34 -9.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.064 0.459 . . . . 71.120000000000005 111.102 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.13 -33.1 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.641 -0.709 . . . . 73.439999999999998 109.933 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 49.2 mt-30 -113.89 106.18 14.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.763 -0.653 . . . . 73.109999999999999 109.378 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.31 -34.49 57.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.262 0.838 . . . . 74.219999999999999 113.262 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.62 144.12 50.35 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.006 -0.278 . . . . 75.439999999999998 110.502 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.9 m-70 -132.49 151.81 51.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.936 176.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 130.05 55.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.916 0.389 . . . . 75.109999999999999 110.701 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.63 140.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.872 -0.788 . . . . 74.420000000000002 108.872 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.1 m120 48.45 30.27 2.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.391 0.886 . . . . 64.209999999999994 113.391 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.96 -0.71 89.58 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.907 -0.663 . . . . 71.400000000000006 114.118 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.49 ' HD2' ' SG ' ' A' ' 175' ' ' CYS . 10.9 p-80 -113.83 135.16 54.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.908 0.854 . . . . 75.099999999999994 110.859 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -99.6 116.49 31.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 65.120000000000005 110.42 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.49 ' SG ' ' HD2' ' A' ' 173' ' ' HIS . 55.8 m -117.21 157.09 26.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 71.420000000000002 111.096 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.4 141.87 28.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.609 . . . . 60.420000000000002 110.368 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.3 m -131.37 162.14 39.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.956 -0.565 . . . . 75.219999999999999 111.075 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -174.09 171.83 3.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.952 -1.022 . . . . 55.200000000000003 111.687 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -60.79 129.96 44.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.879 -0.601 . . . . 73.129999999999995 110.651 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.12 114.1 25.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.34 0.59 . . . . 74.200000000000003 109.61 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.273 -0.876 . . . . 71.409999999999997 109.738 -178.534 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.119 0.485 . . . . 64.329999999999998 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.451 ' OE2' HG11 ' A' ' 65' ' ' VAL . 1.8 mp0 -71.67 132.05 85.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.708 . . . . 75.540000000000006 110.627 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.99 166.36 23.11 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.756 2.304 . . . . 73.239999999999995 111.134 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.9 pt-20 -60.05 -32.9 71.35 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 119.559 -0.257 . . . . 71.530000000000001 111.686 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.42 -25.04 61.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.654 0.264 . . . . 73.239999999999995 111.602 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mp -87.53 -8.69 56.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.705 0.288 . . . . 74.049999999999997 111.064 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -125.79 2.95 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.481 -0.327 . . . . 75.109999999999999 111.078 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 15.1 ttmm -93.47 146.21 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.54 0.686 . . . . 73.430000000000007 111.502 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 141.3 49.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.491 -1.231 . . . . 65.049999999999997 110.079 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -98.33 116.04 29.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.784 -0.821 . . . . 72.209999999999994 108.784 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.13 110.85 23.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.999 -0.371 . . . . 72.129999999999995 109.999 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.23 152.2 17.99 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.834 -0.698 . . . . 64.209999999999994 111.679 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.6 41.77 56.53 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.019 -0.61 . . . . 74.150000000000006 113.618 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.8 mt -75.84 175.15 9.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.92 0.36 . . . . 75.519999999999996 110.382 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.3 p -88.15 172.33 9.57 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.516 -0.55 . . . . 54.210000000000001 109.516 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.04 -5.6 47.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.648 0.261 . . . . 65.239999999999995 111.176 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.88 21.67 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.105 0.409 . . . . 65.140000000000001 112.105 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 m -75.16 121.74 22.55 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 73.230000000000004 110.557 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -99.11 154.64 17.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.885 -0.413 . . . . 71.329999999999998 109.885 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -64.86 -35.24 80.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 111.356 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.96 -36.77 80.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 74.420000000000002 111.211 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -76.87 -34.43 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 75.219999999999999 110.734 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -65.88 -42.87 89.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.035 -0.53 . . . . 64.430000000000007 109.862 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 19.2 ttm-85 -60.03 -57.97 10.53 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.393 -0.367 . . . . 64.310000000000002 110.127 176.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -50.06 -36.87 30.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.151 -0.931 . . . . 74.329999999999998 112.926 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -70.89 -58.38 3.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.433 -0.349 . . . . 75.099999999999994 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -70.53 -22.48 62.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.196 0.443 . . . . 74.200000000000003 112.196 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.1 tt0 -63.39 -17.81 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.095 0.558 . . . . 63.130000000000003 111.898 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.35 -28.43 69.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.389 -0.368 . . . . 64.349999999999994 111.343 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.14 -21.73 14.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 75.140000000000001 111.567 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -166.71 154.16 24.42 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.48 -0.867 . . . . 62.310000000000002 112.027 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -65.22 117.76 8.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 65.109999999999999 111.408 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 31' ' ' ARG . 57.2 mt -86.85 134.65 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.565 0.698 . . . . 73.010000000000005 111.4 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.189 -0.914 . . . . 64.450000000000003 110.254 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -151.16 152.3 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.618 -0.719 . . . . 63.439999999999998 109.956 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -161.73 133.65 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.021 -0.363 . . . . 71.450000000000003 110.021 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.31 125.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.311 0.577 . . . . 60.439999999999998 110.734 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.1 t -86.83 131.41 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.577 -0.897 . . . . 72.040000000000006 108.577 173.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.12 95.3 6.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.651 0.738 . . . . 75.310000000000002 110.439 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -101.04 166.94 10.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.592 -1.185 . . . . 75.329999999999998 109.637 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.74 126.18 86.22 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.126 -0.694 . . . . 65.299999999999997 109.126 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.31 -23.85 75.51 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.216 1.944 . . . . 73.409999999999997 113.929 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.68 -55.85 3.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.096 0.406 . . . . 74.319999999999993 112.096 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -101.57 -11.19 19.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.93 0.395 . . . . 70.439999999999998 111.945 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm 66.17 34.89 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.512 -0.767 . . . . 74.540000000000006 111.525 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -97.64 140.03 32.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.952 -0.759 . . . . 74.140000000000001 108.952 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -70.49 133.03 46.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.987 0.422 . . . . 74.510000000000005 110.379 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.42 -0.6 37.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.685 -0.689 . . . . 74.230000000000004 110.616 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.52 55.93 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.913 -0.66 . . . . 64.150000000000006 113.716 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -158.85 158.58 33.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.937 0.869 . . . . 71.530000000000001 110.942 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.65 -166.75 20.06 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.849 -0.9 . . . . 74.109999999999999 110.849 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.62 151.26 42.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.427 0.614 . . . . 74.340000000000003 110.603 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.12 122.95 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.627 -0.715 . . . . 65.140000000000001 109.172 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.3 m -99.15 118.59 36.22 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.457 -0.572 . . . . 74.340000000000003 109.457 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 25.4 m-85 -84.5 169.49 14.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.364 . . . . 73.049999999999997 110.67 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.7 -50.13 26.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.145 -0.48 . . . . 73.5 109.927 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.37 155.51 37.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.598 -0.728 . . . . 72.219999999999999 110.215 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -63.85 -32.86 58.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.796 0.331 . . . . 72.430000000000007 110.31 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.69 -34.82 71.72 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.862 0.69 . . . . 63.140000000000001 112.862 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 7.2 mm-40 -62.01 -36.19 80.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 75.319999999999993 109.684 175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 4.0 t -64.31 -44.6 97.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.131 -0.94 . . . . 72.310000000000002 111.131 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.81 -43.24 99.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 73.430000000000007 111.04 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -53.91 -38.37 64.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.64 0.608 . . . . 73.129999999999995 112.64 171.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.82 65.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.449 0.643 . . . . 64.129999999999995 109.948 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.477 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 11.7 mmt -70.79 -39.54 73.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 75.349999999999994 112.124 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.553 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 1.1 p30 -79.14 -11.93 59.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.076 0.465 . . . . 75.420000000000002 110.442 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.45 -16.24 33.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 71.329999999999998 111.02 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -56.41 149.4 38.83 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 112.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.75 168.18 73.68 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.335 -1.527 . . . . 75.409999999999997 113.749 2.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -119.21 153.07 35.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.66 -0.7 . . . . 70.409999999999997 111.004 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.6 ttmt -139.5 108.94 6.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 71.030000000000001 111.092 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -121.38 137.18 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.716 -0.675 . . . . 74.120000000000005 109.603 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 66.11 21.69 11.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.774 0.829 . . . . 72.530000000000001 110.872 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.91 23.88 68.23 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.904 -0.589 . . . . 64.519999999999996 111.916 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.1 tpt180 -126.46 134.99 50.81 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.324 -0.251 . . . . 74.439999999999998 110.324 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.36 119.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.1 -0.704 . . . . 71.310000000000002 109.1 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 m -108.14 154.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.906 -0.588 . . . . 73.140000000000001 111.779 -172.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -113.5 93.93 29.71 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.959 -1.019 . . . . 74.230000000000004 110.611 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.477 ' O ' ' HE1' ' A' ' 72' ' ' MET . 6.2 Cg_endo -77.16 128.32 9.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 70.209999999999994 110.716 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -126.28 168.8 13.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.257 -0.645 . . . . 72.430000000000007 109.257 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.665 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.1 tpp180 -75.59 128.65 35.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.122 -0.696 . . . . 74.140000000000001 109.122 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.0 99.78 1.49 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.399 0.619 . . . . 72.439999999999998 110.756 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.2 157.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.024 -0.989 . . . . 65.239999999999995 109.804 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -54.7 147.65 14.24 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 122.626 0.37 . . . . 74.219999999999999 110.585 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.504 0.927 . . . . 74.019999999999996 113.504 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.35 -38.23 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 75.310000000000002 110.995 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.42 -46.1 11.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 109.931 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 t -57.76 -26.04 61.29 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.556 -0.747 . . . . 51.240000000000002 112.29 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.16 -21.48 63.99 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 111.82 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -85.19 143.99 40.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.030000000000001 110.852 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.06 123.26 9.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 75.25 112.268 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 3.3 71.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.799 -0.715 . . . . 62.229999999999997 112.51 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.97 -52.14 8.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.691 0.256 . . . . 72.540000000000006 111.691 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 21.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 73.219999999999999 111.051 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -178.8 6.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.796 -0.816 . . . . 73.209999999999994 108.796 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 m -72.61 99.75 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.335 0.588 . . . . 73.319999999999993 111.041 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -126.55 111.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 75.310000000000002 109.757 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -107.02 14.69 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.034 -0.417 . . . . 72.420000000000002 111.116 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 139.56 51.05 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.342 -0.224 . . . . 72.340000000000003 110.946 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.89 151.7 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.352 0.596 . . . . 75.129999999999995 111.595 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -96.91 139.44 32.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.726 -1.124 . . . . 72.109999999999999 109.99 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.0 110.38 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.331 -0.618 . . . . 73.109999999999999 109.331 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.51 158.82 21.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.013 -1.089 . . . . 74.049999999999997 113.358 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.0 8.37 45.08 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.832 -0.699 . . . . 73.329999999999998 112.055 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.45 66.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 122.112 0.958 . . . . 73.230000000000004 110.512 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -65.3 -34.01 77.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 73.510000000000005 109.442 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -83.11 145.72 29.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.799 -1.091 . . . . 74.450000000000003 108.558 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.24 123.5 16.92 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.064 0.459 . . . . 71.140000000000001 112.203 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -128.08 139.98 52.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.597 -0.729 . . . . 72.239999999999995 110.084 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.25 167.63 10.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.337 -0.847 . . . . 74.219999999999999 111.642 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.53 -45.35 85.13 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.429 -0.805 . . . . 75.099999999999994 110.619 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -55.77 -34.48 65.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.473 0.483 . . . . 74.420000000000002 111.562 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -64.4 -60.79 2.75 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.381 -0.372 . . . . 74.340000000000003 111.507 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -82.41 -24.65 34.27 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 119.962 -0.695 . . . . 70.420000000000002 110.814 -171.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.2 tmm_? -63.23 -54.65 34.04 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 110.108 -0.33 . . . . 63.409999999999997 110.108 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -27.89 69.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.984 0.421 . . . . 73.540000000000006 110.859 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.452 ' CD2' HG21 ' A' ' 170' ' ' VAL . 75.8 t80 -78.36 -53.87 6.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.83 -0.623 . . . . 74.209999999999994 111.619 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -68.72 -22.77 64.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.622 0.249 . . . . 73.230000000000004 111.506 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.9 mm-40 -62.71 -26.33 68.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.236 0.541 . . . . 73.420000000000002 110.884 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.28 -30.62 71.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 75.329999999999998 111.633 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.1 -23.77 32.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.499 -0.319 . . . . 74.510000000000005 111.012 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.92 -176.65 42.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 72.010000000000005 112.928 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -73.37 130.7 40.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.15 0.5 . . . . 71.219999999999999 110.871 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 152' ' ' THR . 62.1 mt -101.25 139.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.636 -0.711 . . . . 71.349999999999994 109.939 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.19 -49.91 6.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.817 0.341 . . . . 74.239999999999995 110.583 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.45 155.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 74.200000000000003 109.929 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.24 126.31 73.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.288 -0.634 . . . . 73.219999999999999 109.288 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.4 mt-10 -98.65 104.53 16.57 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 72.230000000000004 110.994 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.1 116.01 35.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.442 -0.577 . . . . 64.439999999999998 109.442 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 69.0 mmm -87.72 119.28 27.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.861 -0.609 . . . . 75.409999999999997 109.994 -175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 65.340000000000003 110.704 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.176 0 N-CA-C 112.385 -0.286 . . . . 73.530000000000001 112.385 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -157.88 158.0 34.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.548 -0.538 . . . . 73.319999999999993 109.548 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.85 176.3 8.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.706 -0.679 . . . . 74.409999999999997 109.829 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.9 m-85 -139.53 152.67 47.1 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.591 -0.731 . . . . 74.230000000000004 109.186 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.22 133.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.424 0.631 . . . . 63.340000000000003 111.169 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 131' ' ' ILE . 41.1 m -103.26 126.01 50.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.074 -0.966 . . . . 72.140000000000001 110.856 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -100.82 158.45 15.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.06 0.457 . . . . 72.129999999999995 111.412 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.75 -28.94 44.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.479 -0.782 . . . . 73.439999999999998 110.293 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.0 151.36 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 75.120000000000005 110.842 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.426 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 24.2 p80 -80.17 -27.35 38.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 75.219999999999999 110.777 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.621 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 29.6 t70 -58.28 -40.36 81.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.708 -0.678 . . . . 64.409999999999997 111.067 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.2 m -67.56 -30.97 70.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 73.310000000000002 111.508 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.95 -42.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.484 -0.325 . . . . 72.319999999999993 110.471 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 1.8 m-20 -68.36 -24.06 64.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.925 -0.58 . . . . 51.119999999999997 111.424 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.665 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 81.9 mttt -63.66 -42.6 98.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.728 0.775 . . . . 65.299999999999997 110.177 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -74.15 -42.71 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 75.019999999999996 111.663 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 160' ' ' ASP . 29.4 m -79.93 -2.16 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.064 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 5.7 mt -63.07 -28.87 45.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.945 0.878 . . . . 73.140000000000001 109.046 167.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.568 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 49.2 mt-30 -111.47 145.39 39.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.857 -1.164 . . . . 75.200000000000003 107.857 174.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -91.77 -32.43 15.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.327 0.584 . . . . 73.349999999999994 110.684 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -124.69 137.98 54.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.713 -0.676 . . . . 74.549999999999997 109.951 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.568 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 42.8 m-70 -127.41 142.54 51.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.902 0.382 . . . . 73.329999999999998 110.615 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -94.77 110.36 22.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.982 -0.554 . . . . 73.5 111.036 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 124' ' ' TYR . 21.7 t -111.04 127.79 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.326 -0.852 . . . . 75.400000000000006 109.222 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 42.55 48.98 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.666 0.617 . . . . 71.150000000000006 112.666 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.24 0.98 48.47 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.125 -0.56 . . . . 74.230000000000004 114.055 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.83 121.96 45.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.932 -0.396 . . . . 73.439999999999998 109.932 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.49 110.11 19.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.169 0.509 . . . . 72.120000000000005 110.887 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.55 156.99 18.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.498 -0.774 . . . . 71.430000000000007 110.414 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.46 141.54 28.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.289 -0.263 . . . . 75.219999999999999 110.289 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 m -131.97 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.943 0.401 . . . . 72.200000000000003 110.793 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -175.43 170.77 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.021 -0.991 . . . . 73.450000000000003 111.287 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -63.54 132.7 52.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 74.099999999999994 110.501 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.94 127.23 52.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.358 0.599 . . . . 73.120000000000005 110.211 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--N 1.312 -1.039 0 CA-C-N 115.265 -0.879 . . . . 75.519999999999996 108.906 -179.555 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.19 0.519 . . . . 74.030000000000001 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.39 134.99 20.81 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 73.109999999999999 110.355 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 13' ' ' LEU . 29.0 Cg_endo -65.82 167.19 18.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.775 2.317 . . . . 74.140000000000001 112.027 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -40.09 70.2 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.425 0.528 . . . . 72.430000000000007 112.425 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.15 -27.37 67.97 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.163 0.431 . . . . 72.420000000000002 112.163 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 10' ' ' PRO . 4.4 mp -78.99 -22.44 45.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.559 0.218 . . . . 74.219999999999999 111.26 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -120.2 -0.97 10.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.279 0.474 . . . . 74.340000000000003 112.279 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 33.1 ttpt -94.67 143.8 26.14 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.574 0.702 . . . . 74.430000000000007 111.822 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.9 mt -115.65 145.65 42.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.694 -1.139 . . . . 75.450000000000003 109.909 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -96.27 134.3 39.56 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.275 -1.009 . . . . 74.329999999999998 108.275 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.84 112.04 38.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.905 -0.406 . . . . 72.329999999999998 109.905 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.96 153.51 17.08 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.301 -0.952 . . . . 74.209999999999994 111.592 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.87 40.19 52.91 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 75.540000000000006 113.675 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.8 mt -78.27 177.02 8.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.956 -0.387 . . . . 63.130000000000003 109.956 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -84.13 -179.42 7.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.899 0.38 . . . . 72.230000000000004 110.099 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -84.1 -9.16 58.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.349 0.595 . . . . 71.420000000000002 109.851 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.03 20.37 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.791 -0.64 . . . . 75.140000000000001 111.786 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -75.62 131.53 40.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.811 0.339 . . . . 74.040000000000006 111.047 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 p -114.41 160.64 18.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 62.299999999999997 110.531 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 1.9 m-20 -62.59 -38.62 90.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 73.319999999999993 110.616 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.48 -42.14 98.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.381 -0.827 . . . . 70.019999999999996 111.353 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -75.87 -37.76 58.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.024 -0.534 . . . . 71.439999999999998 110.716 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.25 -43.59 90.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 71.209999999999994 110.454 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -60.46 -54.95 39.39 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.092 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -47.41 -39.72 16.08 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.302 1.001 . . . . 75.019999999999996 113.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -68.47 -61.27 1.9 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.967 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -71.08 -24.51 62.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.137 0.421 . . . . 74.299999999999997 112.137 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.1 tt0 -62.49 -21.08 65.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.28 -0.418 . . . . 74.239999999999995 111.837 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -62.1 -27.53 68.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.723 0.297 . . . . 75.129999999999995 111.461 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -98.05 -24.36 15.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.407 -0.361 . . . . 74.329999999999998 111.259 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.5 166.47 39.2 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.173 -1.013 . . . . 53.009999999999998 112.834 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -61.49 141.19 57.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.077 0.551 . . . . 73.209999999999994 111.369 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 mt -118.5 123.3 44.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.362 -0.607 . . . . 74.030000000000001 109.362 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -90.13 -25.1 20.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.087 -0.506 . . . . 74.120000000000005 110.295 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.34 152.16 31.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.488 -0.778 . . . . 72.510000000000005 109.864 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.6 t -160.15 123.99 3.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.294 -0.632 . . . . 71.409999999999997 109.294 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 p -143.26 118.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.516 0.674 . . . . 73.049999999999997 110.431 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 133.12 31.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 107.917 -1.142 . . . . 74.299999999999997 107.917 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.542 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.5 mmt -77.78 96.86 5.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.623 0.725 . . . . 62.409999999999997 110.236 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -96.81 161.27 13.93 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.423 -1.262 . . . . 73.200000000000003 108.975 175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.94 125.54 92.02 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.221 -0.659 . . . . 61.520000000000003 109.221 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.47 -20.94 53.98 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.573 1.515 . . . . 73.099999999999994 112.982 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.9 OUTLIER -86.65 -55.63 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 73.310000000000002 111.223 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -16.48 23.56 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.917 -0.583 . . . . 74.129999999999995 112.18 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp 65.74 29.12 10.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.926 0.89 . . . . 75.420000000000002 111.925 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -107.35 155.14 20.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.02 -0.733 . . . . 71.349999999999994 109.02 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 t -71.05 135.46 47.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.911 0.386 . . . . 75.230000000000004 111.16 -173.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -87.38 5.27 39.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 110.775 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.52 70.62 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.864 -0.684 . . . . 64.5 114.175 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.542 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 25.5 p90 -156.0 156.41 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.04 0.92 . . . . 75.510000000000005 110.801 174.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.05 -165.15 17.25 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.639 -0.585 . . . . 44.140000000000001 111.639 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.51 145.65 31.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.973 0.387 . . . . 74.409999999999997 109.99 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.26 119.87 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 75.329999999999998 110.2 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.5 m -95.69 122.29 38.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.052 -0.351 . . . . 72.150000000000006 110.052 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -85.63 170.24 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 73.239999999999995 110.106 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -74.29 -52.57 11.89 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.671 -0.492 . . . . 74.120000000000005 109.671 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -122.37 150.29 42.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 74.409999999999997 110.502 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -63.81 -35.43 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.576 0.227 . . . . 72.239999999999995 111.263 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -52.29 -41.35 62.83 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.767 0.654 . . . . 74.209999999999994 112.767 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 47.4 mt-10 -68.74 -28.39 66.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.189 0.518 . . . . 72.329999999999998 110.726 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 25.0 t -65.31 -45.39 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.418 -0.81 . . . . 72.209999999999994 111.083 175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.81 -45.01 86.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.544 . . . . 73.120000000000005 110.912 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.1 -41.52 60.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 74.010000000000005 112.095 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -37.7 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 71.530000000000001 110.977 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.5 mmt -68.61 -32.95 73.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.059 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 -10.07 55.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.049 -0.523 . . . . 71.230000000000004 110.851 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.56 -9.27 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.264 0.554 . . . . 71.150000000000006 110.265 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp180 -53.39 142.48 39.45 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.818 -1.083 . . . . 75.319999999999993 111.327 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 6.1 Cg_exo -78.49 168.75 74.58 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.647 -0.981 . . . . 65.430000000000007 113.385 3.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -124.96 155.02 40.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.146 -0.933 . . . . 74.430000000000007 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.7 ttmt -132.79 106.94 8.04 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.84 0.352 . . . . 75.310000000000002 111.22 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.82 127.31 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 71.420000000000002 110.04 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.8 t70 67.15 29.94 7.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.561 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.13 67.34 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.629 -0.714 . . . . 74.040000000000006 111.91 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.8 tpt180 -130.81 139.19 50.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.136 -0.32 . . . . 75.099999999999994 110.136 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.33 113.14 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.087 -0.708 . . . . 75.129999999999995 109.087 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.83 149.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.425 0.631 . . . . 71.109999999999999 111.182 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -112.93 96.64 38.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.027 -0.988 . . . . 74.049999999999997 110.662 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.85 138.3 18.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.309 2.006 . . . . 70.209999999999994 112.136 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -132.96 168.67 18.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.113 -1.44 . . . . 73.109999999999999 107.113 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.436 HH11 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -83.31 142.25 31.22 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.867 -0.733 . . . . 71.349999999999994 109.101 173.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.73 92.15 1.97 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.29 0.567 . . . . 64.140000000000001 109.621 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.36 158.06 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.863 -1.062 . . . . 75.140000000000001 110.457 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -52.9 145.21 13.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.849 -0.614 . . . . 53.130000000000003 110.619 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.48 -41.61 30.23 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.489 0.922 . . . . 74.329999999999998 113.489 -168.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.16 -51.4 67.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.427 0.156 . . . . 70.519999999999996 111.26 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.0 -29.68 66.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.417 -0.356 . . . . 55.450000000000003 110.398 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -64.19 -18.43 64.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 73.209999999999994 111.539 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -96.42 -2.63 45.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 110.73 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -88.91 151.47 47.28 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.405 -0.361 . . . . 75.430000000000007 111.039 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.01 118.55 5.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.711 2.274 . . . . 62.119999999999997 112.16 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.96 21.11 31.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.852 -0.69 . . . . 64.430000000000007 112.468 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.72 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.049 0.452 . . . . 72.030000000000001 111.928 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -104.62 25.67 10.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.081 -0.509 . . . . 62.140000000000001 111.409 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.39 -171.9 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.976 -0.557 . . . . 73.109999999999999 109.809 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 58.87 3.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.616 . . . . 73.099999999999994 110.794 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.97 107.96 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 74.510000000000005 110.181 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.458 ' C ' HG23 ' A' ' 159' ' ' VAL . 63.4 mttt -111.02 14.95 21.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.034 0.445 . . . . 53.240000000000002 110.343 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.58 140.87 47.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.271 -0.422 . . . . 72.200000000000003 110.229 178.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.25 149.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.399 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.9 t80 -97.24 133.16 42.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.086 -0.961 . . . . 75.109999999999999 109.189 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.63 110.02 24.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.23 147.95 16.92 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.034 -1.079 . . . . 71.430000000000007 113.074 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.56 22.22 8.7 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.835 -0.698 . . . . 43.420000000000002 112.158 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.7 pt -91.18 77.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.909 0.861 . . . . 74.439999999999998 110.458 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -66.71 -50.84 61.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.054 -0.975 . . . . 72.329999999999998 111.051 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.12 155.19 40.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.618 -0.512 . . . . 73.019999999999996 109.618 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.42 99.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.404 0.621 . . . . 55.109999999999999 110.884 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.5 m -97.53 134.01 41.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.229 -0.896 . . . . 64.219999999999999 109.719 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' HIS . 61.8 mt-10 -110.64 167.16 10.44 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.736 -1.12 . . . . 75.25 110.408 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.479 ' O ' HD21 ' A' ' 121' ' ' LEU . 26.9 tt0 -59.73 -46.04 90.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.823 . . . . 74.450000000000003 111.548 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -69.36 -22.03 63.77 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.888 -0.325 . . . . 71.510000000000005 111.484 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 61.2 m170 -61.49 -60.16 4.13 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.781 0.324 . . . . 73.319999999999993 110.532 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 118' ' ' GLU . 1.9 pt? -84.2 -21.07 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.292 -0.563 . . . . 71.219999999999999 111.143 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -65.94 -52.87 45.97 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.853 -0.425 . . . . 71.310000000000002 109.853 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -31.9 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.344 0.593 . . . . 72.219999999999999 110.416 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.416 ' OH ' ' HB3' ' A' ' 168' ' ' HIS . 83.1 t80 -72.6 -58.66 3.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.211 -0.904 . . . . 75.25 112.088 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.442 ' CD2' HG22 ' A' ' 151' ' ' VAL . 47.9 m-85 -66.43 -21.12 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.901 0.334 . . . . 73.549999999999997 111.901 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.39 -25.37 67.53 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.471 0.308 . . . . 73.129999999999995 111.31 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.16 -31.51 63.44 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.129 -0.487 . . . . 75.310000000000002 111.304 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.59 -28.56 23.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 65.219999999999999 111.941 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.9 -172.85 45.35 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.384 -0.912 . . . . 62.409999999999997 113.654 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -76.42 128.55 35.03 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.131 0.491 . . . . 75.400000000000006 111.683 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 152' ' ' THR . 61.3 mt -100.87 137.6 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 73.129999999999995 109.994 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -86.88 -52.19 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 73.109999999999999 110.428 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.15 155.74 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.321 -0.4 . . . . 70.209999999999994 110.209 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.89 129.01 72.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.239 0.542 . . . . 75.420000000000002 109.935 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.71 104.22 14.53 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.648 -0.706 . . . . 73.049999999999997 110.977 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.2 mm -90.8 120.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.976 -0.749 . . . . 74.140000000000001 108.976 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.9 mmm -94.88 113.88 25.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.748 0.785 . . . . 75.510000000000005 110.392 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 114.846 -1.07 . . . . 73.230000000000004 109.794 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.325 0 N-CA-C 114.303 0.481 . . . . 61.399999999999999 114.303 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -155.48 157.5 37.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.595 0.697 . . . . 74.310000000000002 110.259 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.24 177.13 8.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 54.200000000000003 109.899 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.441 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -140.87 149.15 41.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.691 -0.686 . . . . 74.519999999999996 109.713 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' A' ' 125' ' ' PHE . 66.7 t -133.75 130.9 56.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.464 -0.334 . . . . 74.430000000000007 110.77 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 131' ' ' ILE . 60.0 m -103.49 125.37 50.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.689 -0.687 . . . . 73.030000000000001 110.616 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.56 162.66 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.987 0.422 . . . . 74.530000000000001 111.208 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.75 -29.34 29.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.591 -0.732 . . . . 71.0 110.253 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.92 144.51 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 74.200000000000003 110.279 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -72.24 -26.53 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 74.109999999999999 110.129 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.551 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -55.44 -44.74 76.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.106 -0.952 . . . . 65.200000000000003 111.399 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -71.56 -33.35 69.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.037 -0.528 . . . . 71.439999999999998 111.212 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.87 -38.49 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.868 0.365 . . . . 64.040000000000006 110.088 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 1.7 t70 -67.05 -34.23 77.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.521 -0.763 . . . . 74.040000000000006 110.841 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.7 mttt -56.58 -40.87 75.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 110.349 172.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.5 mt -73.54 -45.43 51.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.397 -1.274 . . . . 75.109999999999999 112.286 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 160' ' ' ASP . 15.8 m -75.11 -10.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.24 0.543 . . . . 73.120000000000005 111.027 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 mt -61.96 -31.9 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.139 -0.937 . . . . 74.0 109.971 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 64.6 mt-30 -107.84 104.1 13.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.82 -0.807 . . . . 61.439999999999998 108.82 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -54.08 -35.0 61.61 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.714 0.635 . . . . 72.519999999999996 112.714 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -122.15 138.45 54.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.888 0.375 . . . . 73.349999999999994 111.208 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -130.18 146.36 51.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 74.420000000000002 110.152 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -104.04 115.01 29.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 74.540000000000006 111.05 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.9 p -141.43 146.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.626 -0.715 . . . . 71.239999999999995 109.187 177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 58.33 29.52 18.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.343 1.068 . . . . 74.140000000000001 110.54 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.2 0.87 84.49 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.212 -0.904 . . . . 65.239999999999995 113.253 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -121.59 133.59 55.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.071 0.463 . . . . 74.219999999999999 111.068 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.08 108.55 18.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 62.009999999999998 109.715 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.2 p -113.11 157.17 21.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 62.310000000000002 110.677 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -85.76 134.05 33.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.959 0.409 . . . . 71.040000000000006 110.072 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.0 t -130.44 132.46 64.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.564 -0.744 . . . . 72.120000000000005 109.799 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -153.73 173.8 15.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.789 -0.641 . . . . 74.150000000000006 110.994 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -64.56 131.54 47.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.129 0.49 . . . . 73.540000000000006 111.3 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -122.92 118.56 28.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.715 -0.846 . . . . 72.019999999999996 108.715 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 109.756 -0.461 . . . . 75.400000000000006 109.756 -178.33 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 121.337 0.589 . . . . 72.109999999999999 109.782 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.18 135.64 57.88 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.192 -0.913 . . . . 62.119999999999997 110.219 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 11.4 Cg_endo -63.17 160.24 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.118 1.879 . . . . 74.019999999999996 110.965 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.6 63.23 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.1 0.407 . . . . 72.349999999999994 112.1 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.26 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 74.040000000000006 112.434 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 42.7 mt -79.36 -16.92 55.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 64.230000000000004 110.719 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -122.97 4.83 9.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 73.319999999999993 111.492 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.9 ttpt -99.08 149.78 22.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.224 0.535 . . . . 61.219999999999999 110.666 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 7.6 mp -116.38 141.32 48.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.009 -0.996 . . . . 75.299999999999997 110.224 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -97.27 114.4 26.15 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.445 -0.946 . . . . 72.349999999999994 108.445 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 mm -94.08 111.0 24.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 110.053 -0.351 . . . . 72.329999999999998 110.053 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.3 152.68 18.45 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.561 -0.828 . . . . 70.299999999999997 111.314 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.88 45.76 41.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.629 -0.796 . . . . 72.120000000000005 113.142 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.9 mt -79.64 175.27 10.77 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.78 -0.452 . . . . 71.340000000000003 109.78 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 82' ' ' ARG . 21.2 p -91.34 175.33 6.97 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.549 -0.538 . . . . 74.230000000000004 109.549 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -75.23 -8.16 55.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.321 0.581 . . . . 73.230000000000004 110.081 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.77 9.12 17.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.568 -0.742 . . . . 71.129999999999995 112.138 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.536 ' HA ' ' OD2' ' A' ' 80' ' ' ASP . 19.3 m -76.6 120.69 22.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.447 -0.501 . . . . 73.219999999999999 111.161 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 p -103.96 159.98 15.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 71.310000000000002 110.468 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 2.5 m-20 -60.34 -38.84 85.02 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.032 -0.531 . . . . 73.209999999999994 110.93 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.69 -39.56 91.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.736 -0.665 . . . . 74.219999999999999 111.718 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -75.92 -39.89 55.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.541 -0.3 . . . . 65.319999999999993 110.683 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.82 -47.49 83.2 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.041 -0.527 . . . . 73.349999999999994 109.995 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -57.59 -60.33 3.83 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 111.356 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -51.97 -36.6 50.09 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.537 0.523 . . . . 75.200000000000003 112.284 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -71.45 -56.8 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.651 -0.25 . . . . 75.299999999999997 110.908 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -68.55 -25.18 64.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 73.439999999999998 111.851 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.91 -15.11 61.65 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.113 0.412 . . . . 70.340000000000003 112.113 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -29.57 70.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.822 0.344 . . . . 73.530000000000001 111.163 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -98.01 -22.3 16.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.542 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.36 159.39 32.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.36 -0.924 . . . . 73.400000000000006 112.099 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.5 m -64.64 118.27 8.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.048 0.451 . . . . 73.329999999999998 111.999 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -92.12 134.12 35.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.434 0.635 . . . . 73.319999999999993 110.761 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -107.75 -19.41 13.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.001 . . . . 65.310000000000002 110.238 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.454 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 32.0 t70 -151.51 152.44 32.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 75.140000000000001 109.897 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.0 t -163.03 127.24 2.96 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.502 -0.555 . . . . 74.299999999999997 109.502 172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 4.8 p -142.01 123.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.536 0.684 . . . . 64.319999999999993 110.63 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.4 130.67 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.506 -0.924 . . . . 75.310000000000002 108.506 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.88 135.69 46.66 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.959 -0.756 . . . . 73.329999999999998 108.959 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -135.35 156.55 48.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.874 -0.603 . . . . 74.439999999999998 111.493 -170.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 13.3 t70 -66.46 132.3 94.25 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.837 -1.074 . . . . 72.230000000000004 109.323 174.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.82 -18.88 47.34 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 121.897 1.732 . . . . 74.319999999999993 113.864 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -85.56 -57.31 3.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.844 0.354 . . . . 62.049999999999997 111.604 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -105.45 -7.72 18.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.061 -0.518 . . . . 74.140000000000001 111.305 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 40.0 mmtm 63.63 32.06 14.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.803 0.841 . . . . 73.030000000000001 111.555 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -95.94 162.43 13.57 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.808 -0.812 . . . . 74.340000000000003 108.808 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -65.69 139.71 58.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.838 0.351 . . . . 73.040000000000006 111.613 -171.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.14 2.21 47.67 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.769 -0.65 . . . . 75.219999999999999 110.379 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 15.92 61.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.741 -0.743 . . . . 60.130000000000003 113.242 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -161.19 157.15 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.154 0.477 . . . . 72.099999999999994 110.524 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.27 -164.21 16.74 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 111.52 -0.632 . . . . 75.519999999999996 111.52 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.6 m-85 -142.35 150.87 41.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.32 0.56 . . . . 73.209999999999994 110.805 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.84 123.37 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.78 -0.645 . . . . 63.340000000000003 109.87 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 42' ' ' ASP . 5.2 m -98.94 120.64 39.72 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.332 -0.23 . . . . 72.450000000000003 110.609 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.63 161.8 17.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.167 -0.47 . . . . 74.349999999999994 110.322 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 -35.59 62.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.715 -0.675 . . . . 62.530000000000001 110.599 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.86 149.36 52.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 72.329999999999998 110.347 -178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.586 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.5 p -66.44 -34.6 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 120.778 0.323 . . . . 73.400000000000006 111.096 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.94 -37.44 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.206 0.447 . . . . 75.439999999999998 112.206 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.05 -29.49 70.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 71.420000000000002 110.368 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 2.7 t -62.11 -44.52 99.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.175 -0.92 . . . . 73.209999999999994 110.98 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -41.18 97.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 111.131 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.75 -39.88 78.4 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.025 0.38 . . . . 74.239999999999995 112.025 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.95 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 63.409999999999997 110.529 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.0 mmt -66.41 -33.46 75.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.769 -0.65 . . . . 74.530000000000001 110.529 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.592 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 3.4 p30 -82.26 -9.6 59.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.991 0.424 . . . . 75.349999999999994 111.091 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.59 -14.39 45.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.856 -0.611 . . . . 74.530000000000001 112.518 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -49.16 146.35 6.1 Favored Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 112.705 0.631 . . . . 75.140000000000001 112.705 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.4 154.34 85.22 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 124.02 -1.242 . . . . 70.129999999999995 113.287 1.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -107.44 147.16 30.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.705 -0.68 . . . . 74.209999999999994 110.441 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -138.45 104.37 5.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.118 0.485 . . . . 73.540000000000006 111.226 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.34 139.92 43.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.335 -0.617 . . . . 74.439999999999998 109.335 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 1.7 m-20 62.72 31.79 16.44 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.565 0.54 . . . . 73.140000000000001 111.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.67 23.53 77.68 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.396 -0.82 . . . . 45.119999999999997 112.605 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.9 tpt180 -129.38 137.35 50.9 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.848 -0.207 . . . . 71.349999999999994 110.787 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.35 116.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.984 -0.747 . . . . 72.430000000000007 108.984 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -109.91 154.18 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.288 0.566 . . . . 72.450000000000003 111.493 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.85 95.89 35.51 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.142 -0.935 . . . . 74.140000000000001 110.753 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.55 134.11 16.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.09 1.86 . . . . 62.439999999999998 112.155 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.596 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 31.9 mmtt -125.9 -177.82 4.07 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.849 -1.167 . . . . 64.450000000000003 107.849 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.479 HH22 ' HE2' ' A' ' 161' ' ' LYS . 12.2 mmt-85 -80.87 163.14 23.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.281 0.492 . . . . 75.25 109.764 170.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.08 90.49 4.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.817 0.818 . . . . 75.140000000000001 108.822 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 164' ' ' ILE . 16.5 t -82.75 156.35 3.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.58 -1.191 . . . . 75.340000000000003 109.191 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.3 t -54.82 148.38 13.21 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.461 0.476 . . . . 70.120000000000005 109.902 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 6.8 tpp180 -66.52 -6.02 13.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.089 0.471 . . . . 72.209999999999994 111.984 -172.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.85 -43.95 94.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.277 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.11 -43.88 14.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.842 -0.617 . . . . 74.120000000000005 111.088 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 1.5 p -69.34 -12.31 61.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.242 -0.436 . . . . 73.239999999999995 111.875 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 33.9 tt0 -61.59 -34.93 76.47 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.964 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -70.56 145.81 93.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.232 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.34 120.08 7.12 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.349 2.7 . . . . 71.420000000000002 112.712 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.1 29.14 69.18 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 121.18 -0.534 . . . . 63.240000000000002 113.023 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.59 ' O ' ' HE2' ' A' ' 179' ' ' LYS . . . -78.85 -49.6 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.748 0.309 . . . . 75.019999999999996 110.618 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 95' ' ' SER . 4.7 m80 -81.16 25.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.647 0.61 . . . . 61.43 112.647 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.53 -164.09 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.715 -0.846 . . . . 73.120000000000005 108.715 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.444 ' HA ' ' HZ1' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -81.11 88.76 5.97 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.596 -0.69 . . . . 62.119999999999997 111.122 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.92 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 71.209999999999994 109.569 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.405 ' C ' HG21 ' A' ' 159' ' ' VAL . 79.1 mttt -108.47 20.1 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.124 0.488 . . . . 73.040000000000006 110.605 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -120.58 139.74 52.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.192 -0.458 . . . . 72.540000000000006 110.636 178.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 pt -129.94 151.3 35.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.375 0.607 . . . . 74.140000000000001 111.665 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.3 t80 -101.86 133.24 46.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.621 -1.172 . . . . 74.409999999999997 109.809 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.5 110.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.336 -0.616 . . . . 70.310000000000002 109.336 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.28 157.23 19.4 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.297 -0.954 . . . . 72.409999999999997 112.953 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.94 19.66 30.58 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.773 -0.727 . . . . 64.340000000000003 111.828 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.8 pt -78.52 118.39 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.341 0.591 . . . . 73.219999999999999 110.874 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.99 -69.3 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 71.340000000000003 110.759 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.01 154.82 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.777 -0.453 . . . . 74.329999999999998 109.777 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.97 104.84 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.687 -0.688 . . . . 73.310000000000002 110.486 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -79.85 132.91 36.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.833 -0.621 . . . . 61.219999999999999 110.368 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -101.7 167.24 10.23 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.258 -0.883 . . . . 73.200000000000003 110.471 -177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.58 -48.17 82.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 71.129999999999995 110.403 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -62.5 -26.75 68.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 75.530000000000001 111.137 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -63.95 -61.4 2.3 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.17 0.509 . . . . 73.0 110.461 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.47 -26.89 32.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.247 -0.581 . . . . 73.319999999999993 111.595 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -65.26 -50.57 65.28 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.965 -0.294 . . . . 74.439999999999998 110.315 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.15 -31.47 70.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 74.400000000000006 110.822 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' A' ' 170' ' ' VAL . 78.2 t80 -76.96 -56.24 4.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 112.128 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -66.98 -22.11 65.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.174 0.435 . . . . 73.549999999999997 112.174 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.4 mm-40 -64.79 -28.07 69.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.022 0.439 . . . . 71.310000000000002 110.77 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.77 -28.12 60.72 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.158 -0.474 . . . . 75.340000000000003 111.789 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.48 -26.42 24.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.35 -0.387 . . . . 73.549999999999997 111.717 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.75 -176.26 44.28 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 120.889 -0.672 . . . . 74.219999999999999 113.138 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -76.15 134.11 40.04 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 111.439 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 152' ' ' THR . 69.0 mt -105.85 142.02 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.749 -0.659 . . . . 72.519999999999996 110.75 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -91.42 -52.39 4.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 64.329999999999998 111.029 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -155.74 154.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.997 -0.547 . . . . 74.209999999999994 110.187 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.59 128.09 71.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 75.040000000000006 109.819 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.84 103.92 13.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.328 -0.851 . . . . 72.420000000000002 110.789 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -92.17 124.86 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.89 -0.782 . . . . 73.420000000000002 108.89 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.9 mmm -94.67 113.73 25.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.334 0.588 . . . . 74.239999999999995 109.843 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 75.519999999999996 110.406 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.407 -0.107 . . . . 63.039999999999999 112.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.98 157.51 43.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.763 -0.458 . . . . 74.120000000000005 109.763 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.26 166.39 24.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 71.0 109.735 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -133.87 153.44 51.74 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.993 -0.549 . . . . 73.25 110.131 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.13 132.39 18.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.311 0.577 . . . . 75.340000000000003 111.063 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.542 ' O ' HG23 ' A' ' 131' ' ' ILE . 55.9 m -98.49 124.57 43.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.102 -0.954 . . . . 65.219999999999999 110.495 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.02 161.36 13.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.923 0.392 . . . . 75.510000000000005 111.187 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.21 -33.41 56.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.685 -0.689 . . . . 74.329999999999998 110.207 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.4 154.93 50.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.247 -0.888 . . . . 75.439999999999998 110.613 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.596 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 21.6 p80 -80.06 -21.27 43.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 75.140000000000001 110.321 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -53.62 -43.98 69.11 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.91 0.756 . . . . 75.329999999999998 110.96 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 m -71.96 -33.54 68.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.485 -0.779 . . . . 60.350000000000001 111.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.405 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -72.41 -37.62 58.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.206 0.527 . . . . 71.510000000000005 109.724 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.253 -0.885 . . . . 74.340000000000003 111.103 -178.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.5 mttt -68.27 -39.28 82.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.648 0.737 . . . . 75.540000000000006 110.134 172.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.14 -41.72 37.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.85 -1.068 . . . . 75.439999999999998 112.52 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.5 m -73.5 -5.49 6.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.045 0.45 . . . . 72.019999999999996 111.38 -174.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.484 ' HA ' HG11 ' A' ' 90' ' ' VAL . 50.8 mt -61.89 -33.56 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.399 -0.819 . . . . 72.310000000000002 110.295 171.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.1 mt-30 -110.32 108.68 18.84 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -56.0 -33.25 64.69 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.678 0.621 . . . . 75.439999999999998 112.678 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -123.5 139.81 53.64 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.24 -0.288 . . . . 74.319999999999993 110.689 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.2 m-70 -128.19 152.45 48.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 109.946 175.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 m -100.28 110.09 22.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 75.019999999999996 110.113 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 124' ' ' TYR . 12.0 t -124.11 133.16 70.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.005 -0.739 . . . . 75.239999999999995 109.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.07 28.06 14.32 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.608 0.718 . . . . 71.340000000000003 111.486 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.78 7.57 87.34 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.014 -0.613 . . . . 74.299999999999997 113.024 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -112.0 125.26 53.88 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.503 0.321 . . . . 74.519999999999996 110.759 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -82.56 110.69 17.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.478 0.656 . . . . 60.109999999999999 109.735 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 16.0 m -122.36 157.65 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 64.299999999999997 110.792 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -85.59 132.81 34.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.341 -0.391 . . . . 75.530000000000001 110.294 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.9 t -129.16 135.34 62.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.689 -0.687 . . . . 75.019999999999996 110.155 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -158.0 173.29 16.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 72.129999999999995 110.856 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 100' ' ' ALA . 12.5 mmtm -58.92 132.29 53.55 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.353 0.408 . . . . 75.129999999999995 110.979 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.22 114.51 22.53 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.639 -0.504 . . . . 75.310000000000002 109.639 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 108.958 -0.756 . . . . 75.209999999999994 108.958 178.171 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm . . . . . 0 CA--C 1.532 0.256 0 N-CA-C 111.614 0.227 . . . . 73.230000000000004 111.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.4 122.54 78.8 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 74.329999999999998 109.544 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 13' ' ' LEU . 17.4 Cg_endo -60.39 167.24 8.18 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.301 2.668 . . . . 71.319999999999993 112.532 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 2.2 pt-20 -51.18 -42.23 60.73 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 123.294 0.371 . . . . 75.319999999999993 111.54 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 5.5 pt20 -64.93 -19.82 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.622 0.601 . . . . 73.150000000000006 112.622 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 10' ' ' PRO . 3.4 mp -90.07 -21.45 22.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.531 0.197 . . . . 74.230000000000004 111.531 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -117.83 -3.61 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.633 -0.427 . . . . 64.129999999999995 111.501 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -99.17 144.49 28.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.557 0.694 . . . . 71.329999999999998 111.549 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 87' ' ' LYS . 52.5 mt -115.61 148.27 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.741 -1.118 . . . . 63.409999999999997 110.544 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -98.61 125.97 44.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.407 -0.96 . . . . 65.109999999999999 108.407 172.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.7 mm -103.86 111.9 35.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.819 -0.437 . . . . 70.109999999999999 109.819 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.44 17.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.595 -0.812 . . . . 73.109999999999999 111.847 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.63 47.36 27.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.609 -0.805 . . . . 72.219999999999999 113.152 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.424 HD22 ' CG1' ' A' ' 84' ' ' VAL . 86.1 mt -82.26 176.23 9.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.412 . . . . 74.319999999999993 109.889 172.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -88.34 175.23 7.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.054 0.454 . . . . 74.140000000000001 109.849 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -81.7 -4.98 57.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.018 -0.537 . . . . 74.349999999999994 110.438 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.35 9.11 10.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 61.229999999999997 111.549 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 m -75.94 127.23 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 74.219999999999999 111.379 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.9 p -103.19 172.6 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 73.409999999999997 110.37 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.56 -24.2 39.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.221 -0.288 . . . . 74.420000000000002 110.221 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.44 -39.04 68.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 64.420000000000002 111.204 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.5 p -75.4 -38.03 60.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 73.099999999999994 110.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.94 -49.1 76.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.465 -0.789 . . . . 71.040000000000006 109.995 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -56.09 -62.42 1.72 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.519 -0.764 . . . . 75.329999999999998 111.959 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 t -50.65 -33.17 21.44 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.742 0.651 . . . . 75.209999999999994 112.544 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -75.2 -55.27 5.89 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.07 -0.252 . . . . 75.299999999999997 111.083 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.94 -22.77 62.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.067 0.395 . . . . 73.409999999999997 112.067 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -58.36 -22.83 54.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.049 0.539 . . . . 64.299999999999997 111.849 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -63.95 -27.52 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.362 . . . . 71.430000000000007 111.973 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -96.75 -23.74 16.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.762 0.315 . . . . 73.349999999999994 111.253 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.93 154.44 24.46 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.334 -0.936 . . . . 38.950000000000003 111.972 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.2 m -62.51 118.2 7.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 72.450000000000003 111.087 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -85.0 142.46 29.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 110.452 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -104.41 -25.43 12.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.607 -0.724 . . . . 72.219999999999999 109.682 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -153.49 156.2 37.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 70.310000000000002 110.084 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.4 t -161.79 132.32 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.454 -0.572 . . . . 72.109999999999999 109.454 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.68 118.02 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.716 0.769 . . . . 75.219999999999999 110.693 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.43 132.67 31.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.715 -0.846 . . . . 74.219999999999999 108.715 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mmt -76.19 101.37 5.37 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.512 0.673 . . . . 73.420000000000002 110.346 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -99.05 153.71 18.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.804 -1.089 . . . . 74.099999999999994 109.397 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.48 128.01 86.52 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.928 -0.578 . . . . 74.299999999999997 110.336 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 -17.07 58.39 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.284 1.99 . . . . 72.430000000000007 113.424 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -85.63 -56.11 3.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.965 0.412 . . . . 63.420000000000002 111.587 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -11.9 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 74.109999999999999 111.77 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 62.79 34.82 14.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.752 0.821 . . . . 71.239999999999995 110.808 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -112.2 160.9 17.14 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.033 -0.729 . . . . 74.420000000000002 109.033 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -74.09 131.7 41.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.814 0.34 . . . . 64.329999999999998 110.63 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -83.68 7.01 18.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 73.239999999999995 111.38 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.03 16.32 75.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.787 -0.721 . . . . 75.409999999999997 113.521 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -157.19 155.88 31.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.358 0.579 . . . . 75.319999999999993 110.355 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.2 -165.37 16.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.418 -0.673 . . . . 64.450000000000003 111.418 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 1.1 m-85 -142.66 148.77 37.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.046 0.423 . . . . 75.430000000000007 110.31 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.11 127.23 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.719 -0.673 . . . . 65.510000000000005 109.534 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -101.96 117.43 34.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.0 -0.37 . . . . 74.540000000000006 110.0 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.1 m-85 -84.85 170.86 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.328 -0.396 . . . . 75.510000000000005 110.494 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.13 -49.48 28.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.863 -0.608 . . . . 61.240000000000002 110.044 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.507 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -128.83 160.22 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 72.409999999999997 110.792 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.3 p -65.12 -33.43 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.238 -0.437 . . . . 72.230000000000004 111.308 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -55.79 -44.54 77.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.509 0.559 . . . . 74.329999999999998 112.509 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.5 mp0 -61.28 -32.75 72.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.3 0.572 . . . . 73.019999999999996 110.728 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 39.1 t -65.95 -49.63 75.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.236 -0.893 . . . . 74.219999999999999 111.055 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.32 -43.83 88.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 75.349999999999994 110.875 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.63 -42.6 62.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.962 -0.563 . . . . 75.109999999999999 112.284 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.97 -33.07 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.866 0.365 . . . . 71.420000000000002 110.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.68 -42.12 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 73.019999999999996 110.433 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -12.29 59.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.807 -0.633 . . . . 74.5 111.069 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.78 -10.86 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 110.657 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 19.2 ttp-105 -53.49 144.31 33.04 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.279 -0.873 . . . . 75.140000000000001 110.892 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 87.7 Cg_endo -80.53 168.93 70.47 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.56 -1.017 . . . . 73.120000000000005 114.013 2.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -128.21 158.28 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.069 -0.969 . . . . 64.340000000000003 110.165 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -134.55 104.59 6.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.082 -0.508 . . . . 65.439999999999998 110.3 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.7 132.98 55.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 75.310000000000002 109.954 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 65.62 27.42 11.44 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.82 0.7 . . . . 74.150000000000006 110.856 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.51 21.89 76.43 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.804 -0.635 . . . . 38.950000000000003 112.497 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -128.68 137.63 51.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.226 -0.287 . . . . 61.340000000000003 110.226 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.81 111.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.419 -0.586 . . . . 73.019999999999996 109.419 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG1' HD22 ' A' ' 21' ' ' LEU . 4.1 m -107.4 150.04 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.59 0.71 . . . . 71.319999999999993 111.431 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.05 95.46 38.36 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 114.823 -1.081 . . . . 72.219999999999999 110.926 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.97 131.98 17.65 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.418 2.079 . . . . 75.310000000000002 111.949 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' O ' HD21 ' A' ' 16' ' ' LEU . 27.7 mttt -141.08 -177.33 5.05 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.222 -0.899 . . . . 74.0 108.786 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 7.4 tpp180 -75.09 154.3 37.92 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.051 0.453 . . . . 75.140000000000001 111.28 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.22 91.24 6.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.421 -0.955 . . . . 72.200000000000003 108.421 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t -69.44 149.17 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.499 -0.773 . . . . 72.420000000000002 110.288 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 p -56.59 146.41 25.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 123.497 0.498 . . . . 74.329999999999998 110.034 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.21 -16.27 63.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.877 0.695 . . . . 74.150000000000006 112.877 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.63 -51.63 26.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 73.310000000000002 110.234 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.34 -20.66 33.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 63.450000000000003 111.467 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 t -69.66 -15.87 63.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.323 -0.399 . . . . 75.329999999999998 110.357 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.36 -17.91 59.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.656 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -79.32 147.47 68.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 70.129999999999995 110.841 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.69 116.5 4.58 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.699 2.266 . . . . 74.140000000000001 111.97 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.81 18.04 15.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.54 -0.838 . . . . 63.219999999999999 112.515 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.15 50.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.73 0.3 . . . . 71.319999999999993 111.096 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -103.3 13.68 33.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.021 0.439 . . . . 73.209999999999994 111.285 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.59 163.41 23.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.246 -0.65 . . . . 75.25 109.246 173.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.3 82.88 4.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.792 0.806 . . . . 74.200000000000003 110.63 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -108.63 113.69 44.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.699 -1.137 . . . . 74.040000000000006 109.753 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.455 ' C ' HG23 ' A' ' 159' ' ' VAL . 82.2 mttt -109.12 19.4 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.861 0.363 . . . . 75.030000000000001 110.475 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.41 144.54 45.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.546 -0.297 . . . . 72.239999999999995 110.667 175.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.08 148.5 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.224 0.535 . . . . 71.329999999999998 111.19 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.9 t80 -97.74 131.96 43.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.019 -0.992 . . . . 72.120000000000005 109.008 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.46 108.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.981 -0.748 . . . . 75.329999999999998 108.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.37 166.27 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.87 -1.157 . . . . 74.319999999999993 113.294 -174.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.29 58.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.704 -0.76 . . . . 45.329999999999998 111.762 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.36 134.18 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 70.519999999999996 109.478 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.73 -49.28 9.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.882 0.372 . . . . 72.239999999999995 110.204 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.86 -173.56 2.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.056 -0.72 . . . . 74.310000000000002 109.056 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.81 135.27 34.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.297 0.57 . . . . 74.340000000000003 110.983 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 m -106.95 141.43 38.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 110.315 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.37 160.91 16.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.287 -0.415 . . . . 75.510000000000005 109.918 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.17 -51.12 71.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 72.409999999999997 110.093 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -58.88 -31.01 68.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 111.731 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.347 0.405 . . . . 73.310000000000002 110.71 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 pp -81.11 -27.45 35.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.449 -0.5 . . . . 74.450000000000003 110.99 -175.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.41 -53.31 44.9 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 110.182 -0.303 . . . . 73.409999999999997 110.182 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.49 -28.27 69.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.209 0.528 . . . . 73.450000000000003 110.452 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.01 -56.71 4.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.95 -0.568 . . . . 72.319999999999993 111.54 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -66.71 -22.1 66.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 111.773 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.16 -27.72 68.91 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.99 0.424 . . . . 71.209999999999994 111.214 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -58.07 -28.77 64.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 72.140000000000001 111.3 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -86.16 -26.49 25.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.356 . . . . 75.040000000000006 111.658 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -174.91 45.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.708 -0.758 . . . . 72.040000000000006 113.582 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -78.18 131.89 37.37 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.936 0.398 . . . . 73.209999999999994 111.716 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 152' ' ' THR . 55.7 mt -104.82 139.92 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.922 -0.581 . . . . 73.209999999999994 110.384 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 -49.92 6.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 72.340000000000003 110.847 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.59 159.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.684 -0.487 . . . . 74.409999999999997 109.684 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.53 127.82 75.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.923 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.65 103.79 15.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.1 -0.954 . . . . 73.239999999999995 110.326 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.53 117.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.164 -0.68 . . . . 73.409999999999997 109.164 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.4 mmm -91.3 122.33 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.333 -0.617 . . . . 73.129999999999995 109.333 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.429 0.633 . . . . 72.150000000000006 112.039 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.475 -0.25 . . . . 65.439999999999998 112.475 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -157.46 158.8 36.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 110.392 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.5 170.07 16.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.48 -0.782 . . . . 71.209999999999994 109.54 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -134.4 145.21 48.71 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.967 -0.56 . . . . 75.030000000000001 109.909 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.19 129.07 67.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.206 -0.452 . . . . 72.140000000000001 110.623 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.464 ' O ' HG22 ' A' ' 131' ' ' ILE . 96.4 m -100.81 118.74 37.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.643 -0.708 . . . . 73.209999999999994 110.521 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.16 156.81 17.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.768 0.318 . . . . 74.329999999999998 111.178 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.56 -31.93 60.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.931 -0.577 . . . . 73.010000000000005 110.366 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -128.26 152.96 47.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 75.420000000000002 110.663 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -75.96 -25.68 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.553 . . . . 75.439999999999998 109.508 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.59 -48.84 38.72 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.102 -0.954 . . . . 70.510000000000005 111.437 178.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.7 m -72.44 -32.89 66.68 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.82 -0.627 . . . . 62.140000000000001 110.813 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.6 t -69.46 -42.34 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.312 -0.625 . . . . 75.209999999999994 109.312 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 3.6 m-20 -71.43 -22.49 61.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.082 -0.963 . . . . 72.340000000000003 111.804 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -67.01 -39.56 87.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.77 0.795 . . . . 73.329999999999998 109.786 170.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mt -76.02 -40.94 38.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.334 -1.303 . . . . 72.319999999999993 112.054 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 159' ' ' VAL . 7.5 m -73.33 -11.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.001 0.429 . . . . 75.150000000000006 110.924 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.409 HD12 HD12 ' A' ' 13' ' ' LEU . 10.8 mt -63.71 -29.99 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.323 -0.853 . . . . 73.400000000000006 110.193 173.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.551 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 54.6 mt-30 -112.66 98.42 7.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.898 -1.149 . . . . 63.109999999999999 107.898 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -56.67 -33.37 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.108 -0.951 . . . . 71.120000000000005 112.431 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -121.65 131.75 54.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.33 -0.395 . . . . 75.109999999999999 110.381 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -124.49 150.95 45.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.712 -0.676 . . . . 73.349999999999994 109.794 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -115.87 118.1 32.05 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.779 -0.452 . . . . 72.349999999999994 109.779 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.93 117.2 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.054 -0.521 . . . . 74.420000000000002 110.31 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.02 28.23 5.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 73.209999999999994 110.328 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 97.73 -9.13 64.07 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.534 -0.757 . . . . 61.549999999999997 113.309 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -108.61 125.68 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.444 0.622 . . . . 70.420000000000002 111.795 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -93.2 109.91 21.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.332 0.587 . . . . 70.129999999999995 110.014 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.1 p -114.64 155.31 26.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 110.675 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.0 129.94 34.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.504 -0.554 . . . . 75.140000000000001 109.504 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 12.4 t -127.74 134.45 65.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.411 -0.813 . . . . 75.420000000000002 110.202 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.6 177.0 11.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.707 -0.679 . . . . 74.019999999999996 111.134 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -64.1 125.72 25.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.36 -0.382 . . . . 73.040000000000006 110.144 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.67 44.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.016 0.436 . . . . 64.340000000000003 109.911 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.0 mt . . . . . 0 C--N 1.309 -1.168 0 CA-C-N 115.983 -0.553 . . . . 75.510000000000005 109.99 179.485 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.001 0.429 . . . . 73.329999999999998 110.713 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -64.63 128.19 93.23 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 111.107 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.8 167.65 17.03 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.152 2.568 . . . . 63.340000000000003 112.186 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.56 -34.64 72.94 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 112.157 0.429 . . . . 74.109999999999999 112.157 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -67.87 -24.36 65.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.872 0.367 . . . . 75.040000000000006 111.363 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.21 -10.6 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 74.310000000000002 111.188 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -122.34 0.72 9.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 75.140000000000001 111.216 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -97.41 145.64 25.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.597 0.713 . . . . 72.0 111.983 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -117.76 147.66 42.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.12 . . . . 74.209999999999994 110.54 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -99.27 125.75 44.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.542 -0.91 . . . . 75.319999999999993 108.542 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.97 113.18 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.91 -0.404 . . . . 74.109999999999999 109.91 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.27 17.26 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.784 -0.722 . . . . 53.049999999999997 111.858 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.74 47.33 26.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 73.25 113.333 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.003 0.43 . . . . 73.299999999999997 110.494 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 t -92.23 167.36 12.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.332 -0.618 . . . . 61.020000000000003 109.332 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 94.2 m-85 -75.46 -6.12 48.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.307 0.575 . . . . 75.439999999999998 110.789 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.14 -3.8 28.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.201 -0.909 . . . . 75.120000000000005 111.202 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.2 m -76.21 125.18 28.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 71.400000000000006 112.158 -169.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -105.86 160.01 15.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.169 -0.923 . . . . 73.420000000000002 110.072 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 120.475 0.179 . . . . 74.129999999999995 110.829 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -76.69 -38.33 54.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 75.329999999999998 111.499 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -78.51 -35.23 46.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.825 -0.171 . . . . 74.400000000000006 111.227 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.77 -45.97 84.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.248 -0.649 . . . . 72.340000000000003 109.248 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -54.17 -60.32 3.49 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.176 -0.92 . . . . 75.329999999999998 111.386 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -47.72 -34.09 7.85 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.858 0.724 . . . . 74.420000000000002 112.701 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -76.58 -57.6 3.76 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.8 -0.182 . . . . 75.200000000000003 111.114 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.18 -23.13 64.81 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.063 -0.398 . . . . 63.420000000000002 111.849 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.91 -23.33 65.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.228 0.611 . . . . 74.349999999999994 111.209 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -60.79 -26.94 67.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 72.430000000000007 112.038 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -99.95 -20.88 15.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.837 0.31 . . . . 73.239999999999995 111.837 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.73 32.88 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.294 -0.955 . . . . 75.25 112.095 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -63.23 117.28 6.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.927 0.394 . . . . 72.540000000000006 111.394 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.9 mt -85.13 143.0 29.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.482 -0.562 . . . . 72.510000000000005 109.482 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -116.17 -16.12 11.02 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.012 -0.54 . . . . 75.310000000000002 110.099 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -152.39 150.7 29.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 73.409999999999997 109.446 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.4 t -162.72 129.48 3.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.687 -0.486 . . . . 75.409999999999997 109.687 174.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.6 122.08 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.501 0.667 . . . . 72.329999999999998 110.587 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.73 129.93 37.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.150000000000006 108.785 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -75.33 95.0 3.12 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.571 0.701 . . . . 70.230000000000004 110.116 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 52.4 mtp85 -101.34 158.43 16.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.636 -1.166 . . . . 73.109999999999999 110.221 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 23.9 t70 -72.45 126.46 90.91 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.143 -0.935 . . . . 73.310000000000002 110.262 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.29 -12.5 31.99 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.127 1.885 . . . . 74.109999999999999 112.942 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.445 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 32.2 m-80 -85.64 -56.3 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.019 0.377 . . . . 75.040000000000006 112.019 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -107.09 -9.24 16.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 111.459 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 67.07 40.07 3.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.68 0.792 . . . . 75.140000000000001 111.416 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -117.28 154.66 30.84 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.547 -0.909 . . . . 72.450000000000003 108.547 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 31.3 t -72.27 139.86 48.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.147 0.431 . . . . 71.420000000000002 111.391 -171.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -82.53 1.2 39.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.695 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 20.06 57.21 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.568 -0.825 . . . . 74.319999999999993 113.987 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -161.05 156.92 25.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.9 0.85 . . . . 75.400000000000006 110.618 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.17 -163.56 14.4 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.519 -0.632 . . . . 71.450000000000003 111.519 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.15 150.4 41.03 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.374 0.587 . . . . 72.040000000000006 110.293 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 m -131.71 127.96 59.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 64.310000000000002 109.55 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -104.49 119.65 39.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.105 -0.331 . . . . 72.239999999999995 110.105 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 29.9 m-85 -85.33 158.95 20.14 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.24 -0.436 . . . . 73.450000000000003 110.121 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.92 -44.45 73.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.932 -0.576 . . . . 71.530000000000001 110.559 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.437 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -126.4 152.13 46.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.754 -0.657 . . . . 74.019999999999996 110.643 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 2.6 p -60.44 -36.31 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.727 -0.67 . . . . 74.209999999999994 110.983 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.64 -43.3 62.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.241 0.83 . . . . 52.409999999999997 113.241 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.3 mp0 -65.61 -29.24 69.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.88 0.372 . . . . 72.120000000000005 111.207 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.96 -45.7 96.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 75.140000000000001 110.428 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.31 -50.1 70.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.167 -0.924 . . . . 73.420000000000002 111.722 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -52.96 -37.08 60.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.938 0.718 . . . . 73.530000000000001 112.938 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.62 -32.52 71.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.461 0.648 . . . . 62.310000000000002 109.949 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 mmt -73.07 -31.5 64.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.251 -0.886 . . . . 74.349999999999994 112.09 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -81.39 -15.01 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.214 0.531 . . . . 63.219999999999999 110.632 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.27 -11.21 35.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 65.319999999999993 112.097 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -54.11 146.58 29.41 Favored Pre-proline 0 N--CA 1.465 0.282 0 O-C-N 123.241 0.338 . . . . 75.439999999999998 111.631 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.19 168.68 69.19 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.75 -1.354 . . . . 54.140000000000001 113.234 2.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -122.77 155.52 36.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.992 -0.549 . . . . 64.129999999999995 110.77 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 ttmt -135.06 108.47 7.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.082 -0.508 . . . . 74.219999999999999 111.112 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.34 124.76 64.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 74.530000000000001 110.073 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 64.99 27.32 12.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.474 0.71 . . . . 73.439999999999998 111.698 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.3 25.04 59.99 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.919 -0.658 . . . . 53.409999999999997 112.483 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.6 tpt180 -129.04 139.07 52.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.044 -0.354 . . . . 71.329999999999998 110.044 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.7 112.79 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.064 -0.717 . . . . 74.109999999999999 109.064 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.96 149.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 111.592 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.41 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 14.8 tp10 -110.81 98.0 36.02 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.819 -1.082 . . . . 74.420000000000002 110.334 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.18 127.71 9.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.672 1.581 . . . . 73.140000000000001 111.111 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 28.0 mttt -133.98 177.74 7.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.885 -1.154 . . . . 73.409999999999997 107.885 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.568 ' HB3' ' CB ' ' A' ' 160' ' ' ASP . 4.3 tpp180 -86.01 135.74 33.53 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.345 -0.542 . . . . 74.329999999999998 110.3 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.7 94.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.437 0.637 . . . . 73.319999999999993 110.648 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.14 157.91 6.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 74.140000000000001 111.088 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -55.3 151.72 9.38 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.71 -0.677 . . . . 63.130000000000003 111.394 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -37.45 75.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.025 -0.534 . . . . 73.109999999999999 111.54 -173.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.56 -47.97 82.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 111.236 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 -43.09 79.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 62.240000000000002 110.486 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 p -75.94 7.4 4.04 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.754 0.65 . . . . 61.350000000000001 112.754 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.44 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 74.340000000000003 110.432 173.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -91.72 144.59 29.67 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 74.0 110.683 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.37 117.47 4.98 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.604 2.203 . . . . 74.439999999999998 111.791 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.92 4.15 29.74 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.838 -0.696 . . . . 64.140000000000001 112.304 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.59 -42.74 24.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.912 0.387 . . . . 74.430000000000007 111.291 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -93.87 1.27 56.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.8 0.333 . . . . 71.549999999999997 110.777 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -78.66 159.18 28.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.178 -0.675 . . . . 74.349999999999994 109.178 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -75.79 97.9 4.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.382 0.61 . . . . 72.450000000000003 110.99 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.82 119.54 58.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.214 -0.903 . . . . 73.219999999999999 108.883 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -105.34 21.45 17.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 110.394 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.01 139.62 50.92 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.22 -0.446 . . . . 74.030000000000001 110.759 178.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.9 pt -128.96 149.03 33.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.193 0.52 . . . . 71.450000000000003 111.296 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.5 t80 -94.56 133.89 37.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.996 -1.002 . . . . 73.319999999999993 109.76 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -123.09 109.44 23.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.997 -0.742 . . . . 72.439999999999998 108.997 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.49 171.64 26.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.514 -1.327 . . . . 65.310000000000002 113.569 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.47 30.2 30.88 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.198 -0.761 . . . . 74.420000000000002 111.198 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.407 HG21 ' SG ' ' A' ' 175' ' ' CYS . 23.2 pt -75.18 129.45 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 120.975 0.417 . . . . 75.200000000000003 110.311 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.63 -54.93 5.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.106 -0.701 . . . . 72.140000000000001 109.106 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.19 149.46 24.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 73.340000000000003 108.776 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.27 149.13 48.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.276 0.56 . . . . 70.150000000000006 111.517 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -120.77 156.19 32.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 74.219999999999999 111.068 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.02 167.32 10.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.357 -0.838 . . . . 73.5 110.517 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -61.2 -54.07 48.99 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.988 -0.551 . . . . 72.230000000000004 111.01 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -65.19 -17.22 64.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 75.219999999999999 111.773 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -70.18 -57.63 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.015 -0.365 . . . . 75.439999999999998 110.015 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.28 -28.89 38.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.355 -0.538 . . . . 75.319999999999993 110.566 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.429 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 7.3 tmm_? -61.8 -50.01 74.03 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.784 -0.45 . . . . 75.329999999999998 109.784 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.04 -29.31 70.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 75.439999999999998 111.002 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.35 -53.24 6.8 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.994 -0.548 . . . . 73.409999999999997 112.021 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -66.72 -23.97 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.603 0.223 . . . . 71.239999999999995 111.603 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.45 -27.09 68.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.073 0.463 . . . . 72.530000000000001 111.023 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.77 -27.76 68.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 70.510000000000005 111.575 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -86.4 -24.6 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 111.398 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.55 -179.83 43.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.606 -0.807 . . . . 74.310000000000002 112.928 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -73.35 133.65 43.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.357 . . . . 74.019999999999996 110.661 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 152' ' ' THR . 63.9 mt -104.5 137.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.003 -0.544 . . . . 72.420000000000002 109.863 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.25 -46.97 8.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.287 . . . . 73.530000000000001 110.846 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.55 157.46 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.083 -0.339 . . . . 70.319999999999993 110.083 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.86 130.58 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.777 -0.453 . . . . 74.549999999999997 109.777 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 31.8 mt-10 -103.19 103.45 13.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.788 -0.642 . . . . 72.109999999999999 110.746 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.12 116.54 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.502 -0.555 . . . . 75.340000000000003 109.502 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.436 ' HG3' ' CE2' ' A' ' 148' ' ' PHE . 69.3 mmm -84.4 100.99 11.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.554 0.692 . . . . 73.420000000000002 109.559 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 115.007 -0.997 . . . . 53.340000000000003 110.164 -174.821 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 N-CA-C 113.941 0.337 . . . . 75.140000000000001 113.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.436 ' CE2' ' HG3' ' A' ' 137' ' ' MET . 13.3 p90 -154.7 163.46 40.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 75.299999999999997 110.493 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.18 171.91 13.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.208 -0.905 . . . . 74.140000000000001 109.893 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.4 m-85 -139.09 155.06 48.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.46 -0.791 . . . . 74.219999999999999 109.284 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.28 134.52 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-O 121.418 0.628 . . . . 75.219999999999999 111.334 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 131' ' ' ILE . 53.0 m -100.26 125.63 46.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.91 -1.041 . . . . 75.219999999999999 110.672 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -99.88 160.7 14.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.938 0.399 . . . . 73.349999999999994 111.253 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.43 -27.76 37.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 74.129999999999995 110.344 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.94 160.98 31.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.665 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -84.93 -32.08 23.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 74.510000000000005 110.756 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.601 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 35.7 t70 -62.18 -37.99 87.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.955 -0.566 . . . . 71.200000000000003 111.13 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -67.02 -33.69 76.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.526 -0.307 . . . . 64.340000000000003 111.058 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.05 -42.62 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 72.209999999999994 109.868 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.568 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 73.3 m-20 -64.14 -37.87 89.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.106 -0.952 . . . . 72.299999999999997 111.509 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 47.9 mttm -53.8 -42.67 68.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.81 0.814 . . . . 70.25 110.538 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.75 -43.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.281 -1.327 . . . . 73.420000000000002 112.395 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 160' ' ' ASP . 18.9 m -75.24 -7.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 121.972 -0.455 . . . . 75.120000000000005 111.059 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 160' ' ' ASP . 37.8 mt -57.85 -32.28 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.377 -0.829 . . . . 63.5 109.927 170.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -107.58 152.49 24.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.936 -0.575 . . . . 72.150000000000006 109.46 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.21 -39.07 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.976 0.417 . . . . 75.340000000000003 110.388 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.02 137.91 54.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 71.120000000000005 110.033 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -122.71 140.77 52.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.318 -0.401 . . . . 74.150000000000006 110.902 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -96.06 116.28 28.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.814 -0.63 . . . . 64.510000000000005 110.218 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.72 107.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 110.581 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 72.95 28.19 2.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.231 -0.895 . . . . 65.530000000000001 110.007 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.84 -2.63 80.14 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.386 -0.824 . . . . 71.310000000000002 112.678 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -110.56 130.17 55.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.775 -0.25 . . . . 72.109999999999999 110.54 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.09 0.471 . . . . 61.539999999999999 110.988 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' A' ' 112' ' ' ILE . 7.4 m -110.42 150.99 28.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.847 -0.615 . . . . 63.039999999999999 110.297 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -86.9 133.83 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.879 -0.415 . . . . 75.0 109.879 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.8 t -133.13 138.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 72.129999999999995 111.572 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -158.64 177.32 11.33 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.863 -0.608 . . . . 74.219999999999999 111.463 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -62.5 124.74 21.75 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.97 0.508 . . . . 74.219999999999999 110.86 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -111.99 113.61 26.0 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.217 0.532 . . . . 60.310000000000002 109.903 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.551 -0.749 . . . . 73.439999999999998 109.588 -178.029 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 108.845 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -71.2 141.57 86.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.018 -1.446 . . . . 74.200000000000003 109.877 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.98 166.97 19.02 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.71 2.273 . . . . 74.219999999999999 112.462 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.64 -32.29 67.12 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.956 -0.565 . . . . 71.120000000000005 111.97 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -64.05 -31.91 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.794 0.33 . . . . 75.099999999999994 111.551 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.53 -20.23 51.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 60.140000000000001 111.282 -176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -117.18 0.1 12.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.363 -0.381 . . . . 73.510000000000005 111.587 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -98.15 148.53 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.781 0.801 . . . . 75.200000000000003 112.16 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.0 mt -117.01 145.2 43.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.331 -1.304 . . . . 70.310000000000002 110.338 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -97.93 120.27 38.03 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.112 -1.07 . . . . 72.140000000000001 108.112 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -100.52 110.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.79 -0.448 . . . . 75.239999999999995 109.79 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.85 151.61 16.89 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.948 -0.861 . . . . 73.319999999999993 110.948 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 43.3 12.89 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.252 -0.975 . . . . 45.119999999999997 112.974 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.1 175.44 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.039 0.447 . . . . 74.25 110.499 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -90.96 172.79 8.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.382 -0.599 . . . . 71.200000000000003 109.382 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -77.35 -11.49 59.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.365 0.602 . . . . 75.299999999999997 110.28 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 24.0 mt-10 -106.9 -1.41 22.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 73.209999999999994 111.484 -175.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.3 m -69.75 126.41 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.119 0.485 . . . . 74.340000000000003 112.026 -170.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -101.92 167.5 10.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.407 -0.815 . . . . 73.409999999999997 110.0 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -28.1 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.978 -0.378 . . . . 74.239999999999995 109.978 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.9 -41.9 82.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.450000000000003 110.853 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t -72.64 -41.97 64.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 74.019999999999996 110.049 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.6 tp -59.85 -49.03 79.28 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.682 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 14.2 ttm-85 -58.92 -56.54 20.9 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.438 0.695 . . . . 72.239999999999995 111.044 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 m -44.38 -38.77 4.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 63.119999999999997 113.381 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -67.26 -52.2 43.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.981 -0.554 . . . . 74.230000000000004 111.226 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -80.65 -20.27 43.44 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.925 0.343 . . . . 73.420000000000002 111.925 -170.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 31' ' ' ARG . 44.1 mt-10 -56.5 -24.27 45.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.355 0.502 . . . . 72.439999999999998 112.355 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -63.3 -27.08 69.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.468 0.544 . . . . 73.420000000000002 112.468 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -100.06 -21.95 15.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.645 0.259 . . . . 75.519999999999996 111.557 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 156.84 27.25 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.759 -0.734 . . . . 74.120000000000005 111.401 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 83.2 m -67.65 120.24 13.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.911 0.386 . . . . 70.349999999999994 111.143 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 mt -84.34 145.4 28.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.328 0.585 . . . . 75.329999999999998 110.834 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -108.79 -22.94 11.99 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.278 -0.874 . . . . 61.420000000000002 110.17 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -154.52 157.47 38.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.502 . . . . 63.109999999999999 110.62 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.7 t -163.6 136.56 5.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.413 -0.588 . . . . 71.209999999999994 109.413 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -151.01 126.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.533 . . . . 72.140000000000001 110.298 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.77 132.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.7 -0.852 . . . . 73.319999999999993 108.7 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 3.8 mmt -76.05 97.16 3.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.732 0.777 . . . . 73.319999999999993 110.423 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 35.7 mtt180 -101.88 163.59 12.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.37 -1.286 . . . . 75.430000000000007 111.492 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.19 124.19 89.79 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 114.491 -1.231 . . . . 72.040000000000006 110.25 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.95 -20.23 70.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.084 1.856 . . . . 75.209999999999994 112.909 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -83.79 -56.51 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.12 0.415 . . . . 74.129999999999995 112.12 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -6.89 16.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 71.010000000000005 111.677 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm 64.43 40.18 6.49 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.384 -0.826 . . . . 74.439999999999998 111.953 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 27.0 mmm180 -114.42 163.03 15.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.418 -0.586 . . . . 74.209999999999994 109.418 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.487 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.6 t -72.42 133.97 45.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.148 0.499 . . . . 72.409999999999997 111.845 -173.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -81.88 -0.16 42.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.533 -0.758 . . . . 74.239999999999995 110.451 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.04 58.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.731 -0.747 . . . . 73.239999999999995 114.128 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 27.2 p90 -156.35 156.55 34.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.815 0.807 . . . . 61.450000000000003 110.58 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.51 -166.33 18.24 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 111.564 -0.615 . . . . 38.020000000000003 111.564 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.22 148.9 38.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.224 0.512 . . . . 75.530000000000001 110.35 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 m -128.43 130.14 69.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.637 -0.711 . . . . 73.019999999999996 109.318 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -106.72 120.15 41.22 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.304 -0.247 . . . . 74.439999999999998 110.354 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -83.93 169.17 15.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.48 . . . . 73.519999999999996 110.515 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.5 -55.65 12.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.738 -0.665 . . . . 65.230000000000004 109.577 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.3 m -123.24 153.14 40.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 73.099999999999994 111.426 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.7 p -58.04 -38.28 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.777 -0.647 . . . . 75.239999999999995 111.248 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -52.63 -41.8 64.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.066 0.765 . . . . 73.340000000000003 113.066 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -62.54 -31.34 72.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.363 0.602 . . . . 72.019999999999996 110.388 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 32.9 t -68.83 -47.26 77.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.108 -0.951 . . . . 73.010000000000005 111.01 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.76 -48.3 75.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 70.5 110.887 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.4 60.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.625 0.602 . . . . 75.519999999999996 112.625 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.94 -33.59 63.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.981 0.42 . . . . 62.119999999999997 110.659 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.414 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -67.3 -47.1 71.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 75.209999999999994 110.801 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.99 66.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 62.299999999999997 110.682 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.21 -8.04 46.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.943 0.72 . . . . 61.350000000000001 112.943 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.48 ' NH1' ' HG2' ' A' ' 85' ' ' GLU . 11.9 mtp180 -56.66 147.72 49.96 Favored Pre-proline 0 CA--C 1.531 0.225 0 O-C-N 122.897 0.123 . . . . 73.200000000000003 111.013 173.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.65 166.08 78.44 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.8 -1.333 . . . . 74.340000000000003 113.968 4.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -125.9 150.99 47.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.764 -0.653 . . . . 70.540000000000006 110.964 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -141.46 113.01 7.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.909 -0.587 . . . . 74.140000000000001 111.039 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.07 144.41 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.89 -0.596 . . . . 73.209999999999994 109.736 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.9 t70 67.39 22.03 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.592 0.71 . . . . 72.219999999999999 110.567 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.12 74.19 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.385 -0.825 . . . . 64.030000000000001 111.934 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -130.22 141.01 50.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.58 0.229 . . . . 75.519999999999996 110.529 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.56 113.19 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.874 -0.787 . . . . 73.319999999999993 108.874 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.31 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 75.209999999999994 111.602 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.48 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 mt-10 -115.33 98.03 49.68 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.213 -0.903 . . . . 75.409999999999997 111.403 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' HE1' ' A' ' 72' ' ' MET . 32.2 Cg_endo -75.28 133.04 15.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.967 1.778 . . . . 73.340000000000003 110.725 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -139.39 -178.84 5.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.201 -1.407 . . . . 75.150000000000006 107.201 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -86.96 143.29 27.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 119.748 1.158 . . . . 73.409999999999997 111.533 -177.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.81 3.5 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.843 -0.799 . . . . 50.039999999999999 108.843 165.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.79 160.01 5.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.339 -0.846 . . . . 75.209999999999994 110.117 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.7 p -53.21 150.66 5.84 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.407 0.442 . . . . 73.099999999999994 110.888 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 9.9 mpt_? -60.2 -23.73 64.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.916 -0.584 . . . . 73.010000000000005 112.26 -171.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.27 -45.83 91.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.966 0.413 . . . . 74.530000000000001 110.344 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.53 -50.61 7.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 63.539999999999999 111.216 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.9 p -70.91 -9.66 58.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.51 0.93 . . . . 70.409999999999997 113.51 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.89 -2.29 58.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.942 0.401 . . . . 72.010000000000005 110.866 179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -116.99 148.23 41.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.276 -0.42 . . . . 74.150000000000006 110.084 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.09 138.38 77.77 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.833 2.356 . . . . 72.25 112.592 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.09 -15.37 51.34 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.838 -0.696 . . . . 75.010000000000005 112.396 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.79 -44.32 56.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 65.129999999999995 111.671 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -96.42 13.5 27.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.793 0.33 . . . . 70.439999999999998 111.365 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.9 mt -82.12 162.72 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.193 -0.669 . . . . 73.230000000000004 109.193 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -79.23 85.75 5.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.607 0.718 . . . . 72.230000000000004 110.032 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.14 114.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.882 -1.053 . . . . 74.140000000000001 110.11 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -109.27 15.57 23.06 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.657 -0.417 . . . . 75.329999999999998 110.683 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -115.62 139.38 50.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.318 -0.401 . . . . 65.219999999999999 110.537 176.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 pt -131.52 152.96 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.501 0.667 . . . . 74.5 111.62 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.1 t80 -96.88 136.07 37.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.537 -1.21 . . . . 74.409999999999997 109.834 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -122.97 110.65 27.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.103 -0.703 . . . . 74.299999999999997 109.103 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.63 155.11 19.93 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.684 -1.246 . . . . 71.099999999999994 113.237 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.37 7.4 55.97 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.539 -0.838 . . . . 74.109999999999999 112.456 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.7 pt -72.44 105.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.515 0.674 . . . . 73.140000000000001 109.758 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -88.2 -10.08 50.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 72.120000000000005 111.798 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -121.71 165.42 15.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.716 -0.475 . . . . 72.430000000000007 109.716 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.17 104.55 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.404 1.097 . . . . 73.099999999999994 111.399 -175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -96.96 142.72 28.58 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.158 -1.383 . . . . 75.530000000000001 109.55 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 14.4 pt-20 -113.58 169.5 8.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.672 -0.695 . . . . 74.0 110.949 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -53.59 -51.29 63.48 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 114.828 -1.078 . . . . 71.209999999999994 110.405 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.55 -25.05 62.09 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.653 0.612 . . . . 72.519999999999996 112.653 -175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.43 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 63.7 m170 -70.94 -60.4 2.25 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.067 0.46 . . . . 74.209999999999994 110.771 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -81.47 -26.47 35.23 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 120.177 -0.609 . . . . 73.230000000000004 111.229 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -68.0 -43.46 78.82 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 110.257 -0.275 . . . . 74.0 110.257 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.67 -31.25 72.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.082 0.467 . . . . 73.239999999999995 110.422 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.449 ' CD2' HG23 ' A' ' 170' ' ' VAL . 80.5 t80 -79.27 -54.5 5.9 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.09 -0.505 . . . . 74.140000000000001 111.859 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.88 -24.54 63.43 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.621 0.6 . . . . 72.319999999999993 112.621 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 5.1 mt-10 -71.49 -16.59 62.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.844 0.354 . . . . 75.329999999999998 111.152 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.34 -25.79 68.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 75.099999999999994 111.074 172.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.79 -25.56 23.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.504 -0.316 . . . . 74.239999999999995 111.266 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 126' ' ' GLU . . . 168.51 -175.35 43.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.951 -0.642 . . . . 64.209999999999994 112.641 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.64 131.77 42.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.905 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 152' ' ' THR . 76.4 mt -100.03 140.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.676 -0.693 . . . . 74.409999999999997 109.865 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.13 -51.13 6.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 71.040000000000006 110.269 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.16 156.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.93 -0.577 . . . . 74.010000000000005 109.76 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.63 128.93 72.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.745 -0.465 . . . . 75.140000000000001 109.745 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.13 104.44 15.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.95 -0.568 . . . . 75.439999999999998 110.729 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.7 mm -93.31 131.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.341 -0.615 . . . . 75.430000000000007 109.341 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 48.8 mmm -105.14 132.7 51.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.517 -0.549 . . . . 74.200000000000003 109.517 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 72.420000000000002 111.597 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.845 0 N-CA-C 111.328 -0.709 . . . . 45.32 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.98 155.23 3.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.165 -0.68 . . . . 74.420000000000002 109.165 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.04 172.67 12.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.973 -0.558 . . . . 75.5 109.635 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -138.61 152.13 47.86 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.744 -0.662 . . . . 74.319999999999993 109.466 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.68 132.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.365 0.602 . . . . 51.25 111.069 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 131' ' ' ILE . 82.9 m -102.75 125.08 49.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.979 -1.01 . . . . 70.019999999999996 110.918 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -102.6 157.87 16.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.578 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.47 -31.18 57.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.676 -0.693 . . . . 62.530000000000001 110.402 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.36 157.94 42.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.587 -0.733 . . . . 63.130000000000003 110.399 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.437 ' HE2' ' NH1' ' A' ' 75' ' ' ARG . 28.6 p80 -82.5 -22.89 34.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 109.859 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -53.08 -45.81 68.35 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.853 0.721 . . . . 71.439999999999998 111.25 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.429 ' O ' HD13 ' A' ' 162' ' ' ILE . 1.4 m -65.34 -35.29 80.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.783 -0.644 . . . . 74.519999999999996 110.836 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.5 -38.61 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.795 -0.446 . . . . 71.219999999999999 109.795 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 7.0 m-20 -65.92 -33.8 76.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.140000000000001 111.432 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 93.0 mttt -63.47 -38.4 91.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.417 0.627 . . . . 74.400000000000006 110.378 174.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 158' ' ' SER . 14.0 mt -78.1 -40.84 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.891 -1.05 . . . . 70.109999999999999 112.002 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.14 -4.3 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.193 0.521 . . . . 72.400000000000006 111.177 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.5 mt -62.86 -31.95 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.289 -0.869 . . . . 70.219999999999999 109.732 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.569 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 51.5 mt-30 -108.39 153.1 23.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.886 -0.783 . . . . 73.099999999999994 108.886 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -91.49 -38.49 12.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.244 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.56 137.12 53.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.369 -0.378 . . . . 74.299999999999997 110.242 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.569 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 39.2 m-70 -125.38 146.05 49.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.145 -0.479 . . . . 71.439999999999998 110.172 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.6 m -91.75 110.71 22.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.049 -0.523 . . . . 75.010000000000005 111.34 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.449 HG23 ' CD2' ' A' ' 124' ' ' TYR . 41.2 t -117.13 131.09 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.07 -0.715 . . . . 70.120000000000005 109.07 174.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 46.99 42.59 12.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.45 0.7 . . . . 73.049999999999997 111.924 -174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.31 7.08 59.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 113.97 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -110.24 137.29 48.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.024 0.412 . . . . 75.329999999999998 110.16 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -89.39 108.95 19.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 72.109999999999999 110.308 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -112.24 154.81 25.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.833 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.8 139.31 30.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.506 . . . . 72.439999999999998 109.988 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.8 m -130.11 155.3 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.997 0.427 . . . . 74.430000000000007 110.632 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -172.37 169.76 5.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.065 -0.97 . . . . 75.0 111.497 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -58.68 127.84 34.21 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 73.299999999999997 110.663 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.23 119.38 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.11 0.481 . . . . 70.310000000000002 109.884 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 115.695 -0.684 . . . . 73.409999999999997 109.37 -179.59 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 107.893 -1.151 . . . . 73.340000000000003 107.893 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.59 141.66 24.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.407 -1.27 . . . . 72.310000000000002 111.029 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.44 167.77 19.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.904 2.403 . . . . 64.329999999999998 110.778 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -57.36 -37.41 72.57 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 111.698 0.259 . . . . 75.109999999999999 111.698 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -67.22 -27.86 67.59 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.891 0.33 . . . . 75.099999999999994 111.891 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mp -82.42 -9.79 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.385 . . . . 75.120000000000005 111.087 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -123.13 -0.66 8.86 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.129 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 34.5 ttpt -91.66 145.92 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 111.571 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 87' ' ' LYS . 3.9 mp -123.52 145.68 48.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.196 -0.911 . . . . 63.340000000000003 110.136 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -96.96 117.68 31.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.436 -0.579 . . . . 75.239999999999995 109.436 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 mm -94.34 113.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.956 -0.387 . . . . 72.120000000000005 109.956 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.35 150.41 16.84 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.738 -0.744 . . . . 38.189999999999998 111.79 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.7 45.22 29.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.89 -0.672 . . . . 62.219999999999999 113.381 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 ' CG1' ' A' ' 84' ' ' VAL . 79.4 mt -81.85 176.72 9.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.167 0.483 . . . . 73.430000000000007 110.819 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -86.24 178.64 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 73.109999999999999 109.542 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -84.19 -6.34 59.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.051 0.453 . . . . 74.109999999999999 110.534 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.27 20.05 15.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 64.140000000000001 111.061 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 m -81.53 129.4 34.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 75.120000000000005 110.405 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -117.96 160.19 21.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.734 -0.666 . . . . 75.310000000000002 109.377 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.93 -42.94 76.89 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.561 0.538 . . . . 75.200000000000003 111.108 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.67 -30.52 71.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.581 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 m -86.28 -42.07 14.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.62 -0.264 . . . . 72.239999999999995 111.077 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.24 -50.07 67.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 110.528 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -56.42 -58.2 9.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.692 -0.686 . . . . 74.310000000000002 111.598 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -48.8 -34.22 11.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.561 0.538 . . . . 73.319999999999993 112.357 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -74.06 -49.6 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.431 -0.349 . . . . 73.200000000000003 110.99 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -78.18 -18.82 55.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.193 -0.317 . . . . 74.019999999999996 111.758 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -56.6 -22.68 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.111 -0.495 . . . . 73.019999999999996 112.222 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.65 -22.15 66.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 74.549999999999997 111.951 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -102.97 -24.04 13.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.665 0.269 . . . . 74.510000000000005 111.244 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.45 161.59 32.39 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.356 -0.926 . . . . 75.129999999999995 112.475 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -57.59 141.7 47.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.874 0.469 . . . . 72.239999999999995 111.552 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.23 124.72 46.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.31 -0.626 . . . . 72.140000000000001 109.31 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -97.94 -20.45 17.44 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.045 -0.525 . . . . 74.209999999999994 110.621 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -149.94 152.77 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.633 -0.506 . . . . 75.540000000000006 109.633 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -165.45 137.08 4.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.084 -0.71 . . . . 55.210000000000001 109.084 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.34 132.68 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.053 0.454 . . . . 72.400000000000006 110.727 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.11 131.28 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.269 -0.641 . . . . 62.450000000000003 109.269 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 mmt -73.65 133.2 43.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.952 -0.759 . . . . 65.409999999999997 108.952 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -139.95 158.17 44.5 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.892 -0.595 . . . . 75.329999999999998 110.928 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.22 129.49 93.81 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.778 -1.101 . . . . 64.400000000000006 109.646 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.59 -22.34 33.02 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.186 1.924 . . . . 70.019999999999996 113.364 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -55.19 4.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.585 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 m -103.43 -8.87 19.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.504 . . . . 75.230000000000004 111.734 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 63.28 35.31 12.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.331 0.652 . . . . 74.349999999999994 111.758 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -101.48 158.75 15.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.031 -1.099 . . . . 75.420000000000002 108.031 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -70.31 140.43 52.27 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.092 0.472 . . . . 72.209999999999994 110.58 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -84.67 5.87 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.681 -0.69 . . . . 72.439999999999998 110.485 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.39 16.52 71.14 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.628 -0.796 . . . . 38.189999999999998 113.605 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -160.3 157.78 28.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.014 0.907 . . . . 74.099999999999994 110.954 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.08 -163.81 15.7 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.446 -0.661 . . . . 73.25 111.446 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.99 148.71 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.187 0.493 . . . . 61.219999999999999 110.611 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.65 126.32 60.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.907 -0.588 . . . . 74.099999999999994 109.739 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 m -101.28 118.01 36.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.444 -0.344 . . . . 62.43 110.166 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -84.6 165.15 18.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 74.450000000000003 109.856 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.41 63.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.37 -0.377 . . . . 74.239999999999995 110.675 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -132.94 154.01 50.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.309 -0.405 . . . . 74.109999999999999 110.253 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.554 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.8 p -64.88 -33.54 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.736 -0.211 . . . . 65.430000000000007 111.548 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.61 -34.08 72.3 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.38 0.511 . . . . 74.120000000000005 112.38 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.94 -33.79 76.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.303 0.573 . . . . 70.120000000000005 109.791 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 2.4 t -62.61 -46.97 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 72.420000000000002 111.125 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.3 -45.51 92.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 72.349999999999994 111.075 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.646 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.15 -38.4 73.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.332 0.493 . . . . 75.340000000000003 112.332 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.3 83.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.451 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.436 ' HE2' ' O ' ' A' ' 86' ' ' PRO . 1.6 mmt -69.27 -35.18 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.698 . . . . 72.230000000000004 110.974 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.9 p30 -84.84 -7.06 59.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.384 . . . . 51.229999999999997 111.515 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.27 -11.08 20.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.606 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.438 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 10.2 ttp180 -53.2 143.63 32.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.009 -0.996 . . . . 73.439999999999998 110.855 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 4.8 Cg_exo -79.71 169.86 69.13 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.954 -0.853 . . . . 65.129999999999995 114.054 2.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.22 161.16 29.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 75.209999999999994 109.773 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 22.5 ttmt -134.3 104.66 6.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.909 0.385 . . . . 72.549999999999997 111.38 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.63 126.37 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 62.130000000000003 110.137 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.22 40.38 8.84 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.54 0.686 . . . . 75.310000000000002 110.756 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.56 27.78 73.37 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.885 -0.598 . . . . 63.200000000000003 112.785 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.0 tpt180 -132.44 140.22 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 73.430000000000007 110.002 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 t -78.28 110.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.278 -0.638 . . . . 75.519999999999996 109.278 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.0 m -104.96 150.04 8.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.408 0.623 . . . . 64.209999999999994 110.575 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HG2' HH11 ' A' ' 75' ' ' ARG . 7.3 tt0 -117.74 96.11 48.96 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.292 -0.867 . . . . 72.450000000000003 110.853 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.436 ' O ' ' HE2' ' A' ' 72' ' ' MET . 29.3 Cg_endo -69.14 130.83 20.82 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.456 1.437 . . . . 63.329999999999998 110.433 171.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 25.4 mttt -128.35 -179.56 5.09 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.295 -0.866 . . . . 75.519999999999996 108.837 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -77.95 155.08 31.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.795 -0.446 . . . . 73.120000000000005 109.795 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.89 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 74.209999999999994 110.351 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.547 ' HB ' ' OD1' ' A' ' 160' ' ' ASP . 8.1 p -72.78 157.92 6.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.243 -0.89 . . . . 71.230000000000004 110.655 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.72 142.8 27.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.356 -0.609 . . . . 73.140000000000001 109.356 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -62.34 -17.41 58.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.803 0.335 . . . . 74.400000000000006 111.246 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.85 -48.33 74.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 74.209999999999994 110.616 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 25.3 t70 -84.16 -13.78 51.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.88 -0.6 . . . . 73.409999999999997 110.455 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -73.74 8.63 1.82 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.975 0.416 . . . . 65.340000000000003 110.956 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 94' ' ' ASP . 9.7 tt0 -88.38 -18.23 28.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 75.530000000000001 111.262 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 19.6 mmt180 -61.38 148.94 84.78 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 110.127 -0.323 . . . . 74.120000000000005 110.127 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -65.61 112.95 2.32 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.49 1.46 . . . . 64.109999999999999 110.343 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.7 48.98 46.27 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.695 -0.764 . . . . 74.340000000000003 111.465 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.01 -31.31 70.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 70.040000000000006 111.186 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -98.73 21.39 11.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 70.420000000000002 111.332 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.0 mt -76.88 177.58 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.988 -0.745 . . . . 74.420000000000002 108.988 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -81.92 78.31 8.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.471 0.653 . . . . 73.439999999999998 110.384 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.61 109.01 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.105 -0.952 . . . . 75.099999999999994 110.377 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.422 ' C ' HG22 ' A' ' 159' ' ' VAL . 53.5 mttt -107.36 20.99 18.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.998 0.428 . . . . 73.329999999999998 110.264 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.62 53.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.398 -0.364 . . . . 75.329999999999998 110.713 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.91 152.47 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.217 0.532 . . . . 61.409999999999997 111.609 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 6.3 t80 -99.34 131.84 45.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.92 -1.036 . . . . 74.219999999999999 109.452 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.45 110.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.352 -0.61 . . . . 71.519999999999996 109.352 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.43 16.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.75 -1.214 . . . . 70.010000000000005 113.825 -173.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.5 43.35 2.96 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.187 -0.53 . . . . 74.439999999999998 112.556 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 173' ' ' HIS . 22.1 pt -120.92 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.467 0.651 . . . . 74.540000000000006 110.857 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -54.24 3.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.437 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.93 170.54 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.436 0.46 . . . . 54.329999999999998 110.434 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.77 84.85 0.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.578 0.584 . . . . 73.420000000000002 112.578 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -83.87 131.63 34.86 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.938 -0.574 . . . . 61.299999999999997 109.475 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.53 165.44 11.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.377 -0.829 . . . . 74.010000000000005 110.546 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.26 -45.68 72.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.286 -0.87 . . . . 73.239999999999995 109.858 175.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -55.91 -38.65 70.53 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.766 0.666 . . . . 75.230000000000004 111.541 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.16 -59.09 5.97 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.299 -0.409 . . . . 74.310000000000002 111.579 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.05 -29.17 32.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.855 -0.738 . . . . 74.200000000000003 111.206 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 5.7 tmm_? -63.51 -53.34 53.5 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.468 0.175 . . . . 74.209999999999994 110.698 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.12 -26.25 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.152 0.501 . . . . 75.120000000000005 110.729 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -78.19 -56.66 4.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.8 -0.636 . . . . 71.540000000000006 111.82 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -66.85 -24.07 66.1 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.983 0.364 . . . . 73.209999999999994 111.983 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.9 mt-10 -70.33 -20.66 62.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.71 0.291 . . . . 75.299999999999997 111.501 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -56.05 -30.34 61.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 111.35 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.14 -29.17 23.49 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.416 -0.357 . . . . 71.420000000000002 111.779 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.89 -174.17 46.72 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.808 -0.711 . . . . 52.439999999999998 113.213 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -79.23 137.54 37.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.353 . . . . 74.209999999999994 111.248 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 152' ' ' THR . 73.6 mt -108.87 140.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 74.519999999999996 110.175 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.23 -48.33 7.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.495 -0.321 . . . . 75.040000000000006 110.922 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -157.3 156.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 74.150000000000006 110.236 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.1 129.26 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.058 0.456 . . . . 44.299999999999997 110.021 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -104.57 104.41 14.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.503 -0.771 . . . . 75.120000000000005 110.945 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.23 120.04 43.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.184 -1.043 . . . . 73.150000000000006 108.184 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.9 mmm -86.32 107.44 17.98 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.707 -0.397 . . . . 63.020000000000003 110.441 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.758 -0.655 . . . . 75.219999999999999 110.946 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.185 -0.23 . . . . 60.450000000000003 113.62 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -158.83 167.65 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.075 0.437 . . . . 73.5 109.97 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.85 171.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.561 -0.745 . . . . 75.519999999999996 109.755 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -136.18 151.08 49.35 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.487 -0.779 . . . . 75.319999999999993 109.09 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 130.51 25.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.513 0.673 . . . . 74.319999999999993 111.012 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.0 m -99.41 122.09 42.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.839 -1.073 . . . . 74.400000000000006 110.701 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.03 160.16 14.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.912 0.387 . . . . 73.439999999999998 111.321 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.95 -29.94 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.64 . . . . 73.420000000000002 110.185 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.28 151.8 50.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 71.409999999999997 111.092 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -78.94 -29.89 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 73.450000000000003 111.156 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -59.38 -44.26 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.923 -0.58 . . . . 75.540000000000006 110.988 -175.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -33.16 75.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.807 -0.633 . . . . 63.530000000000001 111.515 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -71.55 -39.37 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.961 0.41 . . . . 75.310000000000002 110.09 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.547 ' OD1' ' HB ' ' A' ' 90' ' ' VAL . 13.2 t70 -68.55 -34.59 76.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 73.209999999999994 110.709 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 84.8 mttt -56.11 -38.96 71.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.633 0.73 . . . . 74.430000000000007 110.777 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.5 mt -75.87 -42.29 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.419 -1.264 . . . . 75.319999999999993 112.235 -175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.3 m -76.36 -10.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.351 0.596 . . . . 73.400000000000006 110.753 -173.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.9 mt -61.1 -27.94 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.073 -0.967 . . . . 73.25 110.126 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 45.9 mt-30 -112.7 103.75 11.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.712 -0.847 . . . . 74.310000000000002 108.712 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.2 -35.33 69.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.846 -0.615 . . . . 75.340000000000003 112.627 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.61 134.53 53.78 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.304 . . . . 64.120000000000005 110.609 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.2 m-70 -121.12 153.74 37.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 74.430000000000007 110.029 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -122.76 113.7 19.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.449 . . . . 64.420000000000002 110.469 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.67 119.87 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 110.37 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 71.67 29.49 2.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.045 0.926 . . . . 71.510000000000005 109.059 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.11 -6.53 79.0 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.102 -0.953 . . . . 73.030000000000001 112.534 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.492 ' NE2' HG21 ' A' ' 112' ' ' ILE . 70.5 t60 -102.49 133.86 46.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.785 0.326 . . . . 73.549999999999997 110.604 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.55 141.31 30.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.038 0.447 . . . . 64.299999999999997 110.714 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.06 148.34 36.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 73.430000000000007 110.311 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -91.16 129.79 37.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.421 -0.585 . . . . 72.409999999999997 109.421 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.1 t -128.53 133.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.241 0.543 . . . . 70.409999999999997 110.554 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -155.56 172.99 17.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.399 -0.819 . . . . 71.540000000000006 110.466 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -58.86 133.19 55.79 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.278 0.361 . . . . 74.540000000000006 111.175 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -116.45 114.71 24.61 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.813 -0.81 . . . . 74.230000000000004 108.813 173.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 C--N 1.31 -1.111 0 CA-C-N 115.499 -0.773 . . . . 75.450000000000003 110.303 -174.278 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' HA2' ' OG1' ' A' ' 39' ' ' THR . . . . . . . . 0 N--CA 1.477 1.408 0 N-CA-C 111.596 -0.602 . . . . 63.240000000000002 111.596 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 64.65 87.24 0.12 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.58 0.752 . . . . 74.150000000000006 111.776 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -153.77 127.69 8.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.405 -0.591 . . . . 75.150000000000006 109.405 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 t -71.02 88.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.814 -0.81 . . . . 73.010000000000005 108.814 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.97 151.75 35.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 64.239999999999995 111.253 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -142.03 100.86 5.86 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 107.577 -1.268 . . . . 73.439999999999998 107.577 171.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.32 134.99 65.11 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.9 2.4 . . . . 72.420000000000002 113.065 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -112.49 -10.58 13.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.106 -0.952 . . . . 74.319999999999993 109.094 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -92.98 131.36 33.46 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 114.9 -1.045 . . . . 65.319999999999993 110.655 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.26 167.37 7.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.093 2.529 . . . . 61.25 112.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.96 -39.06 71.22 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.427 -0.351 . . . . 72.040000000000006 111.505 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -68.59 -22.79 64.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.836 0.351 . . . . 73.340000000000003 111.639 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -91.81 -6.98 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.519 -0.31 . . . . 74.299999999999997 111.477 -177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -128.31 1.44 5.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.405 -0.518 . . . . 71.430000000000007 112.124 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.41 145.19 26.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 111.737 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.0 mt -115.09 145.79 41.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.581 -1.191 . . . . 74.219999999999999 110.73 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -98.69 122.69 42.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.534 -0.913 . . . . 75.340000000000003 108.534 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -102.28 111.85 33.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 110.011 -0.366 . . . . 72.239999999999995 110.011 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.8 152.14 17.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.755 -0.736 . . . . 70.120000000000005 111.839 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.69 45.66 57.71 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 65.209999999999994 113.178 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.6 mt -78.33 174.97 10.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.684 -0.487 . . . . 70.109999999999999 109.684 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.76 164.13 19.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.024 -0.732 . . . . 75.439999999999998 109.024 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -73.95 -8.26 55.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.32 0.581 . . . . 64.239999999999995 110.33 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.89 13.81 9.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.588 -0.733 . . . . 61.409999999999997 111.513 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.0 m -74.08 125.39 28.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.456 . . . . 73.019999999999996 110.626 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -99.35 161.87 13.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.816 -0.629 . . . . 73.400000000000006 110.506 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -71.54 -31.51 67.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.437 -0.347 . . . . 72.430000000000007 110.818 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.47 -39.25 93.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.848 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.0 t -72.54 -39.93 67.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.685 . . . . 74.209999999999994 110.362 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.89 -44.87 94.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.825 -0.625 . . . . 63.310000000000002 110.782 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -59.26 -57.12 14.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.734 0.302 . . . . 75.430000000000007 110.383 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -50.16 -36.49 30.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.956 -1.02 . . . . 72.430000000000007 113.215 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.436 ' ND1' HG23 ' A' ' 79' ' ' VAL . 11.7 t-80 -72.67 -56.15 5.74 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.96 -0.296 . . . . 72.049999999999997 111.206 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.205 0.446 . . . . 74.049999999999997 112.205 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.41 -13.15 49.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 111.452 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -63.7 -28.86 70.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.832 -0.167 . . . . 73.340000000000003 111.32 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -99.06 -19.47 17.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.069 0.396 . . . . 72.530000000000001 112.069 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.88 168.97 40.71 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.812 -1.185 . . . . 53.100000000000001 113.0 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 ' OG1' ' HA2' ' A' ' 1' ' ' GLY . 59.3 m -66.86 118.42 10.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.249 0.547 . . . . 70.109999999999999 111.792 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -88.81 130.57 35.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.361 -0.836 . . . . 74.329999999999998 110.827 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 p -95.92 -24.6 16.33 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.158 -0.928 . . . . 74.540000000000006 110.021 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -152.21 152.3 32.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.586 -0.734 . . . . 61.549999999999997 110.127 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.8 t -161.82 130.95 4.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.655 -0.498 . . . . 63.409999999999997 109.655 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.6 129.34 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.318 0.58 . . . . 74.329999999999998 111.011 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.9 132.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.45 -0.944 . . . . 71.030000000000001 108.45 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.1 mmt -74.08 100.0 3.49 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.417 0.627 . . . . 53.439999999999998 109.857 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -102.14 160.72 14.27 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.703 -1.135 . . . . 74.409999999999997 110.833 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 11.4 t0 -75.46 126.16 87.9 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 114.748 -1.115 . . . . 71.219999999999999 110.566 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.4 -11.56 28.59 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.987 1.791 . . . . 71.299999999999997 113.158 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -85.49 -56.51 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 74.450000000000003 111.779 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -108.72 -9.59 15.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 111.4 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 65.67 49.28 1.78 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.647 -0.706 . . . . 72.140000000000001 110.954 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -120.3 159.46 24.96 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 74.409999999999997 109.342 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -73.46 134.37 43.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 45.539999999999999 111.176 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -85.19 3.49 38.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.179 0.514 . . . . 74.109999999999999 110.804 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.33 63.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.749 -0.66 . . . . 52.43 114.074 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.84 155.88 30.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.58 0.69 . . . . 62.240000000000002 109.96 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.44 -163.89 16.2 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.657 -0.577 . . . . 73.540000000000006 111.657 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.87 150.82 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.14 0.47 . . . . 73.540000000000006 110.399 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 m -131.86 131.05 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.636 -0.711 . . . . 75.239999999999995 109.489 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 m -107.3 122.98 47.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.231 -0.285 . . . . 75.349999999999994 110.231 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -89.37 165.54 14.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.922 0.391 . . . . 75.049999999999997 110.919 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.31 -49.14 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 73.200000000000003 110.587 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.37 155.8 41.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 75.430000000000007 110.903 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 8.1 p -62.21 -37.12 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 111.47 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.83 -44.11 69.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.679 0.622 . . . . 63.549999999999997 112.679 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.93 -29.87 70.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.957 0.408 . . . . 74.319999999999993 110.819 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.94 -49.76 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.682 -0.69 . . . . 73.409999999999997 110.745 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.21 -42.0 85.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 64.530000000000001 111.809 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.59 -31.85 68.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.84 0.682 . . . . 74.510000000000005 112.84 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.76 -34.06 40.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 65.209999999999994 110.351 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mmt -62.79 -49.33 75.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.712 -0.676 . . . . 75.349999999999994 110.476 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.49 -26.73 63.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 73.329999999999998 111.194 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.75 -5.61 35.33 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.956 0.724 . . . . 75.109999999999999 112.956 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -57.8 148.43 58.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.503 0.186 . . . . 75.409999999999997 111.503 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.09 165.61 84.43 Favored 'Cis proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.789 -1.338 . . . . 60.219999999999999 113.454 2.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -123.68 158.01 32.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.613 . . . . 74.540000000000006 111.079 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.1 ttmt -139.41 105.1 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.094 -0.503 . . . . 73.239999999999995 111.531 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 HG23 ' ND1' ' A' ' 33' ' ' HIS . 16.2 t -108.2 128.71 63.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 74.140000000000001 109.541 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.52 31.09 10.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.58 0.55 . . . . 61.420000000000002 111.631 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.08 21.16 80.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.938 -0.649 . . . . 51.549999999999997 111.873 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.0 tpt180 -124.12 136.01 53.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.204 -0.295 . . . . 71.099999999999994 110.204 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.53 108.08 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.203 -0.666 . . . . 75.310000000000002 109.203 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.81 148.4 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.168 0.509 . . . . 74.349999999999994 110.932 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -111.47 95.01 24.76 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.277 -0.874 . . . . 62.219999999999999 110.886 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.52 130.58 12.88 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.897 1.732 . . . . 72.099999999999994 111.183 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -137.78 177.4 7.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.464 -0.789 . . . . 74.310000000000002 109.178 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.407 ' NH1' HG13 ' A' ' 68' ' ' VAL . 17.7 tpp180 -77.41 139.54 39.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 110.066 -0.346 . . . . 75.519999999999996 110.066 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.01 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.998 0.428 . . . . 61.450000000000003 110.194 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 136.21 22.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.909 -1.042 . . . . 74.430000000000007 111.568 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.8 147.06 43.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.725 -0.67 . . . . 53.25 109.732 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -63.52 -20.94 66.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.262 0.838 . . . . 73.019999999999996 113.262 -171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.58 -47.87 68.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.755 0.312 . . . . 65.230000000000004 110.68 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.25 -29.56 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.969 0.414 . . . . 72.439999999999998 110.171 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.439 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 t -72.0 -3.01 20.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.921 -0.581 . . . . 74.129999999999995 111.007 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -93.23 -3.15 54.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.327 0.584 . . . . 74.530000000000001 109.916 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -95.44 151.98 38.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.833 -0.622 . . . . 74.219999999999999 110.499 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.1 120.33 7.54 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.748 2.299 . . . . 75.120000000000005 112.346 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.07 40.89 8.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.822 -0.704 . . . . 71.450000000000003 112.389 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -86.01 -46.05 10.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 65.400000000000006 111.525 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.72 10.94 26.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.322 0.582 . . . . 71.319999999999993 110.608 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.01 161.82 19.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.895 -0.78 . . . . 75.519999999999996 108.895 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.3 m -77.05 92.91 3.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.46 0.648 . . . . 74.109999999999999 110.942 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.02 115.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.067 -0.97 . . . . 75.030000000000001 110.032 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' C ' HG23 ' A' ' 159' ' ' VAL . 76.7 mttt -108.88 18.54 20.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 110.833 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -118.23 139.59 51.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.386 -0.37 . . . . 73.439999999999998 110.854 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.28 153.38 36.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.213 0.53 . . . . 72.019999999999996 111.501 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -103.58 138.25 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.78 -1.1 . . . . 75.239999999999995 109.545 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 10.6 t -126.48 109.56 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.124 -0.695 . . . . 75.019999999999996 109.124 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.91 161.03 19.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.029 -1.081 . . . . 74.430000000000007 113.366 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.0 46.42 36.55 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.065 -0.588 . . . . 63.039999999999999 111.655 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.414 HG21 ' SG ' ' A' ' 175' ' ' CYS . 15.5 pt -90.55 -165.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.478 -0.361 . . . . 73.120000000000005 110.582 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -82.36 -167.48 1.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.652 0.263 . . . . 74.430000000000007 111.315 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.8 -22.31 66.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 111.168 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.9 144.05 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.541 -0.754 . . . . 71.549999999999997 109.142 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -140.05 138.7 35.59 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.882 -0.784 . . . . 64.510000000000005 108.882 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.65 158.59 15.36 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.105 -0.498 . . . . 74.219999999999999 110.778 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -47.05 76.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.188 -0.914 . . . . 62.210000000000001 108.933 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -53.63 -34.39 58.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.017 -0.992 . . . . 72.129999999999995 111.894 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -66.32 -59.45 3.7 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.928 0.394 . . . . 74.140000000000001 111.135 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.78 -26.62 31.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.158 -0.617 . . . . 74.439999999999998 111.353 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 6.1 tmm_? -65.42 -48.63 72.14 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.96 -0.385 . . . . 61.149999999999999 109.96 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.56 -26.67 68.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.209 0.528 . . . . 74.420000000000002 110.579 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -78.92 -55.54 5.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.849 -0.614 . . . . 75.040000000000006 111.781 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 151' ' ' VAL . 35.8 m-85 -69.45 -22.93 63.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.428 0.529 . . . . 65.109999999999999 112.428 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -68.61 -22.93 64.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.807 0.337 . . . . 72.219999999999999 111.477 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.74 -28.35 65.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 74.439999999999998 110.816 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -88.99 -23.99 22.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 72.239999999999995 111.105 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.79 -178.12 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.407 -0.901 . . . . 73.430000000000007 113.696 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -73.4 131.28 41.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.92 0.488 . . . . 74.010000000000005 110.963 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 152' ' ' THR . 65.5 mt -103.12 138.35 27.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.465 . . . . 72.420000000000002 109.986 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.88 -48.0 9.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.694 0.283 . . . . 74.25 110.673 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.06 156.95 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.177 -0.465 . . . . 73.140000000000001 109.824 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.33 126.22 71.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.16 0.505 . . . . 61.509999999999998 109.927 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -99.77 105.23 17.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 74.329999999999998 110.544 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.32 122.6 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.247 -0.649 . . . . 75.439999999999998 109.247 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 64.7 mmm -96.12 128.02 42.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.525 -0.546 . . . . 74.109999999999999 109.525 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 154.3 20.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.41 0.624 . . . . 73.120000000000005 111.44 -174.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -83.57 133.77 34.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.885 -1.052 . . . . 73.140000000000001 109.13 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -80.58 -24.23 39.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.763 0.315 . . . . 74.030000000000001 111.164 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.18 -53.82 2.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 73.319999999999993 112.782 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -89.29 -23.18 22.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.056 0.455 . . . . 75.200000000000003 111.181 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.39 19.35 78.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.618 -0.801 . . . . 63.340000000000003 112.296 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -92.82 159.72 15.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.421 -0.585 . . . . 53.310000000000002 109.421 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -86.49 81.62 8.23 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.65 -0.87 . . . . 74.519999999999996 108.65 175.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -150.55 -178.48 6.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.187 -0.915 . . . . 74.140000000000001 111.829 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.11 -46.04 3.36 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.11 -1.404 . . . . 45.299999999999997 112.805 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -174.96 154.92 1.93 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.872 -0.418 . . . . 75.209999999999994 109.872 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.4 171.98 13.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.915 -0.584 . . . . 75.129999999999995 109.79 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.48 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 42.3 m-85 -137.53 145.71 43.27 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.833 -0.621 . . . . 72.219999999999999 109.995 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 125' ' ' PHE . 60.4 t -129.86 130.14 66.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.752 0.31 . . . . 75.200000000000003 110.738 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.513 ' O ' HG21 ' A' ' 131' ' ' ILE . 90.4 m -104.76 119.64 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 75.430000000000007 110.601 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -102.87 159.06 15.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.952 0.405 . . . . 72.120000000000005 111.417 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -77.85 -29.21 50.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.562 -0.744 . . . . 70.400000000000006 110.581 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -130.43 155.36 46.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.476 -0.784 . . . . 65.219999999999999 110.259 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.87 -26.44 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.089 -0.505 . . . . 72.430000000000007 110.513 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -59.83 -41.93 92.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.474 -0.785 . . . . 73.019999999999996 111.493 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.96 -34.92 79.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.586 -0.279 . . . . 74.510000000000005 110.915 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.463 HG23 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -69.61 -40.75 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 73.239999999999995 109.722 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.424 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.82 -31.6 68.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.186 -0.916 . . . . 62.200000000000003 111.441 -178.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 39.3 mttm -56.23 -37.81 70.23 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.779 0.8 . . . . 74.319999999999993 109.871 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.0 mt -79.48 -42.65 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.489 -1.232 . . . . 72.329999999999998 112.522 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 160' ' ' ASP . 21.4 m -74.98 -13.56 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.906 0.384 . . . . 74.109999999999999 111.171 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 28.9 mt -56.44 -34.83 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.438 -0.801 . . . . 74.120000000000005 109.979 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.95 102.48 10.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.64 -0.874 . . . . 65.319999999999993 108.64 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.415 ' HZ1' ' HB2' ' A' ' 166' ' ' LYS . 3.8 ttmp? -57.26 -31.77 65.9 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.899 0.703 . . . . 73.310000000000002 112.899 -175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.61 135.46 54.99 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.248 -0.581 . . . . 72.439999999999998 110.44 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -126.56 154.84 43.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.521 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.3 m -94.22 107.32 19.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.338 -0.392 . . . . 60.210000000000001 110.257 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.79 131.4 70.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.183 -0.673 . . . . 74.549999999999997 109.183 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 45.4 47.16 10.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.287 0.635 . . . . 55.420000000000002 112.491 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.88 73.96 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 113.575 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -142.29 133.22 25.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.01 -0.367 . . . . 75.310000000000002 110.01 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -82.21 109.58 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.872 0.367 . . . . 72.329999999999998 110.251 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.414 ' SG ' HG21 ' A' ' 112' ' ' ILE . 10.3 m -108.72 155.02 21.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.01 -0.541 . . . . 72.409999999999997 109.938 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 27.8 tt0 -90.33 137.78 32.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 72.030000000000001 110.472 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -129.59 160.38 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 73.329999999999998 110.343 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -174.09 175.92 2.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.214 -0.903 . . . . 75.239999999999995 111.507 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -62.29 130.81 47.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.735 -0.666 . . . . 74.549999999999997 110.696 173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -117.57 114.55 23.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.628 -0.878 . . . . 74.109999999999999 108.628 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.2 mt -85.44 142.43 29.24 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.607 -0.437 . . . . 74.219999999999999 109.845 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.488 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 6.7 m -63.35 154.1 32.91 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.503 -0.554 . . . . 61.32 109.503 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -62.63 -29.75 70.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.279 0.474 . . . . 65.099999999999994 112.279 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -47.35 68.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.958 -0.756 . . . . 74.430000000000007 108.958 174.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.488 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 1.3 mp0 -58.82 -40.32 83.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.379 -0.828 . . . . 74.230000000000004 111.149 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 79.1 mtp -70.52 -40.16 73.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 73.530000000000001 111.264 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -54.63 9.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 64.25 110.913 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.1 m 60.15 25.11 14.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.12 0.568 . . . . 65.209999999999994 111.143 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -101.73 176.1 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.505 . . . . 43.43 110.904 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.5 m -80.69 91.51 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.07 -0.513 . . . . 75.430000000000007 111.165 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.8 m -79.06 111.3 15.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 60.530000000000001 110.204 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 23.2 m -115.56 89.87 3.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.605 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -121.18 145.73 47.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.198 -0.455 . . . . 73.450000000000003 109.971 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -122.2 42.73 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.502 0.668 . . . . 74.140000000000001 109.488 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 97.73 -13.92 63.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.14 -1.184 . . . . 64.140000000000001 110.14 -169.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? . . . . . 0 C--O 1.251 1.179 0 N-CA-C 107.491 -1.3 . . . . 75.209999999999994 107.491 178.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.786 -0.526 . . . . 52.219999999999999 111.786 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 t -67.14 120.06 13.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 73.109999999999999 110.154 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -121.04 135.26 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.336 -0.393 . . . . 75.540000000000006 111.238 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 t -71.76 113.85 9.22 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.168 -1.049 . . . . 71.400000000000006 108.168 168.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.54 6.88 15.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.784 0.326 . . . . 62.210000000000001 111.018 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 t -141.78 98.44 6.36 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.297 -0.41 . . . . 73.120000000000005 110.741 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -91.06 165.49 3.78 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.959 2.44 . . . . 62.25 111.992 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -8.96 27.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 171.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -66.95 130.86 93.88 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.816 -1.084 . . . . 61.439999999999998 110.812 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.23 169.29 12.51 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.216 2.611 . . . . 72.129999999999995 111.751 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.7 pt-20 -52.14 -38.86 58.9 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 112.185 0.439 . . . . 64.409999999999997 112.185 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 6.5 pt20 -65.64 -26.31 67.75 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.108 0.41 . . . . 75.510000000000005 112.108 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -88.97 -9.88 49.78 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.185 -0.322 . . . . 74.530000000000001 111.165 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HA ' HG23 ' A' ' 68' ' ' VAL . 12.8 ptt180 -118.72 -5.17 10.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 75.129999999999995 111.301 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.7 ttpt -93.69 148.73 21.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.402 0.62 . . . . 74.120000000000005 111.213 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.0 mt -120.57 146.39 46.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.973 . . . . 75.439999999999998 110.413 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 16.5 t80 -98.13 131.33 44.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.085 -1.08 . . . . 74.049999999999997 108.085 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.6 mm -106.45 111.55 35.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.892 -0.41 . . . . 74.319999999999993 109.892 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.6 148.65 17.51 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.855 -0.688 . . . . 72.319999999999993 111.9 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.77 46.41 30.42 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.785 -0.722 . . . . 72.230000000000004 113.503 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.1 mt -81.34 174.39 11.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.883 0.373 . . . . 63.340000000000003 110.237 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.0 p -87.64 173.88 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.437 -0.579 . . . . 64.340000000000003 109.437 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.9 -11.51 59.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.119 0.485 . . . . 75.540000000000006 109.78 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -103.67 -0.43 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.366 -0.834 . . . . 74.099999999999994 111.941 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -67.91 123.77 21.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.0 0.429 . . . . 74.010000000000005 111.615 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.9 159.51 15.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.552 -0.749 . . . . 64.219999999999999 110.066 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -68.73 -30.92 69.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.344 . . . . 72.0 111.876 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -25.08 45.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.883 -0.327 . . . . 74.230000000000004 111.145 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.8 m -74.94 -43.5 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.415 . . . . 71.340000000000003 110.406 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.25 -46.2 89.92 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.498 -0.774 . . . . 65.349999999999994 110.065 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -55.63 -59.87 4.24 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.445 -0.798 . . . . 73.430000000000007 111.794 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -50.18 -33.73 20.16 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.787 0.68 . . . . 63.549999999999997 112.654 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.433 ' CG ' HG23 ' A' ' 79' ' ' VAL . 62.3 t60 -69.03 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 74.150000000000006 110.684 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.16 -22.63 62.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.198 0.444 . . . . 75.340000000000003 112.198 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 31.8 tt0 -65.15 -21.53 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 74.310000000000002 111.06 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.49 -23.13 66.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 74.329999999999998 111.941 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -102.42 -21.12 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.514 0.197 . . . . 72.420000000000002 111.528 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.91 161.64 32.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.398 -0.906 . . . . 74.239999999999995 112.603 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -67.88 116.05 8.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.144 0.497 . . . . 70.109999999999999 111.443 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -84.41 136.8 33.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 110.205 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -106.45 -16.5 14.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.428 -0.805 . . . . 74.239999999999995 109.749 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.52 149.42 29.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 75.319999999999993 109.886 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.9 t -160.42 131.09 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.215 -0.291 . . . . 75.150000000000006 110.215 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.12 131.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.996 0.427 . . . . 73.340000000000003 110.254 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -92.96 130.51 41.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.222 -1.029 . . . . 50.439999999999998 108.222 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.401 ' HA ' ' HE1' ' A' ' 46' ' ' MET . 4.0 mmt -75.67 97.59 3.85 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.653 0.74 . . . . 72.120000000000005 110.605 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 29.4 mtt180 -101.94 163.94 11.98 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.598 -1.183 . . . . 74.230000000000004 110.391 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 22.6 t70 -79.27 126.79 80.8 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.145 -0.934 . . . . 64.120000000000005 109.512 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.45 -18.95 49.53 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 121.901 1.734 . . . . 72.439999999999998 113.362 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.405 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 35.9 m-80 -86.02 -56.52 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 71.430000000000007 111.482 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 -10.11 24.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.142 -0.481 . . . . 75.230000000000004 111.873 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm 66.17 29.93 9.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.998 0.919 . . . . 75.340000000000003 111.481 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -106.15 150.68 25.6 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.792 -0.447 . . . . 73.120000000000005 109.792 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 30.5 t -73.83 133.96 43.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.107 0.479 . . . . 70.430000000000007 110.73 -174.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -83.71 2.61 36.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.386 -0.824 . . . . 71.230000000000004 111.022 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.88 16.91 60.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.883 -0.675 . . . . 73.340000000000003 113.957 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.6 158.4 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.947 0.874 . . . . 75.140000000000001 111.097 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.76 -165.31 17.31 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.459 -0.656 . . . . 52.219999999999999 111.459 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.28 146.35 33.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 117.213 0.507 . . . . 73.409999999999997 110.302 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.82 126.59 67.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.704 -0.68 . . . . 72.109999999999999 109.333 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 m -103.62 120.72 41.47 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.125 -0.359 . . . . 75.209999999999994 110.426 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -85.98 161.47 18.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.017 -0.538 . . . . 75.109999999999999 110.146 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.58 66.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.591 -0.731 . . . . 64.530000000000001 110.704 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.668 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 89.5 m -141.97 151.8 42.87 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.829 -0.623 . . . . 71.340000000000003 110.785 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -58.06 -36.76 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.609 -0.723 . . . . 73.049999999999997 112.161 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -49.37 -47.73 47.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.017 0.747 . . . . 74.120000000000005 113.017 175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.668 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.9 mp0 -64.7 -31.39 72.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.711 0.291 . . . . 74.239999999999995 111.273 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 52.1 t -63.31 -47.92 89.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 74.450000000000003 110.593 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.29 -43.28 99.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.391 -0.822 . . . . 74.340000000000003 111.062 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.614 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -55.7 -35.65 66.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.746 0.647 . . . . 74.319999999999993 112.746 172.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -31.18 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 74.430000000000007 109.903 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.7 mmt -72.25 -37.69 69.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 72.150000000000006 111.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -76.22 -14.08 60.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.151 0.5 . . . . 64.450000000000003 110.573 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.67 -9.17 50.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.596 -0.729 . . . . 61.109999999999999 111.903 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -56.65 146.88 54.15 Favored Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.22 0.325 . . . . 74.010000000000005 111.642 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.85 167.9 77.46 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.889 -1.296 . . . . 62.530000000000001 113.224 2.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -122.59 154.47 37.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 73.150000000000006 111.315 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.8 ttmt -139.05 109.15 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 74.239999999999995 110.976 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.433 HG23 ' CG ' ' A' ' 33' ' ' HIS . 18.8 t -109.94 129.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.585 -0.524 . . . . 72.150000000000006 109.585 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.9 t70 68.36 22.06 8.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.8 0.81 . . . . 75.549999999999997 110.563 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.08 67.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 64.340000000000003 111.777 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.5 tpt180 -124.0 138.14 54.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.74 -0.467 . . . . 74.040000000000006 109.74 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.7 109.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.48 -0.563 . . . . 72.510000000000005 109.48 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -107.66 148.64 11.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.985 0.422 . . . . 74.129999999999995 110.482 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.51 103.46 52.68 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 111.476 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.52 132.8 19.54 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.008 1.805 . . . . 53.140000000000001 111.363 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 11.4 mmtt -131.6 161.12 33.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.66 -1.237 . . . . 63.32 107.66 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.6 tpp180 -68.34 139.82 55.89 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.465 -0.568 . . . . 74.109999999999999 109.465 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 91.93 1.7 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.471 0.653 . . . . 63.350000000000001 109.786 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.407 ' CG2' HG22 ' A' ' 163' ' ' VAL . 9.8 p -65.18 156.23 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.672 -1.149 . . . . 72.239999999999995 111.598 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 t -60.46 155.71 17.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.649 -0.705 . . . . 71.530000000000001 110.44 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -60.46 -25.31 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.75 -0.659 . . . . 74.430000000000007 112.009 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.28 -54.41 25.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 111.059 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.11 -30.6 63.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.041 -0.264 . . . . 73.340000000000003 111.422 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -68.46 -8.81 44.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.924 0.392 . . . . 72.019999999999996 111.525 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.02 -21.87 59.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.234 -0.439 . . . . 75.340000000000003 110.327 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -79.65 153.98 75.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.409999999999997 110.597 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.26 129.77 16.51 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.693 2.262 . . . . 73.010000000000005 111.4 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.03 57.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 74.329999999999998 112.586 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.32 60.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 110.676 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.469 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 19.8 m170 -100.5 20.93 14.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.51 0.671 . . . . 72.129999999999995 110.548 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.22 179.12 5.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 71.129999999999995 109.423 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 97.08 7.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.172 0.511 . . . . 61.340000000000003 110.597 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.41 113.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.252 -0.885 . . . . 71.540000000000006 109.529 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.446 ' C ' HG22 ' A' ' 159' ' ' VAL . 84.8 mttt -110.72 21.86 16.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.474 -0.49 . . . . 72.519999999999996 111.174 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -126.04 145.78 50.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.855 0.36 . . . . 75.099999999999994 111.859 176.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.77 153.66 39.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.169 0.509 . . . . 75.340000000000003 111.696 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.4 t80 -100.81 139.63 36.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.03 -0.986 . . . . 71.319999999999993 109.364 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t -131.12 111.55 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.622 -0.51 . . . . 74.040000000000006 109.622 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.3 167.88 25.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.546 -1.311 . . . . 75.040000000000006 113.428 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.48 38.34 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.682 -0.77 . . . . 64.099999999999994 112.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.7 143.7 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.701 -0.481 . . . . 70.319999999999993 109.701 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -89.18 -42.05 11.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 74.019999999999996 111.398 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -104.89 -97.28 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.317 -0.401 . . . . 72.209999999999994 110.59 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 147.02 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.67 -0.863 . . . . 73.519999999999996 108.67 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 129.45 36.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.386 0.612 . . . . 74.439999999999998 110.82 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.47 166.14 11.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.905 -1.043 . . . . 75.099999999999994 110.194 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.12 -45.65 90.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 74.340000000000003 109.713 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -57.73 -32.85 67.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 62.219999999999999 111.929 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -67.25 -57.61 6.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.907 0.384 . . . . 75.400000000000006 111.241 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 122' ' ' ARG . 2.4 pp -83.94 -25.0 30.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.298 -0.561 . . . . 73.109999999999999 111.303 -171.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' N ' HD13 ' A' ' 121' ' ' LEU . 6.0 tmm_? -65.28 -51.38 61.09 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.922 -0.399 . . . . 74.120000000000005 109.922 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.66 -27.26 69.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 64.129999999999995 110.635 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.418 ' CD2' HG23 ' A' ' 170' ' ' VAL . 82.0 t80 -80.64 -54.03 6.01 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.012 -0.54 . . . . 74.319999999999993 111.923 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.427 ' CD2' HG22 ' A' ' 151' ' ' VAL . 43.4 m-85 -70.88 -23.01 62.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.16 0.43 . . . . 64.200000000000003 112.16 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -67.15 -20.41 65.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.935 0.398 . . . . 72.310000000000002 111.194 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.01 -20.98 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.833 -0.621 . . . . 72.209999999999994 111.373 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.59 -27.87 17.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.548 -0.296 . . . . 70.340000000000003 111.678 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -171.49 44.39 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.528 -0.844 . . . . 51.219999999999999 113.232 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -76.36 130.7 38.46 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.04 0.447 . . . . 74.200000000000003 111.602 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 152' ' ' THR . 55.0 mt -101.38 140.54 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 75.230000000000004 109.804 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.31 -50.41 6.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 110.269 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 p -158.28 158.66 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.581 -0.736 . . . . 71.230000000000004 109.338 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.78 128.92 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 73.340000000000003 109.851 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -104.29 104.71 14.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 45.229999999999997 110.454 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mm -96.6 116.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.44 -0.948 . . . . 74.049999999999997 108.44 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.2 mmm -87.54 135.59 33.29 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.794 -0.363 . . . . 75.010000000000005 110.481 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 1.6 m -89.53 154.06 20.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.383 0.611 . . . . 71.519999999999996 111.127 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.06 119.74 35.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.96 -1.018 . . . . 74.030000000000001 109.22 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -64.83 -35.88 82.55 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.363 0.415 . . . . 74.150000000000006 111.758 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.89 -48.21 5.56 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.631 -0.795 . . . . 52.109999999999999 112.947 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 m -78.97 -24.46 43.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.79 0.293 . . . . 74.310000000000002 111.79 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.39 88.68 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.17 -0.538 . . . . 62.409999999999997 112.498 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -107.65 155.36 20.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.395 -0.595 . . . . 73.140000000000001 109.395 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 28.8 mtpp -81.88 87.37 6.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.474 ' HG2' ' N ' ' A' ' 147' ' ' GLY . 3.6 ttp180 -157.53 158.23 35.27 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.465 -1.243 . . . . 73.409999999999997 111.183 -166.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.474 ' N ' ' HG2' ' A' ' 146' ' ' ARG . . . 110.57 -43.98 1.6 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.89 -0.595 . . . . 61.439999999999998 112.603 174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.56 161.63 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 74.310000000000002 110.153 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.52 173.09 11.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.572 -0.74 . . . . 72.549999999999997 110.159 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.449 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -137.27 145.47 43.56 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.223 -0.899 . . . . 74.209999999999994 109.351 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.427 HG22 ' CD2' ' A' ' 125' ' ' PHE . 61.4 t -128.42 125.63 64.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 120.99 0.424 . . . . 75.310000000000002 110.879 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.488 ' O ' HG23 ' A' ' 131' ' ' ILE . 87.9 m -101.5 119.93 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 73.030000000000001 111.033 -176.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.08 155.23 18.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.986 0.422 . . . . 74.349999999999994 111.743 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.05 -18.46 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.562 -0.745 . . . . 74.519999999999996 110.579 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.04 151.73 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 63.200000000000003 111.152 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.507 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p80 -82.78 -28.15 30.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.599 -0.273 . . . . 75.129999999999995 111.288 -175.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.608 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 23.9 t70 -68.01 -35.26 78.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.995 -0.548 . . . . 52.240000000000002 110.589 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.0 m -67.72 -34.13 76.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 72.219999999999999 110.825 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 105' ' ' LYS . 2.2 t -72.13 -38.36 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.019 -0.537 . . . . 70.510000000000005 109.558 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 4.2 t70 -66.11 -35.79 81.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 72.340000000000003 111.007 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 83.5 mttt -57.46 -37.98 73.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.504 0.669 . . . . 71.239999999999995 110.7 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.69 -42.07 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.807 -1.088 . . . . 74.319999999999993 111.567 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 160' ' ' ASP . 25.8 m -77.81 -8.19 11.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.465 0.65 . . . . 74.340000000000003 110.902 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 mt -60.79 -32.77 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.997 -1.001 . . . . 72.340000000000003 110.382 170.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.528 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 43.2 mt-30 -113.17 114.73 27.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.046 -0.724 . . . . 74.120000000000005 109.046 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.23 -38.07 67.98 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.049 0.759 . . . . 74.310000000000002 113.049 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -123.09 138.43 54.67 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.089 -0.382 . . . . 73.540000000000006 110.574 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.528 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 36.7 m-70 -123.35 140.01 53.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 110.966 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -87.26 104.38 16.34 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.786 -0.643 . . . . 73.239999999999995 111.11 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 124' ' ' TYR . 28.2 t -111.22 127.26 68.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.488 -0.778 . . . . 75.140000000000001 109.143 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 45.18 40.13 4.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.274 0.63 . . . . 60.119999999999997 112.319 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 -6.15 77.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.034 -0.603 . . . . 64.140000000000001 114.152 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -107.68 128.74 54.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.581 0.691 . . . . 74.420000000000002 110.46 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.36 113.1 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.34 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.4 p -112.18 156.57 22.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.337 -0.847 . . . . 75.299999999999997 109.511 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -86.04 137.38 32.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.206 0.527 . . . . 71.239999999999995 110.898 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -129.53 164.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.205 -0.907 . . . . 73.450000000000003 110.721 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -175.66 173.98 2.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.104 -0.953 . . . . 64.540000000000006 111.245 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -61.01 134.82 57.48 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 123.618 0.574 . . . . 75.349999999999994 110.247 173.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -127.73 122.61 33.31 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.311 -0.626 . . . . 74.329999999999998 109.311 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.7 mt -97.99 116.13 29.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.982 -0.687 . . . . 74.400000000000006 109.546 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.441 ' OG ' ' HG3' ' A' ' 106' ' ' LYS . 6.2 m -65.51 166.83 9.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.499 -0.773 . . . . 73.010000000000005 110.077 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -64.05 -29.95 71.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.114 0.483 . . . . 75.109999999999999 110.03 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.34 -53.12 48.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.393 -0.822 . . . . 72.409999999999997 110.129 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -64.24 -36.59 84.58 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.487 0.551 . . . . 75.439999999999998 112.487 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 69.2 mtp -67.58 -31.67 71.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 72.319999999999993 110.748 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -92.97 -0.29 57.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.091 -0.504 . . . . 70.430000000000007 111.317 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.6 m -82.13 81.74 7.94 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.999 0.428 . . . . 74.129999999999995 111.529 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -85.54 163.86 18.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.639 -0.875 . . . . 72.150000000000006 108.639 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.0 m -72.38 95.18 1.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.179 0.514 . . . . 64.099999999999994 110.123 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.5 p -145.61 -173.76 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.67 . . . . 73.129999999999995 110.654 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 73.26 6.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 71.530000000000001 110.785 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -104.24 161.94 13.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 62.119999999999997 111.04 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -144.18 163.31 34.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.684 -0.689 . . . . 74.430000000000007 109.921 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -104.7 156.65 16.98 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 61.420000000000002 112.263 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.767 -0.635 . . . . 75.319999999999993 109.582 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 111.957 -0.457 . . . . 44.409999999999997 111.957 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -78.67 102.12 7.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.985 0.422 . . . . 74.299999999999997 110.93 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -139.81 -37.02 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.107 -0.497 . . . . 64.400000000000006 110.055 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -85.3 55.02 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.824 -0.625 . . . . 74.430000000000007 110.081 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.94 137.17 32.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 62.32 110.461 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -97.5 114.57 65.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.929 -0.397 . . . . 75.209999999999994 109.929 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.82 135.71 26.29 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.935 1.757 . . . . 74.340000000000003 112.626 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 -2.19 17.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.657 -0.868 . . . . 73.519999999999996 108.657 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -99.44 136.61 20.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.516 -1.22 . . . . 74.219999999999999 110.842 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.51 167.65 14.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.932 2.421 . . . . 75.230000000000004 111.199 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.3 pt-20 -56.49 -35.73 68.31 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.596 0.221 . . . . 73.519999999999996 111.596 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 8.3 pt20 -69.09 -25.49 64.46 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.591 0.234 . . . . 71.430000000000007 111.404 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -88.63 -11.97 43.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.513 0.196 . . . . 75.310000000000002 111.384 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.45 ' HA ' HG22 ' A' ' 68' ' ' VAL . 31.2 ptt180 -124.12 6.53 8.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.195 0.522 . . . . 73.230000000000004 110.835 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.6 ttpt -97.87 146.87 25.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.353 0.597 . . . . 71.209999999999994 110.908 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.36 145.21 43.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.919 -1.037 . . . . 73.230000000000004 110.354 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 13.5 t80 -101.1 125.67 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.446 -0.946 . . . . 74.519999999999996 108.446 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.1 mm -106.25 111.11 33.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.985 -0.376 . . . . 73.540000000000006 109.985 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.48 157.54 18.23 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.548 -0.834 . . . . 74.409999999999997 111.222 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.29 67.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 74.340000000000003 112.932 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.1 mt -80.3 170.66 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 74.319999999999993 110.86 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -92.09 165.65 13.06 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.608 -0.724 . . . . 74.430000000000007 109.726 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -67.3 -22.51 65.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.898 -0.592 . . . . 74.099999999999994 110.092 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -97.22 2.7 51.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.639 -0.71 . . . . 73.0 111.408 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.7 m -77.33 117.67 19.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 75.109999999999999 111.546 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 p -105.35 164.47 11.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.059 -0.973 . . . . 74.510000000000005 109.516 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -40.57 90.9 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.416 0.448 . . . . 74.340000000000003 111.132 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.83 -37.38 87.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.942 -0.572 . . . . 73.040000000000006 111.402 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.1 m -78.48 -41.64 31.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.555 -0.293 . . . . 73.540000000000006 110.96 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.7 tp -62.87 -49.01 76.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.167 -0.47 . . . . 72.239999999999995 110.623 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -57.4 -56.04 27.01 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.443 -0.799 . . . . 75.409999999999997 110.886 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 m -48.24 -39.18 20.46 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -70.22 -53.03 18.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 73.25 110.916 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -73.12 -21.96 60.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.925 0.343 . . . . 74.209999999999994 111.925 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -17.8 54.42 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.667 0.387 . . . . 60.219999999999999 111.921 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.73 -27.11 68.98 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.568 -0.287 . . . . 71.349999999999994 111.7 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -99.25 -17.42 18.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.099999999999994 111.688 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 168.34 38.6 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.042 -1.075 . . . . 74.430000000000007 112.862 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -68.61 121.49 16.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.507 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.5 128.94 36.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.709 -0.678 . . . . 74.099999999999994 111.267 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 p -91.25 -29.27 17.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.95 -1.023 . . . . 70.040000000000006 110.164 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -150.39 152.37 34.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 65.439999999999998 109.455 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.67 136.45 6.18 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.475 -0.565 . . . . 44.420000000000002 109.475 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -152.14 121.75 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.375 0.607 . . . . 72.109999999999999 110.471 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.44 131.01 34.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.431 -0.952 . . . . 72.109999999999999 108.431 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.8 mmt -76.22 99.61 4.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.602 0.715 . . . . 65.120000000000005 110.697 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 57.8 mtp85 -109.47 163.6 13.28 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.524 -1.216 . . . . 75.540000000000006 109.251 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.23 126.92 82.64 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.776 -0.453 . . . . 65.409999999999997 109.776 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.25 -18.92 44.81 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.969 1.779 . . . . 72.120000000000005 112.67 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.11 -56.79 3.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 54.149999999999999 111.607 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.411 ' HB ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -100.85 -8.56 22.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 71.400000000000006 111.74 -172.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm 62.27 39.0 12.92 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.65 0.78 . . . . 72.140000000000001 112.57 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HG3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -115.68 153.49 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.256 -0.277 . . . . 74.420000000000002 110.636 177.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.453 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 36.3 t -69.52 134.33 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.749 0.309 . . . . 73.319999999999993 110.48 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -85.35 -4.11 59.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 74.349999999999994 110.279 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.79 18.96 53.42 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.923 -0.656 . . . . 74.319999999999993 113.777 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -159.07 158.35 32.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.564 0.682 . . . . 75.310000000000002 110.425 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.16 -166.62 18.51 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.636 -0.586 . . . . 50.119999999999997 111.636 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -141.12 148.49 40.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.467 0.634 . . . . 74.340000000000003 110.778 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 m -131.08 121.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 74.540000000000006 109.931 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 m -101.94 123.58 46.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.51 -0.313 . . . . 71.030000000000001 110.442 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -88.23 171.24 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.16 0.505 . . . . 72.150000000000006 111.368 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.4 -48.39 11.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.416 -0.811 . . . . 74.120000000000005 110.146 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -115.43 149.06 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 73.510000000000005 110.158 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.95 -25.28 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.004 0.43 . . . . 63.32 111.122 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.92 -34.76 73.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 72.219999999999999 110.995 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.56 -28.45 66.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 73.219999999999999 110.38 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 14' ' ' ARG . 21.8 t -68.22 -46.34 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.359 -0.837 . . . . 74.319999999999993 110.198 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.98 -46.12 88.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.417 -0.81 . . . . 72.010000000000005 110.938 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.612 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -61.12 -31.4 71.1 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.679 0.622 . . . . 73.439999999999998 112.679 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 -36.25 65.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.039 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.481 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.6 mmt -69.62 -35.22 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.87 -0.604 . . . . 73.109999999999999 110.995 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.612 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 6.6 p30 -79.64 -22.72 43.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.455 -0.339 . . . . 73.099999999999994 111.13 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.84 -5.65 46.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 61.140000000000001 112.449 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mtp-105 -58.96 146.7 76.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.449 -0.341 . . . . 72.019999999999996 111.468 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 168.18 77.85 Favored 'Cis proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.686 -1.381 . . . . 73.400000000000006 113.743 1.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -123.4 155.63 37.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 63.039999999999999 110.654 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.3 ttmt -139.78 104.95 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.042 0.448 . . . . 74.409999999999997 111.176 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 t -105.82 128.23 60.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.787 -0.642 . . . . 74.540000000000006 109.558 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 64.78 29.9 12.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.371 0.668 . . . . 74.310000000000002 111.76 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.89 77.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.784 -0.722 . . . . 71.140000000000001 112.04 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.5 tpt180 -124.93 134.6 52.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.133 -0.321 . . . . 75.299999999999997 110.133 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 113.39 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.834 -0.802 . . . . 71.120000000000005 108.834 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 m -102.5 152.49 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 74.420000000000002 111.272 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' NZ ' ' A' ' 87' ' ' LYS . 5.7 tp10 -113.73 91.8 22.56 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.741 -1.118 . . . . 73.140000000000001 110.542 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -78.37 143.74 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.808 2.338 . . . . 64.049999999999997 111.136 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' NZ ' ' HG3' ' A' ' 85' ' ' GLU . 12.7 mmtm -139.77 159.78 41.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.641 -1.244 . . . . 74.019999999999996 107.641 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.433 ' NH2' ' HA ' ' A' ' 90' ' ' VAL . 2.5 tmm_? -69.49 130.98 43.99 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.845 -1.539 . . . . 72.420000000000002 106.845 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.54 94.7 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.971 0.415 . . . . 64.340000000000003 111.157 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.433 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 25.5 t -58.52 140.82 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.725 -1.125 . . . . 75.219999999999999 111.826 -172.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -56.66 143.32 36.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.386 -0.824 . . . . 71.099999999999994 109.866 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -62.44 -31.31 71.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.593 0.59 . . . . 75.450000000000003 112.593 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.81 -29.1 58.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.463 0.173 . . . . 72.25 111.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.05 -30.46 39.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.391 -0.596 . . . . 73.400000000000006 109.391 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.3 m -74.94 -3.24 31.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.442 -0.799 . . . . 64.439999999999998 111.211 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.38 -13.72 60.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.375 0.607 . . . . 74.209999999999994 109.968 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -106.24 146.96 34.0 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.396 -0.594 . . . . 73.150000000000006 109.396 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.88 140.62 35.47 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.598 2.199 . . . . 72.120000000000005 112.217 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 9.63 60.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.934 -0.651 . . . . 37.57 112.474 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.21 54.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.626 0.251 . . . . 43.020000000000003 111.6 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -96.2 22.7 7.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 72.430000000000007 111.205 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.1 mt -100.46 174.84 5.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 109.957 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 m -78.99 85.49 4.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 72.209999999999994 109.845 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.465 ' HA ' ' HG3' ' A' ' 185' ' ' GLU . 71.7 t -107.94 112.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.182 -0.917 . . . . 64.439999999999998 109.946 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.425 ' C ' HG22 ' A' ' 159' ' ' VAL . 69.8 mttt -106.94 13.76 27.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 74.209999999999994 110.653 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -114.67 138.79 50.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.571 -0.286 . . . . 63.240000000000002 111.27 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 pt -130.13 152.44 37.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.237 0.542 . . . . 72.129999999999995 111.796 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.0 t80 -97.49 137.43 36.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.915 -1.039 . . . . 74.25 109.854 175.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 t -124.72 110.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.128 -0.693 . . . . 72.120000000000005 109.128 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -134.18 155.94 22.12 Favored Glycine 0 CA--C 1.507 -0.45 0 C-N-CA 119.742 -1.218 . . . . 50.329999999999998 113.232 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.48 10.57 31.0 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.564 -0.827 . . . . 74.400000000000006 112.258 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 147' ' ' GLY . 14.1 pt -78.34 110.09 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 70.340000000000003 109.956 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.63 -18.88 24.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 64.109999999999999 111.203 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -112.18 175.22 5.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.841 -0.618 . . . . 71.140000000000001 109.874 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.96 123.98 22.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 71.109999999999999 110.067 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -118.51 144.32 46.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.096 -0.502 . . . . 74.329999999999998 110.125 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.38 162.51 13.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.803 -0.635 . . . . 73.239999999999995 111.217 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -47.69 77.29 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.732 -1.122 . . . . 72.299999999999997 109.755 175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -54.25 -40.65 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.637 0.586 . . . . 74.340000000000003 111.669 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -57.8 -58.51 8.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.855 0.359 . . . . 74.239999999999995 111.127 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.75 -26.41 29.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.802 -0.759 . . . . 73.120000000000005 111.446 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -65.95 -51.46 58.31 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 110.076 -0.342 . . . . 74.430000000000007 110.076 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.21 -25.29 67.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 110.241 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -79.05 -56.75 4.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.857 -0.61 . . . . 74.209999999999994 112.323 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' A' ' 151' ' ' VAL . 45.7 m-85 -69.3 -22.81 63.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.206 0.447 . . . . 74.129999999999995 112.206 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.062 0.458 . . . . 61.030000000000001 110.464 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -58.3 -34.68 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.547 -0.751 . . . . 71.400000000000006 112.001 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -81.51 -31.72 32.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 73.409999999999997 111.316 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.61 48.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.957 -0.639 . . . . 73.239999999999995 112.696 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -72.9 128.04 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 72.019999999999996 111.532 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 152' ' ' THR . 56.6 mt -98.15 136.88 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.661 -0.699 . . . . 75.540000000000006 110.025 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -90.45 -44.02 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.28 . . . . 73.450000000000003 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.7 p -158.18 154.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.45 . . . . 74.439999999999998 109.879 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.19 129.32 70.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.345 0.593 . . . . 75.319999999999993 110.094 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.3 mt-10 -100.83 127.64 47.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.902 -1.045 . . . . 72.109999999999999 110.19 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.1 mm -119.21 122.41 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.594 -0.891 . . . . 64.329999999999998 108.594 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.1 mmm -98.29 123.78 42.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.807 -0.812 . . . . 72.319999999999993 108.807 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 p -92.13 168.56 11.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.089 0.471 . . . . 64.420000000000002 111.163 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -88.95 127.57 35.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.538 -0.912 . . . . 74.409999999999997 108.538 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -76.16 -13.43 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.107 0.41 . . . . 73.409999999999997 112.107 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.62 -50.85 1.36 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.653 -0.784 . . . . 71.340000000000003 112.457 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 m -83.56 -23.45 32.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.517 0.199 . . . . 61.520000000000003 111.498 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 12.24 84.57 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.823 -0.703 . . . . 75.109999999999999 112.628 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -102.01 172.56 6.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.93 -0.396 . . . . 73.239999999999995 109.93 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -91.69 89.58 7.18 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.893 -0.41 . . . . 74.409999999999997 109.893 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -151.29 150.13 30.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.263 0.554 . . . . 72.349999999999994 111.609 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.3 -46.02 1.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.999 -1.001 . . . . 75.140000000000001 113.27 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -175.61 162.6 2.79 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 117.466 0.633 . . . . 74.510000000000005 110.276 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.15 8.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.749 -0.659 . . . . 73.430000000000007 109.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -142.32 145.7 34.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.745 -0.661 . . . . 65.349999999999994 110.016 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.447 HG23 ' CD2' ' A' ' 125' ' ' PHE . 84.0 t -132.75 126.06 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.997 -0.439 . . . . 73.319999999999993 111.049 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 131' ' ' ILE . 30.0 m -102.48 125.17 49.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.835 -0.62 . . . . 75.209999999999994 110.494 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.78 163.62 12.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.992 0.425 . . . . 75.040000000000006 111.671 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.44 -28.2 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.264 -0.88 . . . . 71.120000000000005 110.534 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.46 153.41 51.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.022 -0.535 . . . . 74.239999999999995 110.422 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.446 ' CD2' HG23 ' A' ' 103' ' ' THR . 34.3 p80 -74.73 -28.21 60.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.646 . . . . 71.230000000000004 110.108 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.481 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -58.53 -43.56 89.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.017 -0.992 . . . . 74.340000000000003 111.779 -176.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 m -68.72 -30.75 69.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.718 0.294 . . . . 74.549999999999997 110.937 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.425 HG22 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.17 -39.53 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.636 -0.505 . . . . 73.120000000000005 109.636 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -72.15 -24.64 61.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.448 -0.796 . . . . 64.310000000000002 111.499 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 52.9 mttm -62.81 -40.51 97.58 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.647 0.737 . . . . 71.140000000000001 110.009 170.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.16 -43.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.667 -1.151 . . . . 64.010000000000005 112.574 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 160' ' ' ASP . 32.6 m -73.73 -2.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.115 0.483 . . . . 75.209999999999994 111.63 -173.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 160' ' ' ASP . 76.2 mt -61.27 -38.11 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.508 -0.769 . . . . 74.400000000000006 109.951 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.3 mt-30 -108.47 105.62 15.36 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.45 -0.945 . . . . 74.349999999999994 108.45 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -53.85 -34.27 58.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.856 -0.611 . . . . 72.209999999999994 112.151 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.76 137.83 54.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 110.614 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.5 m-70 -126.0 146.26 49.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.832 -0.622 . . . . 75.420000000000002 110.539 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 m -106.08 118.84 37.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.016 -0.538 . . . . 73.099999999999994 110.726 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.62 142.9 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.548 -0.908 . . . . 74.129999999999995 108.548 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.2 t30 52.11 31.28 8.68 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.537 0.684 . . . . 52.240000000000002 111.767 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.38 10.17 74.35 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.75 -0.659 . . . . 73.25 113.543 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -115.66 139.01 50.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.01 0.405 . . . . 73.120000000000005 110.264 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -101.12 111.2 23.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.643 0.735 . . . . 72.150000000000006 111.016 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.98 156.61 23.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 74.5 110.51 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -86.57 136.64 32.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.003 0.43 . . . . 72.450000000000003 110.184 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.2 t -131.97 132.64 61.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.616 -0.72 . . . . 73.030000000000001 109.862 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -153.46 174.63 14.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.797 -0.638 . . . . 74.239999999999995 111.195 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -65.28 136.9 57.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.596 -0.274 . . . . 74.25 110.898 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -125.99 124.94 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.812 -0.44 . . . . 73.209999999999994 109.812 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt -97.55 110.87 23.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.408 -0.517 . . . . 75.310000000000002 110.525 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.453 ' HB3' ' OE1' ' A' ' 185' ' ' GLU . 23.2 t -89.72 -170.37 2.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.759 -0.83 . . . . 54.130000000000003 108.759 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -69.63 -25.81 64.12 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.243 -0.286 . . . . 74.409999999999997 110.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -74.84 -37.44 62.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.21 0.529 . . . . 74.549999999999997 110.098 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.465 ' HG3' ' HA ' ' A' ' 104' ' ' VAL . 8.4 mp0 -69.16 -37.24 78.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.556 -0.747 . . . . 75.310000000000002 111.283 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.5 mtt -85.47 -70.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 73.409999999999997 111.728 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -95.64 -11.27 27.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 71.450000000000003 112.056 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.0 m 61.9 43.78 8.97 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.832 0.707 . . . . 72.430000000000007 110.743 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.89 111.09 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.428 -0.805 . . . . 55.119999999999997 110.321 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m -147.12 149.27 32.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.593 -0.276 . . . . 71.310000000000002 110.573 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.7 m -67.41 108.26 2.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.499 -0.556 . . . . 73.25 109.499 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 11.5 m -82.56 73.64 9.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 64.209999999999994 111.317 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -104.67 114.47 28.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.288 -0.869 . . . . 74.219999999999999 108.899 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -87.13 88.1 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.215 0.531 . . . . 73.340000000000003 110.834 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -88.88 69.6 2.65 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.21 -0.756 . . . . 72.230000000000004 111.21 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.525 -0.75 . . . . 74.219999999999999 109.165 -178.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.273 -0.331 . . . . 65.109999999999999 112.273 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -82.79 121.7 27.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.071 -0.344 . . . . 73.049999999999997 110.071 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -75.97 104.57 6.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.164 0.507 . . . . 72.329999999999998 110.867 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 p -96.57 -5.95 38.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.669 -0.696 . . . . 64.329999999999998 109.644 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.05 119.78 9.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.123 -0.944 . . . . 75.129999999999995 110.253 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.0 m -86.75 140.23 33.3 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 72.340000000000003 110.704 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 158.77 55.85 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.562 2.175 . . . . 74.019999999999996 111.846 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 2.13 13.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 74.439999999999998 108.43 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 37.5 mp0 -102.5 142.78 25.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.241 -1.345 . . . . 74.530000000000001 110.836 -172.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 12.1 Cg_endo -61.92 166.42 12.29 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.871 2.38 . . . . 72.530000000000001 112.006 172.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.46 -37.18 67.42 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 112.272 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HG3' HD22 ' A' ' 13' ' ' LEU . 10.0 pt20 -61.83 -29.33 70.09 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 74.420000000000002 112.158 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 25.3 mt -89.81 -22.17 22.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.334 . . . . 63.329999999999998 111.162 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HA ' HG22 ' A' ' 68' ' ' VAL . 22.7 ptt180 -106.66 0.05 24.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.332 0.587 . . . . 75.019999999999996 110.071 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -105.47 136.28 45.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.638 0.732 . . . . 74.409999999999997 111.123 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 87' ' ' LYS . 71.3 mt -101.56 146.87 27.09 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.729 -1.123 . . . . 72.409999999999997 110.92 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -97.67 120.79 38.68 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.245 -1.021 . . . . 74.329999999999998 108.245 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.47 110.96 27.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.771 -0.455 . . . . 74.340000000000003 109.771 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.72 147.94 16.32 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.868 -0.893 . . . . 75.239999999999995 110.868 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.9 42.26 13.07 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.978 -1.106 . . . . 53.549999999999997 112.886 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -79.28 174.63 11.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.319 -0.622 . . . . 74.150000000000006 109.319 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -85.98 179.35 7.01 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 60.140000000000001 109.094 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.95 -6.88 59.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.513 0.673 . . . . 71.319999999999993 109.389 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -118.36 20.35 13.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.006 -0.997 . . . . 72.109999999999999 111.845 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 m -85.75 129.45 34.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.983 0.421 . . . . 75.219999999999999 111.477 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -108.09 165.73 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.695 . . . . 71.120000000000005 109.673 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -25.17 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.005 -0.278 . . . . 73.049999999999997 110.792 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.6 -40.36 69.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.127 -0.229 . . . . 71.439999999999998 110.851 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -76.7 -32.71 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 74.310000000000002 110.618 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.2 tp -66.42 -49.88 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 71.519999999999996 110.314 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -56.77 -54.78 42.31 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.556 -0.747 . . . . 74.209999999999994 111.011 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -44.86 -37.98 4.26 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.539 1.149 . . . . 63.409999999999997 113.415 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -69.83 -52.0 28.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.345 -0.389 . . . . 75.349999999999994 110.953 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.32 -19.91 41.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.195 0.443 . . . . 73.530000000000001 112.195 -170.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -56.73 -24.29 48.67 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.396 0.517 . . . . 53.420000000000002 112.396 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.96 -25.57 68.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.196 0.443 . . . . 73.439999999999998 112.196 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -101.21 -23.25 14.47 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.088 -0.245 . . . . 73.409999999999997 111.267 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.3 157.72 29.19 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.311 -0.947 . . . . 73.340000000000003 112.389 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.6 m -63.24 119.81 10.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.981 0.419 . . . . 72.540000000000006 111.591 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.4 mt -88.43 141.85 28.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.815 -0.63 . . . . 73.200000000000003 110.479 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -107.09 -23.25 12.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 53.450000000000003 110.198 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -153.6 153.72 32.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.642 -0.708 . . . . 65.549999999999997 109.598 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 t -163.27 132.81 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.659 -0.497 . . . . 44.310000000000002 109.659 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.13 127.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 73.109999999999999 111.095 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.42 133.78 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.937 -0.764 . . . . 73.439999999999998 108.937 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.473 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.6 mmt -78.19 99.85 6.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.339 0.59 . . . . 71.409999999999997 110.471 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -101.77 160.92 14.06 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.033 -0.985 . . . . 63.130000000000003 109.864 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.28 130.47 62.33 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.1 -0.333 . . . . 63.420000000000002 110.1 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.12 -19.37 51.16 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.182 1.922 . . . . 74.319999999999993 113.295 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.63 -54.37 4.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.34 0.591 . . . . 72.549999999999997 110.707 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -96.86 -16.14 20.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.182 -0.917 . . . . 70.329999999999998 112.348 -172.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm 65.94 31.09 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.865 0.728 . . . . 72.340000000000003 111.183 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -114.15 158.7 20.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.351 -0.611 . . . . 75.120000000000005 109.351 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 t -70.73 140.78 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.967 0.413 . . . . 63.409999999999997 110.993 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -93.34 3.75 55.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 75.219999999999999 110.596 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.06 68.02 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 114.378 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.3 p90 -156.34 154.8 31.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.768 0.784 . . . . 71.030000000000001 110.496 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.78 -166.24 17.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.371 -0.692 . . . . 74.439999999999998 111.371 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.68 148.59 37.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.295 0.547 . . . . 75.439999999999998 110.598 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.9 m -129.13 127.86 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.595 . . . . 74.420000000000002 109.781 174.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.6 m -103.36 121.61 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.335 -0.228 . . . . 74.420000000000002 110.532 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -87.95 164.05 16.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.042 0.449 . . . . 74.209999999999994 110.997 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.83 -49.49 37.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.492 -0.776 . . . . 73.219999999999999 110.598 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.5 m -119.37 152.18 37.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 74.400000000000006 110.816 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -65.64 -28.85 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.099 -0.5 . . . . 75.5 111.455 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.53 -29.35 63.52 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.967 -0.458 . . . . 74.310000000000002 111.509 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 6.1 mm-40 -64.92 -29.75 70.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.49 0.662 . . . . 73.109999999999999 109.282 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 24.8 t -66.88 -48.3 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.825 -1.08 . . . . 75.219999999999999 110.298 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -59.14 -49.96 75.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.797 -0.638 . . . . 73.349999999999994 110.704 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.8 -36.72 38.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.957 0.725 . . . . 74.25 112.957 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -29.6 62.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 71.129999999999995 110.745 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -49.66 64.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 65.049999999999997 109.974 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -64.07 -26.84 68.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.18 0.514 . . . . 72.239999999999995 110.882 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.9 -10.73 60.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.237 -0.892 . . . . 65.340000000000003 113.366 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -56.63 149.78 39.22 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 111.883 0.327 . . . . 55.509999999999998 111.883 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.72 165.67 79.12 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.057 -1.226 . . . . 74.319999999999993 112.837 0.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -123.65 152.67 41.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 74.230000000000004 110.483 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.5 ttmt -134.23 107.55 7.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.114 -0.494 . . . . 70.310000000000002 111.251 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 126.59 66.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.678 -0.692 . . . . 75.120000000000005 109.85 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.7 t70 66.29 28.19 9.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.632 0.73 . . . . 74.019999999999996 110.791 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.12 25.87 70.06 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.765 -0.731 . . . . 73.150000000000006 112.498 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.3 tpt180 -129.64 142.09 50.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.101 -0.703 . . . . 74.129999999999995 109.101 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.47 114.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 74.109999999999999 109.838 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.72 153.37 7.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.872 -0.604 . . . . 73.540000000000006 111.119 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -117.09 100.43 53.25 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.272 -0.876 . . . . 75.219999999999999 110.572 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.59 132.54 17.54 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.867 1.711 . . . . 73.409999999999997 110.909 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' O ' HD22 ' A' ' 16' ' ' LEU . 20.3 mttt -136.2 178.97 6.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.053 -1.091 . . . . 75.239999999999995 108.053 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.2 tmm_? -81.88 128.68 34.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.768 -0.827 . . . . 75.239999999999995 108.768 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.28 98.54 0.33 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.242 0.544 . . . . 64.099999999999994 111.097 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 11.1 t -69.22 142.96 15.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.053 -0.976 . . . . 74.319999999999993 110.835 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.42 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 18.1 t -83.21 172.27 12.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.236 -0.438 . . . . 52.210000000000001 109.991 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -61.65 -42.5 98.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.74 0.644 . . . . 75.150000000000006 112.74 -170.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -71.18 -41.46 70.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 65.120000000000005 110.866 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.0 OUTLIER -78.55 -8.12 58.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 111.478 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.6 m -93.62 -4.14 51.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.592 -0.276 . . . . 70.549999999999997 111.195 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.17 -41.59 99.25 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.602 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.93 146.57 75.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.944 -0.571 . . . . 75.510000000000005 110.262 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.57 147.66 90.27 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.025 2.484 . . . . 74.019999999999996 112.259 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.96 28.71 64.13 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.819 -0.705 . . . . 62.109999999999999 112.664 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.29 -52.16 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 64.439999999999998 110.349 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -93.71 2.47 56.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.637 -0.71 . . . . 74.120000000000005 111.061 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -87.94 161.93 17.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.473 . . . . 74.25 109.724 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 156' ' ' HIS . 3.2 m -83.58 97.61 9.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.218 0.533 . . . . 70.129999999999995 112.122 -172.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.523 ' CG1' ' HE3' ' A' ' 179' ' ' LYS . 0.8 OUTLIER -124.52 124.02 67.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.459 -0.791 . . . . 74.239999999999995 109.061 174.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 159' ' ' VAL . 72.7 mttt -106.65 22.01 16.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.323 0.583 . . . . 73.310000000000002 110.446 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -117.71 139.66 50.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.786 -0.643 . . . . 73.540000000000006 111.085 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.27 148.52 28.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.307 0.575 . . . . 74.239999999999995 111.45 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -98.63 133.79 42.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.869 -1.059 . . . . 75.310000000000002 109.426 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.37 109.12 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.059 -0.719 . . . . 73.230000000000004 109.059 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -135.86 167.88 24.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.682 -1.246 . . . . 73.430000000000007 113.717 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.11 42.11 5.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.925 -0.655 . . . . 75.450000000000003 111.735 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.19 111.23 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.513 0.673 . . . . 74.439999999999998 110.755 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -78.68 -21.78 47.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.717 0.77 . . . . 71.040000000000006 109.261 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -101.3 151.61 21.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.832 -1.076 . . . . 75.319999999999993 109.181 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.17 123.42 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.534 0.683 . . . . 61.530000000000001 110.677 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 m -107.27 141.61 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.849 -0.614 . . . . 70.129999999999995 110.056 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -113.57 173.64 6.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.248 -0.887 . . . . 74.219999999999999 111.449 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -50.73 72.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 71.310000000000002 110.955 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -63.36 -26.34 68.71 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.29 0.369 . . . . 74.340000000000003 111.491 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -64.23 -61.25 2.36 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.427 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 pp -84.1 -23.91 30.55 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.984 -0.686 . . . . 64.120000000000005 111.883 -171.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -67.51 -51.44 51.06 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 110.357 -0.238 . . . . 73.200000000000003 110.357 178.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.2 -28.71 69.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 71.439999999999998 110.3 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -78.79 -56.28 4.52 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.517 -0.765 . . . . 73.439999999999998 112.14 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -67.91 -23.07 65.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.472 0.545 . . . . 74.450000000000003 112.472 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.7 mt-10 -68.05 -23.05 64.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.645 0.26 . . . . 74.030000000000001 111.415 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.78 -33.84 64.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.515 . . . . 75.439999999999998 111.55 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.24 -31.65 33.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.366 . . . . 75.519999999999996 111.443 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.68 -177.33 48.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.704 -0.76 . . . . 62.229999999999997 113.332 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -75.61 129.98 38.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 75.010000000000005 111.418 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 152' ' ' THR . 59.0 mt -102.25 140.18 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 72.530000000000001 110.071 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -91.35 -46.55 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 61.539999999999999 110.957 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.36 156.27 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.882 0.373 . . . . 72.010000000000005 110.427 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.49 127.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 109.933 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -102.45 105.46 16.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 62.520000000000003 111.206 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.1 117.12 38.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.873 -0.788 . . . . 72.439999999999998 108.873 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.5 mmm -84.45 101.21 11.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 72.329999999999998 110.385 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.98 150.0 29.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.382 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 142.55 38.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.391 -0.822 . . . . 54.350000000000001 110.636 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -11.38 59.68 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.237 0.458 . . . . 72.239999999999995 112.237 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -96.86 -54.09 1.33 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.29 -0.957 . . . . 71.519999999999996 113.171 -175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.471 ' OG ' ' HE2' ' A' ' 144' ' ' LYS . 17.8 t -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.007 0.432 . . . . 74.340000000000003 110.687 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 8.92 75.78 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.677 -0.773 . . . . 71.019999999999996 112.816 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.471 ' HE2' ' OG ' ' A' ' 142' ' ' SER . 70.6 mmtt -76.87 158.32 30.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.719 0.259 . . . . 75.430000000000007 110.303 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -74.85 129.16 37.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.307 -0.998 . . . . 74.340000000000003 108.307 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -81.56 23.98 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.822 1.045 . . . . 75.409999999999997 113.822 -170.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.46 3.96 80.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.515 -0.85 . . . . 72.019999999999996 113.894 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.66 161.66 32.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 117.188 0.494 . . . . 71.310000000000002 110.43 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.47 173.97 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.487 -0.779 . . . . 64.310000000000002 109.673 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 45.5 m-85 -138.0 148.93 45.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 74.219999999999999 110.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.35 126.25 52.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 71.200000000000003 110.815 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.7 m -98.82 121.28 40.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 75.430000000000007 110.565 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -101.83 160.97 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.68 -0.236 . . . . 74.310000000000002 110.588 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.32 -29.94 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.386 0.613 . . . . 73.25 110.154 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -137.31 162.39 33.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 110.777 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.4 p80 -82.37 -20.56 36.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.978 -0.555 . . . . 73.299999999999997 110.118 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.596 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.2 p30 -60.3 -41.21 92.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 123.564 0.54 . . . . 63.009999999999998 110.943 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 m -73.67 -29.48 62.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.469 -0.332 . . . . 75.310000000000002 110.355 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.8 t -68.63 -42.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.759 -0.655 . . . . 71.450000000000003 109.745 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.85 -26.05 60.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 110.887 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.6 mttt -62.78 -37.99 88.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.521 0.677 . . . . 71.430000000000007 110.218 172.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.6 -42.61 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 72.019999999999996 112.956 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 159' ' ' VAL . 16.8 m -69.74 -9.01 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.095 0.474 . . . . 74.340000000000003 111.625 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.476 HD11 HD23 ' A' ' 13' ' ' LEU . 58.5 mt -56.46 -36.68 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.306 -0.861 . . . . 62.409999999999997 110.368 171.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -109.5 108.95 19.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.224 -0.658 . . . . 71.439999999999998 109.224 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -53.71 -36.13 61.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.429 -0.805 . . . . 75.120000000000005 112.342 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -122.5 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.884 0.373 . . . . 75.299999999999997 110.49 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -121.09 141.63 50.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.064 -0.516 . . . . 72.230000000000004 110.487 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 m -90.26 102.96 15.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.075 -0.511 . . . . 74.109999999999999 110.587 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.2 126.96 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.008 -0.738 . . . . 73.25 109.008 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 t30 53.42 31.53 12.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.584 0.707 . . . . 75.430000000000007 111.528 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.71 2.04 84.79 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.193 -0.527 . . . . 64.439999999999998 113.231 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -106.55 132.36 52.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.557 -0.534 . . . . 73.200000000000003 109.557 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.318 0.58 . . . . 64.519999999999996 110.676 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -106.82 153.89 21.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 65.400000000000006 109.707 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.47 131.23 34.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.198 -0.297 . . . . 72.219999999999999 110.198 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.9 t -130.44 137.25 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 73.239999999999995 111.06 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -158.2 176.67 12.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.001 -0.545 . . . . 74.140000000000001 112.06 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.523 ' HE3' ' CG1' ' A' ' 104' ' ' VAL . 14.1 mmmt -66.32 123.58 20.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.002 -0.545 . . . . 72.549999999999997 109.94 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -106.19 113.99 27.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 75.040000000000006 111.001 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.28 140.44 37.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.908 -0.587 . . . . 73.239999999999995 110.125 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 186' ' ' MET . 89.4 p -73.03 168.61 18.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.838 -0.801 . . . . 72.409999999999997 108.838 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.01 -30.43 70.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 74.019999999999996 110.5 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 188' ' ' SER . 8.5 tt0 -63.77 -39.77 95.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.157 -0.928 . . . . 64.099999999999994 110.732 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.8 -22.92 31.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.953 -0.567 . . . . 74.310000000000002 111.326 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 182' ' ' SER . 22.7 mtt -79.59 -70.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.176 0.436 . . . . 73.420000000000002 112.176 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -94.1 -62.16 1.4 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.281 -0.418 . . . . 75.299999999999997 111.745 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 184' ' ' GLN . 10.7 p -153.59 167.28 30.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.748 -0.464 . . . . 62.229999999999997 109.748 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 97.44 0.06 Allowed 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.588 0.555 . . . . 61.350000000000001 110.743 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 5.2 m -133.45 90.8 2.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.772 -0.649 . . . . 73.409999999999997 110.217 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.4 t -95.67 82.18 3.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 64.299999999999997 109.761 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.9 m -77.56 128.27 33.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.445 -0.798 . . . . 73.019999999999996 109.861 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -69.0 111.88 5.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.985 0.421 . . . . 74.430000000000007 110.189 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -80.89 135.9 35.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.77 -0.65 . . . . 75.329999999999998 111.066 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.0 35.18 3.33 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.989 -0.844 . . . . 64.409999999999997 110.989 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.592 -0.718 . . . . 73.400000000000006 109.438 -176.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.598 -0.601 . . . . 42.140000000000001 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t -83.51 97.42 9.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.133 0.492 . . . . 63.210000000000001 110.751 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.96 101.99 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 72.319999999999993 109.877 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -127.97 32.05 4.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.08 -0.509 . . . . 74.439999999999998 110.676 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.92 141.38 53.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 74.340000000000003 109.792 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -62.1 113.77 9.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.639 0.587 . . . . 74.5 110.464 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.61 126.59 21.03 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 C-N-CA 122.55 2.167 . . . . 74.510000000000005 112.573 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -100.61 -3.06 31.2 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.963 -1.017 . . . . 60.520000000000003 110.692 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 159.88 37.5 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.028 -0.533 . . . . 65.420000000000002 110.191 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.69 166.94 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.294 1.996 . . . . 74.409999999999997 111.304 170.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -32.79 70.63 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 111.715 0.265 . . . . 73.219999999999999 111.715 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.46 -30.9 71.93 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.063 0.394 . . . . 73.349999999999994 112.063 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -82.97 -12.98 56.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.185 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.41 0.56 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.984 0.421 . . . . 63.119999999999997 111.245 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -96.38 147.18 24.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.379 0.609 . . . . 73.239999999999995 112.108 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -116.31 147.21 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.008 -0.996 . . . . 72.200000000000003 109.727 172.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 29.8 t80 -101.99 118.38 36.78 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.172 -1.048 . . . . 63.100000000000001 108.172 171.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.3 mm -94.78 112.77 27.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 122.108 -0.37 . . . . 75.329999999999998 110.228 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 150.81 18.18 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.958 -0.639 . . . . 61.520000000000003 111.964 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.91 45.14 64.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.168 -0.539 . . . . 64.25 113.586 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD23 ' CG1' ' A' ' 84' ' ' VAL . 50.2 mt -76.47 173.07 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 72.329999999999998 110.409 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -84.4 175.55 9.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 73.340000000000003 109.485 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 92.1 m-85 -84.03 -6.59 59.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 110.632 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -119.51 12.11 12.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.878 -0.601 . . . . 62.340000000000003 111.678 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.9 m -77.41 132.37 38.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.078 0.466 . . . . 70.219999999999999 111.425 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -107.63 167.59 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.633 -0.712 . . . . 75.340000000000003 110.054 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -73.77 -24.42 59.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 72.340000000000003 111.089 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.67 -35.14 58.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.167 -0.213 . . . . 71.420000000000002 110.659 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.8 m -73.23 -38.11 66.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.436 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.95 -45.04 94.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 74.540000000000006 110.178 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -60.0 -52.85 63.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.948 -0.569 . . . . 71.209999999999994 110.559 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m -44.14 -42.3 6.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.327 1.017 . . . . 73.340000000000003 113.603 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 79' ' ' VAL . 66.6 t60 -70.24 -56.45 6.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 64.120000000000005 111.13 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 40' ' ' LEU . 81.8 m-85 -76.05 -17.57 59.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.806 0.299 . . . . 74.439999999999998 111.806 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.6 -28.37 54.7 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.027 0.531 . . . . 72.230000000000004 111.547 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -65.61 -23.96 66.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.465 -0.788 . . . . 71.450000000000003 112.304 -177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -101.41 -21.98 14.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.057 0.391 . . . . 72.010000000000005 112.057 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 177.09 48.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.788 -1.196 . . . . 37.590000000000003 113.24 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -68.01 119.61 12.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.966 0.507 . . . . 74.230000000000004 112.268 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 34' ' ' PHE . 52.8 mt -95.66 125.63 40.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.636 0.731 . . . . 74.420000000000002 110.56 170.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 t -100.92 -17.69 16.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.989 -1.005 . . . . 71.400000000000006 110.12 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.95 151.4 29.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 64.420000000000002 109.981 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.8 t -163.04 133.18 4.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.98 -0.378 . . . . 73.219999999999999 109.98 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 126.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.215 0.531 . . . . 72.120000000000005 110.613 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.56 131.87 33.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.605 -0.887 . . . . 74.209999999999994 108.605 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.9 mmt -79.4 97.44 6.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.773 0.796 . . . . 72.430000000000007 110.94 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -104.51 159.11 16.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.314 -1.312 . . . . 74.400000000000006 109.008 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.37 125.84 91.06 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.885 -0.598 . . . . 74.439999999999998 109.773 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.51 -28.62 87.01 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.214 1.943 . . . . 60.43 113.744 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.92 -55.01 4.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.925 0.393 . . . . 70.150000000000006 111.906 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.43 -15.92 21.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.199 0.444 . . . . 73.400000000000006 112.199 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 65.43 31.34 10.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.71 0.804 . . . . 74.019999999999996 111.747 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -97.92 151.35 20.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.098 -0.704 . . . . 74.120000000000005 109.098 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.1 t -72.7 137.63 46.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.727 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -89.25 -1.65 58.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.778 -0.646 . . . . 63.219999999999999 109.634 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.18 23.52 51.42 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.66 -0.7 . . . . 52.100000000000001 113.825 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -161.51 160.72 29.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.887 0.844 . . . . 73.450000000000003 111.036 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -162.18 12.19 Favored Glycine 0 C--O 1.226 -0.345 0 N-CA-C 111.588 -0.605 . . . . 73.549999999999997 111.588 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -142.32 149.37 39.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.185 0.493 . . . . 75.329999999999998 110.105 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 m -130.69 126.4 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.057 -0.719 . . . . 75.430000000000007 109.057 172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 m -105.85 120.01 40.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.728 0.299 . . . . 75.420000000000002 110.408 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -85.37 171.08 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.854 -0.612 . . . . 73.150000000000006 109.979 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.7 -25.03 24.99 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.139 0.495 . . . . 71.420000000000002 110.488 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 m -143.06 145.4 32.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 64.150000000000006 110.916 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.1 p -56.54 -40.02 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.688 -0.687 . . . . 62.210000000000001 111.867 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -53.05 -42.03 65.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.974 0.731 . . . . 71.200000000000003 112.974 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -65.71 -30.67 71.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.302 0.572 . . . . 74.140000000000001 110.569 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 17.9 t -67.12 -45.57 86.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.381 -0.827 . . . . 73.109999999999999 110.813 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -58.95 -42.94 91.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 73.319999999999993 110.622 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.633 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.71 -37.37 73.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.483 0.549 . . . . 73.120000000000005 112.483 171.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.33 74.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.271 0.558 . . . . 72.510000000000005 110.226 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.25 -36.25 71.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.783 -0.644 . . . . 72.099999999999994 110.786 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 4.5 p30 -79.94 -11.27 59.81 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.968 0.413 . . . . 75.219999999999999 110.952 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.79 -12.06 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 75.209999999999994 111.002 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -55.31 149.14 28.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.68 . . . . 74.420000000000002 111.827 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 168.7 76.62 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 124.274 -1.136 . . . . 75.120000000000005 113.381 2.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -125.77 155.97 40.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.681 -0.691 . . . . 75.200000000000003 110.358 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.3 ttmt -136.75 105.34 5.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.086 0.47 . . . . 73.439999999999998 111.242 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG23 ' CG ' ' A' ' 33' ' ' HIS . 16.4 t -105.62 125.6 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.6 . . . . 74.420000000000002 109.718 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 64.53 33.59 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.776 0.672 . . . . 70.340000000000003 111.281 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.88 26.56 73.77 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.018 -0.611 . . . . 52.25 112.239 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.5 tpt180 -127.5 135.62 50.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.162 -0.31 . . . . 73.510000000000005 110.162 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.95 113.47 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.839 -0.8 . . . . 74.230000000000004 108.839 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' CG1' HD23 ' A' ' 21' ' ' LEU . 5.0 m -106.49 151.99 8.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.356 0.598 . . . . 75.230000000000004 111.208 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -113.82 96.55 41.56 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.956 -1.02 . . . . 74.019999999999996 110.697 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.27 129.97 15.71 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.741 1.627 . . . . 63.210000000000001 110.286 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.559 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 50.9 mmtt -121.26 142.01 50.35 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.844 -0.798 . . . . 74.430000000000007 108.844 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.61 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 7.9 tpp180 -64.05 119.51 10.27 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.644 -0.872 . . . . 75.439999999999998 108.644 172.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 93.29 0.09 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 110.671 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -66.24 156.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.728 -1.124 . . . . 64.409999999999997 110.638 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 p -55.39 153.82 6.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.961 -0.563 . . . . 71.030000000000001 111.428 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 1.4 tmt_? -57.51 -30.62 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.671 -0.695 . . . . 63.210000000000001 111.234 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -52.2 52.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 111.609 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.8 -25.95 59.4 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.789 0.328 . . . . 71.340000000000003 110.318 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -64.4 -17.49 63.82 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.217 -0.447 . . . . 73.030000000000001 111.192 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.29 -11.24 59.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.738 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -79.96 145.55 61.67 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.953 -0.388 . . . . 73.450000000000003 109.953 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.3 115.54 4.08 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.43 2.086 . . . . 75.200000000000003 112.05 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.65 27.59 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.791 -0.719 . . . . 72.340000000000003 112.297 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.01 -36.81 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 111.671 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 18.2 m170 -104.03 21.2 16.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.485 0.66 . . . . 62.219999999999999 110.516 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.2 mt -101.65 -178.55 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 74.129999999999995 109.553 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.408 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.15 100.64 13.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.649 . . . . 72.430000000000007 111.834 -175.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.17 121.97 44.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 74.530000000000001 108.181 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -106.59 19.68 20.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 63.229999999999997 110.505 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -116.43 139.1 50.81 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.378 -0.373 . . . . 73.209999999999994 110.662 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.5 pt -131.7 149.62 33.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.266 0.555 . . . . 74.0 111.293 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -93.45 137.91 32.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 74.150000000000006 109.582 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.82 108.93 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.345 -0.613 . . . . 74.030000000000001 109.345 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.84 147.6 18.08 Favored Glycine 0 CA--C 1.505 -0.587 0 C-N-CA 119.673 -1.251 . . . . 75.049999999999997 112.973 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.87 6.35 22.96 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.32 -0.943 . . . . 73.129999999999995 111.981 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.45 99.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 122.072 0.939 . . . . 71.430000000000007 109.055 175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.427 ' HB2' ' HZ1' ' A' ' 113' ' ' LYS . 2.2 ttmp? -91.47 -6.13 53.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.161 -0.927 . . . . 72.140000000000001 112.126 -166.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -126.47 -162.52 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.024 -0.362 . . . . 63.200000000000003 110.024 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.22 67.98 8.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 54.119999999999997 111.003 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -75.56 136.42 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.321 0.581 . . . . 71.239999999999995 109.799 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.3 166.12 10.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.272 -0.876 . . . . 72.319999999999993 111.436 -171.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.01 -53.17 61.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.336 -0.847 . . . . 74.5 110.516 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.23 -12.76 58.16 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.388 0.514 . . . . 73.5 112.388 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -73.01 -57.74 3.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.084 0.468 . . . . 75.209999999999994 109.764 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -81.47 -28.62 34.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.143 -0.623 . . . . 71.140000000000001 110.544 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -64.3 -53.22 52.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.657 -0.247 . . . . 74.140000000000001 110.592 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.6 -26.4 68.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.979 0.419 . . . . 55.140000000000001 110.486 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.1 -54.59 8.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.815 -0.629 . . . . 74.209999999999994 111.194 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -68.32 -23.53 64.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.5 -0.318 . . . . 73.439999999999998 111.609 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.92 -26.18 67.48 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.886 0.374 . . . . 65.230000000000004 111.236 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -56.9 -30.1 63.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.935 -0.575 . . . . 73.530000000000001 111.31 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -86.26 -26.8 24.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 74.299999999999997 111.936 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.69 46.41 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.372 -0.918 . . . . 63.329999999999998 113.353 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.45 131.77 41.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.078 0.466 . . . . 73.430000000000007 111.316 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 152' ' ' THR . 52.4 mt -105.09 141.18 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 75.409999999999997 110.082 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -90.64 -54.44 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 54.229999999999997 110.796 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.76 155.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 74.319999999999993 110.289 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.54 129.48 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.057 0.456 . . . . 74.519999999999996 109.828 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 21.6 mt-10 -101.78 103.41 14.14 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.291 -0.868 . . . . 70.040000000000006 110.566 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -92.47 118.98 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.067 -0.716 . . . . 75.109999999999999 109.067 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 73.1 mmm -90.46 109.36 20.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.283 0.564 . . . . 72.400000000000006 110.554 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.1 m -132.51 153.51 50.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 74.109999999999999 109.846 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.22 136.48 38.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.26 -0.644 . . . . 74.129999999999995 109.26 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 140' ' ' ARG . 9.9 ttp180 -78.24 -45.13 23.72 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 121.149 -0.22 . . . . 74.530000000000001 110.98 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.21 -48.46 58.87 Favored Glycine 0 CA--C 1.518 0.244 0 CA-C-N 116.131 -0.486 . . . . 71.25 113.281 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -84.1 -23.96 30.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.727 0.299 . . . . 54.140000000000001 111.053 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.12 16.71 78.52 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.054 -0.593 . . . . 75.109999999999999 112.119 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -105.13 141.82 36.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.82 -0.223 . . . . 75.329999999999998 110.544 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -74.71 143.26 44.24 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.986 -0.746 . . . . 72.319999999999993 108.986 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -81.35 20.23 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.325 0.861 . . . . 74.239999999999995 113.325 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.03 10.31 64.88 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.893 -0.67 . . . . 53.030000000000001 113.624 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.28 158.96 33.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.104 0.478 . . . . 75.230000000000004 109.764 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.91 176.91 8.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.255 -0.884 . . . . 74.209999999999994 109.633 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 51.6 m-85 -139.84 151.73 45.92 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.28 -0.873 . . . . 75.319999999999993 109.128 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.09 134.04 15.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.281 0.562 . . . . 75.430000000000007 110.95 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 131' ' ' ILE . 54.8 m -105.7 127.66 53.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.071 -0.968 . . . . 75.099999999999994 110.983 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -101.72 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 110.874 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.26 -23.3 30.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.825 -0.625 . . . . 72.209999999999994 110.29 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.56 158.05 44.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 73.230000000000004 110.8 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.559 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 31.2 p80 -83.98 -27.67 28.28 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.646 -0.252 . . . . 74.040000000000006 111.377 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -59.45 -42.22 91.48 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.382 0.427 . . . . 75.129999999999995 110.886 -176.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -65.43 -32.86 74.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.027 -0.533 . . . . 72.010000000000005 110.976 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.0 t -70.81 -44.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.386 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.507 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 26.4 m-20 -68.17 -25.41 65.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.719 . . . . 74.530000000000001 111.269 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.61 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 96.9 mttt -61.68 -45.2 95.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.842 0.829 . . . . 62.439999999999998 110.276 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.6 mt -75.55 -43.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.492 -1.231 . . . . 74.540000000000006 112.387 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 159' ' ' VAL . 15.9 m -75.01 -5.59 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 74.5 111.096 -174.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 160' ' ' ASP . 31.1 mt -57.97 -31.45 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.42 -0.809 . . . . 75.319999999999993 109.748 168.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -114.49 109.35 18.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.557 -0.747 . . . . 75.329999999999998 109.095 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -55.66 -31.9 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 65.450000000000003 112.259 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.62 137.3 54.76 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.649 -0.421 . . . . 74.450000000000003 111.622 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -129.0 149.24 50.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.578 -0.737 . . . . 74.0 109.622 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.5 m -110.92 124.64 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.885 0.374 . . . . 72.200000000000003 110.935 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.58 131.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.985 -0.552 . . . . 74.129999999999995 109.983 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 72.44 23.24 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.42 1.105 . . . . 72.549999999999997 109.63 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.7 85.96 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.155 -0.93 . . . . 71.340000000000003 112.097 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -118.91 122.14 41.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.318 . . . . 73.25 110.816 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.81 108.07 18.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.751 -0.833 . . . . 71.299999999999997 108.751 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.0 p -110.1 154.3 23.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.426 -0.807 . . . . 73.340000000000003 111.101 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -86.62 127.77 34.95 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.626 -0.715 . . . . 75.140000000000001 109.681 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.8 t -124.87 128.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.352 -0.84 . . . . 71.329999999999998 109.987 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -154.35 171.47 19.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.414 -0.812 . . . . 72.230000000000004 111.26 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -58.02 123.61 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.465 0.478 . . . . 74.230000000000004 111.287 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.81 118.82 31.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.995 -0.548 . . . . 71.219999999999999 109.723 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.72 127.9 46.96 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.486 -0.561 . . . . 72.409999999999997 109.486 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -70.81 166.89 20.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.464 -0.569 . . . . 64.349999999999994 109.464 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.74 -25.41 67.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.782 0.325 . . . . 74.549999999999997 110.969 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.85 -38.97 87.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.993 -0.549 . . . . 62.439999999999998 110.181 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.79 -42.92 19.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 75.519999999999996 110.852 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.08 -58.96 6.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.028 -0.533 . . . . 64.019999999999996 111.141 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.99 62.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 111.106 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.9 m 60.74 30.56 19.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.478 0.656 . . . . 73.230000000000004 110.54 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.21 166.75 23.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.366 -0.834 . . . . 73.230000000000004 110.0 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.0 m -65.02 123.64 19.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.548 0.53 . . . . 62.5 110.539 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.7 t -136.77 142.84 42.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.871 -0.789 . . . . 73.049999999999997 108.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.9 m -77.94 158.72 29.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.438 -0.346 . . . . 71.349999999999994 111.011 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.34 169.39 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.985 0.422 . . . . 74.230000000000004 110.703 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -79.62 -24.73 41.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 110.668 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 43.75 10.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.022 -0.609 . . . . 64.299999999999997 111.968 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.683 -0.675 . . . . 73.129999999999995 109.67 -177.811 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 112.867 -0.093 . . . . 71.310000000000002 112.867 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -82.35 129.21 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 71.230000000000004 110.561 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -70.03 -31.88 69.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.784 -0.644 . . . . 73.349999999999994 112.362 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -92.4 -3.77 54.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.455 . . . . 65.239999999999995 110.851 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.95 119.4 27.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.436 -0.579 . . . . 74.329999999999998 109.436 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m 57.67 79.02 0.34 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 124.082 0.864 . . . . 73.510000000000005 111.2 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.51 155.53 59.39 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.659 2.239 . . . . 75.120000000000005 112.031 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -15.27 14.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.706 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.49 133.78 86.89 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.683 . . . . 74.200000000000003 110.461 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.66 162.73 35.86 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.824 2.349 . . . . 74.25 110.59 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.1 pt-20 -60.34 -30.54 69.59 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 111.819 0.303 . . . . 63.310000000000002 111.819 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.78 -34.63 75.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.871 0.323 . . . . 75.329999999999998 111.871 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.75 -15.1 58.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.964 0.412 . . . . 74.400000000000006 110.839 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HA ' HG22 ' A' ' 68' ' ' VAL . 24.3 ptt180 -121.58 6.61 10.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.754 -0.657 . . . . 73.299999999999997 110.824 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.4 ttmm -95.19 148.77 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.709 0.766 . . . . 73.230000000000004 111.563 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.0 mt -115.8 139.48 50.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.643 -1.162 . . . . 74.219999999999999 110.078 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -96.68 113.26 24.8 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.407 -0.96 . . . . 74.120000000000005 108.407 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.6 mm -92.67 111.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.208 -0.451 . . . . 75.510000000000005 110.252 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.77 147.63 16.72 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.086 -0.578 . . . . 73.25 112.063 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.77 48.57 33.93 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 72.439999999999998 113.399 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 HD23 ' CG1' ' A' ' 84' ' ' VAL . 73.2 mt -79.86 176.94 9.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.118 -0.327 . . . . 75.340000000000003 110.118 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.7 p -89.84 169.57 11.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.003 -0.74 . . . . 71.129999999999995 109.003 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -77.24 -3.61 40.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.973 0.416 . . . . 74.209999999999994 111.377 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.32 13.4 13.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.017 -0.538 . . . . 74.120000000000005 111.29 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -73.13 126.31 29.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 65.209999999999994 110.403 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -105.91 165.53 11.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 109.816 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.81 -24.69 65.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.613 0.244 . . . . 74.340000000000003 110.958 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.96 -35.41 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 65.439999999999998 111.859 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -77.52 -36.1 52.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.93 0.395 . . . . 74.219999999999999 110.362 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.07 -48.51 78.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.62 -0.718 . . . . 65.109999999999999 109.681 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -54.47 -60.05 3.87 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.432 -0.804 . . . . 74.099999999999994 111.878 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -47.82 -38.91 16.97 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.9 0.75 . . . . 75.400000000000006 112.691 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.99 -56.08 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.476 -0.329 . . . . 71.109999999999999 111.084 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -76.01 -18.59 59.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.676 0.274 . . . . 61.32 111.665 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.11 -22.5 51.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.217 0.607 . . . . 74.450000000000003 111.783 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.79 -27.65 66.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.711 -0.677 . . . . 64.209999999999994 112.208 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.16 -20.64 15.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.608 0.225 . . . . 73.310000000000002 111.608 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.51 165.49 35.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.259 -0.972 . . . . 74.25 112.375 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.4 m -71.69 119.71 16.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.018 0.437 . . . . 74.409999999999997 111.458 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.36 138.29 32.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.567 -0.742 . . . . 73.510000000000005 110.967 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -97.79 -25.36 15.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.808 . . . . 74.430000000000007 110.161 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -150.68 150.26 30.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 72.420000000000002 110.164 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.9 t -158.71 126.37 5.03 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.129 -0.323 . . . . 71.010000000000005 110.129 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.62 126.35 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.339 0.59 . . . . 72.430000000000007 110.513 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.73 133.08 33.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.766 -0.828 . . . . 72.140000000000001 108.766 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.493 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mmt -78.21 99.66 6.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.074 0.464 . . . . 71.420000000000002 110.692 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -100.66 161.04 13.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.43 -0.805 . . . . 74.519999999999996 110.498 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.89 123.81 75.44 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.031 -0.986 . . . . 72.510000000000005 110.055 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.87 -24.56 74.31 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.224 1.949 . . . . 73.340000000000003 113.463 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -84.24 -54.92 4.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 74.25 111.505 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -14.45 28.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 75.5 112.12 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm 62.61 31.16 16.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.883 0.873 . . . . 73.430000000000007 111.662 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -114.71 155.6 26.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.648 -0.871 . . . . 72.340000000000003 108.648 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.3 t -70.34 133.89 47.38 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.05 -0.352 . . . . 65.530000000000001 110.05 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -81.68 4.98 19.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.856 -0.611 . . . . 73.030000000000001 111.106 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.65 15.8 65.13 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 73.239999999999995 113.882 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 33.0 p90 -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.764 0.782 . . . . 73.409999999999997 110.625 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.04 -168.11 21.55 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.448 -0.661 . . . . 72.310000000000002 111.448 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.69 146.36 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.164 0.482 . . . . 70.430000000000007 110.634 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -131.77 121.3 47.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 75.109999999999999 109.911 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.0 m -97.58 123.0 41.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.638 -0.504 . . . . 73.120000000000005 109.638 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -86.03 175.21 8.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.033 0.444 . . . . 74.040000000000006 110.918 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.73 -45.54 16.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.005 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -120.08 149.48 42.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.162 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.8 p -65.4 -30.9 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 123.131 0.269 . . . . 75.530000000000001 111.266 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.94 -39.74 87.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.183 0.438 . . . . 72.450000000000003 112.183 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -26.5 68.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 110.784 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 40.4 t -63.79 -50.83 76.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.744 -0.662 . . . . 75.510000000000005 110.59 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -37.96 87.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 60.149999999999999 111.594 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.01 62.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.029 0.381 . . . . 74.530000000000001 112.029 170.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.47 -33.86 58.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 74.329999999999998 110.445 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -63.97 -41.75 97.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.438 -0.346 . . . . 75.049999999999997 110.642 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -30.3 63.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.965 -0.561 . . . . 70.349999999999994 110.902 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.72 -13.2 61.9 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.791 0.663 . . . . 55.229999999999997 112.791 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -55.06 148.98 26.48 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.212 0.449 . . . . 75.420000000000002 112.212 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.65 157.26 92.77 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.57 -1.429 . . . . 64.140000000000001 114.088 3.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -112.76 156.5 22.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.555 -0.748 . . . . 75.219999999999999 110.867 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 20.3 ttmt -139.45 110.35 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.345 -0.389 . . . . 74.450000000000003 111.539 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.04 130.65 64.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 71.340000000000003 109.81 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.22 26.56 12.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.867 0.842 . . . . 74.400000000000006 110.538 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.68 24.13 70.84 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.949 -0.643 . . . . 60.420000000000002 112.461 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 tpt180 -127.07 139.75 52.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.76 -0.459 . . . . 74.310000000000002 109.76 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -76.07 112.68 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 74.340000000000003 109.46 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -109.27 150.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 110.996 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -114.82 96.38 44.26 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.242 -0.89 . . . . 71.010000000000005 111.486 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.453 ' O ' ' HE1' ' A' ' 72' ' ' MET . 19.3 Cg_endo -70.59 131.68 20.53 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.236 1.291 . . . . 61.119999999999997 110.556 170.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HG2' ' CE1' ' A' ' 156' ' ' HIS . 24.3 mttt -129.74 171.83 12.27 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.887 -0.783 . . . . 73.230000000000004 108.887 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -83.54 126.19 32.55 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.209 -0.996 . . . . 75.140000000000001 109.623 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HA ' ' HE2' ' A' ' 101' ' ' HIS . . . -64.22 103.46 0.63 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.879 -0.601 . . . . 64.209999999999994 111.887 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.53 150.06 9.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.968 -1.015 . . . . 73.409999999999997 108.309 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -53.7 129.69 34.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.63 -0.507 . . . . 73.420000000000002 109.63 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -59.03 -24.29 62.7 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.516 0.51 . . . . 73.540000000000006 111.931 -172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.98 -54.81 41.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 73.099999999999994 110.549 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.38 -14.75 58.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.679 . . . . 62.009999999999998 111.201 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 t -64.85 -17.42 64.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.633 -0.712 . . . . 75.420000000000002 111.218 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -68.67 -21.71 64.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.286 -0.416 . . . . 75.109999999999999 111.013 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -78.73 143.94 63.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.072 -0.344 . . . . 62.439999999999998 110.072 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.37 117.86 5.33 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.724 2.283 . . . . 73.109999999999999 112.441 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.51 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.772 . . . . 70.200000000000003 112.658 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.88 86.6 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.351 0.26 . . . . 72.25 111.625 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 89' ' ' ALA . 3.9 m80 -107.24 12.87 27.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.153 0.427 . . . . 70.099999999999994 112.153 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 49.3 mt -77.24 155.75 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.894 -0.409 . . . . 73.219999999999999 109.894 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -76.96 88.96 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.178 0.513 . . . . 73.200000000000003 110.799 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.84 135.69 63.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.84 -1.17 . . . . 73.310000000000002 107.84 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -112.13 20.71 16.59 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.379 0.609 . . . . 64.519999999999996 110.202 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 142.1 47.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.505 -0.771 . . . . 73.129999999999995 110.288 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.4 pt -126.85 149.63 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.165 0.507 . . . . 64.219999999999999 111.066 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.6 t80 -101.45 136.39 41.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.072 -0.967 . . . . 74.109999999999999 109.016 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 7.1 t -125.88 109.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.544 -0.539 . . . . 75.230000000000004 109.544 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.07 146.98 17.08 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.27 -0.967 . . . . 65.140000000000001 112.309 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.8 50.3 4.72 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.541 -1.024 . . . . 63.210000000000001 110.541 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.59 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 15.2 pt -91.55 -177.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.04 -0.58 . . . . 74.109999999999999 111.481 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.564 ' HD3' ' ND2' ' A' ' 171' ' ' ASN . 87.5 tttt -84.79 154.67 22.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.817 -0.629 . . . . 72.519999999999996 109.757 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -59.25 -37.2 77.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.814 0.34 . . . . 71.510000000000005 110.952 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -108.3 85.48 2.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 110.016 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 m -123.61 122.78 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.695 0.759 . . . . 72.349999999999994 110.426 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.448 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.7 pt-20 -113.22 172.47 6.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.471 -1.241 . . . . 74.340000000000003 110.723 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -48.22 73.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.85 -1.068 . . . . 72.120000000000005 110.128 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -57.19 -34.78 68.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.847 -0.615 . . . . 71.230000000000004 111.817 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.448 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 31.0 m170 -61.27 -60.16 4.18 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.676 0.274 . . . . 65.400000000000006 111.479 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -82.63 -22.39 34.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.519 -0.872 . . . . 73.040000000000006 111.461 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -68.32 -50.74 51.27 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.485 -0.191 . . . . 74.040000000000006 110.485 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.43 -30.76 68.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.086 0.47 . . . . 60.229999999999997 110.436 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.71 -57.08 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.7 -0.682 . . . . 74.430000000000007 112.269 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -69.17 -22.74 63.9 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.918 0.71 . . . . 73.239999999999995 112.918 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.76 -23.23 64.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 111.021 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -59.1 -26.53 64.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.058 -0.519 . . . . 75.200000000000003 111.232 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.11 -33.87 20.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 71.109999999999999 111.521 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.421 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 179.54 -174.96 46.62 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.309 -0.948 . . . . 52.43 113.726 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -76.45 129.11 36.06 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.045 0.45 . . . . 75.310000000000002 111.613 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.82 137.95 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 75.510000000000005 109.975 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.49 -52.03 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 63.5 110.518 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.12 157.32 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 74.140000000000001 109.779 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.22 129.58 72.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.897 0.38 . . . . 75.109999999999999 110.228 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -103.4 104.16 14.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.562 -0.744 . . . . 74.030000000000001 110.767 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.1 mm -92.99 112.63 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.831 -0.803 . . . . 72.400000000000006 108.831 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 78.8 mmm -86.07 117.57 24.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.468 -0.493 . . . . 75.329999999999998 109.873 -173.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.96 160.16 37.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 74.129999999999995 110.741 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.11 143.11 28.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.801 -0.636 . . . . 71.450000000000003 109.41 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -68.83 -40.35 79.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.248 -0.433 . . . . 75.510000000000005 111.74 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.62 -46.94 3.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.638 -0.792 . . . . 53.450000000000003 113.457 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -82.81 -24.02 33.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.689 0.245 . . . . 73.439999999999998 111.335 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.13 76.01 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.638 . . . . 54.340000000000003 112.727 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 164.14 12.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.658 -0.497 . . . . 73.420000000000002 109.658 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -62.9 146.21 53.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 75.140000000000001 111.08 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -72.97 -2.6 21.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.996 -0.547 . . . . 75.129999999999995 111.603 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 145' ' ' LYS . . . 97.83 -0.82 59.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.417 -0.673 . . . . 72.209999999999994 111.417 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -160.43 168.17 25.74 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.902 -0.407 . . . . 75.530000000000001 109.902 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.12 169.55 17.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.543 -0.753 . . . . 71.200000000000003 109.184 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -132.21 144.66 50.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.153 0.501 . . . . 73.319999999999993 110.164 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 25.5 t -128.77 130.42 68.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.303 -0.408 . . . . 72.219999999999999 110.284 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.507 ' O ' HG22 ' A' ' 131' ' ' ILE . 94.0 m -105.94 120.62 42.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 71.200000000000003 110.941 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.3 160.44 14.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.936 0.398 . . . . 75.439999999999998 111.013 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.59 -31.38 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.599 -0.728 . . . . 71.510000000000005 110.61 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.85 155.85 44.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 74.420000000000002 110.81 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.455 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 20.6 p80 -77.18 -28.54 54.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.339 -0.391 . . . . 75.310000000000002 110.063 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.08 -48.45 33.48 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.037 0.836 . . . . 62.350000000000001 112.089 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.421 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -74.59 -27.87 60.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.702 -0.681 . . . . 72.239999999999995 111.016 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.7 t -73.76 -41.33 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.230000000000004 109.979 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.461 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 6.9 m-20 -69.7 -23.45 63.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 63.399999999999999 110.988 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -65.36 -43.09 91.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.624 0.726 . . . . 72.109999999999999 110.392 170.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mt -73.19 -39.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.638 -1.164 . . . . 65.329999999999998 111.789 -172.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 160' ' ' ASP . 19.1 m -76.54 -8.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.382 . . . . 73.129999999999995 111.04 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 16.3 mt -64.21 -34.12 66.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.532 0.682 . . . . 71.349999999999994 109.859 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.498 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 58.5 mt-30 -109.13 96.99 6.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.796 -1.187 . . . . 73.409999999999997 107.796 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -56.55 -30.61 63.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 72.0 112.522 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.909 -0.317 . . . . 74.510000000000005 110.514 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.4 m-70 -125.71 152.53 45.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.979 -0.555 . . . . 74.349999999999994 109.56 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 32.1 m -101.76 105.91 16.85 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.173 0.511 . . . . 73.310000000000002 110.053 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.03 138.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.544 -0.753 . . . . 75.0 109.401 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.564 ' ND2' ' HD3' ' A' ' 113' ' ' LYS . 59.7 t30 49.69 36.21 10.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.579 0.704 . . . . 63.420000000000002 112.591 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.96 5.46 90.12 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.968 -0.56 . . . . 62.43 114.122 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -129.3 134.5 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.424 0.612 . . . . 72.439999999999998 111.324 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 20.3 t-20 -81.04 112.37 18.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.545 . . . . 73.409999999999997 110.853 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.59 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 11.6 m -110.32 156.25 21.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.658 -0.701 . . . . 70.430000000000007 110.339 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.0 tt0 -89.41 140.93 29.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 73.409999999999997 110.369 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -130.39 162.99 37.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.973 0.416 . . . . 73.219999999999999 111.014 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -174.68 175.0 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.023 -0.989 . . . . 71.299999999999997 111.767 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -67.9 122.6 18.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 109.508 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -112.4 148.64 33.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.126 0.488 . . . . 63.130000000000003 110.413 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.36 160.15 26.0 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.925 -0.768 . . . . 73.409999999999997 108.925 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 186' ' ' MET . 14.9 t -75.56 161.03 29.51 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.145 -0.687 . . . . 75.420000000000002 109.145 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -56.31 -41.51 76.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.838 0.352 . . . . 71.430000000000007 110.58 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -63.57 -34.48 77.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 74.329999999999998 111.459 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.25 -37.88 57.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 65.549999999999997 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 182' ' ' SER . 85.3 mtp -73.22 -29.41 62.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.928 -0.578 . . . . 75.310000000000002 110.843 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.49 -6.87 58.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 54.509999999999998 110.862 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.4 m 62.3 25.47 15.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.851 0.719 . . . . 74.409999999999997 111.557 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -124.43 89.88 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 110.154 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.2 m -64.48 112.13 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 74.140000000000001 110.36 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 p -149.87 142.43 24.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.875 -0.602 . . . . 75.010000000000005 110.4 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.2 m -116.1 60.83 0.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.22 0.533 . . . . 71.420000000000002 110.156 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.84 120.05 19.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.695 -0.684 . . . . 74.430000000000007 109.881 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -123.72 131.69 53.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.935 -0.575 . . . . 72.030000000000001 111.111 -174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.69 -97.4 2.25 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.195 -1.162 . . . . 71.219999999999999 110.195 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.548 -0.739 . . . . 75.230000000000004 109.59 173.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.87 -0.492 . . . . 75.120000000000005 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -74.92 -37.37 62.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.828 0.347 . . . . 75.120000000000005 110.939 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -89.16 80.78 6.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.344 0.592 . . . . 63.43 110.911 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -97.95 85.99 3.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 73.219999999999999 109.675 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.98 144.27 31.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.218 -0.66 . . . . 75.450000000000003 109.218 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m -70.39 115.75 38.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.341 -0.614 . . . . 65.049999999999997 109.341 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 63' ' ' ALA . 68.0 Cg_endo -75.02 166.75 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.498 2.132 . . . . 60.109999999999999 112.417 -173.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -68.58 -20.49 64.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.478 -0.783 . . . . 70.340000000000003 109.782 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -82.14 125.24 77.55 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 74.439999999999998 109.983 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD2' HD22 ' A' ' 13' ' ' LEU . 18.8 Cg_endo -61.07 168.35 7.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.508 2.805 . . . . 64.299999999999997 112.822 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.57 -39.67 35.88 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.597 -0.729 . . . . 73.420000000000002 112.752 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 4.3 pt20 -62.65 -35.85 80.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.523 0.329 . . . . 71.519999999999996 111.869 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.46 HD22 ' HD2' ' A' ' 10' ' ' PRO . 8.5 mp -79.16 -45.41 20.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.918 -0.313 . . . . 72.129999999999995 110.38 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 18.0 ptt85 -76.7 2.02 15.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.03 0.381 . . . . 65.209999999999994 112.03 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.6 ttpt -95.54 147.9 23.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.671 0.748 . . . . 71.109999999999999 110.976 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.7 mt -117.25 145.15 44.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.835 -1.075 . . . . 72.349999999999994 110.625 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -98.7 119.48 37.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 74.329999999999998 108.405 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mm -99.54 111.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.703 -0.48 . . . . 75.519999999999996 109.703 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.92 154.36 16.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.673 -0.775 . . . . 60.25 111.553 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.94 39.89 53.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.583 -0.818 . . . . 64.129999999999995 113.489 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 HD23 ' CG1' ' A' ' 84' ' ' VAL . 72.5 mt -80.0 174.5 11.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.009 -0.367 . . . . 74.430000000000007 110.009 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -88.38 168.5 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.659 -0.867 . . . . 53.130000000000003 108.659 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.4 -4.29 53.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.243 0.544 . . . . 74.129999999999995 110.188 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -106.53 5.84 29.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.378 -0.828 . . . . 73.150000000000006 111.411 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.7 m -75.02 132.91 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.999 0.428 . . . . 65.120000000000005 111.168 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.614 ' HB ' ' OE2' ' A' ' 28' ' ' GLU . 19.0 p -112.41 168.38 9.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.217 -0.66 . . . . 72.010000000000005 109.217 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -73.71 -25.9 60.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.768 -0.373 . . . . 62.030000000000001 110.883 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.614 ' OE2' ' HB ' ' A' ' 26' ' ' THR . 2.0 pm0 -79.89 -32.5 40.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.848 -0.16 . . . . 74.030000000000001 111.012 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.7 p -75.92 -35.23 59.85 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 109.828 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.59 -48.12 70.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.533 -0.758 . . . . 73.310000000000002 110.036 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -53.93 -58.75 6.14 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.071 -0.513 . . . . 72.230000000000004 111.475 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 8.7 t -51.41 -30.88 20.68 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.698 0.624 . . . . 70.420000000000002 112.214 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.433 ' CD2' HG21 ' A' ' 79' ' ' VAL . 64.1 t60 -72.47 -61.63 1.73 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.739 -0.21 . . . . 64.019999999999996 110.88 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -71.11 -22.78 62.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.086 0.402 . . . . 75.219999999999999 112.086 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 29.2 tt0 -67.0 -17.97 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.259 0.552 . . . . 74.25 110.869 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 32' ' ' SER . 22.7 mt-30 -64.35 -24.14 67.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.64 . . . . 72.019999999999996 111.503 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -102.52 -17.67 15.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.373 -0.376 . . . . 73.219999999999999 111.63 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -177.82 163.54 31.93 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.311 -0.947 . . . . 73.319999999999993 112.582 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -68.12 118.09 10.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.076 0.465 . . . . 72.030000000000001 111.579 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.2 mt -88.04 129.02 35.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.68 0.752 . . . . 71.409999999999997 111.474 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -93.23 -24.64 18.12 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.882 -1.054 . . . . 71.430000000000007 109.838 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.46 152.3 32.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.08 -0.964 . . . . 75.049999999999997 109.584 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.407 ' SG ' HG11 ' A' ' 60' ' ' VAL . 16.8 t -164.08 126.59 2.44 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.297 -0.631 . . . . 74.349999999999994 109.297 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 p -145.69 113.83 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.726 0.774 . . . . 72.040000000000006 110.11 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 139.54 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.557 -0.905 . . . . 72.400000000000006 108.557 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 7.4 mmt -77.33 139.37 39.75 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.979 -0.748 . . . . 72.439999999999998 108.979 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -139.78 157.13 46.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.816 -0.629 . . . . 71.209999999999994 111.749 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 29.2 t70 -70.71 134.67 86.07 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.672 -1.149 . . . . 45.240000000000002 109.939 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD3' HH21 ' A' ' 55' ' ' ARG . 57.2 Cg_endo -75.26 -17.25 19.15 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.171 1.914 . . . . 71.530000000000001 113.297 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.9 OUTLIER -85.79 -56.15 3.63 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.997 0.369 . . . . 54.049999999999997 111.997 -176.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -105.75 -9.15 17.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 72.040000000000006 111.218 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 28.3 mmtp 66.67 39.81 3.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.658 -0.701 . . . . 70.239999999999995 111.168 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -105.87 159.88 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.315 -0.624 . . . . 72.530000000000001 109.315 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.6 t -65.56 140.44 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 110.875 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.418 HH21 ' HD3' ' A' ' 49' ' ' PRO . 56.0 mtt-85 -85.87 -3.64 58.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 75.439999999999998 110.554 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.45 60.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.514 -0.85 . . . . 70.319999999999993 113.754 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.462 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 28.8 p90 -157.98 155.03 28.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.627 0.713 . . . . 74.540000000000006 110.268 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.27 -167.32 20.66 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 111.875 -0.49 . . . . 60.549999999999997 111.875 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.38 148.42 37.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.15 0.475 . . . . 73.150000000000006 110.327 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG11 ' SG ' ' A' ' 43' ' ' CYS . 13.1 m -132.18 131.14 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.545 . . . . 74.239999999999995 109.981 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.457 ' OG1' ' HD3' ' A' ' 15' ' ' LYS . 5.2 m -106.19 120.16 41.1 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.24 -0.287 . . . . 61.409999999999997 110.248 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.545 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 27.8 m-85 -85.7 162.93 18.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.698 0.285 . . . . 74.209999999999994 110.636 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . -75.3 -44.4 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 75.450000000000003 110.66 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.27 154.21 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 75.0 111.058 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.07 -41.3 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 111.055 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -48.39 -40.97 27.51 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.57 0.581 . . . . 63.210000000000001 112.57 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.8 -25.06 59.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 74.219999999999999 111.093 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.79 -44.37 82.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 61.0 109.986 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.39 -50.08 72.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 111.034 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.01 22.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.758 -0.656 . . . . 45.420000000000002 112.701 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.61 57.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.514 . . . . 71.0 110.825 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.78 -40.31 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.894 -0.594 . . . . 75.310000000000002 111.434 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -19.53 61.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.278 0.561 . . . . 71.340000000000003 110.154 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -9.01 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.709 -0.678 . . . . 75.120000000000005 111.541 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -60.08 146.1 83.57 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.402 0.144 . . . . 74.549999999999997 111.326 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.41 164.63 86.17 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.091 -1.212 . . . . 63.109999999999999 113.24 0.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -118.16 155.12 31.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 72.209999999999994 111.084 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.7 ttmt -141.92 107.04 4.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.102 -0.499 . . . . 71.450000000000003 111.176 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 33' ' ' HIS . 11.9 t -106.38 129.42 59.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.755 -0.657 . . . . 73.239999999999995 109.53 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 67.91 21.39 8.99 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.745 0.783 . . . . 72.310000000000002 110.811 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.57 24.16 65.86 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.869 -0.682 . . . . 62.439999999999998 111.771 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.1 tpt180 -124.05 136.93 54.6 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.267 -0.642 . . . . 74.420000000000002 109.267 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.64 112.02 18.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.394 0.616 . . . . 62.130000000000003 109.626 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -107.38 150.84 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.011 -0.541 . . . . 70.299999999999997 110.974 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -112.86 95.46 33.73 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.221 -0.899 . . . . 74.239999999999995 110.828 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.51 127.8 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.95 1.767 . . . . 72.310000000000002 111.095 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -132.45 171.12 14.18 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 74.230000000000004 109.163 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -70.72 133.22 46.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.765 -0.457 . . . . 74.25 109.765 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -67.61 96.62 0.55 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.418 0.628 . . . . 65.239999999999995 109.666 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 t -56.55 135.48 20.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.347 -1.297 . . . . 64.349999999999994 111.643 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t -54.61 143.84 23.5 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.245 -0.889 . . . . 72.140000000000001 109.846 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -61.04 -18.45 57.86 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.43 0.456 . . . . 75.329999999999998 112.137 -173.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.97 -45.24 61.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.458 -0.337 . . . . 74.420000000000002 110.741 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.31 -31.56 24.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.688 -0.233 . . . . 74.040000000000006 111.066 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 21.7 p -76.48 4.05 9.97 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.062 0.458 . . . . 70.439999999999998 111.257 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -86.11 -10.09 55.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 109.138 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -94.94 150.64 38.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.44 -0.8 . . . . 75.140000000000001 109.872 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.54 124.87 7.91 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.585 2.19 . . . . 75.120000000000005 112.511 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.46 30.27 11.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.162 -0.542 . . . . 72.409999999999997 112.23 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.98 -30.28 24.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.976 0.362 . . . . 72.109999999999999 111.976 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.18 8.49 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.654 0.264 . . . . 75.420000000000002 111.55 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.14 159.68 31.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.717 -0.475 . . . . 65.030000000000001 109.717 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 80.28 7.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.595 0.712 . . . . 74.049999999999997 110.481 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -108.78 118.46 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.075 -0.966 . . . . 72.230000000000004 109.46 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -105.53 21.34 17.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.612 . . . . 72.230000000000004 110.081 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -119.2 139.7 51.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 71.420000000000002 110.997 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.7 pt -130.95 149.87 34.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.305 0.574 . . . . 71.239999999999995 111.386 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.8 t80 -94.78 133.33 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.716 -1.129 . . . . 72.129999999999995 109.906 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.58 109.55 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.063 -0.717 . . . . 73.140000000000001 109.063 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.84 159.72 21.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.569 -1.3 . . . . 72.140000000000001 113.755 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.07 6.45 53.84 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.697 -0.764 . . . . 74.310000000000002 112.406 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.0 pt -66.38 124.48 21.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.26 0.553 . . . . 75.140000000000001 109.877 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -21.57 20.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.807 -0.633 . . . . 73.099999999999994 112.284 -169.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -142.16 -168.41 2.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.467 -0.197 . . . . 65.340000000000003 110.467 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.42 101.48 0.05 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 124.073 0.858 . . . . 73.540000000000006 111.364 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -109.63 124.23 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.63 -0.878 . . . . 72.430000000000007 108.63 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -113.01 -179.39 3.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.585 -0.734 . . . . 64.150000000000006 111.635 -169.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.18 -53.66 55.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.929 -1.032 . . . . 70.340000000000003 111.493 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.58 -28.24 69.5 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.079 0.237 . . . . 73.420000000000002 111.182 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -53.84 -62.65 1.52 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.184 0.516 . . . . 72.209999999999994 110.596 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.27 -26.68 28.42 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.113 -0.635 . . . . 75.439999999999998 111.532 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 2.0 tmm_? -67.29 -48.28 68.13 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 110.07 -0.345 . . . . 70.510000000000005 110.07 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.87 -29.76 70.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.99 0.424 . . . . 73.019999999999996 110.5 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -77.39 -56.82 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.081 -0.509 . . . . 71.530000000000001 112.078 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -67.49 -21.99 65.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.414 0.524 . . . . 74.239999999999995 112.414 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.8 mt-10 -69.02 -19.96 64.13 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.527 0.195 . . . . 73.439999999999998 111.527 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.09 -30.05 64.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.985 0.421 . . . . 73.310000000000002 110.98 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.6 -30.89 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 74.329999999999998 111.637 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.23 -172.28 44.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.661 -0.781 . . . . 73.310000000000002 112.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -76.22 136.19 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.176 0.512 . . . . 73.129999999999995 111.681 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 152' ' ' THR . 90.8 mt -106.54 138.45 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 72.230000000000004 110.006 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.61 -46.98 8.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 74.239999999999995 111.038 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.56 154.93 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 75.109999999999999 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -114.62 128.54 71.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.124 0.487 . . . . 73.510000000000005 110.046 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -102.71 104.58 14.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.364 -0.834 . . . . 70.319999999999993 111.047 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.86 122.94 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.261 -0.644 . . . . 70.310000000000002 109.261 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.4 mmm -105.74 141.62 36.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.907 0.384 . . . . 74.030000000000001 110.192 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.79 149.01 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 74.049999999999997 110.87 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.05 131.63 41.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.658 -0.701 . . . . 71.349999999999994 110.368 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -77.23 -25.08 51.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.76 0.314 . . . . 71.129999999999995 111.275 -174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.36 -53.42 2.16 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.634 -0.794 . . . . 52.020000000000003 112.82 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -90.56 -24.24 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.761 0.315 . . . . 62.310000000000002 111.639 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.57 8.53 84.64 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.613 -0.803 . . . . 61.520000000000003 112.876 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -80.92 143.99 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 75.219999999999999 110.026 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -73.96 88.64 1.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.508 -0.553 . . . . 73.230000000000004 109.508 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -162.44 175.33 11.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.697 0.761 . . . . 72.400000000000006 111.839 -170.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.09 -46.89 3.45 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.008 -1.451 . . . . 74.510000000000005 113.835 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -173.04 159.74 4.03 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.054 0.927 . . . . 75.450000000000003 110.509 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.55 175.69 9.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.436 -0.802 . . . . 74.510000000000005 109.182 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.402 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 53.6 m-85 -141.16 154.45 45.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.945 0.402 . . . . 70.420000000000002 110.321 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.67 132.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.318 0.58 . . . . 71.430000000000007 111.271 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 131' ' ' ILE . 26.0 m -101.49 126.6 48.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.344 -0.843 . . . . 75.209999999999994 110.883 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.53 158.03 16.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 71.420000000000002 111.45 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.3 -29.3 53.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.637 -0.71 . . . . 75.450000000000003 110.567 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -130.11 155.55 46.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 74.400000000000006 110.877 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -82.89 -26.5 31.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.540000000000006 110.351 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 31.9 t70 -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 110.673 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 m -68.7 -32.78 72.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 61.240000000000002 110.799 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.16 -39.86 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 74.450000000000003 109.783 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HA ' HG21 ' A' ' 163' ' ' VAL . 2.1 t70 -69.5 -33.49 72.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.224 -0.898 . . . . 74.400000000000006 111.152 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 55.9 mttm -53.54 -38.88 64.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.917 0.865 . . . . 75.140000000000001 110.29 172.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.402 ' CG2' HG13 ' A' ' 177' ' ' VAL . 33.8 mt -77.78 -45.32 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.405 -1.27 . . . . 75.349999999999994 113.011 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 160' ' ' ASP . 24.4 m -75.39 -4.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.198 0.523 . . . . 74.439999999999998 111.69 -172.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 161' ' ' LYS . 14.0 mt -58.35 -32.12 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 109.692 169.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.59 148.75 32.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.385 -0.825 . . . . 73.439999999999998 108.788 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.41 -37.04 13.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.0 0.429 . . . . 75.219999999999999 111.08 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.87 131.92 53.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.169 -0.468 . . . . 75.239999999999995 110.145 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -122.11 140.56 52.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.065 -0.516 . . . . 63.119999999999997 110.337 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 m -89.98 106.72 18.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.147 0.499 . . . . 75.409999999999997 111.402 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.22 130.15 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.83 . . . . 72.140000000000001 109.083 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t30 50.22 41.63 24.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.728 0.775 . . . . 74.329999999999998 111.641 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.55 69.54 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.616 -0.72 . . . . 41.130000000000003 113.347 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -126.52 131.55 51.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.79 0.295 . . . . 51.520000000000003 110.453 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.19 108.19 13.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.477 . . . . 75.5 109.711 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.71 146.81 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 109.755 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -86.4 131.9 34.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.841 0.353 . . . . 72.219999999999999 110.228 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 37.4 t -129.19 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.925 -0.58 . . . . 73.209999999999994 111.06 -173.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -157.78 171.6 20.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.593 -0.73 . . . . 75.409999999999997 111.232 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -61.22 122.76 15.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.854 -0.425 . . . . 75.530000000000001 109.854 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -104.82 111.67 24.5 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.339 0.59 . . . . 61.43 109.884 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.6 mt -97.62 150.42 21.17 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.384 -0.825 . . . . 64.530000000000001 109.395 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.572 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 36.9 m -68.62 163.13 24.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.67 -0.493 . . . . 74.120000000000005 109.67 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -59.06 -41.73 88.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.624 0.249 . . . . 65.140000000000001 111.522 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 2.0 mp0 -68.27 -34.55 76.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 110.159 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.572 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 0.3 OUTLIER -64.49 -40.55 95.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 60.210000000000001 110.582 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 182' ' ' SER . 57.5 mtp -72.83 -37.61 67.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 74.510000000000005 110.263 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.93 -9.78 58.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.534 . . . . 74.129999999999995 111.323 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.6 m 62.67 36.05 13.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.657 0.741 . . . . 73.439999999999998 110.542 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 184' ' ' GLN . . . -114.88 118.66 34.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 74.109999999999999 109.783 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.1 m -70.76 129.79 40.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.105 -0.498 . . . . 70.329999999999998 110.84 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.8 t -156.42 147.41 22.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.728 -0.669 . . . . 73.530000000000001 109.519 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.0 m -76.45 87.72 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.132 0.492 . . . . 54.25 110.446 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 195' ' ' GLY . 35.2 tp60 -132.03 127.96 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.759 -0.655 . . . . 74.109999999999999 109.533 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -85.23 21.18 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 111.73 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HG3' ' A' ' 193' ' ' GLN . . . 114.32 105.22 2.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.916 -0.659 . . . . 55.329999999999998 112.9 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.184 -0.912 . . . . 75.310000000000002 109.522 175.648 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.292 -0.323 . . . . 61.100000000000001 112.292 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.6 m 56.74 76.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.418 0.687 . . . . 73.299999999999997 112.058 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -112.45 80.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 73.409999999999997 109.397 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 p -95.22 5.1 52.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.569 0.581 . . . . 75.010000000000005 112.569 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.18 91.21 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 74.230000000000004 109.748 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 p -90.39 110.69 42.66 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.541 -0.754 . . . . 71.230000000000004 111.27 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -84.65 161.56 12.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.369 2.046 . . . . 74.519999999999996 111.59 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 8.03 5.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.127 0.489 . . . . 72.329999999999998 110.838 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.39 137.36 74.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.655 -0.702 . . . . 74.25 110.202 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 10.5 Cg_endo -61.58 161.33 24.8 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.386 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.02 64.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.164 -0.471 . . . . 62.009999999999998 111.664 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.95 -33.33 75.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.322 0.49 . . . . 64.319999999999993 112.322 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 28.8 mt -85.19 -14.58 46.44 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 122.095 -0.378 . . . . 75.099999999999994 110.838 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -117.75 0.8 12.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 111.363 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -96.71 148.08 23.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.667 0.746 . . . . 75.219999999999999 111.53 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -118.74 144.3 46.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.712 -1.131 . . . . 75.510000000000005 110.424 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -96.47 117.02 30.03 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.326 -0.99 . . . . 74.420000000000002 108.326 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 mm -96.88 110.82 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.779 -0.452 . . . . 75.040000000000006 109.779 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.43 155.0 16.73 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.507 -0.854 . . . . 72.049999999999997 111.578 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.57 45.25 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.774 -0.727 . . . . 55.439999999999998 113.244 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD23 ' CG1' ' A' ' 84' ' ' VAL . 94.3 mt -79.56 175.4 10.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.954 0.407 . . . . 71.219999999999999 110.279 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -88.5 166.73 13.99 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.487 -0.561 . . . . 63.439999999999998 109.487 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -75.93 -4.54 41.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.751 0.31 . . . . 73.329999999999998 110.846 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -122.68 14.74 10.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 74.340000000000003 111.096 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.7 m -79.85 124.33 28.55 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 61.039999999999999 110.821 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.1 p -99.78 165.68 11.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 75.319999999999993 110.346 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.67 -21.09 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.73 -0.388 . . . . 63.149999999999999 110.74 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.05 -27.7 30.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.208 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -80.36 -36.57 33.83 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.81 -0.441 . . . . 72.209999999999994 109.81 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -61.87 -46.58 88.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.583 -0.735 . . . . 75.400000000000006 110.135 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 ttm-85 -56.21 -56.58 19.23 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 115.792 -0.64 . . . . 74.239999999999995 111.314 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.1 t -50.96 -36.2 37.67 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.853 0.721 . . . . 72.409999999999997 112.437 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -70.28 -54.6 11.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.671 -0.24 . . . . 72.310000000000002 111.302 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -78.5 -17.18 56.62 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.895 0.332 . . . . 75.209999999999994 111.895 -170.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.34 -25.65 49.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.454 0.539 . . . . 74.219999999999999 112.454 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.87 -26.36 68.29 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.255 0.465 . . . . 53.219999999999999 112.255 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -99.64 -19.72 16.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.727 0.269 . . . . 74.129999999999995 111.727 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.36 168.74 40.62 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.289 -0.958 . . . . 70.040000000000006 112.343 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -66.96 119.76 12.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.031 0.443 . . . . 74.530000000000001 112.008 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.61 133.54 35.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.76 -0.654 . . . . 70.510000000000005 110.524 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -107.43 -19.02 13.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.237 -0.892 . . . . 75.140000000000001 110.215 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.08 153.55 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.255 -0.646 . . . . 60.340000000000003 109.255 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' SG ' HG11 ' A' ' 60' ' ' VAL . 11.1 t -165.33 131.43 2.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.993 -0.373 . . . . 74.420000000000002 109.993 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.51 128.47 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.509 0.671 . . . . 74.349999999999994 111.348 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.14 133.85 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 73.239999999999995 108.63 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.465 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mmt -74.86 97.66 3.36 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.651 0.738 . . . . 73.530000000000001 110.1 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -99.45 152.32 20.12 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.702 -1.135 . . . . 74.409999999999997 109.49 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 37.2 t70 -70.04 127.89 92.03 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.422 -0.808 . . . . 75.239999999999995 110.619 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.56 -19.3 64.86 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.189 1.926 . . . . 71.420000000000002 113.111 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.506 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 27.6 m-80 -84.76 -56.4 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.785 0.291 . . . . 71.450000000000003 111.785 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -105.48 -8.75 17.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.986 0.422 . . . . 65.329999999999998 111.849 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp 64.16 40.63 6.75 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.577 0.751 . . . . 73.439999999999998 111.626 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -113.83 156.7 23.44 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.952 -0.758 . . . . 74.010000000000005 108.952 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m -75.69 131.68 40.04 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.917 -0.313 . . . . 73.329999999999998 110.358 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -85.66 5.78 30.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 63.5 111.349 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.08 60.07 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.617 -0.801 . . . . 65.530000000000001 114.204 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.4 p90 -158.99 155.31 27.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.82 0.81 . . . . 74.329999999999998 110.343 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.51 -163.13 14.57 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.701 -0.56 . . . . 63.329999999999998 111.701 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.85 148.81 37.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.062 0.431 . . . . 75.030000000000001 110.224 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG11 ' SG ' ' A' ' 43' ' ' CYS . 8.5 m -128.23 128.53 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.826 -0.624 . . . . 72.310000000000002 109.345 171.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.68 118.36 36.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.812 0.339 . . . . 74.349999999999994 110.272 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -85.74 161.67 19.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.902 -0.59 . . . . 65.209999999999994 109.962 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.05 -44.02 64.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.9 -0.591 . . . . 74.099999999999994 110.401 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -120.81 149.22 42.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.916 -0.584 . . . . 64.510000000000005 110.845 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.9 p -62.88 -37.38 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.565 -0.288 . . . . 71.519999999999996 111.044 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.45 -41.74 85.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.588 0.588 . . . . 72.219999999999999 112.588 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.89 -29.24 70.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.019 0.438 . . . . 73.109999999999999 110.78 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 38.9 t -63.14 -49.41 83.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.592 -0.731 . . . . 74.5 111.087 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.22 -40.69 94.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.200000000000003 111.302 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.96 -38.66 57.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 112.295 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.36 58.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.806 0.336 . . . . 74.109999999999999 110.612 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.459 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -66.62 -42.12 87.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 71.439999999999998 111.068 -179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -29.16 66.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.041 -0.527 . . . . 73.129999999999995 111.015 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.71 -9.29 58.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.075 0.768 . . . . 63.420000000000002 113.075 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -54.39 146.61 31.98 Favored Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.169 0.433 . . . . 72.200000000000003 112.169 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.4 168.98 72.66 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.312 -1.12 . . . . 75.140000000000001 113.385 1.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -123.54 161.19 25.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.532 -0.758 . . . . 71.129999999999995 110.39 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.5 ttmt -137.21 112.64 9.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.826 0.346 . . . . 73.299999999999997 111.35 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.14 126.98 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.973 -0.558 . . . . 71.129999999999995 109.936 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.53 26.9 9.82 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.692 0.62 . . . . 72.230000000000004 111.915 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.88 23.36 66.91 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.951 -0.643 . . . . 37.270000000000003 112.191 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 tpt180 -126.29 135.43 51.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.107 -0.331 . . . . 73.140000000000001 110.107 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.66 111.71 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.123 -0.695 . . . . 75.310000000000002 109.123 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.438 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.3 m -107.7 152.49 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 74.140000000000001 111.853 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.26 94.42 30.93 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.762 -1.108 . . . . 74.340000000000003 111.402 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.459 ' O ' ' HE1' ' A' ' 72' ' ' MET . 22.3 Cg_endo -72.19 127.96 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.678 1.585 . . . . 62.420000000000002 110.463 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -131.69 168.88 16.99 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 75.140000000000001 109.324 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 10.0 tpp180 -73.25 130.51 40.37 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.977 -0.289 . . . . 74.140000000000001 110.562 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.68 93.58 0.73 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.073 0.463 . . . . 74.329999999999998 110.3 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.24 156.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.369 -0.832 . . . . 73.040000000000006 110.546 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -55.3 154.16 6.31 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.098 0.559 . . . . 74.340000000000003 111.808 -177.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -58.16 -40.13 80.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.038 -0.528 . . . . 74.129999999999995 111.883 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.92 -50.59 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 50.530000000000001 110.651 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -70.74 -29.29 65.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.632 -0.713 . . . . 65.540000000000006 111.409 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -67.18 -17.55 64.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.403 -0.362 . . . . 75.239999999999995 111.295 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -82.22 -12.47 58.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.953 0.406 . . . . 64.129999999999995 110.837 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.24 151.23 78.12 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.483 -0.326 . . . . 73.150000000000006 110.379 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.83 117.16 4.06 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.101 2.534 . . . . 74.0 112.717 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.63 43.16 69.26 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.958 -0.564 . . . . 44.530000000000001 112.812 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.05 -34.6 73.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.879 0.371 . . . . 64.400000000000006 111.418 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -99.4 19.71 15.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 111.677 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.0 154.38 35.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 75.519999999999996 109.609 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 m -74.38 86.85 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.706 0.765 . . . . 71.319999999999993 110.445 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.0 t -114.89 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 74.319999999999993 109.343 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -104.19 16.5 26.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.11 0.414 . . . . 72.319999999999993 111.101 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -117.16 139.96 50.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.594 -0.276 . . . . 64.540000000000006 111.022 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.3 pt -123.55 147.48 27.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.263 0.554 . . . . 53.130000000000003 111.111 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.2 t80 -97.68 131.43 44.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.779 -1.1 . . . . 72.219999999999999 109.628 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.04 110.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.868 -0.789 . . . . 74.040000000000006 108.868 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.88 148.02 19.27 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.998 -1.096 . . . . 70.319999999999993 112.31 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.61 6.15 29.07 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.207 -0.997 . . . . 61.539999999999999 112.217 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.6 pt -76.54 103.99 4.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.556 0.693 . . . . 74.099999999999994 110.468 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.19 -24.48 34.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 75.450000000000003 110.996 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.45 171.37 7.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.863 0.364 . . . . 72.099999999999994 110.558 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 145' ' ' LYS . 18.3 t70 -66.99 125.45 26.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 73.150000000000006 110.057 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 m -124.12 139.27 54.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.15 0.5 . . . . 75.120000000000005 110.323 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -112.88 174.69 5.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.591 -0.731 . . . . 75.209999999999994 111.796 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.03 -57.24 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.847 -1.07 . . . . 71.549999999999997 112.132 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -64.68 -23.79 67.37 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 123.07 0.231 . . . . 75.219999999999999 111.066 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -57.08 -58.99 5.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.97 0.415 . . . . 74.530000000000001 110.558 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 pp -83.67 -25.3 30.82 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.674 -0.81 . . . . 75.310000000000002 111.549 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.8 -51.5 58.55 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.737 -0.468 . . . . 75.439999999999998 109.737 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.78 -32.99 73.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 74.439999999999998 110.413 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CD2' HG23 ' A' ' 170' ' ' VAL . 92.6 t80 -73.06 -57.81 3.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.982 -0.554 . . . . 72.209999999999994 112.187 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -68.33 -22.3 64.7 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.563 0.579 . . . . 74.329999999999998 112.563 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.97 -24.93 67.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.827 0.346 . . . . 74.040000000000006 111.468 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -55.78 -26.04 44.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.748 -0.66 . . . . 71.409999999999997 111.83 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -91.82 -20.83 21.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.162 0.43 . . . . 75.430000000000007 112.162 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.01 -172.48 42.12 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.416 -0.897 . . . . 63.340000000000003 113.396 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -76.35 131.99 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 74.310000000000002 111.248 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 152' ' ' THR . 71.8 mt -103.79 139.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.735 -0.666 . . . . 73.540000000000006 109.936 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.76 -48.65 6.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.825 0.345 . . . . 75.340000000000003 110.944 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -157.38 157.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.261 -0.427 . . . . 72.230000000000004 109.961 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.52 130.29 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.551 -0.537 . . . . 73.239999999999995 109.551 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -103.69 103.31 13.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.213 -0.449 . . . . 62.530000000000001 110.946 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.2 mm -91.38 125.43 44.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.461 -0.57 . . . . 72.329999999999998 109.461 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.9 mmm -105.91 133.25 50.93 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.083 -0.71 . . . . 71.230000000000004 109.083 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.2 p -100.92 176.94 5.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 74.329999999999998 112.025 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.14 144.76 27.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.096 -0.956 . . . . 75.109999999999999 109.651 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -69.07 -40.28 78.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.495 -0.321 . . . . 75.040000000000006 111.373 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -89.93 -52.94 2.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.905 -0.664 . . . . 75.120000000000005 113.252 -175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -87.13 -23.33 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.678 0.251 . . . . 74.299999999999997 111.678 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.17 83.9 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.006 -0.616 . . . . 73.540000000000006 113.193 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.22 156.15 18.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.416 -0.216 . . . . 73.439999999999998 110.416 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 115' ' ' ASP . 82.9 mttt -78.53 89.43 4.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.511 0.196 . . . . 74.420000000000002 110.535 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -154.12 176.07 12.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.573 0.702 . . . . 74.019999999999996 111.891 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.08 -46.06 3.62 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.199 -1.364 . . . . 75.109999999999999 113.507 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -172.85 157.46 3.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.633 0.717 . . . . 75.409999999999997 109.526 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.0 172.3 13.24 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.63 . . . . 75.319999999999993 109.694 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -138.46 155.67 48.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.732 -0.667 . . . . 75.219999999999999 109.745 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.41 136.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.301 0.572 . . . . 71.400000000000006 110.809 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 131' ' ' ILE . 98.9 m -100.52 125.05 46.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.02 -0.991 . . . . 74.310000000000002 110.944 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -100.61 157.67 16.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.875 0.369 . . . . 63.240000000000002 110.59 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.28 -30.29 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.766 -0.652 . . . . 53.240000000000002 110.312 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -130.97 155.34 46.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 74.400000000000006 110.823 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -80.12 -26.34 39.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.310000000000002 110.514 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.533 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 17.0 t70 -63.01 -39.16 93.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 111.169 -173.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 -31.42 72.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.375 -0.375 . . . . 73.200000000000003 110.781 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 163' ' ' VAL . 3.2 t -69.81 -45.33 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.289 -0.414 . . . . 61.420000000000002 110.195 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.415 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 20.1 m-20 -71.04 -23.96 62.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.845 -0.616 . . . . 73.209999999999994 111.586 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 88.1 mttt -63.78 -40.95 97.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 74.439999999999998 110.095 170.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.37 -42.54 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.695 -1.139 . . . . 71.109999999999999 112.122 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 159' ' ' VAL . 13.4 m -73.81 -12.25 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 74.510000000000005 110.789 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.431 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 6.8 mt -58.55 -29.37 38.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 72.239999999999995 109.829 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.3 mt-30 -112.44 98.7 7.45 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.613 -0.884 . . . . 74.420000000000002 108.613 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' A' ' 166' ' ' LYS . 1.2 ttmp? -53.37 -37.21 62.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.424 0.898 . . . . 75.019999999999996 113.424 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -121.3 131.67 54.34 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.6 -0.44 . . . . 70.25 110.576 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.7 m-70 -124.85 158.09 34.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 74.019999999999996 109.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.2 m -102.82 103.38 13.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.081 0.467 . . . . 74.040000000000006 110.379 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 124' ' ' TYR . 3.7 t -118.53 140.5 41.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.71 -0.677 . . . . 74.219999999999999 109.177 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.5 t30 56.77 31.02 18.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.966 0.889 . . . . 75.420000000000002 111.009 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.85 16.96 74.88 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.341 -0.845 . . . . 51.210000000000001 113.303 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -130.7 138.67 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.767 0.283 . . . . 72.510000000000005 110.356 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.68 110.9 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 73.450000000000003 110.535 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.81 158.07 29.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.066 -0.97 . . . . 75.430000000000007 111.102 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.56 133.1 34.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.123 -0.49 . . . . 54.030000000000001 110.187 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.8 t -128.83 132.12 67.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.345 -0.843 . . . . 75.409999999999997 110.057 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -155.4 175.98 13.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 75.150000000000006 111.15 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -62.14 122.9 16.73 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.82 -0.437 . . . . 75.540000000000006 109.82 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.441 ' HB1' ' N ' ' A' ' 108' ' ' PHE . . . -107.21 115.13 29.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.084 0.469 . . . . 60.409999999999997 110.719 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.1 mt -90.72 114.94 27.4 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.392 -0.966 . . . . 74.5 108.392 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.0 t -72.64 -178.96 2.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.315 -0.402 . . . . 62.509999999999998 110.055 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -30.73 69.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 74.150000000000006 110.512 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -60.68 -53.43 57.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.503 -0.771 . . . . 71.340000000000003 110.529 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -72.15 -38.57 69.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.971 -0.559 . . . . 75.099999999999994 111.586 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.63 -35.57 80.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.332 . . . . 74.019999999999996 111.805 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -93.21 -1.74 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 42.450000000000003 110.878 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.2 p 50.48 30.75 4.91 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.764 1.226 . . . . 62.539999999999999 112.125 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -170.04 171.98 6.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.755 -0.657 . . . . 74.030000000000001 109.702 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.1 t -72.25 101.95 2.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.294 -0.632 . . . . 74.349999999999994 109.294 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 p -100.2 152.87 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.99 -0.55 . . . . 74.409999999999997 111.266 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -92.89 15.67 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.999 -0.546 . . . . 75.420000000000002 110.822 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -70.52 97.01 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.285 0.564 . . . . 62.119999999999997 109.697 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -111.98 -36.62 5.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.133 -0.94 . . . . 74.340000000000003 110.656 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.0 -123.72 8.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.519 -1.032 . . . . 62.549999999999997 110.519 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.523 -0.751 . . . . 74.109999999999999 109.752 176.592 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.969 -0.452 . . . . 51.119999999999997 111.969 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m -93.17 95.88 9.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 73.430000000000007 110.654 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -63.05 -54.73 33.46 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 65.310000000000002 110.104 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.0 m -155.43 106.93 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 74.519999999999996 109.844 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.38 173.47 13.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.448 -0.342 . . . . 64.540000000000006 110.088 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 m -98.08 107.39 40.74 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.474 -0.33 . . . . 75.430000000000007 110.441 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 53.5 Cg_endo -87.61 165.64 7.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.819 2.346 . . . . 73.420000000000002 111.793 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -4.5 7.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.287 0.477 . . . . 73.120000000000005 112.287 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -93.91 150.27 38.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 C-N-CA 120.658 -0.417 . . . . 73.420000000000002 110.175 -177.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' HD23 ' A' ' 13' ' ' LEU . 36.1 Cg_endo -70.65 167.32 25.94 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.254 1.969 . . . . 64.340000000000003 112.076 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -37.06 68.75 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.006 -0.543 . . . . 74.329999999999998 112.283 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.43 -16.41 63.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.044 0.387 . . . . 72.439999999999998 112.044 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD23 ' HD2' ' A' ' 10' ' ' PRO . 5.6 mp -96.01 -14.63 22.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.742 0.306 . . . . 73.329999999999998 111.112 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 68' ' ' VAL . 16.5 ptt180 -118.84 2.22 11.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.044 0.45 . . . . 75.450000000000003 110.767 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -98.98 149.63 22.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.751 0.786 . . . . 74.409999999999997 111.603 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 87' ' ' LYS . 61.0 mt -117.13 146.45 43.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.552 -1.203 . . . . 72.129999999999995 110.46 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -99.21 121.62 41.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.65 -0.87 . . . . 74.409999999999997 108.65 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.92 112.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 110.052 -0.351 . . . . 64.430000000000007 110.052 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.77 150.32 18.31 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.929 -0.653 . . . . 71.239999999999995 111.703 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 45.95 42.5 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.767 -0.73 . . . . 65.010000000000005 113.541 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.9 mt -81.08 163.43 23.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.704 -0.48 . . . . 73.019999999999996 109.704 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 p -80.97 169.21 17.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.327 -0.62 . . . . 71.430000000000007 109.327 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -72.33 -11.52 60.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 73.530000000000001 110.316 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.89 15.26 17.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 71.329999999999998 111.314 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.1 m -82.41 126.9 32.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.152 0.501 . . . . 73.120000000000005 110.942 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 164.09 12.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 63.439999999999998 110.325 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.06 -25.79 60.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.184 -0.206 . . . . 54.43 110.879 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.67 -37.47 82.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 73.329999999999998 110.493 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 m -80.23 -37.25 33.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 72.239999999999995 110.943 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.3 tp -63.0 -43.56 98.44 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.458 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 31' ' ' ARG . 14.6 ttm180 -60.86 -55.49 32.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.886 -0.413 . . . . 75.409999999999997 109.886 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.7 m -47.23 -39.52 14.36 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 124.313 1.008 . . . . 75.030000000000001 113.067 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -70.68 -61.27 1.83 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 71.430000000000007 111.583 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -69.91 -21.82 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 72.530000000000001 112.201 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 28.9 tt0 -63.74 -16.88 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.813 0.445 . . . . 73.209999999999994 111.857 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.27 -26.62 68.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.563 0.221 . . . . 73.439999999999998 111.081 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -99.56 -19.98 16.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.205 0.446 . . . . 75.019999999999996 112.205 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -175.53 168.7 41.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.218 -0.992 . . . . 74.129999999999995 112.707 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.5 m -65.98 119.14 10.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 72.5 111.99 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.72 122.24 34.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.706 0.765 . . . . 71.109999999999999 111.215 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -89.72 -25.77 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.154 -1.385 . . . . 73.099999999999994 110.116 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -152.3 153.34 33.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.394 -0.821 . . . . 62.32 109.642 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -161.06 130.24 4.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.748 -0.464 . . . . 63.32 109.748 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.03 123.8 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.481 0.658 . . . . 71.030000000000001 110.516 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.39 135.06 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.224 -1.028 . . . . 75.329999999999998 108.224 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -74.17 95.35 2.58 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.782 0.801 . . . . 71.150000000000006 109.641 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -104.91 164.57 11.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.102 -1.408 . . . . 75.219999999999999 110.257 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.46 128.46 87.23 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.936 -0.765 . . . . 62.149999999999999 108.936 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.78 -18.73 65.23 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.181 1.921 . . . . 70.030000000000001 113.377 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -86.39 -55.69 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 74.099999999999994 110.89 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -99.63 -14.89 18.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.008 -0.996 . . . . 75.409999999999997 112.331 -170.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm 65.76 26.8 11.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.924 0.89 . . . . 71.409999999999997 111.367 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -102.54 153.32 20.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.552 -0.536 . . . . 75.150000000000006 109.552 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.0 137.72 51.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 73.519999999999996 112.145 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -88.83 4.89 46.14 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.463 -0.79 . . . . 73.129999999999995 110.441 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.08 17.7 58.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.057 -0.592 . . . . 73.129999999999995 114.385 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.4 p90 -159.1 155.68 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.607 0.703 . . . . 73.219999999999999 110.155 174.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.45 20.22 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.825 -0.51 . . . . 50.240000000000002 111.825 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.19 149.76 40.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.032 0.416 . . . . 73.400000000000006 110.852 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.9 127.0 65.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.614 -0.721 . . . . 70.109999999999999 109.496 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 121.37 43.22 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.292 -0.255 . . . . 70.299999999999997 110.654 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.9 178.28 7.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.176 -0.466 . . . . 73.049999999999997 111.084 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.06 -28.81 18.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.683 -0.69 . . . . 41.119999999999997 110.796 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -144.05 147.69 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 74.219999999999999 110.698 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -57.54 -35.38 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 122.863 0.465 . . . . 71.030000000000001 111.913 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.09 -39.56 63.45 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.15 0.796 . . . . 72.230000000000004 113.15 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -70.78 -27.12 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 71.329999999999998 110.303 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 19.7 t -66.61 -47.3 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.334 -0.848 . . . . 72.409999999999997 110.08 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.97 -46.07 85.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 75.409999999999997 110.702 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.53 -41.25 53.55 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.466 0.543 . . . . 65.519999999999996 112.466 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.48 -32.23 58.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 72.120000000000005 110.96 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.3 mmt -70.74 -36.21 73.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 63.130000000000003 110.107 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -12.6 59.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.481 -0.781 . . . . 74.329999999999998 110.512 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.28 -11.35 38.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.731 -0.668 . . . . 71.400000000000006 110.269 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp85 -57.87 142.1 79.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.241 -0.891 . . . . 74.239999999999995 110.402 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 86.7 Cg_endo -79.95 169.0 71.5 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.694 -0.961 . . . . 75.099999999999994 114.363 4.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 86' ' ' PRO . 69.0 m-70 -129.0 158.54 38.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.879 . . . . 71.409999999999997 110.447 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -137.43 106.9 6.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.071 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.95 130.9 59.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.242 -0.435 . . . . 72.040000000000006 109.901 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 65.05 29.31 12.19 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.667 0.604 . . . . 73.049999999999997 111.674 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.44 26.08 72.73 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.936 -0.575 . . . . 73.140000000000001 112.117 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.8 tpt180 -129.0 139.11 52.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 65.140000000000001 109.841 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.25 107.67 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.584 -0.525 . . . . 70.230000000000004 109.584 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.48 151.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.259 0.552 . . . . 63.439999999999998 110.824 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -112.03 94.43 25.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 72.420000000000002 111.087 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.434 ' HG3' ' CD2' ' A' ' 77' ' ' HIS . 38.2 Cg_endo -74.31 132.28 16.2 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.069 1.846 . . . . 74.530000000000001 111.385 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' O ' HD21 ' A' ' 16' ' ' LEU . 8.9 mttt -137.12 174.24 10.83 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.291 -1.003 . . . . 73.439999999999998 108.291 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.0 tmm_? -76.77 131.04 38.49 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.653 -0.869 . . . . 73.049999999999997 108.653 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.09 96.36 0.14 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.043 0.449 . . . . 75.420000000000002 111.755 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 100' ' ' ALA . 40.3 t -69.07 137.23 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.113 -0.948 . . . . 73.239999999999995 110.497 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 t -86.88 -176.56 5.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.732 -0.667 . . . . 73.420000000000002 109.789 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -68.63 -41.6 79.23 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.553 0.946 . . . . 72.400000000000006 113.553 -167.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.71 -35.4 52.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.729 -0.389 . . . . 73.510000000000005 111.198 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -14.3 59.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.771 0.319 . . . . 63.219999999999999 110.363 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t -80.57 -20.09 44.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 63.409999999999997 109.824 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -71.33 -20.37 62.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.811 -0.632 . . . . 75.420000000000002 109.797 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.22 147.67 88.07 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.661 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.14 128.61 17.86 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.817 2.345 . . . . 75.439999999999998 112.098 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.4 39.31 22.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.019 -0.61 . . . . 74.040000000000006 111.993 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -66.03 -54.3 27.72 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.876 0.324 . . . . 75.140000000000001 111.876 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -107.66 11.14 28.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.044 0.449 . . . . 75.519999999999996 110.621 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 151.58 25.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.583 -0.525 . . . . 74.450000000000003 109.583 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.427 HG23 ' CD2' ' A' ' 156' ' ' HIS . 5.8 m -72.52 105.84 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.735 . . . . 73.120000000000005 110.359 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.435 ' HB ' ' CE ' ' A' ' 179' ' ' LYS . 61.4 t -132.21 116.27 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.867 -1.061 . . . . 72.430000000000007 109.43 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -102.6 13.6 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.417 -0.513 . . . . 71.349999999999994 110.67 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.38 139.66 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.315 -0.402 . . . . 71.219999999999999 110.792 177.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -120.97 149.16 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.261 0.553 . . . . 65.219999999999999 111.388 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.3 t80 -98.76 132.21 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.774 -1.103 . . . . 74.150000000000006 109.441 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 111.08 28.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.217 -0.66 . . . . 75.0 109.217 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -132.88 148.41 19.27 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 119.907 -1.139 . . . . 72.109999999999999 112.601 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 6.72 36.7 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.347 -0.93 . . . . 60.32 112.948 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.76 105.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.522 0.677 . . . . 75.219999999999999 110.526 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 46.2 mtmt -74.97 -53.44 8.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.496 -0.775 . . . . 70.219999999999999 110.62 -176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -73.09 155.45 39.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.416 -0.811 . . . . 72.140000000000001 109.805 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.53 134.73 55.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 109.739 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -116.24 145.26 43.27 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.021 -0.536 . . . . 72.120000000000005 109.899 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.86 158.63 17.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.053 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.12 -44.48 79.18 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 123.93 0.769 . . . . 75.140000000000001 110.289 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -56.52 -35.68 68.32 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.409 0.284 . . . . 74.109999999999999 111.603 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -62.66 -59.92 4.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.331 -0.395 . . . . 73.510000000000005 110.841 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -84.29 -21.65 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.253 -0.579 . . . . 74.319999999999993 111.138 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 7.2 tmm_? -66.36 -55.67 14.78 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 110.138 -0.319 . . . . 75.420000000000002 110.138 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -61.39 -26.41 67.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.361 0.6 . . . . 72.420000000000002 110.481 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -75.8 -58.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.39 -0.823 . . . . 75.510000000000005 112.252 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CD2' HG22 ' A' ' 151' ' ' VAL . 47.3 m-85 -69.08 -21.84 64.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 111.735 0.272 . . . . 75.109999999999999 111.735 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mm-40 -64.55 -24.73 67.7 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.917 0.389 . . . . 61.009999999999998 111.076 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -58.69 -27.59 64.97 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.921 -0.582 . . . . 64.239999999999995 111.636 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -87.24 -32.19 19.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 74.230000000000004 112.009 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.41 -174.71 47.17 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.828 -0.701 . . . . 75.200000000000003 113.001 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -74.03 126.62 30.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.302 0.572 . . . . 70.219999999999999 112.184 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 152' ' ' THR . 63.3 mt -97.36 139.42 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.118 -0.946 . . . . 74.400000000000006 109.72 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -90.34 -48.62 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 70.099999999999994 110.731 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.52 154.48 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 109.777 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.63 125.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.376 -0.601 . . . . 75.219999999999999 109.376 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.43 103.91 15.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.666 -0.697 . . . . 55.310000000000002 110.7 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.3 mm -95.63 129.47 45.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.775 -0.454 . . . . 73.219999999999999 109.775 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.6 mtp -110.95 146.16 37.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.746 -0.835 . . . . 62.530000000000001 108.746 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -97.0 167.5 11.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 74.530000000000001 112.222 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.74 137.62 35.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.076 -0.965 . . . . 73.120000000000005 109.721 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -68.78 -37.97 79.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.866 -0.607 . . . . 74.530000000000001 111.3 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.83 -52.6 2.07 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.818 -0.706 . . . . 63.409999999999997 113.15 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.4 t -86.66 -24.34 25.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.706 0.262 . . . . 73.340000000000003 111.706 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.71 19.01 74.28 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.739 -0.743 . . . . 73.049999999999997 112.951 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -86.81 169.3 12.7 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.763 -0.458 . . . . 63.140000000000001 109.763 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -88.13 78.76 8.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.296 -0.631 . . . . 74.0 109.296 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 113' ' ' LYS . 22.1 ptt180 -154.7 -177.54 6.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.783 0.801 . . . . 72.010000000000005 112.453 -171.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.89 -44.93 3.27 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 113.91 -1.495 . . . . 75.030000000000001 112.751 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -169.48 148.33 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.688 -0.486 . . . . 75.239999999999995 109.688 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.98 172.76 12.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.844 -0.616 . . . . 74.329999999999998 109.516 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.474 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 55.1 m-85 -140.89 151.72 44.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.012 -0.54 . . . . 71.519999999999996 110.454 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 125' ' ' PHE . 94.9 t -134.13 129.52 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.587 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 131' ' ' ILE . 64.0 m -99.85 123.23 43.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 70.409999999999997 110.206 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -104.06 159.69 15.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.732 0.301 . . . . 73.109999999999999 110.381 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.94 -24.09 48.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.33 0.586 . . . . 64.349999999999994 110.761 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 4.4 t70 -138.41 156.67 47.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.726 . . . . 72.439999999999998 110.148 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.427 ' CD2' HG23 ' A' ' 103' ' ' THR . 23.6 p80 -79.79 -21.41 44.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.415 -0.357 . . . . 74.239999999999995 110.038 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.551 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.4 p-10 -58.91 -39.61 82.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.443 -0.799 . . . . 72.530000000000001 111.026 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -76.32 -29.35 57.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.073 -0.512 . . . . 75.519999999999996 110.532 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.7 t -69.58 -40.22 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.59 -0.522 . . . . 73.299999999999997 109.59 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.05 -24.3 61.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.348 -0.842 . . . . 74.150000000000006 111.453 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 72.8 mttt -68.21 -34.12 75.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 74.549999999999997 110.234 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.86 -40.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.181 -0.918 . . . . 75.239999999999995 112.281 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 159' ' ' VAL . 12.2 m -73.0 -6.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.15 0.5 . . . . 74.129999999999995 111.362 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.8 mt -54.74 -38.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.079 -0.964 . . . . 75.230000000000004 110.171 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -107.55 114.2 28.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.386 -0.825 . . . . 75.450000000000003 109.473 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -53.85 -41.5 67.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.402 -0.817 . . . . 74.030000000000001 112.187 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.89 138.61 54.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.243 -0.435 . . . . 75.319999999999993 110.859 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -124.25 152.89 42.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.631 -0.713 . . . . 74.150000000000006 109.218 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -122.84 113.28 18.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.324 0.583 . . . . 75.219999999999999 110.035 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.59 113.96 41.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.507 -0.769 . . . . 74.450000000000003 109.92 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 70.44 24.1 4.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.128 0.489 . . . . 53.450000000000003 110.789 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.2 78.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.861 -0.685 . . . . 72.329999999999998 112.448 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.27 111.08 21.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.856 -0.424 . . . . 75.120000000000005 109.856 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.4 131.68 34.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.313 -0.625 . . . . 71.140000000000001 109.313 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 p -143.99 149.27 36.47 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.263 -0.426 . . . . 64.049999999999997 111.436 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.52 130.57 35.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.632 -0.877 . . . . 74.109999999999999 108.632 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.7 t -127.74 137.21 58.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.857 -0.611 . . . . 74.510000000000005 110.501 -175.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -161.99 177.97 9.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.264 -0.88 . . . . 73.450000000000003 110.972 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.435 ' CE ' ' HB ' ' A' ' 104' ' ' VAL . 7.0 mmmm -67.74 122.03 17.23 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.671 -0.492 . . . . 73.439999999999998 109.671 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -93.73 114.9 27.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.895 0.378 . . . . 74.430000000000007 110.445 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.14 132.25 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 110.831 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' A' ' 186' ' ' MET . 9.0 t -71.93 164.57 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.548 -1.278 . . . . 64.439999999999998 107.548 166.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.26 -34.1 73.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.825 0.284 . . . . 75.239999999999995 111.629 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.88 -32.82 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 71.299999999999997 110.489 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -71.42 -38.66 71.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 74.25 110.065 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 182' ' ' SER . 82.0 mtp -67.37 -39.48 85.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.594 -0.73 . . . . 65.010000000000005 110.862 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.67 -4.94 59.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 44.310000000000002 111.662 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t 60.81 47.42 7.88 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.786 0.679 . . . . 45.240000000000002 110.437 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.78 147.85 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 73.340000000000003 111.267 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.5 t -103.96 109.09 20.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.892 -0.595 . . . . 74.540000000000006 109.925 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -86.95 128.34 35.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.312 -0.404 . . . . 61.229999999999997 110.318 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.6 m -80.19 102.11 9.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 110.53 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -142.33 150.76 41.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.058 -0.519 . . . . 63.450000000000003 110.038 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.56 37.13 1.33 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 72.030000000000001 109.48 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -83.61 46.29 3.62 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.754 -0.736 . . . . 75.510000000000005 111.547 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.357 -0.83 . . . . 73.439999999999998 109.047 -176.487 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 112.145 -0.382 . . . . 73.450000000000003 112.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -71.6 115.04 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 55.149999999999999 110.963 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -79.83 115.82 19.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 61.420000000000002 109.972 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.5 m -143.84 60.94 1.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.977 0.418 . . . . 74.420000000000002 109.982 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.04 136.45 37.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 110.384 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -61.3 111.78 4.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.602 0.564 . . . . 74.329999999999998 110.238 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.61 156.97 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.511 2.141 . . . . 64.400000000000006 113.27 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.0 -5.01 21.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.047 -1.094 . . . . 61.539999999999999 108.047 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 1.6 mp0 -61.55 131.44 92.64 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 113.649 -1.614 . . . . 62.229999999999997 111.704 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 16.4 Cg_endo -59.95 168.43 5.85 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.703 2.935 . . . . 72.230000000000004 112.99 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.45 59.85 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.617 -0.719 . . . . 65.519999999999996 111.92 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.14 0.422 . . . . 72.420000000000002 112.14 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 13.3 mt -85.29 -20.91 29.32 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 122.094 -0.379 . . . . 74.230000000000004 110.671 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 ptt-85 -108.7 -2.9 18.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.863 0.363 . . . . 75.409999999999997 111.027 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.8 ttpt -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.599 0.714 . . . . 74.430000000000007 111.944 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.7 mt -118.97 145.28 45.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.801 -1.09 . . . . 65.409999999999997 110.034 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -97.09 123.57 40.88 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.398 -0.964 . . . . 74.209999999999994 108.398 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -103.02 110.22 29.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.83 -0.433 . . . . 62.409999999999997 109.83 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.69 150.48 17.95 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.046 -0.597 . . . . 64.310000000000002 111.794 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.75 52.92 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.846 -0.692 . . . . 53.43 113.168 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.8 mt -78.74 176.8 9.19 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.283 -0.636 . . . . 73.340000000000003 109.283 171.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p -83.5 167.64 17.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.152 -1.055 . . . . 75.450000000000003 108.152 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -79.51 0.42 29.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.933 0.396 . . . . 74.200000000000003 110.639 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -125.38 15.59 8.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.837 -0.62 . . . . 74.209999999999994 111.568 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -74.11 130.62 40.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.662 0.267 . . . . 74.209999999999994 111.072 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.3 p -104.77 163.67 12.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 74.519999999999996 110.293 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -28.31 64.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.405 -0.361 . . . . 70.549999999999997 111.193 -176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.93 -35.77 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.513 0.197 . . . . 75.450000000000003 111.244 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -75.94 -36.61 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.665 -0.243 . . . . 72.209999999999994 110.687 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.9 -48.25 77.39 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.704 -0.48 . . . . 74.450000000000003 109.704 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -54.96 -60.86 2.78 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 115.379 -0.828 . . . . 73.510000000000005 111.951 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -50.23 -31.66 14.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.738 0.648 . . . . 72.299999999999997 112.386 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -73.14 -60.72 2.1 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.201 -0.2 . . . . 74.310000000000002 110.817 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.36 -22.13 64.68 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.109 0.411 . . . . 74.329999999999998 112.109 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.47 -25.51 51.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.312 0.645 . . . . 61.219999999999999 112.078 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.5 -27.03 65.79 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.236 0.458 . . . . 72.450000000000003 112.236 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -99.05 -19.68 17.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.582 0.215 . . . . 72.530000000000001 111.582 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.0 28.09 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.851 -0.69 . . . . 63.439999999999998 111.771 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -63.82 119.49 10.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.441 . . . . 62.140000000000001 111.329 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.7 136.24 33.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.589 -0.732 . . . . 70.319999999999993 110.487 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 p -103.97 -21.79 13.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.42 -0.809 . . . . 74.230000000000004 110.194 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -150.84 150.11 30.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 75.340000000000003 109.674 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -159.9 130.27 5.57 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.713 -0.477 . . . . 75.430000000000007 109.713 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.76 129.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.383 0.611 . . . . 72.200000000000003 111.083 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -87.77 128.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.79 -0.819 . . . . 71.439999999999998 108.79 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -72.9 98.45 2.47 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.669 0.747 . . . . 64.329999999999998 110.278 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -103.37 161.24 14.0 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.385 -1.279 . . . . 74.120000000000005 110.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.52 125.2 91.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.749 -1.114 . . . . 73.299999999999997 109.793 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -65.45 -20.71 60.99 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.202 1.935 . . . . 74.519999999999996 112.575 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -83.83 -55.43 4.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 74.239999999999995 111.63 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 -8.67 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 64.420000000000002 111.85 -173.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 62.19 38.23 13.72 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 111.447 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -110.09 157.48 19.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.547 -0.909 . . . . 73.129999999999995 108.547 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -73.13 137.89 45.44 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.796 -0.362 . . . . 74.010000000000005 110.262 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -83.4 1.27 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.420000000000002 110.204 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.31 18.3 59.23 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.99 -0.624 . . . . 74.409999999999997 113.871 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -159.57 158.4 31.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.059 0.929 . . . . 74.430000000000007 110.614 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.16 -163.07 14.97 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.34 -0.704 . . . . 71.120000000000005 111.34 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.31 149.83 38.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.235 0.518 . . . . 71.510000000000005 110.702 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 m -129.67 122.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.879 -0.6 . . . . 75.310000000000002 109.844 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.1 m -98.9 121.93 41.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.624 -0.262 . . . . 74.409999999999997 110.386 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -87.18 163.4 16.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 72.420000000000002 110.704 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.15 70.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.637 -0.71 . . . . 62.109999999999999 110.144 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -124.38 144.3 50.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.427 -0.806 . . . . 74.409999999999997 110.384 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.596 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -63.17 -37.09 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.258 -0.428 . . . . 73.510000000000005 110.824 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.02 -36.93 68.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.552 0.575 . . . . 73.129999999999995 112.552 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.41 -26.81 65.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.104 0.478 . . . . 74.209999999999994 110.704 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 37.7 t -64.62 -45.46 95.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.538 -0.756 . . . . 74.099999999999994 110.468 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -52.96 -48.23 67.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.699 -0.682 . . . . 65.400000000000006 111.989 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.632 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -58.12 -37.38 74.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.607 0.595 . . . . 73.400000000000006 112.607 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.84 -34.83 78.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.396 0.617 . . . . 73.25 110.166 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.433 ' HE3' ' O ' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -69.39 -38.23 77.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 74.430000000000007 110.877 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.632 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.0 p30 -76.99 -10.46 59.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.894 0.378 . . . . 75.209999999999994 111.335 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.06 -11.59 43.66 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.906 -0.588 . . . . 75.319999999999993 112.438 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.42 148.78 8.51 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 113.284 0.846 . . . . 73.200000000000003 113.284 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 2.8 Cg_endo -81.94 160.87 79.1 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.692 -1.378 . . . . 75.530000000000001 112.438 -2.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -110.4 151.53 27.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 65.400000000000006 110.152 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.1 ttmt -136.76 104.36 5.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.044 0.45 . . . . 74.540000000000006 111.131 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.8 140.31 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.695 -0.684 . . . . 73.439999999999998 109.685 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 66.25 21.68 11.02 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.573 0.749 . . . . 74.420000000000002 110.3 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 25.4 69.1 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.748 -0.66 . . . . 75.530000000000001 112.222 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 tpt180 -129.4 136.64 50.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.374 -0.232 . . . . 72.519999999999996 110.374 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -83.79 111.05 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.655 0.74 . . . . 72.200000000000003 109.992 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 m -102.84 155.34 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 112.183 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' CG ' ' HZ3' ' A' ' 87' ' ' LYS . 22.9 tp10 -111.53 96.62 32.92 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.469 -1.241 . . . . 75.329999999999998 111.006 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' O ' ' HE3' ' A' ' 72' ' ' MET . 2.7 Cg_endo -80.58 130.1 7.68 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.35 2.033 . . . . 75.319999999999993 111.073 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HZ3' ' CG ' ' A' ' 85' ' ' GLU . 30.0 mttm -133.8 170.26 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.849 -0.797 . . . . 73.430000000000007 108.849 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.53 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tpp180 -70.38 137.76 50.77 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.507 -0.553 . . . . 72.299999999999997 109.507 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 97.15 0.45 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.292 0.568 . . . . 73.209999999999994 110.348 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 101' ' ' HIS . 6.6 t -55.26 136.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.433 -1.258 . . . . 64.120000000000005 111.786 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.4 ' HB2' HG12 ' A' ' 164' ' ' ILE . 2.4 t -57.84 147.26 29.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.435 -0.802 . . . . 74.129999999999995 109.904 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -52.52 -40.48 62.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.402 0.681 . . . . 73.409999999999997 112.591 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.03 -39.29 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.142 0.423 . . . . 73.140000000000001 112.142 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.28 -32.31 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.03 -0.359 . . . . 74.040000000000006 110.03 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -69.57 -12.32 61.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.941 -0.572 . . . . 72.209999999999994 110.609 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.17 -7.84 59.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 74.439999999999998 110.056 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -94.62 151.11 38.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 74.420000000000002 110.299 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 122.46 8.19 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.557 2.171 . . . . 74.219999999999999 111.974 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.56 19.5 27.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.586 -0.816 . . . . 73.510000000000005 112.578 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.49 54.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.673 0.249 . . . . 74.209999999999994 111.673 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.41 ' CD2' HG22 ' A' ' 90' ' ' VAL . 7.9 m170 -98.96 13.84 31.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.802 0.334 . . . . 71.239999999999995 111.405 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.38 171.1 13.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.851 -0.425 . . . . 74.319999999999993 109.851 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 m -89.01 78.18 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.423 0.63 . . . . 63.509999999999998 110.778 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.01 121.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.933 -1.03 . . . . 74.329999999999998 109.341 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' C ' HG22 ' A' ' 159' ' ' VAL . 88.2 mttt -107.35 21.73 17.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.164 0.507 . . . . 73.0 110.374 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 142.98 49.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.46 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.7 pt -132.71 150.66 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.31 0.576 . . . . 73.319999999999993 111.561 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.9 t80 -96.29 138.48 33.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.834 -1.075 . . . . 73.420000000000002 110.086 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.98 110.78 25.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.419 -0.585 . . . . 73.239999999999995 109.419 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.17 141.84 12.81 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 119.927 -1.13 . . . . 71.450000000000003 112.387 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.0 6.36 14.04 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.315 -0.945 . . . . 71.409999999999997 112.224 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -73.87 101.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.515 0.674 . . . . 74.219999999999999 109.793 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 22.73 1.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 72.019999999999996 112.628 -170.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.01 175.57 11.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.996 -0.372 . . . . 73.120000000000005 109.996 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.66 120.96 12.2 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.697 0.623 . . . . 65.409999999999997 110.561 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -122.7 146.6 47.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.175 0.512 . . . . 75.099999999999994 110.136 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.5 165.27 11.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.44 -0.8 . . . . 64.439999999999998 111.289 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.52 -47.17 87.35 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.184 -1.371 . . . . 72.109999999999999 109.61 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.47 -0.786 . . . . 74.25 111.712 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.47 -58.03 7.58 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.165 0.291 . . . . 71.349999999999994 111.185 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.16 -27.5 38.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.615 -0.834 . . . . 74.109999999999999 110.918 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.4 tmm_? -66.65 -45.0 80.37 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.977 -0.379 . . . . 73.530000000000001 109.977 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.23 -32.18 71.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.195 0.521 . . . . 75.200000000000003 110.454 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -79.48 -55.82 4.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.503 -0.771 . . . . 71.239999999999995 112.37 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 42.9 m-85 -67.7 -24.03 65.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.095 0.405 . . . . 74.510000000000005 112.095 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.4 mm-40 -66.58 -25.81 66.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.976 0.417 . . . . 74.0 110.899 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -61.03 -32.23 71.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.94 -0.573 . . . . 71.329999999999998 111.589 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -81.69 -27.91 33.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.540000000000006 111.101 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.404 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 171.36 -177.65 44.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.768 -0.651 . . . . 74.109999999999999 112.651 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.6 134.3 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.217 0.532 . . . . 74.150000000000006 111.618 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 152' ' ' THR . 79.4 mt -102.88 144.56 13.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.338 -0.846 . . . . 75.519999999999996 109.872 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -93.49 -49.1 6.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 73.120000000000005 110.825 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.35 155.32 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 109.912 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.74 129.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.344 . . . . 64.530000000000001 110.07 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.79 103.39 14.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 61.420000000000002 111.178 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.38 115.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.561 -0.533 . . . . 55.32 109.561 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ptp -111.48 152.97 26.84 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.349 -0.612 . . . . 54.539999999999999 109.349 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.96 148.97 22.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.68 -173.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.36 132.15 47.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.192 -0.913 . . . . 74.120000000000005 110.19 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -64.05 -23.74 67.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.72 -0.673 . . . . 70.530000000000001 112.311 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -101.49 -52.76 1.03 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.845 -0.693 . . . . 75.120000000000005 112.964 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 m -81.68 -23.65 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.464 0.542 . . . . 72.319999999999993 112.464 -172.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.39 13.87 79.67 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.93 -0.653 . . . . 51.119999999999997 112.724 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -99.49 172.1 7.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.678 -0.49 . . . . 75.120000000000005 109.678 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.72 76.08 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.332 -0.618 . . . . 75.25 109.332 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -152.93 161.31 42.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.615 . . . . 73.409999999999997 111.222 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.8 -45.49 2.33 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.156 -0.929 . . . . 75.340000000000003 113.414 170.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -170.54 153.68 4.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.903 0.852 . . . . 65.109999999999999 109.973 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.38 174.75 11.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 71.349999999999994 109.474 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.85 155.21 47.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.057 -0.52 . . . . 74.439999999999998 109.985 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.07 132.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.54 0.686 . . . . 73.200000000000003 111.097 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 131' ' ' ILE . 65.0 m -97.58 124.08 41.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.085 -0.961 . . . . 75.239999999999995 110.465 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 3.7 m-85 -99.24 157.83 16.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 73.239999999999995 111.289 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.59 -29.12 45.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.14 -0.936 . . . . 52.219999999999999 110.511 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -128.68 152.22 48.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.526 . . . . 72.010000000000005 110.847 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -77.74 -28.21 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 71.349999999999994 109.887 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.9 t70 -58.12 -48.26 80.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.641 -1.163 . . . . 75.400000000000006 111.955 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.404 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 19.5 m -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 65.310000000000002 111.137 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.435 HG22 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -67.76 -41.11 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 71.019999999999996 109.775 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.41 ' OD1' HG23 ' A' ' 90' ' ' VAL . 12.8 t70 -68.08 -38.16 82.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.077 -0.965 . . . . 64.120000000000005 111.377 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 86.4 mttt -52.87 -37.28 60.23 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.517 0.675 . . . . 73.510000000000005 110.696 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mt -78.18 -44.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 74.409999999999997 112.533 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 160' ' ' ASP . 16.5 m -74.21 -15.17 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 75.319999999999993 110.725 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 91' ' ' SER . 19.0 mt -57.69 -32.11 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.935 -1.03 . . . . 75.219999999999999 110.16 172.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.523 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -111.51 101.45 9.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 75.329999999999998 108.197 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -56.98 -33.79 67.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.233 0.827 . . . . 72.519999999999996 113.233 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -122.15 135.24 54.76 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.569 -0.452 . . . . 65.319999999999993 110.989 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 92.6 m-70 -127.39 156.92 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.754 -0.657 . . . . 74.209999999999994 110.176 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 10.2 m -123.5 115.44 21.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.08 0.467 . . . . 74.439999999999998 110.834 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.58 115.57 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.782 . . . . 73.239999999999995 109.99 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 71.48 23.84 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.922 0.868 . . . . 75.150000000000006 109.749 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 95.3 -13.21 67.16 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.559 -0.746 . . . . 65.230000000000004 112.266 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 169' ' ' THR . 2.6 m80 -81.9 109.99 16.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.154 -0.313 . . . . 74.109999999999999 110.154 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -91.86 107.77 19.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.88 0.848 . . . . 63.020000000000003 109.133 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 5.7 p -124.12 156.8 36.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.093 -0.958 . . . . 72.310000000000002 111.463 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -85.97 130.51 34.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.591 -0.731 . . . . 63.119999999999997 109.154 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 11.3 t -126.63 131.24 71.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.333 -0.849 . . . . 70.209999999999994 109.696 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.38 172.93 17.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 72.25 110.933 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -62.67 124.79 21.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.256 0.348 . . . . 64.5 110.708 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -109.71 112.89 25.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.866 0.365 . . . . 63.329999999999998 110.216 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 50.1 mt -98.31 111.39 23.75 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.395 -0.595 . . . . 74.450000000000003 109.395 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.9 m -105.48 -170.24 1.72 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.167 -0.679 . . . . 73.129999999999995 109.167 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -67.51 -16.63 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.693 0.627 . . . . 75.200000000000003 112.693 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -77.15 -48.94 16.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.905 -0.406 . . . . 74.219999999999999 109.905 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.31 -36.05 76.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.849 -0.614 . . . . 71.329999999999998 110.595 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.2 mtt -73.63 -27.59 61.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 111.44 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.36 -0.78 51.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 63.240000000000002 110.828 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.1 t 63.75 46.68 3.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.486 -0.779 . . . . 73.310000000000002 110.426 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.36 62.11 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.555 0.693 . . . . 71.230000000000004 109.977 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.3 m -81.04 108.81 15.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.025 -0.989 . . . . 72.430000000000007 111.157 -175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 p -93.36 97.09 10.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.952 -0.567 . . . . 73.340000000000003 110.655 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 p -92.62 92.16 7.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.969 -0.752 . . . . 63.329999999999998 108.969 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -77.82 158.15 29.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.46 -0.791 . . . . 74.049999999999997 112.108 -171.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 11.3 tpp180 -82.74 102.23 11.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 75.010000000000005 109.577 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.15 -95.04 1.04 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.686 -0.966 . . . . 63.130000000000003 110.686 -172.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 119.158 -0.449 . . . . 74.150000000000006 109.891 174.051 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.077 -0.409 . . . . 74.329999999999998 112.077 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m -104.26 145.76 29.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.108 -0.33 . . . . 72.099999999999994 110.108 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -76.54 -10.5 59.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 71.209999999999994 110.997 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.9 t -80.14 -4.01 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 73.329999999999998 110.681 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -75.86 146.46 39.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.324 -0.398 . . . . 74.040000000000006 110.352 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 m -99.03 128.33 32.45 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 74.120000000000005 110.83 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.19 137.28 18.97 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.369 2.046 . . . . 74.030000000000001 111.853 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -26.34 13.85 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -79.1 133.61 60.78 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.833 -1.076 . . . . 75.140000000000001 109.535 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 14' ' ' ARG . 18.3 Cg_endo -62.83 163.3 22.34 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.553 2.169 . . . . 73.109999999999999 111.009 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 7.5 pt-20 -62.56 -27.1 68.94 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 111.981 0.363 . . . . 74.129999999999995 111.981 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -72.79 -32.51 65.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 110.849 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 mp -81.36 -11.69 59.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 74.239999999999995 111.197 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 10' ' ' PRO . 32.0 ptt85 -127.06 15.77 7.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.126 0.488 . . . . 75.540000000000006 110.952 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 18.3 ttmm -97.32 151.29 20.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 75.420000000000002 111.029 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -116.76 142.6 46.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.939 -1.028 . . . . 73.200000000000003 110.129 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -98.11 120.89 39.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.169 -1.049 . . . . 75.099999999999994 108.169 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.45 110.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.873 -0.417 . . . . 74.310000000000002 109.873 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.29 152.29 17.97 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.877 -0.678 . . . . 64.230000000000004 111.565 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.83 46.8 43.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.487 -0.863 . . . . 74.409999999999997 112.981 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD23 ' CG1' ' A' ' 84' ' ' VAL . 80.5 mt -81.98 176.84 9.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.634 -0.506 . . . . 75.140000000000001 109.634 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 p -85.81 164.6 17.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.107 -1.072 . . . . 73.140000000000001 108.107 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -80.63 2.88 23.92 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.039 0.447 . . . . 73.099999999999994 110.455 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -119.81 10.7 11.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.585 -0.734 . . . . 75.209999999999994 110.995 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -71.3 121.52 18.61 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 74.530000000000001 110.807 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -94.62 154.85 17.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.003 -0.544 . . . . 75.219999999999999 109.99 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -27.45 63.83 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 121.109 -0.236 . . . . 61.229999999999997 110.867 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -77.2 -23.02 51.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 62.399999999999999 110.741 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -81.29 -41.42 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.672 -0.492 . . . . 73.430000000000007 109.672 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.13 -47.14 87.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 73.209999999999994 109.655 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.21 -62.68 1.5 Allowed 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 111.71 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.9 t -48.15 -35.05 10.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.337 0.655 . . . . 74.239999999999995 112.551 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' CG ' HG23 ' A' ' 79' ' ' VAL . 55.9 t60 -68.4 -64.91 0.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 74.150000000000006 110.687 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -71.06 -21.75 62.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.47 0.544 . . . . 74.340000000000003 112.47 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -62.54 -21.0 65.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.722 0.409 . . . . 73.239999999999995 111.703 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.76 -30.03 68.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.544 -0.298 . . . . 74.040000000000006 111.751 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -98.51 -17.29 18.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.963 0.356 . . . . 73.310000000000002 111.963 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.72 164.11 33.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.353 -0.927 . . . . 65.420000000000002 112.36 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -65.38 116.49 6.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 70.209999999999994 111.413 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -85.45 134.57 34.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.745 -0.661 . . . . 74.319999999999993 111.1 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -97.26 -28.61 13.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.202 -0.908 . . . . 63.549999999999997 110.052 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.55 150.42 32.23 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.455 -0.793 . . . . 74.239999999999995 110.373 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -158.41 129.49 6.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.467 -0.568 . . . . 73.310000000000002 109.467 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.22 129.07 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.063 0.458 . . . . 74.519999999999996 110.067 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.06 130.29 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.642 -0.873 . . . . 74.030000000000001 108.642 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 6.8 mmt -69.24 135.85 51.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.955 0.407 . . . . 75.430000000000007 109.966 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -137.43 155.62 49.13 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.53 -0.759 . . . . 73.099999999999994 109.887 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 28.5 t70 -71.57 132.48 85.45 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.829 -1.078 . . . . 55.520000000000003 110.168 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.85 -19.97 35.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.969 1.78 . . . . 73.409999999999997 112.998 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -84.82 -55.52 4.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 74.409999999999997 111.505 -176.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 m -102.77 -9.11 20.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.955 0.407 . . . . 73.519999999999996 111.739 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.5 mmtm 66.85 24.86 9.67 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.575 0.75 . . . . 74.200000000000003 112.455 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.69 163.82 12.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.944 -0.391 . . . . 65.319999999999993 109.944 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 t -69.61 143.09 53.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.103 0.478 . . . . 75.200000000000003 110.305 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -88.47 1.66 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 54.420000000000002 110.526 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.39 17.76 61.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.653 -0.784 . . . . 62.210000000000001 113.813 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 41.9 p90 -158.37 159.05 35.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.334 0.567 . . . . 75.310000000000002 110.292 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.93 19.54 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.474 -0.65 . . . . 53.409999999999997 111.474 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 149.61 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.373 0.586 . . . . 75.340000000000003 110.659 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.7 130.65 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.77 -0.65 . . . . 53.310000000000002 109.694 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 m -106.49 123.28 47.84 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 122.135 -0.353 . . . . 75.230000000000004 110.487 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.7 m-85 -90.36 157.75 17.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.769 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.52 80.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 74.209999999999994 111.188 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -123.63 153.94 40.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.005 -0.543 . . . . 61.329999999999998 109.88 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.64 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 p -64.5 -30.9 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.396 -0.365 . . . . 74.340000000000003 111.352 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.17 -37.46 87.33 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.867 0.691 . . . . 74.540000000000006 112.867 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -63.61 -28.77 70.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.73 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.8 t -63.55 -49.91 80.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 65.319999999999993 109.856 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.67 -51.35 60.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.327 -0.851 . . . . 72.140000000000001 111.29 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -46.67 -41.03 14.23 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.87 0.692 . . . . 71.25 112.87 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.23 -29.84 61.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 72.430000000000007 110.871 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 74.129999999999995 110.851 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -70.48 -36.51 73.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.25 0.548 . . . . 73.120000000000005 110.214 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.0 -11.82 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.29 -0.868 . . . . 60.43 113.175 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -57.05 144.77 67.95 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 111.647 0.24 . . . . 71.549999999999997 111.647 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.65 163.0 84.54 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.518 -1.451 . . . . 61.109999999999999 113.248 2.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -116.83 156.35 27.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 73.549999999999997 110.456 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.5 ttmt -136.84 110.64 8.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.45 -0.341 . . . . 73.030000000000001 110.878 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG23 ' CG ' ' A' ' 33' ' ' HIS . 16.9 t -110.2 127.37 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 61.020000000000003 109.654 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.07 28.92 14.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.446 0.641 . . . . 70.239999999999995 111.136 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.17 27.91 63.19 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.742 -0.742 . . . . 53.43 112.446 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 10.1 tpt180 -131.54 140.39 49.47 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 72.049999999999997 109.564 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.88 112.38 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.417 -0.586 . . . . 75.030000000000001 109.417 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.8 m -105.5 148.25 10.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.484 0.659 . . . . 73.329999999999998 111.209 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -113.03 97.58 42.76 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.776 -1.102 . . . . 75.420000000000002 110.755 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -77.43 128.8 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.685 2.257 . . . . 70.030000000000001 111.27 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -132.99 172.08 13.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.326 -0.852 . . . . 75.319999999999993 108.918 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -77.99 137.5 38.33 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.651 -0.42 . . . . 75.120000000000005 110.338 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.51 2.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.158 0.504 . . . . 62.310000000000002 110.664 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.1 151.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.887 -1.051 . . . . 74.540000000000006 111.064 177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -55.05 148.24 14.18 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.611 -0.722 . . . . 75.040000000000006 110.469 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -51.02 -43.71 60.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.357 1.243 . . . . 73.310000000000002 114.357 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.84 -33.82 68.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.976 0.417 . . . . 74.209999999999994 111.014 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -84.33 -26.63 28.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.618 -0.719 . . . . 60.409999999999997 111.969 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 p -74.29 -15.05 60.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.928 0.394 . . . . 74.530000000000001 111.178 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -85.61 -10.08 56.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.91 -0.586 . . . . 72.329999999999998 110.521 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.52 148.24 43.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 73.109999999999999 110.353 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.1 123.81 11.4 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.491 2.127 . . . . 72.420000000000002 111.842 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.91 12.44 34.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.005 -0.616 . . . . 72.209999999999994 112.299 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.5 7.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 111.395 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -97.39 13.76 28.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.003 0.43 . . . . 72.239999999999995 111.347 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -76.81 155.6 32.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.937 -0.764 . . . . 73.420000000000002 108.937 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.442 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.1 m -77.03 90.44 3.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.398 0.618 . . . . 64.439999999999998 110.043 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.41 112.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.427 -0.806 . . . . 74.010000000000005 110.625 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -104.91 17.27 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 74.239999999999995 110.729 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 138.99 52.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.419 -0.355 . . . . 75.120000000000005 110.981 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 pt -128.21 151.82 35.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.343 0.592 . . . . 75.430000000000007 111.734 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.578 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.9 t80 -100.36 133.12 45.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.623 -1.172 . . . . 75.129999999999995 109.667 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.15 110.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.899 -0.778 . . . . 74.150000000000006 108.899 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.38 154.22 19.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.826 -1.178 . . . . 43.140000000000001 112.819 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.96 8.4 58.02 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.633 -0.794 . . . . 72.549999999999997 112.164 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 147' ' ' GLY . 8.6 pt -72.28 93.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.305 0.574 . . . . 71.140000000000001 110.504 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -80.5 -25.31 38.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.818 -0.628 . . . . 75.25 110.799 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -88.85 161.1 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.67 -0.695 . . . . 65.340000000000003 110.534 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 145' ' ' LYS . 25.5 t70 -65.67 104.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.48 0.487 . . . . 72.200000000000003 109.99 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.5 m -109.34 130.43 55.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.853 -0.612 . . . . 72.219999999999999 110.804 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -112.71 175.24 5.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.002 -0.999 . . . . 71.129999999999995 111.13 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.47 -48.92 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.816 -1.083 . . . . 72.420000000000002 110.834 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -56.24 -37.27 69.52 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.275 0.359 . . . . 74.319999999999993 111.638 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.4 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 64.7 m170 -56.7 -60.74 3.12 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.412 0.445 . . . . 72.310000000000002 111.075 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.79 -26.99 29.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.904 -0.718 . . . . 75.140000000000001 111.59 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -66.07 -50.65 63.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.611 -0.144 . . . . 74.519999999999996 110.611 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.79 -24.43 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.039 0.447 . . . . 72.430000000000007 110.399 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -77.34 -57.32 3.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.898 -0.592 . . . . 72.239999999999995 111.878 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -68.58 -23.15 64.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.713 0.634 . . . . 75.540000000000006 112.713 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -69.54 -20.24 63.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 111.503 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -57.25 -28.92 63.38 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.879 -0.601 . . . . 64.519999999999996 111.078 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.66 -30.37 19.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.068 0.396 . . . . 72.439999999999998 112.068 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.2 -176.1 47.82 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.587 -0.816 . . . . 73.439999999999998 113.347 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -75.97 133.26 40.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.159 0.504 . . . . 73.230000000000004 111.178 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 152' ' ' THR . 75.8 mt -102.92 139.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.472 -0.785 . . . . 75.409999999999997 109.507 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -86.39 -50.83 6.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.462 . . . . 74.200000000000003 110.394 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.437 HG11 ' OE2' ' A' ' 135' ' ' GLU . 9.0 p -160.78 159.34 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.661 -0.7 . . . . 71.230000000000004 109.549 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.85 131.93 71.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.342 0.591 . . . . 74.040000000000006 110.693 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 4.1 mp0 -101.88 103.53 14.21 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.054 -0.975 . . . . 75.0 110.378 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.51 116.7 35.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.078 -0.712 . . . . 64.200000000000003 109.078 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 148' ' ' PHE . 73.8 mmm -93.72 124.75 37.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.012 -0.736 . . . . 71.530000000000001 109.012 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 149.53 29.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.637 -0.711 . . . . 65.510000000000005 110.143 -174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.06 107.11 9.19 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.85 -0.796 . . . . 74.129999999999995 108.85 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -67.72 -33.29 74.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 74.209999999999994 111.251 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.27 -43.58 10.47 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.775 -0.726 . . . . 45.240000000000002 112.956 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -23.1 19.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.67 0.271 . . . . 74.230000000000004 111.586 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.45 22.01 61.17 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.194 -0.527 . . . . 71.099999999999994 112.501 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.54 135.66 43.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 73.5 111.25 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HB3' ' OD1' ' A' ' 115' ' ' ASP . 15.3 ttmt -92.61 79.52 4.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 74.319999999999993 110.807 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.53 -179.14 0.51 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.669 -0.696 . . . . 74.530000000000001 111.089 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.425 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.87 -44.04 1.59 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.067 -0.969 . . . . 64.230000000000004 111.995 175.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 137' ' ' MET . 20.2 p90 -170.86 153.93 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.682 -0.858 . . . . 74.420000000000002 108.682 173.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.56 169.81 17.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.944 0.402 . . . . 74.25 109.969 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 72.4 m-85 -138.74 154.68 48.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 73.510000000000005 109.435 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.6 131.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.392 0.615 . . . . 74.299999999999997 111.546 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 131' ' ' ILE . 34.6 m -92.97 124.5 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.963 -1.017 . . . . 72.230000000000004 110.941 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.17 156.9 17.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.393 -0.367 . . . . 74.030000000000001 110.819 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.42 -25.78 46.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 110.582 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -131.1 148.08 52.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.727 -0.67 . . . . 72.400000000000006 110.822 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.442 ' CD2' HG23 ' A' ' 103' ' ' THR . 19.1 p80 -78.29 -27.24 47.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.625 -0.262 . . . . 74.140000000000001 110.76 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 20.8 t70 -64.72 -36.74 85.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.073 -0.512 . . . . 62.399999999999999 110.802 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 -32.74 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 64.409999999999997 110.56 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.4 t -70.77 -39.43 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.925 -0.58 . . . . 72.420000000000002 109.988 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.409 ' HA ' HG21 ' A' ' 163' ' ' VAL . 2.2 t70 -69.96 -33.5 72.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.643 -0.708 . . . . 73.0 111.332 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.9 mttt -54.0 -38.86 65.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.849 0.833 . . . . 75.510000000000005 109.954 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.3 mt -77.07 -43.58 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.126 -1.397 . . . . 73.120000000000005 112.398 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 159' ' ' VAL . 11.2 m -75.71 -11.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.891 -0.506 . . . . 73.299999999999997 110.769 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.51 -31.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.354 -0.839 . . . . 73.319999999999993 109.932 170.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.468 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -112.63 100.96 9.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.39 -0.967 . . . . 72.040000000000006 108.39 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.546 ' HB2' ' HZ2' ' A' ' 166' ' ' LYS . 3.1 ttmp? -58.35 -33.29 69.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.612 0.597 . . . . 73.439999999999998 112.612 -174.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.61 131.3 54.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.824 0.345 . . . . 73.049999999999997 110.92 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.468 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 84.4 m-70 -123.79 151.3 43.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 73.129999999999995 110.672 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 m -94.39 105.24 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.915 0.388 . . . . 73.409999999999997 110.072 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.3 t -117.52 130.57 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.066 -0.716 . . . . 70.340000000000003 109.066 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 53.02 34.56 17.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.863 0.84 . . . . 73.099999999999994 111.448 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 75.41 0.9 63.5 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.663 -0.699 . . . . 73.439999999999998 113.498 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -111.59 128.75 56.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.169 -0.308 . . . . 72.129999999999995 110.169 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.79 109.32 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.325 0.583 . . . . 74.25 110.707 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.84 156.31 20.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.197 -0.91 . . . . 72.5 109.816 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -89.47 131.14 35.66 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.91 0.385 . . . . 74.109999999999999 110.042 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.9 t -128.56 132.92 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.365 -0.834 . . . . 73.099999999999994 110.195 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -157.7 176.14 12.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.688 -0.687 . . . . 73.409999999999997 110.297 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -61.77 128.94 38.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.802 0.334 . . . . 74.340000000000003 110.841 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -107.92 113.54 26.83 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.212 0.53 . . . . 70.439999999999998 109.69 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.8 mt -99.01 147.3 25.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.389 -0.823 . . . . 75.120000000000005 109.509 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 186' ' ' MET . 8.0 m -68.27 152.98 44.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.509 -0.922 . . . . 73.200000000000003 108.509 172.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -60.99 -24.98 66.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.126 0.488 . . . . 73.400000000000006 110.773 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -68.37 -38.28 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 75.129999999999995 110.428 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -76.12 -33.07 59.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.659 -0.7 . . . . 71.140000000000001 110.721 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 182' ' ' SER . 90.9 mtp -74.34 -13.65 60.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 73.129999999999995 111.159 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.97 58.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.284 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.9 m 63.84 17.94 10.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.274 -0.875 . . . . 72.109999999999999 111.678 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.39 -177.76 5.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.587 -0.894 . . . . 65.109999999999999 108.587 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -67.89 116.61 8.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.821 -0.436 . . . . 53.310000000000002 109.821 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.2 t -139.57 119.17 13.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.079 -0.51 . . . . 62.009999999999998 110.184 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 p -112.94 100.86 8.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.787 -0.642 . . . . 73.150000000000006 109.856 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.25 149.77 35.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.928 0.394 . . . . 71.010000000000005 111.494 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -122.15 161.47 23.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 75.450000000000003 109.949 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.51 116.3 1.18 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.943 -0.646 . . . . 64.150000000000006 111.903 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 119.061 -0.495 . . . . 75.349999999999994 110.586 -179.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.733 -0.547 . . . . 70.230000000000004 111.733 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m 61.47 22.7 13.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.211 0.605 . . . . 73.319999999999993 112.149 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' OG1' ' A' ' 39' ' ' THR . 31.7 mtmm -127.12 10.13 6.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.09 0.471 . . . . 72.319999999999993 111.13 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m -151.26 106.75 3.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 74.420000000000002 109.684 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.85 150.44 51.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.34 -0.391 . . . . 63.100000000000001 111.331 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 103.84 52.67 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.63 -0.714 . . . . 74.510000000000005 109.451 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -84.44 165.28 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.688 2.258 . . . . 73.230000000000004 113.238 -175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -109.27 2.18 20.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.944 -0.762 . . . . 75.099999999999994 108.944 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.42 133.28 31.65 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 114.66 -1.154 . . . . 74.310000000000002 110.231 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HD2' HD22 ' A' ' 13' ' ' LEU . 27.5 Cg_endo -65.0 167.15 16.6 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.114 2.543 . . . . 72.209999999999994 111.323 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.19 -34.89 70.85 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 112.19 0.441 . . . . 71.299999999999997 112.19 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -68.49 -20.1 64.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.014 0.376 . . . . 72.400000000000006 112.014 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.0 mp -89.73 -14.3 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.316 . . . . 64.349999999999994 110.816 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 ptt85 -125.36 -2.96 7.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 64.299999999999997 111.676 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.7 ttpt -98.73 144.73 27.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.752 0.787 . . . . 74.549999999999997 111.22 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 87' ' ' LYS . 50.6 mt -120.2 146.92 45.56 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.326 -1.306 . . . . 75.340000000000003 110.969 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.71 115.67 29.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.33 -0.989 . . . . 64.430000000000007 108.33 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.2 mm -95.0 112.6 27.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.964 -0.384 . . . . 64.219999999999999 109.964 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.55 152.45 17.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.986 -0.626 . . . . 73.409999999999997 111.56 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.16 42.5 50.6 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.553 -0.832 . . . . 60.43 113.314 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD21 ' CG1' ' A' ' 84' ' ' VAL . 76.9 mt -77.94 174.02 11.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.929 0.364 . . . . 74.140000000000001 110.171 174.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -84.76 175.92 8.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 75.010000000000005 109.104 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.97 -9.5 59.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.297 0.57 . . . . 74.129999999999995 109.825 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -114.3 5.15 15.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.47 -0.786 . . . . 73.120000000000005 112.231 -172.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.407 ' HA ' ' OD2' ' A' ' 80' ' ' ASP . 84.9 m -73.0 126.03 29.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.387 0.613 . . . . 73.430000000000007 112.206 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 p -100.73 164.35 11.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.342 -0.844 . . . . 73.549999999999997 110.337 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -24.27 57.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.156 -0.313 . . . . 74.120000000000005 110.156 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -72.43 -37.69 68.53 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.175 0.297 . . . . 70.530000000000001 110.951 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -77.63 -38.26 48.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 71.120000000000005 110.285 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.43 -52.26 65.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.404 -0.816 . . . . 75.019999999999996 109.803 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.86 -60.54 3.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.06 -0.973 . . . . 74.120000000000005 112.009 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -48.31 -36.59 14.54 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.817 0.698 . . . . 74.409999999999997 112.663 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -67.66 -50.8 56.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.785 0.326 . . . . 72.25 110.714 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.44 -20.41 43.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.644 0.239 . . . . 64.349999999999994 111.644 -173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -60.65 -22.76 64.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.036 0.446 . . . . 63.409999999999997 111.476 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -67.48 -28.1 67.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.761 . . . . 71.200000000000003 112.148 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -96.69 -27.64 14.68 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.1 -0.24 . . . . 75.109999999999999 111.381 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.84 160.05 33.41 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.593 -0.813 . . . . 70.140000000000001 112.009 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 3' ' ' LYS . 24.5 m -64.6 120.12 11.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.676 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.8 mt -89.96 139.6 30.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.486 0.66 . . . . 74.420000000000002 111.174 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 p -105.8 -24.57 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.997 -1.001 . . . . 62.310000000000002 110.006 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -153.45 156.9 39.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.636 -0.711 . . . . 61.329999999999998 109.912 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 t -164.13 131.73 3.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.516 -0.55 . . . . 71.239999999999995 109.516 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.09 117.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.564 0.697 . . . . 71.340000000000003 110.416 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.45 136.04 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.058 -0.719 . . . . 62.32 109.058 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.9 mmt -83.18 97.45 8.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.638 0.732 . . . . 72.0 110.396 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 50.2 mtp85 -102.25 163.68 12.1 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.525 -1.216 . . . . 74.340000000000003 111.032 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.78 125.02 83.12 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 114.726 -1.125 . . . . 75.430000000000007 110.216 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.33 -12.73 34.38 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.93 1.753 . . . . 75.010000000000005 112.929 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -85.44 -56.96 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 73.219999999999999 111.77 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -103.26 -10.53 18.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 74.510000000000005 111.358 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 65.81 39.38 4.72 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.364 -0.835 . . . . 75.109999999999999 110.471 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -121.82 154.85 36.48 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.631 -0.507 . . . . 70.209999999999994 109.631 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.7 t -66.21 139.11 58.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.93 0.395 . . . . 62.030000000000001 111.68 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -84.33 -1.85 56.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 74.340000000000003 110.465 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.87 57.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.883 -0.675 . . . . 74.310000000000002 113.962 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -157.27 157.43 34.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.189 0.995 . . . . 75.230000000000004 111.078 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.21 -166.07 18.32 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.387 -0.685 . . . . 71.409999999999997 111.387 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 3.7 m-85 -141.31 149.97 41.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.588 0.694 . . . . 73.439999999999998 110.833 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.53 123.82 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.566 -0.743 . . . . 75.349999999999994 109.869 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.5 m -99.03 118.75 36.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.642 -0.254 . . . . 74.140000000000001 110.498 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.7 169.6 14.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.263 -0.426 . . . . 71.329999999999998 110.62 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.34 -51.56 14.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.843 -0.617 . . . . 75.400000000000006 109.892 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -123.8 155.28 38.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 64.230000000000004 110.606 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -62.22 -34.82 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.663 0.268 . . . . 72.420000000000002 111.308 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -57.97 -37.82 74.9 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.221 0.452 . . . . 72.439999999999998 112.221 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.38 -35.12 78.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.245 0.545 . . . . 62.329999999999998 110.006 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 5.2 t -64.86 -47.6 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.117 -0.947 . . . . 71.329999999999998 110.663 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.93 -52.74 62.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 63.210000000000001 110.626 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.64 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.693 0.627 . . . . 54.340000000000003 112.693 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.18 68.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.938 0.399 . . . . 71.049999999999997 110.703 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.4 mmt -67.79 -43.18 80.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.58 . . . . 74.319999999999993 110.764 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.64 -40.35 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.126 0.488 . . . . 62.43 110.568 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.45 -16.59 64.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.177 -0.92 . . . . 74.430000000000007 112.909 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 75' ' ' ARG . 27.7 mtp-105 -54.09 147.23 26.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.233 0.457 . . . . 71.230000000000004 112.233 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.4 168.41 71.86 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.475 -1.469 . . . . 65.200000000000003 113.732 3.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -121.23 162.22 20.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.239 -0.891 . . . . 73.340000000000003 110.346 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.9 ttmt -136.74 111.85 9.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 73.530000000000001 111.604 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.4 130.51 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 64.140000000000001 109.742 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 4.3 m-20 65.07 29.85 11.91 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.804 0.69 . . . . 75.510000000000005 111.96 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.82 24.73 68.89 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.793 -0.718 . . . . 72.049999999999997 112.445 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.9 tpt180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.448 -0.575 . . . . 73.150000000000006 109.448 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.89 113.18 23.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.791 0.805 . . . . 75.329999999999998 109.368 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' HD21 ' A' ' 21' ' ' LEU . 3.2 m -102.83 151.07 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 74.510000000000005 111.236 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 3.5 tp10 -113.11 97.25 41.88 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.79 -1.095 . . . . 60.539999999999999 111.117 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -73.48 129.49 13.84 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.311 2.007 . . . . 74.420000000000002 111.221 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' O ' HD21 ' A' ' 16' ' ' LEU . 19.7 mttt -134.71 -179.02 5.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.349 -1.723 . . . . 73.120000000000005 106.349 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -86.7 141.16 29.11 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 119.581 1.082 . . . . 73.340000000000003 110.855 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 95.47 0.6 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.071 -0.513 . . . . 72.329999999999998 110.663 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.58 133.57 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.666 -0.697 . . . . 74.049999999999997 109.593 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 t -78.61 174.0 11.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 63.509999999999998 110.859 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -49.2 -54.58 15.88 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.964 0.906 . . . . 73.409999999999997 113.302 -171.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.79 -36.61 65.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.904 0.335 . . . . 74.219999999999999 111.904 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -11.52 58.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.951 0.352 . . . . 74.340000000000003 111.951 -176.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.6 p -97.81 2.48 49.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.565 0.222 . . . . 73.349999999999994 111.266 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.96 -37.68 88.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.29 -0.414 . . . . 74.209999999999994 111.074 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -92.57 145.6 30.77 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.328 -0.396 . . . . 75.420000000000002 110.261 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.44 151.12 70.84 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.913 2.409 . . . . 74.219999999999999 111.847 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.71 8.87 57.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.608 -0.806 . . . . 71.310000000000002 111.925 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.87 -49.04 15.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 64.329999999999998 110.562 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -92.77 3.76 55.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 71.0 111.381 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.6 mt -82.79 158.56 22.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 72.439999999999998 109.782 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -76.31 93.49 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.803 0.811 . . . . 74.409999999999997 110.511 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.9 t -120.26 108.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.749 -1.114 . . . . 74.349999999999994 109.913 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 156' ' ' HIS . 53.7 mttt -100.09 10.49 41.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 72.439999999999998 110.776 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.52 140.68 49.11 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.11 -0.496 . . . . 72.030000000000001 111.106 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.9 pt -122.84 149.88 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.258 0.552 . . . . 75.040000000000006 111.969 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.6 t80 -98.43 133.8 42.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.883 -1.053 . . . . 72.439999999999998 109.054 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.56 109.23 22.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.491 -0.559 . . . . 71.420000000000002 109.491 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.26 149.96 17.0 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.209 -0.996 . . . . 65.439999999999998 113.05 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.56 25.62 38.41 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.335 -0.936 . . . . 64.209999999999994 112.595 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.492 ' HB ' ' OG1' ' A' ' 116' ' ' THR . 5.2 pt -68.91 131.48 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 74.519999999999996 109.946 174.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 65.2 tttp -82.93 107.17 15.34 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.343 0.868 . . . . 74.319999999999993 113.343 -164.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 0.5 OUTLIER 73.27 -53.2 0.7 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.405 1.066 . . . . 63.0 113.456 167.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -165.46 112.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.833 -0.432 . . . . 61.340000000000003 109.833 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 112' ' ' ILE . 14.9 m -123.66 136.77 54.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.283 0.563 . . . . 74.439999999999998 109.629 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -110.88 171.89 7.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.694 -0.684 . . . . 74.129999999999995 111.139 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.44 -49.59 75.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 114.79 -1.095 . . . . 74.409999999999997 110.562 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -54.91 -35.0 63.68 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.399 0.437 . . . . 73.140000000000001 111.783 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.18 -61.18 2.42 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.281 0.363 . . . . 71.329999999999998 111.056 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.77 -23.66 31.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.197 -0.601 . . . . 72.109999999999999 111.46 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -65.33 -55.36 18.69 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.937 -0.394 . . . . 74.209999999999994 109.937 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.323 0.582 . . . . 72.450000000000003 110.495 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -76.32 -56.64 4.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.359 -0.837 . . . . 70.299999999999997 112.22 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.434 ' CD2' HG22 ' A' ' 151' ' ' VAL . 43.1 m-85 -68.95 -23.02 64.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.685 0.254 . . . . 75.439999999999998 111.685 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mm-40 -64.4 -24.54 67.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.027 0.442 . . . . 73.200000000000003 110.905 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.0 -27.42 68.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.822 -0.626 . . . . 72.0 111.777 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.53 -25.79 22.34 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.77 0.285 . . . . 73.510000000000005 111.77 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.25 -175.82 46.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.536 -0.84 . . . . 74.519999999999996 113.312 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -75.47 125.61 29.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 74.200000000000003 112.067 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 152' ' ' THR . 52.8 mt -98.17 136.1 30.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 74.439999999999998 110.301 176.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.29 -50.49 8.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.309 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.56 157.96 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 75.340000000000003 110.091 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.4 128.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.321 0.582 . . . . 72.329999999999998 110.519 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.47 ' HG2' ' HA3' ' A' ' 195' ' ' GLY . 35.7 mt-10 -100.29 104.89 16.38 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.255 -0.884 . . . . 70.219999999999999 110.859 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.65 122.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.229 -0.656 . . . . 73.420000000000002 109.229 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.6 mmm -101.95 135.97 42.6 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.636 -0.876 . . . . 74.239999999999995 108.636 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.51 156.95 16.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 73.450000000000003 111.913 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 143.16 48.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.354 -0.839 . . . . 74.200000000000003 109.937 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -64.04 -47.53 79.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 70.109999999999999 111.596 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.36 -47.13 1.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.327 -0.94 . . . . 63.450000000000003 113.951 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.1 p -81.26 -23.02 38.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.895 0.331 . . . . 71.209999999999994 111.895 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 16.72 80.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 72.120000000000005 112.405 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.95 163.6 16.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.875 -0.787 . . . . 73.420000000000002 108.875 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -90.15 77.66 6.72 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.793 -0.363 . . . . 75.540000000000006 110.075 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -160.74 170.38 20.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.946 0.879 . . . . 64.340000000000003 112.787 -179.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.424 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.98 -44.67 1.46 Allowed Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 113.466 -1.697 . . . . 75.420000000000002 110.56 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -171.54 145.87 2.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.374 -0.602 . . . . 74.010000000000005 109.374 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.51 170.49 14.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.628 -0.714 . . . . 70.129999999999995 109.112 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.508 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -136.24 143.4 44.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.844 -0.616 . . . . 74.019999999999996 109.404 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.434 HG22 ' CD2' ' A' ' 125' ' ' PHE . 58.0 t -129.2 121.73 54.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 O-C-N 122.164 -0.335 . . . . 72.430000000000007 110.483 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 131' ' ' ILE . 85.9 m -96.16 118.92 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.678 -0.692 . . . . 74.040000000000006 110.821 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -102.75 156.64 17.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.601 0.238 . . . . 71.540000000000006 110.889 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.22 -29.71 65.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 71.109999999999999 110.288 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.478 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 1.9 t0 -139.06 159.96 40.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.587 -0.733 . . . . 65.25 110.887 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 15.9 p80 -79.18 -19.87 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 75.409999999999997 110.115 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.591 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 1.3 p-10 -60.84 -38.23 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.029 -0.987 . . . . 70.510000000000005 110.979 -174.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -73.85 -31.08 63.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.132 -0.486 . . . . 65.340000000000003 110.227 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.82 -39.01 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.677 -0.692 . . . . 74.010000000000005 109.835 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.92 -26.77 63.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 62.140000000000001 111.242 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 71.7 mttt -69.07 -33.67 73.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.315 0.579 . . . . 70.340000000000003 110.265 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.3 mt -78.02 -42.68 28.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.564 -0.744 . . . . 75.129999999999995 112.672 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.3 m -70.64 -6.14 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.001 0.429 . . . . 75.219999999999999 111.434 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 71.5 mt -54.91 -38.79 46.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.191 -0.913 . . . . 72.299999999999997 109.861 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -109.49 105.28 14.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.578 -0.897 . . . . 73.150000000000006 108.578 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -55.04 -32.34 61.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.864 -0.607 . . . . 65.439999999999998 111.706 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -124.91 133.9 52.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.455 -0.339 . . . . 75.230000000000004 110.687 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -120.98 144.64 48.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.853 -0.612 . . . . 62.329999999999998 109.887 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.8 m -114.03 106.23 14.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.355 -0.384 . . . . 72.310000000000002 110.569 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.91 114.73 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.309 -0.405 . . . . 75.140000000000001 111.203 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.41 31.74 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.759 0.79 . . . . 61.240000000000002 109.656 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.94 5.46 86.14 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.497 -0.774 . . . . 74.450000000000003 112.385 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.551 ' CD2' ' HB3' ' A' ' 113' ' ' LYS . 61.5 m170 -106.04 110.21 22.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.199 -0.297 . . . . 74.150000000000006 110.199 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.75 107.81 19.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.151 0.5 . . . . 75.140000000000001 109.737 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 p -117.05 156.22 27.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 73.019999999999996 111.451 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.31 134.92 33.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.756 -0.657 . . . . 74.409999999999997 109.853 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 26.9 t -130.9 134.0 62.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.166 0.508 . . . . 72.150000000000006 110.667 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -152.92 173.5 15.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.559 -0.746 . . . . 71.040000000000006 111.372 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -65.68 130.31 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.263 -0.426 . . . . 74.400000000000006 110.298 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -120.75 122.34 40.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.478 . . . . 74.420000000000002 109.711 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.4 mt -80.25 131.44 35.68 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.743 -0.383 . . . . 73.540000000000006 110.375 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 186' ' ' MET . 28.7 t -62.34 154.57 27.57 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.498 -0.556 . . . . 70.450000000000003 109.498 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -58.59 -31.37 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.188 0.518 . . . . 75.219999999999999 110.137 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -58.88 -41.29 86.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.046 -0.979 . . . . 75.530000000000001 110.46 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -37.09 29.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 75.120000000000005 111.291 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' A' ' 182' ' ' SER . 80.5 mtp -66.31 -45.74 79.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.269 -0.423 . . . . 75.040000000000006 111.076 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -87.3 -4.51 59.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 73.230000000000004 111.054 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.0 p 45.04 58.48 4.02 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.032 0.933 . . . . 63.32 111.567 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.67 11.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.379 -0.828 . . . . 61.119999999999997 110.432 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.5 t -80.17 99.2 7.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.799 -0.445 . . . . 75.510000000000005 109.799 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.2 m -149.21 167.01 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 71.019999999999996 110.35 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.5 m -127.46 150.76 49.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 74.310000000000002 109.599 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -124.24 115.02 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 64.109999999999999 111.012 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -130.76 148.82 52.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.508 . . . . 72.329999999999998 110.712 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 135' ' ' GLU . . . -118.64 144.35 17.92 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.296 -0.722 . . . . 61.340000000000003 111.296 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.454 -0.784 . . . . 64.140000000000001 109.631 -179.474 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.788 -0.525 . . . . 70.329999999999998 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 p -80.62 81.37 6.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.503 0.668 . . . . 74.129999999999995 110.453 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -88.74 97.11 10.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.792 -0.64 . . . . 74.430000000000007 110.907 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -77.79 143.96 37.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.525 -0.761 . . . . 73.120000000000005 109.46 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.55 92.54 1.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.45 . . . . 71.030000000000001 111.407 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.527 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 m -71.47 -48.44 12.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.561 -0.745 . . . . 73.340000000000003 111.814 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 6' ' ' SER . 17.1 Cg_endo -56.8 149.49 59.9 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.452 2.101 . . . . 73.209999999999994 113.1 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.8 12.22 22.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.514 -0.766 . . . . 74.409999999999997 110.675 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -76.09 130.93 76.73 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.246 -0.65 . . . . 74.420000000000002 109.246 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.67 166.36 15.93 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.26 1.973 . . . . 71.450000000000003 111.97 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -41.24 64.41 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.566 -0.743 . . . . 72.439999999999998 112.397 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -71.39 -27.37 63.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.818 0.342 . . . . 73.430000000000007 111.842 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -84.51 -6.16 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.493 -0.322 . . . . 75.099999999999994 111.024 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -127.81 6.17 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.981 0.419 . . . . 74.340000000000003 110.685 176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -98.31 146.72 25.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.401 0.62 . . . . 74.019999999999996 111.16 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 87' ' ' LYS . 58.0 mt -115.48 143.47 45.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.664 -1.153 . . . . 72.099999999999994 110.704 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -97.86 120.81 38.92 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.622 -0.881 . . . . 71.439999999999998 108.622 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.49 111.63 29.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 110.093 -0.336 . . . . 74.200000000000003 110.093 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.78 151.26 17.29 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 121.089 -0.577 . . . . 70.219999999999999 111.713 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.9 44.54 55.53 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.683 -0.77 . . . . 71.120000000000005 113.142 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.422 HD23 ' CG1' ' A' ' 84' ' ' VAL . 84.2 mt -78.08 173.73 11.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.736 -0.468 . . . . 72.140000000000001 109.736 171.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -86.11 -178.16 6.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.026 0.441 . . . . 70.010000000000005 110.012 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -81.02 -9.0 59.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.045 -0.525 . . . . 73.310000000000002 110.09 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 19.8 mt-10 -121.81 18.99 11.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.629 0.603 . . . . 72.439999999999998 112.629 -173.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -78.36 115.33 18.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.875 0.369 . . . . 63.409999999999997 110.964 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -97.47 158.76 15.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 110.447 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.664 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 9.6 t0 -59.33 -43.22 92.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.054 0.542 . . . . 55.439999999999998 111.152 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.62 -34.81 77.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.755 . . . . 71.239999999999995 111.543 -175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 m -79.19 -36.37 40.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.452 -0.34 . . . . 70.540000000000006 110.802 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -65.52 -51.72 57.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 74.239999999999995 110.013 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.23 -60.55 3.19 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.304 -0.862 . . . . 65.329999999999998 112.117 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 t -48.67 -33.51 10.14 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.809 0.693 . . . . 75.450000000000003 112.843 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.433 ' ND1' HG21 ' A' ' 79' ' ' VAL . 11.2 t-80 -73.23 -56.12 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.222 -0.191 . . . . 74.409999999999997 110.892 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.45 -23.96 63.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.938 0.347 . . . . 74.409999999999997 111.938 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -57.79 -20.95 39.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.504 0.722 . . . . 72.019999999999996 112.114 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.42 -29.27 69.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.88 0.326 . . . . 73.439999999999998 111.88 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -96.27 -20.82 18.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.689 0.28 . . . . 63.439999999999998 111.203 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.79 164.39 32.77 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.34 -0.933 . . . . 73.439999999999998 112.309 173.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.7 m -62.92 119.79 10.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 73.219999999999999 111.699 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.96 117.04 26.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.739 -0.664 . . . . 75.510000000000005 110.777 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -84.36 -25.71 28.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.037 -0.983 . . . . 74.549999999999997 110.269 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -149.58 150.29 32.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.447 -0.797 . . . . 72.439999999999998 109.486 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.3 t -160.54 138.7 9.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.949 -0.76 . . . . 72.409999999999997 108.949 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.664 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 5.7 p -152.23 122.54 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 121.434 0.635 . . . . 74.010000000000005 111.005 171.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.49 136.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.402 -0.962 . . . . 73.299999999999997 108.402 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.531 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -81.7 100.41 9.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.595 0.712 . . . . 72.019999999999996 110.524 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -101.83 158.11 16.36 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.66 -1.155 . . . . 74.109999999999999 109.205 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.36 132.96 64.62 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.039 -0.356 . . . . 75.120000000000005 110.039 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -22.4 73.18 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.389 2.06 . . . . 43.009999999999998 113.681 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -86.32 -55.71 3.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.288 0.566 . . . . 75.209999999999994 110.792 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -95.84 -14.78 22.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.123 -0.944 . . . . 74.349999999999994 112.346 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm 64.62 26.13 13.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.552 0.741 . . . . 72.439999999999998 111.307 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 23.5 mmm180 -109.18 156.76 19.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.766 -0.457 . . . . 72.409999999999997 109.766 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 m -68.37 132.02 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.178 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -85.84 3.18 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.69 -0.686 . . . . 75.310000000000002 111.225 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 11.44 65.47 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.585 -0.817 . . . . 61.229999999999997 114.069 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.5 p90 -153.82 155.75 36.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.784 0.792 . . . . 75.049999999999997 110.712 175.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.16 -169.51 23.55 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.382 -0.687 . . . . 53.539999999999999 111.382 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.23 142.4 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.178 0.489 . . . . 74.109999999999999 110.389 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 m -126.85 128.19 70.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 64.530000000000001 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 m -104.6 122.06 44.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.525 -0.307 . . . . 70.310000000000002 110.239 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.409 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 31.9 m-85 -88.73 161.37 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.483 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.78 83.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.509 -0.769 . . . . 73.109999999999999 110.744 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.599 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 16.5 m -131.12 154.34 48.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.107 -0.497 . . . . 72.5 110.463 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -65.63 -34.0 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 111.658 0.244 . . . . 64.299999999999997 111.658 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.03 -43.7 78.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.967 0.358 . . . . 72.040000000000006 111.967 175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.599 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 2.7 mp0 -62.01 -33.23 73.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 72.540000000000006 110.644 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 42.3 t -64.21 -50.23 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.281 -0.872 . . . . 74.420000000000002 110.97 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.02 -41.1 91.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.248 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.86 67.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.327 -0.397 . . . . 73.439999999999998 112.026 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.23 66.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 71.430000000000007 110.665 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -37.21 86.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.227 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -28.19 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 64.310000000000002 111.001 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.29 -9.64 54.17 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.741 0.645 . . . . 65.319999999999993 112.741 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 75' ' ' ARG . 24.8 mtp-105 -58.04 146.23 69.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.456 -0.338 . . . . 72.329999999999998 111.501 175.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.01 153.2 99.02 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.967 -1.264 . . . . 64.239999999999995 114.049 3.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -108.65 153.31 23.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.054 -0.976 . . . . 65.150000000000006 110.731 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 13.6 ttmt -136.42 103.16 5.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.037 0.446 . . . . 73.530000000000001 111.198 175.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.433 HG21 ' ND1' ' A' ' 33' ' ' HIS . 21.9 t -107.97 131.52 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.613 -0.721 . . . . 73.400000000000006 109.676 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.0 t70 64.91 29.77 12.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.791 0.805 . . . . 55.109999999999999 110.564 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.35 76.34 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.549 -0.75 . . . . 37.130000000000003 112.16 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 24.8 tpt180 -125.59 136.94 53.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.884 -0.413 . . . . 74.310000000000002 109.884 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.04 109.52 13.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.776 0.798 . . . . 72.439999999999998 109.623 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.422 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.5 m -105.67 152.86 7.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.505 -0.771 . . . . 75.430000000000007 110.787 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -112.07 97.24 37.84 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.423 -0.808 . . . . 73.109999999999999 110.879 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.81 129.63 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.149 1.899 . . . . 75.319999999999993 110.429 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' O ' HD21 ' A' ' 16' ' ' LEU . 25.9 mttt -135.18 179.42 6.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 74.120000000000005 107.781 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 7.8 tpp180 -79.26 162.7 25.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.324 -0.551 . . . . 73.129999999999995 109.667 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.66 93.26 5.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.466 -0.568 . . . . 73.030000000000001 109.466 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.1 154.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.001 -0.999 . . . . 72.439999999999998 111.396 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -59.92 146.98 40.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.59 -0.732 . . . . 60.130000000000003 110.091 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -65.63 -19.17 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.341 -0.39 . . . . 74.239999999999995 111.359 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.39 -39.32 88.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 73.230000000000004 111.65 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.28 -22.02 48.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.226 0.536 . . . . 74.439999999999998 110.12 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 20.1 t -70.41 -0.53 8.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.518 -0.765 . . . . 74.200000000000003 111.233 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -71.08 -24.96 62.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 74.430000000000007 110.222 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -77.78 146.2 72.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 110.216 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.43 114.94 3.82 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.657 2.238 . . . . 74.120000000000005 112.191 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.74 10.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.77 -0.729 . . . . 64.409999999999997 112.185 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -72.79 -27.17 61.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.759 0.314 . . . . 53.539999999999999 111.294 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -99.83 11.85 38.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.359 . . . . 72.030000000000001 111.008 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.16 167.23 19.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.958 -0.756 . . . . 74.230000000000004 108.958 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.453 HG22 ' CD2' ' A' ' 156' ' ' HIS . 7.8 m -75.55 90.17 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 111.054 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.49 115.63 50.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.284 -0.871 . . . . 72.430000000000007 109.831 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.468 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.1 mttt -109.11 22.26 16.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 110.958 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -123.84 140.44 52.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.459 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.4 pt -127.79 154.03 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.164 0.507 . . . . 72.150000000000006 111.812 176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.2 t80 -100.27 137.19 39.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.835 -1.075 . . . . 72.239999999999995 109.384 175.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.03 113.1 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 75.140000000000001 109.533 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.15 152.89 19.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.014 -1.089 . . . . 64.319999999999993 113.072 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.03 6.35 24.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 75.219999999999999 112.61 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.8 pt -79.95 100.36 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.739 0.78 . . . . 63.240000000000002 110.813 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -93.03 3.37 55.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.872 -0.604 . . . . 75.120000000000005 111.193 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.12 165.58 16.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.093 -0.706 . . . . 74.420000000000002 109.093 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.71 99.94 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.371 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -91.22 139.74 30.45 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.853 -0.612 . . . . 73.239999999999995 109.683 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CD ' ' HZ2' ' A' ' 145' ' ' LYS . 11.7 mm-40 -104.46 165.73 10.86 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.502 -0.772 . . . . 70.409999999999997 110.866 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -47.84 84.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.091 -1.413 . . . . 73.400000000000006 108.768 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -55.26 -30.82 60.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.413 -0.812 . . . . 72.299999999999997 111.959 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -66.84 -62.37 1.48 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.213 0.53 . . . . 74.319999999999993 110.844 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 pp -82.42 -24.03 34.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.038 -0.665 . . . . 73.540000000000006 111.458 -172.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.5 tmm_? -66.14 -49.29 67.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.212 -0.292 . . . . 72.109999999999999 110.212 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.33 -30.11 70.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.276 0.56 . . . . 73.420000000000002 110.78 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -80.59 -54.93 5.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 64.450000000000003 112.209 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' CD2' HG21 ' A' ' 151' ' ' VAL . 21.0 m-85 -68.38 -22.79 64.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.679 0.622 . . . . 74.340000000000003 112.679 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mt-10 -68.66 -23.32 64.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.682 0.277 . . . . 72.010000000000005 111.276 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -60.88 -24.99 66.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 75.430000000000007 111.586 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -85.4 -27.42 25.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.405 . . . . 73.319999999999993 111.365 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.63 -177.8 43.56 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.707 -0.758 . . . . 74.109999999999999 113.223 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -74.11 133.62 42.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.956 0.408 . . . . 74.140000000000001 111.194 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.83 139.37 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.724 -0.671 . . . . 73.420000000000002 109.789 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.93 -50.74 6.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.317 0.58 . . . . 63.119999999999997 110.095 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -156.13 157.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.32 -0.855 . . . . 73.219999999999999 109.638 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -114.5 128.18 71.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.26 0.552 . . . . 74.219999999999999 109.794 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.46 126.01 45.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.174 -0.921 . . . . 60.340000000000003 110.232 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.5 mm -119.65 114.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.249 -1.019 . . . . 73.019999999999996 108.249 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mmm -91.14 120.42 32.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.399 -0.593 . . . . 73.340000000000003 109.399 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.32 142.8 27.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.145 0.497 . . . . 74.329999999999998 112.172 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -55.48 121.64 9.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.794 -1.094 . . . . 74.030000000000001 108.748 170.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -71.86 -27.21 62.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.828 0.307 . . . . 72.120000000000005 111.828 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -94.3 -44.11 3.58 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.377 -0.916 . . . . 44.310000000000002 112.611 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.4 m -89.26 -23.85 22.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.82 0.304 . . . . 74.209999999999994 111.82 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.2 24.09 64.45 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.138 -0.553 . . . . 60.219999999999999 113.303 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -100.98 162.64 12.75 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.851 -0.425 . . . . 74.310000000000002 109.851 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HZ2' ' CD ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -98.07 82.71 3.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.762 -0.459 . . . . 72.450000000000003 109.762 -179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -155.4 -179.96 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.375 0.607 . . . . 72.409999999999997 111.856 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.65 3.59 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.593 -1.185 . . . . 63.439999999999998 112.949 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -173.49 158.62 3.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.317 0.558 . . . . 74.200000000000003 109.769 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.04 173.72 11.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.292 -0.632 . . . . 61.039999999999999 109.292 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.48 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 36.7 m-85 -138.06 143.94 40.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.298 -0.41 . . . . 74.030000000000001 110.133 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 125' ' ' PHE . 50.7 t -126.96 127.77 70.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 O-C-N 122.002 -0.436 . . . . 75.219999999999999 110.828 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 131' ' ' ILE . 63.5 m -106.89 120.22 41.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.613 -0.721 . . . . 73.340000000000003 111.222 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -103.37 160.81 14.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.295 0.569 . . . . 74.219999999999999 111.7 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.09 -27.26 39.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.029 -0.987 . . . . 74.200000000000003 110.71 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -129.58 155.15 46.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 71.340000000000003 110.685 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.453 ' CD2' HG22 ' A' ' 103' ' ' THR . 21.9 p80 -77.51 -29.05 52.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 73.25 110.631 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 13.5 t0 -56.5 -43.58 79.85 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.799 -1.092 . . . . 65.040000000000006 111.602 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.1 t -63.23 -36.57 84.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.821 -0.627 . . . . 73.239999999999995 111.312 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.468 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.9 t -70.44 -39.99 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.146 0.498 . . . . 63.310000000000002 109.986 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 4.8 t70 -68.76 -33.42 73.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.975 -1.011 . . . . 75.120000000000005 111.032 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.5 mttt -59.04 -40.74 85.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.564 0.697 . . . . 72.430000000000007 110.716 173.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.81 -40.61 46.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.634 -1.167 . . . . 71.010000000000005 111.893 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 160' ' ' ASP . 30.7 m -78.34 -9.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.064 0.459 . . . . 71.120000000000005 111.102 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.13 -33.1 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.641 -0.709 . . . . 73.439999999999998 109.933 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 49.2 mt-30 -113.89 106.18 14.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.763 -0.653 . . . . 73.109999999999999 109.378 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.31 -34.49 57.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.262 0.838 . . . . 74.219999999999999 113.262 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.62 144.12 50.35 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.006 -0.278 . . . . 75.439999999999998 110.502 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.9 m-70 -132.49 151.81 51.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.936 176.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 130.05 55.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.916 0.389 . . . . 75.109999999999999 110.701 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.63 140.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.872 -0.788 . . . . 74.420000000000002 108.872 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.1 m120 48.45 30.27 2.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.391 0.886 . . . . 64.209999999999994 113.391 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.96 -0.71 89.58 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.907 -0.663 . . . . 71.400000000000006 114.118 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.49 ' HD2' ' SG ' ' A' ' 175' ' ' CYS . 10.9 p-80 -113.83 135.16 54.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.908 0.854 . . . . 75.099999999999994 110.859 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -99.6 116.49 31.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 65.120000000000005 110.42 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.49 ' SG ' ' HD2' ' A' ' 173' ' ' HIS . 55.8 m -117.21 157.09 26.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 71.420000000000002 111.096 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.4 141.87 28.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.609 . . . . 60.420000000000002 110.368 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.3 m -131.37 162.14 39.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.956 -0.565 . . . . 75.219999999999999 111.075 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -174.09 171.83 3.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.952 -1.022 . . . . 55.200000000000003 111.687 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -60.79 129.96 44.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.879 -0.601 . . . . 73.129999999999995 110.651 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.12 114.1 25.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.34 0.59 . . . . 74.200000000000003 109.61 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.55 160.57 14.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.273 -0.876 . . . . 71.409999999999997 109.738 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.8 t -63.28 152.67 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.921 -0.77 . . . . 73.239999999999995 108.921 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -60.68 -25.75 66.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.506 0.193 . . . . 74.239999999999995 111.331 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -67.63 -43.75 79.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.807 0.337 . . . . 75.519999999999996 110.426 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -67.32 -42.61 83.33 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 74.140000000000001 110.221 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 23.9 mtt -60.78 -40.62 93.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.269 -0.878 . . . . 73.209999999999994 111.141 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.01 75.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.977 -0.556 . . . . 73.239999999999995 110.399 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m 71.76 -43.84 0.57 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.076 0.95 . . . . 60.200000000000003 112.037 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.96 69.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.736 0.414 . . . . 64.5 110.913 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.2 m -68.42 105.12 2.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.035 -0.529 . . . . 74.439999999999998 109.594 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 m -143.54 162.17 36.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.466 -0.334 . . . . 60.149999999999999 111.057 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 17.3 m -113.02 85.99 2.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.340000000000003 109.709 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.44 -57.43 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.72 -0.673 . . . . 73.109999999999999 109.955 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -152.45 93.06 1.75 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.04 -0.527 . . . . 74.5 110.296 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -84.53 -54.64 2.9 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.15 -1.18 . . . . 62.219999999999999 110.15 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.489 -0.767 . . . . 74.409999999999997 109.039 175.516 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.009 -0.436 . . . . 51.229999999999997 112.009 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.1 m -83.8 82.59 8.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.162 0.506 . . . . 62.509999999999998 110.388 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -148.09 -72.89 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.14 -0.689 . . . . 75.219999999999999 109.14 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -107.14 126.07 51.9 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.607 -0.516 . . . . 62.329999999999998 109.607 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -112.7 142.87 44.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.377 . . . . 74.549999999999997 110.667 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m -114.06 95.03 36.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.795 -0.639 . . . . 64.120000000000005 109.406 173.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 94.1 Cg_endo -78.54 166.16 24.28 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.815 2.343 . . . . 74.120000000000005 112.677 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -21.18 22.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 64.329999999999998 110.334 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.451 ' OE2' HG11 ' A' ' 65' ' ' VAL . 1.8 mp0 -71.67 132.05 85.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.708 . . . . 75.540000000000006 110.627 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.99 166.36 23.11 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.756 2.304 . . . . 73.239999999999995 111.134 175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.9 pt-20 -60.05 -32.9 71.35 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 119.559 -0.257 . . . . 71.530000000000001 111.686 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.42 -25.04 61.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.654 0.264 . . . . 73.239999999999995 111.602 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mp -87.53 -8.69 56.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.705 0.288 . . . . 74.049999999999997 111.064 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -125.79 2.95 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.481 -0.327 . . . . 75.109999999999999 111.078 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 15.1 ttmm -93.47 146.21 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.54 0.686 . . . . 73.430000000000007 111.502 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 141.3 49.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.491 -1.231 . . . . 65.049999999999997 110.079 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -98.33 116.04 29.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.784 -0.821 . . . . 72.209999999999994 108.784 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -93.13 110.85 23.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.999 -0.371 . . . . 72.129999999999995 109.999 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.23 152.2 17.99 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.834 -0.698 . . . . 64.209999999999994 111.679 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.6 41.77 56.53 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.019 -0.61 . . . . 74.150000000000006 113.618 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.8 mt -75.84 175.15 9.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.92 0.36 . . . . 75.519999999999996 110.382 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.3 p -88.15 172.33 9.57 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.516 -0.55 . . . . 54.210000000000001 109.516 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.04 -5.6 47.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.648 0.261 . . . . 65.239999999999995 111.176 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.88 21.67 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.105 0.409 . . . . 65.140000000000001 112.105 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 m -75.16 121.74 22.55 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 73.230000000000004 110.557 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -99.11 154.64 17.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.885 -0.413 . . . . 71.329999999999998 109.885 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -64.86 -35.24 80.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 111.356 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.96 -36.77 80.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 74.420000000000002 111.211 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -76.87 -34.43 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 75.219999999999999 110.734 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.9 tp -65.88 -42.87 89.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.035 -0.53 . . . . 64.430000000000007 109.862 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 19.2 ttm-85 -60.03 -57.97 10.53 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.393 -0.367 . . . . 64.310000000000002 110.127 176.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -50.06 -36.87 30.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.151 -0.931 . . . . 74.329999999999998 112.926 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -70.89 -58.38 3.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.433 -0.349 . . . . 75.099999999999994 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -70.53 -22.48 62.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.196 0.443 . . . . 74.200000000000003 112.196 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.1 tt0 -63.39 -17.81 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.095 0.558 . . . . 63.130000000000003 111.898 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.35 -28.43 69.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.389 -0.368 . . . . 64.349999999999994 111.343 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.14 -21.73 14.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 75.140000000000001 111.567 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -166.71 154.16 24.42 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.48 -0.867 . . . . 62.310000000000002 112.027 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -65.22 117.76 8.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 65.109999999999999 111.408 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 31' ' ' ARG . 57.2 mt -86.85 134.65 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.565 0.698 . . . . 73.010000000000005 111.4 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.189 -0.914 . . . . 64.450000000000003 110.254 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -151.16 152.3 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.618 -0.719 . . . . 63.439999999999998 109.956 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -161.73 133.65 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.021 -0.363 . . . . 71.450000000000003 110.021 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.31 125.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.311 0.577 . . . . 60.439999999999998 110.734 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.1 t -86.83 131.41 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.577 -0.897 . . . . 72.040000000000006 108.577 173.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.12 95.3 6.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.651 0.738 . . . . 75.310000000000002 110.439 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -101.04 166.94 10.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.592 -1.185 . . . . 75.329999999999998 109.637 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.74 126.18 86.22 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.126 -0.694 . . . . 65.299999999999997 109.126 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.31 -23.85 75.51 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.216 1.944 . . . . 73.409999999999997 113.929 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.68 -55.85 3.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.096 0.406 . . . . 74.319999999999993 112.096 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -101.57 -11.19 19.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.93 0.395 . . . . 70.439999999999998 111.945 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm 66.17 34.89 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.512 -0.767 . . . . 74.540000000000006 111.525 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -97.64 140.03 32.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.952 -0.759 . . . . 74.140000000000001 108.952 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -70.49 133.03 46.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.987 0.422 . . . . 74.510000000000005 110.379 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.42 -0.6 37.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.685 -0.689 . . . . 74.230000000000004 110.616 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.52 55.93 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.913 -0.66 . . . . 64.150000000000006 113.716 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -158.85 158.58 33.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.937 0.869 . . . . 71.530000000000001 110.942 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.65 -166.75 20.06 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.849 -0.9 . . . . 74.109999999999999 110.849 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.62 151.26 42.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.427 0.614 . . . . 74.340000000000003 110.603 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.12 122.95 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.627 -0.715 . . . . 65.140000000000001 109.172 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.3 m -99.15 118.59 36.22 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.457 -0.572 . . . . 74.340000000000003 109.457 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 25.4 m-85 -84.5 169.49 14.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.364 . . . . 73.049999999999997 110.67 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -72.7 -50.13 26.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.145 -0.48 . . . . 73.5 109.927 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.37 155.51 37.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.598 -0.728 . . . . 72.219999999999999 110.215 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -63.85 -32.86 58.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.796 0.331 . . . . 72.430000000000007 110.31 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.69 -34.82 71.72 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.862 0.69 . . . . 63.140000000000001 112.862 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 7.2 mm-40 -62.01 -36.19 80.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 75.319999999999993 109.684 175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 4.0 t -64.31 -44.6 97.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.131 -0.94 . . . . 72.310000000000002 111.131 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.81 -43.24 99.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 73.430000000000007 111.04 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -53.91 -38.37 64.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.64 0.608 . . . . 73.129999999999995 112.64 171.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.82 65.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.449 0.643 . . . . 64.129999999999995 109.948 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.477 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 11.7 mmt -70.79 -39.54 73.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 75.349999999999994 112.124 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.553 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 1.1 p30 -79.14 -11.93 59.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.076 0.465 . . . . 75.420000000000002 110.442 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.45 -16.24 33.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 71.329999999999998 111.02 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -56.41 149.4 38.83 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 112.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.75 168.18 73.68 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.335 -1.527 . . . . 75.409999999999997 113.749 2.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -119.21 153.07 35.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.66 -0.7 . . . . 70.409999999999997 111.004 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.6 ttmt -139.5 108.94 6.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 71.030000000000001 111.092 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -121.38 137.18 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.716 -0.675 . . . . 74.120000000000005 109.603 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 66.11 21.69 11.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.774 0.829 . . . . 72.530000000000001 110.872 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.91 23.88 68.23 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.904 -0.589 . . . . 64.519999999999996 111.916 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.1 tpt180 -126.46 134.99 50.81 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.324 -0.251 . . . . 74.439999999999998 110.324 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.36 119.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.1 -0.704 . . . . 71.310000000000002 109.1 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 m -108.14 154.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.906 -0.588 . . . . 73.140000000000001 111.779 -172.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -113.5 93.93 29.71 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.959 -1.019 . . . . 74.230000000000004 110.611 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.477 ' O ' ' HE1' ' A' ' 72' ' ' MET . 6.2 Cg_endo -77.16 128.32 9.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 70.209999999999994 110.716 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -126.28 168.8 13.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.257 -0.645 . . . . 72.430000000000007 109.257 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.665 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.1 tpp180 -75.59 128.65 35.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.122 -0.696 . . . . 74.140000000000001 109.122 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.0 99.78 1.49 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.399 0.619 . . . . 72.439999999999998 110.756 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.8 p -73.2 157.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.024 -0.989 . . . . 65.239999999999995 109.804 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -54.7 147.65 14.24 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 122.626 0.37 . . . . 74.219999999999999 110.585 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.504 0.927 . . . . 74.019999999999996 113.504 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.35 -38.23 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 75.310000000000002 110.995 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.42 -46.1 11.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 109.931 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 t -57.76 -26.04 61.29 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.556 -0.747 . . . . 51.240000000000002 112.29 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.16 -21.48 63.99 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 111.82 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -85.19 143.99 40.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.030000000000001 110.852 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.06 123.26 9.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 75.25 112.268 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 3.3 71.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.799 -0.715 . . . . 62.229999999999997 112.51 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.97 -52.14 8.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.691 0.256 . . . . 72.540000000000006 111.691 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 21.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 73.219999999999999 111.051 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -178.8 6.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.796 -0.816 . . . . 73.209999999999994 108.796 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 m -72.61 99.75 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.335 0.588 . . . . 73.319999999999993 111.041 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -126.55 111.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 75.310000000000002 109.757 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -107.02 14.69 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.034 -0.417 . . . . 72.420000000000002 111.116 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 139.56 51.05 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.342 -0.224 . . . . 72.340000000000003 110.946 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.89 151.7 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.352 0.596 . . . . 75.129999999999995 111.595 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -96.91 139.44 32.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.726 -1.124 . . . . 72.109999999999999 109.99 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.0 110.38 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.331 -0.618 . . . . 73.109999999999999 109.331 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.51 158.82 21.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.013 -1.089 . . . . 74.049999999999997 113.358 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.0 8.37 45.08 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.832 -0.699 . . . . 73.329999999999998 112.055 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.45 66.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 122.112 0.958 . . . . 73.230000000000004 110.512 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -65.3 -34.01 77.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 73.510000000000005 109.442 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -83.11 145.72 29.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.799 -1.091 . . . . 74.450000000000003 108.558 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.24 123.5 16.92 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.064 0.459 . . . . 71.140000000000001 112.203 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -128.08 139.98 52.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.597 -0.729 . . . . 72.239999999999995 110.084 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.25 167.63 10.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.337 -0.847 . . . . 74.219999999999999 111.642 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.53 -45.35 85.13 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.429 -0.805 . . . . 75.099999999999994 110.619 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -55.77 -34.48 65.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.473 0.483 . . . . 74.420000000000002 111.562 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -64.4 -60.79 2.75 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.381 -0.372 . . . . 74.340000000000003 111.507 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -82.41 -24.65 34.27 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 119.962 -0.695 . . . . 70.420000000000002 110.814 -171.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.2 tmm_? -63.23 -54.65 34.04 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 110.108 -0.33 . . . . 63.409999999999997 110.108 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -27.89 69.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.984 0.421 . . . . 73.540000000000006 110.859 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.452 ' CD2' HG21 ' A' ' 170' ' ' VAL . 75.8 t80 -78.36 -53.87 6.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.83 -0.623 . . . . 74.209999999999994 111.619 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -68.72 -22.77 64.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.622 0.249 . . . . 73.230000000000004 111.506 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.9 mm-40 -62.71 -26.33 68.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.236 0.541 . . . . 73.420000000000002 110.884 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.28 -30.62 71.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 75.329999999999998 111.633 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.1 -23.77 32.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.499 -0.319 . . . . 74.510000000000005 111.012 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.92 -176.65 42.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 72.010000000000005 112.928 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -73.37 130.7 40.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.15 0.5 . . . . 71.219999999999999 110.871 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 152' ' ' THR . 62.1 mt -101.25 139.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.636 -0.711 . . . . 71.349999999999994 109.939 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.19 -49.91 6.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.817 0.341 . . . . 74.239999999999995 110.583 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.45 155.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 74.200000000000003 109.929 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.24 126.31 73.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.288 -0.634 . . . . 73.219999999999999 109.288 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.4 mt-10 -98.65 104.53 16.57 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 72.230000000000004 110.994 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.1 116.01 35.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.442 -0.577 . . . . 64.439999999999998 109.442 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 69.0 mmm -87.72 119.28 27.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.861 -0.609 . . . . 75.409999999999997 109.994 -175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.03 156.36 38.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 65.340000000000003 110.704 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.07 132.16 34.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.003 -0.544 . . . . 74.25 109.774 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -79.89 -29.99 40.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.336 -0.393 . . . . 75.329999999999998 111.496 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.43 -53.56 4.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.392 -0.909 . . . . 64.450000000000003 113.164 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.8 m -99.63 -11.77 20.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.029 0.381 . . . . 71.120000000000005 112.029 -175.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.28 28.65 65.66 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.727 -0.749 . . . . 53.539999999999999 113.163 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -104.93 159.15 16.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.268 -0.641 . . . . 74.450000000000003 109.268 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -69.04 145.01 53.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.26 -0.644 . . . . 75.239999999999995 109.26 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -70.41 -3.09 15.93 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.185 0.809 . . . . 71.219999999999999 113.185 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.0 3.12 89.33 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.247 -0.978 . . . . 73.530000000000001 112.385 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -157.88 158.0 34.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.548 -0.538 . . . . 73.319999999999993 109.548 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.85 176.3 8.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.706 -0.679 . . . . 74.409999999999997 109.829 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.9 m-85 -139.53 152.67 47.1 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.591 -0.731 . . . . 74.230000000000004 109.186 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.22 133.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.424 0.631 . . . . 63.340000000000003 111.169 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 131' ' ' ILE . 41.1 m -103.26 126.01 50.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.074 -0.966 . . . . 72.140000000000001 110.856 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -100.82 158.45 15.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.06 0.457 . . . . 72.129999999999995 111.412 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.75 -28.94 44.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.479 -0.782 . . . . 73.439999999999998 110.293 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.0 151.36 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 75.120000000000005 110.842 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.426 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 24.2 p80 -80.17 -27.35 38.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 75.219999999999999 110.777 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.621 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 29.6 t70 -58.28 -40.36 81.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.708 -0.678 . . . . 64.409999999999997 111.067 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.2 m -67.56 -30.97 70.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 73.310000000000002 111.508 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.95 -42.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.484 -0.325 . . . . 72.319999999999993 110.471 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 1.8 m-20 -68.36 -24.06 64.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.925 -0.58 . . . . 51.119999999999997 111.424 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.665 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 81.9 mttt -63.66 -42.6 98.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.728 0.775 . . . . 65.299999999999997 110.177 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -74.15 -42.71 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 75.019999999999996 111.663 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 160' ' ' ASP . 29.4 m -79.93 -2.16 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.064 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 5.7 mt -63.07 -28.87 45.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.945 0.878 . . . . 73.140000000000001 109.046 167.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.568 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 49.2 mt-30 -111.47 145.39 39.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.857 -1.164 . . . . 75.200000000000003 107.857 174.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -91.77 -32.43 15.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.327 0.584 . . . . 73.349999999999994 110.684 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -124.69 137.98 54.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.713 -0.676 . . . . 74.549999999999997 109.951 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.568 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 42.8 m-70 -127.41 142.54 51.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.902 0.382 . . . . 73.329999999999998 110.615 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -94.77 110.36 22.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.982 -0.554 . . . . 73.5 111.036 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 124' ' ' TYR . 21.7 t -111.04 127.79 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.326 -0.852 . . . . 75.400000000000006 109.222 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 42.55 48.98 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.666 0.617 . . . . 71.150000000000006 112.666 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.24 0.98 48.47 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.125 -0.56 . . . . 74.230000000000004 114.055 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.83 121.96 45.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.932 -0.396 . . . . 73.439999999999998 109.932 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.49 110.11 19.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.169 0.509 . . . . 72.120000000000005 110.887 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.55 156.99 18.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.498 -0.774 . . . . 71.430000000000007 110.414 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.46 141.54 28.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.289 -0.263 . . . . 75.219999999999999 110.289 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 m -131.97 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.943 0.401 . . . . 72.200000000000003 110.793 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -175.43 170.77 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.021 -0.991 . . . . 73.450000000000003 111.287 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -63.54 132.7 52.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 74.099999999999994 110.501 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.94 127.23 52.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.358 0.599 . . . . 73.120000000000005 110.211 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 186' ' ' MET . 17.8 mt -111.27 164.66 12.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.265 -0.879 . . . . 75.519999999999996 108.906 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 61.9 p -61.83 161.92 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.829 -0.434 . . . . 75.420000000000002 109.829 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.32 -26.35 68.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.17 -0.212 . . . . 75.140000000000001 111.338 -176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -63.7 -35.64 81.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.126 0.489 . . . . 55.100000000000001 110.983 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.98 -45.51 13.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.832 -0.622 . . . . 74.340000000000003 111.349 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.401 ' CG ' ' HB2' ' A' ' 181' ' ' LEU . 42.9 mtp -75.59 -59.51 2.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 71.209999999999994 111.554 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -84.96 -42.84 14.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 74.400000000000006 111.138 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.5 m 64.4 20.69 12.25 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.958 0.786 . . . . 64.420000000000002 111.138 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.26 160.08 32.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 62.329999999999998 110.06 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 p -69.17 140.8 54.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.788 0.327 . . . . 74.430000000000007 111.05 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.6 t -79.12 110.54 14.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.133 -0.485 . . . . 75.400000000000006 110.357 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.0 m -100.29 101.78 12.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.066 -0.516 . . . . 71.219999999999999 110.577 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -71.9 128.03 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 110.43 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -70.54 159.79 33.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 74.230000000000004 110.73 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.56 -78.09 0.53 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.63 -0.795 . . . . 62.409999999999997 111.517 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 . . . . . 0 C--O 1.241 0.648 0 CA-C-O 118.62 -0.705 . . . . 75.230000000000004 109.402 177.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.108 -0.397 . . . . 72.400000000000006 112.108 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -60.98 -53.42 57.48 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.951 0.405 . . . . 75.219999999999999 110.887 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.65 93.93 9.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.175 0.512 . . . . 73.140000000000001 109.683 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -91.35 131.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 75.019999999999996 110.731 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.9 30.5 20.25 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.6 -0.727 . . . . 73.150000000000006 111.173 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m -129.23 79.92 73.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.992 -0.549 . . . . 64.439999999999998 110.157 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.66 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 19.8 Cg_exo -70.97 165.48 32.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.547 2.831 . . . . 74.349999999999994 112.56 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -108.12 14.79 24.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.9 -0.591 . . . . 74.030000000000001 110.224 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.39 134.99 20.81 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 73.109999999999999 110.355 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 13' ' ' LEU . 29.0 Cg_endo -65.82 167.19 18.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.775 2.317 . . . . 74.140000000000001 112.027 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -40.09 70.2 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.425 0.528 . . . . 72.430000000000007 112.425 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.15 -27.37 67.97 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.163 0.431 . . . . 72.420000000000002 112.163 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 10' ' ' PRO . 4.4 mp -78.99 -22.44 45.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.559 0.218 . . . . 74.219999999999999 111.26 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -120.2 -0.97 10.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.279 0.474 . . . . 74.340000000000003 112.279 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 33.1 ttpt -94.67 143.8 26.14 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.574 0.702 . . . . 74.430000000000007 111.822 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.9 mt -115.65 145.65 42.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.694 -1.139 . . . . 75.450000000000003 109.909 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -96.27 134.3 39.56 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.275 -1.009 . . . . 74.329999999999998 108.275 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.84 112.04 38.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.905 -0.406 . . . . 72.329999999999998 109.905 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.96 153.51 17.08 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.301 -0.952 . . . . 74.209999999999994 111.592 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.87 40.19 52.91 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 75.540000000000006 113.675 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.8 mt -78.27 177.02 8.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.956 -0.387 . . . . 63.130000000000003 109.956 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -84.13 -179.42 7.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.899 0.38 . . . . 72.230000000000004 110.099 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -84.1 -9.16 58.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.349 0.595 . . . . 71.420000000000002 109.851 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.03 20.37 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.791 -0.64 . . . . 75.140000000000001 111.786 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.1 m -75.62 131.53 40.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.811 0.339 . . . . 74.040000000000006 111.047 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 p -114.41 160.64 18.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 62.299999999999997 110.531 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 1.9 m-20 -62.59 -38.62 90.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 73.319999999999993 110.616 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.48 -42.14 98.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.381 -0.827 . . . . 70.019999999999996 111.353 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -75.87 -37.76 58.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.024 -0.534 . . . . 71.439999999999998 110.716 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.25 -43.59 90.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 71.209999999999994 110.454 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -60.46 -54.95 39.39 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.092 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -47.41 -39.72 16.08 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.302 1.001 . . . . 75.019999999999996 113.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -68.47 -61.27 1.9 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.967 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -71.08 -24.51 62.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.137 0.421 . . . . 74.299999999999997 112.137 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.1 tt0 -62.49 -21.08 65.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.28 -0.418 . . . . 74.239999999999995 111.837 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -62.1 -27.53 68.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.723 0.297 . . . . 75.129999999999995 111.461 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -98.05 -24.36 15.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.407 -0.361 . . . . 74.329999999999998 111.259 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.5 166.47 39.2 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.173 -1.013 . . . . 53.009999999999998 112.834 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -61.49 141.19 57.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.077 0.551 . . . . 73.209999999999994 111.369 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 mt -118.5 123.3 44.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.362 -0.607 . . . . 74.030000000000001 109.362 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -90.13 -25.1 20.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.087 -0.506 . . . . 74.120000000000005 110.295 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.34 152.16 31.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.488 -0.778 . . . . 72.510000000000005 109.864 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.6 t -160.15 123.99 3.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.294 -0.632 . . . . 71.409999999999997 109.294 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 p -143.26 118.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.516 0.674 . . . . 73.049999999999997 110.431 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 133.12 31.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 107.917 -1.142 . . . . 74.299999999999997 107.917 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.542 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.5 mmt -77.78 96.86 5.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.623 0.725 . . . . 62.409999999999997 110.236 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -96.81 161.27 13.93 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.423 -1.262 . . . . 73.200000000000003 108.975 175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.94 125.54 92.02 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.221 -0.659 . . . . 61.520000000000003 109.221 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.47 -20.94 53.98 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.573 1.515 . . . . 73.099999999999994 112.982 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 50' ' ' ASN . 0.9 OUTLIER -86.65 -55.63 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 73.310000000000002 111.223 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -16.48 23.56 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.917 -0.583 . . . . 74.129999999999995 112.18 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp 65.74 29.12 10.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.926 0.89 . . . . 75.420000000000002 111.925 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -107.35 155.14 20.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.02 -0.733 . . . . 71.349999999999994 109.02 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 t -71.05 135.46 47.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.911 0.386 . . . . 75.230000000000004 111.16 -173.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -87.38 5.27 39.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 110.775 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.52 70.62 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.864 -0.684 . . . . 64.5 114.175 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.542 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 25.5 p90 -156.0 156.41 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.04 0.92 . . . . 75.510000000000005 110.801 174.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.05 -165.15 17.25 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.639 -0.585 . . . . 44.140000000000001 111.639 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.51 145.65 31.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.973 0.387 . . . . 74.409999999999997 109.99 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.26 119.87 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 75.329999999999998 110.2 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.5 m -95.69 122.29 38.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.052 -0.351 . . . . 72.150000000000006 110.052 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -85.63 170.24 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 73.239999999999995 110.106 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -74.29 -52.57 11.89 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.671 -0.492 . . . . 74.120000000000005 109.671 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -122.37 150.29 42.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 74.409999999999997 110.502 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -63.81 -35.43 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.576 0.227 . . . . 72.239999999999995 111.263 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -52.29 -41.35 62.83 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.767 0.654 . . . . 74.209999999999994 112.767 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 47.4 mt-10 -68.74 -28.39 66.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.189 0.518 . . . . 72.329999999999998 110.726 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 25.0 t -65.31 -45.39 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.418 -0.81 . . . . 72.209999999999994 111.083 175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.81 -45.01 86.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.544 . . . . 73.120000000000005 110.912 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.1 -41.52 60.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 74.010000000000005 112.095 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -37.7 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 71.530000000000001 110.977 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.5 mmt -68.61 -32.95 73.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.059 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 -10.07 55.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.049 -0.523 . . . . 71.230000000000004 110.851 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.56 -9.27 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.264 0.554 . . . . 71.150000000000006 110.265 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp180 -53.39 142.48 39.45 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.818 -1.083 . . . . 75.319999999999993 111.327 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 6.1 Cg_exo -78.49 168.75 74.58 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.647 -0.981 . . . . 65.430000000000007 113.385 3.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -124.96 155.02 40.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.146 -0.933 . . . . 74.430000000000007 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.7 ttmt -132.79 106.94 8.04 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.84 0.352 . . . . 75.310000000000002 111.22 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.82 127.31 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 71.420000000000002 110.04 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.8 t70 67.15 29.94 7.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.561 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.13 67.34 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.629 -0.714 . . . . 74.040000000000006 111.91 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.8 tpt180 -130.81 139.19 50.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.136 -0.32 . . . . 75.099999999999994 110.136 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.33 113.14 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.087 -0.708 . . . . 75.129999999999995 109.087 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.83 149.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.425 0.631 . . . . 71.109999999999999 111.182 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -112.93 96.64 38.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.027 -0.988 . . . . 74.049999999999997 110.662 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.85 138.3 18.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.309 2.006 . . . . 70.209999999999994 112.136 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -132.96 168.67 18.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.113 -1.44 . . . . 73.109999999999999 107.113 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.436 HH11 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -83.31 142.25 31.22 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.867 -0.733 . . . . 71.349999999999994 109.101 173.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.73 92.15 1.97 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.29 0.567 . . . . 64.140000000000001 109.621 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.36 158.06 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.863 -1.062 . . . . 75.140000000000001 110.457 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -52.9 145.21 13.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.849 -0.614 . . . . 53.130000000000003 110.619 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.48 -41.61 30.23 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.489 0.922 . . . . 74.329999999999998 113.489 -168.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.16 -51.4 67.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.427 0.156 . . . . 70.519999999999996 111.26 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.0 -29.68 66.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.417 -0.356 . . . . 55.450000000000003 110.398 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -64.19 -18.43 64.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 73.209999999999994 111.539 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -96.42 -2.63 45.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.066 0.46 . . . . 72.319999999999993 110.73 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -88.91 151.47 47.28 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.405 -0.361 . . . . 75.430000000000007 111.039 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.01 118.55 5.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.711 2.274 . . . . 62.119999999999997 112.16 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.96 21.11 31.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.852 -0.69 . . . . 64.430000000000007 112.468 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.72 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.049 0.452 . . . . 72.030000000000001 111.928 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -104.62 25.67 10.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.081 -0.509 . . . . 62.140000000000001 111.409 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.39 -171.9 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.976 -0.557 . . . . 73.109999999999999 109.809 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 58.87 3.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.616 . . . . 73.099999999999994 110.794 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.97 107.96 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 74.510000000000005 110.181 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.458 ' C ' HG23 ' A' ' 159' ' ' VAL . 63.4 mttt -111.02 14.95 21.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.034 0.445 . . . . 53.240000000000002 110.343 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.58 140.87 47.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.271 -0.422 . . . . 72.200000000000003 110.229 178.265 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.25 149.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.399 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.9 t80 -97.24 133.16 42.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.086 -0.961 . . . . 75.109999999999999 109.189 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.63 110.02 24.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.23 147.95 16.92 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.034 -1.079 . . . . 71.430000000000007 113.074 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.56 22.22 8.7 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.835 -0.698 . . . . 43.420000000000002 112.158 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.7 pt -91.18 77.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.909 0.861 . . . . 74.439999999999998 110.458 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -66.71 -50.84 61.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.054 -0.975 . . . . 72.329999999999998 111.051 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.12 155.19 40.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.618 -0.512 . . . . 73.019999999999996 109.618 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.42 99.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.404 0.621 . . . . 55.109999999999999 110.884 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.5 m -97.53 134.01 41.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.229 -0.896 . . . . 64.219999999999999 109.719 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' HIS . 61.8 mt-10 -110.64 167.16 10.44 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.736 -1.12 . . . . 75.25 110.408 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.479 ' O ' HD21 ' A' ' 121' ' ' LEU . 26.9 tt0 -59.73 -46.04 90.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.823 . . . . 74.450000000000003 111.548 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -69.36 -22.03 63.77 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.888 -0.325 . . . . 71.510000000000005 111.484 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 61.2 m170 -61.49 -60.16 4.13 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.781 0.324 . . . . 73.319999999999993 110.532 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 118' ' ' GLU . 1.9 pt? -84.2 -21.07 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.292 -0.563 . . . . 71.219999999999999 111.143 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -65.94 -52.87 45.97 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.853 -0.425 . . . . 71.310000000000002 109.853 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -31.9 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.344 0.593 . . . . 72.219999999999999 110.416 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.416 ' OH ' ' HB3' ' A' ' 168' ' ' HIS . 83.1 t80 -72.6 -58.66 3.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.211 -0.904 . . . . 75.25 112.088 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.442 ' CD2' HG22 ' A' ' 151' ' ' VAL . 47.9 m-85 -66.43 -21.12 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.901 0.334 . . . . 73.549999999999997 111.901 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.39 -25.37 67.53 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.471 0.308 . . . . 73.129999999999995 111.31 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.16 -31.51 63.44 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.129 -0.487 . . . . 75.310000000000002 111.304 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.59 -28.56 23.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 65.219999999999999 111.941 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.9 -172.85 45.35 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.384 -0.912 . . . . 62.409999999999997 113.654 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -76.42 128.55 35.03 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.131 0.491 . . . . 75.400000000000006 111.683 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 152' ' ' THR . 61.3 mt -100.87 137.6 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 73.129999999999995 109.994 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -86.88 -52.19 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 73.109999999999999 110.428 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.15 155.74 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.321 -0.4 . . . . 70.209999999999994 110.209 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.89 129.01 72.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.239 0.542 . . . . 75.420000000000002 109.935 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.71 104.22 14.53 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.648 -0.706 . . . . 73.049999999999997 110.977 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.2 mm -90.8 120.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.976 -0.749 . . . . 74.140000000000001 108.976 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 71.9 mmm -94.88 113.88 25.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.748 0.785 . . . . 75.510000000000005 110.392 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.74 165.4 26.52 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.846 -1.07 . . . . 73.230000000000004 109.794 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.78 103.74 16.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.629 -1.249 . . . . 65.530000000000001 107.629 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -65.44 -24.13 67.11 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.159 0.429 . . . . 71.230000000000004 112.159 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.33 -52.79 8.23 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 51.310000000000002 112.959 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.1 m -95.7 -22.69 17.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.126 0.417 . . . . 72.530000000000001 112.126 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 27.23 26.27 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.993 -0.622 . . . . 50.310000000000002 112.086 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -95.87 146.95 24.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 74.340000000000003 111.405 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -72.01 139.72 48.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 74.299999999999997 109.954 175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.59 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 2.8 mmp_? -91.64 2.62 56.34 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.592 -0.443 . . . . 74.049999999999997 112.071 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.97 78.19 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.812 -0.709 . . . . 61.399999999999999 114.303 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -155.48 157.5 37.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.595 0.697 . . . . 74.310000000000002 110.259 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.24 177.13 8.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 54.200000000000003 109.899 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.441 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -140.87 149.15 41.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.691 -0.686 . . . . 74.519999999999996 109.713 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' A' ' 125' ' ' PHE . 66.7 t -133.75 130.9 56.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.464 -0.334 . . . . 74.430000000000007 110.77 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 131' ' ' ILE . 60.0 m -103.49 125.37 50.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.689 -0.687 . . . . 73.030000000000001 110.616 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.56 162.66 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.987 0.422 . . . . 74.530000000000001 111.208 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.75 -29.34 29.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.591 -0.732 . . . . 71.0 110.253 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.92 144.51 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 74.200000000000003 110.279 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -72.24 -26.53 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 74.109999999999999 110.129 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.551 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -55.44 -44.74 76.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.106 -0.952 . . . . 65.200000000000003 111.399 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -71.56 -33.35 69.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.037 -0.528 . . . . 71.439999999999998 111.212 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.87 -38.49 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.868 0.365 . . . . 64.040000000000006 110.088 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 1.7 t70 -67.05 -34.23 77.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.521 -0.763 . . . . 74.040000000000006 110.841 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.7 mttt -56.58 -40.87 75.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 110.349 172.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.5 mt -73.54 -45.43 51.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.397 -1.274 . . . . 75.109999999999999 112.286 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 160' ' ' ASP . 15.8 m -75.11 -10.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.24 0.543 . . . . 73.120000000000005 111.027 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 mt -61.96 -31.9 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.139 -0.937 . . . . 74.0 109.971 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 64.6 mt-30 -107.84 104.1 13.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.82 -0.807 . . . . 61.439999999999998 108.82 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -54.08 -35.0 61.61 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.714 0.635 . . . . 72.519999999999996 112.714 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -122.15 138.45 54.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.888 0.375 . . . . 73.349999999999994 111.208 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -130.18 146.36 51.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 74.420000000000002 110.152 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -104.04 115.01 29.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 74.540000000000006 111.05 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.9 p -141.43 146.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.626 -0.715 . . . . 71.239999999999995 109.187 177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 58.33 29.52 18.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.343 1.068 . . . . 74.140000000000001 110.54 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.2 0.87 84.49 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.212 -0.904 . . . . 65.239999999999995 113.253 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -121.59 133.59 55.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.071 0.463 . . . . 74.219999999999999 111.068 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.08 108.55 18.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 62.009999999999998 109.715 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.2 p -113.11 157.17 21.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 62.310000000000002 110.677 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -85.76 134.05 33.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.959 0.409 . . . . 71.040000000000006 110.072 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.0 t -130.44 132.46 64.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.564 -0.744 . . . . 72.120000000000005 109.799 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -153.73 173.8 15.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.789 -0.641 . . . . 74.150000000000006 110.994 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -64.56 131.54 47.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.129 0.49 . . . . 73.540000000000006 111.3 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -122.92 118.56 28.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.715 -0.846 . . . . 72.019999999999996 108.715 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.4 mt -74.51 123.85 25.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.756 -0.461 . . . . 75.400000000000006 109.756 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 186' ' ' MET . 48.0 t -65.79 161.95 19.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 109.937 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.71 -31.78 69.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.144 0.497 . . . . 63.549999999999997 110.31 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -61.06 -37.04 81.25 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.237 -0.892 . . . . 71.430000000000007 110.7 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -84.37 -43.01 15.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.112 -0.494 . . . . 73.430000000000007 111.569 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 182' ' ' SER . 77.6 mtp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.993 -0.549 . . . . 75.430000000000007 111.127 -176.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -84.54 -12.9 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 75.510000000000005 110.558 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.8 m 60.76 30.19 19.51 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.47 -0.786 . . . . 52.329999999999998 110.225 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.19 138.15 12.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.708 -1.133 . . . . 73.019999999999996 109.35 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m -87.61 155.81 19.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 110.135 -0.32 . . . . 72.420000000000002 110.135 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.2 t -80.77 134.24 35.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.778 0.323 . . . . 53.100000000000001 110.599 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.9 t -80.59 103.66 10.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 62.539999999999999 109.226 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -123.78 134.34 53.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.002 -0.545 . . . . 63.229999999999997 110.306 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.62 88.49 5.04 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 75.099999999999994 109.667 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 156.21 -153.55 24.82 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.106 -0.568 . . . . 75.019999999999996 111.747 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.397 -0.811 . . . . 74.540000000000006 109.946 -179.47 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.523 -0.231 . . . . 74.450000000000003 112.523 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.4 m 57.59 70.34 0.66 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.573 0.749 . . . . 71.430000000000007 112.517 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 61.6 26.13 15.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.558 -0.747 . . . . 75.239999999999995 112.907 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 p -72.77 -21.65 60.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.582 0.706 . . . . 71.409999999999997 109.201 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.79 171.24 13.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.813 -1.085 . . . . 71.129999999999995 108.922 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 t -134.25 90.83 24.33 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.663 -0.415 . . . . 71.319999999999993 111.339 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.57 136.74 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.198 1.932 . . . . 53.5 111.089 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.18 1.68 12.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.337 0.589 . . . . 72.109999999999999 109.782 -177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.18 135.64 57.88 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.192 -0.913 . . . . 62.119999999999997 110.219 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 11.4 Cg_endo -63.17 160.24 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.118 1.879 . . . . 74.019999999999996 110.965 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.6 63.23 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.1 0.407 . . . . 72.349999999999994 112.1 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.26 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 74.040000000000006 112.434 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 42.7 mt -79.36 -16.92 55.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 64.230000000000004 110.719 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -122.97 4.83 9.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 73.319999999999993 111.492 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.9 ttpt -99.08 149.78 22.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.224 0.535 . . . . 61.219999999999999 110.666 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 7.6 mp -116.38 141.32 48.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.009 -0.996 . . . . 75.299999999999997 110.224 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -97.27 114.4 26.15 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.445 -0.946 . . . . 72.349999999999994 108.445 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 mm -94.08 111.0 24.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 110.053 -0.351 . . . . 72.329999999999998 110.053 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.3 152.68 18.45 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.561 -0.828 . . . . 70.299999999999997 111.314 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.88 45.76 41.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.629 -0.796 . . . . 72.120000000000005 113.142 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.9 mt -79.64 175.27 10.77 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.78 -0.452 . . . . 71.340000000000003 109.78 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 82' ' ' ARG . 21.2 p -91.34 175.33 6.97 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.549 -0.538 . . . . 74.230000000000004 109.549 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -75.23 -8.16 55.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.321 0.581 . . . . 73.230000000000004 110.081 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.77 9.12 17.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.568 -0.742 . . . . 71.129999999999995 112.138 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.536 ' HA ' ' OD2' ' A' ' 80' ' ' ASP . 19.3 m -76.6 120.69 22.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.447 -0.501 . . . . 73.219999999999999 111.161 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 p -103.96 159.98 15.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 71.310000000000002 110.468 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 2.5 m-20 -60.34 -38.84 85.02 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.032 -0.531 . . . . 73.209999999999994 110.93 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.69 -39.56 91.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.736 -0.665 . . . . 74.219999999999999 111.718 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -75.92 -39.89 55.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.541 -0.3 . . . . 65.319999999999993 110.683 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.82 -47.49 83.2 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.041 -0.527 . . . . 73.349999999999994 109.995 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -57.59 -60.33 3.83 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 111.356 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -51.97 -36.6 50.09 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.537 0.523 . . . . 75.200000000000003 112.284 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -71.45 -56.8 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.651 -0.25 . . . . 75.299999999999997 110.908 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -68.55 -25.18 64.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 73.439999999999998 111.851 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -64.91 -15.11 61.65 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.113 0.412 . . . . 70.340000000000003 112.113 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -29.57 70.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.822 0.344 . . . . 73.530000000000001 111.163 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -98.01 -22.3 16.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.542 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.36 159.39 32.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.36 -0.924 . . . . 73.400000000000006 112.099 177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.5 m -64.64 118.27 8.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.048 0.451 . . . . 73.329999999999998 111.999 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -92.12 134.12 35.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.434 0.635 . . . . 73.319999999999993 110.761 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -107.75 -19.41 13.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.001 . . . . 65.310000000000002 110.238 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.454 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 32.0 t70 -151.51 152.44 32.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 75.140000000000001 109.897 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.0 t -163.03 127.24 2.96 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.502 -0.555 . . . . 74.299999999999997 109.502 172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 4.8 p -142.01 123.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.536 0.684 . . . . 64.319999999999993 110.63 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.4 130.67 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.506 -0.924 . . . . 75.310000000000002 108.506 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.88 135.69 46.66 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.959 -0.756 . . . . 73.329999999999998 108.959 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -135.35 156.55 48.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.874 -0.603 . . . . 74.439999999999998 111.493 -170.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 13.3 t70 -66.46 132.3 94.25 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.837 -1.074 . . . . 72.230000000000004 109.323 174.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.82 -18.88 47.34 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 121.897 1.732 . . . . 74.319999999999993 113.864 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -85.56 -57.31 3.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.844 0.354 . . . . 62.049999999999997 111.604 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -105.45 -7.72 18.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.061 -0.518 . . . . 74.140000000000001 111.305 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 40.0 mmtm 63.63 32.06 14.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.803 0.841 . . . . 73.030000000000001 111.555 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -95.94 162.43 13.57 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.808 -0.812 . . . . 74.340000000000003 108.808 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -65.69 139.71 58.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.838 0.351 . . . . 73.040000000000006 111.613 -171.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.14 2.21 47.67 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.769 -0.65 . . . . 75.219999999999999 110.379 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 15.92 61.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.741 -0.743 . . . . 60.130000000000003 113.242 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -161.19 157.15 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.154 0.477 . . . . 72.099999999999994 110.524 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.27 -164.21 16.74 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 111.52 -0.632 . . . . 75.519999999999996 111.52 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 4.6 m-85 -142.35 150.87 41.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.32 0.56 . . . . 73.209999999999994 110.805 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.8 m -132.84 123.37 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.78 -0.645 . . . . 63.340000000000003 109.87 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 42' ' ' ASP . 5.2 m -98.94 120.64 39.72 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.332 -0.23 . . . . 72.450000000000003 110.609 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.63 161.8 17.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.167 -0.47 . . . . 74.349999999999994 110.322 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 -35.59 62.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.715 -0.675 . . . . 62.530000000000001 110.599 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.86 149.36 52.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 72.329999999999998 110.347 -178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.586 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.5 p -66.44 -34.6 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 120.778 0.323 . . . . 73.400000000000006 111.096 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.94 -37.44 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.206 0.447 . . . . 75.439999999999998 112.206 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.05 -29.49 70.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 71.420000000000002 110.368 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 2.7 t -62.11 -44.52 99.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.175 -0.92 . . . . 73.209999999999994 110.98 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -41.18 97.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 111.131 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.75 -39.88 78.4 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.025 0.38 . . . . 74.239999999999995 112.025 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.95 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 63.409999999999997 110.529 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.0 mmt -66.41 -33.46 75.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.769 -0.65 . . . . 74.530000000000001 110.529 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.592 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 3.4 p30 -82.26 -9.6 59.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.991 0.424 . . . . 75.349999999999994 111.091 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.59 -14.39 45.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.856 -0.611 . . . . 74.530000000000001 112.518 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -49.16 146.35 6.1 Favored Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 112.705 0.631 . . . . 75.140000000000001 112.705 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.4 154.34 85.22 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 124.02 -1.242 . . . . 70.129999999999995 113.287 1.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -107.44 147.16 30.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.705 -0.68 . . . . 74.209999999999994 110.441 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -138.45 104.37 5.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.118 0.485 . . . . 73.540000000000006 111.226 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.34 139.92 43.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.335 -0.617 . . . . 74.439999999999998 109.335 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 1.7 m-20 62.72 31.79 16.44 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.565 0.54 . . . . 73.140000000000001 111.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.67 23.53 77.68 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.396 -0.82 . . . . 45.119999999999997 112.605 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.9 tpt180 -129.38 137.35 50.9 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.848 -0.207 . . . . 71.349999999999994 110.787 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.35 116.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.984 -0.747 . . . . 72.430000000000007 108.984 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -109.91 154.18 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.288 0.566 . . . . 72.450000000000003 111.493 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.85 95.89 35.51 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.142 -0.935 . . . . 74.140000000000001 110.753 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.55 134.11 16.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.09 1.86 . . . . 62.439999999999998 112.155 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.596 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 31.9 mmtt -125.9 -177.82 4.07 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.849 -1.167 . . . . 64.450000000000003 107.849 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.479 HH22 ' HE2' ' A' ' 161' ' ' LYS . 12.2 mmt-85 -80.87 163.14 23.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.281 0.492 . . . . 75.25 109.764 170.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.08 90.49 4.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.817 0.818 . . . . 75.140000000000001 108.822 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 164' ' ' ILE . 16.5 t -82.75 156.35 3.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.58 -1.191 . . . . 75.340000000000003 109.191 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.3 t -54.82 148.38 13.21 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.461 0.476 . . . . 70.120000000000005 109.902 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 6.8 tpp180 -66.52 -6.02 13.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.089 0.471 . . . . 72.209999999999994 111.984 -172.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.85 -43.95 94.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.277 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.11 -43.88 14.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.842 -0.617 . . . . 74.120000000000005 111.088 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 1.5 p -69.34 -12.31 61.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.242 -0.436 . . . . 73.239999999999995 111.875 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 33.9 tt0 -61.59 -34.93 76.47 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 110.964 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -70.56 145.81 93.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.232 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.34 120.08 7.12 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.349 2.7 . . . . 71.420000000000002 112.712 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.1 29.14 69.18 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 121.18 -0.534 . . . . 63.240000000000002 113.023 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.59 ' O ' ' HE2' ' A' ' 179' ' ' LYS . . . -78.85 -49.6 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.748 0.309 . . . . 75.019999999999996 110.618 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 95' ' ' SER . 4.7 m80 -81.16 25.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.647 0.61 . . . . 61.43 112.647 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.53 -164.09 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.715 -0.846 . . . . 73.120000000000005 108.715 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.444 ' HA ' ' HZ1' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -81.11 88.76 5.97 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.596 -0.69 . . . . 62.119999999999997 111.122 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.92 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 71.209999999999994 109.569 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' C ' HG21 ' A' ' 159' ' ' VAL . 79.1 mttt -108.47 20.1 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.124 0.488 . . . . 73.040000000000006 110.605 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -120.58 139.74 52.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.192 -0.458 . . . . 72.540000000000006 110.636 178.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 pt -129.94 151.3 35.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.375 0.607 . . . . 74.140000000000001 111.665 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.3 t80 -101.86 133.24 46.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.621 -1.172 . . . . 74.409999999999997 109.809 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.5 110.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.336 -0.616 . . . . 70.310000000000002 109.336 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.28 157.23 19.4 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.297 -0.954 . . . . 72.409999999999997 112.953 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.94 19.66 30.58 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.773 -0.727 . . . . 64.340000000000003 111.828 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.8 pt -78.52 118.39 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.341 0.591 . . . . 73.219999999999999 110.874 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.99 -69.3 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 71.340000000000003 110.759 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.01 154.82 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.777 -0.453 . . . . 74.329999999999998 109.777 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.97 104.84 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.687 -0.688 . . . . 73.310000000000002 110.486 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -79.85 132.91 36.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.833 -0.621 . . . . 61.219999999999999 110.368 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -101.7 167.24 10.23 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.258 -0.883 . . . . 73.200000000000003 110.471 -177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.58 -48.17 82.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 71.129999999999995 110.403 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -62.5 -26.75 68.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 75.530000000000001 111.137 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -63.95 -61.4 2.3 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.17 0.509 . . . . 73.0 110.461 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.47 -26.89 32.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.247 -0.581 . . . . 73.319999999999993 111.595 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -65.26 -50.57 65.28 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.965 -0.294 . . . . 74.439999999999998 110.315 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.15 -31.47 70.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 74.400000000000006 110.822 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' A' ' 170' ' ' VAL . 78.2 t80 -76.96 -56.24 4.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 112.128 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -66.98 -22.11 65.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.174 0.435 . . . . 73.549999999999997 112.174 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.4 mm-40 -64.79 -28.07 69.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.022 0.439 . . . . 71.310000000000002 110.77 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.77 -28.12 60.72 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.158 -0.474 . . . . 75.340000000000003 111.789 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.48 -26.42 24.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.35 -0.387 . . . . 73.549999999999997 111.717 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.75 -176.26 44.28 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 120.889 -0.672 . . . . 74.219999999999999 113.138 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -76.15 134.11 40.04 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 111.439 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 152' ' ' THR . 69.0 mt -105.85 142.02 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.749 -0.659 . . . . 72.519999999999996 110.75 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -91.42 -52.39 4.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 64.329999999999998 111.029 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -155.74 154.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.997 -0.547 . . . . 74.209999999999994 110.187 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.59 128.09 71.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 75.040000000000006 109.819 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.84 103.92 13.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.328 -0.851 . . . . 72.420000000000002 110.789 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -92.17 124.86 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.89 -0.782 . . . . 73.420000000000002 108.89 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.9 mmm -94.67 113.73 25.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.334 0.588 . . . . 74.239999999999995 109.843 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.95 158.11 36.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 75.519999999999996 110.406 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -77.82 122.22 25.14 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.965 -0.754 . . . . 71.409999999999997 108.965 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -78.46 -5.69 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.798 0.296 . . . . 73.099999999999994 111.798 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.13 -53.56 1.16 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.755 -0.736 . . . . 41.039999999999999 112.372 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 p -99.28 -25.39 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.354 . . . . 71.310000000000002 111.746 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.81 9.22 64.42 Favored Glycine 0 C--O 1.234 0.112 0 C-N-CA 120.703 -0.761 . . . . 73.400000000000006 112.549 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -78.8 169.63 17.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.737 0.303 . . . . 64.140000000000001 110.622 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -69.55 141.75 53.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 64.150000000000006 110.574 174.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.553 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 2.2 mmp_? -81.47 -8.57 59.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.954 -0.299 . . . . 71.439999999999998 111.421 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.08 -6.39 66.49 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.602 -0.808 . . . . 63.039999999999999 112.888 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.98 157.51 43.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.763 -0.458 . . . . 74.120000000000005 109.763 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.26 166.39 24.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 71.0 109.735 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -133.87 153.44 51.74 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.993 -0.549 . . . . 73.25 110.131 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.13 132.39 18.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.311 0.577 . . . . 75.340000000000003 111.063 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.542 ' O ' HG23 ' A' ' 131' ' ' ILE . 55.9 m -98.49 124.57 43.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.102 -0.954 . . . . 65.219999999999999 110.495 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.02 161.36 13.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.923 0.392 . . . . 75.510000000000005 111.187 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.21 -33.41 56.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.685 -0.689 . . . . 74.329999999999998 110.207 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.4 154.93 50.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.247 -0.888 . . . . 75.439999999999998 110.613 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.596 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 21.6 p80 -80.06 -21.27 43.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 75.140000000000001 110.321 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -53.62 -43.98 69.11 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.91 0.756 . . . . 75.329999999999998 110.96 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 m -71.96 -33.54 68.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.485 -0.779 . . . . 60.350000000000001 111.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.405 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -72.41 -37.62 58.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.206 0.527 . . . . 71.510000000000005 109.724 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.253 -0.885 . . . . 74.340000000000003 111.103 -178.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.5 mttt -68.27 -39.28 82.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.648 0.737 . . . . 75.540000000000006 110.134 172.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.14 -41.72 37.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.85 -1.068 . . . . 75.439999999999998 112.52 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.5 m -73.5 -5.49 6.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.045 0.45 . . . . 72.019999999999996 111.38 -174.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.484 ' HA ' HG11 ' A' ' 90' ' ' VAL . 50.8 mt -61.89 -33.56 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.399 -0.819 . . . . 72.310000000000002 110.295 171.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.1 mt-30 -110.32 108.68 18.84 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -56.0 -33.25 64.69 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.678 0.621 . . . . 75.439999999999998 112.678 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -123.5 139.81 53.64 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.24 -0.288 . . . . 74.319999999999993 110.689 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.2 m-70 -128.19 152.45 48.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 109.946 175.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 m -100.28 110.09 22.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 75.019999999999996 110.113 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 124' ' ' TYR . 12.0 t -124.11 133.16 70.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.005 -0.739 . . . . 75.239999999999995 109.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.07 28.06 14.32 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.608 0.718 . . . . 71.340000000000003 111.486 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.78 7.57 87.34 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.014 -0.613 . . . . 74.299999999999997 113.024 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -112.0 125.26 53.88 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.503 0.321 . . . . 74.519999999999996 110.759 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -82.56 110.69 17.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.478 0.656 . . . . 60.109999999999999 109.735 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 16.0 m -122.36 157.65 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 64.299999999999997 110.792 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -85.59 132.81 34.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.341 -0.391 . . . . 75.530000000000001 110.294 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.9 t -129.16 135.34 62.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.689 -0.687 . . . . 75.019999999999996 110.155 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -158.0 173.29 16.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 72.129999999999995 110.856 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 100' ' ' ALA . 12.5 mmtm -58.92 132.29 53.55 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.353 0.408 . . . . 75.129999999999995 110.979 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.22 114.51 22.53 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.639 -0.504 . . . . 75.310000000000002 109.639 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.4 mt -84.78 110.57 18.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.958 -0.756 . . . . 75.209999999999994 108.958 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 186' ' ' MET . 4.1 t -83.32 -174.82 5.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.771 -0.826 . . . . 71.120000000000005 108.771 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -61.89 -35.42 78.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.052 -0.259 . . . . 74.150000000000006 111.191 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.558 ' HA ' ' C ' ' A' ' 188' ' ' SER . 8.8 tt0 -65.6 -41.34 92.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 70.329999999999998 110.593 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -72.43 -24.31 61.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.38 -0.827 . . . . 65.129999999999995 110.762 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 182' ' ' SER . 21.5 mtt -89.55 -71.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 111.352 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -96.02 -63.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 73.329999999999998 111.0 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.558 ' C ' ' HA ' ' A' ' 184' ' ' GLN . 56.9 p 179.21 171.83 0.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.264 -1.013 . . . . 64.340000000000003 108.264 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -47.69 128.9 13.5 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.498 0.499 . . . . 73.239999999999995 111.355 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 t -64.39 98.26 0.23 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.794 0.684 . . . . 63.420000000000002 110.938 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.9 m -85.86 78.68 9.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 74.430000000000007 110.49 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 47.1 t -137.65 100.94 4.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.32 -0.855 . . . . 71.340000000000003 109.547 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -76.19 99.02 4.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.019 -0.537 . . . . 75.25 109.968 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -130.08 96.45 4.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.54 -0.755 . . . . 74.420000000000002 109.765 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -176.67 27.92 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.088 -0.577 . . . . 41.439999999999998 111.798 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.535 -0.745 . . . . 73.299999999999997 109.545 -178.189 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 112.221 -0.352 . . . . 71.129999999999995 112.221 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t 65.88 27.82 10.85 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.433 0.693 . . . . 73.099999999999994 110.886 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.88 80.11 6.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.283 0.564 . . . . 73.329999999999998 110.623 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.5 t -86.63 71.85 10.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.191 -1.04 . . . . 63.450000000000003 108.191 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -77.74 149.24 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.875 -1.057 . . . . 75.310000000000002 111.135 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -137.55 85.25 21.22 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.697 -0.853 . . . . 75.140000000000001 108.697 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.6 168.39 16.2 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.128 2.552 . . . . 72.209999999999994 111.792 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -67.46 -11.1 57.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.425 -0.352 . . . . 73.230000000000004 111.614 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.4 122.54 78.8 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 74.329999999999998 109.544 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD2' HD23 ' A' ' 13' ' ' LEU . 17.4 Cg_endo -60.39 167.24 8.18 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.301 2.668 . . . . 71.319999999999993 112.532 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 2.2 pt-20 -51.18 -42.23 60.73 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 123.294 0.371 . . . . 75.319999999999993 111.54 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 5.5 pt20 -64.93 -19.82 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.622 0.601 . . . . 73.150000000000006 112.622 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.421 HD23 ' HD2' ' A' ' 10' ' ' PRO . 3.4 mp -90.07 -21.45 22.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.531 0.197 . . . . 74.230000000000004 111.531 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -117.83 -3.61 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.633 -0.427 . . . . 64.129999999999995 111.501 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -99.17 144.49 28.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.557 0.694 . . . . 71.329999999999998 111.549 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 87' ' ' LYS . 52.5 mt -115.61 148.27 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.741 -1.118 . . . . 63.409999999999997 110.544 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -98.61 125.97 44.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.407 -0.96 . . . . 65.109999999999999 108.407 172.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.7 mm -103.86 111.9 35.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.819 -0.437 . . . . 70.109999999999999 109.819 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.44 17.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.595 -0.812 . . . . 73.109999999999999 111.847 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.63 47.36 27.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.609 -0.805 . . . . 72.219999999999999 113.152 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.424 HD22 ' CG1' ' A' ' 84' ' ' VAL . 86.1 mt -82.26 176.23 9.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.412 . . . . 74.319999999999993 109.889 172.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -88.34 175.23 7.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.054 0.454 . . . . 74.140000000000001 109.849 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -81.7 -4.98 57.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.018 -0.537 . . . . 74.349999999999994 110.438 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.35 9.11 10.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 61.229999999999997 111.549 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.4 m -75.94 127.23 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 74.219999999999999 111.379 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.9 p -103.19 172.6 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 73.409999999999997 110.37 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.56 -24.2 39.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.221 -0.288 . . . . 74.420000000000002 110.221 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.44 -39.04 68.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 64.420000000000002 111.204 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.5 p -75.4 -38.03 60.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 73.099999999999994 110.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 tp -62.94 -49.1 76.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.465 -0.789 . . . . 71.040000000000006 109.995 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -56.09 -62.42 1.72 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.519 -0.764 . . . . 75.329999999999998 111.959 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 t -50.65 -33.17 21.44 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.742 0.651 . . . . 75.209999999999994 112.544 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -75.2 -55.27 5.89 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.07 -0.252 . . . . 75.299999999999997 111.083 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.94 -22.77 62.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.067 0.395 . . . . 73.409999999999997 112.067 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -58.36 -22.83 54.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.049 0.539 . . . . 64.299999999999997 111.849 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -63.95 -27.52 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.362 . . . . 71.430000000000007 111.973 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -96.75 -23.74 16.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.762 0.315 . . . . 73.349999999999994 111.253 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.93 154.44 24.46 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.334 -0.936 . . . . 38.950000000000003 111.972 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.2 m -62.51 118.2 7.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 72.450000000000003 111.087 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -85.0 142.46 29.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 110.452 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -104.41 -25.43 12.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.607 -0.724 . . . . 72.219999999999999 109.682 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -153.49 156.2 37.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 70.310000000000002 110.084 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.4 t -161.79 132.32 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.454 -0.572 . . . . 72.109999999999999 109.454 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.68 118.02 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.716 0.769 . . . . 75.219999999999999 110.693 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.43 132.67 31.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.715 -0.846 . . . . 74.219999999999999 108.715 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mmt -76.19 101.37 5.37 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.512 0.673 . . . . 73.420000000000002 110.346 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -99.05 153.71 18.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.804 -1.089 . . . . 74.099999999999994 109.397 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.48 128.01 86.52 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.928 -0.578 . . . . 74.299999999999997 110.336 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 -17.07 58.39 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.284 1.99 . . . . 72.430000000000007 113.424 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -85.63 -56.11 3.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.965 0.412 . . . . 63.420000000000002 111.587 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -11.9 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 74.109999999999999 111.77 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 62.79 34.82 14.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.752 0.821 . . . . 71.239999999999995 110.808 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -112.2 160.9 17.14 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.033 -0.729 . . . . 74.420000000000002 109.033 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -74.09 131.7 41.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.814 0.34 . . . . 64.329999999999998 110.63 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -83.68 7.01 18.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 73.239999999999995 111.38 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.03 16.32 75.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.787 -0.721 . . . . 75.409999999999997 113.521 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -157.19 155.88 31.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.358 0.579 . . . . 75.319999999999993 110.355 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.2 -165.37 16.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.418 -0.673 . . . . 64.450000000000003 111.418 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 1.1 m-85 -142.66 148.77 37.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.046 0.423 . . . . 75.430000000000007 110.31 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.11 127.23 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.719 -0.673 . . . . 65.510000000000005 109.534 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -101.96 117.43 34.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.0 -0.37 . . . . 74.540000000000006 110.0 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.1 m-85 -84.85 170.86 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.328 -0.396 . . . . 75.510000000000005 110.494 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.13 -49.48 28.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.863 -0.608 . . . . 61.240000000000002 110.044 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.507 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -128.83 160.22 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 72.409999999999997 110.792 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.3 p -65.12 -33.43 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.238 -0.437 . . . . 72.230000000000004 111.308 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -55.79 -44.54 77.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.509 0.559 . . . . 74.329999999999998 112.509 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.5 mp0 -61.28 -32.75 72.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.3 0.572 . . . . 73.019999999999996 110.728 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 39.1 t -65.95 -49.63 75.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.236 -0.893 . . . . 74.219999999999999 111.055 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.32 -43.83 88.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 75.349999999999994 110.875 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.63 -42.6 62.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.962 -0.563 . . . . 75.109999999999999 112.284 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.97 -33.07 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.866 0.365 . . . . 71.420000000000002 110.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.68 -42.12 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 73.019999999999996 110.433 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -12.29 59.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.807 -0.633 . . . . 74.5 111.069 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.78 -10.86 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 110.657 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.483 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 19.2 ttp-105 -53.49 144.31 33.04 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.279 -0.873 . . . . 75.140000000000001 110.892 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 87.7 Cg_endo -80.53 168.93 70.47 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.56 -1.017 . . . . 73.120000000000005 114.013 2.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -128.21 158.28 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.069 -0.969 . . . . 64.340000000000003 110.165 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -134.55 104.59 6.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.082 -0.508 . . . . 65.439999999999998 110.3 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.7 132.98 55.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 75.310000000000002 109.954 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 65.62 27.42 11.44 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.82 0.7 . . . . 74.150000000000006 110.856 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.51 21.89 76.43 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.804 -0.635 . . . . 38.950000000000003 112.497 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -128.68 137.63 51.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.226 -0.287 . . . . 61.340000000000003 110.226 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.81 111.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.419 -0.586 . . . . 73.019999999999996 109.419 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.424 ' CG1' HD22 ' A' ' 21' ' ' LEU . 4.1 m -107.4 150.04 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.59 0.71 . . . . 71.319999999999993 111.431 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.05 95.46 38.36 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 114.823 -1.081 . . . . 72.219999999999999 110.926 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.97 131.98 17.65 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.418 2.079 . . . . 75.310000000000002 111.949 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' O ' HD21 ' A' ' 16' ' ' LEU . 27.7 mttt -141.08 -177.33 5.05 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.222 -0.899 . . . . 74.0 108.786 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 7.4 tpp180 -75.09 154.3 37.92 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.051 0.453 . . . . 75.140000000000001 111.28 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.22 91.24 6.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.421 -0.955 . . . . 72.200000000000003 108.421 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t -69.44 149.17 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.499 -0.773 . . . . 72.420000000000002 110.288 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 p -56.59 146.41 25.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 123.497 0.498 . . . . 74.329999999999998 110.034 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.21 -16.27 63.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.877 0.695 . . . . 74.150000000000006 112.877 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.63 -51.63 26.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 73.310000000000002 110.234 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.34 -20.66 33.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 63.450000000000003 111.467 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 t -69.66 -15.87 63.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.323 -0.399 . . . . 75.329999999999998 110.357 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.36 -17.91 59.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.656 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -79.32 147.47 68.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 70.129999999999995 110.841 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.69 116.5 4.58 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.699 2.266 . . . . 74.140000000000001 111.97 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.81 18.04 15.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.54 -0.838 . . . . 63.219999999999999 112.515 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.15 50.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.73 0.3 . . . . 71.319999999999993 111.096 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -103.3 13.68 33.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.021 0.439 . . . . 73.209999999999994 111.285 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.59 163.41 23.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.246 -0.65 . . . . 75.25 109.246 173.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.3 82.88 4.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.792 0.806 . . . . 74.200000000000003 110.63 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -108.63 113.69 44.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.699 -1.137 . . . . 74.040000000000006 109.753 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.455 ' C ' HG23 ' A' ' 159' ' ' VAL . 82.2 mttt -109.12 19.4 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.861 0.363 . . . . 75.030000000000001 110.475 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.41 144.54 45.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.546 -0.297 . . . . 72.239999999999995 110.667 175.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.08 148.5 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.224 0.535 . . . . 71.329999999999998 111.19 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.9 t80 -97.74 131.96 43.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.019 -0.992 . . . . 72.120000000000005 109.008 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.46 108.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.981 -0.748 . . . . 75.329999999999998 108.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.37 166.27 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.87 -1.157 . . . . 74.319999999999993 113.294 -174.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.29 58.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.704 -0.76 . . . . 45.329999999999998 111.762 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.36 134.18 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 70.519999999999996 109.478 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.73 -49.28 9.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.882 0.372 . . . . 72.239999999999995 110.204 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.86 -173.56 2.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.056 -0.72 . . . . 74.310000000000002 109.056 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 145' ' ' LYS . 6.7 p-10 -83.81 135.27 34.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.297 0.57 . . . . 74.340000000000003 110.983 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 m -106.95 141.43 38.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 110.315 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.37 160.91 16.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.287 -0.415 . . . . 75.510000000000005 109.918 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.17 -51.12 71.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 72.409999999999997 110.093 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -58.88 -31.01 68.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 111.731 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.347 0.405 . . . . 73.310000000000002 110.71 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 pp -81.11 -27.45 35.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.449 -0.5 . . . . 74.450000000000003 110.99 -175.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.41 -53.31 44.9 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 110.182 -0.303 . . . . 73.409999999999997 110.182 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.49 -28.27 69.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.209 0.528 . . . . 73.450000000000003 110.452 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.01 -56.71 4.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.95 -0.568 . . . . 72.319999999999993 111.54 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -66.71 -22.1 66.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 111.773 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.16 -27.72 68.91 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.99 0.424 . . . . 71.209999999999994 111.214 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -58.07 -28.77 64.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 72.140000000000001 111.3 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -86.16 -26.49 25.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.356 . . . . 75.040000000000006 111.658 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -174.91 45.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.708 -0.758 . . . . 72.040000000000006 113.582 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -78.18 131.89 37.37 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.936 0.398 . . . . 73.209999999999994 111.716 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 152' ' ' THR . 55.7 mt -104.82 139.92 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.922 -0.581 . . . . 73.209999999999994 110.384 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 -49.92 6.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 72.340000000000003 110.847 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.59 159.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.684 -0.487 . . . . 74.409999999999997 109.684 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.53 127.82 75.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.923 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.65 103.79 15.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.1 -0.954 . . . . 73.239999999999995 110.326 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.53 117.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.164 -0.68 . . . . 73.409999999999997 109.164 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.4 mmm -91.3 122.33 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.333 -0.617 . . . . 73.129999999999995 109.333 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.48 163.06 24.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.429 0.633 . . . . 72.150000000000006 112.039 -173.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.479 ' HA ' ' NH2' ' A' ' 146' ' ' ARG . 12.9 t70 -95.14 128.11 41.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.608 -1.178 . . . . 70.040000000000006 109.963 176.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -9.9 59.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 73.040000000000006 112.273 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.66 -53.85 2.65 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.374 -0.917 . . . . 62.520000000000003 113.039 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.2 m -96.24 -19.74 19.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.736 0.303 . . . . 72.430000000000007 111.122 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.26 28.41 48.95 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.702 -0.761 . . . . 75.109999999999999 111.524 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -108.4 179.64 4.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 72.420000000000002 109.658 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -72.69 150.83 42.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.303 0.573 . . . . 74.099999999999994 111.173 175.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 139' ' ' ASP . 23.6 tpp180 -74.9 -7.61 54.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.683 . . . . 73.099999999999994 111.535 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.46 -3.32 53.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.266 -0.968 . . . . 65.439999999999998 112.475 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -157.46 158.8 36.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 110.392 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.5 170.07 16.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.48 -0.782 . . . . 71.209999999999994 109.54 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -134.4 145.21 48.71 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.967 -0.56 . . . . 75.030000000000001 109.909 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.19 129.07 67.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.206 -0.452 . . . . 72.140000000000001 110.623 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.464 ' O ' HG22 ' A' ' 131' ' ' ILE . 96.4 m -100.81 118.74 37.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.643 -0.708 . . . . 73.209999999999994 110.521 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.16 156.81 17.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.768 0.318 . . . . 74.329999999999998 111.178 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.56 -31.93 60.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.931 -0.577 . . . . 73.010000000000005 110.366 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -128.26 152.96 47.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 75.420000000000002 110.663 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -75.96 -25.68 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.553 . . . . 75.439999999999998 109.508 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.59 -48.84 38.72 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.102 -0.954 . . . . 70.510000000000005 111.437 178.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.7 m -72.44 -32.89 66.68 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.82 -0.627 . . . . 62.140000000000001 110.813 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.6 t -69.46 -42.34 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.312 -0.625 . . . . 75.209999999999994 109.312 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 3.6 m-20 -71.43 -22.49 61.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.082 -0.963 . . . . 72.340000000000003 111.804 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -67.01 -39.56 87.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.77 0.795 . . . . 73.329999999999998 109.786 170.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mt -76.02 -40.94 38.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.334 -1.303 . . . . 72.319999999999993 112.054 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 159' ' ' VAL . 7.5 m -73.33 -11.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.001 0.429 . . . . 75.150000000000006 110.924 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.409 HD12 HD12 ' A' ' 13' ' ' LEU . 10.8 mt -63.71 -29.99 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.323 -0.853 . . . . 73.400000000000006 110.193 173.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.551 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 54.6 mt-30 -112.66 98.42 7.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.898 -1.149 . . . . 63.109999999999999 107.898 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -56.67 -33.37 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.108 -0.951 . . . . 71.120000000000005 112.431 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -121.65 131.75 54.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.33 -0.395 . . . . 75.109999999999999 110.381 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -124.49 150.95 45.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.712 -0.676 . . . . 73.349999999999994 109.794 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -115.87 118.1 32.05 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.779 -0.452 . . . . 72.349999999999994 109.779 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.93 117.2 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.054 -0.521 . . . . 74.420000000000002 110.31 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.02 28.23 5.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 73.209999999999994 110.328 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 97.73 -9.13 64.07 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.534 -0.757 . . . . 61.549999999999997 113.309 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -108.61 125.68 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.444 0.622 . . . . 70.420000000000002 111.795 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -93.2 109.91 21.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.332 0.587 . . . . 70.129999999999995 110.014 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.1 p -114.64 155.31 26.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 110.675 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.0 129.94 34.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.504 -0.554 . . . . 75.140000000000001 109.504 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 12.4 t -127.74 134.45 65.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.411 -0.813 . . . . 75.420000000000002 110.202 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.6 177.0 11.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.707 -0.679 . . . . 74.019999999999996 111.134 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -64.1 125.72 25.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.36 -0.382 . . . . 73.040000000000006 110.144 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.67 44.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.016 0.436 . . . . 64.340000000000003 109.911 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.0 mt -85.15 121.41 27.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.983 -0.553 . . . . 75.510000000000005 109.99 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.531 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 67.1 m -64.54 162.33 15.66 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 74.239999999999995 108.999 171.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -71.02 -26.35 63.07 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.773 -0.579 . . . . 74.439999999999998 112.157 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.3 -36.75 79.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 64.099999999999994 109.731 171.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.531 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 0.6 OUTLIER -70.68 -41.34 72.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.218 -0.901 . . . . 75.030000000000001 110.439 178.017 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 82.1 mtp -64.93 -43.03 94.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.438 -0.801 . . . . 74.319999999999993 111.242 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.3 -23.36 59.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 74.299999999999997 110.622 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.0 m 61.37 26.18 16.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.443 -0.799 . . . . 73.439999999999998 110.298 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.87 172.17 16.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.087 -0.96 . . . . 72.030000000000001 109.276 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.5 m -107.4 152.73 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.732 0.301 . . . . 74.099999999999994 110.344 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.3 p -145.42 124.94 13.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.512 -0.313 . . . . 65.099999999999994 110.433 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 107.16 4.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.346 -0.388 . . . . 70.340000000000003 110.079 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.54 -71.93 0.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.588 -0.733 . . . . 74.129999999999995 110.969 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 61.18 25.76 15.72 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.019 0.824 . . . . 73.329999999999998 110.939 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.76 86.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.963 -0.637 . . . . 65.299999999999997 112.048 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.506 -0.759 . . . . 74.040000000000006 109.588 177.068 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.711 -0.556 . . . . 73.409999999999997 111.711 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -81.74 146.67 29.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.844 0.354 . . . . 52.340000000000003 110.634 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -82.42 127.33 33.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.001 -0.545 . . . . 64.200000000000003 109.548 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 m -82.76 80.99 8.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 64.209999999999994 110.183 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.21 86.46 7.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 73.209999999999994 110.273 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.6 p -75.84 113.68 29.51 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.11 -0.495 . . . . 74.239999999999995 109.866 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.32 167.38 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.301 2.0 . . . . 74.140000000000001 112.916 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -65.9 -12.49 54.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.411 -0.813 . . . . 73.329999999999998 110.713 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -64.63 128.19 93.23 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 111.107 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.8 167.65 17.03 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.152 2.568 . . . . 63.340000000000003 112.186 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.56 -34.64 72.94 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 112.157 0.429 . . . . 74.109999999999999 112.157 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -67.87 -24.36 65.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.872 0.367 . . . . 75.040000000000006 111.363 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.21 -10.6 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 74.310000000000002 111.188 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -122.34 0.72 9.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 75.140000000000001 111.216 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -97.41 145.64 25.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.597 0.713 . . . . 72.0 111.983 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -117.76 147.66 42.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.12 . . . . 74.209999999999994 110.54 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -99.27 125.75 44.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.542 -0.91 . . . . 75.319999999999993 108.542 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.97 113.18 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.91 -0.404 . . . . 74.109999999999999 109.91 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.27 17.26 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.784 -0.722 . . . . 53.049999999999997 111.858 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.74 47.33 26.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 73.25 113.333 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.003 0.43 . . . . 73.299999999999997 110.494 174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 t -92.23 167.36 12.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.332 -0.618 . . . . 61.020000000000003 109.332 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 94.2 m-85 -75.46 -6.12 48.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.307 0.575 . . . . 75.439999999999998 110.789 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.14 -3.8 28.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.201 -0.909 . . . . 75.120000000000005 111.202 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.2 m -76.21 125.18 28.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 71.400000000000006 112.158 -169.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -105.86 160.01 15.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.169 -0.923 . . . . 73.420000000000002 110.072 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 120.475 0.179 . . . . 74.129999999999995 110.829 -177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -76.69 -38.33 54.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 75.329999999999998 111.499 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -78.51 -35.23 46.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.825 -0.171 . . . . 74.400000000000006 111.227 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.77 -45.97 84.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.248 -0.649 . . . . 72.340000000000003 109.248 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -54.17 -60.32 3.49 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.176 -0.92 . . . . 75.329999999999998 111.386 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -47.72 -34.09 7.85 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.858 0.724 . . . . 74.420000000000002 112.701 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -76.58 -57.6 3.76 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.8 -0.182 . . . . 75.200000000000003 111.114 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.18 -23.13 64.81 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.063 -0.398 . . . . 63.420000000000002 111.849 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.91 -23.33 65.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.228 0.611 . . . . 74.349999999999994 111.209 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -60.79 -26.94 67.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 72.430000000000007 112.038 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -99.95 -20.88 15.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.837 0.31 . . . . 73.239999999999995 111.837 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.73 32.88 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.294 -0.955 . . . . 75.25 112.095 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -63.23 117.28 6.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.927 0.394 . . . . 72.540000000000006 111.394 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.9 mt -85.13 143.0 29.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.482 -0.562 . . . . 72.510000000000005 109.482 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -116.17 -16.12 11.02 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.012 -0.54 . . . . 75.310000000000002 110.099 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -152.39 150.7 29.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 73.409999999999997 109.446 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.4 t -162.72 129.48 3.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.687 -0.486 . . . . 75.409999999999997 109.687 174.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.6 122.08 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.501 0.667 . . . . 72.329999999999998 110.587 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.2 t -85.73 129.93 37.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.150000000000006 108.785 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -75.33 95.0 3.12 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.571 0.701 . . . . 70.230000000000004 110.116 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 52.4 mtp85 -101.34 158.43 16.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.636 -1.166 . . . . 73.109999999999999 110.221 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 23.9 t70 -72.45 126.46 90.91 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.143 -0.935 . . . . 73.310000000000002 110.262 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.29 -12.5 31.99 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.127 1.885 . . . . 74.109999999999999 112.942 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.445 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 32.2 m-80 -85.64 -56.3 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.019 0.377 . . . . 75.040000000000006 112.019 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -107.09 -9.24 16.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 111.459 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 67.07 40.07 3.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.68 0.792 . . . . 75.140000000000001 111.416 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -117.28 154.66 30.84 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.547 -0.909 . . . . 72.450000000000003 108.547 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 31.3 t -72.27 139.86 48.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.147 0.431 . . . . 71.420000000000002 111.391 -171.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -82.53 1.2 39.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.695 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 20.06 57.21 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.568 -0.825 . . . . 74.319999999999993 113.987 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -161.05 156.92 25.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.9 0.85 . . . . 75.400000000000006 110.618 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.17 -163.56 14.4 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.519 -0.632 . . . . 71.450000000000003 111.519 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.15 150.4 41.03 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.374 0.587 . . . . 72.040000000000006 110.293 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 m -131.71 127.96 59.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 64.310000000000002 109.55 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -104.49 119.65 39.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.105 -0.331 . . . . 72.239999999999995 110.105 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 29.9 m-85 -85.33 158.95 20.14 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.24 -0.436 . . . . 73.450000000000003 110.121 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.92 -44.45 73.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.932 -0.576 . . . . 71.530000000000001 110.559 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.437 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -126.4 152.13 46.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.754 -0.657 . . . . 74.019999999999996 110.643 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 2.6 p -60.44 -36.31 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.727 -0.67 . . . . 74.209999999999994 110.983 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.64 -43.3 62.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.241 0.83 . . . . 52.409999999999997 113.241 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.3 mp0 -65.61 -29.24 69.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.88 0.372 . . . . 72.120000000000005 111.207 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.96 -45.7 96.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 75.140000000000001 110.428 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.31 -50.1 70.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.167 -0.924 . . . . 73.420000000000002 111.722 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -52.96 -37.08 60.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.938 0.718 . . . . 73.530000000000001 112.938 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.62 -32.52 71.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.461 0.648 . . . . 62.310000000000002 109.949 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.0 mmt -73.07 -31.5 64.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.251 -0.886 . . . . 74.349999999999994 112.09 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.552 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -81.39 -15.01 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.214 0.531 . . . . 63.219999999999999 110.632 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.27 -11.21 35.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 65.319999999999993 112.097 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -54.11 146.58 29.41 Favored Pre-proline 0 N--CA 1.465 0.282 0 O-C-N 123.241 0.338 . . . . 75.439999999999998 111.631 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.19 168.68 69.19 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.75 -1.354 . . . . 54.140000000000001 113.234 2.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -122.77 155.52 36.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.992 -0.549 . . . . 64.129999999999995 110.77 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 ttmt -135.06 108.47 7.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.082 -0.508 . . . . 74.219999999999999 111.112 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.34 124.76 64.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 74.530000000000001 110.073 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 64.99 27.32 12.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.474 0.71 . . . . 73.439999999999998 111.698 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.3 25.04 59.99 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.919 -0.658 . . . . 53.409999999999997 112.483 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.6 tpt180 -129.04 139.07 52.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.044 -0.354 . . . . 71.329999999999998 110.044 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.7 112.79 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.064 -0.717 . . . . 74.109999999999999 109.064 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.96 149.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 111.592 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.41 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 14.8 tp10 -110.81 98.0 36.02 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.819 -1.082 . . . . 74.420000000000002 110.334 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.18 127.71 9.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.672 1.581 . . . . 73.140000000000001 111.111 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 28.0 mttt -133.98 177.74 7.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.885 -1.154 . . . . 73.409999999999997 107.885 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.568 ' HB3' ' CB ' ' A' ' 160' ' ' ASP . 4.3 tpp180 -86.01 135.74 33.53 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.345 -0.542 . . . . 74.329999999999998 110.3 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.7 94.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.437 0.637 . . . . 73.319999999999993 110.648 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.14 157.91 6.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 74.140000000000001 111.088 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -55.3 151.72 9.38 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.71 -0.677 . . . . 63.130000000000003 111.394 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -37.45 75.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.025 -0.534 . . . . 73.109999999999999 111.54 -173.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.56 -47.97 82.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 111.236 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 -43.09 79.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 62.240000000000002 110.486 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 p -75.94 7.4 4.04 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.754 0.65 . . . . 61.350000000000001 112.754 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.44 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 74.340000000000003 110.432 173.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -91.72 144.59 29.67 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 74.0 110.683 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.37 117.47 4.98 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.604 2.203 . . . . 74.439999999999998 111.791 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.92 4.15 29.74 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.838 -0.696 . . . . 64.140000000000001 112.304 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.59 -42.74 24.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.912 0.387 . . . . 74.430000000000007 111.291 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -93.87 1.27 56.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.8 0.333 . . . . 71.549999999999997 110.777 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.4 mt -78.66 159.18 28.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.178 -0.675 . . . . 74.349999999999994 109.178 172.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -75.79 97.9 4.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.382 0.61 . . . . 72.450000000000003 110.99 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.82 119.54 58.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.214 -0.903 . . . . 73.219999999999999 108.883 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -105.34 21.45 17.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 110.394 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.01 139.62 50.92 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.22 -0.446 . . . . 74.030000000000001 110.759 178.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.9 pt -128.96 149.03 33.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.193 0.52 . . . . 71.450000000000003 111.296 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.5 t80 -94.56 133.89 37.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.996 -1.002 . . . . 73.319999999999993 109.76 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -123.09 109.44 23.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.997 -0.742 . . . . 72.439999999999998 108.997 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.49 171.64 26.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.514 -1.327 . . . . 65.310000000000002 113.569 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.47 30.2 30.88 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.198 -0.761 . . . . 74.420000000000002 111.198 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.407 HG21 ' SG ' ' A' ' 175' ' ' CYS . 23.2 pt -75.18 129.45 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 120.975 0.417 . . . . 75.200000000000003 110.311 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.63 -54.93 5.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.106 -0.701 . . . . 72.140000000000001 109.106 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.19 149.46 24.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 73.340000000000003 108.776 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.27 149.13 48.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.276 0.56 . . . . 70.150000000000006 111.517 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -120.77 156.19 32.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 74.219999999999999 111.068 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.02 167.32 10.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.357 -0.838 . . . . 73.5 110.517 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -61.2 -54.07 48.99 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.988 -0.551 . . . . 72.230000000000004 111.01 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -65.19 -17.22 64.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 75.219999999999999 111.773 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -70.18 -57.63 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.015 -0.365 . . . . 75.439999999999998 110.015 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.28 -28.89 38.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.355 -0.538 . . . . 75.319999999999993 110.566 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.429 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 7.3 tmm_? -61.8 -50.01 74.03 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.784 -0.45 . . . . 75.329999999999998 109.784 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.04 -29.31 70.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 75.439999999999998 111.002 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.35 -53.24 6.8 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.994 -0.548 . . . . 73.409999999999997 112.021 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -66.72 -23.97 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.603 0.223 . . . . 71.239999999999995 111.603 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.45 -27.09 68.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.073 0.463 . . . . 72.530000000000001 111.023 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.77 -27.76 68.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 70.510000000000005 111.575 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -86.4 -24.6 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 111.398 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.55 -179.83 43.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.606 -0.807 . . . . 74.310000000000002 112.928 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -73.35 133.65 43.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.357 . . . . 74.019999999999996 110.661 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 152' ' ' THR . 63.9 mt -104.5 137.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.003 -0.544 . . . . 72.420000000000002 109.863 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.25 -46.97 8.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.287 . . . . 73.530000000000001 110.846 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.55 157.46 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.083 -0.339 . . . . 70.319999999999993 110.083 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.86 130.58 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.777 -0.453 . . . . 74.549999999999997 109.777 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 31.8 mt-10 -103.19 103.45 13.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.788 -0.642 . . . . 72.109999999999999 110.746 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.12 116.54 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.502 -0.555 . . . . 75.340000000000003 109.502 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.436 ' HG3' ' CE2' ' A' ' 148' ' ' PHE . 69.3 mmm -84.4 100.99 11.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.554 0.692 . . . . 73.420000000000002 109.559 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -117.57 158.38 24.69 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.007 -0.997 . . . . 53.340000000000003 110.164 -174.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -88.31 123.11 32.57 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.981 -0.748 . . . . 74.299999999999997 108.981 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 34.1 tpt85 -64.45 -31.92 73.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.386 0.429 . . . . 75.140000000000001 111.789 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.85 -47.05 4.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.635 -0.793 . . . . 74.409999999999997 113.279 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -86.22 -23.68 26.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.097 0.406 . . . . 71.239999999999995 112.097 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.11 6.25 87.46 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.909 -0.662 . . . . 62.229999999999997 112.22 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -92.34 146.12 23.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.381 -0.229 . . . . 72.140000000000001 110.381 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 72.409999999999997 109.177 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -81.03 21.8 0.68 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.377 0.88 . . . . 74.400000000000006 113.377 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.62 -2.73 80.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.675 -0.774 . . . . 75.140000000000001 113.941 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.436 ' CE2' ' HG3' ' A' ' 137' ' ' MET . 13.3 p90 -154.7 163.46 40.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 75.299999999999997 110.493 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.18 171.91 13.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.208 -0.905 . . . . 74.140000000000001 109.893 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.4 m-85 -139.09 155.06 48.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.46 -0.791 . . . . 74.219999999999999 109.284 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.28 134.52 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-O 121.418 0.628 . . . . 75.219999999999999 111.334 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 131' ' ' ILE . 53.0 m -100.26 125.63 46.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.91 -1.041 . . . . 75.219999999999999 110.672 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -99.88 160.7 14.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.938 0.399 . . . . 73.349999999999994 111.253 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.43 -27.76 37.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 74.129999999999995 110.344 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.94 160.98 31.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.665 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -84.93 -32.08 23.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 74.510000000000005 110.756 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.601 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 35.7 t70 -62.18 -37.99 87.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.955 -0.566 . . . . 71.200000000000003 111.13 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -67.02 -33.69 76.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.526 -0.307 . . . . 64.340000000000003 111.058 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.05 -42.62 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 72.209999999999994 109.868 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.568 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 73.3 m-20 -64.14 -37.87 89.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.106 -0.952 . . . . 72.299999999999997 111.509 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 47.9 mttm -53.8 -42.67 68.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.81 0.814 . . . . 70.25 110.538 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.75 -43.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.281 -1.327 . . . . 73.420000000000002 112.395 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 160' ' ' ASP . 18.9 m -75.24 -7.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 121.972 -0.455 . . . . 75.120000000000005 111.059 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 160' ' ' ASP . 37.8 mt -57.85 -32.28 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.377 -0.829 . . . . 63.5 109.927 170.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -107.58 152.49 24.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.936 -0.575 . . . . 72.150000000000006 109.46 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.21 -39.07 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.976 0.417 . . . . 75.340000000000003 110.388 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.02 137.91 54.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 71.120000000000005 110.033 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -122.71 140.77 52.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.318 -0.401 . . . . 74.150000000000006 110.902 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -96.06 116.28 28.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.814 -0.63 . . . . 64.510000000000005 110.218 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.72 107.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 110.581 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 72.95 28.19 2.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.231 -0.895 . . . . 65.530000000000001 110.007 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.84 -2.63 80.14 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.386 -0.824 . . . . 71.310000000000002 112.678 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -110.56 130.17 55.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.775 -0.25 . . . . 72.109999999999999 110.54 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.09 0.471 . . . . 61.539999999999999 110.988 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' A' ' 112' ' ' ILE . 7.4 m -110.42 150.99 28.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.847 -0.615 . . . . 63.039999999999999 110.297 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -86.9 133.83 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.879 -0.415 . . . . 75.0 109.879 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.8 t -133.13 138.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 72.129999999999995 111.572 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -158.64 177.32 11.33 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.863 -0.608 . . . . 74.219999999999999 111.463 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -62.5 124.74 21.75 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.97 0.508 . . . . 74.219999999999999 110.86 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -111.99 113.61 26.0 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.217 0.532 . . . . 60.310000000000002 109.903 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 186' ' ' MET . 39.2 mt -98.73 147.97 24.33 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.551 -0.749 . . . . 73.439999999999998 109.588 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t -72.74 174.57 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.71 -0.478 . . . . 73.219999999999999 109.71 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.92 -42.75 97.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.717 0.294 . . . . 64.120000000000005 110.73 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.42 -19.48 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 75.109999999999999 111.493 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -83.13 -46.79 12.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.745 0.307 . . . . 74.450000000000003 110.528 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.427 ' CG ' ' HB2' ' A' ' 181' ' ' LEU . 83.5 mtp -68.5 -50.26 53.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.03 -0.532 . . . . 71.409999999999997 111.124 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.87 -43.02 69.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.951 -0.568 . . . . 74.540000000000006 110.602 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.8 m 60.47 21.37 11.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.692 -0.685 . . . . 53.310000000000002 110.784 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -101.63 130.51 47.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.804 -0.635 . . . . 62.130000000000003 110.795 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.6 m -76.8 155.14 33.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.712 -0.676 . . . . 51.509999999999998 109.781 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.6 p -69.66 142.8 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.025 0.441 . . . . 73.129999999999995 111.14 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 t -94.7 85.4 4.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.433 -0.58 . . . . 62.520000000000003 109.433 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -93.43 141.18 28.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.878 0.37 . . . . 74.409999999999997 110.122 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -102.15 -49.42 3.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.181 -0.463 . . . . 75.439999999999998 110.871 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -162.22 106.61 0.28 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.199 -1.001 . . . . 51.140000000000001 113.023 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.983 -1.008 . . . . 75.239999999999995 109.007 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 CA-C-O 120.055 -0.303 . . . . 74.209999999999994 112.427 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m 74.68 -40.83 0.45 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 71.0 113.132 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -87.64 90.4 8.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.246 0.546 . . . . 75.439999999999998 111.822 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -107.14 7.64 29.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.150000000000006 109.672 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 60.1 78.88 0.26 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.834 -1.076 . . . . 54.32 110.312 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -66.56 123.6 86.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 64.25 111.117 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 60.9 Cg_endo -81.23 165.61 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.97 2.447 . . . . 73.430000000000007 112.219 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -2.53 15.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 108.845 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -71.2 141.57 86.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.018 -1.446 . . . . 74.200000000000003 109.877 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.98 166.97 19.02 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.71 2.273 . . . . 74.219999999999999 112.462 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.64 -32.29 67.12 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.956 -0.565 . . . . 71.120000000000005 111.97 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -64.05 -31.91 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.794 0.33 . . . . 75.099999999999994 111.551 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.53 -20.23 51.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 60.140000000000001 111.282 -176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -117.18 0.1 12.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.363 -0.381 . . . . 73.510000000000005 111.587 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -98.15 148.53 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.781 0.801 . . . . 75.200000000000003 112.16 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.0 mt -117.01 145.2 43.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.331 -1.304 . . . . 70.310000000000002 110.338 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -97.93 120.27 38.03 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.112 -1.07 . . . . 72.140000000000001 108.112 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -100.52 110.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.79 -0.448 . . . . 75.239999999999995 109.79 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.85 151.61 16.89 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.948 -0.861 . . . . 73.319999999999993 110.948 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 43.3 12.89 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.252 -0.975 . . . . 45.119999999999997 112.974 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.1 175.44 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.039 0.447 . . . . 74.25 110.499 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -90.96 172.79 8.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.382 -0.599 . . . . 71.200000000000003 109.382 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -77.35 -11.49 59.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.365 0.602 . . . . 75.299999999999997 110.28 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 24.0 mt-10 -106.9 -1.41 22.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 73.209999999999994 111.484 -175.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.3 m -69.75 126.41 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.119 0.485 . . . . 74.340000000000003 112.026 -170.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -101.92 167.5 10.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.407 -0.815 . . . . 73.409999999999997 110.0 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -28.1 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.978 -0.378 . . . . 74.239999999999995 109.978 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.9 -41.9 82.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.450000000000003 110.853 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t -72.64 -41.97 64.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 74.019999999999996 110.049 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.6 tp -59.85 -49.03 79.28 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.682 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 14.2 ttm-85 -58.92 -56.54 20.9 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.438 0.695 . . . . 72.239999999999995 111.044 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 m -44.38 -38.77 4.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 63.119999999999997 113.381 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -67.26 -52.2 43.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.981 -0.554 . . . . 74.230000000000004 111.226 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -80.65 -20.27 43.44 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.925 0.343 . . . . 73.420000000000002 111.925 -170.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 31' ' ' ARG . 44.1 mt-10 -56.5 -24.27 45.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.355 0.502 . . . . 72.439999999999998 112.355 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -63.3 -27.08 69.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.468 0.544 . . . . 73.420000000000002 112.468 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -100.06 -21.95 15.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.645 0.259 . . . . 75.519999999999996 111.557 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 156.84 27.25 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.759 -0.734 . . . . 74.120000000000005 111.401 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 83.2 m -67.65 120.24 13.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.911 0.386 . . . . 70.349999999999994 111.143 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 mt -84.34 145.4 28.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.328 0.585 . . . . 75.329999999999998 110.834 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -108.79 -22.94 11.99 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.278 -0.874 . . . . 61.420000000000002 110.17 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -154.52 157.47 38.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.502 . . . . 63.109999999999999 110.62 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.7 t -163.6 136.56 5.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.413 -0.588 . . . . 71.209999999999994 109.413 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -151.01 126.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.533 . . . . 72.140000000000001 110.298 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.77 132.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.7 -0.852 . . . . 73.319999999999993 108.7 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 3.8 mmt -76.05 97.16 3.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.732 0.777 . . . . 73.319999999999993 110.423 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 35.7 mtt180 -101.88 163.59 12.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.37 -1.286 . . . . 75.430000000000007 111.492 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.19 124.19 89.79 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 114.491 -1.231 . . . . 72.040000000000006 110.25 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.95 -20.23 70.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.084 1.856 . . . . 75.209999999999994 112.909 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -83.79 -56.51 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.12 0.415 . . . . 74.129999999999995 112.12 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -6.89 16.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 71.010000000000005 111.677 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm 64.43 40.18 6.49 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.384 -0.826 . . . . 74.439999999999998 111.953 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 27.0 mmm180 -114.42 163.03 15.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.418 -0.586 . . . . 74.209999999999994 109.418 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.487 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.6 t -72.42 133.97 45.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.148 0.499 . . . . 72.409999999999997 111.845 -173.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -81.88 -0.16 42.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.533 -0.758 . . . . 74.239999999999995 110.451 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.04 58.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.731 -0.747 . . . . 73.239999999999995 114.128 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 27.2 p90 -156.35 156.55 34.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.815 0.807 . . . . 61.450000000000003 110.58 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.51 -166.33 18.24 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 111.564 -0.615 . . . . 38.020000000000003 111.564 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.22 148.9 38.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.224 0.512 . . . . 75.530000000000001 110.35 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 m -128.43 130.14 69.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.637 -0.711 . . . . 73.019999999999996 109.318 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -106.72 120.15 41.22 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.304 -0.247 . . . . 74.439999999999998 110.354 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -83.93 169.17 15.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.48 . . . . 73.519999999999996 110.515 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -67.5 -55.65 12.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.738 -0.665 . . . . 65.230000000000004 109.577 174.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.3 m -123.24 153.14 40.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 73.099999999999994 111.426 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.7 p -58.04 -38.28 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.777 -0.647 . . . . 75.239999999999995 111.248 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -52.63 -41.8 64.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.066 0.765 . . . . 73.340000000000003 113.066 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -62.54 -31.34 72.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.363 0.602 . . . . 72.019999999999996 110.388 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 32.9 t -68.83 -47.26 77.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.108 -0.951 . . . . 73.010000000000005 111.01 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.76 -48.3 75.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 70.5 110.887 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.4 60.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.625 0.602 . . . . 75.519999999999996 112.625 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.94 -33.59 63.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.981 0.42 . . . . 62.119999999999997 110.659 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.414 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -67.3 -47.1 71.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 75.209999999999994 110.801 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.99 66.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 62.299999999999997 110.682 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.21 -8.04 46.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.943 0.72 . . . . 61.350000000000001 112.943 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.48 ' NH1' ' HG2' ' A' ' 85' ' ' GLU . 11.9 mtp180 -56.66 147.72 49.96 Favored Pre-proline 0 CA--C 1.531 0.225 0 O-C-N 122.897 0.123 . . . . 73.200000000000003 111.013 173.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.65 166.08 78.44 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.8 -1.333 . . . . 74.340000000000003 113.968 4.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -125.9 150.99 47.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.764 -0.653 . . . . 70.540000000000006 110.964 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -141.46 113.01 7.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.909 -0.587 . . . . 74.140000000000001 111.039 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.07 144.41 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.89 -0.596 . . . . 73.209999999999994 109.736 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.9 t70 67.39 22.03 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.592 0.71 . . . . 72.219999999999999 110.567 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.12 74.19 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.385 -0.825 . . . . 64.030000000000001 111.934 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -130.22 141.01 50.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.58 0.229 . . . . 75.519999999999996 110.529 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.56 113.19 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.874 -0.787 . . . . 73.319999999999993 108.874 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.31 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 75.209999999999994 111.602 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.48 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 mt-10 -115.33 98.03 49.68 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.213 -0.903 . . . . 75.409999999999997 111.403 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' O ' ' HE1' ' A' ' 72' ' ' MET . 32.2 Cg_endo -75.28 133.04 15.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.967 1.778 . . . . 73.340000000000003 110.725 171.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -139.39 -178.84 5.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.201 -1.407 . . . . 75.150000000000006 107.201 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -86.96 143.29 27.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 119.748 1.158 . . . . 73.409999999999997 111.533 -177.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.81 3.5 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.843 -0.799 . . . . 50.039999999999999 108.843 165.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.79 160.01 5.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.339 -0.846 . . . . 75.209999999999994 110.117 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.7 p -53.21 150.66 5.84 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.407 0.442 . . . . 73.099999999999994 110.888 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 9.9 mpt_? -60.2 -23.73 64.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.916 -0.584 . . . . 73.010000000000005 112.26 -171.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.27 -45.83 91.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.966 0.413 . . . . 74.530000000000001 110.344 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.53 -50.61 7.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 63.539999999999999 111.216 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.9 p -70.91 -9.66 58.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.51 0.93 . . . . 70.409999999999997 113.51 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.89 -2.29 58.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.942 0.401 . . . . 72.010000000000005 110.866 179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -116.99 148.23 41.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.276 -0.42 . . . . 74.150000000000006 110.084 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.09 138.38 77.77 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.833 2.356 . . . . 72.25 112.592 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.09 -15.37 51.34 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.838 -0.696 . . . . 75.010000000000005 112.396 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.79 -44.32 56.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 65.129999999999995 111.671 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -96.42 13.5 27.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.793 0.33 . . . . 70.439999999999998 111.365 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.9 mt -82.12 162.72 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.193 -0.669 . . . . 73.230000000000004 109.193 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -79.23 85.75 5.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.607 0.718 . . . . 72.230000000000004 110.032 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.14 114.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.882 -1.053 . . . . 74.140000000000001 110.11 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -109.27 15.57 23.06 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.657 -0.417 . . . . 75.329999999999998 110.683 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -115.62 139.38 50.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.318 -0.401 . . . . 65.219999999999999 110.537 176.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 pt -131.52 152.96 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.501 0.667 . . . . 74.5 111.62 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.1 t80 -96.88 136.07 37.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.537 -1.21 . . . . 74.409999999999997 109.834 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -122.97 110.65 27.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.103 -0.703 . . . . 74.299999999999997 109.103 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.63 155.11 19.93 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.684 -1.246 . . . . 71.099999999999994 113.237 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.37 7.4 55.97 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.539 -0.838 . . . . 74.109999999999999 112.456 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.7 pt -72.44 105.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.515 0.674 . . . . 73.140000000000001 109.758 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -88.2 -10.08 50.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 72.120000000000005 111.798 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -121.71 165.42 15.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.716 -0.475 . . . . 72.430000000000007 109.716 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 145' ' ' LYS . 9.2 p-10 -70.17 104.55 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.404 1.097 . . . . 73.099999999999994 111.399 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -96.96 142.72 28.58 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.158 -1.383 . . . . 75.530000000000001 109.55 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 14.4 pt-20 -113.58 169.5 8.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.672 -0.695 . . . . 74.0 110.949 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -53.59 -51.29 63.48 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 114.828 -1.078 . . . . 71.209999999999994 110.405 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.55 -25.05 62.09 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.653 0.612 . . . . 72.519999999999996 112.653 -175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.43 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 63.7 m170 -70.94 -60.4 2.25 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.067 0.46 . . . . 74.209999999999994 110.771 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -81.47 -26.47 35.23 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 120.177 -0.609 . . . . 73.230000000000004 111.229 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -68.0 -43.46 78.82 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 110.257 -0.275 . . . . 74.0 110.257 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.67 -31.25 72.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.082 0.467 . . . . 73.239999999999995 110.422 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.449 ' CD2' HG23 ' A' ' 170' ' ' VAL . 80.5 t80 -79.27 -54.5 5.9 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.09 -0.505 . . . . 74.140000000000001 111.859 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.88 -24.54 63.43 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.621 0.6 . . . . 72.319999999999993 112.621 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 5.1 mt-10 -71.49 -16.59 62.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.844 0.354 . . . . 75.329999999999998 111.152 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.34 -25.79 68.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 75.099999999999994 111.074 172.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.79 -25.56 23.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.504 -0.316 . . . . 74.239999999999995 111.266 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 126' ' ' GLU . . . 168.51 -175.35 43.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.951 -0.642 . . . . 64.209999999999994 112.641 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.64 131.77 42.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.905 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 152' ' ' THR . 76.4 mt -100.03 140.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.676 -0.693 . . . . 74.409999999999997 109.865 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.13 -51.13 6.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 71.040000000000006 110.269 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.16 156.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.93 -0.577 . . . . 74.010000000000005 109.76 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.63 128.93 72.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.745 -0.465 . . . . 75.140000000000001 109.745 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.13 104.44 15.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.95 -0.568 . . . . 75.439999999999998 110.729 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.7 mm -93.31 131.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.341 -0.615 . . . . 75.430000000000007 109.341 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 48.8 mmm -105.14 132.7 51.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.517 -0.549 . . . . 74.200000000000003 109.517 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.89 139.98 32.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 72.420000000000002 111.597 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.1 127.28 32.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.258 -0.883 . . . . 73.200000000000003 109.531 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -68.93 -39.17 79.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.409 -0.36 . . . . 64.129999999999995 111.871 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.98 -46.96 12.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.074 -0.584 . . . . 51.229999999999997 113.497 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -93.19 -22.88 18.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.727 0.299 . . . . 74.299999999999997 111.292 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.45 15.55 80.74 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.097 -0.573 . . . . 70.099999999999994 112.296 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -101.68 150.36 23.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 74.540000000000006 109.396 -178.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -75.83 83.66 2.77 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.317 -0.153 . . . . 65.310000000000002 110.784 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -160.18 172.71 16.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.871 0.843 . . . . 71.420000000000002 113.224 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.93 -44.19 1.53 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.562 -1.653 . . . . 45.32 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.98 155.23 3.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.165 -0.68 . . . . 74.420000000000002 109.165 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.04 172.67 12.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.973 -0.558 . . . . 75.5 109.635 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -138.61 152.13 47.86 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.744 -0.662 . . . . 74.319999999999993 109.466 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.68 132.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.365 0.602 . . . . 51.25 111.069 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 131' ' ' ILE . 82.9 m -102.75 125.08 49.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.979 -1.01 . . . . 70.019999999999996 110.918 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -102.6 157.87 16.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.578 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.47 -31.18 57.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.676 -0.693 . . . . 62.530000000000001 110.402 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.36 157.94 42.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.587 -0.733 . . . . 63.130000000000003 110.399 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.437 ' HE2' ' NH1' ' A' ' 75' ' ' ARG . 28.6 p80 -82.5 -22.89 34.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 109.859 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -53.08 -45.81 68.35 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.853 0.721 . . . . 71.439999999999998 111.25 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.429 ' O ' HD13 ' A' ' 162' ' ' ILE . 1.4 m -65.34 -35.29 80.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.783 -0.644 . . . . 74.519999999999996 110.836 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.5 -38.61 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.795 -0.446 . . . . 71.219999999999999 109.795 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 7.0 m-20 -65.92 -33.8 76.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.140000000000001 111.432 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 93.0 mttt -63.47 -38.4 91.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.417 0.627 . . . . 74.400000000000006 110.378 174.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 158' ' ' SER . 14.0 mt -78.1 -40.84 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.891 -1.05 . . . . 70.109999999999999 112.002 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.14 -4.3 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.193 0.521 . . . . 72.400000000000006 111.177 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.5 mt -62.86 -31.95 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.289 -0.869 . . . . 70.219999999999999 109.732 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.569 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 51.5 mt-30 -108.39 153.1 23.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.886 -0.783 . . . . 73.099999999999994 108.886 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -91.49 -38.49 12.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.244 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.56 137.12 53.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.369 -0.378 . . . . 74.299999999999997 110.242 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.569 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 39.2 m-70 -125.38 146.05 49.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.145 -0.479 . . . . 71.439999999999998 110.172 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.6 m -91.75 110.71 22.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.049 -0.523 . . . . 75.010000000000005 111.34 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.449 HG23 ' CD2' ' A' ' 124' ' ' TYR . 41.2 t -117.13 131.09 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.07 -0.715 . . . . 70.120000000000005 109.07 174.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 46.99 42.59 12.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.45 0.7 . . . . 73.049999999999997 111.924 -174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.31 7.08 59.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 113.97 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -110.24 137.29 48.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.024 0.412 . . . . 75.329999999999998 110.16 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -89.39 108.95 19.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 72.109999999999999 110.308 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -112.24 154.81 25.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.833 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.8 139.31 30.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.506 . . . . 72.439999999999998 109.988 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.8 m -130.11 155.3 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.997 0.427 . . . . 74.430000000000007 110.632 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -172.37 169.76 5.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.065 -0.97 . . . . 75.0 111.497 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -58.68 127.84 34.21 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 73.299999999999997 110.663 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.23 119.38 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.11 0.481 . . . . 70.310000000000002 109.884 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.59 156.2 16.92 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.695 -0.684 . . . . 73.409999999999997 109.37 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.5 t -65.68 152.02 45.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.204 -1.036 . . . . 61.140000000000001 108.204 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -67.96 -19.09 64.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.596 0.236 . . . . 74.209999999999994 110.897 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -63.92 -41.59 97.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.61 -0.515 . . . . 73.329999999999998 109.61 171.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.47 -41.57 60.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.47 . . . . 64.430000000000007 109.888 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.41 -44.52 82.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 72.239999999999995 111.61 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -90.42 -6.28 55.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.882 -0.144 . . . . 62.32 111.309 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t 60.0 29.08 18.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.308 0.643 . . . . 74.409999999999997 110.475 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 184' ' ' GLN . . . -161.93 162.89 29.29 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.37 -0.832 . . . . 63.539999999999999 109.399 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.1 m -64.03 116.53 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.243 0.339 . . . . 74.150000000000006 111.169 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 m -137.51 131.17 31.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.066 -0.516 . . . . 73.319999999999993 109.786 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 t -145.54 139.29 26.64 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 74.519999999999996 111.086 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -105.68 109.87 21.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.478 -0.564 . . . . 72.510000000000005 109.478 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -86.51 117.93 25.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.416 . . . . 74.530000000000001 110.514 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -93.97 -165.43 36.84 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.48 -0.648 . . . . 73.340000000000003 111.48 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.159 -0.924 . . . . 75.120000000000005 110.868 -179.481 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.86 -0.496 . . . . 51.520000000000003 111.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -86.73 98.89 11.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 70.049999999999997 110.598 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -98.89 85.94 3.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.529 0.68 . . . . 75.329999999999998 110.171 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.55 17.7 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.778 -0.646 . . . . 60.509999999999998 110.446 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -66.86 -39.55 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 74.340000000000003 110.405 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m 70.9 124.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 O-C-N 124.137 0.898 . . . . 74.409999999999997 110.105 -174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 150.18 89.35 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.742 2.294 . . . . 73.319999999999993 113.041 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -116.96 -1.5 11.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.893 -1.151 . . . . 73.340000000000003 107.893 177.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.59 141.66 24.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.407 -1.27 . . . . 72.310000000000002 111.029 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.44 167.77 19.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.904 2.403 . . . . 64.329999999999998 110.778 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -57.36 -37.41 72.57 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 111.698 0.259 . . . . 75.109999999999999 111.698 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -67.22 -27.86 67.59 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.891 0.33 . . . . 75.099999999999994 111.891 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mp -82.42 -9.79 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.385 . . . . 75.120000000000005 111.087 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -123.13 -0.66 8.86 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.129 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 34.5 ttpt -91.66 145.92 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 111.571 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 87' ' ' LYS . 3.9 mp -123.52 145.68 48.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.196 -0.911 . . . . 63.340000000000003 110.136 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -96.96 117.68 31.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.436 -0.579 . . . . 75.239999999999995 109.436 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 mm -94.34 113.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.956 -0.387 . . . . 72.120000000000005 109.956 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.35 150.41 16.84 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.738 -0.744 . . . . 38.189999999999998 111.79 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.7 45.22 29.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.89 -0.672 . . . . 62.219999999999999 113.381 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 ' CG1' ' A' ' 84' ' ' VAL . 79.4 mt -81.85 176.72 9.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.167 0.483 . . . . 73.430000000000007 110.819 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -86.24 178.64 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 73.109999999999999 109.542 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -84.19 -6.34 59.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.051 0.453 . . . . 74.109999999999999 110.534 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.27 20.05 15.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 64.140000000000001 111.061 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.6 m -81.53 129.4 34.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 75.120000000000005 110.405 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -117.96 160.19 21.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.734 -0.666 . . . . 75.310000000000002 109.377 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.93 -42.94 76.89 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.561 0.538 . . . . 75.200000000000003 111.108 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.67 -30.52 71.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.581 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 m -86.28 -42.07 14.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.62 -0.264 . . . . 72.239999999999995 111.077 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.24 -50.07 67.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 110.528 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -56.42 -58.2 9.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.692 -0.686 . . . . 74.310000000000002 111.598 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -48.8 -34.22 11.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.561 0.538 . . . . 73.319999999999993 112.357 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -74.06 -49.6 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.431 -0.349 . . . . 73.200000000000003 110.99 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -78.18 -18.82 55.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.193 -0.317 . . . . 74.019999999999996 111.758 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -56.6 -22.68 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.111 -0.495 . . . . 73.019999999999996 112.222 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.65 -22.15 66.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 74.549999999999997 111.951 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -102.97 -24.04 13.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.665 0.269 . . . . 74.510000000000005 111.244 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.45 161.59 32.39 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.356 -0.926 . . . . 75.129999999999995 112.475 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -57.59 141.7 47.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.874 0.469 . . . . 72.239999999999995 111.552 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.3 mt -120.23 124.72 46.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.31 -0.626 . . . . 72.140000000000001 109.31 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -97.94 -20.45 17.44 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.045 -0.525 . . . . 74.209999999999994 110.621 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -149.94 152.77 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.633 -0.506 . . . . 75.540000000000006 109.633 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -165.45 137.08 4.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.084 -0.71 . . . . 55.210000000000001 109.084 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.34 132.68 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.053 0.454 . . . . 72.400000000000006 110.727 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.11 131.28 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.269 -0.641 . . . . 62.450000000000003 109.269 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 mmt -73.65 133.2 43.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.952 -0.759 . . . . 65.409999999999997 108.952 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -139.95 158.17 44.5 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.892 -0.595 . . . . 75.329999999999998 110.928 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -67.22 129.49 93.81 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.778 -1.101 . . . . 64.400000000000006 109.646 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.59 -22.34 33.02 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.186 1.924 . . . . 70.019999999999996 113.364 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -55.19 4.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.585 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 m -103.43 -8.87 19.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.504 . . . . 75.230000000000004 111.734 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 63.28 35.31 12.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.331 0.652 . . . . 74.349999999999994 111.758 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -101.48 158.75 15.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.031 -1.099 . . . . 75.420000000000002 108.031 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -70.31 140.43 52.27 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.092 0.472 . . . . 72.209999999999994 110.58 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -84.67 5.87 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.681 -0.69 . . . . 72.439999999999998 110.485 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.39 16.52 71.14 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.628 -0.796 . . . . 38.189999999999998 113.605 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -160.3 157.78 28.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.014 0.907 . . . . 74.099999999999994 110.954 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.08 -163.81 15.7 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.446 -0.661 . . . . 73.25 111.446 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.99 148.71 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.187 0.493 . . . . 61.219999999999999 110.611 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.65 126.32 60.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.907 -0.588 . . . . 74.099999999999994 109.739 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 m -101.28 118.01 36.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.444 -0.344 . . . . 62.43 110.166 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -84.6 165.15 18.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 74.450000000000003 109.856 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.41 63.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.37 -0.377 . . . . 74.239999999999995 110.675 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -132.94 154.01 50.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.309 -0.405 . . . . 74.109999999999999 110.253 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.554 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.8 p -64.88 -33.54 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.736 -0.211 . . . . 65.430000000000007 111.548 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.61 -34.08 72.3 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.38 0.511 . . . . 74.120000000000005 112.38 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.94 -33.79 76.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.303 0.573 . . . . 70.120000000000005 109.791 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 2.4 t -62.61 -46.97 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 72.420000000000002 111.125 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.3 -45.51 92.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 72.349999999999994 111.075 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.646 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.15 -38.4 73.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.332 0.493 . . . . 75.340000000000003 112.332 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.3 83.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.451 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.436 ' HE2' ' O ' ' A' ' 86' ' ' PRO . 1.6 mmt -69.27 -35.18 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.698 . . . . 72.230000000000004 110.974 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.9 p30 -84.84 -7.06 59.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.384 . . . . 51.229999999999997 111.515 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.27 -11.08 20.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.606 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.438 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 10.2 ttp180 -53.2 143.63 32.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.009 -0.996 . . . . 73.439999999999998 110.855 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 4.8 Cg_exo -79.71 169.86 69.13 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.954 -0.853 . . . . 65.129999999999995 114.054 2.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.22 161.16 29.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 75.209999999999994 109.773 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 22.5 ttmt -134.3 104.66 6.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.909 0.385 . . . . 72.549999999999997 111.38 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.63 126.37 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 62.130000000000003 110.137 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.22 40.38 8.84 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.54 0.686 . . . . 75.310000000000002 110.756 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.56 27.78 73.37 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.885 -0.598 . . . . 63.200000000000003 112.785 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.0 tpt180 -132.44 140.22 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 73.430000000000007 110.002 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 t -78.28 110.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.278 -0.638 . . . . 75.519999999999996 109.278 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.0 m -104.96 150.04 8.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.408 0.623 . . . . 64.209999999999994 110.575 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HG2' HH11 ' A' ' 75' ' ' ARG . 7.3 tt0 -117.74 96.11 48.96 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.292 -0.867 . . . . 72.450000000000003 110.853 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.436 ' O ' ' HE2' ' A' ' 72' ' ' MET . 29.3 Cg_endo -69.14 130.83 20.82 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.456 1.437 . . . . 63.329999999999998 110.433 171.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 25.4 mttt -128.35 -179.56 5.09 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.295 -0.866 . . . . 75.519999999999996 108.837 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB3' ' OD2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -77.95 155.08 31.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.795 -0.446 . . . . 73.120000000000005 109.795 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.89 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 74.209999999999994 110.351 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' HB ' ' OD1' ' A' ' 160' ' ' ASP . 8.1 p -72.78 157.92 6.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.243 -0.89 . . . . 71.230000000000004 110.655 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.72 142.8 27.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.356 -0.609 . . . . 73.140000000000001 109.356 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -62.34 -17.41 58.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.803 0.335 . . . . 74.400000000000006 111.246 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.85 -48.33 74.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 74.209999999999994 110.616 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 25.3 t70 -84.16 -13.78 51.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.88 -0.6 . . . . 73.409999999999997 110.455 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -73.74 8.63 1.82 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.975 0.416 . . . . 65.340000000000003 110.956 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 94' ' ' ASP . 9.7 tt0 -88.38 -18.23 28.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 75.530000000000001 111.262 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 19.6 mmt180 -61.38 148.94 84.78 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 110.127 -0.323 . . . . 74.120000000000005 110.127 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -65.61 112.95 2.32 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.49 1.46 . . . . 64.109999999999999 110.343 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.7 48.98 46.27 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.695 -0.764 . . . . 74.340000000000003 111.465 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.01 -31.31 70.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 70.040000000000006 111.186 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -98.73 21.39 11.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 70.420000000000002 111.332 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.0 mt -76.88 177.58 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.988 -0.745 . . . . 74.420000000000002 108.988 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -81.92 78.31 8.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.471 0.653 . . . . 73.439999999999998 110.384 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.61 109.01 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.105 -0.952 . . . . 75.099999999999994 110.377 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.422 ' C ' HG22 ' A' ' 159' ' ' VAL . 53.5 mttt -107.36 20.99 18.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.998 0.428 . . . . 73.329999999999998 110.264 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.62 53.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.398 -0.364 . . . . 75.329999999999998 110.713 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.91 152.47 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.217 0.532 . . . . 61.409999999999997 111.609 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 6.3 t80 -99.34 131.84 45.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.92 -1.036 . . . . 74.219999999999999 109.452 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.45 110.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.352 -0.61 . . . . 71.519999999999996 109.352 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.43 16.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.75 -1.214 . . . . 70.010000000000005 113.825 -173.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.5 43.35 2.96 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.187 -0.53 . . . . 74.439999999999998 112.556 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 173' ' ' HIS . 22.1 pt -120.92 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.467 0.651 . . . . 74.540000000000006 110.857 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -54.24 3.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.437 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.93 170.54 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.436 0.46 . . . . 54.329999999999998 110.434 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.77 84.85 0.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.578 0.584 . . . . 73.420000000000002 112.578 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -83.87 131.63 34.86 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.938 -0.574 . . . . 61.299999999999997 109.475 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.53 165.44 11.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.377 -0.829 . . . . 74.010000000000005 110.546 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.26 -45.68 72.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.286 -0.87 . . . . 73.239999999999995 109.858 175.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -55.91 -38.65 70.53 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.766 0.666 . . . . 75.230000000000004 111.541 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.16 -59.09 5.97 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.299 -0.409 . . . . 74.310000000000002 111.579 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.05 -29.17 32.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.855 -0.738 . . . . 74.200000000000003 111.206 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 5.7 tmm_? -63.51 -53.34 53.5 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.468 0.175 . . . . 74.209999999999994 110.698 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.12 -26.25 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.152 0.501 . . . . 75.120000000000005 110.729 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -78.19 -56.66 4.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.8 -0.636 . . . . 71.540000000000006 111.82 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -66.85 -24.07 66.1 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.983 0.364 . . . . 73.209999999999994 111.983 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.9 mt-10 -70.33 -20.66 62.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.71 0.291 . . . . 75.299999999999997 111.501 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -56.05 -30.34 61.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 111.35 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.14 -29.17 23.49 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.416 -0.357 . . . . 71.420000000000002 111.779 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.89 -174.17 46.72 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.808 -0.711 . . . . 52.439999999999998 113.213 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -79.23 137.54 37.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.353 . . . . 74.209999999999994 111.248 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 152' ' ' THR . 73.6 mt -108.87 140.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 74.519999999999996 110.175 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.23 -48.33 7.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.495 -0.321 . . . . 75.040000000000006 110.922 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -157.3 156.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 74.150000000000006 110.236 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.1 129.26 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.058 0.456 . . . . 44.299999999999997 110.021 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -104.57 104.41 14.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.503 -0.771 . . . . 75.120000000000005 110.945 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.23 120.04 43.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.184 -1.043 . . . . 73.150000000000006 108.184 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.9 mmm -86.32 107.44 17.98 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.707 -0.397 . . . . 63.020000000000003 110.441 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.0 163.51 24.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.758 -0.655 . . . . 75.219999999999999 110.946 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -94.89 133.98 38.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 75.530000000000001 109.373 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -65.94 -39.76 90.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.294 0.479 . . . . 74.430000000000007 112.294 -176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.14 -52.73 4.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.213 -0.994 . . . . 51.329999999999998 113.49 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.5 p -90.35 -19.72 23.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.64 0.257 . . . . 74.239999999999995 111.672 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.72 81.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.889 -0.672 . . . . 74.329999999999998 112.475 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -87.73 138.12 31.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 110.371 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -71.48 143.36 50.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.651 . . . . 72.340000000000003 109.786 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -82.27 13.69 3.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 112.109 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.47 87.85 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.979 -0.629 . . . . 60.450000000000003 113.62 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -158.83 167.65 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.075 0.437 . . . . 73.5 109.97 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.85 171.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.561 -0.745 . . . . 75.519999999999996 109.755 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -136.18 151.08 49.35 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.487 -0.779 . . . . 75.319999999999993 109.09 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 130.51 25.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.513 0.673 . . . . 74.319999999999993 111.012 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.0 m -99.41 122.09 42.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.839 -1.073 . . . . 74.400000000000006 110.701 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.03 160.16 14.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.912 0.387 . . . . 73.439999999999998 111.321 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.95 -29.94 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.64 . . . . 73.420000000000002 110.185 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.28 151.8 50.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 71.409999999999997 111.092 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -78.94 -29.89 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 73.450000000000003 111.156 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -59.38 -44.26 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.923 -0.58 . . . . 75.540000000000006 110.988 -175.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -33.16 75.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.807 -0.633 . . . . 63.530000000000001 111.515 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -71.55 -39.37 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.961 0.41 . . . . 75.310000000000002 110.09 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.547 ' OD1' ' HB ' ' A' ' 90' ' ' VAL . 13.2 t70 -68.55 -34.59 76.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 73.209999999999994 110.709 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 84.8 mttt -56.11 -38.96 71.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.633 0.73 . . . . 74.430000000000007 110.777 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.5 mt -75.87 -42.29 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.419 -1.264 . . . . 75.319999999999993 112.235 -175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.3 m -76.36 -10.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.351 0.596 . . . . 73.400000000000006 110.753 -173.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.9 mt -61.1 -27.94 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.073 -0.967 . . . . 73.25 110.126 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 45.9 mt-30 -112.7 103.75 11.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.712 -0.847 . . . . 74.310000000000002 108.712 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.2 -35.33 69.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.846 -0.615 . . . . 75.340000000000003 112.627 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.61 134.53 53.78 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.304 . . . . 64.120000000000005 110.609 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.2 m-70 -121.12 153.74 37.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 74.430000000000007 110.029 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -122.76 113.7 19.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.449 . . . . 64.420000000000002 110.469 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.67 119.87 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 110.37 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 71.67 29.49 2.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.045 0.926 . . . . 71.510000000000005 109.059 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.11 -6.53 79.0 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.102 -0.953 . . . . 73.030000000000001 112.534 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.492 ' NE2' HG21 ' A' ' 112' ' ' ILE . 70.5 t60 -102.49 133.86 46.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.785 0.326 . . . . 73.549999999999997 110.604 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.55 141.31 30.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.038 0.447 . . . . 64.299999999999997 110.714 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.06 148.34 36.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 73.430000000000007 110.311 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -91.16 129.79 37.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.421 -0.585 . . . . 72.409999999999997 109.421 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.1 t -128.53 133.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.241 0.543 . . . . 70.409999999999997 110.554 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -155.56 172.99 17.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.399 -0.819 . . . . 71.540000000000006 110.466 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -58.86 133.19 55.79 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.278 0.361 . . . . 74.540000000000006 111.175 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -116.45 114.71 24.61 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.813 -0.81 . . . . 74.230000000000004 108.813 173.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.68 163.44 13.19 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.499 -0.773 . . . . 75.450000000000003 110.303 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.578 ' HB3' ' OE1' ' A' ' 185' ' ' GLU . 19.1 t -57.52 154.05 11.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.222 -0.659 . . . . 75.219999999999999 109.222 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -67.1 -24.54 65.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.49 0.552 . . . . 74.420000000000002 112.49 -171.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -70.61 -32.21 69.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 73.219999999999999 109.839 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.578 ' OE1' ' HB3' ' A' ' 182' ' ' SER . 1.8 mp0 -74.78 -36.77 62.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 71.530000000000001 110.172 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.5 mmt -72.93 -50.94 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.431 -0.804 . . . . 72.010000000000005 111.673 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.13 -18.73 31.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.35 -0.386 . . . . 51.5 111.589 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.2 m 64.58 16.62 10.42 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.383 0.673 . . . . 75.049999999999997 111.592 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -170.84 175.86 4.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.019 -0.537 . . . . 74.219999999999999 110.012 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.3 m -78.61 108.13 11.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.217 -0.66 . . . . 60.509999999999998 109.217 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.9 m -124.12 128.69 49.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.304 -0.407 . . . . 74.430000000000007 111.025 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.5 t -70.79 153.18 43.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.889 -0.596 . . . . 75.150000000000006 110.099 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.43 129.86 39.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 72.329999999999998 111.119 -175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -74.55 99.45 3.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.64 -0.709 . . . . 72.329999999999998 109.921 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.95 -157.29 52.36 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.992 -0.623 . . . . 64.140000000000001 111.668 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.776 -0.631 . . . . 73.349999999999994 110.013 177.035 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 CA--C 1.515 -0.37 0 CA-C-O 121.694 0.759 . . . . 64.409999999999997 109.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 26.6 mp0 -92.98 131.36 33.46 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 114.9 -1.045 . . . . 65.319999999999993 110.655 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.5 Cg_endo -60.26 167.37 7.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.093 2.529 . . . . 61.25 112.002 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.96 -39.06 71.22 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.427 -0.351 . . . . 61.119999999999997 111.505 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -68.59 -22.79 64.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.836 0.351 . . . . 73.239999999999995 111.639 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.3 mp -91.81 -6.98 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.519 -0.31 . . . . 74.299999999999997 111.477 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.439 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.0 ptt180 -128.31 1.44 5.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.405 -0.518 . . . . 71.430000000000007 112.124 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.41 145.19 26.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.601 0.715 . . . . 63.329999999999998 111.737 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 68' ' ' VAL . 50.0 mt -115.09 145.79 41.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.581 -1.191 . . . . 74.219999999999999 110.73 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -98.69 122.69 42.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.534 -0.913 . . . . 75.340000000000003 108.534 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' VAL . 16.1 mm -102.28 111.85 33.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 110.011 -0.366 . . . . 71.109999999999999 110.011 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.8 152.14 17.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.755 -0.736 . . . . 70.120000000000005 111.839 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.69 45.66 57.71 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 65.209999999999994 113.178 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 25' ' ' THR . 73.6 mt -78.33 174.97 10.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.684 -0.487 . . . . 70.109999999999999 109.684 173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.76 164.13 19.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.024 -0.732 . . . . 75.439999999999998 109.024 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -73.95 -8.26 55.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.32 0.581 . . . . 63.140000000000001 110.33 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.89 13.81 9.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.588 -0.733 . . . . 61.409999999999997 111.513 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 HD22 ' A' ' 21' ' ' LEU . 56.0 m -74.08 125.39 28.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.456 . . . . 61.119999999999997 110.626 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -99.35 161.87 13.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.816 -0.629 . . . . 73.400000000000006 110.506 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -71.54 -31.51 67.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.437 -0.347 . . . . 72.430000000000007 110.818 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.47 -39.25 93.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.848 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.0 t -72.54 -39.93 67.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.685 . . . . 51.130000000000003 110.362 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.89 -44.87 94.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.825 -0.625 . . . . 60.109999999999999 110.782 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -59.26 -57.12 14.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.734 0.302 . . . . 75.430000000000007 110.383 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -50.16 -36.49 30.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.956 -1.02 . . . . 72.430000000000007 113.215 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.455 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.7 t-80 -72.67 -56.15 5.74 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.96 -0.296 . . . . 72.049999999999997 111.206 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.205 0.446 . . . . 61.030000000000001 112.205 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.41 -13.15 49.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 111.452 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -63.7 -28.86 70.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.832 -0.167 . . . . 72.420000000000002 111.32 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -99.06 -19.47 17.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.069 0.396 . . . . 72.530000000000001 112.069 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.88 168.97 40.71 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.812 -1.185 . . . . 53.100000000000001 113.0 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.3 m -66.86 118.42 10.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.249 0.547 . . . . 70.109999999999999 111.792 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -88.81 130.57 35.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.361 -0.836 . . . . 53.200000000000003 110.827 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 p -95.92 -24.6 16.33 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.158 -0.928 . . . . 74.540000000000006 110.021 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -152.21 152.3 32.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.586 -0.734 . . . . 61.549999999999997 110.127 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.8 t -161.82 130.95 4.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.655 -0.498 . . . . 63.409999999999997 109.655 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.6 129.34 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.318 0.58 . . . . 61.539999999999999 111.011 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.9 132.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.45 -0.944 . . . . 62.539999999999999 108.45 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 3.1 mmt -74.08 100.0 3.49 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.417 0.627 . . . . 53.439999999999998 109.857 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -102.14 160.72 14.27 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.703 -1.135 . . . . 74.409999999999997 110.833 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 11.4 t0 -75.46 126.16 87.9 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 114.748 -1.115 . . . . 71.219999999999999 110.566 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.4 -11.56 28.59 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.987 1.791 . . . . 71.299999999999997 113.158 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -85.49 -56.51 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 74.450000000000003 111.779 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -108.72 -9.59 15.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 64.049999999999997 111.4 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 65.67 49.28 1.78 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.647 -0.706 . . . . 63.420000000000002 110.954 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -120.3 159.46 24.96 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 64.329999999999998 109.342 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -73.46 134.37 43.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 45.539999999999999 111.176 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -85.19 3.49 38.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.179 0.514 . . . . 72.209999999999994 110.804 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.33 63.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.749 -0.66 . . . . 52.43 114.074 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.84 155.88 30.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.58 0.69 . . . . 62.240000000000002 109.96 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.44 -163.89 16.2 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.657 -0.577 . . . . 73.540000000000006 111.657 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.87 150.82 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.14 0.47 . . . . 73.540000000000006 110.399 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 m -131.86 131.05 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.636 -0.711 . . . . 71.430000000000007 109.489 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 m -107.3 122.98 47.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.231 -0.285 . . . . 74.219999999999999 110.231 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -89.37 165.54 14.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.922 0.391 . . . . 64.209999999999994 110.919 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.31 -49.14 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 73.200000000000003 110.587 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.37 155.8 41.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 75.430000000000007 110.903 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.544 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 8.1 p -62.21 -37.12 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.098 -0.501 . . . . 62.420000000000002 111.47 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.83 -44.11 69.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.679 0.622 . . . . 61.340000000000003 112.679 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.93 -29.87 70.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.957 0.408 . . . . 74.319999999999993 110.819 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 16' ' ' LEU . 41.4 t -63.94 -49.76 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.682 -0.69 . . . . 62.439999999999998 110.745 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.21 -42.0 85.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 63.229999999999997 111.809 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.59 -31.85 68.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.84 0.682 . . . . 72.040000000000006 112.84 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.76 -34.06 40.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 43.329999999999998 110.351 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mmt -62.79 -49.33 75.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.712 -0.676 . . . . 75.349999999999994 110.476 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -26.73 63.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 65.430000000000007 111.194 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.75 -5.61 35.33 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.956 0.724 . . . . 42.049999999999997 112.956 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -57.8 148.43 58.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.503 0.186 . . . . 75.299999999999997 111.503 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.09 165.61 84.43 Favored 'Cis proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.789 -1.338 . . . . 53.420000000000002 113.454 2.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -123.68 158.01 32.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.613 . . . . 64.099999999999994 111.079 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.1 ttmt -139.41 105.1 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.094 -0.503 . . . . 73.239999999999995 111.531 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' ND1' ' A' ' 33' ' ' HIS . 16.2 t -108.2 128.71 63.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 74.140000000000001 109.541 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.52 31.09 10.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.58 0.55 . . . . 61.420000000000002 111.631 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.08 21.16 80.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.938 -0.649 . . . . 51.549999999999997 111.873 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.0 tpt180 -124.12 136.01 53.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.204 -0.295 . . . . 71.099999999999994 110.204 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.53 108.08 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.203 -0.666 . . . . 75.310000000000002 109.203 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.81 148.4 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.168 0.509 . . . . 53.409999999999997 110.932 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 4.6 tp10 -111.47 95.01 24.76 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.277 -0.874 . . . . 62.219999999999999 110.886 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.52 130.58 12.88 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.897 1.732 . . . . 72.099999999999994 111.183 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 30.6 mttt -137.78 177.4 7.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.464 -0.789 . . . . 43.0 109.178 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' NH1' HG11 ' A' ' 68' ' ' VAL . 17.7 tpp180 -77.41 139.54 39.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 110.066 -0.346 . . . . 75.519999999999996 110.066 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.01 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.998 0.428 . . . . 61.450000000000003 110.194 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 136.21 22.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.909 -1.042 . . . . 74.230000000000004 111.568 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.8 147.06 43.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.725 -0.67 . . . . 42.539999999999999 109.732 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -63.52 -20.94 66.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.262 0.838 . . . . 73.019999999999996 113.262 -171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.58 -47.87 68.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.755 0.312 . . . . 65.230000000000004 110.68 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.25 -29.56 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.969 0.414 . . . . 60.219999999999999 110.171 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 t -72.0 -3.01 20.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.921 -0.581 . . . . 52.509999999999998 111.007 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -93.23 -3.15 54.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.327 0.584 . . . . 74.439999999999998 109.916 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -95.44 151.98 38.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.833 -0.622 . . . . 70.510000000000005 110.499 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.1 120.33 7.54 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.748 2.299 . . . . 75.120000000000005 112.346 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.07 40.89 8.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.822 -0.704 . . . . 71.450000000000003 112.389 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -86.01 -46.05 10.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 60.020000000000003 111.525 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.72 10.94 26.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.322 0.582 . . . . 71.319999999999993 110.608 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.01 161.82 19.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.895 -0.78 . . . . 51.420000000000002 108.895 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.3 m -77.05 92.91 3.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.46 0.648 . . . . 74.109999999999999 110.942 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.02 115.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.067 -0.97 . . . . 75.030000000000001 110.032 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.501 ' C ' HG21 ' A' ' 159' ' ' VAL . 76.7 mttt -108.88 18.54 20.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.974 0.416 . . . . 72.340000000000003 110.833 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -118.23 139.59 51.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.386 -0.37 . . . . 70.0 110.854 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.481 HG23 HG13 ' A' ' 159' ' ' VAL . 6.4 pt -127.28 153.38 36.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.213 0.53 . . . . 64.430000000000007 111.501 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -103.58 138.25 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.78 -1.1 . . . . 63.439999999999998 109.545 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.48 109.56 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.124 -0.695 . . . . 75.019999999999996 109.124 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.91 161.03 19.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.029 -1.081 . . . . 74.430000000000007 113.366 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.0 46.42 36.55 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.065 -0.588 . . . . 63.039999999999999 111.655 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.426 HG22 ' SG ' ' A' ' 175' ' ' CYS . 15.5 pt -90.55 -165.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.478 -0.361 . . . . 73.120000000000005 110.582 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -82.36 -167.48 1.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.652 0.263 . . . . 44.310000000000002 111.315 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.8 -22.31 66.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 111.168 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.9 144.05 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.541 -0.754 . . . . 71.549999999999997 109.142 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -140.05 138.7 35.59 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.882 -0.784 . . . . 64.510000000000005 108.882 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.65 158.59 15.36 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.105 -0.498 . . . . 74.219999999999999 110.778 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -47.05 76.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.188 -0.914 . . . . 54.329999999999998 108.933 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -53.63 -34.39 58.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.017 -0.992 . . . . 61.009999999999998 111.894 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -66.32 -59.45 3.7 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.928 0.394 . . . . 70.310000000000002 111.135 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 3.1 pp -82.78 -26.62 31.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.158 -0.617 . . . . 70.329999999999998 111.353 -172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 6.1 tmm_? -65.42 -48.63 72.14 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.96 -0.385 . . . . 61.149999999999999 109.96 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.56 -26.67 68.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.209 0.528 . . . . 74.150000000000006 110.579 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -78.92 -55.54 5.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.849 -0.614 . . . . 75.040000000000006 111.781 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 151' ' ' VAL . 35.8 m-85 -69.45 -22.93 63.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.428 0.529 . . . . 63.43 112.428 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -68.61 -22.93 64.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.807 0.337 . . . . 72.219999999999999 111.477 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.74 -28.35 65.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 74.439999999999998 110.816 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -88.99 -23.99 22.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 71.120000000000005 111.105 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.79 -178.12 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.407 -0.901 . . . . 73.430000000000007 113.696 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -73.4 131.28 41.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.92 0.488 . . . . 64.540000000000006 110.963 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 152' ' ' THR . 65.5 mt -103.12 138.35 27.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.465 . . . . 72.420000000000002 109.986 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.88 -48.0 9.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.694 0.283 . . . . 74.25 110.673 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.06 156.95 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.177 -0.465 . . . . 54.439999999999998 109.824 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.33 126.22 71.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.16 0.505 . . . . 52.200000000000003 109.927 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -99.77 105.23 17.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 74.329999999999998 110.544 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.32 122.6 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.247 -0.649 . . . . 62.539999999999999 109.247 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 64.7 mmm -96.12 128.02 42.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.525 -0.546 . . . . 70.019999999999996 109.525 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.804 0 CA-C-O 121.41 0.624 . . . . 73.120000000000005 111.44 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 119.853 -0.415 . . . . 45.299999999999997 112.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -174.96 154.92 1.93 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.872 -0.418 . . . . 72.319999999999993 109.872 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.4 171.98 13.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.915 -0.584 . . . . 75.129999999999995 109.79 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 42.3 m-85 -137.53 145.71 43.27 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.833 -0.621 . . . . 72.219999999999999 109.995 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 125' ' ' PHE . 60.4 t -129.86 130.14 66.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.752 0.31 . . . . 73.219999999999999 110.738 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 131' ' ' ILE . 90.4 m -104.76 119.64 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 71.319999999999993 110.601 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -102.87 159.06 15.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.952 0.405 . . . . 71.209999999999994 111.417 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -77.85 -29.21 50.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.562 -0.744 . . . . 65.129999999999995 110.581 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -130.43 155.36 46.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.476 -0.784 . . . . 65.219999999999999 110.259 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.41 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.7 p80 -77.87 -26.44 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.089 -0.505 . . . . 72.430000000000007 110.513 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -59.83 -41.93 92.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.474 -0.785 . . . . 64.540000000000006 111.493 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.96 -34.92 79.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.586 -0.279 . . . . 74.510000000000005 110.915 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.501 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -69.61 -40.75 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 73.239999999999995 109.722 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.72 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.82 -31.6 68.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.186 -0.916 . . . . 62.200000000000003 111.441 -178.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 39.3 mttm -56.23 -37.81 70.23 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.779 0.8 . . . . 63.509999999999998 109.871 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.0 mt -79.48 -42.65 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.489 -1.232 . . . . 72.329999999999998 112.522 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 160' ' ' ASP . 21.4 m -74.98 -13.56 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.906 0.384 . . . . 74.109999999999999 111.171 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 13' ' ' LEU . 28.9 mt -56.44 -34.83 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.979 170.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.95 102.48 10.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.64 -0.874 . . . . 63.100000000000001 108.64 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -57.26 -31.77 65.9 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.899 0.703 . . . . 51.109999999999999 112.899 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.61 135.46 54.99 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.248 -0.581 . . . . 63.439999999999998 110.44 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -126.56 154.84 43.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.521 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.3 m -94.22 107.32 19.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.338 -0.392 . . . . 51.200000000000003 110.257 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.79 131.4 70.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.183 -0.673 . . . . 45.439999999999998 109.183 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 45.4 47.16 10.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.287 0.635 . . . . 55.420000000000002 112.491 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.88 73.96 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 113.575 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -142.29 133.22 25.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.01 -0.367 . . . . 75.310000000000002 110.01 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -82.21 109.58 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.872 0.367 . . . . 72.329999999999998 110.251 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 112' ' ' ILE . 10.3 m -108.72 155.02 21.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.01 -0.541 . . . . 71.430000000000007 109.938 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.33 137.78 32.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 72.030000000000001 110.472 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -129.59 160.38 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 73.239999999999995 110.343 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -174.09 175.92 2.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.214 -0.903 . . . . 75.239999999999995 111.507 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' HG11 ' A' ' 163' ' ' VAL . 19.1 mmtm -62.29 130.81 47.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.735 -0.666 . . . . 74.549999999999997 110.696 173.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -117.57 114.55 23.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.628 -0.878 . . . . 63.240000000000002 108.628 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 C--N 1.309 -1.167 0 C-N-CA 120.607 -0.437 . . . . 74.219999999999999 109.845 -177.6 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -66.95 130.86 93.88 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.816 -1.084 . . . . 61.439999999999998 110.812 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.23 169.29 12.51 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.216 2.611 . . . . 54.530000000000001 111.751 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.7 pt-20 -52.14 -38.86 58.9 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 112.185 0.439 . . . . 64.409999999999997 112.185 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 6.5 pt20 -65.64 -26.31 67.75 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.108 0.41 . . . . 75.510000000000005 112.108 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 164' ' ' ILE . 5.4 mp -88.97 -9.88 49.78 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.185 -0.322 . . . . 60.109999999999999 111.165 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 68' ' ' VAL . 12.8 ptt180 -118.72 -5.17 10.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 63.420000000000002 111.301 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.7 ttpt -93.69 148.73 21.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.402 0.62 . . . . 74.120000000000005 111.213 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.556 HD21 HG13 ' A' ' 68' ' ' VAL . 54.0 mt -120.57 146.39 46.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.973 . . . . 75.439999999999998 110.413 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 16.5 t80 -98.13 131.33 44.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.085 -1.08 . . . . 74.049999999999997 108.085 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 60' ' ' VAL . 20.6 mm -106.45 111.55 35.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.892 -0.41 . . . . 74.319999999999993 109.892 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.6 148.65 17.51 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.855 -0.688 . . . . 72.319999999999993 111.9 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.77 46.41 30.42 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.785 -0.722 . . . . 72.230000000000004 113.503 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 25' ' ' THR . 79.1 mt -81.34 174.39 11.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.883 0.373 . . . . 62.049999999999997 110.237 173.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.0 p -87.64 173.88 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.437 -0.579 . . . . 64.340000000000003 109.437 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.9 -11.51 59.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.119 0.485 . . . . 75.540000000000006 109.78 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -103.67 -0.43 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.366 -0.834 . . . . 74.099999999999994 111.941 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 21' ' ' LEU . 33.3 m -67.91 123.77 21.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.0 0.429 . . . . 72.129999999999995 111.615 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.9 159.51 15.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.552 -0.749 . . . . 63.399999999999999 110.066 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -68.73 -30.92 69.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.344 . . . . 72.0 111.876 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -25.08 45.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.883 -0.327 . . . . 74.230000000000004 111.145 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.8 m -74.94 -43.5 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.415 . . . . 34.039999999999999 110.406 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.25 -46.2 89.92 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.498 -0.774 . . . . 62.329999999999998 110.065 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -55.63 -59.87 4.24 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.445 -0.798 . . . . 73.430000000000007 111.794 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -50.18 -33.73 20.16 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.787 0.68 . . . . 63.549999999999997 112.654 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.438 ' CG ' HG22 ' A' ' 79' ' ' VAL . 62.3 t60 -69.03 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 74.150000000000006 110.684 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.16 -22.63 62.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.198 0.444 . . . . 75.340000000000003 112.198 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 31.8 tt0 -65.15 -21.53 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 74.310000000000002 111.06 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -62.49 -23.13 66.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 74.329999999999998 111.941 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -102.42 -21.12 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.514 0.197 . . . . 72.420000000000002 111.528 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.91 161.64 32.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.398 -0.906 . . . . 74.239999999999995 112.603 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -67.88 116.05 8.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.144 0.497 . . . . 70.109999999999999 111.443 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -84.41 136.8 33.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 110.205 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -106.45 -16.5 14.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.428 -0.805 . . . . 60.329999999999998 109.749 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.52 149.42 29.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 75.319999999999993 109.886 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.9 t -160.42 131.09 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.215 -0.291 . . . . 75.150000000000006 110.215 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.12 131.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.996 0.427 . . . . 73.120000000000005 110.254 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -92.96 130.51 41.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.222 -1.029 . . . . 45.200000000000003 108.222 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.67 97.59 3.85 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.653 0.74 . . . . 45.399999999999999 110.605 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 29.4 mtt180 -101.94 163.94 11.98 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.598 -1.183 . . . . 74.230000000000004 110.391 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 22.6 t70 -79.27 126.79 80.8 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.145 -0.934 . . . . 64.120000000000005 109.512 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.45 -18.95 49.53 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 121.901 1.734 . . . . 72.439999999999998 113.362 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 35.9 m-80 -86.02 -56.52 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 62.109999999999999 111.482 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 -10.11 24.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.142 -0.481 . . . . 72.109999999999999 111.873 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm 66.17 29.93 9.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.998 0.919 . . . . 72.109999999999999 111.481 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -106.15 150.68 25.6 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.792 -0.447 . . . . 73.120000000000005 109.792 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 30.5 t -73.83 133.96 43.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.107 0.479 . . . . 70.430000000000007 110.73 -174.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -83.71 2.61 36.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.386 -0.824 . . . . 71.049999999999997 111.022 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.88 16.91 60.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.883 -0.675 . . . . 73.340000000000003 113.957 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.6 158.4 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.947 0.874 . . . . 75.140000000000001 111.097 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.76 -165.31 17.31 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.459 -0.656 . . . . 52.219999999999999 111.459 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.28 146.35 33.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 117.213 0.507 . . . . 73.409999999999997 110.302 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 18' ' ' ILE . 11.0 m -127.82 126.59 67.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.704 -0.68 . . . . 60.520000000000003 109.333 172.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 m -103.62 120.72 41.47 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.125 -0.359 . . . . 75.209999999999994 110.426 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -85.98 161.47 18.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.017 -0.538 . . . . 75.109999999999999 110.146 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.58 66.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.591 -0.731 . . . . 64.530000000000001 110.704 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.688 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 89.5 m -141.97 151.8 42.87 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.829 -0.623 . . . . 61.539999999999999 110.785 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -58.06 -36.76 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.609 -0.723 . . . . 72.120000000000005 112.161 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -49.37 -47.73 47.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.017 0.747 . . . . 73.329999999999998 113.017 175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.9 mp0 -64.7 -31.39 72.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.711 0.291 . . . . 74.239999999999995 111.273 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.556 HG13 HD21 ' A' ' 16' ' ' LEU . 52.1 t -63.31 -47.92 89.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 74.450000000000003 110.593 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.29 -43.28 99.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.391 -0.822 . . . . 74.340000000000003 111.062 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -55.7 -35.65 66.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.746 0.647 . . . . 74.319999999999993 112.746 172.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -31.18 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 74.430000000000007 109.903 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.7 mmt -72.25 -37.69 69.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 72.150000000000006 111.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.625 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -76.22 -14.08 60.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.151 0.5 . . . . 64.450000000000003 110.573 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.67 -9.17 50.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.596 -0.729 . . . . 61.109999999999999 111.903 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -56.65 146.88 54.15 Favored Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.22 0.325 . . . . 53.530000000000001 111.642 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.85 167.9 77.46 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.889 -1.296 . . . . 62.530000000000001 113.224 2.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -122.59 154.47 37.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 70.209999999999994 111.315 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.8 ttmt -139.05 109.15 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 74.109999999999999 110.976 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' CG ' ' A' ' 33' ' ' HIS . 18.8 t -109.94 129.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.585 -0.524 . . . . 72.150000000000006 109.585 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.9 t70 68.36 22.06 8.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.8 0.81 . . . . 75.549999999999997 110.563 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.08 67.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 64.340000000000003 111.777 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.5 tpt180 -124.0 138.14 54.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.74 -0.467 . . . . 74.040000000000006 109.74 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.7 109.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.48 -0.563 . . . . 54.119999999999997 109.48 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -107.66 148.64 11.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.985 0.422 . . . . 71.409999999999997 110.482 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.51 103.46 52.68 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 111.476 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.52 132.8 19.54 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.008 1.805 . . . . 53.140000000000001 111.363 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -131.6 161.12 33.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.66 -1.237 . . . . 63.32 107.66 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.51 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.6 tpp180 -68.34 139.82 55.89 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.465 -0.568 . . . . 61.109999999999999 109.465 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 91.93 1.7 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.471 0.653 . . . . 63.350000000000001 109.786 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.404 ' CG2' HG23 ' A' ' 163' ' ' VAL . 9.8 p -65.18 156.23 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.672 -1.149 . . . . 64.430000000000007 111.598 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 t -60.46 155.71 17.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.649 -0.705 . . . . 71.530000000000001 110.44 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -60.46 -25.31 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.75 -0.659 . . . . 74.430000000000007 112.009 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.28 -54.41 25.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 111.059 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.11 -30.6 63.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.041 -0.264 . . . . 61.399999999999999 111.422 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -68.46 -8.81 44.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.924 0.392 . . . . 53.310000000000002 111.525 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.02 -21.87 59.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 110.327 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -79.65 153.98 75.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 110.597 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.26 129.77 16.51 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.693 2.262 . . . . 73.010000000000005 111.4 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.03 57.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 74.329999999999998 112.586 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.32 60.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 110.676 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.476 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 19.8 m170 -100.5 20.93 14.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.51 0.671 . . . . 71.329999999999998 110.548 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.22 179.12 5.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 43.340000000000003 109.423 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 97.08 7.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.172 0.511 . . . . 33.439999999999998 110.597 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.41 113.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.252 -0.885 . . . . 71.540000000000006 109.529 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' C ' HG21 ' A' ' 159' ' ' VAL . 84.8 mttt -110.72 21.86 16.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.474 -0.49 . . . . 61.119999999999997 111.174 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -126.04 145.78 50.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.855 0.36 . . . . 75.099999999999994 111.859 176.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -129.77 153.66 39.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.169 0.509 . . . . 73.409999999999997 111.696 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.4 t80 -100.81 139.63 36.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.03 -0.986 . . . . 71.319999999999993 109.364 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t -131.12 111.55 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.622 -0.51 . . . . 72.400000000000006 109.622 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.3 167.88 25.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.546 -1.311 . . . . 44.530000000000001 113.428 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.48 38.34 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.682 -0.77 . . . . 63.420000000000002 112.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.7 143.7 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.701 -0.481 . . . . 70.319999999999993 109.701 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -89.18 -42.05 11.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 72.239999999999995 111.398 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -104.89 -97.28 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.317 -0.401 . . . . 72.209999999999994 110.59 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 147.02 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.67 -0.863 . . . . 73.519999999999996 108.67 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 129.45 36.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.386 0.612 . . . . 74.439999999999998 110.82 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.47 166.14 11.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.905 -1.043 . . . . 75.099999999999994 110.194 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.12 -45.65 90.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 74.340000000000003 109.713 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -57.73 -32.85 67.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 62.219999999999999 111.929 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -67.25 -57.61 6.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.907 0.384 . . . . 75.400000000000006 111.241 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 122' ' ' ARG . 2.4 pp -83.94 -25.0 30.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.298 -0.561 . . . . 72.409999999999997 111.303 -171.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' N ' HD12 ' A' ' 121' ' ' LEU . 6.0 tmm_? -65.28 -51.38 61.09 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.922 -0.399 . . . . 74.120000000000005 109.922 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.66 -27.26 69.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 64.129999999999995 110.635 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 170' ' ' VAL . 82.0 t80 -80.64 -54.03 6.01 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.012 -0.54 . . . . 73.129999999999995 111.923 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.4 m-85 -70.88 -23.01 62.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.16 0.43 . . . . 64.200000000000003 112.16 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.7 mt-10 -67.15 -20.41 65.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.935 0.398 . . . . 71.319999999999993 111.194 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.01 -20.98 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.833 -0.621 . . . . 72.209999999999994 111.373 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.59 -27.87 17.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.548 -0.296 . . . . 70.340000000000003 111.678 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -171.49 44.39 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.528 -0.844 . . . . 51.219999999999999 113.232 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -76.36 130.7 38.46 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.04 0.447 . . . . 74.200000000000003 111.602 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.471 HD12 ' HG3' ' A' ' 126' ' ' GLU . 55.0 mt -101.38 140.54 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 71.219999999999999 109.804 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.31 -50.41 6.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 70.329999999999998 110.269 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 p -158.28 158.66 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.581 -0.736 . . . . 63.409999999999997 109.338 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.78 128.92 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 73.340000000000003 109.851 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.8 mt-10 -104.29 104.71 14.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 45.229999999999997 110.454 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mm -96.6 116.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.44 -0.948 . . . . 74.049999999999997 108.44 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.2 mmm -87.54 135.59 33.29 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.794 -0.363 . . . . 75.010000000000005 110.481 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.383 0.611 . . . . 53.409999999999997 111.127 -178.683 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 112.603 -0.199 . . . . 54.539999999999999 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.56 161.63 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 74.310000000000002 110.153 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.52 173.09 11.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.572 -0.74 . . . . 35.32 110.159 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 41.1 m-85 -137.27 145.47 43.56 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.223 -0.899 . . . . 73.310000000000002 109.351 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 125' ' ' PHE . 61.4 t -128.42 125.63 64.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 120.99 0.424 . . . . 75.310000000000002 110.879 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 87.9 m -101.5 119.93 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 73.030000000000001 111.033 -176.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.08 155.23 18.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.986 0.422 . . . . 70.109999999999999 111.743 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.05 -18.46 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.562 -0.745 . . . . 61.340000000000003 110.579 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.04 151.73 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 54.130000000000003 111.152 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -82.78 -28.15 30.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.599 -0.273 . . . . 75.129999999999995 111.288 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.618 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 23.9 t70 -68.01 -35.26 78.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.995 -0.548 . . . . 52.240000000000002 110.589 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.0 m -67.72 -34.13 76.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 60.149999999999999 110.825 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 107' ' ' ILE . 2.2 t -72.13 -38.36 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.019 -0.537 . . . . 70.239999999999995 109.558 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 t70 -66.11 -35.79 81.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 72.340000000000003 111.007 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 83.5 mttt -57.46 -37.98 73.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.504 0.669 . . . . 64.239999999999995 110.7 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.429 HD13 HD13 ' A' ' 107' ' ' ILE . 16.1 mt -75.69 -42.07 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.807 -1.088 . . . . 74.319999999999993 111.567 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.8 m -77.81 -8.19 11.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.465 0.65 . . . . 74.340000000000003 110.902 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.41 HD13 HD12 ' A' ' 13' ' ' LEU . 15.0 mt -60.79 -32.77 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.997 -1.001 . . . . 72.340000000000003 110.382 170.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 43.2 mt-30 -113.17 114.73 27.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.046 -0.724 . . . . 64.510000000000005 109.046 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.23 -38.07 67.98 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.049 0.759 . . . . 63.130000000000003 113.049 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -123.09 138.43 54.67 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.089 -0.382 . . . . 73.540000000000006 110.574 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.53 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 36.7 m-70 -123.35 140.01 53.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 110.966 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -87.26 104.38 16.34 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.786 -0.643 . . . . 73.239999999999995 111.11 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 124' ' ' TYR . 28.2 t -111.22 127.26 68.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.488 -0.778 . . . . 54.350000000000001 109.143 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 45.18 40.13 4.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.274 0.63 . . . . 60.119999999999997 112.319 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 -6.15 77.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.034 -0.603 . . . . 64.140000000000001 114.152 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -107.68 128.74 54.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.581 0.691 . . . . 74.420000000000002 110.46 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.36 113.1 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.34 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.4 p -112.18 156.57 22.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.337 -0.847 . . . . 75.299999999999997 109.511 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -86.04 137.38 32.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.206 0.527 . . . . 71.239999999999995 110.898 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -129.53 164.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.205 -0.907 . . . . 73.450000000000003 110.721 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -175.66 173.98 2.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.104 -0.953 . . . . 64.540000000000006 111.245 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -61.01 134.82 57.48 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 123.618 0.574 . . . . 65.439999999999998 110.247 173.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -127.73 122.61 33.31 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.311 -0.626 . . . . 74.329999999999998 109.311 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 C--N 1.312 -1.049 0 C-N-CA 119.982 -0.687 . . . . 74.400000000000006 109.546 177.424 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 108.657 -0.868 . . . . 73.519999999999996 108.657 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -99.44 136.61 20.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.516 -1.22 . . . . 72.129999999999995 110.842 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' HD22 ' A' ' 13' ' ' LEU . 25.3 Cg_endo -64.51 167.65 14.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.932 2.421 . . . . 61.100000000000001 111.199 172.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.3 pt-20 -56.49 -35.73 68.31 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.596 0.221 . . . . 73.519999999999996 111.596 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.452 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.3 pt20 -69.09 -25.49 64.46 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.591 0.234 . . . . 64.109999999999999 111.404 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 12' ' ' GLN . 4.6 mp -88.63 -11.97 43.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.513 0.196 . . . . 75.310000000000002 111.384 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.549 ' HA ' HG21 ' A' ' 68' ' ' VAL . 31.2 ptt180 -124.12 6.53 8.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.195 0.522 . . . . 73.230000000000004 110.835 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.6 ttpt -97.87 146.87 25.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.353 0.597 . . . . 71.209999999999994 110.908 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.639 HD21 HG13 ' A' ' 68' ' ' VAL . 55.9 mt -116.36 145.21 43.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.919 -1.037 . . . . 73.230000000000004 110.354 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 13.5 t80 -101.1 125.67 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.446 -0.946 . . . . 74.519999999999996 108.446 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -106.25 111.11 33.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.985 -0.376 . . . . 71.319999999999993 109.985 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.48 157.54 18.23 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.548 -0.834 . . . . 74.409999999999997 111.222 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.29 67.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.932 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD22 HG21 ' A' ' 25' ' ' THR . 44.1 mt -80.3 170.66 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 74.209999999999994 110.86 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -92.09 165.65 13.06 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.608 -0.724 . . . . 65.219999999999999 109.726 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -67.3 -22.51 65.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.898 -0.592 . . . . 74.099999999999994 110.092 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -97.22 2.7 51.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.639 -0.71 . . . . 73.0 111.408 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 21' ' ' LEU . 80.7 m -77.33 117.67 19.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 75.109999999999999 111.546 -175.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 p -105.35 164.47 11.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.059 -0.973 . . . . 74.510000000000005 109.516 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -40.57 90.9 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.416 0.448 . . . . 74.340000000000003 111.132 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.83 -37.38 87.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.942 -0.572 . . . . 73.040000000000006 111.402 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.1 m -78.48 -41.64 31.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.555 -0.293 . . . . 73.540000000000006 110.96 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.7 tp -62.87 -49.01 76.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.167 -0.47 . . . . 72.239999999999995 110.623 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -57.4 -56.04 27.01 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.443 -0.799 . . . . 75.409999999999997 110.886 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 m -48.24 -39.18 20.46 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -70.22 -53.03 18.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 73.25 110.916 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -73.12 -21.96 60.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.925 0.343 . . . . 74.209999999999994 111.925 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -17.8 54.42 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.667 0.387 . . . . 60.219999999999999 111.921 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.73 -27.11 68.98 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.568 -0.287 . . . . 71.349999999999994 111.7 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -99.25 -17.42 18.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.688 0.255 . . . . 63.409999999999997 111.688 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 168.34 38.6 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.042 -1.075 . . . . 74.430000000000007 112.862 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -68.61 121.49 16.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.507 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.5 128.94 36.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.709 -0.678 . . . . 63.100000000000001 111.267 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 p -91.25 -29.27 17.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.95 -1.023 . . . . 61.450000000000003 110.164 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -150.39 152.37 34.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 65.439999999999998 109.455 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.67 136.45 6.18 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.475 -0.565 . . . . 42.530000000000001 109.475 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -152.14 121.75 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.375 0.607 . . . . 72.109999999999999 110.471 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.44 131.01 34.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.431 -0.952 . . . . 51.409999999999997 108.431 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.8 mmt -76.22 99.61 4.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.602 0.715 . . . . 53.310000000000002 110.697 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 57.8 mtp85 -109.47 163.6 13.28 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.524 -1.216 . . . . 75.540000000000006 109.251 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.23 126.92 82.64 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.776 -0.453 . . . . 61.530000000000001 109.776 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.25 -18.92 44.81 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.969 1.779 . . . . 42.5 112.67 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.11 -56.79 3.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 54.149999999999999 111.607 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -100.85 -8.56 22.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 71.400000000000006 111.74 -172.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm 62.27 39.0 12.92 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.65 0.78 . . . . 70.219999999999999 112.57 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -115.68 153.49 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.256 -0.277 . . . . 65.299999999999997 110.636 177.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 36.3 t -69.52 134.33 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.749 0.309 . . . . 63.329999999999998 110.48 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -85.35 -4.11 59.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 74.349999999999994 110.279 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.79 18.96 53.42 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.923 -0.656 . . . . 74.319999999999993 113.777 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -159.07 158.35 32.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.564 0.682 . . . . 75.310000000000002 110.425 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.16 -166.62 18.51 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.636 -0.586 . . . . 50.119999999999997 111.636 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -141.12 148.49 40.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.467 0.634 . . . . 74.340000000000003 110.778 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 16' ' ' LEU . 4.7 m -131.08 121.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 73.439999999999998 109.931 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 m -101.94 123.58 46.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.51 -0.313 . . . . 71.030000000000001 110.442 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 68' ' ' VAL . 35.7 m-85 -88.23 171.24 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.16 0.505 . . . . 70.030000000000001 111.368 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.4 -48.39 11.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.416 -0.811 . . . . 74.120000000000005 110.146 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -115.43 149.06 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 73.510000000000005 110.158 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 10.0 p -68.95 -25.28 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.004 0.43 . . . . 54.140000000000001 111.122 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.92 -34.76 73.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 72.219999999999999 110.995 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.56 -28.45 66.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 65.010000000000005 110.38 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.639 HG13 HD21 ' A' ' 16' ' ' LEU . 21.8 t -68.22 -46.34 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.359 -0.837 . . . . 74.319999999999993 110.198 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.98 -46.12 88.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.417 -0.81 . . . . 72.010000000000005 110.938 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -61.12 -31.4 71.1 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.679 0.622 . . . . 33.130000000000003 112.679 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 -36.25 65.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.039 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.6 mmt -69.62 -35.22 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.87 -0.604 . . . . 54.240000000000002 110.995 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.624 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 6.6 p30 -79.64 -22.72 43.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.455 -0.339 . . . . 73.099999999999994 111.13 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.84 -5.65 46.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 44.43 112.449 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mtp-105 -58.96 146.7 76.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.449 -0.341 . . . . 72.019999999999996 111.468 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 168.18 77.85 Favored 'Cis proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.686 -1.381 . . . . 73.400000000000006 113.743 1.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -123.4 155.63 37.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 63.039999999999999 110.654 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.3 ttmt -139.78 104.95 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.042 0.448 . . . . 71.219999999999999 111.176 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 t -105.82 128.23 60.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.787 -0.642 . . . . 73.099999999999994 109.558 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 64.78 29.9 12.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.371 0.668 . . . . 74.310000000000002 111.76 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.89 77.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.784 -0.722 . . . . 52.340000000000003 112.04 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.5 tpt180 -124.93 134.6 52.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.133 -0.321 . . . . 74.439999999999998 110.133 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 113.39 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.834 -0.802 . . . . 71.120000000000005 108.834 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 7.4 m -102.5 152.49 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 74.420000000000002 111.272 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HG3' ' NZ ' ' A' ' 87' ' ' LYS . 5.7 tp10 -113.73 91.8 22.56 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.741 -1.118 . . . . 55.539999999999999 110.542 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -78.37 143.74 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.808 2.338 . . . . 64.049999999999997 111.136 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' NZ ' ' HG3' ' A' ' 85' ' ' GLU . 12.7 mmtm -139.77 159.78 41.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.641 -1.244 . . . . 74.019999999999996 107.641 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' NH2' ' HA ' ' A' ' 90' ' ' VAL . 2.5 tmm_? -69.49 130.98 43.99 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.845 -1.539 . . . . 61.399999999999999 106.845 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.54 94.7 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.971 0.415 . . . . 64.340000000000003 111.157 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 25.5 t -58.52 140.82 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.725 -1.125 . . . . 65.129999999999995 111.826 -172.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -56.66 143.32 36.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.386 -0.824 . . . . 71.099999999999994 109.866 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -62.44 -31.31 71.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.593 0.59 . . . . 74.420000000000002 112.593 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.81 -29.1 58.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.463 0.173 . . . . 71.230000000000004 111.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.05 -30.46 39.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.391 -0.596 . . . . 73.400000000000006 109.391 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.3 m -74.94 -3.24 31.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.442 -0.799 . . . . 50.210000000000001 111.211 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -76.38 -13.72 60.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.375 0.607 . . . . 74.209999999999994 109.968 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -106.24 146.96 34.0 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.396 -0.594 . . . . 63.229999999999997 109.396 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.88 140.62 35.47 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.598 2.199 . . . . 61.119999999999997 112.217 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 9.63 60.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.934 -0.651 . . . . 24.149999999999999 112.474 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.21 54.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.626 0.251 . . . . 43.020000000000003 111.6 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -96.2 22.7 7.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 72.430000000000007 111.205 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.1 mt -100.46 174.84 5.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 72.239999999999995 109.957 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 m -78.99 85.49 4.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 72.209999999999994 109.845 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.94 112.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.182 -0.917 . . . . 44.240000000000002 109.946 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 69.8 mttt -106.94 13.76 27.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 44.219999999999999 110.653 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -114.67 138.79 50.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.571 -0.286 . . . . 63.240000000000002 111.27 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 159' ' ' VAL . 5.2 pt -130.13 152.44 37.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.237 0.542 . . . . 54.539999999999999 111.796 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.0 t80 -97.49 137.43 36.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.915 -1.039 . . . . 64.430000000000007 109.854 175.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 t -124.72 110.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.128 -0.693 . . . . 64.519999999999996 109.128 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -134.18 155.94 22.12 Favored Glycine 0 CA--C 1.507 -0.45 0 C-N-CA 119.742 -1.218 . . . . 50.329999999999998 113.232 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.48 10.57 31.0 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.564 -0.827 . . . . 74.400000000000006 112.258 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.1 pt -78.34 110.09 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 70.340000000000003 109.956 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.63 -18.88 24.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 61.450000000000003 111.203 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -112.18 175.22 5.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.841 -0.618 . . . . 60.240000000000002 109.874 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.96 123.98 22.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 71.109999999999999 110.067 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -118.51 144.32 46.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.096 -0.502 . . . . 65.420000000000002 110.125 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.38 162.51 13.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.803 -0.635 . . . . 73.239999999999995 111.217 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -47.69 77.29 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.732 -1.122 . . . . 61.530000000000001 109.755 175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -54.25 -40.65 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.637 0.586 . . . . 70.140000000000001 111.669 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -57.8 -58.51 8.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.855 0.359 . . . . 74.209999999999994 111.127 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.75 -26.41 29.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.802 -0.759 . . . . 70.0 111.446 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -65.95 -51.46 58.31 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 110.076 -0.342 . . . . 73.319999999999993 110.076 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.21 -25.29 67.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 110.241 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -79.05 -56.75 4.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.857 -0.61 . . . . 72.549999999999997 112.323 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 151' ' ' VAL . 45.7 m-85 -69.3 -22.81 63.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.206 0.447 . . . . 74.129999999999995 112.206 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG2' HD12 ' A' ' 131' ' ' ILE . 2.0 mm-40 -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.062 0.458 . . . . 61.030000000000001 110.464 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.3 -34.68 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.547 -0.751 . . . . 54.409999999999997 112.001 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -81.51 -31.72 32.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 73.409999999999997 111.316 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.61 48.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.957 -0.639 . . . . 73.239999999999995 112.696 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -72.9 128.04 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 72.019999999999996 111.532 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HG2' ' A' ' 126' ' ' GLU . 56.6 mt -98.15 136.88 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.661 -0.699 . . . . 65.310000000000002 110.025 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -90.45 -44.02 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.28 . . . . 73.120000000000005 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.7 p -158.18 154.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.45 . . . . 74.439999999999998 109.879 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.19 129.32 70.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.345 0.593 . . . . 73.409999999999997 110.094 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.3 mt-10 -100.83 127.64 47.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.902 -1.045 . . . . 72.109999999999999 110.19 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.1 mm -119.21 122.41 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.594 -0.891 . . . . 63.130000000000003 108.594 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.1 mmm -98.29 123.78 42.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.807 -0.812 . . . . 72.319999999999993 108.807 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.313 -1.002 0 CA-C-O 121.089 0.471 . . . . 64.420000000000002 111.163 -176.043 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 119.669 -0.517 . . . . 75.140000000000001 113.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -175.61 162.6 2.79 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 117.466 0.633 . . . . 73.439999999999998 110.276 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.15 8.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.749 -0.659 . . . . 73.430000000000007 109.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 40.8 m-85 -142.32 145.7 34.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.745 -0.661 . . . . 63.030000000000001 110.016 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 125' ' ' PHE . 84.0 t -132.75 126.06 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.997 -0.439 . . . . 73.319999999999993 111.049 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.0 m -102.48 125.17 49.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.835 -0.62 . . . . 75.209999999999994 110.494 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.78 163.62 12.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.992 0.425 . . . . 62.210000000000001 111.671 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.44 -28.2 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.264 -0.88 . . . . 55.219999999999999 110.534 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.46 153.41 51.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.022 -0.535 . . . . 74.239999999999995 110.422 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 103' ' ' THR . 34.3 p80 -74.73 -28.21 60.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.646 . . . . 71.230000000000004 110.108 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -58.53 -43.56 89.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.017 -0.992 . . . . 74.340000000000003 111.779 -176.122 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 m -68.72 -30.75 69.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.718 0.294 . . . . 74.549999999999997 110.937 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -71.17 -39.53 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.636 -0.505 . . . . 73.120000000000005 109.636 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.54 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -72.15 -24.64 61.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.448 -0.796 . . . . 64.25 111.499 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 52.9 mttm -62.81 -40.51 97.58 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.647 0.737 . . . . 70.120000000000005 110.009 170.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.16 -43.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.667 -1.151 . . . . 53.420000000000002 112.574 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 160' ' ' ASP . 32.6 m -73.73 -2.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.115 0.483 . . . . 75.209999999999994 111.63 -173.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 160' ' ' ASP . 76.2 mt -61.27 -38.11 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.508 -0.769 . . . . 72.510000000000005 109.951 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.3 mt-30 -108.47 105.62 15.36 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.45 -0.945 . . . . 74.349999999999994 108.45 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -53.85 -34.27 58.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.856 -0.611 . . . . 72.209999999999994 112.151 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.76 137.83 54.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 110.614 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.5 m-70 -126.0 146.26 49.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.832 -0.622 . . . . 75.420000000000002 110.539 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 m -106.08 118.84 37.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.016 -0.538 . . . . 73.099999999999994 110.726 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.62 142.9 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.548 -0.908 . . . . 43.149999999999999 108.548 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 52.11 31.28 8.68 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.537 0.684 . . . . 52.240000000000002 111.767 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.38 10.17 74.35 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.75 -0.659 . . . . 73.25 113.543 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -115.66 139.01 50.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.01 0.405 . . . . 61.210000000000001 110.264 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -101.12 111.2 23.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.643 0.735 . . . . 71.510000000000005 111.016 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.98 156.61 23.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 74.5 110.51 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -86.57 136.64 32.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.003 0.43 . . . . 72.349999999999994 110.184 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.2 t -131.97 132.64 61.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.616 -0.72 . . . . 72.439999999999998 109.862 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -153.46 174.63 14.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.797 -0.638 . . . . 71.140000000000001 111.195 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -65.28 136.9 57.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.596 -0.274 . . . . 74.25 110.898 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -125.99 124.94 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.812 -0.44 . . . . 73.209999999999994 109.812 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 120.408 -0.517 . . . . 75.310000000000002 110.525 -179.671 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 108.43 -0.952 . . . . 55.210000000000001 108.43 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 37.5 mp0 -102.5 142.78 25.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.241 -1.345 . . . . 74.530000000000001 110.836 -172.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 13' ' ' LEU . 12.1 Cg_endo -61.92 166.42 12.29 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.871 2.38 . . . . 72.530000000000001 112.006 172.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.46 -37.18 67.42 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 112.272 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' HD23 ' A' ' 13' ' ' LEU . 10.0 pt20 -61.83 -29.33 70.09 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 61.5 112.158 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 164' ' ' ILE . 25.3 mt -89.81 -22.17 22.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.334 . . . . 54.119999999999997 111.162 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.7 ptt180 -106.66 0.05 24.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.332 0.587 . . . . 75.019999999999996 110.071 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -105.47 136.28 45.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.638 0.732 . . . . 65.150000000000006 111.123 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 68' ' ' VAL . 71.3 mt -101.56 146.87 27.09 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.729 -1.123 . . . . 72.409999999999997 110.92 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -97.67 120.79 38.68 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.245 -1.021 . . . . 74.329999999999998 108.245 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -98.47 110.96 27.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.771 -0.455 . . . . 74.340000000000003 109.771 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.72 147.94 16.32 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.868 -0.893 . . . . 75.239999999999995 110.868 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.9 42.26 13.07 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.978 -1.106 . . . . 53.549999999999997 112.886 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 25' ' ' THR . 90.4 mt -79.28 174.63 11.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.319 -0.622 . . . . 44.310000000000002 109.319 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -85.98 179.35 7.01 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 60.140000000000001 109.094 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 53' ' ' ARG . 3.2 t80 -81.95 -6.88 59.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.513 0.673 . . . . 71.319999999999993 109.389 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -118.36 20.35 13.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.006 -0.997 . . . . 72.109999999999999 111.845 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.575 HG21 HD22 ' A' ' 21' ' ' LEU . 20.4 m -85.75 129.45 34.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.983 0.421 . . . . 74.230000000000004 111.477 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -108.09 165.73 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.695 . . . . 61.32 109.673 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -25.17 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.005 -0.278 . . . . 72.329999999999998 110.792 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.6 -40.36 69.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.127 -0.229 . . . . 71.439999999999998 110.851 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -76.7 -32.71 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 74.310000000000002 110.618 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.2 tp -66.42 -49.88 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 62.549999999999997 110.314 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -56.77 -54.78 42.31 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.556 -0.747 . . . . 74.209999999999994 111.011 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -44.86 -37.98 4.26 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.539 1.149 . . . . 45.240000000000002 113.415 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -69.83 -52.0 28.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.345 -0.389 . . . . 75.349999999999994 110.953 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.32 -19.91 41.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.195 0.443 . . . . 72.209999999999994 112.195 -170.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -56.73 -24.29 48.67 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.396 0.517 . . . . 53.420000000000002 112.396 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.96 -25.57 68.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.196 0.443 . . . . 73.439999999999998 112.196 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -101.21 -23.25 14.47 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.088 -0.245 . . . . 73.409999999999997 111.267 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.3 157.72 29.19 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.311 -0.947 . . . . 73.340000000000003 112.389 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.6 m -63.24 119.81 10.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.981 0.419 . . . . 72.540000000000006 111.591 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.4 mt -88.43 141.85 28.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.815 -0.63 . . . . 70.319999999999993 110.479 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -107.09 -23.25 12.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 51.43 110.198 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -153.6 153.72 32.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.642 -0.708 . . . . 51.219999999999999 109.598 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 t -163.27 132.81 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.659 -0.497 . . . . 44.310000000000002 109.659 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.13 127.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 73.109999999999999 111.095 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.42 133.78 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.937 -0.764 . . . . 73.439999999999998 108.937 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.475 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.6 mmt -78.19 99.85 6.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.339 0.59 . . . . 70.239999999999995 110.471 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -101.77 160.92 14.06 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.033 -0.985 . . . . 63.130000000000003 109.864 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.28 130.47 62.33 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.1 -0.333 . . . . 53.130000000000003 110.1 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.12 -19.37 51.16 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.182 1.922 . . . . 74.319999999999993 113.295 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.63 -54.37 4.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.34 0.591 . . . . 71.439999999999998 110.707 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -96.86 -16.14 20.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.182 -0.917 . . . . 70.329999999999998 112.348 -172.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm 65.94 31.09 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.865 0.728 . . . . 72.340000000000003 111.183 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 23.6 mmm180 -114.15 158.7 20.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.351 -0.611 . . . . 70.400000000000006 109.351 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 t -70.73 140.78 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.967 0.413 . . . . 63.409999999999997 110.993 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -93.34 3.75 55.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 75.219999999999999 110.596 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.06 68.02 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 114.378 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.475 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.3 p90 -156.34 154.8 31.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.768 0.784 . . . . 64.519999999999996 110.496 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.78 -166.24 17.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.371 -0.692 . . . . 74.439999999999998 111.371 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.68 148.59 37.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.295 0.547 . . . . 75.439999999999998 110.598 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 18' ' ' ILE . 7.9 m -129.13 127.86 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.595 . . . . 74.420000000000002 109.781 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.6 m -103.36 121.61 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.335 -0.228 . . . . 74.420000000000002 110.532 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -87.95 164.05 16.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.042 0.449 . . . . 72.439999999999998 110.997 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.83 -49.49 37.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.492 -0.776 . . . . 73.219999999999999 110.598 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.5 m -119.37 152.18 37.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 74.400000000000006 110.816 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -65.64 -28.85 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.455 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.53 -29.35 63.52 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.967 -0.458 . . . . 74.310000000000002 111.509 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 6.1 mm-40 -64.92 -29.75 70.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.49 0.662 . . . . 73.109999999999999 109.282 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 16' ' ' LEU . 24.8 t -66.88 -48.3 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.825 -1.08 . . . . 54.109999999999999 110.298 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -59.14 -49.96 75.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.797 -0.638 . . . . 72.329999999999998 110.704 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.8 -36.72 38.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.957 0.725 . . . . 74.25 112.957 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -29.6 62.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 71.129999999999995 110.745 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -49.66 64.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 63.450000000000003 109.974 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -64.07 -26.84 68.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.18 0.514 . . . . 72.239999999999995 110.882 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.9 -10.73 60.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.237 -0.892 . . . . 65.340000000000003 113.366 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -56.63 149.78 39.22 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 111.883 0.327 . . . . 52.119999999999997 111.883 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.72 165.67 79.12 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.057 -1.226 . . . . 51.420000000000002 112.837 0.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -123.65 152.67 41.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 74.230000000000004 110.483 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.5 ttmt -134.23 107.55 7.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.114 -0.494 . . . . 70.310000000000002 111.251 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 126.59 66.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.678 -0.692 . . . . 75.120000000000005 109.85 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.7 t70 66.29 28.19 9.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.632 0.73 . . . . 74.019999999999996 110.791 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.12 25.87 70.06 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.765 -0.731 . . . . 73.150000000000006 112.498 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.3 tpt180 -129.64 142.09 50.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.101 -0.703 . . . . 74.129999999999995 109.101 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.47 114.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 61.340000000000003 109.838 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.72 153.37 7.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.872 -0.604 . . . . 73.540000000000006 111.119 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -117.09 100.43 53.25 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.272 -0.876 . . . . 75.219999999999999 110.572 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.59 132.54 17.54 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.867 1.711 . . . . 73.409999999999997 110.909 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -136.2 178.97 6.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.053 -1.091 . . . . 75.239999999999995 108.053 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.2 tmm_? -81.88 128.68 34.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.768 -0.827 . . . . 71.400000000000006 108.768 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.28 98.54 0.33 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.242 0.544 . . . . 63.329999999999998 111.097 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 11.1 t -69.22 142.96 15.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.053 -0.976 . . . . 74.319999999999993 110.835 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 18.1 t -83.21 172.27 12.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.236 -0.438 . . . . 52.210000000000001 109.991 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -61.65 -42.5 98.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.74 0.644 . . . . 75.150000000000006 112.74 -170.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -71.18 -41.46 70.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 43.399999999999999 110.866 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.0 OUTLIER -78.55 -8.12 58.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 111.478 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 70.6 m -93.62 -4.14 51.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.592 -0.276 . . . . 70.549999999999997 111.195 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.17 -41.59 99.25 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.602 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.93 146.57 75.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.944 -0.571 . . . . 75.510000000000005 110.262 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.57 147.66 90.27 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.025 2.484 . . . . 60.420000000000002 112.259 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.96 28.71 64.13 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.819 -0.705 . . . . 62.109999999999999 112.664 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -66.29 -52.16 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 64.439999999999998 110.349 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -93.71 2.47 56.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.637 -0.71 . . . . 62.0 111.061 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -87.94 161.93 17.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.473 . . . . 74.25 109.724 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -83.58 97.61 9.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.218 0.533 . . . . 52.539999999999999 112.122 -172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.521 ' CG1' ' HE3' ' A' ' 179' ' ' LYS . 0.8 OUTLIER -124.52 124.02 67.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.459 -0.791 . . . . 72.340000000000003 109.061 174.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 72.7 mttt -106.65 22.01 16.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.323 0.583 . . . . 72.5 110.446 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -117.71 139.66 50.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.786 -0.643 . . . . 64.129999999999995 111.085 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 159' ' ' VAL . 7.2 pt -124.27 148.52 28.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.307 0.575 . . . . 74.239999999999995 111.45 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -98.63 133.79 42.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.869 -1.059 . . . . 75.310000000000002 109.426 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.37 109.12 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.059 -0.719 . . . . 72.450000000000003 109.059 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -135.86 167.88 24.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.682 -1.246 . . . . 51.409999999999997 113.717 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.11 42.11 5.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.925 -0.655 . . . . 75.450000000000003 111.735 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.19 111.23 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.513 0.673 . . . . 74.439999999999998 110.755 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -78.68 -21.78 47.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.717 0.77 . . . . 70.030000000000001 109.261 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -101.3 151.61 21.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.832 -1.076 . . . . 73.019999999999996 109.181 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.17 123.42 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.534 0.683 . . . . 61.530000000000001 110.677 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 m -107.27 141.61 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.849 -0.614 . . . . 65.5 110.056 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -113.57 173.64 6.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.248 -0.887 . . . . 71.400000000000006 111.449 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -50.73 72.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 71.310000000000002 110.955 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -63.36 -26.34 68.71 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.29 0.369 . . . . 74.340000000000003 111.491 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -64.23 -61.25 2.36 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.427 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -84.1 -23.91 30.55 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.984 -0.686 . . . . 64.120000000000005 111.883 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -67.51 -51.44 51.06 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 110.357 -0.238 . . . . 61.210000000000001 110.357 178.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.2 -28.71 69.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 71.439999999999998 110.3 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -78.79 -56.28 4.52 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.517 -0.765 . . . . 73.439999999999998 112.14 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -67.91 -23.07 65.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.472 0.545 . . . . 74.450000000000003 112.472 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.7 mt-10 -68.05 -23.05 64.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.645 0.26 . . . . 74.030000000000001 111.415 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.78 -33.84 64.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.515 . . . . 62.340000000000003 111.55 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.24 -31.65 33.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.366 . . . . 72.040000000000006 111.443 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 178.68 -177.33 48.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.704 -0.76 . . . . 62.229999999999997 113.332 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -75.61 129.98 38.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 74.219999999999999 111.418 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 152' ' ' THR . 59.0 mt -102.25 140.18 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 72.530000000000001 110.071 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -91.35 -46.55 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 61.539999999999999 110.957 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.36 156.27 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.882 0.373 . . . . 72.010000000000005 110.427 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.49 127.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 109.933 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.4 mt-10 -102.45 105.46 16.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 62.520000000000003 111.206 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.1 117.12 38.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.873 -0.788 . . . . 54.140000000000001 108.873 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.5 mmm -84.45 101.21 11.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 65.129999999999995 110.385 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.855 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.382 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 113.894 0.317 . . . . 72.019999999999996 113.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.66 161.66 32.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 117.188 0.494 . . . . 71.310000000000002 110.43 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.47 173.97 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.487 -0.779 . . . . 64.310000000000002 109.673 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 45.5 m-85 -138.0 148.93 45.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 55.329999999999998 110.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.35 126.25 52.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 71.200000000000003 110.815 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.7 m -98.82 121.28 40.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 75.430000000000007 110.565 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -101.83 160.97 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.68 -0.236 . . . . 74.310000000000002 110.588 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.32 -29.94 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.386 0.613 . . . . 73.25 110.154 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -137.31 162.39 33.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 110.777 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -82.37 -20.56 36.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.978 -0.555 . . . . 73.299999999999997 110.118 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.2 p30 -60.3 -41.21 92.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 123.564 0.54 . . . . 63.009999999999998 110.943 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.401 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -73.67 -29.48 62.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.469 -0.332 . . . . 75.310000000000002 110.355 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.8 t -68.63 -42.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.759 -0.655 . . . . 61.420000000000002 109.745 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -73.85 -26.05 60.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 110.887 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.6 mttt -62.78 -37.99 88.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.521 0.677 . . . . 64.519999999999996 110.218 172.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.6 -42.61 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 72.019999999999996 112.956 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 159' ' ' VAL . 16.8 m -69.74 -9.01 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.095 0.474 . . . . 74.340000000000003 111.625 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.602 HD13 HD22 ' A' ' 13' ' ' LEU . 58.5 mt -56.46 -36.68 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.306 -0.861 . . . . 62.009999999999998 110.368 171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 51.7 mt-30 -109.5 108.95 19.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.224 -0.658 . . . . 71.420000000000002 109.224 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -53.71 -36.13 61.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.429 -0.805 . . . . 73.230000000000004 112.342 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -122.5 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.884 0.373 . . . . 75.299999999999997 110.49 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 82.2 m-70 -121.09 141.63 50.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.064 -0.516 . . . . 72.230000000000004 110.487 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 m -90.26 102.96 15.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.075 -0.511 . . . . 74.109999999999999 110.587 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.2 126.96 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.008 -0.738 . . . . 73.25 109.008 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 t30 53.42 31.53 12.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.584 0.707 . . . . 75.430000000000007 111.528 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.71 2.04 84.79 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.193 -0.527 . . . . 64.439999999999998 113.231 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -106.55 132.36 52.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.557 -0.534 . . . . 73.200000000000003 109.557 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.318 0.58 . . . . 63.149999999999999 110.676 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -106.82 153.89 21.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 61.130000000000003 109.707 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.47 131.23 34.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.198 -0.297 . . . . 72.219999999999999 110.198 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.9 t -130.44 137.25 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 72.329999999999998 111.06 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -158.2 176.67 12.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.001 -0.545 . . . . 72.530000000000001 112.06 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.521 ' HE3' ' CG1' ' A' ' 104' ' ' VAL . 14.1 mmmt -66.32 123.58 20.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.002 -0.545 . . . . 72.549999999999997 109.94 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -106.19 113.99 27.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 72.030000000000001 111.001 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.908 -0.587 . . . . 64.129999999999995 110.125 178.876 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.007 0.432 . . . . 60.520000000000003 110.692 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 159.88 37.5 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.028 -0.533 . . . . 65.420000000000002 110.191 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HD2' HD22 ' A' ' 13' ' ' LEU . 54.7 Cg_endo -73.69 166.94 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.294 1.996 . . . . 74.409999999999997 111.304 170.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -32.79 70.63 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 111.715 0.265 . . . . 73.219999999999999 111.715 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.46 -30.9 71.93 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.063 0.394 . . . . 73.349999999999994 112.063 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.5 mp -82.97 -12.98 56.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.185 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.52 ' HA ' HG21 ' A' ' 68' ' ' VAL . 13.3 ptt180 -119.41 0.56 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.984 0.421 . . . . 63.119999999999997 111.245 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -96.38 147.18 24.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.379 0.609 . . . . 73.239999999999995 112.108 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD21 HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -116.31 147.21 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.008 -0.996 . . . . 44.020000000000003 109.727 172.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 29.8 t80 -101.99 118.38 36.78 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.172 -1.048 . . . . 63.100000000000001 108.172 171.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 60' ' ' VAL . 21.3 mm -94.78 112.77 27.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 122.108 -0.37 . . . . 72.219999999999999 110.228 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 150.81 18.18 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.958 -0.639 . . . . 61.520000000000003 111.964 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.91 45.14 64.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.168 -0.539 . . . . 62.32 113.586 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 25' ' ' THR . 50.2 mt -76.47 173.07 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 72.329999999999998 110.409 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -84.4 175.55 9.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 43.350000000000001 109.485 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 92.1 m-85 -84.03 -6.59 59.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 110.632 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -119.51 12.11 12.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.878 -0.601 . . . . 62.340000000000003 111.678 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 21' ' ' LEU . 43.9 m -77.41 132.37 38.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.078 0.466 . . . . 52.030000000000001 111.425 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -107.63 167.59 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.633 -0.712 . . . . 75.340000000000003 110.054 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -73.77 -24.42 59.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 72.340000000000003 111.089 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.67 -35.14 58.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.167 -0.213 . . . . 71.420000000000002 110.659 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.8 m -73.23 -38.11 66.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.436 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.95 -45.04 94.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 64.099999999999994 110.178 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -60.0 -52.85 63.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.948 -0.569 . . . . 65.430000000000007 110.559 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m -44.14 -42.3 6.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.327 1.017 . . . . 51.100000000000001 113.603 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 79' ' ' VAL . 66.6 t60 -70.24 -56.45 6.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 64.120000000000005 111.13 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 40' ' ' LEU . 81.8 m-85 -76.05 -17.57 59.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.806 0.299 . . . . 72.030000000000001 111.806 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.6 -28.37 54.7 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.027 0.531 . . . . 70.319999999999993 111.547 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -65.61 -23.96 66.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.465 -0.788 . . . . 71.450000000000003 112.304 -177.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -101.41 -21.98 14.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.057 0.391 . . . . 72.010000000000005 112.057 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 177.09 48.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.788 -1.196 . . . . 33.149999999999999 113.24 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -68.01 119.61 12.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.966 0.507 . . . . 74.230000000000004 112.268 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 34' ' ' PHE . 52.8 mt -95.66 125.63 40.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.636 0.731 . . . . 74.420000000000002 110.56 170.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 t -100.92 -17.69 16.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.989 -1.005 . . . . 63.049999999999997 110.12 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.95 151.4 29.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 64.420000000000002 109.981 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.8 t -163.04 133.18 4.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.98 -0.378 . . . . 73.219999999999999 109.98 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 126.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.215 0.531 . . . . 62.009999999999998 110.613 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.56 131.87 33.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.605 -0.887 . . . . 74.209999999999994 108.605 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.9 mmt -79.4 97.44 6.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.773 0.796 . . . . 72.400000000000006 110.94 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 30.9 mtp180 -104.51 159.11 16.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.314 -1.312 . . . . 72.040000000000006 109.008 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.37 125.84 91.06 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.885 -0.598 . . . . 74.439999999999998 109.773 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.51 -28.62 87.01 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.214 1.943 . . . . 60.43 113.744 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.92 -55.01 4.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.925 0.393 . . . . 70.150000000000006 111.906 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.43 -15.92 21.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.199 0.444 . . . . 65.209999999999994 112.199 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 65.43 31.34 10.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.71 0.804 . . . . 74.019999999999996 111.747 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -97.92 151.35 20.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.098 -0.704 . . . . 73.239999999999995 109.098 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.1 t -72.7 137.63 46.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.727 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -89.25 -1.65 58.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.778 -0.646 . . . . 63.219999999999999 109.634 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.18 23.52 51.42 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.66 -0.7 . . . . 35.32 113.825 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -161.51 160.72 29.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.887 0.844 . . . . 73.450000000000003 111.036 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -162.18 12.19 Favored Glycine 0 C--O 1.226 -0.345 0 N-CA-C 111.588 -0.605 . . . . 71.299999999999997 111.588 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -142.32 149.37 39.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.185 0.493 . . . . 75.329999999999998 110.105 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 18' ' ' ILE . 7.3 m -130.69 126.4 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.057 -0.719 . . . . 75.430000000000007 109.057 172.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 m -105.85 120.01 40.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.728 0.299 . . . . 75.400000000000006 110.408 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -85.37 171.08 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.854 -0.612 . . . . 64.310000000000002 109.979 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.7 -25.03 24.99 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.139 0.495 . . . . 71.420000000000002 110.488 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 m -143.06 145.4 32.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 64.150000000000006 110.916 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.1 p -56.54 -40.02 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.688 -0.687 . . . . 62.210000000000001 111.867 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -53.05 -42.03 65.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.974 0.731 . . . . 71.200000000000003 112.974 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -65.71 -30.67 71.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.302 0.572 . . . . 74.140000000000001 110.569 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 14' ' ' ARG . 17.9 t -67.12 -45.57 86.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.381 -0.827 . . . . 62.450000000000003 110.813 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -58.95 -42.94 91.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 110.622 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.71 -37.37 73.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.483 0.549 . . . . 73.120000000000005 112.483 171.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.33 74.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.271 0.558 . . . . 71.409999999999997 110.226 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.25 -36.25 71.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.783 -0.644 . . . . 72.099999999999994 110.786 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.645 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 4.5 p30 -79.94 -11.27 59.81 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.968 0.413 . . . . 75.219999999999999 110.952 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.79 -12.06 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 72.409999999999997 111.002 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -55.31 149.14 28.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.68 . . . . 74.109999999999999 111.827 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 168.7 76.62 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 124.274 -1.136 . . . . 75.120000000000005 113.381 2.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -125.77 155.97 40.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.681 -0.691 . . . . 75.200000000000003 110.358 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.3 ttmt -136.75 105.34 5.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.086 0.47 . . . . 73.439999999999998 111.242 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.439 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.4 t -105.62 125.6 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.6 . . . . 70.409999999999997 109.718 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 64.53 33.59 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.776 0.672 . . . . 70.340000000000003 111.281 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.88 26.56 73.77 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.018 -0.611 . . . . 52.25 112.239 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.5 tpt180 -127.5 135.62 50.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.162 -0.31 . . . . 73.510000000000005 110.162 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.95 113.47 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.839 -0.8 . . . . 70.209999999999994 108.839 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -106.49 151.99 8.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.356 0.598 . . . . 74.409999999999997 111.208 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -113.82 96.55 41.56 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.956 -1.02 . . . . 74.019999999999996 110.697 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.27 129.97 15.71 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.741 1.627 . . . . 54.329999999999998 110.286 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 50.9 mmtt -121.26 142.01 50.35 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.844 -0.798 . . . . 74.430000000000007 108.844 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.628 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 7.9 tpp180 -64.05 119.51 10.27 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.644 -0.872 . . . . 72.230000000000004 108.644 172.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 93.29 0.09 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.601 0.715 . . . . 40.229999999999997 110.671 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.483 ' CG2' HG23 ' A' ' 163' ' ' VAL . 8.3 p -66.24 156.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.728 -1.124 . . . . 64.409999999999997 110.638 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 p -55.39 153.82 6.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.961 -0.563 . . . . 62.310000000000002 111.428 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 1.4 tmt_? -57.51 -30.62 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.671 -0.695 . . . . 63.210000000000001 111.234 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -52.2 52.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 111.609 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.8 -25.95 59.4 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.789 0.328 . . . . 71.340000000000003 110.318 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -64.4 -17.49 63.82 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.217 -0.447 . . . . 52.43 111.192 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -81.29 -11.24 59.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.738 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -79.96 145.55 61.67 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.953 -0.388 . . . . 73.450000000000003 109.953 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.3 115.54 4.08 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.43 2.086 . . . . 75.200000000000003 112.05 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.65 27.59 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.791 -0.719 . . . . 72.340000000000003 112.297 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.01 -36.81 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 111.671 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 29.0 m-70 -104.03 21.2 16.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.485 0.66 . . . . 54.119999999999997 110.516 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.2 mt -101.65 -178.55 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 65.510000000000005 109.553 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.15 100.64 13.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.649 . . . . 72.430000000000007 111.834 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.17 121.97 44.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 74.530000000000001 108.181 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 60.5 mttt -106.59 19.68 20.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 63.100000000000001 110.505 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.43 139.1 50.81 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.378 -0.373 . . . . 73.209999999999994 110.662 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 159' ' ' VAL . 7.5 pt -131.7 149.62 33.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.266 0.555 . . . . 70.030000000000001 111.293 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -93.45 137.91 32.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 70.310000000000002 109.582 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.82 108.93 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.345 -0.613 . . . . 55.43 109.345 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.84 147.6 18.08 Favored Glycine 0 CA--C 1.505 -0.587 0 C-N-CA 119.673 -1.251 . . . . 75.049999999999997 112.973 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.87 6.35 22.96 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.32 -0.943 . . . . 73.129999999999995 111.981 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 112' ' ' ILE . 26.7 pt -76.45 99.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 122.072 0.939 . . . . 64.129999999999995 109.055 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -91.47 -6.13 53.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.161 -0.927 . . . . 62.049999999999997 112.126 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -126.47 -162.52 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.024 -0.362 . . . . 60.119999999999997 110.024 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.22 67.98 8.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 54.119999999999997 111.003 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -75.56 136.42 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.321 0.581 . . . . 71.239999999999995 109.799 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.3 166.12 10.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.272 -0.876 . . . . 72.319999999999993 111.436 -171.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.01 -53.17 61.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.336 -0.847 . . . . 74.5 110.516 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.23 -12.76 58.16 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.388 0.514 . . . . 73.099999999999994 112.388 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -73.01 -57.74 3.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.084 0.468 . . . . 75.209999999999994 109.764 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -81.47 -28.62 34.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.143 -0.623 . . . . 71.140000000000001 110.544 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -64.3 -53.22 52.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.657 -0.247 . . . . 74.140000000000001 110.592 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.6 -26.4 68.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.979 0.419 . . . . 55.140000000000001 110.486 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.1 -54.59 8.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.815 -0.629 . . . . 74.209999999999994 111.194 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -68.32 -23.53 64.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.5 -0.318 . . . . 73.439999999999998 111.609 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.4 mt-10 -65.92 -26.18 67.48 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.886 0.374 . . . . 65.230000000000004 111.236 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -56.9 -30.1 63.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.935 -0.575 . . . . 73.530000000000001 111.31 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -86.26 -26.8 24.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 74.299999999999997 111.936 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.69 46.41 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.372 -0.918 . . . . 63.329999999999998 113.353 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.45 131.77 41.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.078 0.466 . . . . 61.310000000000002 111.316 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 152' ' ' THR . 52.4 mt -105.09 141.18 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 64.430000000000007 110.082 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -90.64 -54.44 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 54.229999999999997 110.796 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.76 155.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 73.140000000000001 110.289 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.54 129.48 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.057 0.456 . . . . 62.32 109.828 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 21.6 mt-10 -101.78 103.41 14.14 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.291 -0.868 . . . . 55.25 110.566 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -92.47 118.98 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.067 -0.716 . . . . 53.240000000000002 109.067 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 73.1 mmm -90.46 109.36 20.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.283 0.564 . . . . 72.400000000000006 110.554 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 73.010000000000005 109.846 -177.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.22 0 N-CA-C 113.624 0.209 . . . . 53.030000000000001 113.624 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.28 158.96 33.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.104 0.478 . . . . 75.230000000000004 109.764 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.91 176.91 8.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.255 -0.884 . . . . 60.439999999999998 109.633 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 51.6 m-85 -139.84 151.73 45.92 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.28 -0.873 . . . . 75.319999999999993 109.128 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.09 134.04 15.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.281 0.562 . . . . 75.430000000000007 110.95 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.8 m -105.7 127.66 53.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.071 -0.968 . . . . 74.109999999999999 110.983 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -101.72 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 110.874 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.26 -23.3 30.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.825 -0.625 . . . . 72.209999999999994 110.29 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.56 158.05 44.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 73.230000000000004 110.8 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.568 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 31.2 p80 -83.98 -27.67 28.28 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.646 -0.252 . . . . 74.040000000000006 111.377 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -59.45 -42.22 91.48 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.382 0.427 . . . . 75.129999999999995 110.886 -176.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -65.43 -32.86 74.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.027 -0.533 . . . . 50.329999999999998 110.976 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 163' ' ' VAL . 3.0 t -70.81 -44.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.386 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 26.4 m-20 -68.17 -25.41 65.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.719 . . . . 74.530000000000001 111.269 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.628 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 96.9 mttt -61.68 -45.2 95.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.842 0.829 . . . . 62.439999999999998 110.276 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.6 mt -75.55 -43.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.492 -1.231 . . . . 70.120000000000005 112.387 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.483 HG23 ' CG2' ' A' ' 90' ' ' VAL . 15.9 m -75.01 -5.59 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 74.5 111.096 -174.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 160' ' ' ASP . 31.1 mt -57.97 -31.45 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.42 -0.809 . . . . 63.229999999999997 109.748 168.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -114.49 109.35 18.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.557 -0.747 . . . . 65.400000000000006 109.095 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -55.66 -31.9 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 65.450000000000003 112.259 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.62 137.3 54.76 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.649 -0.421 . . . . 74.450000000000003 111.622 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -129.0 149.24 50.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.578 -0.737 . . . . 74.0 109.622 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.5 m -110.92 124.64 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.885 0.374 . . . . 64.209999999999994 110.935 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.58 131.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.985 -0.552 . . . . 73.310000000000002 109.983 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 72.44 23.24 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.42 1.105 . . . . 72.549999999999997 109.63 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.7 85.96 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.155 -0.93 . . . . 62.140000000000001 112.097 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -118.91 122.14 41.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.318 . . . . 63.310000000000002 110.816 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.81 108.07 18.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.751 -0.833 . . . . 71.299999999999997 108.751 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.0 p -110.1 154.3 23.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.426 -0.807 . . . . 51.340000000000003 111.101 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -86.62 127.77 34.95 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.626 -0.715 . . . . 75.140000000000001 109.681 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.8 t -124.87 128.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.352 -0.84 . . . . 62.399999999999999 109.987 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -154.35 171.47 19.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.414 -0.812 . . . . 61.409999999999997 111.26 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -58.02 123.61 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.465 0.478 . . . . 71.120000000000005 111.287 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.81 118.82 31.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.995 -0.548 . . . . 71.219999999999999 109.723 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--N 1.311 -1.108 0 N-CA-C 109.486 -0.561 . . . . 72.239999999999995 109.486 179.449 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 120.924 0.392 . . . . 75.200000000000003 110.706 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.49 133.78 86.89 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.683 . . . . 74.200000000000003 110.461 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.66 162.73 35.86 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.824 2.349 . . . . 74.25 110.59 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.1 pt-20 -60.34 -30.54 69.59 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 111.819 0.303 . . . . 61.219999999999999 111.819 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.78 -34.63 75.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.871 0.323 . . . . 75.329999999999998 111.871 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.75 -15.1 58.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.964 0.412 . . . . 74.200000000000003 110.839 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG21 ' A' ' 68' ' ' VAL . 24.3 ptt180 -121.58 6.61 10.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.754 -0.657 . . . . 73.299999999999997 110.824 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.4 ttmm -95.19 148.77 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.709 0.766 . . . . 60.020000000000003 111.563 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 68' ' ' VAL . 78.0 mt -115.8 139.48 50.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.643 -1.162 . . . . 70.010000000000005 110.078 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -96.68 113.26 24.8 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.407 -0.96 . . . . 65.230000000000004 108.407 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 60' ' ' VAL . 15.6 mm -92.67 111.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.252 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.77 147.63 16.72 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.086 -0.578 . . . . 73.25 112.063 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.77 48.57 33.93 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 72.439999999999998 113.399 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 25' ' ' THR . 73.2 mt -79.86 176.94 9.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.118 -0.327 . . . . 75.340000000000003 110.118 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.7 p -89.84 169.57 11.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.003 -0.74 . . . . 42.25 109.003 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -77.24 -3.61 40.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.973 0.416 . . . . 74.209999999999994 111.377 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.32 13.4 13.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.017 -0.538 . . . . 74.120000000000005 111.29 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 HD22 ' A' ' 21' ' ' LEU . 31.0 m -73.13 126.31 29.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 65.209999999999994 110.403 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -105.91 165.53 11.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 61.43 109.816 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.81 -24.69 65.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.613 0.244 . . . . 74.340000000000003 110.958 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.96 -35.41 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 65.439999999999998 111.859 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -77.52 -36.1 52.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.93 0.395 . . . . 74.219999999999999 110.362 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.07 -48.51 78.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.62 -0.718 . . . . 63.240000000000002 109.681 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 31' ' ' ARG . 43.9 ttm180 -54.47 -60.05 3.87 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.432 -0.804 . . . . 73.019999999999996 111.878 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -47.82 -38.91 16.97 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.9 0.75 . . . . 71.200000000000003 112.691 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.99 -56.08 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.476 -0.329 . . . . 71.109999999999999 111.084 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 40' ' ' LEU . 70.6 m-85 -76.01 -18.59 59.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.676 0.274 . . . . 61.32 111.665 -174.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.11 -22.5 51.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.217 0.607 . . . . 74.450000000000003 111.783 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.79 -27.65 66.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.711 -0.677 . . . . 54.119999999999997 112.208 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.16 -20.64 15.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.608 0.225 . . . . 64.530000000000001 111.608 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.51 165.49 35.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.259 -0.972 . . . . 60.119999999999997 112.375 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.4 m -71.69 119.71 16.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.018 0.437 . . . . 74.409999999999997 111.458 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 34' ' ' PHE . 95.2 mt -84.36 138.29 32.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.567 -0.742 . . . . 73.510000000000005 110.967 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -97.79 -25.36 15.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.808 . . . . 74.430000000000007 110.161 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -150.68 150.26 30.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 63.109999999999999 110.164 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.9 t -158.71 126.37 5.03 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.129 -0.323 . . . . 71.010000000000005 110.129 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.62 126.35 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.339 0.59 . . . . 72.430000000000007 110.513 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.73 133.08 33.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.766 -0.828 . . . . 72.010000000000005 108.766 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.488 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mmt -78.21 99.66 6.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.074 0.464 . . . . 64.549999999999997 110.692 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -100.66 161.04 13.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.43 -0.805 . . . . 74.519999999999996 110.498 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.89 123.81 75.44 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.031 -0.986 . . . . 72.510000000000005 110.055 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.87 -24.56 74.31 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.224 1.949 . . . . 73.340000000000003 113.463 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -84.24 -54.92 4.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 74.25 111.505 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -14.45 28.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 75.5 112.12 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm 62.61 31.16 16.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.883 0.873 . . . . 73.430000000000007 111.662 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -114.71 155.6 26.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.648 -0.871 . . . . 71.420000000000002 108.648 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.3 t -70.34 133.89 47.38 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.05 -0.352 . . . . 65.530000000000001 110.05 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -81.68 4.98 19.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.856 -0.611 . . . . 72.319999999999993 111.106 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.65 15.8 65.13 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 73.239999999999995 113.882 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 33.0 p90 -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.764 0.782 . . . . 73.409999999999997 110.625 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.04 -168.11 21.55 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.448 -0.661 . . . . 72.310000000000002 111.448 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.69 146.36 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.164 0.482 . . . . 70.430000000000007 110.634 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 18' ' ' ILE . 12.9 m -131.77 121.3 47.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 75.109999999999999 109.911 174.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.0 m -97.58 123.0 41.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.638 -0.504 . . . . 63.350000000000001 109.638 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -86.03 175.21 8.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.033 0.444 . . . . 74.040000000000006 110.918 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.73 -45.54 16.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.005 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -120.08 149.48 42.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 61.140000000000001 110.162 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.8 p -65.4 -30.9 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 123.131 0.269 . . . . 55.109999999999999 111.266 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.94 -39.74 87.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.183 0.438 . . . . 72.450000000000003 112.183 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -26.5 68.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 110.784 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 16' ' ' LEU . 40.4 t -63.79 -50.83 76.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.744 -0.662 . . . . 74.409999999999997 110.59 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -37.96 87.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 60.149999999999999 111.594 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.01 62.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.029 0.381 . . . . 72.120000000000005 112.029 170.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.47 -33.86 58.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 74.329999999999998 110.445 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -63.97 -41.75 97.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.438 -0.346 . . . . 75.049999999999997 110.642 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -30.3 63.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.965 -0.561 . . . . 70.349999999999994 110.902 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.72 -13.2 61.9 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.791 0.663 . . . . 55.0 112.791 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -55.06 148.98 26.48 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.212 0.449 . . . . 75.420000000000002 112.212 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.65 157.26 92.77 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.57 -1.429 . . . . 61.530000000000001 114.088 3.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -112.76 156.5 22.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.555 -0.748 . . . . 75.219999999999999 110.867 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 20.3 ttmt -139.45 110.35 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.345 -0.389 . . . . 62.420000000000002 111.539 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.04 130.65 64.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 71.340000000000003 109.81 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.22 26.56 12.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.867 0.842 . . . . 74.400000000000006 110.538 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.68 24.13 70.84 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.949 -0.643 . . . . 60.420000000000002 112.461 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 tpt180 -127.07 139.75 52.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.76 -0.459 . . . . 74.310000000000002 109.76 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -76.07 112.68 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 54.399999999999999 109.46 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -109.27 150.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 110.996 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -114.82 96.38 44.26 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.242 -0.89 . . . . 53.340000000000003 111.486 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HE1' ' A' ' 72' ' ' MET . 19.3 Cg_endo -70.59 131.68 20.53 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.236 1.291 . . . . 52.530000000000001 110.556 170.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -129.74 171.83 12.27 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.887 -0.783 . . . . 73.230000000000004 108.887 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -83.54 126.19 32.55 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.209 -0.996 . . . . 75.140000000000001 109.623 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.22 103.46 0.63 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.879 -0.601 . . . . 45.329999999999998 111.887 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.53 150.06 9.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.968 -1.015 . . . . 44.100000000000001 108.309 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -53.7 129.69 34.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.63 -0.507 . . . . 65.140000000000001 109.63 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -59.03 -24.29 62.7 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.516 0.51 . . . . 73.540000000000006 111.931 -172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.98 -54.81 41.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 73.099999999999994 110.549 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.38 -14.75 58.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.679 . . . . 54.329999999999998 111.201 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 t -64.85 -17.42 64.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.633 -0.712 . . . . 75.420000000000002 111.218 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -68.67 -21.71 64.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.286 -0.416 . . . . 75.109999999999999 111.013 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -78.73 143.94 63.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.072 -0.344 . . . . 60.119999999999997 110.072 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.37 117.86 5.33 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.724 2.283 . . . . 73.109999999999999 112.441 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.51 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.772 . . . . 61.25 112.658 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.88 86.6 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.351 0.26 . . . . 62.130000000000003 111.625 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -107.24 12.87 27.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.153 0.427 . . . . 70.099999999999994 112.153 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 49.3 mt -77.24 155.75 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.894 -0.409 . . . . 73.219999999999999 109.894 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -76.96 88.96 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.178 0.513 . . . . 64.239999999999995 110.799 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.84 135.69 63.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.84 -1.17 . . . . 73.310000000000002 107.84 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.412 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.5 mttt -112.13 20.71 16.59 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.379 0.609 . . . . 64.519999999999996 110.202 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.22 142.1 47.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.505 -0.771 . . . . 73.129999999999995 110.288 176.23 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 159' ' ' VAL . 7.4 pt -126.85 149.63 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.165 0.507 . . . . 63.020000000000003 111.066 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.6 t80 -101.45 136.39 41.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.072 -0.967 . . . . 73.120000000000005 109.016 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 7.1 t -125.88 109.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.544 -0.539 . . . . 75.230000000000004 109.544 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.07 146.98 17.08 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.27 -0.967 . . . . 65.140000000000001 112.309 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.8 50.3 4.72 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.541 -1.024 . . . . 63.210000000000001 110.541 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.596 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 15.2 pt -91.55 -177.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.04 -0.58 . . . . 64.329999999999998 111.481 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HD3' ' ND2' ' A' ' 171' ' ' ASN . 87.5 tttt -84.79 154.67 22.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.817 -0.629 . . . . 72.519999999999996 109.757 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -59.25 -37.2 77.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.814 0.34 . . . . 64.510000000000005 110.952 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -108.3 85.48 2.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 110.016 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 m -123.61 122.78 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.695 0.759 . . . . 71.310000000000002 110.426 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.7 pt-20 -113.22 172.47 6.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.471 -1.241 . . . . 53.240000000000002 110.723 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -48.22 73.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.85 -1.068 . . . . 72.120000000000005 110.128 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -57.19 -34.78 68.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.847 -0.615 . . . . 71.230000000000004 111.817 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.453 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 31.0 m170 -61.27 -60.16 4.18 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.676 0.274 . . . . 65.400000000000006 111.479 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 151' ' ' VAL . 3.2 pp -82.63 -22.39 34.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.519 -0.872 . . . . 73.040000000000006 111.461 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -68.32 -50.74 51.27 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.485 -0.191 . . . . 73.340000000000003 110.485 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.43 -30.76 68.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.086 0.47 . . . . 53.219999999999999 110.436 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.71 -57.08 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.7 -0.682 . . . . 71.109999999999999 112.269 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -69.17 -22.74 63.9 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.918 0.71 . . . . 73.239999999999995 112.918 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.2 mt-10 -68.76 -23.23 64.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 111.021 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -59.1 -26.53 64.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.058 -0.519 . . . . 75.200000000000003 111.232 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.11 -33.87 20.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 55.140000000000001 111.521 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.432 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 179.54 -174.96 46.62 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.309 -0.948 . . . . 52.43 113.726 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -76.45 129.11 36.06 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.045 0.45 . . . . 74.200000000000003 111.613 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.82 137.95 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 75.510000000000005 109.975 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.49 -52.03 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 63.5 110.518 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.12 157.32 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 51.43 109.779 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.22 129.58 72.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.897 0.38 . . . . 65.209999999999994 110.228 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.0 mt-10 -103.4 104.16 14.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.562 -0.744 . . . . 70.019999999999996 110.767 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.1 mm -92.99 112.63 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.831 -0.803 . . . . 63.350000000000001 108.831 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 78.8 mmm -86.07 117.57 24.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.468 -0.493 . . . . 75.329999999999998 109.873 -173.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 63.439999999999998 110.741 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 111.417 -0.673 . . . . 34.140000000000001 111.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -160.43 168.17 25.74 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.902 -0.407 . . . . 75.219999999999999 109.902 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.12 169.55 17.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.543 -0.753 . . . . 61.340000000000003 109.184 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 44.2 m-85 -132.21 144.66 50.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.153 0.501 . . . . 73.319999999999993 110.164 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 121' ' ' LEU . 25.5 t -128.77 130.42 68.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.303 -0.408 . . . . 64.209999999999994 110.284 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 131' ' ' ILE . 94.0 m -105.94 120.62 42.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 71.200000000000003 110.941 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.3 160.44 14.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.936 0.398 . . . . 63.340000000000003 111.013 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.59 -31.38 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.599 -0.728 . . . . 71.510000000000005 110.61 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.85 155.85 44.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 74.420000000000002 110.81 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -77.18 -28.54 54.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.339 -0.391 . . . . 75.299999999999997 110.063 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.08 -48.45 33.48 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.037 0.836 . . . . 62.350000000000001 112.089 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.432 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -74.59 -27.87 60.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.702 -0.681 . . . . 65.519999999999996 111.016 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 107' ' ' ILE . 3.7 t -73.76 -41.33 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.230000000000004 109.979 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.479 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 6.9 m-20 -69.7 -23.45 63.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 63.399999999999999 110.988 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -65.36 -43.09 91.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.624 0.726 . . . . 53.219999999999999 110.392 170.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mt -73.19 -39.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.638 -1.164 . . . . 65.329999999999998 111.789 -172.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 160' ' ' ASP . 19.1 m -76.54 -8.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.382 . . . . 63.119999999999997 111.04 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 16.3 mt -64.21 -34.12 66.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.532 0.682 . . . . 71.349999999999994 109.859 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 58.5 mt-30 -109.13 96.99 6.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.796 -1.187 . . . . 71.120000000000005 107.796 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -56.55 -30.61 63.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 53.310000000000002 112.522 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.909 -0.317 . . . . 74.510000000000005 110.514 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.4 m-70 -125.71 152.53 45.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.979 -0.555 . . . . 74.349999999999994 109.56 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 32.1 m -101.76 105.91 16.85 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.173 0.511 . . . . 73.310000000000002 110.053 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.03 138.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.544 -0.753 . . . . 75.0 109.401 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.58 ' ND2' ' HD3' ' A' ' 113' ' ' LYS . 59.7 t30 49.69 36.21 10.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.579 0.704 . . . . 63.420000000000002 112.591 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.96 5.46 90.12 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.968 -0.56 . . . . 62.43 114.122 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -129.3 134.5 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.424 0.612 . . . . 72.439999999999998 111.324 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 20.3 t-20 -81.04 112.37 18.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.545 . . . . 73.409999999999997 110.853 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 11.6 m -110.32 156.25 21.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.658 -0.701 . . . . 63.420000000000002 110.339 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.0 tt0 -89.41 140.93 29.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 71.150000000000006 110.369 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -130.39 162.99 37.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.973 0.416 . . . . 73.219999999999999 111.014 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -174.68 175.0 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.023 -0.989 . . . . 71.030000000000001 111.767 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -67.9 122.6 18.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 109.508 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -112.4 148.64 33.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.126 0.488 . . . . 61.310000000000002 110.413 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.314 -0.965 0 N-CA-C 108.925 -0.768 . . . . 63.109999999999999 108.925 178.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.782 -0.451 . . . . 62.310000000000002 109.782 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -82.14 125.24 77.55 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 74.439999999999998 109.983 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD2' HD22 ' A' ' 13' ' ' LEU . 18.8 Cg_endo -61.07 168.35 7.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.508 2.805 . . . . 64.299999999999997 112.822 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.57 -39.67 35.88 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.597 -0.729 . . . . 73.420000000000002 112.752 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 4.3 pt20 -62.65 -35.85 80.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.523 0.329 . . . . 71.519999999999996 111.869 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 10' ' ' PRO . 8.5 mp -79.16 -45.41 20.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.918 -0.313 . . . . 72.129999999999995 110.38 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 18.0 ptt85 -76.7 2.02 15.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.03 0.381 . . . . 65.209999999999994 112.03 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.6 ttpt -95.54 147.9 23.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.671 0.748 . . . . 61.039999999999999 110.976 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD21 HG13 ' A' ' 68' ' ' VAL . 54.7 mt -117.25 145.15 44.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.835 -1.075 . . . . 52.520000000000003 110.625 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -98.7 119.48 37.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 65.040000000000006 108.405 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 60' ' ' VAL . 14.4 mm -99.54 111.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.703 -0.48 . . . . 75.519999999999996 109.703 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.92 154.36 16.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.673 -0.775 . . . . 60.25 111.553 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.94 39.89 53.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.583 -0.818 . . . . 64.129999999999995 113.489 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' THR . 72.5 mt -80.0 174.5 11.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.009 -0.367 . . . . 65.430000000000007 110.009 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -88.38 168.5 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.659 -0.867 . . . . 52.439999999999998 108.659 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.4 -4.29 53.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.243 0.544 . . . . 74.129999999999995 110.188 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -106.53 5.84 29.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.378 -0.828 . . . . 73.150000000000006 111.411 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 21' ' ' LEU . 32.7 m -75.02 132.91 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.999 0.428 . . . . 63.340000000000003 111.168 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.622 ' HB ' ' OE2' ' A' ' 28' ' ' GLU . 19.0 p -112.41 168.38 9.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.217 -0.66 . . . . 60.5 109.217 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -73.71 -25.9 60.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.768 -0.373 . . . . 61.049999999999997 110.883 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.622 ' OE2' ' HB ' ' A' ' 26' ' ' THR . 2.0 pm0 -79.89 -32.5 40.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.848 -0.16 . . . . 70.109999999999999 111.012 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.7 p -75.92 -35.23 59.85 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 109.828 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.59 -48.12 70.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.533 -0.758 . . . . 73.310000000000002 110.036 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -53.93 -58.75 6.14 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.071 -0.513 . . . . 72.230000000000004 111.475 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 8.7 t -51.41 -30.88 20.68 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.698 0.624 . . . . 70.420000000000002 112.214 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.437 ' CD2' HG22 ' A' ' 79' ' ' VAL . 64.1 t60 -72.47 -61.63 1.73 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.739 -0.21 . . . . 53.340000000000003 110.88 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -71.11 -22.78 62.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.086 0.402 . . . . 74.25 112.086 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 29.2 tt0 -67.0 -17.97 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.259 0.552 . . . . 71.049999999999997 110.869 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' SER . 96.2 mt-30 -64.35 -24.14 67.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.64 . . . . 64.019999999999996 111.503 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -102.52 -17.67 15.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.373 -0.376 . . . . 73.219999999999999 111.63 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -177.82 163.54 31.93 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.311 -0.947 . . . . 73.319999999999993 112.582 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -68.12 118.09 10.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.076 0.465 . . . . 50.420000000000002 111.579 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.2 mt -88.04 129.02 35.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.68 0.752 . . . . 62.450000000000003 111.474 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -93.23 -24.64 18.12 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.882 -1.054 . . . . 71.109999999999999 109.838 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.46 152.3 32.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.08 -0.964 . . . . 75.049999999999997 109.584 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.416 ' SG ' HG12 ' A' ' 60' ' ' VAL . 16.8 t -164.08 126.59 2.44 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.297 -0.631 . . . . 74.349999999999994 109.297 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 p -145.69 113.83 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.726 0.774 . . . . 71.230000000000004 110.11 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 139.54 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.557 -0.905 . . . . 71.400000000000006 108.557 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.46 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 7.4 mmt -77.33 139.37 39.75 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.979 -0.748 . . . . 72.230000000000004 108.979 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -139.78 157.13 46.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.816 -0.629 . . . . 71.109999999999999 111.749 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 29.2 t70 -70.71 134.67 86.07 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.672 -1.149 . . . . 45.240000000000002 109.939 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' HH21 ' A' ' 55' ' ' ARG . 57.2 Cg_endo -75.26 -17.25 19.15 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.171 1.914 . . . . 71.530000000000001 113.297 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.79 -56.15 3.63 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.997 0.369 . . . . 54.049999999999997 111.997 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -105.75 -9.15 17.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 52.109999999999999 111.218 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 28.3 mmtp 66.67 39.81 3.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.658 -0.701 . . . . 53.130000000000003 111.168 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -105.87 159.88 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.315 -0.624 . . . . 72.530000000000001 109.315 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.6 t -65.56 140.44 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 110.875 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.443 HH21 ' HD3' ' A' ' 49' ' ' PRO . 56.0 mtt-85 -85.87 -3.64 58.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 64.030000000000001 110.554 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.45 60.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.514 -0.85 . . . . 70.319999999999993 113.754 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 28.8 p90 -157.98 155.03 28.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.627 0.713 . . . . 74.540000000000006 110.268 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.27 -167.32 20.66 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 111.875 -0.49 . . . . 60.549999999999997 111.875 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.38 148.42 37.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.15 0.475 . . . . 72.510000000000005 110.327 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 43' ' ' CYS . 13.1 m -132.18 131.14 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.545 . . . . 73.109999999999999 109.981 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HD3' ' A' ' 15' ' ' LYS . 5.2 m -106.19 120.16 41.1 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.24 -0.287 . . . . 61.409999999999997 110.248 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 27.8 m-85 -85.7 162.93 18.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.698 0.285 . . . . 74.209999999999994 110.636 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.3 -44.4 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 75.450000000000003 110.66 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.27 154.21 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 64.400000000000006 111.058 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.07 -41.3 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 111.055 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -48.39 -40.97 27.51 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.57 0.581 . . . . 63.210000000000001 112.57 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.8 -25.06 59.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 74.219999999999999 111.093 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 HD21 ' A' ' 16' ' ' LEU . 13.0 t -68.79 -44.37 82.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 35.240000000000002 109.986 171.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.39 -50.08 72.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 111.034 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.01 22.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.758 -0.656 . . . . 45.420000000000002 112.701 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.61 57.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.514 . . . . 64.319999999999993 110.825 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.78 -40.31 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.894 -0.594 . . . . 75.310000000000002 111.434 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -19.53 61.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.278 0.561 . . . . 71.340000000000003 110.154 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -9.01 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.709 -0.678 . . . . 62.210000000000001 111.541 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -60.08 146.1 83.57 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.402 0.144 . . . . 50.200000000000003 111.326 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.41 164.63 86.17 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.091 -1.212 . . . . 54.119999999999997 113.24 0.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -118.16 155.12 31.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 72.209999999999994 111.084 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.7 ttmt -141.92 107.04 4.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.102 -0.499 . . . . 71.329999999999998 111.176 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 33' ' ' HIS . 11.9 t -106.38 129.42 59.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.755 -0.657 . . . . 72.120000000000005 109.53 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 67.91 21.39 8.99 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.745 0.783 . . . . 72.310000000000002 110.811 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.57 24.16 65.86 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.869 -0.682 . . . . 62.439999999999998 111.771 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.1 tpt180 -124.05 136.93 54.6 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.267 -0.642 . . . . 64.510000000000005 109.267 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.64 112.02 18.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.394 0.616 . . . . 51.119999999999997 109.626 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -107.38 150.84 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.011 -0.541 . . . . 70.299999999999997 110.974 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -112.86 95.46 33.73 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.221 -0.899 . . . . 74.239999999999995 110.828 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.51 127.8 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.95 1.767 . . . . 72.310000000000002 111.095 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -132.45 171.12 14.18 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 74.230000000000004 109.163 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -70.72 133.22 46.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.765 -0.457 . . . . 71.230000000000004 109.765 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -67.61 96.62 0.55 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.418 0.628 . . . . 65.239999999999995 109.666 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.418 HG22 ' OD1' ' A' ' 160' ' ' ASP . 16.1 t -56.55 135.48 20.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.347 -1.297 . . . . 64.349999999999994 111.643 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t -54.61 143.84 23.5 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.245 -0.889 . . . . 72.140000000000001 109.846 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -61.04 -18.45 57.86 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.43 0.456 . . . . 75.329999999999998 112.137 -173.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.97 -45.24 61.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.458 -0.337 . . . . 74.420000000000002 110.741 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.31 -31.56 24.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.688 -0.233 . . . . 74.040000000000006 111.066 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 21.7 p -76.48 4.05 9.97 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.062 0.458 . . . . 65.409999999999997 111.257 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -86.11 -10.09 55.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.619 0.723 . . . . 44.509999999999998 109.138 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -94.94 150.64 38.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.44 -0.8 . . . . 75.140000000000001 109.872 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.54 124.87 7.91 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.585 2.19 . . . . 75.120000000000005 112.511 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.46 30.27 11.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.162 -0.542 . . . . 62.439999999999998 112.23 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.98 -30.28 24.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.976 0.362 . . . . 72.109999999999999 111.976 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.18 8.49 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.654 0.264 . . . . 74.519999999999996 111.55 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.14 159.68 31.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.717 -0.475 . . . . 65.030000000000001 109.717 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 80.28 7.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.595 0.712 . . . . 74.049999999999997 110.481 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -108.78 118.46 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.075 -0.966 . . . . 72.230000000000004 109.46 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -105.53 21.34 17.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.612 . . . . 62.229999999999997 110.081 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -119.2 139.7 51.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 71.420000000000002 110.997 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 159' ' ' VAL . 6.7 pt -130.95 149.87 34.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.305 0.574 . . . . 65.439999999999998 111.386 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.8 t80 -94.78 133.33 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.716 -1.129 . . . . 72.129999999999995 109.906 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.58 109.55 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.063 -0.717 . . . . 73.140000000000001 109.063 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.84 159.72 21.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.569 -1.3 . . . . 72.140000000000001 113.755 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.07 6.45 53.84 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.697 -0.764 . . . . 74.310000000000002 112.406 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.0 pt -66.38 124.48 21.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.26 0.553 . . . . 75.140000000000001 109.877 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -91.45 -21.57 20.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.807 -0.633 . . . . 73.099999999999994 112.284 -169.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -142.16 -168.41 2.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.467 -0.197 . . . . 65.340000000000003 110.467 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.42 101.48 0.05 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 124.073 0.858 . . . . 73.540000000000006 111.364 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -109.63 124.23 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.63 -0.878 . . . . 64.239999999999995 108.63 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -113.01 -179.39 3.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.585 -0.734 . . . . 64.150000000000006 111.635 -169.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.18 -53.66 55.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.929 -1.032 . . . . 70.340000000000003 111.493 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.58 -28.24 69.5 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.079 0.237 . . . . 64.540000000000006 111.182 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -53.84 -62.65 1.52 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.184 0.516 . . . . 64.310000000000002 110.596 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.27 -26.68 28.42 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.113 -0.635 . . . . 64.239999999999995 111.532 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 2.0 tmm_? -67.29 -48.28 68.13 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 110.07 -0.345 . . . . 70.510000000000005 110.07 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.87 -29.76 70.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.99 0.424 . . . . 73.019999999999996 110.5 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 168' ' ' HIS . 88.2 t80 -77.39 -56.82 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.081 -0.509 . . . . 71.530000000000001 112.078 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -67.49 -21.99 65.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.414 0.524 . . . . 70.310000000000002 112.414 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.8 mt-10 -69.02 -19.96 64.13 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.527 0.195 . . . . 73.439999999999998 111.527 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.09 -30.05 64.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.985 0.421 . . . . 72.209999999999994 110.98 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.6 -30.89 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 73.140000000000001 111.637 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.23 -172.28 44.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.661 -0.781 . . . . 73.310000000000002 112.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -76.22 136.19 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.176 0.512 . . . . 73.129999999999995 111.681 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 152' ' ' THR . 90.8 mt -106.54 138.45 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 65.439999999999998 110.006 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.61 -46.98 8.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 74.239999999999995 111.038 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.56 154.93 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 75.109999999999999 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -114.62 128.54 71.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.124 0.487 . . . . 73.510000000000005 110.046 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 16.8 mt-10 -102.71 104.58 14.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.364 -0.834 . . . . 70.319999999999993 111.047 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.86 122.94 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.261 -0.644 . . . . 70.310000000000002 109.261 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.4 mmm -105.74 141.62 36.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.907 0.384 . . . . 72.019999999999996 110.192 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 74.049999999999997 110.87 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.684 0 CA-C-O 119.408 -0.662 . . . . 74.510000000000005 113.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -173.04 159.74 4.03 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.054 0.927 . . . . 75.450000000000003 110.509 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.55 175.69 9.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.436 -0.802 . . . . 61.030000000000001 109.182 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.6 m-85 -141.16 154.45 45.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.945 0.402 . . . . 63.219999999999999 110.321 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.67 132.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.318 0.58 . . . . 71.25 111.271 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 131' ' ' ILE . 26.0 m -101.49 126.6 48.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.344 -0.843 . . . . 75.209999999999994 110.883 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.53 158.03 16.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 71.420000000000002 111.45 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.3 -29.3 53.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.637 -0.71 . . . . 60.43 110.567 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -130.11 155.55 46.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 74.400000000000006 110.877 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -82.89 -26.5 31.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.540000000000006 110.351 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 31.9 t70 -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.224 -0.444 . . . . 70.120000000000005 110.673 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 m -68.7 -32.78 72.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 61.240000000000002 110.799 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -69.16 -39.86 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 72.319999999999993 109.783 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.491 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.1 t70 -69.5 -33.49 72.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.224 -0.898 . . . . 74.400000000000006 111.152 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 55.9 mttm -53.54 -38.88 64.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.917 0.865 . . . . 75.140000000000001 110.29 172.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 177' ' ' VAL . 33.8 mt -77.78 -45.32 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.405 -1.27 . . . . 72.140000000000001 113.011 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 160' ' ' ASP . 24.4 m -75.39 -4.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.198 0.523 . . . . 74.439999999999998 111.69 -172.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 161' ' ' LYS . 14.0 mt -58.35 -32.12 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 109.692 169.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.59 148.75 32.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.385 -0.825 . . . . 73.439999999999998 108.788 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.41 -37.04 13.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.0 0.429 . . . . 65.530000000000001 111.08 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.87 131.92 53.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.169 -0.468 . . . . 75.239999999999995 110.145 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 124' ' ' TYR . 87.7 m-70 -122.11 140.56 52.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.065 -0.516 . . . . 61.32 110.337 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 m -89.98 106.72 18.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.147 0.499 . . . . 75.409999999999997 111.402 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.22 130.15 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.83 . . . . 72.140000000000001 109.083 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t30 50.22 41.63 24.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.728 0.775 . . . . 74.329999999999998 111.641 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.55 69.54 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.616 -0.72 . . . . 41.130000000000003 113.347 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -126.52 131.55 51.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.79 0.295 . . . . 51.100000000000001 110.453 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.19 108.19 13.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.477 . . . . 72.219999999999999 109.711 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.71 146.81 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 109.755 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -86.4 131.9 34.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.841 0.353 . . . . 72.219999999999999 110.228 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 37.4 t -129.19 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.925 -0.58 . . . . 73.209999999999994 111.06 -173.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -157.78 171.6 20.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.593 -0.73 . . . . 73.129999999999995 111.232 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HD3' HG11 ' A' ' 163' ' ' VAL . 9.0 mmtm -61.22 122.76 15.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.854 -0.425 . . . . 75.530000000000001 109.854 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -104.82 111.67 24.5 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.339 0.59 . . . . 61.43 109.884 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 115.384 -0.825 . . . . 62.310000000000002 109.395 -178.099 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 110.838 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.39 137.36 74.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.655 -0.702 . . . . 74.25 110.202 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 10.5 Cg_endo -61.58 161.33 24.8 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.386 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.02 64.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.164 -0.471 . . . . 62.009999999999998 111.664 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.478 ' HG3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -64.95 -33.33 75.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.322 0.49 . . . . 64.319999999999993 112.322 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 28.8 mt -85.19 -14.58 46.44 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 122.095 -0.378 . . . . 73.510000000000005 110.838 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.602 ' HA ' HG21 ' A' ' 68' ' ' VAL . 33.2 ptt180 -117.75 0.8 12.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 111.363 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -96.71 148.08 23.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.667 0.746 . . . . 72.140000000000001 111.53 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.549 HD21 HG13 ' A' ' 68' ' ' VAL . 57.7 mt -118.74 144.3 46.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.712 -1.131 . . . . 70.439999999999998 110.424 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -96.47 117.02 30.03 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.326 -0.99 . . . . 74.420000000000002 108.326 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 60' ' ' VAL . 15.9 mm -96.88 110.82 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.779 -0.452 . . . . 75.040000000000006 109.779 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.43 155.0 16.73 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.507 -0.854 . . . . 54.43 111.578 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.57 45.25 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.774 -0.727 . . . . 53.030000000000001 113.244 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 25' ' ' THR . 94.3 mt -79.56 175.4 10.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.954 0.407 . . . . 45.329999999999998 110.279 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -88.5 166.73 13.99 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.487 -0.561 . . . . 63.439999999999998 109.487 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -75.93 -4.54 41.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.751 0.31 . . . . 71.439999999999998 110.846 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -122.68 14.74 10.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 74.340000000000003 111.096 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.591 HG21 HD22 ' A' ' 21' ' ' LEU . 94.7 m -79.85 124.33 28.55 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 61.039999999999999 110.821 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.1 p -99.78 165.68 11.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 75.040000000000006 110.346 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.1 p30 -76.67 -21.09 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.73 -0.388 . . . . 63.149999999999999 110.74 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.05 -27.7 30.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.208 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -80.36 -36.57 33.83 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.81 -0.441 . . . . 35.299999999999997 109.81 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 HG22 ' A' ' 45' ' ' VAL . 35.7 tp -61.87 -46.58 88.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.583 -0.735 . . . . 71.040000000000006 110.135 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 ttm-85 -56.21 -56.58 19.23 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 115.792 -0.64 . . . . 74.040000000000006 111.314 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.1 t -50.96 -36.2 37.67 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.853 0.721 . . . . 72.409999999999997 112.437 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -70.28 -54.6 11.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.671 -0.24 . . . . 72.310000000000002 111.302 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -78.5 -17.18 56.62 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.895 0.332 . . . . 75.209999999999994 111.895 -170.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.34 -25.65 49.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.454 0.539 . . . . 74.219999999999999 112.454 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.87 -26.36 68.29 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.255 0.465 . . . . 41.240000000000002 112.255 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -99.64 -19.72 16.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.727 0.269 . . . . 74.129999999999995 111.727 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.36 168.74 40.62 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.289 -0.958 . . . . 70.040000000000006 112.343 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -66.96 119.76 12.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.031 0.443 . . . . 72.299999999999997 112.008 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.61 133.54 35.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.76 -0.654 . . . . 70.510000000000005 110.524 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -107.43 -19.02 13.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.237 -0.892 . . . . 72.140000000000001 110.215 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.08 153.55 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.255 -0.646 . . . . 60.340000000000003 109.255 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 60' ' ' VAL . 11.1 t -165.33 131.43 2.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.993 -0.373 . . . . 71.329999999999998 109.993 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.51 128.47 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.509 0.671 . . . . 53.43 111.348 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 27' ' ' ASP . 87.4 t -88.14 133.85 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 63.219999999999999 108.63 171.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.454 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mmt -74.86 97.66 3.36 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.651 0.738 . . . . 63.140000000000001 110.1 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -99.45 152.32 20.12 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.702 -1.135 . . . . 74.409999999999997 109.49 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 37.2 t70 -70.04 127.89 92.03 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.422 -0.808 . . . . 75.239999999999995 110.619 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.56 -19.3 64.86 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.189 1.926 . . . . 62.329999999999998 113.111 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.505 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 27.6 m-80 -84.76 -56.4 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.785 0.291 . . . . 71.450000000000003 111.785 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -105.48 -8.75 17.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.986 0.422 . . . . 64.140000000000001 111.849 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp 64.16 40.63 6.75 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.577 0.751 . . . . 65.230000000000004 111.626 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -113.83 156.7 23.44 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.952 -0.758 . . . . 74.010000000000005 108.952 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m -75.69 131.68 40.04 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.917 -0.313 . . . . 72.230000000000004 110.358 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -85.66 5.78 30.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 63.5 111.349 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.08 60.07 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.617 -0.801 . . . . 65.530000000000001 114.204 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.454 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.4 p90 -158.99 155.31 27.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.82 0.81 . . . . 74.329999999999998 110.343 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.51 -163.13 14.57 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.701 -0.56 . . . . 63.329999999999998 111.701 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.85 148.81 37.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.062 0.431 . . . . 75.030000000000001 110.224 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 18' ' ' ILE . 8.5 m -128.23 128.53 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.826 -0.624 . . . . 72.310000000000002 109.345 171.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.68 118.36 36.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.812 0.339 . . . . 74.349999999999994 110.272 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -85.74 161.67 19.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.902 -0.59 . . . . 65.209999999999994 109.962 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.05 -44.02 64.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.9 -0.591 . . . . 74.099999999999994 110.401 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -120.81 149.22 42.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.916 -0.584 . . . . 64.510000000000005 110.845 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.9 p -62.88 -37.38 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.565 -0.288 . . . . 70.219999999999999 111.044 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.45 -41.74 85.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.588 0.588 . . . . 72.219999999999999 112.588 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.89 -29.24 70.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.019 0.438 . . . . 73.109999999999999 110.78 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 14' ' ' ARG . 38.9 t -63.14 -49.41 83.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.592 -0.731 . . . . 74.030000000000001 111.087 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.22 -40.69 94.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.200000000000003 111.302 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.96 -38.66 57.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 112.295 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.36 58.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.806 0.336 . . . . 64.040000000000006 110.612 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.12 87.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 71.439999999999998 111.068 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -29.16 66.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.041 -0.527 . . . . 73.129999999999995 111.015 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.71 -9.29 58.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.075 0.768 . . . . 63.420000000000002 113.075 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -54.39 146.61 31.98 Favored Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.169 0.433 . . . . 71.439999999999998 112.169 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.4 168.98 72.66 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.312 -1.12 . . . . 75.140000000000001 113.385 1.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -123.54 161.19 25.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.532 -0.758 . . . . 71.129999999999995 110.39 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.5 ttmt -137.21 112.64 9.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.826 0.346 . . . . 63.210000000000001 111.35 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.14 126.98 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.973 -0.558 . . . . 51.240000000000002 109.936 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.53 26.9 9.82 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.692 0.62 . . . . 72.230000000000004 111.915 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.88 23.36 66.91 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.951 -0.643 . . . . 34.43 112.191 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 tpt180 -126.29 135.43 51.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.107 -0.331 . . . . 73.140000000000001 110.107 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.66 111.71 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.123 -0.695 . . . . 75.310000000000002 109.123 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.3 m -107.7 152.49 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 74.099999999999994 111.853 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.26 94.42 30.93 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.762 -1.108 . . . . 74.340000000000003 111.402 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -72.19 127.96 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.678 1.585 . . . . 53.109999999999999 110.463 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -131.69 168.88 16.99 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 75.140000000000001 109.324 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 10.0 tpp180 -73.25 130.51 40.37 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.977 -0.289 . . . . 64.420000000000002 110.562 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.68 93.58 0.73 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.073 0.463 . . . . 74.329999999999998 110.3 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.24 156.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.369 -0.832 . . . . 51.310000000000002 110.546 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -55.3 154.16 6.31 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.098 0.559 . . . . 74.340000000000003 111.808 -177.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -58.16 -40.13 80.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.038 -0.528 . . . . 72.099999999999994 111.883 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.92 -50.59 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 50.530000000000001 110.651 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -70.74 -29.29 65.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.632 -0.713 . . . . 65.540000000000006 111.409 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -67.18 -17.55 64.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.403 -0.362 . . . . 75.239999999999995 111.295 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -82.22 -12.47 58.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.953 0.406 . . . . 64.129999999999995 110.837 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.24 151.23 78.12 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.483 -0.326 . . . . 72.420000000000002 110.379 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.83 117.16 4.06 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.101 2.534 . . . . 72.430000000000007 112.717 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.63 43.16 69.26 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.958 -0.564 . . . . 44.530000000000001 112.812 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.05 -34.6 73.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.879 0.371 . . . . 35.409999999999997 111.418 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -99.4 19.71 15.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 111.677 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.0 154.38 35.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 74.040000000000006 109.609 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 m -74.38 86.85 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.706 0.765 . . . . 55.350000000000001 110.445 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.0 t -114.89 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 74.319999999999993 109.343 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -104.19 16.5 26.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.11 0.414 . . . . 72.319999999999993 111.101 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -117.16 139.96 50.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.594 -0.276 . . . . 64.230000000000004 111.022 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 159' ' ' VAL . 4.3 pt -123.55 147.48 27.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.263 0.554 . . . . 53.130000000000003 111.111 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.2 t80 -97.68 131.43 44.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.779 -1.1 . . . . 72.219999999999999 109.628 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.04 110.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.868 -0.789 . . . . 64.329999999999998 108.868 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.88 148.02 19.27 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.998 -1.096 . . . . 54.219999999999999 112.31 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.61 6.15 29.07 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.207 -0.997 . . . . 61.539999999999999 112.217 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 173' ' ' HIS . 13.6 pt -76.54 103.99 4.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.556 0.693 . . . . 74.099999999999994 110.468 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.19 -24.48 34.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 62.420000000000002 110.996 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.45 171.37 7.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.863 0.364 . . . . 71.439999999999998 110.558 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.99 125.45 26.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 71.510000000000005 110.057 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 m -124.12 139.27 54.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.15 0.5 . . . . 63.399999999999999 110.323 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -112.88 174.69 5.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.591 -0.731 . . . . 72.25 111.796 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.03 -57.24 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.847 -1.07 . . . . 71.549999999999997 112.132 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -64.68 -23.79 67.37 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 123.07 0.231 . . . . 75.219999999999999 111.066 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -57.08 -58.99 5.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.97 0.415 . . . . 64.439999999999998 110.558 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 134' ' ' ILE . 4.6 pp -83.67 -25.3 30.82 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.674 -0.81 . . . . 73.209999999999994 111.549 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.8 -51.5 58.55 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.737 -0.468 . . . . 54.100000000000001 109.737 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.78 -32.99 73.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 74.439999999999998 110.413 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD2' HG22 ' A' ' 170' ' ' VAL . 92.6 t80 -73.06 -57.81 3.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.982 -0.554 . . . . 65.25 112.187 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -68.33 -22.3 64.7 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.563 0.579 . . . . 64.420000000000002 112.563 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.97 -24.93 67.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.827 0.346 . . . . 74.040000000000006 111.468 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -55.78 -26.04 44.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.748 -0.66 . . . . 71.409999999999997 111.83 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -91.82 -20.83 21.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.162 0.43 . . . . 75.430000000000007 112.162 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.01 -172.48 42.12 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.416 -0.897 . . . . 63.340000000000003 113.396 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -76.35 131.99 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 74.310000000000002 111.248 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 152' ' ' THR . 71.8 mt -103.79 139.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.735 -0.666 . . . . 73.540000000000006 109.936 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.76 -48.65 6.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.825 0.345 . . . . 75.340000000000003 110.944 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -157.38 157.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.261 -0.427 . . . . 65.519999999999996 109.961 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 121' ' ' LEU . 3.2 mp -115.52 130.29 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.551 -0.537 . . . . 71.019999999999996 109.551 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.2 mt-10 -103.69 103.31 13.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.213 -0.449 . . . . 62.530000000000001 110.946 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.2 mm -91.38 125.43 44.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.461 -0.57 . . . . 70.310000000000002 109.461 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.9 mmm -105.91 133.25 50.93 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.083 -0.71 . . . . 71.230000000000004 109.083 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 62.539999999999999 112.025 -174.339 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 119.736 -0.48 . . . . 75.109999999999999 113.507 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -172.85 157.46 3.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.633 0.717 . . . . 75.409999999999997 109.526 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.0 172.3 13.24 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.63 . . . . 75.319999999999993 109.694 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 75.8 m-85 -138.46 155.67 48.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.732 -0.667 . . . . 75.219999999999999 109.745 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.41 136.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.301 0.572 . . . . 71.400000000000006 110.809 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 131' ' ' ILE . 98.9 m -100.52 125.05 46.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.02 -0.991 . . . . 74.310000000000002 110.944 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -100.61 157.67 16.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.875 0.369 . . . . 63.240000000000002 110.59 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.28 -30.29 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.766 -0.652 . . . . 52.140000000000001 110.312 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -130.97 155.34 46.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 74.400000000000006 110.823 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -80.12 -26.34 39.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 72.010000000000005 110.514 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 17.0 t70 -63.01 -39.16 93.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 111.169 -173.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 -31.42 72.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.375 -0.375 . . . . 73.200000000000003 110.781 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 107' ' ' ILE . 3.2 t -69.81 -45.33 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.289 -0.414 . . . . 61.420000000000002 110.195 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.597 ' HA ' HG22 ' A' ' 163' ' ' VAL . 20.1 m-20 -71.04 -23.96 62.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.845 -0.616 . . . . 73.209999999999994 111.586 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 88.1 mttt -63.78 -40.95 97.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.140000000000001 110.095 170.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.37 -42.54 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.695 -1.139 . . . . 64.400000000000006 112.122 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 160' ' ' ASP . 13.4 m -73.81 -12.25 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 53.450000000000003 110.789 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.451 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 6.8 mt -58.55 -29.37 38.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 72.239999999999995 109.829 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.489 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.3 mt-30 -112.44 98.7 7.45 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.613 -0.884 . . . . 72.200000000000003 108.613 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HB2' ' HZ2' ' A' ' 166' ' ' LYS . 1.2 ttmp? -53.37 -37.21 62.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.424 0.898 . . . . 63.039999999999999 113.424 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -121.3 131.67 54.34 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.6 -0.44 . . . . 70.25 110.576 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.7 m-70 -124.85 158.09 34.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 74.019999999999996 109.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.2 m -102.82 103.38 13.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.081 0.467 . . . . 72.450000000000003 110.379 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 124' ' ' TYR . 3.7 t -118.53 140.5 41.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.71 -0.677 . . . . 64.329999999999998 109.177 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.5 t30 56.77 31.02 18.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.966 0.889 . . . . 75.420000000000002 111.009 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.85 16.96 74.88 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.341 -0.845 . . . . 51.210000000000001 113.303 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 85.8 t60 -130.7 138.67 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.767 0.283 . . . . 72.510000000000005 110.356 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.68 110.9 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 73.439999999999998 110.535 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.81 158.07 29.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.066 -0.97 . . . . 64.439999999999998 111.102 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.56 133.1 34.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.123 -0.49 . . . . 54.030000000000001 110.187 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.8 t -128.83 132.12 67.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.345 -0.843 . . . . 75.409999999999997 110.057 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -155.4 175.98 13.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 75.150000000000006 111.15 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -62.14 122.9 16.73 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.82 -0.437 . . . . 75.540000000000006 109.82 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 108' ' ' PHE . . . -107.21 115.13 29.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.084 0.469 . . . . 55.240000000000002 110.719 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 108.392 -0.966 . . . . 71.010000000000005 108.392 173.558 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 N-CA-C 112.287 0.477 . . . . 73.120000000000005 112.287 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.91 150.27 38.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 C-N-CA 120.658 -0.417 . . . . 73.420000000000002 110.175 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 36.1 Cg_endo -70.65 167.32 25.94 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.254 1.969 . . . . 64.340000000000003 112.076 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -37.06 68.75 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.006 -0.543 . . . . 64.409999999999997 112.283 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.43 -16.41 63.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.044 0.387 . . . . 72.439999999999998 112.044 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.6 mp -96.01 -14.63 22.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.742 0.306 . . . . 53.509999999999998 111.112 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.582 ' HA ' HG21 ' A' ' 68' ' ' VAL . 16.5 ptt180 -118.84 2.22 11.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.044 0.45 . . . . 72.439999999999998 110.767 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.98 149.63 22.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.751 0.786 . . . . 62.130000000000003 111.603 174.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.721 HD21 HG13 ' A' ' 68' ' ' VAL . 61.0 mt -117.13 146.45 43.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.552 -1.203 . . . . 62.329999999999998 110.46 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -99.21 121.62 41.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.65 -0.87 . . . . 74.409999999999997 108.65 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.92 112.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 110.052 -0.351 . . . . 51.210000000000001 110.052 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.77 150.32 18.31 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.929 -0.653 . . . . 71.239999999999995 111.703 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 45.95 42.5 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.767 -0.73 . . . . 65.010000000000005 113.541 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 HG21 ' A' ' 25' ' ' THR . 77.9 mt -81.08 163.43 23.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.704 -0.48 . . . . 52.450000000000003 109.704 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 p -80.97 169.21 17.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.327 -0.62 . . . . 71.430000000000007 109.327 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -72.33 -11.52 60.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 72.540000000000006 110.316 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.89 15.26 17.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 71.329999999999998 111.314 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.569 HG21 HD22 ' A' ' 21' ' ' LEU . 53.1 m -82.41 126.9 32.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.152 0.501 . . . . 71.519999999999996 110.942 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 164.09 12.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 63.439999999999998 110.325 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.6 p30 -74.06 -25.79 60.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.184 -0.206 . . . . 54.43 110.879 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.67 -37.47 82.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 73.329999999999998 110.493 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 m -80.23 -37.25 33.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 61.530000000000001 110.943 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 45' ' ' VAL . 32.3 tp -63.0 -43.56 98.44 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.458 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 31' ' ' ARG . 14.6 ttm180 -60.86 -55.49 32.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.886 -0.413 . . . . 65.219999999999999 109.886 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.7 m -47.23 -39.52 14.36 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 124.313 1.008 . . . . 73.230000000000004 113.067 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.403 ' ND1' HG22 ' A' ' 79' ' ' VAL . 8.2 t-80 -70.68 -61.27 1.83 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 70.109999999999999 111.583 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -69.91 -21.82 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 72.450000000000003 112.201 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 28.9 tt0 -63.74 -16.88 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.813 0.445 . . . . 73.209999999999994 111.857 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.27 -26.62 68.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.563 0.221 . . . . 73.439999999999998 111.081 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -99.56 -19.98 16.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.205 0.446 . . . . 61.409999999999997 112.205 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -175.53 168.7 41.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.218 -0.992 . . . . 74.129999999999995 112.707 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.5 m -65.98 119.14 10.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 53.350000000000001 111.99 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.72 122.24 34.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.706 0.765 . . . . 64.230000000000004 111.215 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -89.72 -25.77 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.154 -1.385 . . . . 73.099999999999994 110.116 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -152.3 153.34 33.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.394 -0.821 . . . . 43.140000000000001 109.642 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -161.06 130.24 4.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.748 -0.464 . . . . 63.32 109.748 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.03 123.8 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.481 0.658 . . . . 64.030000000000001 110.516 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 30' ' ' LEU . 92.0 t -84.39 135.06 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.224 -1.028 . . . . 75.329999999999998 108.224 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.459 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -74.17 95.35 2.58 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.782 0.801 . . . . 65.140000000000001 109.641 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -104.91 164.57 11.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.102 -1.408 . . . . 71.540000000000006 110.257 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.46 128.46 87.23 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.936 -0.765 . . . . 62.149999999999999 108.936 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.78 -18.73 65.23 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.181 1.921 . . . . 70.030000000000001 113.377 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -86.39 -55.69 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 74.099999999999994 110.89 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -99.63 -14.89 18.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.008 -0.996 . . . . 75.409999999999997 112.331 -170.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm 65.76 26.8 11.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.924 0.89 . . . . 63.340000000000003 111.367 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -102.54 153.32 20.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.552 -0.536 . . . . 72.519999999999996 109.552 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.0 137.72 51.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 73.519999999999996 112.145 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -88.83 4.89 46.14 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.463 -0.79 . . . . 73.129999999999995 110.441 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.08 17.7 58.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.057 -0.592 . . . . 73.129999999999995 114.385 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.4 p90 -159.1 155.68 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.607 0.703 . . . . 52.109999999999999 110.155 174.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.45 20.22 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.825 -0.51 . . . . 35.310000000000002 111.825 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.19 149.76 40.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.032 0.416 . . . . 63.219999999999999 110.852 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.9 127.0 65.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.614 -0.721 . . . . 70.109999999999999 109.496 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 m -104.34 121.37 43.22 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.292 -0.255 . . . . 61.439999999999998 110.654 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.9 178.28 7.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.176 -0.466 . . . . 73.049999999999997 111.084 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.06 -28.81 18.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.683 -0.69 . . . . 41.119999999999997 110.796 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -144.05 147.69 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 74.219999999999999 110.698 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.55 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -57.54 -35.38 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 122.863 0.465 . . . . 61.100000000000001 111.913 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.09 -39.56 63.45 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.15 0.796 . . . . 72.230000000000004 113.15 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -70.78 -27.12 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 71.329999999999998 110.303 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.721 HG13 HD21 ' A' ' 16' ' ' LEU . 19.7 t -66.61 -47.3 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.334 -0.848 . . . . 72.409999999999997 110.08 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.97 -46.07 85.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 75.409999999999997 110.702 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.53 -41.25 53.55 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.466 0.543 . . . . 63.119999999999997 112.466 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.48 -32.23 58.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 55.020000000000003 110.96 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.3 mmt -70.74 -36.21 73.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 44.310000000000002 110.107 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -12.6 59.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.481 -0.781 . . . . 72.200000000000003 110.512 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.28 -11.35 38.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.731 -0.668 . . . . 64.420000000000002 110.269 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp85 -57.87 142.1 79.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.241 -0.891 . . . . 74.239999999999995 110.402 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 86.7 Cg_endo -79.95 169.0 71.5 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.694 -0.961 . . . . 75.099999999999994 114.363 4.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.463 ' CD2' ' HG3' ' A' ' 86' ' ' PRO . 69.0 m-70 -129.0 158.54 38.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.879 . . . . 61.210000000000001 110.447 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -137.43 106.9 6.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.071 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.403 HG22 ' ND1' ' A' ' 33' ' ' HIS . 15.5 t -107.95 130.9 59.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.242 -0.435 . . . . 72.040000000000006 109.901 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 65.05 29.31 12.19 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.667 0.604 . . . . 73.049999999999997 111.674 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.44 26.08 72.73 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.936 -0.575 . . . . 73.140000000000001 112.117 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.8 tpt180 -129.0 139.11 52.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 65.140000000000001 109.841 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.25 107.67 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.584 -0.525 . . . . 70.230000000000004 109.584 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.48 151.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.259 0.552 . . . . 53.329999999999998 110.824 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -112.03 94.43 25.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 70.549999999999997 111.087 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HG3' ' CD2' ' A' ' 77' ' ' HIS . 38.2 Cg_endo -74.31 132.28 16.2 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.069 1.846 . . . . 74.530000000000001 111.385 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -137.12 174.24 10.83 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.291 -1.003 . . . . 73.439999999999998 108.291 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.0 tmm_? -76.77 131.04 38.49 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.653 -0.869 . . . . 70.209999999999994 108.653 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.09 96.36 0.14 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.043 0.449 . . . . 75.420000000000002 111.755 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 100' ' ' ALA . 40.3 t -69.07 137.23 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.113 -0.948 . . . . 73.239999999999995 110.497 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 t -86.88 -176.56 5.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.732 -0.667 . . . . 73.420000000000002 109.789 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -68.63 -41.6 79.23 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.553 0.946 . . . . 64.230000000000004 113.553 -167.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.71 -35.4 52.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.729 -0.389 . . . . 73.510000000000005 111.198 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -14.3 59.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.771 0.319 . . . . 63.219999999999999 110.363 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 30.5 t -80.57 -20.09 44.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 60.240000000000002 109.824 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -71.33 -20.37 62.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.811 -0.632 . . . . 75.420000000000002 109.797 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.22 147.67 88.07 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.661 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.14 128.61 17.86 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.817 2.345 . . . . 73.530000000000001 112.098 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.4 39.31 22.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.019 -0.61 . . . . 74.040000000000006 111.993 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -66.03 -54.3 27.72 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.876 0.324 . . . . 75.140000000000001 111.876 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -107.66 11.14 28.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.044 0.449 . . . . 75.519999999999996 110.621 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 151.58 25.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.583 -0.525 . . . . 74.450000000000003 109.583 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 m -72.52 105.84 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.735 . . . . 73.120000000000005 110.359 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HB ' ' CE ' ' A' ' 179' ' ' LYS . 61.4 t -132.21 116.27 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.867 -1.061 . . . . 72.430000000000007 109.43 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' C ' HG21 ' A' ' 159' ' ' VAL . 75.3 mttt -102.6 13.6 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.417 -0.513 . . . . 71.349999999999994 110.67 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.38 139.66 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.315 -0.402 . . . . 71.219999999999999 110.792 177.149 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -120.97 149.16 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.261 0.553 . . . . 64.140000000000001 111.388 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.3 t80 -98.76 132.21 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.774 -1.103 . . . . 74.150000000000006 109.441 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 111.08 28.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.217 -0.66 . . . . 71.120000000000005 109.217 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -132.88 148.41 19.27 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 119.907 -1.139 . . . . 31.010000000000002 112.601 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 6.72 36.7 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.347 -0.93 . . . . 60.32 112.948 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.76 105.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.522 0.677 . . . . 71.010000000000005 110.526 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -74.97 -53.44 8.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.496 -0.775 . . . . 62.340000000000003 110.62 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -73.09 155.45 39.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.416 -0.811 . . . . 72.120000000000005 109.805 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.53 134.73 55.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 109.739 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -116.24 145.26 43.27 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.021 -0.536 . . . . 64.430000000000007 109.899 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.86 158.63 17.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.053 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.12 -44.48 79.18 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 123.93 0.769 . . . . 75.140000000000001 110.289 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -56.52 -35.68 68.32 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.409 0.284 . . . . 74.109999999999999 111.603 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -62.66 -59.92 4.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.331 -0.395 . . . . 73.510000000000005 110.841 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 134' ' ' ILE . 1.9 pt? -84.29 -21.65 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.253 -0.579 . . . . 74.319999999999993 111.138 -173.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 7.2 tmm_? -66.36 -55.67 14.78 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 110.138 -0.319 . . . . 75.420000000000002 110.138 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -61.39 -26.41 67.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.361 0.6 . . . . 64.140000000000001 110.481 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -75.8 -58.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.39 -0.823 . . . . 75.510000000000005 112.252 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.3 m-85 -69.08 -21.84 64.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 111.735 0.272 . . . . 71.319999999999993 111.735 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mm-40 -64.55 -24.73 67.7 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.917 0.389 . . . . 61.009999999999998 111.076 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -58.69 -27.59 64.97 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.921 -0.582 . . . . 63.439999999999998 111.636 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -87.24 -32.19 19.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 74.230000000000004 112.009 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.41 -174.71 47.17 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.828 -0.701 . . . . 73.120000000000005 113.001 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -74.03 126.62 30.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.302 0.572 . . . . 63.420000000000002 112.184 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 63.3 mt -97.36 139.42 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.118 -0.946 . . . . 65.340000000000003 109.72 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -90.34 -48.62 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 70.099999999999994 110.731 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.52 154.48 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 109.777 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.401 HG21 HD21 ' A' ' 121' ' ' LEU . 3.7 mp -112.63 125.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.376 -0.601 . . . . 63.32 109.376 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 34.3 mt-10 -100.43 103.91 15.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.666 -0.697 . . . . 55.310000000000002 110.7 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.3 mm -95.63 129.47 45.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.775 -0.454 . . . . 73.219999999999999 109.775 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.6 mtp -110.95 146.16 37.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.746 -0.835 . . . . 61.399999999999999 108.746 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 74.530000000000001 112.222 -175.657 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.895 0 CA-C-O 119.918 -0.379 . . . . 75.030000000000001 112.751 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -169.48 148.33 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.688 -0.486 . . . . 75.239999999999995 109.688 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.98 172.76 12.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.844 -0.616 . . . . 74.329999999999998 109.516 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 55.1 m-85 -140.89 151.72 44.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.012 -0.54 . . . . 70.099999999999994 110.454 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 125' ' ' PHE . 94.9 t -134.13 129.52 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.587 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 131' ' ' ILE . 64.0 m -99.85 123.23 43.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 70.409999999999997 110.206 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -104.06 159.69 15.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.732 0.301 . . . . 73.109999999999999 110.381 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.94 -24.09 48.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.33 0.586 . . . . 64.349999999999994 110.761 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 4.4 t70 -138.41 156.67 47.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.726 . . . . 72.439999999999998 110.148 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -79.79 -21.41 44.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.415 -0.357 . . . . 74.239999999999995 110.038 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.4 p-10 -58.91 -39.61 82.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.443 -0.799 . . . . 72.530000000000001 111.026 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -76.32 -29.35 57.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.073 -0.512 . . . . 60.549999999999997 110.532 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -69.58 -40.22 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.59 -0.522 . . . . 73.299999999999997 109.59 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -72.05 -24.3 61.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.348 -0.842 . . . . 74.150000000000006 111.453 -178.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 72.8 mttt -68.21 -34.12 75.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 74.549999999999997 110.234 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.86 -40.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.181 -0.918 . . . . 72.420000000000002 112.281 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 159' ' ' VAL . 12.2 m -73.0 -6.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.15 0.5 . . . . 74.129999999999995 111.362 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 13' ' ' LEU . 54.8 mt -54.74 -38.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.079 -0.964 . . . . 72.019999999999996 110.171 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -107.55 114.2 28.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.386 -0.825 . . . . 75.450000000000003 109.473 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -53.85 -41.5 67.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.402 -0.817 . . . . 72.209999999999994 112.187 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.89 138.61 54.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.243 -0.435 . . . . 75.319999999999993 110.859 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -124.25 152.89 42.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.631 -0.713 . . . . 74.150000000000006 109.218 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -122.84 113.28 18.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.324 0.583 . . . . 74.140000000000001 110.035 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.59 113.96 41.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.507 -0.769 . . . . 74.450000000000003 109.92 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 70.44 24.1 4.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.128 0.489 . . . . 53.450000000000003 110.789 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.2 78.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.861 -0.685 . . . . 72.329999999999998 112.448 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.27 111.08 21.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.856 -0.424 . . . . 75.120000000000005 109.856 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.4 131.68 34.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.313 -0.625 . . . . 61.350000000000001 109.313 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 p -143.99 149.27 36.47 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.263 -0.426 . . . . 64.049999999999997 111.436 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.52 130.57 35.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.632 -0.877 . . . . 74.099999999999994 108.632 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.7 t -127.74 137.21 58.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.857 -0.611 . . . . 74.510000000000005 110.501 -175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -161.99 177.97 9.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.264 -0.88 . . . . 73.450000000000003 110.972 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.45 ' CE ' ' HB ' ' A' ' 104' ' ' VAL . 7.0 mmmm -67.74 122.03 17.23 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.671 -0.492 . . . . 71.430000000000007 109.671 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -93.73 114.9 27.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.895 0.378 . . . . 42.219999999999999 110.445 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 110.831 179.029 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.047 -1.094 . . . . 61.210000000000001 108.047 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 1.6 mp0 -61.55 131.44 92.64 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 113.649 -1.614 . . . . 62.229999999999997 111.704 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 16.4 Cg_endo -59.95 168.43 5.85 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.703 2.935 . . . . 72.230000000000004 112.99 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.45 59.85 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.617 -0.719 . . . . 65.519999999999996 111.92 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.14 0.422 . . . . 71.209999999999994 112.14 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 13.3 mt -85.29 -20.91 29.32 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 122.094 -0.379 . . . . 61.240000000000002 110.671 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 ptt-85 -108.7 -2.9 18.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.863 0.363 . . . . 75.409999999999997 111.027 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.8 ttpt -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.599 0.714 . . . . 74.430000000000007 111.944 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 HG13 ' A' ' 68' ' ' VAL . 69.7 mt -118.97 145.28 45.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.801 -1.09 . . . . 65.409999999999997 110.034 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -97.09 123.57 40.88 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.398 -0.964 . . . . 74.209999999999994 108.398 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 60' ' ' VAL . 18.6 mm -103.02 110.22 29.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.83 -0.433 . . . . 62.409999999999997 109.83 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.69 150.48 17.95 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.046 -0.597 . . . . 63.119999999999997 111.794 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.75 52.92 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.846 -0.692 . . . . 53.43 113.168 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 25' ' ' THR . 68.8 mt -78.74 176.8 9.19 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.283 -0.636 . . . . 73.340000000000003 109.283 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p -83.5 167.64 17.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.152 -1.055 . . . . 75.450000000000003 108.152 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -79.51 0.42 29.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.933 0.396 . . . . 74.200000000000003 110.639 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -125.38 15.59 8.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.837 -0.62 . . . . 74.209999999999994 111.568 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 21' ' ' LEU . 32.4 m -74.11 130.62 40.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.662 0.267 . . . . 65.519999999999996 111.072 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.3 p -104.77 163.67 12.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 74.519999999999996 110.293 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -28.31 64.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.405 -0.361 . . . . 70.549999999999997 111.193 -176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.93 -35.77 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.513 0.197 . . . . 72.129999999999995 111.244 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -75.94 -36.61 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.665 -0.243 . . . . 72.209999999999994 110.687 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.9 -48.25 77.39 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.704 -0.48 . . . . 74.450000000000003 109.704 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.3 ttm180 -54.96 -60.86 2.78 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 115.379 -0.828 . . . . 73.019999999999996 111.951 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -50.23 -31.66 14.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.738 0.648 . . . . 51.450000000000003 112.386 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -73.14 -60.72 2.1 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.201 -0.2 . . . . 64.409999999999997 110.817 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.36 -22.13 64.68 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.109 0.411 . . . . 74.329999999999998 112.109 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.47 -25.51 51.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.312 0.645 . . . . 60.439999999999998 112.078 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.5 -27.03 65.79 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.236 0.458 . . . . 62.520000000000003 112.236 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -99.05 -19.68 17.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.582 0.215 . . . . 72.530000000000001 111.582 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.0 28.09 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.851 -0.69 . . . . 63.439999999999998 111.771 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -63.82 119.49 10.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.441 . . . . 51.149999999999999 111.329 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.7 136.24 33.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.589 -0.732 . . . . 70.319999999999993 110.487 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 p -103.97 -21.79 13.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.42 -0.809 . . . . 74.230000000000004 110.194 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -150.84 150.11 30.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 75.340000000000003 109.674 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -159.9 130.27 5.57 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.713 -0.477 . . . . 75.430000000000007 109.713 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.76 129.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.383 0.611 . . . . 72.200000000000003 111.083 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -87.77 128.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.79 -0.819 . . . . 54.450000000000003 108.79 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -72.9 98.45 2.47 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.669 0.747 . . . . 63.32 110.278 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -103.37 161.24 14.0 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.385 -1.279 . . . . 54.43 110.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.52 125.2 91.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.749 -1.114 . . . . 61.119999999999997 109.793 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -65.45 -20.71 60.99 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.202 1.935 . . . . 74.519999999999996 112.575 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -83.83 -55.43 4.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 74.239999999999995 111.63 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 -8.67 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 64.420000000000002 111.85 -173.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 62.19 38.23 13.72 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 111.447 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -110.09 157.48 19.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.547 -0.909 . . . . 50.240000000000002 108.547 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -73.13 137.89 45.44 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.796 -0.362 . . . . 74.010000000000005 110.262 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -83.4 1.27 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.420000000000002 110.204 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.31 18.3 59.23 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.99 -0.624 . . . . 74.409999999999997 113.871 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -159.57 158.4 31.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.059 0.929 . . . . 74.430000000000007 110.614 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.16 -163.07 14.97 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.34 -0.704 . . . . 71.120000000000005 111.34 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.31 149.83 38.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.235 0.518 . . . . 71.510000000000005 110.702 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 m -129.67 122.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.879 -0.6 . . . . 75.310000000000002 109.844 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.1 m -98.9 121.93 41.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.624 -0.262 . . . . 74.409999999999997 110.386 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -87.18 163.4 16.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 71.030000000000001 110.704 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.15 70.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.637 -0.71 . . . . 52.340000000000003 110.144 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -124.38 144.3 50.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.427 -0.806 . . . . 74.409999999999997 110.384 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -63.17 -37.09 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.258 -0.428 . . . . 70.030000000000001 110.824 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.02 -36.93 68.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.552 0.575 . . . . 73.129999999999995 112.552 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.41 -26.81 65.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.104 0.478 . . . . 74.209999999999994 110.704 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 37.7 t -64.62 -45.46 95.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.538 -0.756 . . . . 74.099999999999994 110.468 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -52.96 -48.23 67.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.699 -0.682 . . . . 65.400000000000006 111.989 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -58.12 -37.38 74.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.607 0.595 . . . . 73.400000000000006 112.607 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.84 -34.83 78.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.396 0.617 . . . . 72.120000000000005 110.166 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -38.23 77.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 74.430000000000007 110.877 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.644 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.0 p30 -76.99 -10.46 59.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.894 0.378 . . . . 75.209999999999994 111.335 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.06 -11.59 43.66 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 112.438 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.42 148.78 8.51 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 113.284 0.846 . . . . 63.329999999999998 113.284 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.94 160.87 79.1 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.692 -1.378 . . . . 75.530000000000001 112.438 -2.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -110.4 151.53 27.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 63.200000000000003 110.152 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.1 ttmt -136.76 104.36 5.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.044 0.45 . . . . 74.540000000000006 111.131 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.8 140.31 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.695 -0.684 . . . . 32.509999999999998 109.685 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 66.25 21.68 11.02 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.573 0.749 . . . . 74.420000000000002 110.3 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 25.4 69.1 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.748 -0.66 . . . . 75.530000000000001 112.222 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 tpt180 -129.4 136.64 50.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.374 -0.232 . . . . 72.519999999999996 110.374 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -83.79 111.05 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.655 0.74 . . . . 72.200000000000003 109.992 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 m -102.84 155.34 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 112.183 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -111.53 96.62 32.92 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.469 -1.241 . . . . 65.409999999999997 111.006 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.58 130.1 7.68 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.35 2.033 . . . . 75.319999999999993 111.073 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HZ2' HG23 ' A' ' 103' ' ' THR . 30.0 mttm -133.8 170.26 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.849 -0.797 . . . . 63.119999999999997 108.849 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.547 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tpp180 -70.38 137.76 50.77 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.507 -0.553 . . . . 72.299999999999997 109.507 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 97.15 0.45 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.292 0.568 . . . . 52.32 110.348 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' OD1' ' A' ' 160' ' ' ASP . 6.6 t -55.26 136.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.433 -1.258 . . . . 64.120000000000005 111.786 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.432 ' HB2' HG12 ' A' ' 164' ' ' ILE . 2.4 t -57.84 147.26 29.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.435 -0.802 . . . . 74.129999999999995 109.904 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -52.52 -40.48 62.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.402 0.681 . . . . 73.409999999999997 112.591 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.03 -39.29 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.142 0.423 . . . . 71.349999999999994 112.142 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.28 -32.31 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.03 -0.359 . . . . 74.040000000000006 110.03 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -69.57 -12.32 61.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.941 -0.572 . . . . 72.209999999999994 110.609 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -81.17 -7.84 59.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 74.439999999999998 110.056 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -94.62 151.11 38.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 74.420000000000002 110.299 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 122.46 8.19 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.557 2.171 . . . . 74.219999999999999 111.974 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.56 19.5 27.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.586 -0.816 . . . . 73.510000000000005 112.578 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.49 54.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.673 0.249 . . . . 74.209999999999994 111.673 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -98.96 13.84 31.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.802 0.334 . . . . 71.239999999999995 111.405 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.38 171.1 13.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.851 -0.425 . . . . 73.299999999999997 109.851 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' HZ2' ' A' ' 87' ' ' LYS . 2.0 m -89.01 78.18 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.423 0.63 . . . . 63.509999999999998 110.778 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.01 121.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.933 -1.03 . . . . 74.329999999999998 109.341 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 88.2 mttt -107.35 21.73 17.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.164 0.507 . . . . 73.0 110.374 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 142.98 49.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.162 -0.472 . . . . 74.310000000000002 111.46 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 159' ' ' VAL . 7.7 pt -132.71 150.66 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.31 0.576 . . . . 73.319999999999993 111.561 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.9 t80 -96.29 138.48 33.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.834 -1.075 . . . . 73.420000000000002 110.086 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.98 110.78 25.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.419 -0.585 . . . . 73.239999999999995 109.419 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.17 141.84 12.81 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 119.927 -1.13 . . . . 71.450000000000003 112.387 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.0 6.36 14.04 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.315 -0.945 . . . . 71.409999999999997 112.224 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -73.87 101.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.515 0.674 . . . . 74.219999999999999 109.793 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 22.73 1.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 72.019999999999996 112.628 -170.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.01 175.57 11.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.996 -0.372 . . . . 73.120000000000005 109.996 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.66 120.96 12.2 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.697 0.623 . . . . 65.409999999999997 110.561 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -122.7 146.6 47.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.175 0.512 . . . . 75.099999999999994 110.136 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.5 165.27 11.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.44 -0.8 . . . . 64.439999999999998 111.289 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.52 -47.17 87.35 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.184 -1.371 . . . . 62.140000000000001 109.61 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.47 -0.786 . . . . 74.25 111.712 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.47 -58.03 7.58 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.165 0.291 . . . . 71.349999999999994 111.185 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.16 -27.5 38.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.615 -0.834 . . . . 74.109999999999999 110.918 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.4 tmm_? -66.65 -45.0 80.37 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.977 -0.379 . . . . 73.530000000000001 109.977 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.23 -32.18 71.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.195 0.521 . . . . 75.200000000000003 110.454 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -79.48 -55.82 4.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.503 -0.771 . . . . 71.239999999999995 112.37 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 42.9 m-85 -67.7 -24.03 65.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.095 0.405 . . . . 74.129999999999995 112.095 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.4 mm-40 -66.58 -25.81 66.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.976 0.417 . . . . 74.0 110.899 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -61.03 -32.23 71.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.94 -0.573 . . . . 71.329999999999998 111.589 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -81.69 -27.91 33.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.540000000000006 111.101 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.416 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 171.36 -177.65 44.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.768 -0.651 . . . . 74.109999999999999 112.651 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.6 134.3 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.217 0.532 . . . . 70.209999999999994 111.618 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 152' ' ' THR . 79.4 mt -102.88 144.56 13.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.338 -0.846 . . . . 75.519999999999996 109.872 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -93.49 -49.1 6.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 73.120000000000005 110.825 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.35 155.32 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 109.912 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.74 129.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.344 . . . . 64.530000000000001 110.07 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.79 103.39 14.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 61.420000000000002 111.178 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.38 115.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.561 -0.533 . . . . 52.310000000000002 109.561 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ptp -111.48 152.97 26.84 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.349 -0.612 . . . . 54.539999999999999 109.349 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.68 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.834 0 CA-C-O 119.527 -0.596 . . . . 75.340000000000003 113.414 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -170.54 153.68 4.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.903 0.852 . . . . 61.020000000000003 109.973 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.38 174.75 11.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 61.140000000000001 109.474 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.85 155.21 47.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.057 -0.52 . . . . 74.439999999999998 109.985 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.07 132.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.54 0.686 . . . . 64.319999999999993 111.097 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 65.0 m -97.58 124.08 41.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.085 -0.961 . . . . 75.239999999999995 110.465 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 3.7 m-85 -99.24 157.83 16.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 70.109999999999999 111.289 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.59 -29.12 45.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.14 -0.936 . . . . 52.219999999999999 110.511 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -128.68 152.22 48.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.526 . . . . 72.010000000000005 110.847 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -77.74 -28.21 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 71.349999999999994 109.887 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.9 t70 -58.12 -48.26 80.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.641 -1.163 . . . . 75.400000000000006 111.955 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 19.5 m -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 65.310000000000002 111.137 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -67.76 -41.11 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 71.019999999999996 109.775 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 163' ' ' VAL . 12.8 t70 -68.08 -38.16 82.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.077 -0.965 . . . . 55.5 111.377 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.547 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 86.4 mttt -52.87 -37.28 60.23 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.517 0.675 . . . . 70.209999999999994 110.696 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mt -78.18 -44.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 71.010000000000005 112.533 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 16.5 m -74.21 -15.17 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 75.319999999999993 110.725 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 91' ' ' SER . 19.0 mt -57.69 -32.11 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.935 -1.03 . . . . 63.329999999999998 110.16 172.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.534 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -111.51 101.45 9.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 75.329999999999998 108.197 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -56.98 -33.79 67.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.233 0.827 . . . . 64.230000000000004 113.233 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -122.15 135.24 54.76 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.569 -0.452 . . . . 65.319999999999993 110.989 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 92.6 m-70 -127.39 156.92 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.754 -0.657 . . . . 74.209999999999994 110.176 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 10.2 m -123.5 115.44 21.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.08 0.467 . . . . 74.129999999999995 110.834 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.58 115.57 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.782 . . . . 42.140000000000001 109.99 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 71.48 23.84 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.922 0.868 . . . . 75.150000000000006 109.749 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 95.3 -13.21 67.16 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.559 -0.746 . . . . 62.439999999999998 112.266 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.516 ' O ' ' HA ' ' A' ' 169' ' ' THR . 2.6 m80 -81.9 109.99 16.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.154 -0.313 . . . . 74.109999999999999 110.154 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -91.86 107.77 19.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.88 0.848 . . . . 62.310000000000002 109.133 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 5.7 p -124.12 156.8 36.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.093 -0.958 . . . . 72.310000000000002 111.463 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -85.97 130.51 34.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.591 -0.731 . . . . 63.119999999999997 109.154 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 11.3 t -126.63 131.24 71.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.333 -0.849 . . . . 61.539999999999999 109.696 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.38 172.93 17.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 72.25 110.933 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.463 ' HD3' HG11 ' A' ' 163' ' ' VAL . 12.0 mmtm -62.67 124.79 21.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.256 0.348 . . . . 64.5 110.708 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -109.71 112.89 25.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.866 0.365 . . . . 63.329999999999998 110.216 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--N 1.314 -0.968 0 N-CA-C 109.395 -0.595 . . . . 54.119999999999997 109.395 177.684 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -79.1 133.61 60.78 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.833 -1.076 . . . . 75.140000000000001 109.535 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 14' ' ' ARG . 18.3 Cg_endo -62.83 163.3 22.34 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.553 2.169 . . . . 60.030000000000001 111.009 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 7.5 pt-20 -62.56 -27.1 68.94 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 111.981 0.363 . . . . 74.129999999999995 111.981 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HG3' HD12 ' A' ' 13' ' ' LEU . 9.2 pt20 -72.79 -32.51 65.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.795 0.331 . . . . 74.219999999999999 110.849 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 164' ' ' ILE . 5.1 mp -81.36 -11.69 59.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 74.239999999999995 111.197 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 10' ' ' PRO . 32.0 ptt85 -127.06 15.77 7.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.126 0.488 . . . . 75.420000000000002 110.952 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 18.3 ttmm -97.32 151.29 20.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 72.340000000000003 111.029 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 68' ' ' VAL . 70.2 mt -116.76 142.6 46.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.939 -1.028 . . . . 73.200000000000003 110.129 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -98.11 120.89 39.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.169 -1.049 . . . . 75.099999999999994 108.169 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.45 110.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.873 -0.417 . . . . 74.310000000000002 109.873 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.29 152.29 17.97 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.877 -0.678 . . . . 64.230000000000004 111.565 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.83 46.8 43.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.487 -0.863 . . . . 74.409999999999997 112.981 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 25' ' ' THR . 80.5 mt -81.98 176.84 9.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.634 -0.506 . . . . 75.140000000000001 109.634 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 p -85.81 164.6 17.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.107 -1.072 . . . . 73.140000000000001 108.107 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -80.63 2.88 23.92 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.039 0.447 . . . . 73.099999999999994 110.455 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -119.81 10.7 11.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.585 -0.734 . . . . 75.209999999999994 110.995 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.42 HG21 HD22 ' A' ' 21' ' ' LEU . 94.9 m -71.3 121.52 18.61 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 74.530000000000001 110.807 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -94.62 154.85 17.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.003 -0.544 . . . . 63.149999999999999 109.99 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -27.45 63.83 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 121.109 -0.236 . . . . 61.229999999999997 110.867 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -77.2 -23.02 51.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 62.399999999999999 110.741 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -81.29 -41.42 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.672 -0.492 . . . . 70.329999999999998 109.672 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.13 -47.14 87.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 62.420000000000002 109.655 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.21 -62.68 1.5 Allowed 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.094 -0.957 . . . . 73.340000000000003 111.71 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.9 t -48.15 -35.05 10.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.337 0.655 . . . . 74.239999999999995 112.551 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' CG ' HG22 ' A' ' 79' ' ' VAL . 55.9 t60 -68.4 -64.91 0.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 74.150000000000006 110.687 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -71.06 -21.75 62.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.47 0.544 . . . . 74.340000000000003 112.47 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -62.54 -21.0 65.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.722 0.409 . . . . 73.239999999999995 111.703 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.76 -30.03 68.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.544 -0.298 . . . . 73.219999999999999 111.751 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -98.51 -17.29 18.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.963 0.356 . . . . 65.230000000000004 111.963 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.72 164.11 33.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.353 -0.927 . . . . 52.340000000000003 112.36 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -65.38 116.49 6.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 41.439999999999998 111.413 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -85.45 134.57 34.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.745 -0.661 . . . . 65.319999999999993 111.1 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -97.26 -28.61 13.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.202 -0.908 . . . . 63.549999999999997 110.052 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.55 150.42 32.23 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.455 -0.793 . . . . 64.510000000000005 110.373 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -158.41 129.49 6.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.467 -0.568 . . . . 73.310000000000002 109.467 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.22 129.07 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.063 0.458 . . . . 54.210000000000001 110.067 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.06 130.29 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.642 -0.873 . . . . 64.530000000000001 108.642 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.463 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 6.8 mmt -69.24 135.85 51.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.955 0.407 . . . . 75.430000000000007 109.966 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -137.43 155.62 49.13 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.53 -0.759 . . . . 73.099999999999994 109.887 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 28.5 t70 -71.57 132.48 85.45 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.829 -1.078 . . . . 55.520000000000003 110.168 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.85 -19.97 35.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.969 1.78 . . . . 73.409999999999997 112.998 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 4.2 m-20 -84.82 -55.52 4.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 74.409999999999997 111.505 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 m -102.77 -9.11 20.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.955 0.407 . . . . 73.519999999999996 111.739 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.5 mmtm 66.85 24.86 9.67 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.575 0.75 . . . . 70.340000000000003 112.455 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.69 163.82 12.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.944 -0.391 . . . . 65.319999999999993 109.944 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 t -69.61 143.09 53.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.103 0.478 . . . . 74.319999999999993 110.305 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -88.47 1.66 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 53.200000000000003 110.526 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.39 17.76 61.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.653 -0.784 . . . . 62.210000000000001 113.813 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.463 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 41.9 p90 -158.37 159.05 35.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.334 0.567 . . . . 75.310000000000002 110.292 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.93 19.54 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.474 -0.65 . . . . 53.409999999999997 111.474 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 149.61 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.373 0.586 . . . . 75.340000000000003 110.659 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.7 130.65 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.77 -0.65 . . . . 42.119999999999997 109.694 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 m -106.49 123.28 47.84 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 122.135 -0.353 . . . . 75.230000000000004 110.487 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.7 m-85 -90.36 157.75 17.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.769 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.52 80.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 74.209999999999994 111.188 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -123.63 153.94 40.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.005 -0.543 . . . . 61.329999999999998 109.88 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 p -64.5 -30.9 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.396 -0.365 . . . . 74.340000000000003 111.352 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.17 -37.46 87.33 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.867 0.691 . . . . 65.530000000000001 112.867 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -63.61 -28.77 70.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.73 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.8 t -63.55 -49.91 80.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 62.119999999999997 109.856 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.67 -51.35 60.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.327 -0.851 . . . . 72.140000000000001 111.29 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -46.67 -41.03 14.23 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.87 0.692 . . . . 71.25 112.87 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.23 -29.84 61.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 52.43 110.871 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 74.129999999999995 110.851 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -70.48 -36.51 73.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.25 0.548 . . . . 73.120000000000005 110.214 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.0 -11.82 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.29 -0.868 . . . . 60.43 113.175 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -57.05 144.77 67.95 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 111.647 0.24 . . . . 71.209999999999994 111.647 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.65 163.0 84.54 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.518 -1.451 . . . . 61.109999999999999 113.248 2.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -116.83 156.35 27.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 73.549999999999997 110.456 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.5 ttmt -136.84 110.64 8.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.45 -0.341 . . . . 73.030000000000001 110.878 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.9 t -110.2 127.37 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 60.399999999999999 109.654 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.07 28.92 14.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.446 0.641 . . . . 70.239999999999995 111.136 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.17 27.91 63.19 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.742 -0.742 . . . . 45.229999999999997 112.446 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 10.1 tpt180 -131.54 140.39 49.47 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 71.409999999999997 109.564 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.88 112.38 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.417 -0.586 . . . . 44.439999999999998 109.417 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.8 m -105.5 148.25 10.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.484 0.659 . . . . 73.329999999999998 111.209 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -113.03 97.58 42.76 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.776 -1.102 . . . . 75.420000000000002 110.755 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -77.43 128.8 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.685 2.257 . . . . 70.030000000000001 111.27 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -132.99 172.08 13.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.326 -0.852 . . . . 75.319999999999993 108.918 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 4.7 tpp180 -77.99 137.5 38.33 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.651 -0.42 . . . . 74.120000000000005 110.338 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.51 2.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.158 0.504 . . . . 62.310000000000002 110.664 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.1 151.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.887 -1.051 . . . . 74.540000000000006 111.064 177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -55.05 148.24 14.18 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.611 -0.722 . . . . 74.140000000000001 110.469 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -51.02 -43.71 60.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.357 1.243 . . . . 73.299999999999997 114.357 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.84 -33.82 68.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.976 0.417 . . . . 74.209999999999994 111.014 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -84.33 -26.63 28.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.618 -0.719 . . . . 60.409999999999997 111.969 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 p -74.29 -15.05 60.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.178 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -85.61 -10.08 56.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.91 -0.586 . . . . 72.329999999999998 110.521 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.52 148.24 43.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 73.109999999999999 110.353 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.1 123.81 11.4 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.491 2.127 . . . . 72.420000000000002 111.842 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 101.91 12.44 34.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.005 -0.616 . . . . 72.209999999999994 112.299 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.5 7.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 111.395 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -97.39 13.76 28.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.003 0.43 . . . . 72.239999999999995 111.347 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 ' HA2' ' A' ' 99' ' ' GLY . 67.5 mt -76.81 155.6 32.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.937 -0.764 . . . . 53.520000000000003 108.937 170.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 m -77.03 90.44 3.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.398 0.618 . . . . 64.439999999999998 110.043 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.41 112.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.427 -0.806 . . . . 62.240000000000002 110.625 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -104.91 17.27 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 74.239999999999995 110.729 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 138.99 52.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.419 -0.355 . . . . 75.120000000000005 110.981 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.569 HG23 HG13 ' A' ' 159' ' ' VAL . 3.5 pt -128.21 151.82 35.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.343 0.592 . . . . 71.519999999999996 111.734 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.9 t80 -100.36 133.12 45.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.623 -1.172 . . . . 75.129999999999995 109.667 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.15 110.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.899 -0.778 . . . . 74.120000000000005 108.899 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -127.38 154.22 19.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.826 -1.178 . . . . 41.329999999999998 112.819 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.96 8.4 58.02 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.633 -0.794 . . . . 72.549999999999997 112.164 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -72.28 93.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.305 0.574 . . . . 63.219999999999999 110.504 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -80.5 -25.31 38.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.818 -0.628 . . . . 73.540000000000006 110.799 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -88.85 161.1 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.67 -0.695 . . . . 61.210000000000001 110.534 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.67 104.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.48 0.487 . . . . 72.200000000000003 109.99 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.5 m -109.34 130.43 55.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.853 -0.612 . . . . 71.329999999999998 110.804 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -112.71 175.24 5.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.002 -0.999 . . . . 71.129999999999995 111.13 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.47 -48.92 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.816 -1.083 . . . . 65.400000000000006 110.834 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -56.24 -37.27 69.52 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.275 0.359 . . . . 74.319999999999993 111.638 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 64.7 m170 -56.7 -60.74 3.12 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.412 0.445 . . . . 72.310000000000002 111.075 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.79 -26.99 29.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.904 -0.718 . . . . 75.140000000000001 111.59 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -66.07 -50.65 63.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.611 -0.144 . . . . 74.519999999999996 110.611 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.79 -24.43 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.039 0.447 . . . . 53.530000000000001 110.399 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -77.34 -57.32 3.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.898 -0.592 . . . . 71.109999999999999 111.878 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -68.58 -23.15 64.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.713 0.634 . . . . 75.540000000000006 112.713 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -69.54 -20.24 63.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 111.503 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -57.25 -28.92 63.38 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.879 -0.601 . . . . 64.519999999999996 111.078 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.66 -30.37 19.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.068 0.396 . . . . 72.439999999999998 112.068 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.2 -176.1 47.82 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.587 -0.816 . . . . 73.439999999999998 113.347 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -75.97 133.26 40.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.159 0.504 . . . . 64.219999999999999 111.178 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 126' ' ' GLU . 75.8 mt -102.92 139.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.472 -0.785 . . . . 64.310000000000002 109.507 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -86.39 -50.83 6.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.462 . . . . 74.200000000000003 110.394 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.461 HG13 ' OE2' ' A' ' 135' ' ' GLU . 9.0 p -160.78 159.34 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.661 -0.7 . . . . 71.230000000000004 109.549 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.85 131.93 71.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.342 0.591 . . . . 74.040000000000006 110.693 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 4.1 mp0 -101.88 103.53 14.21 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.054 -0.975 . . . . 62.140000000000001 110.378 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.51 116.7 35.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.078 -0.712 . . . . 64.200000000000003 109.078 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' PHE . 73.8 mmm -93.72 124.75 37.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.012 -0.736 . . . . 71.129999999999995 109.012 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.637 -0.711 . . . . 65.510000000000005 110.143 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.995 -0.442 . . . . 64.230000000000004 111.995 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 137' ' ' MET . 20.2 p90 -170.86 153.93 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.682 -0.858 . . . . 74.420000000000002 108.682 173.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.56 169.81 17.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.944 0.402 . . . . 74.25 109.969 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 72.4 m-85 -138.74 154.68 48.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 53.219999999999999 109.435 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 107' ' ' ILE . 2.3 p -144.6 131.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.392 0.615 . . . . 74.299999999999997 111.546 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 131' ' ' ILE . 34.6 m -92.97 124.5 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.963 -1.017 . . . . 62.340000000000003 110.941 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.17 156.9 17.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.393 -0.367 . . . . 74.030000000000001 110.819 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.42 -25.78 46.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 110.582 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -131.1 148.08 52.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.727 -0.67 . . . . 72.400000000000006 110.822 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -78.29 -27.24 47.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.625 -0.262 . . . . 74.140000000000001 110.76 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 20.8 t70 -64.72 -36.74 85.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.073 -0.512 . . . . 62.399999999999999 110.802 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 -32.74 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 44.539999999999999 110.56 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 107' ' ' ILE . 1.4 t -70.77 -39.43 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.925 -0.58 . . . . 62.340000000000003 109.988 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.652 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.2 t70 -69.96 -33.5 72.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.643 -0.708 . . . . 63.399999999999999 111.332 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.9 mttt -54.0 -38.86 65.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.849 0.833 . . . . 75.510000000000005 109.954 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.3 mt -77.07 -43.58 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.126 -1.397 . . . . 62.43 112.398 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 160' ' ' ASP . 11.2 m -75.71 -11.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.891 -0.506 . . . . 73.299999999999997 110.769 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 13' ' ' LEU . 8.6 mt -58.51 -31.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.354 -0.839 . . . . 61.509999999999998 109.932 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -112.63 100.96 9.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.39 -0.967 . . . . 53.140000000000001 108.39 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -58.35 -33.29 69.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.612 0.597 . . . . 73.040000000000006 112.612 -174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.61 131.3 54.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.824 0.345 . . . . 64.140000000000001 110.92 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 84.4 m-70 -123.79 151.3 43.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 73.129999999999995 110.672 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 m -94.39 105.24 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.915 0.388 . . . . 63.240000000000002 110.072 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.3 t -117.52 130.57 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.066 -0.716 . . . . 70.340000000000003 109.066 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 53.02 34.56 17.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.863 0.84 . . . . 73.099999999999994 111.448 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 75.41 0.9 63.5 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.663 -0.699 . . . . 32.039999999999999 113.498 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -111.59 128.75 56.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.169 -0.308 . . . . 72.129999999999995 110.169 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.79 109.32 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.325 0.583 . . . . 74.25 110.707 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.84 156.31 20.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.197 -0.91 . . . . 71.239999999999995 109.816 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -89.47 131.14 35.66 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.91 0.385 . . . . 74.109999999999999 110.042 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.9 t -128.56 132.92 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.365 -0.834 . . . . 73.099999999999994 110.195 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -157.7 176.14 12.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.688 -0.687 . . . . 73.409999999999997 110.297 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -61.77 128.94 38.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.802 0.334 . . . . 74.340000000000003 110.841 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -107.92 113.54 26.83 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.212 0.53 . . . . 41.009999999999998 109.69 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.389 -0.823 . . . . 65.340000000000003 109.509 179.315 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.944 -0.762 . . . . 75.099999999999994 108.944 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.42 133.28 31.65 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 114.66 -1.154 . . . . 53.329999999999998 110.231 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HD2' HD22 ' A' ' 13' ' ' LEU . 27.5 Cg_endo -65.0 167.15 16.6 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.114 2.543 . . . . 72.209999999999994 111.323 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.19 -34.89 70.85 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 112.19 0.441 . . . . 71.299999999999997 112.19 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.1 pt20 -68.49 -20.1 64.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.014 0.376 . . . . 72.400000000000006 112.014 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.541 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.0 mp -89.73 -14.3 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.316 . . . . 64.349999999999994 110.816 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 28.5 ptt85 -125.36 -2.96 7.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 64.299999999999997 111.676 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.7 ttpt -98.73 144.73 27.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.752 0.787 . . . . 74.549999999999997 111.22 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.592 HD21 HG13 ' A' ' 68' ' ' VAL . 50.6 mt -120.2 146.92 45.56 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.326 -1.306 . . . . 63.130000000000003 110.969 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.71 115.67 29.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.33 -0.989 . . . . 64.430000000000007 108.33 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 60' ' ' VAL . 20.2 mm -95.0 112.6 27.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.964 -0.384 . . . . 55.340000000000003 109.964 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.55 152.45 17.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.986 -0.626 . . . . 73.409999999999997 111.56 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.16 42.5 50.6 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.553 -0.832 . . . . 60.43 113.314 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 25' ' ' THR . 76.9 mt -77.94 174.02 11.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.929 0.364 . . . . 74.140000000000001 110.171 174.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -84.76 175.92 8.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 74.230000000000004 109.104 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.97 -9.5 59.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.297 0.57 . . . . 74.129999999999995 109.825 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 53' ' ' ARG . 24.9 mt-10 -114.3 5.15 15.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.47 -0.786 . . . . 63.329999999999998 112.231 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.505 HG21 HD22 ' A' ' 21' ' ' LEU . 84.9 m -73.0 126.03 29.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.387 0.613 . . . . 72.310000000000002 112.206 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 p -100.73 164.35 11.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.342 -0.844 . . . . 64.530000000000001 110.337 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -24.27 57.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.156 -0.313 . . . . 74.120000000000005 110.156 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -72.43 -37.69 68.53 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.175 0.297 . . . . 70.530000000000001 110.951 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -77.63 -38.26 48.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 71.120000000000005 110.285 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 79' ' ' VAL . 35.3 tp -60.43 -52.26 65.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.404 -0.816 . . . . 73.510000000000005 109.803 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.86 -60.54 3.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.06 -0.973 . . . . 74.120000000000005 112.009 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -48.31 -36.59 14.54 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.817 0.698 . . . . 74.409999999999997 112.663 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -67.66 -50.8 56.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.785 0.326 . . . . 72.25 110.714 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.44 -20.41 43.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.644 0.239 . . . . 64.349999999999994 111.644 -173.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -60.65 -22.76 64.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.036 0.446 . . . . 63.409999999999997 111.476 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -67.48 -28.1 67.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.761 . . . . 60.009999999999998 112.148 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -96.69 -27.64 14.68 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.1 -0.24 . . . . 75.109999999999999 111.381 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.84 160.05 33.41 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.593 -0.813 . . . . 70.140000000000001 112.009 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -64.6 120.12 11.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.676 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.8 mt -89.96 139.6 30.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.486 0.66 . . . . 74.420000000000002 111.174 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 p -105.8 -24.57 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.997 -1.001 . . . . 62.310000000000002 110.006 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -153.45 156.9 39.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.636 -0.711 . . . . 61.329999999999998 109.912 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 t -164.13 131.73 3.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.516 -0.55 . . . . 71.239999999999995 109.516 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.09 117.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.564 0.697 . . . . 64.310000000000002 110.416 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.45 136.04 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.058 -0.719 . . . . 60.409999999999997 109.058 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.9 mmt -83.18 97.45 8.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.638 0.732 . . . . 72.0 110.396 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 50.2 mtp85 -102.25 163.68 12.1 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.525 -1.216 . . . . 74.049999999999997 111.032 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.78 125.02 83.12 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 114.726 -1.125 . . . . 75.430000000000007 110.216 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.33 -12.73 34.38 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.93 1.753 . . . . 75.010000000000005 112.929 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -85.44 -56.96 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 73.219999999999999 111.77 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -103.26 -10.53 18.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 74.510000000000005 111.358 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 65.81 39.38 4.72 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.364 -0.835 . . . . 62.229999999999997 110.471 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 24' ' ' GLU . 31.7 mmm180 -121.82 154.85 36.48 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.631 -0.507 . . . . 65.200000000000003 109.631 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.7 t -66.21 139.11 58.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.93 0.395 . . . . 62.030000000000001 111.68 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -84.33 -1.85 56.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 74.340000000000003 110.465 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.87 57.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.883 -0.675 . . . . 74.310000000000002 113.962 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -157.27 157.43 34.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.189 0.995 . . . . 75.230000000000004 111.078 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.21 -166.07 18.32 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.387 -0.685 . . . . 71.409999999999997 111.387 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -141.31 149.97 41.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.588 0.694 . . . . 73.439999999999998 110.833 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' ILE . 6.9 m -131.53 123.82 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.566 -0.743 . . . . 70.129999999999995 109.869 173.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.5 m -99.03 118.75 36.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.642 -0.254 . . . . 74.140000000000001 110.498 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.7 169.6 14.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.263 -0.426 . . . . 60.43 110.62 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.34 -51.56 14.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.843 -0.617 . . . . 53.43 109.892 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -123.8 155.28 38.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 64.219999999999999 110.606 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -62.22 -34.82 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.663 0.268 . . . . 72.420000000000002 111.308 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -57.97 -37.82 74.9 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.221 0.452 . . . . 72.439999999999998 112.221 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.38 -35.12 78.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.245 0.545 . . . . 61.439999999999998 110.006 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 16' ' ' LEU . 5.2 t -64.86 -47.6 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.117 -0.947 . . . . 71.329999999999998 110.663 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.93 -52.74 62.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 63.210000000000001 110.626 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.64 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.693 0.627 . . . . 54.340000000000003 112.693 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.18 68.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.938 0.399 . . . . 70.209999999999994 110.703 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.4 mmt -67.79 -43.18 80.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.58 . . . . 74.319999999999993 110.764 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.64 -40.35 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.126 0.488 . . . . 62.43 110.568 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.45 -16.59 64.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.177 -0.92 . . . . 74.430000000000007 112.909 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 75' ' ' ARG . 27.7 mtp-105 -54.09 147.23 26.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.233 0.457 . . . . 65.019999999999996 112.233 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.4 168.41 71.86 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.475 -1.469 . . . . 63.210000000000001 113.732 3.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -121.23 162.22 20.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.239 -0.891 . . . . 73.340000000000003 110.346 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.9 ttmt -136.74 111.85 9.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 73.530000000000001 111.604 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 30' ' ' LEU . 18.6 t -115.4 130.51 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 64.140000000000001 109.742 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.405 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 4.3 m-20 65.07 29.85 11.91 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.804 0.69 . . . . 75.510000000000005 111.96 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.82 24.73 68.89 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.793 -0.718 . . . . 53.299999999999997 112.445 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.9 tpt180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.448 -0.575 . . . . 65.540000000000006 109.448 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.89 113.18 23.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.791 0.805 . . . . 75.329999999999998 109.368 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.2 m -102.83 151.07 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 62.329999999999998 111.236 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 3.5 tp10 -113.11 97.25 41.88 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.79 -1.095 . . . . 54.539999999999999 111.117 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -73.48 129.49 13.84 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.311 2.007 . . . . 74.010000000000005 111.221 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 19.7 mttt -134.71 -179.02 5.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.349 -1.723 . . . . 60.539999999999999 106.349 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -86.7 141.16 29.11 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 119.581 1.082 . . . . 73.25 110.855 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 95.47 0.6 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.071 -0.513 . . . . 61.329999999999998 110.663 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.58 133.57 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.666 -0.697 . . . . 73.140000000000001 109.593 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 t -78.61 174.0 11.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 63.509999999999998 110.859 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -49.2 -54.58 15.88 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.964 0.906 . . . . 72.209999999999994 113.302 -171.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.79 -36.61 65.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.904 0.335 . . . . 71.109999999999999 111.904 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -11.52 58.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.951 0.352 . . . . 74.340000000000003 111.951 -176.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.6 p -97.81 2.48 49.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.565 0.222 . . . . 73.349999999999994 111.266 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.96 -37.68 88.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.29 -0.414 . . . . 74.209999999999994 111.074 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -92.57 145.6 30.77 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.328 -0.396 . . . . 75.129999999999995 110.261 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.44 151.12 70.84 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.913 2.409 . . . . 64.510000000000005 111.847 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 95.71 8.87 57.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.608 -0.806 . . . . 71.310000000000002 111.925 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.87 -49.04 15.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 60.140000000000001 110.562 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -92.77 3.76 55.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 71.0 111.381 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.434 HD12 ' HA2' ' A' ' 99' ' ' GLY . 70.6 mt -82.79 158.56 22.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 71.219999999999999 109.782 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -76.31 93.49 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.803 0.811 . . . . 74.409999999999997 110.511 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.9 t -120.26 108.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.749 -1.114 . . . . 64.239999999999995 109.913 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 156' ' ' HIS . 53.7 mttt -100.09 10.49 41.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 72.439999999999998 110.776 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.52 140.68 49.11 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.11 -0.496 . . . . 72.030000000000001 111.106 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.499 HG23 HG13 ' A' ' 159' ' ' VAL . 4.9 pt -122.84 149.88 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.258 0.552 . . . . 72.209999999999994 111.969 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.6 t80 -98.43 133.8 42.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.883 -1.053 . . . . 72.439999999999998 109.054 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.56 109.23 22.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.491 -0.559 . . . . 54.420000000000002 109.491 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.26 149.96 17.0 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.209 -0.996 . . . . 65.439999999999998 113.05 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.56 25.62 38.41 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.335 -0.936 . . . . 64.209999999999994 112.595 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.493 ' HB ' ' OG1' ' A' ' 116' ' ' THR . 5.2 pt -68.91 131.48 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 55.229999999999997 109.946 174.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 65.2 tttp -82.93 107.17 15.34 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.343 0.868 . . . . 74.319999999999993 113.343 -164.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.27 -53.2 0.7 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.405 1.066 . . . . 62.340000000000003 113.456 167.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -165.46 112.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.833 -0.432 . . . . 61.340000000000003 109.833 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 112' ' ' ILE . 14.9 m -123.66 136.77 54.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.283 0.563 . . . . 54.450000000000003 109.629 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -110.88 171.89 7.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.694 -0.684 . . . . 74.129999999999995 111.139 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.44 -49.59 75.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 114.79 -1.095 . . . . 74.409999999999997 110.562 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -54.91 -35.0 63.68 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.399 0.437 . . . . 73.140000000000001 111.783 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.18 -61.18 2.42 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.281 0.363 . . . . 71.329999999999998 111.056 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.6 pp -83.77 -23.66 31.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.197 -0.601 . . . . 72.109999999999999 111.46 -171.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -65.33 -55.36 18.69 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.937 -0.394 . . . . 73.340000000000003 109.937 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.323 0.582 . . . . 72.450000000000003 110.495 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -76.32 -56.64 4.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.359 -0.837 . . . . 70.299999999999997 112.22 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.1 m-85 -68.95 -23.02 64.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.685 0.254 . . . . 75.439999999999998 111.685 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mm-40 -64.4 -24.54 67.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.027 0.442 . . . . 73.200000000000003 110.905 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.0 -27.42 68.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.822 -0.626 . . . . 50.329999999999998 111.777 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.53 -25.79 22.34 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.77 0.285 . . . . 73.510000000000005 111.77 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.25 -175.82 46.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.536 -0.84 . . . . 74.519999999999996 113.312 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -75.47 125.61 29.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 71.209999999999994 112.067 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.8 mt -98.17 136.1 30.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 74.439999999999998 110.301 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.29 -50.49 8.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.309 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.56 157.96 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 50.509999999999998 110.091 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.4 128.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.321 0.582 . . . . 71.299999999999997 110.519 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.7 mt-10 -100.29 104.89 16.38 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.255 -0.884 . . . . 62.109999999999999 110.859 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.65 122.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.229 -0.656 . . . . 73.239999999999995 109.229 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.6 mmm -101.95 135.97 42.6 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.636 -0.876 . . . . 74.239999999999995 108.636 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 73.450000000000003 111.913 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.15 0 N-CA-C 110.56 -1.016 . . . . 75.420000000000002 110.56 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -171.54 145.87 2.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.374 -0.602 . . . . 74.010000000000005 109.374 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.51 170.49 14.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.628 -0.714 . . . . 70.129999999999995 109.112 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.529 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -136.24 143.4 44.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.844 -0.616 . . . . 74.019999999999996 109.404 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 125' ' ' PHE . 58.0 t -129.2 121.73 54.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 O-C-N 122.164 -0.335 . . . . 54.5 110.483 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 85.9 m -96.16 118.92 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.678 -0.692 . . . . 74.040000000000006 110.821 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -102.75 156.64 17.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.601 0.238 . . . . 71.230000000000004 110.889 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.22 -29.71 65.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 71.109999999999999 110.288 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 1.9 t0 -139.06 159.96 40.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.587 -0.733 . . . . 65.25 110.887 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 18.0 p-80 -79.18 -19.87 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 75.409999999999997 110.115 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.608 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 1.3 p-10 -60.84 -38.23 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.029 -0.987 . . . . 70.510000000000005 110.979 -174.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -73.85 -31.08 63.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.132 -0.486 . . . . 65.340000000000003 110.227 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.499 HG13 HG23 ' A' ' 107' ' ' ILE . 3.8 t -69.82 -39.01 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.677 -0.692 . . . . 74.010000000000005 109.835 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.92 -26.77 63.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 62.140000000000001 111.242 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 71.7 mttt -69.07 -33.67 73.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.315 0.579 . . . . 70.340000000000003 110.265 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.3 mt -78.02 -42.68 28.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.564 -0.744 . . . . 75.129999999999995 112.672 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.3 m -70.64 -6.14 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.001 0.429 . . . . 75.219999999999999 111.434 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 13' ' ' LEU . 71.5 mt -54.91 -38.79 46.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.191 -0.913 . . . . 63.039999999999999 109.861 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 56.7 mt-30 -109.49 105.28 14.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.578 -0.897 . . . . 54.210000000000001 108.578 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -55.04 -32.34 61.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.864 -0.607 . . . . 65.439999999999998 111.706 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -124.91 133.9 52.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.455 -0.339 . . . . 75.230000000000004 110.687 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.4 m-70 -120.98 144.64 48.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.853 -0.612 . . . . 61.240000000000002 109.887 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.8 m -114.03 106.23 14.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.355 -0.384 . . . . 55.509999999999998 110.569 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.91 114.73 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.309 -0.405 . . . . 73.209999999999994 111.203 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.41 31.74 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.759 0.79 . . . . 55.219999999999999 109.656 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.94 5.46 86.14 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.497 -0.774 . . . . 74.450000000000003 112.385 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.559 ' CD2' ' HB3' ' A' ' 113' ' ' LYS . 61.5 m170 -106.04 110.21 22.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.199 -0.297 . . . . 74.150000000000006 110.199 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.75 107.81 19.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.151 0.5 . . . . 75.140000000000001 109.737 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 p -117.05 156.22 27.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 72.109999999999999 111.451 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.31 134.92 33.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.756 -0.657 . . . . 74.409999999999997 109.853 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 26.9 t -130.9 134.0 62.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.166 0.508 . . . . 51.109999999999999 110.667 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -152.92 173.5 15.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.559 -0.746 . . . . 65.219999999999999 111.372 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -65.68 130.31 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.263 -0.426 . . . . 74.400000000000006 110.298 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -120.75 122.34 40.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.478 . . . . 74.420000000000002 109.711 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 120.743 -0.383 . . . . 73.540000000000006 110.375 -175.766 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.749 0.309 . . . . 73.450000000000003 110.675 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -76.09 130.93 76.73 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.246 -0.65 . . . . 71.030000000000001 109.246 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.67 166.36 15.93 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.26 1.973 . . . . 71.450000000000003 111.97 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -41.24 64.41 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.566 -0.743 . . . . 72.439999999999998 112.397 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -71.39 -27.37 63.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.818 0.342 . . . . 73.430000000000007 111.842 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -84.51 -6.16 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.493 -0.322 . . . . 71.409999999999997 111.024 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.4 ptt180 -127.81 6.17 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.981 0.419 . . . . 70.430000000000007 110.685 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.31 146.72 25.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.401 0.62 . . . . 73.109999999999999 111.16 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.6 HD21 HG13 ' A' ' 68' ' ' VAL . 58.0 mt -115.48 143.47 45.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.664 -1.153 . . . . 72.099999999999994 110.704 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -97.86 120.81 38.92 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.622 -0.881 . . . . 63.219999999999999 108.622 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.49 111.63 29.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 110.093 -0.336 . . . . 64.120000000000005 110.093 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.78 151.26 17.29 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 121.089 -0.577 . . . . 65.420000000000002 111.713 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.9 44.54 55.53 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.683 -0.77 . . . . 71.120000000000005 113.142 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 HG21 ' A' ' 25' ' ' THR . 84.2 mt -78.08 173.73 11.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.736 -0.468 . . . . 72.140000000000001 109.736 171.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -86.11 -178.16 6.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.026 0.441 . . . . 70.010000000000005 110.012 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -81.02 -9.0 59.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.045 -0.525 . . . . 71.5 110.09 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 19.8 mt-10 -121.81 18.99 11.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.629 0.603 . . . . 72.439999999999998 112.629 -173.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.545 HG21 HD22 ' A' ' 21' ' ' LEU . 28.6 m -78.36 115.33 18.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.875 0.369 . . . . 62.43 110.964 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -97.47 158.76 15.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 110.447 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.668 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 9.6 t0 -59.33 -43.22 92.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.054 0.542 . . . . 32.229999999999997 111.152 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.62 -34.81 77.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.755 . . . . 71.239999999999995 111.543 -175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 m -79.19 -36.37 40.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.452 -0.34 . . . . 64.219999999999999 110.802 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HA ' HG11 ' A' ' 79' ' ' VAL . 50.2 tp -65.52 -51.72 57.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 62.020000000000003 110.013 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.23 -60.55 3.19 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.304 -0.862 . . . . 65.329999999999998 112.117 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 t -48.67 -33.51 10.14 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.809 0.693 . . . . 75.450000000000003 112.843 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.2 t-80 -73.23 -56.12 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.222 -0.191 . . . . 73.239999999999995 110.892 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.45 -23.96 63.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.938 0.347 . . . . 72.540000000000006 111.938 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -57.79 -20.95 39.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.504 0.722 . . . . 72.019999999999996 112.114 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.42 -29.27 69.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.88 0.326 . . . . 73.439999999999998 111.88 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -96.27 -20.82 18.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.689 0.28 . . . . 63.439999999999998 111.203 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.79 164.39 32.77 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.34 -0.933 . . . . 73.439999999999998 112.309 173.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.7 m -62.92 119.79 10.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 71.540000000000006 111.699 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.96 117.04 26.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.739 -0.664 . . . . 72.430000000000007 110.777 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -84.36 -25.71 28.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.037 -0.983 . . . . 74.549999999999997 110.269 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -149.58 150.29 32.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.447 -0.797 . . . . 72.439999999999998 109.486 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.3 t -160.54 138.7 9.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.949 -0.76 . . . . 42.310000000000002 108.949 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.668 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 5.7 p -152.23 122.54 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 121.434 0.635 . . . . 74.010000000000005 111.005 171.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.49 136.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.402 -0.962 . . . . 73.299999999999997 108.402 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.532 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -81.7 100.41 9.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.595 0.712 . . . . 72.019999999999996 110.524 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -101.83 158.11 16.36 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.66 -1.155 . . . . 74.109999999999999 109.205 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.36 132.96 64.62 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.039 -0.356 . . . . 75.120000000000005 110.039 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -22.4 73.18 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.389 2.06 . . . . 43.009999999999998 113.681 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -86.32 -55.71 3.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.288 0.566 . . . . 75.209999999999994 110.792 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -95.84 -14.78 22.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.123 -0.944 . . . . 60.229999999999997 112.346 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm 64.62 26.13 13.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.552 0.741 . . . . 72.439999999999998 111.307 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 23.5 mmm180 -109.18 156.76 19.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.766 -0.457 . . . . 62.32 109.766 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 m -68.37 132.02 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.178 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -85.84 3.18 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.69 -0.686 . . . . 74.510000000000005 111.225 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 11.44 65.47 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.585 -0.817 . . . . 61.229999999999997 114.069 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.5 p90 -153.82 155.75 36.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.784 0.792 . . . . 61.200000000000003 110.712 175.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.16 -169.51 23.55 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.382 -0.687 . . . . 53.539999999999999 111.382 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.23 142.4 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.178 0.489 . . . . 74.109999999999999 110.389 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 m -126.85 128.19 70.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 63.210000000000001 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 m -104.6 122.06 44.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.525 -0.307 . . . . 70.310000000000002 110.239 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 31.9 m-85 -88.73 161.37 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.171 -0.468 . . . . 65.129999999999995 110.483 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.78 83.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.509 -0.769 . . . . 73.109999999999999 110.744 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.6 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 16.5 m -131.12 154.34 48.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.107 -0.497 . . . . 72.5 110.463 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -65.63 -34.0 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 111.658 0.244 . . . . 64.299999999999997 111.658 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.03 -43.7 78.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.967 0.358 . . . . 72.040000000000006 111.967 175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 2.7 mp0 -62.01 -33.23 73.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 72.540000000000006 110.644 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 HD21 ' A' ' 16' ' ' LEU . 42.3 t -64.21 -50.23 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.281 -0.872 . . . . 71.120000000000005 110.97 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.02 -41.1 91.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.248 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.86 67.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.327 -0.397 . . . . 73.439999999999998 112.026 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.23 66.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 71.430000000000007 110.665 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -37.21 86.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 73.310000000000002 111.227 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -28.19 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 62.210000000000001 111.001 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.29 -9.64 54.17 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.741 0.645 . . . . 65.319999999999993 112.741 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 75' ' ' ARG . 24.8 mtp-105 -58.04 146.23 69.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.456 -0.338 . . . . 72.329999999999998 111.501 175.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.01 153.2 99.02 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.967 -1.264 . . . . 64.239999999999995 114.049 3.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -108.65 153.31 23.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.054 -0.976 . . . . 65.150000000000006 110.731 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 13.6 ttmt -136.42 103.16 5.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.037 0.446 . . . . 70.400000000000006 111.198 175.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 30' ' ' LEU . 21.9 t -107.97 131.52 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.613 -0.721 . . . . 72.030000000000001 109.676 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.0 t70 64.91 29.77 12.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.791 0.805 . . . . 55.109999999999999 110.564 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.35 76.34 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.549 -0.75 . . . . 32.43 112.16 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 24.8 tpt180 -125.59 136.94 53.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.884 -0.413 . . . . 73.430000000000007 109.884 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.04 109.52 13.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.776 0.798 . . . . 72.439999999999998 109.623 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.5 m -105.67 152.86 7.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.505 -0.771 . . . . 75.430000000000007 110.787 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -112.07 97.24 37.84 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.423 -0.808 . . . . 73.109999999999999 110.879 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.81 129.63 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.149 1.899 . . . . 74.329999999999998 110.429 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -135.18 179.42 6.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 50.130000000000003 107.781 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 7.8 tpp180 -79.26 162.7 25.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.324 -0.551 . . . . 64.099999999999994 109.667 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.66 93.26 5.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.466 -0.568 . . . . 73.030000000000001 109.466 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.1 154.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.001 -0.999 . . . . 61.109999999999999 111.396 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -59.92 146.98 40.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.59 -0.732 . . . . 60.130000000000003 110.091 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -65.63 -19.17 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.341 -0.39 . . . . 74.239999999999995 111.359 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.39 -39.32 88.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 73.230000000000004 111.65 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.28 -22.02 48.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.226 0.536 . . . . 74.25 110.12 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 20.1 t -70.41 -0.53 8.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.518 -0.765 . . . . 74.200000000000003 111.233 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -71.08 -24.96 62.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 110.222 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -77.78 146.2 72.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 110.216 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.43 114.94 3.82 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.657 2.238 . . . . 74.120000000000005 112.191 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.74 10.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.77 -0.729 . . . . 64.409999999999997 112.185 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -72.79 -27.17 61.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.759 0.314 . . . . 51.200000000000003 111.294 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -99.83 11.85 38.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.359 . . . . 72.030000000000001 111.008 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.16 167.23 19.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.958 -0.756 . . . . 63.539999999999999 108.958 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.8 m -75.55 90.17 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.222 0.534 . . . . 74.319999999999993 111.054 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.49 115.63 50.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.284 -0.871 . . . . 62.329999999999998 109.831 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.52 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.1 mttt -109.11 22.26 16.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 63.039999999999999 110.958 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -123.84 140.44 52.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.459 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 159' ' ' VAL . 9.4 pt -127.79 154.03 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.164 0.507 . . . . 72.150000000000006 111.812 176.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.2 t80 -100.27 137.19 39.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.835 -1.075 . . . . 65.200000000000003 109.384 175.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.03 113.1 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 73.099999999999994 109.533 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.15 152.89 19.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.014 -1.089 . . . . 64.319999999999993 113.072 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.03 6.35 24.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 75.219999999999999 112.61 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.8 pt -79.95 100.36 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.739 0.78 . . . . 63.240000000000002 110.813 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -93.03 3.37 55.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.872 -0.604 . . . . 75.120000000000005 111.193 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.12 165.58 16.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.093 -0.706 . . . . 74.420000000000002 109.093 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.71 99.94 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.371 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -91.22 139.74 30.45 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.853 -0.612 . . . . 73.239999999999995 109.683 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.46 165.73 10.86 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.502 -0.772 . . . . 70.409999999999997 110.866 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -47.84 84.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.091 -1.413 . . . . 73.400000000000006 108.768 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -55.26 -30.82 60.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.413 -0.812 . . . . 72.299999999999997 111.959 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -66.84 -62.37 1.48 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.213 0.53 . . . . 74.319999999999993 110.844 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.451 HD13 HG22 ' A' ' 151' ' ' VAL . 3.5 pp -82.42 -24.03 34.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.038 -0.665 . . . . 73.540000000000006 111.458 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 121' ' ' LEU . 8.5 tmm_? -66.14 -49.29 67.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.212 -0.292 . . . . 71.420000000000002 110.212 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.33 -30.11 70.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.276 0.56 . . . . 73.420000000000002 110.78 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -80.59 -54.93 5.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 64.450000000000003 112.209 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' A' ' 151' ' ' VAL . 21.0 m-85 -68.38 -22.79 64.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.679 0.622 . . . . 71.049999999999997 112.679 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.66 -23.32 64.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.682 0.277 . . . . 72.010000000000005 111.276 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -60.88 -24.99 66.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 70.450000000000003 111.586 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -85.4 -27.42 25.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.405 . . . . 73.040000000000006 111.365 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.63 -177.8 43.56 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.707 -0.758 . . . . 74.109999999999999 113.223 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -74.11 133.62 42.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.956 0.408 . . . . 70.439999999999998 111.194 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.83 139.37 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.724 -0.671 . . . . 73.200000000000003 109.789 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.93 -50.74 6.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.317 0.58 . . . . 63.119999999999997 110.095 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -156.13 157.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.32 -0.855 . . . . 65.420000000000002 109.638 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -114.5 128.18 71.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.26 0.552 . . . . 62.409999999999997 109.794 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.1 mt-10 -99.46 126.01 45.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.174 -0.921 . . . . 60.340000000000003 110.232 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.5 mm -119.65 114.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.249 -1.019 . . . . 70.340000000000003 108.249 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mmm -91.14 120.42 32.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.399 -0.593 . . . . 73.340000000000003 109.399 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 121.145 0.497 . . . . 74.329999999999998 112.172 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 CA-C-O 119.682 -0.51 . . . . 63.439999999999998 112.949 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -173.49 158.62 3.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.317 0.558 . . . . 74.200000000000003 109.769 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.04 173.72 11.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.292 -0.632 . . . . 61.039999999999999 109.292 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 36.7 m-85 -138.06 143.94 40.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.298 -0.41 . . . . 70.019999999999996 110.133 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 125' ' ' PHE . 50.7 t -126.96 127.77 70.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 O-C-N 122.002 -0.436 . . . . 71.129999999999995 110.828 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 131' ' ' ILE . 63.5 m -106.89 120.22 41.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.613 -0.721 . . . . 64.409999999999997 111.222 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -103.37 160.81 14.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.295 0.569 . . . . 74.219999999999999 111.7 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.09 -27.26 39.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.029 -0.987 . . . . 74.200000000000003 110.71 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -129.58 155.15 46.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 71.340000000000003 110.685 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.469 ' CD2' HG23 ' A' ' 103' ' ' THR . 21.9 p80 -77.51 -29.05 52.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 73.25 110.631 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 13.5 t0 -56.5 -43.58 79.85 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.799 -1.092 . . . . 65.040000000000006 111.602 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.1 t -63.23 -36.57 84.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.821 -0.627 . . . . 73.239999999999995 111.312 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.52 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.9 t -70.44 -39.99 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.146 0.498 . . . . 63.310000000000002 109.986 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 4.8 t70 -68.76 -33.42 73.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.975 -1.011 . . . . 75.120000000000005 111.032 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.5 mttt -59.04 -40.74 85.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.564 0.697 . . . . 72.430000000000007 110.716 173.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.81 -40.61 46.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.634 -1.167 . . . . 71.010000000000005 111.893 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 30.7 m -78.34 -9.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.064 0.459 . . . . 53.509999999999998 111.102 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.13 -33.1 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.641 -0.709 . . . . 61.43 109.933 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.462 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 49.2 mt-30 -113.89 106.18 14.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.763 -0.653 . . . . 63.409999999999997 109.378 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.31 -34.49 57.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.262 0.838 . . . . 74.219999999999999 113.262 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.62 144.12 50.35 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.006 -0.278 . . . . 75.439999999999998 110.502 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.9 m-70 -132.49 151.81 51.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.936 176.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 130.05 55.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.916 0.389 . . . . 64.450000000000003 110.701 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.63 140.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.872 -0.788 . . . . 61.530000000000001 108.872 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.1 m120 48.45 30.27 2.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.391 0.886 . . . . 64.209999999999994 113.391 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.96 -0.71 89.58 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.907 -0.663 . . . . 63.119999999999997 114.118 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -113.83 135.16 54.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.908 0.854 . . . . 73.439999999999998 110.859 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -99.6 116.49 31.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 65.120000000000005 110.42 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 55.8 m -117.21 157.09 26.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 71.420000000000002 111.096 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.4 141.87 28.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.609 . . . . 60.420000000000002 110.368 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.3 m -131.37 162.14 39.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.956 -0.565 . . . . 72.299999999999997 111.075 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -174.09 171.83 3.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.952 -1.022 . . . . 55.200000000000003 111.687 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -60.79 129.96 44.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.879 -0.601 . . . . 73.129999999999995 110.651 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.12 114.1 25.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.34 0.59 . . . . 74.200000000000003 109.61 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.273 -0.876 . . . . 64.430000000000007 109.738 -178.534 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.119 0.485 . . . . 64.329999999999998 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.43 ' OE2' HG12 ' A' ' 65' ' ' VAL . 1.8 mp0 -71.67 132.05 85.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.708 . . . . 74.310000000000002 110.627 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' HD22 ' A' ' 13' ' ' LEU . 26.1 Cg_endo -66.99 166.36 23.11 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.756 2.304 . . . . 73.239999999999995 111.134 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.9 pt-20 -60.05 -32.9 71.35 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 119.559 -0.257 . . . . 63.149999999999999 111.686 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.42 -25.04 61.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.654 0.264 . . . . 73.239999999999995 111.602 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.1 mp -87.53 -8.69 56.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.705 0.288 . . . . 74.049999999999997 111.064 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -125.79 2.95 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.481 -0.327 . . . . 75.109999999999999 111.078 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 15.1 ttmm -93.47 146.21 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.54 0.686 . . . . 73.109999999999999 111.502 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -119.48 141.3 49.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.491 -1.231 . . . . 54.200000000000003 110.079 177.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -98.33 116.04 29.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.784 -0.821 . . . . 54.409999999999997 108.784 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 60' ' ' VAL . 18.0 mm -93.13 110.85 23.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.999 -0.371 . . . . 71.200000000000003 109.999 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.23 152.2 17.99 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.834 -0.698 . . . . 64.209999999999994 111.679 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.6 41.77 56.53 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.019 -0.61 . . . . 63.119999999999997 113.618 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 25' ' ' THR . 49.8 mt -75.84 175.15 9.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.92 0.36 . . . . 75.519999999999996 110.382 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.3 p -88.15 172.33 9.57 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.516 -0.55 . . . . 43.530000000000001 109.516 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.04 -5.6 47.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.648 0.261 . . . . 63.229999999999997 111.176 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.88 21.67 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.105 0.409 . . . . 65.140000000000001 112.105 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.578 HG21 HD22 ' A' ' 21' ' ' LEU . 14.5 m -75.16 121.74 22.55 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 71.099999999999994 110.557 175.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -99.11 154.64 17.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.885 -0.413 . . . . 71.329999999999998 109.885 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.532 ' HA ' HG23 ' A' ' 45' ' ' VAL . 10.7 p-10 -64.86 -35.24 80.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 74.25 111.356 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.96 -36.77 80.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 74.420000000000002 111.211 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -76.87 -34.43 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 75.219999999999999 110.734 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 45' ' ' VAL . 34.9 tp -65.88 -42.87 89.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.035 -0.53 . . . . 62.439999999999998 109.862 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 19.2 ttm-85 -60.03 -57.97 10.53 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.393 -0.367 . . . . 64.310000000000002 110.127 176.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -50.06 -36.87 30.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.151 -0.931 . . . . 74.329999999999998 112.926 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -70.89 -58.38 3.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.433 -0.349 . . . . 75.099999999999994 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -70.53 -22.48 62.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.196 0.443 . . . . 74.200000000000003 112.196 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.1 tt0 -63.39 -17.81 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.095 0.558 . . . . 63.130000000000003 111.898 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.35 -28.43 69.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.389 -0.368 . . . . 64.349999999999994 111.343 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.14 -21.73 14.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 60.310000000000002 111.567 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -166.71 154.16 24.42 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.48 -0.867 . . . . 62.310000000000002 112.027 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -65.22 117.76 8.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 65.109999999999999 111.408 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 31' ' ' ARG . 57.2 mt -86.85 134.65 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.565 0.698 . . . . 73.010000000000005 111.4 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.189 -0.914 . . . . 64.319999999999993 110.254 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -151.16 152.3 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.618 -0.719 . . . . 33.420000000000002 109.956 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -161.73 133.65 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.021 -0.363 . . . . 71.450000000000003 110.021 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.31 125.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.311 0.577 . . . . 53.229999999999997 110.734 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 27' ' ' ASP . 96.1 t -86.83 131.41 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.577 -0.897 . . . . 71.439999999999998 108.577 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.12 95.3 6.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.651 0.738 . . . . 75.310000000000002 110.439 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -101.04 166.94 10.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.592 -1.185 . . . . 75.329999999999998 109.637 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.74 126.18 86.22 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.126 -0.694 . . . . 65.299999999999997 109.126 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.31 -23.85 75.51 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.216 1.944 . . . . 73.319999999999993 113.929 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.68 -55.85 3.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.096 0.406 . . . . 74.319999999999993 112.096 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -101.57 -11.19 19.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.93 0.395 . . . . 70.439999999999998 111.945 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm 66.17 34.89 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.512 -0.767 . . . . 74.540000000000006 111.525 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -97.64 140.03 32.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.952 -0.759 . . . . 71.519999999999996 108.952 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -70.49 133.03 46.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.987 0.422 . . . . 74.510000000000005 110.379 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.42 -0.6 37.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.685 -0.689 . . . . 74.230000000000004 110.616 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.52 55.93 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.913 -0.66 . . . . 64.150000000000006 113.716 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -158.85 158.58 33.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.937 0.869 . . . . 71.230000000000004 110.942 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.65 -166.75 20.06 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.849 -0.9 . . . . 74.109999999999999 110.849 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.62 151.26 42.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.427 0.614 . . . . 72.0 110.603 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -133.12 122.95 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.627 -0.715 . . . . 63.549999999999997 109.172 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.3 m -99.15 118.59 36.22 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.457 -0.572 . . . . 74.340000000000003 109.457 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 25.4 m-85 -84.5 169.49 14.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.364 . . . . 73.049999999999997 110.67 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.7 -50.13 26.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.145 -0.48 . . . . 54.030000000000001 109.927 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.37 155.51 37.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.598 -0.728 . . . . 65.310000000000002 110.215 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -63.85 -32.86 58.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.796 0.331 . . . . 72.430000000000007 110.31 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.69 -34.82 71.72 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.862 0.69 . . . . 63.140000000000001 112.862 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 7.2 mm-40 -62.01 -36.19 80.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 71.409999999999997 109.684 175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 4.0 t -64.31 -44.6 97.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.131 -0.94 . . . . 72.310000000000002 111.131 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.81 -43.24 99.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 73.430000000000007 111.04 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . . . -53.91 -38.37 64.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.64 0.608 . . . . 65.299999999999997 112.64 171.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.82 65.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.449 0.643 . . . . 64.109999999999999 109.948 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mmt -70.79 -39.54 73.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 71.25 112.124 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -79.14 -11.93 59.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.076 0.465 . . . . 75.420000000000002 110.442 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.45 -16.24 33.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 71.329999999999998 111.02 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -56.41 149.4 38.83 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 112.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.75 168.18 73.68 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.335 -1.527 . . . . 75.409999999999997 113.749 2.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -119.21 153.07 35.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.66 -0.7 . . . . 70.409999999999997 111.004 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.6 ttmt -139.5 108.94 6.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 52.149999999999999 111.092 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -121.38 137.18 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.716 -0.675 . . . . 74.120000000000005 109.603 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 66.11 21.69 11.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.774 0.829 . . . . 72.530000000000001 110.872 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.91 23.88 68.23 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.904 -0.589 . . . . 64.519999999999996 111.916 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.1 tpt180 -126.46 134.99 50.81 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.324 -0.251 . . . . 72.200000000000003 110.324 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.36 119.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.1 -0.704 . . . . 71.310000000000002 109.1 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 m -108.14 154.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.906 -0.588 . . . . 72.450000000000003 111.779 -172.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -113.5 93.93 29.71 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.959 -1.019 . . . . 74.230000000000004 110.611 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.428 ' O ' ' HE1' ' A' ' 156' ' ' HIS . 6.2 Cg_endo -77.16 128.32 9.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 70.209999999999994 110.716 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -126.28 168.8 13.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.257 -0.645 . . . . 70.200000000000003 109.257 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.676 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.1 tpp180 -75.59 128.65 35.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.122 -0.696 . . . . 74.140000000000001 109.122 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.0 99.78 1.49 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.399 0.619 . . . . 72.439999999999998 110.756 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.463 ' CG2' HG23 ' A' ' 163' ' ' VAL . 12.8 p -73.2 157.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.024 -0.989 . . . . 62.310000000000002 109.804 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -54.7 147.65 14.24 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 122.626 0.37 . . . . 74.219999999999999 110.585 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.504 0.927 . . . . 74.019999999999996 113.504 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.35 -38.23 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 75.310000000000002 110.995 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.42 -46.1 11.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 53.340000000000003 109.931 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 t -57.76 -26.04 61.29 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.556 -0.747 . . . . 51.240000000000002 112.29 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -69.16 -21.48 63.99 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 111.82 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -85.19 143.99 40.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.030000000000001 110.852 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.06 123.26 9.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 74.25 112.268 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 3.3 71.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.799 -0.715 . . . . 62.229999999999997 112.51 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.97 -52.14 8.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.691 0.256 . . . . 72.540000000000006 111.691 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 21.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 63.149999999999999 111.051 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -178.8 6.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.796 -0.816 . . . . 70.329999999999998 108.796 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.408 HG23 ' CD2' ' A' ' 156' ' ' HIS . 1.9 m -72.61 99.75 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.335 0.588 . . . . 73.319999999999993 111.041 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -126.55 111.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 71.540000000000006 109.757 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.424 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.6 mttt -107.02 14.69 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.034 -0.417 . . . . 72.420000000000002 111.116 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 139.56 51.05 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.342 -0.224 . . . . 72.340000000000003 110.946 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.89 151.7 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.352 0.596 . . . . 75.129999999999995 111.595 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -96.91 139.44 32.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.726 -1.124 . . . . 72.109999999999999 109.99 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.0 110.38 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.331 -0.618 . . . . 44.240000000000002 109.331 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.51 158.82 21.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.013 -1.089 . . . . 50.310000000000002 113.358 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.0 8.37 45.08 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.832 -0.699 . . . . 72.109999999999999 112.055 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.45 66.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 122.112 0.958 . . . . 62.25 110.512 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -65.3 -34.01 77.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 73.510000000000005 109.442 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -83.11 145.72 29.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.799 -1.091 . . . . 74.450000000000003 108.558 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.24 123.5 16.92 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.064 0.459 . . . . 71.140000000000001 112.203 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -128.08 139.98 52.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.597 -0.729 . . . . 64.510000000000005 110.084 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.25 167.63 10.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.337 -0.847 . . . . 74.219999999999999 111.642 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.53 -45.35 85.13 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.429 -0.805 . . . . 52.030000000000001 110.619 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -55.77 -34.48 65.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.473 0.483 . . . . 71.230000000000004 111.562 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -64.4 -60.79 2.75 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.381 -0.372 . . . . 74.109999999999999 111.507 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.473 HD21 HG21 ' A' ' 134' ' ' ILE . 2.4 pt? -82.41 -24.65 34.27 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 119.962 -0.695 . . . . 63.310000000000002 110.814 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -63.23 -54.65 34.04 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 110.108 -0.33 . . . . 63.409999999999997 110.108 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -27.89 69.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.984 0.421 . . . . 73.540000000000006 110.859 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.46 ' CD2' HG22 ' A' ' 170' ' ' VAL . 75.8 t80 -78.36 -53.87 6.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.83 -0.623 . . . . 74.209999999999994 111.619 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.0 m-85 -68.72 -22.77 64.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.622 0.249 . . . . 73.230000000000004 111.506 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.71 -26.33 68.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.236 0.541 . . . . 73.420000000000002 110.884 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.28 -30.62 71.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 74.230000000000004 111.633 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.1 -23.77 32.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.499 -0.319 . . . . 74.510000000000005 111.012 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.92 -176.65 42.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 72.010000000000005 112.928 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -73.37 130.7 40.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.15 0.5 . . . . 71.219999999999999 110.871 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 152' ' ' THR . 62.1 mt -101.25 139.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.636 -0.711 . . . . 71.349999999999994 109.939 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.19 -49.91 6.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.817 0.341 . . . . 74.239999999999995 110.583 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.45 155.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 61.329999999999998 109.929 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.473 HG21 HD21 ' A' ' 121' ' ' LEU . 4.2 mp -116.24 126.31 73.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.288 -0.634 . . . . 73.219999999999999 109.288 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.4 mt-10 -98.65 104.53 16.57 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 70.230000000000004 110.994 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.1 116.01 35.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.442 -0.577 . . . . 63.210000000000001 109.442 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 69.0 mmm -87.72 119.28 27.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.861 -0.609 . . . . 72.120000000000005 109.994 -175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 63.409999999999997 110.704 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.176 0 N-CA-C 112.385 -0.286 . . . . 73.530000000000001 112.385 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -157.88 158.0 34.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.548 -0.538 . . . . 73.319999999999993 109.548 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.85 176.3 8.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.706 -0.679 . . . . 53.229999999999997 109.829 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.9 m-85 -139.53 152.67 47.1 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.591 -0.731 . . . . 74.230000000000004 109.186 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 107' ' ' ILE . 3.1 p -144.22 133.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.424 0.631 . . . . 61.439999999999998 111.169 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 131' ' ' ILE . 41.1 m -103.26 126.01 50.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.074 -0.966 . . . . 72.140000000000001 110.856 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 7.6 m-85 -100.82 158.45 15.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.06 0.457 . . . . 62.43 111.412 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.75 -28.94 44.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.479 -0.782 . . . . 61.530000000000001 110.293 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.0 151.36 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 75.120000000000005 110.842 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.428 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 24.2 p80 -80.17 -27.35 38.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 64.400000000000006 110.777 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 29.6 t70 -58.28 -40.36 81.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.708 -0.678 . . . . 64.409999999999997 111.067 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.2 m -67.56 -30.97 70.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 73.310000000000002 111.508 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -72.95 -42.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.484 -0.325 . . . . 72.319999999999993 110.471 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 1.8 m-20 -68.36 -24.06 64.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.925 -0.58 . . . . 51.119999999999997 111.424 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 81.9 mttt -63.66 -42.6 98.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.728 0.775 . . . . 65.299999999999997 110.177 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -74.15 -42.71 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 73.230000000000004 111.663 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.587 HG21 ' HD3' ' A' ' 179' ' ' LYS . 29.4 m -79.93 -2.16 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.064 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 5.7 mt -63.07 -28.87 45.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.945 0.878 . . . . 53.32 109.046 167.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.579 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 49.2 mt-30 -111.47 145.39 39.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.857 -1.164 . . . . 75.200000000000003 107.857 174.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -91.77 -32.43 15.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.327 0.584 . . . . 73.349999999999994 110.684 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -124.69 137.98 54.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.713 -0.676 . . . . 74.549999999999997 109.951 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.579 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 42.8 m-70 -127.41 142.54 51.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.902 0.382 . . . . 72.439999999999998 110.615 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -94.77 110.36 22.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.982 -0.554 . . . . 73.5 111.036 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 124' ' ' TYR . 21.7 t -111.04 127.79 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.326 -0.852 . . . . 75.400000000000006 109.222 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.2 t30 42.55 48.98 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.666 0.617 . . . . 53.5 112.666 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.24 0.98 48.47 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.125 -0.56 . . . . 74.230000000000004 114.055 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.83 121.96 45.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.932 -0.396 . . . . 73.439999999999998 109.932 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.49 110.11 19.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.169 0.509 . . . . 61.25 110.887 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.55 156.99 18.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.498 -0.774 . . . . 71.430000000000007 110.414 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.46 141.54 28.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.289 -0.263 . . . . 75.219999999999999 110.289 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 m -131.97 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.943 0.401 . . . . 55.310000000000002 110.793 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -175.43 170.77 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.021 -0.991 . . . . 70.299999999999997 111.287 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 163' ' ' VAL . 5.8 mmmm -63.54 132.7 52.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 63.049999999999997 110.501 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.94 127.23 52.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.358 0.599 . . . . 73.120000000000005 110.211 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--N 1.312 -1.039 0 CA-C-N 115.265 -0.879 . . . . 75.519999999999996 108.906 -179.555 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.19 0.519 . . . . 73.5 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.39 134.99 20.81 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 73.109999999999999 110.355 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 13' ' ' LEU . 29.0 Cg_endo -65.82 167.19 18.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.775 2.317 . . . . 74.140000000000001 112.027 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -40.09 70.2 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.425 0.528 . . . . 71.510000000000005 112.425 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.15 -27.37 67.97 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.163 0.431 . . . . 63.409999999999997 112.163 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.4 mp -78.99 -22.44 45.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.559 0.218 . . . . 74.219999999999999 111.26 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.5 ptt180 -120.2 -0.97 10.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.279 0.474 . . . . 74.340000000000003 112.279 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 33.1 ttpt -94.67 143.8 26.14 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.574 0.702 . . . . 74.400000000000006 111.822 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD21 HG13 ' A' ' 68' ' ' VAL . 65.9 mt -115.65 145.65 42.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.694 -1.139 . . . . 53.32 109.909 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -96.27 134.3 39.56 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.275 -1.009 . . . . 74.329999999999998 108.275 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 60' ' ' VAL . 19.6 mm -110.84 112.04 38.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.905 -0.406 . . . . 70.209999999999994 109.905 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.96 153.51 17.08 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.301 -0.952 . . . . 74.209999999999994 111.592 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.87 40.19 52.91 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 75.540000000000006 113.675 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 25' ' ' THR . 51.8 mt -78.27 177.02 8.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.956 -0.387 . . . . 53.299999999999997 109.956 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -84.13 -179.42 7.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.899 0.38 . . . . 72.230000000000004 110.099 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -84.1 -9.16 58.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.349 0.595 . . . . 71.420000000000002 109.851 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.03 20.37 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.791 -0.64 . . . . 75.140000000000001 111.786 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.478 HG21 HD22 ' A' ' 21' ' ' LEU . 27.1 m -75.62 131.53 40.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.811 0.339 . . . . 74.040000000000006 111.047 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 p -114.41 160.64 18.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 61.439999999999998 110.531 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 1.9 m-20 -62.59 -38.62 90.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 73.319999999999993 110.616 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.48 -42.14 98.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.381 -0.827 . . . . 61.119999999999997 111.353 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -75.87 -37.76 58.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.024 -0.534 . . . . 60.329999999999998 110.716 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.25 -43.59 90.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 64.519999999999996 110.454 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -60.46 -54.95 39.39 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.092 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -47.41 -39.72 16.08 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.302 1.001 . . . . 75.019999999999996 113.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -68.47 -61.27 1.9 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 75.040000000000006 110.967 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -71.08 -24.51 62.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.137 0.421 . . . . 73.150000000000006 112.137 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.1 tt0 -62.49 -21.08 65.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.28 -0.418 . . . . 73.0 111.837 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -62.1 -27.53 68.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.723 0.297 . . . . 75.129999999999995 111.461 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -98.05 -24.36 15.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.407 -0.361 . . . . 72.019999999999996 111.259 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.5 166.47 39.2 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.173 -1.013 . . . . 53.009999999999998 112.834 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -61.49 141.19 57.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.077 0.551 . . . . 73.209999999999994 111.369 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 mt -118.5 123.3 44.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.362 -0.607 . . . . 52.039999999999999 109.362 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -90.13 -25.1 20.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.087 -0.506 . . . . 74.120000000000005 110.295 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.34 152.16 31.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.488 -0.778 . . . . 65.209999999999994 109.864 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.6 t -160.15 123.99 3.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.294 -0.632 . . . . 71.409999999999997 109.294 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.411 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 p -143.26 118.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.516 0.674 . . . . 70.150000000000006 110.431 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 133.12 31.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 107.917 -1.142 . . . . 72.329999999999998 107.917 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.5 mmt -77.78 96.86 5.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.623 0.725 . . . . 51.329999999999998 110.236 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -96.81 161.27 13.93 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.423 -1.262 . . . . 51.450000000000003 108.975 175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.94 125.54 92.02 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.221 -0.659 . . . . 53.32 109.221 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.47 -20.94 53.98 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.573 1.515 . . . . 73.099999999999994 112.982 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -86.65 -55.63 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 72.519999999999996 111.223 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -16.48 23.56 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.917 -0.583 . . . . 74.129999999999995 112.18 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp 65.74 29.12 10.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.926 0.89 . . . . 73.099999999999994 111.925 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -107.35 155.14 20.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.02 -0.733 . . . . 71.349999999999994 109.02 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 t -71.05 135.46 47.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.911 0.386 . . . . 75.230000000000004 111.16 -173.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -87.38 5.27 39.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 73.120000000000005 110.775 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.52 70.62 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.864 -0.684 . . . . 51.310000000000002 114.175 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 25.5 p90 -156.0 156.41 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.04 0.92 . . . . 75.510000000000005 110.801 174.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.05 -165.15 17.25 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.639 -0.585 . . . . 41.350000000000001 111.639 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.51 145.65 31.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.973 0.387 . . . . 74.109999999999999 109.99 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 HD11 ' A' ' 18' ' ' ILE . 8.8 m -128.26 119.87 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 63.030000000000001 110.2 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.5 m -95.69 122.29 38.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.052 -0.351 . . . . 72.150000000000006 110.052 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -85.63 170.24 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 72.019999999999996 110.106 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.446 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -74.29 -52.57 11.89 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.671 -0.492 . . . . 74.120000000000005 109.671 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -122.37 150.29 42.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 74.409999999999997 110.502 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -63.81 -35.43 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.576 0.227 . . . . 72.239999999999995 111.263 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -52.29 -41.35 62.83 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.767 0.654 . . . . 74.209999999999994 112.767 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 47.4 mt-10 -68.74 -28.39 66.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.189 0.518 . . . . 62.399999999999999 110.726 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 14' ' ' ARG . 25.0 t -65.31 -45.39 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.418 -0.81 . . . . 72.209999999999994 111.083 175.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.81 -45.01 86.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.544 . . . . 62.530000000000001 110.912 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.1 -41.52 60.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 74.010000000000005 112.095 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -37.7 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 71.040000000000006 110.977 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.5 mmt -68.61 -32.95 73.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.059 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -10.07 55.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.049 -0.523 . . . . 64.230000000000004 110.851 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.56 -9.27 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.264 0.554 . . . . 71.150000000000006 110.265 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp180 -53.39 142.48 39.45 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.818 -1.083 . . . . 61.119999999999997 111.327 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 6.1 Cg_exo -78.49 168.75 74.58 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.647 -0.981 . . . . 65.430000000000007 113.385 3.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -124.96 155.02 40.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.146 -0.933 . . . . 74.430000000000007 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.7 ttmt -132.79 106.94 8.04 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.84 0.352 . . . . 75.310000000000002 111.22 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.82 127.31 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 61.399999999999999 110.04 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.8 t70 67.15 29.94 7.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.561 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.13 67.34 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.629 -0.714 . . . . 64.040000000000006 111.91 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.8 tpt180 -130.81 139.19 50.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.136 -0.32 . . . . 72.129999999999995 110.136 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.33 113.14 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.087 -0.708 . . . . 71.150000000000006 109.087 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.83 149.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.425 0.631 . . . . 65.409999999999997 111.182 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -112.93 96.64 38.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.027 -0.988 . . . . 74.049999999999997 110.662 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.85 138.3 18.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.309 2.006 . . . . 64.409999999999997 112.136 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -132.96 168.67 18.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.113 -1.44 . . . . 62.140000000000001 107.113 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.442 HH11 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -83.31 142.25 31.22 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.867 -0.733 . . . . 71.349999999999994 109.101 173.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.73 92.15 1.97 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.29 0.567 . . . . 60.399999999999999 109.621 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.36 158.06 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.863 -1.062 . . . . 64.340000000000003 110.457 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -52.9 145.21 13.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.849 -0.614 . . . . 52.009999999999998 110.619 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.48 -41.61 30.23 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.489 0.922 . . . . 74.329999999999998 113.489 -168.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.16 -51.4 67.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.427 0.156 . . . . 70.519999999999996 111.26 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.0 -29.68 66.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.417 -0.356 . . . . 55.450000000000003 110.398 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -64.19 -18.43 64.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 73.209999999999994 111.539 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -96.42 -2.63 45.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.066 0.46 . . . . 71.0 110.73 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -88.91 151.47 47.28 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.405 -0.361 . . . . 74.420000000000002 111.039 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.01 118.55 5.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.711 2.274 . . . . 62.119999999999997 112.16 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.96 21.11 31.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.852 -0.69 . . . . 64.430000000000007 112.468 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.72 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.049 0.452 . . . . 72.030000000000001 111.928 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -104.62 25.67 10.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.081 -0.509 . . . . 62.030000000000001 111.409 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.39 -171.9 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.976 -0.557 . . . . 72.019999999999996 109.809 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 58.87 3.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.616 . . . . 73.099999999999994 110.794 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.97 107.96 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 74.510000000000005 110.181 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.467 ' C ' HG21 ' A' ' 159' ' ' VAL . 63.4 mttt -111.02 14.95 21.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.034 0.445 . . . . 51.140000000000001 110.343 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.58 140.87 47.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.271 -0.422 . . . . 72.200000000000003 110.229 178.265 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 159' ' ' VAL . 3.6 pt -129.25 149.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 64.040000000000006 111.399 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.9 t80 -97.24 133.16 42.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.086 -0.961 . . . . 75.109999999999999 109.189 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.63 110.02 24.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.23 147.95 16.92 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.034 -1.079 . . . . 65.239999999999995 113.074 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.56 22.22 8.7 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.835 -0.698 . . . . 43.420000000000002 112.158 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.7 pt -91.18 77.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.909 0.861 . . . . 74.439999999999998 110.458 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -66.71 -50.84 61.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.054 -0.975 . . . . 72.329999999999998 111.051 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.12 155.19 40.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.618 -0.512 . . . . 73.019999999999996 109.618 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.42 99.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.404 0.621 . . . . 52.240000000000002 110.884 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.5 m -97.53 134.01 41.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.229 -0.896 . . . . 64.219999999999999 109.719 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 120' ' ' HIS . 61.8 mt-10 -110.64 167.16 10.44 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.736 -1.12 . . . . 75.25 110.408 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 121' ' ' LEU . 26.9 tt0 -59.73 -46.04 90.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.823 . . . . 74.450000000000003 111.548 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -69.36 -22.03 63.77 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.888 -0.325 . . . . 71.510000000000005 111.484 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 61.2 m170 -61.49 -60.16 4.13 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.781 0.324 . . . . 53.32 110.532 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 118' ' ' GLU . 1.9 pt? -84.2 -21.07 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.292 -0.563 . . . . 45.25 111.143 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -65.94 -52.87 45.97 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.853 -0.425 . . . . 71.310000000000002 109.853 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -31.9 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.344 0.593 . . . . 72.219999999999999 110.416 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.406 ' OH ' ' HB3' ' A' ' 168' ' ' HIS . 83.1 t80 -72.6 -58.66 3.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.211 -0.904 . . . . 75.25 112.088 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.9 m-85 -66.43 -21.12 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.901 0.334 . . . . 73.549999999999997 111.901 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.39 -25.37 67.53 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.471 0.308 . . . . 73.129999999999995 111.31 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.16 -31.51 63.44 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.129 -0.487 . . . . 75.219999999999999 111.304 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.59 -28.56 23.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 52.539999999999999 111.941 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.9 -172.85 45.35 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.384 -0.912 . . . . 62.409999999999997 113.654 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -76.42 128.55 35.03 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.131 0.491 . . . . 73.5 111.683 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 61.3 mt -100.87 137.6 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 32.32 109.994 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -86.88 -52.19 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 73.109999999999999 110.428 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.15 155.74 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.321 -0.4 . . . . 64.299999999999997 110.209 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.89 129.01 72.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.239 0.542 . . . . 74.409999999999997 109.935 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.71 104.22 14.53 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.648 -0.706 . . . . 73.049999999999997 110.977 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.2 mm -90.8 120.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.976 -0.749 . . . . 72.319999999999993 108.976 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.427 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 71.9 mmm -94.88 113.88 25.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.748 0.785 . . . . 75.129999999999995 110.392 -175.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 114.846 -1.07 . . . . 73.230000000000004 109.794 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.325 0 N-CA-C 114.303 0.481 . . . . 61.399999999999999 114.303 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -155.48 157.5 37.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.595 0.697 . . . . 74.310000000000002 110.259 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.24 177.13 8.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 35.219999999999999 109.899 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -140.87 149.15 41.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.691 -0.686 . . . . 74.519999999999996 109.713 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.449 HG21 ' CD2' ' A' ' 125' ' ' PHE . 66.7 t -133.75 130.9 56.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.464 -0.334 . . . . 73.0 110.77 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.436 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 60.0 m -103.49 125.37 50.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.689 -0.687 . . . . 72.439999999999998 110.616 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.56 162.66 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.987 0.422 . . . . 72.219999999999999 111.208 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.75 -29.34 29.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.591 -0.732 . . . . 71.0 110.253 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.92 144.51 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 74.109999999999999 110.279 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -72.24 -26.53 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 74.109999999999999 110.129 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -55.44 -44.74 76.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.106 -0.952 . . . . 65.200000000000003 111.399 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -71.56 -33.35 69.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.037 -0.528 . . . . 71.439999999999998 111.212 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.467 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.87 -38.49 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.868 0.365 . . . . 55.140000000000001 110.088 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.447 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.7 t70 -67.05 -34.23 77.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.521 -0.763 . . . . 74.040000000000006 110.841 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.7 mttt -56.58 -40.87 75.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 110.349 172.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.5 mt -73.54 -45.43 51.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.397 -1.274 . . . . 75.109999999999999 112.286 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 160' ' ' ASP . 15.8 m -75.11 -10.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.24 0.543 . . . . 63.210000000000001 111.027 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.456 HD13 HD12 ' A' ' 13' ' ' LEU . 14.1 mt -61.96 -31.9 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.139 -0.937 . . . . 73.299999999999997 109.971 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 64.6 mt-30 -107.84 104.1 13.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.82 -0.807 . . . . 41.210000000000001 108.82 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -54.08 -35.0 61.61 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.714 0.635 . . . . 64.200000000000003 112.714 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -122.15 138.45 54.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.888 0.375 . . . . 73.349999999999994 111.208 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -130.18 146.36 51.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 73.140000000000001 110.152 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -104.04 115.01 29.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 74.540000000000006 111.05 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.9 p -141.43 146.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.626 -0.715 . . . . 70.430000000000007 109.187 177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 58.33 29.52 18.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.343 1.068 . . . . 62.140000000000001 110.54 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.2 0.87 84.49 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.212 -0.904 . . . . 65.239999999999995 113.253 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -121.59 133.59 55.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.071 0.463 . . . . 74.219999999999999 111.068 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.08 108.55 18.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 62.009999999999998 109.715 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.2 p -113.11 157.17 21.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 50.149999999999999 110.677 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -85.76 134.05 33.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.959 0.409 . . . . 71.040000000000006 110.072 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.0 t -130.44 132.46 64.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.564 -0.744 . . . . 70.510000000000005 109.799 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -153.73 173.8 15.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.789 -0.641 . . . . 65.430000000000007 110.994 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -64.56 131.54 47.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.129 0.49 . . . . 73.200000000000003 111.3 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -122.92 118.56 28.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.715 -0.846 . . . . 65.430000000000007 108.715 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 109.756 -0.461 . . . . 72.109999999999999 109.756 -178.33 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 121.337 0.589 . . . . 61.420000000000002 109.782 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.18 135.64 57.88 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.192 -0.913 . . . . 62.119999999999997 110.219 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HD2' HD12 ' A' ' 13' ' ' LEU . 11.4 Cg_endo -63.17 160.24 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.118 1.879 . . . . 72.129999999999995 110.965 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.6 63.23 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.1 0.407 . . . . 60.229999999999997 112.1 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.26 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 61.5 112.434 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 10' ' ' PRO . 42.7 mt -79.36 -16.92 55.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 63.219999999999999 110.719 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.507 ' HA ' HG21 ' A' ' 68' ' ' VAL . 17.6 ptt85 -122.97 4.83 9.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 72.140000000000001 111.492 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.9 ttpt -99.08 149.78 22.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.224 0.535 . . . . 52.409999999999997 110.666 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.766 HD11 HG13 ' A' ' 68' ' ' VAL . 7.6 mp -116.38 141.32 48.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.009 -0.996 . . . . 75.299999999999997 110.224 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -97.27 114.4 26.15 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.445 -0.946 . . . . 60.310000000000002 108.445 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 mm -94.08 111.0 24.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 110.053 -0.351 . . . . 54.229999999999997 110.053 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.3 152.68 18.45 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.561 -0.828 . . . . 70.299999999999997 111.314 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.88 45.76 41.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.629 -0.796 . . . . 72.120000000000005 113.142 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 25' ' ' THR . 75.9 mt -79.64 175.27 10.77 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.78 -0.452 . . . . 53.530000000000001 109.78 172.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 82' ' ' ARG . 21.2 p -91.34 175.33 6.97 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.549 -0.538 . . . . 74.230000000000004 109.549 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -75.23 -8.16 55.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.321 0.581 . . . . 64.430000000000007 110.081 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.77 9.12 17.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.568 -0.742 . . . . 70.099999999999994 112.138 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.628 HG21 HD22 ' A' ' 21' ' ' LEU . 19.3 m -76.6 120.69 22.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.447 -0.501 . . . . 71.019999999999996 111.161 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 p -103.96 159.98 15.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 71.310000000000002 110.468 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 2.5 m-20 -60.34 -38.84 85.02 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.032 -0.531 . . . . 73.209999999999994 110.93 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.69 -39.56 91.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.736 -0.665 . . . . 74.219999999999999 111.718 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -75.92 -39.89 55.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.541 -0.3 . . . . 65.319999999999993 110.683 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.82 -47.49 83.2 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.041 -0.527 . . . . 71.109999999999999 109.995 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -57.59 -60.33 3.83 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 111.356 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -51.97 -36.6 50.09 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.537 0.523 . . . . 75.200000000000003 112.284 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -71.45 -56.8 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.651 -0.25 . . . . 74.439999999999998 110.908 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -68.55 -25.18 64.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 63.140000000000001 111.851 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.6 tt0 -64.91 -15.11 61.65 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.113 0.412 . . . . 70.340000000000003 112.113 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -29.57 70.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.822 0.344 . . . . 73.530000000000001 111.163 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -98.01 -22.3 16.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.542 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -168.36 159.39 32.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.36 -0.924 . . . . 73.400000000000006 112.099 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.5 m -64.64 118.27 8.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.048 0.451 . . . . 73.329999999999998 111.999 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -92.12 134.12 35.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.434 0.635 . . . . 53.210000000000001 110.761 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -107.75 -19.41 13.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.001 . . . . 65.310000000000002 110.238 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 32.0 t70 -151.51 152.44 32.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 75.140000000000001 109.897 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.0 t -163.03 127.24 2.96 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.502 -0.555 . . . . 74.299999999999997 109.502 172.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 4.8 p -142.01 123.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.536 0.684 . . . . 61.310000000000002 110.63 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.4 130.67 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.506 -0.924 . . . . 75.310000000000002 108.506 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.88 135.69 46.66 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.959 -0.756 . . . . 70.340000000000003 108.959 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -135.35 156.55 48.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.874 -0.603 . . . . 74.439999999999998 111.493 -170.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 13.3 t70 -66.46 132.3 94.25 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.837 -1.074 . . . . 72.230000000000004 109.323 174.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.82 -18.88 47.34 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 121.897 1.732 . . . . 74.319999999999993 113.864 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -85.56 -57.31 3.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.844 0.354 . . . . 54.039999999999999 111.604 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -105.45 -7.72 18.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.061 -0.518 . . . . 51.5 111.305 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 40.0 mmtm 63.63 32.06 14.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.803 0.841 . . . . 73.019999999999996 111.555 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -95.94 162.43 13.57 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.808 -0.812 . . . . 74.340000000000003 108.808 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -65.69 139.71 58.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.838 0.351 . . . . 73.040000000000006 111.613 -171.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.14 2.21 47.67 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.769 -0.65 . . . . 53.219999999999999 110.379 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 15.92 61.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.741 -0.743 . . . . 60.130000000000003 113.242 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -161.19 157.15 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.154 0.477 . . . . 62.43 110.524 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.27 -164.21 16.74 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 111.52 -0.632 . . . . 75.519999999999996 111.52 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -142.35 150.87 41.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.32 0.56 . . . . 73.209999999999994 110.805 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 16' ' ' LEU . 5.8 m -132.84 123.37 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.78 -0.645 . . . . 54.399999999999999 109.87 172.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 42' ' ' ASP . 5.2 m -98.94 120.64 39.72 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.332 -0.23 . . . . 72.129999999999995 110.609 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.63 161.8 17.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.167 -0.47 . . . . 74.349999999999994 110.322 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 -35.59 62.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 110.599 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.86 149.36 52.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 72.329999999999998 110.347 -178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.5 p -66.44 -34.6 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 120.778 0.323 . . . . 61.450000000000003 111.096 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.94 -37.44 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.206 0.447 . . . . 75.430000000000007 112.206 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.05 -29.49 70.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 71.420000000000002 110.368 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.766 HG13 HD11 ' A' ' 16' ' ' LEU . 2.7 t -62.11 -44.52 99.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.175 -0.92 . . . . 64.129999999999995 110.98 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -41.18 97.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 111.131 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.75 -39.88 78.4 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.025 0.38 . . . . 65.530000000000001 112.025 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.95 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 63.409999999999997 110.529 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.414 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.0 mmt -66.41 -33.46 75.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.769 -0.65 . . . . 63.25 110.529 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.598 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 3.4 p30 -82.26 -9.6 59.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.991 0.424 . . . . 75.349999999999994 111.091 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.59 -14.39 45.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.856 -0.611 . . . . 74.530000000000001 112.518 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -49.16 146.35 6.1 Favored Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 112.705 0.631 . . . . 75.140000000000001 112.705 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.4 154.34 85.22 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 124.02 -1.242 . . . . 70.129999999999995 113.287 1.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -107.44 147.16 30.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.705 -0.68 . . . . 71.340000000000003 110.441 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -138.45 104.37 5.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.118 0.485 . . . . 73.540000000000006 111.226 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.34 139.92 43.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.335 -0.617 . . . . 61.130000000000003 109.335 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 1.7 m-20 62.72 31.79 16.44 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.565 0.54 . . . . 73.140000000000001 111.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.67 23.53 77.68 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.396 -0.82 . . . . 45.119999999999997 112.605 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.9 tpt180 -129.38 137.35 50.9 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.848 -0.207 . . . . 71.329999999999998 110.787 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.35 116.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.984 -0.747 . . . . 71.519999999999996 108.984 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -109.91 154.18 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.288 0.566 . . . . 70.040000000000006 111.493 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.85 95.89 35.51 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.142 -0.935 . . . . 74.140000000000001 110.753 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.55 134.11 16.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.09 1.86 . . . . 62.439999999999998 112.155 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 31.9 mmtt -125.9 -177.82 4.07 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.849 -1.167 . . . . 63.130000000000003 107.849 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.501 HH22 ' HE2' ' A' ' 161' ' ' LYS . 12.2 mmt-85 -80.87 163.14 23.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.281 0.492 . . . . 73.030000000000001 109.764 170.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.08 90.49 4.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.817 0.818 . . . . 75.140000000000001 108.822 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 164' ' ' ILE . 16.5 t -82.75 156.35 3.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.58 -1.191 . . . . 75.340000000000003 109.191 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.3 t -54.82 148.38 13.21 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.461 0.476 . . . . 70.120000000000005 109.902 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.555 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 6.8 tpp180 -66.52 -6.02 13.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.089 0.471 . . . . 64.150000000000006 111.984 -172.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.85 -43.95 94.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.277 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.11 -43.88 14.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.842 -0.617 . . . . 74.120000000000005 111.088 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 1.5 p -69.34 -12.31 61.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.242 -0.436 . . . . 71.200000000000003 111.875 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 33.9 tt0 -61.59 -34.93 76.47 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.239 -0.437 . . . . 70.030000000000001 110.964 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 97' ' ' ARG . 4.0 mpt_? -70.56 145.81 93.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.232 -174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.34 120.08 7.12 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.349 2.7 . . . . 71.420000000000002 112.712 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.1 29.14 69.18 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 121.18 -0.534 . . . . 63.240000000000002 113.023 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' A' ' 179' ' ' LYS . . . -78.85 -49.6 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.748 0.309 . . . . 75.019999999999996 110.618 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 95' ' ' SER . 4.7 m80 -81.16 25.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.647 0.61 . . . . 61.43 112.647 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.53 -164.09 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.715 -0.846 . . . . 73.120000000000005 108.715 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.11 88.76 5.97 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.596 -0.69 . . . . 62.119999999999997 111.122 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.92 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 71.209999999999994 109.569 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' C ' HG21 ' A' ' 159' ' ' VAL . 79.1 mttt -108.47 20.1 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.124 0.488 . . . . 53.520000000000003 110.605 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -120.58 139.74 52.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.192 -0.458 . . . . 53.219999999999999 110.636 178.238 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.523 HG23 HG13 ' A' ' 159' ' ' VAL . 4.6 pt -129.94 151.3 35.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.375 0.607 . . . . 74.010000000000005 111.665 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.3 t80 -101.86 133.24 46.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.621 -1.172 . . . . 74.319999999999993 109.809 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.5 110.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.336 -0.616 . . . . 70.310000000000002 109.336 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.28 157.23 19.4 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.297 -0.954 . . . . 72.409999999999997 112.953 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.94 19.66 30.58 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.773 -0.727 . . . . 64.340000000000003 111.828 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG22 ' SG ' ' A' ' 175' ' ' CYS . 29.8 pt -78.52 118.39 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.341 0.591 . . . . 62.219999999999999 110.874 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.99 -69.3 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 63.119999999999997 110.759 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.01 154.82 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.777 -0.453 . . . . 74.329999999999998 109.777 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.97 104.84 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.687 -0.688 . . . . 73.310000000000002 110.486 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -79.85 132.91 36.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.833 -0.621 . . . . 41.100000000000001 110.368 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -101.7 167.24 10.23 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.258 -0.883 . . . . 73.200000000000003 110.471 -177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 134' ' ' ILE . 5.8 tm-20 -61.58 -48.17 82.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 71.129999999999995 110.403 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -62.5 -26.75 68.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 75.530000000000001 111.137 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -63.95 -61.4 2.3 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.17 0.509 . . . . 73.0 110.461 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 134' ' ' ILE . 4.4 pp -82.47 -26.89 32.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.247 -0.581 . . . . 71.329999999999998 111.595 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -65.26 -50.57 65.28 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.965 -0.294 . . . . 72.140000000000001 110.315 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.15 -31.47 70.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 74.400000000000006 110.822 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 170' ' ' VAL . 78.2 t80 -76.96 -56.24 4.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.196 -0.456 . . . . 73.010000000000005 112.128 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 35.6 m-85 -66.98 -22.11 65.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.174 0.435 . . . . 73.549999999999997 112.174 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.4 mm-40 -64.79 -28.07 69.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.022 0.439 . . . . 71.310000000000002 110.77 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.77 -28.12 60.72 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.158 -0.474 . . . . 62.340000000000003 111.789 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.48 -26.42 24.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.35 -0.387 . . . . 73.549999999999997 111.717 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.75 -176.26 44.28 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 120.889 -0.672 . . . . 74.219999999999999 113.138 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -76.15 134.11 40.04 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 111.439 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 152' ' ' THR . 69.0 mt -105.85 142.02 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.749 -0.659 . . . . 72.519999999999996 110.75 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -91.42 -52.39 4.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 64.329999999999998 111.029 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -155.74 154.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.997 -0.547 . . . . 62.5 110.187 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 118' ' ' GLU . 3.3 mp -114.59 128.09 71.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 75.040000000000006 109.819 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -104.84 103.92 13.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.328 -0.851 . . . . 72.420000000000002 110.789 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -92.17 124.86 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.89 -0.782 . . . . 73.420000000000002 108.89 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.9 mmm -94.67 113.73 25.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.334 0.588 . . . . 72.129999999999995 109.843 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 71.420000000000002 110.406 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.407 -0.107 . . . . 63.039999999999999 112.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.98 157.51 43.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.763 -0.458 . . . . 73.099999999999994 109.763 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.26 166.39 24.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 71.0 109.735 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 67.2 m-85 -133.87 153.44 51.74 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.993 -0.549 . . . . 73.25 110.131 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.13 132.39 18.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.311 0.577 . . . . 75.340000000000003 111.063 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 55.9 m -98.49 124.57 43.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.102 -0.954 . . . . 55.130000000000003 110.495 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 6.4 m-85 -100.02 161.36 13.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.923 0.392 . . . . 75.510000000000005 111.187 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.21 -33.41 56.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.685 -0.689 . . . . 74.329999999999998 110.207 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.4 154.93 50.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.247 -0.888 . . . . 75.439999999999998 110.613 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.599 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 21.6 p80 -80.06 -21.27 43.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 110.321 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -53.62 -43.98 69.11 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.91 0.756 . . . . 75.329999999999998 110.96 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 m -71.96 -33.54 68.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.485 -0.779 . . . . 60.350000000000001 111.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.523 HG13 HG23 ' A' ' 107' ' ' ILE . 2.3 t -72.41 -37.62 58.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.206 0.527 . . . . 52.43 109.724 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.253 -0.885 . . . . 74.340000000000003 111.103 -178.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.5 mttt -68.27 -39.28 82.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.648 0.737 . . . . 60.130000000000003 110.134 172.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.14 -41.72 37.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.85 -1.068 . . . . 75.340000000000003 112.52 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.518 HG11 ' HD3' ' A' ' 179' ' ' LYS . 35.5 m -73.5 -5.49 6.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.045 0.45 . . . . 72.019999999999996 111.38 -174.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.55 ' HA ' HG13 ' A' ' 90' ' ' VAL . 50.8 mt -61.89 -33.56 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.399 -0.819 . . . . 63.119999999999997 110.295 171.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.1 mt-30 -110.32 108.68 18.84 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -56.0 -33.25 64.69 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.678 0.621 . . . . 75.439999999999998 112.678 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -123.5 139.81 53.64 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.24 -0.288 . . . . 73.150000000000006 110.689 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.2 m-70 -128.19 152.45 48.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 109.946 175.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 m -100.28 110.09 22.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 71.239999999999995 110.113 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 124' ' ' TYR . 12.0 t -124.11 133.16 70.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.005 -0.739 . . . . 74.540000000000006 109.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 57.07 28.06 14.32 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.608 0.718 . . . . 71.340000000000003 111.486 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.78 7.57 87.34 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.014 -0.613 . . . . 74.299999999999997 113.024 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -112.0 125.26 53.88 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.503 0.321 . . . . 73.25 110.759 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -82.56 110.69 17.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.478 0.656 . . . . 60.109999999999999 109.735 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 112' ' ' ILE . 16.0 m -122.36 157.65 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 64.299999999999997 110.792 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -85.59 132.81 34.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.341 -0.391 . . . . 73.239999999999995 110.294 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.9 t -129.16 135.34 62.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.689 -0.687 . . . . 75.019999999999996 110.155 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -158.0 173.29 16.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 72.129999999999995 110.856 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 100' ' ' ALA . 12.5 mmtm -58.92 132.29 53.55 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.353 0.408 . . . . 75.129999999999995 110.979 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.22 114.51 22.53 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.639 -0.504 . . . . 75.310000000000002 109.639 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 108.958 -0.756 . . . . 75.209999999999994 108.958 178.171 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm . . . . . 0 CA--C 1.532 0.256 0 N-CA-C 111.614 0.227 . . . . 72.239999999999995 111.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.4 122.54 78.8 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 74.329999999999998 109.544 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.4 Cg_endo -60.39 167.24 8.18 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.301 2.668 . . . . 71.319999999999993 112.532 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 2.2 pt-20 -51.18 -42.23 60.73 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 123.294 0.371 . . . . 65.310000000000002 111.54 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 5.5 pt20 -64.93 -19.82 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.622 0.601 . . . . 72.230000000000004 112.622 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.4 mp -90.07 -21.45 22.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.531 0.197 . . . . 74.230000000000004 111.531 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.3 ptt180 -117.83 -3.61 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.633 -0.427 . . . . 64.129999999999995 111.501 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -99.17 144.49 28.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.557 0.694 . . . . 62.340000000000003 111.549 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 68' ' ' VAL . 52.5 mt -115.61 148.27 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.741 -1.118 . . . . 63.409999999999997 110.544 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -98.61 125.97 44.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.407 -0.96 . . . . 63.049999999999997 108.407 172.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' VAL . 20.7 mm -103.86 111.9 35.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.819 -0.437 . . . . 63.420000000000002 109.819 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.44 17.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.595 -0.812 . . . . 73.109999999999999 111.847 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.63 47.36 27.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.609 -0.805 . . . . 72.219999999999999 113.152 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 25' ' ' THR . 86.1 mt -82.26 176.23 9.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.412 . . . . 73.430000000000007 109.889 172.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -88.34 175.23 7.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.054 0.454 . . . . 74.140000000000001 109.849 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -81.7 -4.98 57.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.018 -0.537 . . . . 72.030000000000001 110.438 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.35 9.11 10.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 61.229999999999997 111.549 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.595 HG21 HD22 ' A' ' 21' ' ' LEU . 53.4 m -75.94 127.23 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 60.509999999999998 111.379 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.9 p -103.19 172.6 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 73.409999999999997 110.37 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.56 -24.2 39.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.221 -0.288 . . . . 74.420000000000002 110.221 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.44 -39.04 68.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 64.420000000000002 111.204 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.5 p -75.4 -38.03 60.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 73.099999999999994 110.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.564 ' HA ' HG11 ' A' ' 79' ' ' VAL . 30.2 tp -62.94 -49.1 76.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.465 -0.789 . . . . 54.409999999999997 109.995 176.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.2 ttm180 -56.09 -62.42 1.72 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.519 -0.764 . . . . 72.200000000000003 111.959 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 t -50.65 -33.17 21.44 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.742 0.651 . . . . 75.209999999999994 112.544 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -75.2 -55.27 5.89 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.07 -0.252 . . . . 75.230000000000004 111.083 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.94 -22.77 62.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.067 0.395 . . . . 73.409999999999997 112.067 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -58.36 -22.83 54.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.049 0.539 . . . . 63.130000000000003 111.849 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -63.95 -27.52 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.362 . . . . 71.430000000000007 111.973 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -96.75 -23.74 16.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.762 0.315 . . . . 72.530000000000001 111.253 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.93 154.44 24.46 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.334 -0.936 . . . . 35.549999999999997 111.972 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.2 m -62.51 118.2 7.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 64.120000000000005 111.087 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -85.0 142.46 29.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 110.452 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -104.41 -25.43 12.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.607 -0.724 . . . . 71.209999999999994 109.682 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -153.49 156.2 37.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 70.310000000000002 110.084 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.4 t -161.79 132.32 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.454 -0.572 . . . . 72.109999999999999 109.454 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.68 118.02 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.716 0.769 . . . . 75.219999999999999 110.693 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.43 132.67 31.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.715 -0.846 . . . . 74.219999999999999 108.715 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mmt -76.19 101.37 5.37 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.512 0.673 . . . . 73.420000000000002 110.346 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -99.05 153.71 18.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.804 -1.089 . . . . 53.340000000000003 109.397 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.48 128.01 86.52 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.928 -0.578 . . . . 74.299999999999997 110.336 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 -17.07 58.39 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.284 1.99 . . . . 72.430000000000007 113.424 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -85.63 -56.11 3.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.965 0.412 . . . . 63.229999999999997 111.587 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -11.9 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 74.109999999999999 111.77 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 62.79 34.82 14.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.752 0.821 . . . . 71.239999999999995 110.808 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -112.2 160.9 17.14 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.033 -0.729 . . . . 74.420000000000002 109.033 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -74.09 131.7 41.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.814 0.34 . . . . 64.329999999999998 110.63 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -83.68 7.01 18.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 64.219999999999999 111.38 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.03 16.32 75.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.787 -0.721 . . . . 75.409999999999997 113.521 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -157.19 155.88 31.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.358 0.579 . . . . 75.319999999999993 110.355 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.2 -165.37 16.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.418 -0.673 . . . . 64.450000000000003 111.418 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.66 148.77 37.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.046 0.423 . . . . 75.430000000000007 110.31 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -128.11 127.23 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.719 -0.673 . . . . 62.409999999999997 109.534 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -101.96 117.43 34.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.0 -0.37 . . . . 74.540000000000006 110.0 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.1 m-85 -84.85 170.86 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.328 -0.396 . . . . 75.510000000000005 110.494 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.13 -49.48 28.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.863 -0.608 . . . . 61.240000000000002 110.044 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.499 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -128.83 160.22 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 71.109999999999999 110.792 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.3 p -65.12 -33.43 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.238 -0.437 . . . . 72.230000000000004 111.308 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -55.79 -44.54 77.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.509 0.559 . . . . 74.329999999999998 112.509 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.5 mp0 -61.28 -32.75 72.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.3 0.572 . . . . 72.129999999999995 110.728 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG13 HD21 ' A' ' 16' ' ' LEU . 39.1 t -65.95 -49.63 75.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.236 -0.893 . . . . 73.540000000000006 111.055 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.32 -43.83 88.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 75.349999999999994 110.875 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.63 -42.6 62.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.962 -0.563 . . . . 75.109999999999999 112.284 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.97 -33.07 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.866 0.365 . . . . 71.420000000000002 110.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.68 -42.12 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 110.433 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -12.29 59.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.807 -0.633 . . . . 74.5 111.069 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.78 -10.86 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 60.030000000000001 110.657 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 19.2 ttp-105 -53.49 144.31 33.04 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.279 -0.873 . . . . 75.140000000000001 110.892 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 87.7 Cg_endo -80.53 168.93 70.47 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.56 -1.017 . . . . 73.120000000000005 114.013 2.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -128.21 158.28 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.069 -0.969 . . . . 64.340000000000003 110.165 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.0 ttmt -134.55 104.59 6.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.082 -0.508 . . . . 65.439999999999998 110.3 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 30' ' ' LEU . 48.5 t -108.7 132.98 55.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 73.439999999999998 109.954 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 65.62 27.42 11.44 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.82 0.7 . . . . 74.109999999999999 110.856 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.51 21.89 76.43 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.804 -0.635 . . . . 31.440000000000001 112.497 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.3 tpt180 -128.68 137.63 51.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.226 -0.287 . . . . 61.119999999999997 110.226 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.81 111.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.419 -0.586 . . . . 71.340000000000003 109.419 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 21' ' ' LEU . 4.1 m -107.4 150.04 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.59 0.71 . . . . 65.230000000000004 111.431 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.05 95.46 38.36 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 114.823 -1.081 . . . . 72.219999999999999 110.926 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.97 131.98 17.65 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 111.949 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -141.08 -177.33 5.05 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.222 -0.899 . . . . 74.0 108.786 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 7.4 tpp180 -75.09 154.3 37.92 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.051 0.453 . . . . 75.140000000000001 111.28 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.22 91.24 6.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.421 -0.955 . . . . 72.200000000000003 108.421 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t -69.44 149.17 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.499 -0.773 . . . . 72.420000000000002 110.288 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 p -56.59 146.41 25.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 123.497 0.498 . . . . 74.310000000000002 110.034 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.21 -16.27 63.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.877 0.695 . . . . 73.430000000000007 112.877 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.63 -51.63 26.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 61.409999999999997 110.234 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.34 -20.66 33.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 63.450000000000003 111.467 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 t -69.66 -15.87 63.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.323 -0.399 . . . . 75.329999999999998 110.357 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.36 -17.91 59.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.656 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -79.32 147.47 68.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 60.43 110.841 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.69 116.5 4.58 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.699 2.266 . . . . 63.200000000000003 111.97 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.81 18.04 15.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.54 -0.838 . . . . 52.530000000000001 112.515 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.15 50.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.73 0.3 . . . . 71.319999999999993 111.096 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -103.3 13.68 33.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.021 0.439 . . . . 73.209999999999994 111.285 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.59 163.41 23.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.246 -0.65 . . . . 75.25 109.246 173.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.3 82.88 4.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.792 0.806 . . . . 74.200000000000003 110.63 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -108.63 113.69 44.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.699 -1.137 . . . . 74.040000000000006 109.753 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 159' ' ' VAL . 82.2 mttt -109.12 19.4 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.861 0.363 . . . . 75.030000000000001 110.475 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.41 144.54 45.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.546 -0.297 . . . . 62.329999999999998 110.667 175.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.457 HG23 HG13 ' A' ' 159' ' ' VAL . 5.3 pt -125.08 148.5 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.224 0.535 . . . . 63.119999999999997 111.19 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.9 t80 -97.74 131.96 43.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.019 -0.992 . . . . 72.120000000000005 109.008 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.46 108.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.981 -0.748 . . . . 75.329999999999998 108.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.37 166.27 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.87 -1.157 . . . . 74.319999999999993 113.294 -174.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.29 58.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.704 -0.76 . . . . 22.100000000000001 111.762 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.36 134.18 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 70.519999999999996 109.478 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.73 -49.28 9.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.882 0.372 . . . . 72.239999999999995 110.204 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.86 -173.56 2.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.056 -0.72 . . . . 74.310000000000002 109.056 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.81 135.27 34.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.297 0.57 . . . . 74.340000000000003 110.983 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 m -106.95 141.43 38.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 110.315 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.37 160.91 16.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.287 -0.415 . . . . 73.129999999999995 109.918 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.17 -51.12 71.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 72.409999999999997 110.093 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -58.88 -31.01 68.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 111.731 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.347 0.405 . . . . 73.310000000000002 110.71 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.7 pp -81.11 -27.45 35.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.449 -0.5 . . . . 74.450000000000003 110.99 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.41 -53.31 44.9 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 110.182 -0.303 . . . . 73.409999999999997 110.182 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.49 -28.27 69.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.209 0.528 . . . . 73.450000000000003 110.452 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.01 -56.71 4.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.95 -0.568 . . . . 71.109999999999999 111.54 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 29.7 m-85 -66.71 -22.1 66.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 72.019999999999996 111.773 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.16 -27.72 68.91 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.99 0.424 . . . . 71.209999999999994 111.214 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -58.07 -28.77 64.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 72.140000000000001 111.3 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -86.16 -26.49 25.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.356 . . . . 75.040000000000006 111.658 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -174.91 45.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.708 -0.758 . . . . 72.040000000000006 113.582 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -78.18 131.89 37.37 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.936 0.398 . . . . 53.340000000000003 111.716 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.82 139.92 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.922 -0.581 . . . . 70.420000000000002 110.384 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 -49.92 6.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 63.530000000000001 110.847 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.59 159.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.684 -0.487 . . . . 74.409999999999997 109.684 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.53 127.82 75.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.923 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.6 mt-10 -99.65 103.79 15.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.1 -0.954 . . . . 73.239999999999995 110.326 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.53 117.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.164 -0.68 . . . . 72.439999999999998 109.164 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.4 mmm -91.3 122.33 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.333 -0.617 . . . . 73.129999999999995 109.333 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.429 0.633 . . . . 72.150000000000006 112.039 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.475 -0.25 . . . . 65.439999999999998 112.475 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -157.46 158.8 36.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 110.392 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.5 170.07 16.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.48 -0.782 . . . . 71.209999999999994 109.54 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.6 m-85 -134.4 145.21 48.71 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.967 -0.56 . . . . 75.030000000000001 109.909 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.19 129.07 67.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.206 -0.452 . . . . 72.140000000000001 110.623 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 96.4 m -100.81 118.74 37.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.643 -0.708 . . . . 73.209999999999994 110.521 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.1 m-85 -102.16 156.81 17.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.768 0.318 . . . . 74.329999999999998 111.178 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.56 -31.93 60.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.931 -0.577 . . . . 73.010000000000005 110.366 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -128.26 152.96 47.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 75.420000000000002 110.663 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -75.96 -25.68 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.553 . . . . 75.439999999999998 109.508 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.59 -48.84 38.72 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.102 -0.954 . . . . 62.119999999999997 111.437 178.192 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 153' ' ' PHE . 1.7 m -72.44 -32.89 66.68 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.82 -0.627 . . . . 62.140000000000001 110.813 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.6 t -69.46 -42.34 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.312 -0.625 . . . . 75.209999999999994 109.312 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.565 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 3.6 m-20 -71.43 -22.49 61.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.082 -0.963 . . . . 72.340000000000003 111.804 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -67.01 -39.56 87.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.77 0.795 . . . . 55.049999999999997 109.786 170.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mt -76.02 -40.94 38.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.334 -1.303 . . . . 70.230000000000004 112.054 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 159' ' ' VAL . 7.5 m -73.33 -11.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.001 0.429 . . . . 64.239999999999995 110.924 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.497 HD13 HD12 ' A' ' 13' ' ' LEU . 10.8 mt -63.71 -29.99 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.323 -0.853 . . . . 73.239999999999995 110.193 173.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.561 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 54.6 mt-30 -112.66 98.42 7.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.898 -1.149 . . . . 63.109999999999999 107.898 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -56.67 -33.37 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.108 -0.951 . . . . 71.120000000000005 112.431 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -121.65 131.75 54.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.33 -0.395 . . . . 75.109999999999999 110.381 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.561 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -124.49 150.95 45.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.712 -0.676 . . . . 73.349999999999994 109.794 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -115.87 118.1 32.05 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.779 -0.452 . . . . 64.329999999999998 109.779 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.93 117.2 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.054 -0.521 . . . . 52.149999999999999 110.31 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.02 28.23 5.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 73.209999999999994 110.328 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 97.73 -9.13 64.07 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.534 -0.757 . . . . 61.549999999999997 113.309 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -108.61 125.68 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.444 0.622 . . . . 62.420000000000002 111.795 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -93.2 109.91 21.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.332 0.587 . . . . 43.329999999999998 110.014 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.1 p -114.64 155.31 26.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 110.675 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.0 129.94 34.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.504 -0.554 . . . . 60.32 109.504 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 12.4 t -127.74 134.45 65.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.411 -0.813 . . . . 54.539999999999999 110.202 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.6 177.0 11.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.707 -0.679 . . . . 64.239999999999995 111.134 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -64.1 125.72 25.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.36 -0.382 . . . . 73.040000000000006 110.144 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.67 44.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.016 0.436 . . . . 64.340000000000003 109.911 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.0 mt . . . . . 0 C--N 1.309 -1.168 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 109.99 179.485 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.001 0.429 . . . . 73.329999999999998 110.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -64.63 128.19 93.23 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 111.107 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HD2' HD22 ' A' ' 13' ' ' LEU . 34.2 Cg_endo -65.8 167.65 17.03 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.152 2.568 . . . . 63.340000000000003 112.186 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.56 -34.64 72.94 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 112.157 0.429 . . . . 74.109999999999999 112.157 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -67.87 -24.36 65.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.872 0.367 . . . . 75.040000000000006 111.363 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.455 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.0 mp -86.21 -10.6 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 53.140000000000001 111.188 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -122.34 0.72 9.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 70.319999999999993 111.216 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.2 ttpt -97.41 145.64 25.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.597 0.713 . . . . 72.0 111.983 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 68' ' ' VAL . 60.7 mt -117.76 147.66 42.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.12 . . . . 63.219999999999999 110.54 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -99.27 125.75 44.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.542 -0.91 . . . . 75.319999999999993 108.542 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 60' ' ' VAL . 20.9 mm -102.97 113.18 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.91 -0.404 . . . . 73.439999999999998 109.91 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.27 17.26 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.784 -0.722 . . . . 53.049999999999997 111.858 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.74 47.33 26.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 73.25 113.333 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 25' ' ' THR . 77.7 mt -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.003 0.43 . . . . 54.229999999999997 110.494 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 t -92.23 167.36 12.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.332 -0.618 . . . . 61.020000000000003 109.332 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 94.2 m-85 -75.46 -6.12 48.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.307 0.575 . . . . 73.209999999999994 110.789 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.14 -3.8 28.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.201 -0.909 . . . . 75.120000000000005 111.202 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.486 HG21 HD22 ' A' ' 21' ' ' LEU . 72.2 m -76.21 125.18 28.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 71.400000000000006 112.158 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -105.86 160.01 15.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.169 -0.923 . . . . 73.420000000000002 110.072 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 120.475 0.179 . . . . 74.129999999999995 110.829 -177.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -76.69 -38.33 54.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 75.329999999999998 111.499 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -78.51 -35.23 46.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.825 -0.171 . . . . 74.400000000000006 111.227 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.77 -45.97 84.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.248 -0.649 . . . . 72.340000000000003 109.248 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -54.17 -60.32 3.49 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.176 -0.92 . . . . 64.439999999999998 111.386 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -47.72 -34.09 7.85 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.858 0.724 . . . . 74.420000000000002 112.701 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -76.58 -57.6 3.76 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.8 -0.182 . . . . 75.200000000000003 111.114 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.18 -23.13 64.81 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.063 -0.398 . . . . 63.240000000000002 111.849 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.91 -23.33 65.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.228 0.611 . . . . 74.349999999999994 111.209 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -60.79 -26.94 67.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 72.109999999999999 112.038 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -99.95 -20.88 15.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.837 0.31 . . . . 73.239999999999995 111.837 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.73 32.88 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.294 -0.955 . . . . 75.25 112.095 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -63.23 117.28 6.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.927 0.394 . . . . 72.540000000000006 111.394 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.9 mt -85.13 143.0 29.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.482 -0.562 . . . . 72.510000000000005 109.482 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -116.17 -16.12 11.02 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.012 -0.54 . . . . 73.310000000000002 110.099 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -152.39 150.7 29.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 73.409999999999997 109.446 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.4 t -162.72 129.48 3.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.687 -0.486 . . . . 75.409999999999997 109.687 174.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.6 122.08 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.501 0.667 . . . . 72.329999999999998 110.587 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 27' ' ' ASP . 91.2 t -85.73 129.93 37.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 53.140000000000001 108.785 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -75.33 95.0 3.12 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.571 0.701 . . . . 70.230000000000004 110.116 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 52.4 mtp85 -101.34 158.43 16.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.636 -1.166 . . . . 72.219999999999999 110.221 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 23.9 t70 -72.45 126.46 90.91 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.143 -0.935 . . . . 73.310000000000002 110.262 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.29 -12.5 31.99 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.127 1.885 . . . . 74.109999999999999 112.942 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 32.2 m-80 -85.64 -56.3 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.019 0.377 . . . . 75.040000000000006 112.019 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -107.09 -9.24 16.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 111.459 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 67.07 40.07 3.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.68 0.792 . . . . 75.140000000000001 111.416 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -117.28 154.66 30.84 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.547 -0.909 . . . . 72.450000000000003 108.547 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 31.3 t -72.27 139.86 48.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.147 0.431 . . . . 71.420000000000002 111.391 -171.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -82.53 1.2 39.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.695 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 20.06 57.21 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.568 -0.825 . . . . 63.32 113.987 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -161.05 156.92 25.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.9 0.85 . . . . 75.400000000000006 110.618 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.17 -163.56 14.4 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.519 -0.632 . . . . 71.450000000000003 111.519 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.15 150.4 41.03 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.374 0.587 . . . . 65.439999999999998 110.293 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 18' ' ' ILE . 7.5 m -131.71 127.96 59.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 60.219999999999999 109.55 172.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.6 m -104.49 119.65 39.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.105 -0.331 . . . . 72.239999999999995 110.105 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 29.9 m-85 -85.33 158.95 20.14 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.24 -0.436 . . . . 73.109999999999999 110.121 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.92 -44.45 73.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.932 -0.576 . . . . 42.219999999999999 110.559 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -126.4 152.13 46.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.754 -0.657 . . . . 74.019999999999996 110.643 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 2.6 p -60.44 -36.31 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.727 -0.67 . . . . 73.319999999999993 110.983 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.64 -43.3 62.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.241 0.83 . . . . 52.409999999999997 113.241 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 1.3 mp0 -65.61 -29.24 69.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.88 0.372 . . . . 53.509999999999998 111.207 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.96 -45.7 96.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 75.140000000000001 110.428 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.31 -50.1 70.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.167 -0.924 . . . . 73.420000000000002 111.722 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -52.96 -37.08 60.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.938 0.718 . . . . 73.530000000000001 112.938 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.62 -32.52 71.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.461 0.648 . . . . 62.310000000000002 109.949 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 75' ' ' ARG . 14.0 mmt -73.07 -31.5 64.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.251 -0.886 . . . . 41.009999999999998 112.09 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -81.39 -15.01 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.214 0.531 . . . . 63.219999999999999 110.632 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.27 -11.21 35.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 64.129999999999995 112.097 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' ' SD ' ' A' ' 72' ' ' MET . 7.8 mtm180 -54.11 146.58 29.41 Favored Pre-proline 0 N--CA 1.465 0.282 0 O-C-N 123.241 0.338 . . . . 75.439999999999998 111.631 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.19 168.68 69.19 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.75 -1.354 . . . . 52.240000000000002 113.234 2.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -122.77 155.52 36.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.992 -0.549 . . . . 64.129999999999995 110.77 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 ttmt -135.06 108.47 7.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.082 -0.508 . . . . 55.310000000000002 111.112 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.34 124.76 64.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 72.340000000000003 110.073 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 64.99 27.32 12.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.474 0.71 . . . . 73.230000000000004 111.698 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.3 25.04 59.99 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.919 -0.658 . . . . 51.229999999999997 112.483 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.6 tpt180 -129.04 139.07 52.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.044 -0.354 . . . . 71.329999999999998 110.044 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.7 112.79 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.064 -0.717 . . . . 71.430000000000007 109.064 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.96 149.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 111.592 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 14.8 tp10 -110.81 98.0 36.02 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.819 -1.082 . . . . 74.420000000000002 110.334 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.18 127.71 9.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.672 1.581 . . . . 73.120000000000005 111.111 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 28.0 mttt -133.98 177.74 7.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.885 -1.154 . . . . 73.409999999999997 107.885 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HB3' ' CB ' ' A' ' 160' ' ' ASP . 4.3 tpp180 -86.01 135.74 33.53 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.345 -0.542 . . . . 74.329999999999998 110.3 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.7 94.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.437 0.637 . . . . 73.319999999999993 110.648 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.14 157.91 6.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 52.130000000000003 111.088 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -55.3 151.72 9.38 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.71 -0.677 . . . . 63.130000000000003 111.394 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -37.45 75.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.025 -0.534 . . . . 64.329999999999998 111.54 -173.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.56 -47.97 82.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 111.236 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 -43.09 79.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 62.240000000000002 110.486 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 p -75.94 7.4 4.04 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.754 0.65 . . . . 61.350000000000001 112.754 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -84.76 -21.44 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 74.340000000000003 110.432 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -91.72 144.59 29.67 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 74.0 110.683 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.37 117.47 4.98 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.604 2.203 . . . . 74.439999999999998 111.791 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 109.92 4.15 29.74 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.838 -0.696 . . . . 64.140000000000001 112.304 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.59 -42.74 24.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.912 0.387 . . . . 74.430000000000007 111.291 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -93.87 1.27 56.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.8 0.333 . . . . 71.549999999999997 110.777 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 99' ' ' GLY . 48.4 mt -78.66 159.18 28.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.178 -0.675 . . . . 74.349999999999994 109.178 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -75.79 97.9 4.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.382 0.61 . . . . 54.109999999999999 110.99 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.82 119.54 58.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.214 -0.903 . . . . 73.219999999999999 108.883 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 75.8 mttt -105.34 21.45 17.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.131 0.491 . . . . 71.340000000000003 110.394 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.01 139.62 50.92 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.22 -0.446 . . . . 51.219999999999999 110.759 178.69 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.42 ' CG2' HG13 ' A' ' 159' ' ' VAL . 8.9 pt -128.96 149.03 33.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.193 0.52 . . . . 53.130000000000003 111.296 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.5 t80 -94.56 133.89 37.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.996 -1.002 . . . . 71.310000000000002 109.76 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -123.09 109.44 23.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.997 -0.742 . . . . 62.299999999999997 108.997 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.49 171.64 26.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.514 -1.327 . . . . 63.130000000000003 113.569 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.47 30.2 30.88 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.198 -0.761 . . . . 63.329999999999998 111.198 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.414 HG22 ' SG ' ' A' ' 175' ' ' CYS . 23.2 pt -75.18 129.45 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 120.975 0.417 . . . . 71.530000000000001 110.311 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.63 -54.93 5.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.106 -0.701 . . . . 72.140000000000001 109.106 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.19 149.46 24.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 73.340000000000003 108.776 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.27 149.13 48.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.276 0.56 . . . . 70.150000000000006 111.517 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -120.77 156.19 32.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 74.219999999999999 111.068 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.02 167.32 10.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.357 -0.838 . . . . 73.5 110.517 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -61.2 -54.07 48.99 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.988 -0.551 . . . . 72.230000000000004 111.01 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -65.19 -17.22 64.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 75.219999999999999 111.773 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -70.18 -57.63 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.015 -0.365 . . . . 74.340000000000003 110.015 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.28 -28.89 38.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.355 -0.538 . . . . 75.319999999999993 110.566 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 7.3 tmm_? -61.8 -50.01 74.03 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.784 -0.45 . . . . 75.329999999999998 109.784 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.04 -29.31 70.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 75.439999999999998 111.002 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.35 -53.24 6.8 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.994 -0.548 . . . . 62.399999999999999 112.021 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 37.3 m-85 -66.72 -23.97 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.603 0.223 . . . . 70.040000000000006 111.603 -178.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.45 -27.09 68.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.073 0.463 . . . . 72.530000000000001 111.023 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -60.77 -27.76 68.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 70.510000000000005 111.575 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -86.4 -24.6 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 111.398 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.55 -179.83 43.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.606 -0.807 . . . . 72.140000000000001 112.928 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -73.35 133.65 43.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.357 . . . . 64.5 110.661 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' THR . 63.9 mt -104.5 137.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.003 -0.544 . . . . 72.230000000000004 109.863 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.25 -46.97 8.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.287 . . . . 73.530000000000001 110.846 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.55 157.46 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.083 -0.339 . . . . 70.239999999999995 110.083 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.86 130.58 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.777 -0.453 . . . . 72.150000000000006 109.777 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 31.8 mt-10 -103.19 103.45 13.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.788 -0.642 . . . . 72.109999999999999 110.746 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.12 116.54 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.502 -0.555 . . . . 73.299999999999997 109.502 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.441 ' HG3' ' CE2' ' A' ' 148' ' ' PHE . 69.3 mmm -84.4 100.99 11.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.554 0.692 . . . . 73.420000000000002 109.559 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 115.007 -0.997 . . . . 51.030000000000001 110.164 -174.821 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 N-CA-C 113.941 0.337 . . . . 75.140000000000001 113.941 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 137' ' ' MET . 13.3 p90 -154.7 163.46 40.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 73.140000000000001 110.493 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.18 171.91 13.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.208 -0.905 . . . . 63.520000000000003 109.893 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.4 m-85 -139.09 155.06 48.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.46 -0.791 . . . . 74.219999999999999 109.284 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.28 134.52 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-O 121.418 0.628 . . . . 75.219999999999999 111.334 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 53.0 m -100.26 125.63 46.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.91 -1.041 . . . . 72.230000000000004 110.672 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.5 m-85 -99.88 160.7 14.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.938 0.399 . . . . 73.349999999999994 111.253 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.43 -27.76 37.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 74.129999999999995 110.344 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.94 160.98 31.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.665 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -84.93 -32.08 23.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 73.340000000000003 110.756 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.611 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 35.7 t70 -62.18 -37.99 87.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.955 -0.566 . . . . 71.200000000000003 111.13 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -67.02 -33.69 76.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.526 -0.307 . . . . 53.43 111.058 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' A' ' 107' ' ' ILE . 2.6 t -68.05 -42.62 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 72.209999999999994 109.868 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.589 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 73.3 m-20 -64.14 -37.87 89.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.106 -0.952 . . . . 72.299999999999997 111.509 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 47.9 mttm -53.8 -42.67 68.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.81 0.814 . . . . 70.25 110.538 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.75 -43.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.281 -1.327 . . . . 64.010000000000005 112.395 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 160' ' ' ASP . 18.9 m -75.24 -7.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 121.972 -0.455 . . . . 75.120000000000005 111.059 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 160' ' ' ASP . 37.8 mt -57.85 -32.28 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.377 -0.829 . . . . 62.340000000000003 109.927 170.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -107.58 152.49 24.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.936 -0.575 . . . . 72.150000000000006 109.46 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.21 -39.07 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.976 0.417 . . . . 75.109999999999999 110.388 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.02 137.91 54.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 65.409999999999997 110.033 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -122.71 140.77 52.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.318 -0.401 . . . . 72.319999999999993 110.902 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -96.06 116.28 28.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.814 -0.63 . . . . 61.439999999999998 110.218 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.72 107.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.581 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.9 m120 72.95 28.19 2.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.231 -0.895 . . . . 60.340000000000003 110.007 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.84 -2.63 80.14 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.386 -0.824 . . . . 71.310000000000002 112.678 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -110.56 130.17 55.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.775 -0.25 . . . . 72.109999999999999 110.54 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.09 0.471 . . . . 61.539999999999999 110.988 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 112' ' ' ILE . 7.4 m -110.42 150.99 28.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.847 -0.615 . . . . 63.039999999999999 110.297 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -86.9 133.83 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.879 -0.415 . . . . 75.0 109.879 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.8 t -133.13 138.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 44.299999999999997 111.572 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -158.64 177.32 11.33 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.863 -0.608 . . . . 74.219999999999999 111.463 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -62.5 124.74 21.75 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.97 0.508 . . . . 73.310000000000002 110.86 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -111.99 113.61 26.0 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.217 0.532 . . . . 45.119999999999997 109.903 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.551 -0.749 . . . . 50.25 109.588 -178.029 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 108.845 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -71.2 141.57 86.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.018 -1.446 . . . . 74.200000000000003 109.877 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.98 166.97 19.02 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.71 2.273 . . . . 61.420000000000002 112.462 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.64 -32.29 67.12 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.956 -0.565 . . . . 64.299999999999997 111.97 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.0 pt20 -64.05 -31.91 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.794 0.33 . . . . 74.109999999999999 111.551 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 164' ' ' ILE . 5.2 mp -78.53 -20.23 51.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 60.140000000000001 111.282 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.545 ' HA ' HG21 ' A' ' 68' ' ' VAL . 23.5 ptt180 -117.18 0.1 12.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.363 -0.381 . . . . 65.310000000000002 111.587 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.6 ttmt -98.15 148.53 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.781 0.801 . . . . 73.219999999999999 112.16 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 68' ' ' VAL . 66.0 mt -117.01 145.2 43.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.331 -1.304 . . . . 70.310000000000002 110.338 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -97.93 120.27 38.03 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.112 -1.07 . . . . 65.209999999999994 108.112 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 60' ' ' VAL . 16.7 mm -100.52 110.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.79 -0.448 . . . . 73.230000000000004 109.79 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.85 151.61 16.89 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.948 -0.861 . . . . 73.319999999999993 110.948 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 43.3 12.89 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.252 -0.975 . . . . 45.119999999999997 112.974 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 25' ' ' THR . 93.3 mt -84.1 175.44 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.039 0.447 . . . . 72.109999999999999 110.499 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -90.96 172.79 8.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.382 -0.599 . . . . 52.310000000000002 109.382 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -77.35 -11.49 59.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.365 0.602 . . . . 75.299999999999997 110.28 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 24.0 mt-10 -106.9 -1.41 22.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 73.209999999999994 111.484 -175.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 HD22 ' A' ' 21' ' ' LEU . 47.3 m -69.75 126.41 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.119 0.485 . . . . 72.120000000000005 112.026 -170.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -101.92 167.5 10.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.407 -0.815 . . . . 73.409999999999997 110.0 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -28.1 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.978 -0.378 . . . . 74.239999999999995 109.978 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.9 -41.9 82.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.450000000000003 110.853 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t -72.64 -41.97 64.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 74.019999999999996 110.049 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.6 tp -59.85 -49.03 79.28 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.875 -0.602 . . . . 64.319999999999993 110.682 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HG3' HD12 ' A' ' 40' ' ' LEU . 14.2 ttm-85 -58.92 -56.54 20.9 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.438 0.695 . . . . 62.229999999999997 111.044 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 m -44.38 -38.77 4.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 44.530000000000001 113.381 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -67.26 -52.2 43.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.981 -0.554 . . . . 74.230000000000004 111.226 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -80.65 -20.27 43.44 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.925 0.343 . . . . 73.420000000000002 111.925 -170.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 31' ' ' ARG . 44.1 mt-10 -56.5 -24.27 45.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.355 0.502 . . . . 72.439999999999998 112.355 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -63.3 -27.08 69.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.468 0.544 . . . . 63.520000000000003 112.468 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -100.06 -21.95 15.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.645 0.259 . . . . 75.519999999999996 111.557 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 156.84 27.25 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.759 -0.734 . . . . 74.120000000000005 111.401 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 83.2 m -67.65 120.24 13.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.911 0.386 . . . . 70.349999999999994 111.143 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 31' ' ' ARG . 49.0 mt -84.34 145.4 28.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.328 0.585 . . . . 74.299999999999997 110.834 177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -108.79 -22.94 11.99 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.278 -0.874 . . . . 61.420000000000002 110.17 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -154.52 157.47 38.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.502 . . . . 63.109999999999999 110.62 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.7 t -163.6 136.56 5.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.413 -0.588 . . . . 62.149999999999999 109.413 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -151.01 126.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.533 . . . . 64.219999999999999 110.298 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.77 132.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.7 -0.852 . . . . 73.319999999999993 108.7 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 mmt -76.05 97.16 3.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.732 0.777 . . . . 73.319999999999993 110.423 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 35.7 mtt180 -101.88 163.59 12.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.37 -1.286 . . . . 75.430000000000007 111.492 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.19 124.19 89.79 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 114.491 -1.231 . . . . 72.040000000000006 110.25 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.95 -20.23 70.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.084 1.856 . . . . 75.209999999999994 112.909 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -83.79 -56.51 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.12 0.415 . . . . 74.129999999999995 112.12 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -6.89 16.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 71.010000000000005 111.677 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm 64.43 40.18 6.49 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.384 -0.826 . . . . 74.439999999999998 111.953 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 27.0 mmm180 -114.42 163.03 15.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.418 -0.586 . . . . 74.209999999999994 109.418 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.6 t -72.42 133.97 45.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.148 0.499 . . . . 72.340000000000003 111.845 -173.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -81.88 -0.16 42.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.533 -0.758 . . . . 74.239999999999995 110.451 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.04 58.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.731 -0.747 . . . . 73.239999999999995 114.128 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -156.35 156.55 34.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.815 0.807 . . . . 61.450000000000003 110.58 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.51 -166.33 18.24 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 111.564 -0.615 . . . . 34.329999999999998 111.564 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.22 148.9 38.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.224 0.512 . . . . 75.530000000000001 110.35 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 m -128.43 130.14 69.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.637 -0.711 . . . . 73.019999999999996 109.318 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.4 m -106.72 120.15 41.22 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.304 -0.247 . . . . 74.439999999999998 110.354 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -83.93 169.17 15.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.48 . . . . 73.519999999999996 110.515 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.5 -55.65 12.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.738 -0.665 . . . . 65.230000000000004 109.577 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 66' ' ' GLU . 36.3 m -123.24 153.14 40.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 72.200000000000003 111.426 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.578 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.7 p -58.04 -38.28 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.777 -0.647 . . . . 70.530000000000001 111.248 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 64' ' ' THR . 6.3 mm-40 -52.63 -41.8 64.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.066 0.765 . . . . 73.340000000000003 113.066 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -62.54 -31.34 72.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.363 0.602 . . . . 72.019999999999996 110.388 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG13 HD21 ' A' ' 16' ' ' LEU . 32.9 t -68.83 -47.26 77.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.108 -0.951 . . . . 62.420000000000002 111.01 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.76 -48.3 75.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 70.5 110.887 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.4 60.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.625 0.602 . . . . 75.519999999999996 112.625 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.94 -33.59 63.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.981 0.42 . . . . 53.219999999999999 110.659 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -47.1 71.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 75.209999999999994 110.801 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.99 66.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 53.299999999999997 110.682 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.21 -8.04 46.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.943 0.72 . . . . 61.350000000000001 112.943 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' NH1' ' HG2' ' A' ' 85' ' ' GLU . 11.9 mtp180 -56.66 147.72 49.96 Favored Pre-proline 0 CA--C 1.531 0.225 0 O-C-N 122.897 0.123 . . . . 71.549999999999997 111.013 173.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.65 166.08 78.44 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.8 -1.333 . . . . 74.340000000000003 113.968 4.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -125.9 150.99 47.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.764 -0.653 . . . . 70.540000000000006 110.964 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -141.46 113.01 7.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.909 -0.587 . . . . 74.140000000000001 111.039 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.07 144.41 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.89 -0.596 . . . . 73.209999999999994 109.736 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.9 t70 67.39 22.03 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.592 0.71 . . . . 72.219999999999999 110.567 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.12 74.19 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.385 -0.825 . . . . 64.030000000000001 111.934 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -130.22 141.01 50.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.58 0.229 . . . . 74.430000000000007 110.529 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.56 113.19 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.874 -0.787 . . . . 73.319999999999993 108.874 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.31 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 75.209999999999994 111.602 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 mt-10 -115.33 98.03 49.68 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.213 -0.903 . . . . 75.409999999999997 111.403 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -75.28 133.04 15.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.967 1.778 . . . . 51.5 110.725 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -139.39 -178.84 5.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.201 -1.407 . . . . 61.149999999999999 107.201 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -86.96 143.29 27.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 119.748 1.158 . . . . 65.209999999999994 111.533 -177.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.81 3.5 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.843 -0.799 . . . . 50.039999999999999 108.843 165.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.79 160.01 5.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.339 -0.846 . . . . 75.209999999999994 110.117 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.7 p -53.21 150.66 5.84 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.407 0.442 . . . . 73.099999999999994 110.888 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 9.9 mpt_? -60.2 -23.73 64.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.916 -0.584 . . . . 65.230000000000004 112.26 -171.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.27 -45.83 91.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.966 0.413 . . . . 74.530000000000001 110.344 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.53 -50.61 7.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 63.539999999999999 111.216 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.9 p -70.91 -9.66 58.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.51 0.93 . . . . 45.43 113.51 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.89 -2.29 58.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.942 0.401 . . . . 72.010000000000005 110.866 179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -116.99 148.23 41.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.276 -0.42 . . . . 74.150000000000006 110.084 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.09 138.38 77.77 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.833 2.356 . . . . 72.25 112.592 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.09 -15.37 51.34 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.838 -0.696 . . . . 75.010000000000005 112.396 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.79 -44.32 56.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 65.099999999999994 111.671 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -96.42 13.5 27.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.793 0.33 . . . . 63.009999999999998 111.365 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.9 mt -82.12 162.72 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.193 -0.669 . . . . 73.230000000000004 109.193 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -79.23 85.75 5.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.607 0.718 . . . . 72.230000000000004 110.032 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.14 114.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.882 -1.053 . . . . 54.439999999999998 110.11 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -109.27 15.57 23.06 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.657 -0.417 . . . . 54.009999999999998 110.683 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -115.62 139.38 50.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.318 -0.401 . . . . 65.219999999999999 110.537 176.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.446 ' CG2' HG13 ' A' ' 159' ' ' VAL . 6.3 pt -131.52 152.96 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.501 0.667 . . . . 73.430000000000007 111.62 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.1 t80 -96.88 136.07 37.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.537 -1.21 . . . . 71.209999999999994 109.834 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -122.97 110.65 27.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.103 -0.703 . . . . 74.219999999999999 109.103 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.63 155.11 19.93 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.684 -1.246 . . . . 52.509999999999998 113.237 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.37 7.4 55.97 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.539 -0.838 . . . . 74.109999999999999 112.456 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.7 pt -72.44 105.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.515 0.674 . . . . 51.520000000000003 109.758 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -88.2 -10.08 50.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 63.420000000000002 111.798 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -121.71 165.42 15.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.716 -0.475 . . . . 72.430000000000007 109.716 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.17 104.55 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.404 1.097 . . . . 73.099999999999994 111.399 -175.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -96.96 142.72 28.58 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.158 -1.383 . . . . 75.129999999999995 109.55 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 14.4 pt-20 -113.58 169.5 8.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.672 -0.695 . . . . 61.439999999999998 110.949 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -53.59 -51.29 63.48 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 114.828 -1.078 . . . . 71.209999999999994 110.405 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.55 -25.05 62.09 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.653 0.612 . . . . 72.519999999999996 112.653 -175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.44 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 63.7 m170 -70.94 -60.4 2.25 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.067 0.46 . . . . 63.210000000000001 110.771 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -81.47 -26.47 35.23 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 120.177 -0.609 . . . . 73.230000000000004 111.229 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -68.0 -43.46 78.82 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 110.257 -0.275 . . . . 71.420000000000002 110.257 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.67 -31.25 72.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.082 0.467 . . . . 73.239999999999995 110.422 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 170' ' ' VAL . 80.5 t80 -79.27 -54.5 5.9 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.09 -0.505 . . . . 71.439999999999998 111.859 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.88 -24.54 63.43 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.621 0.6 . . . . 71.319999999999993 112.621 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.1 mt-10 -71.49 -16.59 62.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.844 0.354 . . . . 75.329999999999998 111.152 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.34 -25.79 68.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 75.099999999999994 111.074 172.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.79 -25.56 23.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.504 -0.316 . . . . 71.420000000000002 111.266 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 126' ' ' GLU . . . 168.51 -175.35 43.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.951 -0.642 . . . . 64.209999999999994 112.641 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.64 131.77 42.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.905 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 152' ' ' THR . 76.4 mt -100.03 140.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.676 -0.693 . . . . 71.200000000000003 109.865 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.13 -51.13 6.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 64.420000000000002 110.269 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.16 156.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.93 -0.577 . . . . 72.150000000000006 109.76 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 122' ' ' ARG . 3.3 mp -115.63 128.93 72.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.745 -0.465 . . . . 75.140000000000001 109.745 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.5 mt-10 -102.13 104.44 15.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.95 -0.568 . . . . 74.129999999999995 110.729 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.7 mm -93.31 131.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.341 -0.615 . . . . 75.430000000000007 109.341 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 48.8 mmm -105.14 132.7 51.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.517 -0.549 . . . . 74.200000000000003 109.517 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 60.039999999999999 111.597 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.845 0 N-CA-C 111.328 -0.709 . . . . 45.32 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.98 155.23 3.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.165 -0.68 . . . . 74.420000000000002 109.165 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.04 172.67 12.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.973 -0.558 . . . . 75.5 109.635 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.1 m-85 -138.61 152.13 47.86 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.744 -0.662 . . . . 64.239999999999995 109.466 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.68 132.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.365 0.602 . . . . 33.43 111.069 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 131' ' ' ILE . 82.9 m -102.75 125.08 49.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.979 -1.01 . . . . 53.0 110.918 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -102.6 157.87 16.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.578 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.47 -31.18 57.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.676 -0.693 . . . . 61.420000000000002 110.402 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.36 157.94 42.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.587 -0.733 . . . . 63.130000000000003 110.399 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -82.5 -22.89 34.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 109.859 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -53.08 -45.81 68.35 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.853 0.721 . . . . 71.439999999999998 111.25 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 162' ' ' ILE . 1.4 m -65.34 -35.29 80.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.783 -0.644 . . . . 74.519999999999996 110.836 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 107' ' ' ILE . 3.2 t -71.5 -38.61 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.795 -0.446 . . . . 71.219999999999999 109.795 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 163' ' ' VAL . 7.0 m-20 -65.92 -33.8 76.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.140000000000001 111.432 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 93.0 mttt -63.47 -38.4 91.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.417 0.627 . . . . 71.329999999999998 110.378 174.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 158' ' ' SER . 14.0 mt -78.1 -40.84 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.891 -1.05 . . . . 70.109999999999999 112.002 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 160' ' ' ASP . 35.1 m -79.14 -4.3 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.193 0.521 . . . . 72.400000000000006 111.177 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 13' ' ' LEU . 11.5 mt -62.86 -31.95 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.289 -0.869 . . . . 63.240000000000002 109.732 169.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 51.5 mt-30 -108.39 153.1 23.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.886 -0.783 . . . . 73.099999999999994 108.886 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -91.49 -38.49 12.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.244 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.56 137.12 53.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.369 -0.378 . . . . 74.129999999999995 110.242 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.575 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 39.2 m-70 -125.38 146.05 49.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.145 -0.479 . . . . 71.439999999999998 110.172 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.6 m -91.75 110.71 22.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.049 -0.523 . . . . 75.010000000000005 111.34 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.457 HG22 ' CD2' ' A' ' 124' ' ' TYR . 41.2 t -117.13 131.09 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.07 -0.715 . . . . 70.120000000000005 109.07 174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 46.99 42.59 12.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.45 0.7 . . . . 73.049999999999997 111.924 -174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.31 7.08 59.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 113.97 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -110.24 137.29 48.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.024 0.412 . . . . 75.329999999999998 110.16 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -89.39 108.95 19.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 64.040000000000006 110.308 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -112.24 154.81 25.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.833 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.8 139.31 30.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 109.988 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.8 m -130.11 155.3 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.997 0.427 . . . . 62.450000000000003 110.632 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -172.37 169.76 5.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.065 -0.97 . . . . 72.109999999999999 111.497 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -58.68 127.84 34.21 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 73.299999999999997 110.663 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.23 119.38 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.11 0.481 . . . . 70.310000000000002 109.884 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 115.695 -0.684 . . . . 64.209999999999994 109.37 -179.59 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 107.893 -1.151 . . . . 71.439999999999998 107.893 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp0 -93.59 141.66 24.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.407 -1.27 . . . . 72.310000000000002 111.029 -172.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 30.8 Cg_endo -67.44 167.77 19.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.904 2.403 . . . . 64.329999999999998 110.778 174.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -57.36 -37.41 72.57 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 111.698 0.259 . . . . 75.109999999999999 111.698 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -67.22 -27.86 67.59 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.891 0.33 . . . . 75.099999999999994 111.891 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.2 mp -82.42 -9.79 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.385 . . . . 75.120000000000005 111.087 -177.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.449 ' HA ' HG21 ' A' ' 68' ' ' VAL . 14.2 ptt180 -123.13 -0.66 8.86 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.129 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 34.5 ttpt -91.66 145.92 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 111.571 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.654 HD11 HG13 ' A' ' 68' ' ' VAL . 3.9 mp -123.52 145.68 48.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.196 -0.911 . . . . 63.340000000000003 110.136 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -96.96 117.68 31.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.436 -0.579 . . . . 75.239999999999995 109.436 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 60' ' ' VAL . 20.3 mm -94.34 113.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.956 -0.387 . . . . 71.129999999999995 109.956 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.35 150.41 16.84 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.738 -0.744 . . . . 24.530000000000001 111.79 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.7 45.22 29.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.89 -0.672 . . . . 62.219999999999999 113.381 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 25' ' ' THR . 79.4 mt -81.85 176.72 9.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.167 0.483 . . . . 73.430000000000007 110.819 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -86.24 178.64 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 62.420000000000002 109.542 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -84.19 -6.34 59.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.051 0.453 . . . . 72.420000000000002 110.534 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.27 20.05 15.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 64.140000000000001 111.061 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.458 HG21 HD22 ' A' ' 21' ' ' LEU . 9.6 m -81.53 129.4 34.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 75.120000000000005 110.405 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -117.96 160.19 21.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.734 -0.666 . . . . 75.310000000000002 109.377 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.93 -42.94 76.89 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.561 0.538 . . . . 75.200000000000003 111.108 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.67 -30.52 71.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.581 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 m -86.28 -42.07 14.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.62 -0.264 . . . . 72.239999999999995 111.077 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.24 -50.07 67.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 110.528 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -56.42 -58.2 9.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.692 -0.686 . . . . 74.310000000000002 111.598 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -48.8 -34.22 11.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.561 0.538 . . . . 71.25 112.357 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -74.06 -49.6 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.431 -0.349 . . . . 73.200000000000003 110.99 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -78.18 -18.82 55.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.193 -0.317 . . . . 71.329999999999998 111.758 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 23.7 mt-10 -56.6 -22.68 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.111 -0.495 . . . . 73.019999999999996 112.222 172.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.65 -22.15 66.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 74.549999999999997 111.951 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -102.97 -24.04 13.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.665 0.269 . . . . 74.510000000000005 111.244 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -173.45 161.59 32.39 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.356 -0.926 . . . . 75.129999999999995 112.475 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -57.59 141.7 47.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.874 0.469 . . . . 71.209999999999994 111.552 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 62' ' ' TYR . 63.3 mt -120.23 124.72 46.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.31 -0.626 . . . . 71.5 109.31 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -97.94 -20.45 17.44 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.045 -0.525 . . . . 72.010000000000005 110.621 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -149.94 152.77 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.633 -0.506 . . . . 75.540000000000006 109.633 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -165.45 137.08 4.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.084 -0.71 . . . . 55.210000000000001 109.084 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.34 132.68 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.053 0.454 . . . . 72.400000000000006 110.727 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.11 131.28 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.269 -0.641 . . . . 61.409999999999997 109.269 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 mmt -73.65 133.2 43.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.952 -0.759 . . . . 65.409999999999997 108.952 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -139.95 158.17 44.5 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.892 -0.595 . . . . 75.329999999999998 110.928 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 22.2 t70 -67.22 129.49 93.81 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.778 -1.101 . . . . 64.400000000000006 109.646 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.59 -22.34 33.02 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.186 1.924 . . . . 70.019999999999996 113.364 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -84.99 -55.19 4.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.585 -175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 m -103.43 -8.87 19.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 111.734 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.9 mmtm 63.28 35.31 12.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.331 0.652 . . . . 74.239999999999995 111.758 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -101.48 158.75 15.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.031 -1.099 . . . . 74.239999999999995 108.031 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -70.31 140.43 52.27 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.092 0.472 . . . . 65.319999999999993 110.58 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -84.67 5.87 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.681 -0.69 . . . . 45.219999999999999 110.485 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.39 16.52 71.14 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.628 -0.796 . . . . 22.440000000000001 113.605 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -160.3 157.78 28.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.014 0.907 . . . . 65.430000000000007 110.954 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.08 -163.81 15.7 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.446 -0.661 . . . . 73.25 111.446 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.99 148.71 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.187 0.493 . . . . 61.219999999999999 110.611 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.457 HG22 HD11 ' A' ' 18' ' ' ILE . 6.4 m -130.65 126.32 60.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.907 -0.588 . . . . 72.120000000000005 109.739 172.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 m -101.28 118.01 36.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.444 -0.344 . . . . 62.43 110.166 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' HA ' HD23 ' A' ' 40' ' ' LEU . 19.4 m-85 -84.6 165.15 18.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 74.450000000000003 109.856 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.41 63.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.37 -0.377 . . . . 74.239999999999995 110.675 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.9 m -132.94 154.01 50.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.309 -0.405 . . . . 74.109999999999999 110.253 -177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.8 p -64.88 -33.54 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.736 -0.211 . . . . 63.219999999999999 111.548 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.61 -34.08 72.3 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.38 0.511 . . . . 74.120000000000005 112.38 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 5.5 mm-40 -64.94 -33.79 76.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.303 0.573 . . . . 70.120000000000005 109.791 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.654 HG13 HD11 ' A' ' 16' ' ' LEU . 2.4 t -62.61 -46.97 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 71.109999999999999 111.125 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.3 -45.51 92.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 72.349999999999994 111.075 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.15 -38.4 73.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.332 0.493 . . . . 75.340000000000003 112.332 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.3 83.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.451 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -69.27 -35.18 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.698 . . . . 63.200000000000003 110.974 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.655 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.9 p30 -84.84 -7.06 59.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.384 . . . . 51.229999999999997 111.515 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.27 -11.08 20.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.461 . . . . 62.420000000000002 110.606 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 10.2 ttp180 -53.2 143.63 32.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.009 -0.996 . . . . 71.230000000000004 110.855 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 4.8 Cg_exo -79.71 169.86 69.13 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.954 -0.853 . . . . 65.129999999999995 114.054 2.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.22 161.16 29.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 61.140000000000001 109.773 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 22.5 ttmt -134.3 104.66 6.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.909 0.385 . . . . 72.549999999999997 111.38 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.63 126.37 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 62.130000000000003 110.137 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.22 40.38 8.84 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.54 0.686 . . . . 73.120000000000005 110.756 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.56 27.78 73.37 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.885 -0.598 . . . . 63.200000000000003 112.785 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.0 tpt180 -132.44 140.22 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 64.549999999999997 110.002 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 t -78.28 110.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.278 -0.638 . . . . 75.519999999999996 109.278 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.0 m -104.96 150.04 8.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.408 0.623 . . . . 64.209999999999994 110.575 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.43 ' HG2' HH11 ' A' ' 75' ' ' ARG . 7.3 tt0 -117.74 96.11 48.96 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.292 -0.867 . . . . 72.450000000000003 110.853 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.14 130.83 20.82 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.456 1.437 . . . . 63.329999999999998 110.433 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 25.4 mttt -128.35 -179.56 5.09 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.295 -0.866 . . . . 75.519999999999996 108.837 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' OD2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -77.95 155.08 31.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.795 -0.446 . . . . 72.109999999999999 109.795 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.89 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 74.209999999999994 110.351 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.555 ' HB ' ' OD1' ' A' ' 160' ' ' ASP . 8.1 p -72.78 157.92 6.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.243 -0.89 . . . . 64.530000000000001 110.655 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.72 142.8 27.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.356 -0.609 . . . . 55.009999999999998 109.356 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -62.34 -17.41 58.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.803 0.335 . . . . 74.400000000000006 111.246 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.85 -48.33 74.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 74.209999999999994 110.616 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.634 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 25.3 t70 -84.16 -13.78 51.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.88 -0.6 . . . . 34.109999999999999 110.455 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -73.74 8.63 1.82 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.975 0.416 . . . . 65.340000000000003 110.956 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.38 -18.23 28.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 75.530000000000001 111.262 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 19.6 mmt180 -61.38 148.94 84.78 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 110.127 -0.323 . . . . 74.120000000000005 110.127 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -65.61 112.95 2.32 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.49 1.46 . . . . 54.229999999999997 110.343 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.7 48.98 46.27 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.695 -0.764 . . . . 74.340000000000003 111.465 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.01 -31.31 70.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 70.040000000000006 111.186 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -98.73 21.39 11.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 64.129999999999995 111.332 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.0 mt -76.88 177.58 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.988 -0.745 . . . . 74.25 108.988 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -81.92 78.31 8.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.471 0.653 . . . . 71.200000000000003 110.384 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.61 109.01 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.105 -0.952 . . . . 75.099999999999994 110.377 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.433 ' C ' HG21 ' A' ' 159' ' ' VAL . 53.5 mttt -107.36 20.99 18.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.998 0.428 . . . . 73.329999999999998 110.264 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.62 53.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.398 -0.364 . . . . 75.329999999999998 110.713 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.552 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.91 152.47 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.217 0.532 . . . . 61.409999999999997 111.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 6.3 t80 -99.34 131.84 45.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.92 -1.036 . . . . 73.239999999999995 109.452 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.45 110.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.352 -0.61 . . . . 70.420000000000002 109.352 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.43 16.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.75 -1.214 . . . . 60.329999999999998 113.825 -173.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.5 43.35 2.96 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.187 -0.53 . . . . 74.439999999999998 112.556 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 173' ' ' HIS . 22.1 pt -120.92 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.467 0.651 . . . . 74.540000000000006 110.857 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -54.24 3.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 110.437 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.93 170.54 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.436 0.46 . . . . 54.329999999999998 110.434 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.77 84.85 0.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.578 0.584 . . . . 72.310000000000002 112.578 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -83.87 131.63 34.86 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.938 -0.574 . . . . 61.299999999999997 109.475 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.53 165.44 11.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.377 -0.829 . . . . 74.010000000000005 110.546 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.26 -45.68 72.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.286 -0.87 . . . . 73.239999999999995 109.858 175.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -55.91 -38.65 70.53 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.766 0.666 . . . . 75.230000000000004 111.541 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.16 -59.09 5.97 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.299 -0.409 . . . . 74.310000000000002 111.579 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.05 -29.17 32.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.855 -0.738 . . . . 71.109999999999999 111.206 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 5.7 tmm_? -63.51 -53.34 53.5 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.468 0.175 . . . . 74.209999999999994 110.698 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.12 -26.25 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.152 0.501 . . . . 75.120000000000005 110.729 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -78.19 -56.66 4.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.8 -0.636 . . . . 71.540000000000006 111.82 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.7 m-85 -66.85 -24.07 66.1 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.983 0.364 . . . . 73.209999999999994 111.983 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.9 mt-10 -70.33 -20.66 62.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.71 0.291 . . . . 75.299999999999997 111.501 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -56.05 -30.34 61.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 111.35 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.14 -29.17 23.49 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.416 -0.357 . . . . 64.319999999999993 111.779 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.89 -174.17 46.72 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.808 -0.711 . . . . 52.439999999999998 113.213 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -79.23 137.54 37.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.353 . . . . 72.120000000000005 111.248 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 152' ' ' THR . 73.6 mt -108.87 140.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 74.519999999999996 110.175 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.23 -48.33 7.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.495 -0.321 . . . . 75.040000000000006 110.922 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -157.3 156.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 74.150000000000006 110.236 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.1 129.26 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.058 0.456 . . . . 42.399999999999999 110.021 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.4 mt-10 -104.57 104.41 14.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.503 -0.771 . . . . 75.120000000000005 110.945 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.23 120.04 43.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.184 -1.043 . . . . 61.530000000000001 108.184 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.9 mmm -86.32 107.44 17.98 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.707 -0.397 . . . . 35.149999999999999 110.441 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.758 -0.655 . . . . 61.299999999999997 110.946 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.185 -0.23 . . . . 60.450000000000003 113.62 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -158.83 167.65 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.075 0.437 . . . . 73.5 109.97 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.85 171.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.561 -0.745 . . . . 75.519999999999996 109.755 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.2 m-85 -136.18 151.08 49.35 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.487 -0.779 . . . . 70.439999999999998 109.09 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 130.51 25.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.513 0.673 . . . . 73.239999999999995 111.012 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.0 m -99.41 122.09 42.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.839 -1.073 . . . . 73.400000000000006 110.701 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.8 m-85 -98.03 160.16 14.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.912 0.387 . . . . 71.209999999999994 111.321 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.95 -29.94 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.64 . . . . 55.140000000000001 110.185 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.28 151.8 50.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 71.409999999999997 111.092 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -78.94 -29.89 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 63.399999999999999 111.156 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -59.38 -44.26 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.923 -0.58 . . . . 75.540000000000006 110.988 -175.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -33.16 75.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.807 -0.633 . . . . 63.530000000000001 111.515 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.552 HG13 HG23 ' A' ' 107' ' ' ILE . 1.1 t -71.55 -39.37 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.961 0.41 . . . . 64.349999999999994 110.09 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.555 ' OD1' ' HB ' ' A' ' 90' ' ' VAL . 13.2 t70 -68.55 -34.59 76.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 73.209999999999994 110.709 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 84.8 mttt -56.11 -38.96 71.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.633 0.73 . . . . 72.310000000000002 110.777 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.5 mt -75.87 -42.29 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.419 -1.264 . . . . 65.140000000000001 112.235 -175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 160' ' ' ASP . 20.3 m -76.36 -10.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.351 0.596 . . . . 73.400000000000006 110.753 -173.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.9 mt -61.1 -27.94 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.073 -0.967 . . . . 63.109999999999999 110.126 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 45.9 mt-30 -112.7 103.75 11.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.712 -0.847 . . . . 74.310000000000002 108.712 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.2 -35.33 69.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.846 -0.615 . . . . 75.340000000000003 112.627 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.61 134.53 53.78 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.304 . . . . 64.120000000000005 110.609 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.2 m-70 -121.12 153.74 37.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 73.129999999999995 110.029 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -122.76 113.7 19.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.449 . . . . 64.299999999999997 110.469 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.67 119.87 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 110.37 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 71.67 29.49 2.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.045 0.926 . . . . 70.200000000000003 109.059 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.11 -6.53 79.0 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.102 -0.953 . . . . 73.030000000000001 112.534 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 112' ' ' ILE . 70.5 t60 -102.49 133.86 46.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.785 0.326 . . . . 73.549999999999997 110.604 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.55 141.31 30.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.038 0.447 . . . . 64.030000000000001 110.714 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.06 148.34 36.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 54.310000000000002 110.311 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -91.16 129.79 37.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.421 -0.585 . . . . 72.409999999999997 109.421 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.1 t -128.53 133.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.241 0.543 . . . . 65.400000000000006 110.554 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -155.56 172.99 17.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.399 -0.819 . . . . 63.409999999999997 110.466 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -58.86 133.19 55.79 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.278 0.361 . . . . 62.509999999999998 111.175 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -116.45 114.71 24.61 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.813 -0.81 . . . . 72.010000000000005 108.813 173.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 C--N 1.31 -1.111 0 CA-C-N 115.499 -0.773 . . . . 70.129999999999995 110.303 -174.278 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' HA2' ' OG1' ' A' ' 39' ' ' THR . . . . . . . . 0 N--CA 1.477 1.408 0 N-CA-C 111.596 -0.602 . . . . 63.240000000000002 111.596 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 64.65 87.24 0.12 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.58 0.752 . . . . 74.150000000000006 111.776 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -153.77 127.69 8.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.405 -0.591 . . . . 71.010000000000005 109.405 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 t -71.02 88.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.814 -0.81 . . . . 72.540000000000006 108.814 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.97 151.75 35.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 64.239999999999995 111.253 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -142.03 100.86 5.86 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 107.577 -1.268 . . . . 73.439999999999998 107.577 171.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.32 134.99 65.11 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.9 2.4 . . . . 60.100000000000001 113.065 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -112.49 -10.58 13.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.106 -0.952 . . . . 64.409999999999997 109.094 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 26.6 mp0 -92.98 131.36 33.46 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 114.9 -1.045 . . . . 65.319999999999993 110.655 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.5 Cg_endo -60.26 167.37 7.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.093 2.529 . . . . 61.25 112.002 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.96 -39.06 71.22 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.427 -0.351 . . . . 61.119999999999997 111.505 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -68.59 -22.79 64.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.836 0.351 . . . . 73.239999999999995 111.639 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.3 mp -91.81 -6.98 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.519 -0.31 . . . . 74.299999999999997 111.477 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.439 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.0 ptt180 -128.31 1.44 5.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.405 -0.518 . . . . 71.430000000000007 112.124 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.41 145.19 26.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.601 0.715 . . . . 63.329999999999998 111.737 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 68' ' ' VAL . 50.0 mt -115.09 145.79 41.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.581 -1.191 . . . . 74.219999999999999 110.73 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -98.69 122.69 42.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.534 -0.913 . . . . 75.340000000000003 108.534 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' VAL . 16.1 mm -102.28 111.85 33.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 110.011 -0.366 . . . . 71.109999999999999 110.011 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.8 152.14 17.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.755 -0.736 . . . . 70.120000000000005 111.839 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.69 45.66 57.71 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 65.209999999999994 113.178 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 25' ' ' THR . 73.6 mt -78.33 174.97 10.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.684 -0.487 . . . . 70.109999999999999 109.684 173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.76 164.13 19.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.024 -0.732 . . . . 75.439999999999998 109.024 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -73.95 -8.26 55.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.32 0.581 . . . . 63.140000000000001 110.33 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.89 13.81 9.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.588 -0.733 . . . . 61.409999999999997 111.513 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 HD22 ' A' ' 21' ' ' LEU . 56.0 m -74.08 125.39 28.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.456 . . . . 61.119999999999997 110.626 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -99.35 161.87 13.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.816 -0.629 . . . . 73.400000000000006 110.506 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -71.54 -31.51 67.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.437 -0.347 . . . . 72.430000000000007 110.818 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.47 -39.25 93.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.848 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.0 t -72.54 -39.93 67.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.685 . . . . 51.130000000000003 110.362 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.89 -44.87 94.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.825 -0.625 . . . . 60.109999999999999 110.782 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -59.26 -57.12 14.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.734 0.302 . . . . 75.430000000000007 110.383 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -50.16 -36.49 30.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.956 -1.02 . . . . 72.430000000000007 113.215 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.455 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.7 t-80 -72.67 -56.15 5.74 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.96 -0.296 . . . . 72.049999999999997 111.206 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.205 0.446 . . . . 61.030000000000001 112.205 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.41 -13.15 49.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 111.452 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -63.7 -28.86 70.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.832 -0.167 . . . . 72.420000000000002 111.32 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -99.06 -19.47 17.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.069 0.396 . . . . 72.530000000000001 112.069 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.88 168.97 40.71 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.812 -1.185 . . . . 53.100000000000001 113.0 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' HA2' ' A' ' 1' ' ' GLY . 59.3 m -66.86 118.42 10.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.249 0.547 . . . . 70.109999999999999 111.792 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -88.81 130.57 35.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.361 -0.836 . . . . 53.200000000000003 110.827 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 p -95.92 -24.6 16.33 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.158 -0.928 . . . . 74.540000000000006 110.021 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -152.21 152.3 32.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.586 -0.734 . . . . 61.549999999999997 110.127 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.8 t -161.82 130.95 4.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.655 -0.498 . . . . 63.409999999999997 109.655 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.6 129.34 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.318 0.58 . . . . 61.539999999999999 111.011 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.9 132.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.45 -0.944 . . . . 62.539999999999999 108.45 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 3.1 mmt -74.08 100.0 3.49 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.417 0.627 . . . . 53.439999999999998 109.857 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -102.14 160.72 14.27 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.703 -1.135 . . . . 74.409999999999997 110.833 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 11.4 t0 -75.46 126.16 87.9 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 114.748 -1.115 . . . . 71.219999999999999 110.566 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.4 -11.56 28.59 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.987 1.791 . . . . 71.299999999999997 113.158 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -85.49 -56.51 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 74.450000000000003 111.779 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -108.72 -9.59 15.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 64.049999999999997 111.4 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 65.67 49.28 1.78 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.647 -0.706 . . . . 63.420000000000002 110.954 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -120.3 159.46 24.96 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 64.329999999999998 109.342 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -73.46 134.37 43.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 45.539999999999999 111.176 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -85.19 3.49 38.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.179 0.514 . . . . 72.209999999999994 110.804 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.33 63.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.749 -0.66 . . . . 52.43 114.074 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.84 155.88 30.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.58 0.69 . . . . 62.240000000000002 109.96 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.44 -163.89 16.2 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.657 -0.577 . . . . 73.540000000000006 111.657 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.87 150.82 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.14 0.47 . . . . 73.540000000000006 110.399 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 m -131.86 131.05 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.636 -0.711 . . . . 71.430000000000007 109.489 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 m -107.3 122.98 47.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.231 -0.285 . . . . 74.219999999999999 110.231 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -89.37 165.54 14.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.922 0.391 . . . . 64.209999999999994 110.919 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.31 -49.14 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 73.200000000000003 110.587 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.37 155.8 41.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 75.430000000000007 110.903 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.544 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 8.1 p -62.21 -37.12 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.098 -0.501 . . . . 62.420000000000002 111.47 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.83 -44.11 69.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.679 0.622 . . . . 61.340000000000003 112.679 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.93 -29.87 70.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.957 0.408 . . . . 74.319999999999993 110.819 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 16' ' ' LEU . 41.4 t -63.94 -49.76 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.682 -0.69 . . . . 62.439999999999998 110.745 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.21 -42.0 85.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 63.229999999999997 111.809 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.59 -31.85 68.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.84 0.682 . . . . 72.040000000000006 112.84 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.76 -34.06 40.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 43.329999999999998 110.351 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mmt -62.79 -49.33 75.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.712 -0.676 . . . . 75.349999999999994 110.476 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -26.73 63.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 65.430000000000007 111.194 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.75 -5.61 35.33 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.956 0.724 . . . . 42.049999999999997 112.956 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -57.8 148.43 58.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.503 0.186 . . . . 75.299999999999997 111.503 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.09 165.61 84.43 Favored 'Cis proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.789 -1.338 . . . . 53.420000000000002 113.454 2.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -123.68 158.01 32.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.613 . . . . 64.099999999999994 111.079 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.1 ttmt -139.41 105.1 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.094 -0.503 . . . . 73.239999999999995 111.531 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' ND1' ' A' ' 33' ' ' HIS . 16.2 t -108.2 128.71 63.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 74.140000000000001 109.541 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.52 31.09 10.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.58 0.55 . . . . 61.420000000000002 111.631 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.08 21.16 80.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.938 -0.649 . . . . 51.549999999999997 111.873 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.0 tpt180 -124.12 136.01 53.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.204 -0.295 . . . . 71.099999999999994 110.204 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.53 108.08 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.203 -0.666 . . . . 75.310000000000002 109.203 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.81 148.4 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.168 0.509 . . . . 53.409999999999997 110.932 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 4.6 tp10 -111.47 95.01 24.76 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.277 -0.874 . . . . 62.219999999999999 110.886 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.52 130.58 12.88 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.897 1.732 . . . . 72.099999999999994 111.183 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 30.6 mttt -137.78 177.4 7.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.464 -0.789 . . . . 43.0 109.178 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' NH1' HG11 ' A' ' 68' ' ' VAL . 17.7 tpp180 -77.41 139.54 39.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 110.066 -0.346 . . . . 75.519999999999996 110.066 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.01 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.998 0.428 . . . . 61.450000000000003 110.194 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 136.21 22.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.909 -1.042 . . . . 74.230000000000004 111.568 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.8 147.06 43.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.725 -0.67 . . . . 42.539999999999999 109.732 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -63.52 -20.94 66.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.262 0.838 . . . . 73.019999999999996 113.262 -171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.58 -47.87 68.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.755 0.312 . . . . 65.230000000000004 110.68 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.25 -29.56 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.969 0.414 . . . . 60.219999999999999 110.171 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 t -72.0 -3.01 20.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.921 -0.581 . . . . 52.509999999999998 111.007 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -93.23 -3.15 54.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.327 0.584 . . . . 74.439999999999998 109.916 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -95.44 151.98 38.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.833 -0.622 . . . . 70.510000000000005 110.499 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.1 120.33 7.54 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.748 2.299 . . . . 75.120000000000005 112.346 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.07 40.89 8.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.822 -0.704 . . . . 71.450000000000003 112.389 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -86.01 -46.05 10.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 60.020000000000003 111.525 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.72 10.94 26.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.322 0.582 . . . . 71.319999999999993 110.608 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.01 161.82 19.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.895 -0.78 . . . . 51.420000000000002 108.895 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.3 m -77.05 92.91 3.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.46 0.648 . . . . 74.109999999999999 110.942 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.02 115.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.067 -0.97 . . . . 75.030000000000001 110.032 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.501 ' C ' HG21 ' A' ' 159' ' ' VAL . 76.7 mttt -108.88 18.54 20.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.974 0.416 . . . . 72.340000000000003 110.833 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -118.23 139.59 51.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.386 -0.37 . . . . 70.0 110.854 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.481 HG23 HG13 ' A' ' 159' ' ' VAL . 6.4 pt -127.28 153.38 36.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.213 0.53 . . . . 64.430000000000007 111.501 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -103.58 138.25 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.78 -1.1 . . . . 63.439999999999998 109.545 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.48 109.56 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.124 -0.695 . . . . 75.019999999999996 109.124 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.91 161.03 19.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.029 -1.081 . . . . 74.430000000000007 113.366 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.0 46.42 36.55 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.065 -0.588 . . . . 63.039999999999999 111.655 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.426 HG22 ' SG ' ' A' ' 175' ' ' CYS . 15.5 pt -90.55 -165.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.478 -0.361 . . . . 73.120000000000005 110.582 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -82.36 -167.48 1.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.652 0.263 . . . . 44.310000000000002 111.315 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.8 -22.31 66.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 111.168 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.9 144.05 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.541 -0.754 . . . . 71.549999999999997 109.142 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -140.05 138.7 35.59 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.882 -0.784 . . . . 64.510000000000005 108.882 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.65 158.59 15.36 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.105 -0.498 . . . . 74.219999999999999 110.778 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -47.05 76.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.188 -0.914 . . . . 54.329999999999998 108.933 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -53.63 -34.39 58.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.017 -0.992 . . . . 61.009999999999998 111.894 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -66.32 -59.45 3.7 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.928 0.394 . . . . 70.310000000000002 111.135 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 3.1 pp -82.78 -26.62 31.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.158 -0.617 . . . . 70.329999999999998 111.353 -172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 6.1 tmm_? -65.42 -48.63 72.14 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.96 -0.385 . . . . 61.149999999999999 109.96 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.56 -26.67 68.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.209 0.528 . . . . 74.150000000000006 110.579 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -78.92 -55.54 5.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.849 -0.614 . . . . 75.040000000000006 111.781 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 151' ' ' VAL . 35.8 m-85 -69.45 -22.93 63.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.428 0.529 . . . . 63.43 112.428 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -68.61 -22.93 64.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.807 0.337 . . . . 72.219999999999999 111.477 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -58.74 -28.35 65.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 74.439999999999998 110.816 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -88.99 -23.99 22.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 71.120000000000005 111.105 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.79 -178.12 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.407 -0.901 . . . . 73.430000000000007 113.696 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -73.4 131.28 41.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.92 0.488 . . . . 64.540000000000006 110.963 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 152' ' ' THR . 65.5 mt -103.12 138.35 27.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.465 . . . . 72.420000000000002 109.986 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.88 -48.0 9.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.694 0.283 . . . . 74.25 110.673 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.06 156.95 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.177 -0.465 . . . . 54.439999999999998 109.824 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.33 126.22 71.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.16 0.505 . . . . 52.200000000000003 109.927 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -99.77 105.23 17.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 74.329999999999998 110.544 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.32 122.6 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.247 -0.649 . . . . 62.539999999999999 109.247 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 64.7 mmm -96.12 128.02 42.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.525 -0.546 . . . . 70.019999999999996 109.525 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 154.3 20.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.41 0.624 . . . . 73.120000000000005 111.44 -174.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -83.57 133.77 34.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.885 -1.052 . . . . 73.140000000000001 109.13 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -80.58 -24.23 39.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.763 0.315 . . . . 73.310000000000002 111.164 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.18 -53.82 2.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 73.319999999999993 112.782 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -89.29 -23.18 22.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.056 0.455 . . . . 75.200000000000003 111.181 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.39 19.35 78.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.618 -0.801 . . . . 63.340000000000003 112.296 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -92.82 159.72 15.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.421 -0.585 . . . . 52.240000000000002 109.421 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -86.49 81.62 8.23 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.65 -0.87 . . . . 65.25 108.65 175.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -150.55 -178.48 6.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.187 -0.915 . . . . 74.140000000000001 111.829 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.11 -46.04 3.36 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.11 -1.404 . . . . 45.299999999999997 112.805 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -174.96 154.92 1.93 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.872 -0.418 . . . . 72.319999999999993 109.872 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.4 171.98 13.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.915 -0.584 . . . . 75.129999999999995 109.79 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 42.3 m-85 -137.53 145.71 43.27 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.833 -0.621 . . . . 72.219999999999999 109.995 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 125' ' ' PHE . 60.4 t -129.86 130.14 66.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.752 0.31 . . . . 73.219999999999999 110.738 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 131' ' ' ILE . 90.4 m -104.76 119.64 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 71.319999999999993 110.601 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -102.87 159.06 15.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.952 0.405 . . . . 71.209999999999994 111.417 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -77.85 -29.21 50.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.562 -0.744 . . . . 65.129999999999995 110.581 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -130.43 155.36 46.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.476 -0.784 . . . . 65.219999999999999 110.259 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.41 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.7 p80 -77.87 -26.44 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.089 -0.505 . . . . 72.430000000000007 110.513 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -59.83 -41.93 92.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.474 -0.785 . . . . 64.540000000000006 111.493 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.96 -34.92 79.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.586 -0.279 . . . . 74.510000000000005 110.915 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.501 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -69.61 -40.75 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 73.239999999999995 109.722 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.72 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.82 -31.6 68.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.186 -0.916 . . . . 62.200000000000003 111.441 -178.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 39.3 mttm -56.23 -37.81 70.23 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.779 0.8 . . . . 63.509999999999998 109.871 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.0 mt -79.48 -42.65 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.489 -1.232 . . . . 72.329999999999998 112.522 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 160' ' ' ASP . 21.4 m -74.98 -13.56 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.906 0.384 . . . . 74.109999999999999 111.171 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 13' ' ' LEU . 28.9 mt -56.44 -34.83 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.979 170.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.95 102.48 10.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.64 -0.874 . . . . 63.100000000000001 108.64 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -57.26 -31.77 65.9 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.899 0.703 . . . . 51.109999999999999 112.899 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.61 135.46 54.99 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.248 -0.581 . . . . 63.439999999999998 110.44 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -126.56 154.84 43.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.521 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.3 m -94.22 107.32 19.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.338 -0.392 . . . . 51.200000000000003 110.257 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.79 131.4 70.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.183 -0.673 . . . . 45.439999999999998 109.183 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 45.4 47.16 10.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.287 0.635 . . . . 55.420000000000002 112.491 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.88 73.96 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 113.575 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -142.29 133.22 25.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.01 -0.367 . . . . 75.310000000000002 110.01 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -82.21 109.58 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.872 0.367 . . . . 72.329999999999998 110.251 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 112' ' ' ILE . 10.3 m -108.72 155.02 21.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.01 -0.541 . . . . 71.430000000000007 109.938 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.33 137.78 32.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 72.030000000000001 110.472 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -129.59 160.38 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 73.239999999999995 110.343 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -174.09 175.92 2.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.214 -0.903 . . . . 75.239999999999995 111.507 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' HG11 ' A' ' 163' ' ' VAL . 19.1 mmtm -62.29 130.81 47.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.735 -0.666 . . . . 74.549999999999997 110.696 173.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -117.57 114.55 23.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.628 -0.878 . . . . 63.240000000000002 108.628 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.2 mt -85.44 142.43 29.24 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.607 -0.437 . . . . 74.219999999999999 109.845 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.499 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 6.7 m -63.35 154.1 32.91 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.503 -0.554 . . . . 54.310000000000002 109.503 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -62.63 -29.75 70.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.279 0.474 . . . . 65.099999999999994 112.279 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -47.35 68.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.958 -0.756 . . . . 74.140000000000001 108.958 174.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 1.3 mp0 -58.82 -40.32 83.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.379 -0.828 . . . . 60.25 111.149 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 79.1 mtp -70.52 -40.16 73.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 73.530000000000001 111.264 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -54.63 9.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 64.25 110.913 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.1 m 60.15 25.11 14.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.12 0.568 . . . . 63.240000000000002 111.143 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -101.73 176.1 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.505 . . . . 33.340000000000003 110.904 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.5 m -80.69 91.51 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.07 -0.513 . . . . 74.430000000000007 111.165 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.8 m -79.06 111.3 15.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 54.009999999999998 110.204 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 23.2 m -115.56 89.87 3.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.164 -0.471 . . . . 54.450000000000003 110.605 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -121.18 145.73 47.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.198 -0.455 . . . . 61.439999999999998 109.971 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -122.2 42.73 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.502 0.668 . . . . 74.140000000000001 109.488 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 97.73 -13.92 63.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.14 -1.184 . . . . 64.140000000000001 110.14 -169.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? . . . . . 0 C--O 1.251 1.179 0 N-CA-C 107.491 -1.3 . . . . 75.209999999999994 107.491 178.384 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.786 -0.526 . . . . 52.219999999999999 111.786 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 t -67.14 120.06 13.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 52.549999999999997 110.154 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -121.04 135.26 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.336 -0.393 . . . . 75.540000000000006 111.238 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 t -71.76 113.85 9.22 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.168 -1.049 . . . . 55.210000000000001 108.168 168.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.54 6.88 15.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.784 0.326 . . . . 62.210000000000001 111.018 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 t -141.78 98.44 6.36 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.297 -0.41 . . . . 73.120000000000005 110.741 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB3' HG23 ' A' ' 64' ' ' THR . 34.1 Cg_endo -91.06 165.49 3.78 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.959 2.44 . . . . 62.25 111.992 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -97.63 -8.96 27.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 171.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -66.95 130.86 93.88 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.816 -1.084 . . . . 61.439999999999998 110.812 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.23 169.29 12.51 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.216 2.611 . . . . 54.530000000000001 111.751 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.7 pt-20 -52.14 -38.86 58.9 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 112.185 0.439 . . . . 64.409999999999997 112.185 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 6.5 pt20 -65.64 -26.31 67.75 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.108 0.41 . . . . 75.510000000000005 112.108 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 164' ' ' ILE . 5.4 mp -88.97 -9.88 49.78 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.185 -0.322 . . . . 60.109999999999999 111.165 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 68' ' ' VAL . 12.8 ptt180 -118.72 -5.17 10.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 63.420000000000002 111.301 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.7 ttpt -93.69 148.73 21.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.402 0.62 . . . . 74.120000000000005 111.213 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.556 HD21 HG13 ' A' ' 68' ' ' VAL . 54.0 mt -120.57 146.39 46.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.973 . . . . 75.439999999999998 110.413 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 16.5 t80 -98.13 131.33 44.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.085 -1.08 . . . . 74.049999999999997 108.085 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 60' ' ' VAL . 20.6 mm -106.45 111.55 35.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.892 -0.41 . . . . 74.319999999999993 109.892 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.6 148.65 17.51 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.855 -0.688 . . . . 72.319999999999993 111.9 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.77 46.41 30.42 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.785 -0.722 . . . . 72.230000000000004 113.503 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 25' ' ' THR . 79.1 mt -81.34 174.39 11.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.883 0.373 . . . . 62.049999999999997 110.237 173.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.0 p -87.64 173.88 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.437 -0.579 . . . . 64.340000000000003 109.437 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.9 -11.51 59.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.119 0.485 . . . . 75.540000000000006 109.78 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -103.67 -0.43 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.366 -0.834 . . . . 74.099999999999994 111.941 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 21' ' ' LEU . 33.3 m -67.91 123.77 21.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.0 0.429 . . . . 72.129999999999995 111.615 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.9 159.51 15.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.552 -0.749 . . . . 63.399999999999999 110.066 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -68.73 -30.92 69.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.344 . . . . 72.0 111.876 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -25.08 45.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.883 -0.327 . . . . 74.230000000000004 111.145 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.8 m -74.94 -43.5 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.415 . . . . 34.039999999999999 110.406 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.25 -46.2 89.92 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.498 -0.774 . . . . 62.329999999999998 110.065 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -55.63 -59.87 4.24 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.445 -0.798 . . . . 73.430000000000007 111.794 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -50.18 -33.73 20.16 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.787 0.68 . . . . 63.549999999999997 112.654 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.438 ' CG ' HG22 ' A' ' 79' ' ' VAL . 62.3 t60 -69.03 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 74.150000000000006 110.684 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.16 -22.63 62.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.198 0.444 . . . . 75.340000000000003 112.198 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 31.8 tt0 -65.15 -21.53 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 74.310000000000002 111.06 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -62.49 -23.13 66.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 74.329999999999998 111.941 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -102.42 -21.12 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.514 0.197 . . . . 72.420000000000002 111.528 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.91 161.64 32.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.398 -0.906 . . . . 74.239999999999995 112.603 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -67.88 116.05 8.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.144 0.497 . . . . 70.109999999999999 111.443 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -84.41 136.8 33.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 110.205 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -106.45 -16.5 14.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.428 -0.805 . . . . 60.329999999999998 109.749 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.52 149.42 29.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 75.319999999999993 109.886 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.9 t -160.42 131.09 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.215 -0.291 . . . . 75.150000000000006 110.215 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.12 131.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.996 0.427 . . . . 73.120000000000005 110.254 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -92.96 130.51 41.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.222 -1.029 . . . . 45.200000000000003 108.222 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.67 97.59 3.85 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.653 0.74 . . . . 45.399999999999999 110.605 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 29.4 mtt180 -101.94 163.94 11.98 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.598 -1.183 . . . . 74.230000000000004 110.391 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 22.6 t70 -79.27 126.79 80.8 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.145 -0.934 . . . . 64.120000000000005 109.512 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.45 -18.95 49.53 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 121.901 1.734 . . . . 72.439999999999998 113.362 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 35.9 m-80 -86.02 -56.52 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 62.109999999999999 111.482 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 -10.11 24.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.142 -0.481 . . . . 72.109999999999999 111.873 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm 66.17 29.93 9.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.998 0.919 . . . . 72.109999999999999 111.481 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -106.15 150.68 25.6 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.792 -0.447 . . . . 73.120000000000005 109.792 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 30.5 t -73.83 133.96 43.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.107 0.479 . . . . 70.430000000000007 110.73 -174.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -83.71 2.61 36.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.386 -0.824 . . . . 71.049999999999997 111.022 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.88 16.91 60.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.883 -0.675 . . . . 73.340000000000003 113.957 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.6 158.4 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.947 0.874 . . . . 75.140000000000001 111.097 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.76 -165.31 17.31 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.459 -0.656 . . . . 52.219999999999999 111.459 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.28 146.35 33.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 117.213 0.507 . . . . 73.409999999999997 110.302 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 18' ' ' ILE . 11.0 m -127.82 126.59 67.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.704 -0.68 . . . . 60.520000000000003 109.333 172.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 m -103.62 120.72 41.47 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.125 -0.359 . . . . 75.209999999999994 110.426 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -85.98 161.47 18.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.017 -0.538 . . . . 75.109999999999999 110.146 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.58 66.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.591 -0.731 . . . . 64.530000000000001 110.704 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.688 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 89.5 m -141.97 151.8 42.87 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.829 -0.623 . . . . 61.539999999999999 110.785 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -58.06 -36.76 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.609 -0.723 . . . . 72.120000000000005 112.161 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -49.37 -47.73 47.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.017 0.747 . . . . 73.329999999999998 113.017 175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.9 mp0 -64.7 -31.39 72.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.711 0.291 . . . . 74.239999999999995 111.273 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.556 HG13 HD21 ' A' ' 16' ' ' LEU . 52.1 t -63.31 -47.92 89.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 74.450000000000003 110.593 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.29 -43.28 99.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.391 -0.822 . . . . 74.340000000000003 111.062 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -55.7 -35.65 66.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.746 0.647 . . . . 74.319999999999993 112.746 172.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -31.18 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 74.430000000000007 109.903 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.7 mmt -72.25 -37.69 69.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 72.150000000000006 111.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.625 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -76.22 -14.08 60.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.151 0.5 . . . . 64.450000000000003 110.573 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.67 -9.17 50.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.596 -0.729 . . . . 61.109999999999999 111.903 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -56.65 146.88 54.15 Favored Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.22 0.325 . . . . 53.530000000000001 111.642 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.85 167.9 77.46 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.889 -1.296 . . . . 62.530000000000001 113.224 2.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -122.59 154.47 37.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 70.209999999999994 111.315 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.8 ttmt -139.05 109.15 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 74.109999999999999 110.976 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' CG ' ' A' ' 33' ' ' HIS . 18.8 t -109.94 129.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.585 -0.524 . . . . 72.150000000000006 109.585 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.9 t70 68.36 22.06 8.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.8 0.81 . . . . 75.549999999999997 110.563 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.08 67.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 64.340000000000003 111.777 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.5 tpt180 -124.0 138.14 54.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.74 -0.467 . . . . 74.040000000000006 109.74 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.7 109.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.48 -0.563 . . . . 54.119999999999997 109.48 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -107.66 148.64 11.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.985 0.422 . . . . 71.409999999999997 110.482 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.51 103.46 52.68 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.821 -0.627 . . . . 72.209999999999994 111.476 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.52 132.8 19.54 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.008 1.805 . . . . 53.140000000000001 111.363 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -131.6 161.12 33.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.66 -1.237 . . . . 63.32 107.66 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.51 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.6 tpp180 -68.34 139.82 55.89 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.465 -0.568 . . . . 61.109999999999999 109.465 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 91.93 1.7 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.471 0.653 . . . . 63.350000000000001 109.786 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.404 ' CG2' HG23 ' A' ' 163' ' ' VAL . 9.8 p -65.18 156.23 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.672 -1.149 . . . . 64.430000000000007 111.598 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 t -60.46 155.71 17.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.649 -0.705 . . . . 71.530000000000001 110.44 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -60.46 -25.31 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.75 -0.659 . . . . 74.430000000000007 112.009 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.28 -54.41 25.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 74.310000000000002 111.059 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.11 -30.6 63.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.041 -0.264 . . . . 61.399999999999999 111.422 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -68.46 -8.81 44.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.924 0.392 . . . . 53.310000000000002 111.525 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -74.02 -21.87 59.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 110.327 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -79.65 153.98 75.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 110.597 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.26 129.77 16.51 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.693 2.262 . . . . 73.010000000000005 111.4 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.03 57.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 74.329999999999998 112.586 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.32 60.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 110.676 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.476 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 19.8 m170 -100.5 20.93 14.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.51 0.671 . . . . 71.329999999999998 110.548 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.22 179.12 5.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 43.340000000000003 109.423 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 97.08 7.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.172 0.511 . . . . 33.439999999999998 110.597 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.41 113.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.252 -0.885 . . . . 71.540000000000006 109.529 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' C ' HG21 ' A' ' 159' ' ' VAL . 84.8 mttt -110.72 21.86 16.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.474 -0.49 . . . . 61.119999999999997 111.174 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -126.04 145.78 50.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.855 0.36 . . . . 75.099999999999994 111.859 176.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -129.77 153.66 39.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.169 0.509 . . . . 73.409999999999997 111.696 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.4 t80 -100.81 139.63 36.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.03 -0.986 . . . . 71.319999999999993 109.364 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t -131.12 111.55 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.622 -0.51 . . . . 72.400000000000006 109.622 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.3 167.88 25.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.546 -1.311 . . . . 44.530000000000001 113.428 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.48 38.34 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.682 -0.77 . . . . 63.420000000000002 112.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.7 143.7 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.701 -0.481 . . . . 70.319999999999993 109.701 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -89.18 -42.05 11.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 72.239999999999995 111.398 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -104.89 -97.28 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.317 -0.401 . . . . 72.209999999999994 110.59 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 147.02 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.67 -0.863 . . . . 73.519999999999996 108.67 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 129.45 36.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.386 0.612 . . . . 74.439999999999998 110.82 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.47 166.14 11.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.905 -1.043 . . . . 75.099999999999994 110.194 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.12 -45.65 90.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 74.340000000000003 109.713 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -57.73 -32.85 67.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 62.219999999999999 111.929 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -67.25 -57.61 6.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.907 0.384 . . . . 75.400000000000006 111.241 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 122' ' ' ARG . 2.4 pp -83.94 -25.0 30.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.298 -0.561 . . . . 72.409999999999997 111.303 -171.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' N ' HD12 ' A' ' 121' ' ' LEU . 6.0 tmm_? -65.28 -51.38 61.09 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.922 -0.399 . . . . 74.120000000000005 109.922 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.66 -27.26 69.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 64.129999999999995 110.635 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 170' ' ' VAL . 82.0 t80 -80.64 -54.03 6.01 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.012 -0.54 . . . . 73.129999999999995 111.923 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.4 m-85 -70.88 -23.01 62.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.16 0.43 . . . . 64.200000000000003 112.16 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.7 mt-10 -67.15 -20.41 65.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.935 0.398 . . . . 71.319999999999993 111.194 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.01 -20.98 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.833 -0.621 . . . . 72.209999999999994 111.373 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.59 -27.87 17.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.548 -0.296 . . . . 70.340000000000003 111.678 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -171.49 44.39 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.528 -0.844 . . . . 51.219999999999999 113.232 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -76.36 130.7 38.46 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.04 0.447 . . . . 74.200000000000003 111.602 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.471 HD12 ' HG3' ' A' ' 126' ' ' GLU . 55.0 mt -101.38 140.54 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 71.219999999999999 109.804 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.31 -50.41 6.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 70.329999999999998 110.269 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 p -158.28 158.66 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.581 -0.736 . . . . 63.409999999999997 109.338 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.78 128.92 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 73.340000000000003 109.851 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.8 mt-10 -104.29 104.71 14.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 45.229999999999997 110.454 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mm -96.6 116.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.44 -0.948 . . . . 74.049999999999997 108.44 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.2 mmm -87.54 135.59 33.29 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.794 -0.363 . . . . 75.010000000000005 110.481 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 1.6 m -89.53 154.06 20.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.383 0.611 . . . . 53.409999999999997 111.127 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.06 119.74 35.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.96 -1.018 . . . . 74.030000000000001 109.22 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -64.83 -35.88 82.55 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.363 0.415 . . . . 74.150000000000006 111.758 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.89 -48.21 5.56 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.631 -0.795 . . . . 52.109999999999999 112.947 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 m -78.97 -24.46 43.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.79 0.293 . . . . 74.310000000000002 111.79 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.39 88.68 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.17 -0.538 . . . . 62.409999999999997 112.498 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -107.65 155.36 20.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.395 -0.595 . . . . 72.209999999999994 109.395 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 28.8 mtpp -81.88 87.37 6.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 147' ' ' GLY . 3.6 ttp180 -157.53 158.23 35.27 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.465 -1.243 . . . . 72.430000000000007 111.183 -166.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' N ' ' HG2' ' A' ' 146' ' ' ARG . . . 110.57 -43.98 1.6 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.89 -0.595 . . . . 54.539999999999999 112.603 174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.56 161.63 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 74.310000000000002 110.153 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.52 173.09 11.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.572 -0.74 . . . . 35.32 110.159 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 41.1 m-85 -137.27 145.47 43.56 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.223 -0.899 . . . . 73.310000000000002 109.351 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 125' ' ' PHE . 61.4 t -128.42 125.63 64.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 120.99 0.424 . . . . 75.310000000000002 110.879 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 87.9 m -101.5 119.93 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 73.030000000000001 111.033 -176.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.08 155.23 18.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.986 0.422 . . . . 70.109999999999999 111.743 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.05 -18.46 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.562 -0.745 . . . . 61.340000000000003 110.579 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.04 151.73 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 54.130000000000003 111.152 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -82.78 -28.15 30.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.599 -0.273 . . . . 75.129999999999995 111.288 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.618 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 23.9 t70 -68.01 -35.26 78.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.995 -0.548 . . . . 52.240000000000002 110.589 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.0 m -67.72 -34.13 76.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 60.149999999999999 110.825 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 107' ' ' ILE . 2.2 t -72.13 -38.36 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.019 -0.537 . . . . 70.239999999999995 109.558 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 t70 -66.11 -35.79 81.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 72.340000000000003 111.007 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 83.5 mttt -57.46 -37.98 73.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.504 0.669 . . . . 64.239999999999995 110.7 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.429 HD13 HD13 ' A' ' 107' ' ' ILE . 16.1 mt -75.69 -42.07 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.807 -1.088 . . . . 74.319999999999993 111.567 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.8 m -77.81 -8.19 11.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.465 0.65 . . . . 74.340000000000003 110.902 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.41 HD13 HD12 ' A' ' 13' ' ' LEU . 15.0 mt -60.79 -32.77 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.997 -1.001 . . . . 72.340000000000003 110.382 170.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 43.2 mt-30 -113.17 114.73 27.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.046 -0.724 . . . . 64.510000000000005 109.046 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.23 -38.07 67.98 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.049 0.759 . . . . 63.130000000000003 113.049 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -123.09 138.43 54.67 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.089 -0.382 . . . . 73.540000000000006 110.574 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.53 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 36.7 m-70 -123.35 140.01 53.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 110.966 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -87.26 104.38 16.34 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.786 -0.643 . . . . 73.239999999999995 111.11 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 124' ' ' TYR . 28.2 t -111.22 127.26 68.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.488 -0.778 . . . . 54.350000000000001 109.143 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 45.18 40.13 4.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.274 0.63 . . . . 60.119999999999997 112.319 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 -6.15 77.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.034 -0.603 . . . . 64.140000000000001 114.152 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -107.68 128.74 54.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.581 0.691 . . . . 74.420000000000002 110.46 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.36 113.1 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.34 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.4 p -112.18 156.57 22.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.337 -0.847 . . . . 75.299999999999997 109.511 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -86.04 137.38 32.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.206 0.527 . . . . 71.239999999999995 110.898 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -129.53 164.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.205 -0.907 . . . . 73.450000000000003 110.721 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -175.66 173.98 2.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.104 -0.953 . . . . 64.540000000000006 111.245 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -61.01 134.82 57.48 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 123.618 0.574 . . . . 65.439999999999998 110.247 173.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -127.73 122.61 33.31 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.311 -0.626 . . . . 74.329999999999998 109.311 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.7 mt -97.99 116.13 29.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.982 -0.687 . . . . 74.400000000000006 109.546 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.444 ' OG ' ' HG3' ' A' ' 106' ' ' LYS . 6.2 m -65.51 166.83 9.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.499 -0.773 . . . . 73.010000000000005 110.077 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -64.05 -29.95 71.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.114 0.483 . . . . 75.109999999999999 110.03 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.34 -53.12 48.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.393 -0.822 . . . . 72.409999999999997 110.129 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -64.24 -36.59 84.58 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.487 0.551 . . . . 75.439999999999998 112.487 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 69.2 mtp -67.58 -31.67 71.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 72.319999999999993 110.748 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -92.97 -0.29 57.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.091 -0.504 . . . . 70.430000000000007 111.317 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.6 m -82.13 81.74 7.94 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.999 0.428 . . . . 74.129999999999995 111.529 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -85.54 163.86 18.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.639 -0.875 . . . . 63.539999999999999 108.639 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.0 m -72.38 95.18 1.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.179 0.514 . . . . 60.409999999999997 110.123 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.5 p -145.61 -173.76 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.67 . . . . 71.450000000000003 110.654 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 73.26 6.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 45.32 110.785 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -104.24 161.94 13.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 54.509999999999998 111.04 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -144.18 163.31 34.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.684 -0.689 . . . . 60.100000000000001 109.921 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -104.7 156.65 16.98 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 61.420000000000002 112.263 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.767 -0.635 . . . . 75.319999999999993 109.582 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 111.957 -0.457 . . . . 44.409999999999997 111.957 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -78.67 102.12 7.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.985 0.422 . . . . 72.129999999999995 110.93 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -139.81 -37.02 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.107 -0.497 . . . . 64.400000000000006 110.055 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -85.3 55.02 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.824 -0.625 . . . . 71.310000000000002 110.081 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.94 137.17 32.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 62.32 110.461 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -97.5 114.57 65.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.929 -0.397 . . . . 75.209999999999994 109.929 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.82 135.71 26.29 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.935 1.757 . . . . 63.32 112.626 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 -2.19 17.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.657 -0.868 . . . . 73.519999999999996 108.657 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -99.44 136.61 20.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.516 -1.22 . . . . 72.129999999999995 110.842 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' HD22 ' A' ' 13' ' ' LEU . 25.3 Cg_endo -64.51 167.65 14.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.932 2.421 . . . . 61.100000000000001 111.199 172.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.3 pt-20 -56.49 -35.73 68.31 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.596 0.221 . . . . 73.519999999999996 111.596 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.452 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.3 pt20 -69.09 -25.49 64.46 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.591 0.234 . . . . 64.109999999999999 111.404 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 12' ' ' GLN . 4.6 mp -88.63 -11.97 43.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.513 0.196 . . . . 75.310000000000002 111.384 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.549 ' HA ' HG21 ' A' ' 68' ' ' VAL . 31.2 ptt180 -124.12 6.53 8.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.195 0.522 . . . . 73.230000000000004 110.835 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.6 ttpt -97.87 146.87 25.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.353 0.597 . . . . 71.209999999999994 110.908 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.639 HD21 HG13 ' A' ' 68' ' ' VAL . 55.9 mt -116.36 145.21 43.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.919 -1.037 . . . . 73.230000000000004 110.354 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 13.5 t80 -101.1 125.67 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.446 -0.946 . . . . 74.519999999999996 108.446 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -106.25 111.11 33.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.985 -0.376 . . . . 71.319999999999993 109.985 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.48 157.54 18.23 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.548 -0.834 . . . . 74.409999999999997 111.222 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.29 67.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.932 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD22 HG21 ' A' ' 25' ' ' THR . 44.1 mt -80.3 170.66 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 74.209999999999994 110.86 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -92.09 165.65 13.06 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.608 -0.724 . . . . 65.219999999999999 109.726 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -67.3 -22.51 65.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.898 -0.592 . . . . 74.099999999999994 110.092 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -97.22 2.7 51.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.639 -0.71 . . . . 73.0 111.408 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 21' ' ' LEU . 80.7 m -77.33 117.67 19.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 75.109999999999999 111.546 -175.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 p -105.35 164.47 11.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.059 -0.973 . . . . 74.510000000000005 109.516 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -40.57 90.9 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.416 0.448 . . . . 74.340000000000003 111.132 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.83 -37.38 87.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.942 -0.572 . . . . 73.040000000000006 111.402 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.1 m -78.48 -41.64 31.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.555 -0.293 . . . . 73.540000000000006 110.96 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.7 tp -62.87 -49.01 76.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.167 -0.47 . . . . 72.239999999999995 110.623 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -57.4 -56.04 27.01 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.443 -0.799 . . . . 75.409999999999997 110.886 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 m -48.24 -39.18 20.46 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -70.22 -53.03 18.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 73.25 110.916 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -73.12 -21.96 60.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.925 0.343 . . . . 74.209999999999994 111.925 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -17.8 54.42 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.667 0.387 . . . . 60.219999999999999 111.921 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.73 -27.11 68.98 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.568 -0.287 . . . . 71.349999999999994 111.7 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -99.25 -17.42 18.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.688 0.255 . . . . 63.409999999999997 111.688 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 168.34 38.6 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.042 -1.075 . . . . 74.430000000000007 112.862 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -68.61 121.49 16.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.194 0.521 . . . . 73.420000000000002 111.507 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.5 128.94 36.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.709 -0.678 . . . . 63.100000000000001 111.267 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 p -91.25 -29.27 17.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.95 -1.023 . . . . 61.450000000000003 110.164 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -150.39 152.37 34.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 65.439999999999998 109.455 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.67 136.45 6.18 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.475 -0.565 . . . . 42.530000000000001 109.475 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -152.14 121.75 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.375 0.607 . . . . 72.109999999999999 110.471 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.44 131.01 34.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.431 -0.952 . . . . 51.409999999999997 108.431 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.8 mmt -76.22 99.61 4.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.602 0.715 . . . . 53.310000000000002 110.697 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 57.8 mtp85 -109.47 163.6 13.28 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.524 -1.216 . . . . 75.540000000000006 109.251 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.23 126.92 82.64 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.776 -0.453 . . . . 61.530000000000001 109.776 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.25 -18.92 44.81 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.969 1.779 . . . . 42.5 112.67 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.11 -56.79 3.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 54.149999999999999 111.607 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -100.85 -8.56 22.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 71.400000000000006 111.74 -172.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm 62.27 39.0 12.92 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.65 0.78 . . . . 70.219999999999999 112.57 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -115.68 153.49 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.256 -0.277 . . . . 65.299999999999997 110.636 177.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 36.3 t -69.52 134.33 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.749 0.309 . . . . 63.329999999999998 110.48 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -85.35 -4.11 59.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 74.349999999999994 110.279 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.79 18.96 53.42 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.923 -0.656 . . . . 74.319999999999993 113.777 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -159.07 158.35 32.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.564 0.682 . . . . 75.310000000000002 110.425 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.16 -166.62 18.51 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.636 -0.586 . . . . 50.119999999999997 111.636 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -141.12 148.49 40.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.467 0.634 . . . . 74.340000000000003 110.778 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 16' ' ' LEU . 4.7 m -131.08 121.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 73.439999999999998 109.931 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 m -101.94 123.58 46.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.51 -0.313 . . . . 71.030000000000001 110.442 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 68' ' ' VAL . 35.7 m-85 -88.23 171.24 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.16 0.505 . . . . 70.030000000000001 111.368 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.4 -48.39 11.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.416 -0.811 . . . . 74.120000000000005 110.146 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -115.43 149.06 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 73.510000000000005 110.158 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 10.0 p -68.95 -25.28 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.004 0.43 . . . . 54.140000000000001 111.122 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.92 -34.76 73.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 72.219999999999999 110.995 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.56 -28.45 66.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 65.010000000000005 110.38 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.639 HG13 HD21 ' A' ' 16' ' ' LEU . 21.8 t -68.22 -46.34 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.359 -0.837 . . . . 74.319999999999993 110.198 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.98 -46.12 88.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.417 -0.81 . . . . 72.010000000000005 110.938 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -61.12 -31.4 71.1 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.679 0.622 . . . . 33.130000000000003 112.679 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 -36.25 65.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.039 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.6 mmt -69.62 -35.22 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.87 -0.604 . . . . 54.240000000000002 110.995 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.624 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 6.6 p30 -79.64 -22.72 43.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.455 -0.339 . . . . 73.099999999999994 111.13 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.84 -5.65 46.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 44.43 112.449 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mtp-105 -58.96 146.7 76.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.449 -0.341 . . . . 72.019999999999996 111.468 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 168.18 77.85 Favored 'Cis proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.686 -1.381 . . . . 73.400000000000006 113.743 1.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -123.4 155.63 37.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 63.039999999999999 110.654 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.3 ttmt -139.78 104.95 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.042 0.448 . . . . 71.219999999999999 111.176 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 t -105.82 128.23 60.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.787 -0.642 . . . . 73.099999999999994 109.558 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 64.78 29.9 12.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.371 0.668 . . . . 74.310000000000002 111.76 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.89 77.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.784 -0.722 . . . . 52.340000000000003 112.04 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.5 tpt180 -124.93 134.6 52.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.133 -0.321 . . . . 74.439999999999998 110.133 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 113.39 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.834 -0.802 . . . . 71.120000000000005 108.834 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 7.4 m -102.5 152.49 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 74.420000000000002 111.272 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HG3' ' NZ ' ' A' ' 87' ' ' LYS . 5.7 tp10 -113.73 91.8 22.56 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.741 -1.118 . . . . 55.539999999999999 110.542 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -78.37 143.74 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.808 2.338 . . . . 64.049999999999997 111.136 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' NZ ' ' HG3' ' A' ' 85' ' ' GLU . 12.7 mmtm -139.77 159.78 41.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.641 -1.244 . . . . 74.019999999999996 107.641 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' NH2' ' HA ' ' A' ' 90' ' ' VAL . 2.5 tmm_? -69.49 130.98 43.99 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.845 -1.539 . . . . 61.399999999999999 106.845 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.54 94.7 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.971 0.415 . . . . 64.340000000000003 111.157 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 25.5 t -58.52 140.82 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.725 -1.125 . . . . 65.129999999999995 111.826 -172.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -56.66 143.32 36.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.386 -0.824 . . . . 71.099999999999994 109.866 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -62.44 -31.31 71.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.593 0.59 . . . . 74.420000000000002 112.593 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.81 -29.1 58.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.463 0.173 . . . . 71.230000000000004 111.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.05 -30.46 39.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.391 -0.596 . . . . 73.400000000000006 109.391 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.3 m -74.94 -3.24 31.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.442 -0.799 . . . . 50.210000000000001 111.211 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -76.38 -13.72 60.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.375 0.607 . . . . 74.209999999999994 109.968 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -106.24 146.96 34.0 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.396 -0.594 . . . . 63.229999999999997 109.396 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.88 140.62 35.47 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.598 2.199 . . . . 61.119999999999997 112.217 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 9.63 60.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.934 -0.651 . . . . 24.149999999999999 112.474 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.21 54.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.626 0.251 . . . . 43.020000000000003 111.6 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -96.2 22.7 7.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 72.430000000000007 111.205 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.1 mt -100.46 174.84 5.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 72.239999999999995 109.957 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 m -78.99 85.49 4.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 72.209999999999994 109.845 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.493 ' HA ' ' HG3' ' A' ' 185' ' ' GLU . 71.7 t -107.94 112.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.182 -0.917 . . . . 44.240000000000002 109.946 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 69.8 mttt -106.94 13.76 27.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 44.219999999999999 110.653 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -114.67 138.79 50.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.571 -0.286 . . . . 63.240000000000002 111.27 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 159' ' ' VAL . 5.2 pt -130.13 152.44 37.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.237 0.542 . . . . 54.539999999999999 111.796 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.0 t80 -97.49 137.43 36.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.915 -1.039 . . . . 64.430000000000007 109.854 175.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 t -124.72 110.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.128 -0.693 . . . . 64.519999999999996 109.128 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -134.18 155.94 22.12 Favored Glycine 0 CA--C 1.507 -0.45 0 C-N-CA 119.742 -1.218 . . . . 50.329999999999998 113.232 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.48 10.57 31.0 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.564 -0.827 . . . . 74.400000000000006 112.258 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 147' ' ' GLY . 14.1 pt -78.34 110.09 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 70.340000000000003 109.956 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.63 -18.88 24.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 61.450000000000003 111.203 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -112.18 175.22 5.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.841 -0.618 . . . . 60.240000000000002 109.874 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.96 123.98 22.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 71.109999999999999 110.067 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -118.51 144.32 46.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.096 -0.502 . . . . 65.420000000000002 110.125 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.38 162.51 13.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.803 -0.635 . . . . 73.239999999999995 111.217 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -47.69 77.29 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.732 -1.122 . . . . 61.530000000000001 109.755 175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -54.25 -40.65 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.637 0.586 . . . . 70.140000000000001 111.669 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -57.8 -58.51 8.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.855 0.359 . . . . 74.209999999999994 111.127 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.75 -26.41 29.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.802 -0.759 . . . . 70.0 111.446 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -65.95 -51.46 58.31 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 110.076 -0.342 . . . . 73.319999999999993 110.076 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.21 -25.29 67.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 110.241 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -79.05 -56.75 4.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.857 -0.61 . . . . 72.549999999999997 112.323 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 151' ' ' VAL . 45.7 m-85 -69.3 -22.81 63.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.206 0.447 . . . . 74.129999999999995 112.206 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG2' HD12 ' A' ' 131' ' ' ILE . 2.0 mm-40 -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.062 0.458 . . . . 61.030000000000001 110.464 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -58.3 -34.68 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.547 -0.751 . . . . 54.409999999999997 112.001 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -81.51 -31.72 32.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 73.409999999999997 111.316 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.61 48.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.957 -0.639 . . . . 73.239999999999995 112.696 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -72.9 128.04 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 72.019999999999996 111.532 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HG2' ' A' ' 126' ' ' GLU . 56.6 mt -98.15 136.88 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.661 -0.699 . . . . 65.310000000000002 110.025 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -90.45 -44.02 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.28 . . . . 73.120000000000005 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.7 p -158.18 154.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.45 . . . . 74.439999999999998 109.879 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.19 129.32 70.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.345 0.593 . . . . 73.409999999999997 110.094 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.3 mt-10 -100.83 127.64 47.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.902 -1.045 . . . . 72.109999999999999 110.19 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.1 mm -119.21 122.41 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.594 -0.891 . . . . 63.130000000000003 108.594 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.1 mmm -98.29 123.78 42.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.807 -0.812 . . . . 72.319999999999993 108.807 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 p -92.13 168.56 11.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.089 0.471 . . . . 64.420000000000002 111.163 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -88.95 127.57 35.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.538 -0.912 . . . . 74.409999999999997 108.538 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -76.16 -13.43 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.107 0.41 . . . . 73.409999999999997 112.107 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.62 -50.85 1.36 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.653 -0.784 . . . . 71.340000000000003 112.457 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 m -83.56 -23.45 32.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.517 0.199 . . . . 61.520000000000003 111.498 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 12.24 84.57 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.823 -0.703 . . . . 75.109999999999999 112.628 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -102.01 172.56 6.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.93 -0.396 . . . . 73.239999999999995 109.93 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -91.69 89.58 7.18 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.893 -0.41 . . . . 74.409999999999997 109.893 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -151.29 150.13 30.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.263 0.554 . . . . 72.349999999999994 111.609 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.3 -46.02 1.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.999 -1.001 . . . . 75.140000000000001 113.27 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -175.61 162.6 2.79 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 117.466 0.633 . . . . 73.439999999999998 110.276 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.15 8.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.749 -0.659 . . . . 73.430000000000007 109.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 40.8 m-85 -142.32 145.7 34.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.745 -0.661 . . . . 63.030000000000001 110.016 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 125' ' ' PHE . 84.0 t -132.75 126.06 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.997 -0.439 . . . . 73.319999999999993 111.049 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.0 m -102.48 125.17 49.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.835 -0.62 . . . . 75.209999999999994 110.494 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.78 163.62 12.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.992 0.425 . . . . 62.210000000000001 111.671 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.44 -28.2 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.264 -0.88 . . . . 55.219999999999999 110.534 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.46 153.41 51.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.022 -0.535 . . . . 74.239999999999995 110.422 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 103' ' ' THR . 34.3 p80 -74.73 -28.21 60.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.646 . . . . 71.230000000000004 110.108 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -58.53 -43.56 89.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.017 -0.992 . . . . 74.340000000000003 111.779 -176.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 m -68.72 -30.75 69.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.718 0.294 . . . . 74.549999999999997 110.937 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -71.17 -39.53 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.636 -0.505 . . . . 73.120000000000005 109.636 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.54 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -72.15 -24.64 61.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.448 -0.796 . . . . 64.25 111.499 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 52.9 mttm -62.81 -40.51 97.58 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.647 0.737 . . . . 70.120000000000005 110.009 170.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.16 -43.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.667 -1.151 . . . . 53.420000000000002 112.574 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 160' ' ' ASP . 32.6 m -73.73 -2.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.115 0.483 . . . . 75.209999999999994 111.63 -173.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 160' ' ' ASP . 76.2 mt -61.27 -38.11 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.508 -0.769 . . . . 72.510000000000005 109.951 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.3 mt-30 -108.47 105.62 15.36 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.45 -0.945 . . . . 74.349999999999994 108.45 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -53.85 -34.27 58.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.856 -0.611 . . . . 72.209999999999994 112.151 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.76 137.83 54.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 110.614 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.5 m-70 -126.0 146.26 49.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.832 -0.622 . . . . 75.420000000000002 110.539 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 m -106.08 118.84 37.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.016 -0.538 . . . . 73.099999999999994 110.726 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.62 142.9 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.548 -0.908 . . . . 43.149999999999999 108.548 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 52.11 31.28 8.68 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.537 0.684 . . . . 52.240000000000002 111.767 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.38 10.17 74.35 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.75 -0.659 . . . . 73.25 113.543 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -115.66 139.01 50.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.01 0.405 . . . . 61.210000000000001 110.264 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -101.12 111.2 23.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.643 0.735 . . . . 71.510000000000005 111.016 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.98 156.61 23.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 74.5 110.51 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -86.57 136.64 32.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.003 0.43 . . . . 72.349999999999994 110.184 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.2 t -131.97 132.64 61.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.616 -0.72 . . . . 72.439999999999998 109.862 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -153.46 174.63 14.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.797 -0.638 . . . . 71.140000000000001 111.195 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -65.28 136.9 57.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.596 -0.274 . . . . 74.25 110.898 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -125.99 124.94 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.812 -0.44 . . . . 73.209999999999994 109.812 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt -97.55 110.87 23.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.408 -0.517 . . . . 75.310000000000002 110.525 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.468 ' HB3' ' OE1' ' A' ' 185' ' ' GLU . 23.2 t -89.72 -170.37 2.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.759 -0.83 . . . . 34.43 108.759 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -69.63 -25.81 64.12 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.243 -0.286 . . . . 74.409999999999997 110.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -74.84 -37.44 62.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.21 0.529 . . . . 74.409999999999997 110.098 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.493 ' HG3' ' HA ' ' A' ' 104' ' ' VAL . 8.4 mp0 -69.16 -37.24 78.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.556 -0.747 . . . . 75.310000000000002 111.283 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.5 mtt -85.47 -70.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 71.5 111.728 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -95.64 -11.27 27.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 71.109999999999999 112.056 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.0 m 61.9 43.78 8.97 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.832 0.707 . . . . 62.549999999999997 110.743 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.89 111.09 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.428 -0.805 . . . . 51.310000000000002 110.321 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m -147.12 149.27 32.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.593 -0.276 . . . . 54.450000000000003 110.573 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.7 m -67.41 108.26 2.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.499 -0.556 . . . . 73.25 109.499 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 11.5 m -82.56 73.64 9.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 61.520000000000003 111.317 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -104.67 114.47 28.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.288 -0.869 . . . . 63.229999999999997 108.899 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -87.13 88.1 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.215 0.531 . . . . 73.340000000000003 110.834 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -88.88 69.6 2.65 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.21 -0.756 . . . . 72.230000000000004 111.21 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.525 -0.75 . . . . 62.210000000000001 109.165 -178.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.273 -0.331 . . . . 65.109999999999999 112.273 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -82.79 121.7 27.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.071 -0.344 . . . . 73.049999999999997 110.071 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -75.97 104.57 6.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.164 0.507 . . . . 65.299999999999997 110.867 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 p -96.57 -5.95 38.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.669 -0.696 . . . . 64.329999999999998 109.644 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.05 119.78 9.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.123 -0.944 . . . . 64.439999999999998 110.253 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.0 m -86.75 140.23 33.3 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 72.340000000000003 110.704 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 158.77 55.85 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.562 2.175 . . . . 74.019999999999996 111.846 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 2.13 13.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 55.210000000000001 108.43 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 37.5 mp0 -102.5 142.78 25.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.241 -1.345 . . . . 74.530000000000001 110.836 -172.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 13' ' ' LEU . 12.1 Cg_endo -61.92 166.42 12.29 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.871 2.38 . . . . 72.530000000000001 112.006 172.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.46 -37.18 67.42 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 112.272 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' HD23 ' A' ' 13' ' ' LEU . 10.0 pt20 -61.83 -29.33 70.09 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 61.5 112.158 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 164' ' ' ILE . 25.3 mt -89.81 -22.17 22.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.334 . . . . 54.119999999999997 111.162 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.7 ptt180 -106.66 0.05 24.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.332 0.587 . . . . 75.019999999999996 110.071 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -105.47 136.28 45.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.638 0.732 . . . . 65.150000000000006 111.123 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 68' ' ' VAL . 71.3 mt -101.56 146.87 27.09 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.729 -1.123 . . . . 72.409999999999997 110.92 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -97.67 120.79 38.68 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.245 -1.021 . . . . 74.329999999999998 108.245 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -98.47 110.96 27.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.771 -0.455 . . . . 74.340000000000003 109.771 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.72 147.94 16.32 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.868 -0.893 . . . . 75.239999999999995 110.868 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.9 42.26 13.07 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.978 -1.106 . . . . 53.549999999999997 112.886 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 25' ' ' THR . 90.4 mt -79.28 174.63 11.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.319 -0.622 . . . . 44.310000000000002 109.319 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -85.98 179.35 7.01 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 60.140000000000001 109.094 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 53' ' ' ARG . 3.2 t80 -81.95 -6.88 59.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.513 0.673 . . . . 71.319999999999993 109.389 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -118.36 20.35 13.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.006 -0.997 . . . . 72.109999999999999 111.845 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.575 HG21 HD22 ' A' ' 21' ' ' LEU . 20.4 m -85.75 129.45 34.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.983 0.421 . . . . 74.230000000000004 111.477 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -108.09 165.73 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.695 . . . . 61.32 109.673 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -25.17 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.005 -0.278 . . . . 72.329999999999998 110.792 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.6 -40.36 69.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.127 -0.229 . . . . 71.439999999999998 110.851 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -76.7 -32.71 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 74.310000000000002 110.618 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.2 tp -66.42 -49.88 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 62.549999999999997 110.314 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -56.77 -54.78 42.31 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.556 -0.747 . . . . 74.209999999999994 111.011 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -44.86 -37.98 4.26 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.539 1.149 . . . . 45.240000000000002 113.415 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -69.83 -52.0 28.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.345 -0.389 . . . . 75.349999999999994 110.953 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.32 -19.91 41.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.195 0.443 . . . . 72.209999999999994 112.195 -170.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -56.73 -24.29 48.67 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.396 0.517 . . . . 53.420000000000002 112.396 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.96 -25.57 68.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.196 0.443 . . . . 73.439999999999998 112.196 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -101.21 -23.25 14.47 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.088 -0.245 . . . . 73.409999999999997 111.267 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.3 157.72 29.19 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.311 -0.947 . . . . 73.340000000000003 112.389 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.6 m -63.24 119.81 10.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.981 0.419 . . . . 72.540000000000006 111.591 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.4 mt -88.43 141.85 28.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.815 -0.63 . . . . 70.319999999999993 110.479 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -107.09 -23.25 12.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 51.43 110.198 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -153.6 153.72 32.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.642 -0.708 . . . . 51.219999999999999 109.598 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 t -163.27 132.81 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.659 -0.497 . . . . 44.310000000000002 109.659 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.13 127.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 73.109999999999999 111.095 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.42 133.78 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.937 -0.764 . . . . 73.439999999999998 108.937 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.475 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.6 mmt -78.19 99.85 6.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.339 0.59 . . . . 70.239999999999995 110.471 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -101.77 160.92 14.06 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.033 -0.985 . . . . 63.130000000000003 109.864 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.28 130.47 62.33 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.1 -0.333 . . . . 53.130000000000003 110.1 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.12 -19.37 51.16 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.182 1.922 . . . . 74.319999999999993 113.295 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.63 -54.37 4.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.34 0.591 . . . . 71.439999999999998 110.707 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -96.86 -16.14 20.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.182 -0.917 . . . . 70.329999999999998 112.348 -172.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm 65.94 31.09 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.865 0.728 . . . . 72.340000000000003 111.183 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 23.6 mmm180 -114.15 158.7 20.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.351 -0.611 . . . . 70.400000000000006 109.351 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 t -70.73 140.78 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.967 0.413 . . . . 63.409999999999997 110.993 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -93.34 3.75 55.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 75.219999999999999 110.596 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.06 68.02 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.675 -0.693 . . . . 75.120000000000005 114.378 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.475 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.3 p90 -156.34 154.8 31.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.768 0.784 . . . . 64.519999999999996 110.496 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.78 -166.24 17.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.371 -0.692 . . . . 74.439999999999998 111.371 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.68 148.59 37.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.295 0.547 . . . . 75.439999999999998 110.598 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 18' ' ' ILE . 7.9 m -129.13 127.86 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.595 . . . . 74.420000000000002 109.781 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.6 m -103.36 121.61 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.335 -0.228 . . . . 74.420000000000002 110.532 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -87.95 164.05 16.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.042 0.449 . . . . 72.439999999999998 110.997 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.83 -49.49 37.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.492 -0.776 . . . . 73.219999999999999 110.598 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.5 m -119.37 152.18 37.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 74.400000000000006 110.816 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -65.64 -28.85 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.455 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.53 -29.35 63.52 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.967 -0.458 . . . . 74.310000000000002 111.509 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 6.1 mm-40 -64.92 -29.75 70.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.49 0.662 . . . . 73.109999999999999 109.282 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 16' ' ' LEU . 24.8 t -66.88 -48.3 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.825 -1.08 . . . . 54.109999999999999 110.298 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -59.14 -49.96 75.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.797 -0.638 . . . . 72.329999999999998 110.704 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.8 -36.72 38.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.957 0.725 . . . . 74.25 112.957 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -29.6 62.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 71.129999999999995 110.745 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -49.66 64.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 63.450000000000003 109.974 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -64.07 -26.84 68.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.18 0.514 . . . . 72.239999999999995 110.882 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.9 -10.73 60.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.237 -0.892 . . . . 65.340000000000003 113.366 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -56.63 149.78 39.22 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 111.883 0.327 . . . . 52.119999999999997 111.883 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.72 165.67 79.12 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.057 -1.226 . . . . 51.420000000000002 112.837 0.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -123.65 152.67 41.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 74.230000000000004 110.483 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.5 ttmt -134.23 107.55 7.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.114 -0.494 . . . . 70.310000000000002 111.251 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 126.59 66.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.678 -0.692 . . . . 75.120000000000005 109.85 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.7 t70 66.29 28.19 9.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.632 0.73 . . . . 74.019999999999996 110.791 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.12 25.87 70.06 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.765 -0.731 . . . . 73.150000000000006 112.498 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.3 tpt180 -129.64 142.09 50.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.101 -0.703 . . . . 74.129999999999995 109.101 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.47 114.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 61.340000000000003 109.838 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.72 153.37 7.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.872 -0.604 . . . . 73.540000000000006 111.119 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -117.09 100.43 53.25 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.272 -0.876 . . . . 75.219999999999999 110.572 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.59 132.54 17.54 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.867 1.711 . . . . 73.409999999999997 110.909 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -136.2 178.97 6.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.053 -1.091 . . . . 75.239999999999995 108.053 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.2 tmm_? -81.88 128.68 34.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.768 -0.827 . . . . 71.400000000000006 108.768 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.28 98.54 0.33 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.242 0.544 . . . . 63.329999999999998 111.097 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 11.1 t -69.22 142.96 15.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.053 -0.976 . . . . 74.319999999999993 110.835 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 18.1 t -83.21 172.27 12.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.236 -0.438 . . . . 52.210000000000001 109.991 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -61.65 -42.5 98.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.74 0.644 . . . . 75.150000000000006 112.74 -170.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -71.18 -41.46 70.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 43.399999999999999 110.866 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.0 OUTLIER -78.55 -8.12 58.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 111.478 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 70.6 m -93.62 -4.14 51.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.592 -0.276 . . . . 70.549999999999997 111.195 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -63.17 -41.59 99.25 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.602 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.93 146.57 75.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.944 -0.571 . . . . 75.510000000000005 110.262 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.57 147.66 90.27 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.025 2.484 . . . . 60.420000000000002 112.259 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.96 28.71 64.13 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.819 -0.705 . . . . 62.109999999999999 112.664 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -66.29 -52.16 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 64.439999999999998 110.349 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -93.71 2.47 56.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.637 -0.71 . . . . 62.0 111.061 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -87.94 161.93 17.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.473 . . . . 74.25 109.724 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -83.58 97.61 9.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.218 0.533 . . . . 52.539999999999999 112.122 -172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' CG1' ' HE3' ' A' ' 179' ' ' LYS . 0.8 OUTLIER -124.52 124.02 67.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.459 -0.791 . . . . 72.340000000000003 109.061 174.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 72.7 mttt -106.65 22.01 16.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.323 0.583 . . . . 72.5 110.446 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -117.71 139.66 50.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.786 -0.643 . . . . 64.129999999999995 111.085 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 159' ' ' VAL . 7.2 pt -124.27 148.52 28.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.307 0.575 . . . . 74.239999999999995 111.45 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -98.63 133.79 42.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.869 -1.059 . . . . 75.310000000000002 109.426 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.37 109.12 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.059 -0.719 . . . . 72.450000000000003 109.059 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -135.86 167.88 24.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.682 -1.246 . . . . 51.409999999999997 113.717 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.11 42.11 5.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.925 -0.655 . . . . 75.450000000000003 111.735 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.19 111.23 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.513 0.673 . . . . 74.439999999999998 110.755 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -78.68 -21.78 47.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.717 0.77 . . . . 70.030000000000001 109.261 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -101.3 151.61 21.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.832 -1.076 . . . . 73.019999999999996 109.181 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.17 123.42 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.534 0.683 . . . . 61.530000000000001 110.677 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 m -107.27 141.61 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.849 -0.614 . . . . 65.5 110.056 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -113.57 173.64 6.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.248 -0.887 . . . . 71.400000000000006 111.449 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -50.73 72.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 71.310000000000002 110.955 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -63.36 -26.34 68.71 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.29 0.369 . . . . 74.340000000000003 111.491 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -64.23 -61.25 2.36 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.427 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -84.1 -23.91 30.55 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.984 -0.686 . . . . 64.120000000000005 111.883 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -67.51 -51.44 51.06 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 110.357 -0.238 . . . . 61.210000000000001 110.357 178.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.2 -28.71 69.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 71.439999999999998 110.3 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -78.79 -56.28 4.52 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.517 -0.765 . . . . 73.439999999999998 112.14 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -67.91 -23.07 65.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.472 0.545 . . . . 74.450000000000003 112.472 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.7 mt-10 -68.05 -23.05 64.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.645 0.26 . . . . 74.030000000000001 111.415 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.78 -33.84 64.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.515 . . . . 62.340000000000003 111.55 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.24 -31.65 33.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.366 . . . . 72.040000000000006 111.443 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 178.68 -177.33 48.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.704 -0.76 . . . . 62.229999999999997 113.332 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -75.61 129.98 38.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 74.219999999999999 111.418 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 152' ' ' THR . 59.0 mt -102.25 140.18 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 72.530000000000001 110.071 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -91.35 -46.55 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 61.539999999999999 110.957 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.36 156.27 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.882 0.373 . . . . 72.010000000000005 110.427 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.49 127.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.056 -0.52 . . . . 74.439999999999998 109.933 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.4 mt-10 -102.45 105.46 16.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 62.520000000000003 111.206 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.1 117.12 38.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.873 -0.788 . . . . 54.140000000000001 108.873 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.5 mmm -84.45 101.21 11.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 65.129999999999995 110.385 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.98 150.0 29.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.147 -0.933 . . . . 72.319999999999993 111.382 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 142.55 38.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.391 -0.822 . . . . 54.350000000000001 110.636 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -11.38 59.68 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.237 0.458 . . . . 51.119999999999997 112.237 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -96.86 -54.09 1.33 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.29 -0.957 . . . . 71.519999999999996 113.171 -175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.48 ' OG ' ' HE2' ' A' ' 144' ' ' LYS . 17.8 t -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.007 0.432 . . . . 74.340000000000003 110.687 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 8.92 75.78 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.677 -0.773 . . . . 71.019999999999996 112.816 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' HE2' ' OG ' ' A' ' 142' ' ' SER . 70.6 mmtt -76.87 158.32 30.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.719 0.259 . . . . 75.430000000000007 110.303 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -74.85 129.16 37.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.307 -0.998 . . . . 74.340000000000003 108.307 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -81.56 23.98 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.822 1.045 . . . . 75.219999999999999 113.822 -170.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.46 3.96 80.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.515 -0.85 . . . . 72.019999999999996 113.894 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.66 161.66 32.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 117.188 0.494 . . . . 71.310000000000002 110.43 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.47 173.97 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.487 -0.779 . . . . 64.310000000000002 109.673 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 45.5 m-85 -138.0 148.93 45.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 55.329999999999998 110.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.35 126.25 52.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 71.200000000000003 110.815 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.7 m -98.82 121.28 40.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 75.430000000000007 110.565 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -101.83 160.97 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.68 -0.236 . . . . 74.310000000000002 110.588 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.32 -29.94 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.386 0.613 . . . . 73.25 110.154 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -137.31 162.39 33.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 110.777 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -82.37 -20.56 36.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.978 -0.555 . . . . 73.299999999999997 110.118 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.2 p30 -60.3 -41.21 92.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 123.564 0.54 . . . . 63.009999999999998 110.943 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.401 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -73.67 -29.48 62.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.469 -0.332 . . . . 75.310000000000002 110.355 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.8 t -68.63 -42.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.759 -0.655 . . . . 61.420000000000002 109.745 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -73.85 -26.05 60.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 110.887 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.6 mttt -62.78 -37.99 88.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.521 0.677 . . . . 64.519999999999996 110.218 172.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.6 -42.61 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 72.019999999999996 112.956 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 159' ' ' VAL . 16.8 m -69.74 -9.01 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.095 0.474 . . . . 74.340000000000003 111.625 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.602 HD13 HD22 ' A' ' 13' ' ' LEU . 58.5 mt -56.46 -36.68 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.306 -0.861 . . . . 62.009999999999998 110.368 171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 51.7 mt-30 -109.5 108.95 19.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.224 -0.658 . . . . 71.420000000000002 109.224 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -53.71 -36.13 61.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.429 -0.805 . . . . 73.230000000000004 112.342 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -122.5 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.884 0.373 . . . . 75.299999999999997 110.49 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 82.2 m-70 -121.09 141.63 50.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.064 -0.516 . . . . 72.230000000000004 110.487 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 m -90.26 102.96 15.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.075 -0.511 . . . . 74.109999999999999 110.587 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.2 126.96 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.008 -0.738 . . . . 73.25 109.008 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 t30 53.42 31.53 12.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.584 0.707 . . . . 75.430000000000007 111.528 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.71 2.04 84.79 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.193 -0.527 . . . . 64.439999999999998 113.231 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -106.55 132.36 52.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.557 -0.534 . . . . 73.200000000000003 109.557 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.318 0.58 . . . . 63.149999999999999 110.676 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -106.82 153.89 21.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 61.130000000000003 109.707 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.47 131.23 34.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.198 -0.297 . . . . 72.219999999999999 110.198 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.9 t -130.44 137.25 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 72.329999999999998 111.06 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -158.2 176.67 12.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.001 -0.545 . . . . 72.530000000000001 112.06 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.521 ' HE3' ' CG1' ' A' ' 104' ' ' VAL . 14.1 mmmt -66.32 123.58 20.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.002 -0.545 . . . . 72.549999999999997 109.94 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -106.19 113.99 27.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 72.030000000000001 111.001 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.28 140.44 37.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.908 -0.587 . . . . 64.129999999999995 110.125 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.501 ' O ' ' HG3' ' A' ' 186' ' ' MET . 89.4 p -73.03 168.61 18.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.838 -0.801 . . . . 65.319999999999993 108.838 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.01 -30.43 70.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 70.0 110.5 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 188' ' ' SER . 58.8 tt0 -63.77 -39.77 95.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.157 -0.928 . . . . 64.099999999999994 110.732 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.8 -22.92 31.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.953 -0.567 . . . . 65.109999999999999 111.326 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 182' ' ' SER . 22.7 mtt -79.59 -70.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.176 0.436 . . . . 73.420000000000002 112.176 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -94.1 -62.16 1.4 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.281 -0.418 . . . . 75.299999999999997 111.745 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 184' ' ' GLN . 10.7 p -153.59 167.28 30.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.748 -0.464 . . . . 62.229999999999997 109.748 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' A' ' 184' ' ' GLN . . . -60.94 97.44 0.06 Allowed 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.588 0.555 . . . . 60.420000000000002 110.743 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 5.2 m -133.45 90.8 2.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.772 -0.649 . . . . 73.349999999999994 110.217 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.4 t -95.67 82.18 3.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 64.299999999999997 109.761 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.9 m -77.56 128.27 33.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.445 -0.798 . . . . 64.109999999999999 109.861 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -69.0 111.88 5.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.985 0.421 . . . . 73.030000000000001 110.189 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -80.89 135.9 35.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.77 -0.65 . . . . 75.120000000000005 111.066 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.0 35.18 3.33 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.989 -0.844 . . . . 64.409999999999997 110.989 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.592 -0.718 . . . . 73.400000000000006 109.438 -176.679 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.598 -0.601 . . . . 42.140000000000001 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t -83.51 97.42 9.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.133 0.492 . . . . 63.210000000000001 110.751 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.96 101.99 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 70.219999999999999 109.877 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -127.97 32.05 4.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.08 -0.509 . . . . 74.439999999999998 110.676 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.92 141.38 53.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 74.340000000000003 109.792 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -62.1 113.77 9.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.639 0.587 . . . . 74.5 110.464 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.61 126.59 21.03 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 C-N-CA 122.55 2.167 . . . . 74.510000000000005 112.573 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -100.61 -3.06 31.2 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.963 -1.017 . . . . 60.520000000000003 110.692 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 159.88 37.5 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.028 -0.533 . . . . 65.420000000000002 110.191 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HD2' HD22 ' A' ' 13' ' ' LEU . 54.7 Cg_endo -73.69 166.94 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.294 1.996 . . . . 74.409999999999997 111.304 170.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -32.79 70.63 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 111.715 0.265 . . . . 73.219999999999999 111.715 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.46 -30.9 71.93 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.063 0.394 . . . . 73.349999999999994 112.063 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.5 mp -82.97 -12.98 56.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.518 0.199 . . . . 71.420000000000002 111.185 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.52 ' HA ' HG21 ' A' ' 68' ' ' VAL . 13.3 ptt180 -119.41 0.56 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.984 0.421 . . . . 63.119999999999997 111.245 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -96.38 147.18 24.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.379 0.609 . . . . 73.239999999999995 112.108 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD21 HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -116.31 147.21 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.008 -0.996 . . . . 44.020000000000003 109.727 172.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 29.8 t80 -101.99 118.38 36.78 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.172 -1.048 . . . . 63.100000000000001 108.172 171.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 60' ' ' VAL . 21.3 mm -94.78 112.77 27.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 122.108 -0.37 . . . . 72.219999999999999 110.228 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 150.81 18.18 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.958 -0.639 . . . . 61.520000000000003 111.964 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.91 45.14 64.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.168 -0.539 . . . . 62.32 113.586 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 25' ' ' THR . 50.2 mt -76.47 173.07 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 72.329999999999998 110.409 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -84.4 175.55 9.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 43.350000000000001 109.485 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 92.1 m-85 -84.03 -6.59 59.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 110.632 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -119.51 12.11 12.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.878 -0.601 . . . . 62.340000000000003 111.678 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 21' ' ' LEU . 43.9 m -77.41 132.37 38.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.078 0.466 . . . . 52.030000000000001 111.425 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -107.63 167.59 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.633 -0.712 . . . . 75.340000000000003 110.054 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -73.77 -24.42 59.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 72.340000000000003 111.089 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.67 -35.14 58.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.167 -0.213 . . . . 71.420000000000002 110.659 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.8 m -73.23 -38.11 66.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.436 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.95 -45.04 94.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 64.099999999999994 110.178 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -60.0 -52.85 63.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.948 -0.569 . . . . 65.430000000000007 110.559 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m -44.14 -42.3 6.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.327 1.017 . . . . 51.100000000000001 113.603 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 79' ' ' VAL . 66.6 t60 -70.24 -56.45 6.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 64.120000000000005 111.13 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 40' ' ' LEU . 81.8 m-85 -76.05 -17.57 59.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.806 0.299 . . . . 72.030000000000001 111.806 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.6 -28.37 54.7 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.027 0.531 . . . . 70.319999999999993 111.547 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -65.61 -23.96 66.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.465 -0.788 . . . . 71.450000000000003 112.304 -177.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -101.41 -21.98 14.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.057 0.391 . . . . 72.010000000000005 112.057 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 177.09 48.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.788 -1.196 . . . . 33.149999999999999 113.24 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -68.01 119.61 12.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.966 0.507 . . . . 74.230000000000004 112.268 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 34' ' ' PHE . 52.8 mt -95.66 125.63 40.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.636 0.731 . . . . 74.420000000000002 110.56 170.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 t -100.92 -17.69 16.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.989 -1.005 . . . . 63.049999999999997 110.12 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.95 151.4 29.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 64.420000000000002 109.981 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.8 t -163.04 133.18 4.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.98 -0.378 . . . . 73.219999999999999 109.98 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 126.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.215 0.531 . . . . 62.009999999999998 110.613 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.56 131.87 33.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.605 -0.887 . . . . 74.209999999999994 108.605 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.9 mmt -79.4 97.44 6.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.773 0.796 . . . . 72.400000000000006 110.94 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 30.9 mtp180 -104.51 159.11 16.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.314 -1.312 . . . . 72.040000000000006 109.008 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.37 125.84 91.06 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.885 -0.598 . . . . 74.439999999999998 109.773 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.51 -28.62 87.01 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.214 1.943 . . . . 60.43 113.744 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.92 -55.01 4.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.925 0.393 . . . . 70.150000000000006 111.906 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.43 -15.92 21.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.199 0.444 . . . . 65.209999999999994 112.199 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 65.43 31.34 10.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.71 0.804 . . . . 74.019999999999996 111.747 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -97.92 151.35 20.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.098 -0.704 . . . . 73.239999999999995 109.098 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.1 t -72.7 137.63 46.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.727 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -89.25 -1.65 58.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.778 -0.646 . . . . 63.219999999999999 109.634 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.18 23.52 51.42 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.66 -0.7 . . . . 35.32 113.825 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -161.51 160.72 29.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.887 0.844 . . . . 73.450000000000003 111.036 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -162.18 12.19 Favored Glycine 0 C--O 1.226 -0.345 0 N-CA-C 111.588 -0.605 . . . . 71.299999999999997 111.588 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -142.32 149.37 39.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.185 0.493 . . . . 75.329999999999998 110.105 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 18' ' ' ILE . 7.3 m -130.69 126.4 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.057 -0.719 . . . . 75.430000000000007 109.057 172.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 m -105.85 120.01 40.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.728 0.299 . . . . 75.400000000000006 110.408 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -85.37 171.08 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.854 -0.612 . . . . 64.310000000000002 109.979 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.7 -25.03 24.99 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.139 0.495 . . . . 71.420000000000002 110.488 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 m -143.06 145.4 32.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 64.150000000000006 110.916 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.1 p -56.54 -40.02 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.688 -0.687 . . . . 62.210000000000001 111.867 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -53.05 -42.03 65.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.974 0.731 . . . . 71.200000000000003 112.974 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -65.71 -30.67 71.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.302 0.572 . . . . 74.140000000000001 110.569 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 14' ' ' ARG . 17.9 t -67.12 -45.57 86.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.381 -0.827 . . . . 62.450000000000003 110.813 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -58.95 -42.94 91.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 71.430000000000007 110.622 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.71 -37.37 73.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.483 0.549 . . . . 73.120000000000005 112.483 171.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.33 74.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.271 0.558 . . . . 71.409999999999997 110.226 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.25 -36.25 71.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.783 -0.644 . . . . 72.099999999999994 110.786 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.645 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 4.5 p30 -79.94 -11.27 59.81 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.968 0.413 . . . . 75.219999999999999 110.952 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.79 -12.06 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 72.409999999999997 111.002 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -55.31 149.14 28.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.68 . . . . 74.109999999999999 111.827 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 168.7 76.62 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 124.274 -1.136 . . . . 75.120000000000005 113.381 2.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -125.77 155.97 40.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.681 -0.691 . . . . 75.200000000000003 110.358 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.3 ttmt -136.75 105.34 5.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.086 0.47 . . . . 73.439999999999998 111.242 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.439 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.4 t -105.62 125.6 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.6 . . . . 70.409999999999997 109.718 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 64.53 33.59 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.776 0.672 . . . . 70.340000000000003 111.281 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.88 26.56 73.77 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.018 -0.611 . . . . 52.25 112.239 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.5 tpt180 -127.5 135.62 50.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.162 -0.31 . . . . 73.510000000000005 110.162 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.95 113.47 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.839 -0.8 . . . . 70.209999999999994 108.839 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -106.49 151.99 8.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.356 0.598 . . . . 74.409999999999997 111.208 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -113.82 96.55 41.56 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.956 -1.02 . . . . 74.019999999999996 110.697 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.27 129.97 15.71 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.741 1.627 . . . . 54.329999999999998 110.286 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 50.9 mmtt -121.26 142.01 50.35 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.844 -0.798 . . . . 74.430000000000007 108.844 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.628 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 7.9 tpp180 -64.05 119.51 10.27 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.644 -0.872 . . . . 72.230000000000004 108.644 172.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 93.29 0.09 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.601 0.715 . . . . 40.229999999999997 110.671 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.483 ' CG2' HG23 ' A' ' 163' ' ' VAL . 8.3 p -66.24 156.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.728 -1.124 . . . . 64.409999999999997 110.638 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 p -55.39 153.82 6.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.961 -0.563 . . . . 62.310000000000002 111.428 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 1.4 tmt_? -57.51 -30.62 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.671 -0.695 . . . . 63.210000000000001 111.234 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -52.2 52.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 111.609 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.8 -25.95 59.4 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.789 0.328 . . . . 71.340000000000003 110.318 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -64.4 -17.49 63.82 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.217 -0.447 . . . . 52.43 111.192 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -81.29 -11.24 59.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.738 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -79.96 145.55 61.67 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.953 -0.388 . . . . 73.450000000000003 109.953 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.3 115.54 4.08 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.43 2.086 . . . . 75.200000000000003 112.05 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.65 27.59 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.791 -0.719 . . . . 72.340000000000003 112.297 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.01 -36.81 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 111.671 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 29.0 m-70 -104.03 21.2 16.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.485 0.66 . . . . 54.119999999999997 110.516 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.2 mt -101.65 -178.55 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 65.510000000000005 109.553 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.15 100.64 13.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.649 . . . . 72.430000000000007 111.834 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.17 121.97 44.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 74.530000000000001 108.181 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 60.5 mttt -106.59 19.68 20.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 63.100000000000001 110.505 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.43 139.1 50.81 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.378 -0.373 . . . . 73.209999999999994 110.662 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 159' ' ' VAL . 7.5 pt -131.7 149.62 33.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.266 0.555 . . . . 70.030000000000001 111.293 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -93.45 137.91 32.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 70.310000000000002 109.582 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.82 108.93 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.345 -0.613 . . . . 55.43 109.345 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.84 147.6 18.08 Favored Glycine 0 CA--C 1.505 -0.587 0 C-N-CA 119.673 -1.251 . . . . 75.049999999999997 112.973 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.87 6.35 22.96 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.32 -0.943 . . . . 73.129999999999995 111.981 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 112' ' ' ILE . 26.7 pt -76.45 99.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 122.072 0.939 . . . . 64.129999999999995 109.055 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -91.47 -6.13 53.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.161 -0.927 . . . . 62.049999999999997 112.126 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -126.47 -162.52 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.024 -0.362 . . . . 60.119999999999997 110.024 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.22 67.98 8.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 54.119999999999997 111.003 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -75.56 136.42 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.321 0.581 . . . . 71.239999999999995 109.799 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.3 166.12 10.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.272 -0.876 . . . . 72.319999999999993 111.436 -171.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.01 -53.17 61.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.336 -0.847 . . . . 74.5 110.516 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.23 -12.76 58.16 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.388 0.514 . . . . 73.099999999999994 112.388 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -73.01 -57.74 3.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.084 0.468 . . . . 75.209999999999994 109.764 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -81.47 -28.62 34.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.143 -0.623 . . . . 71.140000000000001 110.544 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -64.3 -53.22 52.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.657 -0.247 . . . . 74.140000000000001 110.592 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.6 -26.4 68.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.979 0.419 . . . . 55.140000000000001 110.486 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.1 -54.59 8.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.815 -0.629 . . . . 74.209999999999994 111.194 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -68.32 -23.53 64.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.5 -0.318 . . . . 73.439999999999998 111.609 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.4 mt-10 -65.92 -26.18 67.48 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.886 0.374 . . . . 65.230000000000004 111.236 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -56.9 -30.1 63.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.935 -0.575 . . . . 73.530000000000001 111.31 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -86.26 -26.8 24.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 74.299999999999997 111.936 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.69 46.41 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.372 -0.918 . . . . 63.329999999999998 113.353 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.45 131.77 41.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.078 0.466 . . . . 61.310000000000002 111.316 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 152' ' ' THR . 52.4 mt -105.09 141.18 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 64.430000000000007 110.082 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -90.64 -54.44 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 54.229999999999997 110.796 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.76 155.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 73.140000000000001 110.289 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.54 129.48 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.057 0.456 . . . . 62.32 109.828 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 21.6 mt-10 -101.78 103.41 14.14 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.291 -0.868 . . . . 55.25 110.566 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -92.47 118.98 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.067 -0.716 . . . . 53.240000000000002 109.067 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 73.1 mmm -90.46 109.36 20.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.283 0.564 . . . . 72.400000000000006 110.554 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 2.1 m -132.51 153.51 50.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 73.010000000000005 109.846 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.22 136.48 38.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.26 -0.644 . . . . 61.420000000000002 109.26 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.24 -45.13 23.72 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 121.149 -0.22 . . . . 61.439999999999998 110.98 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.21 -48.46 58.87 Favored Glycine 0 CA--C 1.518 0.244 0 CA-C-N 116.131 -0.486 . . . . 64.200000000000003 113.281 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -84.1 -23.96 30.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.727 0.299 . . . . 41.140000000000001 111.053 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.12 16.71 78.52 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.054 -0.593 . . . . 74.200000000000003 112.119 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -105.13 141.82 36.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.82 -0.223 . . . . 64.010000000000005 110.544 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 91.7 mttt -74.71 143.26 44.24 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.986 -0.746 . . . . 64.420000000000002 108.986 173.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -81.35 20.23 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.325 0.861 . . . . 72.340000000000003 113.325 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.03 10.31 64.88 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.893 -0.67 . . . . 53.030000000000001 113.624 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.28 158.96 33.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.104 0.478 . . . . 75.230000000000004 109.764 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.91 176.91 8.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.255 -0.884 . . . . 60.439999999999998 109.633 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 51.6 m-85 -139.84 151.73 45.92 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.28 -0.873 . . . . 75.319999999999993 109.128 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.09 134.04 15.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.281 0.562 . . . . 75.430000000000007 110.95 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.8 m -105.7 127.66 53.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.071 -0.968 . . . . 74.109999999999999 110.983 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -101.72 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.782 0.325 . . . . 74.230000000000004 110.874 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.26 -23.3 30.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.825 -0.625 . . . . 72.209999999999994 110.29 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.56 158.05 44.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 73.230000000000004 110.8 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.568 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 31.2 p80 -83.98 -27.67 28.28 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.646 -0.252 . . . . 74.040000000000006 111.377 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -59.45 -42.22 91.48 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.382 0.427 . . . . 75.129999999999995 110.886 -176.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -65.43 -32.86 74.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.027 -0.533 . . . . 50.329999999999998 110.976 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 163' ' ' VAL . 3.0 t -70.81 -44.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.386 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 26.4 m-20 -68.17 -25.41 65.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.719 . . . . 74.530000000000001 111.269 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.628 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 96.9 mttt -61.68 -45.2 95.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.842 0.829 . . . . 62.439999999999998 110.276 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.6 mt -75.55 -43.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.492 -1.231 . . . . 70.120000000000005 112.387 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.483 HG23 ' CG2' ' A' ' 90' ' ' VAL . 15.9 m -75.01 -5.59 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 74.5 111.096 -174.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 160' ' ' ASP . 31.1 mt -57.97 -31.45 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.42 -0.809 . . . . 63.229999999999997 109.748 168.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -114.49 109.35 18.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.557 -0.747 . . . . 65.400000000000006 109.095 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -55.66 -31.9 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 65.450000000000003 112.259 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.62 137.3 54.76 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.649 -0.421 . . . . 74.450000000000003 111.622 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -129.0 149.24 50.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.578 -0.737 . . . . 74.0 109.622 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.5 m -110.92 124.64 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.885 0.374 . . . . 64.209999999999994 110.935 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.58 131.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.985 -0.552 . . . . 73.310000000000002 109.983 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 72.44 23.24 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.42 1.105 . . . . 72.549999999999997 109.63 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.7 85.96 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.155 -0.93 . . . . 62.140000000000001 112.097 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -118.91 122.14 41.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.318 . . . . 63.310000000000002 110.816 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.81 108.07 18.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.751 -0.833 . . . . 71.299999999999997 108.751 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.0 p -110.1 154.3 23.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.426 -0.807 . . . . 51.340000000000003 111.101 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -86.62 127.77 34.95 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.626 -0.715 . . . . 75.140000000000001 109.681 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.8 t -124.87 128.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.352 -0.84 . . . . 62.399999999999999 109.987 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -154.35 171.47 19.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.414 -0.812 . . . . 61.409999999999997 111.26 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -58.02 123.61 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.465 0.478 . . . . 71.120000000000005 111.287 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.81 118.82 31.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.995 -0.548 . . . . 71.219999999999999 109.723 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.72 127.9 46.96 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.486 -0.561 . . . . 72.239999999999995 109.486 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -70.81 166.89 20.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.464 -0.569 . . . . 61.219999999999999 109.464 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.74 -25.41 67.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.782 0.325 . . . . 74.209999999999994 110.969 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.85 -38.97 87.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.993 -0.549 . . . . 35.5 110.181 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.79 -42.92 19.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 75.519999999999996 110.852 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.08 -58.96 6.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.028 -0.533 . . . . 64.019999999999996 111.141 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.99 62.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 45.32 111.106 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.9 m 60.74 30.56 19.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.478 0.656 . . . . 64.420000000000002 110.54 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.21 166.75 23.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.366 -0.834 . . . . 73.230000000000004 110.0 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.0 m -65.02 123.64 19.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.548 0.53 . . . . 62.5 110.539 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.7 t -136.77 142.84 42.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.871 -0.789 . . . . 73.049999999999997 108.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.9 m -77.94 158.72 29.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.438 -0.346 . . . . 71.349999999999994 111.011 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.34 169.39 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.985 0.422 . . . . 74.230000000000004 110.703 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -79.62 -24.73 41.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.196 -0.456 . . . . 62.310000000000002 110.668 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 43.75 10.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.022 -0.609 . . . . 64.109999999999999 111.968 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.683 -0.675 . . . . 53.240000000000002 109.67 -177.811 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 112.867 -0.093 . . . . 71.310000000000002 112.867 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -82.35 129.21 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 53.420000000000002 110.561 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -70.03 -31.88 69.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.784 -0.644 . . . . 64.230000000000004 112.362 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -92.4 -3.77 54.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.455 . . . . 65.239999999999995 110.851 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.95 119.4 27.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.436 -0.579 . . . . 74.299999999999997 109.436 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m 57.67 79.02 0.34 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 124.082 0.864 . . . . 73.510000000000005 111.2 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.51 155.53 59.39 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.659 2.239 . . . . 61.140000000000001 112.031 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -15.27 14.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.706 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.49 133.78 86.89 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.683 . . . . 74.200000000000003 110.461 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.66 162.73 35.86 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.824 2.349 . . . . 74.25 110.59 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.1 pt-20 -60.34 -30.54 69.59 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 111.819 0.303 . . . . 61.219999999999999 111.819 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.78 -34.63 75.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.871 0.323 . . . . 75.329999999999998 111.871 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.75 -15.1 58.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.964 0.412 . . . . 74.200000000000003 110.839 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG21 ' A' ' 68' ' ' VAL . 24.3 ptt180 -121.58 6.61 10.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.754 -0.657 . . . . 73.299999999999997 110.824 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.4 ttmm -95.19 148.77 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.709 0.766 . . . . 60.020000000000003 111.563 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 68' ' ' VAL . 78.0 mt -115.8 139.48 50.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.643 -1.162 . . . . 70.010000000000005 110.078 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -96.68 113.26 24.8 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.407 -0.96 . . . . 65.230000000000004 108.407 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 60' ' ' VAL . 15.6 mm -92.67 111.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.252 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.77 147.63 16.72 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.086 -0.578 . . . . 73.25 112.063 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.77 48.57 33.93 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 72.439999999999998 113.399 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 25' ' ' THR . 73.2 mt -79.86 176.94 9.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.118 -0.327 . . . . 75.340000000000003 110.118 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.7 p -89.84 169.57 11.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.003 -0.74 . . . . 42.25 109.003 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -77.24 -3.61 40.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.973 0.416 . . . . 74.209999999999994 111.377 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.32 13.4 13.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.017 -0.538 . . . . 74.120000000000005 111.29 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 HD22 ' A' ' 21' ' ' LEU . 31.0 m -73.13 126.31 29.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 65.209999999999994 110.403 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -105.91 165.53 11.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 61.43 109.816 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.81 -24.69 65.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.613 0.244 . . . . 74.340000000000003 110.958 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.96 -35.41 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 65.439999999999998 111.859 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -77.52 -36.1 52.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.93 0.395 . . . . 74.219999999999999 110.362 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.07 -48.51 78.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.62 -0.718 . . . . 63.240000000000002 109.681 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 31' ' ' ARG . 43.9 ttm180 -54.47 -60.05 3.87 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.432 -0.804 . . . . 73.019999999999996 111.878 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -47.82 -38.91 16.97 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.9 0.75 . . . . 71.200000000000003 112.691 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.99 -56.08 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.476 -0.329 . . . . 71.109999999999999 111.084 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 40' ' ' LEU . 70.6 m-85 -76.01 -18.59 59.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.676 0.274 . . . . 61.32 111.665 -174.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.11 -22.5 51.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.217 0.607 . . . . 74.450000000000003 111.783 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.79 -27.65 66.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.711 -0.677 . . . . 54.119999999999997 112.208 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.16 -20.64 15.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.608 0.225 . . . . 64.530000000000001 111.608 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.51 165.49 35.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.259 -0.972 . . . . 60.119999999999997 112.375 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.4 m -71.69 119.71 16.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.018 0.437 . . . . 74.409999999999997 111.458 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 34' ' ' PHE . 95.2 mt -84.36 138.29 32.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.567 -0.742 . . . . 73.510000000000005 110.967 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -97.79 -25.36 15.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.808 . . . . 74.430000000000007 110.161 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -150.68 150.26 30.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 63.109999999999999 110.164 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.9 t -158.71 126.37 5.03 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.129 -0.323 . . . . 71.010000000000005 110.129 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.62 126.35 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.339 0.59 . . . . 72.430000000000007 110.513 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.73 133.08 33.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.766 -0.828 . . . . 72.010000000000005 108.766 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.488 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mmt -78.21 99.66 6.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.074 0.464 . . . . 64.549999999999997 110.692 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -100.66 161.04 13.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.43 -0.805 . . . . 74.519999999999996 110.498 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.89 123.81 75.44 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.031 -0.986 . . . . 72.510000000000005 110.055 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.87 -24.56 74.31 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.224 1.949 . . . . 73.340000000000003 113.463 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -84.24 -54.92 4.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 74.25 111.505 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -14.45 28.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 75.5 112.12 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm 62.61 31.16 16.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.883 0.873 . . . . 73.430000000000007 111.662 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -114.71 155.6 26.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.648 -0.871 . . . . 71.420000000000002 108.648 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.3 t -70.34 133.89 47.38 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.05 -0.352 . . . . 65.530000000000001 110.05 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -81.68 4.98 19.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.856 -0.611 . . . . 72.319999999999993 111.106 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.65 15.8 65.13 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 73.239999999999995 113.882 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 33.0 p90 -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.764 0.782 . . . . 73.409999999999997 110.625 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.04 -168.11 21.55 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.448 -0.661 . . . . 72.310000000000002 111.448 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.69 146.36 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.164 0.482 . . . . 70.430000000000007 110.634 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 18' ' ' ILE . 12.9 m -131.77 121.3 47.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 75.109999999999999 109.911 174.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.0 m -97.58 123.0 41.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.638 -0.504 . . . . 63.350000000000001 109.638 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -86.03 175.21 8.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.033 0.444 . . . . 74.040000000000006 110.918 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.73 -45.54 16.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.005 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -120.08 149.48 42.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 61.140000000000001 110.162 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.8 p -65.4 -30.9 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 123.131 0.269 . . . . 55.109999999999999 111.266 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.94 -39.74 87.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.183 0.438 . . . . 72.450000000000003 112.183 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -26.5 68.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 110.784 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 16' ' ' LEU . 40.4 t -63.79 -50.83 76.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.744 -0.662 . . . . 74.409999999999997 110.59 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -37.96 87.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 60.149999999999999 111.594 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.01 62.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.029 0.381 . . . . 72.120000000000005 112.029 170.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.47 -33.86 58.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 74.329999999999998 110.445 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -63.97 -41.75 97.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.438 -0.346 . . . . 75.049999999999997 110.642 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -30.3 63.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.965 -0.561 . . . . 70.349999999999994 110.902 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.72 -13.2 61.9 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.791 0.663 . . . . 55.0 112.791 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -55.06 148.98 26.48 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.212 0.449 . . . . 75.420000000000002 112.212 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.65 157.26 92.77 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.57 -1.429 . . . . 61.530000000000001 114.088 3.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -112.76 156.5 22.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.555 -0.748 . . . . 75.219999999999999 110.867 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 20.3 ttmt -139.45 110.35 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.345 -0.389 . . . . 62.420000000000002 111.539 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.04 130.65 64.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 71.340000000000003 109.81 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.22 26.56 12.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.867 0.842 . . . . 74.400000000000006 110.538 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.68 24.13 70.84 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.949 -0.643 . . . . 60.420000000000002 112.461 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 tpt180 -127.07 139.75 52.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.76 -0.459 . . . . 74.310000000000002 109.76 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -76.07 112.68 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 54.399999999999999 109.46 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -109.27 150.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 110.996 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -114.82 96.38 44.26 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.242 -0.89 . . . . 53.340000000000003 111.486 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HE1' ' A' ' 72' ' ' MET . 19.3 Cg_endo -70.59 131.68 20.53 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.236 1.291 . . . . 52.530000000000001 110.556 170.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -129.74 171.83 12.27 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.887 -0.783 . . . . 73.230000000000004 108.887 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -83.54 126.19 32.55 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.209 -0.996 . . . . 75.140000000000001 109.623 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.22 103.46 0.63 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.879 -0.601 . . . . 45.329999999999998 111.887 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.53 150.06 9.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.968 -1.015 . . . . 44.100000000000001 108.309 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -53.7 129.69 34.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.63 -0.507 . . . . 65.140000000000001 109.63 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -59.03 -24.29 62.7 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.516 0.51 . . . . 73.540000000000006 111.931 -172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.98 -54.81 41.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 73.099999999999994 110.549 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.38 -14.75 58.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.679 . . . . 54.329999999999998 111.201 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 t -64.85 -17.42 64.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.633 -0.712 . . . . 75.420000000000002 111.218 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -68.67 -21.71 64.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.286 -0.416 . . . . 75.109999999999999 111.013 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -78.73 143.94 63.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.072 -0.344 . . . . 60.119999999999997 110.072 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.37 117.86 5.33 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.724 2.283 . . . . 73.109999999999999 112.441 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.51 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.772 . . . . 61.25 112.658 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.88 86.6 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.351 0.26 . . . . 62.130000000000003 111.625 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -107.24 12.87 27.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.153 0.427 . . . . 70.099999999999994 112.153 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 49.3 mt -77.24 155.75 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.894 -0.409 . . . . 73.219999999999999 109.894 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -76.96 88.96 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.178 0.513 . . . . 64.239999999999995 110.799 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.84 135.69 63.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.84 -1.17 . . . . 73.310000000000002 107.84 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.412 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.5 mttt -112.13 20.71 16.59 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.379 0.609 . . . . 64.519999999999996 110.202 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.22 142.1 47.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.505 -0.771 . . . . 73.129999999999995 110.288 176.23 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 159' ' ' VAL . 7.4 pt -126.85 149.63 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.165 0.507 . . . . 63.020000000000003 111.066 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.6 t80 -101.45 136.39 41.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.072 -0.967 . . . . 73.120000000000005 109.016 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 7.1 t -125.88 109.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.544 -0.539 . . . . 75.230000000000004 109.544 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.07 146.98 17.08 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.27 -0.967 . . . . 65.140000000000001 112.309 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.8 50.3 4.72 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.541 -1.024 . . . . 63.210000000000001 110.541 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.596 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 15.2 pt -91.55 -177.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.04 -0.58 . . . . 64.329999999999998 111.481 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HD3' ' ND2' ' A' ' 171' ' ' ASN . 87.5 tttt -84.79 154.67 22.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.817 -0.629 . . . . 72.519999999999996 109.757 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -59.25 -37.2 77.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.814 0.34 . . . . 64.510000000000005 110.952 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -108.3 85.48 2.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 110.016 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 m -123.61 122.78 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.695 0.759 . . . . 71.310000000000002 110.426 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.7 pt-20 -113.22 172.47 6.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.471 -1.241 . . . . 53.240000000000002 110.723 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -48.22 73.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.85 -1.068 . . . . 72.120000000000005 110.128 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -57.19 -34.78 68.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.847 -0.615 . . . . 71.230000000000004 111.817 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.453 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 31.0 m170 -61.27 -60.16 4.18 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.676 0.274 . . . . 65.400000000000006 111.479 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 151' ' ' VAL . 3.2 pp -82.63 -22.39 34.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.519 -0.872 . . . . 73.040000000000006 111.461 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -68.32 -50.74 51.27 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.485 -0.191 . . . . 73.340000000000003 110.485 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.43 -30.76 68.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.086 0.47 . . . . 53.219999999999999 110.436 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.71 -57.08 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.7 -0.682 . . . . 71.109999999999999 112.269 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -69.17 -22.74 63.9 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.918 0.71 . . . . 73.239999999999995 112.918 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.2 mt-10 -68.76 -23.23 64.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 111.021 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -59.1 -26.53 64.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.058 -0.519 . . . . 75.200000000000003 111.232 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.11 -33.87 20.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 55.140000000000001 111.521 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.432 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 179.54 -174.96 46.62 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.309 -0.948 . . . . 52.43 113.726 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -76.45 129.11 36.06 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.045 0.45 . . . . 74.200000000000003 111.613 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.82 137.95 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 75.510000000000005 109.975 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.49 -52.03 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 63.5 110.518 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.12 157.32 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 51.43 109.779 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.22 129.58 72.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.897 0.38 . . . . 65.209999999999994 110.228 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.0 mt-10 -103.4 104.16 14.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.562 -0.744 . . . . 70.019999999999996 110.767 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.1 mm -92.99 112.63 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.831 -0.803 . . . . 63.350000000000001 108.831 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 78.8 mmm -86.07 117.57 24.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.468 -0.493 . . . . 75.329999999999998 109.873 -173.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.96 160.16 37.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 63.439999999999998 110.741 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.11 143.11 28.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.801 -0.636 . . . . 71.450000000000003 109.41 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -68.83 -40.35 79.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.248 -0.433 . . . . 75.510000000000005 111.74 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.62 -46.94 3.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.638 -0.792 . . . . 33.509999999999998 113.457 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -82.81 -24.02 33.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.689 0.245 . . . . 54.350000000000001 111.335 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.13 76.01 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.638 . . . . 42.130000000000003 112.727 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 164.14 12.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.658 -0.497 . . . . 73.099999999999994 109.658 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -62.9 146.21 53.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 63.409999999999997 111.08 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -72.97 -2.6 21.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.996 -0.547 . . . . 75.129999999999995 111.603 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 145' ' ' LYS . . . 97.83 -0.82 59.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.417 -0.673 . . . . 34.140000000000001 111.417 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -160.43 168.17 25.74 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.902 -0.407 . . . . 75.219999999999999 109.902 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.12 169.55 17.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.543 -0.753 . . . . 61.340000000000003 109.184 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 44.2 m-85 -132.21 144.66 50.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.153 0.501 . . . . 73.319999999999993 110.164 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 121' ' ' LEU . 25.5 t -128.77 130.42 68.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.303 -0.408 . . . . 64.209999999999994 110.284 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 131' ' ' ILE . 94.0 m -105.94 120.62 42.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 71.200000000000003 110.941 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.3 160.44 14.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.936 0.398 . . . . 63.340000000000003 111.013 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.59 -31.38 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.599 -0.728 . . . . 71.510000000000005 110.61 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.85 155.85 44.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 74.420000000000002 110.81 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -77.18 -28.54 54.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.339 -0.391 . . . . 75.299999999999997 110.063 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.08 -48.45 33.48 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.037 0.836 . . . . 62.350000000000001 112.089 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.432 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -74.59 -27.87 60.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.702 -0.681 . . . . 65.519999999999996 111.016 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 107' ' ' ILE . 3.7 t -73.76 -41.33 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.230000000000004 109.979 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.479 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 6.9 m-20 -69.7 -23.45 63.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 63.399999999999999 110.988 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -65.36 -43.09 91.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.624 0.726 . . . . 53.219999999999999 110.392 170.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mt -73.19 -39.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.638 -1.164 . . . . 65.329999999999998 111.789 -172.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 160' ' ' ASP . 19.1 m -76.54 -8.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.382 . . . . 63.119999999999997 111.04 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 16.3 mt -64.21 -34.12 66.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.532 0.682 . . . . 71.349999999999994 109.859 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 58.5 mt-30 -109.13 96.99 6.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.796 -1.187 . . . . 71.120000000000005 107.796 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -56.55 -30.61 63.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 53.310000000000002 112.522 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.909 -0.317 . . . . 74.510000000000005 110.514 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.4 m-70 -125.71 152.53 45.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.979 -0.555 . . . . 74.349999999999994 109.56 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 32.1 m -101.76 105.91 16.85 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.173 0.511 . . . . 73.310000000000002 110.053 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.03 138.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.544 -0.753 . . . . 75.0 109.401 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.58 ' ND2' ' HD3' ' A' ' 113' ' ' LYS . 59.7 t30 49.69 36.21 10.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.579 0.704 . . . . 63.420000000000002 112.591 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.96 5.46 90.12 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.968 -0.56 . . . . 62.43 114.122 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -129.3 134.5 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.424 0.612 . . . . 72.439999999999998 111.324 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 20.3 t-20 -81.04 112.37 18.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.545 . . . . 73.409999999999997 110.853 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 11.6 m -110.32 156.25 21.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.658 -0.701 . . . . 63.420000000000002 110.339 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.0 tt0 -89.41 140.93 29.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 71.150000000000006 110.369 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -130.39 162.99 37.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.973 0.416 . . . . 73.219999999999999 111.014 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -174.68 175.0 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.023 -0.989 . . . . 71.030000000000001 111.767 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -67.9 122.6 18.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 75.230000000000004 109.508 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -112.4 148.64 33.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.126 0.488 . . . . 61.310000000000002 110.413 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.36 160.15 26.0 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.925 -0.768 . . . . 63.109999999999999 108.925 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 186' ' ' MET . 14.9 t -75.56 161.03 29.51 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.145 -0.687 . . . . 75.420000000000002 109.145 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -56.31 -41.51 76.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.838 0.352 . . . . 62.119999999999997 110.58 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -63.57 -34.48 77.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 74.329999999999998 111.459 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.25 -37.88 57.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 65.549999999999997 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.427 ' HG3' ' O ' ' A' ' 182' ' ' SER . 85.3 mtp -73.22 -29.41 62.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.928 -0.578 . . . . 75.310000000000002 110.843 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.49 -6.87 58.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 54.509999999999998 110.862 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.4 m 62.3 25.47 15.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.851 0.719 . . . . 74.409999999999997 111.557 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -124.43 89.88 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.872 -0.604 . . . . 71.409999999999997 110.154 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.2 m -64.48 112.13 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 74.140000000000001 110.36 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 p -149.87 142.43 24.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.875 -0.602 . . . . 73.430000000000007 110.4 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.2 m -116.1 60.83 0.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.22 0.533 . . . . 71.420000000000002 110.156 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.84 120.05 19.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.695 -0.684 . . . . 74.209999999999994 109.881 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -123.72 131.69 53.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.935 -0.575 . . . . 72.030000000000001 111.111 -174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.69 -97.4 2.25 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.195 -1.162 . . . . 71.219999999999999 110.195 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.548 -0.739 . . . . 75.230000000000004 109.59 173.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.87 -0.492 . . . . 75.120000000000005 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -74.92 -37.37 62.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.828 0.347 . . . . 51.140000000000001 110.939 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -89.16 80.78 6.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.344 0.592 . . . . 63.43 110.911 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -97.95 85.99 3.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 73.219999999999999 109.675 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.98 144.27 31.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.218 -0.66 . . . . 75.120000000000005 109.218 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m -70.39 115.75 38.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.341 -0.614 . . . . 65.049999999999997 109.341 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 63' ' ' ALA . 68.0 Cg_endo -75.02 166.75 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.498 2.132 . . . . 52.130000000000003 112.417 -173.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -68.58 -20.49 64.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.478 -0.783 . . . . 62.310000000000002 109.782 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -82.14 125.24 77.55 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 74.439999999999998 109.983 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD2' HD22 ' A' ' 13' ' ' LEU . 18.8 Cg_endo -61.07 168.35 7.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.508 2.805 . . . . 64.299999999999997 112.822 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.57 -39.67 35.88 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.597 -0.729 . . . . 73.420000000000002 112.752 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 4.3 pt20 -62.65 -35.85 80.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.523 0.329 . . . . 71.519999999999996 111.869 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 10' ' ' PRO . 8.5 mp -79.16 -45.41 20.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.918 -0.313 . . . . 72.129999999999995 110.38 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 18.0 ptt85 -76.7 2.02 15.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.03 0.381 . . . . 65.209999999999994 112.03 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.6 ttpt -95.54 147.9 23.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.671 0.748 . . . . 61.039999999999999 110.976 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD21 HG13 ' A' ' 68' ' ' VAL . 54.7 mt -117.25 145.15 44.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.835 -1.075 . . . . 52.520000000000003 110.625 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -98.7 119.48 37.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 65.040000000000006 108.405 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 60' ' ' VAL . 14.4 mm -99.54 111.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.703 -0.48 . . . . 75.519999999999996 109.703 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.92 154.36 16.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.673 -0.775 . . . . 60.25 111.553 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.94 39.89 53.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.583 -0.818 . . . . 64.129999999999995 113.489 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' THR . 72.5 mt -80.0 174.5 11.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.009 -0.367 . . . . 65.430000000000007 110.009 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -88.38 168.5 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.659 -0.867 . . . . 52.439999999999998 108.659 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.4 -4.29 53.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.243 0.544 . . . . 74.129999999999995 110.188 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -106.53 5.84 29.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.378 -0.828 . . . . 73.150000000000006 111.411 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 21' ' ' LEU . 32.7 m -75.02 132.91 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.999 0.428 . . . . 63.340000000000003 111.168 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.622 ' HB ' ' OE2' ' A' ' 28' ' ' GLU . 19.0 p -112.41 168.38 9.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.217 -0.66 . . . . 60.5 109.217 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -73.71 -25.9 60.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.768 -0.373 . . . . 61.049999999999997 110.883 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.622 ' OE2' ' HB ' ' A' ' 26' ' ' THR . 2.0 pm0 -79.89 -32.5 40.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.848 -0.16 . . . . 70.109999999999999 111.012 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.7 p -75.92 -35.23 59.85 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 109.828 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.59 -48.12 70.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.533 -0.758 . . . . 73.310000000000002 110.036 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -53.93 -58.75 6.14 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.071 -0.513 . . . . 72.230000000000004 111.475 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 8.7 t -51.41 -30.88 20.68 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.698 0.624 . . . . 70.420000000000002 112.214 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.437 ' CD2' HG22 ' A' ' 79' ' ' VAL . 64.1 t60 -72.47 -61.63 1.73 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.739 -0.21 . . . . 53.340000000000003 110.88 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -71.11 -22.78 62.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.086 0.402 . . . . 74.25 112.086 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 29.2 tt0 -67.0 -17.97 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.259 0.552 . . . . 71.049999999999997 110.869 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' SER . 96.2 mt-30 -64.35 -24.14 67.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.64 . . . . 64.019999999999996 111.503 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -102.52 -17.67 15.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.373 -0.376 . . . . 73.219999999999999 111.63 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -177.82 163.54 31.93 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.311 -0.947 . . . . 73.319999999999993 112.582 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -68.12 118.09 10.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.076 0.465 . . . . 50.420000000000002 111.579 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.2 mt -88.04 129.02 35.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.68 0.752 . . . . 62.450000000000003 111.474 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -93.23 -24.64 18.12 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.882 -1.054 . . . . 71.109999999999999 109.838 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.46 152.3 32.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.08 -0.964 . . . . 75.049999999999997 109.584 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.416 ' SG ' HG12 ' A' ' 60' ' ' VAL . 16.8 t -164.08 126.59 2.44 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.297 -0.631 . . . . 74.349999999999994 109.297 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 p -145.69 113.83 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.726 0.774 . . . . 71.230000000000004 110.11 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 139.54 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.557 -0.905 . . . . 71.400000000000006 108.557 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.46 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 7.4 mmt -77.33 139.37 39.75 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.979 -0.748 . . . . 72.230000000000004 108.979 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -139.78 157.13 46.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.816 -0.629 . . . . 71.109999999999999 111.749 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 29.2 t70 -70.71 134.67 86.07 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.672 -1.149 . . . . 45.240000000000002 109.939 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' HH21 ' A' ' 55' ' ' ARG . 57.2 Cg_endo -75.26 -17.25 19.15 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.171 1.914 . . . . 71.530000000000001 113.297 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.79 -56.15 3.63 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.997 0.369 . . . . 54.049999999999997 111.997 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -105.75 -9.15 17.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 52.109999999999999 111.218 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 28.3 mmtp 66.67 39.81 3.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.658 -0.701 . . . . 53.130000000000003 111.168 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -105.87 159.88 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.315 -0.624 . . . . 72.530000000000001 109.315 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.6 t -65.56 140.44 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 110.875 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.443 HH21 ' HD3' ' A' ' 49' ' ' PRO . 56.0 mtt-85 -85.87 -3.64 58.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 64.030000000000001 110.554 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.45 60.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.514 -0.85 . . . . 70.319999999999993 113.754 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 28.8 p90 -157.98 155.03 28.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.627 0.713 . . . . 74.540000000000006 110.268 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.27 -167.32 20.66 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 111.875 -0.49 . . . . 60.549999999999997 111.875 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.38 148.42 37.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.15 0.475 . . . . 72.510000000000005 110.327 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 43' ' ' CYS . 13.1 m -132.18 131.14 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.545 . . . . 73.109999999999999 109.981 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HD3' ' A' ' 15' ' ' LYS . 5.2 m -106.19 120.16 41.1 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.24 -0.287 . . . . 61.409999999999997 110.248 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 27.8 m-85 -85.7 162.93 18.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.698 0.285 . . . . 74.209999999999994 110.636 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . -75.3 -44.4 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 75.450000000000003 110.66 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.27 154.21 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 64.400000000000006 111.058 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.07 -41.3 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.379 -0.373 . . . . 74.510000000000005 111.055 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -48.39 -40.97 27.51 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.57 0.581 . . . . 63.210000000000001 112.57 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.8 -25.06 59.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 74.219999999999999 111.093 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 HD21 ' A' ' 16' ' ' LEU . 13.0 t -68.79 -44.37 82.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 35.240000000000002 109.986 171.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.39 -50.08 72.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 111.034 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.01 22.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.758 -0.656 . . . . 45.420000000000002 112.701 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.61 57.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.514 . . . . 64.319999999999993 110.825 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.78 -40.31 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.894 -0.594 . . . . 75.310000000000002 111.434 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -19.53 61.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.278 0.561 . . . . 71.340000000000003 110.154 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -9.01 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.709 -0.678 . . . . 62.210000000000001 111.541 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -60.08 146.1 83.57 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.402 0.144 . . . . 50.200000000000003 111.326 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.41 164.63 86.17 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.091 -1.212 . . . . 54.119999999999997 113.24 0.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -118.16 155.12 31.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 72.209999999999994 111.084 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.7 ttmt -141.92 107.04 4.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.102 -0.499 . . . . 71.329999999999998 111.176 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 33' ' ' HIS . 11.9 t -106.38 129.42 59.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.755 -0.657 . . . . 72.120000000000005 109.53 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 67.91 21.39 8.99 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.745 0.783 . . . . 72.310000000000002 110.811 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.57 24.16 65.86 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.869 -0.682 . . . . 62.439999999999998 111.771 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.1 tpt180 -124.05 136.93 54.6 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.267 -0.642 . . . . 64.510000000000005 109.267 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.64 112.02 18.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.394 0.616 . . . . 51.119999999999997 109.626 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -107.38 150.84 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.011 -0.541 . . . . 70.299999999999997 110.974 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -112.86 95.46 33.73 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.221 -0.899 . . . . 74.239999999999995 110.828 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.51 127.8 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.95 1.767 . . . . 72.310000000000002 111.095 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -132.45 171.12 14.18 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 74.230000000000004 109.163 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -70.72 133.22 46.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.765 -0.457 . . . . 71.230000000000004 109.765 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -67.61 96.62 0.55 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.418 0.628 . . . . 65.239999999999995 109.666 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.418 HG22 ' OD1' ' A' ' 160' ' ' ASP . 16.1 t -56.55 135.48 20.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.347 -1.297 . . . . 64.349999999999994 111.643 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t -54.61 143.84 23.5 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.245 -0.889 . . . . 72.140000000000001 109.846 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -61.04 -18.45 57.86 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.43 0.456 . . . . 75.329999999999998 112.137 -173.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.97 -45.24 61.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.458 -0.337 . . . . 74.420000000000002 110.741 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.31 -31.56 24.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.688 -0.233 . . . . 74.040000000000006 111.066 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 21.7 p -76.48 4.05 9.97 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.062 0.458 . . . . 65.409999999999997 111.257 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -86.11 -10.09 55.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.619 0.723 . . . . 44.509999999999998 109.138 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -94.94 150.64 38.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.44 -0.8 . . . . 75.140000000000001 109.872 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.54 124.87 7.91 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.585 2.19 . . . . 75.120000000000005 112.511 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.46 30.27 11.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.162 -0.542 . . . . 62.439999999999998 112.23 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.98 -30.28 24.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.976 0.362 . . . . 72.109999999999999 111.976 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.18 8.49 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.654 0.264 . . . . 74.519999999999996 111.55 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.14 159.68 31.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.717 -0.475 . . . . 65.030000000000001 109.717 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 80.28 7.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.595 0.712 . . . . 74.049999999999997 110.481 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -108.78 118.46 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.075 -0.966 . . . . 72.230000000000004 109.46 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -105.53 21.34 17.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.612 . . . . 62.229999999999997 110.081 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -119.2 139.7 51.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 71.420000000000002 110.997 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 159' ' ' VAL . 6.7 pt -130.95 149.87 34.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.305 0.574 . . . . 65.439999999999998 111.386 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.8 t80 -94.78 133.33 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.716 -1.129 . . . . 72.129999999999995 109.906 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.58 109.55 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.063 -0.717 . . . . 73.140000000000001 109.063 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.84 159.72 21.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.569 -1.3 . . . . 72.140000000000001 113.755 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.07 6.45 53.84 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.697 -0.764 . . . . 74.310000000000002 112.406 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.0 pt -66.38 124.48 21.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.26 0.553 . . . . 75.140000000000001 109.877 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -91.45 -21.57 20.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.807 -0.633 . . . . 73.099999999999994 112.284 -169.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -142.16 -168.41 2.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.467 -0.197 . . . . 65.340000000000003 110.467 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.42 101.48 0.05 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 124.073 0.858 . . . . 73.540000000000006 111.364 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -109.63 124.23 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.63 -0.878 . . . . 64.239999999999995 108.63 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -113.01 -179.39 3.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.585 -0.734 . . . . 64.150000000000006 111.635 -169.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.18 -53.66 55.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.929 -1.032 . . . . 70.340000000000003 111.493 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.58 -28.24 69.5 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.079 0.237 . . . . 64.540000000000006 111.182 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -53.84 -62.65 1.52 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.184 0.516 . . . . 64.310000000000002 110.596 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.27 -26.68 28.42 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.113 -0.635 . . . . 64.239999999999995 111.532 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 2.0 tmm_? -67.29 -48.28 68.13 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 110.07 -0.345 . . . . 70.510000000000005 110.07 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.87 -29.76 70.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.99 0.424 . . . . 73.019999999999996 110.5 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 168' ' ' HIS . 88.2 t80 -77.39 -56.82 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.081 -0.509 . . . . 71.530000000000001 112.078 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -67.49 -21.99 65.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.414 0.524 . . . . 70.310000000000002 112.414 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.8 mt-10 -69.02 -19.96 64.13 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.527 0.195 . . . . 73.439999999999998 111.527 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.09 -30.05 64.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.985 0.421 . . . . 72.209999999999994 110.98 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.6 -30.89 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 73.140000000000001 111.637 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.23 -172.28 44.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.661 -0.781 . . . . 73.310000000000002 112.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -76.22 136.19 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.176 0.512 . . . . 73.129999999999995 111.681 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 152' ' ' THR . 90.8 mt -106.54 138.45 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 65.439999999999998 110.006 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.61 -46.98 8.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 74.239999999999995 111.038 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.56 154.93 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 75.109999999999999 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -114.62 128.54 71.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.124 0.487 . . . . 73.510000000000005 110.046 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 16.8 mt-10 -102.71 104.58 14.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.364 -0.834 . . . . 70.319999999999993 111.047 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.86 122.94 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.261 -0.644 . . . . 70.310000000000002 109.261 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.4 mmm -105.74 141.62 36.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.907 0.384 . . . . 72.019999999999996 110.192 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.79 149.01 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 74.049999999999997 110.87 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.05 131.63 41.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.658 -0.701 . . . . 71.349999999999994 110.368 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -77.23 -25.08 51.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.76 0.314 . . . . 71.129999999999995 111.275 -174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.36 -53.42 2.16 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.634 -0.794 . . . . 52.020000000000003 112.82 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -90.56 -24.24 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.761 0.315 . . . . 62.310000000000002 111.639 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.57 8.53 84.64 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.613 -0.803 . . . . 61.520000000000003 112.876 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -80.92 143.99 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 74.310000000000002 110.026 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -73.96 88.64 1.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.508 -0.553 . . . . 73.230000000000004 109.508 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -162.44 175.33 11.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.697 0.761 . . . . 61.229999999999997 111.839 -170.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.09 -46.89 3.45 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.008 -1.451 . . . . 74.510000000000005 113.835 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -173.04 159.74 4.03 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.054 0.927 . . . . 75.450000000000003 110.509 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.55 175.69 9.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.436 -0.802 . . . . 61.030000000000001 109.182 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.6 m-85 -141.16 154.45 45.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.945 0.402 . . . . 63.219999999999999 110.321 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.67 132.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.318 0.58 . . . . 71.25 111.271 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 131' ' ' ILE . 26.0 m -101.49 126.6 48.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.344 -0.843 . . . . 75.209999999999994 110.883 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.53 158.03 16.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 71.420000000000002 111.45 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.3 -29.3 53.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.637 -0.71 . . . . 60.43 110.567 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -130.11 155.55 46.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 74.400000000000006 110.877 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -82.89 -26.5 31.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.540000000000006 110.351 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 31.9 t70 -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.224 -0.444 . . . . 70.120000000000005 110.673 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 m -68.7 -32.78 72.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 61.240000000000002 110.799 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -69.16 -39.86 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 72.319999999999993 109.783 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.491 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.1 t70 -69.5 -33.49 72.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.224 -0.898 . . . . 74.400000000000006 111.152 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 55.9 mttm -53.54 -38.88 64.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.917 0.865 . . . . 75.140000000000001 110.29 172.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 177' ' ' VAL . 33.8 mt -77.78 -45.32 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.405 -1.27 . . . . 72.140000000000001 113.011 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 160' ' ' ASP . 24.4 m -75.39 -4.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.198 0.523 . . . . 74.439999999999998 111.69 -172.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 161' ' ' LYS . 14.0 mt -58.35 -32.12 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 109.692 169.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.59 148.75 32.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.385 -0.825 . . . . 73.439999999999998 108.788 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.41 -37.04 13.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.0 0.429 . . . . 65.530000000000001 111.08 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.87 131.92 53.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.169 -0.468 . . . . 75.239999999999995 110.145 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 124' ' ' TYR . 87.7 m-70 -122.11 140.56 52.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.065 -0.516 . . . . 61.32 110.337 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 m -89.98 106.72 18.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.147 0.499 . . . . 75.409999999999997 111.402 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.22 130.15 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.83 . . . . 72.140000000000001 109.083 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t30 50.22 41.63 24.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.728 0.775 . . . . 74.329999999999998 111.641 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.55 69.54 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.616 -0.72 . . . . 41.130000000000003 113.347 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -126.52 131.55 51.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.79 0.295 . . . . 51.100000000000001 110.453 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.19 108.19 13.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.477 . . . . 72.219999999999999 109.711 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.71 146.81 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 109.755 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -86.4 131.9 34.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.841 0.353 . . . . 72.219999999999999 110.228 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 37.4 t -129.19 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.925 -0.58 . . . . 73.209999999999994 111.06 -173.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -157.78 171.6 20.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.593 -0.73 . . . . 73.129999999999995 111.232 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HD3' HG11 ' A' ' 163' ' ' VAL . 9.0 mmtm -61.22 122.76 15.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.854 -0.425 . . . . 75.530000000000001 109.854 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -104.82 111.67 24.5 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.339 0.59 . . . . 61.43 109.884 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.6 mt -97.62 150.42 21.17 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.384 -0.825 . . . . 62.310000000000002 109.395 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.587 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 36.9 m -68.62 163.13 24.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.67 -0.493 . . . . 74.120000000000005 109.67 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -59.06 -41.73 88.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.624 0.249 . . . . 65.140000000000001 111.522 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 2.0 mp0 -68.27 -34.55 76.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 75.209999999999994 110.159 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 0.3 OUTLIER -64.49 -40.55 95.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 60.210000000000001 110.582 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 182' ' ' SER . 57.5 mtp -72.83 -37.61 67.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 74.510000000000005 110.263 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.93 -9.78 58.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.534 . . . . 74.129999999999995 111.323 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.6 m 62.67 36.05 13.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.657 0.741 . . . . 73.439999999999998 110.542 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 184' ' ' GLN . . . -114.88 118.66 34.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 74.109999999999999 109.783 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.1 m -70.76 129.79 40.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.105 -0.498 . . . . 70.329999999999998 110.84 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.8 t -156.42 147.41 22.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.728 -0.669 . . . . 73.530000000000001 109.519 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.0 m -76.45 87.72 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.132 0.492 . . . . 54.25 110.446 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.484 ' HG3' ' H ' ' A' ' 195' ' ' GLY . 35.2 tp60 -132.03 127.96 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.759 -0.655 . . . . 74.109999999999999 109.533 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -85.23 21.18 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 73.010000000000005 111.73 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 193' ' ' GLN . . . 114.32 105.22 2.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.916 -0.659 . . . . 55.329999999999998 112.9 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.184 -0.912 . . . . 75.310000000000002 109.522 175.648 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.292 -0.323 . . . . 61.100000000000001 112.292 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.6 m 56.74 76.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.418 0.687 . . . . 32.450000000000003 112.058 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -112.45 80.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 73.409999999999997 109.397 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 p -95.22 5.1 52.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.569 0.581 . . . . 75.010000000000005 112.569 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.18 91.21 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 74.230000000000004 109.748 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 p -90.39 110.69 42.66 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.541 -0.754 . . . . 53.509999999999998 111.27 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -84.65 161.56 12.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.369 2.046 . . . . 64.540000000000006 111.59 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 8.03 5.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 110.838 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.39 137.36 74.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.655 -0.702 . . . . 74.25 110.202 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 10.5 Cg_endo -61.58 161.33 24.8 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.386 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.02 64.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.164 -0.471 . . . . 62.009999999999998 111.664 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.478 ' HG3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -64.95 -33.33 75.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.322 0.49 . . . . 64.319999999999993 112.322 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 28.8 mt -85.19 -14.58 46.44 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 122.095 -0.378 . . . . 73.510000000000005 110.838 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.602 ' HA ' HG21 ' A' ' 68' ' ' VAL . 33.2 ptt180 -117.75 0.8 12.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.229 -0.441 . . . . 74.540000000000006 111.363 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -96.71 148.08 23.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.667 0.746 . . . . 72.140000000000001 111.53 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.549 HD21 HG13 ' A' ' 68' ' ' VAL . 57.7 mt -118.74 144.3 46.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.712 -1.131 . . . . 70.439999999999998 110.424 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -96.47 117.02 30.03 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.326 -0.99 . . . . 74.420000000000002 108.326 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 60' ' ' VAL . 15.9 mm -96.88 110.82 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.779 -0.452 . . . . 75.040000000000006 109.779 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.43 155.0 16.73 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.507 -0.854 . . . . 54.43 111.578 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.57 45.25 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.774 -0.727 . . . . 53.030000000000001 113.244 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 25' ' ' THR . 94.3 mt -79.56 175.4 10.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.954 0.407 . . . . 45.329999999999998 110.279 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -88.5 166.73 13.99 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.487 -0.561 . . . . 63.439999999999998 109.487 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -75.93 -4.54 41.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.751 0.31 . . . . 71.439999999999998 110.846 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -122.68 14.74 10.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 74.340000000000003 111.096 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.591 HG21 HD22 ' A' ' 21' ' ' LEU . 94.7 m -79.85 124.33 28.55 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 61.039999999999999 110.821 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.1 p -99.78 165.68 11.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 75.040000000000006 110.346 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.1 p30 -76.67 -21.09 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.73 -0.388 . . . . 63.149999999999999 110.74 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.05 -27.7 30.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.208 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -80.36 -36.57 33.83 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.81 -0.441 . . . . 35.299999999999997 109.81 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 HG22 ' A' ' 45' ' ' VAL . 35.7 tp -61.87 -46.58 88.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.583 -0.735 . . . . 71.040000000000006 110.135 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 ttm-85 -56.21 -56.58 19.23 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 115.792 -0.64 . . . . 74.040000000000006 111.314 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.1 t -50.96 -36.2 37.67 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.853 0.721 . . . . 72.409999999999997 112.437 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -70.28 -54.6 11.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.671 -0.24 . . . . 72.310000000000002 111.302 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -78.5 -17.18 56.62 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.895 0.332 . . . . 75.209999999999994 111.895 -170.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.34 -25.65 49.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.454 0.539 . . . . 74.219999999999999 112.454 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.87 -26.36 68.29 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.255 0.465 . . . . 41.240000000000002 112.255 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -99.64 -19.72 16.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.727 0.269 . . . . 74.129999999999995 111.727 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.36 168.74 40.62 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.289 -0.958 . . . . 70.040000000000006 112.343 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -66.96 119.76 12.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.031 0.443 . . . . 72.299999999999997 112.008 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.61 133.54 35.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.76 -0.654 . . . . 70.510000000000005 110.524 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -107.43 -19.02 13.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.237 -0.892 . . . . 72.140000000000001 110.215 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.08 153.55 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.255 -0.646 . . . . 60.340000000000003 109.255 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 60' ' ' VAL . 11.1 t -165.33 131.43 2.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.993 -0.373 . . . . 71.329999999999998 109.993 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.51 128.47 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.509 0.671 . . . . 53.43 111.348 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 27' ' ' ASP . 87.4 t -88.14 133.85 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 63.219999999999999 108.63 171.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.454 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mmt -74.86 97.66 3.36 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.651 0.738 . . . . 63.140000000000001 110.1 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -99.45 152.32 20.12 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.702 -1.135 . . . . 74.409999999999997 109.49 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 37.2 t70 -70.04 127.89 92.03 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.422 -0.808 . . . . 75.239999999999995 110.619 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.56 -19.3 64.86 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.189 1.926 . . . . 62.329999999999998 113.111 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.505 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 27.6 m-80 -84.76 -56.4 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.785 0.291 . . . . 71.450000000000003 111.785 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -105.48 -8.75 17.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.986 0.422 . . . . 64.140000000000001 111.849 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp 64.16 40.63 6.75 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.577 0.751 . . . . 65.230000000000004 111.626 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -113.83 156.7 23.44 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.952 -0.758 . . . . 74.010000000000005 108.952 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m -75.69 131.68 40.04 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.917 -0.313 . . . . 72.230000000000004 110.358 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -85.66 5.78 30.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 63.5 111.349 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.08 60.07 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.617 -0.801 . . . . 65.530000000000001 114.204 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.454 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.4 p90 -158.99 155.31 27.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.82 0.81 . . . . 74.329999999999998 110.343 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.51 -163.13 14.57 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.701 -0.56 . . . . 63.329999999999998 111.701 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.85 148.81 37.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.062 0.431 . . . . 75.030000000000001 110.224 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 18' ' ' ILE . 8.5 m -128.23 128.53 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.826 -0.624 . . . . 72.310000000000002 109.345 171.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.68 118.36 36.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.812 0.339 . . . . 74.349999999999994 110.272 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -85.74 161.67 19.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.902 -0.59 . . . . 65.209999999999994 109.962 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.05 -44.02 64.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.9 -0.591 . . . . 74.099999999999994 110.401 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -120.81 149.22 42.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.916 -0.584 . . . . 64.510000000000005 110.845 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.9 p -62.88 -37.38 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.565 -0.288 . . . . 70.219999999999999 111.044 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.45 -41.74 85.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.588 0.588 . . . . 72.219999999999999 112.588 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.89 -29.24 70.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.019 0.438 . . . . 73.109999999999999 110.78 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 14' ' ' ARG . 38.9 t -63.14 -49.41 83.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.592 -0.731 . . . . 74.030000000000001 111.087 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.22 -40.69 94.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.200000000000003 111.302 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.96 -38.66 57.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 112.295 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.36 58.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.806 0.336 . . . . 64.040000000000006 110.612 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.12 87.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 71.439999999999998 111.068 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -29.16 66.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.041 -0.527 . . . . 73.129999999999995 111.015 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.71 -9.29 58.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.075 0.768 . . . . 63.420000000000002 113.075 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -54.39 146.61 31.98 Favored Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.169 0.433 . . . . 71.439999999999998 112.169 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.4 168.98 72.66 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.312 -1.12 . . . . 75.140000000000001 113.385 1.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -123.54 161.19 25.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.532 -0.758 . . . . 71.129999999999995 110.39 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.5 ttmt -137.21 112.64 9.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.826 0.346 . . . . 63.210000000000001 111.35 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.14 126.98 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.973 -0.558 . . . . 51.240000000000002 109.936 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.53 26.9 9.82 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.692 0.62 . . . . 72.230000000000004 111.915 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.88 23.36 66.91 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.951 -0.643 . . . . 34.43 112.191 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 tpt180 -126.29 135.43 51.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.107 -0.331 . . . . 73.140000000000001 110.107 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.66 111.71 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.123 -0.695 . . . . 75.310000000000002 109.123 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.3 m -107.7 152.49 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 74.099999999999994 111.853 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.26 94.42 30.93 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.762 -1.108 . . . . 74.340000000000003 111.402 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -72.19 127.96 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.678 1.585 . . . . 53.109999999999999 110.463 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -131.69 168.88 16.99 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 75.140000000000001 109.324 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 10.0 tpp180 -73.25 130.51 40.37 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.977 -0.289 . . . . 64.420000000000002 110.562 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.68 93.58 0.73 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.073 0.463 . . . . 74.329999999999998 110.3 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.24 156.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.369 -0.832 . . . . 51.310000000000002 110.546 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -55.3 154.16 6.31 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.098 0.559 . . . . 74.340000000000003 111.808 -177.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -58.16 -40.13 80.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.038 -0.528 . . . . 72.099999999999994 111.883 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.92 -50.59 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 50.530000000000001 110.651 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -70.74 -29.29 65.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.632 -0.713 . . . . 65.540000000000006 111.409 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -67.18 -17.55 64.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.403 -0.362 . . . . 75.239999999999995 111.295 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -82.22 -12.47 58.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.953 0.406 . . . . 64.129999999999995 110.837 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.24 151.23 78.12 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.483 -0.326 . . . . 72.420000000000002 110.379 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.83 117.16 4.06 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.101 2.534 . . . . 72.430000000000007 112.717 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.63 43.16 69.26 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.958 -0.564 . . . . 44.530000000000001 112.812 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.05 -34.6 73.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.879 0.371 . . . . 35.409999999999997 111.418 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -99.4 19.71 15.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 111.677 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.0 154.38 35.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 74.040000000000006 109.609 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 m -74.38 86.85 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.706 0.765 . . . . 55.350000000000001 110.445 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.0 t -114.89 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 74.319999999999993 109.343 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -104.19 16.5 26.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.11 0.414 . . . . 72.319999999999993 111.101 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -117.16 139.96 50.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.594 -0.276 . . . . 64.230000000000004 111.022 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 159' ' ' VAL . 4.3 pt -123.55 147.48 27.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.263 0.554 . . . . 53.130000000000003 111.111 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.2 t80 -97.68 131.43 44.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.779 -1.1 . . . . 72.219999999999999 109.628 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.04 110.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.868 -0.789 . . . . 64.329999999999998 108.868 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.88 148.02 19.27 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.998 -1.096 . . . . 54.219999999999999 112.31 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.61 6.15 29.07 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.207 -0.997 . . . . 61.539999999999999 112.217 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 173' ' ' HIS . 13.6 pt -76.54 103.99 4.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.556 0.693 . . . . 74.099999999999994 110.468 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.19 -24.48 34.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 62.420000000000002 110.996 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.45 171.37 7.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.863 0.364 . . . . 71.439999999999998 110.558 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 145' ' ' LYS . 18.3 t70 -66.99 125.45 26.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 71.510000000000005 110.057 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 m -124.12 139.27 54.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.15 0.5 . . . . 63.399999999999999 110.323 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -112.88 174.69 5.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.591 -0.731 . . . . 72.25 111.796 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.03 -57.24 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.847 -1.07 . . . . 71.549999999999997 112.132 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -64.68 -23.79 67.37 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 123.07 0.231 . . . . 75.219999999999999 111.066 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -57.08 -58.99 5.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.97 0.415 . . . . 64.439999999999998 110.558 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 134' ' ' ILE . 4.6 pp -83.67 -25.3 30.82 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.674 -0.81 . . . . 73.209999999999994 111.549 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.8 -51.5 58.55 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.737 -0.468 . . . . 54.100000000000001 109.737 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.78 -32.99 73.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 74.439999999999998 110.413 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD2' HG22 ' A' ' 170' ' ' VAL . 92.6 t80 -73.06 -57.81 3.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.982 -0.554 . . . . 65.25 112.187 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -68.33 -22.3 64.7 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.563 0.579 . . . . 64.420000000000002 112.563 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.97 -24.93 67.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.827 0.346 . . . . 74.040000000000006 111.468 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -55.78 -26.04 44.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.748 -0.66 . . . . 71.409999999999997 111.83 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -91.82 -20.83 21.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.162 0.43 . . . . 75.430000000000007 112.162 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.01 -172.48 42.12 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.416 -0.897 . . . . 63.340000000000003 113.396 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -76.35 131.99 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 74.310000000000002 111.248 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 152' ' ' THR . 71.8 mt -103.79 139.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.735 -0.666 . . . . 73.540000000000006 109.936 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.76 -48.65 6.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.825 0.345 . . . . 75.340000000000003 110.944 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -157.38 157.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.261 -0.427 . . . . 65.519999999999996 109.961 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 121' ' ' LEU . 3.2 mp -115.52 130.29 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.551 -0.537 . . . . 71.019999999999996 109.551 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.2 mt-10 -103.69 103.31 13.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.213 -0.449 . . . . 62.530000000000001 110.946 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.2 mm -91.38 125.43 44.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.461 -0.57 . . . . 70.310000000000002 109.461 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.9 mmm -105.91 133.25 50.93 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.083 -0.71 . . . . 71.230000000000004 109.083 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.2 p -100.92 176.94 5.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 62.539999999999999 112.025 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.14 144.76 27.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.096 -0.956 . . . . 75.109999999999999 109.651 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -69.07 -40.28 78.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.495 -0.321 . . . . 53.240000000000002 111.373 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -89.93 -52.94 2.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.905 -0.664 . . . . 72.310000000000002 113.252 -175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -87.13 -23.33 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.678 0.251 . . . . 74.299999999999997 111.678 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.17 83.9 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.006 -0.616 . . . . 73.540000000000006 113.193 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.22 156.15 18.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.416 -0.216 . . . . 73.019999999999996 110.416 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 115' ' ' ASP . 82.9 mttt -78.53 89.43 4.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.511 0.196 . . . . 61.219999999999999 110.535 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -154.12 176.07 12.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.573 0.702 . . . . 65.439999999999998 111.891 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.08 -46.06 3.62 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.199 -1.364 . . . . 75.109999999999999 113.507 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -172.85 157.46 3.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.633 0.717 . . . . 75.409999999999997 109.526 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.0 172.3 13.24 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.63 . . . . 75.319999999999993 109.694 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 75.8 m-85 -138.46 155.67 48.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.732 -0.667 . . . . 75.219999999999999 109.745 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.41 136.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.301 0.572 . . . . 71.400000000000006 110.809 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 131' ' ' ILE . 98.9 m -100.52 125.05 46.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.02 -0.991 . . . . 74.310000000000002 110.944 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -100.61 157.67 16.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.875 0.369 . . . . 63.240000000000002 110.59 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.28 -30.29 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.766 -0.652 . . . . 52.140000000000001 110.312 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -130.97 155.34 46.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 74.400000000000006 110.823 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -80.12 -26.34 39.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 72.010000000000005 110.514 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 17.0 t70 -63.01 -39.16 93.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 111.169 -173.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 -31.42 72.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.375 -0.375 . . . . 73.200000000000003 110.781 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 107' ' ' ILE . 3.2 t -69.81 -45.33 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.289 -0.414 . . . . 61.420000000000002 110.195 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.597 ' HA ' HG22 ' A' ' 163' ' ' VAL . 20.1 m-20 -71.04 -23.96 62.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.845 -0.616 . . . . 73.209999999999994 111.586 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 88.1 mttt -63.78 -40.95 97.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.140000000000001 110.095 170.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.37 -42.54 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.695 -1.139 . . . . 64.400000000000006 112.122 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 160' ' ' ASP . 13.4 m -73.81 -12.25 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 53.450000000000003 110.789 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.451 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 6.8 mt -58.55 -29.37 38.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 72.239999999999995 109.829 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.489 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.3 mt-30 -112.44 98.7 7.45 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.613 -0.884 . . . . 72.200000000000003 108.613 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HB2' ' HZ2' ' A' ' 166' ' ' LYS . 1.2 ttmp? -53.37 -37.21 62.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.424 0.898 . . . . 63.039999999999999 113.424 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -121.3 131.67 54.34 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.6 -0.44 . . . . 70.25 110.576 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.7 m-70 -124.85 158.09 34.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 74.019999999999996 109.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.2 m -102.82 103.38 13.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.081 0.467 . . . . 72.450000000000003 110.379 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 124' ' ' TYR . 3.7 t -118.53 140.5 41.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.71 -0.677 . . . . 64.329999999999998 109.177 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.5 t30 56.77 31.02 18.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.966 0.889 . . . . 75.420000000000002 111.009 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.85 16.96 74.88 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.341 -0.845 . . . . 51.210000000000001 113.303 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 85.8 t60 -130.7 138.67 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.767 0.283 . . . . 72.510000000000005 110.356 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.68 110.9 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 73.439999999999998 110.535 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.81 158.07 29.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.066 -0.97 . . . . 64.439999999999998 111.102 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.56 133.1 34.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.123 -0.49 . . . . 54.030000000000001 110.187 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.8 t -128.83 132.12 67.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.345 -0.843 . . . . 75.409999999999997 110.057 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -155.4 175.98 13.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 75.150000000000006 111.15 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -62.14 122.9 16.73 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.82 -0.437 . . . . 75.540000000000006 109.82 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 108' ' ' PHE . . . -107.21 115.13 29.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.084 0.469 . . . . 55.240000000000002 110.719 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.1 mt -90.72 114.94 27.4 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.392 -0.966 . . . . 71.010000000000005 108.392 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.0 t -72.64 -178.96 2.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.315 -0.402 . . . . 62.509999999999998 110.055 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -30.73 69.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 70.319999999999993 110.512 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -60.68 -53.43 57.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.503 -0.771 . . . . 71.340000000000003 110.529 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -72.15 -38.57 69.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.971 -0.559 . . . . 75.099999999999994 111.586 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.63 -35.57 80.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.332 . . . . 71.319999999999993 111.805 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -93.21 -1.74 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 32.219999999999999 110.878 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.2 p 50.48 30.75 4.91 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.764 1.226 . . . . 62.539999999999999 112.125 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -170.04 171.98 6.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.755 -0.657 . . . . 55.219999999999999 109.702 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.1 t -72.25 101.95 2.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.294 -0.632 . . . . 74.349999999999994 109.294 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 p -100.2 152.87 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.99 -0.55 . . . . 74.409999999999997 111.266 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -92.89 15.67 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.999 -0.546 . . . . 75.420000000000002 110.822 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -70.52 97.01 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.285 0.564 . . . . 62.119999999999997 109.697 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -111.98 -36.62 5.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.133 -0.94 . . . . 71.239999999999995 110.656 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.0 -123.72 8.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.519 -1.032 . . . . 52.219999999999999 110.519 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.523 -0.751 . . . . 53.43 109.752 176.592 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.969 -0.452 . . . . 45.039999999999999 111.969 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m -93.17 95.88 9.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 73.430000000000007 110.654 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -63.05 -54.73 33.46 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 50.140000000000001 110.104 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.0 m -155.43 106.93 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 74.519999999999996 109.844 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.38 173.47 13.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.448 -0.342 . . . . 62.030000000000001 110.088 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 m -98.08 107.39 40.74 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.474 -0.33 . . . . 75.430000000000007 110.441 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 53.5 Cg_endo -87.61 165.64 7.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.819 2.346 . . . . 73.420000000000002 111.793 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -4.5 7.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.287 0.477 . . . . 73.120000000000005 112.287 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.564 ' OE1' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -93.91 150.27 38.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 C-N-CA 120.658 -0.417 . . . . 73.420000000000002 110.175 -177.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 36.1 Cg_endo -70.65 167.32 25.94 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.254 1.969 . . . . 64.340000000000003 112.076 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -37.06 68.75 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.006 -0.543 . . . . 64.409999999999997 112.283 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.43 -16.41 63.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.044 0.387 . . . . 72.439999999999998 112.044 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.6 mp -96.01 -14.63 22.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.742 0.306 . . . . 53.509999999999998 111.112 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.582 ' HA ' HG21 ' A' ' 68' ' ' VAL . 16.5 ptt180 -118.84 2.22 11.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.044 0.45 . . . . 72.439999999999998 110.767 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.98 149.63 22.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.751 0.786 . . . . 62.130000000000003 111.603 174.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.721 HD21 HG13 ' A' ' 68' ' ' VAL . 61.0 mt -117.13 146.45 43.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.552 -1.203 . . . . 62.329999999999998 110.46 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -99.21 121.62 41.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.65 -0.87 . . . . 74.409999999999997 108.65 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.92 112.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 110.052 -0.351 . . . . 51.210000000000001 110.052 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.77 150.32 18.31 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.929 -0.653 . . . . 71.239999999999995 111.703 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 45.95 42.5 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.767 -0.73 . . . . 65.010000000000005 113.541 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 HG21 ' A' ' 25' ' ' THR . 77.9 mt -81.08 163.43 23.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.704 -0.48 . . . . 52.450000000000003 109.704 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 p -80.97 169.21 17.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.327 -0.62 . . . . 71.430000000000007 109.327 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -72.33 -11.52 60.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 72.540000000000006 110.316 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.89 15.26 17.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 71.329999999999998 111.314 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.569 HG21 HD22 ' A' ' 21' ' ' LEU . 53.1 m -82.41 126.9 32.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.152 0.501 . . . . 71.519999999999996 110.942 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 164.09 12.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 63.439999999999998 110.325 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.6 p30 -74.06 -25.79 60.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.184 -0.206 . . . . 54.43 110.879 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.67 -37.47 82.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 73.329999999999998 110.493 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 m -80.23 -37.25 33.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 61.530000000000001 110.943 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 45' ' ' VAL . 32.3 tp -63.0 -43.56 98.44 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.458 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 31' ' ' ARG . 14.6 ttm180 -60.86 -55.49 32.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.886 -0.413 . . . . 65.219999999999999 109.886 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.7 m -47.23 -39.52 14.36 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 124.313 1.008 . . . . 73.230000000000004 113.067 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.403 ' ND1' HG22 ' A' ' 79' ' ' VAL . 8.2 t-80 -70.68 -61.27 1.83 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 70.109999999999999 111.583 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -69.91 -21.82 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 72.450000000000003 112.201 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 28.9 tt0 -63.74 -16.88 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.813 0.445 . . . . 73.209999999999994 111.857 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.27 -26.62 68.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.563 0.221 . . . . 73.439999999999998 111.081 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -99.56 -19.98 16.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.205 0.446 . . . . 61.409999999999997 112.205 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -175.53 168.7 41.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.218 -0.992 . . . . 74.129999999999995 112.707 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.5 m -65.98 119.14 10.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 53.350000000000001 111.99 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.72 122.24 34.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.706 0.765 . . . . 64.230000000000004 111.215 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -89.72 -25.77 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.154 -1.385 . . . . 73.099999999999994 110.116 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -152.3 153.34 33.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.394 -0.821 . . . . 43.140000000000001 109.642 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -161.06 130.24 4.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.748 -0.464 . . . . 63.32 109.748 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.03 123.8 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.481 0.658 . . . . 64.030000000000001 110.516 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 30' ' ' LEU . 92.0 t -84.39 135.06 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.224 -1.028 . . . . 75.329999999999998 108.224 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.459 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -74.17 95.35 2.58 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.782 0.801 . . . . 65.140000000000001 109.641 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -104.91 164.57 11.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.102 -1.408 . . . . 71.540000000000006 110.257 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.46 128.46 87.23 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.936 -0.765 . . . . 62.149999999999999 108.936 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.78 -18.73 65.23 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.181 1.921 . . . . 70.030000000000001 113.377 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -86.39 -55.69 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 74.099999999999994 110.89 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -99.63 -14.89 18.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.008 -0.996 . . . . 75.409999999999997 112.331 -170.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm 65.76 26.8 11.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.924 0.89 . . . . 63.340000000000003 111.367 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -102.54 153.32 20.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.552 -0.536 . . . . 72.519999999999996 109.552 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.0 137.72 51.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 73.519999999999996 112.145 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -88.83 4.89 46.14 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.463 -0.79 . . . . 73.129999999999995 110.441 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.08 17.7 58.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.057 -0.592 . . . . 73.129999999999995 114.385 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.4 p90 -159.1 155.68 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.607 0.703 . . . . 52.109999999999999 110.155 174.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.45 20.22 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.825 -0.51 . . . . 35.310000000000002 111.825 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.19 149.76 40.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.032 0.416 . . . . 63.219999999999999 110.852 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.9 127.0 65.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.614 -0.721 . . . . 70.109999999999999 109.496 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 m -104.34 121.37 43.22 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.292 -0.255 . . . . 61.439999999999998 110.654 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.9 178.28 7.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.176 -0.466 . . . . 73.049999999999997 111.084 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.06 -28.81 18.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.683 -0.69 . . . . 41.119999999999997 110.796 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -144.05 147.69 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 74.219999999999999 110.698 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.55 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -57.54 -35.38 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 122.863 0.465 . . . . 61.100000000000001 111.913 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.09 -39.56 63.45 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.15 0.796 . . . . 72.230000000000004 113.15 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -70.78 -27.12 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 71.329999999999998 110.303 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.721 HG13 HD21 ' A' ' 16' ' ' LEU . 19.7 t -66.61 -47.3 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.334 -0.848 . . . . 72.409999999999997 110.08 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.97 -46.07 85.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 75.409999999999997 110.702 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.53 -41.25 53.55 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.466 0.543 . . . . 63.119999999999997 112.466 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.48 -32.23 58.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 55.020000000000003 110.96 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.3 mmt -70.74 -36.21 73.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 44.310000000000002 110.107 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -12.6 59.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.481 -0.781 . . . . 72.200000000000003 110.512 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.28 -11.35 38.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.731 -0.668 . . . . 64.420000000000002 110.269 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp85 -57.87 142.1 79.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.241 -0.891 . . . . 74.239999999999995 110.402 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 86.7 Cg_endo -79.95 169.0 71.5 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.694 -0.961 . . . . 75.099999999999994 114.363 4.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.463 ' CD2' ' HG3' ' A' ' 86' ' ' PRO . 69.0 m-70 -129.0 158.54 38.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.879 . . . . 61.210000000000001 110.447 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -137.43 106.9 6.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.071 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.403 HG22 ' ND1' ' A' ' 33' ' ' HIS . 15.5 t -107.95 130.9 59.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.242 -0.435 . . . . 72.040000000000006 109.901 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 65.05 29.31 12.19 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.667 0.604 . . . . 73.049999999999997 111.674 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.44 26.08 72.73 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.936 -0.575 . . . . 73.140000000000001 112.117 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.8 tpt180 -129.0 139.11 52.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 65.140000000000001 109.841 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.25 107.67 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.584 -0.525 . . . . 70.230000000000004 109.584 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.48 151.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.259 0.552 . . . . 53.329999999999998 110.824 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -112.03 94.43 25.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 70.549999999999997 111.087 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HG3' ' CD2' ' A' ' 77' ' ' HIS . 38.2 Cg_endo -74.31 132.28 16.2 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.069 1.846 . . . . 74.530000000000001 111.385 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -137.12 174.24 10.83 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.291 -1.003 . . . . 73.439999999999998 108.291 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.0 tmm_? -76.77 131.04 38.49 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.653 -0.869 . . . . 70.209999999999994 108.653 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.09 96.36 0.14 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.043 0.449 . . . . 75.420000000000002 111.755 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 100' ' ' ALA . 40.3 t -69.07 137.23 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.113 -0.948 . . . . 73.239999999999995 110.497 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 t -86.88 -176.56 5.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.732 -0.667 . . . . 73.420000000000002 109.789 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -68.63 -41.6 79.23 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.553 0.946 . . . . 64.230000000000004 113.553 -167.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.71 -35.4 52.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.729 -0.389 . . . . 73.510000000000005 111.198 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -14.3 59.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.771 0.319 . . . . 63.219999999999999 110.363 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 30.5 t -80.57 -20.09 44.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 60.240000000000002 109.824 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -71.33 -20.37 62.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.811 -0.632 . . . . 75.420000000000002 109.797 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.22 147.67 88.07 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.661 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.14 128.61 17.86 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.817 2.345 . . . . 73.530000000000001 112.098 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.4 39.31 22.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.019 -0.61 . . . . 74.040000000000006 111.993 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -66.03 -54.3 27.72 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.876 0.324 . . . . 75.140000000000001 111.876 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -107.66 11.14 28.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.044 0.449 . . . . 75.519999999999996 110.621 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 151.58 25.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.583 -0.525 . . . . 74.450000000000003 109.583 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 m -72.52 105.84 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.735 . . . . 73.120000000000005 110.359 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HB ' ' CE ' ' A' ' 179' ' ' LYS . 61.4 t -132.21 116.27 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.867 -1.061 . . . . 72.430000000000007 109.43 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' C ' HG21 ' A' ' 159' ' ' VAL . 75.3 mttt -102.6 13.6 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.417 -0.513 . . . . 71.349999999999994 110.67 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.38 139.66 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.315 -0.402 . . . . 71.219999999999999 110.792 177.149 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -120.97 149.16 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.261 0.553 . . . . 64.140000000000001 111.388 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.3 t80 -98.76 132.21 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.774 -1.103 . . . . 74.150000000000006 109.441 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 111.08 28.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.217 -0.66 . . . . 71.120000000000005 109.217 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -132.88 148.41 19.27 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 119.907 -1.139 . . . . 31.010000000000002 112.601 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 6.72 36.7 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.347 -0.93 . . . . 60.32 112.948 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.76 105.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.522 0.677 . . . . 71.010000000000005 110.526 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 46.2 mtmt -74.97 -53.44 8.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.496 -0.775 . . . . 62.340000000000003 110.62 -176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -73.09 155.45 39.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.416 -0.811 . . . . 72.120000000000005 109.805 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.53 134.73 55.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.279 0.561 . . . . 75.230000000000004 109.739 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -116.24 145.26 43.27 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.021 -0.536 . . . . 64.430000000000007 109.899 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.86 158.63 17.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.053 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.12 -44.48 79.18 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 123.93 0.769 . . . . 75.140000000000001 110.289 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -56.52 -35.68 68.32 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.409 0.284 . . . . 74.109999999999999 111.603 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -62.66 -59.92 4.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.331 -0.395 . . . . 73.510000000000005 110.841 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 134' ' ' ILE . 1.9 pt? -84.29 -21.65 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.253 -0.579 . . . . 74.319999999999993 111.138 -173.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 7.2 tmm_? -66.36 -55.67 14.78 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 110.138 -0.319 . . . . 75.420000000000002 110.138 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -61.39 -26.41 67.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.361 0.6 . . . . 64.140000000000001 110.481 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -75.8 -58.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.39 -0.823 . . . . 75.510000000000005 112.252 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.3 m-85 -69.08 -21.84 64.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 111.735 0.272 . . . . 71.319999999999993 111.735 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mm-40 -64.55 -24.73 67.7 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.917 0.389 . . . . 61.009999999999998 111.076 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -58.69 -27.59 64.97 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.921 -0.582 . . . . 63.439999999999998 111.636 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -87.24 -32.19 19.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 74.230000000000004 112.009 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.41 -174.71 47.17 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.828 -0.701 . . . . 73.120000000000005 113.001 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -74.03 126.62 30.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.302 0.572 . . . . 63.420000000000002 112.184 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 63.3 mt -97.36 139.42 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.118 -0.946 . . . . 65.340000000000003 109.72 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -90.34 -48.62 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 70.099999999999994 110.731 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.52 154.48 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 109.777 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.401 HG21 HD21 ' A' ' 121' ' ' LEU . 3.7 mp -112.63 125.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.376 -0.601 . . . . 63.32 109.376 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 34.3 mt-10 -100.43 103.91 15.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.666 -0.697 . . . . 55.310000000000002 110.7 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.3 mm -95.63 129.47 45.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.775 -0.454 . . . . 73.219999999999999 109.775 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.6 mtp -110.95 146.16 37.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.746 -0.835 . . . . 61.399999999999999 108.746 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -97.0 167.5 11.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 74.530000000000001 112.222 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.74 137.62 35.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.076 -0.965 . . . . 73.120000000000005 109.721 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -68.78 -37.97 79.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.866 -0.607 . . . . 64.030000000000001 111.3 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.83 -52.6 2.07 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.818 -0.706 . . . . 63.409999999999997 113.15 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.4 t -86.66 -24.34 25.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.706 0.262 . . . . 73.340000000000003 111.706 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.71 19.01 74.28 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.739 -0.743 . . . . 73.049999999999997 112.951 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -86.81 169.3 12.7 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.763 -0.458 . . . . 55.530000000000001 109.763 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -88.13 78.76 8.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.296 -0.631 . . . . 74.0 109.296 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 113' ' ' LYS . 22.1 ptt180 -154.7 -177.54 6.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.783 0.801 . . . . 72.010000000000005 112.453 -171.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.89 -44.93 3.27 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 113.91 -1.495 . . . . 75.030000000000001 112.751 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -169.48 148.33 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.688 -0.486 . . . . 75.239999999999995 109.688 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.98 172.76 12.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.844 -0.616 . . . . 74.329999999999998 109.516 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 55.1 m-85 -140.89 151.72 44.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.012 -0.54 . . . . 70.099999999999994 110.454 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 125' ' ' PHE . 94.9 t -134.13 129.52 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.587 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 131' ' ' ILE . 64.0 m -99.85 123.23 43.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 70.409999999999997 110.206 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -104.06 159.69 15.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.732 0.301 . . . . 73.109999999999999 110.381 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.94 -24.09 48.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.33 0.586 . . . . 64.349999999999994 110.761 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 4.4 t70 -138.41 156.67 47.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.726 . . . . 72.439999999999998 110.148 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -79.79 -21.41 44.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.415 -0.357 . . . . 74.239999999999995 110.038 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.4 p-10 -58.91 -39.61 82.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.443 -0.799 . . . . 72.530000000000001 111.026 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -76.32 -29.35 57.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.073 -0.512 . . . . 60.549999999999997 110.532 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -69.58 -40.22 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.59 -0.522 . . . . 73.299999999999997 109.59 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -72.05 -24.3 61.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.348 -0.842 . . . . 74.150000000000006 111.453 -178.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 72.8 mttt -68.21 -34.12 75.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 74.549999999999997 110.234 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.86 -40.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.181 -0.918 . . . . 72.420000000000002 112.281 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 159' ' ' VAL . 12.2 m -73.0 -6.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.15 0.5 . . . . 74.129999999999995 111.362 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 13' ' ' LEU . 54.8 mt -54.74 -38.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.079 -0.964 . . . . 72.019999999999996 110.171 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -107.55 114.2 28.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.386 -0.825 . . . . 75.450000000000003 109.473 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -53.85 -41.5 67.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.402 -0.817 . . . . 72.209999999999994 112.187 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.89 138.61 54.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.243 -0.435 . . . . 75.319999999999993 110.859 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -124.25 152.89 42.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.631 -0.713 . . . . 74.150000000000006 109.218 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -122.84 113.28 18.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.324 0.583 . . . . 74.140000000000001 110.035 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.59 113.96 41.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.507 -0.769 . . . . 74.450000000000003 109.92 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 70.44 24.1 4.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.128 0.489 . . . . 53.450000000000003 110.789 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.2 78.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.861 -0.685 . . . . 72.329999999999998 112.448 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.27 111.08 21.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.856 -0.424 . . . . 75.120000000000005 109.856 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.4 131.68 34.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.313 -0.625 . . . . 61.350000000000001 109.313 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 p -143.99 149.27 36.47 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.263 -0.426 . . . . 64.049999999999997 111.436 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.52 130.57 35.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.632 -0.877 . . . . 74.099999999999994 108.632 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.7 t -127.74 137.21 58.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.857 -0.611 . . . . 74.510000000000005 110.501 -175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -161.99 177.97 9.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.264 -0.88 . . . . 73.450000000000003 110.972 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.45 ' CE ' ' HB ' ' A' ' 104' ' ' VAL . 7.0 mmmm -67.74 122.03 17.23 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.671 -0.492 . . . . 71.430000000000007 109.671 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -93.73 114.9 27.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.895 0.378 . . . . 42.219999999999999 110.445 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.14 132.25 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.751 -0.659 . . . . 73.230000000000004 110.831 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 186' ' ' MET . 9.0 t -71.93 164.57 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.548 -1.278 . . . . 64.230000000000004 107.548 166.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.26 -34.1 73.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.825 0.284 . . . . 75.239999999999995 111.629 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -68.88 -32.82 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 70.450000000000003 110.489 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -71.42 -38.66 71.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 74.25 110.065 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' SER . 82.0 mtp -67.37 -39.48 85.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.594 -0.73 . . . . 51.119999999999997 110.862 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.67 -4.94 59.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 44.240000000000002 111.662 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t 60.81 47.42 7.88 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.786 0.679 . . . . 33.210000000000001 110.437 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.78 147.85 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 54.549999999999997 111.267 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.5 t -103.96 109.09 20.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.892 -0.595 . . . . 74.540000000000006 109.925 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -86.95 128.34 35.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.312 -0.404 . . . . 61.229999999999997 110.318 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.6 m -80.19 102.11 9.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 110.53 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -142.33 150.76 41.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.058 -0.519 . . . . 62.130000000000003 110.038 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.56 37.13 1.33 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 72.030000000000001 109.48 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -83.61 46.29 3.62 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.754 -0.736 . . . . 75.510000000000005 111.547 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.357 -0.83 . . . . 73.439999999999998 109.047 -176.487 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 112.145 -0.382 . . . . 73.450000000000003 112.145 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -71.6 115.04 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 44.130000000000003 110.963 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -79.83 115.82 19.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 61.420000000000002 109.972 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.5 m -143.84 60.94 1.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.977 0.418 . . . . 74.420000000000002 109.982 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.04 136.45 37.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 110.384 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -61.3 111.78 4.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.602 0.564 . . . . 74.329999999999998 110.238 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.61 156.97 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.511 2.141 . . . . 43.039999999999999 113.27 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.0 -5.01 21.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.047 -1.094 . . . . 61.210000000000001 108.047 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 1.6 mp0 -61.55 131.44 92.64 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 113.649 -1.614 . . . . 62.229999999999997 111.704 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 16.4 Cg_endo -59.95 168.43 5.85 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.703 2.935 . . . . 72.230000000000004 112.99 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.45 59.85 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.617 -0.719 . . . . 65.519999999999996 111.92 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.14 0.422 . . . . 71.209999999999994 112.14 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 13.3 mt -85.29 -20.91 29.32 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 122.094 -0.379 . . . . 61.240000000000002 110.671 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 ptt-85 -108.7 -2.9 18.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.863 0.363 . . . . 75.409999999999997 111.027 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.8 ttpt -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.599 0.714 . . . . 74.430000000000007 111.944 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 HG13 ' A' ' 68' ' ' VAL . 69.7 mt -118.97 145.28 45.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.801 -1.09 . . . . 65.409999999999997 110.034 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -97.09 123.57 40.88 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.398 -0.964 . . . . 74.209999999999994 108.398 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 60' ' ' VAL . 18.6 mm -103.02 110.22 29.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.83 -0.433 . . . . 62.409999999999997 109.83 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.69 150.48 17.95 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.046 -0.597 . . . . 63.119999999999997 111.794 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.75 52.92 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.846 -0.692 . . . . 53.43 113.168 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 25' ' ' THR . 68.8 mt -78.74 176.8 9.19 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.283 -0.636 . . . . 73.340000000000003 109.283 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p -83.5 167.64 17.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.152 -1.055 . . . . 75.450000000000003 108.152 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -79.51 0.42 29.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.933 0.396 . . . . 74.200000000000003 110.639 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -125.38 15.59 8.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.837 -0.62 . . . . 74.209999999999994 111.568 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 21' ' ' LEU . 32.4 m -74.11 130.62 40.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.662 0.267 . . . . 65.519999999999996 111.072 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.3 p -104.77 163.67 12.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 74.519999999999996 110.293 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -28.31 64.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.405 -0.361 . . . . 70.549999999999997 111.193 -176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.93 -35.77 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.513 0.197 . . . . 72.129999999999995 111.244 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -75.94 -36.61 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.665 -0.243 . . . . 72.209999999999994 110.687 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.9 -48.25 77.39 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.704 -0.48 . . . . 74.450000000000003 109.704 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.3 ttm180 -54.96 -60.86 2.78 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 115.379 -0.828 . . . . 73.019999999999996 111.951 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -50.23 -31.66 14.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.738 0.648 . . . . 51.450000000000003 112.386 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -73.14 -60.72 2.1 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.201 -0.2 . . . . 64.409999999999997 110.817 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.36 -22.13 64.68 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.109 0.411 . . . . 74.329999999999998 112.109 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.47 -25.51 51.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.312 0.645 . . . . 60.439999999999998 112.078 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.5 -27.03 65.79 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.236 0.458 . . . . 62.520000000000003 112.236 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -99.05 -19.68 17.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.582 0.215 . . . . 72.530000000000001 111.582 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.0 28.09 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.851 -0.69 . . . . 63.439999999999998 111.771 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -63.82 119.49 10.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.441 . . . . 51.149999999999999 111.329 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.7 136.24 33.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.589 -0.732 . . . . 70.319999999999993 110.487 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 p -103.97 -21.79 13.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.42 -0.809 . . . . 74.230000000000004 110.194 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -150.84 150.11 30.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 75.340000000000003 109.674 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -159.9 130.27 5.57 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.713 -0.477 . . . . 75.430000000000007 109.713 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.76 129.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.383 0.611 . . . . 72.200000000000003 111.083 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -87.77 128.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.79 -0.819 . . . . 54.450000000000003 108.79 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -72.9 98.45 2.47 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.669 0.747 . . . . 63.32 110.278 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -103.37 161.24 14.0 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.385 -1.279 . . . . 54.43 110.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.52 125.2 91.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.749 -1.114 . . . . 61.119999999999997 109.793 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -65.45 -20.71 60.99 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.202 1.935 . . . . 74.519999999999996 112.575 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -83.83 -55.43 4.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 74.239999999999995 111.63 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 -8.67 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 64.420000000000002 111.85 -173.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 62.19 38.23 13.72 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.287 0.635 . . . . 73.140000000000001 111.447 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -110.09 157.48 19.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.547 -0.909 . . . . 50.240000000000002 108.547 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -73.13 137.89 45.44 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.796 -0.362 . . . . 74.010000000000005 110.262 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -83.4 1.27 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.420000000000002 110.204 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.31 18.3 59.23 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.99 -0.624 . . . . 74.409999999999997 113.871 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -159.57 158.4 31.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.059 0.929 . . . . 74.430000000000007 110.614 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.16 -163.07 14.97 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.34 -0.704 . . . . 71.120000000000005 111.34 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.31 149.83 38.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.235 0.518 . . . . 71.510000000000005 110.702 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 m -129.67 122.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.879 -0.6 . . . . 75.310000000000002 109.844 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.1 m -98.9 121.93 41.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.624 -0.262 . . . . 74.409999999999997 110.386 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -87.18 163.4 16.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 71.030000000000001 110.704 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.15 70.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.637 -0.71 . . . . 52.340000000000003 110.144 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -124.38 144.3 50.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.427 -0.806 . . . . 74.409999999999997 110.384 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -63.17 -37.09 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.258 -0.428 . . . . 70.030000000000001 110.824 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.02 -36.93 68.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.552 0.575 . . . . 73.129999999999995 112.552 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.41 -26.81 65.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.104 0.478 . . . . 74.209999999999994 110.704 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 37.7 t -64.62 -45.46 95.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.538 -0.756 . . . . 74.099999999999994 110.468 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -52.96 -48.23 67.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.699 -0.682 . . . . 65.400000000000006 111.989 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -58.12 -37.38 74.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.607 0.595 . . . . 73.400000000000006 112.607 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.84 -34.83 78.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.396 0.617 . . . . 72.120000000000005 110.166 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -38.23 77.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 74.430000000000007 110.877 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.644 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.0 p30 -76.99 -10.46 59.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.894 0.378 . . . . 75.209999999999994 111.335 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.06 -11.59 43.66 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.906 -0.588 . . . . 75.109999999999999 112.438 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.42 148.78 8.51 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 113.284 0.846 . . . . 63.329999999999998 113.284 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 2.8 Cg_endo -81.94 160.87 79.1 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.692 -1.378 . . . . 75.530000000000001 112.438 -2.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -110.4 151.53 27.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 63.200000000000003 110.152 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.1 ttmt -136.76 104.36 5.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.044 0.45 . . . . 74.540000000000006 111.131 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.8 140.31 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.695 -0.684 . . . . 32.509999999999998 109.685 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 66.25 21.68 11.02 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.573 0.749 . . . . 74.420000000000002 110.3 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 25.4 69.1 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.748 -0.66 . . . . 75.530000000000001 112.222 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 tpt180 -129.4 136.64 50.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.374 -0.232 . . . . 72.519999999999996 110.374 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -83.79 111.05 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.655 0.74 . . . . 72.200000000000003 109.992 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 m -102.84 155.34 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 112.183 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -111.53 96.62 32.92 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.469 -1.241 . . . . 65.409999999999997 111.006 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.58 130.1 7.68 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.35 2.033 . . . . 75.319999999999993 111.073 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HZ2' HG23 ' A' ' 103' ' ' THR . 30.0 mttm -133.8 170.26 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.849 -0.797 . . . . 63.119999999999997 108.849 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.547 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tpp180 -70.38 137.76 50.77 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.507 -0.553 . . . . 72.299999999999997 109.507 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 97.15 0.45 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.292 0.568 . . . . 52.32 110.348 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' OD1' ' A' ' 160' ' ' ASP . 6.6 t -55.26 136.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.433 -1.258 . . . . 64.120000000000005 111.786 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.432 ' HB2' HG12 ' A' ' 164' ' ' ILE . 2.4 t -57.84 147.26 29.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.435 -0.802 . . . . 74.129999999999995 109.904 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -52.52 -40.48 62.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.402 0.681 . . . . 73.409999999999997 112.591 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.03 -39.29 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.142 0.423 . . . . 71.349999999999994 112.142 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.28 -32.31 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.03 -0.359 . . . . 74.040000000000006 110.03 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -69.57 -12.32 61.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.941 -0.572 . . . . 72.209999999999994 110.609 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -81.17 -7.84 59.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 74.439999999999998 110.056 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -94.62 151.11 38.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 74.420000000000002 110.299 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 122.46 8.19 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.557 2.171 . . . . 74.219999999999999 111.974 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.56 19.5 27.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.586 -0.816 . . . . 73.510000000000005 112.578 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.49 54.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.673 0.249 . . . . 74.209999999999994 111.673 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -98.96 13.84 31.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.802 0.334 . . . . 71.239999999999995 111.405 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.38 171.1 13.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.851 -0.425 . . . . 73.299999999999997 109.851 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' HZ2' ' A' ' 87' ' ' LYS . 2.0 m -89.01 78.18 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.423 0.63 . . . . 63.509999999999998 110.778 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.01 121.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.933 -1.03 . . . . 74.329999999999998 109.341 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 88.2 mttt -107.35 21.73 17.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.164 0.507 . . . . 73.0 110.374 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 142.98 49.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.162 -0.472 . . . . 74.310000000000002 111.46 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 159' ' ' VAL . 7.7 pt -132.71 150.66 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.31 0.576 . . . . 73.319999999999993 111.561 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.9 t80 -96.29 138.48 33.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.834 -1.075 . . . . 73.420000000000002 110.086 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.98 110.78 25.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.419 -0.585 . . . . 73.239999999999995 109.419 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.17 141.84 12.81 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 119.927 -1.13 . . . . 71.450000000000003 112.387 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.0 6.36 14.04 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.315 -0.945 . . . . 71.409999999999997 112.224 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -73.87 101.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.515 0.674 . . . . 74.219999999999999 109.793 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 22.73 1.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 72.019999999999996 112.628 -170.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.01 175.57 11.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.996 -0.372 . . . . 73.120000000000005 109.996 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.66 120.96 12.2 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.697 0.623 . . . . 65.409999999999997 110.561 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -122.7 146.6 47.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.175 0.512 . . . . 75.099999999999994 110.136 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.5 165.27 11.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.44 -0.8 . . . . 64.439999999999998 111.289 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.52 -47.17 87.35 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.184 -1.371 . . . . 62.140000000000001 109.61 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.47 -0.786 . . . . 74.25 111.712 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.47 -58.03 7.58 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.165 0.291 . . . . 71.349999999999994 111.185 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.16 -27.5 38.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.615 -0.834 . . . . 74.109999999999999 110.918 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.4 tmm_? -66.65 -45.0 80.37 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.977 -0.379 . . . . 73.530000000000001 109.977 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.23 -32.18 71.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.195 0.521 . . . . 75.200000000000003 110.454 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -79.48 -55.82 4.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.503 -0.771 . . . . 71.239999999999995 112.37 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 42.9 m-85 -67.7 -24.03 65.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.095 0.405 . . . . 74.129999999999995 112.095 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.4 mm-40 -66.58 -25.81 66.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.976 0.417 . . . . 74.0 110.899 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -61.03 -32.23 71.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.94 -0.573 . . . . 71.329999999999998 111.589 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -81.69 -27.91 33.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.540000000000006 111.101 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.416 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 171.36 -177.65 44.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.768 -0.651 . . . . 74.109999999999999 112.651 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.6 134.3 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.217 0.532 . . . . 70.209999999999994 111.618 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 152' ' ' THR . 79.4 mt -102.88 144.56 13.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.338 -0.846 . . . . 75.519999999999996 109.872 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -93.49 -49.1 6.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 73.120000000000005 110.825 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.35 155.32 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 109.912 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.74 129.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.344 . . . . 64.530000000000001 110.07 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.79 103.39 14.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 61.420000000000002 111.178 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.38 115.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.561 -0.533 . . . . 52.310000000000002 109.561 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ptp -111.48 152.97 26.84 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.349 -0.612 . . . . 54.539999999999999 109.349 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.96 148.97 22.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.68 -173.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.36 132.15 47.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.192 -0.913 . . . . 74.120000000000005 110.19 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 140' ' ' ARG . 1.7 ppt_? -64.05 -23.74 67.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.72 -0.673 . . . . 70.530000000000001 112.311 -175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -101.49 -52.76 1.03 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.845 -0.693 . . . . 72.329999999999998 112.964 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 m -81.68 -23.65 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.464 0.542 . . . . 72.319999999999993 112.464 -172.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.39 13.87 79.67 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.93 -0.653 . . . . 51.119999999999997 112.724 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -99.49 172.1 7.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.678 -0.49 . . . . 54.219999999999999 109.678 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.72 76.08 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.332 -0.618 . . . . 75.25 109.332 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -152.93 161.31 42.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.615 . . . . 73.409999999999997 111.222 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.8 -45.49 2.33 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.156 -0.929 . . . . 75.340000000000003 113.414 170.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -170.54 153.68 4.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.903 0.852 . . . . 61.020000000000003 109.973 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.38 174.75 11.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 61.140000000000001 109.474 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.85 155.21 47.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.057 -0.52 . . . . 74.439999999999998 109.985 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.07 132.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.54 0.686 . . . . 64.319999999999993 111.097 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 65.0 m -97.58 124.08 41.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.085 -0.961 . . . . 75.239999999999995 110.465 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 3.7 m-85 -99.24 157.83 16.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 70.109999999999999 111.289 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.59 -29.12 45.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.14 -0.936 . . . . 52.219999999999999 110.511 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -128.68 152.22 48.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.526 . . . . 72.010000000000005 110.847 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -77.74 -28.21 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 71.349999999999994 109.887 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.9 t70 -58.12 -48.26 80.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.641 -1.163 . . . . 75.400000000000006 111.955 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 19.5 m -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 65.310000000000002 111.137 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -67.76 -41.11 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 71.019999999999996 109.775 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 163' ' ' VAL . 12.8 t70 -68.08 -38.16 82.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.077 -0.965 . . . . 55.5 111.377 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.547 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 86.4 mttt -52.87 -37.28 60.23 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.517 0.675 . . . . 70.209999999999994 110.696 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mt -78.18 -44.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 71.010000000000005 112.533 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 16.5 m -74.21 -15.17 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 75.319999999999993 110.725 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 91' ' ' SER . 19.0 mt -57.69 -32.11 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.935 -1.03 . . . . 63.329999999999998 110.16 172.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.534 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -111.51 101.45 9.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 75.329999999999998 108.197 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -56.98 -33.79 67.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.233 0.827 . . . . 64.230000000000004 113.233 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -122.15 135.24 54.76 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.569 -0.452 . . . . 65.319999999999993 110.989 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 92.6 m-70 -127.39 156.92 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.754 -0.657 . . . . 74.209999999999994 110.176 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 10.2 m -123.5 115.44 21.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.08 0.467 . . . . 74.129999999999995 110.834 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.58 115.57 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.782 . . . . 42.140000000000001 109.99 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 71.48 23.84 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.922 0.868 . . . . 75.150000000000006 109.749 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 95.3 -13.21 67.16 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.559 -0.746 . . . . 62.439999999999998 112.266 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.516 ' O ' ' HA ' ' A' ' 169' ' ' THR . 2.6 m80 -81.9 109.99 16.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.154 -0.313 . . . . 74.109999999999999 110.154 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -91.86 107.77 19.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.88 0.848 . . . . 62.310000000000002 109.133 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 5.7 p -124.12 156.8 36.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.093 -0.958 . . . . 72.310000000000002 111.463 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -85.97 130.51 34.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.591 -0.731 . . . . 63.119999999999997 109.154 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 11.3 t -126.63 131.24 71.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.333 -0.849 . . . . 61.539999999999999 109.696 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.38 172.93 17.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 72.25 110.933 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.463 ' HD3' HG11 ' A' ' 163' ' ' VAL . 12.0 mmtm -62.67 124.79 21.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.256 0.348 . . . . 64.5 110.708 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -109.71 112.89 25.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.866 0.365 . . . . 63.329999999999998 110.216 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 50.1 mt -98.31 111.39 23.75 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.395 -0.595 . . . . 54.119999999999997 109.395 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.477 ' H ' ' HG2' ' A' ' 185' ' ' GLU . 8.9 m -105.48 -170.24 1.72 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.167 -0.679 . . . . 73.129999999999995 109.167 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -67.51 -16.63 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.693 0.627 . . . . 60.350000000000001 112.693 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -77.15 -48.94 16.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.905 -0.406 . . . . 65.0 109.905 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 182' ' ' SER . 3.0 mm-40 -69.31 -36.05 76.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.849 -0.614 . . . . 71.329999999999998 110.595 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.2 mtt -73.63 -27.59 61.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.897 -0.592 . . . . 75.420000000000002 111.44 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.36 -0.78 51.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 63.240000000000002 110.828 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.1 t 63.75 46.68 3.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.486 -0.779 . . . . 73.239999999999995 110.426 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.36 62.11 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.555 0.693 . . . . 71.230000000000004 109.977 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.3 m -81.04 108.81 15.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.025 -0.989 . . . . 72.430000000000007 111.157 -175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 p -93.36 97.09 10.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.952 -0.567 . . . . 73.340000000000003 110.655 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 p -92.62 92.16 7.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.969 -0.752 . . . . 63.329999999999998 108.969 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 196' ' ' ARG . 4.5 pm0 -77.82 158.15 29.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.46 -0.791 . . . . 74.049999999999997 112.108 -171.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 11.3 tpp180 -82.74 102.23 11.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 72.0 109.577 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.15 -95.04 1.04 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.686 -0.966 . . . . 23.109999999999999 110.686 -172.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.416 ' HA ' ' HG3' ' A' ' 193' ' ' GLN . 7.7 ptm180 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 119.158 -0.449 . . . . 71.230000000000004 109.891 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.077 -0.409 . . . . 74.329999999999998 112.077 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m -104.26 145.76 29.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.108 -0.33 . . . . 72.099999999999994 110.108 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -76.54 -10.5 59.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 51.020000000000003 110.997 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.9 t -80.14 -4.01 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 73.329999999999998 110.681 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -75.86 146.46 39.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.324 -0.398 . . . . 72.109999999999999 110.352 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 m -99.03 128.33 32.45 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 74.120000000000005 110.83 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.19 137.28 18.97 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.369 2.046 . . . . 73.409999999999997 111.853 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -26.34 13.85 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.112 -0.699 . . . . 75.430000000000007 109.112 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -79.1 133.61 60.78 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.833 -1.076 . . . . 75.140000000000001 109.535 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 14' ' ' ARG . 18.3 Cg_endo -62.83 163.3 22.34 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.553 2.169 . . . . 60.030000000000001 111.009 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 7.5 pt-20 -62.56 -27.1 68.94 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 111.981 0.363 . . . . 74.129999999999995 111.981 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HG3' HD12 ' A' ' 13' ' ' LEU . 9.2 pt20 -72.79 -32.51 65.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.795 0.331 . . . . 74.219999999999999 110.849 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 164' ' ' ILE . 5.1 mp -81.36 -11.69 59.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 74.239999999999995 111.197 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 10' ' ' PRO . 32.0 ptt85 -127.06 15.77 7.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.126 0.488 . . . . 75.420000000000002 110.952 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 18.3 ttmm -97.32 151.29 20.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 72.340000000000003 111.029 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 68' ' ' VAL . 70.2 mt -116.76 142.6 46.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.939 -1.028 . . . . 73.200000000000003 110.129 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -98.11 120.89 39.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.169 -1.049 . . . . 75.099999999999994 108.169 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.45 110.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.873 -0.417 . . . . 74.310000000000002 109.873 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.29 152.29 17.97 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.877 -0.678 . . . . 64.230000000000004 111.565 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.83 46.8 43.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.487 -0.863 . . . . 74.409999999999997 112.981 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 25' ' ' THR . 80.5 mt -81.98 176.84 9.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.634 -0.506 . . . . 75.140000000000001 109.634 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 p -85.81 164.6 17.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.107 -1.072 . . . . 73.140000000000001 108.107 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -80.63 2.88 23.92 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.039 0.447 . . . . 73.099999999999994 110.455 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -119.81 10.7 11.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.585 -0.734 . . . . 75.209999999999994 110.995 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.42 HG21 HD22 ' A' ' 21' ' ' LEU . 94.9 m -71.3 121.52 18.61 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 74.530000000000001 110.807 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -94.62 154.85 17.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.003 -0.544 . . . . 63.149999999999999 109.99 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -27.45 63.83 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 121.109 -0.236 . . . . 61.229999999999997 110.867 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -77.2 -23.02 51.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 62.399999999999999 110.741 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -81.29 -41.42 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.672 -0.492 . . . . 70.329999999999998 109.672 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.13 -47.14 87.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 62.420000000000002 109.655 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.21 -62.68 1.5 Allowed 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.094 -0.957 . . . . 73.340000000000003 111.71 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.9 t -48.15 -35.05 10.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.337 0.655 . . . . 74.239999999999995 112.551 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' CG ' HG22 ' A' ' 79' ' ' VAL . 55.9 t60 -68.4 -64.91 0.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 74.150000000000006 110.687 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -71.06 -21.75 62.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.47 0.544 . . . . 74.340000000000003 112.47 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -62.54 -21.0 65.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.722 0.409 . . . . 73.239999999999995 111.703 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.76 -30.03 68.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.544 -0.298 . . . . 73.219999999999999 111.751 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -98.51 -17.29 18.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.963 0.356 . . . . 65.230000000000004 111.963 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.72 164.11 33.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.353 -0.927 . . . . 52.340000000000003 112.36 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -65.38 116.49 6.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 41.439999999999998 111.413 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -85.45 134.57 34.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.745 -0.661 . . . . 65.319999999999993 111.1 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -97.26 -28.61 13.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.202 -0.908 . . . . 63.549999999999997 110.052 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.55 150.42 32.23 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.455 -0.793 . . . . 64.510000000000005 110.373 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -158.41 129.49 6.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.467 -0.568 . . . . 73.310000000000002 109.467 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.22 129.07 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.063 0.458 . . . . 54.210000000000001 110.067 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.06 130.29 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.642 -0.873 . . . . 64.530000000000001 108.642 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.463 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 6.8 mmt -69.24 135.85 51.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.955 0.407 . . . . 75.430000000000007 109.966 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -137.43 155.62 49.13 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.53 -0.759 . . . . 73.099999999999994 109.887 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 28.5 t70 -71.57 132.48 85.45 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.829 -1.078 . . . . 55.520000000000003 110.168 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.85 -19.97 35.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.969 1.78 . . . . 73.409999999999997 112.998 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 4.2 m-20 -84.82 -55.52 4.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 74.409999999999997 111.505 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 m -102.77 -9.11 20.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.955 0.407 . . . . 73.519999999999996 111.739 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.5 mmtm 66.85 24.86 9.67 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.575 0.75 . . . . 70.340000000000003 112.455 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.69 163.82 12.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.944 -0.391 . . . . 65.319999999999993 109.944 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 t -69.61 143.09 53.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.103 0.478 . . . . 74.319999999999993 110.305 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -88.47 1.66 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 53.200000000000003 110.526 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.39 17.76 61.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.653 -0.784 . . . . 62.210000000000001 113.813 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.463 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 41.9 p90 -158.37 159.05 35.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.334 0.567 . . . . 75.310000000000002 110.292 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.93 19.54 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.474 -0.65 . . . . 53.409999999999997 111.474 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 149.61 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.373 0.586 . . . . 75.340000000000003 110.659 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.7 130.65 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.77 -0.65 . . . . 42.119999999999997 109.694 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 m -106.49 123.28 47.84 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 122.135 -0.353 . . . . 75.230000000000004 110.487 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.7 m-85 -90.36 157.75 17.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.769 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.52 80.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 74.209999999999994 111.188 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -123.63 153.94 40.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.005 -0.543 . . . . 61.329999999999998 109.88 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 p -64.5 -30.9 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.396 -0.365 . . . . 74.340000000000003 111.352 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.17 -37.46 87.33 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.867 0.691 . . . . 65.530000000000001 112.867 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -63.61 -28.77 70.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.73 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.8 t -63.55 -49.91 80.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 62.119999999999997 109.856 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.67 -51.35 60.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.327 -0.851 . . . . 72.140000000000001 111.29 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -46.67 -41.03 14.23 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.87 0.692 . . . . 71.25 112.87 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.23 -29.84 61.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 52.43 110.871 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 74.129999999999995 110.851 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -70.48 -36.51 73.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.25 0.548 . . . . 73.120000000000005 110.214 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.0 -11.82 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.29 -0.868 . . . . 60.43 113.175 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -57.05 144.77 67.95 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 111.647 0.24 . . . . 71.209999999999994 111.647 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.65 163.0 84.54 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.518 -1.451 . . . . 61.109999999999999 113.248 2.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -116.83 156.35 27.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 73.549999999999997 110.456 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.5 ttmt -136.84 110.64 8.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.45 -0.341 . . . . 73.030000000000001 110.878 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.9 t -110.2 127.37 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 60.399999999999999 109.654 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.07 28.92 14.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.446 0.641 . . . . 70.239999999999995 111.136 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.17 27.91 63.19 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.742 -0.742 . . . . 45.229999999999997 112.446 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 10.1 tpt180 -131.54 140.39 49.47 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 71.409999999999997 109.564 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.88 112.38 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.417 -0.586 . . . . 44.439999999999998 109.417 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.8 m -105.5 148.25 10.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.484 0.659 . . . . 73.329999999999998 111.209 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -113.03 97.58 42.76 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.776 -1.102 . . . . 75.420000000000002 110.755 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -77.43 128.8 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.685 2.257 . . . . 70.030000000000001 111.27 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -132.99 172.08 13.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.326 -0.852 . . . . 75.319999999999993 108.918 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 4.7 tpp180 -77.99 137.5 38.33 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.651 -0.42 . . . . 74.120000000000005 110.338 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.51 2.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.158 0.504 . . . . 62.310000000000002 110.664 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.1 151.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.887 -1.051 . . . . 74.540000000000006 111.064 177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -55.05 148.24 14.18 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.611 -0.722 . . . . 74.140000000000001 110.469 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -51.02 -43.71 60.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.357 1.243 . . . . 73.299999999999997 114.357 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.84 -33.82 68.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.976 0.417 . . . . 74.209999999999994 111.014 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -84.33 -26.63 28.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.618 -0.719 . . . . 60.409999999999997 111.969 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 p -74.29 -15.05 60.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 111.178 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -85.61 -10.08 56.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.91 -0.586 . . . . 72.329999999999998 110.521 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.52 148.24 43.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 73.109999999999999 110.353 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.1 123.81 11.4 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.491 2.127 . . . . 72.420000000000002 111.842 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 101.91 12.44 34.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.005 -0.616 . . . . 72.209999999999994 112.299 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.5 7.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 111.395 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -97.39 13.76 28.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.003 0.43 . . . . 72.239999999999995 111.347 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 ' HA2' ' A' ' 99' ' ' GLY . 67.5 mt -76.81 155.6 32.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.937 -0.764 . . . . 53.520000000000003 108.937 170.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 m -77.03 90.44 3.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.398 0.618 . . . . 64.439999999999998 110.043 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.41 112.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.427 -0.806 . . . . 62.240000000000002 110.625 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -104.91 17.27 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 74.239999999999995 110.729 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 138.99 52.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.419 -0.355 . . . . 75.120000000000005 110.981 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.569 HG23 HG13 ' A' ' 159' ' ' VAL . 3.5 pt -128.21 151.82 35.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.343 0.592 . . . . 71.519999999999996 111.734 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.9 t80 -100.36 133.12 45.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.623 -1.172 . . . . 75.129999999999995 109.667 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.15 110.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.899 -0.778 . . . . 74.120000000000005 108.899 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -127.38 154.22 19.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.826 -1.178 . . . . 41.329999999999998 112.819 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.96 8.4 58.02 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.633 -0.794 . . . . 72.549999999999997 112.164 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.481 HG13 ' H ' ' A' ' 147' ' ' GLY . 8.6 pt -72.28 93.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.305 0.574 . . . . 63.219999999999999 110.504 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -80.5 -25.31 38.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.818 -0.628 . . . . 73.540000000000006 110.799 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -88.85 161.1 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.67 -0.695 . . . . 61.210000000000001 110.534 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 145' ' ' LYS . 25.5 t70 -65.67 104.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.48 0.487 . . . . 72.200000000000003 109.99 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.5 m -109.34 130.43 55.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.853 -0.612 . . . . 71.329999999999998 110.804 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -112.71 175.24 5.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.002 -0.999 . . . . 71.129999999999995 111.13 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.47 -48.92 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.816 -1.083 . . . . 65.400000000000006 110.834 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -56.24 -37.27 69.52 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.275 0.359 . . . . 74.319999999999993 111.638 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 64.7 m170 -56.7 -60.74 3.12 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.412 0.445 . . . . 72.310000000000002 111.075 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.79 -26.99 29.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.904 -0.718 . . . . 75.140000000000001 111.59 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -66.07 -50.65 63.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.611 -0.144 . . . . 74.519999999999996 110.611 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.79 -24.43 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.039 0.447 . . . . 53.530000000000001 110.399 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -77.34 -57.32 3.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.898 -0.592 . . . . 71.109999999999999 111.878 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -68.58 -23.15 64.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.713 0.634 . . . . 75.540000000000006 112.713 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -69.54 -20.24 63.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 111.503 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -57.25 -28.92 63.38 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.879 -0.601 . . . . 64.519999999999996 111.078 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.66 -30.37 19.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.068 0.396 . . . . 72.439999999999998 112.068 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.2 -176.1 47.82 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.587 -0.816 . . . . 73.439999999999998 113.347 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -75.97 133.26 40.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.159 0.504 . . . . 64.219999999999999 111.178 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 126' ' ' GLU . 75.8 mt -102.92 139.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.472 -0.785 . . . . 64.310000000000002 109.507 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -86.39 -50.83 6.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.462 . . . . 74.200000000000003 110.394 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.461 HG13 ' OE2' ' A' ' 135' ' ' GLU . 9.0 p -160.78 159.34 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.661 -0.7 . . . . 71.230000000000004 109.549 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.85 131.93 71.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.342 0.591 . . . . 74.040000000000006 110.693 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 4.1 mp0 -101.88 103.53 14.21 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.054 -0.975 . . . . 62.140000000000001 110.378 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.51 116.7 35.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.078 -0.712 . . . . 64.200000000000003 109.078 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' PHE . 73.8 mmm -93.72 124.75 37.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.012 -0.736 . . . . 71.129999999999995 109.012 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 149.53 29.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.637 -0.711 . . . . 65.510000000000005 110.143 -174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.06 107.11 9.19 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.85 -0.796 . . . . 73.400000000000006 108.85 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -67.72 -33.29 74.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 74.209999999999994 111.251 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.27 -43.58 10.47 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.775 -0.726 . . . . 45.240000000000002 112.956 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -23.1 19.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.67 0.271 . . . . 72.109999999999999 111.586 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.45 22.01 61.17 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.194 -0.527 . . . . 71.099999999999994 112.501 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.54 135.66 43.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 73.5 111.25 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HB3' ' OD1' ' A' ' 115' ' ' ASP . 15.3 ttmt -92.61 79.52 4.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 74.319999999999993 110.807 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.53 -179.14 0.51 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.669 -0.696 . . . . 74.409999999999997 111.089 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.481 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.87 -44.04 1.59 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.067 -0.969 . . . . 64.230000000000004 111.995 175.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 137' ' ' MET . 20.2 p90 -170.86 153.93 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.682 -0.858 . . . . 74.420000000000002 108.682 173.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.56 169.81 17.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.944 0.402 . . . . 74.25 109.969 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 72.4 m-85 -138.74 154.68 48.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 53.219999999999999 109.435 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 107' ' ' ILE . 2.3 p -144.6 131.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.392 0.615 . . . . 74.299999999999997 111.546 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 131' ' ' ILE . 34.6 m -92.97 124.5 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.963 -1.017 . . . . 62.340000000000003 110.941 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.17 156.9 17.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.393 -0.367 . . . . 74.030000000000001 110.819 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.42 -25.78 46.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 110.582 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -131.1 148.08 52.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.727 -0.67 . . . . 72.400000000000006 110.822 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -78.29 -27.24 47.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.625 -0.262 . . . . 74.140000000000001 110.76 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 20.8 t70 -64.72 -36.74 85.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.073 -0.512 . . . . 62.399999999999999 110.802 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 -32.74 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 44.539999999999999 110.56 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 107' ' ' ILE . 1.4 t -70.77 -39.43 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.925 -0.58 . . . . 62.340000000000003 109.988 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.652 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.2 t70 -69.96 -33.5 72.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.643 -0.708 . . . . 63.399999999999999 111.332 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.9 mttt -54.0 -38.86 65.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.849 0.833 . . . . 75.510000000000005 109.954 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.3 mt -77.07 -43.58 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.126 -1.397 . . . . 62.43 112.398 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 160' ' ' ASP . 11.2 m -75.71 -11.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.891 -0.506 . . . . 73.299999999999997 110.769 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 13' ' ' LEU . 8.6 mt -58.51 -31.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.354 -0.839 . . . . 61.509999999999998 109.932 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -112.63 100.96 9.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.39 -0.967 . . . . 53.140000000000001 108.39 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -58.35 -33.29 69.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.612 0.597 . . . . 73.040000000000006 112.612 -174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.61 131.3 54.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.824 0.345 . . . . 64.140000000000001 110.92 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 84.4 m-70 -123.79 151.3 43.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 73.129999999999995 110.672 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 m -94.39 105.24 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.915 0.388 . . . . 63.240000000000002 110.072 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.3 t -117.52 130.57 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.066 -0.716 . . . . 70.340000000000003 109.066 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 53.02 34.56 17.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.863 0.84 . . . . 73.099999999999994 111.448 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 75.41 0.9 63.5 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.663 -0.699 . . . . 32.039999999999999 113.498 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -111.59 128.75 56.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.169 -0.308 . . . . 72.129999999999995 110.169 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.79 109.32 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.325 0.583 . . . . 74.25 110.707 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.84 156.31 20.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.197 -0.91 . . . . 71.239999999999995 109.816 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -89.47 131.14 35.66 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.91 0.385 . . . . 74.109999999999999 110.042 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.9 t -128.56 132.92 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.365 -0.834 . . . . 73.099999999999994 110.195 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -157.7 176.14 12.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.688 -0.687 . . . . 73.409999999999997 110.297 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -61.77 128.94 38.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.802 0.334 . . . . 74.340000000000003 110.841 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -107.92 113.54 26.83 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.212 0.53 . . . . 41.009999999999998 109.69 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.8 mt -99.01 147.3 25.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.389 -0.823 . . . . 65.340000000000003 109.509 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' A' ' 186' ' ' MET . 8.0 m -68.27 152.98 44.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.509 -0.922 . . . . 73.200000000000003 108.509 172.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -60.99 -24.98 66.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.126 0.488 . . . . 71.519999999999996 110.773 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -68.37 -38.28 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 65.409999999999997 110.428 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -76.12 -33.07 59.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.659 -0.7 . . . . 71.140000000000001 110.721 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 182' ' ' SER . 90.9 mtp -74.34 -13.65 60.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 73.129999999999995 111.159 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.97 58.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.284 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.9 m 63.84 17.94 10.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.274 -0.875 . . . . 72.109999999999999 111.678 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.39 -177.76 5.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.587 -0.894 . . . . 52.450000000000003 108.587 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -67.89 116.61 8.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.821 -0.436 . . . . 51.539999999999999 109.821 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.2 t -139.57 119.17 13.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.079 -0.51 . . . . 62.009999999999998 110.184 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 p -112.94 100.86 8.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.787 -0.642 . . . . 73.150000000000006 109.856 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.25 149.77 35.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.928 0.394 . . . . 71.010000000000005 111.494 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -122.15 161.47 23.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 75.450000000000003 109.949 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.51 116.3 1.18 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.943 -0.646 . . . . 64.150000000000006 111.903 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 119.061 -0.495 . . . . 53.240000000000002 110.586 -179.144 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.733 -0.547 . . . . 70.230000000000004 111.733 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m 61.47 22.7 13.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.211 0.605 . . . . 71.109999999999999 112.149 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.468 ' HA ' ' OG1' ' A' ' 39' ' ' THR . 31.7 mtmm -127.12 10.13 6.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.09 0.471 . . . . 72.120000000000005 111.13 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m -151.26 106.75 3.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 72.109999999999999 109.684 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.85 150.44 51.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.34 -0.391 . . . . 63.100000000000001 111.331 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 103.84 52.67 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.63 -0.714 . . . . 74.510000000000005 109.451 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -84.44 165.28 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.688 2.258 . . . . 73.230000000000004 113.238 -175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -109.27 2.18 20.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.944 -0.762 . . . . 75.099999999999994 108.944 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.42 133.28 31.65 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 114.66 -1.154 . . . . 53.329999999999998 110.231 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HD2' HD22 ' A' ' 13' ' ' LEU . 27.5 Cg_endo -65.0 167.15 16.6 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.114 2.543 . . . . 72.209999999999994 111.323 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.19 -34.89 70.85 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 112.19 0.441 . . . . 71.299999999999997 112.19 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.1 pt20 -68.49 -20.1 64.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.014 0.376 . . . . 72.400000000000006 112.014 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.541 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.0 mp -89.73 -14.3 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.316 . . . . 64.349999999999994 110.816 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 28.5 ptt85 -125.36 -2.96 7.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 64.299999999999997 111.676 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.7 ttpt -98.73 144.73 27.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.752 0.787 . . . . 74.549999999999997 111.22 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.592 HD21 HG13 ' A' ' 68' ' ' VAL . 50.6 mt -120.2 146.92 45.56 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.326 -1.306 . . . . 63.130000000000003 110.969 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.71 115.67 29.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.33 -0.989 . . . . 64.430000000000007 108.33 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 60' ' ' VAL . 20.2 mm -95.0 112.6 27.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.964 -0.384 . . . . 55.340000000000003 109.964 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.55 152.45 17.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.986 -0.626 . . . . 73.409999999999997 111.56 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.16 42.5 50.6 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.553 -0.832 . . . . 60.43 113.314 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 25' ' ' THR . 76.9 mt -77.94 174.02 11.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.929 0.364 . . . . 74.140000000000001 110.171 174.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -84.76 175.92 8.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 74.230000000000004 109.104 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.97 -9.5 59.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.297 0.57 . . . . 74.129999999999995 109.825 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 53' ' ' ARG . 24.9 mt-10 -114.3 5.15 15.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.47 -0.786 . . . . 63.329999999999998 112.231 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.505 HG21 HD22 ' A' ' 21' ' ' LEU . 84.9 m -73.0 126.03 29.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.387 0.613 . . . . 72.310000000000002 112.206 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 p -100.73 164.35 11.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.342 -0.844 . . . . 64.530000000000001 110.337 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -24.27 57.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.156 -0.313 . . . . 74.120000000000005 110.156 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -72.43 -37.69 68.53 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.175 0.297 . . . . 70.530000000000001 110.951 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -77.63 -38.26 48.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 71.120000000000005 110.285 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 79' ' ' VAL . 35.3 tp -60.43 -52.26 65.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.404 -0.816 . . . . 73.510000000000005 109.803 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.86 -60.54 3.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.06 -0.973 . . . . 74.120000000000005 112.009 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -48.31 -36.59 14.54 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.817 0.698 . . . . 74.409999999999997 112.663 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -67.66 -50.8 56.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.785 0.326 . . . . 72.25 110.714 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.44 -20.41 43.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.644 0.239 . . . . 64.349999999999994 111.644 -173.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -60.65 -22.76 64.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.036 0.446 . . . . 63.409999999999997 111.476 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -67.48 -28.1 67.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.761 . . . . 60.009999999999998 112.148 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -96.69 -27.64 14.68 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.1 -0.24 . . . . 75.109999999999999 111.381 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.84 160.05 33.41 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.593 -0.813 . . . . 70.140000000000001 112.009 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 3' ' ' LYS . 24.5 m -64.6 120.12 11.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.676 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.8 mt -89.96 139.6 30.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.486 0.66 . . . . 74.420000000000002 111.174 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 p -105.8 -24.57 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.997 -1.001 . . . . 62.310000000000002 110.006 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -153.45 156.9 39.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.636 -0.711 . . . . 61.329999999999998 109.912 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 t -164.13 131.73 3.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.516 -0.55 . . . . 71.239999999999995 109.516 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.09 117.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.564 0.697 . . . . 64.310000000000002 110.416 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.45 136.04 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.058 -0.719 . . . . 60.409999999999997 109.058 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.9 mmt -83.18 97.45 8.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.638 0.732 . . . . 72.0 110.396 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 50.2 mtp85 -102.25 163.68 12.1 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.525 -1.216 . . . . 74.049999999999997 111.032 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.78 125.02 83.12 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 114.726 -1.125 . . . . 75.430000000000007 110.216 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.33 -12.73 34.38 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.93 1.753 . . . . 75.010000000000005 112.929 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -85.44 -56.96 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 73.219999999999999 111.77 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -103.26 -10.53 18.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 74.510000000000005 111.358 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 65.81 39.38 4.72 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.364 -0.835 . . . . 62.229999999999997 110.471 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 24' ' ' GLU . 31.7 mmm180 -121.82 154.85 36.48 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.631 -0.507 . . . . 65.200000000000003 109.631 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.7 t -66.21 139.11 58.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.93 0.395 . . . . 62.030000000000001 111.68 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -84.33 -1.85 56.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 74.340000000000003 110.465 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.87 57.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.883 -0.675 . . . . 74.310000000000002 113.962 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -157.27 157.43 34.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.189 0.995 . . . . 75.230000000000004 111.078 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.21 -166.07 18.32 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.387 -0.685 . . . . 71.409999999999997 111.387 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -141.31 149.97 41.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.588 0.694 . . . . 73.439999999999998 110.833 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' ILE . 6.9 m -131.53 123.82 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.566 -0.743 . . . . 70.129999999999995 109.869 173.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.5 m -99.03 118.75 36.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.642 -0.254 . . . . 74.140000000000001 110.498 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.7 169.6 14.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.263 -0.426 . . . . 60.43 110.62 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.34 -51.56 14.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.843 -0.617 . . . . 53.43 109.892 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -123.8 155.28 38.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 64.219999999999999 110.606 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -62.22 -34.82 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.663 0.268 . . . . 72.420000000000002 111.308 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -57.97 -37.82 74.9 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.221 0.452 . . . . 72.439999999999998 112.221 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.38 -35.12 78.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.245 0.545 . . . . 61.439999999999998 110.006 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 16' ' ' LEU . 5.2 t -64.86 -47.6 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.117 -0.947 . . . . 71.329999999999998 110.663 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.93 -52.74 62.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 63.210000000000001 110.626 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.64 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.693 0.627 . . . . 54.340000000000003 112.693 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.18 68.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.938 0.399 . . . . 70.209999999999994 110.703 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.4 mmt -67.79 -43.18 80.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.58 . . . . 74.319999999999993 110.764 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.64 -40.35 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.126 0.488 . . . . 62.43 110.568 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.45 -16.59 64.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.177 -0.92 . . . . 74.430000000000007 112.909 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 75' ' ' ARG . 27.7 mtp-105 -54.09 147.23 26.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.233 0.457 . . . . 65.019999999999996 112.233 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.4 168.41 71.86 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.475 -1.469 . . . . 63.210000000000001 113.732 3.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -121.23 162.22 20.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.239 -0.891 . . . . 73.340000000000003 110.346 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.9 ttmt -136.74 111.85 9.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 73.530000000000001 111.604 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 30' ' ' LEU . 18.6 t -115.4 130.51 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 64.140000000000001 109.742 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 4.3 m-20 65.07 29.85 11.91 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.804 0.69 . . . . 75.510000000000005 111.96 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.82 24.73 68.89 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.793 -0.718 . . . . 53.299999999999997 112.445 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.9 tpt180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.448 -0.575 . . . . 65.540000000000006 109.448 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.89 113.18 23.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.791 0.805 . . . . 75.329999999999998 109.368 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.2 m -102.83 151.07 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 62.329999999999998 111.236 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 3.5 tp10 -113.11 97.25 41.88 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.79 -1.095 . . . . 54.539999999999999 111.117 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -73.48 129.49 13.84 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.311 2.007 . . . . 74.010000000000005 111.221 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 19.7 mttt -134.71 -179.02 5.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.349 -1.723 . . . . 60.539999999999999 106.349 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -86.7 141.16 29.11 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 119.581 1.082 . . . . 73.25 110.855 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 95.47 0.6 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.071 -0.513 . . . . 61.329999999999998 110.663 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.58 133.57 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.666 -0.697 . . . . 73.140000000000001 109.593 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 t -78.61 174.0 11.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 63.509999999999998 110.859 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -49.2 -54.58 15.88 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.964 0.906 . . . . 72.209999999999994 113.302 -171.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.79 -36.61 65.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.904 0.335 . . . . 71.109999999999999 111.904 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -11.52 58.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.951 0.352 . . . . 74.340000000000003 111.951 -176.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.6 p -97.81 2.48 49.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.565 0.222 . . . . 73.349999999999994 111.266 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.96 -37.68 88.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.29 -0.414 . . . . 74.209999999999994 111.074 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -92.57 145.6 30.77 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.328 -0.396 . . . . 75.129999999999995 110.261 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.44 151.12 70.84 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.913 2.409 . . . . 64.510000000000005 111.847 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 95.71 8.87 57.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.608 -0.806 . . . . 71.310000000000002 111.925 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.87 -49.04 15.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 60.140000000000001 110.562 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -92.77 3.76 55.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 71.0 111.381 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.434 HD12 ' HA2' ' A' ' 99' ' ' GLY . 70.6 mt -82.79 158.56 22.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 71.219999999999999 109.782 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -76.31 93.49 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.803 0.811 . . . . 74.409999999999997 110.511 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.9 t -120.26 108.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.749 -1.114 . . . . 64.239999999999995 109.913 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 156' ' ' HIS . 53.7 mttt -100.09 10.49 41.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 72.439999999999998 110.776 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.52 140.68 49.11 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.11 -0.496 . . . . 72.030000000000001 111.106 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.499 HG23 HG13 ' A' ' 159' ' ' VAL . 4.9 pt -122.84 149.88 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.258 0.552 . . . . 72.209999999999994 111.969 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.6 t80 -98.43 133.8 42.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.883 -1.053 . . . . 72.439999999999998 109.054 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.56 109.23 22.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.491 -0.559 . . . . 54.420000000000002 109.491 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.26 149.96 17.0 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.209 -0.996 . . . . 65.439999999999998 113.05 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.56 25.62 38.41 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.335 -0.936 . . . . 64.209999999999994 112.595 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.493 ' HB ' ' OG1' ' A' ' 116' ' ' THR . 5.2 pt -68.91 131.48 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 55.229999999999997 109.946 174.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 65.2 tttp -82.93 107.17 15.34 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.343 0.868 . . . . 74.319999999999993 113.343 -164.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 0.5 OUTLIER 73.27 -53.2 0.7 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.405 1.066 . . . . 62.340000000000003 113.456 167.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -165.46 112.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.833 -0.432 . . . . 61.340000000000003 109.833 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 112' ' ' ILE . 14.9 m -123.66 136.77 54.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.283 0.563 . . . . 54.450000000000003 109.629 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -110.88 171.89 7.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.694 -0.684 . . . . 74.129999999999995 111.139 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.44 -49.59 75.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 114.79 -1.095 . . . . 74.409999999999997 110.562 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -54.91 -35.0 63.68 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.399 0.437 . . . . 73.140000000000001 111.783 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.18 -61.18 2.42 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.281 0.363 . . . . 71.329999999999998 111.056 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.6 pp -83.77 -23.66 31.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.197 -0.601 . . . . 72.109999999999999 111.46 -171.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -65.33 -55.36 18.69 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.937 -0.394 . . . . 73.340000000000003 109.937 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.323 0.582 . . . . 72.450000000000003 110.495 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -76.32 -56.64 4.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.359 -0.837 . . . . 70.299999999999997 112.22 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.1 m-85 -68.95 -23.02 64.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.685 0.254 . . . . 75.439999999999998 111.685 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mm-40 -64.4 -24.54 67.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.027 0.442 . . . . 73.200000000000003 110.905 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.0 -27.42 68.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.822 -0.626 . . . . 50.329999999999998 111.777 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.53 -25.79 22.34 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.77 0.285 . . . . 73.510000000000005 111.77 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.25 -175.82 46.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.536 -0.84 . . . . 74.519999999999996 113.312 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -75.47 125.61 29.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 71.209999999999994 112.067 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.8 mt -98.17 136.1 30.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 74.439999999999998 110.301 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.29 -50.49 8.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 74.230000000000004 110.309 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.56 157.96 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 50.509999999999998 110.091 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.4 128.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.321 0.582 . . . . 71.299999999999997 110.519 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.531 ' HG2' ' HA3' ' A' ' 195' ' ' GLY . 35.7 mt-10 -100.29 104.89 16.38 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.255 -0.884 . . . . 62.109999999999999 110.859 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.65 122.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.229 -0.656 . . . . 73.239999999999995 109.229 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.6 mmm -101.95 135.97 42.6 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.636 -0.876 . . . . 74.239999999999995 108.636 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.51 156.95 16.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 73.450000000000003 111.913 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 143.16 48.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.354 -0.839 . . . . 74.200000000000003 109.937 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -64.04 -47.53 79.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 70.109999999999999 111.596 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.36 -47.13 1.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.327 -0.94 . . . . 63.450000000000003 113.951 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.1 p -81.26 -23.02 38.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.895 0.331 . . . . 54.32 111.895 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 16.72 80.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 72.120000000000005 112.405 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HB2' ' HD2' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -87.95 163.6 16.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.875 -0.787 . . . . 63.310000000000002 108.875 178.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -90.15 77.66 6.72 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.793 -0.363 . . . . 75.540000000000006 110.075 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.426 ' HD2' ' HB2' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -160.74 170.38 20.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.946 0.879 . . . . 64.219999999999999 112.787 -179.19 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.98 -44.67 1.46 Allowed Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 113.466 -1.697 . . . . 75.420000000000002 110.56 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -171.54 145.87 2.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.374 -0.602 . . . . 74.010000000000005 109.374 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.51 170.49 14.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.628 -0.714 . . . . 70.129999999999995 109.112 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.529 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -136.24 143.4 44.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.844 -0.616 . . . . 74.019999999999996 109.404 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 125' ' ' PHE . 58.0 t -129.2 121.73 54.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 O-C-N 122.164 -0.335 . . . . 54.5 110.483 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 85.9 m -96.16 118.92 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.678 -0.692 . . . . 74.040000000000006 110.821 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -102.75 156.64 17.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.601 0.238 . . . . 71.230000000000004 110.889 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.22 -29.71 65.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 71.109999999999999 110.288 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 1.9 t0 -139.06 159.96 40.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.587 -0.733 . . . . 65.25 110.887 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 18.0 p-80 -79.18 -19.87 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 75.409999999999997 110.115 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.608 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 1.3 p-10 -60.84 -38.23 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.029 -0.987 . . . . 70.510000000000005 110.979 -174.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -73.85 -31.08 63.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.132 -0.486 . . . . 65.340000000000003 110.227 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.499 HG13 HG23 ' A' ' 107' ' ' ILE . 3.8 t -69.82 -39.01 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.677 -0.692 . . . . 74.010000000000005 109.835 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.92 -26.77 63.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 62.140000000000001 111.242 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 71.7 mttt -69.07 -33.67 73.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.315 0.579 . . . . 70.340000000000003 110.265 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.3 mt -78.02 -42.68 28.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.564 -0.744 . . . . 75.129999999999995 112.672 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.3 m -70.64 -6.14 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.001 0.429 . . . . 75.219999999999999 111.434 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 13' ' ' LEU . 71.5 mt -54.91 -38.79 46.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.191 -0.913 . . . . 63.039999999999999 109.861 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 56.7 mt-30 -109.49 105.28 14.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.578 -0.897 . . . . 54.210000000000001 108.578 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -55.04 -32.34 61.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.864 -0.607 . . . . 65.439999999999998 111.706 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -124.91 133.9 52.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.455 -0.339 . . . . 75.230000000000004 110.687 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.4 m-70 -120.98 144.64 48.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.853 -0.612 . . . . 61.240000000000002 109.887 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.8 m -114.03 106.23 14.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.355 -0.384 . . . . 55.509999999999998 110.569 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.91 114.73 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.309 -0.405 . . . . 73.209999999999994 111.203 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.41 31.74 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.759 0.79 . . . . 55.219999999999999 109.656 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.94 5.46 86.14 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.497 -0.774 . . . . 74.450000000000003 112.385 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.559 ' CD2' ' HB3' ' A' ' 113' ' ' LYS . 61.5 m170 -106.04 110.21 22.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.199 -0.297 . . . . 74.150000000000006 110.199 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.75 107.81 19.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.151 0.5 . . . . 75.140000000000001 109.737 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 p -117.05 156.22 27.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 72.109999999999999 111.451 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.31 134.92 33.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.756 -0.657 . . . . 74.409999999999997 109.853 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 26.9 t -130.9 134.0 62.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.166 0.508 . . . . 51.109999999999999 110.667 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -152.92 173.5 15.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.559 -0.746 . . . . 65.219999999999999 111.372 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -65.68 130.31 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.263 -0.426 . . . . 74.400000000000006 110.298 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -120.75 122.34 40.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.478 . . . . 74.420000000000002 109.711 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.4 mt -80.25 131.44 35.68 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.743 -0.383 . . . . 73.540000000000006 110.375 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 186' ' ' MET . 28.7 t -62.34 154.57 27.57 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.498 -0.556 . . . . 70.450000000000003 109.498 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -58.59 -31.37 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.188 0.518 . . . . 75.219999999999999 110.137 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -58.88 -41.29 86.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.046 -0.979 . . . . 74.340000000000003 110.46 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -37.09 29.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 60.43 111.291 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 182' ' ' SER . 80.5 mtp -66.31 -45.74 79.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.269 -0.423 . . . . 74.239999999999995 111.076 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -87.3 -4.51 59.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 73.230000000000004 111.054 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.0 p 45.04 58.48 4.02 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.032 0.933 . . . . 63.32 111.567 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.67 11.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.379 -0.828 . . . . 52.229999999999997 110.432 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.5 t -80.17 99.2 7.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.799 -0.445 . . . . 41.43 109.799 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.2 m -149.21 167.01 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 65.140000000000001 110.35 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.5 m -127.46 150.76 49.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 73.409999999999997 109.599 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -124.24 115.02 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 64.109999999999999 111.012 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -130.76 148.82 52.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.508 . . . . 64.209999999999994 110.712 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.531 ' HA3' ' HG2' ' A' ' 135' ' ' GLU . . . -118.64 144.35 17.92 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.296 -0.722 . . . . 61.340000000000003 111.296 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.454 -0.784 . . . . 63.210000000000001 109.631 -179.474 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.788 -0.525 . . . . 63.210000000000001 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 p -80.62 81.37 6.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.503 0.668 . . . . 72.140000000000001 110.453 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -88.74 97.11 10.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.792 -0.64 . . . . 64.040000000000006 110.907 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -77.79 143.96 37.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.525 -0.761 . . . . 72.540000000000006 109.46 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.55 92.54 1.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.45 . . . . 50.340000000000003 111.407 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 m -71.47 -48.44 12.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.561 -0.745 . . . . 55.439999999999998 111.814 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 6' ' ' SER . 17.1 Cg_endo -56.8 149.49 59.9 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.452 2.101 . . . . 73.209999999999994 113.1 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.8 12.22 22.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.514 -0.766 . . . . 73.450000000000003 110.675 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -76.09 130.93 76.73 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.246 -0.65 . . . . 71.030000000000001 109.246 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.67 166.36 15.93 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.26 1.973 . . . . 71.450000000000003 111.97 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -41.24 64.41 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.566 -0.743 . . . . 72.439999999999998 112.397 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -71.39 -27.37 63.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.818 0.342 . . . . 73.430000000000007 111.842 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -84.51 -6.16 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.493 -0.322 . . . . 71.409999999999997 111.024 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.4 ptt180 -127.81 6.17 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.981 0.419 . . . . 70.430000000000007 110.685 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.31 146.72 25.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.401 0.62 . . . . 73.109999999999999 111.16 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD21 HG13 ' A' ' 68' ' ' VAL . 58.0 mt -115.48 143.47 45.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.664 -1.153 . . . . 72.099999999999994 110.704 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -97.86 120.81 38.92 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.622 -0.881 . . . . 63.219999999999999 108.622 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.49 111.63 29.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 110.093 -0.336 . . . . 64.120000000000005 110.093 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.78 151.26 17.29 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 121.089 -0.577 . . . . 65.420000000000002 111.713 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.9 44.54 55.53 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.683 -0.77 . . . . 71.120000000000005 113.142 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 HG21 ' A' ' 25' ' ' THR . 84.2 mt -78.08 173.73 11.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.736 -0.468 . . . . 72.140000000000001 109.736 171.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -86.11 -178.16 6.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.026 0.441 . . . . 70.010000000000005 110.012 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -81.02 -9.0 59.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.045 -0.525 . . . . 71.5 110.09 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 19.8 mt-10 -121.81 18.99 11.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.629 0.603 . . . . 72.439999999999998 112.629 -173.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.545 HG21 HD22 ' A' ' 21' ' ' LEU . 28.6 m -78.36 115.33 18.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.875 0.369 . . . . 62.43 110.964 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -97.47 158.76 15.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 110.447 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.668 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 9.6 t0 -59.33 -43.22 92.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.054 0.542 . . . . 32.229999999999997 111.152 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.62 -34.81 77.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.755 . . . . 71.239999999999995 111.543 -175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 m -79.19 -36.37 40.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.452 -0.34 . . . . 64.219999999999999 110.802 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HA ' HG11 ' A' ' 79' ' ' VAL . 50.2 tp -65.52 -51.72 57.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 62.020000000000003 110.013 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.23 -60.55 3.19 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.304 -0.862 . . . . 65.329999999999998 112.117 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 t -48.67 -33.51 10.14 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.809 0.693 . . . . 75.450000000000003 112.843 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.2 t-80 -73.23 -56.12 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.222 -0.191 . . . . 73.239999999999995 110.892 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.45 -23.96 63.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.938 0.347 . . . . 72.540000000000006 111.938 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -57.79 -20.95 39.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.504 0.722 . . . . 72.019999999999996 112.114 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.42 -29.27 69.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.88 0.326 . . . . 73.439999999999998 111.88 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -96.27 -20.82 18.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.689 0.28 . . . . 63.439999999999998 111.203 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.79 164.39 32.77 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.34 -0.933 . . . . 73.439999999999998 112.309 173.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.7 m -62.92 119.79 10.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 71.540000000000006 111.699 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.96 117.04 26.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.739 -0.664 . . . . 72.430000000000007 110.777 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -84.36 -25.71 28.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.037 -0.983 . . . . 74.549999999999997 110.269 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -149.58 150.29 32.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.447 -0.797 . . . . 72.439999999999998 109.486 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.3 t -160.54 138.7 9.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.949 -0.76 . . . . 42.310000000000002 108.949 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.668 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 5.7 p -152.23 122.54 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 121.434 0.635 . . . . 74.010000000000005 111.005 171.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.49 136.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.402 -0.962 . . . . 73.299999999999997 108.402 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.532 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -81.7 100.41 9.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.595 0.712 . . . . 72.019999999999996 110.524 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -101.83 158.11 16.36 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.66 -1.155 . . . . 74.109999999999999 109.205 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.36 132.96 64.62 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.039 -0.356 . . . . 75.120000000000005 110.039 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -22.4 73.18 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.389 2.06 . . . . 43.009999999999998 113.681 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -86.32 -55.71 3.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.288 0.566 . . . . 75.209999999999994 110.792 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -95.84 -14.78 22.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.123 -0.944 . . . . 60.229999999999997 112.346 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm 64.62 26.13 13.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.552 0.741 . . . . 72.439999999999998 111.307 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 23.5 mmm180 -109.18 156.76 19.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.766 -0.457 . . . . 62.32 109.766 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 m -68.37 132.02 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.846 0.355 . . . . 74.109999999999999 111.178 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -85.84 3.18 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.69 -0.686 . . . . 74.510000000000005 111.225 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 11.44 65.47 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.585 -0.817 . . . . 61.229999999999997 114.069 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.5 p90 -153.82 155.75 36.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.784 0.792 . . . . 61.200000000000003 110.712 175.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.16 -169.51 23.55 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.382 -0.687 . . . . 53.539999999999999 111.382 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.23 142.4 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.178 0.489 . . . . 74.109999999999999 110.389 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 m -126.85 128.19 70.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 63.210000000000001 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 m -104.6 122.06 44.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.525 -0.307 . . . . 70.310000000000002 110.239 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 31.9 m-85 -88.73 161.37 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.171 -0.468 . . . . 65.129999999999995 110.483 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.78 83.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.509 -0.769 . . . . 73.109999999999999 110.744 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.6 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 16.5 m -131.12 154.34 48.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.107 -0.497 . . . . 72.5 110.463 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -65.63 -34.0 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 111.658 0.244 . . . . 64.299999999999997 111.658 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.03 -43.7 78.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.967 0.358 . . . . 72.040000000000006 111.967 175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 2.7 mp0 -62.01 -33.23 73.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 72.540000000000006 110.644 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 HD21 ' A' ' 16' ' ' LEU . 42.3 t -64.21 -50.23 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.281 -0.872 . . . . 71.120000000000005 110.97 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.02 -41.1 91.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.248 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.86 67.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.327 -0.397 . . . . 73.439999999999998 112.026 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.23 66.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 71.430000000000007 110.665 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -37.21 86.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 73.310000000000002 111.227 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -28.19 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 62.210000000000001 111.001 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.29 -9.64 54.17 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.741 0.645 . . . . 65.319999999999993 112.741 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 75' ' ' ARG . 24.8 mtp-105 -58.04 146.23 69.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.456 -0.338 . . . . 72.329999999999998 111.501 175.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.01 153.2 99.02 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.967 -1.264 . . . . 64.239999999999995 114.049 3.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -108.65 153.31 23.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.054 -0.976 . . . . 65.150000000000006 110.731 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 13.6 ttmt -136.42 103.16 5.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.037 0.446 . . . . 70.400000000000006 111.198 175.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 30' ' ' LEU . 21.9 t -107.97 131.52 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.613 -0.721 . . . . 72.030000000000001 109.676 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.0 t70 64.91 29.77 12.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.791 0.805 . . . . 55.109999999999999 110.564 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.35 76.34 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.549 -0.75 . . . . 32.43 112.16 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 24.8 tpt180 -125.59 136.94 53.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.884 -0.413 . . . . 73.430000000000007 109.884 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.04 109.52 13.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.776 0.798 . . . . 72.439999999999998 109.623 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.5 m -105.67 152.86 7.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.505 -0.771 . . . . 75.430000000000007 110.787 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -112.07 97.24 37.84 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.423 -0.808 . . . . 73.109999999999999 110.879 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.81 129.63 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.149 1.899 . . . . 74.329999999999998 110.429 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -135.18 179.42 6.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 50.130000000000003 107.781 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 7.8 tpp180 -79.26 162.7 25.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.324 -0.551 . . . . 64.099999999999994 109.667 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.66 93.26 5.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.466 -0.568 . . . . 73.030000000000001 109.466 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.1 154.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.001 -0.999 . . . . 61.109999999999999 111.396 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -59.92 146.98 40.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.59 -0.732 . . . . 60.130000000000003 110.091 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -65.63 -19.17 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.341 -0.39 . . . . 74.239999999999995 111.359 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.39 -39.32 88.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 73.230000000000004 111.65 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.28 -22.02 48.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.226 0.536 . . . . 74.25 110.12 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 20.1 t -70.41 -0.53 8.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.518 -0.765 . . . . 74.200000000000003 111.233 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -71.08 -24.96 62.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 110.222 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -77.78 146.2 72.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 110.216 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.43 114.94 3.82 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.657 2.238 . . . . 74.120000000000005 112.191 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.74 10.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.77 -0.729 . . . . 64.409999999999997 112.185 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -72.79 -27.17 61.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.759 0.314 . . . . 51.200000000000003 111.294 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -99.83 11.85 38.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.359 . . . . 72.030000000000001 111.008 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.16 167.23 19.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.958 -0.756 . . . . 63.539999999999999 108.958 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.8 m -75.55 90.17 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.222 0.534 . . . . 74.319999999999993 111.054 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.49 115.63 50.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.284 -0.871 . . . . 62.329999999999998 109.831 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.52 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.1 mttt -109.11 22.26 16.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 63.039999999999999 110.958 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -123.84 140.44 52.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.459 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 159' ' ' VAL . 9.4 pt -127.79 154.03 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.164 0.507 . . . . 72.150000000000006 111.812 176.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.2 t80 -100.27 137.19 39.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.835 -1.075 . . . . 65.200000000000003 109.384 175.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.03 113.1 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 73.099999999999994 109.533 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.15 152.89 19.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.014 -1.089 . . . . 64.319999999999993 113.072 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.03 6.35 24.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 75.219999999999999 112.61 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.8 pt -79.95 100.36 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.739 0.78 . . . . 63.240000000000002 110.813 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -93.03 3.37 55.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.872 -0.604 . . . . 75.120000000000005 111.193 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.12 165.58 16.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.093 -0.706 . . . . 74.420000000000002 109.093 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.71 99.94 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 72.430000000000007 110.371 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -91.22 139.74 30.45 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.853 -0.612 . . . . 73.239999999999995 109.683 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.46 165.73 10.86 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.502 -0.772 . . . . 70.409999999999997 110.866 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -47.84 84.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.091 -1.413 . . . . 73.400000000000006 108.768 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -55.26 -30.82 60.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.413 -0.812 . . . . 72.299999999999997 111.959 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -66.84 -62.37 1.48 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.213 0.53 . . . . 74.319999999999993 110.844 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.451 HD13 HG22 ' A' ' 151' ' ' VAL . 3.5 pp -82.42 -24.03 34.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.038 -0.665 . . . . 73.540000000000006 111.458 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 121' ' ' LEU . 8.5 tmm_? -66.14 -49.29 67.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.212 -0.292 . . . . 71.420000000000002 110.212 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.33 -30.11 70.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.276 0.56 . . . . 73.420000000000002 110.78 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -80.59 -54.93 5.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 64.450000000000003 112.209 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' A' ' 151' ' ' VAL . 21.0 m-85 -68.38 -22.79 64.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.679 0.622 . . . . 71.049999999999997 112.679 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.66 -23.32 64.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.682 0.277 . . . . 72.010000000000005 111.276 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -60.88 -24.99 66.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 70.450000000000003 111.586 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -85.4 -27.42 25.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.405 . . . . 73.040000000000006 111.365 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.63 -177.8 43.56 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.707 -0.758 . . . . 74.109999999999999 113.223 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -74.11 133.62 42.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.956 0.408 . . . . 70.439999999999998 111.194 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.83 139.37 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.724 -0.671 . . . . 73.200000000000003 109.789 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.93 -50.74 6.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.317 0.58 . . . . 63.119999999999997 110.095 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -156.13 157.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.32 -0.855 . . . . 65.420000000000002 109.638 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -114.5 128.18 71.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.26 0.552 . . . . 62.409999999999997 109.794 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.1 mt-10 -99.46 126.01 45.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.174 -0.921 . . . . 60.340000000000003 110.232 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.5 mm -119.65 114.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.249 -1.019 . . . . 70.340000000000003 108.249 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mmm -91.14 120.42 32.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.399 -0.593 . . . . 73.340000000000003 109.399 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.32 142.8 27.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.145 0.497 . . . . 74.329999999999998 112.172 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 144' ' ' LYS . 9.9 t0 -55.48 121.64 9.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.794 -1.094 . . . . 74.030000000000001 108.748 170.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -71.86 -27.21 62.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.828 0.307 . . . . 72.120000000000005 111.828 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -94.3 -44.11 3.58 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.377 -0.916 . . . . 44.310000000000002 112.611 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.4 m -89.26 -23.85 22.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.82 0.304 . . . . 74.209999999999994 111.82 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.2 24.09 64.45 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.138 -0.553 . . . . 44.020000000000003 113.303 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 18.5 mmmt -100.98 162.64 12.75 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.851 -0.425 . . . . 71.310000000000002 109.851 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.07 82.71 3.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.762 -0.459 . . . . 72.420000000000002 109.762 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -155.4 -179.96 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.375 0.607 . . . . 54.109999999999999 111.856 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.65 3.59 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.593 -1.185 . . . . 63.439999999999998 112.949 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -173.49 158.62 3.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.317 0.558 . . . . 74.200000000000003 109.769 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.04 173.72 11.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.292 -0.632 . . . . 61.039999999999999 109.292 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 36.7 m-85 -138.06 143.94 40.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.298 -0.41 . . . . 70.019999999999996 110.133 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 125' ' ' PHE . 50.7 t -126.96 127.77 70.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 O-C-N 122.002 -0.436 . . . . 71.129999999999995 110.828 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 131' ' ' ILE . 63.5 m -106.89 120.22 41.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.613 -0.721 . . . . 64.409999999999997 111.222 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -103.37 160.81 14.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.295 0.569 . . . . 74.219999999999999 111.7 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.09 -27.26 39.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.029 -0.987 . . . . 74.200000000000003 110.71 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -129.58 155.15 46.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 71.340000000000003 110.685 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.469 ' CD2' HG23 ' A' ' 103' ' ' THR . 21.9 p80 -77.51 -29.05 52.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 73.25 110.631 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 13.5 t0 -56.5 -43.58 79.85 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.799 -1.092 . . . . 65.040000000000006 111.602 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.1 t -63.23 -36.57 84.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.821 -0.627 . . . . 73.239999999999995 111.312 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.52 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.9 t -70.44 -39.99 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.146 0.498 . . . . 63.310000000000002 109.986 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 4.8 t70 -68.76 -33.42 73.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.975 -1.011 . . . . 75.120000000000005 111.032 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.5 mttt -59.04 -40.74 85.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.564 0.697 . . . . 72.430000000000007 110.716 173.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.81 -40.61 46.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.634 -1.167 . . . . 71.010000000000005 111.893 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 30.7 m -78.34 -9.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.064 0.459 . . . . 53.509999999999998 111.102 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.13 -33.1 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.641 -0.709 . . . . 61.43 109.933 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.462 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 49.2 mt-30 -113.89 106.18 14.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.763 -0.653 . . . . 63.409999999999997 109.378 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.31 -34.49 57.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.262 0.838 . . . . 74.219999999999999 113.262 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.62 144.12 50.35 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.006 -0.278 . . . . 75.439999999999998 110.502 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.9 m-70 -132.49 151.81 51.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.936 176.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 130.05 55.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.916 0.389 . . . . 64.450000000000003 110.701 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.63 140.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.872 -0.788 . . . . 61.530000000000001 108.872 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.1 m120 48.45 30.27 2.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.391 0.886 . . . . 64.209999999999994 113.391 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.96 -0.71 89.58 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.907 -0.663 . . . . 63.119999999999997 114.118 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -113.83 135.16 54.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.908 0.854 . . . . 73.439999999999998 110.859 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -99.6 116.49 31.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 65.120000000000005 110.42 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 55.8 m -117.21 157.09 26.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 71.420000000000002 111.096 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.4 141.87 28.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.609 . . . . 60.420000000000002 110.368 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.3 m -131.37 162.14 39.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.956 -0.565 . . . . 72.299999999999997 111.075 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -174.09 171.83 3.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.952 -1.022 . . . . 55.200000000000003 111.687 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -60.79 129.96 44.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.879 -0.601 . . . . 73.129999999999995 110.651 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.12 114.1 25.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.34 0.59 . . . . 74.200000000000003 109.61 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.55 160.57 14.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.273 -0.876 . . . . 64.430000000000007 109.738 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.8 t -63.28 152.67 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.921 -0.77 . . . . 73.239999999999995 108.921 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -60.68 -25.75 66.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.506 0.193 . . . . 74.239999999999995 111.331 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -67.63 -43.75 79.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.807 0.337 . . . . 75.519999999999996 110.426 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -67.32 -42.61 83.33 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 74.140000000000001 110.221 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 23.9 mtt -60.78 -40.62 93.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.269 -0.878 . . . . 71.109999999999999 111.141 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.01 75.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.977 -0.556 . . . . 73.239999999999995 110.399 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m 71.76 -43.84 0.57 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.076 0.95 . . . . 60.200000000000003 112.037 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.96 69.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.736 0.414 . . . . 64.5 110.913 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.2 m -68.42 105.12 2.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.035 -0.529 . . . . 74.439999999999998 109.594 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 m -143.54 162.17 36.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.466 -0.334 . . . . 60.149999999999999 111.057 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 17.3 m -113.02 85.99 2.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.340000000000003 109.709 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.44 -57.43 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.72 -0.673 . . . . 73.109999999999999 109.955 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -152.45 93.06 1.75 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.04 -0.527 . . . . 74.5 110.296 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -84.53 -54.64 2.9 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.15 -1.18 . . . . 62.219999999999999 110.15 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.489 -0.767 . . . . 74.409999999999997 109.039 175.516 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.009 -0.436 . . . . 42.240000000000002 112.009 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.1 m -83.8 82.59 8.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.162 0.506 . . . . 62.509999999999998 110.388 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -148.09 -72.89 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.14 -0.689 . . . . 73.230000000000004 109.14 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -107.14 126.07 51.9 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.607 -0.516 . . . . 61.32 109.607 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -112.7 142.87 44.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.377 . . . . 74.549999999999997 110.667 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m -114.06 95.03 36.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.795 -0.639 . . . . 64.120000000000005 109.406 173.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 94.1 Cg_endo -78.54 166.16 24.28 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.815 2.343 . . . . 74.120000000000005 112.677 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -21.18 22.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 64.329999999999998 110.334 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.43 ' OE2' HG12 ' A' ' 65' ' ' VAL . 1.8 mp0 -71.67 132.05 85.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.708 . . . . 74.310000000000002 110.627 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' HD22 ' A' ' 13' ' ' LEU . 26.1 Cg_endo -66.99 166.36 23.11 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.756 2.304 . . . . 73.239999999999995 111.134 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.9 pt-20 -60.05 -32.9 71.35 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 119.559 -0.257 . . . . 63.149999999999999 111.686 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.42 -25.04 61.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.654 0.264 . . . . 73.239999999999995 111.602 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.1 mp -87.53 -8.69 56.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.705 0.288 . . . . 74.049999999999997 111.064 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -125.79 2.95 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.481 -0.327 . . . . 75.109999999999999 111.078 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 15.1 ttmm -93.47 146.21 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.54 0.686 . . . . 73.109999999999999 111.502 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -119.48 141.3 49.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.491 -1.231 . . . . 54.200000000000003 110.079 177.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -98.33 116.04 29.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.784 -0.821 . . . . 54.409999999999997 108.784 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 60' ' ' VAL . 18.0 mm -93.13 110.85 23.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.999 -0.371 . . . . 71.200000000000003 109.999 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.23 152.2 17.99 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.834 -0.698 . . . . 64.209999999999994 111.679 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.6 41.77 56.53 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.019 -0.61 . . . . 63.119999999999997 113.618 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 25' ' ' THR . 49.8 mt -75.84 175.15 9.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.92 0.36 . . . . 75.519999999999996 110.382 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.3 p -88.15 172.33 9.57 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.516 -0.55 . . . . 43.530000000000001 109.516 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.04 -5.6 47.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.648 0.261 . . . . 63.229999999999997 111.176 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.88 21.67 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.105 0.409 . . . . 65.140000000000001 112.105 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.578 HG21 HD22 ' A' ' 21' ' ' LEU . 14.5 m -75.16 121.74 22.55 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 71.099999999999994 110.557 175.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -99.11 154.64 17.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.885 -0.413 . . . . 71.329999999999998 109.885 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.532 ' HA ' HG23 ' A' ' 45' ' ' VAL . 10.7 p-10 -64.86 -35.24 80.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 74.25 111.356 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.96 -36.77 80.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 74.420000000000002 111.211 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -76.87 -34.43 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 75.219999999999999 110.734 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 45' ' ' VAL . 34.9 tp -65.88 -42.87 89.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.035 -0.53 . . . . 62.439999999999998 109.862 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 19.2 ttm-85 -60.03 -57.97 10.53 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.393 -0.367 . . . . 64.310000000000002 110.127 176.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -50.06 -36.87 30.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.151 -0.931 . . . . 74.329999999999998 112.926 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -70.89 -58.38 3.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.433 -0.349 . . . . 75.099999999999994 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -70.53 -22.48 62.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.196 0.443 . . . . 74.200000000000003 112.196 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.1 tt0 -63.39 -17.81 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.095 0.558 . . . . 63.130000000000003 111.898 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.35 -28.43 69.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.389 -0.368 . . . . 64.349999999999994 111.343 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.14 -21.73 14.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 60.310000000000002 111.567 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -166.71 154.16 24.42 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.48 -0.867 . . . . 62.310000000000002 112.027 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -65.22 117.76 8.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 65.109999999999999 111.408 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 31' ' ' ARG . 57.2 mt -86.85 134.65 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.565 0.698 . . . . 73.010000000000005 111.4 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.189 -0.914 . . . . 64.319999999999993 110.254 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -151.16 152.3 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.618 -0.719 . . . . 33.420000000000002 109.956 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -161.73 133.65 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.021 -0.363 . . . . 71.450000000000003 110.021 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.31 125.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.311 0.577 . . . . 53.229999999999997 110.734 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 27' ' ' ASP . 96.1 t -86.83 131.41 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.577 -0.897 . . . . 71.439999999999998 108.577 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.12 95.3 6.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.651 0.738 . . . . 75.310000000000002 110.439 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -101.04 166.94 10.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.592 -1.185 . . . . 75.329999999999998 109.637 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.74 126.18 86.22 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.126 -0.694 . . . . 65.299999999999997 109.126 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.31 -23.85 75.51 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.216 1.944 . . . . 73.319999999999993 113.929 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.68 -55.85 3.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.096 0.406 . . . . 74.319999999999993 112.096 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -101.57 -11.19 19.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.93 0.395 . . . . 70.439999999999998 111.945 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm 66.17 34.89 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.512 -0.767 . . . . 74.540000000000006 111.525 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -97.64 140.03 32.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.952 -0.759 . . . . 71.519999999999996 108.952 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -70.49 133.03 46.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.987 0.422 . . . . 74.510000000000005 110.379 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.42 -0.6 37.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.685 -0.689 . . . . 74.230000000000004 110.616 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.52 55.93 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.913 -0.66 . . . . 64.150000000000006 113.716 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -158.85 158.58 33.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.937 0.869 . . . . 71.230000000000004 110.942 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.65 -166.75 20.06 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.849 -0.9 . . . . 74.109999999999999 110.849 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.62 151.26 42.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.427 0.614 . . . . 72.0 110.603 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -133.12 122.95 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.627 -0.715 . . . . 63.549999999999997 109.172 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.3 m -99.15 118.59 36.22 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.457 -0.572 . . . . 74.340000000000003 109.457 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 25.4 m-85 -84.5 169.49 14.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.364 . . . . 73.049999999999997 110.67 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.539 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -72.7 -50.13 26.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.145 -0.48 . . . . 54.030000000000001 109.927 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.37 155.51 37.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.598 -0.728 . . . . 65.310000000000002 110.215 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -63.85 -32.86 58.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.796 0.331 . . . . 72.430000000000007 110.31 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.69 -34.82 71.72 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.862 0.69 . . . . 63.140000000000001 112.862 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 7.2 mm-40 -62.01 -36.19 80.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 71.409999999999997 109.684 175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 4.0 t -64.31 -44.6 97.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.131 -0.94 . . . . 72.310000000000002 111.131 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.81 -43.24 99.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 73.430000000000007 111.04 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . . . -53.91 -38.37 64.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.64 0.608 . . . . 65.299999999999997 112.64 171.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.82 65.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.449 0.643 . . . . 64.109999999999999 109.948 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mmt -70.79 -39.54 73.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 71.25 112.124 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -79.14 -11.93 59.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.076 0.465 . . . . 75.420000000000002 110.442 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.45 -16.24 33.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 71.329999999999998 111.02 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -56.41 149.4 38.83 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 112.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.75 168.18 73.68 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.335 -1.527 . . . . 75.409999999999997 113.749 2.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -119.21 153.07 35.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.66 -0.7 . . . . 70.409999999999997 111.004 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.6 ttmt -139.5 108.94 6.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 52.149999999999999 111.092 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -121.38 137.18 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.716 -0.675 . . . . 74.120000000000005 109.603 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 66.11 21.69 11.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.774 0.829 . . . . 72.530000000000001 110.872 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.91 23.88 68.23 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.904 -0.589 . . . . 64.519999999999996 111.916 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.1 tpt180 -126.46 134.99 50.81 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.324 -0.251 . . . . 72.200000000000003 110.324 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.36 119.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.1 -0.704 . . . . 71.310000000000002 109.1 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 m -108.14 154.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.906 -0.588 . . . . 72.450000000000003 111.779 -172.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -113.5 93.93 29.71 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.959 -1.019 . . . . 74.230000000000004 110.611 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.428 ' O ' ' HE1' ' A' ' 156' ' ' HIS . 6.2 Cg_endo -77.16 128.32 9.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 70.209999999999994 110.716 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -126.28 168.8 13.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.257 -0.645 . . . . 70.200000000000003 109.257 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.676 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.1 tpp180 -75.59 128.65 35.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.122 -0.696 . . . . 74.140000000000001 109.122 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.0 99.78 1.49 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.399 0.619 . . . . 72.439999999999998 110.756 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.463 ' CG2' HG23 ' A' ' 163' ' ' VAL . 12.8 p -73.2 157.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.024 -0.989 . . . . 62.310000000000002 109.804 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -54.7 147.65 14.24 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 122.626 0.37 . . . . 74.219999999999999 110.585 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.504 0.927 . . . . 74.019999999999996 113.504 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.35 -38.23 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 75.310000000000002 110.995 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.42 -46.1 11.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 53.340000000000003 109.931 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 t -57.76 -26.04 61.29 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.556 -0.747 . . . . 51.240000000000002 112.29 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -69.16 -21.48 63.99 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.325 -0.398 . . . . 73.030000000000001 111.82 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -85.19 143.99 40.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.030000000000001 110.852 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.06 123.26 9.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 74.25 112.268 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 3.3 71.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.799 -0.715 . . . . 62.229999999999997 112.51 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.97 -52.14 8.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.691 0.256 . . . . 72.540000000000006 111.691 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 21.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 63.149999999999999 111.051 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -178.8 6.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.796 -0.816 . . . . 70.329999999999998 108.796 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.408 HG23 ' CD2' ' A' ' 156' ' ' HIS . 1.9 m -72.61 99.75 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.335 0.588 . . . . 73.319999999999993 111.041 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -126.55 111.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 71.540000000000006 109.757 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.424 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.6 mttt -107.02 14.69 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.034 -0.417 . . . . 72.420000000000002 111.116 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 139.56 51.05 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.342 -0.224 . . . . 72.340000000000003 110.946 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.89 151.7 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.352 0.596 . . . . 75.129999999999995 111.595 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -96.91 139.44 32.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.726 -1.124 . . . . 72.109999999999999 109.99 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.0 110.38 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.331 -0.618 . . . . 44.240000000000002 109.331 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.51 158.82 21.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.013 -1.089 . . . . 50.310000000000002 113.358 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.0 8.37 45.08 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.832 -0.699 . . . . 72.109999999999999 112.055 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.45 66.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 122.112 0.958 . . . . 62.25 110.512 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -65.3 -34.01 77.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 73.510000000000005 109.442 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -83.11 145.72 29.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.799 -1.091 . . . . 74.450000000000003 108.558 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.24 123.5 16.92 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.064 0.459 . . . . 71.140000000000001 112.203 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -128.08 139.98 52.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.597 -0.729 . . . . 64.510000000000005 110.084 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.25 167.63 10.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.337 -0.847 . . . . 74.219999999999999 111.642 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.53 -45.35 85.13 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.429 -0.805 . . . . 52.030000000000001 110.619 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -55.77 -34.48 65.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.473 0.483 . . . . 71.230000000000004 111.562 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -64.4 -60.79 2.75 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.381 -0.372 . . . . 74.109999999999999 111.507 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.473 HD21 HG21 ' A' ' 134' ' ' ILE . 2.4 pt? -82.41 -24.65 34.27 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 119.962 -0.695 . . . . 63.310000000000002 110.814 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -63.23 -54.65 34.04 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 110.108 -0.33 . . . . 63.409999999999997 110.108 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -27.89 69.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.984 0.421 . . . . 73.540000000000006 110.859 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.46 ' CD2' HG22 ' A' ' 170' ' ' VAL . 75.8 t80 -78.36 -53.87 6.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.83 -0.623 . . . . 74.209999999999994 111.619 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.0 m-85 -68.72 -22.77 64.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.622 0.249 . . . . 73.230000000000004 111.506 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.71 -26.33 68.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.236 0.541 . . . . 73.420000000000002 110.884 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.28 -30.62 71.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 74.230000000000004 111.633 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.1 -23.77 32.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.499 -0.319 . . . . 74.510000000000005 111.012 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.92 -176.65 42.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 72.010000000000005 112.928 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -73.37 130.7 40.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.15 0.5 . . . . 71.219999999999999 110.871 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 152' ' ' THR . 62.1 mt -101.25 139.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.636 -0.711 . . . . 71.349999999999994 109.939 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.19 -49.91 6.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.817 0.341 . . . . 74.239999999999995 110.583 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.45 155.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 61.329999999999998 109.929 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.473 HG21 HD21 ' A' ' 121' ' ' LEU . 4.2 mp -116.24 126.31 73.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.288 -0.634 . . . . 73.219999999999999 109.288 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.4 mt-10 -98.65 104.53 16.57 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 70.230000000000004 110.994 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.1 116.01 35.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.442 -0.577 . . . . 63.210000000000001 109.442 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 69.0 mmm -87.72 119.28 27.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.861 -0.609 . . . . 72.120000000000005 109.994 -175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.03 156.36 38.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 63.409999999999997 110.704 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.07 132.16 34.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.003 -0.544 . . . . 74.25 109.774 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -79.89 -29.99 40.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.336 -0.393 . . . . 63.350000000000001 111.496 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.43 -53.56 4.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.392 -0.909 . . . . 64.450000000000003 113.164 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.8 m -99.63 -11.77 20.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.029 0.381 . . . . 71.010000000000005 112.029 -175.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.28 28.65 65.66 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.727 -0.749 . . . . 53.539999999999999 113.163 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -104.93 159.15 16.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.268 -0.641 . . . . 73.310000000000002 109.268 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -69.04 145.01 53.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.26 -0.644 . . . . 62.210000000000001 109.26 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -70.41 -3.09 15.93 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.185 0.809 . . . . 71.099999999999994 113.185 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.0 3.12 89.33 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.247 -0.978 . . . . 73.530000000000001 112.385 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -157.88 158.0 34.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.548 -0.538 . . . . 73.319999999999993 109.548 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.85 176.3 8.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.706 -0.679 . . . . 53.229999999999997 109.829 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.9 m-85 -139.53 152.67 47.1 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.591 -0.731 . . . . 74.230000000000004 109.186 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 107' ' ' ILE . 3.1 p -144.22 133.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.424 0.631 . . . . 61.439999999999998 111.169 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 131' ' ' ILE . 41.1 m -103.26 126.01 50.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.074 -0.966 . . . . 72.140000000000001 110.856 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 7.6 m-85 -100.82 158.45 15.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.06 0.457 . . . . 62.43 111.412 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.75 -28.94 44.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.479 -0.782 . . . . 61.530000000000001 110.293 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.0 151.36 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 75.120000000000005 110.842 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.428 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 24.2 p80 -80.17 -27.35 38.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 64.400000000000006 110.777 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 29.6 t70 -58.28 -40.36 81.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.708 -0.678 . . . . 64.409999999999997 111.067 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.2 m -67.56 -30.97 70.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 73.310000000000002 111.508 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -72.95 -42.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.484 -0.325 . . . . 72.319999999999993 110.471 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 1.8 m-20 -68.36 -24.06 64.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.925 -0.58 . . . . 51.119999999999997 111.424 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 81.9 mttt -63.66 -42.6 98.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.728 0.775 . . . . 65.299999999999997 110.177 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -74.15 -42.71 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 73.230000000000004 111.663 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.587 HG21 ' HD3' ' A' ' 179' ' ' LYS . 29.4 m -79.93 -2.16 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.064 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 5.7 mt -63.07 -28.87 45.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.945 0.878 . . . . 53.32 109.046 167.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.579 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 49.2 mt-30 -111.47 145.39 39.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.857 -1.164 . . . . 75.200000000000003 107.857 174.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -91.77 -32.43 15.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.327 0.584 . . . . 73.349999999999994 110.684 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -124.69 137.98 54.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.713 -0.676 . . . . 74.549999999999997 109.951 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.579 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 42.8 m-70 -127.41 142.54 51.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.902 0.382 . . . . 72.439999999999998 110.615 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -94.77 110.36 22.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.982 -0.554 . . . . 73.5 111.036 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 124' ' ' TYR . 21.7 t -111.04 127.79 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.326 -0.852 . . . . 75.400000000000006 109.222 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.2 t30 42.55 48.98 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.666 0.617 . . . . 53.5 112.666 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.24 0.98 48.47 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.125 -0.56 . . . . 74.230000000000004 114.055 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.83 121.96 45.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.932 -0.396 . . . . 73.439999999999998 109.932 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.49 110.11 19.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.169 0.509 . . . . 61.25 110.887 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.55 156.99 18.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.498 -0.774 . . . . 71.430000000000007 110.414 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.46 141.54 28.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.289 -0.263 . . . . 75.219999999999999 110.289 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 m -131.97 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.943 0.401 . . . . 55.310000000000002 110.793 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -175.43 170.77 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.021 -0.991 . . . . 70.299999999999997 111.287 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 163' ' ' VAL . 5.8 mmmm -63.54 132.7 52.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 63.049999999999997 110.501 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.94 127.23 52.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.358 0.599 . . . . 73.120000000000005 110.211 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.408 ' HB2' ' CG ' ' A' ' 186' ' ' MET . 17.8 mt -111.27 164.66 12.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.265 -0.879 . . . . 75.519999999999996 108.906 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 61.9 p -61.83 161.92 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.829 -0.434 . . . . 75.420000000000002 109.829 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.32 -26.35 68.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.17 -0.212 . . . . 75.140000000000001 111.338 -176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -63.7 -35.64 81.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.126 0.489 . . . . 55.100000000000001 110.983 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.98 -45.51 13.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.832 -0.622 . . . . 72.430000000000007 111.349 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.408 ' CG ' ' HB2' ' A' ' 181' ' ' LEU . 42.9 mtp -75.59 -59.51 2.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 71.209999999999994 111.554 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -84.96 -42.84 14.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 65.25 111.138 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.5 m 64.4 20.69 12.25 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.958 0.786 . . . . 64.420000000000002 111.138 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.26 160.08 32.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 62.329999999999998 110.06 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 p -69.17 140.8 54.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.788 0.327 . . . . 74.430000000000007 111.05 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.6 t -79.12 110.54 14.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.133 -0.485 . . . . 75.400000000000006 110.357 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.0 m -100.29 101.78 12.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.066 -0.516 . . . . 41.420000000000002 110.577 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -71.9 128.03 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 110.43 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -70.54 159.79 33.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 62.140000000000001 110.73 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.56 -78.09 0.53 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.63 -0.795 . . . . 62.409999999999997 111.517 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 . . . . . 0 C--O 1.241 0.648 0 CA-C-O 118.62 -0.705 . . . . 75.230000000000004 109.402 177.822 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.108 -0.397 . . . . 61.020000000000003 112.108 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -60.98 -53.42 57.48 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.951 0.405 . . . . 75.219999999999999 110.887 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.65 93.93 9.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.175 0.512 . . . . 73.140000000000001 109.683 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -91.35 131.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 74.299999999999997 110.731 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.9 30.5 20.25 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.6 -0.727 . . . . 73.150000000000006 111.173 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m -129.23 79.92 73.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.992 -0.549 . . . . 64.439999999999998 110.157 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.664 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 19.8 Cg_exo -70.97 165.48 32.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.547 2.831 . . . . 60.549999999999997 112.56 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -108.12 14.79 24.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.9 -0.591 . . . . 73.5 110.224 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.39 134.99 20.81 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 73.109999999999999 110.355 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 13' ' ' LEU . 29.0 Cg_endo -65.82 167.19 18.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.775 2.317 . . . . 74.140000000000001 112.027 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -40.09 70.2 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.425 0.528 . . . . 71.510000000000005 112.425 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.15 -27.37 67.97 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.163 0.431 . . . . 63.409999999999997 112.163 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.4 mp -78.99 -22.44 45.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.559 0.218 . . . . 74.219999999999999 111.26 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.5 ptt180 -120.2 -0.97 10.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.279 0.474 . . . . 74.340000000000003 112.279 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 33.1 ttpt -94.67 143.8 26.14 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.574 0.702 . . . . 74.400000000000006 111.822 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD21 HG13 ' A' ' 68' ' ' VAL . 65.9 mt -115.65 145.65 42.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.694 -1.139 . . . . 53.32 109.909 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -96.27 134.3 39.56 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.275 -1.009 . . . . 74.329999999999998 108.275 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 60' ' ' VAL . 19.6 mm -110.84 112.04 38.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.905 -0.406 . . . . 70.209999999999994 109.905 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.96 153.51 17.08 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.301 -0.952 . . . . 74.209999999999994 111.592 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.87 40.19 52.91 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 75.540000000000006 113.675 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 25' ' ' THR . 51.8 mt -78.27 177.02 8.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.956 -0.387 . . . . 53.299999999999997 109.956 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -84.13 -179.42 7.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.899 0.38 . . . . 72.230000000000004 110.099 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -84.1 -9.16 58.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.349 0.595 . . . . 71.420000000000002 109.851 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.03 20.37 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.791 -0.64 . . . . 75.140000000000001 111.786 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.478 HG21 HD22 ' A' ' 21' ' ' LEU . 27.1 m -75.62 131.53 40.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.811 0.339 . . . . 74.040000000000006 111.047 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 p -114.41 160.64 18.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 61.439999999999998 110.531 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 1.9 m-20 -62.59 -38.62 90.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 73.319999999999993 110.616 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.48 -42.14 98.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.381 -0.827 . . . . 61.119999999999997 111.353 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -75.87 -37.76 58.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.024 -0.534 . . . . 60.329999999999998 110.716 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.25 -43.59 90.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 64.519999999999996 110.454 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -60.46 -54.95 39.39 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.092 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -47.41 -39.72 16.08 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.302 1.001 . . . . 75.019999999999996 113.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -68.47 -61.27 1.9 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 75.040000000000006 110.967 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -71.08 -24.51 62.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.137 0.421 . . . . 73.150000000000006 112.137 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.1 tt0 -62.49 -21.08 65.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.28 -0.418 . . . . 73.0 111.837 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -62.1 -27.53 68.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.723 0.297 . . . . 75.129999999999995 111.461 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -98.05 -24.36 15.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.407 -0.361 . . . . 72.019999999999996 111.259 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.5 166.47 39.2 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.173 -1.013 . . . . 53.009999999999998 112.834 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -61.49 141.19 57.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.077 0.551 . . . . 73.209999999999994 111.369 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 mt -118.5 123.3 44.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.362 -0.607 . . . . 52.039999999999999 109.362 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -90.13 -25.1 20.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.087 -0.506 . . . . 74.120000000000005 110.295 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.34 152.16 31.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.488 -0.778 . . . . 65.209999999999994 109.864 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.6 t -160.15 123.99 3.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.294 -0.632 . . . . 71.409999999999997 109.294 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.411 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 p -143.26 118.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.516 0.674 . . . . 70.150000000000006 110.431 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 133.12 31.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 107.917 -1.142 . . . . 72.329999999999998 107.917 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.5 mmt -77.78 96.86 5.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.623 0.725 . . . . 51.329999999999998 110.236 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -96.81 161.27 13.93 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.423 -1.262 . . . . 51.450000000000003 108.975 175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.94 125.54 92.02 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.221 -0.659 . . . . 53.32 109.221 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.47 -20.94 53.98 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.573 1.515 . . . . 73.099999999999994 112.982 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -86.65 -55.63 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 72.519999999999996 111.223 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -16.48 23.56 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.917 -0.583 . . . . 74.129999999999995 112.18 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp 65.74 29.12 10.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.926 0.89 . . . . 73.099999999999994 111.925 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -107.35 155.14 20.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.02 -0.733 . . . . 71.349999999999994 109.02 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 t -71.05 135.46 47.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.911 0.386 . . . . 75.230000000000004 111.16 -173.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -87.38 5.27 39.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 73.120000000000005 110.775 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.52 70.62 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.864 -0.684 . . . . 51.310000000000002 114.175 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 25.5 p90 -156.0 156.41 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.04 0.92 . . . . 75.510000000000005 110.801 174.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.05 -165.15 17.25 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.639 -0.585 . . . . 41.350000000000001 111.639 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.51 145.65 31.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.973 0.387 . . . . 74.109999999999999 109.99 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 HD11 ' A' ' 18' ' ' ILE . 8.8 m -128.26 119.87 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 63.030000000000001 110.2 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.5 m -95.69 122.29 38.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.052 -0.351 . . . . 72.150000000000006 110.052 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -85.63 170.24 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 72.019999999999996 110.106 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -74.29 -52.57 11.89 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.671 -0.492 . . . . 74.120000000000005 109.671 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -122.37 150.29 42.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 74.409999999999997 110.502 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -63.81 -35.43 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.576 0.227 . . . . 72.239999999999995 111.263 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -52.29 -41.35 62.83 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.767 0.654 . . . . 74.209999999999994 112.767 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 47.4 mt-10 -68.74 -28.39 66.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.189 0.518 . . . . 62.399999999999999 110.726 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 14' ' ' ARG . 25.0 t -65.31 -45.39 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.418 -0.81 . . . . 72.209999999999994 111.083 175.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.81 -45.01 86.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.544 . . . . 62.530000000000001 110.912 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.1 -41.52 60.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 74.010000000000005 112.095 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -37.7 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 71.040000000000006 110.977 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.5 mmt -68.61 -32.95 73.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.059 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -10.07 55.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.049 -0.523 . . . . 64.230000000000004 110.851 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.56 -9.27 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.264 0.554 . . . . 71.150000000000006 110.265 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp180 -53.39 142.48 39.45 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.818 -1.083 . . . . 61.119999999999997 111.327 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 6.1 Cg_exo -78.49 168.75 74.58 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.647 -0.981 . . . . 65.430000000000007 113.385 3.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -124.96 155.02 40.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.146 -0.933 . . . . 74.430000000000007 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.7 ttmt -132.79 106.94 8.04 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.84 0.352 . . . . 75.310000000000002 111.22 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.82 127.31 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 61.399999999999999 110.04 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.8 t70 67.15 29.94 7.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.759 0.79 . . . . 72.319999999999993 110.561 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.13 67.34 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.629 -0.714 . . . . 64.040000000000006 111.91 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.8 tpt180 -130.81 139.19 50.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.136 -0.32 . . . . 72.129999999999995 110.136 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.33 113.14 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.087 -0.708 . . . . 71.150000000000006 109.087 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.83 149.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.425 0.631 . . . . 65.409999999999997 111.182 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -112.93 96.64 38.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.027 -0.988 . . . . 74.049999999999997 110.662 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.85 138.3 18.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.309 2.006 . . . . 64.409999999999997 112.136 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -132.96 168.67 18.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.113 -1.44 . . . . 62.140000000000001 107.113 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.442 HH11 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -83.31 142.25 31.22 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.867 -0.733 . . . . 71.349999999999994 109.101 173.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.73 92.15 1.97 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.29 0.567 . . . . 60.399999999999999 109.621 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.36 158.06 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.863 -1.062 . . . . 64.340000000000003 110.457 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -52.9 145.21 13.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.849 -0.614 . . . . 52.009999999999998 110.619 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.48 -41.61 30.23 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.489 0.922 . . . . 74.329999999999998 113.489 -168.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.16 -51.4 67.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.427 0.156 . . . . 70.519999999999996 111.26 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.0 -29.68 66.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.417 -0.356 . . . . 55.450000000000003 110.398 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -64.19 -18.43 64.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 73.209999999999994 111.539 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -96.42 -2.63 45.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.066 0.46 . . . . 71.0 110.73 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -88.91 151.47 47.28 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.405 -0.361 . . . . 74.420000000000002 111.039 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.01 118.55 5.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.711 2.274 . . . . 62.119999999999997 112.16 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.96 21.11 31.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.852 -0.69 . . . . 64.430000000000007 112.468 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.72 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.049 0.452 . . . . 72.030000000000001 111.928 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -104.62 25.67 10.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.081 -0.509 . . . . 62.030000000000001 111.409 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.39 -171.9 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.976 -0.557 . . . . 72.019999999999996 109.809 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 58.87 3.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.616 . . . . 73.099999999999994 110.794 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.97 107.96 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 74.510000000000005 110.181 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.467 ' C ' HG21 ' A' ' 159' ' ' VAL . 63.4 mttt -111.02 14.95 21.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.034 0.445 . . . . 51.140000000000001 110.343 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.58 140.87 47.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.271 -0.422 . . . . 72.200000000000003 110.229 178.265 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 159' ' ' VAL . 3.6 pt -129.25 149.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 64.040000000000006 111.399 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.9 t80 -97.24 133.16 42.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.086 -0.961 . . . . 75.109999999999999 109.189 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.63 110.02 24.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.23 147.95 16.92 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.034 -1.079 . . . . 65.239999999999995 113.074 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.56 22.22 8.7 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.835 -0.698 . . . . 43.420000000000002 112.158 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.7 pt -91.18 77.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.909 0.861 . . . . 74.439999999999998 110.458 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -66.71 -50.84 61.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.054 -0.975 . . . . 72.329999999999998 111.051 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.12 155.19 40.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.618 -0.512 . . . . 73.019999999999996 109.618 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.42 99.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.404 0.621 . . . . 52.240000000000002 110.884 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.5 m -97.53 134.01 41.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.229 -0.896 . . . . 64.219999999999999 109.719 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 120' ' ' HIS . 61.8 mt-10 -110.64 167.16 10.44 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.736 -1.12 . . . . 75.25 110.408 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 121' ' ' LEU . 26.9 tt0 -59.73 -46.04 90.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.823 . . . . 74.450000000000003 111.548 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -69.36 -22.03 63.77 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.888 -0.325 . . . . 71.510000000000005 111.484 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 61.2 m170 -61.49 -60.16 4.13 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.781 0.324 . . . . 53.32 110.532 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 118' ' ' GLU . 1.9 pt? -84.2 -21.07 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.292 -0.563 . . . . 45.25 111.143 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -65.94 -52.87 45.97 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.853 -0.425 . . . . 71.310000000000002 109.853 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -31.9 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.344 0.593 . . . . 72.219999999999999 110.416 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.406 ' OH ' ' HB3' ' A' ' 168' ' ' HIS . 83.1 t80 -72.6 -58.66 3.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.211 -0.904 . . . . 75.25 112.088 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.9 m-85 -66.43 -21.12 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.901 0.334 . . . . 73.549999999999997 111.901 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.39 -25.37 67.53 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.471 0.308 . . . . 73.129999999999995 111.31 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.16 -31.51 63.44 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.129 -0.487 . . . . 75.219999999999999 111.304 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.59 -28.56 23.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 52.539999999999999 111.941 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.9 -172.85 45.35 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.384 -0.912 . . . . 62.409999999999997 113.654 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -76.42 128.55 35.03 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.131 0.491 . . . . 73.5 111.683 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 61.3 mt -100.87 137.6 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 32.32 109.994 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -86.88 -52.19 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 73.109999999999999 110.428 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.15 155.74 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.321 -0.4 . . . . 64.299999999999997 110.209 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.89 129.01 72.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.239 0.542 . . . . 74.409999999999997 109.935 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.71 104.22 14.53 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.648 -0.706 . . . . 73.049999999999997 110.977 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.2 mm -90.8 120.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.976 -0.749 . . . . 72.319999999999993 108.976 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.427 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 71.9 mmm -94.88 113.88 25.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.748 0.785 . . . . 75.129999999999995 110.392 -175.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 145' ' ' LYS . 0.7 OUTLIER -137.74 165.4 26.52 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.846 -1.07 . . . . 73.230000000000004 109.794 -178.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.78 103.74 16.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.629 -1.249 . . . . 51.43 107.629 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -65.44 -24.13 67.11 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.159 0.429 . . . . 71.230000000000004 112.159 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.33 -52.79 8.23 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 51.310000000000002 112.959 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.1 m -95.7 -22.69 17.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.126 0.417 . . . . 72.530000000000001 112.126 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 27.23 26.27 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.993 -0.622 . . . . 50.310000000000002 112.086 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -95.87 146.95 24.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 74.340000000000003 111.405 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 138' ' ' THR . 44.5 mtmt -72.01 139.72 48.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 74.299999999999997 109.954 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 2.8 mmp_? -91.64 2.62 56.34 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.592 -0.443 . . . . 65.109999999999999 112.071 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.97 78.19 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.812 -0.709 . . . . 61.399999999999999 114.303 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -155.48 157.5 37.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.595 0.697 . . . . 74.310000000000002 110.259 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.24 177.13 8.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 35.219999999999999 109.899 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -140.87 149.15 41.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.691 -0.686 . . . . 74.519999999999996 109.713 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.449 HG21 ' CD2' ' A' ' 125' ' ' PHE . 66.7 t -133.75 130.9 56.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.464 -0.334 . . . . 73.0 110.77 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.436 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 60.0 m -103.49 125.37 50.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.689 -0.687 . . . . 72.439999999999998 110.616 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.56 162.66 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.987 0.422 . . . . 72.219999999999999 111.208 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.75 -29.34 29.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.591 -0.732 . . . . 71.0 110.253 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.92 144.51 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 74.109999999999999 110.279 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -72.24 -26.53 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 74.109999999999999 110.129 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -55.44 -44.74 76.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.106 -0.952 . . . . 65.200000000000003 111.399 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -71.56 -33.35 69.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.037 -0.528 . . . . 71.439999999999998 111.212 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.467 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.87 -38.49 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.868 0.365 . . . . 55.140000000000001 110.088 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.447 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.7 t70 -67.05 -34.23 77.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.521 -0.763 . . . . 74.040000000000006 110.841 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.7 mttt -56.58 -40.87 75.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 110.349 172.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.5 mt -73.54 -45.43 51.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.397 -1.274 . . . . 75.109999999999999 112.286 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 160' ' ' ASP . 15.8 m -75.11 -10.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.24 0.543 . . . . 63.210000000000001 111.027 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.456 HD13 HD12 ' A' ' 13' ' ' LEU . 14.1 mt -61.96 -31.9 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.139 -0.937 . . . . 73.299999999999997 109.971 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 64.6 mt-30 -107.84 104.1 13.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.82 -0.807 . . . . 41.210000000000001 108.82 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -54.08 -35.0 61.61 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.714 0.635 . . . . 64.200000000000003 112.714 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -122.15 138.45 54.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.888 0.375 . . . . 73.349999999999994 111.208 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -130.18 146.36 51.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 73.140000000000001 110.152 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -104.04 115.01 29.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 74.540000000000006 111.05 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.9 p -141.43 146.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.626 -0.715 . . . . 70.430000000000007 109.187 177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 58.33 29.52 18.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.343 1.068 . . . . 62.140000000000001 110.54 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.2 0.87 84.49 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.212 -0.904 . . . . 65.239999999999995 113.253 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -121.59 133.59 55.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.071 0.463 . . . . 74.219999999999999 111.068 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.08 108.55 18.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 62.009999999999998 109.715 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.2 p -113.11 157.17 21.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 50.149999999999999 110.677 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -85.76 134.05 33.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.959 0.409 . . . . 71.040000000000006 110.072 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.0 t -130.44 132.46 64.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.564 -0.744 . . . . 70.510000000000005 109.799 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -153.73 173.8 15.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.789 -0.641 . . . . 65.430000000000007 110.994 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -64.56 131.54 47.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.129 0.49 . . . . 73.200000000000003 111.3 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -122.92 118.56 28.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.715 -0.846 . . . . 65.430000000000007 108.715 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.4 mt -74.51 123.85 25.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.756 -0.461 . . . . 72.109999999999999 109.756 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 186' ' ' MET . 48.0 t -65.79 161.95 19.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 109.937 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.71 -31.78 69.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.144 0.497 . . . . 63.219999999999999 110.31 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -61.06 -37.04 81.25 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.237 -0.892 . . . . 71.230000000000004 110.7 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -84.37 -43.01 15.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.112 -0.494 . . . . 73.430000000000007 111.569 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' SER . 77.6 mtp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.993 -0.549 . . . . 75.430000000000007 111.127 -176.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -84.54 -12.9 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 64.310000000000002 110.558 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.8 m 60.76 30.19 19.51 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.47 -0.786 . . . . 52.329999999999998 110.225 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.19 138.15 12.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.708 -1.133 . . . . 73.019999999999996 109.35 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m -87.61 155.81 19.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 110.135 -0.32 . . . . 72.420000000000002 110.135 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.2 t -80.77 134.24 35.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.778 0.323 . . . . 44.210000000000001 110.599 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.9 t -80.59 103.66 10.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 62.539999999999999 109.226 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -123.78 134.34 53.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.002 -0.545 . . . . 53.219999999999999 110.306 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.62 88.49 5.04 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 75.099999999999994 109.667 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 156.21 -153.55 24.82 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.106 -0.568 . . . . 75.019999999999996 111.747 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.397 -0.811 . . . . 70.129999999999995 109.946 -179.47 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.523 -0.231 . . . . 74.450000000000003 112.523 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.4 m 57.59 70.34 0.66 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.573 0.749 . . . . 71.430000000000007 112.517 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 61.6 26.13 15.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.558 -0.747 . . . . 75.239999999999995 112.907 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 p -72.77 -21.65 60.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.582 0.706 . . . . 63.25 109.201 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.79 171.24 13.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.813 -1.085 . . . . 71.129999999999995 108.922 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 t -134.25 90.83 24.33 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.663 -0.415 . . . . 51.329999999999998 111.339 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.57 136.74 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.198 1.932 . . . . 53.5 111.089 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.18 1.68 12.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.337 0.589 . . . . 61.420000000000002 109.782 -177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.18 135.64 57.88 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.192 -0.913 . . . . 62.119999999999997 110.219 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HD2' HD12 ' A' ' 13' ' ' LEU . 11.4 Cg_endo -63.17 160.24 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.118 1.879 . . . . 72.129999999999995 110.965 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.6 63.23 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.1 0.407 . . . . 60.229999999999997 112.1 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.26 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 61.5 112.434 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 10' ' ' PRO . 42.7 mt -79.36 -16.92 55.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 63.219999999999999 110.719 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.507 ' HA ' HG21 ' A' ' 68' ' ' VAL . 17.6 ptt85 -122.97 4.83 9.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 72.140000000000001 111.492 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.9 ttpt -99.08 149.78 22.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.224 0.535 . . . . 52.409999999999997 110.666 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.766 HD11 HG13 ' A' ' 68' ' ' VAL . 7.6 mp -116.38 141.32 48.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.009 -0.996 . . . . 75.299999999999997 110.224 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -97.27 114.4 26.15 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.445 -0.946 . . . . 60.310000000000002 108.445 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 mm -94.08 111.0 24.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 110.053 -0.351 . . . . 54.229999999999997 110.053 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.3 152.68 18.45 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.561 -0.828 . . . . 70.299999999999997 111.314 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.88 45.76 41.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.629 -0.796 . . . . 72.120000000000005 113.142 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 25' ' ' THR . 75.9 mt -79.64 175.27 10.77 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.78 -0.452 . . . . 53.530000000000001 109.78 172.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 82' ' ' ARG . 21.2 p -91.34 175.33 6.97 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.549 -0.538 . . . . 74.230000000000004 109.549 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -75.23 -8.16 55.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.321 0.581 . . . . 64.430000000000007 110.081 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.77 9.12 17.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.568 -0.742 . . . . 70.099999999999994 112.138 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.628 HG21 HD22 ' A' ' 21' ' ' LEU . 19.3 m -76.6 120.69 22.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.447 -0.501 . . . . 71.019999999999996 111.161 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 p -103.96 159.98 15.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 71.310000000000002 110.468 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 2.5 m-20 -60.34 -38.84 85.02 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.032 -0.531 . . . . 73.209999999999994 110.93 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.69 -39.56 91.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.736 -0.665 . . . . 74.219999999999999 111.718 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -75.92 -39.89 55.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.541 -0.3 . . . . 65.319999999999993 110.683 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.82 -47.49 83.2 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.041 -0.527 . . . . 71.109999999999999 109.995 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -57.59 -60.33 3.83 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.081 -0.509 . . . . 72.409999999999997 111.356 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -51.97 -36.6 50.09 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.537 0.523 . . . . 75.200000000000003 112.284 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -71.45 -56.8 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.651 -0.25 . . . . 74.439999999999998 110.908 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -68.55 -25.18 64.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 63.140000000000001 111.851 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.6 tt0 -64.91 -15.11 61.65 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.113 0.412 . . . . 70.340000000000003 112.113 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -29.57 70.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.822 0.344 . . . . 73.530000000000001 111.163 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -98.01 -22.3 16.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.542 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -168.36 159.39 32.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.36 -0.924 . . . . 73.400000000000006 112.099 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.5 m -64.64 118.27 8.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.048 0.451 . . . . 73.329999999999998 111.999 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -92.12 134.12 35.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.434 0.635 . . . . 53.210000000000001 110.761 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -107.75 -19.41 13.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.001 . . . . 65.310000000000002 110.238 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 32.0 t70 -151.51 152.44 32.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 75.140000000000001 109.897 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.0 t -163.03 127.24 2.96 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.502 -0.555 . . . . 74.299999999999997 109.502 172.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 4.8 p -142.01 123.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.536 0.684 . . . . 61.310000000000002 110.63 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.4 130.67 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.506 -0.924 . . . . 75.310000000000002 108.506 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.88 135.69 46.66 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.959 -0.756 . . . . 70.340000000000003 108.959 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -135.35 156.55 48.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.874 -0.603 . . . . 74.439999999999998 111.493 -170.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 13.3 t70 -66.46 132.3 94.25 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.837 -1.074 . . . . 72.230000000000004 109.323 174.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.82 -18.88 47.34 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 121.897 1.732 . . . . 74.319999999999993 113.864 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -85.56 -57.31 3.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.844 0.354 . . . . 54.039999999999999 111.604 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -105.45 -7.72 18.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.061 -0.518 . . . . 51.5 111.305 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 40.0 mmtm 63.63 32.06 14.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.803 0.841 . . . . 73.019999999999996 111.555 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -95.94 162.43 13.57 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.808 -0.812 . . . . 74.340000000000003 108.808 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -65.69 139.71 58.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.838 0.351 . . . . 73.040000000000006 111.613 -171.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.14 2.21 47.67 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.769 -0.65 . . . . 53.219999999999999 110.379 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 15.92 61.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.741 -0.743 . . . . 60.130000000000003 113.242 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -161.19 157.15 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.154 0.477 . . . . 62.43 110.524 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.27 -164.21 16.74 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 111.52 -0.632 . . . . 75.519999999999996 111.52 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -142.35 150.87 41.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.32 0.56 . . . . 73.209999999999994 110.805 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 16' ' ' LEU . 5.8 m -132.84 123.37 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.78 -0.645 . . . . 54.399999999999999 109.87 172.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 42' ' ' ASP . 5.2 m -98.94 120.64 39.72 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.332 -0.23 . . . . 72.129999999999995 110.609 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.63 161.8 17.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.167 -0.47 . . . . 74.349999999999994 110.322 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 -35.59 62.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.715 -0.675 . . . . 62.229999999999997 110.599 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.86 149.36 52.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 72.329999999999998 110.347 -178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.5 p -66.44 -34.6 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 120.778 0.323 . . . . 61.450000000000003 111.096 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.94 -37.44 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.206 0.447 . . . . 75.430000000000007 112.206 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.05 -29.49 70.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 71.420000000000002 110.368 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.766 HG13 HD11 ' A' ' 16' ' ' LEU . 2.7 t -62.11 -44.52 99.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.175 -0.92 . . . . 64.129999999999995 110.98 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -41.18 97.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 111.131 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.75 -39.88 78.4 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.025 0.38 . . . . 65.530000000000001 112.025 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.95 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 63.409999999999997 110.529 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.414 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.0 mmt -66.41 -33.46 75.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.769 -0.65 . . . . 63.25 110.529 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.598 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 3.4 p30 -82.26 -9.6 59.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.991 0.424 . . . . 75.349999999999994 111.091 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.59 -14.39 45.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.856 -0.611 . . . . 74.530000000000001 112.518 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -49.16 146.35 6.1 Favored Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 112.705 0.631 . . . . 75.140000000000001 112.705 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.4 154.34 85.22 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 124.02 -1.242 . . . . 70.129999999999995 113.287 1.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -107.44 147.16 30.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.705 -0.68 . . . . 71.340000000000003 110.441 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -138.45 104.37 5.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.118 0.485 . . . . 73.540000000000006 111.226 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.34 139.92 43.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.335 -0.617 . . . . 61.130000000000003 109.335 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 1.7 m-20 62.72 31.79 16.44 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.565 0.54 . . . . 73.140000000000001 111.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.67 23.53 77.68 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.396 -0.82 . . . . 45.119999999999997 112.605 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.9 tpt180 -129.38 137.35 50.9 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.848 -0.207 . . . . 71.329999999999998 110.787 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.35 116.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.984 -0.747 . . . . 71.519999999999996 108.984 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -109.91 154.18 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.288 0.566 . . . . 70.040000000000006 111.493 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.85 95.89 35.51 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.142 -0.935 . . . . 74.140000000000001 110.753 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.55 134.11 16.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.09 1.86 . . . . 62.439999999999998 112.155 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 31.9 mmtt -125.9 -177.82 4.07 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.849 -1.167 . . . . 63.130000000000003 107.849 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.501 HH22 ' HE2' ' A' ' 161' ' ' LYS . 12.2 mmt-85 -80.87 163.14 23.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.281 0.492 . . . . 73.030000000000001 109.764 170.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.08 90.49 4.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.817 0.818 . . . . 75.140000000000001 108.822 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 164' ' ' ILE . 16.5 t -82.75 156.35 3.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.58 -1.191 . . . . 75.340000000000003 109.191 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.3 t -54.82 148.38 13.21 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.461 0.476 . . . . 70.120000000000005 109.902 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.555 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 6.8 tpp180 -66.52 -6.02 13.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.089 0.471 . . . . 64.150000000000006 111.984 -172.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.85 -43.95 94.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.277 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.11 -43.88 14.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.842 -0.617 . . . . 74.120000000000005 111.088 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 1.5 p -69.34 -12.31 61.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.242 -0.436 . . . . 71.200000000000003 111.875 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 33.9 tt0 -61.59 -34.93 76.47 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.239 -0.437 . . . . 70.030000000000001 110.964 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 97' ' ' ARG . 4.0 mpt_? -70.56 145.81 93.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 111.232 -174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.34 120.08 7.12 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.349 2.7 . . . . 71.420000000000002 112.712 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.1 29.14 69.18 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 121.18 -0.534 . . . . 63.240000000000002 113.023 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' A' ' 179' ' ' LYS . . . -78.85 -49.6 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.748 0.309 . . . . 75.019999999999996 110.618 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 95' ' ' SER . 4.7 m80 -81.16 25.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.647 0.61 . . . . 61.43 112.647 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.53 -164.09 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.715 -0.846 . . . . 73.120000000000005 108.715 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.11 88.76 5.97 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.596 -0.69 . . . . 62.119999999999997 111.122 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.92 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 71.209999999999994 109.569 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' C ' HG21 ' A' ' 159' ' ' VAL . 79.1 mttt -108.47 20.1 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.124 0.488 . . . . 53.520000000000003 110.605 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -120.58 139.74 52.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.192 -0.458 . . . . 53.219999999999999 110.636 178.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.523 HG23 HG13 ' A' ' 159' ' ' VAL . 4.6 pt -129.94 151.3 35.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.375 0.607 . . . . 74.010000000000005 111.665 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.3 t80 -101.86 133.24 46.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.621 -1.172 . . . . 74.319999999999993 109.809 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.5 110.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.336 -0.616 . . . . 70.310000000000002 109.336 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.28 157.23 19.4 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.297 -0.954 . . . . 72.409999999999997 112.953 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.94 19.66 30.58 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.773 -0.727 . . . . 64.340000000000003 111.828 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG22 ' SG ' ' A' ' 175' ' ' CYS . 29.8 pt -78.52 118.39 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.341 0.591 . . . . 62.219999999999999 110.874 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.99 -69.3 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 63.119999999999997 110.759 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.01 154.82 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.777 -0.453 . . . . 74.329999999999998 109.777 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.97 104.84 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.687 -0.688 . . . . 73.310000000000002 110.486 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -79.85 132.91 36.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.833 -0.621 . . . . 41.100000000000001 110.368 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -101.7 167.24 10.23 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.258 -0.883 . . . . 73.200000000000003 110.471 -177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 134' ' ' ILE . 5.8 tm-20 -61.58 -48.17 82.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 71.129999999999995 110.403 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -62.5 -26.75 68.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 75.530000000000001 111.137 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -63.95 -61.4 2.3 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.17 0.509 . . . . 73.0 110.461 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 134' ' ' ILE . 4.4 pp -82.47 -26.89 32.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.247 -0.581 . . . . 71.329999999999998 111.595 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -65.26 -50.57 65.28 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.965 -0.294 . . . . 72.140000000000001 110.315 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.15 -31.47 70.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 74.400000000000006 110.822 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 170' ' ' VAL . 78.2 t80 -76.96 -56.24 4.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.196 -0.456 . . . . 73.010000000000005 112.128 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 35.6 m-85 -66.98 -22.11 65.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.174 0.435 . . . . 73.549999999999997 112.174 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.4 mm-40 -64.79 -28.07 69.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.022 0.439 . . . . 71.310000000000002 110.77 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.77 -28.12 60.72 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.158 -0.474 . . . . 62.340000000000003 111.789 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.48 -26.42 24.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.35 -0.387 . . . . 73.549999999999997 111.717 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.75 -176.26 44.28 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 120.889 -0.672 . . . . 74.219999999999999 113.138 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -76.15 134.11 40.04 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 111.439 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 152' ' ' THR . 69.0 mt -105.85 142.02 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.749 -0.659 . . . . 72.519999999999996 110.75 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -91.42 -52.39 4.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 64.329999999999998 111.029 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -155.74 154.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.997 -0.547 . . . . 62.5 110.187 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 118' ' ' GLU . 3.3 mp -114.59 128.09 71.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 75.040000000000006 109.819 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -104.84 103.92 13.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.328 -0.851 . . . . 72.420000000000002 110.789 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -92.17 124.86 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.89 -0.782 . . . . 73.420000000000002 108.89 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.9 mmm -94.67 113.73 25.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.334 0.588 . . . . 72.129999999999995 109.843 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.95 158.11 36.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 71.420000000000002 110.406 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -77.82 122.22 25.14 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.965 -0.754 . . . . 71.409999999999997 108.965 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -78.46 -5.69 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.798 0.296 . . . . 52.350000000000001 111.798 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.13 -53.56 1.16 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.755 -0.736 . . . . 41.039999999999999 112.372 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 p -99.28 -25.39 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.354 . . . . 64.400000000000006 111.746 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.81 9.22 64.42 Favored Glycine 0 C--O 1.234 0.112 0 C-N-CA 120.703 -0.761 . . . . 73.400000000000006 112.549 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -78.8 169.63 17.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.737 0.303 . . . . 60.32 110.622 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 141.75 53.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 62.240000000000002 110.574 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 2.2 mmp_? -81.47 -8.57 59.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.954 -0.299 . . . . 71.439999999999998 111.421 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.08 -6.39 66.49 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.602 -0.808 . . . . 63.039999999999999 112.888 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.98 157.51 43.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.763 -0.458 . . . . 73.099999999999994 109.763 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.26 166.39 24.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 71.0 109.735 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 67.2 m-85 -133.87 153.44 51.74 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.993 -0.549 . . . . 73.25 110.131 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.13 132.39 18.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.311 0.577 . . . . 75.340000000000003 111.063 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 55.9 m -98.49 124.57 43.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.102 -0.954 . . . . 55.130000000000003 110.495 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 6.4 m-85 -100.02 161.36 13.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.923 0.392 . . . . 75.510000000000005 111.187 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.21 -33.41 56.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.685 -0.689 . . . . 74.329999999999998 110.207 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.4 154.93 50.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.247 -0.888 . . . . 75.439999999999998 110.613 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.599 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 21.6 p80 -80.06 -21.27 43.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 110.321 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -53.62 -43.98 69.11 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.91 0.756 . . . . 75.329999999999998 110.96 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 m -71.96 -33.54 68.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.485 -0.779 . . . . 60.350000000000001 111.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.523 HG13 HG23 ' A' ' 107' ' ' ILE . 2.3 t -72.41 -37.62 58.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.206 0.527 . . . . 52.43 109.724 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.253 -0.885 . . . . 74.340000000000003 111.103 -178.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.5 mttt -68.27 -39.28 82.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.648 0.737 . . . . 60.130000000000003 110.134 172.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.14 -41.72 37.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.85 -1.068 . . . . 75.340000000000003 112.52 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.518 HG11 ' HD3' ' A' ' 179' ' ' LYS . 35.5 m -73.5 -5.49 6.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.045 0.45 . . . . 72.019999999999996 111.38 -174.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.55 ' HA ' HG13 ' A' ' 90' ' ' VAL . 50.8 mt -61.89 -33.56 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.399 -0.819 . . . . 63.119999999999997 110.295 171.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.1 mt-30 -110.32 108.68 18.84 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -56.0 -33.25 64.69 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.678 0.621 . . . . 75.439999999999998 112.678 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -123.5 139.81 53.64 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.24 -0.288 . . . . 73.150000000000006 110.689 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.2 m-70 -128.19 152.45 48.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 109.946 175.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 m -100.28 110.09 22.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 71.239999999999995 110.113 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 124' ' ' TYR . 12.0 t -124.11 133.16 70.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.005 -0.739 . . . . 74.540000000000006 109.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 57.07 28.06 14.32 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.608 0.718 . . . . 71.340000000000003 111.486 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.78 7.57 87.34 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.014 -0.613 . . . . 74.299999999999997 113.024 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -112.0 125.26 53.88 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.503 0.321 . . . . 73.25 110.759 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -82.56 110.69 17.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.478 0.656 . . . . 60.109999999999999 109.735 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 112' ' ' ILE . 16.0 m -122.36 157.65 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 64.299999999999997 110.792 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -85.59 132.81 34.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.341 -0.391 . . . . 73.239999999999995 110.294 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.9 t -129.16 135.34 62.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.689 -0.687 . . . . 75.019999999999996 110.155 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -158.0 173.29 16.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 72.129999999999995 110.856 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 100' ' ' ALA . 12.5 mmtm -58.92 132.29 53.55 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.353 0.408 . . . . 75.129999999999995 110.979 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.22 114.51 22.53 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.639 -0.504 . . . . 75.310000000000002 109.639 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.4 mt -84.78 110.57 18.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.958 -0.756 . . . . 75.209999999999994 108.958 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 186' ' ' MET . 4.1 t -83.32 -174.82 5.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.771 -0.826 . . . . 65.230000000000004 108.771 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -61.89 -35.42 78.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.052 -0.259 . . . . 74.150000000000006 111.191 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.567 ' HA ' ' C ' ' A' ' 188' ' ' SER . 61.7 tt0 -65.6 -41.34 92.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 70.329999999999998 110.593 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -72.43 -24.31 61.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.38 -0.827 . . . . 65.129999999999995 110.762 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 182' ' ' SER . 21.5 mtt -89.55 -71.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 111.352 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -96.02 -63.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 73.329999999999998 111.0 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.567 ' C ' ' HA ' ' A' ' 184' ' ' GLN . 56.9 p 179.21 171.83 0.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.264 -1.013 . . . . 64.340000000000003 108.264 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -47.69 128.9 13.5 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.498 0.499 . . . . 73.239999999999995 111.355 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 t -64.39 98.26 0.23 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.794 0.684 . . . . 63.420000000000002 110.938 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.9 m -85.86 78.68 9.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 63.240000000000002 110.49 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 47.1 t -137.65 100.94 4.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.32 -0.855 . . . . 71.340000000000003 109.547 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -76.19 99.02 4.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.019 -0.537 . . . . 71.439999999999998 109.968 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -130.08 96.45 4.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.54 -0.755 . . . . 74.420000000000002 109.765 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -176.67 27.92 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.088 -0.577 . . . . 32.140000000000001 111.798 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.535 -0.745 . . . . 73.299999999999997 109.545 -178.189 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 112.221 -0.352 . . . . 71.129999999999995 112.221 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t 65.88 27.82 10.85 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.433 0.693 . . . . 71.310000000000002 110.886 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.88 80.11 6.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.283 0.564 . . . . 73.329999999999998 110.623 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.5 t -86.63 71.85 10.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.191 -1.04 . . . . 53.409999999999997 108.191 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -77.74 149.24 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.875 -1.057 . . . . 72.140000000000001 111.135 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -137.55 85.25 21.22 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.697 -0.853 . . . . 71.409999999999997 108.697 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.6 168.39 16.2 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.128 2.552 . . . . 72.209999999999994 111.792 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -67.46 -11.1 57.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.425 -0.352 . . . . 72.239999999999995 111.614 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.4 122.54 78.8 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 74.329999999999998 109.544 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.4 Cg_endo -60.39 167.24 8.18 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.301 2.668 . . . . 71.319999999999993 112.532 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 2.2 pt-20 -51.18 -42.23 60.73 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 123.294 0.371 . . . . 65.310000000000002 111.54 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 5.5 pt20 -64.93 -19.82 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.622 0.601 . . . . 72.230000000000004 112.622 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.4 mp -90.07 -21.45 22.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.531 0.197 . . . . 74.230000000000004 111.531 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.3 ptt180 -117.83 -3.61 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.633 -0.427 . . . . 64.129999999999995 111.501 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -99.17 144.49 28.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.557 0.694 . . . . 62.340000000000003 111.549 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 68' ' ' VAL . 52.5 mt -115.61 148.27 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.741 -1.118 . . . . 63.409999999999997 110.544 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -98.61 125.97 44.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.407 -0.96 . . . . 63.049999999999997 108.407 172.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' VAL . 20.7 mm -103.86 111.9 35.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.819 -0.437 . . . . 63.420000000000002 109.819 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.44 17.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.595 -0.812 . . . . 73.109999999999999 111.847 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.63 47.36 27.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.609 -0.805 . . . . 72.219999999999999 113.152 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 25' ' ' THR . 86.1 mt -82.26 176.23 9.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.412 . . . . 73.430000000000007 109.889 172.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -88.34 175.23 7.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.054 0.454 . . . . 74.140000000000001 109.849 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -81.7 -4.98 57.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.018 -0.537 . . . . 72.030000000000001 110.438 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.35 9.11 10.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 61.229999999999997 111.549 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.595 HG21 HD22 ' A' ' 21' ' ' LEU . 53.4 m -75.94 127.23 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 60.509999999999998 111.379 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.9 p -103.19 172.6 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 73.409999999999997 110.37 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.56 -24.2 39.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.221 -0.288 . . . . 74.420000000000002 110.221 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.44 -39.04 68.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 64.420000000000002 111.204 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.5 p -75.4 -38.03 60.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 73.099999999999994 110.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.564 ' HA ' HG11 ' A' ' 79' ' ' VAL . 30.2 tp -62.94 -49.1 76.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.465 -0.789 . . . . 54.409999999999997 109.995 176.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.2 ttm180 -56.09 -62.42 1.72 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.519 -0.764 . . . . 72.200000000000003 111.959 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 t -50.65 -33.17 21.44 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.742 0.651 . . . . 75.209999999999994 112.544 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -75.2 -55.27 5.89 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.07 -0.252 . . . . 75.230000000000004 111.083 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.94 -22.77 62.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.067 0.395 . . . . 73.409999999999997 112.067 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -58.36 -22.83 54.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.049 0.539 . . . . 63.130000000000003 111.849 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -63.95 -27.52 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.362 . . . . 71.430000000000007 111.973 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -96.75 -23.74 16.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.762 0.315 . . . . 72.530000000000001 111.253 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.93 154.44 24.46 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.334 -0.936 . . . . 35.549999999999997 111.972 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.2 m -62.51 118.2 7.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 64.120000000000005 111.087 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -85.0 142.46 29.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 110.452 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -104.41 -25.43 12.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.607 -0.724 . . . . 71.209999999999994 109.682 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -153.49 156.2 37.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 70.310000000000002 110.084 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.4 t -161.79 132.32 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.454 -0.572 . . . . 72.109999999999999 109.454 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.68 118.02 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.716 0.769 . . . . 75.219999999999999 110.693 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.43 132.67 31.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.715 -0.846 . . . . 74.219999999999999 108.715 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mmt -76.19 101.37 5.37 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.512 0.673 . . . . 73.420000000000002 110.346 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -99.05 153.71 18.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.804 -1.089 . . . . 53.340000000000003 109.397 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.48 128.01 86.52 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.928 -0.578 . . . . 74.299999999999997 110.336 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 -17.07 58.39 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.284 1.99 . . . . 72.430000000000007 113.424 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -85.63 -56.11 3.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.965 0.412 . . . . 63.229999999999997 111.587 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -11.9 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 74.109999999999999 111.77 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 62.79 34.82 14.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.752 0.821 . . . . 71.239999999999995 110.808 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -112.2 160.9 17.14 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.033 -0.729 . . . . 74.420000000000002 109.033 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -74.09 131.7 41.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.814 0.34 . . . . 64.329999999999998 110.63 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -83.68 7.01 18.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 64.219999999999999 111.38 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.03 16.32 75.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.787 -0.721 . . . . 75.409999999999997 113.521 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -157.19 155.88 31.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.358 0.579 . . . . 75.319999999999993 110.355 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.2 -165.37 16.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.418 -0.673 . . . . 64.450000000000003 111.418 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.66 148.77 37.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.046 0.423 . . . . 75.430000000000007 110.31 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -128.11 127.23 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.719 -0.673 . . . . 62.409999999999997 109.534 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -101.96 117.43 34.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.0 -0.37 . . . . 74.540000000000006 110.0 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.1 m-85 -84.85 170.86 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.328 -0.396 . . . . 75.510000000000005 110.494 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.13 -49.48 28.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.863 -0.608 . . . . 61.240000000000002 110.044 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.499 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -128.83 160.22 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 71.109999999999999 110.792 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.3 p -65.12 -33.43 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.238 -0.437 . . . . 72.230000000000004 111.308 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -55.79 -44.54 77.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.509 0.559 . . . . 74.329999999999998 112.509 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.5 mp0 -61.28 -32.75 72.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.3 0.572 . . . . 72.129999999999995 110.728 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG13 HD21 ' A' ' 16' ' ' LEU . 39.1 t -65.95 -49.63 75.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.236 -0.893 . . . . 73.540000000000006 111.055 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.32 -43.83 88.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 75.349999999999994 110.875 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.63 -42.6 62.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.962 -0.563 . . . . 75.109999999999999 112.284 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.97 -33.07 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.866 0.365 . . . . 71.420000000000002 110.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.68 -42.12 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 110.433 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -12.29 59.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.807 -0.633 . . . . 74.5 111.069 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.78 -10.86 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 60.030000000000001 110.657 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 19.2 ttp-105 -53.49 144.31 33.04 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.279 -0.873 . . . . 75.140000000000001 110.892 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 87.7 Cg_endo -80.53 168.93 70.47 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.56 -1.017 . . . . 73.120000000000005 114.013 2.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -128.21 158.28 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.069 -0.969 . . . . 64.340000000000003 110.165 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.0 ttmt -134.55 104.59 6.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.082 -0.508 . . . . 65.439999999999998 110.3 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 30' ' ' LEU . 48.5 t -108.7 132.98 55.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 73.439999999999998 109.954 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 65.62 27.42 11.44 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.82 0.7 . . . . 74.109999999999999 110.856 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.51 21.89 76.43 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.804 -0.635 . . . . 31.440000000000001 112.497 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.3 tpt180 -128.68 137.63 51.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.226 -0.287 . . . . 61.119999999999997 110.226 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.81 111.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.419 -0.586 . . . . 71.340000000000003 109.419 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 21' ' ' LEU . 4.1 m -107.4 150.04 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.59 0.71 . . . . 65.230000000000004 111.431 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.05 95.46 38.36 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 114.823 -1.081 . . . . 72.219999999999999 110.926 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.97 131.98 17.65 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.418 2.079 . . . . 74.129999999999995 111.949 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -141.08 -177.33 5.05 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.222 -0.899 . . . . 74.0 108.786 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 7.4 tpp180 -75.09 154.3 37.92 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.051 0.453 . . . . 75.140000000000001 111.28 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.22 91.24 6.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.421 -0.955 . . . . 72.200000000000003 108.421 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t -69.44 149.17 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.499 -0.773 . . . . 72.420000000000002 110.288 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 p -56.59 146.41 25.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 123.497 0.498 . . . . 74.310000000000002 110.034 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.21 -16.27 63.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.877 0.695 . . . . 73.430000000000007 112.877 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.63 -51.63 26.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 61.409999999999997 110.234 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.34 -20.66 33.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 63.450000000000003 111.467 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 t -69.66 -15.87 63.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.323 -0.399 . . . . 75.329999999999998 110.357 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.36 -17.91 59.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.656 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -79.32 147.47 68.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 60.43 110.841 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.69 116.5 4.58 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.699 2.266 . . . . 63.200000000000003 111.97 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.81 18.04 15.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.54 -0.838 . . . . 52.530000000000001 112.515 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.15 50.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.73 0.3 . . . . 71.319999999999993 111.096 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -103.3 13.68 33.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.021 0.439 . . . . 73.209999999999994 111.285 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.59 163.41 23.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.246 -0.65 . . . . 75.25 109.246 173.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.3 82.88 4.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.792 0.806 . . . . 74.200000000000003 110.63 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -108.63 113.69 44.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.699 -1.137 . . . . 74.040000000000006 109.753 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 159' ' ' VAL . 82.2 mttt -109.12 19.4 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.861 0.363 . . . . 75.030000000000001 110.475 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.41 144.54 45.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.546 -0.297 . . . . 62.329999999999998 110.667 175.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.457 HG23 HG13 ' A' ' 159' ' ' VAL . 5.3 pt -125.08 148.5 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.224 0.535 . . . . 63.119999999999997 111.19 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.9 t80 -97.74 131.96 43.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.019 -0.992 . . . . 72.120000000000005 109.008 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.46 108.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.981 -0.748 . . . . 75.329999999999998 108.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.37 166.27 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.87 -1.157 . . . . 74.319999999999993 113.294 -174.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.29 58.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.704 -0.76 . . . . 22.100000000000001 111.762 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.36 134.18 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 70.519999999999996 109.478 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.73 -49.28 9.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.882 0.372 . . . . 72.239999999999995 110.204 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.86 -173.56 2.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.056 -0.72 . . . . 74.310000000000002 109.056 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 145' ' ' LYS . 6.7 p-10 -83.81 135.27 34.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.297 0.57 . . . . 74.340000000000003 110.983 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 m -106.95 141.43 38.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.596 -0.729 . . . . 72.319999999999993 110.315 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.37 160.91 16.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.287 -0.415 . . . . 73.129999999999995 109.918 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.17 -51.12 71.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 72.409999999999997 110.093 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -58.88 -31.01 68.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 111.731 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.347 0.405 . . . . 73.310000000000002 110.71 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.7 pp -81.11 -27.45 35.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.449 -0.5 . . . . 74.450000000000003 110.99 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.41 -53.31 44.9 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 110.182 -0.303 . . . . 73.409999999999997 110.182 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.49 -28.27 69.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.209 0.528 . . . . 73.450000000000003 110.452 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.01 -56.71 4.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.95 -0.568 . . . . 71.109999999999999 111.54 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 29.7 m-85 -66.71 -22.1 66.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 72.019999999999996 111.773 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.16 -27.72 68.91 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.99 0.424 . . . . 71.209999999999994 111.214 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -58.07 -28.77 64.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 72.140000000000001 111.3 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -86.16 -26.49 25.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.356 . . . . 75.040000000000006 111.658 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -174.91 45.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.708 -0.758 . . . . 72.040000000000006 113.582 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -78.18 131.89 37.37 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.936 0.398 . . . . 53.340000000000003 111.716 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.82 139.92 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.922 -0.581 . . . . 70.420000000000002 110.384 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 -49.92 6.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 63.530000000000001 110.847 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.59 159.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.684 -0.487 . . . . 74.409999999999997 109.684 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.53 127.82 75.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 109.923 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.6 mt-10 -99.65 103.79 15.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.1 -0.954 . . . . 73.239999999999995 110.326 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.53 117.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.164 -0.68 . . . . 72.439999999999998 109.164 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.4 mmm -91.3 122.33 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.333 -0.617 . . . . 73.129999999999995 109.333 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.48 163.06 24.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.429 0.633 . . . . 72.150000000000006 112.039 -173.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.491 ' HA ' ' NH2' ' A' ' 146' ' ' ARG . 12.9 t70 -95.14 128.11 41.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.608 -1.178 . . . . 70.040000000000006 109.963 176.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -9.9 59.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 73.040000000000006 112.273 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.66 -53.85 2.65 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.374 -0.917 . . . . 62.520000000000003 113.039 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.2 m -96.24 -19.74 19.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.736 0.303 . . . . 72.430000000000007 111.122 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.26 28.41 48.95 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.702 -0.761 . . . . 72.239999999999995 111.524 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -108.4 179.64 4.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 72.420000000000002 109.658 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -72.69 150.83 42.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.303 0.573 . . . . 74.099999999999994 111.173 175.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.491 ' NH2' ' HA ' ' A' ' 139' ' ' ASP . 23.6 tpp180 -74.9 -7.61 54.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.683 . . . . 73.099999999999994 111.535 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.46 -3.32 53.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.266 -0.968 . . . . 65.439999999999998 112.475 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -157.46 158.8 36.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 110.392 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.5 170.07 16.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.48 -0.782 . . . . 71.209999999999994 109.54 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.6 m-85 -134.4 145.21 48.71 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.967 -0.56 . . . . 75.030000000000001 109.909 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.19 129.07 67.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.206 -0.452 . . . . 72.140000000000001 110.623 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 96.4 m -100.81 118.74 37.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.643 -0.708 . . . . 73.209999999999994 110.521 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.1 m-85 -102.16 156.81 17.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.768 0.318 . . . . 74.329999999999998 111.178 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.56 -31.93 60.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.931 -0.577 . . . . 73.010000000000005 110.366 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -128.26 152.96 47.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 75.420000000000002 110.663 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -75.96 -25.68 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.553 . . . . 75.439999999999998 109.508 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.59 -48.84 38.72 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.102 -0.954 . . . . 62.119999999999997 111.437 178.192 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 153' ' ' PHE . 1.7 m -72.44 -32.89 66.68 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.82 -0.627 . . . . 62.140000000000001 110.813 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.6 t -69.46 -42.34 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.312 -0.625 . . . . 75.209999999999994 109.312 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.565 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 3.6 m-20 -71.43 -22.49 61.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.082 -0.963 . . . . 72.340000000000003 111.804 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -67.01 -39.56 87.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.77 0.795 . . . . 55.049999999999997 109.786 170.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mt -76.02 -40.94 38.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.334 -1.303 . . . . 70.230000000000004 112.054 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 159' ' ' VAL . 7.5 m -73.33 -11.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.001 0.429 . . . . 64.239999999999995 110.924 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.497 HD13 HD12 ' A' ' 13' ' ' LEU . 10.8 mt -63.71 -29.99 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.323 -0.853 . . . . 73.239999999999995 110.193 173.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.561 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 54.6 mt-30 -112.66 98.42 7.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.898 -1.149 . . . . 63.109999999999999 107.898 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -56.67 -33.37 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.108 -0.951 . . . . 71.120000000000005 112.431 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -121.65 131.75 54.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.33 -0.395 . . . . 75.109999999999999 110.381 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.561 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -124.49 150.95 45.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.712 -0.676 . . . . 73.349999999999994 109.794 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -115.87 118.1 32.05 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.779 -0.452 . . . . 64.329999999999998 109.779 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.93 117.2 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.054 -0.521 . . . . 52.149999999999999 110.31 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.02 28.23 5.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 73.209999999999994 110.328 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 97.73 -9.13 64.07 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.534 -0.757 . . . . 61.549999999999997 113.309 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -108.61 125.68 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.444 0.622 . . . . 62.420000000000002 111.795 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -93.2 109.91 21.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.332 0.587 . . . . 43.329999999999998 110.014 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.1 p -114.64 155.31 26.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.596 -0.729 . . . . 75.010000000000005 110.675 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.0 129.94 34.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.504 -0.554 . . . . 60.32 109.504 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 12.4 t -127.74 134.45 65.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.411 -0.813 . . . . 54.539999999999999 110.202 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.6 177.0 11.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.707 -0.679 . . . . 64.239999999999995 111.134 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -64.1 125.72 25.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.36 -0.382 . . . . 73.040000000000006 110.144 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.67 44.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.016 0.436 . . . . 64.340000000000003 109.911 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.0 mt -85.15 121.41 27.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 109.99 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.551 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 67.1 m -64.54 162.33 15.66 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 74.239999999999995 108.999 171.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -71.02 -26.35 63.07 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.773 -0.579 . . . . 73.430000000000007 112.157 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.3 -36.75 79.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 64.099999999999994 109.731 171.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.551 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 0.6 OUTLIER -70.68 -41.34 72.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.218 -0.901 . . . . 75.030000000000001 110.439 178.017 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 82.1 mtp -64.93 -43.03 94.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.438 -0.801 . . . . 70.109999999999999 111.242 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.3 -23.36 59.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 42.119999999999997 110.622 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.0 m 61.37 26.18 16.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.443 -0.799 . . . . 73.420000000000002 110.298 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.87 172.17 16.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.087 -0.96 . . . . 72.030000000000001 109.276 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.5 m -107.4 152.73 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.732 0.301 . . . . 71.299999999999997 110.344 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.3 p -145.42 124.94 13.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.512 -0.313 . . . . 65.099999999999994 110.433 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 107.16 4.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.346 -0.388 . . . . 70.340000000000003 110.079 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.54 -71.93 0.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.588 -0.733 . . . . 74.129999999999995 110.969 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 61.18 25.76 15.72 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.019 0.824 . . . . 72.540000000000006 110.939 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.76 86.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.963 -0.637 . . . . 65.299999999999997 112.048 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.506 -0.759 . . . . 74.040000000000006 109.588 177.068 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.711 -0.556 . . . . 54.399999999999999 111.711 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -81.74 146.67 29.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.844 0.354 . . . . 52.340000000000003 110.634 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -82.42 127.33 33.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.001 -0.545 . . . . 64.200000000000003 109.548 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 m -82.76 80.99 8.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 61.539999999999999 110.183 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.21 86.46 7.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 73.209999999999994 110.273 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.6 p -75.84 113.68 29.51 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.11 -0.495 . . . . 72.030000000000001 109.866 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 72.0 Cg_endo -79.32 167.38 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.301 2.0 . . . . 74.140000000000001 112.916 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -65.9 -12.49 54.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.411 -0.813 . . . . 73.329999999999998 110.713 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' OE1' ' HB2' ' A' ' 7' ' ' PRO . 3.6 mp0 -64.63 128.19 93.23 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 111.107 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HD2' HD22 ' A' ' 13' ' ' LEU . 34.2 Cg_endo -65.8 167.65 17.03 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.152 2.568 . . . . 63.340000000000003 112.186 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.56 -34.64 72.94 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 112.157 0.429 . . . . 74.109999999999999 112.157 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -67.87 -24.36 65.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.872 0.367 . . . . 75.040000000000006 111.363 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.455 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.0 mp -86.21 -10.6 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 53.140000000000001 111.188 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -122.34 0.72 9.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 70.319999999999993 111.216 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.2 ttpt -97.41 145.64 25.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.597 0.713 . . . . 72.0 111.983 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 68' ' ' VAL . 60.7 mt -117.76 147.66 42.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.12 . . . . 63.219999999999999 110.54 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -99.27 125.75 44.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.542 -0.91 . . . . 75.319999999999993 108.542 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 60' ' ' VAL . 20.9 mm -102.97 113.18 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.91 -0.404 . . . . 73.439999999999998 109.91 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.27 17.26 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.784 -0.722 . . . . 53.049999999999997 111.858 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.74 47.33 26.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 73.25 113.333 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 25' ' ' THR . 77.7 mt -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.003 0.43 . . . . 54.229999999999997 110.494 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 t -92.23 167.36 12.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.332 -0.618 . . . . 61.020000000000003 109.332 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 94.2 m-85 -75.46 -6.12 48.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.307 0.575 . . . . 73.209999999999994 110.789 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.14 -3.8 28.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.201 -0.909 . . . . 75.120000000000005 111.202 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.486 HG21 HD22 ' A' ' 21' ' ' LEU . 72.2 m -76.21 125.18 28.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 71.400000000000006 112.158 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -105.86 160.01 15.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.169 -0.923 . . . . 73.420000000000002 110.072 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 120.475 0.179 . . . . 74.129999999999995 110.829 -177.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -76.69 -38.33 54.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 75.329999999999998 111.499 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -78.51 -35.23 46.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.825 -0.171 . . . . 74.400000000000006 111.227 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.77 -45.97 84.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.248 -0.649 . . . . 72.340000000000003 109.248 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -54.17 -60.32 3.49 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.176 -0.92 . . . . 64.439999999999998 111.386 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -47.72 -34.09 7.85 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.858 0.724 . . . . 74.420000000000002 112.701 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -76.58 -57.6 3.76 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.8 -0.182 . . . . 75.200000000000003 111.114 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.18 -23.13 64.81 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.063 -0.398 . . . . 63.240000000000002 111.849 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.91 -23.33 65.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.228 0.611 . . . . 74.349999999999994 111.209 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -60.79 -26.94 67.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 72.109999999999999 112.038 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -99.95 -20.88 15.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.837 0.31 . . . . 73.239999999999995 111.837 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.73 32.88 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.294 -0.955 . . . . 75.25 112.095 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -63.23 117.28 6.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.927 0.394 . . . . 72.540000000000006 111.394 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.9 mt -85.13 143.0 29.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.482 -0.562 . . . . 72.510000000000005 109.482 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -116.17 -16.12 11.02 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.012 -0.54 . . . . 73.310000000000002 110.099 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -152.39 150.7 29.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 73.409999999999997 109.446 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.4 t -162.72 129.48 3.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.687 -0.486 . . . . 75.409999999999997 109.687 174.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.6 122.08 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.501 0.667 . . . . 72.329999999999998 110.587 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 27' ' ' ASP . 91.2 t -85.73 129.93 37.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 53.140000000000001 108.785 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -75.33 95.0 3.12 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.571 0.701 . . . . 70.230000000000004 110.116 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 52.4 mtp85 -101.34 158.43 16.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.636 -1.166 . . . . 72.219999999999999 110.221 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 23.9 t70 -72.45 126.46 90.91 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.143 -0.935 . . . . 73.310000000000002 110.262 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.29 -12.5 31.99 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.127 1.885 . . . . 74.109999999999999 112.942 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 32.2 m-80 -85.64 -56.3 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.019 0.377 . . . . 75.040000000000006 112.019 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -107.09 -9.24 16.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 111.459 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 67.07 40.07 3.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.68 0.792 . . . . 75.140000000000001 111.416 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -117.28 154.66 30.84 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.547 -0.909 . . . . 72.450000000000003 108.547 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 31.3 t -72.27 139.86 48.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.147 0.431 . . . . 71.420000000000002 111.391 -171.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -82.53 1.2 39.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.695 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 20.06 57.21 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.568 -0.825 . . . . 63.32 113.987 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -161.05 156.92 25.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.9 0.85 . . . . 75.400000000000006 110.618 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.17 -163.56 14.4 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.519 -0.632 . . . . 71.450000000000003 111.519 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.15 150.4 41.03 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.374 0.587 . . . . 65.439999999999998 110.293 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 18' ' ' ILE . 7.5 m -131.71 127.96 59.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 60.219999999999999 109.55 172.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.6 m -104.49 119.65 39.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.105 -0.331 . . . . 72.239999999999995 110.105 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 29.9 m-85 -85.33 158.95 20.14 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.24 -0.436 . . . . 73.109999999999999 110.121 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.92 -44.45 73.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.932 -0.576 . . . . 42.219999999999999 110.559 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -126.4 152.13 46.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.754 -0.657 . . . . 74.019999999999996 110.643 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 2.6 p -60.44 -36.31 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.727 -0.67 . . . . 73.319999999999993 110.983 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.64 -43.3 62.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.241 0.83 . . . . 52.409999999999997 113.241 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 1.3 mp0 -65.61 -29.24 69.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.88 0.372 . . . . 53.509999999999998 111.207 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.96 -45.7 96.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 75.140000000000001 110.428 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.31 -50.1 70.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.167 -0.924 . . . . 73.420000000000002 111.722 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -52.96 -37.08 60.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.938 0.718 . . . . 73.530000000000001 112.938 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.62 -32.52 71.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.461 0.648 . . . . 62.310000000000002 109.949 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 75' ' ' ARG . 14.0 mmt -73.07 -31.5 64.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.251 -0.886 . . . . 41.009999999999998 112.09 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -81.39 -15.01 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.214 0.531 . . . . 63.219999999999999 110.632 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.27 -11.21 35.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 64.129999999999995 112.097 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' ' SD ' ' A' ' 72' ' ' MET . 7.8 mtm180 -54.11 146.58 29.41 Favored Pre-proline 0 N--CA 1.465 0.282 0 O-C-N 123.241 0.338 . . . . 75.439999999999998 111.631 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.19 168.68 69.19 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.75 -1.354 . . . . 52.240000000000002 113.234 2.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -122.77 155.52 36.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.992 -0.549 . . . . 64.129999999999995 110.77 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 ttmt -135.06 108.47 7.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.082 -0.508 . . . . 55.310000000000002 111.112 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.34 124.76 64.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 72.340000000000003 110.073 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 64.99 27.32 12.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.474 0.71 . . . . 73.230000000000004 111.698 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.3 25.04 59.99 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.919 -0.658 . . . . 51.229999999999997 112.483 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.6 tpt180 -129.04 139.07 52.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.044 -0.354 . . . . 71.329999999999998 110.044 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.7 112.79 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.064 -0.717 . . . . 71.430000000000007 109.064 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.96 149.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.413 0.625 . . . . 74.219999999999999 111.592 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.421 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 14.8 tp10 -110.81 98.0 36.02 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.819 -1.082 . . . . 74.420000000000002 110.334 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.18 127.71 9.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.672 1.581 . . . . 73.120000000000005 111.111 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 28.0 mttt -133.98 177.74 7.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.885 -1.154 . . . . 73.409999999999997 107.885 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HB3' ' CB ' ' A' ' 160' ' ' ASP . 4.3 tpp180 -86.01 135.74 33.53 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.345 -0.542 . . . . 74.329999999999998 110.3 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.7 94.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.437 0.637 . . . . 73.319999999999993 110.648 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.14 157.91 6.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 52.130000000000003 111.088 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -55.3 151.72 9.38 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.71 -0.677 . . . . 63.130000000000003 111.394 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -37.45 75.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.025 -0.534 . . . . 64.329999999999998 111.54 -173.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.56 -47.97 82.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 111.236 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 -43.09 79.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 62.240000000000002 110.486 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 p -75.94 7.4 4.04 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.754 0.65 . . . . 61.350000000000001 112.754 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -84.76 -21.44 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 74.340000000000003 110.432 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -91.72 144.59 29.67 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 74.0 110.683 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.37 117.47 4.98 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.604 2.203 . . . . 74.439999999999998 111.791 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 109.92 4.15 29.74 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.838 -0.696 . . . . 64.140000000000001 112.304 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.59 -42.74 24.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.912 0.387 . . . . 74.430000000000007 111.291 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -93.87 1.27 56.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.8 0.333 . . . . 71.549999999999997 110.777 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 99' ' ' GLY . 48.4 mt -78.66 159.18 28.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.178 -0.675 . . . . 74.349999999999994 109.178 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -75.79 97.9 4.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.382 0.61 . . . . 54.109999999999999 110.99 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.82 119.54 58.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.214 -0.903 . . . . 73.219999999999999 108.883 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 75.8 mttt -105.34 21.45 17.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.131 0.491 . . . . 71.340000000000003 110.394 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.01 139.62 50.92 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.22 -0.446 . . . . 51.219999999999999 110.759 178.69 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.42 ' CG2' HG13 ' A' ' 159' ' ' VAL . 8.9 pt -128.96 149.03 33.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.193 0.52 . . . . 53.130000000000003 111.296 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.5 t80 -94.56 133.89 37.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.996 -1.002 . . . . 71.310000000000002 109.76 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -123.09 109.44 23.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.997 -0.742 . . . . 62.299999999999997 108.997 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.49 171.64 26.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.514 -1.327 . . . . 63.130000000000003 113.569 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.47 30.2 30.88 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.198 -0.761 . . . . 63.329999999999998 111.198 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.414 HG22 ' SG ' ' A' ' 175' ' ' CYS . 23.2 pt -75.18 129.45 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 120.975 0.417 . . . . 71.530000000000001 110.311 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.63 -54.93 5.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.106 -0.701 . . . . 72.140000000000001 109.106 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.19 149.46 24.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 73.340000000000003 108.776 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.27 149.13 48.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.276 0.56 . . . . 70.150000000000006 111.517 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -120.77 156.19 32.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 74.219999999999999 111.068 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.02 167.32 10.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.357 -0.838 . . . . 73.5 110.517 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -61.2 -54.07 48.99 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.988 -0.551 . . . . 72.230000000000004 111.01 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -65.19 -17.22 64.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 75.219999999999999 111.773 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -70.18 -57.63 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.015 -0.365 . . . . 74.340000000000003 110.015 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.28 -28.89 38.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.355 -0.538 . . . . 75.319999999999993 110.566 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 7.3 tmm_? -61.8 -50.01 74.03 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.784 -0.45 . . . . 75.329999999999998 109.784 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.04 -29.31 70.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 75.439999999999998 111.002 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.35 -53.24 6.8 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.994 -0.548 . . . . 62.399999999999999 112.021 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 37.3 m-85 -66.72 -23.97 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.603 0.223 . . . . 70.040000000000006 111.603 -178.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.45 -27.09 68.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.073 0.463 . . . . 72.530000000000001 111.023 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -60.77 -27.76 68.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 70.510000000000005 111.575 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -86.4 -24.6 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 111.398 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.55 -179.83 43.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.606 -0.807 . . . . 72.140000000000001 112.928 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -73.35 133.65 43.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.357 . . . . 64.5 110.661 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' THR . 63.9 mt -104.5 137.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.003 -0.544 . . . . 72.230000000000004 109.863 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.25 -46.97 8.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.287 . . . . 73.530000000000001 110.846 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.55 157.46 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.083 -0.339 . . . . 70.239999999999995 110.083 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.86 130.58 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.777 -0.453 . . . . 72.150000000000006 109.777 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 31.8 mt-10 -103.19 103.45 13.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.788 -0.642 . . . . 72.109999999999999 110.746 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.12 116.54 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.502 -0.555 . . . . 73.299999999999997 109.502 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.441 ' HG3' ' CE2' ' A' ' 148' ' ' PHE . 69.3 mmm -84.4 100.99 11.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.554 0.692 . . . . 73.420000000000002 109.559 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -117.57 158.38 24.69 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.007 -0.997 . . . . 51.030000000000001 110.164 -174.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -88.31 123.11 32.57 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.981 -0.748 . . . . 71.310000000000002 108.981 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 34.1 tpt85 -64.45 -31.92 73.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.386 0.429 . . . . 71.120000000000005 111.789 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.85 -47.05 4.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.635 -0.793 . . . . 74.409999999999997 113.279 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -86.22 -23.68 26.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.097 0.406 . . . . 63.130000000000003 112.097 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.11 6.25 87.46 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.909 -0.662 . . . . 62.229999999999997 112.22 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -92.34 146.12 23.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.381 -0.229 . . . . 72.109999999999999 110.381 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 72.409999999999997 109.177 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -81.03 21.8 0.68 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.377 0.88 . . . . 74.400000000000006 113.377 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.62 -2.73 80.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.675 -0.774 . . . . 75.140000000000001 113.941 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 137' ' ' MET . 13.3 p90 -154.7 163.46 40.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 73.140000000000001 110.493 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.18 171.91 13.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.208 -0.905 . . . . 63.520000000000003 109.893 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.4 m-85 -139.09 155.06 48.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.46 -0.791 . . . . 74.219999999999999 109.284 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.28 134.52 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-O 121.418 0.628 . . . . 75.219999999999999 111.334 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 53.0 m -100.26 125.63 46.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.91 -1.041 . . . . 72.230000000000004 110.672 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.5 m-85 -99.88 160.7 14.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.938 0.399 . . . . 73.349999999999994 111.253 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.43 -27.76 37.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 74.129999999999995 110.344 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.94 160.98 31.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 111.665 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -84.93 -32.08 23.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 73.340000000000003 110.756 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.611 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 35.7 t70 -62.18 -37.99 87.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.955 -0.566 . . . . 71.200000000000003 111.13 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -67.02 -33.69 76.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.526 -0.307 . . . . 53.43 111.058 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' A' ' 107' ' ' ILE . 2.6 t -68.05 -42.62 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 72.209999999999994 109.868 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.589 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 73.3 m-20 -64.14 -37.87 89.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.106 -0.952 . . . . 72.299999999999997 111.509 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 47.9 mttm -53.8 -42.67 68.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.81 0.814 . . . . 70.25 110.538 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.75 -43.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.281 -1.327 . . . . 64.010000000000005 112.395 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 160' ' ' ASP . 18.9 m -75.24 -7.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 121.972 -0.455 . . . . 75.120000000000005 111.059 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 160' ' ' ASP . 37.8 mt -57.85 -32.28 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.377 -0.829 . . . . 62.340000000000003 109.927 170.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -107.58 152.49 24.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.936 -0.575 . . . . 72.150000000000006 109.46 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.21 -39.07 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.976 0.417 . . . . 75.109999999999999 110.388 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.02 137.91 54.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 65.409999999999997 110.033 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -122.71 140.77 52.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.318 -0.401 . . . . 72.319999999999993 110.902 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -96.06 116.28 28.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.814 -0.63 . . . . 61.439999999999998 110.218 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.72 107.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.581 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.9 m120 72.95 28.19 2.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.231 -0.895 . . . . 60.340000000000003 110.007 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.84 -2.63 80.14 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.386 -0.824 . . . . 71.310000000000002 112.678 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -110.56 130.17 55.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.775 -0.25 . . . . 72.109999999999999 110.54 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.09 0.471 . . . . 61.539999999999999 110.988 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 112' ' ' ILE . 7.4 m -110.42 150.99 28.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.847 -0.615 . . . . 63.039999999999999 110.297 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -86.9 133.83 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.879 -0.415 . . . . 75.0 109.879 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.8 t -133.13 138.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 44.299999999999997 111.572 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -158.64 177.32 11.33 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.863 -0.608 . . . . 74.219999999999999 111.463 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -62.5 124.74 21.75 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.97 0.508 . . . . 73.310000000000002 110.86 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -111.99 113.61 26.0 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.217 0.532 . . . . 45.119999999999997 109.903 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.445 ' HB2' ' CG ' ' A' ' 186' ' ' MET . 39.2 mt -98.73 147.97 24.33 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.551 -0.749 . . . . 50.25 109.588 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t -72.74 174.57 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.71 -0.478 . . . . 72.340000000000003 109.71 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.92 -42.75 97.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.717 0.294 . . . . 64.120000000000005 110.73 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.42 -19.48 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 75.109999999999999 111.493 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -83.13 -46.79 12.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.745 0.307 . . . . 74.450000000000003 110.528 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.445 ' CG ' ' HB2' ' A' ' 181' ' ' LEU . 83.5 mtp -68.5 -50.26 53.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.03 -0.532 . . . . 64.519999999999996 111.124 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.87 -43.02 69.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.951 -0.568 . . . . 52.310000000000002 110.602 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.8 m 60.47 21.37 11.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.692 -0.685 . . . . 53.310000000000002 110.784 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -101.63 130.51 47.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.804 -0.635 . . . . 55.109999999999999 110.795 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.6 m -76.8 155.14 33.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.712 -0.676 . . . . 51.509999999999998 109.781 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.6 p -69.66 142.8 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.025 0.441 . . . . 73.129999999999995 111.14 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 t -94.7 85.4 4.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.433 -0.58 . . . . 62.520000000000003 109.433 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -93.43 141.18 28.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.878 0.37 . . . . 74.409999999999997 110.122 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -102.15 -49.42 3.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.181 -0.463 . . . . 73.299999999999997 110.871 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -162.22 106.61 0.28 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.199 -1.001 . . . . 51.140000000000001 113.023 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.983 -1.008 . . . . 75.239999999999995 109.007 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 CA-C-O 120.055 -0.303 . . . . 74.209999999999994 112.427 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m 74.68 -40.83 0.45 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 32.240000000000002 113.132 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -87.64 90.4 8.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.246 0.546 . . . . 73.030000000000001 111.822 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -107.14 7.64 29.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.150000000000006 109.672 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 60.1 78.88 0.26 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.834 -1.076 . . . . 50.240000000000002 110.312 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -66.56 123.6 86.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 64.25 111.117 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 60.9 Cg_endo -81.23 165.61 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.97 2.447 . . . . 72.519999999999996 112.219 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -2.53 15.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 108.845 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -71.2 141.57 86.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.018 -1.446 . . . . 74.200000000000003 109.877 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.98 166.97 19.02 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.71 2.273 . . . . 61.420000000000002 112.462 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.64 -32.29 67.12 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.956 -0.565 . . . . 64.299999999999997 111.97 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.0 pt20 -64.05 -31.91 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.794 0.33 . . . . 74.109999999999999 111.551 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 164' ' ' ILE . 5.2 mp -78.53 -20.23 51.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 60.140000000000001 111.282 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.545 ' HA ' HG21 ' A' ' 68' ' ' VAL . 23.5 ptt180 -117.18 0.1 12.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.363 -0.381 . . . . 65.310000000000002 111.587 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.6 ttmt -98.15 148.53 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.781 0.801 . . . . 73.219999999999999 112.16 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 68' ' ' VAL . 66.0 mt -117.01 145.2 43.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.331 -1.304 . . . . 70.310000000000002 110.338 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -97.93 120.27 38.03 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.112 -1.07 . . . . 65.209999999999994 108.112 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 60' ' ' VAL . 16.7 mm -100.52 110.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.79 -0.448 . . . . 73.230000000000004 109.79 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.85 151.61 16.89 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.948 -0.861 . . . . 73.319999999999993 110.948 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 43.3 12.89 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.252 -0.975 . . . . 45.119999999999997 112.974 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 25' ' ' THR . 93.3 mt -84.1 175.44 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.039 0.447 . . . . 72.109999999999999 110.499 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -90.96 172.79 8.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.382 -0.599 . . . . 52.310000000000002 109.382 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -77.35 -11.49 59.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.365 0.602 . . . . 75.299999999999997 110.28 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 24.0 mt-10 -106.9 -1.41 22.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 73.209999999999994 111.484 -175.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 HD22 ' A' ' 21' ' ' LEU . 47.3 m -69.75 126.41 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.119 0.485 . . . . 72.120000000000005 112.026 -170.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -101.92 167.5 10.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.407 -0.815 . . . . 73.409999999999997 110.0 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -28.1 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.978 -0.378 . . . . 74.239999999999995 109.978 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.9 -41.9 82.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.450000000000003 110.853 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t -72.64 -41.97 64.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 74.019999999999996 110.049 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.6 tp -59.85 -49.03 79.28 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.875 -0.602 . . . . 64.319999999999993 110.682 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HG3' HD12 ' A' ' 40' ' ' LEU . 14.2 ttm-85 -58.92 -56.54 20.9 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.438 0.695 . . . . 62.229999999999997 111.044 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 m -44.38 -38.77 4.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 44.530000000000001 113.381 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -67.26 -52.2 43.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.981 -0.554 . . . . 74.230000000000004 111.226 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -80.65 -20.27 43.44 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.925 0.343 . . . . 73.420000000000002 111.925 -170.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 31' ' ' ARG . 44.1 mt-10 -56.5 -24.27 45.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.355 0.502 . . . . 72.439999999999998 112.355 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -63.3 -27.08 69.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.468 0.544 . . . . 63.520000000000003 112.468 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -100.06 -21.95 15.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.645 0.259 . . . . 75.519999999999996 111.557 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 156.84 27.25 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.759 -0.734 . . . . 74.120000000000005 111.401 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 83.2 m -67.65 120.24 13.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.911 0.386 . . . . 70.349999999999994 111.143 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 31' ' ' ARG . 49.0 mt -84.34 145.4 28.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.328 0.585 . . . . 74.299999999999997 110.834 177.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -108.79 -22.94 11.99 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.278 -0.874 . . . . 61.420000000000002 110.17 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -154.52 157.47 38.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.502 . . . . 63.109999999999999 110.62 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.7 t -163.6 136.56 5.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.413 -0.588 . . . . 62.149999999999999 109.413 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -151.01 126.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.533 . . . . 64.219999999999999 110.298 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.77 132.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.7 -0.852 . . . . 73.319999999999993 108.7 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 mmt -76.05 97.16 3.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.732 0.777 . . . . 73.319999999999993 110.423 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 35.7 mtt180 -101.88 163.59 12.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.37 -1.286 . . . . 75.430000000000007 111.492 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.19 124.19 89.79 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 114.491 -1.231 . . . . 72.040000000000006 110.25 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.95 -20.23 70.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.084 1.856 . . . . 75.209999999999994 112.909 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -83.79 -56.51 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.12 0.415 . . . . 74.129999999999995 112.12 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -6.89 16.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 71.010000000000005 111.677 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm 64.43 40.18 6.49 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.384 -0.826 . . . . 74.439999999999998 111.953 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 27.0 mmm180 -114.42 163.03 15.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.418 -0.586 . . . . 74.209999999999994 109.418 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.6 t -72.42 133.97 45.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.148 0.499 . . . . 72.340000000000003 111.845 -173.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -81.88 -0.16 42.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.533 -0.758 . . . . 74.239999999999995 110.451 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.04 58.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.731 -0.747 . . . . 73.239999999999995 114.128 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -156.35 156.55 34.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.815 0.807 . . . . 61.450000000000003 110.58 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.51 -166.33 18.24 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 111.564 -0.615 . . . . 34.329999999999998 111.564 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.22 148.9 38.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.224 0.512 . . . . 75.530000000000001 110.35 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 m -128.43 130.14 69.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.637 -0.711 . . . . 73.019999999999996 109.318 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.4 m -106.72 120.15 41.22 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.304 -0.247 . . . . 74.439999999999998 110.354 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -83.93 169.17 15.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.48 . . . . 73.519999999999996 110.515 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -67.5 -55.65 12.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.738 -0.665 . . . . 65.230000000000004 109.577 174.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 66' ' ' GLU . 36.3 m -123.24 153.14 40.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 72.200000000000003 111.426 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.578 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.7 p -58.04 -38.28 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.777 -0.647 . . . . 70.530000000000001 111.248 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 64' ' ' THR . 6.3 mm-40 -52.63 -41.8 64.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.066 0.765 . . . . 73.340000000000003 113.066 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -62.54 -31.34 72.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.363 0.602 . . . . 72.019999999999996 110.388 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG13 HD21 ' A' ' 16' ' ' LEU . 32.9 t -68.83 -47.26 77.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.108 -0.951 . . . . 62.420000000000002 111.01 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.76 -48.3 75.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 70.5 110.887 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.4 60.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.625 0.602 . . . . 75.519999999999996 112.625 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.94 -33.59 63.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.981 0.42 . . . . 53.219999999999999 110.659 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -47.1 71.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 75.209999999999994 110.801 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.99 66.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 53.299999999999997 110.682 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.21 -8.04 46.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.943 0.72 . . . . 61.350000000000001 112.943 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' NH1' ' HG2' ' A' ' 85' ' ' GLU . 11.9 mtp180 -56.66 147.72 49.96 Favored Pre-proline 0 CA--C 1.531 0.225 0 O-C-N 122.897 0.123 . . . . 71.549999999999997 111.013 173.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.65 166.08 78.44 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.8 -1.333 . . . . 74.340000000000003 113.968 4.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -125.9 150.99 47.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.764 -0.653 . . . . 70.540000000000006 110.964 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -141.46 113.01 7.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.909 -0.587 . . . . 74.140000000000001 111.039 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.07 144.41 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.89 -0.596 . . . . 73.209999999999994 109.736 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.9 t70 67.39 22.03 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.592 0.71 . . . . 72.219999999999999 110.567 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.12 74.19 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.385 -0.825 . . . . 64.030000000000001 111.934 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -130.22 141.01 50.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.58 0.229 . . . . 74.430000000000007 110.529 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.56 113.19 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.874 -0.787 . . . . 73.319999999999993 108.874 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.31 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 75.209999999999994 111.602 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 mt-10 -115.33 98.03 49.68 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.213 -0.903 . . . . 75.409999999999997 111.403 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -75.28 133.04 15.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.967 1.778 . . . . 51.5 110.725 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -139.39 -178.84 5.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.201 -1.407 . . . . 61.149999999999999 107.201 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -86.96 143.29 27.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 119.748 1.158 . . . . 65.209999999999994 111.533 -177.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.81 3.5 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.843 -0.799 . . . . 50.039999999999999 108.843 165.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.79 160.01 5.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.339 -0.846 . . . . 75.209999999999994 110.117 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.7 p -53.21 150.66 5.84 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.407 0.442 . . . . 73.099999999999994 110.888 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 9.9 mpt_? -60.2 -23.73 64.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.916 -0.584 . . . . 65.230000000000004 112.26 -171.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.27 -45.83 91.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.966 0.413 . . . . 74.530000000000001 110.344 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.53 -50.61 7.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 63.539999999999999 111.216 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.9 p -70.91 -9.66 58.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.51 0.93 . . . . 45.43 113.51 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.89 -2.29 58.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.942 0.401 . . . . 72.010000000000005 110.866 179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -116.99 148.23 41.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.276 -0.42 . . . . 74.150000000000006 110.084 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.09 138.38 77.77 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.833 2.356 . . . . 72.25 112.592 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.09 -15.37 51.34 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.838 -0.696 . . . . 75.010000000000005 112.396 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.79 -44.32 56.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 65.099999999999994 111.671 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -96.42 13.5 27.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.793 0.33 . . . . 63.009999999999998 111.365 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.9 mt -82.12 162.72 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.193 -0.669 . . . . 73.230000000000004 109.193 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -79.23 85.75 5.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.607 0.718 . . . . 72.230000000000004 110.032 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.14 114.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.882 -1.053 . . . . 54.439999999999998 110.11 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -109.27 15.57 23.06 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.657 -0.417 . . . . 54.009999999999998 110.683 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -115.62 139.38 50.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.318 -0.401 . . . . 65.219999999999999 110.537 176.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.446 ' CG2' HG13 ' A' ' 159' ' ' VAL . 6.3 pt -131.52 152.96 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.501 0.667 . . . . 73.430000000000007 111.62 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.1 t80 -96.88 136.07 37.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.537 -1.21 . . . . 71.209999999999994 109.834 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -122.97 110.65 27.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.103 -0.703 . . . . 74.219999999999999 109.103 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.63 155.11 19.93 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.684 -1.246 . . . . 52.509999999999998 113.237 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.37 7.4 55.97 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.539 -0.838 . . . . 74.109999999999999 112.456 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.7 pt -72.44 105.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.515 0.674 . . . . 51.520000000000003 109.758 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -88.2 -10.08 50.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 63.420000000000002 111.798 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -121.71 165.42 15.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.716 -0.475 . . . . 72.430000000000007 109.716 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 145' ' ' LYS . 9.2 p-10 -70.17 104.55 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.404 1.097 . . . . 73.099999999999994 111.399 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -96.96 142.72 28.58 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.158 -1.383 . . . . 75.129999999999995 109.55 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 14.4 pt-20 -113.58 169.5 8.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.672 -0.695 . . . . 61.439999999999998 110.949 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -53.59 -51.29 63.48 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 114.828 -1.078 . . . . 71.209999999999994 110.405 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.55 -25.05 62.09 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.653 0.612 . . . . 72.519999999999996 112.653 -175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.44 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 63.7 m170 -70.94 -60.4 2.25 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.067 0.46 . . . . 63.210000000000001 110.771 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -81.47 -26.47 35.23 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 120.177 -0.609 . . . . 73.230000000000004 111.229 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -68.0 -43.46 78.82 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 110.257 -0.275 . . . . 71.420000000000002 110.257 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.67 -31.25 72.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.082 0.467 . . . . 73.239999999999995 110.422 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 170' ' ' VAL . 80.5 t80 -79.27 -54.5 5.9 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.09 -0.505 . . . . 71.439999999999998 111.859 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.88 -24.54 63.43 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.621 0.6 . . . . 71.319999999999993 112.621 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.1 mt-10 -71.49 -16.59 62.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.844 0.354 . . . . 75.329999999999998 111.152 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.34 -25.79 68.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 75.099999999999994 111.074 172.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.79 -25.56 23.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.504 -0.316 . . . . 71.420000000000002 111.266 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 126' ' ' GLU . . . 168.51 -175.35 43.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.951 -0.642 . . . . 64.209999999999994 112.641 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.64 131.77 42.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.905 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 152' ' ' THR . 76.4 mt -100.03 140.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.676 -0.693 . . . . 71.200000000000003 109.865 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.13 -51.13 6.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 64.420000000000002 110.269 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.16 156.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.93 -0.577 . . . . 72.150000000000006 109.76 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 122' ' ' ARG . 3.3 mp -115.63 128.93 72.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.745 -0.465 . . . . 75.140000000000001 109.745 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.5 mt-10 -102.13 104.44 15.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.95 -0.568 . . . . 74.129999999999995 110.729 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 145' ' ' LYS . 24.7 mm -93.31 131.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.341 -0.615 . . . . 75.430000000000007 109.341 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 48.8 mmm -105.14 132.7 51.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.517 -0.549 . . . . 74.200000000000003 109.517 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.89 139.98 32.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 60.039999999999999 111.597 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.1 127.28 32.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.258 -0.883 . . . . 73.200000000000003 109.531 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -68.93 -39.17 79.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.409 -0.36 . . . . 63.539999999999999 111.871 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.98 -46.96 12.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.074 -0.584 . . . . 51.229999999999997 113.497 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -93.19 -22.88 18.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.727 0.299 . . . . 60.520000000000003 111.292 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.45 15.55 80.74 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.097 -0.573 . . . . 64.329999999999998 112.296 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -101.68 150.36 23.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 74.540000000000006 109.396 -178.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -75.83 83.66 2.77 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.317 -0.153 . . . . 65.310000000000002 110.784 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -160.18 172.71 16.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.871 0.843 . . . . 71.420000000000002 113.224 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.93 -44.19 1.53 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.562 -1.653 . . . . 45.32 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.98 155.23 3.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.165 -0.68 . . . . 74.420000000000002 109.165 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.04 172.67 12.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.973 -0.558 . . . . 75.5 109.635 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.1 m-85 -138.61 152.13 47.86 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.744 -0.662 . . . . 64.239999999999995 109.466 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.68 132.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.365 0.602 . . . . 33.43 111.069 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 131' ' ' ILE . 82.9 m -102.75 125.08 49.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.979 -1.01 . . . . 53.0 110.918 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -102.6 157.87 16.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.578 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.47 -31.18 57.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.676 -0.693 . . . . 61.420000000000002 110.402 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.36 157.94 42.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.587 -0.733 . . . . 63.130000000000003 110.399 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -82.5 -22.89 34.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.076 -0.511 . . . . 73.109999999999999 109.859 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -53.08 -45.81 68.35 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.853 0.721 . . . . 71.439999999999998 111.25 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 162' ' ' ILE . 1.4 m -65.34 -35.29 80.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.783 -0.644 . . . . 74.519999999999996 110.836 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 107' ' ' ILE . 3.2 t -71.5 -38.61 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.795 -0.446 . . . . 71.219999999999999 109.795 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 163' ' ' VAL . 7.0 m-20 -65.92 -33.8 76.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.140000000000001 111.432 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 93.0 mttt -63.47 -38.4 91.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.417 0.627 . . . . 71.329999999999998 110.378 174.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 158' ' ' SER . 14.0 mt -78.1 -40.84 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.891 -1.05 . . . . 70.109999999999999 112.002 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 160' ' ' ASP . 35.1 m -79.14 -4.3 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.193 0.521 . . . . 72.400000000000006 111.177 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 13' ' ' LEU . 11.5 mt -62.86 -31.95 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.289 -0.869 . . . . 63.240000000000002 109.732 169.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 51.5 mt-30 -108.39 153.1 23.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.886 -0.783 . . . . 73.099999999999994 108.886 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -91.49 -38.49 12.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.831 0.348 . . . . 71.340000000000003 111.244 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.56 137.12 53.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.369 -0.378 . . . . 74.129999999999995 110.242 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.575 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 39.2 m-70 -125.38 146.05 49.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.145 -0.479 . . . . 71.439999999999998 110.172 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.6 m -91.75 110.71 22.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.049 -0.523 . . . . 75.010000000000005 111.34 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.457 HG22 ' CD2' ' A' ' 124' ' ' TYR . 41.2 t -117.13 131.09 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.07 -0.715 . . . . 70.120000000000005 109.07 174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 46.99 42.59 12.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.45 0.7 . . . . 73.049999999999997 111.924 -174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.31 7.08 59.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.788 -0.642 . . . . 62.119999999999997 113.97 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -110.24 137.29 48.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.024 0.412 . . . . 75.329999999999998 110.16 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -89.39 108.95 19.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 64.040000000000006 110.308 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -112.24 154.81 25.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.12 -0.491 . . . . 72.129999999999995 110.833 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.8 139.31 30.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.506 . . . . 63.329999999999998 109.988 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.8 m -130.11 155.3 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.997 0.427 . . . . 62.450000000000003 110.632 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -172.37 169.76 5.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.065 -0.97 . . . . 72.109999999999999 111.497 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -58.68 127.84 34.21 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 73.299999999999997 110.663 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.23 119.38 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.11 0.481 . . . . 70.310000000000002 109.884 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.59 156.2 16.92 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.695 -0.684 . . . . 64.209999999999994 109.37 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 7.5 t -65.68 152.02 45.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.204 -1.036 . . . . 61.140000000000001 108.204 172.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -67.96 -19.09 64.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.596 0.236 . . . . 74.209999999999994 110.897 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -63.92 -41.59 97.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.61 -0.515 . . . . 65.420000000000002 109.61 171.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 5.1 mm-40 -74.47 -41.57 60.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.47 . . . . 63.240000000000002 109.888 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.41 -44.52 82.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 72.239999999999995 111.61 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -90.42 -6.28 55.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.882 -0.144 . . . . 62.32 111.309 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t 60.0 29.08 18.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.308 0.643 . . . . 74.409999999999997 110.475 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 184' ' ' GLN . . . -161.93 162.89 29.29 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.37 -0.832 . . . . 63.539999999999999 109.399 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.1 m -64.03 116.53 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.243 0.339 . . . . 74.150000000000006 111.169 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 m -137.51 131.17 31.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.066 -0.516 . . . . 42.149999999999999 109.786 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 t -145.54 139.29 26.64 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 74.519999999999996 111.086 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -105.68 109.87 21.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.478 -0.564 . . . . 72.510000000000005 109.478 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -86.51 117.93 25.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.416 . . . . 74.530000000000001 110.514 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -93.97 -165.43 36.84 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.48 -0.648 . . . . 73.340000000000003 111.48 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.159 -0.924 . . . . 63.399999999999999 110.868 -179.481 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.86 -0.496 . . . . 51.520000000000003 111.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -86.73 98.89 11.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 70.049999999999997 110.598 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -98.89 85.94 3.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.529 0.68 . . . . 75.329999999999998 110.171 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.55 17.7 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.778 -0.646 . . . . 60.509999999999998 110.446 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -66.86 -39.55 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 74.340000000000003 110.405 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m 70.9 124.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 O-C-N 124.137 0.898 . . . . 73.049999999999997 110.105 -174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 150.18 89.35 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.742 2.294 . . . . 63.520000000000003 113.041 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -116.96 -1.5 11.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.893 -1.151 . . . . 71.439999999999998 107.893 177.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp0 -93.59 141.66 24.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.407 -1.27 . . . . 72.310000000000002 111.029 -172.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 30.8 Cg_endo -67.44 167.77 19.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.904 2.403 . . . . 64.329999999999998 110.778 174.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -57.36 -37.41 72.57 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 111.698 0.259 . . . . 75.109999999999999 111.698 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -67.22 -27.86 67.59 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.891 0.33 . . . . 75.099999999999994 111.891 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.2 mp -82.42 -9.79 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.385 . . . . 75.120000000000005 111.087 -177.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.449 ' HA ' HG21 ' A' ' 68' ' ' VAL . 14.2 ptt180 -123.13 -0.66 8.86 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.129 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 34.5 ttpt -91.66 145.92 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 111.571 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD11 HG13 ' A' ' 68' ' ' VAL . 3.9 mp -123.52 145.68 48.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.196 -0.911 . . . . 63.340000000000003 110.136 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -96.96 117.68 31.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.436 -0.579 . . . . 75.239999999999995 109.436 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 60' ' ' VAL . 20.3 mm -94.34 113.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.956 -0.387 . . . . 71.129999999999995 109.956 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.35 150.41 16.84 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.738 -0.744 . . . . 24.530000000000001 111.79 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.7 45.22 29.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.89 -0.672 . . . . 62.219999999999999 113.381 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 25' ' ' THR . 79.4 mt -81.85 176.72 9.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.167 0.483 . . . . 73.430000000000007 110.819 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -86.24 178.64 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 62.420000000000002 109.542 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -84.19 -6.34 59.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.051 0.453 . . . . 72.420000000000002 110.534 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.27 20.05 15.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 64.140000000000001 111.061 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.458 HG21 HD22 ' A' ' 21' ' ' LEU . 9.6 m -81.53 129.4 34.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 75.120000000000005 110.405 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -117.96 160.19 21.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.734 -0.666 . . . . 75.310000000000002 109.377 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.93 -42.94 76.89 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.561 0.538 . . . . 75.200000000000003 111.108 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.67 -30.52 71.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.581 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 m -86.28 -42.07 14.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.62 -0.264 . . . . 72.239999999999995 111.077 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.24 -50.07 67.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 110.528 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -56.42 -58.2 9.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.692 -0.686 . . . . 74.310000000000002 111.598 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -48.8 -34.22 11.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.561 0.538 . . . . 71.25 112.357 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -74.06 -49.6 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.431 -0.349 . . . . 73.200000000000003 110.99 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -78.18 -18.82 55.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.193 -0.317 . . . . 71.329999999999998 111.758 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 23.7 mt-10 -56.6 -22.68 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.111 -0.495 . . . . 73.019999999999996 112.222 172.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.65 -22.15 66.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 74.549999999999997 111.951 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -102.97 -24.04 13.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.665 0.269 . . . . 74.510000000000005 111.244 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -173.45 161.59 32.39 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.356 -0.926 . . . . 75.129999999999995 112.475 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -57.59 141.7 47.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.874 0.469 . . . . 71.209999999999994 111.552 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 62' ' ' TYR . 63.3 mt -120.23 124.72 46.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.31 -0.626 . . . . 71.5 109.31 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -97.94 -20.45 17.44 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.045 -0.525 . . . . 72.010000000000005 110.621 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -149.94 152.77 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.633 -0.506 . . . . 75.540000000000006 109.633 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -165.45 137.08 4.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.084 -0.71 . . . . 55.210000000000001 109.084 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.34 132.68 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.053 0.454 . . . . 72.400000000000006 110.727 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.11 131.28 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.269 -0.641 . . . . 61.409999999999997 109.269 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 mmt -73.65 133.2 43.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.952 -0.759 . . . . 65.409999999999997 108.952 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -139.95 158.17 44.5 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.892 -0.595 . . . . 75.329999999999998 110.928 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 22.2 t70 -67.22 129.49 93.81 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.778 -1.101 . . . . 64.400000000000006 109.646 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.59 -22.34 33.02 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.186 1.924 . . . . 70.019999999999996 113.364 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -84.99 -55.19 4.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.585 -175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 m -103.43 -8.87 19.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 111.734 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.9 mmtm 63.28 35.31 12.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.331 0.652 . . . . 74.239999999999995 111.758 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -101.48 158.75 15.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.031 -1.099 . . . . 74.239999999999995 108.031 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -70.31 140.43 52.27 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.092 0.472 . . . . 65.319999999999993 110.58 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -84.67 5.87 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.681 -0.69 . . . . 45.219999999999999 110.485 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.39 16.52 71.14 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.628 -0.796 . . . . 22.440000000000001 113.605 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -160.3 157.78 28.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.014 0.907 . . . . 65.430000000000007 110.954 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.08 -163.81 15.7 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.446 -0.661 . . . . 73.25 111.446 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.99 148.71 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.187 0.493 . . . . 61.219999999999999 110.611 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.457 HG22 HD11 ' A' ' 18' ' ' ILE . 6.4 m -130.65 126.32 60.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.907 -0.588 . . . . 72.120000000000005 109.739 172.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 m -101.28 118.01 36.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.444 -0.344 . . . . 62.43 110.166 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' HA ' HD23 ' A' ' 40' ' ' LEU . 19.4 m-85 -84.6 165.15 18.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 74.450000000000003 109.856 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.41 63.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.37 -0.377 . . . . 74.239999999999995 110.675 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.9 m -132.94 154.01 50.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.309 -0.405 . . . . 74.109999999999999 110.253 -177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.8 p -64.88 -33.54 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.736 -0.211 . . . . 63.219999999999999 111.548 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.61 -34.08 72.3 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.38 0.511 . . . . 74.120000000000005 112.38 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 5.5 mm-40 -64.94 -33.79 76.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.303 0.573 . . . . 70.120000000000005 109.791 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.654 HG13 HD11 ' A' ' 16' ' ' LEU . 2.4 t -62.61 -46.97 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 71.109999999999999 111.125 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.3 -45.51 92.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 72.349999999999994 111.075 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.15 -38.4 73.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.332 0.493 . . . . 75.340000000000003 112.332 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.3 83.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 74.510000000000005 110.451 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -69.27 -35.18 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.698 . . . . 63.200000000000003 110.974 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.655 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.9 p30 -84.84 -7.06 59.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.384 . . . . 51.229999999999997 111.515 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.27 -11.08 20.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.461 . . . . 62.420000000000002 110.606 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 10.2 ttp180 -53.2 143.63 32.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.009 -0.996 . . . . 71.230000000000004 110.855 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 4.8 Cg_exo -79.71 169.86 69.13 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.954 -0.853 . . . . 65.129999999999995 114.054 2.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.22 161.16 29.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 61.140000000000001 109.773 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 22.5 ttmt -134.3 104.66 6.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.909 0.385 . . . . 72.549999999999997 111.38 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.63 126.37 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 62.130000000000003 110.137 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.22 40.38 8.84 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.54 0.686 . . . . 73.120000000000005 110.756 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.56 27.78 73.37 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.885 -0.598 . . . . 63.200000000000003 112.785 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.0 tpt180 -132.44 140.22 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 64.549999999999997 110.002 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 t -78.28 110.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.278 -0.638 . . . . 75.519999999999996 109.278 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.0 m -104.96 150.04 8.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.408 0.623 . . . . 64.209999999999994 110.575 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.43 ' HG2' HH11 ' A' ' 75' ' ' ARG . 7.3 tt0 -117.74 96.11 48.96 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.292 -0.867 . . . . 72.450000000000003 110.853 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.14 130.83 20.82 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.456 1.437 . . . . 63.329999999999998 110.433 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 25.4 mttt -128.35 -179.56 5.09 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.295 -0.866 . . . . 75.519999999999996 108.837 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' OD2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -77.95 155.08 31.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.795 -0.446 . . . . 72.109999999999999 109.795 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.89 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 74.209999999999994 110.351 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.555 ' HB ' ' OD1' ' A' ' 160' ' ' ASP . 8.1 p -72.78 157.92 6.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.243 -0.89 . . . . 64.530000000000001 110.655 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.72 142.8 27.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.356 -0.609 . . . . 55.009999999999998 109.356 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -62.34 -17.41 58.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.803 0.335 . . . . 74.400000000000006 111.246 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.85 -48.33 74.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 74.209999999999994 110.616 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.634 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 25.3 t70 -84.16 -13.78 51.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.88 -0.6 . . . . 34.109999999999999 110.455 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -73.74 8.63 1.82 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.975 0.416 . . . . 65.340000000000003 110.956 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.38 -18.23 28.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 75.530000000000001 111.262 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 19.6 mmt180 -61.38 148.94 84.78 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 110.127 -0.323 . . . . 74.120000000000005 110.127 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -65.61 112.95 2.32 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.49 1.46 . . . . 54.229999999999997 110.343 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.7 48.98 46.27 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.695 -0.764 . . . . 74.340000000000003 111.465 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.01 -31.31 70.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 70.040000000000006 111.186 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -98.73 21.39 11.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 64.129999999999995 111.332 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.0 mt -76.88 177.58 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.988 -0.745 . . . . 74.25 108.988 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -81.92 78.31 8.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.471 0.653 . . . . 71.200000000000003 110.384 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.61 109.01 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.105 -0.952 . . . . 75.099999999999994 110.377 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.433 ' C ' HG21 ' A' ' 159' ' ' VAL . 53.5 mttt -107.36 20.99 18.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.998 0.428 . . . . 73.329999999999998 110.264 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.62 53.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.398 -0.364 . . . . 75.329999999999998 110.713 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.552 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.91 152.47 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.217 0.532 . . . . 61.409999999999997 111.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 6.3 t80 -99.34 131.84 45.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.92 -1.036 . . . . 73.239999999999995 109.452 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.45 110.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.352 -0.61 . . . . 70.420000000000002 109.352 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.43 16.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.75 -1.214 . . . . 60.329999999999998 113.825 -173.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.5 43.35 2.96 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.187 -0.53 . . . . 74.439999999999998 112.556 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 173' ' ' HIS . 22.1 pt -120.92 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.467 0.651 . . . . 74.540000000000006 110.857 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -54.24 3.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 110.437 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.93 170.54 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.436 0.46 . . . . 54.329999999999998 110.434 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.77 84.85 0.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.578 0.584 . . . . 72.310000000000002 112.578 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -83.87 131.63 34.86 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.938 -0.574 . . . . 61.299999999999997 109.475 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.53 165.44 11.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.377 -0.829 . . . . 74.010000000000005 110.546 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.26 -45.68 72.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.286 -0.87 . . . . 73.239999999999995 109.858 175.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -55.91 -38.65 70.53 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.766 0.666 . . . . 75.230000000000004 111.541 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.16 -59.09 5.97 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.299 -0.409 . . . . 74.310000000000002 111.579 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.05 -29.17 32.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.855 -0.738 . . . . 71.109999999999999 111.206 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 5.7 tmm_? -63.51 -53.34 53.5 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.468 0.175 . . . . 74.209999999999994 110.698 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.12 -26.25 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.152 0.501 . . . . 75.120000000000005 110.729 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -78.19 -56.66 4.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.8 -0.636 . . . . 71.540000000000006 111.82 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.7 m-85 -66.85 -24.07 66.1 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.983 0.364 . . . . 73.209999999999994 111.983 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.9 mt-10 -70.33 -20.66 62.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.71 0.291 . . . . 75.299999999999997 111.501 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -56.05 -30.34 61.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.099999999999994 111.35 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.14 -29.17 23.49 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.416 -0.357 . . . . 64.319999999999993 111.779 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.89 -174.17 46.72 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.808 -0.711 . . . . 52.439999999999998 113.213 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -79.23 137.54 37.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.353 . . . . 72.120000000000005 111.248 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 152' ' ' THR . 73.6 mt -108.87 140.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 74.519999999999996 110.175 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.23 -48.33 7.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.495 -0.321 . . . . 75.040000000000006 110.922 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -157.3 156.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 74.150000000000006 110.236 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.1 129.26 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.058 0.456 . . . . 42.399999999999999 110.021 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.4 mt-10 -104.57 104.41 14.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.503 -0.771 . . . . 75.120000000000005 110.945 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.23 120.04 43.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.184 -1.043 . . . . 61.530000000000001 108.184 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.9 mmm -86.32 107.44 17.98 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.707 -0.397 . . . . 35.149999999999999 110.441 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.0 163.51 24.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.758 -0.655 . . . . 61.299999999999997 110.946 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -94.89 133.98 38.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 75.530000000000001 109.373 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -65.94 -39.76 90.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.294 0.479 . . . . 74.430000000000007 112.294 -176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.14 -52.73 4.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.213 -0.994 . . . . 51.329999999999998 113.49 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.5 p -90.35 -19.72 23.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.64 0.257 . . . . 74.239999999999995 111.672 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.72 81.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.889 -0.672 . . . . 74.329999999999998 112.475 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -87.73 138.12 31.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 60.229999999999997 110.371 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -71.48 143.36 50.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.651 . . . . 72.340000000000003 109.786 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -82.27 13.69 3.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 112.109 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.47 87.85 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.979 -0.629 . . . . 60.450000000000003 113.62 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -158.83 167.65 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.075 0.437 . . . . 73.5 109.97 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.85 171.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.561 -0.745 . . . . 75.519999999999996 109.755 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.2 m-85 -136.18 151.08 49.35 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.487 -0.779 . . . . 70.439999999999998 109.09 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 130.51 25.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.513 0.673 . . . . 73.239999999999995 111.012 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.0 m -99.41 122.09 42.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.839 -1.073 . . . . 73.400000000000006 110.701 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.8 m-85 -98.03 160.16 14.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.912 0.387 . . . . 71.209999999999994 111.321 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.95 -29.94 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.64 . . . . 55.140000000000001 110.185 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.28 151.8 50.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 71.409999999999997 111.092 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -78.94 -29.89 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 63.399999999999999 111.156 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -59.38 -44.26 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.923 -0.58 . . . . 75.540000000000006 110.988 -175.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -33.16 75.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.807 -0.633 . . . . 63.530000000000001 111.515 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.552 HG13 HG23 ' A' ' 107' ' ' ILE . 1.1 t -71.55 -39.37 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.961 0.41 . . . . 64.349999999999994 110.09 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.555 ' OD1' ' HB ' ' A' ' 90' ' ' VAL . 13.2 t70 -68.55 -34.59 76.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 73.209999999999994 110.709 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 84.8 mttt -56.11 -38.96 71.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.633 0.73 . . . . 72.310000000000002 110.777 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.5 mt -75.87 -42.29 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.419 -1.264 . . . . 65.140000000000001 112.235 -175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 160' ' ' ASP . 20.3 m -76.36 -10.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.351 0.596 . . . . 73.400000000000006 110.753 -173.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.9 mt -61.1 -27.94 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.073 -0.967 . . . . 63.109999999999999 110.126 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 45.9 mt-30 -112.7 103.75 11.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.712 -0.847 . . . . 74.310000000000002 108.712 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.2 -35.33 69.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.846 -0.615 . . . . 75.340000000000003 112.627 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.61 134.53 53.78 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.304 . . . . 64.120000000000005 110.609 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.2 m-70 -121.12 153.74 37.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 73.129999999999995 110.029 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -122.76 113.7 19.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.449 . . . . 64.299999999999997 110.469 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.67 119.87 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 110.37 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 71.67 29.49 2.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.045 0.926 . . . . 70.200000000000003 109.059 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.11 -6.53 79.0 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.102 -0.953 . . . . 73.030000000000001 112.534 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 112' ' ' ILE . 70.5 t60 -102.49 133.86 46.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.785 0.326 . . . . 73.549999999999997 110.604 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.55 141.31 30.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.038 0.447 . . . . 64.030000000000001 110.714 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.06 148.34 36.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 54.310000000000002 110.311 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -91.16 129.79 37.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.421 -0.585 . . . . 72.409999999999997 109.421 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.1 t -128.53 133.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.241 0.543 . . . . 65.400000000000006 110.554 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -155.56 172.99 17.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.399 -0.819 . . . . 63.409999999999997 110.466 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -58.86 133.19 55.79 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.278 0.361 . . . . 62.509999999999998 111.175 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -116.45 114.71 24.61 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.813 -0.81 . . . . 72.010000000000005 108.813 173.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.68 163.44 13.19 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.499 -0.773 . . . . 70.129999999999995 110.303 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.589 ' HB3' ' OE1' ' A' ' 185' ' ' GLU . 19.1 t -57.52 154.05 11.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.222 -0.659 . . . . 64.349999999999994 109.222 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -67.1 -24.54 65.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.49 0.552 . . . . 74.420000000000002 112.49 -171.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -70.61 -32.21 69.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 73.219999999999999 109.839 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.589 ' OE1' ' HB3' ' A' ' 182' ' ' SER . 1.8 mp0 -74.78 -36.77 62.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 70.400000000000006 110.172 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.5 mmt -72.93 -50.94 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.431 -0.804 . . . . 71.120000000000005 111.673 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.13 -18.73 31.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.35 -0.386 . . . . 41.130000000000003 111.589 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.2 m 64.58 16.62 10.42 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.383 0.673 . . . . 75.049999999999997 111.592 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -170.84 175.86 4.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.019 -0.537 . . . . 74.219999999999999 110.012 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.3 m -78.61 108.13 11.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.217 -0.66 . . . . 60.509999999999998 109.217 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.9 m -124.12 128.69 49.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.304 -0.407 . . . . 70.510000000000005 111.025 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.5 t -70.79 153.18 43.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.889 -0.596 . . . . 75.150000000000006 110.099 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -71.43 129.86 39.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 72.129999999999995 111.119 -175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -74.55 99.45 3.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.64 -0.709 . . . . 64.340000000000003 109.921 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.95 -157.29 52.36 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.992 -0.623 . . . . 64.140000000000001 111.668 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.776 -0.631 . . . . 73.349999999999994 110.013 177.035 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 CA--C 1.515 -0.37 0 CA-C-O 121.694 0.759 . . . . 64.41 109.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 26.6 mp0 -92.98 131.36 33.46 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 114.9 -1.045 . . . . 65.32 110.655 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.5 Cg_endo -60.26 167.37 7.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.093 2.529 . . . . 61.25 112.002 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.96 -39.06 71.22 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.427 -0.351 . . . . 61.12 111.505 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -68.59 -22.79 64.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.836 0.351 . . . . 73.24 111.639 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.3 mp -91.81 -6.98 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.519 -0.31 . . . . 74.3 111.477 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.439 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.0 ptt180 -128.31 1.44 5.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.405 -0.518 . . . . 71.43 112.124 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.41 145.19 26.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.601 0.715 . . . . 63.33 111.737 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 68' ' ' VAL . 50.0 mt -115.09 145.79 41.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.581 -1.191 . . . . 74.22 110.73 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -98.69 122.69 42.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.534 -0.913 . . . . 75.34 108.534 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' VAL . 16.1 mm -102.28 111.85 33.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 110.011 -0.366 . . . . 71.11 110.011 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.8 152.14 17.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.755 -0.736 . . . . 70.12 111.839 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.69 45.66 57.71 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 65.21 113.178 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 25' ' ' THR . 73.6 mt -78.33 174.97 10.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.684 -0.487 . . . . 70.11 109.684 173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.76 164.13 19.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.024 -0.732 . . . . 75.44 109.024 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -73.95 -8.26 55.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.32 0.581 . . . . 63.14 110.33 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.89 13.81 9.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.588 -0.733 . . . . 61.41 111.513 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 HD22 ' A' ' 21' ' ' LEU . 56.0 m -74.08 125.39 28.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.456 . . . . 61.12 110.626 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -99.35 161.87 13.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.816 -0.629 . . . . 73.4 110.506 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -71.54 -31.51 67.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.437 -0.347 . . . . 72.43 110.818 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.47 -39.25 93.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.848 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.0 t -72.54 -39.93 67.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.685 . . . . 51.13 110.362 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.89 -44.87 94.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.825 -0.625 . . . . 60.11 110.782 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -59.26 -57.12 14.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.734 0.302 . . . . 75.43 110.383 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -50.16 -36.49 30.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.956 -1.02 . . . . 72.43 113.215 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.455 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.7 t-80 -72.67 -56.15 5.74 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.96 -0.296 . . . . 72.05 111.206 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.205 0.446 . . . . 61.03 112.205 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.41 -13.15 49.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 74.34 111.452 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -63.7 -28.86 70.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.832 -0.167 . . . . 72.42 111.32 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -99.06 -19.47 17.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.069 0.396 . . . . 72.53 112.069 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.88 168.97 40.71 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.812 -1.185 . . . . 53.1 113.0 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.3 m -66.86 118.42 10.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.249 0.547 . . . . 70.11 111.792 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -88.81 130.57 35.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.361 -0.836 . . . . 53.2 110.827 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 p -95.92 -24.6 16.33 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.158 -0.928 . . . . 74.54 110.021 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -152.21 152.3 32.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.586 -0.734 . . . . 61.55 110.127 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.8 t -161.82 130.95 4.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.655 -0.498 . . . . 63.41 109.655 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.6 129.34 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.318 0.58 . . . . 61.54 111.011 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.9 132.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.45 -0.944 . . . . 62.54 108.45 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 3.1 mmt -74.08 100.0 3.49 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.417 0.627 . . . . 53.44 109.857 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -102.14 160.72 14.27 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.703 -1.135 . . . . 74.41 110.833 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 11.4 t0 -75.46 126.16 87.9 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 114.748 -1.115 . . . . 71.22 110.566 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.4 -11.56 28.59 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.987 1.791 . . . . 71.3 113.158 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -85.49 -56.51 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 74.45 111.779 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -108.72 -9.59 15.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 64.05 111.4 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 65.67 49.28 1.78 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.647 -0.706 . . . . 63.42 110.954 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -120.3 159.46 24.96 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 64.33 109.342 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -73.46 134.37 43.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 45.54 111.176 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -85.19 3.49 38.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.179 0.514 . . . . 72.21 110.804 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.33 63.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.749 -0.66 . . . . 52.43 114.074 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.84 155.88 30.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.58 0.69 . . . . 62.24 109.96 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.44 -163.89 16.2 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.657 -0.577 . . . . 73.54 111.657 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.87 150.82 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.14 0.47 . . . . 73.54 110.399 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 m -131.86 131.05 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.636 -0.711 . . . . 71.43 109.489 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 m -107.3 122.98 47.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.231 -0.285 . . . . 74.22 110.231 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -89.37 165.54 14.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.922 0.391 . . . . 64.21 110.919 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.31 -49.14 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 73.2 110.587 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.37 155.8 41.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 75.43 110.903 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.544 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 8.1 p -62.21 -37.12 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.098 -0.501 . . . . 62.42 111.47 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.83 -44.11 69.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.679 0.622 . . . . 61.34 112.679 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.93 -29.87 70.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.957 0.408 . . . . 74.32 110.819 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 16' ' ' LEU . 41.4 t -63.94 -49.76 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.682 -0.69 . . . . 62.44 110.745 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.21 -42.0 85.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 63.23 111.809 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HA ' HD22 ' A' ' 73' ' ' ASN . . . -58.59 -31.85 68.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.84 0.682 . . . . 72.04 112.84 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.76 -34.06 40.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 43.33 110.351 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mmt -62.79 -49.33 75.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.712 -0.676 . . . . 75.35 110.476 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -70.49 -26.73 63.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 65.43 111.194 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.75 -5.61 35.33 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.956 0.724 . . . . 42.05 112.956 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -57.8 148.43 58.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.503 0.186 . . . . 75.3 111.503 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.09 165.61 84.43 Favored 'Cis proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.789 -1.338 . . . . 53.42 113.454 2.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -123.68 158.01 32.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.613 . . . . 64.1 111.079 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.1 ttmt -139.41 105.1 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.094 -0.503 . . . . 73.24 111.531 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' ND1' ' A' ' 33' ' ' HIS . 16.2 t -108.2 128.71 63.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 74.14 109.541 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.52 31.09 10.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.58 0.55 . . . . 61.42 111.631 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.08 21.16 80.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.938 -0.649 . . . . 51.55 111.873 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.0 tpt180 -124.12 136.01 53.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.204 -0.295 . . . . 71.1 110.204 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.53 108.08 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.203 -0.666 . . . . 75.31 109.203 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.81 148.4 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.168 0.509 . . . . 53.41 110.932 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 4.6 tp10 -111.47 95.01 24.76 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.277 -0.874 . . . . 62.22 110.886 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.52 130.58 12.88 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.897 1.732 . . . . 72.1 111.183 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 30.6 mttt -137.78 177.4 7.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.464 -0.789 . . . . 43.0 109.178 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' NH1' HG11 ' A' ' 68' ' ' VAL . 17.7 tpp180 -77.41 139.54 39.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 110.066 -0.346 . . . . 75.52 110.066 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.01 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.998 0.428 . . . . 61.45 110.194 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 136.21 22.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.909 -1.042 . . . . 74.23 111.568 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.8 147.06 43.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.725 -0.67 . . . . 42.54 109.732 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -63.52 -20.94 66.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.262 0.838 . . . . 73.02 113.262 -171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.58 -47.87 68.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.755 0.312 . . . . 65.23 110.68 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.25 -29.56 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.969 0.414 . . . . 60.22 110.171 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 t -72.0 -3.01 20.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.921 -0.581 . . . . 52.51 111.007 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -93.23 -3.15 54.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.327 0.584 . . . . 74.44 109.916 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -95.44 151.98 38.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.833 -0.622 . . . . 70.51 110.499 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.1 120.33 7.54 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.748 2.299 . . . . 75.12 112.346 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.07 40.89 8.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.822 -0.704 . . . . 71.45 112.389 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -86.01 -46.05 10.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 60.02 111.525 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.72 10.94 26.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.322 0.582 . . . . 71.32 110.608 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.01 161.82 19.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.895 -0.78 . . . . 51.42 108.895 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.3 m -77.05 92.91 3.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.46 0.648 . . . . 74.11 110.942 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.02 115.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.067 -0.97 . . . . 75.03 110.032 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.501 ' C ' HG21 ' A' ' 159' ' ' VAL . 76.7 mttt -108.88 18.54 20.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.974 0.416 . . . . 72.34 110.833 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -118.23 139.59 51.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.386 -0.37 . . . . 70.0 110.854 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.481 HG23 HG13 ' A' ' 159' ' ' VAL . 6.4 pt -127.28 153.38 36.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.213 0.53 . . . . 64.43 111.501 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -103.58 138.25 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.78 -1.1 . . . . 63.44 109.545 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.48 109.56 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.91 161.03 19.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.029 -1.081 . . . . 74.43 113.366 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.0 46.42 36.55 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.065 -0.588 . . . . 63.04 111.655 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.426 HG22 ' SG ' ' A' ' 175' ' ' CYS . 15.5 pt -90.55 -165.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.478 -0.361 . . . . 73.12 110.582 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -82.36 -167.48 1.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.652 0.263 . . . . 44.31 111.315 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.8 -22.31 66.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.186 -0.461 . . . . 75.34 111.168 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.9 144.05 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.541 -0.754 . . . . 71.55 109.142 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -140.05 138.7 35.59 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.882 -0.784 . . . . 64.51 108.882 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.65 158.59 15.36 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.105 -0.498 . . . . 74.22 110.778 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -47.05 76.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.188 -0.914 . . . . 54.33 108.933 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -53.63 -34.39 58.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.017 -0.992 . . . . 61.01 111.894 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -66.32 -59.45 3.7 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.928 0.394 . . . . 70.31 111.135 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 3.1 pp -82.78 -26.62 31.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.158 -0.617 . . . . 70.33 111.353 -172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 6.1 tmm_? -65.42 -48.63 72.14 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.96 -0.385 . . . . 61.15 109.96 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.56 -26.67 68.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.209 0.528 . . . . 74.15 110.579 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.431 ' HA ' HE21 ' A' ' 127' ' ' GLN . 82.7 t80 -78.92 -55.54 5.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.849 -0.614 . . . . 75.04 111.781 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 151' ' ' VAL . 35.8 m-85 -69.45 -22.93 63.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.428 0.529 . . . . 63.43 112.428 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -68.61 -22.93 64.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.807 0.337 . . . . 72.22 111.477 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 124' ' ' TYR . 57.0 mt-30 -58.74 -28.35 65.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 74.44 110.816 172.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -88.99 -23.99 22.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 71.12 111.105 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.79 -178.12 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.407 -0.901 . . . . 73.43 113.696 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -73.4 131.28 41.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.92 0.488 . . . . 64.54 110.963 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 152' ' ' THR . 65.5 mt -103.12 138.35 27.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.465 . . . . 72.42 109.986 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.88 -48.0 9.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.694 0.283 . . . . 74.25 110.673 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.06 156.95 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.177 -0.465 . . . . 54.44 109.824 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.33 126.22 71.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.16 0.505 . . . . 52.2 109.927 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -99.77 105.23 17.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 74.33 110.544 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.32 122.6 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.247 -0.649 . . . . 62.54 109.247 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 64.7 mmm -96.12 128.02 42.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.525 -0.546 . . . . 70.02 109.525 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.804 0 CA-C-O 121.41 0.624 . . . . 73.12 111.44 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 119.853 -0.415 . . . . 45.3 112.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -174.96 154.92 1.93 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.4 171.98 13.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.915 -0.584 . . . . 75.13 109.79 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 42.3 m-85 -137.53 145.71 43.27 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.833 -0.621 . . . . 72.22 109.995 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 125' ' ' PHE . 60.4 t -129.86 130.14 66.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.752 0.31 . . . . 73.22 110.738 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 131' ' ' ILE . 90.4 m -104.76 119.64 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 71.32 110.601 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -102.87 159.06 15.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.952 0.405 . . . . 71.21 111.417 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -77.85 -29.21 50.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.562 -0.744 . . . . 65.13 110.581 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -130.43 155.36 46.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.476 -0.784 . . . . 65.22 110.259 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.41 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.7 p80 -77.87 -26.44 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.089 -0.505 . . . . 72.43 110.513 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -59.83 -41.93 92.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.474 -0.785 . . . . 64.54 111.493 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.96 -34.92 79.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.586 -0.279 . . . . 74.51 110.915 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.501 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -69.61 -40.75 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 73.24 109.722 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.72 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.82 -31.6 68.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.186 -0.916 . . . . 62.2 111.441 -178.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 39.3 mttm -56.23 -37.81 70.23 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.779 0.8 . . . . 63.51 109.871 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.0 mt -79.48 -42.65 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.489 -1.232 . . . . 72.33 112.522 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 160' ' ' ASP . 21.4 m -74.98 -13.56 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.906 0.384 . . . . 74.11 111.171 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 13' ' ' LEU . 28.9 mt -56.44 -34.83 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.979 170.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.95 102.48 10.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.64 -0.874 . . . . 63.1 108.64 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -57.26 -31.77 65.9 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.899 0.703 . . . . 51.11 112.899 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.61 135.46 54.99 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.248 -0.581 . . . . 63.44 110.44 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -126.56 154.84 43.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.521 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.3 m -94.22 107.32 19.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.338 -0.392 . . . . 51.2 110.257 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.79 131.4 70.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.183 -0.673 . . . . 45.44 109.183 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 45.4 47.16 10.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.287 0.635 . . . . 55.42 112.491 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.88 73.96 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.031 -0.531 . . . . 71.32 113.575 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -142.29 133.22 25.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.01 -0.367 . . . . 75.31 110.01 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -82.21 109.58 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.872 0.367 . . . . 72.33 110.251 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 112' ' ' ILE . 10.3 m -108.72 155.02 21.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.01 -0.541 . . . . 71.43 109.938 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.33 137.78 32.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 72.03 110.472 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -129.59 160.38 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 73.24 110.343 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -174.09 175.92 2.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.214 -0.903 . . . . 75.24 111.507 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' HG11 ' A' ' 163' ' ' VAL . 19.1 mmtm -62.29 130.81 47.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.735 -0.666 . . . . 74.55 110.696 173.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -117.57 114.55 23.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.628 -0.878 . . . . 63.24 108.628 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 C--N 1.309 -1.167 0 C-N-CA 120.607 -0.437 . . . . 74.22 109.845 -177.6 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 109.08 -0.711 . . . . 71.33 109.08 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -66.95 130.86 93.88 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.816 -1.084 . . . . 61.44 110.812 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.23 169.29 12.51 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.216 2.611 . . . . 54.53 111.751 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.7 pt-20 -52.14 -38.86 58.9 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 112.185 0.439 . . . . 64.41 112.185 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 6.5 pt20 -65.64 -26.31 67.75 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.108 0.41 . . . . 75.51 112.108 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 164' ' ' ILE . 5.4 mp -88.97 -9.88 49.78 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.185 -0.322 . . . . 60.11 111.165 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 68' ' ' VAL . 12.8 ptt180 -118.72 -5.17 10.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 63.42 111.301 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.7 ttpt -93.69 148.73 21.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.402 0.62 . . . . 74.12 111.213 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.556 HD21 HG13 ' A' ' 68' ' ' VAL . 54.0 mt -120.57 146.39 46.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.973 . . . . 75.44 110.413 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 16.5 t80 -98.13 131.33 44.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.085 -1.08 . . . . 74.05 108.085 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 60' ' ' VAL . 20.6 mm -106.45 111.55 35.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.892 -0.41 . . . . 74.32 109.892 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.6 148.65 17.51 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.855 -0.688 . . . . 72.32 111.9 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.77 46.41 30.42 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.785 -0.722 . . . . 72.23 113.503 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 25' ' ' THR . 79.1 mt -81.34 174.39 11.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.883 0.373 . . . . 62.05 110.237 173.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.0 p -87.64 173.88 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.437 -0.579 . . . . 64.34 109.437 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.9 -11.51 59.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.119 0.485 . . . . 75.54 109.78 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -103.67 -0.43 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.366 -0.834 . . . . 74.1 111.941 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 21' ' ' LEU . 33.3 m -67.91 123.77 21.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.0 0.429 . . . . 72.13 111.615 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.9 159.51 15.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.552 -0.749 . . . . 63.4 110.066 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -68.73 -30.92 69.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.344 . . . . 72.0 111.876 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -25.08 45.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.883 -0.327 . . . . 74.23 111.145 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.8 m -74.94 -43.5 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.415 . . . . 34.04 110.406 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.25 -46.2 89.92 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.498 -0.774 . . . . 62.33 110.065 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -55.63 -59.87 4.24 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.445 -0.798 . . . . 73.43 111.794 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -50.18 -33.73 20.16 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.787 0.68 . . . . 63.55 112.654 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.438 ' CG ' HG22 ' A' ' 79' ' ' VAL . 62.3 t60 -69.03 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 74.15 110.684 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.16 -22.63 62.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.198 0.444 . . . . 75.34 112.198 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 31.8 tt0 -65.15 -21.53 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 74.31 111.06 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.49 -23.13 66.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 74.33 111.941 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -102.42 -21.12 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.514 0.197 . . . . 72.42 111.528 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.91 161.64 32.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.398 -0.906 . . . . 74.24 112.603 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -67.88 116.05 8.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.144 0.497 . . . . 70.11 111.443 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -84.41 136.8 33.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.464 -0.789 . . . . 75.3 110.205 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -106.45 -16.5 14.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.428 -0.805 . . . . 60.33 109.749 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.52 149.42 29.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 75.32 109.886 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.9 t -160.42 131.09 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.215 -0.291 . . . . 75.15 110.215 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.12 131.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.996 0.427 . . . . 73.12 110.254 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -92.96 130.51 41.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.222 -1.029 . . . . 45.2 108.222 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.67 97.59 3.85 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.653 0.74 . . . . 45.4 110.605 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 29.4 mtt180 -101.94 163.94 11.98 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.598 -1.183 . . . . 74.23 110.391 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 22.6 t70 -79.27 126.79 80.8 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.145 -0.934 . . . . 64.12 109.512 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.45 -18.95 49.53 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 121.901 1.734 . . . . 72.44 113.362 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 35.9 m-80 -86.02 -56.52 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 62.11 111.482 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 -10.11 24.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.142 -0.481 . . . . 72.11 111.873 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm 66.17 29.93 9.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.998 0.919 . . . . 72.11 111.481 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -106.15 150.68 25.6 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.792 -0.447 . . . . 73.12 109.792 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 30.5 t -73.83 133.96 43.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.107 0.479 . . . . 70.43 110.73 -174.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -83.71 2.61 36.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.386 -0.824 . . . . 71.05 111.022 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.88 16.91 60.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.883 -0.675 . . . . 73.34 113.957 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.6 158.4 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.947 0.874 . . . . 75.14 111.097 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.76 -165.31 17.31 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.459 -0.656 . . . . 52.22 111.459 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.28 146.35 33.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 117.213 0.507 . . . . 73.41 110.302 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 18' ' ' ILE . 11.0 m -127.82 126.59 67.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.704 -0.68 . . . . 60.52 109.333 172.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 m -103.62 120.72 41.47 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.125 -0.359 . . . . 75.21 110.426 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -85.98 161.47 18.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.017 -0.538 . . . . 75.11 110.146 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.58 66.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.591 -0.731 . . . . 64.53 110.704 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.688 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 89.5 m -141.97 151.8 42.87 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.829 -0.623 . . . . 61.54 110.785 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -58.06 -36.76 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.161 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -49.37 -47.73 47.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.017 0.747 . . . . 73.33 113.017 175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.9 mp0 -64.7 -31.39 72.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.711 0.291 . . . . 74.24 111.273 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.556 HG13 HD21 ' A' ' 16' ' ' LEU . 52.1 t -63.31 -47.92 89.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 74.45 110.593 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.29 -43.28 99.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.391 -0.822 . . . . 74.34 111.062 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -55.7 -35.65 66.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.746 0.647 . . . . 74.32 112.746 172.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -31.18 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 74.43 109.903 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.7 mmt -72.25 -37.69 69.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 72.15 111.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.625 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -76.22 -14.08 60.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.151 0.5 . . . . 64.45 110.573 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.67 -9.17 50.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.596 -0.729 . . . . 61.11 111.903 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -56.65 146.88 54.15 Favored Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.22 0.325 . . . . 53.53 111.642 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.85 167.9 77.46 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.889 -1.296 . . . . 62.53 113.224 2.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -122.59 154.47 37.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 70.21 111.315 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.8 ttmt -139.05 109.15 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 74.11 110.976 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' CG ' ' A' ' 33' ' ' HIS . 18.8 t -109.94 129.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.585 -0.524 . . . . 72.15 109.585 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.9 t70 68.36 22.06 8.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.8 0.81 . . . . 75.55 110.563 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.08 67.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 64.34 111.777 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.5 tpt180 -124.0 138.14 54.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.74 -0.467 . . . . 74.04 109.74 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.7 109.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.48 -0.563 . . . . 54.12 109.48 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -107.66 148.64 11.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.985 0.422 . . . . 71.41 110.482 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.51 103.46 52.68 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.821 -0.627 . . . . 72.21 111.476 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.52 132.8 19.54 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.008 1.805 . . . . 53.14 111.363 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.517 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 11.4 mmtt -131.6 161.12 33.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.66 -1.237 . . . . 63.32 107.66 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.51 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.6 tpp180 -68.34 139.82 55.89 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.465 -0.568 . . . . 61.11 109.465 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 91.93 1.7 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.471 0.653 . . . . 63.35 109.786 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.404 ' CG2' HG23 ' A' ' 163' ' ' VAL . 9.8 p -65.18 156.23 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.672 -1.149 . . . . 64.43 111.598 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 t -60.46 155.71 17.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.649 -0.705 . . . . 71.53 110.44 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -60.46 -25.31 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.75 -0.659 . . . . 74.43 112.009 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.28 -54.41 25.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.059 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.11 -30.6 63.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.041 -0.264 . . . . 61.4 111.422 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -68.46 -8.81 44.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.924 0.392 . . . . 53.31 111.525 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.02 -21.87 59.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.327 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -79.65 153.98 75.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.12 110.597 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.26 129.77 16.51 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.693 2.262 . . . . 73.01 111.4 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.03 57.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 74.33 112.586 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.32 60.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.143 0.497 . . . . 74.14 110.676 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.476 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 19.8 m170 -100.5 20.93 14.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.51 0.671 . . . . 71.33 110.548 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.22 179.12 5.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 43.34 109.423 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 97.08 7.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.172 0.511 . . . . 33.44 110.597 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.41 113.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.252 -0.885 . . . . 71.54 109.529 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.457 ' C ' HG21 ' A' ' 159' ' ' VAL . 84.8 mttt -110.72 21.86 16.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.474 -0.49 . . . . 61.12 111.174 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -126.04 145.78 50.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.855 0.36 . . . . 75.1 111.859 176.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -129.77 153.66 39.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.169 0.509 . . . . 73.41 111.696 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.4 t80 -100.81 139.63 36.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.03 -0.986 . . . . 71.32 109.364 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t -131.12 111.55 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.622 -0.51 . . . . 72.4 109.622 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.3 167.88 25.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.546 -1.311 . . . . 44.53 113.428 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.48 38.34 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.682 -0.77 . . . . 63.42 112.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.7 143.7 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.701 -0.481 . . . . 70.32 109.701 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -89.18 -42.05 11.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 72.24 111.398 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -104.89 -97.28 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.317 -0.401 . . . . 72.21 110.59 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 147.02 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.67 -0.863 . . . . 73.52 108.67 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 129.45 36.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.386 0.612 . . . . 74.44 110.82 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.47 166.14 11.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.905 -1.043 . . . . 75.1 110.194 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.12 -45.65 90.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 74.34 109.713 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -57.73 -32.85 67.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 62.22 111.929 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -67.25 -57.61 6.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.907 0.384 . . . . 75.4 111.241 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 122' ' ' ARG . 2.4 pp -83.94 -25.0 30.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.298 -0.561 . . . . 72.41 111.303 -171.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' N ' HD12 ' A' ' 121' ' ' LEU . 6.0 tmm_? -65.28 -51.38 61.09 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.922 -0.399 . . . . 74.12 109.922 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.66 -27.26 69.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 64.13 110.635 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 170' ' ' VAL . 82.0 t80 -80.64 -54.03 6.01 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.012 -0.54 . . . . 73.13 111.923 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.4 m-85 -70.88 -23.01 62.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.16 0.43 . . . . 64.2 112.16 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.7 mt-10 -67.15 -20.41 65.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.935 0.398 . . . . 71.32 111.194 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.01 -20.98 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.833 -0.621 . . . . 72.21 111.373 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.59 -27.87 17.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.548 -0.296 . . . . 70.34 111.678 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -171.49 44.39 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.528 -0.844 . . . . 51.22 113.232 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -76.36 130.7 38.46 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.04 0.447 . . . . 74.2 111.602 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.471 HD12 ' HG3' ' A' ' 126' ' ' GLU . 55.0 mt -101.38 140.54 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 71.22 109.804 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.31 -50.41 6.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 70.33 110.269 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 p -158.28 158.66 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.581 -0.736 . . . . 63.41 109.338 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.78 128.92 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 73.34 109.851 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.8 mt-10 -104.29 104.71 14.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 45.23 110.454 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mm -96.6 116.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.44 -0.948 . . . . 74.05 108.44 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.2 mmm -87.54 135.59 33.29 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.794 -0.363 . . . . 75.01 110.481 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.383 0.611 . . . . 53.41 111.127 -178.683 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 112.603 -0.199 . . . . 54.54 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.56 161.63 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 74.31 110.153 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.52 173.09 11.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.572 -0.74 . . . . 35.32 110.159 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 41.1 m-85 -137.27 145.47 43.56 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.223 -0.899 . . . . 73.31 109.351 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 125' ' ' PHE . 61.4 t -128.42 125.63 64.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 120.99 0.424 . . . . 75.31 110.879 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 87.9 m -101.5 119.93 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 73.03 111.033 -176.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.08 155.23 18.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.986 0.422 . . . . 70.11 111.743 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.05 -18.46 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.562 -0.745 . . . . 61.34 110.579 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.04 151.73 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 54.13 111.152 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.517 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p80 -82.78 -28.15 30.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.599 -0.273 . . . . 75.13 111.288 -175.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.618 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 23.9 t70 -68.01 -35.26 78.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.995 -0.548 . . . . 52.24 110.589 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.0 m -67.72 -34.13 76.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 60.15 110.825 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 107' ' ' ILE . 2.2 t -72.13 -38.36 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.019 -0.537 . . . . 70.24 109.558 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 t70 -66.11 -35.79 81.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 72.34 111.007 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 83.5 mttt -57.46 -37.98 73.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.504 0.669 . . . . 64.24 110.7 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.429 HD13 HD13 ' A' ' 107' ' ' ILE . 16.1 mt -75.69 -42.07 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.807 -1.088 . . . . 74.32 111.567 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.8 m -77.81 -8.19 11.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.465 0.65 . . . . 74.34 110.902 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.41 HD13 HD12 ' A' ' 13' ' ' LEU . 15.0 mt -60.79 -32.77 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.997 -1.001 . . . . 72.34 110.382 170.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 43.2 mt-30 -113.17 114.73 27.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.046 -0.724 . . . . 64.51 109.046 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.23 -38.07 67.98 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.049 0.759 . . . . 63.13 113.049 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -123.09 138.43 54.67 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.089 -0.382 . . . . 73.54 110.574 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.53 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 36.7 m-70 -123.35 140.01 53.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 74.14 110.966 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -87.26 104.38 16.34 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.786 -0.643 . . . . 73.24 111.11 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 124' ' ' TYR . 28.2 t -111.22 127.26 68.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.488 -0.778 . . . . 54.35 109.143 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 45.18 40.13 4.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.274 0.63 . . . . 60.12 112.319 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 -6.15 77.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.034 -0.603 . . . . 64.14 114.152 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -107.68 128.74 54.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.581 0.691 . . . . 74.42 110.46 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.36 113.1 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.693 0.759 . . . . 74.53 110.34 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.4 p -112.18 156.57 22.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.337 -0.847 . . . . 75.3 109.511 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -86.04 137.38 32.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.206 0.527 . . . . 71.24 110.898 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -129.53 164.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.205 -0.907 . . . . 73.45 110.721 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -175.66 173.98 2.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.104 -0.953 . . . . 64.54 111.245 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -61.01 134.82 57.48 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 123.618 0.574 . . . . 65.44 110.247 173.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -127.73 122.61 33.31 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.311 -0.626 . . . . 74.33 109.311 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 C--N 1.312 -1.049 0 C-N-CA 119.982 -0.687 . . . . 74.4 109.546 177.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 108.657 -0.868 . . . . 73.52 108.657 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -99.44 136.61 20.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.516 -1.22 . . . . 72.13 110.842 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' HD22 ' A' ' 13' ' ' LEU . 25.3 Cg_endo -64.51 167.65 14.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.932 2.421 . . . . 61.1 111.199 172.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.3 pt-20 -56.49 -35.73 68.31 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.596 0.221 . . . . 73.52 111.596 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.452 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.3 pt20 -69.09 -25.49 64.46 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.591 0.234 . . . . 64.11 111.404 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 12' ' ' GLN . 4.6 mp -88.63 -11.97 43.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.513 0.196 . . . . 75.31 111.384 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.549 ' HA ' HG21 ' A' ' 68' ' ' VAL . 31.2 ptt180 -124.12 6.53 8.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.195 0.522 . . . . 73.23 110.835 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.6 ttpt -97.87 146.87 25.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.353 0.597 . . . . 71.21 110.908 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.639 HD21 HG13 ' A' ' 68' ' ' VAL . 55.9 mt -116.36 145.21 43.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.919 -1.037 . . . . 73.23 110.354 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 13.5 t80 -101.1 125.67 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.446 -0.946 . . . . 74.52 108.446 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -106.25 111.11 33.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.985 -0.376 . . . . 71.32 109.985 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.48 157.54 18.23 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.548 -0.834 . . . . 74.41 111.222 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.29 67.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.932 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD22 HG21 ' A' ' 25' ' ' THR . 44.1 mt -80.3 170.66 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 74.21 110.86 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -92.09 165.65 13.06 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.608 -0.724 . . . . 65.22 109.726 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -67.3 -22.51 65.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.898 -0.592 . . . . 74.1 110.092 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -97.22 2.7 51.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.639 -0.71 . . . . 73.0 111.408 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 21' ' ' LEU . 80.7 m -77.33 117.67 19.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 75.11 111.546 -175.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 p -105.35 164.47 11.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.059 -0.973 . . . . 74.51 109.516 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -40.57 90.9 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.416 0.448 . . . . 74.34 111.132 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.83 -37.38 87.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.942 -0.572 . . . . 73.04 111.402 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.1 m -78.48 -41.64 31.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.555 -0.293 . . . . 73.54 110.96 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.7 tp -62.87 -49.01 76.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.167 -0.47 . . . . 72.24 110.623 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -57.4 -56.04 27.01 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.443 -0.799 . . . . 75.41 110.886 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 m -48.24 -39.18 20.46 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.439 0.903 . . . . 74.11 113.439 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -70.22 -53.03 18.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 73.25 110.916 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -73.12 -21.96 60.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.925 0.343 . . . . 74.21 111.925 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -17.8 54.42 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.667 0.387 . . . . 60.22 111.921 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.73 -27.11 68.98 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.568 -0.287 . . . . 71.35 111.7 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -99.25 -17.42 18.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.688 0.255 . . . . 63.41 111.688 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 168.34 38.6 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.042 -1.075 . . . . 74.43 112.862 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -68.61 121.49 16.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.194 0.521 . . . . 73.42 111.507 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.5 128.94 36.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.709 -0.678 . . . . 63.1 111.267 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 p -91.25 -29.27 17.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.95 -1.023 . . . . 61.45 110.164 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -150.39 152.37 34.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 65.44 109.455 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.67 136.45 6.18 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.475 -0.565 . . . . 42.53 109.475 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -152.14 121.75 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.375 0.607 . . . . 72.11 110.471 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.44 131.01 34.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.431 -0.952 . . . . 51.41 108.431 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.8 mmt -76.22 99.61 4.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.602 0.715 . . . . 53.31 110.697 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 57.8 mtp85 -109.47 163.6 13.28 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.524 -1.216 . . . . 75.54 109.251 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.23 126.92 82.64 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.776 -0.453 . . . . 61.53 109.776 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.25 -18.92 44.81 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.969 1.779 . . . . 42.5 112.67 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.11 -56.79 3.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 54.15 111.607 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -100.85 -8.56 22.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 71.4 111.74 -172.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm 62.27 39.0 12.92 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.65 0.78 . . . . 70.22 112.57 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -115.68 153.49 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.256 -0.277 . . . . 65.3 110.636 177.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 36.3 t -69.52 134.33 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.749 0.309 . . . . 63.33 110.48 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -85.35 -4.11 59.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 74.35 110.279 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.79 18.96 53.42 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.923 -0.656 . . . . 74.32 113.777 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -159.07 158.35 32.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.564 0.682 . . . . 75.31 110.425 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.16 -166.62 18.51 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.636 -0.586 . . . . 50.12 111.636 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -141.12 148.49 40.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.467 0.634 . . . . 74.34 110.778 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 16' ' ' LEU . 4.7 m -131.08 121.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 73.44 109.931 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 m -101.94 123.58 46.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.51 -0.313 . . . . 71.03 110.442 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 68' ' ' VAL . 35.7 m-85 -88.23 171.24 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.16 0.505 . . . . 70.03 111.368 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.4 -48.39 11.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.416 -0.811 . . . . 74.12 110.146 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -115.43 149.06 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 73.51 110.158 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 10.0 p -68.95 -25.28 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.004 0.43 . . . . 54.14 111.122 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.92 -34.76 73.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 72.22 110.995 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.56 -28.45 66.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 65.01 110.38 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.639 HG13 HD21 ' A' ' 16' ' ' LEU . 21.8 t -68.22 -46.34 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.359 -0.837 . . . . 74.32 110.198 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.98 -46.12 88.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.417 -0.81 . . . . 72.01 110.938 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -61.12 -31.4 71.1 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.679 0.622 . . . . 33.13 112.679 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 -36.25 65.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.098 0.475 . . . . 54.42 110.039 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.6 mmt -69.62 -35.22 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.87 -0.604 . . . . 54.24 110.995 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.624 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 6.6 p30 -79.64 -22.72 43.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.455 -0.339 . . . . 73.1 111.13 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.84 -5.65 46.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 44.43 112.449 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mtp-105 -58.96 146.7 76.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.449 -0.341 . . . . 72.02 111.468 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 168.18 77.85 Favored 'Cis proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.686 -1.381 . . . . 73.4 113.743 1.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -123.4 155.63 37.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 63.04 110.654 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.3 ttmt -139.78 104.95 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.042 0.448 . . . . 71.22 111.176 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 t -105.82 128.23 60.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.787 -0.642 . . . . 73.1 109.558 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 64.78 29.9 12.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.371 0.668 . . . . 74.31 111.76 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.89 77.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.784 -0.722 . . . . 52.34 112.04 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.5 tpt180 -124.93 134.6 52.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.133 -0.321 . . . . 74.44 110.133 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 113.39 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 7.4 m -102.5 152.49 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 74.42 111.272 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HG3' ' NZ ' ' A' ' 87' ' ' LYS . 5.7 tp10 -113.73 91.8 22.56 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.741 -1.118 . . . . 55.54 110.542 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -78.37 143.74 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.808 2.338 . . . . 64.05 111.136 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' NZ ' ' HG3' ' A' ' 85' ' ' GLU . 12.7 mmtm -139.77 159.78 41.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.641 -1.244 . . . . 74.02 107.641 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' NH2' ' HA ' ' A' ' 90' ' ' VAL . 2.5 tmm_? -69.49 130.98 43.99 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.845 -1.539 . . . . 61.4 106.845 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.54 94.7 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.971 0.415 . . . . 64.34 111.157 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 25.5 t -58.52 140.82 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.725 -1.125 . . . . 65.13 111.826 -172.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -56.66 143.32 36.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.386 -0.824 . . . . 71.1 109.866 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -62.44 -31.31 71.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.593 0.59 . . . . 74.42 112.593 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.81 -29.1 58.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.463 0.173 . . . . 71.23 111.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.05 -30.46 39.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.391 -0.596 . . . . 73.4 109.391 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.3 m -74.94 -3.24 31.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.442 -0.799 . . . . 50.21 111.211 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.38 -13.72 60.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.375 0.607 . . . . 74.21 109.968 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -106.24 146.96 34.0 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.396 -0.594 . . . . 63.23 109.396 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.88 140.62 35.47 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.598 2.199 . . . . 61.12 112.217 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 9.63 60.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.934 -0.651 . . . . 24.15 112.474 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.21 54.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.626 0.251 . . . . 43.02 111.6 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -96.2 22.7 7.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 72.43 111.205 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.1 mt -100.46 174.84 5.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 72.24 109.957 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 m -78.99 85.49 4.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 72.21 109.845 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.94 112.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.182 -0.917 . . . . 44.24 109.946 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 69.8 mttt -106.94 13.76 27.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 44.22 110.653 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -114.67 138.79 50.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.571 -0.286 . . . . 63.24 111.27 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 159' ' ' VAL . 5.2 pt -130.13 152.44 37.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.237 0.542 . . . . 54.54 111.796 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.0 t80 -97.49 137.43 36.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.915 -1.039 . . . . 64.43 109.854 175.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 t -124.72 110.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.128 -0.693 . . . . 64.52 109.128 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -134.18 155.94 22.12 Favored Glycine 0 CA--C 1.507 -0.45 0 C-N-CA 119.742 -1.218 . . . . 50.33 113.232 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.48 10.57 31.0 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.564 -0.827 . . . . 74.4 112.258 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.1 pt -78.34 110.09 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 70.34 109.956 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.63 -18.88 24.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 61.45 111.203 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -112.18 175.22 5.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.841 -0.618 . . . . 60.24 109.874 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.96 123.98 22.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 71.11 110.067 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -118.51 144.32 46.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.096 -0.502 . . . . 65.42 110.125 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.38 162.51 13.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.803 -0.635 . . . . 73.24 111.217 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -47.69 77.29 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.732 -1.122 . . . . 61.53 109.755 175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -54.25 -40.65 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.637 0.586 . . . . 70.14 111.669 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -57.8 -58.51 8.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.855 0.359 . . . . 74.21 111.127 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.75 -26.41 29.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.802 -0.759 . . . . 70.0 111.446 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -65.95 -51.46 58.31 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 110.076 -0.342 . . . . 73.32 110.076 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.21 -25.29 67.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.184 0.516 . . . . 71.52 110.241 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -79.05 -56.75 4.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.857 -0.61 . . . . 72.55 112.323 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 151' ' ' VAL . 45.7 m-85 -69.3 -22.81 63.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.206 0.447 . . . . 74.13 112.206 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG2' HD12 ' A' ' 131' ' ' ILE . 2.0 mm-40 -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.062 0.458 . . . . 61.03 110.464 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -58.3 -34.68 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.547 -0.751 . . . . 54.41 112.001 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -81.51 -31.72 32.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 73.41 111.316 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.61 48.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.957 -0.639 . . . . 73.24 112.696 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -72.9 128.04 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 72.02 111.532 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HG2' ' A' ' 126' ' ' GLU . 56.6 mt -98.15 136.88 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.661 -0.699 . . . . 65.31 110.025 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -90.45 -44.02 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.28 . . . . 73.12 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.7 p -158.18 154.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.45 . . . . 74.44 109.879 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.19 129.32 70.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.345 0.593 . . . . 73.41 110.094 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.3 mt-10 -100.83 127.64 47.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.902 -1.045 . . . . 72.11 110.19 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.1 mm -119.21 122.41 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.594 -0.891 . . . . 63.13 108.594 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.1 mmm -98.29 123.78 42.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.807 -0.812 . . . . 72.32 108.807 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.313 -1.002 0 CA-C-O 121.089 0.471 . . . . 64.42 111.163 -176.043 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 119.669 -0.517 . . . . 75.14 113.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -175.61 162.6 2.79 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 117.466 0.633 . . . . 73.44 110.276 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.15 8.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.749 -0.659 . . . . 73.43 109.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 40.8 m-85 -142.32 145.7 34.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.745 -0.661 . . . . 63.03 110.016 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 125' ' ' PHE . 84.0 t -132.75 126.06 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.997 -0.439 . . . . 73.32 111.049 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.0 m -102.48 125.17 49.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.835 -0.62 . . . . 75.21 110.494 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.78 163.62 12.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.992 0.425 . . . . 62.21 111.671 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.44 -28.2 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.264 -0.88 . . . . 55.22 110.534 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.46 153.41 51.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.022 -0.535 . . . . 74.24 110.422 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 103' ' ' THR . 34.3 p80 -74.73 -28.21 60.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.646 . . . . 71.23 110.108 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -58.53 -43.56 89.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.017 -0.992 . . . . 74.34 111.779 -176.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 m -68.72 -30.75 69.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.718 0.294 . . . . 74.55 110.937 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -71.17 -39.53 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.636 -0.505 . . . . 73.12 109.636 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.54 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -72.15 -24.64 61.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.448 -0.796 . . . . 64.25 111.499 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 52.9 mttm -62.81 -40.51 97.58 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.647 0.737 . . . . 70.12 110.009 170.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.16 -43.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.667 -1.151 . . . . 53.42 112.574 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 160' ' ' ASP . 32.6 m -73.73 -2.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.115 0.483 . . . . 75.21 111.63 -173.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 160' ' ' ASP . 76.2 mt -61.27 -38.11 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.508 -0.769 . . . . 72.51 109.951 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.3 mt-30 -108.47 105.62 15.36 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.45 -0.945 . . . . 74.35 108.45 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -53.85 -34.27 58.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.856 -0.611 . . . . 72.21 112.151 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.76 137.83 54.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.802 0.334 . . . . 73.44 110.614 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.5 m-70 -126.0 146.26 49.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.832 -0.622 . . . . 75.42 110.539 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 m -106.08 118.84 37.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.016 -0.538 . . . . 73.1 110.726 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.62 142.9 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.548 -0.908 . . . . 43.15 108.548 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.2 t30 52.11 31.28 8.68 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.537 0.684 . . . . 52.24 111.767 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.38 10.17 74.35 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.75 -0.659 . . . . 73.25 113.543 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -115.66 139.01 50.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.01 0.405 . . . . 61.21 110.264 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -101.12 111.2 23.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.643 0.735 . . . . 71.51 111.016 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.98 156.61 23.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 74.5 110.51 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -86.57 136.64 32.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.003 0.43 . . . . 72.35 110.184 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.2 t -131.97 132.64 61.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.616 -0.72 . . . . 72.44 109.862 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -153.46 174.63 14.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.797 -0.638 . . . . 71.14 111.195 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -65.28 136.9 57.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.596 -0.274 . . . . 74.25 110.898 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -125.99 124.94 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.812 -0.44 . . . . 73.21 109.812 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 120.408 -0.517 . . . . 75.31 110.525 -179.671 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.406 0 N-CA-C 108.43 -0.952 . . . . 55.21 108.43 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 37.5 mp0 -102.5 142.78 25.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.241 -1.345 . . . . 74.53 110.836 -172.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 13' ' ' LEU . 12.1 Cg_endo -61.92 166.42 12.29 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.871 2.38 . . . . 72.53 112.006 172.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.46 -37.18 67.42 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.145 -0.48 . . . . 74.31 112.272 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' HD23 ' A' ' 13' ' ' LEU . 10.0 pt20 -61.83 -29.33 70.09 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 61.5 112.158 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 164' ' ' ILE . 25.3 mt -89.81 -22.17 22.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.334 . . . . 54.12 111.162 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.7 ptt180 -106.66 0.05 24.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.332 0.587 . . . . 75.02 110.071 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -105.47 136.28 45.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.638 0.732 . . . . 65.15 111.123 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 68' ' ' VAL . 71.3 mt -101.56 146.87 27.09 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.729 -1.123 . . . . 72.41 110.92 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -97.67 120.79 38.68 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.245 -1.021 . . . . 74.33 108.245 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -98.47 110.96 27.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.771 -0.455 . . . . 74.34 109.771 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.72 147.94 16.32 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.868 -0.893 . . . . 75.24 110.868 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.9 42.26 13.07 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.978 -1.106 . . . . 53.55 112.886 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 25' ' ' THR . 90.4 mt -79.28 174.63 11.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.319 -0.622 . . . . 44.31 109.319 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -85.98 179.35 7.01 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 60.14 109.094 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 53' ' ' ARG . 3.2 t80 -81.95 -6.88 59.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.513 0.673 . . . . 71.32 109.389 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -118.36 20.35 13.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.006 -0.997 . . . . 72.11 111.845 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.575 HG21 HD22 ' A' ' 21' ' ' LEU . 20.4 m -85.75 129.45 34.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.983 0.421 . . . . 74.23 111.477 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -108.09 165.73 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.695 . . . . 61.32 109.673 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -25.17 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.005 -0.278 . . . . 72.33 110.792 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.6 -40.36 69.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.127 -0.229 . . . . 71.44 110.851 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -76.7 -32.71 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 74.31 110.618 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.2 tp -66.42 -49.88 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 62.55 110.314 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -56.77 -54.78 42.31 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.556 -0.747 . . . . 74.21 111.011 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -44.86 -37.98 4.26 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.539 1.149 . . . . 45.24 113.415 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -69.83 -52.0 28.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.345 -0.389 . . . . 75.35 110.953 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.32 -19.91 41.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.195 0.443 . . . . 72.21 112.195 -170.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -56.73 -24.29 48.67 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.396 0.517 . . . . 53.42 112.396 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.96 -25.57 68.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.196 0.443 . . . . 73.44 112.196 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -101.21 -23.25 14.47 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.088 -0.245 . . . . 73.41 111.267 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.3 157.72 29.19 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.311 -0.947 . . . . 73.34 112.389 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.6 m -63.24 119.81 10.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.981 0.419 . . . . 72.54 111.591 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.4 mt -88.43 141.85 28.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.815 -0.63 . . . . 70.32 110.479 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -107.09 -23.25 12.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 51.43 110.198 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -153.6 153.72 32.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.642 -0.708 . . . . 51.22 109.598 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 t -163.27 132.81 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.659 -0.497 . . . . 44.31 109.659 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.13 127.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 73.11 111.095 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.42 133.78 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.937 -0.764 . . . . 73.44 108.937 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.475 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.6 mmt -78.19 99.85 6.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.339 0.59 . . . . 70.24 110.471 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -101.77 160.92 14.06 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.033 -0.985 . . . . 63.13 109.864 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.28 130.47 62.33 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.1 -0.333 . . . . 53.13 110.1 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.12 -19.37 51.16 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.182 1.922 . . . . 74.32 113.295 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.63 -54.37 4.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.34 0.591 . . . . 71.44 110.707 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -96.86 -16.14 20.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.182 -0.917 . . . . 70.33 112.348 -172.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm 65.94 31.09 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.865 0.728 . . . . 72.34 111.183 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 23.6 mmm180 -114.15 158.7 20.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.351 -0.611 . . . . 70.4 109.351 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 t -70.73 140.78 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.967 0.413 . . . . 63.41 110.993 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -93.34 3.75 55.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 75.22 110.596 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.06 68.02 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.675 -0.693 . . . . 75.12 114.378 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.475 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.3 p90 -156.34 154.8 31.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.768 0.784 . . . . 64.52 110.496 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.78 -166.24 17.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.371 -0.692 . . . . 74.44 111.371 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.68 148.59 37.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.295 0.547 . . . . 75.44 110.598 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 18' ' ' ILE . 7.9 m -129.13 127.86 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.595 . . . . 74.42 109.781 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.6 m -103.36 121.61 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.335 -0.228 . . . . 74.42 110.532 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -87.95 164.05 16.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.042 0.449 . . . . 72.44 110.997 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.83 -49.49 37.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.492 -0.776 . . . . 73.22 110.598 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.5 m -119.37 152.18 37.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 74.4 110.816 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -65.64 -28.85 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.455 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.53 -29.35 63.52 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.967 -0.458 . . . . 74.31 111.509 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 6.1 mm-40 -64.92 -29.75 70.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.49 0.662 . . . . 73.11 109.282 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 16' ' ' LEU . 24.8 t -66.88 -48.3 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.825 -1.08 . . . . 54.11 110.298 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -59.14 -49.96 75.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.797 -0.638 . . . . 72.33 110.704 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.8 -36.72 38.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.957 0.725 . . . . 74.25 112.957 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -29.6 62.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 71.13 110.745 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -49.66 64.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 63.45 109.974 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -64.07 -26.84 68.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.18 0.514 . . . . 72.24 110.882 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.9 -10.73 60.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.237 -0.892 . . . . 65.34 113.366 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -56.63 149.78 39.22 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 111.883 0.327 . . . . 52.12 111.883 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.72 165.67 79.12 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.057 -1.226 . . . . 51.42 112.837 0.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -123.65 152.67 41.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 74.23 110.483 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.5 ttmt -134.23 107.55 7.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.114 -0.494 . . . . 70.31 111.251 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 126.59 66.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.678 -0.692 . . . . 75.12 109.85 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.7 t70 66.29 28.19 9.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.632 0.73 . . . . 74.02 110.791 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.12 25.87 70.06 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.765 -0.731 . . . . 73.15 112.498 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.3 tpt180 -129.64 142.09 50.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.101 -0.703 . . . . 74.13 109.101 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.47 114.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 61.34 109.838 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.72 153.37 7.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.872 -0.604 . . . . 73.54 111.119 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -117.09 100.43 53.25 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.272 -0.876 . . . . 75.22 110.572 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.59 132.54 17.54 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.867 1.711 . . . . 73.41 110.909 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -136.2 178.97 6.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.053 -1.091 . . . . 75.24 108.053 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.2 tmm_? -81.88 128.68 34.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.768 -0.827 . . . . 71.4 108.768 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.28 98.54 0.33 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.242 0.544 . . . . 63.33 111.097 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 11.1 t -69.22 142.96 15.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.053 -0.976 . . . . 74.32 110.835 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 18.1 t -83.21 172.27 12.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.236 -0.438 . . . . 52.21 109.991 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -61.65 -42.5 98.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.74 0.644 . . . . 75.15 112.74 -170.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -71.18 -41.46 70.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 43.4 110.866 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.0 OUTLIER -78.55 -8.12 58.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 63.4 111.478 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 70.6 m -93.62 -4.14 51.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.592 -0.276 . . . . 70.55 111.195 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.17 -41.59 99.25 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.975 0.417 . . . . 74.11 110.602 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.93 146.57 75.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.944 -0.571 . . . . 75.51 110.262 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.57 147.66 90.27 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.025 2.484 . . . . 60.42 112.259 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.96 28.71 64.13 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.819 -0.705 . . . . 62.11 112.664 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -66.29 -52.16 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 64.44 110.349 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -93.71 2.47 56.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.637 -0.71 . . . . 62.0 111.061 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -87.94 161.93 17.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.473 . . . . 74.25 109.724 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.493 HG23 ' CD2' ' A' ' 156' ' ' HIS . 3.2 m -83.58 97.61 9.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.218 0.533 . . . . 52.54 112.122 -172.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.521 ' CG1' ' HE3' ' A' ' 179' ' ' LYS . 0.8 OUTLIER -124.52 124.02 67.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.459 -0.791 . . . . 72.34 109.061 174.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 72.7 mttt -106.65 22.01 16.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.323 0.583 . . . . 72.5 110.446 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -117.71 139.66 50.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.786 -0.643 . . . . 64.13 111.085 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 159' ' ' VAL . 7.2 pt -124.27 148.52 28.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.307 0.575 . . . . 74.24 111.45 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -98.63 133.79 42.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.869 -1.059 . . . . 75.31 109.426 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.37 109.12 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.059 -0.719 . . . . 72.45 109.059 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -135.86 167.88 24.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.682 -1.246 . . . . 51.41 113.717 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.11 42.11 5.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.925 -0.655 . . . . 75.45 111.735 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.19 111.23 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.513 0.673 . . . . 74.44 110.755 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -78.68 -21.78 47.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.717 0.77 . . . . 70.03 109.261 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -101.3 151.61 21.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.832 -1.076 . . . . 73.02 109.181 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.17 123.42 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.534 0.683 . . . . 61.53 110.677 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 m -107.27 141.61 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.849 -0.614 . . . . 65.5 110.056 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -113.57 173.64 6.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.248 -0.887 . . . . 71.4 111.449 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -50.73 72.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 71.31 110.955 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -63.36 -26.34 68.71 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.29 0.369 . . . . 74.34 111.491 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -64.23 -61.25 2.36 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.049 0.452 . . . . 74.34 110.427 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -84.1 -23.91 30.55 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.984 -0.686 . . . . 64.12 111.883 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -67.51 -51.44 51.06 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 110.357 -0.238 . . . . 61.21 110.357 178.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.2 -28.71 69.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 71.44 110.3 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -78.79 -56.28 4.52 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.517 -0.765 . . . . 73.44 112.14 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -67.91 -23.07 65.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.472 0.545 . . . . 74.45 112.472 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.7 mt-10 -68.05 -23.05 64.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.645 0.26 . . . . 74.03 111.415 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.78 -33.84 64.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.515 . . . . 62.34 111.55 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.24 -31.65 33.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.366 . . . . 72.04 111.443 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 178.68 -177.33 48.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.704 -0.76 . . . . 62.23 113.332 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -75.61 129.98 38.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 74.22 111.418 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 152' ' ' THR . 59.0 mt -102.25 140.18 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 72.53 110.071 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -91.35 -46.55 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 61.54 110.957 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.36 156.27 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.882 0.373 . . . . 72.01 110.427 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.49 127.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.056 -0.52 . . . . 74.44 109.933 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.4 mt-10 -102.45 105.46 16.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 62.52 111.206 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.1 117.12 38.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.873 -0.788 . . . . 54.14 108.873 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.5 mmm -84.45 101.21 11.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 65.13 110.385 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.855 0 CA-C-N 115.147 -0.933 . . . . 72.32 111.382 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 113.894 0.317 . . . . 72.02 113.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.66 161.66 32.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 117.188 0.494 . . . . 71.31 110.43 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.47 173.97 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.487 -0.779 . . . . 64.31 109.673 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 45.5 m-85 -138.0 148.93 45.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 55.33 110.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.35 126.25 52.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 71.2 110.815 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.7 m -98.82 121.28 40.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 75.43 110.565 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -101.83 160.97 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.68 -0.236 . . . . 74.31 110.588 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.32 -29.94 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.386 0.613 . . . . 73.25 110.154 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -137.31 162.39 33.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 74.14 110.777 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.493 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.4 p80 -82.37 -20.56 36.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.978 -0.555 . . . . 73.3 110.118 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.2 p30 -60.3 -41.21 92.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 123.564 0.54 . . . . 63.01 110.943 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.401 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -73.67 -29.48 62.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.469 -0.332 . . . . 75.31 110.355 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.8 t -68.63 -42.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.759 -0.655 . . . . 61.42 109.745 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -73.85 -26.05 60.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.535 -0.757 . . . . 72.33 110.887 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.6 mttt -62.78 -37.99 88.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.521 0.677 . . . . 64.52 110.218 172.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.6 -42.61 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 72.02 112.956 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 159' ' ' VAL . 16.8 m -69.74 -9.01 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.095 0.474 . . . . 74.34 111.625 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.602 HD13 HD22 ' A' ' 13' ' ' LEU . 58.5 mt -56.46 -36.68 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.306 -0.861 . . . . 62.01 110.368 171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 51.7 mt-30 -109.5 108.95 19.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.224 -0.658 . . . . 71.42 109.224 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -53.71 -36.13 61.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.429 -0.805 . . . . 73.23 112.342 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -122.5 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.884 0.373 . . . . 75.3 110.49 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 82.2 m-70 -121.09 141.63 50.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.064 -0.516 . . . . 72.23 110.487 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 m -90.26 102.96 15.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.075 -0.511 . . . . 74.11 110.587 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.2 126.96 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.008 -0.738 . . . . 73.25 109.008 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 t30 53.42 31.53 12.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.584 0.707 . . . . 75.43 111.528 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.71 2.04 84.79 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.193 -0.527 . . . . 64.44 113.231 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -106.55 132.36 52.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.557 -0.534 . . . . 73.2 109.557 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.318 0.58 . . . . 63.15 110.676 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -106.82 153.89 21.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 61.13 109.707 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.47 131.23 34.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.198 -0.297 . . . . 72.22 110.198 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.9 t -130.44 137.25 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 72.33 111.06 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -158.2 176.67 12.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.001 -0.545 . . . . 72.53 112.06 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.521 ' HE3' ' CG1' ' A' ' 104' ' ' VAL . 14.1 mmmt -66.32 123.58 20.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.002 -0.545 . . . . 72.55 109.94 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -106.19 113.99 27.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 72.03 111.001 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.908 -0.587 . . . . 64.13 110.125 178.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.007 0.432 . . . . 60.52 110.692 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 159.88 37.5 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.028 -0.533 . . . . 65.42 110.191 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HD2' HD22 ' A' ' 13' ' ' LEU . 54.7 Cg_endo -73.69 166.94 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.294 1.996 . . . . 74.41 111.304 170.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -32.79 70.63 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 111.715 0.265 . . . . 73.22 111.715 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.46 -30.9 71.93 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.063 0.394 . . . . 73.35 112.063 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.5 mp -82.97 -12.98 56.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.518 0.199 . . . . 71.42 111.185 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.52 ' HA ' HG21 ' A' ' 68' ' ' VAL . 13.3 ptt180 -119.41 0.56 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.984 0.421 . . . . 63.12 111.245 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -96.38 147.18 24.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.379 0.609 . . . . 73.24 112.108 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD21 HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -116.31 147.21 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.008 -0.996 . . . . 44.02 109.727 172.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 29.8 t80 -101.99 118.38 36.78 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.172 -1.048 . . . . 63.1 108.172 171.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 60' ' ' VAL . 21.3 mm -94.78 112.77 27.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 122.108 -0.37 . . . . 72.22 110.228 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 150.81 18.18 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.958 -0.639 . . . . 61.52 111.964 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.91 45.14 64.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.168 -0.539 . . . . 62.32 113.586 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 25' ' ' THR . 50.2 mt -76.47 173.07 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 72.33 110.409 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -84.4 175.55 9.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 43.35 109.485 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 92.1 m-85 -84.03 -6.59 59.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.018 0.437 . . . . 74.14 110.632 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -119.51 12.11 12.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.878 -0.601 . . . . 62.34 111.678 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 21' ' ' LEU . 43.9 m -77.41 132.37 38.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.078 0.466 . . . . 52.03 111.425 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -107.63 167.59 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.633 -0.712 . . . . 75.34 110.054 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -73.77 -24.42 59.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 72.34 111.089 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.67 -35.14 58.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.167 -0.213 . . . . 71.42 110.659 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.8 m -73.23 -38.11 66.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 73.21 110.436 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.95 -45.04 94.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 64.1 110.178 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -60.0 -52.85 63.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.948 -0.569 . . . . 65.43 110.559 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m -44.14 -42.3 6.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.327 1.017 . . . . 51.1 113.603 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 79' ' ' VAL . 66.6 t60 -70.24 -56.45 6.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 64.12 111.13 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 40' ' ' LEU . 81.8 m-85 -76.05 -17.57 59.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.806 0.299 . . . . 72.03 111.806 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.6 -28.37 54.7 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.027 0.531 . . . . 70.32 111.547 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -65.61 -23.96 66.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.465 -0.788 . . . . 71.45 112.304 -177.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -101.41 -21.98 14.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.057 0.391 . . . . 72.01 112.057 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 177.09 48.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.788 -1.196 . . . . 33.15 113.24 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -68.01 119.61 12.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.966 0.507 . . . . 74.23 112.268 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 34' ' ' PHE . 52.8 mt -95.66 125.63 40.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.636 0.731 . . . . 74.42 110.56 170.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 t -100.92 -17.69 16.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.989 -1.005 . . . . 63.05 110.12 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.95 151.4 29.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 64.42 109.981 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.8 t -163.04 133.18 4.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.98 -0.378 . . . . 73.22 109.98 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 126.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.215 0.531 . . . . 62.01 110.613 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.56 131.87 33.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.605 -0.887 . . . . 74.21 108.605 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.9 mmt -79.4 97.44 6.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.773 0.796 . . . . 72.4 110.94 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 30.9 mtp180 -104.51 159.11 16.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.314 -1.312 . . . . 72.04 109.008 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.37 125.84 91.06 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.885 -0.598 . . . . 74.44 109.773 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.51 -28.62 87.01 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.214 1.943 . . . . 60.43 113.744 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.92 -55.01 4.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.925 0.393 . . . . 70.15 111.906 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.43 -15.92 21.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.199 0.444 . . . . 65.21 112.199 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 65.43 31.34 10.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.71 0.804 . . . . 74.02 111.747 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -97.92 151.35 20.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.098 -0.704 . . . . 73.24 109.098 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.1 t -72.7 137.63 46.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.95 0.405 . . . . 72.43 110.727 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -89.25 -1.65 58.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.778 -0.646 . . . . 63.22 109.634 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.18 23.52 51.42 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.66 -0.7 . . . . 35.32 113.825 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -161.51 160.72 29.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.887 0.844 . . . . 73.45 111.036 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -162.18 12.19 Favored Glycine 0 C--O 1.226 -0.345 0 N-CA-C 111.588 -0.605 . . . . 71.3 111.588 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -142.32 149.37 39.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.185 0.493 . . . . 75.33 110.105 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 18' ' ' ILE . 7.3 m -130.69 126.4 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.057 -0.719 . . . . 75.43 109.057 172.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 m -105.85 120.01 40.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.728 0.299 . . . . 75.4 110.408 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -85.37 171.08 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.854 -0.612 . . . . 64.31 109.979 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.7 -25.03 24.99 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.139 0.495 . . . . 71.42 110.488 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 m -143.06 145.4 32.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 64.15 110.916 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.1 p -56.54 -40.02 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.688 -0.687 . . . . 62.21 111.867 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -53.05 -42.03 65.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.974 0.731 . . . . 71.2 112.974 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -65.71 -30.67 71.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.302 0.572 . . . . 74.14 110.569 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 14' ' ' ARG . 17.9 t -67.12 -45.57 86.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.381 -0.827 . . . . 62.45 110.813 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -58.95 -42.94 91.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 71.43 110.622 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.71 -37.37 73.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.483 0.549 . . . . 73.12 112.483 171.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.33 74.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.271 0.558 . . . . 71.41 110.226 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.25 -36.25 71.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.783 -0.644 . . . . 72.1 110.786 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.645 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 4.5 p30 -79.94 -11.27 59.81 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.968 0.413 . . . . 75.22 110.952 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.79 -12.06 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 72.41 111.002 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -55.31 149.14 28.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.68 . . . . 74.11 111.827 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 168.7 76.62 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 124.274 -1.136 . . . . 75.12 113.381 2.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -125.77 155.97 40.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.681 -0.691 . . . . 75.2 110.358 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.3 ttmt -136.75 105.34 5.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.086 0.47 . . . . 73.44 111.242 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.439 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.4 t -105.62 125.6 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.6 . . . . 70.41 109.718 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 64.53 33.59 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.776 0.672 . . . . 70.34 111.281 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.88 26.56 73.77 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.018 -0.611 . . . . 52.25 112.239 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.5 tpt180 -127.5 135.62 50.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.162 -0.31 . . . . 73.51 110.162 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.95 113.47 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.839 -0.8 . . . . 70.21 108.839 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -106.49 151.99 8.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.356 0.598 . . . . 74.41 111.208 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -113.82 96.55 41.56 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.956 -1.02 . . . . 74.02 110.697 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.27 129.97 15.71 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.741 1.627 . . . . 54.33 110.286 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 50.9 mmtt -121.26 142.01 50.35 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.628 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 7.9 tpp180 -64.05 119.51 10.27 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.644 -0.872 . . . . 72.23 108.644 172.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 93.29 0.09 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.601 0.715 . . . . 40.23 110.671 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.483 ' CG2' HG23 ' A' ' 163' ' ' VAL . 8.3 p -66.24 156.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.728 -1.124 . . . . 64.41 110.638 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 p -55.39 153.82 6.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.961 -0.563 . . . . 62.31 111.428 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 1.4 tmt_? -57.51 -30.62 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.671 -0.695 . . . . 63.21 111.234 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -52.2 52.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.609 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.8 -25.95 59.4 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.789 0.328 . . . . 71.34 110.318 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -64.4 -17.49 63.82 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.217 -0.447 . . . . 52.43 111.192 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.29 -11.24 59.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.974 0.416 . . . . 73.44 110.738 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -79.96 145.55 61.67 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.953 -0.388 . . . . 73.45 109.953 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.3 115.54 4.08 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.43 2.086 . . . . 75.2 112.05 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.65 27.59 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.791 -0.719 . . . . 72.34 112.297 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.01 -36.81 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 72.42 111.671 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 18.2 m170 -104.03 21.2 16.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.485 0.66 . . . . 54.12 110.516 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.2 mt -101.65 -178.55 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 65.51 109.553 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.15 100.64 13.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.649 . . . . 72.43 111.834 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.17 121.97 44.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 74.53 108.181 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 60.5 mttt -106.59 19.68 20.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 63.1 110.505 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.43 139.1 50.81 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.378 -0.373 . . . . 73.21 110.662 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 159' ' ' VAL . 7.5 pt -131.7 149.62 33.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.266 0.555 . . . . 70.03 111.293 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -93.45 137.91 32.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 70.31 109.582 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.82 108.93 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.345 -0.613 . . . . 55.43 109.345 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.84 147.6 18.08 Favored Glycine 0 CA--C 1.505 -0.587 0 C-N-CA 119.673 -1.251 . . . . 75.05 112.973 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.87 6.35 22.96 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.32 -0.943 . . . . 73.13 111.981 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 112' ' ' ILE . 26.7 pt -76.45 99.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 122.072 0.939 . . . . 64.13 109.055 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -91.47 -6.13 53.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.161 -0.927 . . . . 62.05 112.126 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -126.47 -162.52 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.024 -0.362 . . . . 60.12 110.024 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.22 67.98 8.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 54.12 111.003 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -75.56 136.42 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.321 0.581 . . . . 71.24 109.799 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.3 166.12 10.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.272 -0.876 . . . . 72.32 111.436 -171.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.01 -53.17 61.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.336 -0.847 . . . . 74.5 110.516 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.23 -12.76 58.16 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.388 0.514 . . . . 73.1 112.388 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -73.01 -57.74 3.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.084 0.468 . . . . 75.21 109.764 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -81.47 -28.62 34.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.143 -0.623 . . . . 71.14 110.544 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -64.3 -53.22 52.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.657 -0.247 . . . . 74.14 110.592 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.6 -26.4 68.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.979 0.419 . . . . 55.14 110.486 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.1 -54.59 8.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.815 -0.629 . . . . 74.21 111.194 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -68.32 -23.53 64.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.5 -0.318 . . . . 73.44 111.609 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.4 mt-10 -65.92 -26.18 67.48 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.886 0.374 . . . . 65.23 111.236 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -56.9 -30.1 63.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.935 -0.575 . . . . 73.53 111.31 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -86.26 -26.8 24.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 74.3 111.936 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.69 46.41 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.372 -0.918 . . . . 63.33 113.353 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.45 131.77 41.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.078 0.466 . . . . 61.31 111.316 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 152' ' ' THR . 52.4 mt -105.09 141.18 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 64.43 110.082 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -90.64 -54.44 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 54.23 110.796 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.76 155.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 73.14 110.289 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.54 129.48 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.057 0.456 . . . . 62.32 109.828 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 21.6 mt-10 -101.78 103.41 14.14 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.291 -0.868 . . . . 55.25 110.566 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -92.47 118.98 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.067 -0.716 . . . . 53.24 109.067 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 73.1 mmm -90.46 109.36 20.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.283 0.564 . . . . 72.4 110.554 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 73.01 109.846 -177.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.22 0 N-CA-C 113.624 0.209 . . . . 53.03 113.624 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.28 158.96 33.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.104 0.478 . . . . 75.23 109.764 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.91 176.91 8.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.255 -0.884 . . . . 60.44 109.633 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 51.6 m-85 -139.84 151.73 45.92 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.28 -0.873 . . . . 75.32 109.128 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.09 134.04 15.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.281 0.562 . . . . 75.43 110.95 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.8 m -105.7 127.66 53.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.071 -0.968 . . . . 74.11 110.983 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -101.72 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.782 0.325 . . . . 74.23 110.874 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.26 -23.3 30.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.825 -0.625 . . . . 72.21 110.29 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.56 158.05 44.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 73.23 110.8 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.568 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 31.2 p80 -83.98 -27.67 28.28 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.646 -0.252 . . . . 74.04 111.377 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -59.45 -42.22 91.48 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.382 0.427 . . . . 75.13 110.886 -176.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -65.43 -32.86 74.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.027 -0.533 . . . . 50.33 110.976 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 163' ' ' VAL . 3.0 t -70.81 -44.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.386 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 26.4 m-20 -68.17 -25.41 65.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.719 . . . . 74.53 111.269 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.628 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 96.9 mttt -61.68 -45.2 95.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.842 0.829 . . . . 62.44 110.276 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.6 mt -75.55 -43.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.492 -1.231 . . . . 70.12 112.387 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.483 HG23 ' CG2' ' A' ' 90' ' ' VAL . 15.9 m -75.01 -5.59 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 74.5 111.096 -174.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 160' ' ' ASP . 31.1 mt -57.97 -31.45 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.42 -0.809 . . . . 63.23 109.748 168.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -114.49 109.35 18.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.557 -0.747 . . . . 65.4 109.095 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -55.66 -31.9 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 65.45 112.259 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.62 137.3 54.76 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.649 -0.421 . . . . 74.45 111.622 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -129.0 149.24 50.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.578 -0.737 . . . . 74.0 109.622 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.5 m -110.92 124.64 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.885 0.374 . . . . 64.21 110.935 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.58 131.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.985 -0.552 . . . . 73.31 109.983 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 72.44 23.24 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.42 1.105 . . . . 72.55 109.63 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.7 85.96 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.155 -0.93 . . . . 62.14 112.097 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -118.91 122.14 41.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.318 . . . . 63.31 110.816 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.81 108.07 18.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.751 -0.833 . . . . 71.3 108.751 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.0 p -110.1 154.3 23.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.426 -0.807 . . . . 51.34 111.101 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -86.62 127.77 34.95 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.626 -0.715 . . . . 75.14 109.681 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.8 t -124.87 128.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.352 -0.84 . . . . 62.4 109.987 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -154.35 171.47 19.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.414 -0.812 . . . . 61.41 111.26 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -58.02 123.61 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.465 0.478 . . . . 71.12 111.287 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.81 118.82 31.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.995 -0.548 . . . . 71.22 109.723 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--N 1.311 -1.108 0 N-CA-C 109.486 -0.561 . . . . 72.24 109.486 179.449 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 120.924 0.392 . . . . 75.2 110.706 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.49 133.78 86.89 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.683 . . . . 74.2 110.461 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.66 162.73 35.86 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.824 2.349 . . . . 74.25 110.59 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.1 pt-20 -60.34 -30.54 69.59 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 111.819 0.303 . . . . 61.22 111.819 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.78 -34.63 75.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.871 0.323 . . . . 75.33 111.871 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.75 -15.1 58.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.964 0.412 . . . . 74.2 110.839 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG21 ' A' ' 68' ' ' VAL . 24.3 ptt180 -121.58 6.61 10.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.754 -0.657 . . . . 73.3 110.824 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.4 ttmm -95.19 148.77 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.709 0.766 . . . . 60.02 111.563 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 68' ' ' VAL . 78.0 mt -115.8 139.48 50.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.643 -1.162 . . . . 70.01 110.078 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -96.68 113.26 24.8 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.407 -0.96 . . . . 65.23 108.407 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 60' ' ' VAL . 15.6 mm -92.67 111.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.252 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.77 147.63 16.72 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.086 -0.578 . . . . 73.25 112.063 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.77 48.57 33.93 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 72.44 113.399 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 25' ' ' THR . 73.2 mt -79.86 176.94 9.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.118 -0.327 . . . . 75.34 110.118 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.7 p -89.84 169.57 11.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.003 -0.74 . . . . 42.25 109.003 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -77.24 -3.61 40.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.973 0.416 . . . . 74.21 111.377 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.32 13.4 13.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.017 -0.538 . . . . 74.12 111.29 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 HD22 ' A' ' 21' ' ' LEU . 31.0 m -73.13 126.31 29.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 65.21 110.403 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -105.91 165.53 11.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 61.43 109.816 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.81 -24.69 65.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.613 0.244 . . . . 74.34 110.958 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.96 -35.41 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 65.44 111.859 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -77.52 -36.1 52.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.93 0.395 . . . . 74.22 110.362 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.07 -48.51 78.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.62 -0.718 . . . . 63.24 109.681 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 31' ' ' ARG . 43.9 ttm180 -54.47 -60.05 3.87 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.432 -0.804 . . . . 73.02 111.878 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -47.82 -38.91 16.97 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.9 0.75 . . . . 71.2 112.691 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.99 -56.08 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.476 -0.329 . . . . 71.11 111.084 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 40' ' ' LEU . 70.6 m-85 -76.01 -18.59 59.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.676 0.274 . . . . 61.32 111.665 -174.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.11 -22.5 51.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.217 0.607 . . . . 74.45 111.783 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.79 -27.65 66.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.711 -0.677 . . . . 54.12 112.208 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.16 -20.64 15.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.608 0.225 . . . . 64.53 111.608 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.51 165.49 35.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.259 -0.972 . . . . 60.12 112.375 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.4 m -71.69 119.71 16.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.018 0.437 . . . . 74.41 111.458 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 34' ' ' PHE . 95.2 mt -84.36 138.29 32.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.567 -0.742 . . . . 73.51 110.967 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -97.79 -25.36 15.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.808 . . . . 74.43 110.161 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -150.68 150.26 30.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 63.11 110.164 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.9 t -158.71 126.37 5.03 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.129 -0.323 . . . . 71.01 110.129 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.62 126.35 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.339 0.59 . . . . 72.43 110.513 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.73 133.08 33.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.766 -0.828 . . . . 72.01 108.766 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.488 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mmt -78.21 99.66 6.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.074 0.464 . . . . 64.55 110.692 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -100.66 161.04 13.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.43 -0.805 . . . . 74.52 110.498 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.89 123.81 75.44 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.031 -0.986 . . . . 72.51 110.055 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.87 -24.56 74.31 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.224 1.949 . . . . 73.34 113.463 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -84.24 -54.92 4.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 74.25 111.505 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -14.45 28.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 75.5 112.12 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm 62.61 31.16 16.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.883 0.873 . . . . 73.43 111.662 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -114.71 155.6 26.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.648 -0.871 . . . . 71.42 108.648 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.3 t -70.34 133.89 47.38 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.05 -0.352 . . . . 65.53 110.05 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -81.68 4.98 19.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.856 -0.611 . . . . 72.32 111.106 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.65 15.8 65.13 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 73.24 113.882 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 33.0 p90 -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.764 0.782 . . . . 73.41 110.625 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.04 -168.11 21.55 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.448 -0.661 . . . . 72.31 111.448 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.69 146.36 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.164 0.482 . . . . 70.43 110.634 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 18' ' ' ILE . 12.9 m -131.77 121.3 47.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 75.11 109.911 174.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.0 m -97.58 123.0 41.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.638 -0.504 . . . . 63.35 109.638 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -86.03 175.21 8.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.033 0.444 . . . . 74.04 110.918 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.73 -45.54 16.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.016 -0.538 . . . . 72.24 110.005 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -120.08 149.48 42.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 61.14 110.162 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.8 p -65.4 -30.9 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 123.131 0.269 . . . . 55.11 111.266 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.94 -39.74 87.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.183 0.438 . . . . 72.45 112.183 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -26.5 68.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 74.21 110.784 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 16' ' ' LEU . 40.4 t -63.79 -50.83 76.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.744 -0.662 . . . . 74.41 110.59 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -37.96 87.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 60.15 111.594 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.01 62.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.029 0.381 . . . . 72.12 112.029 170.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.47 -33.86 58.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 74.33 110.445 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -63.97 -41.75 97.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.438 -0.346 . . . . 75.05 110.642 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -30.3 63.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.965 -0.561 . . . . 70.35 110.902 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.72 -13.2 61.9 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.791 0.663 . . . . 55.0 112.791 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -55.06 148.98 26.48 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.212 0.449 . . . . 75.42 112.212 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.65 157.26 92.77 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.57 -1.429 . . . . 61.53 114.088 3.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -112.76 156.5 22.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.555 -0.748 . . . . 75.22 110.867 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 20.3 ttmt -139.45 110.35 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.345 -0.389 . . . . 62.42 111.539 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.04 130.65 64.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 71.34 109.81 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.22 26.56 12.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.867 0.842 . . . . 74.4 110.538 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.68 24.13 70.84 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.949 -0.643 . . . . 60.42 112.461 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 tpt180 -127.07 139.75 52.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.76 -0.459 . . . . 74.31 109.76 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -76.07 112.68 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 54.4 109.46 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -109.27 150.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.332 0.587 . . . . 74.21 110.996 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -114.82 96.38 44.26 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.242 -0.89 . . . . 53.34 111.486 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HE1' ' A' ' 72' ' ' MET . 19.3 Cg_endo -70.59 131.68 20.53 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.236 1.291 . . . . 52.53 110.556 170.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 156' ' ' HIS . 24.3 mttt -129.74 171.83 12.27 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.887 -0.783 . . . . 73.23 108.887 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -83.54 126.19 32.55 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.209 -0.996 . . . . 75.14 109.623 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.22 103.46 0.63 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.879 -0.601 . . . . 45.33 111.887 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.53 150.06 9.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.968 -1.015 . . . . 44.1 108.309 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -53.7 129.69 34.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.63 -0.507 . . . . 65.14 109.63 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -59.03 -24.29 62.7 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.516 0.51 . . . . 73.54 111.931 -172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.98 -54.81 41.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 73.1 110.549 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.38 -14.75 58.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.679 . . . . 54.33 111.201 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 t -64.85 -17.42 64.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.633 -0.712 . . . . 75.42 111.218 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -68.67 -21.71 64.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.286 -0.416 . . . . 75.11 111.013 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -78.73 143.94 63.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.072 -0.344 . . . . 60.12 110.072 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.37 117.86 5.33 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.724 2.283 . . . . 73.11 112.441 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.51 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.772 . . . . 61.25 112.658 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.88 86.6 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.351 0.26 . . . . 62.13 111.625 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -107.24 12.87 27.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.153 0.427 . . . . 70.1 112.153 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 49.3 mt -77.24 155.75 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.894 -0.409 . . . . 73.22 109.894 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -76.96 88.96 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.178 0.513 . . . . 64.24 110.799 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.84 135.69 63.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.84 -1.17 . . . . 73.31 107.84 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.412 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.5 mttt -112.13 20.71 16.59 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.379 0.609 . . . . 64.52 110.202 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.22 142.1 47.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.505 -0.771 . . . . 73.13 110.288 176.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 159' ' ' VAL . 7.4 pt -126.85 149.63 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.165 0.507 . . . . 63.02 111.066 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.6 t80 -101.45 136.39 41.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.072 -0.967 . . . . 73.12 109.016 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 7.1 t -125.88 109.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.544 -0.539 . . . . 75.23 109.544 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.07 146.98 17.08 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.27 -0.967 . . . . 65.14 112.309 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.8 50.3 4.72 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.541 -1.024 . . . . 63.21 110.541 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.596 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 15.2 pt -91.55 -177.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.04 -0.58 . . . . 64.33 111.481 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HD3' ' ND2' ' A' ' 171' ' ' ASN . 87.5 tttt -84.79 154.67 22.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.817 -0.629 . . . . 72.52 109.757 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -59.25 -37.2 77.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.814 0.34 . . . . 64.51 110.952 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -108.3 85.48 2.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.153 -0.476 . . . . 74.3 110.016 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 m -123.61 122.78 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.695 0.759 . . . . 71.31 110.426 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.7 pt-20 -113.22 172.47 6.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.471 -1.241 . . . . 53.24 110.723 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -48.22 73.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.85 -1.068 . . . . 72.12 110.128 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -57.19 -34.78 68.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.847 -0.615 . . . . 71.23 111.817 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.453 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 31.0 m170 -61.27 -60.16 4.18 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.676 0.274 . . . . 65.4 111.479 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 151' ' ' VAL . 3.2 pp -82.63 -22.39 34.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.519 -0.872 . . . . 73.04 111.461 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -68.32 -50.74 51.27 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.485 -0.191 . . . . 73.34 110.485 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.43 -30.76 68.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.086 0.47 . . . . 53.22 110.436 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.71 -57.08 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.7 -0.682 . . . . 71.11 112.269 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -69.17 -22.74 63.9 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.918 0.71 . . . . 73.24 112.918 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.2 mt-10 -68.76 -23.23 64.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.852 0.358 . . . . 73.41 111.021 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -59.1 -26.53 64.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.058 -0.519 . . . . 75.2 111.232 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.11 -33.87 20.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 55.14 111.521 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.432 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 179.54 -174.96 46.62 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.309 -0.948 . . . . 52.43 113.726 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -76.45 129.11 36.06 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.045 0.45 . . . . 74.2 111.613 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.82 137.95 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 75.51 109.975 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.49 -52.03 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 63.5 110.518 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.12 157.32 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 51.43 109.779 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.22 129.58 72.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.897 0.38 . . . . 65.21 110.228 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.0 mt-10 -103.4 104.16 14.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.562 -0.744 . . . . 70.02 110.767 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.1 mm -92.99 112.63 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.831 -0.803 . . . . 63.35 108.831 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 78.8 mmm -86.07 117.57 24.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.468 -0.493 . . . . 75.33 109.873 -173.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 63.44 110.741 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 111.417 -0.673 . . . . 34.14 111.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -160.43 168.17 25.74 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.902 -0.407 . . . . 75.22 109.902 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.12 169.55 17.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.543 -0.753 . . . . 61.34 109.184 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 44.2 m-85 -132.21 144.66 50.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.153 0.501 . . . . 73.32 110.164 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 121' ' ' LEU . 25.5 t -128.77 130.42 68.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.303 -0.408 . . . . 64.21 110.284 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 131' ' ' ILE . 94.0 m -105.94 120.62 42.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 71.2 110.941 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.3 160.44 14.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.936 0.398 . . . . 63.34 111.013 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.59 -31.38 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.599 -0.728 . . . . 71.51 110.61 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.85 155.85 44.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 74.42 110.81 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.449 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 20.6 p80 -77.18 -28.54 54.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.339 -0.391 . . . . 75.3 110.063 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.08 -48.45 33.48 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.037 0.836 . . . . 62.35 112.089 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.432 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -74.59 -27.87 60.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.702 -0.681 . . . . 65.52 111.016 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 107' ' ' ILE . 3.7 t -73.76 -41.33 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.23 109.979 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.479 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 6.9 m-20 -69.7 -23.45 63.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 63.4 110.988 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -65.36 -43.09 91.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.624 0.726 . . . . 53.22 110.392 170.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mt -73.19 -39.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.638 -1.164 . . . . 65.33 111.789 -172.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 160' ' ' ASP . 19.1 m -76.54 -8.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.382 . . . . 63.12 111.04 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 16.3 mt -64.21 -34.12 66.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.532 0.682 . . . . 71.35 109.859 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 58.5 mt-30 -109.13 96.99 6.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.796 -1.187 . . . . 71.12 107.796 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -56.55 -30.61 63.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 53.31 112.522 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.909 -0.317 . . . . 74.51 110.514 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.4 m-70 -125.71 152.53 45.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.979 -0.555 . . . . 74.35 109.56 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 32.1 m -101.76 105.91 16.85 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.173 0.511 . . . . 73.31 110.053 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.03 138.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.544 -0.753 . . . . 75.0 109.401 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.58 ' ND2' ' HD3' ' A' ' 113' ' ' LYS . 59.7 t30 49.69 36.21 10.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.579 0.704 . . . . 63.42 112.591 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.96 5.46 90.12 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.968 -0.56 . . . . 62.43 114.122 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -129.3 134.5 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.424 0.612 . . . . 72.44 111.324 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 20.3 t-20 -81.04 112.37 18.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.545 . . . . 73.41 110.853 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 11.6 m -110.32 156.25 21.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.658 -0.701 . . . . 63.42 110.339 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.0 tt0 -89.41 140.93 29.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 71.15 110.369 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -130.39 162.99 37.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.973 0.416 . . . . 73.22 111.014 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -174.68 175.0 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.023 -0.989 . . . . 71.03 111.767 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -67.9 122.6 18.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 75.23 109.508 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -112.4 148.64 33.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.126 0.488 . . . . 61.31 110.413 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.314 -0.965 0 N-CA-C 108.925 -0.768 . . . . 63.11 108.925 178.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.782 -0.451 . . . . 62.31 109.782 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -82.14 125.24 77.55 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 74.44 109.983 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD2' HD22 ' A' ' 13' ' ' LEU . 18.8 Cg_endo -61.07 168.35 7.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.508 2.805 . . . . 64.3 112.822 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.57 -39.67 35.88 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.597 -0.729 . . . . 73.42 112.752 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 4.3 pt20 -62.65 -35.85 80.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.523 0.329 . . . . 71.52 111.869 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 10' ' ' PRO . 8.5 mp -79.16 -45.41 20.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.918 -0.313 . . . . 72.13 110.38 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 18.0 ptt85 -76.7 2.02 15.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.03 0.381 . . . . 65.21 112.03 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.6 ttpt -95.54 147.9 23.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.671 0.748 . . . . 61.04 110.976 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD21 HG13 ' A' ' 68' ' ' VAL . 54.7 mt -117.25 145.15 44.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.835 -1.075 . . . . 52.52 110.625 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -98.7 119.48 37.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 65.04 108.405 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 60' ' ' VAL . 14.4 mm -99.54 111.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.703 -0.48 . . . . 75.52 109.703 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.92 154.36 16.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.673 -0.775 . . . . 60.25 111.553 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.94 39.89 53.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.583 -0.818 . . . . 64.13 113.489 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' THR . 72.5 mt -80.0 174.5 11.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.009 -0.367 . . . . 65.43 110.009 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -88.38 168.5 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.659 -0.867 . . . . 52.44 108.659 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.4 -4.29 53.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.243 0.544 . . . . 74.13 110.188 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -106.53 5.84 29.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.378 -0.828 . . . . 73.15 111.411 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 21' ' ' LEU . 32.7 m -75.02 132.91 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.999 0.428 . . . . 63.34 111.168 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.622 ' HB ' ' OE2' ' A' ' 28' ' ' GLU . 19.0 p -112.41 168.38 9.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.217 -0.66 . . . . 60.5 109.217 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -73.71 -25.9 60.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.768 -0.373 . . . . 61.05 110.883 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.622 ' OE2' ' HB ' ' A' ' 26' ' ' THR . 2.0 pm0 -79.89 -32.5 40.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.848 -0.16 . . . . 70.11 111.012 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.7 p -75.92 -35.23 59.85 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.143 0.497 . . . . 74.14 109.828 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.59 -48.12 70.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.533 -0.758 . . . . 73.31 110.036 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -53.93 -58.75 6.14 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.071 -0.513 . . . . 72.23 111.475 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 8.7 t -51.41 -30.88 20.68 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.698 0.624 . . . . 70.42 112.214 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.437 ' CD2' HG22 ' A' ' 79' ' ' VAL . 64.1 t60 -72.47 -61.63 1.73 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.739 -0.21 . . . . 53.34 110.88 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -71.11 -22.78 62.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.086 0.402 . . . . 74.25 112.086 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 29.2 tt0 -67.0 -17.97 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.259 0.552 . . . . 71.05 110.869 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' SER . 22.7 mt-30 -64.35 -24.14 67.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.64 . . . . 64.02 111.503 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -102.52 -17.67 15.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.373 -0.376 . . . . 73.22 111.63 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -177.82 163.54 31.93 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.311 -0.947 . . . . 73.32 112.582 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -68.12 118.09 10.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.076 0.465 . . . . 50.42 111.579 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.2 mt -88.04 129.02 35.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.68 0.752 . . . . 62.45 111.474 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -93.23 -24.64 18.12 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.882 -1.054 . . . . 71.11 109.838 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.46 152.3 32.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.08 -0.964 . . . . 75.05 109.584 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.416 ' SG ' HG12 ' A' ' 60' ' ' VAL . 16.8 t -164.08 126.59 2.44 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.297 -0.631 . . . . 74.35 109.297 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 p -145.69 113.83 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.726 0.774 . . . . 71.23 110.11 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 139.54 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.557 -0.905 . . . . 71.4 108.557 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.46 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 7.4 mmt -77.33 139.37 39.75 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.979 -0.748 . . . . 72.23 108.979 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -139.78 157.13 46.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.816 -0.629 . . . . 71.11 111.749 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 29.2 t70 -70.71 134.67 86.07 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.672 -1.149 . . . . 45.24 109.939 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' HH21 ' A' ' 55' ' ' ARG . 57.2 Cg_endo -75.26 -17.25 19.15 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.171 1.914 . . . . 71.53 113.297 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 50' ' ' ASN . 0.9 OUTLIER -85.79 -56.15 3.63 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.997 0.369 . . . . 54.05 111.997 -176.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -105.75 -9.15 17.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 52.11 111.218 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 28.3 mmtp 66.67 39.81 3.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.658 -0.701 . . . . 53.13 111.168 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -105.87 159.88 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.315 -0.624 . . . . 72.53 109.315 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.6 t -65.56 140.44 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.428 . . . . 75.51 110.875 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.443 HH21 ' HD3' ' A' ' 49' ' ' PRO . 56.0 mtt-85 -85.87 -3.64 58.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 64.03 110.554 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.45 60.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.514 -0.85 . . . . 70.32 113.754 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 28.8 p90 -157.98 155.03 28.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.627 0.713 . . . . 74.54 110.268 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.27 -167.32 20.66 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 111.875 -0.49 . . . . 60.55 111.875 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.38 148.42 37.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.15 0.475 . . . . 72.51 110.327 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 43' ' ' CYS . 13.1 m -132.18 131.14 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.545 . . . . 73.11 109.981 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HD3' ' A' ' 15' ' ' LYS . 5.2 m -106.19 120.16 41.1 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.24 -0.287 . . . . 61.41 110.248 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 27.8 m-85 -85.7 162.93 18.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.698 0.285 . . . . 74.21 110.636 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.3 -44.4 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 75.45 110.66 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.27 154.21 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 64.4 111.058 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.07 -41.3 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.379 -0.373 . . . . 74.51 111.055 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -48.39 -40.97 27.51 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.57 0.581 . . . . 63.21 112.57 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.8 -25.06 59.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 74.22 111.093 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 HD21 ' A' ' 16' ' ' LEU . 13.0 t -68.79 -44.37 82.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 35.24 109.986 171.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.39 -50.08 72.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 73.32 111.034 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.01 22.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.758 -0.656 . . . . 45.42 112.701 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.61 57.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.514 . . . . 64.32 110.825 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.78 -40.31 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.894 -0.594 . . . . 75.31 111.434 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -19.53 61.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.278 0.561 . . . . 71.34 110.154 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -9.01 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.709 -0.678 . . . . 62.21 111.541 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -60.08 146.1 83.57 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.402 0.144 . . . . 50.2 111.326 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.41 164.63 86.17 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.091 -1.212 . . . . 54.12 113.24 0.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -118.16 155.12 31.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 72.21 111.084 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.7 ttmt -141.92 107.04 4.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.102 -0.499 . . . . 71.33 111.176 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 33' ' ' HIS . 11.9 t -106.38 129.42 59.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.755 -0.657 . . . . 72.12 109.53 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 67.91 21.39 8.99 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.745 0.783 . . . . 72.31 110.811 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.57 24.16 65.86 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.869 -0.682 . . . . 62.44 111.771 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.1 tpt180 -124.05 136.93 54.6 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.267 -0.642 . . . . 64.51 109.267 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.64 112.02 18.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.394 0.616 . . . . 51.12 109.626 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -107.38 150.84 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.011 -0.541 . . . . 70.3 110.974 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -112.86 95.46 33.73 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.221 -0.899 . . . . 74.24 110.828 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.51 127.8 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.95 1.767 . . . . 72.31 111.095 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HA ' ' HE1' ' A' ' 156' ' ' HIS . 40.5 mttt -132.45 171.12 14.18 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 74.23 109.163 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -70.72 133.22 46.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.765 -0.457 . . . . 71.23 109.765 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -67.61 96.62 0.55 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.418 0.628 . . . . 65.24 109.666 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.418 HG22 ' OD1' ' A' ' 160' ' ' ASP . 16.1 t -56.55 135.48 20.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.347 -1.297 . . . . 64.35 111.643 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t -54.61 143.84 23.5 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.245 -0.889 . . . . 72.14 109.846 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -61.04 -18.45 57.86 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.43 0.456 . . . . 75.33 112.137 -173.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.97 -45.24 61.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.458 -0.337 . . . . 74.42 110.741 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.31 -31.56 24.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.688 -0.233 . . . . 74.04 111.066 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 21.7 p -76.48 4.05 9.97 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.062 0.458 . . . . 65.41 111.257 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -86.11 -10.09 55.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.619 0.723 . . . . 44.51 109.138 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -94.94 150.64 38.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.44 -0.8 . . . . 75.14 109.872 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.54 124.87 7.91 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.585 2.19 . . . . 75.12 112.511 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.46 30.27 11.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.162 -0.542 . . . . 62.44 112.23 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.98 -30.28 24.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.976 0.362 . . . . 72.11 111.976 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.18 8.49 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.654 0.264 . . . . 74.52 111.55 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.14 159.68 31.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.717 -0.475 . . . . 65.03 109.717 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 80.28 7.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.595 0.712 . . . . 74.05 110.481 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -108.78 118.46 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.075 -0.966 . . . . 72.23 109.46 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -105.53 21.34 17.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.612 . . . . 62.23 110.081 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -119.2 139.7 51.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 71.42 110.997 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 159' ' ' VAL . 6.7 pt -130.95 149.87 34.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.305 0.574 . . . . 65.44 111.386 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.8 t80 -94.78 133.33 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.716 -1.129 . . . . 72.13 109.906 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.58 109.55 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.063 -0.717 . . . . 73.14 109.063 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.84 159.72 21.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.569 -1.3 . . . . 72.14 113.755 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.07 6.45 53.84 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.697 -0.764 . . . . 74.31 112.406 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.0 pt -66.38 124.48 21.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.26 0.553 . . . . 75.14 109.877 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -91.45 -21.57 20.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.807 -0.633 . . . . 73.1 112.284 -169.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -142.16 -168.41 2.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.467 -0.197 . . . . 65.34 110.467 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.42 101.48 0.05 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 124.073 0.858 . . . . 73.54 111.364 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -109.63 124.23 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.63 -0.878 . . . . 64.24 108.63 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -113.01 -179.39 3.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.585 -0.734 . . . . 64.15 111.635 -169.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.18 -53.66 55.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.929 -1.032 . . . . 70.34 111.493 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.58 -28.24 69.5 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.079 0.237 . . . . 64.54 111.182 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -53.84 -62.65 1.52 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.184 0.516 . . . . 64.31 110.596 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.27 -26.68 28.42 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.113 -0.635 . . . . 64.24 111.532 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 2.0 tmm_? -67.29 -48.28 68.13 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 110.07 -0.345 . . . . 70.51 110.07 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.87 -29.76 70.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.99 0.424 . . . . 73.02 110.5 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 168' ' ' HIS . 88.2 t80 -77.39 -56.82 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.081 -0.509 . . . . 71.53 112.078 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -67.49 -21.99 65.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.414 0.524 . . . . 70.31 112.414 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.8 mt-10 -69.02 -19.96 64.13 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.527 0.195 . . . . 73.44 111.527 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.09 -30.05 64.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.985 0.421 . . . . 72.21 110.98 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.6 -30.89 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 73.14 111.637 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.23 -172.28 44.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.661 -0.781 . . . . 73.31 112.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -76.22 136.19 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.176 0.512 . . . . 73.13 111.681 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 152' ' ' THR . 90.8 mt -106.54 138.45 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 65.44 110.006 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.61 -46.98 8.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 74.24 111.038 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.56 154.93 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 75.11 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -114.62 128.54 71.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.124 0.487 . . . . 73.51 110.046 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 16.8 mt-10 -102.71 104.58 14.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.364 -0.834 . . . . 70.32 111.047 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.86 122.94 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.261 -0.644 . . . . 70.31 109.261 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.4 mmm -105.74 141.62 36.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.907 0.384 . . . . 72.02 110.192 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 74.05 110.87 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.684 0 CA-C-O 119.408 -0.662 . . . . 74.51 113.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -173.04 159.74 4.03 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.054 0.927 . . . . 75.45 110.509 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.55 175.69 9.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.436 -0.802 . . . . 61.03 109.182 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.6 m-85 -141.16 154.45 45.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.945 0.402 . . . . 63.22 110.321 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.67 132.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.318 0.58 . . . . 71.25 111.271 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 131' ' ' ILE . 26.0 m -101.49 126.6 48.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.344 -0.843 . . . . 75.21 110.883 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.53 158.03 16.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 71.42 111.45 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.3 -29.3 53.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.637 -0.71 . . . . 60.43 110.567 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -130.11 155.55 46.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 74.4 110.877 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.412 ' HE1' ' HA ' ' A' ' 87' ' ' LYS . 27.2 p80 -82.89 -26.5 31.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.54 110.351 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 31.9 t70 -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.224 -0.444 . . . . 70.12 110.673 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 m -68.7 -32.78 72.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 61.24 110.799 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -69.16 -39.86 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 72.32 109.783 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.491 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.1 t70 -69.5 -33.49 72.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.224 -0.898 . . . . 74.4 111.152 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 55.9 mttm -53.54 -38.88 64.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.917 0.865 . . . . 75.14 110.29 172.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 177' ' ' VAL . 33.8 mt -77.78 -45.32 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.405 -1.27 . . . . 72.14 113.011 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 160' ' ' ASP . 24.4 m -75.39 -4.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.198 0.523 . . . . 74.44 111.69 -172.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 161' ' ' LYS . 14.0 mt -58.35 -32.12 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.877 . . . . 73.22 109.692 169.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.59 148.75 32.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.385 -0.825 . . . . 73.44 108.788 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.41 -37.04 13.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.0 0.429 . . . . 65.53 111.08 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.87 131.92 53.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.169 -0.468 . . . . 75.24 110.145 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 124' ' ' TYR . 87.7 m-70 -122.11 140.56 52.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.065 -0.516 . . . . 61.32 110.337 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 m -89.98 106.72 18.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.147 0.499 . . . . 75.41 111.402 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.22 130.15 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.83 . . . . 72.14 109.083 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t30 50.22 41.63 24.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.728 0.775 . . . . 74.33 111.641 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.55 69.54 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.616 -0.72 . . . . 41.13 113.347 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -126.52 131.55 51.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.79 0.295 . . . . 51.1 110.453 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.19 108.19 13.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.477 . . . . 72.22 109.711 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.71 146.81 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.179 -0.464 . . . . 71.03 109.755 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -86.4 131.9 34.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.841 0.353 . . . . 72.22 110.228 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 37.4 t -129.19 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.925 -0.58 . . . . 73.21 111.06 -173.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -157.78 171.6 20.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.593 -0.73 . . . . 73.13 111.232 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HD3' HG11 ' A' ' 163' ' ' VAL . 9.0 mmtm -61.22 122.76 15.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.854 -0.425 . . . . 75.53 109.854 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -104.82 111.67 24.5 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.339 0.59 . . . . 61.43 109.884 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--N 1.309 -1.166 0 CA-C-N 115.384 -0.825 . . . . 62.31 109.395 -178.099 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.127 0.489 . . . . 71.21 110.838 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.39 137.36 74.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.655 -0.702 . . . . 74.25 110.202 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 10.5 Cg_endo -61.58 161.33 24.8 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.256 1.971 . . . . 74.41 111.386 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.02 64.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.164 -0.471 . . . . 62.01 111.664 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.478 ' HG3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -64.95 -33.33 75.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.322 0.49 . . . . 64.32 112.322 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 28.8 mt -85.19 -14.58 46.44 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 122.095 -0.378 . . . . 73.51 110.838 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.602 ' HA ' HG21 ' A' ' 68' ' ' VAL . 33.2 ptt180 -117.75 0.8 12.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.229 -0.441 . . . . 74.54 111.363 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -96.71 148.08 23.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.667 0.746 . . . . 72.14 111.53 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.549 HD21 HG13 ' A' ' 68' ' ' VAL . 57.7 mt -118.74 144.3 46.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.712 -1.131 . . . . 70.44 110.424 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -96.47 117.02 30.03 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 60' ' ' VAL . 15.9 mm -96.88 110.82 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.779 -0.452 . . . . 75.04 109.779 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.43 155.0 16.73 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.507 -0.854 . . . . 54.43 111.578 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.57 45.25 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.774 -0.727 . . . . 53.03 113.244 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 25' ' ' THR . 94.3 mt -79.56 175.4 10.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.954 0.407 . . . . 45.33 110.279 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -88.5 166.73 13.99 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.487 -0.561 . . . . 63.44 109.487 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -75.93 -4.54 41.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.751 0.31 . . . . 71.44 110.846 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -122.68 14.74 10.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 74.34 111.096 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.591 HG21 HD22 ' A' ' 21' ' ' LEU . 94.7 m -79.85 124.33 28.55 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 61.04 110.821 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.1 p -99.78 165.68 11.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 75.04 110.346 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.1 p30 -76.67 -21.09 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.73 -0.388 . . . . 63.15 110.74 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.05 -27.7 30.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 74.44 111.208 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -80.36 -36.57 33.83 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.81 -0.441 . . . . 35.3 109.81 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 HG22 ' A' ' 45' ' ' VAL . 35.7 tp -61.87 -46.58 88.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.583 -0.735 . . . . 71.04 110.135 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 ttm-85 -56.21 -56.58 19.23 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 115.792 -0.64 . . . . 74.04 111.314 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.1 t -50.96 -36.2 37.67 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.853 0.721 . . . . 72.41 112.437 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -70.28 -54.6 11.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.671 -0.24 . . . . 72.31 111.302 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -78.5 -17.18 56.62 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.895 0.332 . . . . 75.21 111.895 -170.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.34 -25.65 49.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.454 0.539 . . . . 74.22 112.454 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.87 -26.36 68.29 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.255 0.465 . . . . 41.24 112.255 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -99.64 -19.72 16.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.727 0.269 . . . . 74.13 111.727 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.36 168.74 40.62 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.289 -0.958 . . . . 70.04 112.343 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -66.96 119.76 12.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.031 0.443 . . . . 72.3 112.008 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.61 133.54 35.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.76 -0.654 . . . . 70.51 110.524 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -107.43 -19.02 13.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.237 -0.892 . . . . 72.14 110.215 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.08 153.55 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.255 -0.646 . . . . 60.34 109.255 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 60' ' ' VAL . 11.1 t -165.33 131.43 2.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.993 -0.373 . . . . 71.33 109.993 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.51 128.47 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.509 0.671 . . . . 53.43 111.348 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 27' ' ' ASP . 87.4 t -88.14 133.85 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 63.22 108.63 171.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.454 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mmt -74.86 97.66 3.36 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.651 0.738 . . . . 63.14 110.1 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -99.45 152.32 20.12 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.702 -1.135 . . . . 74.41 109.49 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 37.2 t70 -70.04 127.89 92.03 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.422 -0.808 . . . . 75.24 110.619 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.56 -19.3 64.86 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.189 1.926 . . . . 62.33 113.111 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.505 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 27.6 m-80 -84.76 -56.4 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.785 0.291 . . . . 71.45 111.785 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -105.48 -8.75 17.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.986 0.422 . . . . 64.14 111.849 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp 64.16 40.63 6.75 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.577 0.751 . . . . 65.23 111.626 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -113.83 156.7 23.44 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.952 -0.758 . . . . 74.01 108.952 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m -75.69 131.68 40.04 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.917 -0.313 . . . . 72.23 110.358 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -85.66 5.78 30.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 63.5 111.349 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.08 60.07 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.617 -0.801 . . . . 65.53 114.204 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.454 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.4 p90 -158.99 155.31 27.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.82 0.81 . . . . 74.33 110.343 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.51 -163.13 14.57 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.701 -0.56 . . . . 63.33 111.701 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.85 148.81 37.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.062 0.431 . . . . 75.03 110.224 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 18' ' ' ILE . 8.5 m -128.23 128.53 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.826 -0.624 . . . . 72.31 109.345 171.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.68 118.36 36.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.812 0.339 . . . . 74.35 110.272 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -85.74 161.67 19.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.902 -0.59 . . . . 65.21 109.962 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.05 -44.02 64.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.9 -0.591 . . . . 74.1 110.401 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -120.81 149.22 42.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.916 -0.584 . . . . 64.51 110.845 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.9 p -62.88 -37.38 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.565 -0.288 . . . . 70.22 111.044 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.45 -41.74 85.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.588 0.588 . . . . 72.22 112.588 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.89 -29.24 70.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.019 0.438 . . . . 73.11 110.78 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 14' ' ' ARG . 38.9 t -63.14 -49.41 83.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.592 -0.731 . . . . 74.03 111.087 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.22 -40.69 94.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.2 111.302 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.96 -38.66 57.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.14 -0.482 . . . . 74.43 112.295 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.36 58.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.806 0.336 . . . . 64.04 110.612 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.12 87.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 71.44 111.068 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -29.16 66.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.041 -0.527 . . . . 73.13 111.015 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.71 -9.29 58.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.075 0.768 . . . . 63.42 113.075 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -54.39 146.61 31.98 Favored Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.169 0.433 . . . . 71.44 112.169 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.4 168.98 72.66 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.312 -1.12 . . . . 75.14 113.385 1.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -123.54 161.19 25.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.532 -0.758 . . . . 71.13 110.39 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.5 ttmt -137.21 112.64 9.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.826 0.346 . . . . 63.21 111.35 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.14 126.98 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.973 -0.558 . . . . 51.24 109.936 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.53 26.9 9.82 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.692 0.62 . . . . 72.23 111.915 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.88 23.36 66.91 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.951 -0.643 . . . . 34.43 112.191 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 tpt180 -126.29 135.43 51.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.107 -0.331 . . . . 73.14 110.107 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.66 111.71 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.123 -0.695 . . . . 75.31 109.123 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.3 m -107.7 152.49 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 74.1 111.853 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.26 94.42 30.93 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.762 -1.108 . . . . 74.34 111.402 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -72.19 127.96 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.678 1.585 . . . . 53.11 110.463 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -131.69 168.88 16.99 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 75.14 109.324 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 10.0 tpp180 -73.25 130.51 40.37 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.977 -0.289 . . . . 64.42 110.562 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.68 93.58 0.73 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.073 0.463 . . . . 74.33 110.3 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.24 156.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.369 -0.832 . . . . 51.31 110.546 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -55.3 154.16 6.31 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.098 0.559 . . . . 74.34 111.808 -177.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -58.16 -40.13 80.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.038 -0.528 . . . . 72.1 111.883 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.92 -50.59 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 50.53 110.651 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -70.74 -29.29 65.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.632 -0.713 . . . . 65.54 111.409 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -67.18 -17.55 64.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.403 -0.362 . . . . 75.24 111.295 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -82.22 -12.47 58.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.953 0.406 . . . . 64.13 110.837 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.24 151.23 78.12 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.483 -0.326 . . . . 72.42 110.379 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.83 117.16 4.06 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.101 2.534 . . . . 72.43 112.717 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.63 43.16 69.26 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.958 -0.564 . . . . 44.53 112.812 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.05 -34.6 73.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.879 0.371 . . . . 35.41 111.418 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -99.4 19.71 15.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.677 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.0 154.38 35.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 74.04 109.609 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 m -74.38 86.85 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.706 0.765 . . . . 55.35 110.445 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.0 t -114.89 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 74.32 109.343 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -104.19 16.5 26.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.11 0.414 . . . . 72.32 111.101 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -117.16 139.96 50.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.594 -0.276 . . . . 64.23 111.022 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 159' ' ' VAL . 4.3 pt -123.55 147.48 27.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.263 0.554 . . . . 53.13 111.111 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.2 t80 -97.68 131.43 44.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.779 -1.1 . . . . 72.22 109.628 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.04 110.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.868 -0.789 . . . . 64.33 108.868 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.88 148.02 19.27 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.998 -1.096 . . . . 54.22 112.31 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.61 6.15 29.07 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.207 -0.997 . . . . 61.54 112.217 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 173' ' ' HIS . 13.6 pt -76.54 103.99 4.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.556 0.693 . . . . 74.1 110.468 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.19 -24.48 34.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 62.42 110.996 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.45 171.37 7.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.863 0.364 . . . . 71.44 110.558 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.99 125.45 26.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 71.51 110.057 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 m -124.12 139.27 54.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.15 0.5 . . . . 63.4 110.323 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -112.88 174.69 5.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.591 -0.731 . . . . 72.25 111.796 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.03 -57.24 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.847 -1.07 . . . . 71.55 112.132 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -64.68 -23.79 67.37 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 123.07 0.231 . . . . 75.22 111.066 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -57.08 -58.99 5.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.97 0.415 . . . . 64.44 110.558 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 134' ' ' ILE . 4.6 pp -83.67 -25.3 30.82 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.674 -0.81 . . . . 73.21 111.549 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.8 -51.5 58.55 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.737 -0.468 . . . . 54.1 109.737 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.78 -32.99 73.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 74.44 110.413 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD2' HG22 ' A' ' 170' ' ' VAL . 92.6 t80 -73.06 -57.81 3.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.982 -0.554 . . . . 65.25 112.187 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -68.33 -22.3 64.7 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.563 0.579 . . . . 64.42 112.563 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.97 -24.93 67.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.827 0.346 . . . . 74.04 111.468 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -55.78 -26.04 44.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.748 -0.66 . . . . 71.41 111.83 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -91.82 -20.83 21.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.162 0.43 . . . . 75.43 112.162 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.01 -172.48 42.12 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.416 -0.897 . . . . 63.34 113.396 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -76.35 131.99 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 74.31 111.248 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 152' ' ' THR . 71.8 mt -103.79 139.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.735 -0.666 . . . . 73.54 109.936 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.76 -48.65 6.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.825 0.345 . . . . 75.34 110.944 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -157.38 157.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.261 -0.427 . . . . 65.52 109.961 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 121' ' ' LEU . 3.2 mp -115.52 130.29 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.551 -0.537 . . . . 71.02 109.551 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.2 mt-10 -103.69 103.31 13.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.213 -0.449 . . . . 62.53 110.946 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.2 mm -91.38 125.43 44.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.461 -0.57 . . . . 70.31 109.461 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.9 mmm -105.91 133.25 50.93 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.083 -0.71 . . . . 71.23 109.083 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 62.54 112.025 -174.339 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 119.736 -0.48 . . . . 75.11 113.507 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -172.85 157.46 3.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.633 0.717 . . . . 75.41 109.526 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.0 172.3 13.24 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.63 . . . . 75.32 109.694 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 75.8 m-85 -138.46 155.67 48.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.732 -0.667 . . . . 75.22 109.745 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.41 136.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.301 0.572 . . . . 71.4 110.809 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 131' ' ' ILE . 98.9 m -100.52 125.05 46.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.02 -0.991 . . . . 74.31 110.944 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -100.61 157.67 16.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.875 0.369 . . . . 63.24 110.59 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.28 -30.29 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.766 -0.652 . . . . 52.14 110.312 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -130.97 155.34 46.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 74.4 110.823 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -80.12 -26.34 39.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 72.01 110.514 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 17.0 t70 -63.01 -39.16 93.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.624 -0.716 . . . . 74.52 111.169 -173.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 -31.42 72.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.375 -0.375 . . . . 73.2 110.781 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 107' ' ' ILE . 3.2 t -69.81 -45.33 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.289 -0.414 . . . . 61.42 110.195 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.597 ' HA ' HG22 ' A' ' 163' ' ' VAL . 20.1 m-20 -71.04 -23.96 62.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.845 -0.616 . . . . 73.21 111.586 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 88.1 mttt -63.78 -40.95 97.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.14 110.095 170.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.37 -42.54 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.695 -1.139 . . . . 64.4 112.122 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 160' ' ' ASP . 13.4 m -73.81 -12.25 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 53.45 110.789 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.451 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 6.8 mt -58.55 -29.37 38.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 72.24 109.829 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.489 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.3 mt-30 -112.44 98.7 7.45 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.613 -0.884 . . . . 72.2 108.613 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HZ2' ' HB2' ' A' ' 166' ' ' LYS . 1.2 ttmp? -53.37 -37.21 62.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.424 0.898 . . . . 63.04 113.424 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -121.3 131.67 54.34 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.6 -0.44 . . . . 70.25 110.576 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.7 m-70 -124.85 158.09 34.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 74.02 109.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.2 m -102.82 103.38 13.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.081 0.467 . . . . 72.45 110.379 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 124' ' ' TYR . 3.7 t -118.53 140.5 41.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.71 -0.677 . . . . 64.33 109.177 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.5 t30 56.77 31.02 18.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.966 0.889 . . . . 75.42 111.009 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.85 16.96 74.88 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.341 -0.845 . . . . 51.21 113.303 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 85.8 t60 -130.7 138.67 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.767 0.283 . . . . 72.51 110.356 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.68 110.9 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 73.44 110.535 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.81 158.07 29.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.066 -0.97 . . . . 64.44 111.102 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.56 133.1 34.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.123 -0.49 . . . . 54.03 110.187 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.8 t -128.83 132.12 67.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.345 -0.843 . . . . 75.41 110.057 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -155.4 175.98 13.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 75.15 111.15 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -62.14 122.9 16.73 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.82 -0.437 . . . . 75.54 109.82 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 108' ' ' PHE . . . -107.21 115.13 29.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.084 0.469 . . . . 55.24 110.719 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 C--N 1.308 -1.232 0 N-CA-C 108.392 -0.966 . . . . 71.01 108.392 173.558 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 N-CA-C 112.287 0.477 . . . . 73.12 112.287 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.91 150.27 38.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 C-N-CA 120.658 -0.417 . . . . 73.42 110.175 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 36.1 Cg_endo -70.65 167.32 25.94 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.254 1.969 . . . . 64.34 112.076 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -37.06 68.75 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.006 -0.543 . . . . 64.41 112.283 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.43 -16.41 63.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.044 0.387 . . . . 72.44 112.044 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.6 mp -96.01 -14.63 22.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.742 0.306 . . . . 53.51 111.112 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.582 ' HA ' HG21 ' A' ' 68' ' ' VAL . 16.5 ptt180 -118.84 2.22 11.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.044 0.45 . . . . 72.44 110.767 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.98 149.63 22.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.751 0.786 . . . . 62.13 111.603 174.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.721 HD21 HG13 ' A' ' 68' ' ' VAL . 61.0 mt -117.13 146.45 43.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.552 -1.203 . . . . 62.33 110.46 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -99.21 121.62 41.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.65 -0.87 . . . . 74.41 108.65 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.92 112.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 110.052 -0.351 . . . . 51.21 110.052 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.77 150.32 18.31 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.929 -0.653 . . . . 71.24 111.703 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 45.95 42.5 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.767 -0.73 . . . . 65.01 113.541 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 HG21 ' A' ' 25' ' ' THR . 77.9 mt -81.08 163.43 23.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.704 -0.48 . . . . 52.45 109.704 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 p -80.97 169.21 17.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.327 -0.62 . . . . 71.43 109.327 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -72.33 -11.52 60.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 72.54 110.316 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.89 15.26 17.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 71.33 111.314 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.569 HG21 HD22 ' A' ' 21' ' ' LEU . 53.1 m -82.41 126.9 32.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.152 0.501 . . . . 71.52 110.942 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 164.09 12.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 63.44 110.325 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.6 p30 -74.06 -25.79 60.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.184 -0.206 . . . . 54.43 110.879 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.67 -37.47 82.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 73.33 110.493 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 m -80.23 -37.25 33.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 61.53 110.943 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 45' ' ' VAL . 32.3 tp -63.0 -43.56 98.44 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.133 -0.485 . . . . 72.12 110.458 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 31' ' ' ARG . 14.6 ttm180 -60.86 -55.49 32.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.886 -0.413 . . . . 65.22 109.886 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.7 m -47.23 -39.52 14.36 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 124.313 1.008 . . . . 73.23 113.067 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.403 ' ND1' HG22 ' A' ' 79' ' ' VAL . 8.2 t-80 -70.68 -61.27 1.83 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 70.11 111.583 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -69.91 -21.82 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 72.45 112.201 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 28.9 tt0 -63.74 -16.88 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.813 0.445 . . . . 73.21 111.857 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.27 -26.62 68.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.563 0.221 . . . . 73.44 111.081 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -99.56 -19.98 16.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.205 0.446 . . . . 61.41 112.205 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -175.53 168.7 41.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.218 -0.992 . . . . 74.13 112.707 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.5 m -65.98 119.14 10.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 53.35 111.99 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.72 122.24 34.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.706 0.765 . . . . 64.23 111.215 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -89.72 -25.77 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.154 -1.385 . . . . 73.1 110.116 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -152.3 153.34 33.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.394 -0.821 . . . . 43.14 109.642 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -161.06 130.24 4.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.748 -0.464 . . . . 63.32 109.748 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.03 123.8 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.481 0.658 . . . . 64.03 110.516 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 30' ' ' LEU . 92.0 t -84.39 135.06 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.224 -1.028 . . . . 75.33 108.224 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.459 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -74.17 95.35 2.58 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.782 0.801 . . . . 65.14 109.641 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -104.91 164.57 11.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.102 -1.408 . . . . 71.54 110.257 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.46 128.46 87.23 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.936 -0.765 . . . . 62.15 108.936 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.78 -18.73 65.23 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.181 1.921 . . . . 70.03 113.377 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -86.39 -55.69 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 74.1 110.89 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -99.63 -14.89 18.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.008 -0.996 . . . . 75.41 112.331 -170.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm 65.76 26.8 11.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.924 0.89 . . . . 63.34 111.367 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -102.54 153.32 20.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.552 -0.536 . . . . 72.52 109.552 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.0 137.72 51.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 73.52 112.145 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -88.83 4.89 46.14 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.463 -0.79 . . . . 73.13 110.441 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.08 17.7 58.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.057 -0.592 . . . . 73.13 114.385 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.4 p90 -159.1 155.68 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.607 0.703 . . . . 52.11 110.155 174.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.45 20.22 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.825 -0.51 . . . . 35.31 111.825 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.19 149.76 40.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.032 0.416 . . . . 63.22 110.852 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.9 127.0 65.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.614 -0.721 . . . . 70.11 109.496 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 m -104.34 121.37 43.22 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.292 -0.255 . . . . 61.44 110.654 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.9 178.28 7.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.176 -0.466 . . . . 73.05 111.084 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.06 -28.81 18.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.683 -0.69 . . . . 41.12 110.796 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -144.05 147.69 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 74.22 110.698 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.55 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -57.54 -35.38 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 122.863 0.465 . . . . 61.1 111.913 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.09 -39.56 63.45 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.15 0.796 . . . . 72.23 113.15 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -70.78 -27.12 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 71.33 110.303 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.721 HG13 HD21 ' A' ' 16' ' ' LEU . 19.7 t -66.61 -47.3 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.334 -0.848 . . . . 72.41 110.08 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.97 -46.07 85.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 75.41 110.702 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.53 -41.25 53.55 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.466 0.543 . . . . 63.12 112.466 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.48 -32.23 58.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 55.02 110.96 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.3 mmt -70.74 -36.21 73.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 44.31 110.107 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -12.6 59.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.481 -0.781 . . . . 72.2 110.512 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.28 -11.35 38.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.731 -0.668 . . . . 64.42 110.269 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp85 -57.87 142.1 79.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.241 -0.891 . . . . 74.24 110.402 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 86.7 Cg_endo -79.95 169.0 71.5 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.694 -0.961 . . . . 75.1 114.363 4.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.463 ' CD2' ' HG3' ' A' ' 86' ' ' PRO . 69.0 m-70 -129.0 158.54 38.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.879 . . . . 61.21 110.447 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -137.43 106.9 6.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.071 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.403 HG22 ' ND1' ' A' ' 33' ' ' HIS . 15.5 t -107.95 130.9 59.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.242 -0.435 . . . . 72.04 109.901 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 65.05 29.31 12.19 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.667 0.604 . . . . 73.05 111.674 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.44 26.08 72.73 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.936 -0.575 . . . . 73.14 112.117 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.8 tpt180 -129.0 139.11 52.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 65.14 109.841 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.25 107.67 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.584 -0.525 . . . . 70.23 109.584 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.48 151.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.259 0.552 . . . . 53.33 110.824 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -112.03 94.43 25.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 70.55 111.087 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HG3' ' CD2' ' A' ' 77' ' ' HIS . 38.2 Cg_endo -74.31 132.28 16.2 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.069 1.846 . . . . 74.53 111.385 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -137.12 174.24 10.83 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.291 -1.003 . . . . 73.44 108.291 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.0 tmm_? -76.77 131.04 38.49 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.653 -0.869 . . . . 70.21 108.653 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.09 96.36 0.14 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.043 0.449 . . . . 75.42 111.755 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 100' ' ' ALA . 40.3 t -69.07 137.23 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.113 -0.948 . . . . 73.24 110.497 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 t -86.88 -176.56 5.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.732 -0.667 . . . . 73.42 109.789 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -68.63 -41.6 79.23 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.553 0.946 . . . . 64.23 113.553 -167.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.71 -35.4 52.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.729 -0.389 . . . . 73.51 111.198 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -14.3 59.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.771 0.319 . . . . 63.22 110.363 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 30.5 t -80.57 -20.09 44.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 60.24 109.824 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -71.33 -20.37 62.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.811 -0.632 . . . . 75.42 109.797 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.22 147.67 88.07 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 74.41 110.661 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.14 128.61 17.86 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.817 2.345 . . . . 73.53 112.098 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.4 39.31 22.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.019 -0.61 . . . . 74.04 111.993 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -66.03 -54.3 27.72 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.876 0.324 . . . . 75.14 111.876 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -107.66 11.14 28.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.044 0.449 . . . . 75.52 110.621 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 151.58 25.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.583 -0.525 . . . . 74.45 109.583 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 156' ' ' HIS . 5.8 m -72.52 105.84 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.735 . . . . 73.12 110.359 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HB ' ' CE ' ' A' ' 179' ' ' LYS . 61.4 t -132.21 116.27 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.867 -1.061 . . . . 72.43 109.43 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' C ' HG21 ' A' ' 159' ' ' VAL . 75.3 mttt -102.6 13.6 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.417 -0.513 . . . . 71.35 110.67 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.38 139.66 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.315 -0.402 . . . . 71.22 110.792 177.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -120.97 149.16 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.261 0.553 . . . . 64.14 111.388 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.3 t80 -98.76 132.21 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.774 -1.103 . . . . 74.15 109.441 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 111.08 28.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.217 -0.66 . . . . 71.12 109.217 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -132.88 148.41 19.27 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 119.907 -1.139 . . . . 31.01 112.601 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 6.72 36.7 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.347 -0.93 . . . . 60.32 112.948 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.76 105.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.522 0.677 . . . . 71.01 110.526 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -74.97 -53.44 8.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.496 -0.775 . . . . 62.34 110.62 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -73.09 155.45 39.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.416 -0.811 . . . . 72.12 109.805 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.53 134.73 55.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.279 0.561 . . . . 75.23 109.739 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -116.24 145.26 43.27 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.021 -0.536 . . . . 64.43 109.899 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.86 158.63 17.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.053 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.12 -44.48 79.18 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 123.93 0.769 . . . . 75.14 110.289 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -56.52 -35.68 68.32 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.409 0.284 . . . . 74.11 111.603 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -62.66 -59.92 4.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.331 -0.395 . . . . 73.51 110.841 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 134' ' ' ILE . 1.9 pt? -84.29 -21.65 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.253 -0.579 . . . . 74.32 111.138 -173.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 7.2 tmm_? -66.36 -55.67 14.78 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 110.138 -0.319 . . . . 75.42 110.138 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -61.39 -26.41 67.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.361 0.6 . . . . 64.14 110.481 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -75.8 -58.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.39 -0.823 . . . . 75.51 112.252 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.3 m-85 -69.08 -21.84 64.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 111.735 0.272 . . . . 71.32 111.735 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mm-40 -64.55 -24.73 67.7 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.917 0.389 . . . . 61.01 111.076 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -58.69 -27.59 64.97 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.921 -0.582 . . . . 63.44 111.636 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -87.24 -32.19 19.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 74.23 112.009 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.41 -174.71 47.17 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.828 -0.701 . . . . 73.12 113.001 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -74.03 126.62 30.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.302 0.572 . . . . 63.42 112.184 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 63.3 mt -97.36 139.42 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.118 -0.946 . . . . 65.34 109.72 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -90.34 -48.62 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 70.1 110.731 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.52 154.48 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.164 -0.471 . . . . 61.42 109.777 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.401 HG21 HD21 ' A' ' 121' ' ' LEU . 3.7 mp -112.63 125.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.376 -0.601 . . . . 63.32 109.376 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 34.3 mt-10 -100.43 103.91 15.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.666 -0.697 . . . . 55.31 110.7 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.3 mm -95.63 129.47 45.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.775 -0.454 . . . . 73.22 109.775 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.6 mtp -110.95 146.16 37.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.746 -0.835 . . . . 61.4 108.746 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 74.53 112.222 -175.657 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.895 0 CA-C-O 119.918 -0.379 . . . . 75.03 112.751 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -169.48 148.33 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.688 -0.486 . . . . 75.24 109.688 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.98 172.76 12.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.844 -0.616 . . . . 74.33 109.516 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 55.1 m-85 -140.89 151.72 44.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.012 -0.54 . . . . 70.1 110.454 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 125' ' ' PHE . 94.9 t -134.13 129.52 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.23 -0.441 . . . . 74.12 110.587 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 131' ' ' ILE . 64.0 m -99.85 123.23 43.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 70.41 110.206 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -104.06 159.69 15.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.732 0.301 . . . . 73.11 110.381 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.94 -24.09 48.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.33 0.586 . . . . 64.35 110.761 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 4.4 t70 -138.41 156.67 47.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.726 . . . . 72.44 110.148 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 103' ' ' THR . 23.6 p80 -79.79 -21.41 44.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.415 -0.357 . . . . 74.24 110.038 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.4 p-10 -58.91 -39.61 82.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.443 -0.799 . . . . 72.53 111.026 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -76.32 -29.35 57.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.073 -0.512 . . . . 60.55 110.532 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -69.58 -40.22 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.59 -0.522 . . . . 73.3 109.59 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -72.05 -24.3 61.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.348 -0.842 . . . . 74.15 111.453 -178.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 72.8 mttt -68.21 -34.12 75.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 74.55 110.234 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.86 -40.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.181 -0.918 . . . . 72.42 112.281 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 159' ' ' VAL . 12.2 m -73.0 -6.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.15 0.5 . . . . 74.13 111.362 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 13' ' ' LEU . 54.8 mt -54.74 -38.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.079 -0.964 . . . . 72.02 110.171 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -107.55 114.2 28.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.386 -0.825 . . . . 75.45 109.473 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -53.85 -41.5 67.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.402 -0.817 . . . . 72.21 112.187 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.89 138.61 54.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.859 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -124.25 152.89 42.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.631 -0.713 . . . . 74.15 109.218 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -122.84 113.28 18.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.324 0.583 . . . . 74.14 110.035 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.59 113.96 41.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.507 -0.769 . . . . 74.45 109.92 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 70.44 24.1 4.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.128 0.489 . . . . 53.45 110.789 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.2 78.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.861 -0.685 . . . . 72.33 112.448 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.27 111.08 21.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.856 -0.424 . . . . 75.12 109.856 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.4 131.68 34.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.313 -0.625 . . . . 61.35 109.313 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 p -143.99 149.27 36.47 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.263 -0.426 . . . . 64.05 111.436 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.52 130.57 35.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.632 -0.877 . . . . 74.1 108.632 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.7 t -127.74 137.21 58.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.857 -0.611 . . . . 74.51 110.501 -175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -161.99 177.97 9.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.264 -0.88 . . . . 73.45 110.972 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.45 ' CE ' ' HB ' ' A' ' 104' ' ' VAL . 7.0 mmmm -67.74 122.03 17.23 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.671 -0.492 . . . . 71.43 109.671 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -93.73 114.9 27.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.895 0.378 . . . . 42.22 110.445 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 115.751 -0.659 . . . . 73.23 110.831 179.029 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.047 -1.094 . . . . 61.21 108.047 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 1.6 mp0 -61.55 131.44 92.64 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 113.649 -1.614 . . . . 62.23 111.704 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 16.4 Cg_endo -59.95 168.43 5.85 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.703 2.935 . . . . 72.23 112.99 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.45 59.85 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.617 -0.719 . . . . 65.52 111.92 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.14 0.422 . . . . 71.21 112.14 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 13.3 mt -85.29 -20.91 29.32 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 122.094 -0.379 . . . . 61.24 110.671 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 ptt-85 -108.7 -2.9 18.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.863 0.363 . . . . 75.41 111.027 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.8 ttpt -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.599 0.714 . . . . 74.43 111.944 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 HG13 ' A' ' 68' ' ' VAL . 69.7 mt -118.97 145.28 45.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.801 -1.09 . . . . 65.41 110.034 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -97.09 123.57 40.88 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.398 -0.964 . . . . 74.21 108.398 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 60' ' ' VAL . 18.6 mm -103.02 110.22 29.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.83 -0.433 . . . . 62.41 109.83 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.69 150.48 17.95 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.046 -0.597 . . . . 63.12 111.794 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.75 52.92 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.846 -0.692 . . . . 53.43 113.168 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 25' ' ' THR . 68.8 mt -78.74 176.8 9.19 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.283 -0.636 . . . . 73.34 109.283 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p -83.5 167.64 17.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.152 -1.055 . . . . 75.45 108.152 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -79.51 0.42 29.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.933 0.396 . . . . 74.2 110.639 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -125.38 15.59 8.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.837 -0.62 . . . . 74.21 111.568 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 21' ' ' LEU . 32.4 m -74.11 130.62 40.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.662 0.267 . . . . 65.52 111.072 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.3 p -104.77 163.67 12.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 74.52 110.293 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -28.31 64.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.405 -0.361 . . . . 70.55 111.193 -176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.93 -35.77 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.513 0.197 . . . . 72.13 111.244 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -75.94 -36.61 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.665 -0.243 . . . . 72.21 110.687 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.9 -48.25 77.39 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.704 -0.48 . . . . 74.45 109.704 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.3 ttm180 -54.96 -60.86 2.78 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 115.379 -0.828 . . . . 73.02 111.951 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -50.23 -31.66 14.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.738 0.648 . . . . 51.45 112.386 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -73.14 -60.72 2.1 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.201 -0.2 . . . . 64.41 110.817 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.36 -22.13 64.68 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.109 0.411 . . . . 74.33 112.109 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.47 -25.51 51.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.312 0.645 . . . . 60.44 112.078 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.5 -27.03 65.79 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.236 0.458 . . . . 62.52 112.236 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -99.05 -19.68 17.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.582 0.215 . . . . 72.53 111.582 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.0 28.09 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.851 -0.69 . . . . 63.44 111.771 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -63.82 119.49 10.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.441 . . . . 51.15 111.329 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.7 136.24 33.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.589 -0.732 . . . . 70.32 110.487 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 p -103.97 -21.79 13.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.42 -0.809 . . . . 74.23 110.194 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -150.84 150.11 30.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 75.34 109.674 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -159.9 130.27 5.57 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.713 -0.477 . . . . 75.43 109.713 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.76 129.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.383 0.611 . . . . 72.2 111.083 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -87.77 128.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.79 -0.819 . . . . 54.45 108.79 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -72.9 98.45 2.47 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.669 0.747 . . . . 63.32 110.278 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -103.37 161.24 14.0 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.385 -1.279 . . . . 54.43 110.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.52 125.2 91.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.749 -1.114 . . . . 61.12 109.793 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -65.45 -20.71 60.99 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.202 1.935 . . . . 74.52 112.575 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -83.83 -55.43 4.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 74.24 111.63 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 -8.67 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 64.42 111.85 -173.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 62.19 38.23 13.72 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.287 0.635 . . . . 73.14 111.447 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -110.09 157.48 19.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.547 -0.909 . . . . 50.24 108.547 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -73.13 137.89 45.44 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.796 -0.362 . . . . 74.01 110.262 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -83.4 1.27 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.42 110.204 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.31 18.3 59.23 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.99 -0.624 . . . . 74.41 113.871 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -159.57 158.4 31.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.059 0.929 . . . . 74.43 110.614 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.16 -163.07 14.97 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.34 -0.704 . . . . 71.12 111.34 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.31 149.83 38.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.235 0.518 . . . . 71.51 110.702 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 m -129.67 122.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.879 -0.6 . . . . 75.31 109.844 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.1 m -98.9 121.93 41.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.624 -0.262 . . . . 74.41 110.386 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -87.18 163.4 16.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 71.03 110.704 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.15 70.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.637 -0.71 . . . . 52.34 110.144 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -124.38 144.3 50.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.427 -0.806 . . . . 74.41 110.384 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -63.17 -37.09 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.258 -0.428 . . . . 70.03 110.824 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.02 -36.93 68.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.552 0.575 . . . . 73.13 112.552 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.41 -26.81 65.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.104 0.478 . . . . 74.21 110.704 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 37.7 t -64.62 -45.46 95.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.538 -0.756 . . . . 74.1 110.468 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -52.96 -48.23 67.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.699 -0.682 . . . . 65.4 111.989 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -58.12 -37.38 74.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.607 0.595 . . . . 73.4 112.607 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.84 -34.83 78.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.396 0.617 . . . . 72.12 110.166 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -38.23 77.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 74.43 110.877 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.644 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.0 p30 -76.99 -10.46 59.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.894 0.378 . . . . 75.21 111.335 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.06 -11.59 43.66 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.906 -0.588 . . . . 75.11 112.438 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.42 148.78 8.51 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 113.284 0.846 . . . . 63.33 113.284 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.94 160.87 79.1 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.692 -1.378 . . . . 75.53 112.438 -2.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -110.4 151.53 27.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 63.2 110.152 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.1 ttmt -136.76 104.36 5.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.044 0.45 . . . . 74.54 111.131 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.8 140.31 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.695 -0.684 . . . . 32.51 109.685 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 66.25 21.68 11.02 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.573 0.749 . . . . 74.42 110.3 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 25.4 69.1 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.748 -0.66 . . . . 75.53 112.222 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 tpt180 -129.4 136.64 50.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.374 -0.232 . . . . 72.52 110.374 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -83.79 111.05 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.655 0.74 . . . . 72.2 109.992 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 m -102.84 155.34 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.576 0.703 . . . . 63.41 112.183 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -111.53 96.62 32.92 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.469 -1.241 . . . . 65.41 111.006 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.58 130.1 7.68 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.35 2.033 . . . . 75.32 111.073 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HZ2' HG23 ' A' ' 103' ' ' THR . 30.0 mttm -133.8 170.26 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.849 -0.797 . . . . 63.12 108.849 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.547 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tpp180 -70.38 137.76 50.77 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.507 -0.553 . . . . 72.3 109.507 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 97.15 0.45 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.292 0.568 . . . . 52.32 110.348 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' OD1' ' A' ' 160' ' ' ASP . 6.6 t -55.26 136.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.433 -1.258 . . . . 64.12 111.786 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.432 ' HB2' HG12 ' A' ' 164' ' ' ILE . 2.4 t -57.84 147.26 29.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.435 -0.802 . . . . 74.13 109.904 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -52.52 -40.48 62.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.402 0.681 . . . . 73.41 112.591 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.03 -39.29 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.142 0.423 . . . . 71.35 112.142 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.28 -32.31 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.03 -0.359 . . . . 74.04 110.03 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -69.57 -12.32 61.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.941 -0.572 . . . . 72.21 110.609 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.17 -7.84 59.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 74.44 110.056 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -94.62 151.11 38.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 74.42 110.299 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 122.46 8.19 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.557 2.171 . . . . 74.22 111.974 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.56 19.5 27.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.586 -0.816 . . . . 73.51 112.578 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.49 54.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.673 0.249 . . . . 74.21 111.673 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -98.96 13.84 31.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.802 0.334 . . . . 71.24 111.405 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.38 171.1 13.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.851 -0.425 . . . . 73.3 109.851 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' HZ2' ' A' ' 87' ' ' LYS . 2.0 m -89.01 78.18 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.423 0.63 . . . . 63.51 110.778 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.01 121.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.933 -1.03 . . . . 74.33 109.341 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 88.2 mttt -107.35 21.73 17.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.164 0.507 . . . . 73.0 110.374 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 142.98 49.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.162 -0.472 . . . . 74.31 111.46 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 159' ' ' VAL . 7.7 pt -132.71 150.66 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.31 0.576 . . . . 73.32 111.561 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.9 t80 -96.29 138.48 33.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.834 -1.075 . . . . 73.42 110.086 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.98 110.78 25.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.419 -0.585 . . . . 73.24 109.419 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.17 141.84 12.81 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 119.927 -1.13 . . . . 71.45 112.387 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.0 6.36 14.04 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.315 -0.945 . . . . 71.41 112.224 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -73.87 101.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.515 0.674 . . . . 74.22 109.793 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 22.73 1.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 72.02 112.628 -170.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.01 175.57 11.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.996 -0.372 . . . . 73.12 109.996 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.66 120.96 12.2 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.697 0.623 . . . . 65.41 110.561 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -122.7 146.6 47.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.175 0.512 . . . . 75.1 110.136 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.5 165.27 11.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.44 -0.8 . . . . 64.44 111.289 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.52 -47.17 87.35 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.184 -1.371 . . . . 62.14 109.61 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.47 -0.786 . . . . 74.25 111.712 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.47 -58.03 7.58 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.165 0.291 . . . . 71.35 111.185 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.16 -27.5 38.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.615 -0.834 . . . . 74.11 110.918 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.4 tmm_? -66.65 -45.0 80.37 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.977 -0.379 . . . . 73.53 109.977 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.23 -32.18 71.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.195 0.521 . . . . 75.2 110.454 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -79.48 -55.82 4.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.503 -0.771 . . . . 71.24 112.37 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 42.9 m-85 -67.7 -24.03 65.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.095 0.405 . . . . 74.13 112.095 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.4 mm-40 -66.58 -25.81 66.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.976 0.417 . . . . 74.0 110.899 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -61.03 -32.23 71.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.94 -0.573 . . . . 71.33 111.589 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -81.69 -27.91 33.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.54 111.101 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.416 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 171.36 -177.65 44.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.768 -0.651 . . . . 74.11 112.651 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.6 134.3 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.217 0.532 . . . . 70.21 111.618 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 152' ' ' THR . 79.4 mt -102.88 144.56 13.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.338 -0.846 . . . . 75.52 109.872 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -93.49 -49.1 6.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 73.12 110.825 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.35 155.32 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 74.24 109.912 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.74 129.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.344 . . . . 64.53 110.07 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.79 103.39 14.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 61.42 111.178 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.38 115.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.561 -0.533 . . . . 52.31 109.561 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ptp -111.48 152.97 26.84 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.349 -0.612 . . . . 54.54 109.349 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 116.239 -0.437 . . . . 72.44 111.68 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.834 0 CA-C-O 119.527 -0.596 . . . . 75.34 113.414 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -170.54 153.68 4.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.903 0.852 . . . . 61.02 109.973 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.38 174.75 11.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 61.14 109.474 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.85 155.21 47.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.057 -0.52 . . . . 74.44 109.985 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.07 132.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.54 0.686 . . . . 64.32 111.097 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 65.0 m -97.58 124.08 41.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.085 -0.961 . . . . 75.24 110.465 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 3.7 m-85 -99.24 157.83 16.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 70.11 111.289 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.59 -29.12 45.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.14 -0.936 . . . . 52.22 110.511 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -128.68 152.22 48.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.526 . . . . 72.01 110.847 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -77.74 -28.21 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 71.35 109.887 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.9 t70 -58.12 -48.26 80.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.641 -1.163 . . . . 75.4 111.955 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 19.5 m -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 65.31 111.137 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -67.76 -41.11 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 71.02 109.775 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 163' ' ' VAL . 12.8 t70 -68.08 -38.16 82.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.077 -0.965 . . . . 55.5 111.377 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.547 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 86.4 mttt -52.87 -37.28 60.23 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.517 0.675 . . . . 70.21 110.696 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mt -78.18 -44.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 71.01 112.533 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 16.5 m -74.21 -15.17 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 75.32 110.725 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 91' ' ' SER . 19.0 mt -57.69 -32.11 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.935 -1.03 . . . . 63.33 110.16 172.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.534 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -111.51 101.45 9.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 75.33 108.197 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -56.98 -33.79 67.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.233 0.827 . . . . 64.23 113.233 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -122.15 135.24 54.76 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.569 -0.452 . . . . 65.32 110.989 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 92.6 m-70 -127.39 156.92 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.754 -0.657 . . . . 74.21 110.176 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 10.2 m -123.5 115.44 21.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.08 0.467 . . . . 74.13 110.834 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.58 115.57 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.782 . . . . 42.14 109.99 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 71.48 23.84 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.922 0.868 . . . . 75.15 109.749 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 95.3 -13.21 67.16 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.559 -0.746 . . . . 62.44 112.266 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.516 ' O ' ' HA ' ' A' ' 169' ' ' THR . 2.6 m80 -81.9 109.99 16.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.154 -0.313 . . . . 74.11 110.154 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -91.86 107.77 19.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.88 0.848 . . . . 62.31 109.133 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 5.7 p -124.12 156.8 36.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.093 -0.958 . . . . 72.31 111.463 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -85.97 130.51 34.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.591 -0.731 . . . . 63.12 109.154 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 11.3 t -126.63 131.24 71.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.333 -0.849 . . . . 61.54 109.696 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.38 172.93 17.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 72.25 110.933 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.463 ' HD3' HG11 ' A' ' 163' ' ' VAL . 12.0 mmtm -62.67 124.79 21.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.256 0.348 . . . . 64.5 110.708 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -109.71 112.89 25.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.866 0.365 . . . . 63.33 110.216 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--N 1.314 -0.968 0 N-CA-C 109.395 -0.595 . . . . 54.12 109.395 177.684 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 109.112 -0.699 . . . . 75.43 109.112 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -79.1 133.61 60.78 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.833 -1.076 . . . . 75.14 109.535 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 14' ' ' ARG . 18.3 Cg_endo -62.83 163.3 22.34 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.553 2.169 . . . . 60.03 111.009 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 7.5 pt-20 -62.56 -27.1 68.94 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 111.981 0.363 . . . . 74.13 111.981 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HG3' HD12 ' A' ' 13' ' ' LEU . 9.2 pt20 -72.79 -32.51 65.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.795 0.331 . . . . 74.22 110.849 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 164' ' ' ILE . 5.1 mp -81.36 -11.69 59.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 74.24 111.197 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 10' ' ' PRO . 32.0 ptt85 -127.06 15.77 7.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.126 0.488 . . . . 75.42 110.952 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 18.3 ttmm -97.32 151.29 20.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 72.34 111.029 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 68' ' ' VAL . 70.2 mt -116.76 142.6 46.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.939 -1.028 . . . . 73.2 110.129 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -98.11 120.89 39.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.169 -1.049 . . . . 75.1 108.169 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.45 110.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.873 -0.417 . . . . 74.31 109.873 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.29 152.29 17.97 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.877 -0.678 . . . . 64.23 111.565 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.83 46.8 43.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.487 -0.863 . . . . 74.41 112.981 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 25' ' ' THR . 80.5 mt -81.98 176.84 9.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.634 -0.506 . . . . 75.14 109.634 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 p -85.81 164.6 17.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.107 -1.072 . . . . 73.14 108.107 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -80.63 2.88 23.92 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.039 0.447 . . . . 73.1 110.455 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -119.81 10.7 11.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.585 -0.734 . . . . 75.21 110.995 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.42 HG21 HD22 ' A' ' 21' ' ' LEU . 94.9 m -71.3 121.52 18.61 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 74.53 110.807 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -94.62 154.85 17.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.003 -0.544 . . . . 63.15 109.99 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -27.45 63.83 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 121.109 -0.236 . . . . 61.23 110.867 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -77.2 -23.02 51.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 62.4 110.741 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -81.29 -41.42 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.672 -0.492 . . . . 70.33 109.672 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.13 -47.14 87.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 62.42 109.655 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.21 -62.68 1.5 Allowed 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.094 -0.957 . . . . 73.34 111.71 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.9 t -48.15 -35.05 10.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.337 0.655 . . . . 74.24 112.551 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' CG ' HG22 ' A' ' 79' ' ' VAL . 55.9 t60 -68.4 -64.91 0.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 74.15 110.687 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -71.06 -21.75 62.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.47 0.544 . . . . 74.34 112.47 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -62.54 -21.0 65.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.722 0.409 . . . . 73.24 111.703 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.76 -30.03 68.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.544 -0.298 . . . . 73.22 111.751 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -98.51 -17.29 18.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.963 0.356 . . . . 65.23 111.963 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.72 164.11 33.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.353 -0.927 . . . . 52.34 112.36 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -65.38 116.49 6.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 41.44 111.413 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -85.45 134.57 34.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.745 -0.661 . . . . 65.32 111.1 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -97.26 -28.61 13.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.202 -0.908 . . . . 63.55 110.052 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.55 150.42 32.23 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.455 -0.793 . . . . 64.51 110.373 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -158.41 129.49 6.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.467 -0.568 . . . . 73.31 109.467 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.22 129.07 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.063 0.458 . . . . 54.21 110.067 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.06 130.29 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.642 -0.873 . . . . 64.53 108.642 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.463 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 6.8 mmt -69.24 135.85 51.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.955 0.407 . . . . 75.43 109.966 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -137.43 155.62 49.13 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.53 -0.759 . . . . 73.1 109.887 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 28.5 t70 -71.57 132.48 85.45 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.829 -1.078 . . . . 55.52 110.168 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.85 -19.97 35.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.969 1.78 . . . . 73.41 112.998 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -84.82 -55.52 4.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 74.41 111.505 -176.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 m -102.77 -9.11 20.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.955 0.407 . . . . 73.52 111.739 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.5 mmtm 66.85 24.86 9.67 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.575 0.75 . . . . 70.34 112.455 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.69 163.82 12.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.944 -0.391 . . . . 65.32 109.944 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 t -69.61 143.09 53.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.103 0.478 . . . . 74.32 110.305 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -88.47 1.66 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 53.2 110.526 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.39 17.76 61.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.653 -0.784 . . . . 62.21 113.813 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.463 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 41.9 p90 -158.37 159.05 35.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.334 0.567 . . . . 75.31 110.292 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.93 19.54 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.474 -0.65 . . . . 53.41 111.474 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 149.61 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.373 0.586 . . . . 75.34 110.659 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.7 130.65 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.77 -0.65 . . . . 42.12 109.694 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 m -106.49 123.28 47.84 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 122.135 -0.353 . . . . 75.23 110.487 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.7 m-85 -90.36 157.75 17.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.529 -0.305 . . . . 73.31 110.769 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.52 80.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 74.21 111.188 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -123.63 153.94 40.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.005 -0.543 . . . . 61.33 109.88 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 p -64.5 -30.9 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.396 -0.365 . . . . 74.34 111.352 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.17 -37.46 87.33 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.867 0.691 . . . . 65.53 112.867 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -63.61 -28.77 70.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.989 0.423 . . . . 74.44 110.73 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.8 t -63.55 -49.91 80.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 62.12 109.856 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.67 -51.35 60.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.327 -0.851 . . . . 72.14 111.29 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -46.67 -41.03 14.23 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.87 0.692 . . . . 71.25 112.87 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.23 -29.84 61.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 52.43 110.871 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 74.13 110.851 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -70.48 -36.51 73.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.25 0.548 . . . . 73.12 110.214 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.0 -11.82 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.29 -0.868 . . . . 60.43 113.175 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -57.05 144.77 67.95 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 111.647 0.24 . . . . 71.21 111.647 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.65 163.0 84.54 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.518 -1.451 . . . . 61.11 113.248 2.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -116.83 156.35 27.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 73.55 110.456 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.5 ttmt -136.84 110.64 8.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.45 -0.341 . . . . 73.03 110.878 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.9 t -110.2 127.37 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 60.4 109.654 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.07 28.92 14.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.446 0.641 . . . . 70.24 111.136 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.17 27.91 63.19 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.742 -0.742 . . . . 45.23 112.446 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 10.1 tpt180 -131.54 140.39 49.47 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 71.41 109.564 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.88 112.38 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.417 -0.586 . . . . 44.44 109.417 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.8 m -105.5 148.25 10.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.484 0.659 . . . . 73.33 111.209 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -113.03 97.58 42.76 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.776 -1.102 . . . . 75.42 110.755 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -77.43 128.8 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.685 2.257 . . . . 70.03 111.27 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -132.99 172.08 13.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.326 -0.852 . . . . 75.32 108.918 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 4.7 tpp180 -77.99 137.5 38.33 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.651 -0.42 . . . . 74.12 110.338 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.51 2.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.158 0.504 . . . . 62.31 110.664 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.1 151.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.887 -1.051 . . . . 74.54 111.064 177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -55.05 148.24 14.18 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.611 -0.722 . . . . 74.14 110.469 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -51.02 -43.71 60.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.357 1.243 . . . . 73.3 114.357 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.84 -33.82 68.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.976 0.417 . . . . 74.21 111.014 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -84.33 -26.63 28.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.618 -0.719 . . . . 60.41 111.969 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 p -74.29 -15.05 60.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.928 0.394 . . . . 72.44 111.178 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -85.61 -10.08 56.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.91 -0.586 . . . . 72.33 110.521 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.52 148.24 43.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 73.11 110.353 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.1 123.81 11.4 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.491 2.127 . . . . 72.42 111.842 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 101.91 12.44 34.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.005 -0.616 . . . . 72.21 112.299 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.5 7.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.328 . . . . 73.33 111.395 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -97.39 13.76 28.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.003 0.43 . . . . 72.24 111.347 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 ' HA2' ' A' ' 99' ' ' GLY . 67.5 mt -76.81 155.6 32.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.937 -0.764 . . . . 53.52 108.937 170.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.461 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.1 m -77.03 90.44 3.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.398 0.618 . . . . 64.44 110.043 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.41 112.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.427 -0.806 . . . . 62.24 110.625 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -104.91 17.27 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 74.24 110.729 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 138.99 52.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.419 -0.355 . . . . 75.12 110.981 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.569 HG23 HG13 ' A' ' 159' ' ' VAL . 3.5 pt -128.21 151.82 35.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.343 0.592 . . . . 71.52 111.734 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.9 t80 -100.36 133.12 45.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.623 -1.172 . . . . 75.13 109.667 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.15 110.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.899 -0.778 . . . . 74.12 108.899 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -127.38 154.22 19.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.826 -1.178 . . . . 41.33 112.819 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.96 8.4 58.02 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.633 -0.794 . . . . 72.55 112.164 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -72.28 93.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.305 0.574 . . . . 63.22 110.504 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -80.5 -25.31 38.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.818 -0.628 . . . . 73.54 110.799 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -88.85 161.1 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.67 -0.695 . . . . 61.21 110.534 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.67 104.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.48 0.487 . . . . 72.2 109.99 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.5 m -109.34 130.43 55.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.853 -0.612 . . . . 71.33 110.804 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -112.71 175.24 5.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.002 -0.999 . . . . 71.13 111.13 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.47 -48.92 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.816 -1.083 . . . . 65.4 110.834 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -56.24 -37.27 69.52 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.275 0.359 . . . . 74.32 111.638 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 64.7 m170 -56.7 -60.74 3.12 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.412 0.445 . . . . 72.31 111.075 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.79 -26.99 29.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.904 -0.718 . . . . 75.14 111.59 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -66.07 -50.65 63.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.611 -0.144 . . . . 74.52 110.611 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.79 -24.43 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.039 0.447 . . . . 53.53 110.399 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -77.34 -57.32 3.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.898 -0.592 . . . . 71.11 111.878 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -68.58 -23.15 64.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.713 0.634 . . . . 75.54 112.713 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -69.54 -20.24 63.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.005 0.431 . . . . 71.31 111.503 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -57.25 -28.92 63.38 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.879 -0.601 . . . . 64.52 111.078 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.66 -30.37 19.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.068 0.396 . . . . 72.44 112.068 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.2 -176.1 47.82 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.587 -0.816 . . . . 73.44 113.347 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -75.97 133.26 40.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.159 0.504 . . . . 64.22 111.178 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 126' ' ' GLU . 75.8 mt -102.92 139.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.472 -0.785 . . . . 64.31 109.507 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -86.39 -50.83 6.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.462 . . . . 74.2 110.394 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.461 HG13 ' OE2' ' A' ' 135' ' ' GLU . 9.0 p -160.78 159.34 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.661 -0.7 . . . . 71.23 109.549 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.85 131.93 71.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.342 0.591 . . . . 74.04 110.693 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 4.1 mp0 -101.88 103.53 14.21 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.054 -0.975 . . . . 62.14 110.378 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.51 116.7 35.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.078 -0.712 . . . . 64.2 109.078 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' PHE . 73.8 mmm -93.72 124.75 37.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.012 -0.736 . . . . 71.13 109.012 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.637 -0.711 . . . . 65.51 110.143 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.995 -0.442 . . . . 64.23 111.995 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 137' ' ' MET . 20.2 p90 -170.86 153.93 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.682 -0.858 . . . . 74.42 108.682 173.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.56 169.81 17.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.944 0.402 . . . . 74.25 109.969 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 72.4 m-85 -138.74 154.68 48.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 53.22 109.435 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 107' ' ' ILE . 2.3 p -144.6 131.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.392 0.615 . . . . 74.3 111.546 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 131' ' ' ILE . 34.6 m -92.97 124.5 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.963 -1.017 . . . . 62.34 110.941 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.17 156.9 17.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.393 -0.367 . . . . 74.03 110.819 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.42 -25.78 46.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.977 -0.556 . . . . 75.34 110.582 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -131.1 148.08 52.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.727 -0.67 . . . . 72.4 110.822 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.461 ' CD2' HG23 ' A' ' 103' ' ' THR . 19.1 p80 -78.29 -27.24 47.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.625 -0.262 . . . . 74.14 110.76 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 20.8 t70 -64.72 -36.74 85.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.073 -0.512 . . . . 62.4 110.802 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 -32.74 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 44.54 110.56 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 107' ' ' ILE . 1.4 t -70.77 -39.43 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.925 -0.58 . . . . 62.34 109.988 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.652 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.2 t70 -69.96 -33.5 72.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.643 -0.708 . . . . 63.4 111.332 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.9 mttt -54.0 -38.86 65.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.849 0.833 . . . . 75.51 109.954 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.3 mt -77.07 -43.58 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.126 -1.397 . . . . 62.43 112.398 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 160' ' ' ASP . 11.2 m -75.71 -11.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.891 -0.506 . . . . 73.3 110.769 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 13' ' ' LEU . 8.6 mt -58.51 -31.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.354 -0.839 . . . . 61.51 109.932 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -112.63 100.96 9.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.39 -0.967 . . . . 53.14 108.39 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -58.35 -33.29 69.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.612 0.597 . . . . 73.04 112.612 -174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.61 131.3 54.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.824 0.345 . . . . 64.14 110.92 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 84.4 m-70 -123.79 151.3 43.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 73.13 110.672 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 m -94.39 105.24 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.915 0.388 . . . . 63.24 110.072 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.3 t -117.52 130.57 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.066 -0.716 . . . . 70.34 109.066 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 53.02 34.56 17.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.863 0.84 . . . . 73.1 111.448 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 75.41 0.9 63.5 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.663 -0.699 . . . . 32.04 113.498 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -111.59 128.75 56.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.169 -0.308 . . . . 72.13 110.169 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.79 109.32 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.325 0.583 . . . . 74.25 110.707 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.84 156.31 20.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.197 -0.91 . . . . 71.24 109.816 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -89.47 131.14 35.66 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.91 0.385 . . . . 74.11 110.042 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.9 t -128.56 132.92 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.365 -0.834 . . . . 73.1 110.195 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -157.7 176.14 12.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.688 -0.687 . . . . 73.41 110.297 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -61.77 128.94 38.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.802 0.334 . . . . 74.34 110.841 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -107.92 113.54 26.83 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.212 0.53 . . . . 41.01 109.69 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.389 -0.823 . . . . 65.34 109.509 179.315 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.944 -0.762 . . . . 75.1 108.944 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.42 133.28 31.65 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 114.66 -1.154 . . . . 53.33 110.231 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HD2' HD22 ' A' ' 13' ' ' LEU . 27.5 Cg_endo -65.0 167.15 16.6 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.114 2.543 . . . . 72.21 111.323 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.19 -34.89 70.85 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 112.19 0.441 . . . . 71.3 112.19 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.1 pt20 -68.49 -20.1 64.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.014 0.376 . . . . 72.4 112.014 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.541 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.0 mp -89.73 -14.3 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.316 . . . . 64.35 110.816 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 28.5 ptt85 -125.36 -2.96 7.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 64.3 111.676 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.7 ttpt -98.73 144.73 27.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.752 0.787 . . . . 74.55 111.22 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.592 HD21 HG13 ' A' ' 68' ' ' VAL . 50.6 mt -120.2 146.92 45.56 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.326 -1.306 . . . . 63.13 110.969 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.71 115.67 29.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.33 -0.989 . . . . 64.43 108.33 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 60' ' ' VAL . 20.2 mm -95.0 112.6 27.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.964 -0.384 . . . . 55.34 109.964 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.55 152.45 17.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.986 -0.626 . . . . 73.41 111.56 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.16 42.5 50.6 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.553 -0.832 . . . . 60.43 113.314 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 25' ' ' THR . 76.9 mt -77.94 174.02 11.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.929 0.364 . . . . 74.14 110.171 174.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -84.76 175.92 8.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 74.23 109.104 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.97 -9.5 59.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.297 0.57 . . . . 74.13 109.825 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 53' ' ' ARG . 24.9 mt-10 -114.3 5.15 15.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.47 -0.786 . . . . 63.33 112.231 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.505 HG21 HD22 ' A' ' 21' ' ' LEU . 84.9 m -73.0 126.03 29.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.387 0.613 . . . . 72.31 112.206 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 p -100.73 164.35 11.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.342 -0.844 . . . . 64.53 110.337 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -24.27 57.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.156 -0.313 . . . . 74.12 110.156 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -72.43 -37.69 68.53 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.175 0.297 . . . . 70.53 110.951 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -77.63 -38.26 48.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 71.12 110.285 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 79' ' ' VAL . 35.3 tp -60.43 -52.26 65.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.404 -0.816 . . . . 73.51 109.803 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.86 -60.54 3.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.06 -0.973 . . . . 74.12 112.009 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -48.31 -36.59 14.54 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.817 0.698 . . . . 74.41 112.663 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -67.66 -50.8 56.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.785 0.326 . . . . 72.25 110.714 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.44 -20.41 43.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.644 0.239 . . . . 64.35 111.644 -173.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -60.65 -22.76 64.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.036 0.446 . . . . 63.41 111.476 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -67.48 -28.1 67.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.761 . . . . 60.01 112.148 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -96.69 -27.64 14.68 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.1 -0.24 . . . . 75.11 111.381 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.84 160.05 33.41 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.593 -0.813 . . . . 70.14 112.009 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -64.6 120.12 11.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.73 0.3 . . . . 74.34 111.676 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.8 mt -89.96 139.6 30.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.486 0.66 . . . . 74.42 111.174 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 p -105.8 -24.57 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.997 -1.001 . . . . 62.31 110.006 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -153.45 156.9 39.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.636 -0.711 . . . . 61.33 109.912 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 t -164.13 131.73 3.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.516 -0.55 . . . . 71.24 109.516 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.09 117.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.564 0.697 . . . . 64.31 110.416 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.45 136.04 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.058 -0.719 . . . . 60.41 109.058 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.9 mmt -83.18 97.45 8.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.638 0.732 . . . . 72.0 110.396 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 50.2 mtp85 -102.25 163.68 12.1 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.525 -1.216 . . . . 74.05 111.032 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.78 125.02 83.12 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 114.726 -1.125 . . . . 75.43 110.216 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.33 -12.73 34.38 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.93 1.753 . . . . 75.01 112.929 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -85.44 -56.96 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 73.22 111.77 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -103.26 -10.53 18.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 74.51 111.358 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 65.81 39.38 4.72 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.364 -0.835 . . . . 62.23 110.471 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 24' ' ' GLU . 31.7 mmm180 -121.82 154.85 36.48 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.631 -0.507 . . . . 65.2 109.631 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.7 t -66.21 139.11 58.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.93 0.395 . . . . 62.03 111.68 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -84.33 -1.85 56.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 74.34 110.465 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.87 57.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.883 -0.675 . . . . 74.31 113.962 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -157.27 157.43 34.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.189 0.995 . . . . 75.23 111.078 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.21 -166.07 18.32 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.387 -0.685 . . . . 71.41 111.387 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -141.31 149.97 41.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.588 0.694 . . . . 73.44 110.833 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' ILE . 6.9 m -131.53 123.82 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.566 -0.743 . . . . 70.13 109.869 173.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.5 m -99.03 118.75 36.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.642 -0.254 . . . . 74.14 110.498 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.7 169.6 14.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.263 -0.426 . . . . 60.43 110.62 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.34 -51.56 14.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.843 -0.617 . . . . 53.43 109.892 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -123.8 155.28 38.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 64.22 110.606 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -62.22 -34.82 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.663 0.268 . . . . 72.42 111.308 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -57.97 -37.82 74.9 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.221 0.452 . . . . 72.44 112.221 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.38 -35.12 78.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.245 0.545 . . . . 61.44 110.006 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 16' ' ' LEU . 5.2 t -64.86 -47.6 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.117 -0.947 . . . . 71.33 110.663 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.93 -52.74 62.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 63.21 110.626 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.64 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.693 0.627 . . . . 54.34 112.693 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.18 68.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.938 0.399 . . . . 70.21 110.703 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.4 mmt -67.79 -43.18 80.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.58 . . . . 74.32 110.764 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.64 -40.35 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.126 0.488 . . . . 62.43 110.568 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.45 -16.59 64.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.177 -0.92 . . . . 74.43 112.909 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 75' ' ' ARG . 27.7 mtp-105 -54.09 147.23 26.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.233 0.457 . . . . 65.02 112.233 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.4 168.41 71.86 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.475 -1.469 . . . . 63.21 113.732 3.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -121.23 162.22 20.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.239 -0.891 . . . . 73.34 110.346 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.9 ttmt -136.74 111.85 9.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 73.53 111.604 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 30' ' ' LEU . 18.6 t -115.4 130.51 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 64.14 109.742 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.405 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 4.3 m-20 65.07 29.85 11.91 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.804 0.69 . . . . 75.51 111.96 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.82 24.73 68.89 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.793 -0.718 . . . . 53.3 112.445 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.9 tpt180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.448 -0.575 . . . . 65.54 109.448 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.89 113.18 23.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.791 0.805 . . . . 75.33 109.368 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.2 m -102.83 151.07 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 62.33 111.236 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 3.5 tp10 -113.11 97.25 41.88 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.79 -1.095 . . . . 54.54 111.117 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -73.48 129.49 13.84 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.311 2.007 . . . . 74.01 111.221 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 19.7 mttt -134.71 -179.02 5.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.349 -1.723 . . . . 60.54 106.349 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -86.7 141.16 29.11 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 119.581 1.082 . . . . 73.25 110.855 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 95.47 0.6 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.071 -0.513 . . . . 61.33 110.663 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.58 133.57 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.666 -0.697 . . . . 73.14 109.593 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 t -78.61 174.0 11.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 63.51 110.859 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -49.2 -54.58 15.88 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.964 0.906 . . . . 72.21 113.302 -171.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.79 -36.61 65.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.904 0.335 . . . . 71.11 111.904 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -11.52 58.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.951 0.352 . . . . 74.34 111.951 -176.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.6 p -97.81 2.48 49.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.565 0.222 . . . . 73.35 111.266 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.96 -37.68 88.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.29 -0.414 . . . . 74.21 111.074 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -92.57 145.6 30.77 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.328 -0.396 . . . . 75.13 110.261 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.44 151.12 70.84 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.913 2.409 . . . . 64.51 111.847 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 95.71 8.87 57.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.608 -0.806 . . . . 71.31 111.925 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.87 -49.04 15.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 60.14 110.562 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -92.77 3.76 55.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 71.0 111.381 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.434 HD12 ' HA2' ' A' ' 99' ' ' GLY . 70.6 mt -82.79 158.56 22.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 71.22 109.782 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.406 HG23 ' CD2' ' A' ' 156' ' ' HIS . 2.9 m -76.31 93.49 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.803 0.811 . . . . 74.41 110.511 -176.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.9 t -120.26 108.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.749 -1.114 . . . . 64.24 109.913 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 156' ' ' HIS . 53.7 mttt -100.09 10.49 41.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 72.44 110.776 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.52 140.68 49.11 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.11 -0.496 . . . . 72.03 111.106 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.499 HG23 HG13 ' A' ' 159' ' ' VAL . 4.9 pt -122.84 149.88 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.258 0.552 . . . . 72.21 111.969 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.6 t80 -98.43 133.8 42.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.883 -1.053 . . . . 72.44 109.054 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.56 109.23 22.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.491 -0.559 . . . . 54.42 109.491 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.26 149.96 17.0 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.209 -0.996 . . . . 65.44 113.05 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.56 25.62 38.41 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.335 -0.936 . . . . 64.21 112.595 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.493 ' HB ' ' OG1' ' A' ' 116' ' ' THR . 5.2 pt -68.91 131.48 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 55.23 109.946 174.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 65.2 tttp -82.93 107.17 15.34 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.343 0.868 . . . . 74.32 113.343 -164.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 73.27 -53.2 0.7 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.405 1.066 . . . . 62.34 113.456 167.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -165.46 112.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.833 -0.432 . . . . 61.34 109.833 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 112' ' ' ILE . 14.9 m -123.66 136.77 54.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.283 0.563 . . . . 54.45 109.629 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -110.88 171.89 7.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.694 -0.684 . . . . 74.13 111.139 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.44 -49.59 75.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 114.79 -1.095 . . . . 74.41 110.562 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -54.91 -35.0 63.68 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.399 0.437 . . . . 73.14 111.783 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.18 -61.18 2.42 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.281 0.363 . . . . 71.33 111.056 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.6 pp -83.77 -23.66 31.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.197 -0.601 . . . . 72.11 111.46 -171.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -65.33 -55.36 18.69 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.937 -0.394 . . . . 73.34 109.937 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.323 0.582 . . . . 72.45 110.495 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -76.32 -56.64 4.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.359 -0.837 . . . . 70.3 112.22 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.1 m-85 -68.95 -23.02 64.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.685 0.254 . . . . 75.44 111.685 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mm-40 -64.4 -24.54 67.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.027 0.442 . . . . 73.2 110.905 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.0 -27.42 68.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.822 -0.626 . . . . 50.33 111.777 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.53 -25.79 22.34 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.77 0.285 . . . . 73.51 111.77 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.25 -175.82 46.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.536 -0.84 . . . . 74.52 113.312 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -75.47 125.61 29.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 71.21 112.067 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.8 mt -98.17 136.1 30.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 74.44 110.301 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.29 -50.49 8.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 74.23 110.309 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.56 157.96 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 50.51 110.091 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.4 128.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.321 0.582 . . . . 71.3 110.519 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.7 mt-10 -100.29 104.89 16.38 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.255 -0.884 . . . . 62.11 110.859 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.65 122.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.229 -0.656 . . . . 73.24 109.229 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.6 mmm -101.95 135.97 42.6 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.636 -0.876 . . . . 74.24 108.636 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 73.45 111.913 -172.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.15 0 N-CA-C 110.56 -1.016 . . . . 75.42 110.56 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -171.54 145.87 2.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.374 -0.602 . . . . 74.01 109.374 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.51 170.49 14.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.628 -0.714 . . . . 70.13 109.112 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.529 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -136.24 143.4 44.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.844 -0.616 . . . . 74.02 109.404 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 125' ' ' PHE . 58.0 t -129.2 121.73 54.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 O-C-N 122.164 -0.335 . . . . 54.5 110.483 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 85.9 m -96.16 118.92 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.678 -0.692 . . . . 74.04 110.821 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -102.75 156.64 17.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.601 0.238 . . . . 71.23 110.889 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.22 -29.71 65.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 71.11 110.288 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 1.9 t0 -139.06 159.96 40.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.587 -0.733 . . . . 65.25 110.887 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 15.9 p80 -79.18 -19.87 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 75.41 110.115 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.608 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 1.3 p-10 -60.84 -38.23 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.029 -0.987 . . . . 70.51 110.979 -174.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -73.85 -31.08 63.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.132 -0.486 . . . . 65.34 110.227 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.499 HG13 HG23 ' A' ' 107' ' ' ILE . 3.8 t -69.82 -39.01 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.677 -0.692 . . . . 74.01 109.835 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.92 -26.77 63.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 62.14 111.242 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 71.7 mttt -69.07 -33.67 73.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.315 0.579 . . . . 70.34 110.265 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.3 mt -78.02 -42.68 28.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.564 -0.744 . . . . 75.13 112.672 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.3 m -70.64 -6.14 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.001 0.429 . . . . 75.22 111.434 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 13' ' ' LEU . 71.5 mt -54.91 -38.79 46.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.191 -0.913 . . . . 63.04 109.861 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 56.7 mt-30 -109.49 105.28 14.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.578 -0.897 . . . . 54.21 108.578 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -55.04 -32.34 61.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.864 -0.607 . . . . 65.44 111.706 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -124.91 133.9 52.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.455 -0.339 . . . . 75.23 110.687 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.4 m-70 -120.98 144.64 48.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.853 -0.612 . . . . 61.24 109.887 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.8 m -114.03 106.23 14.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.355 -0.384 . . . . 55.51 110.569 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.91 114.73 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.309 -0.405 . . . . 73.21 111.203 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.41 31.74 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.759 0.79 . . . . 55.22 109.656 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.94 5.46 86.14 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.497 -0.774 . . . . 74.45 112.385 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.559 ' CD2' ' HB3' ' A' ' 113' ' ' LYS . 61.5 m170 -106.04 110.21 22.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.199 -0.297 . . . . 74.15 110.199 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.75 107.81 19.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.151 0.5 . . . . 75.14 109.737 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 p -117.05 156.22 27.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 72.11 111.451 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.31 134.92 33.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.756 -0.657 . . . . 74.41 109.853 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 26.9 t -130.9 134.0 62.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.166 0.508 . . . . 51.11 110.667 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -152.92 173.5 15.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.559 -0.746 . . . . 65.22 111.372 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -65.68 130.31 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.263 -0.426 . . . . 74.4 110.298 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -120.75 122.34 40.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.478 . . . . 74.42 109.711 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 120.743 -0.383 . . . . 73.54 110.375 -175.766 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.749 0.309 . . . . 73.45 110.675 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -76.09 130.93 76.73 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.246 -0.65 . . . . 71.03 109.246 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.67 166.36 15.93 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.26 1.973 . . . . 71.45 111.97 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -41.24 64.41 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.566 -0.743 . . . . 72.44 112.397 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -71.39 -27.37 63.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.818 0.342 . . . . 73.43 111.842 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -84.51 -6.16 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.493 -0.322 . . . . 71.41 111.024 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.4 ptt180 -127.81 6.17 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.981 0.419 . . . . 70.43 110.685 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.31 146.72 25.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.401 0.62 . . . . 73.11 111.16 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.6 HD21 HG13 ' A' ' 68' ' ' VAL . 58.0 mt -115.48 143.47 45.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.664 -1.153 . . . . 72.1 110.704 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -97.86 120.81 38.92 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.622 -0.881 . . . . 63.22 108.622 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.49 111.63 29.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 110.093 -0.336 . . . . 64.12 110.093 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.78 151.26 17.29 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 121.089 -0.577 . . . . 65.42 111.713 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.9 44.54 55.53 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.683 -0.77 . . . . 71.12 113.142 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 HG21 ' A' ' 25' ' ' THR . 84.2 mt -78.08 173.73 11.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.736 -0.468 . . . . 72.14 109.736 171.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -86.11 -178.16 6.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.026 0.441 . . . . 70.01 110.012 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -81.02 -9.0 59.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.045 -0.525 . . . . 71.5 110.09 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 19.8 mt-10 -121.81 18.99 11.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.629 0.603 . . . . 72.44 112.629 -173.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.545 HG21 HD22 ' A' ' 21' ' ' LEU . 28.6 m -78.36 115.33 18.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.875 0.369 . . . . 62.43 110.964 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -97.47 158.76 15.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.167 -0.469 . . . . 75.1 110.447 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.668 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 9.6 t0 -59.33 -43.22 92.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.054 0.542 . . . . 32.23 111.152 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.62 -34.81 77.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.755 . . . . 71.24 111.543 -175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 m -79.19 -36.37 40.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.452 -0.34 . . . . 64.22 110.802 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HA ' HG11 ' A' ' 79' ' ' VAL . 50.2 tp -65.52 -51.72 57.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 62.02 110.013 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.23 -60.55 3.19 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.304 -0.862 . . . . 65.33 112.117 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 t -48.67 -33.51 10.14 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.809 0.693 . . . . 75.45 112.843 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.2 t-80 -73.23 -56.12 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.222 -0.191 . . . . 73.24 110.892 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.45 -23.96 63.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.938 0.347 . . . . 72.54 111.938 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -57.79 -20.95 39.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.504 0.722 . . . . 72.02 112.114 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.42 -29.27 69.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.88 0.326 . . . . 73.44 111.88 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -96.27 -20.82 18.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.689 0.28 . . . . 63.44 111.203 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.79 164.39 32.77 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.34 -0.933 . . . . 73.44 112.309 173.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.7 m -62.92 119.79 10.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 71.54 111.699 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.96 117.04 26.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.739 -0.664 . . . . 72.43 110.777 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -84.36 -25.71 28.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.037 -0.983 . . . . 74.55 110.269 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -149.58 150.29 32.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.447 -0.797 . . . . 72.44 109.486 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.3 t -160.54 138.7 9.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.949 -0.76 . . . . 42.31 108.949 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.668 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 5.7 p -152.23 122.54 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 121.434 0.635 . . . . 74.01 111.005 171.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.49 136.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.402 -0.962 . . . . 73.3 108.402 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.532 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -81.7 100.41 9.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.595 0.712 . . . . 72.02 110.524 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -101.83 158.11 16.36 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.66 -1.155 . . . . 74.11 109.205 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.36 132.96 64.62 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.039 -0.356 . . . . 75.12 110.039 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -22.4 73.18 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.389 2.06 . . . . 43.01 113.681 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -86.32 -55.71 3.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.288 0.566 . . . . 75.21 110.792 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -95.84 -14.78 22.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.123 -0.944 . . . . 60.23 112.346 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm 64.62 26.13 13.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.552 0.741 . . . . 72.44 111.307 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 23.5 mmm180 -109.18 156.76 19.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.766 -0.457 . . . . 62.32 109.766 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 m -68.37 132.02 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.846 0.355 . . . . 74.11 111.178 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -85.84 3.18 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.69 -0.686 . . . . 74.51 111.225 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 11.44 65.47 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.585 -0.817 . . . . 61.23 114.069 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.5 p90 -153.82 155.75 36.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.784 0.792 . . . . 61.2 110.712 175.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.16 -169.51 23.55 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.382 -0.687 . . . . 53.54 111.382 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.23 142.4 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.178 0.489 . . . . 74.11 110.389 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 m -126.85 128.19 70.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 63.21 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 m -104.6 122.06 44.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.525 -0.307 . . . . 70.31 110.239 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 31.9 m-85 -88.73 161.37 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.171 -0.468 . . . . 65.13 110.483 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.78 83.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.509 -0.769 . . . . 73.11 110.744 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.6 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 16.5 m -131.12 154.34 48.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.107 -0.497 . . . . 72.5 110.463 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -65.63 -34.0 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 111.658 0.244 . . . . 64.3 111.658 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.03 -43.7 78.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.967 0.358 . . . . 72.04 111.967 175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 2.7 mp0 -62.01 -33.23 73.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 72.54 110.644 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 HD21 ' A' ' 16' ' ' LEU . 42.3 t -64.21 -50.23 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.281 -0.872 . . . . 71.12 110.97 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.02 -41.1 91.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.248 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.86 67.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.327 -0.397 . . . . 73.44 112.026 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.23 66.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 71.43 110.665 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -37.21 86.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 73.31 111.227 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -28.19 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 62.21 111.001 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.29 -9.64 54.17 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.741 0.645 . . . . 65.32 112.741 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 75' ' ' ARG . 24.8 mtp-105 -58.04 146.23 69.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.456 -0.338 . . . . 72.33 111.501 175.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.01 153.2 99.02 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.967 -1.264 . . . . 64.24 114.049 3.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -108.65 153.31 23.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.054 -0.976 . . . . 65.15 110.731 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 13.6 ttmt -136.42 103.16 5.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.037 0.446 . . . . 70.4 111.198 175.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 30' ' ' LEU . 21.9 t -107.97 131.52 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.613 -0.721 . . . . 72.03 109.676 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.0 t70 64.91 29.77 12.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.791 0.805 . . . . 55.11 110.564 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.35 76.34 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.549 -0.75 . . . . 32.43 112.16 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 24.8 tpt180 -125.59 136.94 53.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.884 -0.413 . . . . 73.43 109.884 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.04 109.52 13.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.776 0.798 . . . . 72.44 109.623 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.5 m -105.67 152.86 7.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.505 -0.771 . . . . 75.43 110.787 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -112.07 97.24 37.84 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.423 -0.808 . . . . 73.11 110.879 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.81 129.63 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.149 1.899 . . . . 74.33 110.429 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -135.18 179.42 6.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 50.13 107.781 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 7.8 tpp180 -79.26 162.7 25.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.324 -0.551 . . . . 64.1 109.667 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.66 93.26 5.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.466 -0.568 . . . . 73.03 109.466 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.1 154.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.001 -0.999 . . . . 61.11 111.396 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -59.92 146.98 40.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.59 -0.732 . . . . 60.13 110.091 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -65.63 -19.17 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.341 -0.39 . . . . 74.24 111.359 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.39 -39.32 88.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 73.23 111.65 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.28 -22.02 48.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.226 0.536 . . . . 74.25 110.12 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 20.1 t -70.41 -0.53 8.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.518 -0.765 . . . . 74.2 111.233 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -71.08 -24.96 62.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 74.34 110.222 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -77.78 146.2 72.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.24 110.216 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.43 114.94 3.82 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.657 2.238 . . . . 74.12 112.191 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.74 10.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.77 -0.729 . . . . 64.41 112.185 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -72.79 -27.17 61.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.759 0.314 . . . . 51.2 111.294 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -99.83 11.85 38.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.359 . . . . 72.03 111.008 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.16 167.23 19.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.958 -0.756 . . . . 63.54 108.958 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.8 m -75.55 90.17 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.222 0.534 . . . . 74.32 111.054 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.49 115.63 50.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.284 -0.871 . . . . 62.33 109.831 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.52 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.1 mttt -109.11 22.26 16.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 63.04 110.958 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -123.84 140.44 52.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.162 -0.472 . . . . 71.1 111.459 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 159' ' ' VAL . 9.4 pt -127.79 154.03 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.164 0.507 . . . . 72.15 111.812 176.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.2 t80 -100.27 137.19 39.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.835 -1.075 . . . . 65.2 109.384 175.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.03 113.1 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 73.1 109.533 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.15 152.89 19.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.014 -1.089 . . . . 64.32 113.072 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.03 6.35 24.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 75.22 112.61 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.8 pt -79.95 100.36 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.739 0.78 . . . . 63.24 110.813 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -93.03 3.37 55.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.872 -0.604 . . . . 75.12 111.193 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.12 165.58 16.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.093 -0.706 . . . . 74.42 109.093 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.71 99.94 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 72.43 110.371 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -91.22 139.74 30.45 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.853 -0.612 . . . . 73.24 109.683 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.46 165.73 10.86 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.502 -0.772 . . . . 70.41 110.866 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -47.84 84.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.091 -1.413 . . . . 73.4 108.768 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -55.26 -30.82 60.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.413 -0.812 . . . . 72.3 111.959 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -66.84 -62.37 1.48 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.213 0.53 . . . . 74.32 110.844 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.451 HD13 HG22 ' A' ' 151' ' ' VAL . 3.5 pp -82.42 -24.03 34.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.038 -0.665 . . . . 73.54 111.458 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 121' ' ' LEU . 8.5 tmm_? -66.14 -49.29 67.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.212 -0.292 . . . . 71.42 110.212 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.33 -30.11 70.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.276 0.56 . . . . 73.42 110.78 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -80.59 -54.93 5.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 64.45 112.209 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' A' ' 151' ' ' VAL . 21.0 m-85 -68.38 -22.79 64.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.679 0.622 . . . . 71.05 112.679 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.66 -23.32 64.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.682 0.277 . . . . 72.01 111.276 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -60.88 -24.99 66.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 70.45 111.586 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -85.4 -27.42 25.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.405 . . . . 73.04 111.365 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.63 -177.8 43.56 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.707 -0.758 . . . . 74.11 113.223 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -74.11 133.62 42.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.956 0.408 . . . . 70.44 111.194 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.83 139.37 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.724 -0.671 . . . . 73.2 109.789 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.93 -50.74 6.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.317 0.58 . . . . 63.12 110.095 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -156.13 157.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.32 -0.855 . . . . 65.42 109.638 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -114.5 128.18 71.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.26 0.552 . . . . 62.41 109.794 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.1 mt-10 -99.46 126.01 45.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.174 -0.921 . . . . 60.34 110.232 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.5 mm -119.65 114.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.249 -1.019 . . . . 70.34 108.249 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mmm -91.14 120.42 32.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.399 -0.593 . . . . 73.34 109.399 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 121.145 0.497 . . . . 74.33 112.172 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 CA-C-O 119.682 -0.51 . . . . 63.44 112.949 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -173.49 158.62 3.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.317 0.558 . . . . 74.2 109.769 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.04 173.72 11.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.292 -0.632 . . . . 61.04 109.292 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 36.7 m-85 -138.06 143.94 40.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.298 -0.41 . . . . 70.02 110.133 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 125' ' ' PHE . 50.7 t -126.96 127.77 70.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 O-C-N 122.002 -0.436 . . . . 71.13 110.828 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 131' ' ' ILE . 63.5 m -106.89 120.22 41.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.613 -0.721 . . . . 64.41 111.222 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -103.37 160.81 14.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.295 0.569 . . . . 74.22 111.7 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.09 -27.26 39.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.029 -0.987 . . . . 74.2 110.71 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -129.58 155.15 46.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 71.34 110.685 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.469 ' CD2' HG23 ' A' ' 103' ' ' THR . 21.9 p80 -77.51 -29.05 52.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 73.25 110.631 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 13.5 t0 -56.5 -43.58 79.85 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.799 -1.092 . . . . 65.04 111.602 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.1 t -63.23 -36.57 84.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.821 -0.627 . . . . 73.24 111.312 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.52 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.9 t -70.44 -39.99 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.146 0.498 . . . . 63.31 109.986 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 4.8 t70 -68.76 -33.42 73.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.975 -1.011 . . . . 75.12 111.032 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.5 mttt -59.04 -40.74 85.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.564 0.697 . . . . 72.43 110.716 173.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.81 -40.61 46.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.634 -1.167 . . . . 71.01 111.893 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 30.7 m -78.34 -9.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.064 0.459 . . . . 53.51 111.102 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.13 -33.1 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.641 -0.709 . . . . 61.43 109.933 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.462 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 49.2 mt-30 -113.89 106.18 14.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.763 -0.653 . . . . 63.41 109.378 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.31 -34.49 57.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.262 0.838 . . . . 74.22 113.262 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.62 144.12 50.35 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.006 -0.278 . . . . 75.44 110.502 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.9 m-70 -132.49 151.81 51.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.936 176.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 130.05 55.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.916 0.389 . . . . 64.45 110.701 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.63 140.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.872 -0.788 . . . . 61.53 108.872 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.1 m120 48.45 30.27 2.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.391 0.886 . . . . 64.21 113.391 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.96 -0.71 89.58 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.907 -0.663 . . . . 63.12 114.118 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.488 ' HD2' ' SG ' ' A' ' 175' ' ' CYS . 10.9 p-80 -113.83 135.16 54.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.908 0.854 . . . . 73.44 110.859 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -99.6 116.49 31.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 65.12 110.42 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.488 ' SG ' ' HD2' ' A' ' 173' ' ' HIS . 55.8 m -117.21 157.09 26.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 71.42 111.096 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.4 141.87 28.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.609 . . . . 60.42 110.368 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.3 m -131.37 162.14 39.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.956 -0.565 . . . . 72.3 111.075 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -174.09 171.83 3.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.952 -1.022 . . . . 55.2 111.687 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -60.79 129.96 44.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.879 -0.601 . . . . 73.13 110.651 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.12 114.1 25.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.34 0.59 . . . . 74.2 109.61 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.273 -0.876 . . . . 64.43 109.738 -178.534 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.119 0.485 . . . . 64.33 110.334 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.43 ' OE2' HG12 ' A' ' 65' ' ' VAL . 1.8 mp0 -71.67 132.05 85.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.708 . . . . 74.31 110.627 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' HD22 ' A' ' 13' ' ' LEU . 26.1 Cg_endo -66.99 166.36 23.11 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.756 2.304 . . . . 73.24 111.134 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.9 pt-20 -60.05 -32.9 71.35 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 119.559 -0.257 . . . . 63.15 111.686 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.42 -25.04 61.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.654 0.264 . . . . 73.24 111.602 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.1 mp -87.53 -8.69 56.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.705 0.288 . . . . 74.05 111.064 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -125.79 2.95 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.481 -0.327 . . . . 75.11 111.078 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 15.1 ttmm -93.47 146.21 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.54 0.686 . . . . 73.11 111.502 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -119.48 141.3 49.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.491 -1.231 . . . . 54.2 110.079 177.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -98.33 116.04 29.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.784 -0.821 . . . . 54.41 108.784 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 60' ' ' VAL . 18.0 mm -93.13 110.85 23.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.999 -0.371 . . . . 71.2 109.999 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.23 152.2 17.99 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.834 -0.698 . . . . 64.21 111.679 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.6 41.77 56.53 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.019 -0.61 . . . . 63.12 113.618 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 25' ' ' THR . 49.8 mt -75.84 175.15 9.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.92 0.36 . . . . 75.52 110.382 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.3 p -88.15 172.33 9.57 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.516 -0.55 . . . . 43.53 109.516 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.04 -5.6 47.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.648 0.261 . . . . 63.23 111.176 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.88 21.67 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.105 0.409 . . . . 65.14 112.105 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.578 HG21 HD22 ' A' ' 21' ' ' LEU . 14.5 m -75.16 121.74 22.55 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 71.1 110.557 175.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -99.11 154.64 17.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.885 -0.413 . . . . 71.33 109.885 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.532 ' HA ' HG23 ' A' ' 45' ' ' VAL . 10.7 p-10 -64.86 -35.24 80.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 74.25 111.356 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.96 -36.77 80.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 74.42 111.211 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -76.87 -34.43 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 75.22 110.734 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 45' ' ' VAL . 34.9 tp -65.88 -42.87 89.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.035 -0.53 . . . . 62.44 109.862 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 19.2 ttm-85 -60.03 -57.97 10.53 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.393 -0.367 . . . . 64.31 110.127 176.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -50.06 -36.87 30.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.151 -0.931 . . . . 74.33 112.926 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -70.89 -58.38 3.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.433 -0.349 . . . . 75.1 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -70.53 -22.48 62.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.196 0.443 . . . . 74.2 112.196 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.1 tt0 -63.39 -17.81 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.095 0.558 . . . . 63.13 111.898 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.35 -28.43 69.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.389 -0.368 . . . . 64.35 111.343 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.14 -21.73 14.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 60.31 111.567 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -166.71 154.16 24.42 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.48 -0.867 . . . . 62.31 112.027 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -65.22 117.76 8.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 65.11 111.408 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 31' ' ' ARG . 57.2 mt -86.85 134.65 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.565 0.698 . . . . 73.01 111.4 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.189 -0.914 . . . . 64.32 110.254 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -151.16 152.3 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.618 -0.719 . . . . 33.42 109.956 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -161.73 133.65 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.021 -0.363 . . . . 71.45 110.021 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.31 125.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.311 0.577 . . . . 53.23 110.734 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 27' ' ' ASP . 96.1 t -86.83 131.41 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.577 -0.897 . . . . 71.44 108.577 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.12 95.3 6.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.651 0.738 . . . . 75.31 110.439 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -101.04 166.94 10.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.592 -1.185 . . . . 75.33 109.637 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.74 126.18 86.22 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.126 -0.694 . . . . 65.3 109.126 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.31 -23.85 75.51 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.216 1.944 . . . . 73.32 113.929 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.68 -55.85 3.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.096 0.406 . . . . 74.32 112.096 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -101.57 -11.19 19.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.93 0.395 . . . . 70.44 111.945 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm 66.17 34.89 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.512 -0.767 . . . . 74.54 111.525 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -97.64 140.03 32.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.952 -0.759 . . . . 71.52 108.952 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -70.49 133.03 46.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.987 0.422 . . . . 74.51 110.379 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.42 -0.6 37.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.685 -0.689 . . . . 74.23 110.616 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.52 55.93 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.913 -0.66 . . . . 64.15 113.716 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -158.85 158.58 33.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.937 0.869 . . . . 71.23 110.942 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.65 -166.75 20.06 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.849 -0.9 . . . . 74.11 110.849 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.62 151.26 42.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.427 0.614 . . . . 72.0 110.603 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -133.12 122.95 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.627 -0.715 . . . . 63.55 109.172 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.3 m -99.15 118.59 36.22 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.457 -0.572 . . . . 74.34 109.457 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 25.4 m-85 -84.5 169.49 14.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.364 . . . . 73.05 110.67 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.7 -50.13 26.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.145 -0.48 . . . . 54.03 109.927 176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.37 155.51 37.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.598 -0.728 . . . . 65.31 110.215 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -63.85 -32.86 58.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.796 0.331 . . . . 72.43 110.31 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.69 -34.82 71.72 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.862 0.69 . . . . 63.14 112.862 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 7.2 mm-40 -62.01 -36.19 80.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 71.41 109.684 175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 4.0 t -64.31 -44.6 97.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.131 -0.94 . . . . 72.31 111.131 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.81 -43.24 99.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 73.43 111.04 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -53.91 -38.37 64.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.64 0.608 . . . . 65.3 112.64 171.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.82 65.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.449 0.643 . . . . 64.11 109.948 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mmt -70.79 -39.54 73.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 71.25 112.124 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 1.1 p30 -79.14 -11.93 59.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.076 0.465 . . . . 75.42 110.442 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.45 -16.24 33.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 71.33 111.02 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -56.41 149.4 38.83 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 74.31 112.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.75 168.18 73.68 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.335 -1.527 . . . . 75.41 113.749 2.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -119.21 153.07 35.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.66 -0.7 . . . . 70.41 111.004 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.6 ttmt -139.5 108.94 6.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 52.15 111.092 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -121.38 137.18 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.716 -0.675 . . . . 74.12 109.603 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 66.11 21.69 11.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.774 0.829 . . . . 72.53 110.872 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.91 23.88 68.23 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.904 -0.589 . . . . 64.52 111.916 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.1 tpt180 -126.46 134.99 50.81 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.324 -0.251 . . . . 72.2 110.324 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.36 119.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.1 -0.704 . . . . 71.31 109.1 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 m -108.14 154.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.906 -0.588 . . . . 72.45 111.779 -172.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -113.5 93.93 29.71 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.959 -1.019 . . . . 74.23 110.611 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.428 ' O ' ' HE1' ' A' ' 156' ' ' HIS . 6.2 Cg_endo -77.16 128.32 9.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 70.21 110.716 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -126.28 168.8 13.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.257 -0.645 . . . . 70.2 109.257 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.676 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.1 tpp180 -75.59 128.65 35.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.122 -0.696 . . . . 74.14 109.122 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.0 99.78 1.49 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.399 0.619 . . . . 72.44 110.756 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.463 ' CG2' HG23 ' A' ' 163' ' ' VAL . 12.8 p -73.2 157.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.024 -0.989 . . . . 62.31 109.804 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -54.7 147.65 14.24 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 122.626 0.37 . . . . 74.22 110.585 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.504 0.927 . . . . 74.02 113.504 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.35 -38.23 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 75.31 110.995 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.42 -46.1 11.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 53.34 109.931 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 t -57.76 -26.04 61.29 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.556 -0.747 . . . . 51.24 112.29 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.16 -21.48 63.99 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.325 -0.398 . . . . 73.03 111.82 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -85.19 143.99 40.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.03 110.852 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.06 123.26 9.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 74.25 112.268 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 3.3 71.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.799 -0.715 . . . . 62.23 112.51 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.97 -52.14 8.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.691 0.256 . . . . 72.54 111.691 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 21.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 63.15 111.051 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -178.8 6.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.796 -0.816 . . . . 70.33 108.796 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.408 HG23 ' CD2' ' A' ' 156' ' ' HIS . 1.9 m -72.61 99.75 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.335 0.588 . . . . 73.32 111.041 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -126.55 111.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 71.54 109.757 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.424 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.6 mttt -107.02 14.69 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.034 -0.417 . . . . 72.42 111.116 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 139.56 51.05 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.342 -0.224 . . . . 72.34 110.946 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.89 151.7 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.352 0.596 . . . . 75.13 111.595 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -96.91 139.44 32.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.726 -1.124 . . . . 72.11 109.99 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.0 110.38 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.331 -0.618 . . . . 44.24 109.331 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.51 158.82 21.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.013 -1.089 . . . . 50.31 113.358 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.0 8.37 45.08 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.832 -0.699 . . . . 72.11 112.055 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.45 66.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 122.112 0.958 . . . . 62.25 110.512 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -65.3 -34.01 77.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 73.51 109.442 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -83.11 145.72 29.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.799 -1.091 . . . . 74.45 108.558 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.24 123.5 16.92 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.064 0.459 . . . . 71.14 112.203 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -128.08 139.98 52.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.597 -0.729 . . . . 64.51 110.084 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.25 167.63 10.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.337 -0.847 . . . . 74.22 111.642 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.53 -45.35 85.13 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.429 -0.805 . . . . 52.03 110.619 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -55.77 -34.48 65.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.473 0.483 . . . . 71.23 111.562 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -64.4 -60.79 2.75 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.381 -0.372 . . . . 74.11 111.507 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.473 HD21 HG21 ' A' ' 134' ' ' ILE . 2.4 pt? -82.41 -24.65 34.27 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 119.962 -0.695 . . . . 63.31 110.814 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -63.23 -54.65 34.04 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 110.108 -0.33 . . . . 63.41 110.108 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -27.89 69.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.984 0.421 . . . . 73.54 110.859 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.46 ' CD2' HG22 ' A' ' 170' ' ' VAL . 75.8 t80 -78.36 -53.87 6.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.83 -0.623 . . . . 74.21 111.619 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.0 m-85 -68.72 -22.77 64.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.622 0.249 . . . . 73.23 111.506 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.71 -26.33 68.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.236 0.541 . . . . 73.42 110.884 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.28 -30.62 71.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 74.23 111.633 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.1 -23.77 32.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.499 -0.319 . . . . 74.51 111.012 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.92 -176.65 42.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 72.01 112.928 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -73.37 130.7 40.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.15 0.5 . . . . 71.22 110.871 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 152' ' ' THR . 62.1 mt -101.25 139.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.636 -0.711 . . . . 71.35 109.939 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.19 -49.91 6.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.817 0.341 . . . . 74.24 110.583 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.45 155.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 61.33 109.929 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.473 HG21 HD21 ' A' ' 121' ' ' LEU . 4.2 mp -116.24 126.31 73.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.288 -0.634 . . . . 73.22 109.288 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.4 mt-10 -98.65 104.53 16.57 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 70.23 110.994 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.1 116.01 35.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.442 -0.577 . . . . 63.21 109.442 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 69.0 mmm -87.72 119.28 27.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.861 -0.609 . . . . 72.12 109.994 -175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 63.41 110.704 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.176 0 N-CA-C 112.385 -0.286 . . . . 73.53 112.385 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -157.88 158.0 34.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.548 -0.538 . . . . 73.32 109.548 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.85 176.3 8.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.706 -0.679 . . . . 53.23 109.829 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.9 m-85 -139.53 152.67 47.1 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.591 -0.731 . . . . 74.23 109.186 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 107' ' ' ILE . 3.1 p -144.22 133.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.424 0.631 . . . . 61.44 111.169 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 131' ' ' ILE . 41.1 m -103.26 126.01 50.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.074 -0.966 . . . . 72.14 110.856 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 7.6 m-85 -100.82 158.45 15.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.06 0.457 . . . . 62.43 111.412 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.75 -28.94 44.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.479 -0.782 . . . . 61.53 110.293 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.0 151.36 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 75.12 110.842 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.428 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 24.2 p80 -80.17 -27.35 38.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 64.4 110.777 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 29.6 t70 -58.28 -40.36 81.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.708 -0.678 . . . . 64.41 111.067 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.2 m -67.56 -30.97 70.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 73.31 111.508 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -72.95 -42.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.484 -0.325 . . . . 72.32 110.471 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 1.8 m-20 -68.36 -24.06 64.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.925 -0.58 . . . . 51.12 111.424 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 81.9 mttt -63.66 -42.6 98.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.728 0.775 . . . . 65.3 110.177 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -74.15 -42.71 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 73.23 111.663 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.587 HG21 ' HD3' ' A' ' 179' ' ' LYS . 29.4 m -79.93 -2.16 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.123 0.487 . . . . 71.44 111.064 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 5.7 mt -63.07 -28.87 45.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.945 0.878 . . . . 53.32 109.046 167.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.579 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 49.2 mt-30 -111.47 145.39 39.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.857 -1.164 . . . . 75.2 107.857 174.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -91.77 -32.43 15.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.327 0.584 . . . . 73.35 110.684 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -124.69 137.98 54.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.713 -0.676 . . . . 74.55 109.951 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.579 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 42.8 m-70 -127.41 142.54 51.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.902 0.382 . . . . 72.44 110.615 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -94.77 110.36 22.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.982 -0.554 . . . . 73.5 111.036 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 124' ' ' TYR . 21.7 t -111.04 127.79 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.326 -0.852 . . . . 75.4 109.222 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 42.55 48.98 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.666 0.617 . . . . 53.5 112.666 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.24 0.98 48.47 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.125 -0.56 . . . . 74.23 114.055 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.83 121.96 45.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.932 -0.396 . . . . 73.44 109.932 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.49 110.11 19.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.169 0.509 . . . . 61.25 110.887 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.55 156.99 18.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.498 -0.774 . . . . 71.43 110.414 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.46 141.54 28.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.289 -0.263 . . . . 75.22 110.289 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 m -131.97 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.943 0.401 . . . . 55.31 110.793 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -175.43 170.77 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.021 -0.991 . . . . 70.3 111.287 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 163' ' ' VAL . 5.8 mmmm -63.54 132.7 52.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 63.05 110.501 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.94 127.23 52.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.358 0.599 . . . . 73.12 110.211 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--N 1.312 -1.039 0 CA-C-N 115.265 -0.879 . . . . 75.52 108.906 -179.555 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.19 0.519 . . . . 73.5 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.39 134.99 20.81 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 73.11 110.355 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 13' ' ' LEU . 29.0 Cg_endo -65.82 167.19 18.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.775 2.317 . . . . 74.14 112.027 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -40.09 70.2 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.425 0.528 . . . . 71.51 112.425 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.15 -27.37 67.97 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.163 0.431 . . . . 63.41 112.163 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.4 mp -78.99 -22.44 45.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.559 0.218 . . . . 74.22 111.26 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.5 ptt180 -120.2 -0.97 10.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.279 0.474 . . . . 74.34 112.279 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 33.1 ttpt -94.67 143.8 26.14 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.574 0.702 . . . . 74.4 111.822 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD21 HG13 ' A' ' 68' ' ' VAL . 65.9 mt -115.65 145.65 42.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.694 -1.139 . . . . 53.32 109.909 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -96.27 134.3 39.56 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.275 -1.009 . . . . 74.33 108.275 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 60' ' ' VAL . 19.6 mm -110.84 112.04 38.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.905 -0.406 . . . . 70.21 109.905 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.96 153.51 17.08 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.301 -0.952 . . . . 74.21 111.592 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.87 40.19 52.91 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 75.54 113.675 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 25' ' ' THR . 51.8 mt -78.27 177.02 8.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.956 -0.387 . . . . 53.3 109.956 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -84.13 -179.42 7.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.899 0.38 . . . . 72.23 110.099 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -84.1 -9.16 58.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.349 0.595 . . . . 71.42 109.851 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.03 20.37 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.791 -0.64 . . . . 75.14 111.786 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.478 HG21 HD22 ' A' ' 21' ' ' LEU . 27.1 m -75.62 131.53 40.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.811 0.339 . . . . 74.04 111.047 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 p -114.41 160.64 18.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 61.44 110.531 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 1.9 m-20 -62.59 -38.62 90.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 73.32 110.616 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.48 -42.14 98.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.381 -0.827 . . . . 61.12 111.353 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -75.87 -37.76 58.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.024 -0.534 . . . . 60.33 110.716 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.25 -43.59 90.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 64.52 110.454 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -60.46 -54.95 39.39 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.092 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -47.41 -39.72 16.08 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.302 1.001 . . . . 75.02 113.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -68.47 -61.27 1.9 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.967 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -71.08 -24.51 62.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.137 0.421 . . . . 73.15 112.137 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.1 tt0 -62.49 -21.08 65.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.28 -0.418 . . . . 73.0 111.837 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -62.1 -27.53 68.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.723 0.297 . . . . 75.13 111.461 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -98.05 -24.36 15.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.407 -0.361 . . . . 72.02 111.259 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.5 166.47 39.2 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.173 -1.013 . . . . 53.01 112.834 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -61.49 141.19 57.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.077 0.551 . . . . 73.21 111.369 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 mt -118.5 123.3 44.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.362 -0.607 . . . . 52.04 109.362 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -90.13 -25.1 20.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.087 -0.506 . . . . 74.12 110.295 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.34 152.16 31.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.488 -0.778 . . . . 65.21 109.864 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.6 t -160.15 123.99 3.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.294 -0.632 . . . . 71.41 109.294 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.411 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 p -143.26 118.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.516 0.674 . . . . 70.15 110.431 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 133.12 31.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 107.917 -1.142 . . . . 72.33 107.917 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.5 mmt -77.78 96.86 5.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.623 0.725 . . . . 51.33 110.236 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -96.81 161.27 13.93 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.423 -1.262 . . . . 51.45 108.975 175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.94 125.54 92.02 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.221 -0.659 . . . . 53.32 109.221 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.47 -20.94 53.98 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.573 1.515 . . . . 73.1 112.982 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -86.65 -55.63 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 72.52 111.223 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -16.48 23.56 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.917 -0.583 . . . . 74.13 112.18 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp 65.74 29.12 10.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.926 0.89 . . . . 73.1 111.925 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -107.35 155.14 20.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.02 -0.733 . . . . 71.35 109.02 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 t -71.05 135.46 47.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.911 0.386 . . . . 75.23 111.16 -173.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -87.38 5.27 39.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 73.12 110.775 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.52 70.62 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.864 -0.684 . . . . 51.31 114.175 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 25.5 p90 -156.0 156.41 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.04 0.92 . . . . 75.51 110.801 174.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.05 -165.15 17.25 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.639 -0.585 . . . . 41.35 111.639 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.51 145.65 31.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.973 0.387 . . . . 74.11 109.99 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 HD11 ' A' ' 18' ' ' ILE . 8.8 m -128.26 119.87 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 63.03 110.2 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.5 m -95.69 122.29 38.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.052 -0.351 . . . . 72.15 110.052 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -85.63 170.24 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 72.02 110.106 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.446 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -74.29 -52.57 11.89 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.671 -0.492 . . . . 74.12 109.671 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -122.37 150.29 42.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 74.41 110.502 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -63.81 -35.43 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.576 0.227 . . . . 72.24 111.263 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -52.29 -41.35 62.83 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.767 0.654 . . . . 74.21 112.767 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 47.4 mt-10 -68.74 -28.39 66.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.189 0.518 . . . . 62.4 110.726 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 14' ' ' ARG . 25.0 t -65.31 -45.39 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.418 -0.81 . . . . 72.21 111.083 175.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.81 -45.01 86.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.544 . . . . 62.53 110.912 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.1 -41.52 60.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 74.01 112.095 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -37.7 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 71.04 110.977 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.5 mmt -68.61 -32.95 73.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 74.44 111.059 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 -10.07 55.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.049 -0.523 . . . . 64.23 110.851 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.56 -9.27 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.264 0.554 . . . . 71.15 110.265 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp180 -53.39 142.48 39.45 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.818 -1.083 . . . . 61.12 111.327 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 6.1 Cg_exo -78.49 168.75 74.58 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.647 -0.981 . . . . 65.43 113.385 3.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -124.96 155.02 40.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.146 -0.933 . . . . 74.43 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.7 ttmt -132.79 106.94 8.04 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.84 0.352 . . . . 75.31 111.22 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.82 127.31 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 61.4 110.04 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.8 t70 67.15 29.94 7.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.759 0.79 . . . . 72.32 110.561 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.13 67.34 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.629 -0.714 . . . . 64.04 111.91 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.8 tpt180 -130.81 139.19 50.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.136 -0.32 . . . . 72.13 110.136 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.33 113.14 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.087 -0.708 . . . . 71.15 109.087 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.83 149.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.425 0.631 . . . . 65.41 111.182 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -112.93 96.64 38.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.027 -0.988 . . . . 74.05 110.662 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.85 138.3 18.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.309 2.006 . . . . 64.41 112.136 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 51.4 mmtt -132.96 168.67 18.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.113 -1.44 . . . . 62.14 107.113 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HB2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -83.31 142.25 31.22 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.867 -0.733 . . . . 71.35 109.101 173.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.73 92.15 1.97 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.29 0.567 . . . . 60.4 109.621 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.36 158.06 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.863 -1.062 . . . . 64.34 110.457 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -52.9 145.21 13.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.849 -0.614 . . . . 52.01 110.619 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.48 -41.61 30.23 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.489 0.922 . . . . 74.33 113.489 -168.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.16 -51.4 67.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.427 0.156 . . . . 70.52 111.26 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.0 -29.68 66.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.417 -0.356 . . . . 55.45 110.398 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -64.19 -18.43 64.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 73.21 111.539 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -96.42 -2.63 45.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.066 0.46 . . . . 71.0 110.73 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -88.91 151.47 47.28 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.405 -0.361 . . . . 74.42 111.039 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.01 118.55 5.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.711 2.274 . . . . 62.12 112.16 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.96 21.11 31.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.852 -0.69 . . . . 64.43 112.468 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.72 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.049 0.452 . . . . 72.03 111.928 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -104.62 25.67 10.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.081 -0.509 . . . . 62.03 111.409 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.39 -171.9 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.976 -0.557 . . . . 72.02 109.809 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 58.87 3.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.616 . . . . 73.1 110.794 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.97 107.96 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 74.51 110.181 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.467 ' C ' HG21 ' A' ' 159' ' ' VAL . 63.4 mttt -111.02 14.95 21.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.034 0.445 . . . . 51.14 110.343 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.58 140.87 47.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.271 -0.422 . . . . 72.2 110.229 178.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 159' ' ' VAL . 3.6 pt -129.25 149.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 64.04 111.399 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.9 t80 -97.24 133.16 42.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.086 -0.961 . . . . 75.11 109.189 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.63 110.02 24.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.432 -0.581 . . . . 74.33 109.432 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.23 147.95 16.92 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.034 -1.079 . . . . 65.24 113.074 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.56 22.22 8.7 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.835 -0.698 . . . . 43.42 112.158 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.7 pt -91.18 77.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.909 0.861 . . . . 74.44 110.458 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -66.71 -50.84 61.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.054 -0.975 . . . . 72.33 111.051 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.12 155.19 40.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.618 -0.512 . . . . 73.02 109.618 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.42 99.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.404 0.621 . . . . 52.24 110.884 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.5 m -97.53 134.01 41.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.229 -0.896 . . . . 64.22 109.719 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 120' ' ' HIS . 61.8 mt-10 -110.64 167.16 10.44 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.736 -1.12 . . . . 75.25 110.408 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 121' ' ' LEU . 26.9 tt0 -59.73 -46.04 90.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.823 . . . . 74.45 111.548 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -69.36 -22.03 63.77 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.888 -0.325 . . . . 71.51 111.484 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 61.2 m170 -61.49 -60.16 4.13 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.781 0.324 . . . . 53.32 110.532 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 118' ' ' GLU . 1.9 pt? -84.2 -21.07 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.292 -0.563 . . . . 45.25 111.143 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -65.94 -52.87 45.97 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.853 -0.425 . . . . 71.31 109.853 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -31.9 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.344 0.593 . . . . 72.22 110.416 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.406 ' OH ' ' HB3' ' A' ' 168' ' ' HIS . 83.1 t80 -72.6 -58.66 3.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.211 -0.904 . . . . 75.25 112.088 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.9 m-85 -66.43 -21.12 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.901 0.334 . . . . 73.55 111.901 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.39 -25.37 67.53 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.471 0.308 . . . . 73.13 111.31 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.16 -31.51 63.44 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.129 -0.487 . . . . 75.22 111.304 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.59 -28.56 23.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 52.54 111.941 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.9 -172.85 45.35 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.384 -0.912 . . . . 62.41 113.654 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -76.42 128.55 35.03 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.131 0.491 . . . . 73.5 111.683 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 61.3 mt -100.87 137.6 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 32.32 109.994 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -86.88 -52.19 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 73.11 110.428 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.15 155.74 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.321 -0.4 . . . . 64.3 110.209 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.89 129.01 72.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.239 0.542 . . . . 74.41 109.935 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.71 104.22 14.53 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.648 -0.706 . . . . 73.05 110.977 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.2 mm -90.8 120.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.976 -0.749 . . . . 72.32 108.976 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.427 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 71.9 mmm -94.88 113.88 25.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.748 0.785 . . . . 75.13 110.392 -175.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 114.846 -1.07 . . . . 73.23 109.794 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.325 0 N-CA-C 114.303 0.481 . . . . 61.4 114.303 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -155.48 157.5 37.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.595 0.697 . . . . 74.31 110.259 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.24 177.13 8.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 35.22 109.899 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -140.87 149.15 41.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.691 -0.686 . . . . 74.52 109.713 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.449 HG21 ' CD2' ' A' ' 125' ' ' PHE . 66.7 t -133.75 130.9 56.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.464 -0.334 . . . . 73.0 110.77 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.436 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 60.0 m -103.49 125.37 50.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.689 -0.687 . . . . 72.44 110.616 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.56 162.66 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.987 0.422 . . . . 72.22 111.208 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.75 -29.34 29.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.591 -0.732 . . . . 71.0 110.253 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.92 144.51 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 74.11 110.279 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.402 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 28.3 p80 -72.24 -26.53 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 74.11 110.129 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -55.44 -44.74 76.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.106 -0.952 . . . . 65.2 111.399 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -71.56 -33.35 69.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.037 -0.528 . . . . 71.44 111.212 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.467 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.87 -38.49 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.868 0.365 . . . . 55.14 110.088 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.447 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.7 t70 -67.05 -34.23 77.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.521 -0.763 . . . . 74.04 110.841 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.7 mttt -56.58 -40.87 75.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.662 0.744 . . . . 72.22 110.349 172.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.5 mt -73.54 -45.43 51.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.397 -1.274 . . . . 75.11 112.286 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 160' ' ' ASP . 15.8 m -75.11 -10.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.24 0.543 . . . . 63.21 111.027 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.456 HD13 HD12 ' A' ' 13' ' ' LEU . 14.1 mt -61.96 -31.9 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.139 -0.937 . . . . 73.3 109.971 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 64.6 mt-30 -107.84 104.1 13.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.82 -0.807 . . . . 41.21 108.82 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -54.08 -35.0 61.61 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.714 0.635 . . . . 64.2 112.714 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -122.15 138.45 54.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.888 0.375 . . . . 73.35 111.208 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -130.18 146.36 51.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 73.14 110.152 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -104.04 115.01 29.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 74.54 111.05 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.9 p -141.43 146.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.626 -0.715 . . . . 70.43 109.187 177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 58.33 29.52 18.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.343 1.068 . . . . 62.14 110.54 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.2 0.87 84.49 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.212 -0.904 . . . . 65.24 113.253 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -121.59 133.59 55.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.071 0.463 . . . . 74.22 111.068 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.08 108.55 18.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 62.01 109.715 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.2 p -113.11 157.17 21.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 50.15 110.677 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -85.76 134.05 33.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.959 0.409 . . . . 71.04 110.072 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.0 t -130.44 132.46 64.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.564 -0.744 . . . . 70.51 109.799 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -153.73 173.8 15.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.789 -0.641 . . . . 65.43 110.994 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -64.56 131.54 47.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.129 0.49 . . . . 73.2 111.3 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -122.92 118.56 28.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.715 -0.846 . . . . 65.43 108.715 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 C--N 1.311 -1.087 0 N-CA-C 109.756 -0.461 . . . . 72.11 109.756 -178.33 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.337 0 CA-C-O 121.337 0.589 . . . . 61.42 109.782 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.18 135.64 57.88 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.192 -0.913 . . . . 62.12 110.219 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HD2' HD12 ' A' ' 13' ' ' LEU . 11.4 Cg_endo -63.17 160.24 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.118 1.879 . . . . 72.13 110.965 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.6 63.23 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.1 0.407 . . . . 60.23 112.1 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.26 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 61.5 112.434 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 10' ' ' PRO . 42.7 mt -79.36 -16.92 55.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 63.22 110.719 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.507 ' HA ' HG21 ' A' ' 68' ' ' VAL . 17.6 ptt85 -122.97 4.83 9.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 72.14 111.492 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.9 ttpt -99.08 149.78 22.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.224 0.535 . . . . 52.41 110.666 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.766 HD11 HG13 ' A' ' 68' ' ' VAL . 7.6 mp -116.38 141.32 48.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.009 -0.996 . . . . 75.3 110.224 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -97.27 114.4 26.15 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.445 -0.946 . . . . 60.31 108.445 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 mm -94.08 111.0 24.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 110.053 -0.351 . . . . 54.23 110.053 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.3 152.68 18.45 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.561 -0.828 . . . . 70.3 111.314 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.88 45.76 41.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.629 -0.796 . . . . 72.12 113.142 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 25' ' ' THR . 75.9 mt -79.64 175.27 10.77 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.78 -0.452 . . . . 53.53 109.78 172.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 82' ' ' ARG . 21.2 p -91.34 175.33 6.97 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.549 -0.538 . . . . 74.23 109.549 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -75.23 -8.16 55.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.321 0.581 . . . . 64.43 110.081 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.77 9.12 17.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.568 -0.742 . . . . 70.1 112.138 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.628 HG21 HD22 ' A' ' 21' ' ' LEU . 19.3 m -76.6 120.69 22.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.447 -0.501 . . . . 71.02 111.161 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 p -103.96 159.98 15.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 71.31 110.468 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 2.5 m-20 -60.34 -38.84 85.02 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.032 -0.531 . . . . 73.21 110.93 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.69 -39.56 91.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.736 -0.665 . . . . 74.22 111.718 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -75.92 -39.89 55.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.541 -0.3 . . . . 65.32 110.683 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.82 -47.49 83.2 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.041 -0.527 . . . . 71.11 109.995 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -57.59 -60.33 3.83 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.081 -0.509 . . . . 72.41 111.356 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -51.97 -36.6 50.09 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.537 0.523 . . . . 75.2 112.284 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -71.45 -56.8 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.651 -0.25 . . . . 74.44 110.908 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -68.55 -25.18 64.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 63.14 111.851 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.6 tt0 -64.91 -15.11 61.65 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.113 0.412 . . . . 70.34 112.113 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -29.57 70.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.822 0.344 . . . . 73.53 111.163 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -98.01 -22.3 16.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.542 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -168.36 159.39 32.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.36 -0.924 . . . . 73.4 112.099 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.5 m -64.64 118.27 8.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.048 0.451 . . . . 73.33 111.999 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -92.12 134.12 35.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.434 0.635 . . . . 53.21 110.761 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -107.75 -19.41 13.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.001 . . . . 65.31 110.238 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 32.0 t70 -151.51 152.44 32.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 75.14 109.897 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.0 t -163.03 127.24 2.96 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.502 -0.555 . . . . 74.3 109.502 172.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 4.8 p -142.01 123.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.536 0.684 . . . . 61.31 110.63 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.4 130.67 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.506 -0.924 . . . . 75.31 108.506 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.88 135.69 46.66 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.959 -0.756 . . . . 70.34 108.959 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -135.35 156.55 48.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.874 -0.603 . . . . 74.44 111.493 -170.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 13.3 t70 -66.46 132.3 94.25 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.837 -1.074 . . . . 72.23 109.323 174.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.82 -18.88 47.34 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 121.897 1.732 . . . . 74.32 113.864 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -85.56 -57.31 3.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.844 0.354 . . . . 54.04 111.604 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -105.45 -7.72 18.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.061 -0.518 . . . . 51.5 111.305 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 40.0 mmtm 63.63 32.06 14.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.803 0.841 . . . . 73.02 111.555 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -95.94 162.43 13.57 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.808 -0.812 . . . . 74.34 108.808 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -65.69 139.71 58.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.838 0.351 . . . . 73.04 111.613 -171.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.14 2.21 47.67 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.769 -0.65 . . . . 53.22 110.379 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 15.92 61.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.741 -0.743 . . . . 60.13 113.242 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -161.19 157.15 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.154 0.477 . . . . 62.43 110.524 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.27 -164.21 16.74 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 111.52 -0.632 . . . . 75.52 111.52 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -142.35 150.87 41.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.32 0.56 . . . . 73.21 110.805 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 16' ' ' LEU . 5.8 m -132.84 123.37 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.78 -0.645 . . . . 54.4 109.87 172.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 42' ' ' ASP . 5.2 m -98.94 120.64 39.72 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.332 -0.23 . . . . 72.13 110.609 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.63 161.8 17.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.167 -0.47 . . . . 74.35 110.322 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 -35.59 62.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.715 -0.675 . . . . 62.23 110.599 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.86 149.36 52.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.347 -178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.5 p -66.44 -34.6 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 120.778 0.323 . . . . 61.45 111.096 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.94 -37.44 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.206 0.447 . . . . 75.43 112.206 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.05 -29.49 70.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 71.42 110.368 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.766 HG13 HD11 ' A' ' 16' ' ' LEU . 2.7 t -62.11 -44.52 99.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.175 -0.92 . . . . 64.13 110.98 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -41.18 97.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.201 -0.454 . . . . 74.51 111.131 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.75 -39.88 78.4 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.025 0.38 . . . . 65.53 112.025 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.95 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 63.41 110.529 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.414 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.0 mmt -66.41 -33.46 75.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.769 -0.65 . . . . 63.25 110.529 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.598 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 3.4 p30 -82.26 -9.6 59.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.991 0.424 . . . . 75.35 111.091 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.59 -14.39 45.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.856 -0.611 . . . . 74.53 112.518 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -49.16 146.35 6.1 Favored Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 112.705 0.631 . . . . 75.14 112.705 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.4 154.34 85.22 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 124.02 -1.242 . . . . 70.13 113.287 1.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -107.44 147.16 30.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.705 -0.68 . . . . 71.34 110.441 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -138.45 104.37 5.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.118 0.485 . . . . 73.54 111.226 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.34 139.92 43.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.335 -0.617 . . . . 61.13 109.335 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 1.7 m-20 62.72 31.79 16.44 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.565 0.54 . . . . 73.14 111.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.67 23.53 77.68 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.396 -0.82 . . . . 45.12 112.605 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.9 tpt180 -129.38 137.35 50.9 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.848 -0.207 . . . . 71.33 110.787 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.35 116.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.984 -0.747 . . . . 71.52 108.984 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -109.91 154.18 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.288 0.566 . . . . 70.04 111.493 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.85 95.89 35.51 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.142 -0.935 . . . . 74.14 110.753 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.55 134.11 16.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.09 1.86 . . . . 62.44 112.155 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 31.9 mmtt -125.9 -177.82 4.07 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.849 -1.167 . . . . 63.13 107.849 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.501 HH22 ' HE2' ' A' ' 161' ' ' LYS . 12.2 mmt-85 -80.87 163.14 23.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.281 0.492 . . . . 73.03 109.764 170.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.08 90.49 4.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.817 0.818 . . . . 75.14 108.822 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 164' ' ' ILE . 16.5 t -82.75 156.35 3.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.58 -1.191 . . . . 75.34 109.191 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.3 t -54.82 148.38 13.21 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.461 0.476 . . . . 70.12 109.902 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.555 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 6.8 tpp180 -66.52 -6.02 13.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.089 0.471 . . . . 64.15 111.984 -172.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.85 -43.95 94.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.277 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.11 -43.88 14.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.842 -0.617 . . . . 74.12 111.088 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 1.5 p -69.34 -12.31 61.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.242 -0.436 . . . . 71.2 111.875 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 33.9 tt0 -61.59 -34.93 76.47 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.239 -0.437 . . . . 70.03 110.964 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 97' ' ' ARG . 4.0 mpt_? -70.56 145.81 93.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 74.44 111.232 -174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.34 120.08 7.12 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.349 2.7 . . . . 71.42 112.712 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.1 29.14 69.18 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 121.18 -0.534 . . . . 63.24 113.023 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' A' ' 179' ' ' LYS . . . -78.85 -49.6 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.748 0.309 . . . . 75.02 110.618 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 95' ' ' SER . 4.7 m80 -81.16 25.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.647 0.61 . . . . 61.43 112.647 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.53 -164.09 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.715 -0.846 . . . . 73.12 108.715 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.11 88.76 5.97 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.596 -0.69 . . . . 62.12 111.122 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.92 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 71.21 109.569 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' C ' HG21 ' A' ' 159' ' ' VAL . 79.1 mttt -108.47 20.1 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.124 0.488 . . . . 53.52 110.605 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -120.58 139.74 52.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.192 -0.458 . . . . 53.22 110.636 178.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.523 HG23 HG13 ' A' ' 159' ' ' VAL . 4.6 pt -129.94 151.3 35.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.375 0.607 . . . . 74.01 111.665 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.3 t80 -101.86 133.24 46.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.621 -1.172 . . . . 74.32 109.809 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.5 110.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.336 -0.616 . . . . 70.31 109.336 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.28 157.23 19.4 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.297 -0.954 . . . . 72.41 112.953 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.94 19.66 30.58 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.773 -0.727 . . . . 64.34 111.828 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG22 ' SG ' ' A' ' 175' ' ' CYS . 29.8 pt -78.52 118.39 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.341 0.591 . . . . 62.22 110.874 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.99 -69.3 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 63.12 110.759 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.01 154.82 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.777 -0.453 . . . . 74.33 109.777 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.97 104.84 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.687 -0.688 . . . . 73.31 110.486 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -79.85 132.91 36.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.833 -0.621 . . . . 41.1 110.368 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -101.7 167.24 10.23 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.258 -0.883 . . . . 73.2 110.471 -177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 134' ' ' ILE . 5.8 tm-20 -61.58 -48.17 82.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 71.13 110.403 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -62.5 -26.75 68.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 75.53 111.137 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -63.95 -61.4 2.3 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.17 0.509 . . . . 73.0 110.461 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 134' ' ' ILE . 4.4 pp -82.47 -26.89 32.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.247 -0.581 . . . . 71.33 111.595 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -65.26 -50.57 65.28 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.965 -0.294 . . . . 72.14 110.315 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.15 -31.47 70.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 74.4 110.822 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 170' ' ' VAL . 78.2 t80 -76.96 -56.24 4.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.196 -0.456 . . . . 73.01 112.128 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 35.6 m-85 -66.98 -22.11 65.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.174 0.435 . . . . 73.55 112.174 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.4 mm-40 -64.79 -28.07 69.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.022 0.439 . . . . 71.31 110.77 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.77 -28.12 60.72 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.158 -0.474 . . . . 62.34 111.789 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.48 -26.42 24.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.35 -0.387 . . . . 73.55 111.717 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.75 -176.26 44.28 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 120.889 -0.672 . . . . 74.22 113.138 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -76.15 134.11 40.04 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.037 0.446 . . . . 73.51 111.439 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 152' ' ' THR . 69.0 mt -105.85 142.02 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.749 -0.659 . . . . 72.52 110.75 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -91.42 -52.39 4.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 64.33 111.029 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -155.74 154.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.997 -0.547 . . . . 62.5 110.187 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 118' ' ' GLU . 3.3 mp -114.59 128.09 71.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 75.04 109.819 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -104.84 103.92 13.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.328 -0.851 . . . . 72.42 110.789 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -92.17 124.86 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.89 -0.782 . . . . 73.42 108.89 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.9 mmm -94.67 113.73 25.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.334 0.588 . . . . 72.13 109.843 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 71.42 110.406 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.407 -0.107 . . . . 63.04 112.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.98 157.51 43.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.763 -0.458 . . . . 73.1 109.763 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.26 166.39 24.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 71.0 109.735 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 67.2 m-85 -133.87 153.44 51.74 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.993 -0.549 . . . . 73.25 110.131 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.13 132.39 18.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.311 0.577 . . . . 75.34 111.063 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 55.9 m -98.49 124.57 43.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.102 -0.954 . . . . 55.13 110.495 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 6.4 m-85 -100.02 161.36 13.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.923 0.392 . . . . 75.51 111.187 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.21 -33.41 56.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.685 -0.689 . . . . 74.33 110.207 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.4 154.93 50.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.247 -0.888 . . . . 75.44 110.613 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.599 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 21.6 p80 -80.06 -21.27 43.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 73.31 110.321 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -53.62 -43.98 69.11 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.91 0.756 . . . . 75.33 110.96 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 m -71.96 -33.54 68.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.485 -0.779 . . . . 60.35 111.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.523 HG13 HG23 ' A' ' 107' ' ' ILE . 2.3 t -72.41 -37.62 58.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.206 0.527 . . . . 52.43 109.724 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.253 -0.885 . . . . 74.34 111.103 -178.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.5 mttt -68.27 -39.28 82.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.648 0.737 . . . . 60.13 110.134 172.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.14 -41.72 37.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.85 -1.068 . . . . 75.34 112.52 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.518 HG11 ' HD3' ' A' ' 179' ' ' LYS . 35.5 m -73.5 -5.49 6.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.045 0.45 . . . . 72.02 111.38 -174.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.55 ' HA ' HG13 ' A' ' 90' ' ' VAL . 50.8 mt -61.89 -33.56 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.399 -0.819 . . . . 63.12 110.295 171.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.1 mt-30 -110.32 108.68 18.84 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.171 -0.677 . . . . 74.43 109.171 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -56.0 -33.25 64.69 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.678 0.621 . . . . 75.44 112.678 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -123.5 139.81 53.64 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.24 -0.288 . . . . 73.15 110.689 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.2 m-70 -128.19 152.45 48.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 74.42 109.946 175.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 m -100.28 110.09 22.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 71.24 110.113 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 124' ' ' TYR . 12.0 t -124.11 133.16 70.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.005 -0.739 . . . . 74.54 109.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.07 28.06 14.32 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.608 0.718 . . . . 71.34 111.486 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.78 7.57 87.34 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.014 -0.613 . . . . 74.3 113.024 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -112.0 125.26 53.88 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.503 0.321 . . . . 73.25 110.759 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -82.56 110.69 17.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.478 0.656 . . . . 60.11 109.735 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 112' ' ' ILE . 16.0 m -122.36 157.65 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 64.3 110.792 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -85.59 132.81 34.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.341 -0.391 . . . . 73.24 110.294 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.9 t -129.16 135.34 62.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.689 -0.687 . . . . 75.02 110.155 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -158.0 173.29 16.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 72.13 110.856 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 100' ' ' ALA . 12.5 mmtm -58.92 132.29 53.55 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.353 0.408 . . . . 75.13 110.979 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.22 114.51 22.53 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.639 -0.504 . . . . 75.31 109.639 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.311 -1.101 0 N-CA-C 108.958 -0.756 . . . . 75.21 108.958 178.171 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm . . . . . 0 CA--C 1.532 0.256 0 N-CA-C 111.614 0.227 . . . . 72.24 111.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.4 122.54 78.8 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 74.33 109.544 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.4 Cg_endo -60.39 167.24 8.18 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.301 2.668 . . . . 71.32 112.532 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 2.2 pt-20 -51.18 -42.23 60.73 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 123.294 0.371 . . . . 65.31 111.54 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 5.5 pt20 -64.93 -19.82 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.622 0.601 . . . . 72.23 112.622 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.4 mp -90.07 -21.45 22.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.531 0.197 . . . . 74.23 111.531 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.3 ptt180 -117.83 -3.61 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.633 -0.427 . . . . 64.13 111.501 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -99.17 144.49 28.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.557 0.694 . . . . 62.34 111.549 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 68' ' ' VAL . 52.5 mt -115.61 148.27 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.741 -1.118 . . . . 63.41 110.544 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -98.61 125.97 44.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.407 -0.96 . . . . 63.05 108.407 172.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' VAL . 20.7 mm -103.86 111.9 35.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.819 -0.437 . . . . 63.42 109.819 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.44 17.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.595 -0.812 . . . . 73.11 111.847 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.63 47.36 27.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.609 -0.805 . . . . 72.22 113.152 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 25' ' ' THR . 86.1 mt -82.26 176.23 9.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.412 . . . . 73.43 109.889 172.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -88.34 175.23 7.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.054 0.454 . . . . 74.14 109.849 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -81.7 -4.98 57.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.018 -0.537 . . . . 72.03 110.438 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.35 9.11 10.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 61.23 111.549 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.595 HG21 HD22 ' A' ' 21' ' ' LEU . 53.4 m -75.94 127.23 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 60.51 111.379 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.9 p -103.19 172.6 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 73.41 110.37 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.56 -24.2 39.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.221 -0.288 . . . . 74.42 110.221 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.44 -39.04 68.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 64.42 111.204 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.5 p -75.4 -38.03 60.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 73.1 110.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.564 ' HA ' HG11 ' A' ' 79' ' ' VAL . 30.2 tp -62.94 -49.1 76.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.465 -0.789 . . . . 54.41 109.995 176.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.2 ttm180 -56.09 -62.42 1.72 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.519 -0.764 . . . . 72.2 111.959 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 t -50.65 -33.17 21.44 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.742 0.651 . . . . 75.21 112.544 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -75.2 -55.27 5.89 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.07 -0.252 . . . . 75.23 111.083 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.94 -22.77 62.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.067 0.395 . . . . 73.41 112.067 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -58.36 -22.83 54.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.049 0.539 . . . . 63.13 111.849 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -63.95 -27.52 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.362 . . . . 71.43 111.973 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -96.75 -23.74 16.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.762 0.315 . . . . 72.53 111.253 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.93 154.44 24.46 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.334 -0.936 . . . . 35.55 111.972 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.2 m -62.51 118.2 7.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 64.12 111.087 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -85.0 142.46 29.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.71 -0.677 . . . . 63.41 110.452 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -104.41 -25.43 12.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.607 -0.724 . . . . 71.21 109.682 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -153.49 156.2 37.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 70.31 110.084 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.4 t -161.79 132.32 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.454 -0.572 . . . . 72.11 109.454 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.68 118.02 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.716 0.769 . . . . 75.22 110.693 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.43 132.67 31.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.715 -0.846 . . . . 74.22 108.715 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mmt -76.19 101.37 5.37 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.512 0.673 . . . . 73.42 110.346 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -99.05 153.71 18.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.804 -1.089 . . . . 53.34 109.397 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.48 128.01 86.52 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.928 -0.578 . . . . 74.3 110.336 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 -17.07 58.39 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.284 1.99 . . . . 72.43 113.424 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -85.63 -56.11 3.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.965 0.412 . . . . 63.23 111.587 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -11.9 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 74.11 111.77 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 62.79 34.82 14.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.752 0.821 . . . . 71.24 110.808 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -112.2 160.9 17.14 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -74.09 131.7 41.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.814 0.34 . . . . 64.33 110.63 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -83.68 7.01 18.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 64.22 111.38 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.03 16.32 75.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.787 -0.721 . . . . 75.41 113.521 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -157.19 155.88 31.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.358 0.579 . . . . 75.32 110.355 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.2 -165.37 16.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.418 -0.673 . . . . 64.45 111.418 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.66 148.77 37.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.046 0.423 . . . . 75.43 110.31 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -128.11 127.23 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.719 -0.673 . . . . 62.41 109.534 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -101.96 117.43 34.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.0 -0.37 . . . . 74.54 110.0 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.1 m-85 -84.85 170.86 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.328 -0.396 . . . . 75.51 110.494 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.13 -49.48 28.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.863 -0.608 . . . . 61.24 110.044 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.499 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -128.83 160.22 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 71.11 110.792 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.3 p -65.12 -33.43 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.238 -0.437 . . . . 72.23 111.308 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -55.79 -44.54 77.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.509 0.559 . . . . 74.33 112.509 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.5 mp0 -61.28 -32.75 72.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.3 0.572 . . . . 72.13 110.728 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 14' ' ' ARG . 39.1 t -65.95 -49.63 75.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.236 -0.893 . . . . 73.54 111.055 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.32 -43.83 88.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 75.35 110.875 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.63 -42.6 62.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.962 -0.563 . . . . 75.11 112.284 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.97 -33.07 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.866 0.365 . . . . 71.42 110.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.68 -42.12 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 72.24 110.433 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -12.29 59.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.807 -0.633 . . . . 74.5 111.069 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.78 -10.86 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 60.03 110.657 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 19.2 ttp-105 -53.49 144.31 33.04 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.279 -0.873 . . . . 75.14 110.892 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 87.7 Cg_endo -80.53 168.93 70.47 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.56 -1.017 . . . . 73.12 114.013 2.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -128.21 158.28 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.069 -0.969 . . . . 64.34 110.165 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.0 ttmt -134.55 104.59 6.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.082 -0.508 . . . . 65.44 110.3 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 30' ' ' LEU . 48.5 t -108.7 132.98 55.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 73.44 109.954 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 65.62 27.42 11.44 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.82 0.7 . . . . 74.11 110.856 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.51 21.89 76.43 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.804 -0.635 . . . . 31.44 112.497 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.3 tpt180 -128.68 137.63 51.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.226 -0.287 . . . . 61.12 110.226 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.81 111.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.419 -0.586 . . . . 71.34 109.419 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 21' ' ' LEU . 4.1 m -107.4 150.04 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.59 0.71 . . . . 65.23 111.431 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.05 95.46 38.36 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 114.823 -1.081 . . . . 72.22 110.926 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.97 131.98 17.65 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.418 2.079 . . . . 74.13 111.949 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -141.08 -177.33 5.05 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.222 -0.899 . . . . 74.0 108.786 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 7.4 tpp180 -75.09 154.3 37.92 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.051 0.453 . . . . 75.14 111.28 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.22 91.24 6.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.421 -0.955 . . . . 72.2 108.421 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t -69.44 149.17 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.499 -0.773 . . . . 72.42 110.288 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 p -56.59 146.41 25.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 123.497 0.498 . . . . 74.31 110.034 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.21 -16.27 63.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.877 0.695 . . . . 73.43 112.877 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.63 -51.63 26.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 61.41 110.234 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.34 -20.66 33.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 63.45 111.467 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 t -69.66 -15.87 63.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.323 -0.399 . . . . 75.33 110.357 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.36 -17.91 59.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 71.1 110.656 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -79.32 147.47 68.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 60.43 110.841 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.69 116.5 4.58 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.699 2.266 . . . . 63.2 111.97 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.81 18.04 15.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.54 -0.838 . . . . 52.53 112.515 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.15 50.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.73 0.3 . . . . 71.32 111.096 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -103.3 13.68 33.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.021 0.439 . . . . 73.21 111.285 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.59 163.41 23.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.246 -0.65 . . . . 75.25 109.246 173.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.3 82.88 4.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.792 0.806 . . . . 74.2 110.63 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -108.63 113.69 44.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.753 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 159' ' ' VAL . 82.2 mttt -109.12 19.4 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.861 0.363 . . . . 75.03 110.475 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.41 144.54 45.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.546 -0.297 . . . . 62.33 110.667 175.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.457 HG23 HG13 ' A' ' 159' ' ' VAL . 5.3 pt -125.08 148.5 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.224 0.535 . . . . 63.12 111.19 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.9 t80 -97.74 131.96 43.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.019 -0.992 . . . . 72.12 109.008 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.46 108.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.981 -0.748 . . . . 75.33 108.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.37 166.27 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.87 -1.157 . . . . 74.32 113.294 -174.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.29 58.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.704 -0.76 . . . . 22.1 111.762 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.36 134.18 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 70.52 109.478 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.73 -49.28 9.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.882 0.372 . . . . 72.24 110.204 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.86 -173.56 2.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.056 -0.72 . . . . 74.31 109.056 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -83.81 135.27 34.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.297 0.57 . . . . 74.34 110.983 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 m -106.95 141.43 38.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.596 -0.729 . . . . 72.32 110.315 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.37 160.91 16.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.287 -0.415 . . . . 73.13 109.918 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.17 -51.12 71.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 72.41 110.093 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -58.88 -31.01 68.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 74.3 111.731 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.347 0.405 . . . . 73.31 110.71 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.7 pp -81.11 -27.45 35.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.449 -0.5 . . . . 74.45 110.99 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.41 -53.31 44.9 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 110.182 -0.303 . . . . 73.41 110.182 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.49 -28.27 69.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.209 0.528 . . . . 73.45 110.452 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.01 -56.71 4.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.95 -0.568 . . . . 71.11 111.54 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 29.7 m-85 -66.71 -22.1 66.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 72.02 111.773 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.16 -27.72 68.91 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.99 0.424 . . . . 71.21 111.214 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -58.07 -28.77 64.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 72.14 111.3 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -86.16 -26.49 25.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.356 . . . . 75.04 111.658 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -174.91 45.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.708 -0.758 . . . . 72.04 113.582 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -78.18 131.89 37.37 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.936 0.398 . . . . 53.34 111.716 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.82 139.92 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.922 -0.581 . . . . 70.42 110.384 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 -49.92 6.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 63.53 110.847 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.59 159.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.684 -0.487 . . . . 74.41 109.684 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.53 127.82 75.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.244 0.545 . . . . 73.34 109.923 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.6 mt-10 -99.65 103.79 15.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.1 -0.954 . . . . 73.24 110.326 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.53 117.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.164 -0.68 . . . . 72.44 109.164 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.4 mmm -91.3 122.33 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.333 -0.617 . . . . 73.13 109.333 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-O 121.429 0.633 . . . . 72.15 112.039 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.475 -0.25 . . . . 65.44 112.475 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -157.46 158.8 36.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.987 0.422 . . . . 74.41 110.392 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.5 170.07 16.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.48 -0.782 . . . . 71.21 109.54 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.6 m-85 -134.4 145.21 48.71 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.967 -0.56 . . . . 75.03 109.909 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.19 129.07 67.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.206 -0.452 . . . . 72.14 110.623 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 96.4 m -100.81 118.74 37.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.643 -0.708 . . . . 73.21 110.521 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.1 m-85 -102.16 156.81 17.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.768 0.318 . . . . 74.33 111.178 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.56 -31.93 60.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.931 -0.577 . . . . 73.01 110.366 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -128.26 152.96 47.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 75.42 110.663 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -75.96 -25.68 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.553 . . . . 75.44 109.508 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.59 -48.84 38.72 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.102 -0.954 . . . . 62.12 111.437 178.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 153' ' ' PHE . 1.7 m -72.44 -32.89 66.68 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.82 -0.627 . . . . 62.14 110.813 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.6 t -69.46 -42.34 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.312 -0.625 . . . . 75.21 109.312 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.565 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 3.6 m-20 -71.43 -22.49 61.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.082 -0.963 . . . . 72.34 111.804 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -67.01 -39.56 87.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.77 0.795 . . . . 55.05 109.786 170.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mt -76.02 -40.94 38.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.334 -1.303 . . . . 70.23 112.054 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 159' ' ' VAL . 7.5 m -73.33 -11.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.001 0.429 . . . . 64.24 110.924 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.497 HD13 HD12 ' A' ' 13' ' ' LEU . 10.8 mt -63.71 -29.99 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.323 -0.853 . . . . 73.24 110.193 173.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.561 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 54.6 mt-30 -112.66 98.42 7.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.898 -1.149 . . . . 63.11 107.898 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -56.67 -33.37 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.108 -0.951 . . . . 71.12 112.431 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -121.65 131.75 54.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.33 -0.395 . . . . 75.11 110.381 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.561 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -124.49 150.95 45.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.712 -0.676 . . . . 73.35 109.794 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -115.87 118.1 32.05 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.779 -0.452 . . . . 64.33 109.779 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.93 117.2 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.054 -0.521 . . . . 52.15 110.31 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.02 28.23 5.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 73.21 110.328 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 97.73 -9.13 64.07 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.534 -0.757 . . . . 61.55 113.309 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -108.61 125.68 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.444 0.622 . . . . 62.42 111.795 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -93.2 109.91 21.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.332 0.587 . . . . 43.33 110.014 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.1 p -114.64 155.31 26.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.596 -0.729 . . . . 75.01 110.675 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.0 129.94 34.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.504 -0.554 . . . . 60.32 109.504 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 12.4 t -127.74 134.45 65.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.411 -0.813 . . . . 54.54 110.202 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.6 177.0 11.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.707 -0.679 . . . . 64.24 111.134 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -64.1 125.72 25.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.36 -0.382 . . . . 73.04 110.144 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.67 44.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.016 0.436 . . . . 64.34 109.911 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.0 mt . . . . . 0 C--N 1.309 -1.168 0 CA-C-N 115.983 -0.553 . . . . 71.33 109.99 179.485 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.001 0.429 . . . . 73.33 110.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -64.63 128.19 93.23 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.376 -0.829 . . . . 75.11 111.107 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HD2' HD22 ' A' ' 13' ' ' LEU . 34.2 Cg_endo -65.8 167.65 17.03 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.152 2.568 . . . . 63.34 112.186 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.56 -34.64 72.94 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 112.157 0.429 . . . . 74.11 112.157 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -67.87 -24.36 65.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.872 0.367 . . . . 75.04 111.363 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.455 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.0 mp -86.21 -10.6 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 53.14 111.188 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -122.34 0.72 9.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 70.32 111.216 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.2 ttpt -97.41 145.64 25.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.597 0.713 . . . . 72.0 111.983 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 68' ' ' VAL . 60.7 mt -117.76 147.66 42.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.12 . . . . 63.22 110.54 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -99.27 125.75 44.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.542 -0.91 . . . . 75.32 108.542 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 60' ' ' VAL . 20.9 mm -102.97 113.18 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.91 -0.404 . . . . 73.44 109.91 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.27 17.26 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.784 -0.722 . . . . 53.05 111.858 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.74 47.33 26.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 73.25 113.333 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 25' ' ' THR . 77.7 mt -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.003 0.43 . . . . 54.23 110.494 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 t -92.23 167.36 12.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.332 -0.618 . . . . 61.02 109.332 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 94.2 m-85 -75.46 -6.12 48.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.307 0.575 . . . . 73.21 110.789 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.14 -3.8 28.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.201 -0.909 . . . . 75.12 111.202 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.486 HG21 HD22 ' A' ' 21' ' ' LEU . 72.2 m -76.21 125.18 28.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 71.4 112.158 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -105.86 160.01 15.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.169 -0.923 . . . . 73.42 110.072 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 120.475 0.179 . . . . 74.13 110.829 -177.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -76.69 -38.33 54.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 75.33 111.499 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -78.51 -35.23 46.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.825 -0.171 . . . . 74.4 111.227 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.77 -45.97 84.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.248 -0.649 . . . . 72.34 109.248 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -54.17 -60.32 3.49 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.176 -0.92 . . . . 64.44 111.386 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -47.72 -34.09 7.85 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.858 0.724 . . . . 74.42 112.701 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -76.58 -57.6 3.76 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.8 -0.182 . . . . 75.2 111.114 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.18 -23.13 64.81 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.063 -0.398 . . . . 63.24 111.849 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.91 -23.33 65.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.228 0.611 . . . . 74.35 111.209 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -60.79 -26.94 67.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 72.11 112.038 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -99.95 -20.88 15.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.837 0.31 . . . . 73.24 111.837 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.73 32.88 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.294 -0.955 . . . . 75.25 112.095 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -63.23 117.28 6.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.927 0.394 . . . . 72.54 111.394 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.9 mt -85.13 143.0 29.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.482 -0.562 . . . . 72.51 109.482 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -116.17 -16.12 11.02 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.012 -0.54 . . . . 73.31 110.099 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -152.39 150.7 29.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 73.41 109.446 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.4 t -162.72 129.48 3.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.687 -0.486 . . . . 75.41 109.687 174.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.6 122.08 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.501 0.667 . . . . 72.33 110.587 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 27' ' ' ASP . 91.2 t -85.73 129.93 37.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 53.14 108.785 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -75.33 95.0 3.12 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.571 0.701 . . . . 70.23 110.116 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 52.4 mtp85 -101.34 158.43 16.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.636 -1.166 . . . . 72.22 110.221 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 23.9 t70 -72.45 126.46 90.91 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.143 -0.935 . . . . 73.31 110.262 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.29 -12.5 31.99 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.127 1.885 . . . . 74.11 112.942 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 32.2 m-80 -85.64 -56.3 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.019 0.377 . . . . 75.04 112.019 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -107.09 -9.24 16.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 75.12 111.459 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 67.07 40.07 3.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.68 0.792 . . . . 75.14 111.416 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -117.28 154.66 30.84 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.547 -0.909 . . . . 72.45 108.547 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 31.3 t -72.27 139.86 48.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.147 0.431 . . . . 71.42 111.391 -171.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -82.53 1.2 39.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.673 -0.694 . . . . 72.45 110.695 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 20.06 57.21 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.568 -0.825 . . . . 63.32 113.987 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -161.05 156.92 25.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.9 0.85 . . . . 75.4 110.618 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.17 -163.56 14.4 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.519 -0.632 . . . . 71.45 111.519 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.15 150.4 41.03 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.374 0.587 . . . . 65.44 110.293 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 18' ' ' ILE . 7.5 m -131.71 127.96 59.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 60.22 109.55 172.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.6 m -104.49 119.65 39.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.105 -0.331 . . . . 72.24 110.105 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 29.9 m-85 -85.33 158.95 20.14 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.24 -0.436 . . . . 73.11 110.121 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.92 -44.45 73.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.932 -0.576 . . . . 42.22 110.559 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -126.4 152.13 46.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.754 -0.657 . . . . 74.02 110.643 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 2.6 p -60.44 -36.31 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.727 -0.67 . . . . 73.32 110.983 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.64 -43.3 62.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.241 0.83 . . . . 52.41 113.241 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 1.3 mp0 -65.61 -29.24 69.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.88 0.372 . . . . 53.51 111.207 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.96 -45.7 96.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 75.14 110.428 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.31 -50.1 70.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.167 -0.924 . . . . 73.42 111.722 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -52.96 -37.08 60.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.938 0.718 . . . . 73.53 112.938 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.62 -32.52 71.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.461 0.648 . . . . 62.31 109.949 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 75' ' ' ARG . 14.0 mmt -73.07 -31.5 64.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.251 -0.886 . . . . 41.01 112.09 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -81.39 -15.01 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.214 0.531 . . . . 63.22 110.632 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.27 -11.21 35.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 64.13 112.097 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' ' SD ' ' A' ' 72' ' ' MET . 7.8 mtm180 -54.11 146.58 29.41 Favored Pre-proline 0 N--CA 1.465 0.282 0 O-C-N 123.241 0.338 . . . . 75.44 111.631 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.19 168.68 69.19 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.75 -1.354 . . . . 52.24 113.234 2.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -122.77 155.52 36.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.992 -0.549 . . . . 64.13 110.77 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 ttmt -135.06 108.47 7.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.082 -0.508 . . . . 55.31 111.112 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.34 124.76 64.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 72.34 110.073 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 64.99 27.32 12.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.474 0.71 . . . . 73.23 111.698 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.3 25.04 59.99 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.919 -0.658 . . . . 51.23 112.483 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.6 tpt180 -129.04 139.07 52.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.044 -0.354 . . . . 71.33 110.044 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.7 112.79 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.064 -0.717 . . . . 71.43 109.064 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.96 149.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.413 0.625 . . . . 74.22 111.592 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 14.8 tp10 -110.81 98.0 36.02 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.819 -1.082 . . . . 74.42 110.334 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.18 127.71 9.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.672 1.581 . . . . 73.12 111.111 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 28.0 mttt -133.98 177.74 7.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.885 -1.154 . . . . 73.41 107.885 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HB3' ' CB ' ' A' ' 160' ' ' ASP . 4.3 tpp180 -86.01 135.74 33.53 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.345 -0.542 . . . . 74.33 110.3 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.7 94.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.437 0.637 . . . . 73.32 110.648 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.14 157.91 6.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 52.13 111.088 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -55.3 151.72 9.38 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.71 -0.677 . . . . 63.13 111.394 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -37.45 75.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.025 -0.534 . . . . 64.33 111.54 -173.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.56 -47.97 82.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.149 -0.478 . . . . 73.51 111.236 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 -43.09 79.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 62.24 110.486 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 p -75.94 7.4 4.04 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.754 0.65 . . . . 61.35 112.754 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HA ' HE21 ' A' ' 96' ' ' GLN . 0.0 OUTLIER -84.76 -21.44 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 74.34 110.432 173.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -91.72 144.59 29.67 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 74.0 110.683 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.37 117.47 4.98 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.604 2.203 . . . . 74.44 111.791 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 109.92 4.15 29.74 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.838 -0.696 . . . . 64.14 112.304 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.59 -42.74 24.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.912 0.387 . . . . 74.43 111.291 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -93.87 1.27 56.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.8 0.333 . . . . 71.55 110.777 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 99' ' ' GLY . 48.4 mt -78.66 159.18 28.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.178 -0.675 . . . . 74.35 109.178 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -75.79 97.9 4.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.382 0.61 . . . . 54.11 110.99 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.82 119.54 58.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.214 -0.903 . . . . 73.22 108.883 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 75.8 mttt -105.34 21.45 17.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.131 0.491 . . . . 71.34 110.394 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.01 139.62 50.92 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.22 -0.446 . . . . 51.22 110.759 178.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.42 ' CG2' HG13 ' A' ' 159' ' ' VAL . 8.9 pt -128.96 149.03 33.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.193 0.52 . . . . 53.13 111.296 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.5 t80 -94.56 133.89 37.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.996 -1.002 . . . . 71.31 109.76 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -123.09 109.44 23.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.997 -0.742 . . . . 62.3 108.997 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.49 171.64 26.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.514 -1.327 . . . . 63.13 113.569 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.47 30.2 30.88 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.198 -0.761 . . . . 63.33 111.198 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.414 HG22 ' SG ' ' A' ' 175' ' ' CYS . 23.2 pt -75.18 129.45 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 120.975 0.417 . . . . 71.53 110.311 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.63 -54.93 5.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.106 -0.701 . . . . 72.14 109.106 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.19 149.46 24.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 73.34 108.776 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.27 149.13 48.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.276 0.56 . . . . 70.15 111.517 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -120.77 156.19 32.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 74.22 111.068 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.02 167.32 10.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.357 -0.838 . . . . 73.5 110.517 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -61.2 -54.07 48.99 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.988 -0.551 . . . . 72.23 111.01 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -65.19 -17.22 64.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 75.22 111.773 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -70.18 -57.63 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.015 -0.365 . . . . 74.34 110.015 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.28 -28.89 38.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.355 -0.538 . . . . 75.32 110.566 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HD2' ' C ' ' A' ' 122' ' ' ARG . 7.3 tmm_? -61.8 -50.01 74.03 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.784 -0.45 . . . . 75.33 109.784 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.04 -29.31 70.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 75.44 111.002 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.35 -53.24 6.8 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.994 -0.548 . . . . 62.4 112.021 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 37.3 m-85 -66.72 -23.97 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.603 0.223 . . . . 70.04 111.603 -178.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.45 -27.09 68.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.073 0.463 . . . . 72.53 111.023 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.77 -27.76 68.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 70.51 111.575 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -86.4 -24.6 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 71.44 111.398 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.55 -179.83 43.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.606 -0.807 . . . . 72.14 112.928 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -73.35 133.65 43.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.357 . . . . 64.5 110.661 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' THR . 63.9 mt -104.5 137.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.003 -0.544 . . . . 72.23 109.863 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.25 -46.97 8.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.287 . . . . 73.53 110.846 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.55 157.46 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.083 -0.339 . . . . 70.24 110.083 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.86 130.58 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.777 -0.453 . . . . 72.15 109.777 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 31.8 mt-10 -103.19 103.45 13.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.788 -0.642 . . . . 72.11 110.746 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.12 116.54 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.502 -0.555 . . . . 73.3 109.502 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.441 ' HG3' ' CE2' ' A' ' 148' ' ' PHE . 69.3 mmm -84.4 100.99 11.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.554 0.692 . . . . 73.42 109.559 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 115.007 -0.997 . . . . 51.03 110.164 -174.821 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 N-CA-C 113.941 0.337 . . . . 75.14 113.941 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 137' ' ' MET . 13.3 p90 -154.7 163.46 40.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 73.14 110.493 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.18 171.91 13.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.208 -0.905 . . . . 63.52 109.893 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.4 m-85 -139.09 155.06 48.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.46 -0.791 . . . . 74.22 109.284 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.28 134.52 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-O 121.418 0.628 . . . . 75.22 111.334 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 53.0 m -100.26 125.63 46.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.91 -1.041 . . . . 72.23 110.672 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.5 m-85 -99.88 160.7 14.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.938 0.399 . . . . 73.35 111.253 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.43 -27.76 37.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 74.13 110.344 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.94 160.98 31.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.197 -0.456 . . . . 75.13 111.665 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -84.93 -32.08 23.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 73.34 110.756 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.611 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 35.7 t70 -62.18 -37.99 87.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.955 -0.566 . . . . 71.2 111.13 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -67.02 -33.69 76.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.526 -0.307 . . . . 53.43 111.058 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' A' ' 107' ' ' ILE . 2.6 t -68.05 -42.62 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 72.21 109.868 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.589 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 73.3 m-20 -64.14 -37.87 89.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.106 -0.952 . . . . 72.3 111.509 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 47.9 mttm -53.8 -42.67 68.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.81 0.814 . . . . 70.25 110.538 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.75 -43.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.281 -1.327 . . . . 64.01 112.395 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 160' ' ' ASP . 18.9 m -75.24 -7.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 121.972 -0.455 . . . . 75.12 111.059 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 160' ' ' ASP . 37.8 mt -57.85 -32.28 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.377 -0.829 . . . . 62.34 109.927 170.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -107.58 152.49 24.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.936 -0.575 . . . . 72.15 109.46 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.21 -39.07 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.976 0.417 . . . . 75.11 110.388 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.02 137.91 54.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 65.41 110.033 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -122.71 140.77 52.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.318 -0.401 . . . . 72.32 110.902 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -96.06 116.28 28.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.814 -0.63 . . . . 61.44 110.218 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.72 107.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.581 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 72.95 28.19 2.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.231 -0.895 . . . . 60.34 110.007 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.84 -2.63 80.14 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.386 -0.824 . . . . 71.31 112.678 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -110.56 130.17 55.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.775 -0.25 . . . . 72.11 110.54 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.09 0.471 . . . . 61.54 110.988 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 112' ' ' ILE . 7.4 m -110.42 150.99 28.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.847 -0.615 . . . . 63.04 110.297 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -86.9 133.83 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.879 -0.415 . . . . 75.0 109.879 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.8 t -133.13 138.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 44.3 111.572 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -158.64 177.32 11.33 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.863 -0.608 . . . . 74.22 111.463 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -62.5 124.74 21.75 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.97 0.508 . . . . 73.31 110.86 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -111.99 113.61 26.0 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.217 0.532 . . . . 45.12 109.903 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.551 -0.749 . . . . 50.25 109.588 -178.029 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.805 0.812 . . . . 73.32 108.845 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -71.2 141.57 86.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.018 -1.446 . . . . 74.2 109.877 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.98 166.97 19.02 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.71 2.273 . . . . 61.42 112.462 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.64 -32.29 67.12 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.956 -0.565 . . . . 64.3 111.97 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.0 pt20 -64.05 -31.91 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.794 0.33 . . . . 74.11 111.551 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 164' ' ' ILE . 5.2 mp -78.53 -20.23 51.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 60.14 111.282 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.545 ' HA ' HG21 ' A' ' 68' ' ' VAL . 23.5 ptt180 -117.18 0.1 12.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.363 -0.381 . . . . 65.31 111.587 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.6 ttmt -98.15 148.53 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.781 0.801 . . . . 73.22 112.16 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 68' ' ' VAL . 66.0 mt -117.01 145.2 43.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.331 -1.304 . . . . 70.31 110.338 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -97.93 120.27 38.03 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.112 -1.07 . . . . 65.21 108.112 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 60' ' ' VAL . 16.7 mm -100.52 110.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.79 -0.448 . . . . 73.23 109.79 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.85 151.61 16.89 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.948 -0.861 . . . . 73.32 110.948 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 43.3 12.89 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.252 -0.975 . . . . 45.12 112.974 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 25' ' ' THR . 93.3 mt -84.1 175.44 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.039 0.447 . . . . 72.11 110.499 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -90.96 172.79 8.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.382 -0.599 . . . . 52.31 109.382 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -77.35 -11.49 59.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.365 0.602 . . . . 75.3 110.28 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 24.0 mt-10 -106.9 -1.41 22.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 73.21 111.484 -175.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 HD22 ' A' ' 21' ' ' LEU . 47.3 m -69.75 126.41 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.119 0.485 . . . . 72.12 112.026 -170.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -101.92 167.5 10.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.407 -0.815 . . . . 73.41 110.0 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -28.1 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.978 -0.378 . . . . 74.24 109.978 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.9 -41.9 82.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.45 110.853 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t -72.64 -41.97 64.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 74.02 110.049 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.6 tp -59.85 -49.03 79.28 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.875 -0.602 . . . . 64.32 110.682 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HG3' HD12 ' A' ' 40' ' ' LEU . 14.2 ttm-85 -58.92 -56.54 20.9 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.438 0.695 . . . . 62.23 111.044 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 m -44.38 -38.77 4.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 44.53 113.381 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -67.26 -52.2 43.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.981 -0.554 . . . . 74.23 111.226 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -80.65 -20.27 43.44 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.925 0.343 . . . . 73.42 111.925 -170.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 31' ' ' ARG . 44.1 mt-10 -56.5 -24.27 45.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.355 0.502 . . . . 72.44 112.355 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -63.3 -27.08 69.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.468 0.544 . . . . 63.52 112.468 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -100.06 -21.95 15.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.645 0.259 . . . . 75.52 111.557 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 156.84 27.25 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.759 -0.734 . . . . 74.12 111.401 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 83.2 m -67.65 120.24 13.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.911 0.386 . . . . 70.35 111.143 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 31' ' ' ARG . 49.0 mt -84.34 145.4 28.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.328 0.585 . . . . 74.3 110.834 177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -108.79 -22.94 11.99 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.278 -0.874 . . . . 61.42 110.17 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -154.52 157.47 38.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.502 . . . . 63.11 110.62 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.7 t -163.6 136.56 5.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.413 -0.588 . . . . 62.15 109.413 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -151.01 126.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.533 . . . . 64.22 110.298 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.77 132.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.7 -0.852 . . . . 73.32 108.7 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 mmt -76.05 97.16 3.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.732 0.777 . . . . 73.32 110.423 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 35.7 mtt180 -101.88 163.59 12.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.37 -1.286 . . . . 75.43 111.492 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.19 124.19 89.79 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 114.491 -1.231 . . . . 72.04 110.25 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.95 -20.23 70.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.084 1.856 . . . . 75.21 112.909 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -83.79 -56.51 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.12 0.415 . . . . 74.13 112.12 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -6.89 16.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 71.01 111.677 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm 64.43 40.18 6.49 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.384 -0.826 . . . . 74.44 111.953 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 27.0 mmm180 -114.42 163.03 15.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.418 -0.586 . . . . 74.21 109.418 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.6 t -72.42 133.97 45.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.148 0.499 . . . . 72.34 111.845 -173.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -81.88 -0.16 42.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.533 -0.758 . . . . 74.24 110.451 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.04 58.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.731 -0.747 . . . . 73.24 114.128 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -156.35 156.55 34.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.815 0.807 . . . . 61.45 110.58 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.51 -166.33 18.24 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 111.564 -0.615 . . . . 34.33 111.564 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.22 148.9 38.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.224 0.512 . . . . 75.53 110.35 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 m -128.43 130.14 69.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.637 -0.711 . . . . 73.02 109.318 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.4 m -106.72 120.15 41.22 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.304 -0.247 . . . . 74.44 110.354 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -83.93 169.17 15.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.48 . . . . 73.52 110.515 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.5 -55.65 12.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.738 -0.665 . . . . 65.23 109.577 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 66' ' ' GLU . 36.3 m -123.24 153.14 40.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 72.2 111.426 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.578 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.7 p -58.04 -38.28 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.777 -0.647 . . . . 70.53 111.248 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 64' ' ' THR . 6.3 mm-40 -52.63 -41.8 64.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.066 0.765 . . . . 73.34 113.066 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -62.54 -31.34 72.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.363 0.602 . . . . 72.02 110.388 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG13 HD21 ' A' ' 16' ' ' LEU . 32.9 t -68.83 -47.26 77.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.108 -0.951 . . . . 62.42 111.01 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.76 -48.3 75.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 70.5 110.887 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.4 60.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.625 0.602 . . . . 75.52 112.625 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.94 -33.59 63.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.981 0.42 . . . . 53.22 110.659 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -47.1 71.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 75.21 110.801 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.99 66.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 53.3 110.682 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.21 -8.04 46.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.943 0.72 . . . . 61.35 112.943 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' NH1' ' HG2' ' A' ' 85' ' ' GLU . 11.9 mtp180 -56.66 147.72 49.96 Favored Pre-proline 0 CA--C 1.531 0.225 0 O-C-N 122.897 0.123 . . . . 71.55 111.013 173.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.65 166.08 78.44 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.8 -1.333 . . . . 74.34 113.968 4.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -125.9 150.99 47.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.764 -0.653 . . . . 70.54 110.964 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -141.46 113.01 7.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.909 -0.587 . . . . 74.14 111.039 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.07 144.41 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.89 -0.596 . . . . 73.21 109.736 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.9 t70 67.39 22.03 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.592 0.71 . . . . 72.22 110.567 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.12 74.19 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.385 -0.825 . . . . 64.03 111.934 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -130.22 141.01 50.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.58 0.229 . . . . 74.43 110.529 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.56 113.19 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.874 -0.787 . . . . 73.32 108.874 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.31 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 75.21 111.602 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 mt-10 -115.33 98.03 49.68 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.213 -0.903 . . . . 75.41 111.403 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -75.28 133.04 15.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.967 1.778 . . . . 51.5 110.725 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -139.39 -178.84 5.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.201 -1.407 . . . . 61.15 107.201 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -86.96 143.29 27.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 119.748 1.158 . . . . 65.21 111.533 -177.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.81 3.5 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.843 -0.799 . . . . 50.04 108.843 165.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.79 160.01 5.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.339 -0.846 . . . . 75.21 110.117 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.7 p -53.21 150.66 5.84 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.407 0.442 . . . . 73.1 110.888 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 9.9 mpt_? -60.2 -23.73 64.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.916 -0.584 . . . . 65.23 112.26 -171.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.27 -45.83 91.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.966 0.413 . . . . 74.53 110.344 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.53 -50.61 7.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 63.54 111.216 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.9 p -70.91 -9.66 58.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.51 0.93 . . . . 45.43 113.51 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.549 HE21 ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -89.89 -2.29 58.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.942 0.401 . . . . 72.01 110.866 179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -116.99 148.23 41.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.276 -0.42 . . . . 74.15 110.084 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.09 138.38 77.77 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.833 2.356 . . . . 72.25 112.592 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.09 -15.37 51.34 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.838 -0.696 . . . . 75.01 112.396 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.79 -44.32 56.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 65.1 111.671 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -96.42 13.5 27.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.793 0.33 . . . . 63.01 111.365 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.9 mt -82.12 162.72 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.193 -0.669 . . . . 73.23 109.193 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -79.23 85.75 5.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.607 0.718 . . . . 72.23 110.032 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.14 114.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.882 -1.053 . . . . 54.44 110.11 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -109.27 15.57 23.06 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.657 -0.417 . . . . 54.01 110.683 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -115.62 139.38 50.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.318 -0.401 . . . . 65.22 110.537 176.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.446 ' CG2' HG13 ' A' ' 159' ' ' VAL . 6.3 pt -131.52 152.96 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.501 0.667 . . . . 73.43 111.62 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.1 t80 -96.88 136.07 37.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.537 -1.21 . . . . 71.21 109.834 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -122.97 110.65 27.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.103 -0.703 . . . . 74.22 109.103 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.63 155.11 19.93 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.684 -1.246 . . . . 52.51 113.237 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.37 7.4 55.97 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.539 -0.838 . . . . 74.11 112.456 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.7 pt -72.44 105.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.515 0.674 . . . . 51.52 109.758 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -88.2 -10.08 50.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 63.42 111.798 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -121.71 165.42 15.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.716 -0.475 . . . . 72.43 109.716 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -70.17 104.55 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.404 1.097 . . . . 73.1 111.399 -175.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -96.96 142.72 28.58 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.158 -1.383 . . . . 75.13 109.55 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 14.4 pt-20 -113.58 169.5 8.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.672 -0.695 . . . . 61.44 110.949 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -53.59 -51.29 63.48 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 114.828 -1.078 . . . . 71.21 110.405 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.55 -25.05 62.09 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.653 0.612 . . . . 72.52 112.653 -175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.44 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 63.7 m170 -70.94 -60.4 2.25 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.067 0.46 . . . . 63.21 110.771 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -81.47 -26.47 35.23 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 120.177 -0.609 . . . . 73.23 111.229 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -68.0 -43.46 78.82 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 110.257 -0.275 . . . . 71.42 110.257 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.67 -31.25 72.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.082 0.467 . . . . 73.24 110.422 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 170' ' ' VAL . 80.5 t80 -79.27 -54.5 5.9 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.09 -0.505 . . . . 71.44 111.859 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.88 -24.54 63.43 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.621 0.6 . . . . 71.32 112.621 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.1 mt-10 -71.49 -16.59 62.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.844 0.354 . . . . 75.33 111.152 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.34 -25.79 68.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 75.1 111.074 172.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.79 -25.56 23.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.504 -0.316 . . . . 71.42 111.266 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 126' ' ' GLU . . . 168.51 -175.35 43.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.951 -0.642 . . . . 64.21 112.641 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.64 131.77 42.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.051 0.453 . . . . 73.32 111.905 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 152' ' ' THR . 76.4 mt -100.03 140.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.676 -0.693 . . . . 71.2 109.865 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.13 -51.13 6.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 64.42 110.269 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.16 156.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.76 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 122' ' ' ARG . 3.3 mp -115.63 128.93 72.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.745 -0.465 . . . . 75.14 109.745 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.5 mt-10 -102.13 104.44 15.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.95 -0.568 . . . . 74.13 110.729 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.7 mm -93.31 131.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.341 -0.615 . . . . 75.43 109.341 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 48.8 mmm -105.14 132.7 51.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.517 -0.549 . . . . 74.2 109.517 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 60.04 111.597 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.845 0 N-CA-C 111.328 -0.709 . . . . 45.32 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.98 155.23 3.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.165 -0.68 . . . . 74.42 109.165 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.04 172.67 12.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.973 -0.558 . . . . 75.5 109.635 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.1 m-85 -138.61 152.13 47.86 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.744 -0.662 . . . . 64.24 109.466 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.68 132.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.365 0.602 . . . . 33.43 111.069 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 131' ' ' ILE . 82.9 m -102.75 125.08 49.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.979 -1.01 . . . . 53.0 110.918 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -102.6 157.87 16.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 74.13 111.578 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.47 -31.18 57.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.676 -0.693 . . . . 61.42 110.402 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.36 157.94 42.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.587 -0.733 . . . . 63.13 110.399 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -82.5 -22.89 34.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.076 -0.511 . . . . 73.11 109.859 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -53.08 -45.81 68.35 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.853 0.721 . . . . 71.44 111.25 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 162' ' ' ILE . 1.4 m -65.34 -35.29 80.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.783 -0.644 . . . . 74.52 110.836 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 107' ' ' ILE . 3.2 t -71.5 -38.61 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.795 -0.446 . . . . 71.22 109.795 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 163' ' ' VAL . 7.0 m-20 -65.92 -33.8 76.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.14 111.432 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 93.0 mttt -63.47 -38.4 91.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.417 0.627 . . . . 71.33 110.378 174.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 158' ' ' SER . 14.0 mt -78.1 -40.84 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.891 -1.05 . . . . 70.11 112.002 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 160' ' ' ASP . 35.1 m -79.14 -4.3 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.193 0.521 . . . . 72.4 111.177 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 13' ' ' LEU . 11.5 mt -62.86 -31.95 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.289 -0.869 . . . . 63.24 109.732 169.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 51.5 mt-30 -108.39 153.1 23.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.886 -0.783 . . . . 73.1 108.886 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -91.49 -38.49 12.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.831 0.348 . . . . 71.34 111.244 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.56 137.12 53.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.369 -0.378 . . . . 74.13 110.242 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.575 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 39.2 m-70 -125.38 146.05 49.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.145 -0.479 . . . . 71.44 110.172 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.6 m -91.75 110.71 22.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.049 -0.523 . . . . 75.01 111.34 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.457 HG22 ' CD2' ' A' ' 124' ' ' TYR . 41.2 t -117.13 131.09 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.07 -0.715 . . . . 70.12 109.07 174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 46.99 42.59 12.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.45 0.7 . . . . 73.05 111.924 -174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.31 7.08 59.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.788 -0.642 . . . . 62.12 113.97 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -110.24 137.29 48.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.024 0.412 . . . . 75.33 110.16 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -89.39 108.95 19.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 64.04 110.308 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -112.24 154.81 25.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.833 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.8 139.31 30.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.506 . . . . 63.33 109.988 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.8 m -130.11 155.3 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.997 0.427 . . . . 62.45 110.632 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -172.37 169.76 5.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.065 -0.97 . . . . 72.11 111.497 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -58.68 127.84 34.21 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 73.3 110.663 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.23 119.38 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.11 0.481 . . . . 70.31 109.884 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 115.695 -0.684 . . . . 64.21 109.37 -179.59 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 107.893 -1.151 . . . . 71.44 107.893 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp0 -93.59 141.66 24.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.407 -1.27 . . . . 72.31 111.029 -172.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 30.8 Cg_endo -67.44 167.77 19.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.904 2.403 . . . . 64.33 110.778 174.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -57.36 -37.41 72.57 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 111.698 0.259 . . . . 75.11 111.698 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -67.22 -27.86 67.59 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.891 0.33 . . . . 75.1 111.891 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.2 mp -82.42 -9.79 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.385 . . . . 75.12 111.087 -177.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.449 ' HA ' HG21 ' A' ' 68' ' ' VAL . 14.2 ptt180 -123.13 -0.66 8.86 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.463 -0.335 . . . . 74.44 111.129 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 34.5 ttpt -91.66 145.92 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 71.14 111.571 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.654 HD11 HG13 ' A' ' 68' ' ' VAL . 3.9 mp -123.52 145.68 48.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.196 -0.911 . . . . 63.34 110.136 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -96.96 117.68 31.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.436 -0.579 . . . . 75.24 109.436 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 60' ' ' VAL . 20.3 mm -94.34 113.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.956 -0.387 . . . . 71.13 109.956 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.35 150.41 16.84 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.738 -0.744 . . . . 24.53 111.79 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.7 45.22 29.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.89 -0.672 . . . . 62.22 113.381 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 25' ' ' THR . 79.4 mt -81.85 176.72 9.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.167 0.483 . . . . 73.43 110.819 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -86.24 178.64 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 62.42 109.542 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -84.19 -6.34 59.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.051 0.453 . . . . 72.42 110.534 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.27 20.05 15.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 64.14 111.061 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.458 HG21 HD22 ' A' ' 21' ' ' LEU . 9.6 m -81.53 129.4 34.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 75.12 110.405 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -117.96 160.19 21.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.734 -0.666 . . . . 75.31 109.377 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.93 -42.94 76.89 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.561 0.538 . . . . 75.2 111.108 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.67 -30.52 71.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 72.22 111.581 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 m -86.28 -42.07 14.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.62 -0.264 . . . . 72.24 111.077 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.24 -50.07 67.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.257 -0.429 . . . . 73.22 110.528 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -56.42 -58.2 9.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.692 -0.686 . . . . 74.31 111.598 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -48.8 -34.22 11.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.561 0.538 . . . . 71.25 112.357 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -74.06 -49.6 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.431 -0.349 . . . . 73.2 110.99 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -78.18 -18.82 55.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.193 -0.317 . . . . 71.33 111.758 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 23.7 mt-10 -56.6 -22.68 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.111 -0.495 . . . . 73.02 112.222 172.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.65 -22.15 66.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 74.55 111.951 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -102.97 -24.04 13.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.665 0.269 . . . . 74.51 111.244 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -173.45 161.59 32.39 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.356 -0.926 . . . . 75.13 112.475 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -57.59 141.7 47.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.874 0.469 . . . . 71.21 111.552 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 62' ' ' TYR . 63.3 mt -120.23 124.72 46.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.31 -0.626 . . . . 71.5 109.31 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -97.94 -20.45 17.44 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.045 -0.525 . . . . 72.01 110.621 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -149.94 152.77 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.633 -0.506 . . . . 75.54 109.633 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -165.45 137.08 4.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.084 -0.71 . . . . 55.21 109.084 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.34 132.68 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.053 0.454 . . . . 72.4 110.727 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.11 131.28 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.269 -0.641 . . . . 61.41 109.269 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 mmt -73.65 133.2 43.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.952 -0.759 . . . . 65.41 108.952 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -139.95 158.17 44.5 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.892 -0.595 . . . . 75.33 110.928 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 22.2 t70 -67.22 129.49 93.81 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.778 -1.101 . . . . 64.4 109.646 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.59 -22.34 33.02 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.186 1.924 . . . . 70.02 113.364 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -55.19 4.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 74.23 111.585 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 m -103.43 -8.87 19.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.504 . . . . 74.22 111.734 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.9 mmtm 63.28 35.31 12.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.331 0.652 . . . . 74.24 111.758 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -101.48 158.75 15.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.031 -1.099 . . . . 74.24 108.031 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -70.31 140.43 52.27 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.092 0.472 . . . . 65.32 110.58 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -84.67 5.87 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.681 -0.69 . . . . 45.22 110.485 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.39 16.52 71.14 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.628 -0.796 . . . . 22.44 113.605 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -160.3 157.78 28.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.014 0.907 . . . . 65.43 110.954 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.08 -163.81 15.7 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.446 -0.661 . . . . 73.25 111.446 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.99 148.71 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.187 0.493 . . . . 61.22 110.611 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.457 HG22 HD11 ' A' ' 18' ' ' ILE . 6.4 m -130.65 126.32 60.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.907 -0.588 . . . . 72.12 109.739 172.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 m -101.28 118.01 36.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.444 -0.344 . . . . 62.43 110.166 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' HA ' HD23 ' A' ' 40' ' ' LEU . 19.4 m-85 -84.6 165.15 18.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.856 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.41 63.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.37 -0.377 . . . . 74.24 110.675 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.9 m -132.94 154.01 50.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.309 -0.405 . . . . 74.11 110.253 -177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.8 p -64.88 -33.54 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.736 -0.211 . . . . 63.22 111.548 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.61 -34.08 72.3 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.38 0.511 . . . . 74.12 112.38 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 5.5 mm-40 -64.94 -33.79 76.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.303 0.573 . . . . 70.12 109.791 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.654 HG13 HD11 ' A' ' 16' ' ' LEU . 2.4 t -62.61 -46.97 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 71.11 111.125 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.3 -45.51 92.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 72.35 111.075 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.15 -38.4 73.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.332 0.493 . . . . 75.34 112.332 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.3 83.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 74.51 110.451 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -69.27 -35.18 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.698 . . . . 63.2 110.974 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.655 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.9 p30 -84.84 -7.06 59.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.384 . . . . 51.23 111.515 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.27 -11.08 20.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.461 . . . . 62.42 110.606 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 10.2 ttp180 -53.2 143.63 32.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.009 -0.996 . . . . 71.23 110.855 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 4.8 Cg_exo -79.71 169.86 69.13 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.954 -0.853 . . . . 65.13 114.054 2.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.22 161.16 29.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 61.14 109.773 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 22.5 ttmt -134.3 104.66 6.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.909 0.385 . . . . 72.55 111.38 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.63 126.37 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 62.13 110.137 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.22 40.38 8.84 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.54 0.686 . . . . 73.12 110.756 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.56 27.78 73.37 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.885 -0.598 . . . . 63.2 112.785 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.0 tpt180 -132.44 140.22 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 64.55 110.002 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 t -78.28 110.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.278 -0.638 . . . . 75.52 109.278 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.0 m -104.96 150.04 8.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.408 0.623 . . . . 64.21 110.575 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.43 ' HG2' HH11 ' A' ' 75' ' ' ARG . 7.3 tt0 -117.74 96.11 48.96 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.292 -0.867 . . . . 72.45 110.853 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.14 130.83 20.82 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.456 1.437 . . . . 63.33 110.433 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 25.4 mttt -128.35 -179.56 5.09 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.295 -0.866 . . . . 75.52 108.837 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' OD2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -77.95 155.08 31.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.795 -0.446 . . . . 72.11 109.795 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.89 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 74.21 110.351 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.555 ' HB ' ' OD1' ' A' ' 160' ' ' ASP . 8.1 p -72.78 157.92 6.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.243 -0.89 . . . . 64.53 110.655 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.72 142.8 27.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.356 -0.609 . . . . 55.01 109.356 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -62.34 -17.41 58.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.803 0.335 . . . . 74.4 111.246 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.85 -48.33 74.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 74.21 110.616 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.634 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 25.3 t70 -84.16 -13.78 51.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.88 -0.6 . . . . 34.11 110.455 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -73.74 8.63 1.82 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.975 0.416 . . . . 65.34 110.956 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -88.38 -18.23 28.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 75.53 111.262 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 19.6 mmt180 -61.38 148.94 84.78 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 110.127 -0.323 . . . . 74.12 110.127 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -65.61 112.95 2.32 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.49 1.46 . . . . 54.23 110.343 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.7 48.98 46.27 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.695 -0.764 . . . . 74.34 111.465 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.01 -31.31 70.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 70.04 111.186 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -98.73 21.39 11.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 64.13 111.332 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.0 mt -76.88 177.58 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.988 -0.745 . . . . 74.25 108.988 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -81.92 78.31 8.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.471 0.653 . . . . 71.2 110.384 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.61 109.01 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.105 -0.952 . . . . 75.1 110.377 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.433 ' C ' HG21 ' A' ' 159' ' ' VAL . 53.5 mttt -107.36 20.99 18.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.998 0.428 . . . . 73.33 110.264 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.62 53.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.398 -0.364 . . . . 75.33 110.713 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.552 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.91 152.47 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.217 0.532 . . . . 61.41 111.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 6.3 t80 -99.34 131.84 45.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.92 -1.036 . . . . 73.24 109.452 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.45 110.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.352 -0.61 . . . . 70.42 109.352 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.43 16.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.75 -1.214 . . . . 60.33 113.825 -173.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.5 43.35 2.96 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.187 -0.53 . . . . 74.44 112.556 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 173' ' ' HIS . 22.1 pt -120.92 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.467 0.651 . . . . 74.54 110.857 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -54.24 3.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.437 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.93 170.54 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.436 0.46 . . . . 54.33 110.434 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.77 84.85 0.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.578 0.584 . . . . 72.31 112.578 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -83.87 131.63 34.86 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.938 -0.574 . . . . 61.3 109.475 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.53 165.44 11.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.377 -0.829 . . . . 74.01 110.546 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.26 -45.68 72.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.286 -0.87 . . . . 73.24 109.858 175.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -55.91 -38.65 70.53 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.766 0.666 . . . . 75.23 111.541 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.16 -59.09 5.97 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.299 -0.409 . . . . 74.31 111.579 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.05 -29.17 32.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.855 -0.738 . . . . 71.11 111.206 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 5.7 tmm_? -63.51 -53.34 53.5 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.468 0.175 . . . . 74.21 110.698 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.12 -26.25 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.152 0.501 . . . . 75.12 110.729 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -78.19 -56.66 4.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.8 -0.636 . . . . 71.54 111.82 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.7 m-85 -66.85 -24.07 66.1 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.983 0.364 . . . . 73.21 111.983 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.9 mt-10 -70.33 -20.66 62.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.71 0.291 . . . . 75.3 111.501 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -56.05 -30.34 61.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.1 111.35 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.14 -29.17 23.49 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.416 -0.357 . . . . 64.32 111.779 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.89 -174.17 46.72 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.808 -0.711 . . . . 52.44 113.213 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -79.23 137.54 37.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.353 . . . . 72.12 111.248 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 152' ' ' THR . 73.6 mt -108.87 140.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 74.52 110.175 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.23 -48.33 7.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.495 -0.321 . . . . 75.04 110.922 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -157.3 156.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 74.15 110.236 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.1 129.26 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.058 0.456 . . . . 42.4 110.021 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.4 mt-10 -104.57 104.41 14.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.503 -0.771 . . . . 75.12 110.945 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.23 120.04 43.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.184 -1.043 . . . . 61.53 108.184 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.9 mmm -86.32 107.44 17.98 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.707 -0.397 . . . . 35.15 110.441 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.758 -0.655 . . . . 61.3 110.946 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.185 -0.23 . . . . 60.45 113.62 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -158.83 167.65 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.075 0.437 . . . . 73.5 109.97 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.85 171.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.561 -0.745 . . . . 75.52 109.755 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.2 m-85 -136.18 151.08 49.35 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.487 -0.779 . . . . 70.44 109.09 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 130.51 25.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.513 0.673 . . . . 73.24 111.012 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.0 m -99.41 122.09 42.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.839 -1.073 . . . . 73.4 110.701 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.8 m-85 -98.03 160.16 14.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.912 0.387 . . . . 71.21 111.321 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.95 -29.94 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.64 . . . . 55.14 110.185 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.28 151.8 50.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 71.41 111.092 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -78.94 -29.89 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 63.4 111.156 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -59.38 -44.26 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.923 -0.58 . . . . 75.54 110.988 -175.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -33.16 75.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.807 -0.633 . . . . 63.53 111.515 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.552 HG13 HG23 ' A' ' 107' ' ' ILE . 1.1 t -71.55 -39.37 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.961 0.41 . . . . 64.35 110.09 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.555 ' OD1' ' HB ' ' A' ' 90' ' ' VAL . 13.2 t70 -68.55 -34.59 76.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 73.21 110.709 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 84.8 mttt -56.11 -38.96 71.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.633 0.73 . . . . 72.31 110.777 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.5 mt -75.87 -42.29 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.419 -1.264 . . . . 65.14 112.235 -175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 160' ' ' ASP . 20.3 m -76.36 -10.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.351 0.596 . . . . 73.4 110.753 -173.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.9 mt -61.1 -27.94 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.073 -0.967 . . . . 63.11 110.126 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 45.9 mt-30 -112.7 103.75 11.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.712 -0.847 . . . . 74.31 108.712 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.2 -35.33 69.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.846 -0.615 . . . . 75.34 112.627 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.61 134.53 53.78 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.304 . . . . 64.12 110.609 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.2 m-70 -121.12 153.74 37.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 73.13 110.029 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -122.76 113.7 19.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.449 . . . . 64.3 110.469 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.67 119.87 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.705 -0.68 . . . . 74.34 110.37 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 71.67 29.49 2.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.045 0.926 . . . . 70.2 109.059 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.11 -6.53 79.0 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.102 -0.953 . . . . 73.03 112.534 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 112' ' ' ILE . 70.5 t60 -102.49 133.86 46.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.785 0.326 . . . . 73.55 110.604 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.55 141.31 30.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.038 0.447 . . . . 64.03 110.714 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.06 148.34 36.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 54.31 110.311 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -91.16 129.79 37.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.421 -0.585 . . . . 72.41 109.421 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.1 t -128.53 133.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.241 0.543 . . . . 65.4 110.554 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -155.56 172.99 17.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.399 -0.819 . . . . 63.41 110.466 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -58.86 133.19 55.79 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.278 0.361 . . . . 62.51 111.175 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -116.45 114.71 24.61 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.813 -0.81 . . . . 72.01 108.813 173.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 C--N 1.31 -1.111 0 CA-C-N 115.499 -0.773 . . . . 70.13 110.303 -174.278 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' HA2' ' OG1' ' A' ' 39' ' ' THR . . . . . . . . 0 N--CA 1.477 1.408 0 N-CA-C 111.596 -0.602 . . . . 63.24 111.596 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 64.65 87.24 0.12 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.58 0.752 . . . . 74.15 111.776 177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -153.77 127.69 8.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.405 -0.591 . . . . 71.01 109.405 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 t -71.02 88.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.814 -0.81 . . . . 72.54 108.814 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.97 151.75 35.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 64.24 111.253 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -142.03 100.86 5.86 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 107.577 -1.268 . . . . 73.44 107.577 171.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.32 134.99 65.11 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.9 2.4 . . . . 60.1 113.065 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -112.49 -10.58 13.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.106 -0.952 . . . . 64.41 109.094 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 26.6 mp0 -92.98 131.36 33.46 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 114.9 -1.045 . . . . 65.32 110.655 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.5 Cg_endo -60.26 167.37 7.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.093 2.529 . . . . 61.25 112.002 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.96 -39.06 71.22 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.427 -0.351 . . . . 61.12 111.505 -176.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -68.59 -22.79 64.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.836 0.351 . . . . 73.24 111.639 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.3 mp -91.81 -6.98 50.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.519 -0.31 . . . . 74.3 111.477 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.439 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.0 ptt180 -128.31 1.44 5.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.405 -0.518 . . . . 71.43 112.124 176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -97.41 145.19 26.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.601 0.715 . . . . 63.33 111.737 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 68' ' ' VAL . 50.0 mt -115.09 145.79 41.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.581 -1.191 . . . . 74.22 110.73 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -98.69 122.69 42.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.534 -0.913 . . . . 75.34 108.534 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 60' ' ' VAL . 16.1 mm -102.28 111.85 33.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 110.011 -0.366 . . . . 71.11 110.011 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.8 152.14 17.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.755 -0.736 . . . . 70.12 111.839 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.69 45.66 57.71 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 65.21 113.178 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 25' ' ' THR . 73.6 mt -78.33 174.97 10.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.684 -0.487 . . . . 70.11 109.684 173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.76 164.13 19.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.024 -0.732 . . . . 75.44 109.024 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -73.95 -8.26 55.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.32 0.581 . . . . 63.14 110.33 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.89 13.81 9.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.588 -0.733 . . . . 61.41 111.513 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 HD22 ' A' ' 21' ' ' LEU . 56.0 m -74.08 125.39 28.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.057 0.456 . . . . 61.12 110.626 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -99.35 161.87 13.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.816 -0.629 . . . . 73.4 110.506 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -71.54 -31.51 67.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.437 -0.347 . . . . 72.43 110.818 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.47 -39.25 93.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.848 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.0 t -72.54 -39.93 67.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.685 . . . . 51.13 110.362 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.89 -44.87 94.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.825 -0.625 . . . . 60.11 110.782 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.5 ttm-85 -59.26 -57.12 14.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.734 0.302 . . . . 75.43 110.383 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -50.16 -36.49 30.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.956 -1.02 . . . . 72.43 113.215 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.455 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.7 t-80 -72.67 -56.15 5.74 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.96 -0.296 . . . . 72.05 111.206 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -72.39 -20.44 61.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.205 0.446 . . . . 61.03 112.205 -175.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -64.41 -13.15 49.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 74.34 111.452 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -63.7 -28.86 70.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.832 -0.167 . . . . 72.42 111.32 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -99.06 -19.47 17.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.069 0.396 . . . . 72.53 112.069 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.88 168.97 40.71 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.812 -1.185 . . . . 53.1 113.0 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' HA2' ' A' ' 1' ' ' GLY . 59.3 m -66.86 118.42 10.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.249 0.547 . . . . 70.11 111.792 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -88.81 130.57 35.35 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.361 -0.836 . . . . 53.2 110.827 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.7 p -95.92 -24.6 16.33 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.158 -0.928 . . . . 74.54 110.021 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -152.21 152.3 32.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.586 -0.734 . . . . 61.55 110.127 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.8 t -161.82 130.95 4.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.655 -0.498 . . . . 63.41 109.655 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.6 129.34 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 121.318 0.58 . . . . 61.54 111.011 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.9 132.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.45 -0.944 . . . . 62.54 108.45 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.404 ' HA ' ' CE ' ' A' ' 46' ' ' MET . 3.1 mmt -74.08 100.0 3.49 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.417 0.627 . . . . 53.44 109.857 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -102.14 160.72 14.27 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.703 -1.135 . . . . 74.41 110.833 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 11.4 t0 -75.46 126.16 87.9 Favored Pre-proline 0 C--N 1.31 -1.109 0 CA-C-N 114.748 -1.115 . . . . 71.22 110.566 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.4 -11.56 28.59 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.987 1.791 . . . . 71.3 113.158 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -85.49 -56.51 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 74.45 111.779 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -108.72 -9.59 15.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 64.05 111.4 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 65.67 49.28 1.78 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.647 -0.706 . . . . 63.42 110.954 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -120.3 159.46 24.96 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 64.33 109.342 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.7 m -73.46 134.37 43.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 45.54 111.176 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -85.19 3.49 38.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.179 0.514 . . . . 72.21 110.804 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.02 22.33 63.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.749 -0.66 . . . . 52.43 114.074 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.84 155.88 30.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.58 0.69 . . . . 62.24 109.96 172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.44 -163.89 16.2 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.657 -0.577 . . . . 73.54 111.657 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.87 150.82 40.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.14 0.47 . . . . 73.54 110.399 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.449 HG22 HD11 ' A' ' 18' ' ' ILE . 7.8 m -131.86 131.05 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.636 -0.711 . . . . 71.43 109.489 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 m -107.3 122.98 47.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.231 -0.285 . . . . 74.22 110.231 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -89.37 165.54 14.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.922 0.391 . . . . 64.21 110.919 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.31 -49.14 58.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.601 -0.727 . . . . 73.2 110.587 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -126.37 155.8 41.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.976 -0.556 . . . . 75.43 110.903 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.544 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 8.1 p -62.21 -37.12 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.098 -0.501 . . . . 62.42 111.47 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -53.83 -44.11 69.98 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.679 0.622 . . . . 61.34 112.679 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.93 -29.87 70.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.957 0.408 . . . . 74.32 110.819 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 16' ' ' LEU . 41.4 t -63.94 -49.76 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.682 -0.69 . . . . 62.44 110.745 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.21 -42.0 85.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 63.23 111.809 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HA ' HD22 ' A' ' 73' ' ' ASN . . . -58.59 -31.85 68.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.84 0.682 . . . . 72.04 112.84 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.76 -34.06 40.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 43.33 110.351 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mmt -62.79 -49.33 75.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.712 -0.676 . . . . 75.35 110.476 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -70.49 -26.73 63.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 65.43 111.194 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.75 -5.61 35.33 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.956 0.724 . . . . 42.05 112.956 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -57.8 148.43 58.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 111.503 0.186 . . . . 75.3 111.503 174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.09 165.61 84.43 Favored 'Cis proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.789 -1.338 . . . . 53.42 113.454 2.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -123.68 158.01 32.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.85 -0.613 . . . . 64.1 111.079 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.1 ttmt -139.41 105.1 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.094 -0.503 . . . . 73.24 111.531 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' ND1' ' A' ' 33' ' ' HIS . 16.2 t -108.2 128.71 63.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.816 -0.629 . . . . 74.14 109.541 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 65.52 31.09 10.35 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.58 0.55 . . . . 61.42 111.631 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.08 21.16 80.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.938 -0.649 . . . . 51.55 111.873 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.0 tpt180 -124.12 136.01 53.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.204 -0.295 . . . . 71.1 110.204 -176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.53 108.08 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.203 -0.666 . . . . 75.31 109.203 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.81 148.4 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.168 0.509 . . . . 53.41 110.932 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 4.6 tp10 -111.47 95.01 24.76 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.277 -0.874 . . . . 62.22 110.886 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -75.52 130.58 12.88 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.897 1.732 . . . . 72.1 111.183 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 30.6 mttt -137.78 177.4 7.9 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.464 -0.789 . . . . 43.0 109.178 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' NH1' HG11 ' A' ' 68' ' ' VAL . 17.7 tpp180 -77.41 139.54 39.71 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 110.066 -0.346 . . . . 75.52 110.066 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.01 0.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.998 0.428 . . . . 61.45 110.194 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.5 t -58.93 136.21 22.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 114.909 -1.042 . . . . 74.23 111.568 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.8 147.06 43.97 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.725 -0.67 . . . . 42.54 109.732 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -63.52 -20.94 66.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.262 0.838 . . . . 73.02 113.262 -171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -67.58 -47.87 68.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.755 0.312 . . . . 65.23 110.68 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.25 -29.56 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.969 0.414 . . . . 60.22 110.171 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 t -72.0 -3.01 20.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.921 -0.581 . . . . 52.51 111.007 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -93.23 -3.15 54.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.327 0.584 . . . . 74.44 109.916 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -95.44 151.98 38.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.833 -0.622 . . . . 70.51 110.499 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.1 120.33 7.54 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.748 2.299 . . . . 75.12 112.346 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.07 40.89 8.93 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.822 -0.704 . . . . 71.45 112.389 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -86.01 -46.05 10.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 60.02 111.525 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -91.72 10.94 26.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.322 0.582 . . . . 71.32 110.608 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.01 161.82 19.6 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.895 -0.78 . . . . 51.42 108.895 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.3 m -77.05 92.91 3.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.46 0.648 . . . . 74.11 110.942 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -114.02 115.83 50.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.067 -0.97 . . . . 75.03 110.032 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.501 ' C ' HG21 ' A' ' 159' ' ' VAL . 76.7 mttt -108.88 18.54 20.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.974 0.416 . . . . 72.34 110.833 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -118.23 139.59 51.07 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.386 -0.37 . . . . 70.0 110.854 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.481 HG23 HG13 ' A' ' 159' ' ' VAL . 6.4 pt -127.28 153.38 36.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.213 0.53 . . . . 64.43 111.501 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -103.58 138.25 40.52 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.78 -1.1 . . . . 63.44 109.545 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.48 109.56 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -124.91 161.03 19.52 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.029 -1.081 . . . . 74.43 113.366 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 72.0 46.42 36.55 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.065 -0.588 . . . . 63.04 111.655 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.426 HG22 ' SG ' ' A' ' 175' ' ' CYS . 15.5 pt -90.55 -165.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.478 -0.361 . . . . 73.12 110.582 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -82.36 -167.48 1.6 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.652 0.263 . . . . 44.31 111.315 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.8 -22.31 66.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.186 -0.461 . . . . 75.34 111.168 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.9 144.05 14.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.541 -0.754 . . . . 71.55 109.142 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.9 m -140.05 138.7 35.59 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.882 -0.784 . . . . 64.51 108.882 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -96.65 158.59 15.36 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.105 -0.498 . . . . 74.22 110.778 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -47.05 76.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.188 -0.914 . . . . 54.33 108.933 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -53.63 -34.39 58.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.017 -0.992 . . . . 61.01 111.894 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -66.32 -59.45 3.7 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.928 0.394 . . . . 70.31 111.135 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 3.1 pp -82.78 -26.62 31.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.158 -0.617 . . . . 70.33 111.353 -172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 6.1 tmm_? -65.42 -48.63 72.14 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.96 -0.385 . . . . 61.15 109.96 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.56 -26.67 68.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.209 0.528 . . . . 74.15 110.579 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.431 ' HA ' HE21 ' A' ' 127' ' ' GLN . 82.7 t80 -78.92 -55.54 5.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.849 -0.614 . . . . 75.04 111.781 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD2' HG21 ' A' ' 151' ' ' VAL . 35.8 m-85 -69.45 -22.93 63.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.428 0.529 . . . . 63.43 112.428 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -68.61 -22.93 64.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.807 0.337 . . . . 72.22 111.477 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 124' ' ' TYR . 57.0 mt-30 -58.74 -28.35 65.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 74.44 110.816 172.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -88.99 -23.99 22.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.743 -0.662 . . . . 71.12 111.105 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 169.79 -178.12 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.407 -0.901 . . . . 73.43 113.696 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -73.4 131.28 41.66 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.92 0.488 . . . . 64.54 110.963 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 152' ' ' THR . 65.5 mt -103.12 138.35 27.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.465 . . . . 72.42 109.986 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.88 -48.0 9.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.694 0.283 . . . . 74.25 110.673 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.06 156.95 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.177 -0.465 . . . . 54.44 109.824 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.33 126.22 71.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.16 0.505 . . . . 52.2 109.927 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -99.77 105.23 17.0 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 74.33 110.544 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.7 mm -94.32 122.6 45.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.247 -0.649 . . . . 62.54 109.247 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 64.7 mmm -96.12 128.02 42.65 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.525 -0.546 . . . . 70.02 109.525 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 154.3 20.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.41 0.624 . . . . 73.12 111.44 -174.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -83.57 133.77 34.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.885 -1.052 . . . . 73.14 109.13 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -80.58 -24.23 39.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.763 0.315 . . . . 73.31 111.164 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.18 -53.82 2.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.64 -0.791 . . . . 73.32 112.782 -177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -89.29 -23.18 22.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.056 0.455 . . . . 75.2 111.181 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.39 19.35 78.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.618 -0.801 . . . . 63.34 112.296 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -92.82 159.72 15.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.421 -0.585 . . . . 52.24 109.421 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -86.49 81.62 8.23 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.65 -0.87 . . . . 65.25 108.65 175.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -150.55 -178.48 6.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.187 -0.915 . . . . 74.14 111.829 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.11 -46.04 3.36 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.11 -1.404 . . . . 45.3 112.805 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -174.96 154.92 1.93 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.4 171.98 13.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.915 -0.584 . . . . 75.13 109.79 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 42.3 m-85 -137.53 145.71 43.27 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.833 -0.621 . . . . 72.22 109.995 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 125' ' ' PHE . 60.4 t -129.86 130.14 66.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.752 0.31 . . . . 73.22 110.738 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 131' ' ' ILE . 90.4 m -104.76 119.64 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 71.32 110.601 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -102.87 159.06 15.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.952 0.405 . . . . 71.21 111.417 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -77.85 -29.21 50.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.562 -0.744 . . . . 65.13 110.581 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -130.43 155.36 46.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.476 -0.784 . . . . 65.22 110.259 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.41 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.7 p80 -77.87 -26.44 49.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.089 -0.505 . . . . 72.43 110.513 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.3 OUTLIER -59.83 -41.93 92.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.474 -0.785 . . . . 64.54 111.493 -176.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.96 -34.92 79.21 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.586 -0.279 . . . . 74.51 110.915 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.501 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.3 t -69.61 -40.75 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 73.24 109.722 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.72 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.82 -31.6 68.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.186 -0.916 . . . . 62.2 111.441 -178.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 39.3 mttm -56.23 -37.81 70.23 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.779 0.8 . . . . 63.51 109.871 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.0 mt -79.48 -42.65 23.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.489 -1.232 . . . . 72.33 112.522 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 160' ' ' ASP . 21.4 m -74.98 -13.56 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.906 0.384 . . . . 74.11 111.171 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 13' ' ' LEU . 28.9 mt -56.44 -34.83 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.438 -0.801 . . . . 53.32 109.979 170.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -113.95 102.48 10.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.64 -0.874 . . . . 63.1 108.64 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -57.26 -31.77 65.9 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 112.899 0.703 . . . . 51.11 112.899 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.61 135.46 54.99 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.248 -0.581 . . . . 63.44 110.44 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -126.56 154.84 43.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.521 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.3 m -94.22 107.32 19.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.338 -0.392 . . . . 51.2 110.257 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 t -117.79 131.4 70.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.183 -0.673 . . . . 45.44 109.183 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 t30 45.4 47.16 10.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.287 0.635 . . . . 55.42 112.491 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 64.79 28.88 73.96 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.031 -0.531 . . . . 71.32 113.575 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -142.29 133.22 25.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.01 -0.367 . . . . 75.31 110.01 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -82.21 109.58 16.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.872 0.367 . . . . 72.33 110.251 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 112' ' ' ILE . 10.3 m -108.72 155.02 21.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.01 -0.541 . . . . 71.43 109.938 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.33 137.78 32.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.007 0.432 . . . . 72.03 110.472 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -129.59 160.38 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.626 -0.715 . . . . 73.24 110.343 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -174.09 175.92 2.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.214 -0.903 . . . . 75.24 111.507 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.43 ' HD3' HG11 ' A' ' 163' ' ' VAL . 19.1 mmtm -62.29 130.81 47.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.735 -0.666 . . . . 74.55 110.696 173.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -117.57 114.55 23.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.628 -0.878 . . . . 63.24 108.628 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.2 mt -85.44 142.43 29.24 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.607 -0.437 . . . . 74.22 109.845 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.499 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 6.7 m -63.35 154.1 32.91 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.503 -0.554 . . . . 54.31 109.503 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -62.63 -29.75 70.85 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.279 0.474 . . . . 65.1 112.279 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -47.35 68.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.958 -0.756 . . . . 74.14 108.958 174.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 1.3 mp0 -58.82 -40.32 83.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.379 -0.828 . . . . 60.25 111.149 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 79.1 mtp -70.52 -40.16 73.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 73.53 111.264 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -54.63 9.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 64.25 110.913 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.1 m 60.15 25.11 14.43 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.12 0.568 . . . . 63.24 111.143 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -101.73 176.1 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.505 . . . . 33.34 110.904 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.5 m -80.69 91.51 5.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.07 -0.513 . . . . 74.43 111.165 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.8 m -79.06 111.3 15.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.986 -0.552 . . . . 54.01 110.204 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 23.2 m -115.56 89.87 3.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.164 -0.471 . . . . 54.45 110.605 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -121.18 145.73 47.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.198 -0.455 . . . . 61.44 109.971 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -122.2 42.73 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.502 0.668 . . . . 74.14 109.488 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 97.73 -13.92 63.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.14 -1.184 . . . . 64.14 110.14 -169.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? . . . . . 0 C--O 1.251 1.179 0 N-CA-C 107.491 -1.3 . . . . 75.21 107.491 178.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.786 -0.526 . . . . 52.22 111.786 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 t -67.14 120.06 13.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 52.55 110.154 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -121.04 135.26 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.336 -0.393 . . . . 75.54 111.238 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 t -71.76 113.85 9.22 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.168 -1.049 . . . . 55.21 108.168 168.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.54 6.88 15.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.784 0.326 . . . . 62.21 111.018 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 t -141.78 98.44 6.36 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.297 -0.41 . . . . 73.12 110.741 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HB3' HG23 ' A' ' 64' ' ' THR . 34.1 Cg_endo -91.06 165.49 3.78 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.959 2.44 . . . . 62.25 111.992 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -97.63 -8.96 27.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.08 -0.711 . . . . 71.33 109.08 171.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -66.95 130.86 93.88 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.816 -1.084 . . . . 61.44 110.812 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.23 169.29 12.51 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.216 2.611 . . . . 54.53 111.751 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.7 pt-20 -52.14 -38.86 58.9 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 112.185 0.439 . . . . 64.41 112.185 -177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 6.5 pt20 -65.64 -26.31 67.75 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.108 0.41 . . . . 75.51 112.108 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 164' ' ' ILE . 5.4 mp -88.97 -9.88 49.78 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.185 -0.322 . . . . 60.11 111.165 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 68' ' ' VAL . 12.8 ptt180 -118.72 -5.17 10.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 63.42 111.301 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.7 ttpt -93.69 148.73 21.84 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.402 0.62 . . . . 74.12 111.213 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.556 HD21 HG13 ' A' ' 68' ' ' VAL . 54.0 mt -120.57 146.39 46.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.058 -0.973 . . . . 75.44 110.413 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 16.5 t80 -98.13 131.33 44.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.085 -1.08 . . . . 74.05 108.085 173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 60' ' ' VAL . 20.6 mm -106.45 111.55 35.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.892 -0.41 . . . . 74.32 109.892 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.6 148.65 17.51 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.855 -0.688 . . . . 72.32 111.9 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.77 46.41 30.42 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.785 -0.722 . . . . 72.23 113.503 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 25' ' ' THR . 79.1 mt -81.34 174.39 11.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.883 0.373 . . . . 62.05 110.237 173.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 91.0 p -87.64 173.88 8.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.437 -0.579 . . . . 64.34 109.437 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -77.9 -11.51 59.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.119 0.485 . . . . 75.54 109.78 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -103.67 -0.43 29.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.366 -0.834 . . . . 74.1 111.941 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 21' ' ' LEU . 33.3 m -67.91 123.77 21.5 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.0 0.429 . . . . 72.13 111.615 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.9 159.51 15.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.552 -0.749 . . . . 63.4 110.066 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -68.73 -30.92 69.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.344 . . . . 72.0 111.876 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -25.08 45.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.883 -0.327 . . . . 74.23 111.145 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.8 m -74.94 -43.5 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.415 . . . . 34.04 110.406 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.25 -46.2 89.92 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.498 -0.774 . . . . 62.33 110.065 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -55.63 -59.87 4.24 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.445 -0.798 . . . . 73.43 111.794 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -50.18 -33.73 20.16 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.787 0.68 . . . . 63.55 112.654 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.438 ' CG ' HG22 ' A' ' 79' ' ' VAL . 62.3 t60 -69.03 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.63 0.252 . . . . 74.15 110.684 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.16 -22.63 62.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.198 0.444 . . . . 75.34 112.198 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 31.8 tt0 -65.15 -21.53 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 74.31 111.06 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.49 -23.13 66.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.871 -0.604 . . . . 74.33 111.941 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -102.42 -21.12 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.514 0.197 . . . . 72.42 111.528 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.91 161.64 32.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.398 -0.906 . . . . 74.24 112.603 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.6 m -67.88 116.05 8.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.144 0.497 . . . . 70.11 111.443 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -84.41 136.8 33.71 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.464 -0.789 . . . . 75.3 110.205 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -106.45 -16.5 14.53 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.428 -0.805 . . . . 60.33 109.749 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.52 149.42 29.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 75.32 109.886 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.9 t -160.42 131.09 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.215 -0.291 . . . . 75.15 110.215 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.12 131.57 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.996 0.427 . . . . 73.12 110.254 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 p -92.96 130.51 41.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.222 -1.029 . . . . 45.2 108.222 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.67 97.59 3.85 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.653 0.74 . . . . 45.4 110.605 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 29.4 mtt180 -101.94 163.94 11.98 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.598 -1.183 . . . . 74.23 110.391 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 22.6 t70 -79.27 126.79 80.8 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 115.145 -0.934 . . . . 64.12 109.512 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.45 -18.95 49.53 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 121.901 1.734 . . . . 72.44 113.362 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 35.9 m-80 -86.02 -56.52 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 62.11 111.482 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.46 -10.11 24.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.142 -0.481 . . . . 72.11 111.873 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm 66.17 29.93 9.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.998 0.919 . . . . 72.11 111.481 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -106.15 150.68 25.6 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.792 -0.447 . . . . 73.12 109.792 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 30.5 t -73.83 133.96 43.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.107 0.479 . . . . 70.43 110.73 -174.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -83.71 2.61 36.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.386 -0.824 . . . . 71.05 111.022 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.88 16.91 60.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.883 -0.675 . . . . 73.34 113.957 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.6 158.4 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.947 0.874 . . . . 75.14 111.097 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.76 -165.31 17.31 Favored Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 111.459 -0.656 . . . . 52.22 111.459 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.28 146.35 33.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 117.213 0.507 . . . . 73.41 110.302 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 18' ' ' ILE . 11.0 m -127.82 126.59 67.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.704 -0.68 . . . . 60.52 109.333 172.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 m -103.62 120.72 41.47 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.125 -0.359 . . . . 75.21 110.426 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -85.98 161.47 18.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.017 -0.538 . . . . 75.11 110.146 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.18 -36.58 66.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.591 -0.731 . . . . 64.53 110.704 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.688 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 89.5 m -141.97 151.8 42.87 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.829 -0.623 . . . . 61.54 110.785 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -58.06 -36.76 58.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.609 -0.723 . . . . 72.12 112.161 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -49.37 -47.73 47.34 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.017 0.747 . . . . 73.33 113.017 175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.9 mp0 -64.7 -31.39 72.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.711 0.291 . . . . 74.24 111.273 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.556 HG13 HD21 ' A' ' 16' ' ' LEU . 52.1 t -63.31 -47.92 89.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 74.45 110.593 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.29 -43.28 99.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.391 -0.822 . . . . 74.34 111.062 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -55.7 -35.65 66.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.746 0.647 . . . . 74.32 112.746 172.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -31.18 67.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.475 0.655 . . . . 74.43 109.903 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 13.7 mmt -72.25 -37.69 69.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 72.15 111.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.625 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -76.22 -14.08 60.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.151 0.5 . . . . 64.45 110.573 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.67 -9.17 50.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.596 -0.729 . . . . 61.11 111.903 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.3 mtm105 -56.65 146.88 54.15 Favored Pre-proline 0 N--CA 1.466 0.365 0 O-C-N 123.22 0.325 . . . . 53.53 111.642 175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.85 167.9 77.46 Favored 'Cis proline' 0 C--N 1.346 0.411 0 C-N-CA 123.889 -1.296 . . . . 62.53 113.224 2.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -122.59 154.47 37.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 70.21 111.315 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.8 ttmt -139.05 109.15 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 74.11 110.976 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' CG ' ' A' ' 33' ' ' HIS . 18.8 t -109.94 129.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.585 -0.524 . . . . 72.15 109.585 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.9 t70 68.36 22.06 8.11 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.8 0.81 . . . . 75.55 110.563 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.21 25.08 67.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 64.34 111.777 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.5 tpt180 -124.0 138.14 54.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.74 -0.467 . . . . 74.04 109.74 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.6 t -76.7 109.02 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.48 -0.563 . . . . 54.12 109.48 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -107.66 148.64 11.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.985 0.422 . . . . 71.41 110.482 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.51 103.46 52.68 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.821 -0.627 . . . . 72.21 111.476 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.52 132.8 19.54 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.008 1.805 . . . . 53.14 111.363 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.517 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 11.4 mmtt -131.6 161.12 33.41 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.66 -1.237 . . . . 63.32 107.66 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.51 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.6 tpp180 -68.34 139.82 55.89 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.465 -0.568 . . . . 61.11 109.465 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.2 91.93 1.7 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.471 0.653 . . . . 63.35 109.786 171.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.404 ' CG2' HG23 ' A' ' 163' ' ' VAL . 9.8 p -65.18 156.23 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.672 -1.149 . . . . 64.43 111.598 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 t -60.46 155.71 17.72 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.649 -0.705 . . . . 71.53 110.44 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -60.46 -25.31 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.75 -0.659 . . . . 74.43 112.009 -175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.28 -54.41 25.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.251 -0.431 . . . . 74.31 111.059 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.11 -30.6 63.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.041 -0.264 . . . . 61.4 111.422 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -68.46 -8.81 44.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.924 0.392 . . . . 53.31 111.525 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.02 -21.87 59.8 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.327 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -79.65 153.98 75.95 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.12 110.597 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.26 129.77 16.51 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.693 2.262 . . . . 73.01 111.4 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.03 57.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 74.33 112.586 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.76 -34.32 60.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.143 0.497 . . . . 74.14 110.676 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.476 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 19.8 m170 -100.5 20.93 14.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.51 0.671 . . . . 71.33 110.548 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.22 179.12 5.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.471 -0.786 . . . . 43.34 109.423 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 97.08 7.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.172 0.511 . . . . 33.44 110.597 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.41 113.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.252 -0.885 . . . . 71.54 109.529 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.457 ' C ' HG21 ' A' ' 159' ' ' VAL . 84.8 mttt -110.72 21.86 16.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.474 -0.49 . . . . 61.12 111.174 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -126.04 145.78 50.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.855 0.36 . . . . 75.1 111.859 176.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -129.77 153.66 39.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.169 0.509 . . . . 73.41 111.696 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.4 t80 -100.81 139.63 36.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.03 -0.986 . . . . 71.32 109.364 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.3 t -131.12 111.55 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.622 -0.51 . . . . 72.4 109.622 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -142.3 167.88 25.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 119.546 -1.311 . . . . 44.53 113.428 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.48 38.34 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.682 -0.77 . . . . 63.42 112.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.7 143.7 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.701 -0.481 . . . . 70.32 109.701 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -89.18 -42.05 11.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 72.24 111.398 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -104.89 -97.28 0.33 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.317 -0.401 . . . . 72.21 110.59 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 147.02 27.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.67 -0.863 . . . . 73.52 108.67 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 129.45 36.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.386 0.612 . . . . 74.44 110.82 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.47 166.14 11.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.905 -1.043 . . . . 75.1 110.194 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.12 -45.65 90.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 74.34 109.713 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -57.73 -32.85 67.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 62.22 111.929 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -67.25 -57.61 6.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.907 0.384 . . . . 75.4 111.241 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 122' ' ' ARG . 2.4 pp -83.94 -25.0 30.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.298 -0.561 . . . . 72.41 111.303 -171.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' N ' HD12 ' A' ' 121' ' ' LEU . 6.0 tmm_? -65.28 -51.38 61.09 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.922 -0.399 . . . . 74.12 109.922 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.66 -27.26 69.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 64.13 110.635 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 170' ' ' VAL . 82.0 t80 -80.64 -54.03 6.01 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.012 -0.54 . . . . 73.13 111.923 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.4 m-85 -70.88 -23.01 62.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.16 0.43 . . . . 64.2 112.16 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.7 mt-10 -67.15 -20.41 65.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.935 0.398 . . . . 71.32 111.194 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.01 -20.98 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.833 -0.621 . . . . 72.21 111.373 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -91.59 -27.87 17.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.548 -0.296 . . . . 70.34 111.678 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -171.49 44.39 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.528 -0.844 . . . . 51.22 113.232 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -76.36 130.7 38.46 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.04 0.447 . . . . 74.2 111.602 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.471 HD12 ' HG3' ' A' ' 126' ' ' GLU . 55.0 mt -101.38 140.54 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 71.22 109.804 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.31 -50.41 6.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.122 -0.49 . . . . 70.33 110.269 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.1 p -158.28 158.66 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.581 -0.736 . . . . 63.41 109.338 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.1 mp -116.78 128.92 74.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.224 0.535 . . . . 73.34 109.851 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.8 mt-10 -104.29 104.71 14.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.27 -0.877 . . . . 45.23 110.454 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mm -96.6 116.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.44 -0.948 . . . . 74.05 108.44 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.2 mmm -87.54 135.59 33.29 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.794 -0.363 . . . . 75.01 110.481 -172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 1.6 m -89.53 154.06 20.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.383 0.611 . . . . 53.41 111.127 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.06 119.74 35.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.96 -1.018 . . . . 74.03 109.22 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -64.83 -35.88 82.55 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.363 0.415 . . . . 74.15 111.758 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.89 -48.21 5.56 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.631 -0.795 . . . . 52.11 112.947 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 m -78.97 -24.46 43.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.79 0.293 . . . . 74.31 111.79 -174.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.39 88.68 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.17 -0.538 . . . . 62.41 112.498 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -107.65 155.36 20.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.395 -0.595 . . . . 72.21 109.395 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 28.8 mtpp -81.88 87.37 6.39 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.921 -0.77 . . . . 74.31 108.921 174.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 147' ' ' GLY . 3.6 ttp180 -157.53 158.23 35.27 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.465 -1.243 . . . . 72.43 111.183 -166.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' N ' ' HG2' ' A' ' 146' ' ' ARG . . . 110.57 -43.98 1.6 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.89 -0.595 . . . . 54.54 112.603 174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.56 161.63 6.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 74.31 110.153 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.52 173.09 11.84 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.572 -0.74 . . . . 35.32 110.159 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 41.1 m-85 -137.27 145.47 43.56 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.223 -0.899 . . . . 73.31 109.351 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 125' ' ' PHE . 61.4 t -128.42 125.63 64.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 120.99 0.424 . . . . 75.31 110.879 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 87.9 m -101.5 119.93 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 73.03 111.033 -176.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.08 155.23 18.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.986 0.422 . . . . 70.11 111.743 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.05 -18.46 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.562 -0.745 . . . . 61.34 110.579 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.04 151.73 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 54.13 111.152 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.517 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 30.5 p80 -82.78 -28.15 30.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.599 -0.273 . . . . 75.13 111.288 -175.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.618 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 23.9 t70 -68.01 -35.26 78.0 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.995 -0.548 . . . . 52.24 110.589 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.0 m -67.72 -34.13 76.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 60.15 110.825 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 107' ' ' ILE . 2.2 t -72.13 -38.36 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.019 -0.537 . . . . 70.24 109.558 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 163' ' ' VAL . 4.2 t70 -66.11 -35.79 81.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 72.34 111.007 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 83.5 mttt -57.46 -37.98 73.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.504 0.669 . . . . 64.24 110.7 174.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.429 HD13 HD13 ' A' ' 107' ' ' ILE . 16.1 mt -75.69 -42.07 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.807 -1.088 . . . . 74.32 111.567 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.8 m -77.81 -8.19 11.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.465 0.65 . . . . 74.34 110.902 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.41 HD13 HD12 ' A' ' 13' ' ' LEU . 15.0 mt -60.79 -32.77 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.997 -1.001 . . . . 72.34 110.382 170.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 43.2 mt-30 -113.17 114.73 27.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.046 -0.724 . . . . 64.51 109.046 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -55.23 -38.07 67.98 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.049 0.759 . . . . 63.13 113.049 -176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -123.09 138.43 54.67 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.089 -0.382 . . . . 73.54 110.574 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.53 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 36.7 m-70 -123.35 140.01 53.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 74.14 110.966 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -87.26 104.38 16.34 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.786 -0.643 . . . . 73.24 111.11 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 124' ' ' TYR . 28.2 t -111.22 127.26 68.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.488 -0.778 . . . . 54.35 109.143 177.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 45.18 40.13 4.67 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.274 0.63 . . . . 60.12 112.319 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 -6.15 77.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.034 -0.603 . . . . 64.14 114.152 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -107.68 128.74 54.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.581 0.691 . . . . 74.42 110.46 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.36 113.1 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.693 0.759 . . . . 74.53 110.34 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.4 p -112.18 156.57 22.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.337 -0.847 . . . . 75.3 109.511 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -86.04 137.38 32.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.206 0.527 . . . . 71.24 110.898 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -129.53 164.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.205 -0.907 . . . . 73.45 110.721 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -175.66 173.98 2.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.104 -0.953 . . . . 64.54 111.245 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -61.01 134.82 57.48 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 123.618 0.574 . . . . 65.44 110.247 173.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -127.73 122.61 33.31 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.311 -0.626 . . . . 74.33 109.311 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.7 mt -97.99 116.13 29.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.982 -0.687 . . . . 74.4 109.546 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.444 ' OG ' ' HG3' ' A' ' 106' ' ' LYS . 6.2 m -65.51 166.83 9.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.499 -0.773 . . . . 73.01 110.077 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -64.05 -29.95 71.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.114 0.483 . . . . 75.11 110.03 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -65.34 -53.12 48.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.393 -0.822 . . . . 72.41 110.129 171.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -64.24 -36.59 84.58 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.487 0.551 . . . . 75.44 112.487 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 69.2 mtp -67.58 -31.67 71.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 72.32 110.748 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -92.97 -0.29 57.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.091 -0.504 . . . . 70.43 111.317 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.6 m -82.13 81.74 7.94 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.999 0.428 . . . . 74.13 111.529 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -85.54 163.86 18.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.639 -0.875 . . . . 63.54 108.639 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.0 m -72.38 95.18 1.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.179 0.514 . . . . 60.41 110.123 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.5 p -145.61 -173.76 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.67 . . . . 71.45 110.654 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.67 73.26 6.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.062 0.458 . . . . 45.32 110.785 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -104.24 161.94 13.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.059 0.457 . . . . 54.51 111.04 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -144.18 163.31 34.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.684 -0.689 . . . . 60.1 109.921 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -104.7 156.65 16.98 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.627 -0.797 . . . . 61.42 112.263 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.767 -0.635 . . . . 75.32 109.582 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 111.957 -0.457 . . . . 44.41 111.957 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -78.67 102.12 7.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.985 0.422 . . . . 72.13 110.93 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -139.81 -37.02 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.107 -0.497 . . . . 64.4 110.055 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -85.3 55.02 3.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.824 -0.625 . . . . 71.31 110.081 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.94 137.17 32.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.53 . . . . 62.32 110.461 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -97.5 114.57 65.06 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.929 -0.397 . . . . 75.21 109.929 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.82 135.71 26.29 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.935 1.757 . . . . 63.32 112.626 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 -2.19 17.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.657 -0.868 . . . . 73.52 108.657 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -99.44 136.61 20.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.516 -1.22 . . . . 72.13 110.842 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' HD22 ' A' ' 13' ' ' LEU . 25.3 Cg_endo -64.51 167.65 14.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.932 2.421 . . . . 61.1 111.199 172.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 5.3 pt-20 -56.49 -35.73 68.31 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.596 0.221 . . . . 73.52 111.596 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.452 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.3 pt20 -69.09 -25.49 64.46 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.591 0.234 . . . . 64.11 111.404 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' A' ' 12' ' ' GLN . 4.6 mp -88.63 -11.97 43.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.513 0.196 . . . . 75.31 111.384 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.549 ' HA ' HG21 ' A' ' 68' ' ' VAL . 31.2 ptt180 -124.12 6.53 8.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.195 0.522 . . . . 73.23 110.835 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.6 ttpt -97.87 146.87 25.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.353 0.597 . . . . 71.21 110.908 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.639 HD21 HG13 ' A' ' 68' ' ' VAL . 55.9 mt -116.36 145.21 43.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.919 -1.037 . . . . 73.23 110.354 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 13.5 t80 -101.1 125.67 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.446 -0.946 . . . . 74.52 108.446 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -106.25 111.11 33.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 109.985 -0.376 . . . . 71.32 109.985 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.48 157.54 18.23 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.548 -0.834 . . . . 74.41 111.222 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.09 44.29 67.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.932 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD22 HG21 ' A' ' 25' ' ' THR . 44.1 mt -80.3 170.66 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 74.21 110.86 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -92.09 165.65 13.06 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.608 -0.724 . . . . 65.22 109.726 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -67.3 -22.51 65.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.898 -0.592 . . . . 74.1 110.092 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -97.22 2.7 51.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.639 -0.71 . . . . 73.0 111.408 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 21' ' ' LEU . 80.7 m -77.33 117.67 19.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.614 0.721 . . . . 75.11 111.546 -175.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 p -105.35 164.47 11.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.059 -0.973 . . . . 74.51 109.516 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -40.57 90.9 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.416 0.448 . . . . 74.34 111.132 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.83 -37.38 87.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.942 -0.572 . . . . 73.04 111.402 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.1 m -78.48 -41.64 31.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.555 -0.293 . . . . 73.54 110.96 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.7 tp -62.87 -49.01 76.53 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.167 -0.47 . . . . 72.24 110.623 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -57.4 -56.04 27.01 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.443 -0.799 . . . . 75.41 110.886 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 m -48.24 -39.18 20.46 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.439 0.903 . . . . 74.11 113.439 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -70.22 -53.03 18.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.741 -0.384 . . . . 73.25 110.916 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -73.12 -21.96 60.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.925 0.343 . . . . 74.21 111.925 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -17.8 54.42 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.667 0.387 . . . . 60.22 111.921 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -63.73 -27.11 68.98 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.568 -0.287 . . . . 71.35 111.7 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -99.25 -17.42 18.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.688 0.255 . . . . 63.41 111.688 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 168.34 38.6 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.042 -1.075 . . . . 74.43 112.862 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -68.61 121.49 16.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.194 0.521 . . . . 73.42 111.507 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.5 128.94 36.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.709 -0.678 . . . . 63.1 111.267 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 p -91.25 -29.27 17.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.95 -1.023 . . . . 61.45 110.164 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -150.39 152.37 34.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.412 -0.813 . . . . 65.44 109.455 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.67 136.45 6.18 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.475 -0.565 . . . . 42.53 109.475 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -152.14 121.75 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.375 0.607 . . . . 72.11 110.471 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -81.44 131.01 34.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.431 -0.952 . . . . 51.41 108.431 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.8 mmt -76.22 99.61 4.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.602 0.715 . . . . 53.31 110.697 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 57.8 mtp85 -109.47 163.6 13.28 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.524 -1.216 . . . . 75.54 109.251 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.23 126.92 82.64 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.776 -0.453 . . . . 61.53 109.776 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.25 -18.92 44.81 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.969 1.779 . . . . 42.5 112.67 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.11 -56.79 3.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.282 0.563 . . . . 54.15 111.607 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.457 ' HB ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -100.85 -8.56 22.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 71.4 111.74 -172.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm 62.27 39.0 12.92 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.65 0.78 . . . . 70.22 112.57 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -115.68 153.49 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.256 -0.277 . . . . 65.3 110.636 177.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 36.3 t -69.52 134.33 48.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.749 0.309 . . . . 63.33 110.48 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -85.35 -4.11 59.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.814 -0.63 . . . . 74.35 110.279 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.79 18.96 53.42 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.923 -0.656 . . . . 74.32 113.777 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -159.07 158.35 32.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.564 0.682 . . . . 75.31 110.425 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.16 -166.62 18.51 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.636 -0.586 . . . . 50.12 111.636 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -141.12 148.49 40.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 117.467 0.634 . . . . 74.34 110.778 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 16' ' ' LEU . 4.7 m -131.08 121.47 49.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 73.44 109.931 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 m -101.94 123.58 46.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.51 -0.313 . . . . 71.03 110.442 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.447 ' HB2' HG23 ' A' ' 68' ' ' VAL . 35.7 m-85 -88.23 171.24 10.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.16 0.505 . . . . 70.03 111.368 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.4 -48.39 11.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.416 -0.811 . . . . 74.12 110.146 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -115.43 149.06 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 73.51 110.158 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 10.0 p -68.95 -25.28 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.004 0.43 . . . . 54.14 111.122 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.92 -34.76 73.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 72.22 110.995 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.56 -28.45 66.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 65.01 110.38 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.639 HG13 HD21 ' A' ' 16' ' ' LEU . 21.8 t -68.22 -46.34 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.359 -0.837 . . . . 74.32 110.198 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -58.98 -46.12 88.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.417 -0.81 . . . . 72.01 110.938 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.624 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -61.12 -31.4 71.1 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.679 0.622 . . . . 33.13 112.679 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 -36.25 65.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.098 0.475 . . . . 54.42 110.039 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.6 mmt -69.62 -35.22 75.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.87 -0.604 . . . . 54.24 110.995 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.624 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 6.6 p30 -79.64 -22.72 43.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.455 -0.339 . . . . 73.1 111.13 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.84 -5.65 46.97 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.449 0.537 . . . . 44.43 112.449 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.0 mtp-105 -58.96 146.7 76.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.449 -0.341 . . . . 72.02 111.468 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.02 168.18 77.85 Favored 'Cis proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.686 -1.381 . . . . 73.4 113.743 1.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -123.4 155.63 37.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.723 -0.671 . . . . 63.04 110.654 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.3 ttmt -139.78 104.95 5.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.042 0.448 . . . . 71.22 111.176 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.2 t -105.82 128.23 60.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.787 -0.642 . . . . 73.1 109.558 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 64.78 29.9 12.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.371 0.668 . . . . 74.31 111.76 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.89 77.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.784 -0.722 . . . . 52.34 112.04 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.5 tpt180 -124.93 134.6 52.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.133 -0.321 . . . . 74.44 110.133 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -76.75 113.39 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 7.4 m -102.5 152.49 5.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 74.42 111.272 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HG3' ' NZ ' ' A' ' 87' ' ' LYS . 5.7 tp10 -113.73 91.8 22.56 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.741 -1.118 . . . . 55.54 110.542 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -78.37 143.74 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.808 2.338 . . . . 64.05 111.136 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' NZ ' ' HG3' ' A' ' 85' ' ' GLU . 12.7 mmtm -139.77 159.78 41.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.641 -1.244 . . . . 74.02 107.641 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' NH2' ' HA ' ' A' ' 90' ' ' VAL . 2.5 tmm_? -69.49 130.98 43.99 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 106.845 -1.539 . . . . 61.4 106.845 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.54 94.7 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.971 0.415 . . . . 64.34 111.157 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HA ' ' NH2' ' A' ' 88' ' ' ARG . 25.5 t -58.52 140.82 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.725 -1.125 . . . . 65.13 111.826 -172.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.8 m -56.66 143.32 36.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.386 -0.824 . . . . 71.1 109.866 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -62.44 -31.31 71.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.593 0.59 . . . . 74.42 112.593 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.81 -29.1 58.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.463 0.173 . . . . 71.23 111.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.05 -30.46 39.41 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.391 -0.596 . . . . 73.4 109.391 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.3 m -74.94 -3.24 31.04 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.442 -0.799 . . . . 50.21 111.211 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.38 -13.72 60.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.375 0.607 . . . . 74.21 109.968 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -106.24 146.96 34.0 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.396 -0.594 . . . . 63.23 109.396 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.88 140.62 35.47 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.598 2.199 . . . . 61.12 112.217 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.18 9.63 60.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.934 -0.651 . . . . 24.15 112.474 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.21 54.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.626 0.251 . . . . 43.02 111.6 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -96.2 22.7 7.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 72.43 111.205 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.1 mt -100.46 174.84 5.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 72.24 109.957 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CD2' ' A' ' 156' ' ' HIS . 6.4 m -78.99 85.49 4.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.293 0.568 . . . . 72.21 109.845 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.493 ' HA ' ' HG3' ' A' ' 185' ' ' GLU . 71.7 t -107.94 112.77 41.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.182 -0.917 . . . . 44.24 109.946 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 69.8 mttt -106.94 13.76 27.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 44.22 110.653 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -114.67 138.79 50.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.571 -0.286 . . . . 63.24 111.27 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 159' ' ' VAL . 5.2 pt -130.13 152.44 37.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.237 0.542 . . . . 54.54 111.796 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.0 t80 -97.49 137.43 36.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.915 -1.039 . . . . 64.43 109.854 175.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.0 t -124.72 110.41 24.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.128 -0.693 . . . . 64.52 109.128 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -134.18 155.94 22.12 Favored Glycine 0 CA--C 1.507 -0.45 0 C-N-CA 119.742 -1.218 . . . . 50.33 113.232 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.48 10.57 31.0 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.564 -0.827 . . . . 74.4 112.258 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 147' ' ' GLY . 14.1 pt -78.34 110.09 13.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 70.34 109.956 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.63 -18.88 24.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 61.45 111.203 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -112.18 175.22 5.52 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.841 -0.618 . . . . 60.24 109.874 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.96 123.98 22.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 71.11 110.067 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -118.51 144.32 46.12 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.096 -0.502 . . . . 65.42 110.125 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.38 162.51 13.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.803 -0.635 . . . . 73.24 111.217 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -47.69 77.29 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.732 -1.122 . . . . 61.53 109.755 175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -54.25 -40.65 67.95 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.637 0.586 . . . . 70.14 111.669 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -57.8 -58.51 8.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.855 0.359 . . . . 74.21 111.127 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.75 -26.41 29.71 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.802 -0.759 . . . . 70.0 111.446 -173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -65.95 -51.46 58.31 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 110.076 -0.342 . . . . 73.32 110.076 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.21 -25.29 67.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.184 0.516 . . . . 71.52 110.241 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -79.05 -56.75 4.14 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.857 -0.61 . . . . 72.55 112.323 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 151' ' ' VAL . 45.7 m-85 -69.3 -22.81 63.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.206 0.447 . . . . 74.13 112.206 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG2' HD12 ' A' ' 131' ' ' ILE . 2.0 mm-40 -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.062 0.458 . . . . 61.03 110.464 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -58.3 -34.68 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.547 -0.751 . . . . 54.41 112.001 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -81.51 -31.72 32.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 73.41 111.316 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.85 179.61 48.64 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.957 -0.639 . . . . 73.24 112.696 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -72.9 128.04 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 72.02 111.532 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.423 HD12 ' HG2' ' A' ' 126' ' ' GLU . 56.6 mt -98.15 136.88 27.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.661 -0.699 . . . . 65.31 110.025 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -90.45 -44.02 9.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.28 . . . . 73.12 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.7 p -158.18 154.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.45 . . . . 74.44 109.879 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.19 129.32 70.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.345 0.593 . . . . 73.41 110.094 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.3 mt-10 -100.83 127.64 47.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.902 -1.045 . . . . 72.11 110.19 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.1 mm -119.21 122.41 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.594 -0.891 . . . . 63.13 108.594 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.1 mmm -98.29 123.78 42.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.807 -0.812 . . . . 72.32 108.807 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 p -92.13 168.56 11.28 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.089 0.471 . . . . 64.42 111.163 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -88.95 127.57 35.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.538 -0.912 . . . . 74.41 108.538 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -76.16 -13.43 60.19 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.107 0.41 . . . . 73.41 112.107 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.62 -50.85 1.36 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.653 -0.784 . . . . 71.34 112.457 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.7 m -83.56 -23.45 32.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.517 0.199 . . . . 61.52 111.498 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.09 12.24 84.57 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.823 -0.703 . . . . 75.11 112.628 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -102.01 172.56 6.85 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.93 -0.396 . . . . 73.24 109.93 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -91.69 89.58 7.18 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.893 -0.41 . . . . 74.41 109.893 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -151.29 150.13 30.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.263 0.554 . . . . 72.35 111.609 -170.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.3 -46.02 1.23 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.999 -1.001 . . . . 75.14 113.27 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -175.61 162.6 2.79 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 117.466 0.633 . . . . 73.44 110.276 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.15 8.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.749 -0.659 . . . . 73.43 109.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 40.8 m-85 -142.32 145.7 34.24 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.745 -0.661 . . . . 63.03 110.016 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 125' ' ' PHE . 84.0 t -132.75 126.06 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 O-C-N 121.997 -0.439 . . . . 73.32 111.049 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.0 m -102.48 125.17 49.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.835 -0.62 . . . . 75.21 110.494 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -104.78 163.62 12.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.992 0.425 . . . . 62.21 111.671 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.44 -28.2 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.264 -0.88 . . . . 55.22 110.534 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.46 153.41 51.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.022 -0.535 . . . . 74.24 110.422 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.455 ' CD2' HG23 ' A' ' 103' ' ' THR . 34.3 p80 -74.73 -28.21 60.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.646 . . . . 71.23 110.108 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -58.53 -43.56 89.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.017 -0.992 . . . . 74.34 111.779 -176.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 m -68.72 -30.75 69.46 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.718 0.294 . . . . 74.55 110.937 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -71.17 -39.53 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.636 -0.505 . . . . 73.12 109.636 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.54 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -72.15 -24.64 61.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.448 -0.796 . . . . 64.25 111.499 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 52.9 mttm -62.81 -40.51 97.58 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.647 0.737 . . . . 70.12 110.009 170.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.16 -43.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.667 -1.151 . . . . 53.42 112.574 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 160' ' ' ASP . 32.6 m -73.73 -2.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.115 0.483 . . . . 75.21 111.63 -173.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 160' ' ' ASP . 76.2 mt -61.27 -38.11 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.508 -0.769 . . . . 72.51 109.951 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.487 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.3 mt-30 -108.47 105.62 15.36 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.45 -0.945 . . . . 74.35 108.45 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -53.85 -34.27 58.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.856 -0.611 . . . . 72.21 112.151 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.76 137.83 54.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.802 0.334 . . . . 73.44 110.614 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.5 m-70 -126.0 146.26 49.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.832 -0.622 . . . . 75.42 110.539 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 m -106.08 118.84 37.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.016 -0.538 . . . . 73.1 110.726 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.62 142.9 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.548 -0.908 . . . . 43.15 108.548 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.2 t30 52.11 31.28 8.68 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.537 0.684 . . . . 52.24 111.767 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.38 10.17 74.35 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.75 -0.659 . . . . 73.25 113.543 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -115.66 139.01 50.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.01 0.405 . . . . 61.21 110.264 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -101.12 111.2 23.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.643 0.735 . . . . 71.51 111.016 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.98 156.61 23.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 74.5 110.51 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -86.57 136.64 32.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.003 0.43 . . . . 72.35 110.184 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.2 t -131.97 132.64 61.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.616 -0.72 . . . . 72.44 109.862 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -153.46 174.63 14.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.797 -0.638 . . . . 71.14 111.195 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -65.28 136.9 57.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.596 -0.274 . . . . 74.25 110.898 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -125.99 124.94 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.812 -0.44 . . . . 73.21 109.812 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.3 mt -97.55 110.87 23.35 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.408 -0.517 . . . . 75.31 110.525 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.468 ' HB3' ' OE1' ' A' ' 185' ' ' GLU . 23.2 t -89.72 -170.37 2.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.759 -0.83 . . . . 34.43 108.759 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -69.63 -25.81 64.12 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.243 -0.286 . . . . 74.41 110.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -74.84 -37.44 62.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.21 0.529 . . . . 74.41 110.098 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.493 ' HG3' ' HA ' ' A' ' 104' ' ' VAL . 8.4 mp0 -69.16 -37.24 78.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.556 -0.747 . . . . 75.31 111.283 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 17.5 mtt -85.47 -70.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 71.5 111.728 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -95.64 -11.27 27.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 71.11 112.056 -174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.0 m 61.9 43.78 8.97 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.832 0.707 . . . . 62.55 110.743 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.89 111.09 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.428 -0.805 . . . . 51.31 110.321 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.1 m -147.12 149.27 32.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.593 -0.276 . . . . 54.45 110.573 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.7 m -67.41 108.26 2.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.499 -0.556 . . . . 73.25 109.499 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 11.5 m -82.56 73.64 9.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.743 -0.662 . . . . 61.52 111.317 -173.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -104.67 114.47 28.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.288 -0.869 . . . . 63.23 108.899 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -87.13 88.1 7.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.215 0.531 . . . . 73.34 110.834 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -88.88 69.6 2.65 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.21 -0.756 . . . . 72.23 111.21 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.525 -0.75 . . . . 62.21 109.165 -178.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.273 -0.331 . . . . 65.11 112.273 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -82.79 121.7 27.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.071 -0.344 . . . . 73.05 110.071 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -75.97 104.57 6.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.164 0.507 . . . . 65.3 110.867 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 p -96.57 -5.95 38.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.669 -0.696 . . . . 64.33 109.644 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.05 119.78 9.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.123 -0.944 . . . . 64.44 110.253 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.0 m -86.75 140.23 33.3 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 72.34 110.704 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 158.77 55.85 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.562 2.175 . . . . 74.02 111.846 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 2.13 13.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 55.21 108.43 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 37.5 mp0 -102.5 142.78 25.26 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 114.241 -1.345 . . . . 74.53 110.836 -172.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 13' ' ' LEU . 12.1 Cg_endo -61.92 166.42 12.29 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.871 2.38 . . . . 72.53 112.006 172.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.46 -37.18 67.42 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.145 -0.48 . . . . 74.31 112.272 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' HD23 ' A' ' 13' ' ' LEU . 10.0 pt20 -61.83 -29.33 70.09 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 61.5 112.158 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.602 HD22 HD13 ' A' ' 164' ' ' ILE . 25.3 mt -89.81 -22.17 22.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.334 . . . . 54.12 111.162 -173.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.7 ptt180 -106.66 0.05 24.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.332 0.587 . . . . 75.02 110.071 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -105.47 136.28 45.32 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.638 0.732 . . . . 65.15 111.123 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 68' ' ' VAL . 71.3 mt -101.56 146.87 27.09 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.729 -1.123 . . . . 72.41 110.92 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -97.67 120.79 38.68 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.245 -1.021 . . . . 74.33 108.245 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 60' ' ' VAL . 17.1 mm -98.47 110.96 27.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.771 -0.455 . . . . 74.34 109.771 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.72 147.94 16.32 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.868 -0.893 . . . . 75.24 110.868 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.9 42.26 13.07 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.978 -1.106 . . . . 53.55 112.886 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 25' ' ' THR . 90.4 mt -79.28 174.63 11.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.319 -0.622 . . . . 44.31 109.319 171.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.4 p -85.98 179.35 7.01 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.094 -0.706 . . . . 60.14 109.094 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 53' ' ' ARG . 3.2 t80 -81.95 -6.88 59.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.513 0.673 . . . . 71.32 109.389 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -118.36 20.35 13.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.006 -0.997 . . . . 72.11 111.845 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.575 HG21 HD22 ' A' ' 21' ' ' LEU . 20.4 m -85.75 129.45 34.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.983 0.421 . . . . 74.23 111.477 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.0 p -108.09 165.73 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.695 . . . . 61.32 109.673 173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -25.17 60.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.005 -0.278 . . . . 72.33 110.792 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -71.6 -40.36 69.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.127 -0.229 . . . . 71.44 110.851 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -76.7 -32.71 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 74.31 110.618 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.2 tp -66.42 -49.88 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.994 -0.548 . . . . 62.55 110.314 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -56.77 -54.78 42.31 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.556 -0.747 . . . . 74.21 111.011 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -44.86 -37.98 4.26 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.539 1.149 . . . . 45.24 113.415 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -69.83 -52.0 28.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.345 -0.389 . . . . 75.35 110.953 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.32 -19.91 41.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.195 0.443 . . . . 72.21 112.195 -170.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -56.73 -24.29 48.67 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.396 0.517 . . . . 53.42 112.396 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.96 -25.57 68.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.196 0.443 . . . . 73.44 112.196 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -101.21 -23.25 14.47 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 121.088 -0.245 . . . . 73.41 111.267 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.3 157.72 29.19 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.311 -0.947 . . . . 73.34 112.389 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.6 m -63.24 119.81 10.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.981 0.419 . . . . 72.54 111.591 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.4 mt -88.43 141.85 28.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.815 -0.63 . . . . 70.32 110.479 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -107.09 -23.25 12.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.662 -0.699 . . . . 51.43 110.198 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -153.6 153.72 32.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.642 -0.708 . . . . 51.22 109.598 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 t -163.27 132.81 4.17 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.659 -0.497 . . . . 44.31 109.659 176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.13 127.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 73.11 111.095 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.42 133.78 31.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.937 -0.764 . . . . 73.44 108.937 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.475 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.6 mmt -78.19 99.85 6.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.339 0.59 . . . . 70.24 110.471 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -101.77 160.92 14.06 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.033 -0.985 . . . . 63.13 109.864 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.28 130.47 62.33 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.1 -0.333 . . . . 53.13 110.1 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.12 -19.37 51.16 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.182 1.922 . . . . 74.32 113.295 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.63 -54.37 4.59 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.34 0.591 . . . . 71.44 110.707 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -96.86 -16.14 20.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.182 -0.917 . . . . 70.33 112.348 -172.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm 65.94 31.09 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.865 0.728 . . . . 72.34 111.183 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 23.6 mmm180 -114.15 158.7 20.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.351 -0.611 . . . . 70.4 109.351 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 t -70.73 140.78 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.967 0.413 . . . . 63.41 110.993 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -93.34 3.75 55.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 75.22 110.596 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.06 68.02 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.675 -0.693 . . . . 75.12 114.378 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.475 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.3 p90 -156.34 154.8 31.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.768 0.784 . . . . 64.52 110.496 176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.78 -166.24 17.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.371 -0.692 . . . . 74.44 111.371 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.68 148.59 37.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.295 0.547 . . . . 75.44 110.598 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 18' ' ' ILE . 7.9 m -129.13 127.86 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.595 . . . . 74.42 109.781 174.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.6 m -103.36 121.61 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.335 -0.228 . . . . 74.42 110.532 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -87.95 164.05 16.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.042 0.449 . . . . 72.44 110.997 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.83 -49.49 37.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.492 -0.776 . . . . 73.22 110.598 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.5 m -119.37 152.18 37.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 74.4 110.816 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.575 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -65.64 -28.85 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.455 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.53 -29.35 63.52 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.967 -0.458 . . . . 74.31 111.509 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 6.1 mm-40 -64.92 -29.75 70.71 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.49 0.662 . . . . 73.11 109.282 174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.704 HG13 HD21 ' A' ' 16' ' ' LEU . 24.8 t -66.88 -48.3 80.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.825 -1.08 . . . . 54.11 110.298 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -59.14 -49.96 75.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.797 -0.638 . . . . 72.33 110.704 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.8 -36.72 38.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.957 0.725 . . . . 74.25 112.957 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.63 -29.6 62.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 71.13 110.745 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -49.66 64.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 63.45 109.974 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -64.07 -26.84 68.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.18 0.514 . . . . 72.24 110.882 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.9 -10.73 60.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.237 -0.892 . . . . 65.34 113.366 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -56.63 149.78 39.22 Favored Pre-proline 0 N--CA 1.467 0.39 0 N-CA-C 111.883 0.327 . . . . 52.12 111.883 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.72 165.67 79.12 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 124.057 -1.226 . . . . 51.42 112.837 0.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -123.65 152.67 41.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.939 -0.573 . . . . 74.23 110.483 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.5 ttmt -134.23 107.55 7.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.114 -0.494 . . . . 70.31 111.251 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 126.59 66.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.678 -0.692 . . . . 75.12 109.85 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.7 t70 66.29 28.19 9.96 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.632 0.73 . . . . 74.02 110.791 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.12 25.87 70.06 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.765 -0.731 . . . . 73.15 112.498 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 16.3 tpt180 -129.64 142.09 50.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.101 -0.703 . . . . 74.13 109.101 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.47 114.83 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 61.34 109.838 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.72 153.37 7.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.872 -0.604 . . . . 73.54 111.119 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -117.09 100.43 53.25 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.272 -0.876 . . . . 75.22 110.572 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.59 132.54 17.54 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.867 1.711 . . . . 73.41 110.909 171.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -136.2 178.97 6.64 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.053 -1.091 . . . . 75.24 108.053 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.2 tmm_? -81.88 128.68 34.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.768 -0.827 . . . . 71.4 108.768 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.28 98.54 0.33 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.242 0.544 . . . . 63.33 111.097 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 11.1 t -69.22 142.96 15.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.053 -0.976 . . . . 74.32 110.835 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 18.1 t -83.21 172.27 12.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.236 -0.438 . . . . 52.21 109.991 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -61.65 -42.5 98.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.74 0.644 . . . . 75.15 112.74 -170.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -71.18 -41.46 70.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.854 0.359 . . . . 43.4 110.866 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.0 OUTLIER -78.55 -8.12 58.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.269 -0.423 . . . . 63.4 111.478 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 70.6 m -93.62 -4.14 51.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.592 -0.276 . . . . 70.55 111.195 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.17 -41.59 99.25 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.975 0.417 . . . . 74.11 110.602 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -76.93 146.57 75.92 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.944 -0.571 . . . . 75.51 110.262 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.57 147.66 90.27 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.025 2.484 . . . . 60.42 112.259 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.96 28.71 64.13 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.819 -0.705 . . . . 62.11 112.664 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -66.29 -52.16 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 64.44 110.349 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -93.71 2.47 56.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.637 -0.71 . . . . 62.0 111.061 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -87.94 161.93 17.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.473 . . . . 74.25 109.724 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.493 HG23 ' CD2' ' A' ' 156' ' ' HIS . 3.2 m -83.58 97.61 9.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.218 0.533 . . . . 52.54 112.122 -172.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' CG1' ' HE3' ' A' ' 179' ' ' LYS . 0.8 OUTLIER -124.52 124.02 67.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.459 -0.791 . . . . 72.34 109.061 174.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 72.7 mttt -106.65 22.01 16.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.323 0.583 . . . . 72.5 110.446 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -117.71 139.66 50.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.786 -0.643 . . . . 64.13 111.085 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.412 HG23 HG13 ' A' ' 159' ' ' VAL . 7.2 pt -124.27 148.52 28.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.307 0.575 . . . . 74.24 111.45 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -98.63 133.79 42.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.869 -1.059 . . . . 75.31 109.426 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.37 109.12 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.059 -0.719 . . . . 72.45 109.059 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -135.86 167.88 24.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.682 -1.246 . . . . 51.41 113.717 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.11 42.11 5.06 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.925 -0.655 . . . . 75.45 111.735 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.19 111.23 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.513 0.673 . . . . 74.44 110.755 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -78.68 -21.78 47.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.717 0.77 . . . . 70.03 109.261 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -101.3 151.61 21.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.832 -1.076 . . . . 73.02 109.181 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.17 123.42 25.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.534 0.683 . . . . 61.53 110.677 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 m -107.27 141.61 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.849 -0.614 . . . . 65.5 110.056 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -113.57 173.64 6.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.248 -0.887 . . . . 71.4 111.449 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -50.73 72.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 71.31 110.955 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -63.36 -26.34 68.71 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.29 0.369 . . . . 74.34 111.491 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -64.23 -61.25 2.36 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.049 0.452 . . . . 74.34 110.427 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -84.1 -23.91 30.55 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.984 -0.686 . . . . 64.12 111.883 -171.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -67.51 -51.44 51.06 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 110.357 -0.238 . . . . 61.21 110.357 178.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.2 -28.71 69.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 71.44 110.3 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -78.79 -56.28 4.52 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.517 -0.765 . . . . 73.44 112.14 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -67.91 -23.07 65.06 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.472 0.545 . . . . 74.45 112.472 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.7 mt-10 -68.05 -23.05 64.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.645 0.26 . . . . 74.03 111.415 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.78 -33.84 64.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.515 . . . . 62.34 111.55 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -81.24 -31.65 33.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.366 . . . . 72.04 111.443 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 178.68 -177.33 48.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.704 -0.76 . . . . 62.23 113.332 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -75.61 129.98 38.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 74.22 111.418 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 152' ' ' THR . 59.0 mt -102.25 140.18 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.97 -0.559 . . . . 72.53 110.071 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -91.35 -46.55 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 61.54 110.957 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.36 156.27 4.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 120.882 0.373 . . . . 72.01 110.427 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.49 127.45 73.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.056 -0.52 . . . . 74.44 109.933 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 20.4 mt-10 -102.45 105.46 16.03 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.455 -0.793 . . . . 62.52 111.206 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.9 mm -95.1 117.12 38.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.873 -0.788 . . . . 54.14 108.873 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.5 mmm -84.45 101.21 11.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.382 0.611 . . . . 65.13 110.385 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.98 150.0 29.89 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.147 -0.933 . . . . 72.32 111.382 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -77.99 142.55 38.2 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.391 -0.822 . . . . 54.35 110.636 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -11.38 59.68 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.237 0.458 . . . . 51.12 112.237 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -96.86 -54.09 1.33 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.29 -0.957 . . . . 71.52 113.171 -175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.48 ' OG ' ' HE2' ' A' ' 144' ' ' LYS . 17.8 t -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.007 0.432 . . . . 74.34 110.687 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 8.92 75.78 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.677 -0.773 . . . . 71.02 112.816 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' HE2' ' OG ' ' A' ' 142' ' ' SER . 70.6 mmtt -76.87 158.32 30.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.719 0.259 . . . . 75.43 110.303 -177.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -74.85 129.16 37.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.307 -0.998 . . . . 74.34 108.307 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -81.56 23.98 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.822 1.045 . . . . 75.22 113.822 -170.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.46 3.96 80.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.515 -0.85 . . . . 72.02 113.894 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.66 161.66 32.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 117.188 0.494 . . . . 71.31 110.43 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.47 173.97 10.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.487 -0.779 . . . . 64.31 109.673 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 45.5 m-85 -138.0 148.93 45.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 55.33 110.204 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.35 126.25 52.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 71.2 110.815 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.7 m -98.82 121.28 40.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 75.43 110.565 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -101.83 160.97 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.68 -0.236 . . . . 74.31 110.588 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.32 -29.94 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.386 0.613 . . . . 73.25 110.154 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -137.31 162.39 33.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.357 -0.838 . . . . 74.14 110.777 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.493 ' CD2' HG23 ' A' ' 103' ' ' THR . 26.4 p80 -82.37 -20.56 36.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.978 -0.555 . . . . 73.3 110.118 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.2 p30 -60.3 -41.21 92.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 123.564 0.54 . . . . 63.01 110.943 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.401 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -73.67 -29.48 62.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.469 -0.332 . . . . 75.31 110.355 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.8 t -68.63 -42.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.759 -0.655 . . . . 61.42 109.745 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.421 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -73.85 -26.05 60.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.535 -0.757 . . . . 72.33 110.887 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.6 mttt -62.78 -37.99 88.86 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.521 0.677 . . . . 64.52 110.218 172.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.6 -42.61 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.086 -0.961 . . . . 72.02 112.956 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 159' ' ' VAL . 16.8 m -69.74 -9.01 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.095 0.474 . . . . 74.34 111.625 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.602 HD13 HD22 ' A' ' 13' ' ' LEU . 58.5 mt -56.46 -36.68 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.306 -0.861 . . . . 62.01 110.368 171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 51.7 mt-30 -109.5 108.95 19.61 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.224 -0.658 . . . . 71.42 109.224 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -53.71 -36.13 61.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.429 -0.805 . . . . 73.23 112.342 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -122.5 135.97 54.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.884 0.373 . . . . 75.3 110.49 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 82.2 m-70 -121.09 141.63 50.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.064 -0.516 . . . . 72.23 110.487 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 m -90.26 102.96 15.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.075 -0.511 . . . . 74.11 110.587 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.2 126.96 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.008 -0.738 . . . . 73.25 109.008 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 t30 53.42 31.53 12.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.584 0.707 . . . . 75.43 111.528 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.71 2.04 84.79 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.193 -0.527 . . . . 64.44 113.231 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -106.55 132.36 52.64 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.557 -0.534 . . . . 73.2 109.557 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.318 0.58 . . . . 63.15 110.676 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -106.82 153.89 21.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 61.13 109.707 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.47 131.23 34.41 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.198 -0.297 . . . . 72.22 110.198 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.9 t -130.44 137.25 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.302 -0.408 . . . . 72.33 111.06 -175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -158.2 176.67 12.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.001 -0.545 . . . . 72.53 112.06 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.521 ' HE3' ' CG1' ' A' ' 104' ' ' VAL . 14.1 mmmt -66.32 123.58 20.35 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.002 -0.545 . . . . 72.55 109.94 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -106.19 113.99 27.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.907 0.384 . . . . 72.03 111.001 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.28 140.44 37.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.908 -0.587 . . . . 64.13 110.125 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.501 ' O ' ' HG3' ' A' ' 186' ' ' MET . 89.4 p -73.03 168.61 18.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.838 -0.801 . . . . 65.32 108.838 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -61.01 -30.43 70.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 70.0 110.5 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 188' ' ' SER . 8.5 tt0 -63.77 -39.77 95.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.157 -0.928 . . . . 64.1 110.732 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.8 -22.92 31.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.953 -0.567 . . . . 65.11 111.326 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 182' ' ' SER . 22.7 mtt -79.59 -70.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.176 0.436 . . . . 73.42 112.176 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -94.1 -62.16 1.4 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.281 -0.418 . . . . 75.3 111.745 -172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 184' ' ' GLN . 10.7 p -153.59 167.28 30.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.748 -0.464 . . . . 62.23 109.748 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' A' ' 184' ' ' GLN . . . -60.94 97.44 0.06 Allowed 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.588 0.555 . . . . 60.42 110.743 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 5.2 m -133.45 90.8 2.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.772 -0.649 . . . . 73.35 110.217 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.4 t -95.67 82.18 3.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 64.3 109.761 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.9 m -77.56 128.27 33.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.445 -0.798 . . . . 64.11 109.861 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -69.0 111.88 5.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.985 0.421 . . . . 73.03 110.189 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -80.89 135.9 35.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.77 -0.65 . . . . 75.12 111.066 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -124.0 35.18 3.33 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.989 -0.844 . . . . 64.41 110.989 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.592 -0.718 . . . . 73.4 109.438 -176.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.598 -0.601 . . . . 42.14 111.598 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t -83.51 97.42 9.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.133 0.492 . . . . 63.21 110.751 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.96 101.99 5.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 70.22 109.877 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -127.97 32.05 4.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.08 -0.509 . . . . 74.44 110.676 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -69.92 141.38 53.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 74.34 109.792 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -62.1 113.77 9.59 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 123.639 0.587 . . . . 74.5 110.464 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.61 126.59 21.03 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 C-N-CA 122.55 2.167 . . . . 74.51 112.573 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -100.61 -3.06 31.2 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.963 -1.017 . . . . 60.52 110.692 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.96 159.88 37.5 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.028 -0.533 . . . . 65.42 110.191 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HD2' HD22 ' A' ' 13' ' ' LEU . 54.7 Cg_endo -73.69 166.94 28.48 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.294 1.996 . . . . 74.41 111.304 170.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -32.79 70.63 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 111.715 0.265 . . . . 73.22 111.715 -176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -64.46 -30.9 71.93 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.063 0.394 . . . . 73.35 112.063 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.5 mp -82.97 -12.98 56.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.518 0.199 . . . . 71.42 111.185 -176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.52 ' HA ' HG21 ' A' ' 68' ' ' VAL . 13.3 ptt180 -119.41 0.56 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.984 0.421 . . . . 63.12 111.245 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -96.38 147.18 24.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.379 0.609 . . . . 73.24 112.108 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD21 HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -116.31 147.21 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.008 -0.996 . . . . 44.02 109.727 172.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 101' ' ' HIS . 29.8 t80 -101.99 118.38 36.78 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.172 -1.048 . . . . 63.1 108.172 171.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 60' ' ' VAL . 21.3 mm -94.78 112.77 27.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 122.108 -0.37 . . . . 72.22 110.228 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.34 150.81 18.18 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.958 -0.639 . . . . 61.52 111.964 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.91 45.14 64.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.168 -0.539 . . . . 62.32 113.586 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 25' ' ' THR . 50.2 mt -76.47 173.07 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.768 0.318 . . . . 72.33 110.409 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 p -84.4 175.55 9.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 43.35 109.485 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 92.1 m-85 -84.03 -6.59 59.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.018 0.437 . . . . 74.14 110.632 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -119.51 12.11 12.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.878 -0.601 . . . . 62.34 111.678 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 21' ' ' LEU . 43.9 m -77.41 132.37 38.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.078 0.466 . . . . 52.03 111.425 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -107.63 167.59 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.633 -0.712 . . . . 75.34 110.054 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -73.77 -24.42 59.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 72.34 111.089 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.67 -35.14 58.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.167 -0.213 . . . . 71.42 110.659 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.8 m -73.23 -38.11 66.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 73.21 110.436 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.95 -45.04 94.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 64.1 110.178 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -60.0 -52.85 63.63 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.948 -0.569 . . . . 65.43 110.559 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m -44.14 -42.3 6.26 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.327 1.017 . . . . 51.1 113.603 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 79' ' ' VAL . 66.6 t60 -70.24 -56.45 6.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.114 -0.494 . . . . 64.12 111.13 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 40' ' ' LEU . 81.8 m-85 -76.05 -17.57 59.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.806 0.299 . . . . 72.03 111.806 -173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.6 -28.37 54.7 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.027 0.531 . . . . 70.32 111.547 172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -65.61 -23.96 66.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.465 -0.788 . . . . 71.45 112.304 -177.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -101.41 -21.98 14.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.057 0.391 . . . . 72.01 112.057 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.81 177.09 48.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.788 -1.196 . . . . 33.15 113.24 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -68.01 119.61 12.91 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.966 0.507 . . . . 74.23 112.268 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 34' ' ' PHE . 52.8 mt -95.66 125.63 40.38 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.636 0.731 . . . . 74.42 110.56 170.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 t -100.92 -17.69 16.69 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.989 -1.005 . . . . 63.05 110.12 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -153.95 151.4 29.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.996 -0.547 . . . . 64.42 109.981 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.8 t -163.04 133.18 4.43 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.98 -0.378 . . . . 73.22 109.98 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 126.82 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.215 0.531 . . . . 62.01 110.613 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.56 131.87 33.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.605 -0.887 . . . . 74.21 108.605 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.9 mmt -79.4 97.44 6.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.773 0.796 . . . . 72.4 110.94 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 30.9 mtp180 -104.51 159.11 16.01 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.314 -1.312 . . . . 72.04 109.008 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.37 125.84 91.06 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.885 -0.598 . . . . 74.44 109.773 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.51 -28.62 87.01 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.214 1.943 . . . . 60.43 113.744 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.92 -55.01 4.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.925 0.393 . . . . 70.15 111.906 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.43 -15.92 21.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.199 0.444 . . . . 65.21 112.199 -171.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 65.43 31.34 10.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.71 0.804 . . . . 74.02 111.747 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -97.92 151.35 20.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.098 -0.704 . . . . 73.24 109.098 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.1 t -72.7 137.63 46.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.95 0.405 . . . . 72.43 110.727 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -89.25 -1.65 58.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.778 -0.646 . . . . 63.22 109.634 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.18 23.52 51.42 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.66 -0.7 . . . . 35.32 113.825 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -161.51 160.72 29.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.887 0.844 . . . . 73.45 111.036 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -162.18 12.19 Favored Glycine 0 C--O 1.226 -0.345 0 N-CA-C 111.588 -0.605 . . . . 71.3 111.588 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -142.32 149.37 39.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.185 0.493 . . . . 75.33 110.105 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 18' ' ' ILE . 7.3 m -130.69 126.4 60.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.057 -0.719 . . . . 75.43 109.057 172.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 m -105.85 120.01 40.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.728 0.299 . . . . 75.4 110.408 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -85.37 171.08 12.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.854 -0.612 . . . . 64.31 109.979 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.7 -25.03 24.99 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.139 0.495 . . . . 71.42 110.488 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 m -143.06 145.4 32.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 64.15 110.916 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.1 p -56.54 -40.02 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.688 -0.687 . . . . 62.21 111.867 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -53.05 -42.03 65.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.974 0.731 . . . . 71.2 112.974 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -65.71 -30.67 71.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.302 0.572 . . . . 74.14 110.569 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 14' ' ' ARG . 17.9 t -67.12 -45.57 86.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.381 -0.827 . . . . 62.45 110.813 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -58.95 -42.94 91.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 71.43 110.622 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.71 -37.37 73.38 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.483 0.549 . . . . 73.12 112.483 171.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.33 74.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.271 0.558 . . . . 71.41 110.226 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.25 -36.25 71.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.783 -0.644 . . . . 72.1 110.786 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.645 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 4.5 p30 -79.94 -11.27 59.81 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.968 0.413 . . . . 75.22 110.952 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.79 -12.06 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 72.41 111.002 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -55.31 149.14 28.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.68 . . . . 74.11 111.827 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 168.7 76.62 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 124.274 -1.136 . . . . 75.12 113.381 2.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -125.77 155.97 40.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.681 -0.691 . . . . 75.2 110.358 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.3 ttmt -136.75 105.34 5.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.086 0.47 . . . . 73.44 111.242 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.439 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.4 t -105.62 125.6 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.6 . . . . 70.41 109.718 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 64.53 33.59 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.776 0.672 . . . . 70.34 111.281 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.88 26.56 73.77 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.018 -0.611 . . . . 52.25 112.239 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.5 tpt180 -127.5 135.62 50.63 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.162 -0.31 . . . . 73.51 110.162 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.95 113.47 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.839 -0.8 . . . . 70.21 108.839 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -106.49 151.99 8.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.356 0.598 . . . . 74.41 111.208 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -113.82 96.55 41.56 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.956 -1.02 . . . . 74.02 110.697 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.27 129.97 15.71 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 121.741 1.627 . . . . 54.33 110.286 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 50.9 mmtt -121.26 142.01 50.35 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.844 -0.798 . . . . 74.43 108.844 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.628 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 7.9 tpp180 -64.05 119.51 10.27 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.644 -0.872 . . . . 72.23 108.644 172.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 93.29 0.09 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.601 0.715 . . . . 40.23 110.671 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.483 ' CG2' HG23 ' A' ' 163' ' ' VAL . 8.3 p -66.24 156.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.728 -1.124 . . . . 64.41 110.638 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 p -55.39 153.82 6.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.961 -0.563 . . . . 62.31 111.428 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 92' ' ' ARG . 1.4 tmt_? -57.51 -30.62 65.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.671 -0.695 . . . . 63.21 111.234 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -52.2 52.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.609 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.8 -25.95 59.4 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.789 0.328 . . . . 71.34 110.318 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.7 t -64.4 -17.49 63.82 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.217 -0.447 . . . . 52.43 111.192 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.29 -11.24 59.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.974 0.416 . . . . 73.44 110.738 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -79.96 145.55 61.67 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 109.953 -0.388 . . . . 73.45 109.953 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.3 115.54 4.08 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.43 2.086 . . . . 75.2 112.05 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.65 27.59 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.791 -0.719 . . . . 72.34 112.297 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.01 -36.81 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 72.42 111.671 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 18.2 m170 -104.03 21.2 16.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.485 0.66 . . . . 54.12 110.516 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.2 mt -101.65 -178.55 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.329 -0.85 . . . . 65.51 109.553 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.15 100.64 13.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.462 0.649 . . . . 72.43 111.834 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 p -133.17 121.97 44.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 74.53 108.181 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 60.5 mttt -106.59 19.68 20.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 63.1 110.505 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.43 139.1 50.81 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.378 -0.373 . . . . 73.21 110.662 179.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 159' ' ' VAL . 7.5 pt -131.7 149.62 33.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.266 0.555 . . . . 70.03 111.293 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 t80 -93.45 137.91 32.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.873 -1.058 . . . . 70.31 109.582 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.82 108.93 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.345 -0.613 . . . . 55.43 109.345 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.84 147.6 18.08 Favored Glycine 0 CA--C 1.505 -0.587 0 C-N-CA 119.673 -1.251 . . . . 75.05 112.973 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.87 6.35 22.96 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.32 -0.943 . . . . 73.13 111.981 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 112' ' ' ILE . 26.7 pt -76.45 99.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 122.072 0.939 . . . . 64.13 109.055 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -91.47 -6.13 53.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.161 -0.927 . . . . 62.05 112.126 -166.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -126.47 -162.52 1.15 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.024 -0.362 . . . . 60.12 110.024 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.22 67.98 8.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 54.12 111.003 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -75.56 136.42 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.321 0.581 . . . . 71.24 109.799 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.3 166.12 10.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.272 -0.876 . . . . 72.32 111.436 -171.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.01 -53.17 61.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.336 -0.847 . . . . 74.5 110.516 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.23 -12.76 58.16 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.388 0.514 . . . . 73.1 112.388 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 m170 -73.01 -57.74 3.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.084 0.468 . . . . 75.21 109.764 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 pp -81.47 -28.62 34.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.143 -0.623 . . . . 71.14 110.544 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -64.3 -53.22 52.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.657 -0.247 . . . . 74.14 110.592 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.6 -26.4 68.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.979 0.419 . . . . 55.14 110.486 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.1 -54.59 8.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.815 -0.629 . . . . 74.21 111.194 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -68.32 -23.53 64.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.5 -0.318 . . . . 73.44 111.609 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.427 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.4 mt-10 -65.92 -26.18 67.48 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.886 0.374 . . . . 65.23 111.236 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -56.9 -30.1 63.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.935 -0.575 . . . . 73.53 111.31 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -86.26 -26.8 24.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.344 -0.389 . . . . 74.3 111.936 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.69 46.41 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.372 -0.918 . . . . 63.33 113.353 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.45 131.77 41.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.078 0.466 . . . . 61.31 111.316 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 152' ' ' THR . 52.4 mt -105.09 141.18 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 64.43 110.082 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -90.64 -54.44 3.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 54.23 110.796 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -152.76 155.32 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.379 -0.373 . . . . 73.14 110.289 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.54 129.48 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.057 0.456 . . . . 62.32 109.828 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 21.6 mt-10 -101.78 103.41 14.14 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.291 -0.868 . . . . 55.25 110.566 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.5 mm -92.47 118.98 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.067 -0.716 . . . . 53.24 109.067 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 73.1 mmm -90.46 109.36 20.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.283 0.564 . . . . 72.4 110.554 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 2.1 m -132.51 153.51 50.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 73.01 109.846 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.22 136.48 38.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.26 -0.644 . . . . 61.42 109.26 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -78.24 -45.13 23.72 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 121.149 -0.22 . . . . 61.44 110.98 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.21 -48.46 58.87 Favored Glycine 0 CA--C 1.518 0.244 0 CA-C-N 116.131 -0.486 . . . . 64.2 113.281 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 m -84.1 -23.96 30.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.727 0.299 . . . . 41.14 111.053 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.12 16.71 78.52 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.054 -0.593 . . . . 74.2 112.119 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -105.13 141.82 36.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.82 -0.223 . . . . 64.01 110.544 -176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 91.7 mttt -74.71 143.26 44.24 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.986 -0.746 . . . . 64.42 108.986 173.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -81.35 20.23 0.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.325 0.861 . . . . 72.34 113.325 -167.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.03 10.31 64.88 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.893 -0.67 . . . . 53.03 113.624 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.28 158.96 33.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.104 0.478 . . . . 75.23 109.764 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.91 176.91 8.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.255 -0.884 . . . . 60.44 109.633 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 51.6 m-85 -139.84 151.73 45.92 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.28 -0.873 . . . . 75.32 109.128 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -146.09 134.04 15.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.281 0.562 . . . . 75.43 110.95 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.8 m -105.7 127.66 53.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.071 -0.968 . . . . 74.11 110.983 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -101.72 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.782 0.325 . . . . 74.23 110.874 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.26 -23.3 30.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.825 -0.625 . . . . 72.21 110.29 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -133.56 158.05 44.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 73.23 110.8 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.568 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 31.2 p80 -83.98 -27.67 28.28 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.646 -0.252 . . . . 74.04 111.377 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -59.45 -42.22 91.48 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.382 0.427 . . . . 75.13 110.886 -176.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -65.43 -32.86 74.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.027 -0.533 . . . . 50.33 110.976 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 163' ' ' VAL . 3.0 t -70.81 -44.75 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.386 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 26.4 m-20 -68.17 -25.41 65.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.719 . . . . 74.53 111.269 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.628 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 96.9 mttt -61.68 -45.2 95.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.842 0.829 . . . . 62.44 110.276 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.6 mt -75.55 -43.26 41.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.492 -1.231 . . . . 70.12 112.387 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.483 HG23 ' CG2' ' A' ' 90' ' ' VAL . 15.9 m -75.01 -5.59 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 74.5 111.096 -174.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 160' ' ' ASP . 31.1 mt -57.97 -31.45 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.42 -0.809 . . . . 63.23 109.748 168.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -114.49 109.35 18.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.557 -0.747 . . . . 65.4 109.095 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -55.66 -31.9 62.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.955 -0.566 . . . . 65.45 112.259 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -123.62 137.3 54.76 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.649 -0.421 . . . . 74.45 111.622 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -129.0 149.24 50.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.578 -0.737 . . . . 74.0 109.622 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.5 m -110.92 124.64 52.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.885 0.374 . . . . 64.21 110.935 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.58 131.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.985 -0.552 . . . . 73.31 109.983 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 72.44 23.24 3.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 122.42 1.105 . . . . 72.55 109.63 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.7 85.96 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.155 -0.93 . . . . 62.14 112.097 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -118.91 122.14 41.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.318 . . . . 63.31 110.816 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.81 108.07 18.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.751 -0.833 . . . . 71.3 108.751 172.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.0 p -110.1 154.3 23.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.426 -0.807 . . . . 51.34 111.101 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -86.62 127.77 34.95 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.626 -0.715 . . . . 75.14 109.681 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.8 t -124.87 128.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.352 -0.84 . . . . 62.4 109.987 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -154.35 171.47 19.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.414 -0.812 . . . . 61.41 111.26 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -58.02 123.61 16.49 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.465 0.478 . . . . 71.12 111.287 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.81 118.82 31.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.995 -0.548 . . . . 71.22 109.723 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.72 127.9 46.96 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.486 -0.561 . . . . 72.24 109.486 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -70.81 166.89 20.05 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.464 -0.569 . . . . 61.22 109.464 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -65.74 -25.41 67.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.782 0.325 . . . . 74.21 110.969 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.85 -38.97 87.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.993 -0.549 . . . . 35.5 110.181 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -81.79 -42.92 19.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.613 -0.721 . . . . 75.52 110.852 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.08 -58.96 6.21 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.028 -0.533 . . . . 64.02 111.141 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.88 -17.99 62.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 45.32 111.106 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.9 m 60.74 30.56 19.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.478 0.656 . . . . 64.42 110.54 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.21 166.75 23.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.366 -0.834 . . . . 73.23 110.0 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.0 m -65.02 123.64 19.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.548 0.53 . . . . 62.5 110.539 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.7 t -136.77 142.84 42.99 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.871 -0.789 . . . . 73.05 108.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.9 m -77.94 158.72 29.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.438 -0.346 . . . . 71.35 111.011 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -70.34 169.39 13.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.985 0.422 . . . . 74.23 110.703 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -79.62 -24.73 41.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.196 -0.456 . . . . 62.31 110.668 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 43.75 10.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.022 -0.609 . . . . 64.11 111.968 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.683 -0.675 . . . . 53.24 109.67 -177.811 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 112.867 -0.093 . . . . 71.31 112.867 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -82.35 129.21 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 53.42 110.561 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -70.03 -31.88 69.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.784 -0.644 . . . . 64.23 112.362 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -92.4 -3.77 54.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.455 . . . . 65.24 110.851 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -86.95 119.4 27.12 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.436 -0.579 . . . . 74.3 109.436 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m 57.67 79.02 0.34 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 124.082 0.864 . . . . 73.51 111.2 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.51 155.53 59.39 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.659 2.239 . . . . 61.14 112.031 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.97 -15.27 14.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.228 -0.442 . . . . 75.2 110.706 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.49 133.78 86.89 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.683 . . . . 74.2 110.461 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -66.66 162.73 35.86 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.824 2.349 . . . . 74.25 110.59 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.1 pt-20 -60.34 -30.54 69.59 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 111.819 0.303 . . . . 61.22 111.819 -174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.78 -34.63 75.87 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.871 0.323 . . . . 75.33 111.871 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.75 -15.1 58.85 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.964 0.412 . . . . 74.2 110.839 -174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' HA ' HG21 ' A' ' 68' ' ' VAL . 24.3 ptt180 -121.58 6.61 10.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.754 -0.657 . . . . 73.3 110.824 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.4 ttmm -95.19 148.77 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.709 0.766 . . . . 60.02 111.563 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 68' ' ' VAL . 78.0 mt -115.8 139.48 50.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.643 -1.162 . . . . 70.01 110.078 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -96.68 113.26 24.8 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.407 -0.96 . . . . 65.23 108.407 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 60' ' ' VAL . 15.6 mm -92.67 111.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.208 -0.451 . . . . 72.0 110.252 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.77 147.63 16.72 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.086 -0.578 . . . . 73.25 112.063 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.77 48.57 33.93 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 72.44 113.399 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 25' ' ' THR . 73.2 mt -79.86 176.94 9.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.118 -0.327 . . . . 75.34 110.118 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 77.7 p -89.84 169.57 11.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.003 -0.74 . . . . 42.25 109.003 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -77.24 -3.61 40.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.973 0.416 . . . . 74.21 111.377 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.32 13.4 13.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.017 -0.538 . . . . 74.12 111.29 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 HD22 ' A' ' 21' ' ' LEU . 31.0 m -73.13 126.31 29.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 65.21 110.403 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.2 p -105.91 165.53 11.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 61.43 109.816 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.81 -24.69 65.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.613 0.244 . . . . 74.34 110.958 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.96 -35.41 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 65.44 111.859 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 p -77.52 -36.1 52.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.93 0.395 . . . . 74.22 110.362 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.07 -48.51 78.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.62 -0.718 . . . . 63.24 109.681 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 31' ' ' ARG . 43.9 ttm180 -54.47 -60.05 3.87 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.432 -0.804 . . . . 73.02 111.878 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -47.82 -38.91 16.97 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.9 0.75 . . . . 71.2 112.691 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -66.99 -56.08 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.476 -0.329 . . . . 71.11 111.084 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 40' ' ' LEU . 70.6 m-85 -76.01 -18.59 59.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.676 0.274 . . . . 61.32 111.665 -174.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -58.11 -22.5 51.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.217 0.607 . . . . 74.45 111.783 172.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -67.79 -27.65 66.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.711 -0.677 . . . . 54.12 112.208 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.16 -20.64 15.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.608 0.225 . . . . 64.53 111.608 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.51 165.49 35.84 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.259 -0.972 . . . . 60.12 112.375 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.4 m -71.69 119.71 16.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.018 0.437 . . . . 74.41 111.458 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 34' ' ' PHE . 95.2 mt -84.36 138.29 32.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.567 -0.742 . . . . 73.51 110.967 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.0 p -97.79 -25.36 15.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.808 . . . . 74.43 110.161 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -150.68 150.26 30.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.873 -0.603 . . . . 63.11 110.164 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.9 t -158.71 126.37 5.03 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.129 -0.323 . . . . 71.01 110.129 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.62 126.35 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.339 0.59 . . . . 72.43 110.513 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.73 133.08 33.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.766 -0.828 . . . . 72.01 108.766 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.488 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mmt -78.21 99.66 6.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.074 0.464 . . . . 64.55 110.692 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -100.66 161.04 13.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.43 -0.805 . . . . 74.52 110.498 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -83.89 123.81 75.44 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.031 -0.986 . . . . 72.51 110.055 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.87 -24.56 74.31 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.224 1.949 . . . . 73.34 113.463 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -84.24 -54.92 4.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 74.25 111.505 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.38 -14.45 28.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 75.5 112.12 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm 62.61 31.16 16.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.883 0.873 . . . . 73.43 111.662 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -114.71 155.6 26.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.648 -0.871 . . . . 71.42 108.648 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.3 t -70.34 133.89 47.38 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.05 -0.352 . . . . 65.53 110.05 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -81.68 4.98 19.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.856 -0.611 . . . . 72.32 111.106 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.65 15.8 65.13 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.739 -0.743 . . . . 73.24 113.882 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 33.0 p90 -156.31 155.2 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.764 0.782 . . . . 73.41 110.625 175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.04 -168.11 21.55 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.448 -0.661 . . . . 72.31 111.448 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.69 146.36 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.164 0.482 . . . . 70.43 110.634 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 18' ' ' ILE . 12.9 m -131.77 121.3 47.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 75.11 109.911 174.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.0 m -97.58 123.0 41.31 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.638 -0.504 . . . . 63.35 109.638 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -86.03 175.21 8.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.033 0.444 . . . . 74.04 110.918 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.73 -45.54 16.92 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.016 -0.538 . . . . 72.24 110.005 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -120.08 149.48 42.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.127 -0.488 . . . . 61.14 110.162 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.8 p -65.4 -30.9 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 123.131 0.269 . . . . 55.11 111.266 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.94 -39.74 87.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.183 0.438 . . . . 72.45 112.183 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -26.5 68.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 74.21 110.784 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 16' ' ' LEU . 40.4 t -63.79 -50.83 76.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.744 -0.662 . . . . 74.41 110.59 172.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.29 -37.96 87.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.139 -0.482 . . . . 60.15 111.594 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.79 -40.01 62.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.029 0.381 . . . . 72.12 112.029 170.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.47 -33.86 58.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.816 0.341 . . . . 74.33 110.445 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -63.97 -41.75 97.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.438 -0.346 . . . . 75.05 110.642 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -30.3 63.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.965 -0.561 . . . . 70.35 110.902 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.72 -13.2 61.9 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.791 0.663 . . . . 55.0 112.791 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -55.06 148.98 26.48 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 112.212 0.449 . . . . 75.42 112.212 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.65 157.26 92.77 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.57 -1.429 . . . . 61.53 114.088 3.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -112.76 156.5 22.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.555 -0.748 . . . . 75.22 110.867 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 20.3 ttmt -139.45 110.35 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.345 -0.389 . . . . 62.42 111.539 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.04 130.65 64.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.011 -0.541 . . . . 71.34 109.81 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 65.22 26.56 12.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.867 0.842 . . . . 74.4 110.538 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.68 24.13 70.84 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.949 -0.643 . . . . 60.42 112.461 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 tpt180 -127.07 139.75 52.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.76 -0.459 . . . . 74.31 109.76 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -76.07 112.68 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 54.4 109.46 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -109.27 150.23 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.332 0.587 . . . . 74.21 110.996 -176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -114.82 96.38 44.26 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.242 -0.89 . . . . 53.34 111.486 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.46 ' O ' ' HE1' ' A' ' 72' ' ' MET . 19.3 Cg_endo -70.59 131.68 20.53 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.236 1.291 . . . . 52.53 110.556 170.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 156' ' ' HIS . 24.3 mttt -129.74 171.83 12.27 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.887 -0.783 . . . . 73.23 108.887 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -83.54 126.19 32.55 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.209 -0.996 . . . . 75.14 109.623 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.22 103.46 0.63 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.879 -0.601 . . . . 45.33 111.887 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.53 150.06 9.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.968 -1.015 . . . . 44.1 108.309 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -53.7 129.69 34.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.63 -0.507 . . . . 65.14 109.63 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -59.03 -24.29 62.7 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.516 0.51 . . . . 73.54 111.931 -172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.98 -54.81 41.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 73.1 110.549 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.38 -14.75 58.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.679 . . . . 54.33 111.201 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 t -64.85 -17.42 64.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.633 -0.712 . . . . 75.42 111.218 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -68.67 -21.71 64.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.286 -0.416 . . . . 75.11 111.013 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -78.73 143.94 63.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.072 -0.344 . . . . 60.12 110.072 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.37 117.86 5.33 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.724 2.283 . . . . 73.11 112.441 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.51 26.36 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.772 . . . . 61.25 112.658 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.88 86.6 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.351 0.26 . . . . 62.13 111.625 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -107.24 12.87 27.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.153 0.427 . . . . 70.1 112.153 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 49.3 mt -77.24 155.75 31.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.894 -0.409 . . . . 73.22 109.894 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -76.96 88.96 3.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.178 0.513 . . . . 64.24 110.799 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.84 135.69 63.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.84 -1.17 . . . . 73.31 107.84 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.412 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.5 mttt -112.13 20.71 16.59 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.379 0.609 . . . . 64.52 110.202 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.22 142.1 47.27 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.505 -0.771 . . . . 73.13 110.288 176.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.431 HG23 HG13 ' A' ' 159' ' ' VAL . 7.4 pt -126.85 149.63 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.165 0.507 . . . . 63.02 111.066 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.6 t80 -101.45 136.39 41.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.072 -0.967 . . . . 73.12 109.016 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 7.1 t -125.88 109.28 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.544 -0.539 . . . . 75.23 109.544 177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.07 146.98 17.08 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.27 -0.967 . . . . 65.14 112.309 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.8 50.3 4.72 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.541 -1.024 . . . . 63.21 110.541 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.596 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 15.2 pt -91.55 -177.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.04 -0.58 . . . . 64.33 111.481 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.58 ' HD3' ' ND2' ' A' ' 171' ' ' ASN . 87.5 tttt -84.79 154.67 22.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.817 -0.629 . . . . 72.52 109.757 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -59.25 -37.2 77.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.814 0.34 . . . . 64.51 110.952 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -108.3 85.48 2.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.153 -0.476 . . . . 74.3 110.016 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 m -123.61 122.78 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.695 0.759 . . . . 71.31 110.426 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.7 pt-20 -113.22 172.47 6.93 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.471 -1.241 . . . . 53.24 110.723 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -48.22 73.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.85 -1.068 . . . . 72.12 110.128 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -57.19 -34.78 68.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.847 -0.615 . . . . 71.23 111.817 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.453 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 31.0 m170 -61.27 -60.16 4.18 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.676 0.274 . . . . 65.4 111.479 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD13 HG22 ' A' ' 151' ' ' VAL . 3.2 pp -82.63 -22.39 34.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.519 -0.872 . . . . 73.04 111.461 -174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -68.32 -50.74 51.27 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.485 -0.191 . . . . 73.34 110.485 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.43 -30.76 68.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.086 0.47 . . . . 53.22 110.436 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.71 -57.08 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.7 -0.682 . . . . 71.11 112.269 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -69.17 -22.74 63.9 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.918 0.71 . . . . 73.24 112.918 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.2 mt-10 -68.76 -23.23 64.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.852 0.358 . . . . 73.41 111.021 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -59.1 -26.53 64.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.058 -0.519 . . . . 75.2 111.232 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.11 -33.87 20.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 55.14 111.521 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.432 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 179.54 -174.96 46.62 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.309 -0.948 . . . . 52.43 113.726 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -76.45 129.11 36.06 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.045 0.45 . . . . 74.2 111.613 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.82 137.95 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 75.51 109.975 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.49 -52.03 5.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.055 -0.521 . . . . 63.5 110.518 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.0 p -156.12 157.32 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 51.43 109.779 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.22 129.58 72.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.897 0.38 . . . . 65.21 110.228 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.0 mt-10 -103.4 104.16 14.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.562 -0.744 . . . . 70.02 110.767 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 35.1 mm -92.99 112.63 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.831 -0.803 . . . . 63.35 108.831 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 78.8 mmm -86.07 117.57 24.99 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.468 -0.493 . . . . 75.33 109.873 -173.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.96 160.16 37.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.681 -0.69 . . . . 63.44 110.741 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.11 143.11 28.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.801 -0.636 . . . . 71.45 109.41 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -68.83 -40.35 79.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.248 -0.433 . . . . 75.51 111.74 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.62 -46.94 3.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.638 -0.792 . . . . 33.51 113.457 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -82.81 -24.02 33.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.689 0.245 . . . . 54.35 111.335 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.13 76.01 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.638 . . . . 42.13 112.727 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 164.14 12.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.658 -0.497 . . . . 73.1 109.658 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -62.9 146.21 53.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 63.41 111.08 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -72.97 -2.6 21.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.996 -0.547 . . . . 75.13 111.603 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 145' ' ' LYS . . . 97.83 -0.82 59.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.417 -0.673 . . . . 34.14 111.417 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -160.43 168.17 25.74 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.902 -0.407 . . . . 75.22 109.902 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.407 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.12 169.55 17.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.543 -0.753 . . . . 61.34 109.184 176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.419 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 44.2 m-85 -132.21 144.66 50.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.153 0.501 . . . . 73.32 110.164 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.481 HG22 HD13 ' A' ' 121' ' ' LEU . 25.5 t -128.77 130.42 68.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.303 -0.408 . . . . 64.21 110.284 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 131' ' ' ILE . 94.0 m -105.94 120.62 42.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 71.2 110.941 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.3 160.44 14.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.936 0.398 . . . . 63.34 111.013 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.59 -31.38 41.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.599 -0.728 . . . . 71.51 110.61 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -128.85 155.85 44.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.662 -0.699 . . . . 74.42 110.81 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.449 ' CE1' ' HG2' ' A' ' 87' ' ' LYS . 20.6 p80 -77.18 -28.54 54.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.339 -0.391 . . . . 75.3 110.063 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.08 -48.45 33.48 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.037 0.836 . . . . 62.35 112.089 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.432 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 1.8 m -74.59 -27.87 60.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.702 -0.681 . . . . 65.52 111.016 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 107' ' ' ILE . 3.7 t -73.76 -41.33 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.105 -0.498 . . . . 72.23 109.979 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.479 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 6.9 m-20 -69.7 -23.45 63.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.772 -0.649 . . . . 63.4 110.988 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -65.36 -43.09 91.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.624 0.726 . . . . 53.22 110.392 170.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mt -73.19 -39.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.638 -1.164 . . . . 65.33 111.789 -172.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 160' ' ' ASP . 19.1 m -76.54 -8.45 11.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.382 . . . . 63.12 111.04 -175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 16.3 mt -64.21 -34.12 66.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 121.532 0.682 . . . . 71.35 109.859 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.51 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 58.5 mt-30 -109.13 96.99 6.68 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.796 -1.187 . . . . 71.12 107.796 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -56.55 -30.61 63.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.748 -0.66 . . . . 53.31 112.522 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.909 -0.317 . . . . 74.51 110.514 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.4 m-70 -125.71 152.53 45.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.979 -0.555 . . . . 74.35 109.56 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 32.1 m -101.76 105.91 16.85 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.173 0.511 . . . . 73.31 110.053 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.6 t -114.03 138.05 45.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.544 -0.753 . . . . 75.0 109.401 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.58 ' ND2' ' HD3' ' A' ' 113' ' ' LYS . 59.7 t30 49.69 36.21 10.34 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.579 0.704 . . . . 63.42 112.591 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.96 5.46 90.12 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.968 -0.56 . . . . 62.43 114.122 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -129.3 134.5 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.424 0.612 . . . . 72.44 111.324 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 20.3 t-20 -81.04 112.37 18.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.545 . . . . 73.41 110.853 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 11.6 m -110.32 156.25 21.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.658 -0.701 . . . . 63.42 110.339 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 24.0 tt0 -89.41 140.93 29.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.337 -0.392 . . . . 71.15 110.369 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.0 m -130.39 162.99 37.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.973 0.416 . . . . 73.22 111.014 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -174.68 175.0 2.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.023 -0.989 . . . . 71.03 111.767 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -67.9 122.6 18.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.678 -0.692 . . . . 75.23 109.508 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -112.4 148.64 33.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.126 0.488 . . . . 61.31 110.413 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.36 160.15 26.0 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.925 -0.768 . . . . 63.11 108.925 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 186' ' ' MET . 14.9 t -75.56 161.03 29.51 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.145 -0.687 . . . . 75.42 109.145 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -56.31 -41.51 76.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.838 0.352 . . . . 62.12 110.58 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -63.57 -34.48 77.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 74.33 111.459 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.25 -37.88 57.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 65.55 110.87 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.427 ' HG3' ' O ' ' A' ' 182' ' ' SER . 85.3 mtp -73.22 -29.41 62.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.928 -0.578 . . . . 75.31 110.843 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.49 -6.87 58.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 54.51 110.862 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.4 m 62.3 25.47 15.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.851 0.719 . . . . 74.41 111.557 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -124.43 89.88 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.872 -0.604 . . . . 71.41 110.154 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.2 m -64.48 112.13 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.946 -0.57 . . . . 74.14 110.36 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.1 p -149.87 142.43 24.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.875 -0.602 . . . . 73.43 110.4 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.2 m -116.1 60.83 0.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.22 0.533 . . . . 71.42 110.156 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.84 120.05 19.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.695 -0.684 . . . . 74.21 109.881 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -123.72 131.69 53.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.935 -0.575 . . . . 72.03 111.111 -174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -113.69 -97.4 2.25 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.195 -1.162 . . . . 71.22 110.195 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.548 -0.739 . . . . 75.23 109.59 173.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.87 -0.492 . . . . 75.12 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -74.92 -37.37 62.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.828 0.347 . . . . 51.14 110.939 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -89.16 80.78 6.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.344 0.592 . . . . 63.43 110.911 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 m -97.95 85.99 3.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.552 -0.749 . . . . 73.22 109.675 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.98 144.27 31.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.218 -0.66 . . . . 75.12 109.218 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m -70.39 115.75 38.08 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.341 -0.614 . . . . 65.05 109.341 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 63' ' ' ALA . 68.0 Cg_endo -75.02 166.75 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.498 2.132 . . . . 52.13 112.417 -173.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -68.58 -20.49 64.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.478 -0.783 . . . . 62.31 109.782 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -82.14 125.24 77.55 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.669 -0.696 . . . . 74.44 109.983 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD2' HD22 ' A' ' 13' ' ' LEU . 18.8 Cg_endo -61.07 168.35 7.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.508 2.805 . . . . 64.3 112.822 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.57 -39.67 35.88 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.597 -0.729 . . . . 73.42 112.752 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 4.3 pt20 -62.65 -35.85 80.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.523 0.329 . . . . 71.52 111.869 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 10' ' ' PRO . 8.5 mp -79.16 -45.41 20.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.918 -0.313 . . . . 72.13 110.38 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 62' ' ' TYR . 18.0 ptt85 -76.7 2.02 15.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.03 0.381 . . . . 65.21 112.03 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.6 ttpt -95.54 147.9 23.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.671 0.748 . . . . 61.04 110.976 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD21 HG13 ' A' ' 68' ' ' VAL . 54.7 mt -117.25 145.15 44.12 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.835 -1.075 . . . . 52.52 110.625 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -98.7 119.48 37.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 65.04 108.405 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 60' ' ' VAL . 14.4 mm -99.54 111.24 28.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.703 -0.48 . . . . 75.52 109.703 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.92 154.36 16.98 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.673 -0.775 . . . . 60.25 111.553 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.94 39.89 53.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.583 -0.818 . . . . 64.13 113.489 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' THR . 72.5 mt -80.0 174.5 11.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.009 -0.367 . . . . 65.43 110.009 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.9 p -88.38 168.5 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.659 -0.867 . . . . 52.44 108.659 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.4 -4.29 53.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.243 0.544 . . . . 74.13 110.188 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -106.53 5.84 29.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.378 -0.828 . . . . 73.15 111.411 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 21' ' ' LEU . 32.7 m -75.02 132.91 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.999 0.428 . . . . 63.34 111.168 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.622 ' HB ' ' OE2' ' A' ' 28' ' ' GLU . 19.0 p -112.41 168.38 9.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.217 -0.66 . . . . 60.5 109.217 173.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -73.71 -25.9 60.44 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.768 -0.373 . . . . 61.05 110.883 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.622 ' OE2' ' HB ' ' A' ' 26' ' ' THR . 2.0 pm0 -79.89 -32.5 40.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.848 -0.16 . . . . 70.11 111.012 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.7 p -75.92 -35.23 59.85 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.143 0.497 . . . . 74.14 109.828 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.59 -48.12 70.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.533 -0.758 . . . . 73.31 110.036 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -53.93 -58.75 6.14 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.071 -0.513 . . . . 72.23 111.475 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 8.7 t -51.41 -30.88 20.68 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.698 0.624 . . . . 70.42 112.214 -177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.437 ' CD2' HG22 ' A' ' 79' ' ' VAL . 64.1 t60 -72.47 -61.63 1.73 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.739 -0.21 . . . . 53.34 110.88 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -71.11 -22.78 62.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.086 0.402 . . . . 74.25 112.086 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 29.2 tt0 -67.0 -17.97 65.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.259 0.552 . . . . 71.05 110.869 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' SER . 22.7 mt-30 -64.35 -24.14 67.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.791 -0.64 . . . . 64.02 111.503 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -102.52 -17.67 15.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.373 -0.376 . . . . 73.22 111.63 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -177.82 163.54 31.93 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.311 -0.947 . . . . 73.32 112.582 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -68.12 118.09 10.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.076 0.465 . . . . 50.42 111.579 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.2 mt -88.04 129.02 35.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.68 0.752 . . . . 62.45 111.474 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -93.23 -24.64 18.12 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.882 -1.054 . . . . 71.11 109.838 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.46 152.3 32.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.08 -0.964 . . . . 75.05 109.584 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.416 ' SG ' HG12 ' A' ' 60' ' ' VAL . 16.8 t -164.08 126.59 2.44 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.297 -0.631 . . . . 74.35 109.297 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 p -145.69 113.83 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-O 121.726 0.774 . . . . 71.23 110.11 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -80.64 139.54 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.557 -0.905 . . . . 71.4 108.557 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.46 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 7.4 mmt -77.33 139.37 39.75 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.979 -0.748 . . . . 72.23 108.979 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -139.78 157.13 46.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.816 -0.629 . . . . 71.11 111.749 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 29.2 t70 -70.71 134.67 86.07 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.672 -1.149 . . . . 45.24 109.939 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HD3' HH21 ' A' ' 55' ' ' ARG . 57.2 Cg_endo -75.26 -17.25 19.15 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.171 1.914 . . . . 71.53 113.297 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 50' ' ' ASN . 0.9 OUTLIER -85.79 -56.15 3.63 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.997 0.369 . . . . 54.05 111.997 -176.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -105.75 -9.15 17.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.321 -0.4 . . . . 52.11 111.218 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 28.3 mmtp 66.67 39.81 3.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.658 -0.701 . . . . 53.13 111.168 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -105.87 159.88 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.315 -0.624 . . . . 72.53 109.315 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.6 t -65.56 140.44 58.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.428 . . . . 75.51 110.875 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.443 HH21 ' HD3' ' A' ' 49' ' ' PRO . 56.0 mtt-85 -85.87 -3.64 58.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.818 -0.628 . . . . 64.03 110.554 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.45 60.2 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.514 -0.85 . . . . 70.32 113.754 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 28.8 p90 -157.98 155.03 28.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.627 0.713 . . . . 74.54 110.268 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.27 -167.32 20.66 Favored Glycine 0 C--O 1.226 -0.37 0 N-CA-C 111.875 -0.49 . . . . 60.55 111.875 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.38 148.42 37.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.15 0.475 . . . . 72.51 110.327 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 43' ' ' CYS . 13.1 m -132.18 131.14 61.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.545 . . . . 73.11 109.981 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HD3' ' A' ' 15' ' ' LYS . 5.2 m -106.19 120.16 41.1 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.24 -0.287 . . . . 61.41 110.248 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.553 ' O ' ' HD2' ' A' ' 14' ' ' ARG . 27.8 m-85 -85.7 162.93 18.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.698 0.285 . . . . 74.21 110.636 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . -75.3 -44.4 45.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 75.45 110.66 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.27 154.21 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 64.4 111.058 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.07 -41.3 88.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.379 -0.373 . . . . 74.51 111.055 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -48.39 -40.97 27.51 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.57 0.581 . . . . 63.21 112.57 173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -73.8 -25.06 59.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.404 . . . . 74.22 111.093 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 HD21 ' A' ' 16' ' ' LEU . 13.0 t -68.79 -44.37 82.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.276 -0.42 . . . . 35.24 109.986 171.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.39 -50.08 72.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 73.32 111.034 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.01 22.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.758 -0.656 . . . . 45.42 112.701 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.61 57.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.178 0.514 . . . . 64.32 110.825 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.5 mmt -72.78 -40.31 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.894 -0.594 . . . . 75.31 111.434 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -19.53 61.51 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.278 0.561 . . . . 71.34 110.154 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.13 -9.01 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.709 -0.678 . . . . 62.21 111.541 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -60.08 146.1 83.57 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.402 0.144 . . . . 50.2 111.326 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.41 164.63 86.17 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 124.091 -1.212 . . . . 54.12 113.24 0.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -118.16 155.12 31.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.831 -0.622 . . . . 72.21 111.084 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 16.7 ttmt -141.92 107.04 4.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.102 -0.499 . . . . 71.33 111.176 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 33' ' ' HIS . 11.9 t -106.38 129.42 59.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.755 -0.657 . . . . 72.12 109.53 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 67.91 21.39 8.99 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.745 0.783 . . . . 72.31 110.811 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.57 24.16 65.86 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.869 -0.682 . . . . 62.44 111.771 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.1 tpt180 -124.05 136.93 54.6 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.267 -0.642 . . . . 64.51 109.267 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.64 112.02 18.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.394 0.616 . . . . 51.12 109.626 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.9 m -107.38 150.84 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.011 -0.541 . . . . 70.3 110.974 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -112.86 95.46 33.73 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.221 -0.899 . . . . 74.24 110.828 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -77.51 127.8 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.95 1.767 . . . . 72.31 111.095 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HA ' ' HE1' ' A' ' 156' ' ' HIS . 40.5 mttt -132.45 171.12 14.18 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 74.23 109.163 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -70.72 133.22 46.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.765 -0.457 . . . . 71.23 109.765 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -67.61 96.62 0.55 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.418 0.628 . . . . 65.24 109.666 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.418 HG22 ' OD1' ' A' ' 160' ' ' ASP . 16.1 t -56.55 135.48 20.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.347 -1.297 . . . . 64.35 111.643 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 t -54.61 143.84 23.5 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.245 -0.889 . . . . 72.14 109.846 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -61.04 -18.45 57.86 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.43 0.456 . . . . 75.33 112.137 -173.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.97 -45.24 61.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.458 -0.337 . . . . 74.42 110.741 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -84.31 -31.56 24.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.688 -0.233 . . . . 74.04 111.066 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 21.7 p -76.48 4.05 9.97 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.062 0.458 . . . . 65.41 111.257 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -86.11 -10.09 55.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.619 0.723 . . . . 44.51 109.138 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -94.94 150.64 38.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.44 -0.8 . . . . 75.14 109.872 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.54 124.87 7.91 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.585 2.19 . . . . 75.12 112.511 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.46 30.27 11.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.162 -0.542 . . . . 62.44 112.23 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.98 -30.28 24.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.976 0.362 . . . . 72.11 111.976 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.18 8.49 44.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.654 0.264 . . . . 74.52 111.55 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.14 159.68 31.34 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.717 -0.475 . . . . 65.03 109.717 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 80.28 7.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.595 0.712 . . . . 74.05 110.481 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 p -108.78 118.46 56.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.075 -0.966 . . . . 72.23 109.46 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -105.53 21.34 17.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.612 . . . . 62.23 110.081 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -119.2 139.7 51.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 71.42 110.997 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 159' ' ' VAL . 6.7 pt -130.95 149.87 34.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.305 0.574 . . . . 65.44 111.386 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.8 t80 -94.78 133.33 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.716 -1.129 . . . . 72.13 109.906 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.58 109.55 25.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.063 -0.717 . . . . 73.14 109.063 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.84 159.72 21.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.569 -1.3 . . . . 72.14 113.755 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.07 6.45 53.84 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.697 -0.764 . . . . 74.31 112.406 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.0 pt -66.38 124.48 21.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.26 0.553 . . . . 75.14 109.877 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -91.45 -21.57 20.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.807 -0.633 . . . . 73.1 112.284 -169.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -142.16 -168.41 2.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.467 -0.197 . . . . 65.34 110.467 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -55.42 101.48 0.05 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 124.073 0.858 . . . . 73.54 111.364 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -109.63 124.23 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.63 -0.878 . . . . 64.24 108.63 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -113.01 -179.39 3.63 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.585 -0.734 . . . . 64.15 111.635 -169.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.18 -53.66 55.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.929 -1.032 . . . . 70.34 111.493 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.58 -28.24 69.5 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.079 0.237 . . . . 64.54 111.182 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.4 m170 -53.84 -62.65 1.52 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.184 0.516 . . . . 64.31 110.596 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.27 -26.68 28.42 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.113 -0.635 . . . . 64.24 111.532 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 2.0 tmm_? -67.29 -48.28 68.13 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 110.07 -0.345 . . . . 70.51 110.07 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -64.87 -29.76 70.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.99 0.424 . . . . 73.02 110.5 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 168' ' ' HIS . 88.2 t80 -77.39 -56.82 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.081 -0.509 . . . . 71.53 112.078 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -67.49 -21.99 65.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.414 0.524 . . . . 70.31 112.414 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 1.8 mt-10 -69.02 -19.96 64.13 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.527 0.195 . . . . 73.44 111.527 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.09 -30.05 64.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.985 0.421 . . . . 72.21 110.98 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.6 -30.89 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 73.14 111.637 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.23 -172.28 44.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.661 -0.781 . . . . 73.31 112.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -76.22 136.19 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.176 0.512 . . . . 73.13 111.681 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 152' ' ' THR . 90.8 mt -106.54 138.45 32.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 65.44 110.006 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.61 -46.98 8.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 74.24 111.038 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 p -156.56 154.93 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 75.11 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.0 mp -114.62 128.54 71.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.124 0.487 . . . . 73.51 110.046 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 16.8 mt-10 -102.71 104.58 14.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.364 -0.834 . . . . 70.32 111.047 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.86 122.94 43.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.261 -0.644 . . . . 70.31 109.261 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 68.4 mmm -105.74 141.62 36.86 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.907 0.384 . . . . 72.02 110.192 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.79 149.01 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 74.05 110.87 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.05 131.63 41.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.658 -0.701 . . . . 71.35 110.368 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -77.23 -25.08 51.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.76 0.314 . . . . 71.13 111.275 -174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.36 -53.42 2.16 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.634 -0.794 . . . . 52.02 112.82 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -90.56 -24.24 20.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.761 0.315 . . . . 62.31 111.639 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.57 8.53 84.64 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.613 -0.803 . . . . 61.52 112.876 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -80.92 143.99 32.25 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 74.31 110.026 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -73.96 88.64 1.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.508 -0.553 . . . . 73.23 109.508 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -162.44 175.33 11.62 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.697 0.761 . . . . 61.23 111.839 -170.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.09 -46.89 3.45 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.008 -1.451 . . . . 74.51 113.835 171.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -173.04 159.74 4.03 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.054 0.927 . . . . 75.45 110.509 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -142.55 175.69 9.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.436 -0.802 . . . . 61.03 109.182 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.6 m-85 -141.16 154.45 45.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.945 0.402 . . . . 63.22 110.321 -178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.67 132.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.318 0.58 . . . . 71.25 111.271 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 131' ' ' ILE . 26.0 m -101.49 126.6 48.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.344 -0.843 . . . . 75.21 110.883 -177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.53 158.03 16.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 71.42 111.45 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.3 -29.3 53.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.637 -0.71 . . . . 60.43 110.567 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -130.11 155.55 46.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 74.4 110.877 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.412 ' HE1' ' HA ' ' A' ' 87' ' ' LYS . 27.2 p80 -82.89 -26.5 31.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.54 110.351 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 31.9 t70 -64.92 -36.88 85.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.224 -0.444 . . . . 70.12 110.673 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 m -68.7 -32.78 72.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 61.24 110.799 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 107' ' ' ILE . 2.0 t -69.16 -39.86 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 72.32 109.783 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.491 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.1 t70 -69.5 -33.49 72.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.224 -0.898 . . . . 74.4 111.152 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 55.9 mttm -53.54 -38.88 64.25 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.917 0.865 . . . . 75.14 110.29 172.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.403 ' CG2' HG11 ' A' ' 177' ' ' VAL . 33.8 mt -77.78 -45.32 28.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.405 -1.27 . . . . 72.14 113.011 -174.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 160' ' ' ASP . 24.4 m -75.39 -4.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.198 0.523 . . . . 74.44 111.69 -172.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' A' ' 161' ' ' LYS . 14.0 mt -58.35 -32.12 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.877 . . . . 73.22 109.692 169.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.59 148.75 32.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.385 -0.825 . . . . 73.44 108.788 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.41 -37.04 13.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.0 0.429 . . . . 65.53 111.08 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.87 131.92 53.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.169 -0.468 . . . . 75.24 110.145 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.409 ' HB3' ' CE2' ' A' ' 124' ' ' TYR . 87.7 m-70 -122.11 140.56 52.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.065 -0.516 . . . . 61.32 110.337 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.6 m -89.98 106.72 18.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.147 0.499 . . . . 75.41 111.402 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.7 t -119.22 130.15 74.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.83 . . . . 72.14 109.083 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.2 t30 50.22 41.63 24.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.728 0.775 . . . . 74.33 111.641 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.55 69.54 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.616 -0.72 . . . . 41.13 113.347 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -126.52 131.55 51.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.79 0.295 . . . . 51.1 110.453 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.19 108.19 13.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.477 . . . . 72.22 109.711 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.71 146.81 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.179 -0.464 . . . . 71.03 109.755 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -86.4 131.9 34.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.841 0.353 . . . . 72.22 110.228 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 37.4 t -129.19 139.86 50.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.925 -0.58 . . . . 73.21 111.06 -173.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -157.78 171.6 20.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.593 -0.73 . . . . 73.13 111.232 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HD3' HG11 ' A' ' 163' ' ' VAL . 9.0 mmtm -61.22 122.76 15.87 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.854 -0.425 . . . . 75.53 109.854 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -104.82 111.67 24.5 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.339 0.59 . . . . 61.43 109.884 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.6 mt -97.62 150.42 21.17 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.384 -0.825 . . . . 62.31 109.395 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.587 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 36.9 m -68.62 163.13 24.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.67 -0.493 . . . . 74.12 109.67 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -59.06 -41.73 88.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.624 0.249 . . . . 65.14 111.522 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 189' ' ' ALA . 2.0 mp0 -68.27 -34.55 76.37 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 75.21 110.159 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.587 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 0.3 OUTLIER -64.49 -40.55 95.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 60.21 110.582 179.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 182' ' ' SER . 57.5 mtp -72.83 -37.61 67.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 74.51 110.263 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.93 -9.78 58.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.534 . . . . 74.13 111.323 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.6 m 62.67 36.05 13.75 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.657 0.741 . . . . 73.44 110.542 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 184' ' ' GLN . . . -114.88 118.66 34.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.115 -0.948 . . . . 74.11 109.783 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.1 m -70.76 129.79 40.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.105 -0.498 . . . . 70.33 110.84 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.8 t -156.42 147.41 22.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.728 -0.669 . . . . 73.53 109.519 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.0 m -76.45 87.72 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.132 0.492 . . . . 54.25 110.446 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.484 ' HG3' ' H ' ' A' ' 195' ' ' GLY . 35.2 tp60 -132.03 127.96 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.759 -0.655 . . . . 74.11 109.533 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -85.23 21.18 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.205 -0.452 . . . . 73.01 111.73 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.484 ' H ' ' HG3' ' A' ' 193' ' ' GLN . . . 114.32 105.22 2.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.916 -0.659 . . . . 55.33 112.9 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.184 -0.912 . . . . 75.31 109.522 175.648 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.292 -0.323 . . . . 61.1 112.292 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.6 m 56.74 76.69 0.29 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.418 0.687 . . . . 32.45 112.058 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -112.45 80.96 1.4 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.473 -0.785 . . . . 73.41 109.397 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 p -95.22 5.1 52.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.569 0.581 . . . . 75.01 112.569 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.18 91.21 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 74.23 109.748 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 p -90.39 110.69 42.66 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.541 -0.754 . . . . 53.51 111.27 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -84.65 161.56 12.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.369 2.046 . . . . 64.54 111.59 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.28 8.03 5.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.127 0.489 . . . . 71.21 110.838 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.39 137.36 74.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.655 -0.702 . . . . 74.25 110.202 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 10.5 Cg_endo -61.58 161.33 24.8 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.256 1.971 . . . . 74.41 111.386 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -31.02 64.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.164 -0.471 . . . . 62.01 111.664 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.478 ' HG3' HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -64.95 -33.33 75.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.322 0.49 . . . . 64.32 112.322 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 28.8 mt -85.19 -14.58 46.44 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 122.095 -0.378 . . . . 73.51 110.838 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.602 ' HA ' HG21 ' A' ' 68' ' ' VAL . 33.2 ptt180 -117.75 0.8 12.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.229 -0.441 . . . . 74.54 111.363 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -96.71 148.08 23.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.667 0.746 . . . . 72.14 111.53 172.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.549 HD21 HG13 ' A' ' 68' ' ' VAL . 57.7 mt -118.74 144.3 46.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.712 -1.131 . . . . 70.44 110.424 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -96.47 117.02 30.03 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 60' ' ' VAL . 15.9 mm -96.88 110.82 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 109.779 -0.452 . . . . 75.04 109.779 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.43 155.0 16.73 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.507 -0.854 . . . . 54.43 111.578 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.57 45.25 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.774 -0.727 . . . . 53.03 113.244 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 25' ' ' THR . 94.3 mt -79.56 175.4 10.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.954 0.407 . . . . 45.33 110.279 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -88.5 166.73 13.99 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.487 -0.561 . . . . 63.44 109.487 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -75.93 -4.54 41.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.751 0.31 . . . . 71.44 110.846 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -122.68 14.74 10.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 74.34 111.096 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.591 HG21 HD22 ' A' ' 21' ' ' LEU . 94.7 m -79.85 124.33 28.55 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 61.04 110.821 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.1 p -99.78 165.68 11.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.786 -0.643 . . . . 75.04 110.346 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.1 p30 -76.67 -21.09 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.73 -0.388 . . . . 63.15 110.74 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.05 -27.7 30.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 74.44 111.208 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 p -80.36 -36.57 33.83 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.81 -0.441 . . . . 35.3 109.81 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD22 HG22 ' A' ' 45' ' ' VAL . 35.7 tp -61.87 -46.58 88.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.583 -0.735 . . . . 71.04 110.135 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.4 ttm-85 -56.21 -56.58 19.23 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 115.792 -0.64 . . . . 74.04 111.314 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.1 t -50.96 -36.2 37.67 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.853 0.721 . . . . 72.41 112.437 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -70.28 -54.6 11.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.671 -0.24 . . . . 72.31 111.302 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -78.5 -17.18 56.62 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.895 0.332 . . . . 75.21 111.895 -170.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -56.34 -25.65 49.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.454 0.539 . . . . 74.22 112.454 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -64.87 -26.36 68.29 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.255 0.465 . . . . 41.24 112.255 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -99.64 -19.72 16.68 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.727 0.269 . . . . 74.13 111.727 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.36 168.74 40.62 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.289 -0.958 . . . . 70.04 112.343 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -66.96 119.76 12.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.031 0.443 . . . . 72.3 112.008 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -90.61 133.54 35.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.76 -0.654 . . . . 70.51 110.524 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 t -107.43 -19.02 13.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.237 -0.892 . . . . 72.14 110.215 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.08 153.55 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.255 -0.646 . . . . 60.34 109.255 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.46 ' SG ' HG12 ' A' ' 60' ' ' VAL . 11.1 t -165.33 131.43 2.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.993 -0.373 . . . . 71.33 109.993 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.51 128.47 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.509 0.671 . . . . 53.43 111.348 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 27' ' ' ASP . 87.4 t -88.14 133.85 29.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.63 -0.878 . . . . 63.22 108.63 171.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.454 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mmt -74.86 97.66 3.36 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.651 0.738 . . . . 63.14 110.1 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -99.45 152.32 20.12 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.702 -1.135 . . . . 74.41 109.49 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 37.2 t70 -70.04 127.89 92.03 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 115.422 -0.808 . . . . 75.24 110.619 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.56 -19.3 64.86 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.189 1.926 . . . . 62.33 113.111 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.505 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 27.6 m-80 -84.76 -56.4 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.785 0.291 . . . . 71.45 111.785 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -105.48 -8.75 17.88 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.986 0.422 . . . . 64.14 111.849 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp 64.16 40.63 6.75 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.577 0.751 . . . . 65.23 111.626 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -113.83 156.7 23.44 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.952 -0.758 . . . . 74.01 108.952 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m -75.69 131.68 40.04 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.917 -0.313 . . . . 72.23 110.358 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -85.66 5.78 30.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 63.5 111.349 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.86 21.08 60.07 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.617 -0.801 . . . . 65.53 114.204 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.454 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 39.4 p90 -158.99 155.31 27.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.82 0.81 . . . . 74.33 110.343 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.51 -163.13 14.57 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.701 -0.56 . . . . 63.33 111.701 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.85 148.81 37.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.062 0.431 . . . . 75.03 110.224 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 18' ' ' ILE . 8.5 m -128.23 128.53 68.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.826 -0.624 . . . . 72.31 109.345 171.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 m -103.68 118.36 36.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.812 0.339 . . . . 74.35 110.272 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -85.74 161.67 19.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.902 -0.59 . . . . 65.21 109.962 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.05 -44.02 64.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.9 -0.591 . . . . 74.1 110.401 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -120.81 149.22 42.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.916 -0.584 . . . . 64.51 110.845 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 14.9 p -62.88 -37.38 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.565 -0.288 . . . . 70.22 111.044 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.45 -41.74 85.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.588 0.588 . . . . 72.22 112.588 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -63.89 -29.24 70.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.019 0.438 . . . . 73.11 110.78 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 14' ' ' ARG . 38.9 t -63.14 -49.41 83.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.592 -0.731 . . . . 74.03 111.087 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.22 -40.69 94.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.2 111.302 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.96 -38.66 57.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.14 -0.482 . . . . 74.43 112.295 171.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.36 58.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.806 0.336 . . . . 64.04 110.612 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -42.12 87.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 71.44 111.068 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -29.16 66.59 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.041 -0.527 . . . . 73.13 111.015 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.71 -9.29 58.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.075 0.768 . . . . 63.42 113.075 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -54.39 146.61 31.98 Favored Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.169 0.433 . . . . 71.44 112.169 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.4 168.98 72.66 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.312 -1.12 . . . . 75.14 113.385 1.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -123.54 161.19 25.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.532 -0.758 . . . . 71.13 110.39 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.5 ttmt -137.21 112.64 9.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.826 0.346 . . . . 63.21 111.35 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.14 126.98 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.973 -0.558 . . . . 51.24 109.936 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 66.53 26.9 9.82 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.692 0.62 . . . . 72.23 111.915 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.88 23.36 66.91 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.951 -0.643 . . . . 34.43 112.191 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 8.6 tpt180 -126.29 135.43 51.52 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.107 -0.331 . . . . 73.14 110.107 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.66 111.71 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.123 -0.695 . . . . 75.31 109.123 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.3 m -107.7 152.49 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 74.1 111.853 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.26 94.42 30.93 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.762 -1.108 . . . . 74.34 111.402 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -72.19 127.96 13.31 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.678 1.585 . . . . 53.11 110.463 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -131.69 168.88 16.99 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 75.14 109.324 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 10.0 tpp180 -73.25 130.51 40.37 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.977 -0.289 . . . . 64.42 110.562 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.68 93.58 0.73 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.073 0.463 . . . . 74.33 110.3 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.24 156.95 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.369 -0.832 . . . . 51.31 110.546 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 164' ' ' ILE . 0.0 OUTLIER -55.3 154.16 6.31 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.098 0.559 . . . . 74.34 111.808 -177.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -58.16 -40.13 80.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.038 -0.528 . . . . 72.1 111.883 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.92 -50.59 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 50.53 110.651 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -70.74 -29.29 65.49 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.632 -0.713 . . . . 65.54 111.409 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -67.18 -17.55 64.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.403 -0.362 . . . . 75.24 111.295 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -82.22 -12.47 58.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.953 0.406 . . . . 64.13 110.837 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.24 151.23 78.12 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.483 -0.326 . . . . 72.42 110.379 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.83 117.16 4.06 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.101 2.534 . . . . 72.43 112.717 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.63 43.16 69.26 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.958 -0.564 . . . . 44.53 112.812 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.05 -34.6 73.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.879 0.371 . . . . 35.41 111.418 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -99.4 19.71 15.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.194 -0.457 . . . . 71.41 111.677 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.6 mt -76.0 154.38 35.82 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 74.04 109.609 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.6 m -74.38 86.85 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.706 0.765 . . . . 55.35 110.445 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.0 t -114.89 116.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 74.32 109.343 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -104.19 16.5 26.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.11 0.414 . . . . 72.32 111.101 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -117.16 139.96 50.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.594 -0.276 . . . . 64.23 111.022 176.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 159' ' ' VAL . 4.3 pt -123.55 147.48 27.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.263 0.554 . . . . 53.13 111.111 174.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.2 t80 -97.68 131.43 44.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.779 -1.1 . . . . 72.22 109.628 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.04 110.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.868 -0.789 . . . . 64.33 108.868 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.88 148.02 19.27 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.998 -1.096 . . . . 54.22 112.31 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.61 6.15 29.07 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.207 -0.997 . . . . 61.54 112.217 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 173' ' ' HIS . 13.6 pt -76.54 103.99 4.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.556 0.693 . . . . 74.1 110.468 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.19 -24.48 34.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.522 -0.763 . . . . 62.42 110.996 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.45 171.37 7.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.863 0.364 . . . . 71.44 110.558 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 145' ' ' LYS . 18.3 t70 -66.99 125.45 26.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 71.51 110.057 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.2 m -124.12 139.27 54.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.15 0.5 . . . . 63.4 110.323 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -112.88 174.69 5.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.591 -0.731 . . . . 72.25 111.796 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -61.03 -57.24 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.847 -1.07 . . . . 71.55 112.132 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -64.68 -23.79 67.37 Favored 'General case' 0 C--O 1.223 -0.305 0 O-C-N 123.07 0.231 . . . . 75.22 111.066 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -57.08 -58.99 5.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.97 0.415 . . . . 64.44 110.558 174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.406 HD11 HG23 ' A' ' 134' ' ' ILE . 4.6 pp -83.67 -25.3 30.82 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.674 -0.81 . . . . 73.21 111.549 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -65.8 -51.5 58.55 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.737 -0.468 . . . . 54.1 109.737 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.78 -32.99 73.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 74.44 110.413 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD2' HG22 ' A' ' 170' ' ' VAL . 92.6 t80 -73.06 -57.81 3.76 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.982 -0.554 . . . . 65.25 112.187 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -68.33 -22.3 64.7 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.563 0.579 . . . . 64.42 112.563 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.97 -24.93 67.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.827 0.346 . . . . 74.04 111.468 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -55.78 -26.04 44.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.748 -0.66 . . . . 71.41 111.83 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -91.82 -20.83 21.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.162 0.43 . . . . 75.43 112.162 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.01 -172.48 42.12 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.416 -0.897 . . . . 63.34 113.396 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -76.35 131.99 39.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 74.31 111.248 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 152' ' ' THR . 71.8 mt -103.79 139.74 23.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.735 -0.666 . . . . 73.54 109.936 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.76 -48.65 6.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.825 0.345 . . . . 75.34 110.944 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -157.38 157.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.261 -0.427 . . . . 65.52 109.961 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 121' ' ' LEU . 3.2 mp -115.52 130.29 70.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.551 -0.537 . . . . 71.02 109.551 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.2 mt-10 -103.69 103.31 13.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.213 -0.449 . . . . 62.53 110.946 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.2 mm -91.38 125.43 44.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.461 -0.57 . . . . 70.31 109.461 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.9 mmm -105.91 133.25 50.93 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.083 -0.71 . . . . 71.23 109.083 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.2 p -100.92 176.94 5.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 62.54 112.025 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.14 144.76 27.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.096 -0.956 . . . . 75.11 109.651 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.2 ttm105 -69.07 -40.28 78.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.495 -0.321 . . . . 53.24 111.373 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -89.93 -52.94 2.48 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.905 -0.664 . . . . 72.31 113.252 -175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -87.13 -23.33 24.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.678 0.251 . . . . 74.3 111.678 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.21 13.17 83.9 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.006 -0.616 . . . . 73.54 113.193 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -89.22 156.15 18.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.416 -0.216 . . . . 73.02 110.416 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 115' ' ' ASP . 82.9 mttt -78.53 89.43 4.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.511 0.196 . . . . 61.22 110.535 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -154.12 176.07 12.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.573 0.702 . . . . 65.44 111.891 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.08 -46.06 3.62 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 114.199 -1.364 . . . . 75.11 113.507 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -172.85 157.46 3.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.633 0.717 . . . . 75.41 109.526 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.0 172.3 13.24 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.63 . . . . 75.32 109.694 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 75.8 m-85 -138.46 155.67 48.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.732 -0.667 . . . . 75.22 109.745 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.41 136.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.301 0.572 . . . . 71.4 110.809 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 131' ' ' ILE . 98.9 m -100.52 125.05 46.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.02 -0.991 . . . . 74.31 110.944 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -100.61 157.67 16.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.875 0.369 . . . . 63.24 110.59 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.28 -30.29 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.766 -0.652 . . . . 52.14 110.312 176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -130.97 155.34 46.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.52 -0.764 . . . . 74.4 110.823 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -80.12 -26.34 39.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 72.01 110.514 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 17.0 t70 -63.01 -39.16 93.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.624 -0.716 . . . . 74.52 111.169 -173.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 -31.42 72.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.375 -0.375 . . . . 73.2 110.781 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 107' ' ' ILE . 3.2 t -69.81 -45.33 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.289 -0.414 . . . . 61.42 110.195 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.597 ' HA ' HG22 ' A' ' 163' ' ' VAL . 20.1 m-20 -71.04 -23.96 62.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.845 -0.616 . . . . 73.21 111.586 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 88.1 mttt -63.78 -40.95 97.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.14 110.095 170.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.37 -42.54 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.695 -1.139 . . . . 64.4 112.122 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 160' ' ' ASP . 13.4 m -73.81 -12.25 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 53.45 110.789 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.451 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 6.8 mt -58.55 -29.37 38.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.493 -0.776 . . . . 72.24 109.829 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.489 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.3 mt-30 -112.44 98.7 7.45 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.613 -0.884 . . . . 72.2 108.613 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HZ2' ' HB2' ' A' ' 166' ' ' LYS . 1.2 ttmp? -53.37 -37.21 62.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.424 0.898 . . . . 63.04 113.424 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -121.3 131.67 54.34 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.6 -0.44 . . . . 70.25 110.576 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.7 m-70 -124.85 158.09 34.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.769 -0.651 . . . . 74.02 109.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.2 m -102.82 103.38 13.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.081 0.467 . . . . 72.45 110.379 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 124' ' ' TYR . 3.7 t -118.53 140.5 41.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.71 -0.677 . . . . 64.33 109.177 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.5 t30 56.77 31.02 18.72 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.966 0.889 . . . . 75.42 111.009 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.85 16.96 74.88 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.341 -0.845 . . . . 51.21 113.303 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 85.8 t60 -130.7 138.67 50.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.767 0.283 . . . . 72.51 110.356 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.68 110.9 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 73.44 110.535 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.81 158.07 29.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.066 -0.97 . . . . 64.44 111.102 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.56 133.1 34.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.123 -0.49 . . . . 54.03 110.187 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.8 t -128.83 132.12 67.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.345 -0.843 . . . . 75.41 110.057 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -155.4 175.98 13.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.667 -0.697 . . . . 75.15 111.15 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -62.14 122.9 16.73 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.82 -0.437 . . . . 75.54 109.82 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 108' ' ' PHE . . . -107.21 115.13 29.62 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.084 0.469 . . . . 55.24 110.719 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.1 mt -90.72 114.94 27.4 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.392 -0.966 . . . . 71.01 108.392 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.0 t -72.64 -178.96 2.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.315 -0.402 . . . . 62.51 110.055 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -30.73 69.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 70.32 110.512 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -60.68 -53.43 57.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.503 -0.771 . . . . 71.34 110.529 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -72.15 -38.57 69.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.971 -0.559 . . . . 75.1 111.586 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.63 -35.57 80.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.332 . . . . 71.32 111.805 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -93.21 -1.74 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 32.22 110.878 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.2 p 50.48 30.75 4.91 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.764 1.226 . . . . 62.54 112.125 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -170.04 171.98 6.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.755 -0.657 . . . . 55.22 109.702 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.1 t -72.25 101.95 2.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.294 -0.632 . . . . 74.35 109.294 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 p -100.2 152.87 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.99 -0.55 . . . . 74.41 111.266 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -92.89 15.67 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.999 -0.546 . . . . 75.42 110.822 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -70.52 97.01 1.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.285 0.564 . . . . 62.12 109.697 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -111.98 -36.62 5.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.133 -0.94 . . . . 71.24 110.656 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.0 -123.72 8.01 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.519 -1.032 . . . . 52.22 110.519 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.523 -0.751 . . . . 53.43 109.752 176.592 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.969 -0.452 . . . . 45.04 111.969 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m -93.17 95.88 9.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 73.43 110.654 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -63.05 -54.73 33.46 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 50.14 110.104 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.0 m -155.43 106.93 2.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 74.52 109.844 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.38 173.47 13.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.448 -0.342 . . . . 62.03 110.088 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 m -98.08 107.39 40.74 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.474 -0.33 . . . . 75.43 110.441 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 53.5 Cg_endo -87.61 165.64 7.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.819 2.346 . . . . 73.42 111.793 177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 -4.5 7.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.287 0.477 . . . . 73.12 112.287 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.564 ' OE1' ' HB2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -93.91 150.27 38.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 C-N-CA 120.658 -0.417 . . . . 73.42 110.175 -177.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 36.1 Cg_endo -70.65 167.32 25.94 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.254 1.969 . . . . 64.34 112.076 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -37.06 68.75 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.006 -0.543 . . . . 64.41 112.283 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -69.43 -16.41 63.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.044 0.387 . . . . 72.44 112.044 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.6 mp -96.01 -14.63 22.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.742 0.306 . . . . 53.51 111.112 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.582 ' HA ' HG21 ' A' ' 68' ' ' VAL . 16.5 ptt180 -118.84 2.22 11.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.044 0.45 . . . . 72.44 110.767 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.98 149.63 22.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.751 0.786 . . . . 62.13 111.603 174.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.721 HD21 HG13 ' A' ' 68' ' ' VAL . 61.0 mt -117.13 146.45 43.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.552 -1.203 . . . . 62.33 110.46 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -99.21 121.62 41.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.65 -0.87 . . . . 74.41 108.65 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.92 112.19 34.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 110.052 -0.351 . . . . 51.21 110.052 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.77 150.32 18.31 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.929 -0.653 . . . . 71.24 111.703 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.59 45.95 42.5 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.767 -0.73 . . . . 65.01 113.541 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 HG21 ' A' ' 25' ' ' THR . 77.9 mt -81.08 163.43 23.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.704 -0.48 . . . . 52.45 109.704 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.6 p -80.97 169.21 17.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.327 -0.62 . . . . 71.43 109.327 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -72.33 -11.52 60.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 72.54 110.316 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.89 15.26 17.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 71.33 111.314 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.569 HG21 HD22 ' A' ' 21' ' ' LEU . 53.1 m -82.41 126.9 32.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.152 0.501 . . . . 71.52 110.942 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 p -109.15 164.09 12.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 63.44 110.325 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HA ' HG23 ' A' ' 45' ' ' VAL . 3.6 p30 -74.06 -25.79 60.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.184 -0.206 . . . . 54.43 110.879 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -67.67 -37.47 82.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 73.33 110.493 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.3 m -80.23 -37.25 33.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 61.53 110.943 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 45' ' ' VAL . 32.3 tp -63.0 -43.56 98.44 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.133 -0.485 . . . . 72.12 110.458 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 31' ' ' ARG . 14.6 ttm180 -60.86 -55.49 32.46 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.886 -0.413 . . . . 65.22 109.886 176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.7 m -47.23 -39.52 14.36 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 124.313 1.008 . . . . 73.23 113.067 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.403 ' ND1' HG22 ' A' ' 79' ' ' VAL . 8.2 t-80 -70.68 -61.27 1.83 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 70.11 111.583 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -69.91 -21.82 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 72.45 112.201 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 28.9 tt0 -63.74 -16.88 62.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.813 0.445 . . . . 73.21 111.857 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.27 -26.62 68.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.563 0.221 . . . . 73.44 111.081 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -99.56 -19.98 16.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.205 0.446 . . . . 61.41 112.205 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -175.53 168.7 41.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.218 -0.992 . . . . 74.13 112.707 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.5 m -65.98 119.14 10.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 53.35 111.99 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.72 122.24 34.93 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.706 0.765 . . . . 64.23 111.215 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -89.72 -25.77 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.154 -1.385 . . . . 73.1 110.116 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -152.3 153.34 33.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.394 -0.821 . . . . 43.14 109.642 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -161.06 130.24 4.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.748 -0.464 . . . . 63.32 109.748 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.03 123.8 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.481 0.658 . . . . 64.03 110.516 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 30' ' ' LEU . 92.0 t -84.39 135.06 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.224 -1.028 . . . . 75.33 108.224 173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.459 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -74.17 95.35 2.58 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.782 0.801 . . . . 65.14 109.641 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -104.91 164.57 11.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.102 -1.408 . . . . 71.54 110.257 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.46 128.46 87.23 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.936 -0.765 . . . . 62.15 108.936 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.78 -18.73 65.23 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.181 1.921 . . . . 70.03 113.377 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -86.39 -55.69 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.14 0.495 . . . . 74.1 110.89 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -99.63 -14.89 18.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.008 -0.996 . . . . 75.41 112.331 -170.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm 65.76 26.8 11.28 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.924 0.89 . . . . 63.34 111.367 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -102.54 153.32 20.19 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.552 -0.536 . . . . 72.52 109.552 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.0 137.72 51.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.141 0.496 . . . . 73.52 112.145 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -88.83 4.89 46.14 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.463 -0.79 . . . . 73.13 110.441 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.08 17.7 58.91 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.057 -0.592 . . . . 73.13 114.385 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.4 p90 -159.1 155.68 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.607 0.703 . . . . 52.11 110.155 174.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.45 20.22 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.825 -0.51 . . . . 35.31 111.825 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -142.19 149.76 40.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.032 0.416 . . . . 63.22 110.852 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.9 127.0 65.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.614 -0.721 . . . . 70.11 109.496 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 m -104.34 121.37 43.22 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.292 -0.255 . . . . 61.44 110.654 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -85.9 178.28 7.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.176 -0.466 . . . . 73.05 111.084 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.06 -28.81 18.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.683 -0.69 . . . . 41.12 110.796 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -144.05 147.69 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 74.22 110.698 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.55 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.3 p -57.54 -35.38 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 122.863 0.465 . . . . 61.1 111.913 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.09 -39.56 63.45 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.15 0.796 . . . . 72.23 113.15 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -70.78 -27.12 63.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 71.33 110.303 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.721 HG13 HD21 ' A' ' 16' ' ' LEU . 19.7 t -66.61 -47.3 83.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.334 -0.848 . . . . 72.41 110.08 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.97 -46.07 85.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.896 -0.593 . . . . 75.41 110.702 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.53 -41.25 53.55 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.466 0.543 . . . . 63.12 112.466 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.48 -32.23 58.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 55.02 110.96 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.3 mmt -70.74 -36.21 73.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 44.31 110.107 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -12.6 59.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.481 -0.781 . . . . 72.2 110.512 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.28 -11.35 38.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.731 -0.668 . . . . 64.42 110.269 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp85 -57.87 142.1 79.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.241 -0.891 . . . . 74.24 110.402 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 86.7 Cg_endo -79.95 169.0 71.5 Favored 'Cis proline' 0 C--N 1.352 0.739 0 C-N-CA 124.694 -0.961 . . . . 75.1 114.363 4.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.463 ' CD2' ' HG3' ' A' ' 86' ' ' PRO . 69.0 m-70 -129.0 158.54 38.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.879 . . . . 61.21 110.447 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -137.43 106.9 6.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.071 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.403 HG22 ' ND1' ' A' ' 33' ' ' HIS . 15.5 t -107.95 130.9 59.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.242 -0.435 . . . . 72.04 109.901 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 65.05 29.31 12.19 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.667 0.604 . . . . 73.05 111.674 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.44 26.08 72.73 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.936 -0.575 . . . . 73.14 112.117 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.8 tpt180 -129.0 139.11 52.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 65.14 109.841 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.25 107.67 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.584 -0.525 . . . . 70.23 109.584 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 m -102.48 151.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.259 0.552 . . . . 53.33 110.824 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -112.03 94.43 25.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.136 -0.938 . . . . 70.55 111.087 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HG3' ' CD2' ' A' ' 77' ' ' HIS . 38.2 Cg_endo -74.31 132.28 16.2 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.069 1.846 . . . . 74.53 111.385 173.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -137.12 174.24 10.83 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.291 -1.003 . . . . 73.44 108.291 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 90' ' ' VAL . 3.0 tmm_? -76.77 131.04 38.49 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.653 -0.869 . . . . 70.21 108.653 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.09 96.36 0.14 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.043 0.449 . . . . 75.42 111.755 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 100' ' ' ALA . 40.3 t -69.07 137.23 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.113 -0.948 . . . . 73.24 110.497 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 t -86.88 -176.56 5.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.732 -0.667 . . . . 73.42 109.789 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -68.63 -41.6 79.23 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.553 0.946 . . . . 64.23 113.553 -167.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.71 -35.4 52.13 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.729 -0.389 . . . . 73.51 111.198 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -14.3 59.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.771 0.319 . . . . 63.22 110.363 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 30.5 t -80.57 -20.09 44.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.094 -0.503 . . . . 60.24 109.824 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -71.33 -20.37 62.19 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.811 -0.632 . . . . 75.42 109.797 173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -73.22 147.67 88.07 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 74.41 110.661 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.14 128.61 17.86 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.817 2.345 . . . . 73.53 112.098 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.4 39.31 22.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.019 -0.61 . . . . 74.04 111.993 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -66.03 -54.3 27.72 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 111.876 0.324 . . . . 75.14 111.876 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -107.66 11.14 28.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.044 0.449 . . . . 75.52 110.621 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.4 151.58 25.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.583 -0.525 . . . . 74.45 109.583 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 156' ' ' HIS . 5.8 m -72.52 105.84 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.735 . . . . 73.12 110.359 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.45 ' HB ' ' CE ' ' A' ' 179' ' ' LYS . 61.4 t -132.21 116.27 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.867 -1.061 . . . . 72.43 109.43 -176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' C ' HG21 ' A' ' 159' ' ' VAL . 75.3 mttt -102.6 13.6 34.07 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.417 -0.513 . . . . 71.35 110.67 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.38 139.66 48.7 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.315 -0.402 . . . . 71.22 110.792 177.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -120.97 149.16 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.261 0.553 . . . . 64.14 111.388 174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 5.3 t80 -98.76 132.21 44.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.774 -1.103 . . . . 74.15 109.441 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 111.08 28.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.217 -0.66 . . . . 71.12 109.217 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -132.88 148.41 19.27 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 119.907 -1.139 . . . . 31.01 112.601 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 6.72 36.7 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.347 -0.93 . . . . 60.32 112.948 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -75.76 105.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.522 0.677 . . . . 71.01 110.526 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 46.2 mtmt -74.97 -53.44 8.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.496 -0.775 . . . . 62.34 110.62 -176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -73.09 155.45 39.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.416 -0.811 . . . . 72.12 109.805 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.53 134.73 55.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.279 0.561 . . . . 75.23 109.739 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -116.24 145.26 43.27 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.021 -0.536 . . . . 64.43 109.899 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.86 158.63 17.17 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.053 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.12 -44.48 79.18 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 123.93 0.769 . . . . 75.14 110.289 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -56.52 -35.68 68.32 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.409 0.284 . . . . 74.11 111.603 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -62.66 -59.92 4.24 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.331 -0.395 . . . . 73.51 110.841 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 134' ' ' ILE . 1.9 pt? -84.29 -21.65 30.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.253 -0.579 . . . . 74.32 111.138 -173.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 7.2 tmm_? -66.36 -55.67 14.78 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 110.138 -0.319 . . . . 75.42 110.138 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -61.39 -26.41 67.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.361 0.6 . . . . 64.14 110.481 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -75.8 -58.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.39 -0.823 . . . . 75.51 112.252 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.3 m-85 -69.08 -21.84 64.04 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 111.735 0.272 . . . . 71.32 111.735 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mm-40 -64.55 -24.73 67.7 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.917 0.389 . . . . 61.01 111.076 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -58.69 -27.59 64.97 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.921 -0.582 . . . . 63.44 111.636 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -87.24 -32.19 19.88 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 74.23 112.009 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.41 -174.71 47.17 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.828 -0.701 . . . . 73.12 113.001 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -74.03 126.62 30.92 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.302 0.572 . . . . 63.42 112.184 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 63.3 mt -97.36 139.42 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.118 -0.946 . . . . 65.34 109.72 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -90.34 -48.62 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 70.1 110.731 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.4 p -156.52 154.48 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.164 -0.471 . . . . 61.42 109.777 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.401 HG21 HD21 ' A' ' 121' ' ' LEU . 3.7 mp -112.63 125.45 69.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.376 -0.601 . . . . 63.32 109.376 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 34.3 mt-10 -100.43 103.91 15.29 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.666 -0.697 . . . . 55.31 110.7 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.3 mm -95.63 129.47 45.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.775 -0.454 . . . . 73.22 109.775 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.6 mtp -110.95 146.16 37.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.746 -0.835 . . . . 61.4 108.746 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 p -97.0 167.5 11.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.402 0.62 . . . . 74.53 112.222 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.74 137.62 35.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.076 -0.965 . . . . 73.12 109.721 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -68.78 -37.97 79.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.866 -0.607 . . . . 64.03 111.3 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.83 -52.6 2.07 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.818 -0.706 . . . . 63.41 113.15 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.4 t -86.66 -24.34 25.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.706 0.262 . . . . 73.34 111.706 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.71 19.01 74.28 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.739 -0.743 . . . . 73.05 112.951 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -86.81 169.3 12.7 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.763 -0.458 . . . . 55.53 109.763 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -88.13 78.76 8.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.296 -0.631 . . . . 74.0 109.296 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 113' ' ' LYS . 22.1 ptt180 -154.7 -177.54 6.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.783 0.801 . . . . 72.01 112.453 -171.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.89 -44.93 3.27 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 113.91 -1.495 . . . . 75.03 112.751 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -169.48 148.33 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.688 -0.486 . . . . 75.24 109.688 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.98 172.76 12.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.844 -0.616 . . . . 74.33 109.516 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 55.1 m-85 -140.89 151.72 44.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.012 -0.54 . . . . 70.1 110.454 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 125' ' ' PHE . 94.9 t -134.13 129.52 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.23 -0.441 . . . . 74.12 110.587 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 131' ' ' ILE . 64.0 m -99.85 123.23 43.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 70.41 110.206 177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -104.06 159.69 15.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.732 0.301 . . . . 73.11 110.381 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.94 -24.09 48.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.33 0.586 . . . . 64.35 110.761 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 4.4 t70 -138.41 156.67 47.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.726 . . . . 72.44 110.148 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 103' ' ' THR . 23.6 p80 -79.79 -21.41 44.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.415 -0.357 . . . . 74.24 110.038 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.4 p-10 -58.91 -39.61 82.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.443 -0.799 . . . . 72.53 111.026 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -76.32 -29.35 57.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.073 -0.512 . . . . 60.55 110.532 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -69.58 -40.22 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.59 -0.522 . . . . 73.3 109.59 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -72.05 -24.3 61.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.348 -0.842 . . . . 74.15 111.453 -178.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 72.8 mttt -68.21 -34.12 75.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 74.55 110.234 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.86 -40.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.181 -0.918 . . . . 72.42 112.281 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 159' ' ' VAL . 12.2 m -73.0 -6.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.15 0.5 . . . . 74.13 111.362 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 13' ' ' LEU . 54.8 mt -54.74 -38.37 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.079 -0.964 . . . . 72.02 110.171 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -107.55 114.2 28.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.386 -0.825 . . . . 75.45 109.473 -177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -53.85 -41.5 67.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.402 -0.817 . . . . 72.21 112.187 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.89 138.61 54.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.859 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -124.25 152.89 42.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.631 -0.713 . . . . 74.15 109.218 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 42.4 m -122.84 113.28 18.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.324 0.583 . . . . 74.14 110.035 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.59 113.96 41.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.507 -0.769 . . . . 74.45 109.92 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 70.44 24.1 4.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.128 0.489 . . . . 53.45 110.789 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.2 78.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.861 -0.685 . . . . 72.33 112.448 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.27 111.08 21.8 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.856 -0.424 . . . . 75.12 109.856 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.4 131.68 34.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.313 -0.625 . . . . 61.35 109.313 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.2 p -143.99 149.27 36.47 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.263 -0.426 . . . . 64.05 111.436 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.52 130.57 35.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.632 -0.877 . . . . 74.1 108.632 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.7 t -127.74 137.21 58.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.857 -0.611 . . . . 74.51 110.501 -175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -161.99 177.97 9.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.264 -0.88 . . . . 73.45 110.972 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.45 ' CE ' ' HB ' ' A' ' 104' ' ' VAL . 7.0 mmmm -67.74 122.03 17.23 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.671 -0.492 . . . . 71.43 109.671 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -93.73 114.9 27.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.895 0.378 . . . . 42.22 110.445 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.14 132.25 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.751 -0.659 . . . . 73.23 110.831 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 186' ' ' MET . 9.0 t -71.93 164.57 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.548 -1.278 . . . . 64.23 107.548 166.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.26 -34.1 73.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.825 0.284 . . . . 75.24 111.629 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.88 -32.82 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 70.45 110.489 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -71.42 -38.66 71.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 74.25 110.065 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' SER . 82.0 mtp -67.37 -39.48 85.66 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.594 -0.73 . . . . 51.12 110.862 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.67 -4.94 59.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 44.24 111.662 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t 60.81 47.42 7.88 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.786 0.679 . . . . 33.21 110.437 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.78 147.85 33.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 54.55 111.267 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.5 t -103.96 109.09 20.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.892 -0.595 . . . . 74.54 109.925 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -86.95 128.34 35.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.312 -0.404 . . . . 61.23 110.318 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 39.6 m -80.19 102.11 9.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 72.34 110.53 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -142.33 150.76 41.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.058 -0.519 . . . . 62.13 110.038 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.56 37.13 1.33 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 72.03 109.48 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -83.61 46.29 3.62 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.754 -0.736 . . . . 75.51 111.547 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.357 -0.83 . . . . 73.44 109.047 -176.487 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 112.145 -0.382 . . . . 73.45 112.145 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -71.6 115.04 10.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 44.13 110.963 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -79.83 115.82 19.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 61.42 109.972 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.5 m -143.84 60.94 1.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.977 0.418 . . . . 74.42 109.982 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -79.04 136.45 37.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 73.21 110.384 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -61.3 111.78 4.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.602 0.564 . . . . 74.33 110.238 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.61 156.97 9.12 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.511 2.141 . . . . 43.04 113.27 -174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.0 -5.01 21.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.047 -1.094 . . . . 61.21 108.047 171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 1.6 mp0 -61.55 131.44 92.64 Favored Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 113.649 -1.614 . . . . 62.23 111.704 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HG2' ' HG ' ' A' ' 13' ' ' LEU . 16.4 Cg_endo -59.95 168.43 5.85 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.703 2.935 . . . . 72.23 112.99 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -34.45 59.85 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.617 -0.719 . . . . 65.52 111.92 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.14 0.422 . . . . 71.21 112.14 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 10' ' ' PRO . 13.3 mt -85.29 -20.91 29.32 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 122.094 -0.379 . . . . 61.24 110.671 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.6 ptt-85 -108.7 -2.9 18.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.863 0.363 . . . . 75.41 111.027 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 37.8 ttpt -100.68 154.41 18.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.599 0.714 . . . . 74.43 111.944 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 HG13 ' A' ' 68' ' ' VAL . 69.7 mt -118.97 145.28 45.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.801 -1.09 . . . . 65.41 110.034 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -97.09 123.57 40.88 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.398 -0.964 . . . . 74.21 108.398 173.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 60' ' ' VAL . 18.6 mm -103.02 110.22 29.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.83 -0.433 . . . . 62.41 109.83 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.69 150.48 17.95 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.046 -0.597 . . . . 63.12 111.794 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.9 47.75 52.92 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.846 -0.692 . . . . 53.43 113.168 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 25' ' ' THR . 68.8 mt -78.74 176.8 9.19 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.283 -0.636 . . . . 73.34 109.283 171.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.6 p -83.5 167.64 17.22 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.152 -1.055 . . . . 75.45 108.152 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -79.51 0.42 29.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.933 0.396 . . . . 74.2 110.639 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -125.38 15.59 8.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.837 -0.62 . . . . 74.21 111.568 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 21' ' ' LEU . 32.4 m -74.11 130.62 40.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.662 0.267 . . . . 65.52 111.072 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.3 p -104.77 163.67 12.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 74.52 110.293 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -28.31 64.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.405 -0.361 . . . . 70.55 111.193 -176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.93 -35.77 42.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.513 0.197 . . . . 72.13 111.244 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -75.94 -36.61 59.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.665 -0.243 . . . . 72.21 110.687 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.9 -48.25 77.39 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.704 -0.48 . . . . 74.45 109.704 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.3 ttm180 -54.96 -60.86 2.78 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-N 115.379 -0.828 . . . . 73.02 111.951 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.7 t -50.23 -31.66 14.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.738 0.648 . . . . 51.45 112.386 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -73.14 -60.72 2.1 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.201 -0.2 . . . . 64.41 110.817 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.36 -22.13 64.68 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.109 0.411 . . . . 74.33 112.109 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.47 -25.51 51.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.312 0.645 . . . . 60.44 112.078 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -59.5 -27.03 65.79 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.236 0.458 . . . . 62.52 112.236 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.7 m-90 -99.05 -19.68 17.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.582 0.215 . . . . 72.53 111.582 -175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.64 160.0 28.09 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.851 -0.69 . . . . 63.44 111.771 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -63.82 119.49 10.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.441 . . . . 51.15 111.329 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.7 136.24 33.81 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.589 -0.732 . . . . 70.32 110.487 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 p -103.97 -21.79 13.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.42 -0.809 . . . . 74.23 110.194 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -150.84 150.11 30.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.521 -0.763 . . . . 75.34 109.674 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -159.9 130.27 5.57 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.713 -0.477 . . . . 75.43 109.713 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.76 129.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.383 0.611 . . . . 72.2 111.083 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.1 t -87.77 128.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.79 -0.819 . . . . 54.45 108.79 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -72.9 98.45 2.47 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.669 0.747 . . . . 63.32 110.278 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -103.37 161.24 14.0 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.385 -1.279 . . . . 54.43 110.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -72.52 125.2 91.4 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.749 -1.114 . . . . 61.12 109.793 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -65.45 -20.71 60.99 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.202 1.935 . . . . 74.52 112.575 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -83.83 -55.43 4.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 74.24 111.63 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 -8.67 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 64.42 111.85 -173.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 62.19 38.23 13.72 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.287 0.635 . . . . 73.14 111.447 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -110.09 157.48 19.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.547 -0.909 . . . . 50.24 108.547 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -73.13 137.89 45.44 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.796 -0.362 . . . . 74.01 110.262 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -83.4 1.27 42.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.42 110.204 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.31 18.3 59.23 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.99 -0.624 . . . . 74.41 113.871 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -159.57 158.4 31.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.059 0.929 . . . . 74.43 110.614 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.16 -163.07 14.97 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.34 -0.704 . . . . 71.12 111.34 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.31 149.83 38.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.235 0.518 . . . . 71.51 110.702 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 18' ' ' ILE . 5.4 m -129.67 122.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.879 -0.6 . . . . 75.31 109.844 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.1 m -98.9 121.93 41.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.624 -0.262 . . . . 74.41 110.386 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -87.18 163.4 16.96 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 71.03 110.704 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.8 -44.15 70.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.637 -0.71 . . . . 52.34 110.144 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -124.38 144.3 50.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.427 -0.806 . . . . 74.41 110.384 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -63.17 -37.09 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.258 -0.428 . . . . 70.03 110.824 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -56.02 -36.93 68.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.552 0.575 . . . . 73.13 112.552 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.41 -26.81 65.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.104 0.478 . . . . 74.21 110.704 177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 37.7 t -64.62 -45.46 95.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.538 -0.756 . . . . 74.1 110.468 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -52.96 -48.23 67.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.699 -0.682 . . . . 65.4 111.989 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.644 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -58.12 -37.38 74.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.607 0.595 . . . . 73.4 112.607 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.84 -34.83 78.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.396 0.617 . . . . 72.12 110.166 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -38.23 77.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.678 -0.692 . . . . 74.43 110.877 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.644 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.0 p30 -76.99 -10.46 59.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.894 0.378 . . . . 75.21 111.335 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.06 -11.59 43.66 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.906 -0.588 . . . . 75.11 112.438 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.42 148.78 8.51 Favored Pre-proline 0 N--CA 1.475 0.777 0 N-CA-C 113.284 0.846 . . . . 63.33 113.284 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 194' ' ' ARG . 2.8 Cg_endo -81.94 160.87 79.1 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.692 -1.378 . . . . 75.53 112.438 -2.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -110.4 151.53 27.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.458 -0.792 . . . . 63.2 110.152 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.1 ttmt -136.76 104.36 5.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.044 0.45 . . . . 74.54 111.131 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.8 140.31 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.695 -0.684 . . . . 32.51 109.685 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 66.25 21.68 11.02 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.573 0.749 . . . . 74.42 110.3 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.05 25.4 69.1 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.748 -0.66 . . . . 75.53 112.222 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 tpt180 -129.4 136.64 50.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.374 -0.232 . . . . 72.52 110.374 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -83.79 111.05 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 121.655 0.74 . . . . 72.2 109.992 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 m -102.84 155.34 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.576 0.703 . . . . 63.41 112.183 -170.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -111.53 96.62 32.92 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 114.469 -1.241 . . . . 65.41 111.006 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.58 130.1 7.68 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.35 2.033 . . . . 75.32 111.073 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HZ2' HG23 ' A' ' 103' ' ' THR . 30.0 mttm -133.8 170.26 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.849 -0.797 . . . . 63.12 108.849 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.547 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tpp180 -70.38 137.76 50.77 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.507 -0.553 . . . . 72.3 109.507 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 97.15 0.45 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.292 0.568 . . . . 52.32 110.348 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' OD1' ' A' ' 160' ' ' ASP . 6.6 t -55.26 136.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.433 -1.258 . . . . 64.12 111.786 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.432 ' HB2' HG12 ' A' ' 164' ' ' ILE . 2.4 t -57.84 147.26 29.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.435 -0.802 . . . . 74.13 109.904 176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -52.52 -40.48 62.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.402 0.681 . . . . 73.41 112.591 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.03 -39.29 79.32 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.142 0.423 . . . . 71.35 112.142 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.28 -32.31 38.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.03 -0.359 . . . . 74.04 110.03 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 t -69.57 -12.32 61.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.941 -0.572 . . . . 72.21 110.609 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.17 -7.84 59.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 74.44 110.056 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -94.62 151.11 38.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 74.42 110.299 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 122.46 8.19 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.557 2.171 . . . . 74.22 111.974 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 96.56 19.5 27.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.586 -0.816 . . . . 73.51 112.578 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.49 54.59 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.673 0.249 . . . . 74.21 111.673 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -98.96 13.84 31.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.802 0.334 . . . . 71.24 111.405 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.38 171.1 13.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.851 -0.425 . . . . 73.3 109.851 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' HZ2' ' A' ' 87' ' ' LYS . 2.0 m -89.01 78.18 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.423 0.63 . . . . 63.51 110.778 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.01 121.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 114.933 -1.03 . . . . 74.33 109.341 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.443 ' C ' HG21 ' A' ' 159' ' ' VAL . 88.2 mttt -107.35 21.73 17.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.164 0.507 . . . . 73.0 110.374 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 142.98 49.72 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.162 -0.472 . . . . 74.31 111.46 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.425 HG23 HG13 ' A' ' 159' ' ' VAL . 7.7 pt -132.71 150.66 33.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.31 0.576 . . . . 73.32 111.561 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.9 t80 -96.29 138.48 33.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.834 -1.075 . . . . 73.42 110.086 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.98 110.78 25.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.419 -0.585 . . . . 73.24 109.419 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -137.17 141.84 12.81 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 119.927 -1.13 . . . . 71.45 112.387 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.0 6.36 14.04 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.315 -0.945 . . . . 71.41 112.224 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.9 pt -73.87 101.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.515 0.674 . . . . 74.22 109.793 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 22.73 1.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 72.02 112.628 -170.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.01 175.57 11.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.996 -0.372 . . . . 73.12 109.996 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.66 120.96 12.2 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.697 0.623 . . . . 65.41 110.561 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -122.7 146.6 47.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.175 0.512 . . . . 75.1 110.136 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -110.5 165.27 11.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.44 -0.8 . . . . 64.44 111.289 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.52 -47.17 87.35 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.184 -1.371 . . . . 62.14 109.61 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -55.8 -33.78 64.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.47 -0.786 . . . . 74.25 111.712 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.47 -58.03 7.58 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.165 0.291 . . . . 71.35 111.185 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.16 -27.5 38.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.615 -0.834 . . . . 74.11 110.918 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.4 tmm_? -66.65 -45.0 80.37 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.977 -0.379 . . . . 73.53 109.977 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.23 -32.18 71.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.195 0.521 . . . . 75.2 110.454 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -79.48 -55.82 4.77 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.503 -0.771 . . . . 71.24 112.37 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 42.9 m-85 -67.7 -24.03 65.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.095 0.405 . . . . 74.13 112.095 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.4 mm-40 -66.58 -25.81 66.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.976 0.417 . . . . 74.0 110.899 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -61.03 -32.23 71.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.94 -0.573 . . . . 71.33 111.589 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -81.69 -27.91 33.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.54 111.101 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.416 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 171.36 -177.65 44.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.768 -0.651 . . . . 74.11 112.651 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.6 134.3 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.217 0.532 . . . . 70.21 111.618 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 152' ' ' THR . 79.4 mt -102.88 144.56 13.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.338 -0.846 . . . . 75.52 109.872 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -93.49 -49.1 6.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 73.12 110.825 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.35 155.32 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.46 . . . . 74.24 109.912 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -114.74 129.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.07 -0.344 . . . . 64.53 110.07 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.79 103.39 14.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 61.42 111.178 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.7 mm -98.38 115.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.561 -0.533 . . . . 52.31 109.561 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ptp -111.48 152.97 26.84 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.349 -0.612 . . . . 54.54 109.349 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.96 148.97 22.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.239 -0.437 . . . . 72.44 111.68 -173.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.36 132.15 47.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.192 -0.913 . . . . 74.12 110.19 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 140' ' ' ARG . 1.7 ppt_? -64.05 -23.74 67.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.72 -0.673 . . . . 70.53 112.311 -175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -101.49 -52.76 1.03 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.845 -0.693 . . . . 72.33 112.964 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.0 m -81.68 -23.65 36.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.464 0.542 . . . . 72.32 112.464 -172.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.39 13.87 79.67 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.93 -0.653 . . . . 51.12 112.724 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -99.49 172.1 7.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.678 -0.49 . . . . 54.22 109.678 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -75.72 76.08 2.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.332 -0.618 . . . . 75.25 109.332 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -152.93 161.31 42.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.615 . . . . 73.41 111.222 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.8 -45.49 2.33 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.156 -0.929 . . . . 75.34 113.414 170.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -170.54 153.68 4.31 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.903 0.852 . . . . 61.02 109.973 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -148.38 174.75 11.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.807 -0.633 . . . . 61.14 109.474 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.85 155.21 47.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.057 -0.52 . . . . 74.44 109.985 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.07 132.18 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.54 0.686 . . . . 64.32 111.097 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 131' ' ' ILE . 65.0 m -97.58 124.08 41.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.085 -0.961 . . . . 75.24 110.465 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 3.7 m-85 -99.24 157.83 16.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 70.11 111.289 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.59 -29.12 45.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.14 -0.936 . . . . 52.22 110.511 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -128.68 152.22 48.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.526 . . . . 72.01 110.847 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -77.74 -28.21 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 71.35 109.887 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 8.9 t70 -58.12 -48.26 80.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.641 -1.163 . . . . 75.4 111.955 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 19.5 m -67.77 -30.42 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.205 -0.452 . . . . 65.31 111.137 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' C ' ' A' ' 105' ' ' LYS . 1.1 t -67.76 -41.11 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 71.02 109.775 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 163' ' ' VAL . 12.8 t70 -68.08 -38.16 82.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.077 -0.965 . . . . 55.5 111.377 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.547 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 86.4 mttt -52.87 -37.28 60.23 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.517 0.675 . . . . 70.21 110.696 175.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mt -78.18 -44.06 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 71.01 112.533 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 16.5 m -74.21 -15.17 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.217 0.532 . . . . 75.32 110.725 -173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 91' ' ' SER . 19.0 mt -57.69 -32.11 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 114.935 -1.03 . . . . 63.33 110.16 172.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.534 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -111.51 101.45 9.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 75.33 108.197 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -56.98 -33.79 67.44 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.233 0.827 . . . . 64.23 113.233 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -122.15 135.24 54.76 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.569 -0.452 . . . . 65.32 110.989 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 92.6 m-70 -127.39 156.92 41.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.754 -0.657 . . . . 74.21 110.176 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 10.2 m -123.5 115.44 21.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.08 0.467 . . . . 74.13 110.834 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.58 115.57 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.481 -0.782 . . . . 42.14 109.99 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 71.48 23.84 3.77 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.922 0.868 . . . . 75.15 109.749 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 95.3 -13.21 67.16 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.559 -0.746 . . . . 62.44 112.266 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.516 ' O ' ' HA ' ' A' ' 169' ' ' THR . 2.6 m80 -81.9 109.99 16.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.154 -0.313 . . . . 74.11 110.154 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -91.86 107.77 19.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.88 0.848 . . . . 62.31 109.133 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 5.7 p -124.12 156.8 36.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.093 -0.958 . . . . 72.31 111.463 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -85.97 130.51 34.52 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.591 -0.731 . . . . 63.12 109.154 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 11.3 t -126.63 131.24 71.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.333 -0.849 . . . . 61.54 109.696 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -156.38 172.93 17.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 72.25 110.933 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.463 ' HD3' HG11 ' A' ' 163' ' ' VAL . 12.0 mmtm -62.67 124.79 21.93 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.256 0.348 . . . . 64.5 110.708 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -109.71 112.89 25.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.866 0.365 . . . . 63.33 110.216 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 50.1 mt -98.31 111.39 23.75 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.395 -0.595 . . . . 54.12 109.395 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.477 ' H ' ' HG2' ' A' ' 185' ' ' GLU . 8.9 m -105.48 -170.24 1.72 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.167 -0.679 . . . . 73.13 109.167 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -67.51 -16.63 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.693 0.627 . . . . 60.35 112.693 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -77.15 -48.94 16.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.905 -0.406 . . . . 65.0 109.905 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 182' ' ' SER . 3.0 mm-40 -69.31 -36.05 76.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.849 -0.614 . . . . 71.33 110.595 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 22.2 mtt -73.63 -27.59 61.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.897 -0.592 . . . . 75.42 111.44 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -83.36 -0.78 51.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.613 0.244 . . . . 63.24 110.828 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.1 t 63.75 46.68 3.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.486 -0.779 . . . . 73.24 110.426 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.36 62.11 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.555 0.693 . . . . 71.23 109.977 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.3 m -81.04 108.81 15.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.025 -0.989 . . . . 72.43 111.157 -175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 p -93.36 97.09 10.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.952 -0.567 . . . . 73.34 110.655 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 p -92.62 92.16 7.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.969 -0.752 . . . . 63.33 108.969 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 196' ' ' ARG . 4.5 pm0 -77.82 158.15 29.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.46 -0.791 . . . . 74.05 112.108 -171.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.462 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 11.3 tpp180 -82.74 102.23 11.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 72.0 109.577 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.15 -95.04 1.04 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.686 -0.966 . . . . 23.11 110.686 -172.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.416 ' HA ' ' HG3' ' A' ' 193' ' ' GLN . 7.7 ptm180 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 119.158 -0.449 . . . . 71.23 109.891 174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.077 -0.409 . . . . 74.33 112.077 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m -104.26 145.76 29.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.108 -0.33 . . . . 72.1 110.108 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -76.54 -10.5 59.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 51.02 110.997 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.9 t -80.14 -4.01 51.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 73.33 110.681 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -75.86 146.46 39.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.324 -0.398 . . . . 72.11 110.352 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 m -99.03 128.33 32.45 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 74.12 110.83 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.19 137.28 18.97 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.369 2.046 . . . . 73.41 111.853 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -26.34 13.85 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.112 -0.699 . . . . 75.43 109.112 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -79.1 133.61 60.78 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.833 -1.076 . . . . 75.14 109.535 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 14' ' ' ARG . 18.3 Cg_endo -62.83 163.3 22.34 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.553 2.169 . . . . 60.03 111.009 174.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 7.5 pt-20 -62.56 -27.1 68.94 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 111.981 0.363 . . . . 74.13 111.981 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HG3' HD12 ' A' ' 13' ' ' LEU . 9.2 pt20 -72.79 -32.51 65.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.795 0.331 . . . . 74.22 110.849 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 164' ' ' ILE . 5.1 mp -81.36 -11.69 59.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 74.24 111.197 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 10' ' ' PRO . 32.0 ptt85 -127.06 15.77 7.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.126 0.488 . . . . 75.42 110.952 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 18.3 ttmm -97.32 151.29 20.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 72.34 111.029 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 68' ' ' VAL . 70.2 mt -116.76 142.6 46.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.939 -1.028 . . . . 73.2 110.129 176.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -98.11 120.89 39.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.169 -1.049 . . . . 75.1 108.169 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.45 110.91 28.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.873 -0.417 . . . . 74.31 109.873 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.29 152.29 17.97 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.877 -0.678 . . . . 64.23 111.565 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.83 46.8 43.36 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.487 -0.863 . . . . 74.41 112.981 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 25' ' ' THR . 80.5 mt -81.98 176.84 9.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.634 -0.506 . . . . 75.14 109.634 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 p -85.81 164.6 17.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.107 -1.072 . . . . 73.14 108.107 172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -80.63 2.88 23.92 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.039 0.447 . . . . 73.1 110.455 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -119.81 10.7 11.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.585 -0.734 . . . . 75.21 110.995 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.42 HG21 HD22 ' A' ' 21' ' ' LEU . 94.9 m -71.3 121.52 18.61 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 74.53 110.807 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -94.62 154.85 17.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.003 -0.544 . . . . 63.15 109.99 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -27.45 63.83 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 121.109 -0.236 . . . . 61.23 110.867 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -77.2 -23.02 51.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 62.4 110.741 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -81.29 -41.42 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.672 -0.492 . . . . 70.33 109.672 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.13 -47.14 87.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 62.42 109.655 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.21 -62.68 1.5 Allowed 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.094 -0.957 . . . . 73.34 111.71 171.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.9 t -48.15 -35.05 10.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.337 0.655 . . . . 74.24 112.551 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' CG ' HG22 ' A' ' 79' ' ' VAL . 55.9 t60 -68.4 -64.91 0.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 74.15 110.687 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -71.06 -21.75 62.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.47 0.544 . . . . 74.34 112.47 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -62.54 -21.0 65.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.722 0.409 . . . . 73.24 111.703 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.76 -30.03 68.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.544 -0.298 . . . . 73.22 111.751 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -98.51 -17.29 18.8 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.963 0.356 . . . . 65.23 111.963 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.72 164.11 33.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.353 -0.927 . . . . 52.34 112.36 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.9 m -65.38 116.49 6.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 41.44 111.413 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 mt -85.45 134.57 34.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.745 -0.661 . . . . 65.32 111.1 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -97.26 -28.61 13.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.202 -0.908 . . . . 63.55 110.052 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.55 150.42 32.23 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.455 -0.793 . . . . 64.51 110.373 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.4 t -158.41 129.49 6.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.467 -0.568 . . . . 73.31 109.467 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.22 129.07 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-O 121.063 0.458 . . . . 54.21 110.067 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -94.06 130.29 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.642 -0.873 . . . . 64.53 108.642 175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.463 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 6.8 mmt -69.24 135.85 51.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.955 0.407 . . . . 75.43 109.966 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -137.43 155.62 49.13 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.53 -0.759 . . . . 73.1 109.887 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' A' ' 50' ' ' ASN . 28.5 t70 -71.57 132.48 85.45 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.829 -1.078 . . . . 55.52 110.168 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.85 -19.97 35.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.969 1.78 . . . . 73.41 112.998 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -84.82 -55.52 4.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 74.41 111.505 -176.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 m -102.77 -9.11 20.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.955 0.407 . . . . 73.52 111.739 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.5 mmtm 66.85 24.86 9.67 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.575 0.75 . . . . 70.34 112.455 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.69 163.82 12.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.944 -0.391 . . . . 65.32 109.944 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 t -69.61 143.09 53.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.103 0.478 . . . . 74.32 110.305 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -88.47 1.66 54.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 53.2 110.526 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.39 17.76 61.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.653 -0.784 . . . . 62.21 113.813 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.463 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 41.9 p90 -158.37 159.05 35.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.334 0.567 . . . . 75.31 110.292 174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.66 -166.93 19.54 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.474 -0.65 . . . . 53.41 111.474 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -144.35 149.61 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.373 0.586 . . . . 75.34 110.659 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.7 130.65 56.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.77 -0.65 . . . . 42.12 109.694 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 m -106.49 123.28 47.84 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 122.135 -0.353 . . . . 75.23 110.487 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.7 m-85 -90.36 157.75 17.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.529 -0.305 . . . . 73.31 110.769 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.52 80.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 74.21 111.188 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -123.63 153.94 40.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.005 -0.543 . . . . 61.33 109.88 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 9.4 p -64.5 -30.9 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.396 -0.365 . . . . 74.34 111.352 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -63.17 -37.46 87.33 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.867 0.691 . . . . 65.53 112.867 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -63.61 -28.77 70.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.989 0.423 . . . . 74.44 110.73 174.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.8 t -63.55 -49.91 80.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 62.12 109.856 171.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.67 -51.35 60.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.327 -0.851 . . . . 72.14 111.29 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -46.67 -41.03 14.23 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.87 0.692 . . . . 71.25 112.87 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.23 -29.84 61.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.068 0.461 . . . . 52.43 110.871 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -71.53 -35.55 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 74.13 110.851 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -70.48 -36.51 73.9 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.25 0.548 . . . . 73.12 110.214 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.0 -11.82 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.29 -0.868 . . . . 60.43 113.175 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -57.05 144.77 67.95 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 111.647 0.24 . . . . 71.21 111.647 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.65 163.0 84.54 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.518 -1.451 . . . . 61.11 113.248 2.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -116.83 156.35 27.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 73.55 110.456 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.5 ttmt -136.84 110.64 8.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.45 -0.341 . . . . 73.03 110.878 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG22 ' CG ' ' A' ' 33' ' ' HIS . 16.9 t -110.2 127.37 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 60.4 109.654 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 t70 64.07 28.92 14.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.446 0.641 . . . . 70.24 111.136 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.17 27.91 63.19 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.742 -0.742 . . . . 45.23 112.446 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 10.1 tpt180 -131.54 140.39 49.47 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.564 -0.532 . . . . 71.41 109.564 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.88 112.38 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.417 -0.586 . . . . 44.44 109.417 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' HD23 ' A' ' 21' ' ' LEU . 2.8 m -105.5 148.25 10.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.484 0.659 . . . . 73.33 111.209 -175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -113.03 97.58 42.76 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.776 -1.102 . . . . 75.42 110.755 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -77.43 128.8 9.81 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.685 2.257 . . . . 70.03 111.27 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -132.99 172.08 13.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.326 -0.852 . . . . 75.32 108.918 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 4.7 tpp180 -77.99 137.5 38.33 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.651 -0.42 . . . . 74.12 110.338 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.51 2.58 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.158 0.504 . . . . 62.31 110.664 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.1 151.66 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.887 -1.051 . . . . 74.54 111.064 177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 t -55.05 148.24 14.18 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.611 -0.722 . . . . 74.14 110.469 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -51.02 -43.71 60.92 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.357 1.243 . . . . 73.3 114.357 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.84 -33.82 68.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.976 0.417 . . . . 74.21 111.014 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -84.33 -26.63 28.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.618 -0.719 . . . . 60.41 111.969 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.4 p -74.29 -15.05 60.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.928 0.394 . . . . 72.44 111.178 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -85.61 -10.08 56.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.91 -0.586 . . . . 72.33 110.521 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -87.52 148.24 43.72 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 73.11 110.353 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.1 123.81 11.4 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.491 2.127 . . . . 72.42 111.842 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 101.91 12.44 34.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.005 -0.616 . . . . 72.21 112.299 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.95 -52.5 7.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.328 . . . . 73.33 111.395 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -97.39 13.76 28.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.003 0.43 . . . . 72.24 111.347 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD12 ' HA2' ' A' ' 99' ' ' GLY . 67.5 mt -76.81 155.6 32.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.937 -0.764 . . . . 53.52 108.937 170.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.461 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.1 m -77.03 90.44 3.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.398 0.618 . . . . 64.44 110.043 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -115.41 112.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.427 -0.806 . . . . 62.24 110.625 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -104.91 17.27 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 74.24 110.729 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 138.99 52.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.419 -0.355 . . . . 75.12 110.981 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.569 HG23 HG13 ' A' ' 159' ' ' VAL . 3.5 pt -128.21 151.82 35.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.343 0.592 . . . . 71.52 111.734 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.9 t80 -100.36 133.12 45.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.623 -1.172 . . . . 75.13 109.667 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.15 110.7 30.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.899 -0.778 . . . . 74.12 108.899 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . -127.38 154.22 19.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.826 -1.178 . . . . 41.33 112.819 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.96 8.4 58.02 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.633 -0.794 . . . . 72.55 112.164 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.481 HG13 ' H ' ' A' ' 147' ' ' GLY . 8.6 pt -72.28 93.32 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.305 0.574 . . . . 63.22 110.504 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -80.5 -25.31 38.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.818 -0.628 . . . . 73.54 110.799 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -88.85 161.1 16.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.67 -0.695 . . . . 61.21 110.534 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 145' ' ' LYS . 25.5 t70 -65.67 104.16 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.48 0.487 . . . . 72.2 109.99 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.5 m -109.34 130.43 55.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.853 -0.612 . . . . 71.33 110.804 -173.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -112.71 175.24 5.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.002 -0.999 . . . . 71.13 111.13 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -59.47 -48.92 79.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.816 -1.083 . . . . 65.4 110.834 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -56.24 -37.27 69.52 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.275 0.359 . . . . 74.32 111.638 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 64.7 m170 -56.7 -60.74 3.12 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 123.412 0.445 . . . . 72.31 111.075 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.79 -26.99 29.15 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.904 -0.718 . . . . 75.14 111.59 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -66.07 -50.65 63.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.611 -0.144 . . . . 74.52 110.611 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.79 -24.43 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.039 0.447 . . . . 53.53 110.399 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -77.34 -57.32 3.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.898 -0.592 . . . . 71.11 111.878 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -68.58 -23.15 64.45 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.713 0.634 . . . . 75.54 112.713 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 3.1 mt-10 -69.54 -20.24 63.68 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.005 0.431 . . . . 71.31 111.503 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -57.25 -28.92 63.38 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.879 -0.601 . . . . 64.52 111.078 171.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.66 -30.37 19.22 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.068 0.396 . . . . 72.44 112.068 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.2 -176.1 47.82 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.587 -0.816 . . . . 73.44 113.347 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -75.97 133.26 40.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.159 0.504 . . . . 64.22 111.178 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 126' ' ' GLU . 75.8 mt -102.92 139.16 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.472 -0.785 . . . . 64.31 109.507 176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -86.39 -50.83 6.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.462 . . . . 74.2 110.394 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.461 HG13 ' OE2' ' A' ' 135' ' ' GLU . 9.0 p -160.78 159.34 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.661 -0.7 . . . . 71.23 109.549 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.85 131.93 71.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.342 0.591 . . . . 74.04 110.693 -175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 4.1 mp0 -101.88 103.53 14.21 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.054 -0.975 . . . . 62.14 110.378 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 43.2 mm -93.51 116.7 35.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.078 -0.712 . . . . 64.2 109.078 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 148' ' ' PHE . 73.8 mmm -93.72 124.75 37.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.012 -0.736 . . . . 71.13 109.012 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 149.53 29.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.637 -0.711 . . . . 65.51 110.143 -174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -77.06 107.11 9.19 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.85 -0.796 . . . . 73.4 108.85 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -67.72 -33.29 74.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 74.21 111.251 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.27 -43.58 10.47 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.775 -0.726 . . . . 45.24 112.956 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -92.56 -23.1 19.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.67 0.271 . . . . 72.11 111.586 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.45 22.01 61.17 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.194 -0.527 . . . . 71.1 112.501 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.54 135.66 43.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.054 0.454 . . . . 73.5 111.25 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HB3' ' OD1' ' A' ' 115' ' ' ASP . 15.3 ttmt -92.61 79.52 4.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 74.32 110.807 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.53 -179.14 0.51 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.669 -0.696 . . . . 74.41 111.089 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.481 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.87 -44.04 1.59 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.067 -0.969 . . . . 64.23 111.995 175.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.405 ' O ' ' HB2' ' A' ' 137' ' ' MET . 20.2 p90 -170.86 153.93 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.682 -0.858 . . . . 74.42 108.682 173.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.56 169.81 17.67 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.944 0.402 . . . . 74.25 109.969 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 72.4 m-85 -138.74 154.68 48.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 53.22 109.435 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 107' ' ' ILE . 2.3 p -144.6 131.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.392 0.615 . . . . 74.3 111.546 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 131' ' ' ILE . 34.6 m -92.97 124.5 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.963 -1.017 . . . . 62.34 110.941 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -101.17 156.9 17.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.393 -0.367 . . . . 74.03 110.819 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.42 -25.78 46.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.977 -0.556 . . . . 75.34 110.582 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -131.1 148.08 52.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.727 -0.67 . . . . 72.4 110.822 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.461 ' CD2' HG23 ' A' ' 103' ' ' THR . 19.1 p80 -78.29 -27.24 47.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.625 -0.262 . . . . 74.14 110.76 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 20.8 t70 -64.72 -36.74 85.28 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.073 -0.512 . . . . 62.4 110.802 -176.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -65.72 -32.74 74.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 44.54 110.56 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 107' ' ' ILE . 1.4 t -70.77 -39.43 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.925 -0.58 . . . . 62.34 109.988 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.652 ' HA ' HG22 ' A' ' 163' ' ' VAL . 2.2 t70 -69.96 -33.5 72.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.643 -0.708 . . . . 63.4 111.332 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 86.9 mttt -54.0 -38.86 65.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.849 0.833 . . . . 75.51 109.954 171.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.3 mt -77.07 -43.58 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.126 -1.397 . . . . 62.43 112.398 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 160' ' ' ASP . 11.2 m -75.71 -11.65 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.891 -0.506 . . . . 73.3 110.769 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 13' ' ' LEU . 8.6 mt -58.51 -31.07 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.354 -0.839 . . . . 61.51 109.932 170.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 53.1 mt-30 -112.63 100.96 9.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.39 -0.967 . . . . 53.14 108.39 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -58.35 -33.29 69.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.612 0.597 . . . . 73.04 112.612 -174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.61 131.3 54.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.824 0.345 . . . . 64.14 110.92 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 84.4 m-70 -123.79 151.3 43.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 73.13 110.672 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 m -94.39 105.24 17.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.915 0.388 . . . . 63.24 110.072 175.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.3 t -117.52 130.57 72.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.066 -0.716 . . . . 70.34 109.066 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 53.02 34.56 17.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.863 0.84 . . . . 73.1 111.448 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 75.41 0.9 63.5 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.663 -0.699 . . . . 32.04 113.498 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -111.59 128.75 56.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.169 -0.308 . . . . 72.13 110.169 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.79 109.32 11.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.325 0.583 . . . . 74.25 110.707 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.84 156.31 20.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.197 -0.91 . . . . 71.24 109.816 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -89.47 131.14 35.66 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.91 0.385 . . . . 74.11 110.042 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.9 t -128.56 132.92 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.365 -0.834 . . . . 73.1 110.195 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -157.7 176.14 12.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.688 -0.687 . . . . 73.41 110.297 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -61.77 128.94 38.64 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.802 0.334 . . . . 74.34 110.841 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -107.92 113.54 26.83 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.212 0.53 . . . . 41.01 109.69 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.8 mt -99.01 147.3 25.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.389 -0.823 . . . . 65.34 109.509 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' A' ' 186' ' ' MET . 8.0 m -68.27 152.98 44.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 172.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -60.99 -24.98 66.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.126 0.488 . . . . 71.52 110.773 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -68.37 -38.28 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 65.41 110.428 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -76.12 -33.07 59.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.659 -0.7 . . . . 71.14 110.721 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 182' ' ' SER . 90.9 mtp -74.34 -13.65 60.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 73.13 111.159 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.97 58.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 71.03 110.284 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.9 m 63.84 17.94 10.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.274 -0.875 . . . . 72.11 111.678 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.39 -177.76 5.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.587 -0.894 . . . . 52.45 108.587 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t -67.89 116.61 8.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.821 -0.436 . . . . 51.54 109.821 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.2 t -139.57 119.17 13.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.079 -0.51 . . . . 62.01 110.184 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 p -112.94 100.86 8.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.787 -0.642 . . . . 73.15 109.856 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -114.25 149.77 35.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.928 0.394 . . . . 71.01 111.494 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -122.15 161.47 23.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.812 -0.631 . . . . 75.45 109.949 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 142.51 116.3 1.18 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.943 -0.646 . . . . 64.15 111.903 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 119.061 -0.495 . . . . 53.24 110.586 -179.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.733 -0.547 . . . . 70.23 111.733 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m 61.47 22.7 13.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.211 0.605 . . . . 71.11 112.149 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.468 ' HA ' ' OG1' ' A' ' 39' ' ' THR . 31.7 mtmm -127.12 10.13 6.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.09 0.471 . . . . 72.12 111.13 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.1 m -151.26 106.75 3.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 72.11 109.684 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.85 150.44 51.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.34 -0.391 . . . . 63.1 111.331 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 103.84 52.67 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.63 -0.714 . . . . 74.51 109.451 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -84.44 165.28 12.5 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.688 2.258 . . . . 73.23 113.238 -175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -109.27 2.18 20.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.944 -0.762 . . . . 75.1 108.944 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.42 133.28 31.65 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-N 114.66 -1.154 . . . . 53.33 110.231 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HD2' HD22 ' A' ' 13' ' ' LEU . 27.5 Cg_endo -65.0 167.15 16.6 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.114 2.543 . . . . 72.21 111.323 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.19 -34.89 70.85 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 112.19 0.441 . . . . 71.3 112.19 -173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.1 pt20 -68.49 -20.1 64.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.014 0.376 . . . . 72.4 112.014 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.541 HD22 ' HD2' ' A' ' 10' ' ' PRO . 5.0 mp -89.73 -14.3 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.316 . . . . 64.35 110.816 -177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.57 ' HA ' HG21 ' A' ' 68' ' ' VAL . 28.5 ptt85 -125.36 -2.96 7.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 64.3 111.676 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.7 ttpt -98.73 144.73 27.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.752 0.787 . . . . 74.55 111.22 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.592 HD21 HG13 ' A' ' 68' ' ' VAL . 50.6 mt -120.2 146.92 45.56 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.326 -1.306 . . . . 63.13 110.969 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -98.71 115.67 29.24 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.33 -0.989 . . . . 64.43 108.33 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 60' ' ' VAL . 20.2 mm -95.0 112.6 27.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.964 -0.384 . . . . 55.34 109.964 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.55 152.45 17.89 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.986 -0.626 . . . . 73.41 111.56 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.16 42.5 50.6 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.553 -0.832 . . . . 60.43 113.314 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 25' ' ' THR . 76.9 mt -77.94 174.02 11.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.929 0.364 . . . . 74.14 110.171 174.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -84.76 175.92 8.86 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.104 -0.702 . . . . 74.23 109.104 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.97 -9.5 59.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.297 0.57 . . . . 74.13 109.825 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 53' ' ' ARG . 24.9 mt-10 -114.3 5.15 15.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.47 -0.786 . . . . 63.33 112.231 -172.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.505 HG21 HD22 ' A' ' 21' ' ' LEU . 84.9 m -73.0 126.03 29.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.387 0.613 . . . . 72.31 112.206 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 p -100.73 164.35 11.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.342 -0.844 . . . . 64.53 110.337 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.18 -24.27 57.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.156 -0.313 . . . . 74.12 110.156 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -72.43 -37.69 68.53 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.175 0.297 . . . . 70.53 110.951 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -77.63 -38.26 48.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 71.12 110.285 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 79' ' ' VAL . 35.3 tp -60.43 -52.26 65.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.404 -0.816 . . . . 73.51 109.803 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -53.86 -60.54 3.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.06 -0.973 . . . . 74.12 112.009 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -48.31 -36.59 14.54 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.817 0.698 . . . . 74.41 112.663 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -67.66 -50.8 56.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.785 0.326 . . . . 72.25 110.714 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -80.44 -20.41 43.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.644 0.239 . . . . 64.35 111.644 -173.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -60.65 -22.76 64.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.036 0.446 . . . . 63.41 111.476 173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -67.48 -28.1 67.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.761 . . . . 60.01 112.148 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -96.69 -27.64 14.68 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.1 -0.24 . . . . 75.11 111.381 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.84 160.05 33.41 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.593 -0.813 . . . . 70.14 112.009 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 3' ' ' LYS . 24.5 m -64.6 120.12 11.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.73 0.3 . . . . 74.34 111.676 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.8 mt -89.96 139.6 30.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.486 0.66 . . . . 74.42 111.174 173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 p -105.8 -24.57 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.997 -1.001 . . . . 62.31 110.006 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -153.45 156.9 39.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.636 -0.711 . . . . 61.33 109.912 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.0 t -164.13 131.73 3.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.516 -0.55 . . . . 71.24 109.516 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.09 117.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.564 0.697 . . . . 64.31 110.416 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.45 136.04 23.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.058 -0.719 . . . . 60.41 109.058 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.9 mmt -83.18 97.45 8.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.638 0.732 . . . . 72.0 110.396 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 50.2 mtp85 -102.25 163.68 12.1 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.525 -1.216 . . . . 74.05 111.032 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.78 125.02 83.12 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 114.726 -1.125 . . . . 75.43 110.216 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.33 -12.73 34.38 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.93 1.753 . . . . 75.01 112.929 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -85.44 -56.96 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 73.22 111.77 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -103.26 -10.53 18.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 74.51 111.358 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp 65.81 39.38 4.72 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.364 -0.835 . . . . 62.23 110.471 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 24' ' ' GLU . 31.7 mmm180 -121.82 154.85 36.48 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.631 -0.507 . . . . 65.2 109.631 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.7 t -66.21 139.11 58.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.93 0.395 . . . . 62.03 111.68 -174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -84.33 -1.85 56.09 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 74.34 110.465 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.87 57.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.883 -0.675 . . . . 74.31 113.962 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -157.27 157.43 34.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.189 0.995 . . . . 75.23 111.078 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.21 -166.07 18.32 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.387 -0.685 . . . . 71.41 111.387 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -141.31 149.97 41.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.588 0.694 . . . . 73.44 110.833 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG22 HD11 ' A' ' 18' ' ' ILE . 6.9 m -131.53 123.82 53.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.566 -0.743 . . . . 70.13 109.869 173.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.5 m -99.03 118.75 36.51 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.642 -0.254 . . . . 74.14 110.498 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.7 169.6 14.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.263 -0.426 . . . . 60.43 110.62 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.34 -51.56 14.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.843 -0.617 . . . . 53.43 109.892 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -123.8 155.28 38.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 64.22 110.606 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -62.22 -34.82 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 120.663 0.268 . . . . 72.42 111.308 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -57.97 -37.82 74.9 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.221 0.452 . . . . 72.44 112.221 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -62.38 -35.12 78.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.245 0.545 . . . . 61.44 110.006 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 16' ' ' LEU . 5.2 t -64.86 -47.6 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.117 -0.947 . . . . 71.33 110.663 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -54.93 -52.74 62.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 63.21 110.626 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.64 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.693 0.627 . . . . 54.34 112.693 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.18 68.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.938 0.399 . . . . 70.21 110.703 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.4 mmt -67.79 -43.18 80.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.923 -0.58 . . . . 74.32 110.764 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.64 -40.35 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.126 0.488 . . . . 62.43 110.568 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.45 -16.59 64.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.177 -0.92 . . . . 74.43 112.909 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 75' ' ' ARG . 27.7 mtp-105 -54.09 147.23 26.51 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.233 0.457 . . . . 65.02 112.233 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.4 168.41 71.86 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.475 -1.469 . . . . 63.21 113.732 3.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -121.23 162.22 20.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.239 -0.891 . . . . 73.34 110.346 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 19.9 ttmt -136.74 111.85 9.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.991 0.424 . . . . 73.53 111.604 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 30' ' ' LEU . 18.6 t -115.4 130.51 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 64.14 109.742 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 4.3 m-20 65.07 29.85 11.91 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.804 0.69 . . . . 75.51 111.96 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.82 24.73 68.89 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.793 -0.718 . . . . 53.3 112.445 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.9 tpt180 -132.64 142.12 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.448 -0.575 . . . . 65.54 109.448 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.89 113.18 23.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.791 0.805 . . . . 75.33 109.368 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.2 m -102.83 151.07 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 62.33 111.236 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . 3.5 tp10 -113.11 97.25 41.88 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.79 -1.095 . . . . 54.54 111.117 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -73.48 129.49 13.84 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.311 2.007 . . . . 74.01 111.221 173.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 19.7 mttt -134.71 -179.02 5.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.349 -1.723 . . . . 60.54 106.349 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ttt-85 -86.7 141.16 29.11 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 119.581 1.082 . . . . 73.25 110.855 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.32 95.47 0.6 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.071 -0.513 . . . . 61.33 110.663 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.58 133.57 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.666 -0.697 . . . . 73.14 109.593 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.3 t -78.61 174.0 11.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 63.51 110.859 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -49.2 -54.58 15.88 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.964 0.906 . . . . 72.21 113.302 -171.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.79 -36.61 65.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.904 0.335 . . . . 71.11 111.904 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 -11.52 58.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.951 0.352 . . . . 74.34 111.951 -176.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.6 p -97.81 2.48 49.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.565 0.222 . . . . 73.35 111.266 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -62.96 -37.68 88.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.29 -0.414 . . . . 74.21 111.074 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -92.57 145.6 30.77 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.328 -0.396 . . . . 75.13 110.261 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.44 151.12 70.84 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.913 2.409 . . . . 64.51 111.847 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 95.71 8.87 57.99 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.608 -0.806 . . . . 71.31 111.925 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.87 -49.04 15.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 60.14 110.562 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -92.77 3.76 55.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 71.0 111.381 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.434 HD12 ' HA2' ' A' ' 99' ' ' GLY . 70.6 mt -82.79 158.56 22.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 71.22 109.782 176.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.406 HG23 ' CD2' ' A' ' 156' ' ' HIS . 2.9 m -76.31 93.49 3.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.803 0.811 . . . . 74.41 110.511 -176.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.9 t -120.26 108.21 22.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.749 -1.114 . . . . 64.24 109.913 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 156' ' ' HIS . 53.7 mttt -100.09 10.49 41.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 72.44 110.776 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -116.52 140.68 49.11 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.11 -0.496 . . . . 72.03 111.106 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.499 HG23 HG13 ' A' ' 159' ' ' VAL . 4.9 pt -122.84 149.88 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.258 0.552 . . . . 72.21 111.969 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.6 t80 -98.43 133.8 42.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.883 -1.053 . . . . 72.44 109.054 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.56 109.23 22.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.491 -0.559 . . . . 54.42 109.491 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.26 149.96 17.0 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.209 -0.996 . . . . 65.44 113.05 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.56 25.62 38.41 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.335 -0.936 . . . . 64.21 112.595 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.493 ' HB ' ' OG1' ' A' ' 116' ' ' THR . 5.2 pt -68.91 131.48 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.054 0.454 . . . . 55.23 109.946 174.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 173' ' ' HIS . 65.2 tttp -82.93 107.17 15.34 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.343 0.868 . . . . 74.32 113.343 -164.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 0.5 OUTLIER 73.27 -53.2 0.7 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.405 1.066 . . . . 62.34 113.456 167.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -165.46 112.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.833 -0.432 . . . . 61.34 109.833 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 112' ' ' ILE . 14.9 m -123.66 136.77 54.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.283 0.563 . . . . 54.45 109.629 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -110.88 171.89 7.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.694 -0.684 . . . . 74.13 111.139 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -57.44 -49.59 75.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 114.79 -1.095 . . . . 74.41 110.562 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -54.91 -35.0 63.68 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.399 0.437 . . . . 73.14 111.783 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.18 -61.18 2.42 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.281 0.363 . . . . 71.33 111.056 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.6 pp -83.77 -23.66 31.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.197 -0.601 . . . . 72.11 111.46 -171.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -65.33 -55.36 18.69 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 109.937 -0.394 . . . . 73.34 109.937 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.23 -28.97 69.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.323 0.582 . . . . 72.45 110.495 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -76.32 -56.64 4.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.359 -0.837 . . . . 70.3 112.22 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 151' ' ' VAL . 43.1 m-85 -68.95 -23.02 64.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 111.685 0.254 . . . . 75.44 111.685 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.7 mm-40 -64.4 -24.54 67.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.027 0.442 . . . . 73.2 110.905 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -61.0 -27.42 68.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.822 -0.626 . . . . 50.33 111.777 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.53 -25.79 22.34 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.77 0.285 . . . . 73.51 111.77 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.25 -175.82 46.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.536 -0.84 . . . . 74.52 113.312 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -75.47 125.61 29.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.204 0.526 . . . . 71.21 112.067 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 52.8 mt -98.17 136.1 30.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 74.44 110.301 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.29 -50.49 8.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 74.23 110.309 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.8 p -159.56 157.96 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 50.51 110.091 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.4 128.51 71.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.321 0.582 . . . . 71.3 110.519 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.531 ' HG2' ' HA3' ' A' ' 195' ' ' GLY . 35.7 mt-10 -100.29 104.89 16.38 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.255 -0.884 . . . . 62.11 110.859 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -95.65 122.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.229 -0.656 . . . . 73.24 109.229 174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 60.6 mmm -101.95 135.97 42.6 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.636 -0.876 . . . . 74.24 108.636 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.51 156.95 16.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 73.45 111.913 -172.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -72.7 143.16 48.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.354 -0.839 . . . . 74.2 109.937 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -64.04 -47.53 79.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 70.11 111.596 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.36 -47.13 1.89 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.327 -0.94 . . . . 63.45 113.951 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.1 p -81.26 -23.02 38.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.895 0.331 . . . . 54.32 111.895 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 16.72 80.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 72.12 112.405 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HB2' ' HD2' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -87.95 163.6 16.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.875 -0.787 . . . . 63.31 108.875 178.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -90.15 77.66 6.72 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.793 -0.363 . . . . 75.54 110.075 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.426 ' HD2' ' HB2' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -160.74 170.38 20.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.946 0.879 . . . . 64.22 112.787 -179.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 112' ' ' ILE . . . 110.98 -44.67 1.46 Allowed Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 113.466 -1.697 . . . . 75.42 110.56 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -171.54 145.87 2.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.374 -0.602 . . . . 74.01 109.374 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.51 170.49 14.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.628 -0.714 . . . . 70.13 109.112 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.529 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 41.1 m-85 -136.24 143.4 44.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.844 -0.616 . . . . 74.02 109.404 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 125' ' ' PHE . 58.0 t -129.2 121.73 54.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 O-C-N 122.164 -0.335 . . . . 54.5 110.483 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 85.9 m -96.16 118.92 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.678 -0.692 . . . . 74.04 110.821 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -102.75 156.64 17.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.601 0.238 . . . . 71.23 110.889 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.22 -29.71 65.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 71.11 110.288 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . 1.9 t0 -139.06 159.96 40.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.587 -0.733 . . . . 65.25 110.887 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 105' ' ' LYS . 15.9 p80 -79.18 -19.87 49.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 75.41 110.115 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.608 ' HB2' ' SD ' ' A' ' 72' ' ' MET . 1.3 p-10 -60.84 -38.23 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.029 -0.987 . . . . 70.51 110.979 -174.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -73.85 -31.08 63.01 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.132 -0.486 . . . . 65.34 110.227 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.499 HG13 HG23 ' A' ' 107' ' ' ILE . 3.8 t -69.82 -39.01 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.677 -0.692 . . . . 74.01 109.835 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -70.92 -26.77 63.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 62.14 111.242 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 71.7 mttt -69.07 -33.67 73.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.315 0.579 . . . . 70.34 110.265 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.3 mt -78.02 -42.68 28.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.564 -0.744 . . . . 75.13 112.672 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 160' ' ' ASP . 25.3 m -70.64 -6.14 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.001 0.429 . . . . 75.22 111.434 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 13' ' ' LEU . 71.5 mt -54.91 -38.79 46.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.191 -0.913 . . . . 63.04 109.861 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.401 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 56.7 mt-30 -109.49 105.28 14.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.578 -0.897 . . . . 54.21 108.578 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -55.04 -32.34 61.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.864 -0.607 . . . . 65.44 111.706 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -124.91 133.9 52.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.455 -0.339 . . . . 75.23 110.687 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 88.4 m-70 -120.98 144.64 48.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.853 -0.612 . . . . 61.24 109.887 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.8 m -114.03 106.23 14.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.355 -0.384 . . . . 55.51 110.569 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.91 114.73 44.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.309 -0.405 . . . . 73.21 111.203 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t30 67.41 31.74 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.759 0.79 . . . . 55.22 109.656 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.94 5.46 86.14 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.497 -0.774 . . . . 74.45 112.385 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.559 ' CD2' ' HB3' ' A' ' 113' ' ' LYS . 61.5 m170 -106.04 110.21 22.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.199 -0.297 . . . . 74.15 110.199 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.75 107.81 19.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.151 0.5 . . . . 75.14 109.737 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 p -117.05 156.22 27.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.577 -0.738 . . . . 72.11 111.451 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.31 134.92 33.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.756 -0.657 . . . . 74.41 109.853 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 26.9 t -130.9 134.0 62.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.166 0.508 . . . . 51.11 110.667 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -152.92 173.5 15.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.559 -0.746 . . . . 65.22 111.372 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -65.68 130.31 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.263 -0.426 . . . . 74.4 110.298 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -120.75 122.34 40.17 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.711 -0.478 . . . . 74.42 109.711 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.4 mt -80.25 131.44 35.68 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.743 -0.383 . . . . 73.54 110.375 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 186' ' ' MET . 28.7 t -62.34 154.57 27.57 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.498 -0.556 . . . . 70.45 109.498 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -58.59 -31.37 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.188 0.518 . . . . 75.22 110.137 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -58.88 -41.29 86.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.046 -0.979 . . . . 74.34 110.46 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -37.09 29.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.654 -0.703 . . . . 60.43 111.291 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 182' ' ' SER . 80.5 mtp -66.31 -45.74 79.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.269 -0.423 . . . . 74.24 111.076 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -87.3 -4.51 59.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 73.23 111.054 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.0 p 45.04 58.48 4.02 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.032 0.933 . . . . 63.32 111.567 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.18 173.67 11.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.379 -0.828 . . . . 52.23 110.432 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.5 t -80.17 99.2 7.67 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.799 -0.445 . . . . 41.43 109.799 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.2 m -149.21 167.01 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 65.14 110.35 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.5 m -127.46 150.76 49.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 73.41 109.599 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -124.24 115.02 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 64.11 111.012 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -130.76 148.82 52.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.508 . . . . 64.21 110.712 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.531 ' HA3' ' HG2' ' A' ' 135' ' ' GLU . . . -118.64 144.35 17.92 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.296 -0.722 . . . . 61.34 111.296 177.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.454 -0.784 . . . . 63.21 109.631 -179.474 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.788 -0.525 . . . . 63.21 111.788 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 p -80.62 81.37 6.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.503 0.668 . . . . 72.14 110.453 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -88.74 97.11 10.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.792 -0.64 . . . . 64.04 110.907 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -77.79 143.96 37.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.525 -0.761 . . . . 72.54 109.46 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.55 92.54 1.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.044 0.45 . . . . 50.34 111.407 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 m -71.47 -48.44 12.41 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.561 -0.745 . . . . 55.44 111.814 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 6' ' ' SER . 17.1 Cg_endo -56.8 149.49 59.9 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.452 2.101 . . . . 73.21 113.1 178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.8 12.22 22.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.514 -0.766 . . . . 73.45 110.675 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -76.09 130.93 76.73 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.246 -0.65 . . . . 71.03 109.246 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.67 166.36 15.93 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.26 1.973 . . . . 71.45 111.97 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -41.24 64.41 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.566 -0.743 . . . . 72.44 112.397 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -71.39 -27.37 63.27 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.818 0.342 . . . . 73.43 111.842 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -84.51 -6.16 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.493 -0.322 . . . . 71.41 111.024 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.4 ptt180 -127.81 6.17 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.981 0.419 . . . . 70.43 110.685 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.9 ttpt -98.31 146.72 25.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.401 0.62 . . . . 73.11 111.16 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD21 HG13 ' A' ' 68' ' ' VAL . 58.0 mt -115.48 143.47 45.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.664 -1.153 . . . . 72.1 110.704 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -97.86 120.81 38.92 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.622 -0.881 . . . . 63.22 108.622 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.49 111.63 29.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 110.093 -0.336 . . . . 64.12 110.093 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.78 151.26 17.29 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 121.089 -0.577 . . . . 65.42 111.713 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.9 44.54 55.53 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.683 -0.77 . . . . 71.12 113.142 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD22 HG21 ' A' ' 25' ' ' THR . 84.2 mt -78.08 173.73 11.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.736 -0.468 . . . . 72.14 109.736 171.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -86.11 -178.16 6.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.026 0.441 . . . . 70.01 110.012 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -81.02 -9.0 59.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.045 -0.525 . . . . 71.5 110.09 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 19.8 mt-10 -121.81 18.99 11.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.629 0.603 . . . . 72.44 112.629 -173.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.545 HG21 HD22 ' A' ' 21' ' ' LEU . 28.6 m -78.36 115.33 18.0 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.875 0.369 . . . . 62.43 110.964 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.9 p -97.47 158.76 15.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.167 -0.469 . . . . 75.1 110.447 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.668 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 9.6 t0 -59.33 -43.22 92.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.054 0.542 . . . . 32.23 111.152 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.62 -34.81 77.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.755 . . . . 71.24 111.543 -175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 m -79.19 -36.37 40.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.452 -0.34 . . . . 64.22 110.802 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HA ' HG11 ' A' ' 79' ' ' VAL . 50.2 tp -65.52 -51.72 57.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 62.02 110.013 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -54.23 -60.55 3.19 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.304 -0.862 . . . . 65.33 112.117 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 t -48.67 -33.51 10.14 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.809 0.693 . . . . 75.45 112.843 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.442 ' ND1' HG22 ' A' ' 79' ' ' VAL . 11.2 t-80 -73.23 -56.12 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.222 -0.191 . . . . 73.24 110.892 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.45 -23.96 63.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.938 0.347 . . . . 72.54 111.938 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -57.79 -20.95 39.09 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.504 0.722 . . . . 72.02 112.114 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.42 -29.27 69.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.88 0.326 . . . . 73.44 111.88 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -96.27 -20.82 18.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.689 0.28 . . . . 63.44 111.203 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.79 164.39 32.77 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.34 -0.933 . . . . 73.44 112.309 173.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.7 m -62.92 119.79 10.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.919 0.39 . . . . 71.54 111.699 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.96 117.04 26.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.739 -0.664 . . . . 72.43 110.777 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -84.36 -25.71 28.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.037 -0.983 . . . . 74.55 110.269 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -149.58 150.29 32.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.447 -0.797 . . . . 72.44 109.486 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.3 t -160.54 138.7 9.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.949 -0.76 . . . . 42.31 108.949 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.668 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 5.7 p -152.23 122.54 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 121.434 0.635 . . . . 74.01 111.005 171.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.49 136.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.402 -0.962 . . . . 73.3 108.402 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.532 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.1 mmt -81.7 100.41 9.46 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.595 0.712 . . . . 72.02 110.524 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -101.83 158.11 16.36 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.66 -1.155 . . . . 74.11 109.205 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.36 132.96 64.62 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.039 -0.356 . . . . 75.12 110.039 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -22.4 73.18 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.389 2.06 . . . . 43.01 113.681 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -86.32 -55.71 3.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.288 0.566 . . . . 75.21 110.792 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 p -95.84 -14.78 22.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.123 -0.944 . . . . 60.23 112.346 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm 64.62 26.13 13.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.552 0.741 . . . . 72.44 111.307 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 23.5 mmm180 -109.18 156.76 19.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.766 -0.457 . . . . 62.32 109.766 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 m -68.37 132.02 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.846 0.355 . . . . 74.11 111.178 -174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -85.84 3.18 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.69 -0.686 . . . . 74.51 111.225 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 11.44 65.47 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.585 -0.817 . . . . 61.23 114.069 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 22.5 p90 -153.82 155.75 36.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.784 0.792 . . . . 61.2 110.712 175.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.16 -169.51 23.55 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.382 -0.687 . . . . 53.54 111.382 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.23 142.4 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.178 0.489 . . . . 74.11 110.389 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 m -126.85 128.19 70.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 63.21 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 m -104.6 122.06 44.83 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.525 -0.307 . . . . 70.31 110.239 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 31.9 m-85 -88.73 161.37 16.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.171 -0.468 . . . . 65.13 110.483 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.78 83.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.509 -0.769 . . . . 73.11 110.744 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.6 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 16.5 m -131.12 154.34 48.41 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.107 -0.497 . . . . 72.5 110.463 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.5 p -65.63 -34.0 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 111.658 0.244 . . . . 64.3 111.658 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.03 -43.7 78.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.967 0.358 . . . . 72.04 111.967 175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 2.7 mp0 -62.01 -33.23 73.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.794 -0.639 . . . . 72.54 110.644 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 HD21 ' A' ' 16' ' ' LEU . 42.3 t -64.21 -50.23 77.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.281 -0.872 . . . . 71.12 110.97 175.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.02 -41.1 91.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.248 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.86 67.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.327 -0.397 . . . . 73.44 112.026 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.26 -36.23 66.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.913 0.387 . . . . 71.43 110.665 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -37.21 86.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.127 -0.488 . . . . 73.31 111.227 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -28.19 45.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.128 -0.487 . . . . 62.21 111.001 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.29 -9.64 54.17 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.741 0.645 . . . . 65.32 112.741 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 75' ' ' ARG . 24.8 mtp-105 -58.04 146.23 69.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.456 -0.338 . . . . 72.33 111.501 175.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.01 153.2 99.02 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.967 -1.264 . . . . 64.24 114.049 3.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -108.65 153.31 23.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.054 -0.976 . . . . 65.15 110.731 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 13.6 ttmt -136.42 103.16 5.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.037 0.446 . . . . 70.4 111.198 175.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 30' ' ' LEU . 21.9 t -107.97 131.52 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.613 -0.721 . . . . 72.03 109.676 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.0 t70 64.91 29.77 12.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.791 0.805 . . . . 55.11 110.564 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.35 76.34 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.549 -0.75 . . . . 32.43 112.16 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 24.8 tpt180 -125.59 136.94 53.82 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.884 -0.413 . . . . 73.43 109.884 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.04 109.52 13.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.776 0.798 . . . . 72.44 109.623 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.5 m -105.67 152.86 7.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.505 -0.771 . . . . 75.43 110.787 -173.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -112.07 97.24 37.84 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.423 -0.808 . . . . 73.11 110.879 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.81 129.63 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.149 1.899 . . . . 74.33 110.429 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -135.18 179.42 6.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.781 -1.192 . . . . 50.13 107.781 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 160' ' ' ASP . 7.8 tpp180 -79.26 162.7 25.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.324 -0.551 . . . . 64.1 109.667 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.66 93.26 5.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.466 -0.568 . . . . 73.03 109.466 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.1 154.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.001 -0.999 . . . . 61.11 111.396 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m -59.92 146.98 40.31 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.59 -0.732 . . . . 60.13 110.091 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -65.63 -19.17 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.341 -0.39 . . . . 74.24 111.359 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.39 -39.32 88.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.025 -0.534 . . . . 73.23 111.65 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.28 -22.02 48.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.226 0.536 . . . . 74.25 110.12 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.428 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 20.1 t -70.41 -0.53 8.44 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.518 -0.765 . . . . 74.2 111.233 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -71.08 -24.96 62.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 74.34 110.222 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -77.78 146.2 72.07 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 73.24 110.216 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.43 114.94 3.82 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.657 2.238 . . . . 74.12 112.191 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.88 41.74 10.37 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.77 -0.729 . . . . 64.41 112.185 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 95' ' ' SER . . . -72.79 -27.17 61.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.759 0.314 . . . . 51.2 111.294 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -99.83 11.85 38.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.855 0.359 . . . . 72.03 111.008 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -81.16 167.23 19.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.958 -0.756 . . . . 63.54 108.958 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.469 HG23 ' CD2' ' A' ' 156' ' ' HIS . 7.8 m -75.55 90.17 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.222 0.534 . . . . 74.32 111.054 -176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.49 115.63 50.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.284 -0.871 . . . . 62.33 109.831 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.52 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.1 mttt -109.11 22.26 16.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.14 0.495 . . . . 63.04 110.958 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -123.84 140.44 52.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.162 -0.472 . . . . 71.1 111.459 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 159' ' ' VAL . 9.4 pt -127.79 154.03 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.164 0.507 . . . . 72.15 111.812 176.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.2 t80 -100.27 137.19 39.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.835 -1.075 . . . . 65.2 109.384 175.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.9 t -126.03 113.1 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 73.1 109.533 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.15 152.89 19.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.014 -1.089 . . . . 64.32 113.072 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.03 6.35 24.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 75.22 112.61 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.8 pt -79.95 100.36 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.739 0.78 . . . . 63.24 110.813 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? -93.03 3.37 55.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.872 -0.604 . . . . 75.12 111.193 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -123.12 165.58 16.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.093 -0.706 . . . . 74.42 109.093 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.71 99.94 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 72.43 110.371 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -91.22 139.74 30.45 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.853 -0.612 . . . . 73.24 109.683 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.46 165.73 10.86 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.502 -0.772 . . . . 70.41 110.866 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -47.84 84.59 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.091 -1.413 . . . . 73.4 108.768 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -55.26 -30.82 60.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.413 -0.812 . . . . 72.3 111.959 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.8 m170 -66.84 -62.37 1.48 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.213 0.53 . . . . 74.32 110.844 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.451 HD13 HG22 ' A' ' 151' ' ' VAL . 3.5 pp -82.42 -24.03 34.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 120.038 -0.665 . . . . 73.54 111.458 -172.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.416 ' N ' HD12 ' A' ' 121' ' ' LEU . 8.5 tmm_? -66.14 -49.29 67.95 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.212 -0.292 . . . . 71.42 110.212 177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.33 -30.11 70.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.276 0.56 . . . . 73.42 110.78 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -80.59 -54.93 5.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.802 -0.635 . . . . 64.45 112.209 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' A' ' 151' ' ' VAL . 21.0 m-85 -68.38 -22.79 64.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.679 0.622 . . . . 71.05 112.679 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.66 -23.32 64.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.682 0.277 . . . . 72.01 111.276 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -60.88 -24.99 66.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 70.45 111.586 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -85.4 -27.42 25.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.308 -0.405 . . . . 73.04 111.365 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.63 -177.8 43.56 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.707 -0.758 . . . . 74.11 113.223 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -74.11 133.62 42.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.956 0.408 . . . . 70.44 111.194 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 152' ' ' THR . 58.8 mt -103.83 139.37 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.724 -0.671 . . . . 73.2 109.789 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -85.93 -50.74 6.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.317 0.58 . . . . 63.12 110.095 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -156.13 157.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.32 -0.855 . . . . 65.42 109.638 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.2 mp -114.5 128.18 71.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.26 0.552 . . . . 62.41 109.794 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 40.1 mt-10 -99.46 126.01 45.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.174 -0.921 . . . . 60.34 110.232 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.5 mm -119.65 114.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.249 -1.019 . . . . 70.34 108.249 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mmm -91.14 120.42 32.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.399 -0.593 . . . . 73.34 109.399 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.32 142.8 27.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.145 0.497 . . . . 74.33 112.172 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 144' ' ' LYS . 9.9 t0 -55.48 121.64 9.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.794 -1.094 . . . . 74.03 108.748 170.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -71.86 -27.21 62.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.828 0.307 . . . . 72.12 111.828 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -94.3 -44.11 3.58 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.377 -0.916 . . . . 44.31 112.611 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.4 m -89.26 -23.85 22.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.82 0.304 . . . . 74.21 111.82 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.2 24.09 64.45 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.138 -0.553 . . . . 44.02 113.303 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 18.5 mmmt -100.98 162.64 12.75 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.851 -0.425 . . . . 71.31 109.851 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.07 82.71 3.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.762 -0.459 . . . . 72.42 109.762 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -155.4 -179.96 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.375 0.607 . . . . 54.11 111.856 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.65 3.59 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.593 -1.185 . . . . 63.44 112.949 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -173.49 158.62 3.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.317 0.558 . . . . 74.2 109.769 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.04 173.72 11.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.292 -0.632 . . . . 61.04 109.292 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.498 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 36.7 m-85 -138.06 143.94 40.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.298 -0.41 . . . . 70.02 110.133 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 125' ' ' PHE . 50.7 t -126.96 127.77 70.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 O-C-N 122.002 -0.436 . . . . 71.13 110.828 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 131' ' ' ILE . 63.5 m -106.89 120.22 41.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.613 -0.721 . . . . 64.41 111.222 -176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -103.37 160.81 14.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.295 0.569 . . . . 74.22 111.7 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.09 -27.26 39.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.029 -0.987 . . . . 74.2 110.71 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -129.58 155.15 46.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.984 -0.553 . . . . 71.34 110.685 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.469 ' CD2' HG23 ' A' ' 103' ' ' THR . 21.9 p80 -77.51 -29.05 52.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.852 -0.613 . . . . 73.25 110.631 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 13.5 t0 -56.5 -43.58 79.85 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.799 -1.092 . . . . 65.04 111.602 -177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.1 t -63.23 -36.57 84.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.821 -0.627 . . . . 73.24 111.312 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.52 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.9 t -70.44 -39.99 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.146 0.498 . . . . 63.31 109.986 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 88' ' ' ARG . 4.8 t70 -68.76 -33.42 73.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.975 -1.011 . . . . 75.12 111.032 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.5 mttt -59.04 -40.74 85.96 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.564 0.697 . . . . 72.43 110.716 173.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.81 -40.61 46.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.634 -1.167 . . . . 71.01 111.893 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 160' ' ' ASP . 30.7 m -78.34 -9.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.064 0.459 . . . . 53.51 111.102 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 33.6 mt -60.13 -33.1 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.641 -0.709 . . . . 61.43 109.933 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.462 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 49.2 mt-30 -113.89 106.18 14.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.763 -0.653 . . . . 63.41 109.378 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.31 -34.49 57.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.262 0.838 . . . . 74.22 113.262 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -124.62 144.12 50.35 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 121.006 -0.278 . . . . 75.44 110.502 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.9 m-70 -132.49 151.81 51.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.936 176.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 130.05 55.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.916 0.389 . . . . 64.45 110.701 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -144.63 140.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.872 -0.788 . . . . 61.53 108.872 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.1 m120 48.45 30.27 2.32 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.391 0.886 . . . . 64.21 113.391 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.96 -0.71 89.58 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.907 -0.663 . . . . 63.12 114.118 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.488 ' HD2' ' SG ' ' A' ' 175' ' ' CYS . 10.9 p-80 -113.83 135.16 54.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.908 0.854 . . . . 73.44 110.859 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -99.6 116.49 31.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.894 -0.594 . . . . 65.12 110.42 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.488 ' SG ' ' HD2' ' A' ' 173' ' ' HIS . 55.8 m -117.21 157.09 26.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 71.42 111.096 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.4 141.87 28.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.609 . . . . 60.42 110.368 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 4.3 m -131.37 162.14 39.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.956 -0.565 . . . . 72.3 111.075 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -174.09 171.83 3.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.952 -1.022 . . . . 55.2 111.687 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -60.79 129.96 44.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.879 -0.601 . . . . 73.13 110.651 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.12 114.1 25.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.34 0.59 . . . . 74.2 109.61 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.55 160.57 14.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.273 -0.876 . . . . 64.43 109.738 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.8 t -63.28 152.67 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.921 -0.77 . . . . 73.24 108.921 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -60.68 -25.75 66.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.506 0.193 . . . . 74.24 111.331 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -67.63 -43.75 79.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.807 0.337 . . . . 75.52 110.426 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -67.32 -42.61 83.33 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 74.14 110.221 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 23.9 mtt -60.78 -40.62 93.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.269 -0.878 . . . . 71.11 111.141 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.01 75.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.977 -0.556 . . . . 73.24 110.399 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m 71.76 -43.84 0.57 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.076 0.95 . . . . 60.2 112.037 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -63.93 -27.96 69.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.736 0.414 . . . . 64.5 110.913 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.2 m -68.42 105.12 2.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.035 -0.529 . . . . 74.44 109.594 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 m -143.54 162.17 36.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.466 -0.334 . . . . 60.15 111.057 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 17.3 m -113.02 85.99 2.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 63.34 109.709 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.44 -57.43 0.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.72 -0.673 . . . . 73.11 109.955 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -152.45 93.06 1.75 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.04 -0.527 . . . . 74.5 110.296 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -84.53 -54.64 2.9 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.15 -1.18 . . . . 62.22 110.15 169.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.489 -0.767 . . . . 74.41 109.039 175.516 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 112.009 -0.436 . . . . 42.24 112.009 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.1 m -83.8 82.59 8.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.162 0.506 . . . . 62.51 110.388 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -148.09 -72.89 0.2 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.14 -0.689 . . . . 73.23 109.14 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -107.14 126.07 51.9 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.607 -0.516 . . . . 61.32 109.607 176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -112.7 142.87 44.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.893 0.377 . . . . 74.55 110.667 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m -114.06 95.03 36.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.795 -0.639 . . . . 64.12 109.406 173.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 94.1 Cg_endo -78.54 166.16 24.28 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.815 2.343 . . . . 74.12 112.677 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -21.18 22.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 64.33 110.334 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.43 ' OE2' HG12 ' A' ' 65' ' ' VAL . 1.8 mp0 -71.67 132.05 85.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.641 -0.708 . . . . 74.31 110.627 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' HD22 ' A' ' 13' ' ' LEU . 26.1 Cg_endo -66.99 166.36 23.11 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.756 2.304 . . . . 73.24 111.134 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 6.9 pt-20 -60.05 -32.9 71.35 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 119.559 -0.257 . . . . 63.15 111.686 -174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -72.42 -25.04 61.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.654 0.264 . . . . 73.24 111.602 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.1 mp -87.53 -8.69 56.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.705 0.288 . . . . 74.05 111.064 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -125.79 2.95 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.481 -0.327 . . . . 75.11 111.078 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 15.1 ttmm -93.47 146.21 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.54 0.686 . . . . 73.11 111.502 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -119.48 141.3 49.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.491 -1.231 . . . . 54.2 110.079 177.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -98.33 116.04 29.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.784 -0.821 . . . . 54.41 108.784 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 60' ' ' VAL . 18.0 mm -93.13 110.85 23.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.999 -0.371 . . . . 71.2 109.999 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.23 152.2 17.99 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.834 -0.698 . . . . 64.21 111.679 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.6 41.77 56.53 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.019 -0.61 . . . . 63.12 113.618 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 25' ' ' THR . 49.8 mt -75.84 175.15 9.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.92 0.36 . . . . 75.52 110.382 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 86.3 p -88.15 172.33 9.57 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.516 -0.55 . . . . 43.53 109.516 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -76.04 -5.6 47.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.648 0.261 . . . . 63.23 111.176 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.88 21.67 7.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.105 0.409 . . . . 65.14 112.105 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.578 HG21 HD22 ' A' ' 21' ' ' LEU . 14.5 m -75.16 121.74 22.55 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.769 -0.372 . . . . 71.1 110.557 175.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 p -99.11 154.64 17.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.885 -0.413 . . . . 71.33 109.885 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.532 ' HA ' HG23 ' A' ' 45' ' ' VAL . 10.7 p-10 -64.86 -35.24 80.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 74.25 111.356 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.96 -36.77 80.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 74.42 111.211 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -76.87 -34.43 57.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.345 -0.388 . . . . 75.22 110.734 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 45' ' ' VAL . 34.9 tp -65.88 -42.87 89.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.035 -0.53 . . . . 62.44 109.862 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 19.2 ttm-85 -60.03 -57.97 10.53 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.393 -0.367 . . . . 64.31 110.127 176.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 m -50.06 -36.87 30.86 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.151 -0.931 . . . . 74.33 112.926 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -70.89 -58.38 3.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.433 -0.349 . . . . 75.1 111.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -70.53 -22.48 62.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.196 0.443 . . . . 74.2 112.196 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.1 tt0 -63.39 -17.81 63.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.095 0.558 . . . . 63.13 111.898 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.35 -28.43 69.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.389 -0.368 . . . . 64.35 111.343 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -101.14 -21.73 14.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 60.31 111.567 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -166.71 154.16 24.42 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.48 -0.867 . . . . 62.31 112.027 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.9 m -65.22 117.76 8.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 65.11 111.408 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 31' ' ' ARG . 57.2 mt -86.85 134.65 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.565 0.698 . . . . 73.01 111.4 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.0 p -98.53 -27.97 13.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.189 -0.914 . . . . 64.32 110.254 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -151.16 152.3 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.618 -0.719 . . . . 33.42 109.956 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -161.73 133.65 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.021 -0.363 . . . . 71.45 110.021 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.31 125.27 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.311 0.577 . . . . 53.23 110.734 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 27' ' ' ASP . 96.1 t -86.83 131.41 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.577 -0.897 . . . . 71.44 108.577 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.12 95.3 6.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.651 0.738 . . . . 75.31 110.439 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -101.04 166.94 10.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.592 -1.185 . . . . 75.33 109.637 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -76.74 126.18 86.22 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.126 -0.694 . . . . 65.3 109.126 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.31 -23.85 75.51 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.216 1.944 . . . . 73.32 113.929 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -85.68 -55.85 3.78 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.096 0.406 . . . . 74.32 112.096 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -101.57 -11.19 19.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.93 0.395 . . . . 70.44 111.945 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm 66.17 34.89 6.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.512 -0.767 . . . . 74.54 111.525 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -97.64 140.03 32.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.952 -0.759 . . . . 71.52 108.952 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -70.49 133.03 46.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.987 0.422 . . . . 74.51 110.379 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.42 -0.6 37.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.685 -0.689 . . . . 74.23 110.616 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.03 17.52 55.93 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.913 -0.66 . . . . 64.15 113.716 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -158.85 158.58 33.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.937 0.869 . . . . 71.23 110.942 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.65 -166.75 20.06 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.849 -0.9 . . . . 74.11 110.849 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.62 151.26 42.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.427 0.614 . . . . 72.0 110.603 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -133.12 122.95 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.627 -0.715 . . . . 63.55 109.172 175.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.3 m -99.15 118.59 36.22 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.457 -0.572 . . . . 74.34 109.457 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 25.4 m-85 -84.5 169.49 14.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.364 . . . . 73.05 110.67 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.539 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -72.7 -50.13 26.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.145 -0.48 . . . . 54.03 109.927 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.37 155.51 37.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.598 -0.728 . . . . 65.31 110.215 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -63.85 -32.86 58.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.796 0.331 . . . . 72.43 110.31 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.69 -34.82 71.72 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.862 0.69 . . . . 63.14 112.862 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 7.2 mm-40 -62.01 -36.19 80.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 71.41 109.684 175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 4.0 t -64.31 -44.6 97.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.131 -0.94 . . . . 72.31 111.131 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.81 -43.24 99.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 73.43 111.04 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -53.91 -38.37 64.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.64 0.608 . . . . 65.3 112.64 171.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.82 65.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.449 0.643 . . . . 64.11 109.948 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mmt -70.79 -39.54 73.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 71.25 112.124 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.574 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 1.1 p30 -79.14 -11.93 59.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.076 0.465 . . . . 75.42 110.442 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.45 -16.24 33.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.767 -0.651 . . . . 71.33 111.02 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -56.41 149.4 38.83 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 74.31 112.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.75 168.18 73.68 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.335 -1.527 . . . . 75.41 113.749 2.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -119.21 153.07 35.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.66 -0.7 . . . . 70.41 111.004 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 15.6 ttmt -139.5 108.94 6.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 52.15 111.092 177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -121.38 137.18 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.716 -0.675 . . . . 74.12 109.603 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.3 t70 66.11 21.69 11.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.774 0.829 . . . . 72.53 110.872 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.91 23.88 68.23 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.904 -0.589 . . . . 64.52 111.916 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.1 tpt180 -126.46 134.99 50.81 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.324 -0.251 . . . . 72.2 110.324 -178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.36 119.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.1 -0.704 . . . . 71.31 109.1 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 m -108.14 154.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.906 -0.588 . . . . 72.45 111.779 -172.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -113.5 93.93 29.71 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.959 -1.019 . . . . 74.23 110.611 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.428 ' O ' ' HE1' ' A' ' 156' ' ' HIS . 6.2 Cg_endo -77.16 128.32 9.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 70.21 110.716 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -126.28 168.8 13.62 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.257 -0.645 . . . . 70.2 109.257 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.676 ' NH2' ' HE2' ' A' ' 161' ' ' LYS . 4.1 tpp180 -75.59 128.65 35.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.122 -0.696 . . . . 74.14 109.122 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.0 99.78 1.49 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.399 0.619 . . . . 72.44 110.756 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.463 ' CG2' HG23 ' A' ' 163' ' ' VAL . 12.8 p -73.2 157.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.024 -0.989 . . . . 62.31 109.804 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -54.7 147.65 14.24 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 122.626 0.37 . . . . 74.22 110.585 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.504 0.927 . . . . 74.02 113.504 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.35 -38.23 90.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 75.31 110.995 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -85.42 -46.1 11.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 53.34 109.931 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 t -57.76 -26.04 61.29 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.556 -0.747 . . . . 51.24 112.29 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.16 -21.48 63.99 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.325 -0.398 . . . . 73.03 111.82 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -85.19 143.99 40.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.03 110.852 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.06 123.26 9.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 74.25 112.268 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 3.3 71.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.799 -0.715 . . . . 62.23 112.51 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.97 -52.14 8.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.691 0.256 . . . . 72.54 111.691 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 21.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 63.15 111.051 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -178.8 6.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.796 -0.816 . . . . 70.33 108.796 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.408 HG23 ' CD2' ' A' ' 156' ' ' HIS . 1.9 m -72.61 99.75 2.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.335 0.588 . . . . 73.32 111.041 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.5 t -126.55 111.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.299 -0.864 . . . . 71.54 109.757 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.424 ' C ' HG21 ' A' ' 159' ' ' VAL . 77.6 mttt -107.02 14.69 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.034 -0.417 . . . . 72.42 111.116 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 139.56 51.05 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.342 -0.224 . . . . 72.34 110.946 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.556 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.89 151.7 35.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.352 0.596 . . . . 75.13 111.595 175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.8 t80 -96.91 139.44 32.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.726 -1.124 . . . . 72.11 109.99 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.0 110.38 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.331 -0.618 . . . . 44.24 109.331 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.51 158.82 21.34 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.013 -1.089 . . . . 50.31 113.358 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.0 8.37 45.08 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.832 -0.699 . . . . 72.11 112.055 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.45 66.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 122.112 0.958 . . . . 62.25 110.512 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -65.3 -34.01 77.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 73.51 109.442 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -83.11 145.72 29.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.799 -1.091 . . . . 74.45 108.558 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.24 123.5 16.92 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.064 0.459 . . . . 71.14 112.203 -172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.8 m -128.08 139.98 52.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.597 -0.729 . . . . 64.51 110.084 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -114.25 167.63 10.53 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.337 -0.847 . . . . 74.22 111.642 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.53 -45.35 85.13 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.429 -0.805 . . . . 52.03 110.619 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -55.77 -34.48 65.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.473 0.483 . . . . 71.23 111.562 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -64.4 -60.79 2.75 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.381 -0.372 . . . . 74.11 111.507 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.473 HD21 HG21 ' A' ' 134' ' ' ILE . 2.4 pt? -82.41 -24.65 34.27 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 119.962 -0.695 . . . . 63.31 110.814 -171.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -63.23 -54.65 34.04 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 110.108 -0.33 . . . . 63.41 110.108 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.77 -27.89 69.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.984 0.421 . . . . 73.54 110.859 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.46 ' CD2' HG22 ' A' ' 170' ' ' VAL . 75.8 t80 -78.36 -53.87 6.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.83 -0.623 . . . . 74.21 111.619 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.0 m-85 -68.72 -22.77 64.31 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.622 0.249 . . . . 73.23 111.506 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.71 -26.33 68.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.236 0.541 . . . . 73.42 110.884 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.28 -30.62 71.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.713 -0.676 . . . . 74.23 111.633 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.1 -23.77 32.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.499 -0.319 . . . . 74.51 111.012 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.92 -176.65 42.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.581 -0.819 . . . . 72.01 112.928 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -73.37 130.7 40.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.15 0.5 . . . . 71.22 110.871 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 152' ' ' THR . 62.1 mt -101.25 139.73 21.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.636 -0.711 . . . . 71.35 109.939 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.19 -49.91 6.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.817 0.341 . . . . 74.24 110.583 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.0 p -155.45 155.32 5.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.091 -0.504 . . . . 61.33 109.929 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.473 HG21 HD21 ' A' ' 121' ' ' LEU . 4.2 mp -116.24 126.31 73.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.288 -0.634 . . . . 73.22 109.288 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.4 mt-10 -98.65 104.53 16.57 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 70.23 110.994 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.1 116.01 35.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.442 -0.577 . . . . 63.21 109.442 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 69.0 mmm -87.72 119.28 27.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.861 -0.609 . . . . 72.12 109.994 -175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.03 156.36 38.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 63.41 110.704 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.07 132.16 34.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.003 -0.544 . . . . 74.25 109.774 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -79.89 -29.99 40.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.336 -0.393 . . . . 63.35 111.496 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.43 -53.56 4.06 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.392 -0.909 . . . . 64.45 113.164 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.8 m -99.63 -11.77 20.64 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.029 0.381 . . . . 71.01 112.029 -175.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.28 28.65 65.66 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.727 -0.749 . . . . 53.54 113.163 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -104.93 159.15 16.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.268 -0.641 . . . . 73.31 109.268 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -69.04 145.01 53.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.26 -0.644 . . . . 62.21 109.26 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -70.41 -3.09 15.93 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.185 0.809 . . . . 71.1 113.185 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.0 3.12 89.33 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.247 -0.978 . . . . 73.53 112.385 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -157.88 158.0 34.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.548 -0.538 . . . . 73.32 109.548 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.85 176.3 8.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.706 -0.679 . . . . 53.23 109.829 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 53.9 m-85 -139.53 152.67 47.1 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.591 -0.731 . . . . 74.23 109.186 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 107' ' ' ILE . 3.1 p -144.22 133.11 18.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.424 0.631 . . . . 61.44 111.169 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 131' ' ' ILE . 41.1 m -103.26 126.01 50.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.074 -0.966 . . . . 72.14 110.856 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 7.6 m-85 -100.82 158.45 15.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.06 0.457 . . . . 62.43 111.412 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.75 -28.94 44.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.479 -0.782 . . . . 61.53 110.293 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -128.0 151.36 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 75.12 110.842 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.428 ' HE1' ' O ' ' A' ' 86' ' ' PRO . 24.2 p80 -80.17 -27.35 38.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.006 -0.543 . . . . 64.4 110.777 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.629 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 29.6 t70 -58.28 -40.36 81.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.708 -0.678 . . . . 64.41 111.067 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.2 m -67.56 -30.97 70.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.916 -0.584 . . . . 73.31 111.508 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.556 HG13 HG23 ' A' ' 107' ' ' ILE . 2.7 t -72.95 -42.86 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.484 -0.325 . . . . 72.32 110.471 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 1.8 m-20 -68.36 -24.06 64.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.925 -0.58 . . . . 51.12 111.424 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.676 ' HE2' ' NH2' ' A' ' 88' ' ' ARG . 81.9 mttt -63.66 -42.6 98.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.728 0.775 . . . . 65.3 110.177 170.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.1 mt -74.15 -42.71 51.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.441 -1.254 . . . . 73.23 111.663 -174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.587 HG21 ' HD3' ' A' ' 179' ' ' LYS . 29.4 m -79.93 -2.16 5.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.123 0.487 . . . . 71.44 111.064 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 161' ' ' LYS . 5.7 mt -63.07 -28.87 45.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.945 0.878 . . . . 53.32 109.046 167.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.579 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 49.2 mt-30 -111.47 145.39 39.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.857 -1.164 . . . . 75.2 107.857 174.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -91.77 -32.43 15.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.327 0.584 . . . . 73.35 110.684 -173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -124.69 137.98 54.32 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.713 -0.676 . . . . 74.55 109.951 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.579 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 42.8 m-70 -127.41 142.54 51.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.902 0.382 . . . . 72.44 110.615 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.0 m -94.77 110.36 22.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.982 -0.554 . . . . 73.5 111.036 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 124' ' ' TYR . 21.7 t -111.04 127.79 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.326 -0.852 . . . . 75.4 109.222 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 42.55 48.98 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.666 0.617 . . . . 53.5 112.666 -172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 72.24 0.98 48.47 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.125 -0.56 . . . . 74.23 114.055 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.83 121.96 45.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.932 -0.396 . . . . 73.44 109.932 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.49 110.11 19.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.169 0.509 . . . . 61.25 110.887 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.55 156.99 18.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.498 -0.774 . . . . 71.43 110.414 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.46 141.54 28.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.289 -0.263 . . . . 75.22 110.289 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 5.6 m -131.97 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.943 0.401 . . . . 55.31 110.793 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -175.43 170.77 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.021 -0.991 . . . . 70.3 111.287 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.587 ' HD3' HG21 ' A' ' 163' ' ' VAL . 5.8 mmmm -63.54 132.7 52.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 63.05 110.501 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.94 127.23 52.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.358 0.599 . . . . 73.12 110.211 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.408 ' HB2' ' CG ' ' A' ' 186' ' ' MET . 17.8 mt -111.27 164.66 12.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.265 -0.879 . . . . 75.52 108.906 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 61.9 p -61.83 161.92 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.829 -0.434 . . . . 75.42 109.829 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.32 -26.35 68.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.17 -0.212 . . . . 75.14 111.338 -176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -63.7 -35.64 81.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.126 0.489 . . . . 55.1 110.983 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.98 -45.51 13.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.832 -0.622 . . . . 72.43 111.349 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.408 ' CG ' ' HB2' ' A' ' 181' ' ' LEU . 42.9 mtp -75.59 -59.51 2.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 71.21 111.554 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -84.96 -42.84 14.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 65.25 111.138 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.5 m 64.4 20.69 12.25 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.958 0.786 . . . . 64.42 111.138 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.26 160.08 32.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 62.33 110.06 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.8 p -69.17 140.8 54.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.788 0.327 . . . . 74.43 111.05 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.6 t -79.12 110.54 14.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.133 -0.485 . . . . 75.4 110.357 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.0 m -100.29 101.78 12.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.066 -0.516 . . . . 41.42 110.577 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -71.9 128.03 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 71.42 110.43 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -70.54 159.79 33.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 62.14 110.73 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.56 -78.09 0.53 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.63 -0.795 . . . . 62.41 111.517 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 . . . . . 0 C--O 1.241 0.648 0 CA-C-O 118.62 -0.705 . . . . 75.23 109.402 177.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.108 -0.397 . . . . 61.02 112.108 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -60.98 -53.42 57.48 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.951 0.405 . . . . 75.22 110.887 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.65 93.93 9.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.175 0.512 . . . . 73.14 109.683 177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -91.35 131.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.619 -0.719 . . . . 74.3 110.731 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.9 30.5 20.25 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.6 -0.727 . . . . 73.15 111.173 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m -129.23 79.92 73.39 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.992 -0.549 . . . . 64.44 110.157 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.664 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 19.8 Cg_exo -70.97 165.48 32.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.547 2.831 . . . . 60.55 112.56 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -108.12 14.79 24.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.9 -0.591 . . . . 73.5 110.224 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.39 134.99 20.81 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 73.11 110.355 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 13' ' ' LEU . 29.0 Cg_endo -65.82 167.19 18.13 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.775 2.317 . . . . 74.14 112.027 175.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -40.09 70.2 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 112.425 0.528 . . . . 71.51 112.425 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.15 -27.37 67.97 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.163 0.431 . . . . 63.41 112.163 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.4 mp -78.99 -22.44 45.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.559 0.218 . . . . 74.22 111.26 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HA ' HG21 ' A' ' 68' ' ' VAL . 25.5 ptt180 -120.2 -0.97 10.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.279 0.474 . . . . 74.34 112.279 -175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 33.1 ttpt -94.67 143.8 26.14 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.574 0.702 . . . . 74.4 111.822 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD21 HG13 ' A' ' 68' ' ' VAL . 65.9 mt -115.65 145.65 42.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.694 -1.139 . . . . 53.32 109.909 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -96.27 134.3 39.56 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.275 -1.009 . . . . 74.33 108.275 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 60' ' ' VAL . 19.6 mm -110.84 112.04 38.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.905 -0.406 . . . . 70.21 109.905 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.96 153.51 17.08 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.301 -0.952 . . . . 74.21 111.592 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.87 40.19 52.91 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 75.54 113.675 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 25' ' ' THR . 51.8 mt -78.27 177.02 8.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.956 -0.387 . . . . 53.3 109.956 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p -84.13 -179.42 7.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.899 0.38 . . . . 72.23 110.099 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -84.1 -9.16 58.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.349 0.595 . . . . 71.42 109.851 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.03 20.37 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.791 -0.64 . . . . 75.14 111.786 -175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.478 HG21 HD22 ' A' ' 21' ' ' LEU . 27.1 m -75.62 131.53 40.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.811 0.339 . . . . 74.04 111.047 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 p -114.41 160.64 18.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 61.44 110.531 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 1.9 m-20 -62.59 -38.62 90.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 73.32 110.616 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.48 -42.14 98.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.381 -0.827 . . . . 61.12 111.353 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 m -75.87 -37.76 58.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.024 -0.534 . . . . 60.33 110.716 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.25 -43.59 90.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 64.52 110.454 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -60.46 -54.95 39.39 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.092 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -47.41 -39.72 16.08 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.302 1.001 . . . . 75.02 113.14 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -68.47 -61.27 1.9 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.967 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -71.08 -24.51 62.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.137 0.421 . . . . 73.15 112.137 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 33.1 tt0 -62.49 -21.08 65.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.28 -0.418 . . . . 73.0 111.837 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -62.1 -27.53 68.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.723 0.297 . . . . 75.13 111.461 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -98.05 -24.36 15.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.407 -0.361 . . . . 72.02 111.259 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -172.5 166.47 39.2 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.173 -1.013 . . . . 53.01 112.834 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -61.49 141.19 57.87 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.077 0.551 . . . . 73.21 111.369 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 mt -118.5 123.3 44.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.362 -0.607 . . . . 52.04 109.362 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -90.13 -25.1 20.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.087 -0.506 . . . . 74.12 110.295 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -152.34 152.16 31.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.488 -0.778 . . . . 65.21 109.864 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.6 t -160.15 123.99 3.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.294 -0.632 . . . . 71.41 109.294 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.411 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 p -143.26 118.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.516 0.674 . . . . 70.15 110.431 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 133.12 31.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 107.917 -1.142 . . . . 72.33 107.917 173.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 2.5 mmt -77.78 96.86 5.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.623 0.725 . . . . 51.33 110.236 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -96.81 161.27 13.93 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.423 -1.262 . . . . 51.45 108.975 175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.94 125.54 92.02 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.221 -0.659 . . . . 53.32 109.221 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.47 -20.94 53.98 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.573 1.515 . . . . 73.1 112.982 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 50' ' ' ASN . 0.9 OUTLIER -86.65 -55.63 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 72.52 111.223 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -16.48 23.56 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.917 -0.583 . . . . 74.13 112.18 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp 65.74 29.12 10.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.926 0.89 . . . . 73.1 111.925 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -107.35 155.14 20.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.02 -0.733 . . . . 71.35 109.02 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 t -71.05 135.46 47.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.911 0.386 . . . . 75.23 111.16 -173.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -87.38 5.27 39.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 73.12 110.775 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.52 70.62 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.864 -0.684 . . . . 51.31 114.175 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 25.5 p90 -156.0 156.41 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.04 0.92 . . . . 75.51 110.801 174.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.05 -165.15 17.25 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.639 -0.585 . . . . 41.35 111.639 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.51 145.65 31.14 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.973 0.387 . . . . 74.11 109.99 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 HD11 ' A' ' 18' ' ' ILE . 8.8 m -128.26 119.87 51.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 63.03 110.2 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 9.5 m -95.69 122.29 38.29 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.052 -0.351 . . . . 72.15 110.052 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -85.63 170.24 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.341 -0.39 . . . . 72.02 110.106 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -74.29 -52.57 11.89 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.671 -0.492 . . . . 74.12 109.671 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -122.37 150.29 42.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.263 -0.426 . . . . 74.41 110.502 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.4 p -63.81 -35.43 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.576 0.227 . . . . 72.24 111.263 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -52.29 -41.35 62.83 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.767 0.654 . . . . 74.21 112.767 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 63' ' ' ALA . 47.4 mt-10 -68.74 -28.39 66.77 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.189 0.518 . . . . 62.4 110.726 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 14' ' ' ARG . 25.0 t -65.31 -45.39 93.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.418 -0.81 . . . . 72.21 111.083 175.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.81 -45.01 86.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.002 -0.544 . . . . 62.53 110.912 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.1 -41.52 60.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 74.01 112.095 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -37.7 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.95 0.405 . . . . 71.04 110.977 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 1.5 mmt -68.61 -32.95 73.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 74.44 111.059 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 -10.07 55.8 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.049 -0.523 . . . . 64.23 110.851 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.56 -9.27 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.264 0.554 . . . . 71.15 110.265 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 30.7 ttp180 -53.39 142.48 39.45 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.818 -1.083 . . . . 61.12 111.327 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 6.1 Cg_exo -78.49 168.75 74.58 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.647 -0.981 . . . . 65.43 113.385 3.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -124.96 155.02 40.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.146 -0.933 . . . . 74.43 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.7 ttmt -132.79 106.94 8.04 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.84 0.352 . . . . 75.31 111.22 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.82 127.31 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.042 -0.526 . . . . 61.4 110.04 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.8 t70 67.15 29.94 7.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.759 0.79 . . . . 72.32 110.561 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.01 29.13 67.34 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.629 -0.714 . . . . 64.04 111.91 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 11.8 tpt180 -130.81 139.19 50.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.136 -0.32 . . . . 72.13 110.136 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.33 113.14 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.087 -0.708 . . . . 71.15 109.087 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.83 149.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.425 0.631 . . . . 65.41 111.182 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -112.93 96.64 38.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.027 -0.988 . . . . 74.05 110.662 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.85 138.3 18.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.309 2.006 . . . . 64.41 112.136 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 51.4 mmtt -132.96 168.67 18.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.113 -1.44 . . . . 62.14 107.113 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HB2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -83.31 142.25 31.22 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.867 -0.733 . . . . 71.35 109.101 173.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.73 92.15 1.97 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.29 0.567 . . . . 60.4 109.621 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 p -66.36 158.06 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.863 -1.062 . . . . 64.34 110.457 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -52.9 145.21 13.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.849 -0.614 . . . . 52.01 110.619 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.48 -41.61 30.23 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.489 0.922 . . . . 74.33 113.489 -168.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.16 -51.4 67.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.427 0.156 . . . . 70.52 111.26 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.0 -29.68 66.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.417 -0.356 . . . . 55.45 110.398 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -64.19 -18.43 64.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 73.21 111.539 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -96.42 -2.63 45.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.066 0.46 . . . . 71.0 110.73 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -88.91 151.47 47.28 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.405 -0.361 . . . . 74.42 111.039 -176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.01 118.55 5.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.711 2.274 . . . . 62.12 112.16 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.96 21.11 31.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.852 -0.69 . . . . 64.43 112.468 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.72 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.049 0.452 . . . . 72.03 111.928 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -104.62 25.67 10.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.081 -0.509 . . . . 62.03 111.409 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.39 -171.9 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.976 -0.557 . . . . 72.02 109.809 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 58.87 3.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.616 . . . . 73.1 110.794 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.97 107.96 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 74.51 110.181 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.467 ' C ' HG21 ' A' ' 159' ' ' VAL . 63.4 mttt -111.02 14.95 21.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.034 0.445 . . . . 51.14 110.343 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -113.58 140.87 47.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.271 -0.422 . . . . 72.2 110.229 178.265 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 159' ' ' VAL . 3.6 pt -129.25 149.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 64.04 111.399 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.9 t80 -97.24 133.16 42.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.086 -0.961 . . . . 75.11 109.189 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -123.63 110.02 24.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.432 -0.581 . . . . 74.33 109.432 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.23 147.95 16.92 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.034 -1.079 . . . . 65.24 113.074 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.56 22.22 8.7 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.835 -0.698 . . . . 43.42 112.158 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.7 pt -91.18 77.93 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.909 0.861 . . . . 74.44 110.458 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -66.71 -50.84 61.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.054 -0.975 . . . . 72.33 111.051 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.12 155.19 40.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.618 -0.512 . . . . 73.02 109.618 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.42 99.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.404 0.621 . . . . 52.24 110.884 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.5 m -97.53 134.01 41.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.229 -0.896 . . . . 64.22 109.719 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 120' ' ' HIS . 61.8 mt-10 -110.64 167.16 10.44 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.736 -1.12 . . . . 75.25 110.408 -175.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 121' ' ' LEU . 26.9 tt0 -59.73 -46.04 90.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.823 . . . . 74.45 111.548 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -69.36 -22.03 63.77 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.888 -0.325 . . . . 71.51 111.484 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 61.2 m170 -61.49 -60.16 4.13 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.781 0.324 . . . . 53.32 110.532 176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 118' ' ' GLU . 1.9 pt? -84.2 -21.07 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.292 -0.563 . . . . 45.25 111.143 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -65.94 -52.87 45.97 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 109.853 -0.425 . . . . 71.31 109.853 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.41 -31.9 70.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.344 0.593 . . . . 72.22 110.416 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.406 ' OH ' ' HB3' ' A' ' 168' ' ' HIS . 83.1 t80 -72.6 -58.66 3.2 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.211 -0.904 . . . . 75.25 112.088 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CD2' HG21 ' A' ' 151' ' ' VAL . 47.9 m-85 -66.43 -21.12 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.901 0.334 . . . . 73.55 111.901 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.39 -25.37 67.53 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 122.471 0.308 . . . . 73.13 111.31 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.16 -31.51 63.44 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.129 -0.487 . . . . 75.22 111.304 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -86.59 -28.56 23.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 52.54 111.941 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.9 -172.85 45.35 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.384 -0.912 . . . . 62.41 113.654 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -76.42 128.55 35.03 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.131 0.491 . . . . 73.5 111.683 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 152' ' ' THR . 61.3 mt -100.87 137.6 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 32.32 109.994 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -86.88 -52.19 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.391 -0.368 . . . . 73.11 110.428 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.15 155.74 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.321 -0.4 . . . . 64.3 110.209 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.89 129.01 72.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.239 0.542 . . . . 74.41 109.935 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.71 104.22 14.53 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.648 -0.706 . . . . 73.05 110.977 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 45.2 mm -90.8 120.87 40.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.976 -0.749 . . . . 72.32 108.976 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.427 ' HG2' ' HA ' ' A' ' 149' ' ' ALA . 71.9 mmm -94.88 113.88 25.67 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.748 0.785 . . . . 75.13 110.392 -175.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 145' ' ' LYS . 0.7 OUTLIER -137.74 165.4 26.52 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.846 -1.07 . . . . 73.23 109.794 -178.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.78 103.74 16.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.629 -1.249 . . . . 51.43 107.629 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -65.44 -24.13 67.11 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.159 0.429 . . . . 71.23 112.159 -171.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.33 -52.79 8.23 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.422 -0.894 . . . . 51.31 112.959 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.1 m -95.7 -22.69 17.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.126 0.417 . . . . 72.53 112.126 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 27.23 26.27 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.993 -0.622 . . . . 50.31 112.086 -178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -95.87 146.95 24.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 74.34 111.405 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 138' ' ' THR . 44.5 mtmt -72.01 139.72 48.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.254 -0.43 . . . . 74.3 109.954 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 2.8 mmp_? -91.64 2.62 56.34 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.592 -0.443 . . . . 65.11 112.071 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.97 78.19 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.812 -0.709 . . . . 61.4 114.303 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -155.48 157.5 37.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.595 0.697 . . . . 74.31 110.259 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 137' ' ' MET . . . -139.24 177.13 8.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.622 -0.717 . . . . 35.22 109.899 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 40.8 m-85 -140.87 149.15 41.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.691 -0.686 . . . . 74.52 109.713 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.449 HG21 ' CD2' ' A' ' 125' ' ' PHE . 66.7 t -133.75 130.9 56.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.464 -0.334 . . . . 73.0 110.77 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.436 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 60.0 m -103.49 125.37 50.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.689 -0.687 . . . . 72.44 110.616 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -105.56 162.66 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.987 0.422 . . . . 72.22 111.208 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.75 -29.34 29.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.591 -0.732 . . . . 71.0 110.253 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.92 144.51 50.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 74.11 110.279 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.402 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 28.3 p80 -72.24 -26.53 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 74.11 110.129 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -55.44 -44.74 76.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.106 -0.952 . . . . 65.2 111.399 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -71.56 -33.35 69.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.037 -0.528 . . . . 71.44 111.212 -176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.467 HG21 ' C ' ' A' ' 105' ' ' LYS . 2.0 t -71.87 -38.49 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 120.868 0.365 . . . . 55.14 110.088 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.447 ' HA ' HG22 ' A' ' 163' ' ' VAL . 1.7 t70 -67.05 -34.23 77.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.521 -0.763 . . . . 74.04 110.841 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 91.7 mttt -56.58 -40.87 75.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.662 0.744 . . . . 72.22 110.349 172.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 25.5 mt -73.54 -45.43 51.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.397 -1.274 . . . . 75.11 112.286 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 160' ' ' ASP . 15.8 m -75.11 -10.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.24 0.543 . . . . 63.21 111.027 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.456 HD13 HD12 ' A' ' 13' ' ' LEU . 14.1 mt -61.96 -31.9 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.139 -0.937 . . . . 73.3 109.971 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 64.6 mt-30 -107.84 104.1 13.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.82 -0.807 . . . . 41.21 108.82 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -54.08 -35.0 61.61 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.714 0.635 . . . . 64.2 112.714 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -122.15 138.45 54.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.888 0.375 . . . . 73.35 111.208 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -130.18 146.36 51.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 73.14 110.152 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -104.04 115.01 29.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.074 0.464 . . . . 74.54 111.05 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.9 p -141.43 146.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.626 -0.715 . . . . 70.43 109.187 177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 58.33 29.52 18.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.343 1.068 . . . . 62.14 110.54 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.2 0.87 84.49 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.212 -0.904 . . . . 65.24 113.253 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -121.59 133.59 55.0 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.071 0.463 . . . . 74.22 111.068 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.08 108.55 18.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.717 -0.674 . . . . 62.01 109.715 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 4.2 p -113.11 157.17 21.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 50.15 110.677 -175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -85.76 134.05 33.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.959 0.409 . . . . 71.04 110.072 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 15.0 t -130.44 132.46 64.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.564 -0.744 . . . . 70.51 109.799 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -153.73 173.8 15.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.789 -0.641 . . . . 65.43 110.994 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -64.56 131.54 47.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.129 0.49 . . . . 73.2 111.3 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -122.92 118.56 28.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.715 -0.846 . . . . 65.43 108.715 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.4 mt -74.51 123.85 25.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.756 -0.461 . . . . 72.11 109.756 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 186' ' ' MET . 48.0 t -65.79 161.95 19.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.983 -0.553 . . . . 71.33 109.937 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -59.71 -31.78 69.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.144 0.497 . . . . 63.22 110.31 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -61.06 -37.04 81.25 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.237 -0.892 . . . . 71.23 110.7 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -84.37 -43.01 15.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.112 -0.494 . . . . 73.43 111.569 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 182' ' ' SER . 77.6 mtp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.993 -0.549 . . . . 75.43 111.127 -176.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -84.54 -12.9 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 64.31 110.558 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.8 m 60.76 30.19 19.51 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.47 -0.786 . . . . 52.33 110.225 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.19 138.15 12.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.708 -1.133 . . . . 73.02 109.35 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.0 m -87.61 155.81 19.79 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 110.135 -0.32 . . . . 72.42 110.135 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.2 t -80.77 134.24 35.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.778 0.323 . . . . 44.21 110.599 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.9 t -80.59 103.66 10.59 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.226 -0.657 . . . . 62.54 109.226 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -123.78 134.34 53.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.002 -0.545 . . . . 53.22 110.306 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.62 88.49 5.04 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 75.1 109.667 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 156.21 -153.55 24.82 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.106 -0.568 . . . . 75.02 111.747 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.397 -0.811 . . . . 70.13 109.946 -179.47 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.523 -0.231 . . . . 74.45 112.523 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.4 m 57.59 70.34 0.66 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.573 0.749 . . . . 71.43 112.517 175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 61.6 26.13 15.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.558 -0.747 . . . . 75.24 112.907 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 p -72.77 -21.65 60.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.582 0.706 . . . . 63.25 109.201 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -83.79 171.24 13.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.813 -1.085 . . . . 71.13 108.922 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 t -134.25 90.83 24.33 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.663 -0.415 . . . . 51.33 111.339 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.57 136.74 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.198 1.932 . . . . 53.5 111.089 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.18 1.68 12.52 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.337 0.589 . . . . 61.42 109.782 -177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.18 135.64 57.88 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.192 -0.913 . . . . 62.12 110.219 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.613 ' HD2' HD12 ' A' ' 13' ' ' LEU . 11.4 Cg_endo -63.17 160.24 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.118 1.879 . . . . 72.13 110.965 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -33.6 63.23 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.1 0.407 . . . . 60.23 112.1 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.26 -32.87 74.55 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.434 0.531 . . . . 61.5 112.434 -176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 10' ' ' PRO . 42.7 mt -79.36 -16.92 55.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 63.22 110.719 -176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.507 ' HA ' HG21 ' A' ' 68' ' ' VAL . 17.6 ptt85 -122.97 4.83 9.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 72.14 111.492 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 30.9 ttpt -99.08 149.78 22.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.224 0.535 . . . . 52.41 110.666 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.766 HD11 HG13 ' A' ' 68' ' ' VAL . 7.6 mp -116.38 141.32 48.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.009 -0.996 . . . . 75.3 110.224 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -97.27 114.4 26.15 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.445 -0.946 . . . . 60.31 108.445 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.0 mm -94.08 111.0 24.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 110.053 -0.351 . . . . 54.23 110.053 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.3 152.68 18.45 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.561 -0.828 . . . . 70.3 111.314 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.88 45.76 41.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.629 -0.796 . . . . 72.12 113.142 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 25' ' ' THR . 75.9 mt -79.64 175.27 10.77 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.78 -0.452 . . . . 53.53 109.78 172.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 82' ' ' ARG . 21.2 p -91.34 175.33 6.97 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.549 -0.538 . . . . 74.23 109.549 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -75.23 -8.16 55.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.321 0.581 . . . . 64.43 110.081 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.77 9.12 17.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.568 -0.742 . . . . 70.1 112.138 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.628 HG21 HD22 ' A' ' 21' ' ' LEU . 19.3 m -76.6 120.69 22.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.447 -0.501 . . . . 71.02 111.161 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 p -103.96 159.98 15.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.087 -0.506 . . . . 71.31 110.468 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 44' ' ' VAL . 2.5 m-20 -60.34 -38.84 85.02 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.032 -0.531 . . . . 73.21 110.93 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.69 -39.56 91.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.736 -0.665 . . . . 74.22 111.718 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -75.92 -39.89 55.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.541 -0.3 . . . . 65.32 110.683 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.82 -47.49 83.2 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.041 -0.527 . . . . 71.11 109.995 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -57.59 -60.33 3.83 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.081 -0.509 . . . . 72.41 111.356 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -51.97 -36.6 50.09 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.537 0.523 . . . . 75.2 112.284 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -71.45 -56.8 5.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.651 -0.25 . . . . 74.44 110.908 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -68.55 -25.18 64.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 63.14 111.851 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 26.6 tt0 -64.91 -15.11 61.65 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.113 0.412 . . . . 70.34 112.113 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -29.57 70.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.822 0.344 . . . . 73.53 111.163 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -98.01 -22.3 16.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.542 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -168.36 159.39 32.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.36 -0.924 . . . . 73.4 112.099 177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.5 m -64.64 118.27 8.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.048 0.451 . . . . 73.33 111.999 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -92.12 134.12 35.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.434 0.635 . . . . 53.21 110.761 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -107.75 -19.41 13.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.997 -1.001 . . . . 65.31 110.238 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 32.0 t70 -151.51 152.44 32.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 75.14 109.897 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.0 t -163.03 127.24 2.96 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.502 -0.555 . . . . 74.3 109.502 172.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 4.8 p -142.01 123.56 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.536 0.684 . . . . 61.31 110.63 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.4 130.67 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.506 -0.924 . . . . 75.31 108.506 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.88 135.69 46.66 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.959 -0.756 . . . . 70.34 108.959 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -135.35 156.55 48.76 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.874 -0.603 . . . . 74.44 111.493 -170.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 13.3 t70 -66.46 132.3 94.25 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.837 -1.074 . . . . 72.23 109.323 174.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.82 -18.88 47.34 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 121.897 1.732 . . . . 74.32 113.864 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -85.56 -57.31 3.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.844 0.354 . . . . 54.04 111.604 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -105.45 -7.72 18.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.061 -0.518 . . . . 51.5 111.305 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 40.0 mmtm 63.63 32.06 14.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.803 0.841 . . . . 73.02 111.555 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -95.94 162.43 13.57 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.808 -0.812 . . . . 74.34 108.808 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -65.69 139.71 58.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.838 0.351 . . . . 73.04 111.613 -171.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -86.14 2.21 47.67 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.769 -0.65 . . . . 53.22 110.379 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 15.92 61.43 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.741 -0.743 . . . . 60.13 113.242 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -161.19 157.15 25.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.154 0.477 . . . . 62.43 110.524 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.27 -164.21 16.74 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 111.52 -0.632 . . . . 75.52 111.52 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -142.35 150.87 41.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.32 0.56 . . . . 73.21 110.805 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 16' ' ' LEU . 5.8 m -132.84 123.37 48.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.78 -0.645 . . . . 54.4 109.87 172.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 42' ' ' ASP . 5.2 m -98.94 120.64 39.72 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.332 -0.23 . . . . 72.13 110.609 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.63 161.8 17.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.167 -0.47 . . . . 74.35 110.322 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 -35.59 62.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.715 -0.675 . . . . 62.23 110.599 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.86 149.36 52.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.347 -178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.5 p -66.44 -34.6 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 120.778 0.323 . . . . 61.45 111.096 178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.94 -37.44 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.206 0.447 . . . . 75.43 112.206 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -65.05 -29.49 70.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.197 0.522 . . . . 71.42 110.368 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.766 HG13 HD11 ' A' ' 16' ' ' LEU . 2.7 t -62.11 -44.52 99.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.175 -0.92 . . . . 64.13 110.98 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -41.18 97.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.201 -0.454 . . . . 74.51 111.131 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.75 -39.88 78.4 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.025 0.38 . . . . 65.53 112.025 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.95 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 63.41 110.529 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.414 ' SD ' ' HB2' ' A' ' 157' ' ' ASP . 2.0 mmt -66.41 -33.46 75.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.769 -0.65 . . . . 63.25 110.529 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.598 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 3.4 p30 -82.26 -9.6 59.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.991 0.424 . . . . 75.35 111.091 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.59 -14.39 45.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.856 -0.611 . . . . 74.53 112.518 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -49.16 146.35 6.1 Favored Pre-proline 0 N--CA 1.47 0.568 0 N-CA-C 112.705 0.631 . . . . 75.14 112.705 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.4 154.34 85.22 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 124.02 -1.242 . . . . 70.13 113.287 1.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -107.44 147.16 30.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.705 -0.68 . . . . 71.34 110.441 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 17.1 ttmt -138.45 104.37 5.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.118 0.485 . . . . 73.54 111.226 177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.34 139.92 43.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.335 -0.617 . . . . 61.13 109.335 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 25' ' ' THR . 1.7 m-20 62.72 31.79 16.44 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.565 0.54 . . . . 73.14 111.264 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.67 23.53 77.68 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.396 -0.82 . . . . 45.12 112.605 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 15.9 tpt180 -129.38 137.35 50.9 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.848 -0.207 . . . . 71.33 110.787 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.35 116.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.984 -0.747 . . . . 71.52 108.984 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 m -109.91 154.18 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.288 0.566 . . . . 70.04 111.493 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.85 95.89 35.51 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.142 -0.935 . . . . 74.14 110.753 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.55 134.11 16.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.09 1.86 . . . . 62.44 112.155 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 156' ' ' HIS . 31.9 mmtt -125.9 -177.82 4.07 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.849 -1.167 . . . . 63.13 107.849 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.501 HH22 ' HE2' ' A' ' 161' ' ' LYS . 12.2 mmt-85 -80.87 163.14 23.61 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.281 0.492 . . . . 73.03 109.764 170.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.08 90.49 4.62 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.817 0.818 . . . . 75.14 108.822 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 164' ' ' ILE . 16.5 t -82.75 156.35 3.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 114.58 -1.191 . . . . 75.34 109.191 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.3 t -54.82 148.38 13.21 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.461 0.476 . . . . 70.12 109.902 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.555 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 6.8 tpp180 -66.52 -6.02 13.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.089 0.471 . . . . 64.15 111.984 -172.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -63.85 -43.95 94.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.277 172.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -84.11 -43.88 14.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.842 -0.617 . . . . 74.12 111.088 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.555 ' OG ' ' HA ' ' A' ' 92' ' ' ARG . 1.5 p -69.34 -12.31 61.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.242 -0.436 . . . . 71.2 111.875 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 33.9 tt0 -61.59 -34.93 76.47 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.239 -0.437 . . . . 70.03 110.964 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 97' ' ' ARG . 4.0 mpt_? -70.56 145.81 93.11 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 74.44 111.232 -174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.34 120.08 7.12 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.349 2.7 . . . . 71.42 112.712 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.1 29.14 69.18 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 121.18 -0.534 . . . . 63.24 113.023 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.606 ' O ' ' HE2' ' A' ' 179' ' ' LYS . . . -78.85 -49.6 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.748 0.309 . . . . 75.02 110.618 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 95' ' ' SER . 4.7 m80 -81.16 25.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.647 0.61 . . . . 61.43 112.647 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -87.53 -164.09 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.715 -0.846 . . . . 73.12 108.715 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.11 88.76 5.97 Favored 'General case' 0 C--N 1.32 -0.674 0 O-C-N 121.596 -0.69 . . . . 62.12 111.122 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.92 110.18 31.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 71.21 109.569 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' C ' HG21 ' A' ' 159' ' ' VAL . 79.1 mttt -108.47 20.1 19.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.124 0.488 . . . . 53.52 110.605 176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -120.58 139.74 52.52 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.192 -0.458 . . . . 53.22 110.636 178.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.523 HG23 HG13 ' A' ' 159' ' ' VAL . 4.6 pt -129.94 151.3 35.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.375 0.607 . . . . 74.01 111.665 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 3.3 t80 -101.86 133.24 46.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.621 -1.172 . . . . 74.32 109.809 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.5 110.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.336 -0.616 . . . . 70.31 109.336 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.28 157.23 19.4 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.297 -0.954 . . . . 72.41 112.953 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.94 19.66 30.58 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.773 -0.727 . . . . 64.34 111.828 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG22 ' SG ' ' A' ' 175' ' ' CYS . 29.8 pt -78.52 118.39 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.341 0.591 . . . . 62.22 110.874 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -77.99 -69.3 0.56 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.016 -0.538 . . . . 63.12 110.759 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.01 154.82 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.777 -0.453 . . . . 74.33 109.777 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.97 104.84 0.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.687 -0.688 . . . . 73.31 110.486 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.6 m -79.85 132.91 36.21 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.833 -0.621 . . . . 41.1 110.368 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -101.7 167.24 10.23 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.258 -0.883 . . . . 73.2 110.471 -177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 134' ' ' ILE . 5.8 tm-20 -61.58 -48.17 82.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 71.13 110.403 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -62.5 -26.75 68.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 75.53 111.137 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -63.95 -61.4 2.3 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.17 0.509 . . . . 73.0 110.461 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 134' ' ' ILE . 4.4 pp -82.47 -26.89 32.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.247 -0.581 . . . . 71.33 111.595 -173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.0 tmm_? -65.26 -50.57 65.28 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.965 -0.294 . . . . 72.14 110.315 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.15 -31.47 70.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 74.4 110.822 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.4 ' CD2' HG22 ' A' ' 170' ' ' VAL . 78.2 t80 -76.96 -56.24 4.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.196 -0.456 . . . . 73.01 112.128 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 35.6 m-85 -66.98 -22.11 65.93 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.174 0.435 . . . . 73.55 112.174 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.4 mm-40 -64.79 -28.07 69.32 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.022 0.439 . . . . 71.31 110.77 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -56.77 -28.12 60.72 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.158 -0.474 . . . . 62.34 111.789 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.48 -26.42 24.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.35 -0.387 . . . . 73.55 111.717 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 170.75 -176.26 44.28 Favored Glycine 0 C--N 1.328 0.119 0 C-N-CA 120.889 -0.672 . . . . 74.22 113.138 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -76.15 134.11 40.04 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.037 0.446 . . . . 73.51 111.439 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 152' ' ' THR . 69.0 mt -105.85 142.02 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.749 -0.659 . . . . 72.52 110.75 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -91.42 -52.39 4.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 64.33 111.029 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -155.74 154.68 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.997 -0.547 . . . . 62.5 110.187 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 118' ' ' GLU . 3.3 mp -114.59 128.09 71.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 75.04 109.819 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -104.84 103.92 13.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.328 -0.851 . . . . 72.42 110.789 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.3 mm -92.17 124.86 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.89 -0.782 . . . . 73.42 108.89 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.9 mmm -94.67 113.73 25.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.334 0.588 . . . . 72.13 109.843 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.95 158.11 36.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 71.42 110.406 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -77.82 122.22 25.14 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.965 -0.754 . . . . 71.41 108.965 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -78.46 -5.69 53.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.798 0.296 . . . . 52.35 111.798 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -99.13 -53.56 1.16 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.755 -0.736 . . . . 41.04 112.372 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 p -99.28 -25.39 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.842 0.354 . . . . 64.4 111.746 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.81 9.22 64.42 Favored Glycine 0 C--O 1.234 0.112 0 C-N-CA 120.703 -0.761 . . . . 73.4 112.549 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -78.8 169.63 17.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.737 0.303 . . . . 60.32 110.622 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 141.75 53.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 62.24 110.574 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 2.2 mmp_? -81.47 -8.57 59.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.954 -0.299 . . . . 71.44 111.421 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.08 -6.39 66.49 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.602 -0.808 . . . . 63.04 112.888 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -149.98 157.51 43.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.763 -0.458 . . . . 73.1 109.763 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.26 166.39 24.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.775 -0.648 . . . . 71.0 109.735 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 67.2 m-85 -133.87 153.44 51.74 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.993 -0.549 . . . . 73.25 110.131 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.13 132.39 18.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.311 0.577 . . . . 75.34 111.063 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 55.9 m -98.49 124.57 43.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.102 -0.954 . . . . 55.13 110.495 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 6.4 m-85 -100.02 161.36 13.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.923 0.392 . . . . 75.51 111.187 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -77.21 -33.41 56.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.685 -0.689 . . . . 74.33 110.207 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -133.4 154.93 50.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.247 -0.888 . . . . 75.44 110.613 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.599 ' CE1' ' HD3' ' A' ' 87' ' ' LYS . 21.6 p80 -80.06 -21.27 43.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 73.31 110.321 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -53.62 -43.98 69.11 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.91 0.756 . . . . 75.33 110.96 179.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 m -71.96 -33.54 68.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.485 -0.779 . . . . 60.35 111.078 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.523 HG13 HG23 ' A' ' 107' ' ' ILE . 2.3 t -72.41 -37.62 58.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.206 0.527 . . . . 52.43 109.724 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.253 -0.885 . . . . 74.34 111.103 -178.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.5 mttt -68.27 -39.28 82.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.648 0.737 . . . . 60.13 110.134 172.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 22.4 mt -76.14 -41.72 37.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.85 -1.068 . . . . 75.34 112.52 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.518 HG11 ' HD3' ' A' ' 179' ' ' LYS . 35.5 m -73.5 -5.49 6.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.045 0.45 . . . . 72.02 111.38 -174.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.55 ' HA ' HG13 ' A' ' 90' ' ' VAL . 50.8 mt -61.89 -33.56 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.399 -0.819 . . . . 63.12 110.295 171.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 52.1 mt-30 -110.32 108.68 18.84 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.171 -0.677 . . . . 74.43 109.171 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -56.0 -33.25 64.69 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.678 0.621 . . . . 75.44 112.678 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -123.5 139.81 53.64 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.24 -0.288 . . . . 73.15 110.689 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.2 m-70 -128.19 152.45 48.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 74.42 109.946 175.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 m -100.28 110.09 22.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 71.24 110.113 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 124' ' ' TYR . 12.0 t -124.11 133.16 70.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.005 -0.739 . . . . 74.54 109.005 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.07 28.06 14.32 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.608 0.718 . . . . 71.34 111.486 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.78 7.57 87.34 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.014 -0.613 . . . . 74.3 113.024 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -112.0 125.26 53.88 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.503 0.321 . . . . 73.25 110.759 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -82.56 110.69 17.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.478 0.656 . . . . 60.11 109.735 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 112' ' ' ILE . 16.0 m -122.36 157.65 31.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.755 -0.657 . . . . 64.3 110.792 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -85.59 132.81 34.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.341 -0.391 . . . . 73.24 110.294 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 21.9 t -129.16 135.34 62.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.689 -0.687 . . . . 75.02 110.155 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -158.0 173.29 16.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 72.13 110.856 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.606 ' HE2' ' O ' ' A' ' 100' ' ' ALA . 12.5 mmtm -58.92 132.29 53.55 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.353 0.408 . . . . 75.13 110.979 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -119.22 114.51 22.53 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.639 -0.504 . . . . 75.31 109.639 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.4 mt -84.78 110.57 18.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.958 -0.756 . . . . 75.21 108.958 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 186' ' ' MET . 4.1 t -83.32 -174.82 5.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.771 -0.826 . . . . 65.23 108.771 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -61.89 -35.42 78.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.052 -0.259 . . . . 74.15 111.191 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.567 ' HA ' ' C ' ' A' ' 188' ' ' SER . 8.8 tt0 -65.6 -41.34 92.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.95 -0.568 . . . . 70.33 110.593 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -72.43 -24.31 61.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.38 -0.827 . . . . 65.13 110.762 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 182' ' ' SER . 21.5 mtt -89.55 -71.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 75.44 111.352 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -96.02 -63.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.402 . . . . 73.33 111.0 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.567 ' C ' ' HA ' ' A' ' 184' ' ' GLN . 56.9 p 179.21 171.83 0.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.264 -1.013 . . . . 64.34 108.264 -176.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -47.69 128.9 13.5 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.498 0.499 . . . . 73.24 111.355 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 t -64.39 98.26 0.23 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.794 0.684 . . . . 63.42 110.938 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.9 m -85.86 78.68 9.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 63.24 110.49 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 47.1 t -137.65 100.94 4.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.32 -0.855 . . . . 71.34 109.547 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -76.19 99.02 4.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.019 -0.537 . . . . 71.44 109.968 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -130.08 96.45 4.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.54 -0.755 . . . . 74.42 109.765 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -176.67 27.92 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.088 -0.577 . . . . 32.14 111.798 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.535 -0.745 . . . . 73.3 109.545 -178.189 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 112.221 -0.352 . . . . 71.13 112.221 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t 65.88 27.82 10.85 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.433 0.693 . . . . 71.31 110.886 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.88 80.11 6.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.283 0.564 . . . . 73.33 110.623 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.5 t -86.63 71.85 10.32 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.191 -1.04 . . . . 53.41 108.191 170.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -77.74 149.24 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.875 -1.057 . . . . 72.14 111.135 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -137.55 85.25 21.22 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.697 -0.853 . . . . 71.41 108.697 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.6 168.39 16.2 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.128 2.552 . . . . 72.21 111.792 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -67.46 -11.1 57.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.425 -0.352 . . . . 72.24 111.614 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.4 122.54 78.8 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.544 -0.539 . . . . 74.33 109.544 172.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 13' ' ' LEU . 17.4 Cg_endo -60.39 167.24 8.18 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.301 2.668 . . . . 71.32 112.532 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 12' ' ' GLN . 2.2 pt-20 -51.18 -42.23 60.73 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 123.294 0.371 . . . . 65.31 111.54 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 5.5 pt20 -64.93 -19.82 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.622 0.601 . . . . 72.23 112.622 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.4 mp -90.07 -21.45 22.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.531 0.197 . . . . 74.23 111.531 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.596 ' HA ' HG21 ' A' ' 68' ' ' VAL . 22.3 ptt180 -117.83 -3.61 11.2 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.633 -0.427 . . . . 64.13 111.501 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -99.17 144.49 28.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.557 0.694 . . . . 62.34 111.549 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 68' ' ' VAL . 52.5 mt -115.61 148.27 39.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.741 -1.118 . . . . 63.41 110.544 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -98.61 125.97 44.05 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.407 -0.96 . . . . 63.05 108.407 172.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 60' ' ' VAL . 20.7 mm -103.86 111.9 35.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.819 -0.437 . . . . 63.42 109.819 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.44 17.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.595 -0.812 . . . . 73.11 111.847 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.63 47.36 27.36 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.609 -0.805 . . . . 72.22 113.152 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.595 HD22 HG21 ' A' ' 25' ' ' THR . 86.1 mt -82.26 176.23 9.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.889 -0.412 . . . . 73.43 109.889 172.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 t -88.34 175.23 7.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.054 0.454 . . . . 74.14 109.849 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -81.7 -4.98 57.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.018 -0.537 . . . . 72.03 110.438 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -120.35 9.11 10.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.153 -0.476 . . . . 61.23 111.549 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.595 HG21 HD22 ' A' ' 21' ' ' LEU . 53.4 m -75.94 127.23 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 60.51 111.379 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.9 p -103.19 172.6 6.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 73.41 110.37 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.56 -24.2 39.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.221 -0.288 . . . . 74.42 110.221 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.44 -39.04 68.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 64.42 111.204 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.5 p -75.4 -38.03 60.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 73.1 110.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.564 ' HA ' HG11 ' A' ' 79' ' ' VAL . 30.2 tp -62.94 -49.1 76.06 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.465 -0.789 . . . . 54.41 109.995 176.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 31' ' ' ARG . 10.2 ttm180 -56.09 -62.42 1.72 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.519 -0.764 . . . . 72.2 111.959 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 t -50.65 -33.17 21.44 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.742 0.651 . . . . 75.21 112.544 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -75.2 -55.27 5.89 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 121.07 -0.252 . . . . 75.23 111.083 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -70.94 -22.77 62.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.067 0.395 . . . . 73.41 112.067 -177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -58.36 -22.83 54.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.049 0.539 . . . . 63.13 111.849 176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -63.95 -27.52 69.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.405 -0.362 . . . . 71.43 111.973 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -96.75 -23.74 16.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.762 0.315 . . . . 72.53 111.253 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.93 154.44 24.46 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.334 -0.936 . . . . 35.55 111.972 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.2 m -62.51 118.2 7.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 64.12 111.087 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -85.0 142.46 29.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.71 -0.677 . . . . 63.41 110.452 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.5 p -104.41 -25.43 12.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.607 -0.724 . . . . 71.21 109.682 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -153.49 156.2 37.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.537 -0.756 . . . . 70.31 110.084 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.4 t -161.79 132.32 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.454 -0.572 . . . . 72.11 109.454 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.68 118.02 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.716 0.769 . . . . 75.22 110.693 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.43 132.67 31.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.715 -0.846 . . . . 74.22 108.715 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mmt -76.19 101.37 5.37 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.512 0.673 . . . . 73.42 110.346 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -99.05 153.71 18.66 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.804 -1.089 . . . . 53.34 109.397 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.48 128.01 86.52 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.928 -0.578 . . . . 74.3 110.336 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 -17.07 58.39 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.284 1.99 . . . . 72.43 113.424 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -85.63 -56.11 3.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.965 0.412 . . . . 63.23 111.587 -178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 -11.9 20.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.061 -0.518 . . . . 74.11 111.77 -173.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp 62.79 34.82 14.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.752 0.821 . . . . 71.24 110.808 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -112.2 160.9 17.14 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.033 -0.729 . . . . 74.42 109.033 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -74.09 131.7 41.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.814 0.34 . . . . 64.33 110.63 -174.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -83.68 7.01 18.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 64.22 111.38 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.03 16.32 75.02 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.787 -0.721 . . . . 75.41 113.521 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -157.19 155.88 31.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.358 0.579 . . . . 75.32 110.355 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.2 -165.37 16.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.418 -0.673 . . . . 64.45 111.418 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.66 148.77 37.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.046 0.423 . . . . 75.43 110.31 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 18' ' ' ILE . 6.3 m -128.11 127.23 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.719 -0.673 . . . . 62.41 109.534 173.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.4 m -101.96 117.43 34.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.0 -0.37 . . . . 74.54 110.0 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 30.1 m-85 -84.85 170.86 12.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.328 -0.396 . . . . 75.51 110.494 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.13 -49.48 28.06 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.863 -0.608 . . . . 61.24 110.044 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.499 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -128.83 160.22 33.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.755 . . . . 71.11 110.792 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.3 p -65.12 -33.43 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.238 -0.437 . . . . 72.23 111.308 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -55.79 -44.54 77.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.509 0.559 . . . . 74.33 112.509 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' HB ' ' A' ' 64' ' ' THR . 1.5 mp0 -61.28 -32.75 72.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.3 0.572 . . . . 72.13 110.728 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 14' ' ' ARG . 39.1 t -65.95 -49.63 75.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.236 -0.893 . . . . 73.54 111.055 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.32 -43.83 88.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.913 -0.585 . . . . 75.35 110.875 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.63 -42.6 62.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.962 -0.563 . . . . 75.11 112.284 171.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.97 -33.07 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.866 0.365 . . . . 71.42 110.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.68 -42.12 87.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.977 -0.556 . . . . 72.24 110.433 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -12.29 59.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.807 -0.633 . . . . 74.5 111.069 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.78 -10.86 43.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 60.03 110.657 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 76' ' ' PRO . 19.2 ttp-105 -53.49 144.31 33.04 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.279 -0.873 . . . . 75.14 110.892 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 87.7 Cg_endo -80.53 168.93 70.47 Favored 'Cis proline' 0 C--N 1.353 0.774 0 C-N-CA 124.56 -1.017 . . . . 73.12 114.013 2.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -128.21 158.28 38.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.069 -0.969 . . . . 64.34 110.165 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 14.0 ttmt -134.55 104.59 6.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.082 -0.508 . . . . 65.44 110.3 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 30' ' ' LEU . 48.5 t -108.7 132.98 55.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.789 -0.641 . . . . 73.44 109.954 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t70 65.62 27.42 11.44 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.82 0.7 . . . . 74.11 110.856 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.51 21.89 76.43 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.804 -0.635 . . . . 31.44 112.497 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.3 tpt180 -128.68 137.63 51.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.226 -0.287 . . . . 61.12 110.226 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.81 111.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.419 -0.586 . . . . 71.34 109.419 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 21' ' ' LEU . 4.1 m -107.4 150.04 10.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.59 0.71 . . . . 65.23 111.431 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.05 95.46 38.36 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 114.823 -1.081 . . . . 72.22 110.926 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.97 131.98 17.65 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.418 2.079 . . . . 74.13 111.949 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -141.08 -177.33 5.05 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.222 -0.899 . . . . 74.0 108.786 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 7.4 tpp180 -75.09 154.3 37.92 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.051 0.453 . . . . 75.14 111.28 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.22 91.24 6.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.421 -0.955 . . . . 72.2 108.421 169.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.0 t -69.44 149.17 11.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.499 -0.773 . . . . 72.42 110.288 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.6 p -56.59 146.41 25.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 123.497 0.498 . . . . 74.31 110.034 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.21 -16.27 63.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.877 0.695 . . . . 73.43 112.877 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.63 -51.63 26.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.898 0.38 . . . . 61.41 110.234 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.34 -20.66 33.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 63.45 111.467 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 t -69.66 -15.87 63.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.323 -0.399 . . . . 75.33 110.357 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -76.36 -17.91 59.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 71.1 110.656 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -79.32 147.47 68.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 60.43 110.841 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.69 116.5 4.58 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.699 2.266 . . . . 63.2 111.97 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.81 18.04 15.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.54 -0.838 . . . . 52.53 112.515 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.15 50.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.73 0.3 . . . . 71.32 111.096 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -103.3 13.68 33.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.021 0.439 . . . . 73.21 111.285 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.59 163.41 23.68 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.246 -0.65 . . . . 75.25 109.246 173.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.3 82.88 4.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.792 0.806 . . . . 74.2 110.63 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -108.63 113.69 44.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.753 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.492 ' C ' HG21 ' A' ' 159' ' ' VAL . 82.2 mttt -109.12 19.4 19.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.861 0.363 . . . . 75.03 110.475 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.41 144.54 45.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.546 -0.297 . . . . 62.33 110.667 175.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.457 HG23 HG13 ' A' ' 159' ' ' VAL . 5.3 pt -125.08 148.5 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.224 0.535 . . . . 63.12 111.19 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 1.9 t80 -97.74 131.96 43.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.019 -0.992 . . . . 72.12 109.008 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 t -120.46 108.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.981 -0.748 . . . . 75.33 108.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.37 166.27 25.29 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.87 -1.157 . . . . 74.32 113.294 -174.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.29 58.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.704 -0.76 . . . . 22.1 111.762 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.5 pt -67.36 134.18 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 70.52 109.478 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -83.73 -49.28 9.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.882 0.372 . . . . 72.24 110.204 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.86 -173.56 2.34 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.056 -0.72 . . . . 74.31 109.056 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 145' ' ' LYS . 6.7 p-10 -83.81 135.27 34.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.297 0.57 . . . . 74.34 110.983 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 m -106.95 141.43 38.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.596 -0.729 . . . . 72.32 110.315 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.37 160.91 16.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.287 -0.415 . . . . 73.13 109.918 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.17 -51.12 71.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.93 -0.577 . . . . 72.41 110.093 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -58.88 -31.01 68.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 74.3 111.731 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -61.76 -57.97 9.84 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.347 0.405 . . . . 73.31 110.71 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 121' ' ' LEU . 2.7 pp -81.11 -27.45 35.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.449 -0.5 . . . . 74.45 110.99 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.41 -53.31 44.9 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 110.182 -0.303 . . . . 73.41 110.182 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.49 -28.27 69.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.209 0.528 . . . . 73.45 110.452 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.01 -56.71 4.6 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.95 -0.568 . . . . 71.11 111.54 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 29.7 m-85 -66.71 -22.1 66.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 72.02 111.773 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.16 -27.72 68.91 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.99 0.424 . . . . 71.21 111.214 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -58.07 -28.77 64.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 72.14 111.3 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -86.16 -26.49 25.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.418 -0.356 . . . . 75.04 111.658 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.69 -174.91 45.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.708 -0.758 . . . . 72.04 113.582 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -78.18 131.89 37.37 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.936 0.398 . . . . 53.34 111.716 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.7 mt -104.82 139.92 24.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.922 -0.581 . . . . 70.42 110.384 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 -49.92 6.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 63.53 110.847 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.59 159.72 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.684 -0.487 . . . . 74.41 109.684 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.53 127.82 75.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.244 0.545 . . . . 73.34 109.923 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 39.6 mt-10 -99.65 103.79 15.51 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.1 -0.954 . . . . 73.24 110.326 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.0 mm -93.53 117.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.164 -0.68 . . . . 72.44 109.164 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 66.4 mmm -91.3 122.33 33.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.333 -0.617 . . . . 73.13 109.333 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.48 163.06 24.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.429 0.633 . . . . 72.15 112.039 -173.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.491 ' HA ' ' NH2' ' A' ' 146' ' ' ARG . 12.9 t70 -95.14 128.11 41.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.608 -1.178 . . . . 70.04 109.963 176.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -9.9 59.74 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 73.04 112.273 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.66 -53.85 2.65 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.374 -0.917 . . . . 62.52 113.039 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.2 m -96.24 -19.74 19.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.736 0.303 . . . . 72.43 111.122 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.26 28.41 48.95 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.702 -0.761 . . . . 72.24 111.524 -176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -108.4 179.64 4.14 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 72.42 109.658 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -72.69 150.83 42.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.303 0.573 . . . . 74.1 111.173 175.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.491 ' NH2' ' HA ' ' A' ' 139' ' ' ASP . 23.6 tpp180 -74.9 -7.61 54.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.683 . . . . 73.1 111.535 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.46 -3.32 53.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.266 -0.968 . . . . 65.44 112.475 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -157.46 158.8 36.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.987 0.422 . . . . 74.41 110.392 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.5 170.07 16.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.48 -0.782 . . . . 71.21 109.54 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.6 m-85 -134.4 145.21 48.71 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.967 -0.56 . . . . 75.03 109.909 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.19 129.07 67.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.206 -0.452 . . . . 72.14 110.623 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 96.4 m -100.81 118.74 37.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.643 -0.708 . . . . 73.21 110.521 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.1 m-85 -102.16 156.81 17.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.768 0.318 . . . . 74.33 111.178 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -75.56 -31.93 60.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.931 -0.577 . . . . 73.01 110.366 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -128.26 152.96 47.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 75.42 110.663 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -75.96 -25.68 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.508 -0.553 . . . . 75.44 109.508 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -48.59 -48.84 38.72 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.102 -0.954 . . . . 62.12 111.437 178.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 153' ' ' PHE . 1.7 m -72.44 -32.89 66.68 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.82 -0.627 . . . . 62.14 110.813 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.6 t -69.46 -42.34 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 N-CA-C 109.312 -0.625 . . . . 75.21 109.312 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.565 ' HB3' ' CB ' ' A' ' 88' ' ' ARG . 3.6 m-20 -71.43 -22.49 61.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.082 -0.963 . . . . 72.34 111.804 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 92.4 mttt -67.01 -39.56 87.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.77 0.795 . . . . 55.05 109.786 170.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mt -76.02 -40.94 38.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.334 -1.303 . . . . 70.23 112.054 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 159' ' ' VAL . 7.5 m -73.33 -11.86 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.001 0.429 . . . . 64.24 110.924 -175.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.497 HD13 HD12 ' A' ' 13' ' ' LEU . 10.8 mt -63.71 -29.99 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.323 -0.853 . . . . 73.24 110.193 173.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.561 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 54.6 mt-30 -112.66 98.42 7.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.898 -1.149 . . . . 63.11 107.898 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -56.67 -33.37 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.108 -0.951 . . . . 71.12 112.431 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -121.65 131.75 54.27 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.33 -0.395 . . . . 75.11 110.381 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.561 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 91.3 m-70 -124.49 150.95 45.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.712 -0.676 . . . . 73.35 109.794 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.0 m -115.87 118.1 32.05 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.779 -0.452 . . . . 64.33 109.779 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.93 117.2 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.054 -0.521 . . . . 52.15 110.31 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 69.02 28.23 5.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.435 -0.802 . . . . 73.21 110.328 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 97.73 -9.13 64.07 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.534 -0.757 . . . . 61.55 113.309 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -108.61 125.68 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 117.444 0.622 . . . . 62.42 111.795 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -93.2 109.91 21.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.332 0.587 . . . . 43.33 110.014 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.1 p -114.64 155.31 26.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.596 -0.729 . . . . 75.01 110.675 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.0 129.94 34.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.504 -0.554 . . . . 60.32 109.504 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 12.4 t -127.74 134.45 65.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.411 -0.813 . . . . 54.54 110.202 -178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -156.6 177.0 11.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.707 -0.679 . . . . 64.24 111.134 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -64.1 125.72 25.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.36 -0.382 . . . . 73.04 110.144 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.67 44.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 121.016 0.436 . . . . 64.34 109.911 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 39.0 mt -85.15 121.41 27.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.983 -0.553 . . . . 71.33 109.99 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.551 ' HB2' ' OE1' ' A' ' 185' ' ' GLU . 67.1 m -64.54 162.33 15.66 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.999 -0.741 . . . . 74.24 108.999 171.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -71.02 -26.35 63.07 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.773 -0.579 . . . . 73.43 112.157 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.3 -36.75 79.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 64.1 109.731 171.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.551 ' OE1' ' HB2' ' A' ' 182' ' ' SER . 0.6 OUTLIER -70.68 -41.34 72.15 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.218 -0.901 . . . . 75.03 110.439 178.017 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 82.1 mtp -64.93 -43.03 94.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.438 -0.801 . . . . 70.11 111.242 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.3 -23.36 59.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 42.12 110.622 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.0 m 61.37 26.18 16.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.443 -0.799 . . . . 73.42 110.298 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.87 172.17 16.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.087 -0.96 . . . . 72.03 109.276 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.5 m -107.4 152.73 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.732 0.301 . . . . 71.3 110.344 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.3 p -145.42 124.94 13.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.512 -0.313 . . . . 65.1 110.433 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 107.16 4.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.346 -0.388 . . . . 70.34 110.079 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -73.54 -71.93 0.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.588 -0.733 . . . . 74.13 110.969 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 61.18 25.76 15.72 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.019 0.824 . . . . 72.54 110.939 -175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -114.76 86.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.963 -0.637 . . . . 65.3 112.048 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.506 -0.759 . . . . 74.04 109.588 177.068 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.711 -0.556 . . . . 54.4 111.711 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -81.74 146.67 29.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.844 0.354 . . . . 52.34 110.634 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -82.42 127.33 33.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.001 -0.545 . . . . 64.2 109.548 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 m -82.76 80.99 8.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.247 0.546 . . . . 61.54 110.183 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.21 86.46 7.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 73.21 110.273 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.6 p -75.84 113.68 29.51 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.11 -0.495 . . . . 72.03 109.866 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 72.0 Cg_endo -79.32 167.38 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.301 2.0 . . . . 74.14 112.916 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -65.9 -12.49 54.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.411 -0.813 . . . . 73.33 110.713 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' OE1' ' HB2' ' A' ' 7' ' ' PRO . 3.6 mp0 -64.63 128.19 93.23 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.376 -0.829 . . . . 75.11 111.107 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HD2' HD22 ' A' ' 13' ' ' LEU . 34.2 Cg_endo -65.8 167.65 17.03 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.152 2.568 . . . . 63.34 112.186 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.56 -34.64 72.94 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 112.157 0.429 . . . . 74.11 112.157 -173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -67.87 -24.36 65.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.872 0.367 . . . . 75.04 111.363 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.455 HD22 ' HD2' ' A' ' 10' ' ' PRO . 4.0 mp -86.21 -10.6 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 53.14 111.188 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -122.34 0.72 9.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.942 0.401 . . . . 70.32 111.216 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 36.2 ttpt -97.41 145.64 25.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.597 0.713 . . . . 72.0 111.983 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 68' ' ' VAL . 60.7 mt -117.76 147.66 42.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.12 . . . . 63.22 110.54 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -99.27 125.75 44.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.542 -0.91 . . . . 75.32 108.542 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 60' ' ' VAL . 20.9 mm -102.97 113.18 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 109.91 -0.404 . . . . 73.44 109.91 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.27 17.26 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.784 -0.722 . . . . 53.05 111.858 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.74 47.33 26.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.942 -0.647 . . . . 73.25 113.333 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD22 HG21 ' A' ' 25' ' ' THR . 77.7 mt -84.78 175.84 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.003 0.43 . . . . 54.23 110.494 174.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 t -92.23 167.36 12.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.332 -0.618 . . . . 61.02 109.332 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 54' ' ' SER . 94.2 m-85 -75.46 -6.12 48.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.307 0.575 . . . . 73.21 110.789 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -101.14 -3.8 28.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.201 -0.909 . . . . 75.12 111.202 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.486 HG21 HD22 ' A' ' 21' ' ' LEU . 72.2 m -76.21 125.18 28.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 71.4 112.158 -169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 p -105.86 160.01 15.58 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.169 -0.923 . . . . 73.42 110.072 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -67.05 -27.97 67.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 120.475 0.179 . . . . 74.13 110.829 -177.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -76.69 -38.33 54.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.469 -0.332 . . . . 75.33 111.499 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -78.51 -35.23 46.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.825 -0.171 . . . . 74.4 111.227 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.5 tp -64.77 -45.97 84.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.248 -0.649 . . . . 72.34 109.248 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -54.17 -60.32 3.49 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.176 -0.92 . . . . 64.44 111.386 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -47.72 -34.09 7.85 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.858 0.724 . . . . 74.42 112.701 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -76.58 -57.6 3.76 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.8 -0.182 . . . . 75.2 111.114 -178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.18 -23.13 64.81 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.063 -0.398 . . . . 63.24 111.849 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.91 -23.33 65.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.228 0.611 . . . . 74.35 111.209 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -60.79 -26.94 67.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 72.11 112.038 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -99.95 -20.88 15.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.837 0.31 . . . . 73.24 111.837 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.73 32.88 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.294 -0.955 . . . . 75.25 112.095 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 m -63.23 117.28 6.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.927 0.394 . . . . 72.54 111.394 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.9 mt -85.13 143.0 29.1 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.482 -0.562 . . . . 72.51 109.482 169.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -116.17 -16.12 11.02 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.012 -0.54 . . . . 73.31 110.099 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -152.39 150.7 29.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 73.41 109.446 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.4 t -162.72 129.48 3.55 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.687 -0.486 . . . . 75.41 109.687 174.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -145.6 122.08 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.501 0.667 . . . . 72.33 110.587 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 27' ' ' ASP . 91.2 t -85.73 129.93 37.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 53.14 108.785 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.1 mmt -75.33 95.0 3.12 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.571 0.701 . . . . 70.23 110.116 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 52.4 mtp85 -101.34 158.43 16.06 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.636 -1.166 . . . . 72.22 110.221 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 23.9 t70 -72.45 126.46 90.91 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.143 -0.935 . . . . 73.31 110.262 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.29 -12.5 31.99 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.127 1.885 . . . . 74.11 112.942 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 32.2 m-80 -85.64 -56.3 3.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.019 0.377 . . . . 75.04 112.019 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -107.09 -9.24 16.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 75.12 111.459 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 29.1 mmtp 67.07 40.07 3.0 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.68 0.792 . . . . 75.14 111.416 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -117.28 154.66 30.84 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.547 -0.909 . . . . 72.45 108.547 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 31.3 t -72.27 139.86 48.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.147 0.431 . . . . 71.42 111.391 -171.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -82.53 1.2 39.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.673 -0.694 . . . . 72.45 110.695 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.54 20.06 57.21 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.568 -0.825 . . . . 63.32 113.987 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -161.05 156.92 25.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.9 0.85 . . . . 75.4 110.618 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.17 -163.56 14.4 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.519 -0.632 . . . . 71.45 111.519 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -142.15 150.4 41.03 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.374 0.587 . . . . 65.44 110.293 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 18' ' ' ILE . 7.5 m -131.71 127.96 59.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 60.22 109.55 172.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.6 m -104.49 119.65 39.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.105 -0.331 . . . . 72.24 110.105 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 67' ' ' GLU . 29.9 m-85 -85.33 158.95 20.14 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.24 -0.436 . . . . 73.11 110.121 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.92 -44.45 73.1 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.932 -0.576 . . . . 42.22 110.559 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 67' ' ' GLU . 2.0 m -126.4 152.13 46.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.754 -0.657 . . . . 74.02 110.643 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 2.6 p -60.44 -36.31 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.727 -0.67 . . . . 73.32 110.983 177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.64 -43.3 62.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.241 0.83 . . . . 52.41 113.241 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 62' ' ' TYR . 1.3 mp0 -65.61 -29.24 69.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.88 0.372 . . . . 53.51 111.207 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 65' ' ' VAL . 41.4 t -63.96 -45.7 96.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 75.14 110.428 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.31 -50.1 70.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.167 -0.924 . . . . 73.42 111.722 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -52.96 -37.08 60.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.938 0.718 . . . . 73.53 112.938 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.62 -32.52 71.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.461 0.648 . . . . 62.31 109.949 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 75' ' ' ARG . 14.0 mmt -73.07 -31.5 64.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.251 -0.886 . . . . 41.01 112.09 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.1 p30 -81.39 -15.01 56.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.214 0.531 . . . . 63.22 110.632 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.27 -11.21 35.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 64.13 112.097 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HD3' ' SD ' ' A' ' 72' ' ' MET . 7.8 mtm180 -54.11 146.58 29.41 Favored Pre-proline 0 N--CA 1.465 0.282 0 O-C-N 123.241 0.338 . . . . 75.44 111.631 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.19 168.68 69.19 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.75 -1.354 . . . . 52.24 113.234 2.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -122.77 155.52 36.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.992 -0.549 . . . . 64.13 110.77 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 ttmt -135.06 108.47 7.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.082 -0.508 . . . . 55.31 111.112 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.34 124.76 64.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 72.34 110.073 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 64.99 27.32 12.66 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.474 0.71 . . . . 73.23 111.698 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.3 25.04 59.99 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.919 -0.658 . . . . 51.23 112.483 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 9.6 tpt180 -129.04 139.07 52.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.044 -0.354 . . . . 71.33 110.044 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.7 112.79 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.064 -0.717 . . . . 71.43 109.064 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -104.96 149.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.413 0.625 . . . . 74.22 111.592 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.421 ' CG ' ' HE2' ' A' ' 87' ' ' LYS . 14.8 tp10 -110.81 98.0 36.02 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.819 -1.082 . . . . 74.42 110.334 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.18 127.71 9.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.672 1.581 . . . . 73.12 111.111 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HE2' ' CG ' ' A' ' 85' ' ' GLU . 28.0 mttt -133.98 177.74 7.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.885 -1.154 . . . . 73.41 107.885 -177.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HB3' ' CB ' ' A' ' 160' ' ' ASP . 4.3 tpp180 -86.01 135.74 33.53 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.345 -0.542 . . . . 74.33 110.3 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.7 94.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.437 0.637 . . . . 73.32 110.648 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.14 157.91 6.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 52.13 111.088 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -55.3 151.72 9.38 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.71 -0.677 . . . . 63.13 111.394 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -37.45 75.54 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.025 -0.534 . . . . 64.33 111.54 -173.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.56 -47.97 82.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.149 -0.478 . . . . 73.51 111.236 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 -43.09 79.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 62.24 110.486 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 p -75.94 7.4 4.04 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.754 0.65 . . . . 61.35 112.754 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HA ' HE21 ' A' ' 96' ' ' GLN . 0.0 OUTLIER -84.76 -21.44 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 74.34 110.432 173.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -91.72 144.59 29.67 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.244 -0.434 . . . . 74.0 110.683 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.37 117.47 4.98 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.604 2.203 . . . . 74.44 111.791 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 109.92 4.15 29.74 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.838 -0.696 . . . . 64.14 112.304 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.59 -42.74 24.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.912 0.387 . . . . 74.43 111.291 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -93.87 1.27 56.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.8 0.333 . . . . 71.55 110.777 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 99' ' ' GLY . 48.4 mt -78.66 159.18 28.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.178 -0.675 . . . . 74.35 109.178 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.5 m -75.79 97.9 4.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.382 0.61 . . . . 54.11 110.99 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -122.82 119.54 58.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.214 -0.903 . . . . 73.22 108.883 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.413 ' HA ' HG21 ' A' ' 159' ' ' VAL . 75.8 mttt -105.34 21.45 17.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.131 0.491 . . . . 71.34 110.394 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.01 139.62 50.92 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.22 -0.446 . . . . 51.22 110.759 178.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.42 ' CG2' HG13 ' A' ' 159' ' ' VAL . 8.9 pt -128.96 149.03 33.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.193 0.52 . . . . 53.13 111.296 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.591 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 4.5 t80 -94.56 133.89 37.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.996 -1.002 . . . . 71.31 109.76 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -123.09 109.44 23.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.997 -0.742 . . . . 62.3 108.997 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.49 171.64 26.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 119.514 -1.327 . . . . 63.13 113.569 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.47 30.2 30.88 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.198 -0.761 . . . . 63.33 111.198 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.414 HG22 ' SG ' ' A' ' 175' ' ' CYS . 23.2 pt -75.18 129.45 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 120.975 0.417 . . . . 71.53 110.311 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -78.63 -54.93 5.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.106 -0.701 . . . . 72.14 109.106 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -102.19 149.46 24.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.776 -0.824 . . . . 73.34 108.776 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.27 149.13 48.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.276 0.56 . . . . 70.15 111.517 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -120.77 156.19 32.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.819 -0.628 . . . . 74.22 111.068 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -112.02 167.32 10.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.357 -0.838 . . . . 73.5 110.517 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -61.2 -54.07 48.99 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.988 -0.551 . . . . 72.23 111.01 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -65.19 -17.22 64.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 75.22 111.773 -174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -70.18 -57.63 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.015 -0.365 . . . . 74.34 110.015 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.28 -28.89 38.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 120.355 -0.538 . . . . 75.32 110.566 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HD2' ' C ' ' A' ' 122' ' ' ARG . 7.3 tmm_? -61.8 -50.01 74.03 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.784 -0.45 . . . . 75.33 109.784 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.04 -29.31 70.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 75.44 111.002 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -80.35 -53.24 6.8 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.994 -0.548 . . . . 62.4 112.021 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 37.3 m-85 -66.72 -23.97 66.18 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.603 0.223 . . . . 70.04 111.603 -178.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.45 -27.09 68.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.073 0.463 . . . . 72.53 111.023 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -60.77 -27.76 68.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.605 -0.725 . . . . 70.51 111.575 175.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -86.4 -24.6 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 71.44 111.398 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.55 -179.83 43.05 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.606 -0.807 . . . . 72.14 112.928 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -73.35 133.65 43.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.357 . . . . 64.5 110.661 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 152' ' ' THR . 63.9 mt -104.5 137.77 32.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.003 -0.544 . . . . 72.23 109.863 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.25 -46.97 8.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.287 . . . . 73.53 110.846 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.55 157.46 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.083 -0.339 . . . . 70.24 110.083 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.86 130.58 73.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.777 -0.453 . . . . 72.15 109.777 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 31.8 mt-10 -103.19 103.45 13.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.788 -0.642 . . . . 72.11 110.746 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.12 116.54 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.502 -0.555 . . . . 73.3 109.502 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.441 ' HG3' ' CE2' ' A' ' 148' ' ' PHE . 69.3 mmm -84.4 100.99 11.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.554 0.692 . . . . 73.42 109.559 -175.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -117.57 158.38 24.69 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.007 -0.997 . . . . 51.03 110.164 -174.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -88.31 123.11 32.57 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.981 -0.748 . . . . 71.31 108.981 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 34.1 tpt85 -64.45 -31.92 73.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.386 0.429 . . . . 71.12 111.789 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.85 -47.05 4.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.635 -0.793 . . . . 74.41 113.279 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 m -86.22 -23.68 26.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.097 0.406 . . . . 63.13 112.097 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.11 6.25 87.46 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.909 -0.662 . . . . 62.23 112.22 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -92.34 146.12 23.95 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.381 -0.229 . . . . 72.11 110.381 -177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 133.21 46.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 72.41 109.177 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -81.03 21.8 0.68 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.377 0.88 . . . . 74.4 113.377 -170.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.62 -2.73 80.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.675 -0.774 . . . . 75.14 113.941 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 137' ' ' MET . 13.3 p90 -154.7 163.46 40.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.473 0.637 . . . . 73.14 110.493 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.18 171.91 13.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.208 -0.905 . . . . 63.52 109.893 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.491 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.4 m-85 -139.09 155.06 48.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.46 -0.791 . . . . 74.22 109.284 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.28 134.52 14.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-O 121.418 0.628 . . . . 75.22 111.334 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 53.0 m -100.26 125.63 46.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.91 -1.041 . . . . 72.23 110.672 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.5 m-85 -99.88 160.7 14.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.938 0.399 . . . . 73.35 111.253 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.43 -27.76 37.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 74.13 110.344 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.94 160.98 31.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.197 -0.456 . . . . 75.13 111.665 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -84.93 -32.08 23.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 73.34 110.756 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.611 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 35.7 t70 -62.18 -37.99 87.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.955 -0.566 . . . . 71.2 111.13 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -67.02 -33.69 76.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.526 -0.307 . . . . 53.43 111.058 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG13 ' CG2' ' A' ' 107' ' ' ILE . 2.6 t -68.05 -42.62 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 72.21 109.868 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.589 ' CB ' ' HB3' ' A' ' 88' ' ' ARG . 73.3 m-20 -64.14 -37.87 89.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.106 -0.952 . . . . 72.3 111.509 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 47.9 mttm -53.8 -42.67 68.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.81 0.814 . . . . 70.25 110.538 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.75 -43.81 33.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.281 -1.327 . . . . 64.01 112.395 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 160' ' ' ASP . 18.9 m -75.24 -7.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 121.972 -0.455 . . . . 75.12 111.059 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 160' ' ' ASP . 37.8 mt -57.85 -32.28 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.377 -0.829 . . . . 62.34 109.927 170.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -107.58 152.49 24.2 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.936 -0.575 . . . . 72.15 109.46 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.21 -39.07 13.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.976 0.417 . . . . 75.11 110.388 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.02 137.91 54.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 65.41 110.033 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -122.71 140.77 52.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.318 -0.401 . . . . 72.32 110.902 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -96.06 116.28 28.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.814 -0.63 . . . . 61.44 110.218 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.72 107.02 12.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.581 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 72.95 28.19 2.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.231 -0.895 . . . . 60.34 110.007 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.84 -2.63 80.14 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.386 -0.824 . . . . 71.31 112.678 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -110.56 130.17 55.63 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.775 -0.25 . . . . 72.11 110.54 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -100.92 112.49 24.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.09 0.471 . . . . 61.54 110.988 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 112' ' ' ILE . 7.4 m -110.42 150.99 28.03 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.847 -0.615 . . . . 63.04 110.297 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -86.9 133.83 33.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.879 -0.415 . . . . 75.0 109.879 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 18.8 t -133.13 138.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.277 -0.42 . . . . 44.3 111.572 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -158.64 177.32 11.33 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.863 -0.608 . . . . 74.22 111.463 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -62.5 124.74 21.75 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.97 0.508 . . . . 73.31 110.86 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -111.99 113.61 26.0 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.217 0.532 . . . . 45.12 109.903 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.445 ' HB2' ' CG ' ' A' ' 186' ' ' MET . 39.2 mt -98.73 147.97 24.33 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.551 -0.749 . . . . 50.25 109.588 -178.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 t -72.74 174.57 7.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.71 -0.478 . . . . 72.34 109.71 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.92 -42.75 97.29 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.717 0.294 . . . . 64.12 110.73 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.42 -19.48 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 75.11 111.493 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -83.13 -46.79 12.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.745 0.307 . . . . 74.45 110.528 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.445 ' CG ' ' HB2' ' A' ' 181' ' ' LEU . 83.5 mtp -68.5 -50.26 53.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.03 -0.532 . . . . 64.52 111.124 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.87 -43.02 69.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.951 -0.568 . . . . 52.31 110.602 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.8 m 60.47 21.37 11.06 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.692 -0.685 . . . . 53.31 110.784 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -101.63 130.51 47.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.804 -0.635 . . . . 55.11 110.795 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.6 m -76.8 155.14 33.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.712 -0.676 . . . . 51.51 109.781 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.6 p -69.66 142.8 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.025 0.441 . . . . 73.13 111.14 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 t -94.7 85.4 4.46 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.433 -0.58 . . . . 62.52 109.433 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -93.43 141.18 28.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.878 0.37 . . . . 74.41 110.122 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -102.15 -49.42 3.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.181 -0.463 . . . . 73.3 110.871 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -162.22 106.61 0.28 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.199 -1.001 . . . . 51.14 113.023 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.983 -1.008 . . . . 75.24 109.007 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 CA-C-O 120.055 -0.303 . . . . 74.21 112.427 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m 74.68 -40.83 0.45 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.125 0.97 . . . . 32.24 113.132 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -87.64 90.4 8.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.246 0.546 . . . . 73.03 111.822 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -107.14 7.64 29.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.65 -0.705 . . . . 73.15 109.672 172.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 60.1 78.88 0.26 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.834 -1.076 . . . . 50.24 110.312 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -66.56 123.6 86.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 64.25 111.117 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 60.9 Cg_endo -81.23 165.61 18.88 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.97 2.447 . . . . 72.52 112.219 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.98 -2.53 15.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.805 0.812 . . . . 73.32 108.845 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -71.2 141.57 86.3 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.018 -1.446 . . . . 74.2 109.877 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.98 166.97 19.02 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.71 2.273 . . . . 61.42 112.462 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.64 -32.29 67.12 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.956 -0.565 . . . . 64.3 111.97 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HG3' HD12 ' A' ' 13' ' ' LEU . 8.0 pt20 -64.05 -31.91 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.794 0.33 . . . . 74.11 111.551 -177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 164' ' ' ILE . 5.2 mp -78.53 -20.23 51.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 60.14 111.282 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.545 ' HA ' HG21 ' A' ' 68' ' ' VAL . 23.5 ptt180 -117.18 0.1 12.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.363 -0.381 . . . . 65.31 111.587 -176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 31.6 ttmt -98.15 148.53 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.781 0.801 . . . . 73.22 112.16 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 68' ' ' VAL . 66.0 mt -117.01 145.2 43.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.331 -1.304 . . . . 70.31 110.338 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -97.93 120.27 38.03 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.112 -1.07 . . . . 65.21 108.112 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 60' ' ' VAL . 16.7 mm -100.52 110.96 28.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.79 -0.448 . . . . 73.23 109.79 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.85 151.61 16.89 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.948 -0.861 . . . . 73.32 110.948 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 43.3 12.89 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.252 -0.975 . . . . 45.12 112.974 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 25' ' ' THR . 93.3 mt -84.1 175.44 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.039 0.447 . . . . 72.11 110.499 173.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.1 t -90.96 172.79 8.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.382 -0.599 . . . . 52.31 109.382 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -77.35 -11.49 59.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.365 0.602 . . . . 75.3 110.28 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HA ' ' NH2' ' A' ' 53' ' ' ARG . 24.0 mt-10 -106.9 -1.41 22.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.635 -0.711 . . . . 73.21 111.484 -175.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 HD22 ' A' ' 21' ' ' LEU . 47.3 m -69.75 126.41 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.119 0.485 . . . . 72.12 112.026 -170.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -101.92 167.5 10.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.407 -0.815 . . . . 73.41 110.0 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -28.1 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.978 -0.378 . . . . 74.24 109.978 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.9 -41.9 82.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.45 110.853 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t -72.64 -41.97 64.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 74.02 110.049 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.6 tp -59.85 -49.03 79.28 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.875 -0.602 . . . . 64.32 110.682 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HG3' HD12 ' A' ' 40' ' ' LEU . 14.2 ttm-85 -58.92 -56.54 20.9 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 123.438 0.695 . . . . 62.23 111.044 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 m -44.38 -38.77 4.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 44.53 113.381 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -67.26 -52.2 43.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.981 -0.554 . . . . 74.23 111.226 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -80.65 -20.27 43.44 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.925 0.343 . . . . 73.42 111.925 -170.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 31' ' ' ARG . 44.1 mt-10 -56.5 -24.27 45.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.355 0.502 . . . . 72.44 112.355 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -63.3 -27.08 69.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.468 0.544 . . . . 63.52 112.468 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -100.06 -21.95 15.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.645 0.259 . . . . 75.52 111.557 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 156.84 27.25 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.759 -0.734 . . . . 74.12 111.401 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 83.2 m -67.65 120.24 13.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.911 0.386 . . . . 70.35 111.143 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 31' ' ' ARG . 49.0 mt -84.34 145.4 28.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.328 0.585 . . . . 74.3 110.834 177.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.9 p -108.79 -22.94 11.99 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.278 -0.874 . . . . 61.42 110.17 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -154.52 157.47 38.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.502 . . . . 63.11 110.62 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.7 t -163.6 136.56 5.38 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.413 -0.588 . . . . 62.15 109.413 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 p -151.01 126.42 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.218 0.533 . . . . 64.22 110.298 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.77 132.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.7 -0.852 . . . . 73.32 108.7 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 mmt -76.05 97.16 3.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.732 0.777 . . . . 73.32 110.423 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 35.7 mtt180 -101.88 163.59 12.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.37 -1.286 . . . . 75.43 111.492 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.19 124.19 89.79 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 114.491 -1.231 . . . . 72.04 110.25 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.95 -20.23 70.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.084 1.856 . . . . 75.21 112.909 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -83.79 -56.51 3.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.12 0.415 . . . . 74.13 112.12 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -6.89 16.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 71.01 111.677 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm 64.43 40.18 6.49 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.384 -0.826 . . . . 74.44 111.953 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' NH2' ' HA ' ' A' ' 24' ' ' GLU . 27.0 mmm180 -114.42 163.03 15.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.418 -0.586 . . . . 74.21 109.418 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 40.6 t -72.42 133.97 45.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.148 0.499 . . . . 72.34 111.845 -173.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -81.88 -0.16 42.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.533 -0.758 . . . . 74.24 110.451 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.05 12.04 58.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.731 -0.747 . . . . 73.24 114.128 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -156.35 156.55 34.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.815 0.807 . . . . 61.45 110.58 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.51 -166.33 18.24 Favored Glycine 0 C--O 1.227 -0.333 0 N-CA-C 111.564 -0.615 . . . . 34.33 111.564 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -142.22 148.9 38.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.224 0.512 . . . . 75.53 110.35 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 18' ' ' ILE . 8.2 m -128.43 130.14 69.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.637 -0.711 . . . . 73.02 109.318 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 7.4 m -106.72 120.15 41.22 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 122.304 -0.247 . . . . 74.44 110.354 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -83.93 169.17 15.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.143 -0.48 . . . . 73.52 110.515 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -67.5 -55.65 12.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.738 -0.665 . . . . 65.23 109.577 174.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 66' ' ' GLU . 36.3 m -123.24 153.14 40.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.39 -0.823 . . . . 72.2 111.426 -177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.578 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 4.7 p -58.04 -38.28 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.777 -0.647 . . . . 70.53 111.248 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 64' ' ' THR . 6.3 mm-40 -52.63 -41.8 64.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.066 0.765 . . . . 73.34 113.066 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -62.54 -31.34 72.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.363 0.602 . . . . 72.02 110.388 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG13 HD21 ' A' ' 16' ' ' LEU . 32.9 t -68.83 -47.26 77.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.108 -0.951 . . . . 62.42 111.01 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -55.76 -48.3 75.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 70.5 110.887 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.4 60.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.625 0.602 . . . . 75.52 112.625 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.94 -33.59 63.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.981 0.42 . . . . 53.22 110.659 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -47.1 71.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 75.21 110.801 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -27.99 66.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 53.3 110.682 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.21 -8.04 46.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.943 0.72 . . . . 61.35 112.943 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' NH1' ' HG2' ' A' ' 85' ' ' GLU . 11.9 mtp180 -56.66 147.72 49.96 Favored Pre-proline 0 CA--C 1.531 0.225 0 O-C-N 122.897 0.123 . . . . 71.55 111.013 173.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.65 166.08 78.44 Favored 'Cis proline' 0 C--N 1.349 0.591 0 C-N-CA 123.8 -1.333 . . . . 74.34 113.968 4.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -125.9 150.99 47.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.764 -0.653 . . . . 70.54 110.964 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -141.46 113.01 7.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.909 -0.587 . . . . 74.14 111.039 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.07 144.41 38.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.89 -0.596 . . . . 73.21 109.736 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.9 t70 67.39 22.03 9.56 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.592 0.71 . . . . 72.22 110.567 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.46 23.12 74.19 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.385 -0.825 . . . . 64.03 111.934 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -130.22 141.01 50.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.58 0.229 . . . . 74.43 110.529 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.56 113.19 21.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.874 -0.787 . . . . 73.32 108.874 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.5 m -107.31 153.58 8.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 75.21 111.602 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HG2' ' NH1' ' A' ' 75' ' ' ARG . 2.3 mt-10 -115.33 98.03 49.68 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.213 -0.903 . . . . 75.41 111.403 176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -75.28 133.04 15.71 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.967 1.778 . . . . 51.5 110.725 171.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -139.39 -178.84 5.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.201 -1.407 . . . . 61.15 107.201 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.421 ' CB ' ' HB3' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -86.96 143.29 27.43 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 119.748 1.158 . . . . 65.21 111.533 -177.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.81 3.5 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.843 -0.799 . . . . 50.04 108.843 165.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.79 160.01 5.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.339 -0.846 . . . . 75.21 110.117 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.7 p -53.21 150.66 5.84 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.407 0.442 . . . . 73.1 110.888 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 96' ' ' GLN . 9.9 mpt_? -60.2 -23.73 64.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.916 -0.584 . . . . 65.23 112.26 -171.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -62.27 -45.83 91.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.966 0.413 . . . . 74.53 110.344 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.53 -50.61 7.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 63.54 111.216 -177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.9 p -70.91 -9.66 58.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.51 0.93 . . . . 45.43 113.51 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.549 HE21 ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -89.89 -2.29 58.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.942 0.401 . . . . 72.01 110.866 179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -116.99 148.23 41.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.276 -0.42 . . . . 74.15 110.084 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.09 138.38 77.77 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.833 2.356 . . . . 72.25 112.592 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.09 -15.37 51.34 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.838 -0.696 . . . . 75.01 112.396 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.79 -44.32 56.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 65.1 111.671 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -96.42 13.5 27.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.793 0.33 . . . . 63.01 111.365 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.9 mt -82.12 162.72 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.193 -0.669 . . . . 73.23 109.193 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.0 m -79.23 85.75 5.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.607 0.718 . . . . 72.23 110.032 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.14 114.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.882 -1.053 . . . . 54.44 110.11 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -109.27 15.57 23.06 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.657 -0.417 . . . . 54.01 110.683 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -115.62 139.38 50.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.318 -0.401 . . . . 65.22 110.537 176.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.446 ' CG2' HG13 ' A' ' 159' ' ' VAL . 6.3 pt -131.52 152.96 38.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.501 0.667 . . . . 73.43 111.62 176.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 2.1 t80 -96.88 136.07 37.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.537 -1.21 . . . . 71.21 109.834 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -122.97 110.65 27.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.103 -0.703 . . . . 74.22 109.103 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.63 155.11 19.93 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.684 -1.246 . . . . 52.51 113.237 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.37 7.4 55.97 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.539 -0.838 . . . . 74.11 112.456 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.7 pt -72.44 105.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 121.515 0.674 . . . . 51.52 109.758 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -88.2 -10.08 50.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 63.42 111.798 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -121.71 165.42 15.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.716 -0.475 . . . . 72.43 109.716 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 145' ' ' LYS . 9.2 p-10 -70.17 104.55 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.404 1.097 . . . . 73.1 111.399 -175.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 m -96.96 142.72 28.58 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.158 -1.383 . . . . 75.13 109.55 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 120' ' ' HIS . 14.4 pt-20 -113.58 169.5 8.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.672 -0.695 . . . . 61.44 110.949 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -53.59 -51.29 63.48 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 114.828 -1.078 . . . . 71.21 110.405 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.55 -25.05 62.09 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.653 0.612 . . . . 72.52 112.653 -175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.44 ' CE1' ' HG2' ' A' ' 117' ' ' GLU . 63.7 m170 -70.94 -60.4 2.25 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.067 0.46 . . . . 63.21 110.771 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.5 pp -81.47 -26.47 35.23 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 120.177 -0.609 . . . . 73.23 111.229 -172.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 8.9 tmm_? -68.0 -43.46 78.82 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 110.257 -0.275 . . . . 71.42 110.257 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.67 -31.25 72.36 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.082 0.467 . . . . 73.24 110.422 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD2' HG22 ' A' ' 170' ' ' VAL . 80.5 t80 -79.27 -54.5 5.9 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.09 -0.505 . . . . 71.44 111.859 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -69.88 -24.54 63.43 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.621 0.6 . . . . 71.32 112.621 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG3' HD12 ' A' ' 131' ' ' ILE . 5.1 mt-10 -71.49 -16.59 62.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.844 0.354 . . . . 75.33 111.152 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.34 -25.79 68.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 75.1 111.074 172.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -87.79 -25.56 23.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.504 -0.316 . . . . 71.42 111.266 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 126' ' ' GLU . . . 168.51 -175.35 43.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.951 -0.642 . . . . 64.21 112.641 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.64 131.77 42.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.051 0.453 . . . . 73.32 111.905 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 152' ' ' THR . 76.4 mt -100.03 140.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.676 -0.693 . . . . 71.2 109.865 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -87.13 -51.13 6.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 64.42 110.269 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.16 156.79 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.93 -0.577 . . . . 72.15 109.76 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 122' ' ' ARG . 3.3 mp -115.63 128.93 72.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.745 -0.465 . . . . 75.14 109.745 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 35.5 mt-10 -102.13 104.44 15.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.95 -0.568 . . . . 74.13 110.729 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 145' ' ' LYS . 24.7 mm -93.31 131.58 39.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.341 -0.615 . . . . 75.43 109.341 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 48.8 mmm -105.14 132.7 51.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.517 -0.549 . . . . 74.2 109.517 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.89 139.98 32.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 60.04 111.597 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.1 127.28 32.28 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.258 -0.883 . . . . 73.2 109.531 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 -68.93 -39.17 79.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.409 -0.36 . . . . 63.54 111.871 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.98 -46.96 12.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.074 -0.584 . . . . 51.23 113.497 -173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.8 m -93.19 -22.88 18.78 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.727 0.299 . . . . 60.52 111.292 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.45 15.55 80.74 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.097 -0.573 . . . . 64.33 112.296 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -101.68 150.36 23.2 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.396 -0.594 . . . . 74.54 109.396 -178.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -75.83 83.66 2.77 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.317 -0.153 . . . . 65.31 110.784 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -160.18 172.71 16.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.871 0.843 . . . . 71.42 113.224 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.93 -44.19 1.53 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.562 -1.653 . . . . 45.32 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.98 155.23 3.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.165 -0.68 . . . . 74.42 109.165 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.04 172.67 12.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.973 -0.558 . . . . 75.5 109.635 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 54.1 m-85 -138.61 152.13 47.86 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.744 -0.662 . . . . 64.24 109.466 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.68 132.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.365 0.602 . . . . 33.43 111.069 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 131' ' ' ILE . 82.9 m -102.75 125.08 49.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.979 -1.01 . . . . 53.0 110.918 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -102.6 157.87 16.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.848 0.356 . . . . 74.13 111.578 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -76.47 -31.18 57.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.676 -0.693 . . . . 61.42 110.402 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.36 157.94 42.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.587 -0.733 . . . . 63.13 110.399 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -82.5 -22.89 34.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.076 -0.511 . . . . 73.11 109.859 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -53.08 -45.81 68.35 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.853 0.721 . . . . 71.44 111.25 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 162' ' ' ILE . 1.4 m -65.34 -35.29 80.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.783 -0.644 . . . . 74.52 110.836 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 107' ' ' ILE . 3.2 t -71.5 -38.61 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 109.795 -0.446 . . . . 71.22 109.795 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 163' ' ' VAL . 7.0 m-20 -65.92 -33.8 76.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.14 111.432 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 93.0 mttt -63.47 -38.4 91.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.417 0.627 . . . . 71.33 110.378 174.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 158' ' ' SER . 14.0 mt -78.1 -40.84 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.891 -1.05 . . . . 70.11 112.002 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 160' ' ' ASP . 35.1 m -79.14 -4.3 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.193 0.521 . . . . 72.4 111.177 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 13' ' ' LEU . 11.5 mt -62.86 -31.95 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.289 -0.869 . . . . 63.24 109.732 169.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 168' ' ' HIS . 51.5 mt-30 -108.39 153.1 23.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.886 -0.783 . . . . 73.1 108.886 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -91.49 -38.49 12.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.831 0.348 . . . . 71.34 111.244 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -125.56 137.12 53.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.369 -0.378 . . . . 74.13 110.242 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.575 ' NE2' ' HB2' ' A' ' 165' ' ' GLN . 39.2 m-70 -125.38 146.05 49.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.145 -0.479 . . . . 71.44 110.172 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.6 m -91.75 110.71 22.05 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.049 -0.523 . . . . 75.01 111.34 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.457 HG22 ' CD2' ' A' ' 124' ' ' TYR . 41.2 t -117.13 131.09 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.07 -0.715 . . . . 70.12 109.07 174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 46.99 42.59 12.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.45 0.7 . . . . 73.05 111.924 -174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.31 7.08 59.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.788 -0.642 . . . . 62.12 113.97 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -110.24 137.29 48.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.024 0.412 . . . . 75.33 110.16 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -89.39 108.95 19.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.037 0.446 . . . . 64.04 110.308 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 3.8 p -112.24 154.81 25.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.833 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.8 139.31 30.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.506 . . . . 63.33 109.988 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.8 m -130.11 155.3 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.997 0.427 . . . . 62.45 110.632 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -172.37 169.76 5.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.065 -0.97 . . . . 72.11 111.497 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -58.68 127.84 34.21 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.983 -0.553 . . . . 73.3 110.663 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -114.23 119.38 36.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.11 0.481 . . . . 70.31 109.884 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.8 mt -98.59 156.2 16.92 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.695 -0.684 . . . . 64.21 109.37 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.409 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 7.5 t -65.68 152.02 45.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.204 -1.036 . . . . 61.14 108.204 172.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -67.96 -19.09 64.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.596 0.236 . . . . 74.21 110.897 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 189' ' ' ALA . 0.8 OUTLIER -63.92 -41.59 97.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.61 -0.515 . . . . 65.42 109.61 171.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 5.1 mm-40 -74.47 -41.57 60.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.47 . . . . 63.24 109.888 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 74.7 mtp -66.41 -44.52 82.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 72.24 111.61 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -90.42 -6.28 55.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.882 -0.144 . . . . 62.32 111.309 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 t 60.0 29.08 18.67 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.308 0.643 . . . . 74.41 110.475 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 184' ' ' GLN . . . -161.93 162.89 29.29 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.37 -0.832 . . . . 63.54 109.399 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.1 m -64.03 116.53 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.243 0.339 . . . . 74.15 111.169 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.1 m -137.51 131.17 31.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.066 -0.516 . . . . 42.15 109.786 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 t -145.54 139.29 26.64 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.962 -0.295 . . . . 74.52 111.086 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -105.68 109.87 21.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.478 -0.564 . . . . 72.51 109.478 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -86.51 117.93 25.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.284 -0.416 . . . . 74.53 110.514 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -93.97 -165.43 36.84 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 111.48 -0.648 . . . . 73.34 111.48 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.159 -0.924 . . . . 63.4 110.868 -179.481 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.86 -0.496 . . . . 51.52 111.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -86.73 98.89 11.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 70.05 110.598 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -98.89 85.94 3.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.529 0.68 . . . . 75.33 110.171 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.55 17.7 9.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.778 -0.646 . . . . 60.51 110.446 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -66.86 -39.55 87.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 74.34 110.405 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m 70.9 124.78 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 O-C-N 124.137 0.898 . . . . 73.05 110.105 -174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.14 150.18 89.35 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.742 2.294 . . . . 63.52 113.041 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -116.96 -1.5 11.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.893 -1.151 . . . . 71.44 107.893 177.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp0 -93.59 141.66 24.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.407 -1.27 . . . . 72.31 111.029 -172.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HD2' HD22 ' A' ' 13' ' ' LEU . 30.8 Cg_endo -67.44 167.77 19.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.904 2.403 . . . . 64.33 110.778 174.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -57.36 -37.41 72.57 Favored 'General case' 0 C--O 1.217 -0.658 0 N-CA-C 111.698 0.259 . . . . 75.11 111.698 -175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -67.22 -27.86 67.59 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.891 0.33 . . . . 75.1 111.891 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 10' ' ' PRO . 3.2 mp -82.42 -9.79 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.385 . . . . 75.12 111.087 -177.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.449 ' HA ' HG21 ' A' ' 68' ' ' VAL . 14.2 ptt180 -123.13 -0.66 8.86 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.463 -0.335 . . . . 74.44 111.129 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 34.5 ttpt -91.66 145.92 24.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.116 0.484 . . . . 71.14 111.571 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD11 HG13 ' A' ' 68' ' ' VAL . 3.9 mp -123.52 145.68 48.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.196 -0.911 . . . . 63.34 110.136 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -96.96 117.68 31.7 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.436 -0.579 . . . . 75.24 109.436 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 60' ' ' VAL . 20.3 mm -94.34 113.12 28.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.956 -0.387 . . . . 71.13 109.956 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.35 150.41 16.84 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.738 -0.744 . . . . 24.53 111.79 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.7 45.22 29.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.89 -0.672 . . . . 62.22 113.381 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 25' ' ' THR . 79.4 mt -81.85 176.72 9.35 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.167 0.483 . . . . 73.43 110.819 174.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -86.24 178.64 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.965 -0.561 . . . . 62.42 109.542 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -84.19 -6.34 59.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.051 0.453 . . . . 72.42 110.534 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.27 20.05 15.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 64.14 111.061 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.458 HG21 HD22 ' A' ' 21' ' ' LEU . 9.6 m -81.53 129.4 34.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 75.12 110.405 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.5 p -117.96 160.19 21.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.734 -0.666 . . . . 75.31 109.377 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.93 -42.94 76.89 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.561 0.538 . . . . 75.2 111.108 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.67 -30.52 71.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.191 -0.459 . . . . 72.22 111.581 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 m -86.28 -42.07 14.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.62 -0.264 . . . . 72.24 111.077 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.24 -50.07 67.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.257 -0.429 . . . . 73.22 110.528 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -56.42 -58.2 9.01 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.692 -0.686 . . . . 74.31 111.598 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -48.8 -34.22 11.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.561 0.538 . . . . 71.25 112.357 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -74.06 -49.6 23.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.431 -0.349 . . . . 73.2 110.99 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -78.18 -18.82 55.04 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.193 -0.317 . . . . 71.33 111.758 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 23.7 mt-10 -56.6 -22.68 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.111 -0.495 . . . . 73.02 112.222 172.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -65.65 -22.15 66.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 74.55 111.951 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -102.97 -24.04 13.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.665 0.269 . . . . 74.51 111.244 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -173.45 161.59 32.39 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.356 -0.926 . . . . 75.13 112.475 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -57.59 141.7 47.14 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.874 0.469 . . . . 71.21 111.552 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 62' ' ' TYR . 63.3 mt -120.23 124.72 46.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.31 -0.626 . . . . 71.5 109.31 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 t -97.94 -20.45 17.44 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.045 -0.525 . . . . 72.01 110.621 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -149.94 152.77 35.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.633 -0.506 . . . . 75.54 109.633 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -165.45 137.08 4.03 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.084 -0.71 . . . . 55.21 109.084 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.34 132.68 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.053 0.454 . . . . 72.4 110.727 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.11 131.28 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.269 -0.641 . . . . 61.41 109.269 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 mmt -73.65 133.2 43.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.952 -0.759 . . . . 65.41 108.952 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -139.95 158.17 44.5 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.892 -0.595 . . . . 75.33 110.928 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 22.2 t70 -67.22 129.49 93.81 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 114.778 -1.101 . . . . 64.4 109.646 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.59 -22.34 33.02 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.186 1.924 . . . . 70.02 113.364 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -55.19 4.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.925 0.393 . . . . 74.23 111.585 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.7 m -103.43 -8.87 19.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.504 . . . . 74.22 111.734 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 48' ' ' ASP . 36.9 mmtm 63.28 35.31 12.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.331 0.652 . . . . 74.24 111.758 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -101.48 158.75 15.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.031 -1.099 . . . . 74.24 108.031 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -70.31 140.43 52.27 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.092 0.472 . . . . 65.32 110.58 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -84.67 5.87 26.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.681 -0.69 . . . . 45.22 110.485 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.39 16.52 71.14 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.628 -0.796 . . . . 22.44 113.605 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -160.3 157.78 28.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.014 0.907 . . . . 65.43 110.954 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.08 -163.81 15.7 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.446 -0.661 . . . . 73.25 111.446 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -142.99 148.71 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.187 0.493 . . . . 61.22 110.611 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.457 HG22 HD11 ' A' ' 18' ' ' ILE . 6.4 m -130.65 126.32 60.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.907 -0.588 . . . . 72.12 109.739 172.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 m -101.28 118.01 36.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.444 -0.344 . . . . 62.43 110.166 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' HA ' HD23 ' A' ' 40' ' ' LEU . 19.4 m-85 -84.6 165.15 18.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 74.45 109.856 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.41 63.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.37 -0.377 . . . . 74.24 110.675 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 1.9 m -132.94 154.01 50.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.309 -0.405 . . . . 74.11 110.253 -177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.8 p -64.88 -33.54 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.736 -0.211 . . . . 63.22 111.548 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -59.61 -34.08 72.3 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.38 0.511 . . . . 74.12 112.38 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 5.5 mm-40 -64.94 -33.79 76.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.303 0.573 . . . . 70.12 109.791 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.654 HG13 HD11 ' A' ' 16' ' ' LEU . 2.4 t -62.61 -46.97 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 71.11 111.125 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.3 -45.51 92.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 72.35 111.075 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . . . -57.15 -38.4 73.47 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.332 0.493 . . . . 75.34 112.332 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.3 83.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 74.51 110.451 177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 mmt -69.27 -35.18 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.698 . . . . 63.2 110.974 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.655 ' ND2' ' HA ' ' A' ' 70' ' ' ALA . 5.9 p30 -84.84 -7.06 59.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.384 . . . . 51.23 111.515 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.27 -11.08 20.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.461 . . . . 62.42 110.606 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' CG ' ' HA ' ' A' ' 76' ' ' PRO . 10.2 ttp180 -53.2 143.63 32.95 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.009 -0.996 . . . . 71.23 110.855 175.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HA ' ' CG ' ' A' ' 75' ' ' ARG . 4.8 Cg_exo -79.71 169.86 69.13 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 124.954 -0.853 . . . . 65.13 114.054 2.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -128.22 161.16 29.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 61.14 109.773 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 22.5 ttmt -134.3 104.66 6.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.909 0.385 . . . . 72.55 111.38 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.63 126.37 59.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 62.13 110.137 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.9 t70 63.22 40.38 8.84 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.54 0.686 . . . . 73.12 110.756 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.56 27.78 73.37 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.885 -0.598 . . . . 63.2 112.785 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 13.0 tpt180 -132.44 140.22 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 64.55 110.002 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 t -78.28 110.03 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.278 -0.638 . . . . 75.52 109.278 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 21' ' ' LEU . 3.0 m -104.96 150.04 8.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.408 0.623 . . . . 64.21 110.575 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.43 ' HG2' HH11 ' A' ' 75' ' ' ARG . 7.3 tt0 -117.74 96.11 48.96 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.292 -0.867 . . . . 72.45 110.853 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -69.14 130.83 20.82 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.456 1.437 . . . . 63.33 110.433 171.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 25.4 mttt -128.35 -179.56 5.09 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.295 -0.866 . . . . 75.52 108.837 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' HB3' ' OD2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -77.95 155.08 31.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.795 -0.446 . . . . 72.11 109.795 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.31 96.89 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 74.21 110.351 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.555 ' HB ' ' OD1' ' A' ' 160' ' ' ASP . 8.1 p -72.78 157.92 6.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.243 -0.89 . . . . 64.53 110.655 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.72 142.8 27.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.356 -0.609 . . . . 55.01 109.356 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -62.34 -17.41 58.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.803 0.335 . . . . 74.4 111.246 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.85 -48.33 74.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.864 -0.607 . . . . 74.21 110.616 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.634 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 25.3 t70 -84.16 -13.78 51.95 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.88 -0.6 . . . . 34.11 110.455 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.6 t -73.74 8.63 1.82 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.975 0.416 . . . . 65.34 110.956 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -88.38 -18.23 28.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.908 -0.587 . . . . 75.53 111.262 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 19.6 mmt180 -61.38 148.94 84.78 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 110.127 -0.323 . . . . 74.12 110.127 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -65.61 112.95 2.32 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.49 1.46 . . . . 54.23 110.343 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.7 48.98 46.27 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.695 -0.764 . . . . 74.34 111.465 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.01 -31.31 70.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.904 0.383 . . . . 70.04 111.186 -178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -98.73 21.39 11.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 64.13 111.332 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.0 mt -76.88 177.58 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.988 -0.745 . . . . 74.25 108.988 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -81.92 78.31 8.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.471 0.653 . . . . 71.2 110.384 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.61 109.01 22.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.105 -0.952 . . . . 75.1 110.377 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.433 ' C ' HG21 ' A' ' 159' ' ' VAL . 53.5 mttt -107.36 20.99 18.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.998 0.428 . . . . 73.33 110.264 175.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.99 139.62 53.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.398 -0.364 . . . . 75.33 110.713 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.552 HG23 HG13 ' A' ' 159' ' ' VAL . 5.5 pt -131.91 152.47 36.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.217 0.532 . . . . 61.41 111.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 6.3 t80 -99.34 131.84 45.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.92 -1.036 . . . . 73.24 109.452 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.45 110.21 27.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.352 -0.61 . . . . 70.42 109.352 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.43 16.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.75 -1.214 . . . . 60.33 113.825 -173.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.5 43.35 2.96 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.187 -0.53 . . . . 74.44 112.556 174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 173' ' ' HIS . 22.1 pt -120.92 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.467 0.651 . . . . 74.54 110.857 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -54.24 3.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.437 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.93 170.54 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.436 0.46 . . . . 54.33 110.434 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -71.77 84.85 0.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.578 0.584 . . . . 72.31 112.578 -170.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -83.87 131.63 34.86 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.938 -0.574 . . . . 61.3 109.475 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.53 165.44 11.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.377 -0.829 . . . . 74.01 110.546 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.26 -45.68 72.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.286 -0.87 . . . . 73.24 109.858 175.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -55.91 -38.65 70.53 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.766 0.666 . . . . 75.23 111.541 -178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.16 -59.09 5.97 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.299 -0.409 . . . . 74.31 111.579 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.05 -29.17 32.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.855 -0.738 . . . . 71.11 111.206 -172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 5.7 tmm_? -63.51 -53.34 53.5 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.468 0.175 . . . . 74.21 110.698 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.12 -26.25 68.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.152 0.501 . . . . 75.12 110.729 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -78.19 -56.66 4.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.8 -0.636 . . . . 71.54 111.82 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 41.7 m-85 -66.85 -24.07 66.1 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 111.983 0.364 . . . . 73.21 111.983 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 122' ' ' ARG . 2.9 mt-10 -70.33 -20.66 62.98 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.71 0.291 . . . . 75.3 111.501 -177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -56.05 -30.34 61.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.1 111.35 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.14 -29.17 23.49 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.416 -0.357 . . . . 64.32 111.779 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 175.89 -174.17 46.72 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.808 -0.711 . . . . 52.44 113.213 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -79.23 137.54 37.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.84 0.353 . . . . 72.12 111.248 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 152' ' ' THR . 73.6 mt -108.87 140.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 74.52 110.175 178.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.23 -48.33 7.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.495 -0.321 . . . . 75.04 110.922 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.9 p -157.3 156.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 74.15 110.236 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.1 129.26 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.058 0.456 . . . . 42.4 110.021 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.4 mt-10 -104.57 104.41 14.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.503 -0.771 . . . . 75.12 110.945 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.23 120.04 43.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.184 -1.043 . . . . 61.53 108.184 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 77.9 mmm -86.32 107.44 17.98 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.707 -0.397 . . . . 35.15 110.441 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.0 163.51 24.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.758 -0.655 . . . . 61.3 110.946 -178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -94.89 133.98 38.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 75.53 109.373 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -65.94 -39.76 90.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.294 0.479 . . . . 74.43 112.294 -176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.14 -52.73 4.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.213 -0.994 . . . . 51.33 113.49 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.5 p -90.35 -19.72 23.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.64 0.257 . . . . 74.24 111.672 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.72 81.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.889 -0.672 . . . . 74.33 112.475 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -87.73 138.12 31.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 60.23 110.371 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -71.48 143.36 50.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.767 -0.651 . . . . 72.34 109.786 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -82.27 13.69 3.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.189 -0.459 . . . . 75.23 112.109 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.45 1.47 87.85 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.979 -0.629 . . . . 60.45 113.62 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -158.83 167.65 28.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 117.075 0.437 . . . . 73.5 109.97 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.85 171.57 14.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.561 -0.745 . . . . 75.52 109.755 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 52.2 m-85 -136.18 151.08 49.35 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.487 -0.779 . . . . 70.44 109.09 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 130.51 25.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.513 0.673 . . . . 73.24 111.012 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 131' ' ' ILE . 54.0 m -99.41 122.09 42.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.839 -1.073 . . . . 73.4 110.701 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 125' ' ' PHE . 4.8 m-85 -98.03 160.16 14.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.912 0.387 . . . . 71.21 111.321 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.95 -29.94 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.64 . . . . 55.14 110.185 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.28 151.8 50.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 71.41 111.092 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -78.94 -29.89 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 63.4 111.156 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -59.38 -44.26 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.923 -0.58 . . . . 75.54 110.988 -175.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -33.16 75.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.807 -0.633 . . . . 63.53 111.515 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.552 HG13 HG23 ' A' ' 107' ' ' ILE . 1.1 t -71.55 -39.37 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.961 0.41 . . . . 64.35 110.09 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.555 ' OD1' ' HB ' ' A' ' 90' ' ' VAL . 13.2 t70 -68.55 -34.59 76.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 73.21 110.709 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 157' ' ' ASP . 84.8 mttt -56.11 -38.96 71.48 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.633 0.73 . . . . 72.31 110.777 173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 21.5 mt -75.87 -42.29 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.419 -1.264 . . . . 65.14 112.235 -175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 160' ' ' ASP . 20.3 m -76.36 -10.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.351 0.596 . . . . 73.4 110.753 -173.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.9 mt -61.1 -27.94 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.073 -0.967 . . . . 63.11 110.126 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 168' ' ' HIS . 45.9 mt-30 -112.7 103.75 11.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.712 -0.847 . . . . 74.31 108.712 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -57.2 -35.33 69.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.846 -0.615 . . . . 75.34 112.627 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -123.61 134.53 53.78 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.304 . . . . 64.12 110.609 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 165' ' ' GLN . 89.2 m-70 -121.12 153.74 37.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 73.13 110.029 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -122.76 113.7 19.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.044 0.449 . . . . 64.3 110.469 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.6 p -127.67 119.87 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.705 -0.68 . . . . 74.34 110.37 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 71.67 29.49 2.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.045 0.926 . . . . 70.2 109.059 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.11 -6.53 79.0 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.102 -0.953 . . . . 73.03 112.534 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 112' ' ' ILE . 70.5 t60 -102.49 133.86 46.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.785 0.326 . . . . 73.55 110.604 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.55 141.31 30.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.038 0.447 . . . . 64.03 110.714 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 6.0 p -143.06 148.34 36.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 54.31 110.311 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -91.16 129.79 37.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.421 -0.585 . . . . 72.41 109.421 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 16.1 t -128.53 133.59 66.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.241 0.543 . . . . 65.4 110.554 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -155.56 172.99 17.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.399 -0.819 . . . . 63.41 110.466 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -58.86 133.19 55.79 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.278 0.361 . . . . 62.51 111.175 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -116.45 114.71 24.61 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.813 -0.81 . . . . 72.01 108.813 173.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.68 163.44 13.19 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.499 -0.773 . . . . 70.13 110.303 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.589 ' HB3' ' OE1' ' A' ' 185' ' ' GLU . 19.1 t -57.52 154.05 11.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.222 -0.659 . . . . 64.35 109.222 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -67.1 -24.54 65.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.49 0.552 . . . . 74.42 112.49 -171.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -70.61 -32.21 69.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 73.22 109.839 173.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.589 ' OE1' ' HB3' ' A' ' 182' ' ' SER . 1.8 mp0 -74.78 -36.77 62.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.758 -0.655 . . . . 70.4 110.172 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.5 mmt -72.93 -50.94 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.431 -0.804 . . . . 71.12 111.673 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.13 -18.73 31.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.35 -0.386 . . . . 41.13 111.589 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.2 m 64.58 16.62 10.42 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.383 0.673 . . . . 75.05 111.592 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -170.84 175.86 4.34 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.019 -0.537 . . . . 74.22 110.012 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.3 m -78.61 108.13 11.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.217 -0.66 . . . . 60.51 109.217 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.9 m -124.12 128.69 49.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.304 -0.407 . . . . 70.51 111.025 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 21.5 t -70.79 153.18 43.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.889 -0.596 . . . . 75.15 110.099 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.43 129.86 39.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 72.13 111.119 -175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -74.55 99.45 3.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.64 -0.709 . . . . 64.34 109.921 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.95 -157.29 52.36 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.992 -0.623 . . . . 64.14 111.668 -176.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.776 -0.631 . . . . 73.35 110.013 177.035 . . . . . . . . 0 0 . 1 stop_ save_